Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 1678.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1319.0;Endothelial cells: 797.7;Hepatic stellate cells: 526.1;Hepatocytes: 910.1;Horizontal cells: 681.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.5"	"Group enriched"	"Detected in some"	5	"AF22: 772.0;ASC diff: 223.5;Hep G2: 649.8;SK-MEL-30: 230.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	NA	NA	1630000000000	170000000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	451.5	182.3	157.5	149.8	158.5	5.6	295.3	169.3	223.5	227.2	163.3	257.0	141.2	306.2	244.1	218.3	228.4	452.4	312.8	149.8	175.0	311.4	1250.0	1678.3	98.2	192.9	167.6	101.7	91.5	153.7	135.3	445.2	193.0	293.8	316.3	129.9	131.8	226.7	147.8	71.5	182.7	520.0	196.2	240.6	171.6	58.9	190.7	53.9	202.7	285.6	59.2	847.0	160.2	192.7	0.3	0.0	772.0	0.0	223.5	16.2	2.0	93.1	25.5	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	10.1	649.8	0.0	0.8	0.8	36.9	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.2	2.0	3.3	0.0	0.1	1.8	0.9	0.8	0.0	0.3	0.3	0.7	1.8	0.0	230.1	3.2	0.0	0.3	0.3	0.1	6.7	1.5	0.5	0.7	0.3	0.7	0.2	0.5	15.4	0.0	0.1	0.0	1.5	0.0	0.8	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	157.5	158.5	169.3	223.5	149.8	175.0	192.9	167.6	193.0	196.2	190.7	192.7	1319.0	12.8	85.6	5.2	9.0	19.5	2.3	0.0	12.0	5.5	10.8	95.5	106.1	22.8	6.8	1.8	8.4	2.5	8.1	0.0	0.0	0.2	18.8	8.3	54.7	797.7	0.0	45.9	3.2	5.5	2.9	241.3	9.2	14.7	27.8	2.5	526.1	910.1	233.0	681.4	2.9	0.0	0.0	123.1	41.4	36.8	77.3	130.7	23.2	355.1	37.8	6.1	1.0	5.5	4.7	0.2	0.0	141.4	11.2	4.7	0.0	0.3	4.4	21.2	335.2	22.1	328.0	2.7	8.8	8.2	14.1	4.1	13.0	73.3	0.0	3.6
A4GALT	"A14GALT, Gb3S, P(k), P1"	ENSG00000128274	"Alpha 1,4-galactosyltransferase (P blood group)"	Q9NPC4	22	42692121-42721298	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 70.7;Proximal tubular cells: 91.0;Urothelial cells: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.7;ASC TERT1: 31.3;RPTEC TERT1: 27.1;TIME: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001141			Uncertain	Mitochondria		NA	NA		22000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA001141: AB_1078139"	"unprognostic (2.59e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.24e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.74e-1)"	41.5	14.3	6.2	6.1	6.0	4.1	31.3	5.0	8.0	29.6	8.0	30.9	4.5	28.1	3.3	30.6	29.2	4.4	77.0	6.2	5.3	51.3	4.3	26.0	6.8	7.8	5.8	7.8	6.2	1.2	16.7	9.1	5.6	35.1	1.7	0.3	36.1	21.3	19.4	20.8	18.2	6.9	6.0	16.2	26.6	6.2	7.1	1.6	25.1	6.3	5.1	38.1	38.2	6.0	1.2	13.6	0.0	0.0	38.7	31.3	20.1	5.5	5.8	1.2	2.1	4.3	2.2	13.6	9.4	9.7	6.7	1.3	12.9	6.5	0.2	0.0	2.7	0.3	21.1	0.5	11.5	0.0	0.9	18.6	1.8	5.5	0.9	1.8	4.7	0.0	0.1	0.0	5.1	19.0	0.0	0.0	1.6	0.9	3.3	0.0	3.0	1.4	27.1	23.4	0.2	0.0	16.9	0.3	0.0	2.4	10.6	1.6	29.3	0.0	2.6	24.3	7.3	2.8	13.1	0.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	6.2	6.0	5.0	8.0	6.2	5.3	7.8	5.8	5.6	6.0	7.1	6.0	47.1	0.0	0.5	0.3	1.6	9.2	28.9	70.7	0.0	0.1	4.2	1.5	15.8	1.5	41.2	18.4	0.0	48.7	0.4	0.2	13.7	23.1	0.7	11.1	10.3	43.7	0.0	10.7	0.1	1.1	35.3	43.8	2.6	17.4	1.3	0.2	30.7	0.2	5.3	0.0	0.1	0.0	14.2	1.0	11.8	4.4	46.3	4.0	7.2	7.5	30.0	0.8	0.0	0.5	0.0	3.6	0.0	30.1	0.1	40.1	0.0	91.0	12.1	0.6	39.5	7.6	29.3	0.6	0.6	1.2	8.8	9.4	1.5	19.9	0.1	74.7
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 89.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 777.7;Rod photoreceptor cells: 640.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebral cortex: 31.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	9.1	12.6	0.3	8.1	0.6	12.0	8.1	0.9	31.0	7.1	0.0	7.0	4.6	9.9	9.9	7.4	7.5	5.4	20.4	2.9	0.0	10.5	5.1	10.3	9.0	4.7	2.9	5.5	13.1	89.7	13.7	9.9	3.5	8.6	6.3	28.2	6.7	8.2	13.0	6.3	8.5	7.6	0.0	8.6	12.6	6.7	4.8	13.2	23.4	6.7	7.7	7.8	7.1	4.8	25.1	15.3	14.6	12.3	13.7	14.3	41.0	19.4	16.8	12.0	11.3	15.6	10.0	0.9	4.6	27.6	16.5	11.4	11.7	11.4	27.1	20.6	4.4	13.3	9.0	10.0	11.7	9.5	31.3	12.9	9.6	23.7	30.9	10.2	27.4	12.3	3.2	14.1	22.5	3.7	8.8	5.6	6.4	4.9	8.3	5.8	13.8	2.2	10.0	51.0	4.2	6.6	12.0	8.8	10.2	9.9	5.3	12.9	25.6	26.4	17.5	19.7	19.4	12.9	3.9	1.5	23.0	16.0	19.1	1.4	0.5	0.2	1.4	0.2	1.4	0.1	1.3	1.0	0.3	0.3	1.7	1.5	1.5	1.1	2.2	0.2	1.0	0.5	0.3	0.6	0.9	31.0	2.9	0.0	4.7	2.9	3.5	0.0	4.8	4.8	54.6	35.3	34.2	77.7	13.4	15.9	20.8	15.9	32.5	254.4	42.2	40.9	86.7	102.9	19.3	143.5	777.7	81.6	149.1	130.6	43.0	46.0	23.9	36.6	67.4	56.0	72.1	35.3	265.8	67.4	56.3	29.5	44.9	65.7	21.0	24.4	118.2	38.2	62.4	306.2	327.7	31.6	12.2	128.8	23.5	32.7	38.2	67.1	10.6	156.4	72.7	53.2	252.4	147.8	113.9	55.9	76.3	46.6	57.4	42.1	56.0	90.0	10.7	640.8	19.7	26.7	45.5	46.9	59.3	23.3	9.9	213.3	158.1	33.6	21.7	49.0
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.9;kidney: 133.3;liver: 345.6;pancreas: 138.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	3.3	27.7	94.6	4.7	105.4	2.2	5.1	85.2	103.4	3.8	70.7	7.6	43.6	3.8	9.6	7.7	6.2	4.4	14.1	90.2	120.7	133.3	345.6	4.5	5.0	90.8	107.4	10.5	138.3	8.2	55.8	3.4	137.6	21.7	7.8	29.6	6.5	3.5	1.6	2.7	20.1	2.7	88.1	4.1	7.4	13.4	137.9	4.2	29.3	1.4	5.9	9.9	4.1	70.9	0.7	0.2	32.1	18.7	5.0	1.7	2.0	4.2	2.2	1.8	0.7	12.7	0.9	4.0	1.4	2.3	1.2	8.3	2.1	7.7	2.4	2.3	2.1	5.5	0.1	127.5	8.1	1.3	8.3	6.5	3.4	3.2	1.4	0.9	0.6	10.7	1.1	2.6	0.6	81.9	2.1	0.6	2.8	23.2	0.3	9.7	67.4	1.8	1.2	20.9	5.1	15.7	1.9	1.0	0.2	6.2	42.6	3.4	0.6	0.8	5.7	2.7	0.1	3.0	0.3	0.8	0.8	5.7	4.2	0.7	1.9	2.7	1.5	2.2	0.7	0.6	1.0	1.1	1.2	1.2	0.7	1.1	6.1	1.2	4.2	0.2	1.1	1.2	94.6	105.4	85.2	103.4	90.2	120.7	90.8	107.4	137.6	88.1	137.9	70.9	1.7	0.0	6.9	39.5	6.1	1.5	4.0	3.3	2.2	27.3	9.1	5.0	10.8	20.0	5.8	1.8	4.2	1.4	5.3	8.9	23.5	1.6	13.0	12.9	6.2	2.4	15.6	13.9	41.8	6.2	1.5	3.2	5.6	12.9	1.3	59.5	7.1	268.2	5.2	35.3	95.0	3.9	2.0	15.7	7.4	8.7	3.7	8.2	1.8	19.7	6.5	48.6	9.2	76.9	17.7	6.8	6.1	4.5	1.0	7.4	15.7	94.9	3.6	5.8	0.0	4.3	3.8	3.7	0.9	9.5	0.6	1.4	6.3	2.3	6.9	5.0
ABCA10	EST698739	ENSG00000154263	"ATP binding cassette subfamily A member 10"	Q8WWZ4	17	69147214-69244846	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"ovary: 18.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 231.0;Excitatory neurons: 91.9;Fibroblasts: 64.3;Inhibitory neurons: 112.4;Late spermatids: 93.1;Microglial cells: 187.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.3;HUVEC TERT2: 1.3;RT4: 1.3;U-2197: 2.1"									HPA014535	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA014535: AB_1844426"	"unprognostic (1.45e-4)"	"unprognostic (3.17e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.91e-1)"	"unprognostic (2.70e-4)"	"unprognostic (5.23e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.86e-3)"	8.7	1.7	2.2	0.0	3.1	0.0	10.4	4.8	6.6	4.1	2.4	2.8	1.1	3.2	2.6	2.7	12.7	3.5	7.2	2.9	2.3	1.8	4.5	3.0	0.6	4.0	2.3	18.3	2.7	0.4	2.6	0.2	4.7	2.2	4.0	3.4	5.6	0.6	6.4	4.6	3.0	1.9	1.6	1.1	2.4	3.5	3.8	0.8	5.5	2.3	0.7	3.2	4.2	3.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	1.3	0.2	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.1	4.8	6.6	2.9	2.3	4.0	2.3	4.7	1.6	3.8	3.8	4.3	0.0	3.2	2.6	0.3	1.0	0.5	1.1	1.2	6.7	1.8	2.3	3.9	1.5	0.2	0.0	25.0	0.0	1.2	6.9	0.0	0.6	231.0	2.1	0.7	1.9	4.9	0.0	91.9	0.2	0.0	64.3	2.0	3.3	0.0	6.9	0.4	1.8	0.1	0.0	112.4	3.7	0.0	0.0	3.3	93.1	51.0	1.0	1.8	187.4	1.6	1.9	4.1	26.2	13.5	0.4	0.4	11.7	0.7	0.3	5.6	0.5	3.1	9.0	0.0	6.1	4.5	8.1	2.6	1.1	0.4	0.0	0.6	18.9	0.7	0.5
ABCA9	EST640918	ENSG00000154258	"ATP binding cassette subfamily A member 9"	Q8IUA7	17	68974488-69060949	"Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 55.5;Fibroblasts: 86.6;Inhibitory neurons: 73.2;Leydig cells: 96.3;Microglial cells: 227.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 21.8;ASC TERT1: 47.7;HSkMC: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052113, HPA054823"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA052113: AB_2732573, HPA054823: AB_2682615"	"unprognostic (3.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.51e-4)"	"unprognostic (1.83e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.77e-6)"	"unprognostic (5.32e-4)"	"unprognostic (7.22e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-3)"	33.7	4.1	2.8	1.4	5.1	1.8	22.3	7.7	8.0	14.7	6.3	12.4	1.8	11.2	8.9	4.8	20.6	8.2	22.6	3.0	1.4	2.7	11.9	8.8	2.3	3.1	1.2	27.4	3.5	2.3	4.9	1.2	4.5	3.3	4.0	8.4	9.0	2.8	13.1	9.2	6.6	6.6	1.2	1.6	7.8	5.2	3.5	2.5	11.1	10.6	1.1	10.9	12.7	7.7	0.2	0.4	0.8	0.8	21.8	47.7	0.6	0.4	0.4	0.0	0.4	0.5	0.5	0.6	0.2	0.8	0.3	0.5	0.4	0.7	0.2	0.3	0.4	0.6	2.4	0.6	2.3	0.9	1.3	17.0	0.5	3.6	0.3	0.9	4.8	0.6	0.8	1.3	0.1	0.3	0.3	2.1	0.3	0.2	0.4	2.2	0.1	0.3	0.3	1.9	0.7	0.6	0.5	0.3	0.3	0.4	0.4	0.8	2.0	1.3	0.5	2.3	0.5	1.0	0.5	0.4	0.4	0.5	2.4	0.5	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.2	0.4	0.2	0.0	0.1	0.0	0.0	2.8	5.1	7.7	8.0	3.0	1.4	3.1	1.2	4.5	1.2	3.5	7.7	7.4	0.0	1.5	2.6	0.5	1.8	0.3	0.1	1.2	3.9	0.7	0.8	3.9	1.5	0.1	0.0	0.0	0.0	0.6	0.9	0.0	0.1	1.3	0.4	2.1	2.6	0.0	0.0	55.5	0.0	0.0	86.6	2.0	1.4	0.0	2.2	18.5	11.4	0.3	0.0	73.2	0.1	0.0	1.3	5.1	3.6	96.3	4.9	0.0	227.7	0.0	7.9	1.0	6.0	10.9	0.2	0.0	15.4	0.2	0.1	0.3	0.0	1.7	5.6	13.1	26.3	7.1	1.3	0.8	1.3	1.6	0.0	0.5	26.3	0.1	0.3
ABHD1	"FLJ36128, LABH1"	ENSG00000143994	"Abhydrolase domain containing 1"	Q96SE0	2	27123789-27130812	"Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 21.6"	"Group enriched"	"Detected in many"	9	"Early spermatids: 295.1;Late spermatids: 1030.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.5;T-47d: 3.3;U-266/70: 3.0;U-266/84: 2.8"					"Low region specificity"	"Detected in all"			HPA044390	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044390: AB_10959380"	"unprognostic (1.20e-3)"	"unprognostic (6.07e-3)"	"unprognostic (7.71e-4)"	"unprognostic (1.63e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.09e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.09e-2)"	"unprognostic (7.97e-2)"	1.2	0.6	0.8	0.1	0.7	0.0	0.5	1.5	1.1	0.1	0.3	0.1	0.0	0.3	0.4	0.1	0.2	0.2	0.5	0.7	0.8	0.3	3.3	0.1	0.2	0.9	0.7	0.4	0.1	0.4	0.2	0.0	0.9	0.7	0.0	0.4	1.5	0.2	1.9	0.0	0.1	0.3	0.9	0.1	0.2	21.6	0.9	0.0	0.4	1.7	0.1	0.0	0.0	0.9	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.2	3.0	2.8	0.0	0.1	0.1	0.1	0.0	0.2	0.8	0.6	0.0	0.2	0.5	0.3	0.3	0.0	0.3	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.8	0.7	1.5	1.1	0.7	0.8	0.9	0.7	0.9	0.9	0.9	0.9	0.8	0.0	0.0	4.9	1.0	0.0	3.3	0.0	2.8	5.1	1.9	2.8	3.1	1.5	0.0	0.0	8.4	0.2	0.9	0.2	0.0	0.3	295.1	0.4	0.6	1.9	0.0	3.2	0.6	0.2	0.0	1.3	0.0	0.5	1.3	1.6	2.5	3.9	0.1	0.0	0.8	0.2	0.0	0.3	0.3	1030.5	6.5	1.2	0.0	1.9	0.5	8.1	3.1	2.0	2.2	0.0	0.0	5.7	0.5	3.6	0.2	3.0	0.7	4.9	0.0	2.4	1.2	70.5	3.9	0.3	0.3	0.0	1.8	0.3	0.2	2.2
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12, lysophospholipase"	Q8N2K0	20	25294742-25390835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease variant, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 315.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA026866: AB_1844446"	"prognostic unfavorable (3.81e-5)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	29.5	33.0	55.7	27.4	67.3	26.5	26.9	70.0	64.7	32.1	35.9	37.0	47.0	25.3	133.1	50.0	24.8	33.4	30.5	77.3	58.2	45.5	29.8	32.6	30.8	70.9	64.6	30.6	117.8	55.3	42.1	29.6	73.3	35.5	36.4	30.8	36.9	39.9	13.3	52.4	52.8	23.6	66.0	22.0	55.0	19.2	71.8	23.4	80.8	14.8	41.5	37.2	35.1	96.9	67.2	148.3	41.6	50.9	79.6	47.1	93.3	97.0	84.5	73.7	84.6	90.1	93.0	21.8	53.3	77.0	155.1	116.5	44.4	56.8	62.8	22.7	41.9	33.3	46.8	128.4	59.3	33.3	71.6	58.7	42.0	85.4	44.1	95.7	33.2	37.8	25.8	315.3	72.8	142.5	51.8	31.0	29.4	77.8	96.8	39.2	95.3	195.0	43.4	145.7	46.6	39.7	75.4	198.9	133.8	72.3	67.4	47.6	44.6	98.3	63.0	57.1	54.0	38.8	36.1	33.4	61.8	38.7	57.3	15.8	18.8	17.3	9.9	17.0	7.5	3.8	10.2	13.7	17.9	5.1	8.9	8.9	3.6	15.4	17.7	17.0	10.4	8.6	55.7	67.3	70.0	64.7	77.3	58.2	70.9	64.6	73.3	66.0	71.8	96.9	20.7	6.4	6.5	19.2	13.8	17.7	32.0	9.8	19.4	34.5	19.6	19.7	16.6	30.0	13.7	27.6	10.4	91.6	22.2	97.0	27.4	33.7	53.0	24.9	18.1	17.5	34.0	14.5	37.7	34.3	95.2	22.9	35.2	28.3	10.2	26.9	15.0	19.5	114.1	42.1	46.0	28.9	20.3	37.8	43.8	107.1	16.1	62.4	33.8	42.2	58.7	44.1	23.7	50.8	67.5	22.9	77.7	20.7	39.3	31.6	126.7	24.6	13.1	23.3	26.3	13.8	19.5	19.9	37.7	27.2	18.3	130.8	18.0	19.6	33.3	35.2
ABHD16A	"BAT5, D6S82E, NG26"	ENSG00000204427	"Abhydrolase domain containing 16A, phospholipase"	O95870	6	31686955-31703356	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.2;OE19: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058606	Approved					NA	NA		37000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA058606: AB_2683774"	"unprognostic (1.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.60e-3)"	16.2	22.1	1.1	11.7	1.3	6.7	13.3	1.2	4.1	20.5	0.9	20.9	0.0	21.5	19.0	21.1	18.9	9.9	17.4	1.2	1.2	17.0	30.0	16.0	13.0	1.6	2.0	15.0	18.7	5.8	40.0	7.9	1.4	19.6	7.3	6.7	17.4	4.2	35.0	12.9	17.6	0.0	1.5	18.5	21.5	31.6	1.5	4.5	21.3	0.0	0.0	20.7	15.0	1.5	0.0	15.7	0.0	41.2	29.0	11.7	0.0	14.5	16.2	16.5	15.6	0.0	26.1	16.5	33.7	21.2	0.0	0.0	0.0	19.7	9.0	16.0	12.7	0.0	0.0	0.0	34.7	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.3	0.0	0.0	0.0	0.5	0.0	42.4	0.0	0.7	0.0	29.3	21.0	0.0	0.2	20.0	0.9	0.5	0.4	0.0	0.0	0.0	14.9	19.6	14.5	0.0	0.0	10.5	21.1	8.5	13.6	0.1	16.1	2.5	6.8	8.4	4.1	8.9	1.9	2.8	1.2	4.2	6.2	2.8	3.5	2.7	13.3	5.9	0.5	4.1	4.1	6.3	1.1	1.3	1.2	4.1	1.2	1.2	1.6	2.0	1.4	1.5	1.5	1.5	1.2	0.0	8.2	11.4	10.7	0.4	0.3	1.7	15.4	1.2	1.5	1.0	0.5	0.0	1.6	0.0	0.0	3.9	2.2	12.0	3.9	18.3	1.3	1.4	1.7	2.7	12.5	14.9	13.4	13.3	1.5	5.3	12.2	1.2	1.3	0.5	0.7	0.8	3.3	0.0	14.6	9.7	2.0	2.2	2.1	0.4	0.9	8.8	3.6	13.1	8.1	1.0	5.2	15.6	21.1	12.7	16.0	0.4	16.4	0.4	16.5	0.7	1.7	1.4	0.0	0.7	4.9	2.5	1.6	16.8	1.0	5.3	7.6	0.2	12.1	0.3
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 265.1;testis: 101.9"	"Group enriched"	"Detected in many"	20	"Early spermatids: 543.6;Late spermatids: 1322.9;Proximal enterocytes: 1172.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.1"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC TERT1: 63.3;HUVEC TERT2: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	170000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	13.4	4.9	1.7	4.8	8.1	0.1	8.1	0.2	2.5	18.1	0.5	11.2	176.4	8.1	3.5	4.1	6.3	8.2	10.4	1.3	1.0	10.8	1.9	49.0	4.9	1.3	0.9	1.9	6.2	18.7	9.2	11.6	1.3	8.9	6.1	0.4	7.6	23.8	16.1	3.8	265.1	9.6	0.8	2.8	8.3	101.9	2.0	0.8	19.2	10.0	2.1	5.5	3.8	1.1	0.0	0.0	0.0	0.0	2.6	63.3	0.6	2.4	4.7	0.0	0.0	0.9	5.1	1.3	1.8	11.4	0.1	0.0	3.1	0.0	0.0	0.0	1.4	6.6	0.0	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	1.2	33.8	0.0	5.8	0.0	0.1	1.1	0.0	1.4	0.4	11.7	0.7	0.1	0.5	0.9	0.0	0.0	8.2	5.6	0.0	0.0	0.0	1.3	2.9	0.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	1.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	8.1	0.2	2.5	1.3	1.0	1.3	0.9	1.3	0.8	2.0	1.1	50.0	0.0	3.3	0.0	0.5	1.5	2.6	0.1	1.2	4.0	3.6	1.9	2.1	1.5	0.7	0.0	0.0	0.1	0.3	11.9	0.0	5.9	543.6	10.8	8.0	34.7	18.0	0.0	4.7	0.4	0.1	11.5	2.0	36.3	7.0	24.1	3.6	0.8	4.2	0.0	1.8	39.8	0.0	33.7	3.5	1322.9	4.4	13.6	3.6	4.7	0.0	1.8	0.0	1.0	0.2	0.7	40.9	2.6	0.1	4.2	1172.8	21.7	0.0	1.1	0.0	2.0	4.2	13.5	6.4	0.2	0.1	0.1	2.2	0.3	26.2	2.1
ACKR4	"CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1"	ENSG00000129048	"Atypical chemokine receptor 4"	Q9NPB9	3	132597270-132618967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Fibroblasts: 21.4;Proximal enterocytes: 19.1;Respiratory ciliated cells: 15.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"BJ hTERT+: 285.1"	"Group enriched"	"Detected in some"	7	"cerebellum: 4.7;pons and medulla: 1.5"	"Low region specificity"	"Detected in all"			HPA054926			Approved	Vesicles,Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Mitochondria"		"HPA054926: "	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	11.1	1.4	0.6	1.0	0.2	0.8	5.5	0.3	0.3	0.7	0.9	1.9	15.8	3.7	1.7	1.4	2.0	6.5	5.7	0.4	0.0	1.1	1.0	8.0	2.1	0.3	0.5	1.0	2.6	0.0	6.7	0.2	0.3	0.5	1.3	0.6	7.1	1.9	0.5	8.9	13.0	2.2	0.3	1.6	10.2	0.4	0.1	0.5	1.4	1.0	1.6	4.6	1.1	0.2	0.2	0.0	0.2	0.2	19.9	10.7	0.1	47.7	285.1	2.8	7.9	0.2	0.4	3.3	0.0	29.9	0.2	0.1	0.0	0.0	1.8	1.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	1.3	0.0	0.0	4.9	0.1	0.2	0.6	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.0	0.5	0.1	0.7	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.3	0.4	0.0	0.3	0.5	0.3	0.3	0.1	0.2	1.6	38.5	1.1	0.7	0.1	6.5	0.6	1.3	0.0	1.6	0.3	0.3	0.7	1.5	2.3	5.5	6.2	0.2	0.1	1.1	0.0	0.2	2.9	2.9	0.6	3.9	0.0	0.0	0.6	12.1	0.1	21.4	10.7	0.6	0.0	0.7	9.7	0.2	0.4	1.7	0.5	0.8	0.0	0.3	5.1	0.4	2.1	0.3	1.8	1.9	6.8	0.9	0.0	0.0	0.3	5.1	0.1	2.6	0.5	0.4	19.1	3.0	15.7	3.4	0.0	1.3	2.6	0.1	0.1	0.6	6.5	0.3	0.5	12.5	3.7	1.2
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 32.0;retina: 45.8;testis: 20.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 229.2;Cone photoreceptor cells: 229.4;Erythroid cells: 110.5;Inhibitory neurons: 110.6;Rod photoreceptor cells: 130.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 7.6;U-937: 6.2"									HPA040470	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.2	4.2	14.8	1.4	18.3	22.6	0.2	26.3	32.0	0.1	1.2	0.5	4.7	0.1	0.5	0.3	0.2	0.3	1.4	18.6	12.8	1.9	2.0	0.3	2.4	22.2	18.2	0.0	1.1	11.3	4.2	0.6	18.9	0.3	0.3	45.8	0.3	18.0	2.3	0.1	2.4	0.1	13.8	1.1	0.6	20.7	25.0	0.6	0.4	1.4	1.0	0.2	0.1	14.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.2	6.2	0.3	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.7	1.6	0.0	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	0.3	14.8	18.3	26.3	32.0	18.6	12.8	22.2	18.2	18.9	13.8	25.0	14.3	0.6	25.6	29.2	229.2	1.4	1.9	1.5	0.0	2.2	65.2	2.1	0.4	0.0	1.5	16.1	1.8	229.4	0.3	3.3	0.6	7.9	0.6	43.7	0.3	0.1	3.9	2.4	110.5	70.6	0.2	0.1	4.2	0.0	0.2	10.1	0.2	1.8	8.4	0.1	21.9	110.6	1.8	0.0	1.0	15.9	7.9	0.3	6.4	0.0	15.9	0.9	24.5	0.0	41.7	9.8	0.3	1.6	1.9	0.8	1.1	1.8	0.4	8.1	130.0	0.0	2.3	1.1	45.3	1.7	0.1	1.3	0.3	15.3	0.1	0.4	1.3
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650730	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 77.7;kidney: 58.2;liver: 33.8;pancreas: 22.2"	"Group enriched"	"Detected in many"	8	"Proximal enterocytes: 255.7;Proximal tubular cells: 437.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 34.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.7;monocytes: 34.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;CAPAN-2: 15.3;Daudi: 57.7;OE19: 15.3;RPMI-8226: 9.8"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced					NA	NA		13000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	4.0	4.2	3.0	1.4	0.9	3.6	3.5	10.5	2.0	6.7	77.7	0.5	0.8	0.8	0.9	1.9	0.0	4.1	5.0	58.2	33.8	0.2	7.0	5.0	3.5	0.2	22.2	0.4	0.3	0.2	4.3	0.6	4.5	0.0	2.4	0.4	0.0	0.2	70.8	0.3	5.7	1.4	11.9	0.1	5.1	1.9	0.1	0.0	8.9	0.3	0.1	4.6	0.2	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.6	15.3	57.7	0.6	0.0	1.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.1	2.1	2.5	0.0	15.3	0.0	1.8	0.0	9.8	0.0	0.0	0.0	0.1	0.3	1.3	0.1	0.0	0.1	2.8	0.2	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	6.4	0.5	0.0	0.7	0.0	0.2	7.6	0.7	1.3	0.4	0.2	3.8	1.4	1.3	0.9	0.0	3.9	34.1	8.7	0.0	1.9	4.0	3.0	3.6	3.5	4.1	5.0	5.0	3.5	4.3	5.7	5.1	4.6	0.1	0.0	1.7	0.0	4.7	0.0	0.1	0.7	0.0	0.0	1.6	2.2	0.5	8.6	1.6	22.0	0.0	0.2	0.1	9.2	31.3	4.1	0.0	0.5	0.2	0.1	1.2	0.0	0.0	10.4	0.3	0.1	19.4	0.9	0.0	0.0	0.0	25.3	2.2	0.0	0.0	40.8	0.0	0.6	0.9	0.0	0.0	3.0	5.4	10.3	0.4	0.0	0.0	0.0	0.0	5.7	10.6	0.0	3.3	0.5	255.7	437.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	2.7	0.1	14.7	0.9
ACYP2		ENSG00000170634	"Acylphosphatase 2"	P14621	2	53970838-54305300	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.4;tongue: 163.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 162.6;Excitatory neurons: 158.8;Oligodendrocytes: 180.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035301	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035301: AB_10670291"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.90e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.24e-2)"	19.5	42.8	64.9	5.4	72.9	7.1	15.7	74.8	85.4	10.6	61.5	14.3	7.4	11.5	12.8	10.4	11.6	8.5	63.4	63.9	72.8	14.5	28.0	10.6	10.9	69.5	68.8	9.3	12.7	13.6	26.2	6.5	70.3	14.4	5.3	24.1	15.2	9.2	207.4	9.9	9.0	7.9	70.4	12.7	12.9	10.2	70.4	10.7	12.6	163.2	8.4	14.0	10.7	76.9	11.7	5.9	6.0	4.4	23.7	17.3	3.7	11.5	9.7	8.3	7.3	1.5	7.1	21.5	33.0	12.6	7.8	8.5	3.3	10.8	7.4	14.4	13.1	13.4	6.3	16.3	8.5	12.7	6.3	13.6	19.3	5.6	9.5	15.2	3.9	9.8	5.5	11.5	17.9	7.6	7.5	17.0	5.9	8.4	6.7	5.4	4.7	12.2	18.8	10.6	17.6	10.0	17.4	10.0	5.7	1.9	3.4	13.2	10.9	11.5	10.6	3.5	11.1	21.4	12.5	10.2	16.3	24.3	12.4	41.2	14.0	26.1	16.9	13.0	15.4	29.0	16.6	16.1	20.3	26.9	20.1	16.4	11.5	18.6	13.5	33.4	16.3	11.3	64.9	72.9	74.8	85.4	63.9	72.8	69.5	68.8	70.3	70.4	70.4	76.9	21.7	16.0	17.9	84.9	30.6	20.5	41.9	52.8	18.8	15.5	49.7	65.7	162.6	34.3	32.0	18.4	10.4	13.6	27.9	24.5	62.6	24.3	86.8	29.5	23.6	23.1	30.6	14.5	158.8	38.1	6.1	21.0	26.0	19.5	19.7	17.6	30.7	74.2	31.9	28.6	134.1	21.9	36.7	40.0	28.5	64.7	13.4	25.4	23.2	59.0	26.1	90.1	24.7	67.8	180.1	29.9	18.8	30.9	36.4	27.4	29.1	55.6	32.2	31.6	52.6	30.8	30.0	22.9	9.8	28.9	21.3	10.3	22.7	29.7	18.6	45.0
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294069-24359014	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 357.5;stomach 1: 110.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.9;Club cells: 62.9;Gastric mucus-secreting cells: 141.7;Microglial cells: 233.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 71.6;naive B-cell: 87.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 27.8;OE19: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.2	2.2	5.9	24.7	4.6	9.3	3.9	7.1	5.0	16.1	4.0	14.3	8.8	6.9	357.5	2.8	12.3	40.2	1.0	5.8	8.8	5.1	1.2	3.9	26.7	12.0	9.3	2.3	3.5	1.1	18.5	3.7	11.7	5.3	12.1	1.3	15.9	5.7	0.3	3.3	24.7	2.9	9.8	19.9	110.3	0.7	10.1	5.1	1.9	0.4	32.3	11.3	1.7	18.6	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.1	27.8	0.3	0.8	0.0	0.9	0.1	0.0	0.8	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.7	0.7	8.8	0.1	0.1	0.0	0.4	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.2	2.5	0.1	2.1	1.0	0.2	42.4	2.5	18.5	0.0	0.6	0.0	71.6	0.1	0.0	21.0	87.0	0.1	0.0	4.3	2.7	0.2	1.1	0.1	2.5	5.9	4.6	7.1	5.0	5.8	8.8	12.0	9.3	11.7	9.8	10.1	18.6	1.5	3.2	6.0	0.7	240.9	0.9	3.0	36.9	0.0	0.1	2.3	2.2	2.0	28.6	62.9	3.7	0.0	0.4	9.9	0.7	0.0	7.9	1.3	7.6	1.0	3.7	0.0	8.2	4.3	3.5	8.7	3.9	141.7	18.4	2.5	0.0	0.0	0.0	9.4	0.0	2.7	0.4	28.5	12.3	30.9	1.8	0.6	46.4	5.4	233.3	7.8	0.1	23.7	3.5	1.6	55.7	0.1	0.4	43.3	1.5	0.6	4.4	13.1	0.1	6.6	0.0	1.1	0.4	0.2	0.7	0.6	0.5	9.0	6.4	1.3	7.6
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892019	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 25.2;Fibroblasts: 22.9;Leydig cells: 22.1;Microglial cells: 73.1;Sertoli cells: 52.6;Theca cells: 55.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 47.4;hTERT-RPE1: 88.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: AB_2732278"	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (6.78e-4)"	9.0	5.2	0.9	1.6	0.7	0.0	7.8	0.5	0.4	2.7	1.7	2.5	0.5	3.8	0.5	0.9	3.2	4.0	1.6	0.2	0.4	1.3	1.4	5.6	0.9	1.2	0.9	2.7	0.6	0.5	0.6	3.9	1.0	1.3	1.0	0.7	0.9	1.4	0.8	1.5	1.1	6.5	1.5	0.5	1.2	2.0	1.3	0.3	1.9	0.7	0.6	2.2	2.0	3.3	28.7	0.9	25.5	0.0	35.9	17.2	0.0	13.3	33.1	16.8	19.5	0.0	0.0	0.0	0.0	9.0	29.1	0.8	0.7	16.7	24.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	13.8	0.0	47.4	12.2	88.0	0.0	0.0	0.0	0.1	26.6	0.0	0.0	0.0	5.0	0.0	0.0	0.0	29.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	28.0	36.2	0.3	7.9	4.4	3.5	0.0	23.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.5	0.4	0.2	0.4	1.2	0.9	1.0	1.5	1.3	3.3	6.4	0.0	0.0	1.3	0.5	0.8	0.0	0.0	0.0	0.1	1.5	2.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	4.9	1.2	25.2	2.1	0.0	0.0	3.0	0.2	0.4	22.9	0.0	0.6	0.0	3.3	11.4	0.2	0.6	0.0	6.2	0.0	0.0	0.3	2.1	3.0	22.1	0.2	7.2	73.1	0.0	5.3	0.0	0.5	7.8	0.1	0.0	17.7	0.0	0.1	0.0	2.4	0.7	0.2	52.6	1.7	19.1	0.4	4.7	0.1	0.9	0.8	0.3	55.4	0.0	0.1
ADAMTSL1	"ADAMTSR1, C9orf94, FLJ35283"	ENSG00000178031	"ADAMTS like 1"	Q8N6G6	9	17906563-18910950	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 13.3"	"Cell type enriched"	"Detected in some"	6	"Excitatory neurons: 245.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.6"	"Region enhanced"	"Detected in many"		"thalamus: 9.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 118.3;HSkMC: 61.2;hTEC/SVTERT24-B: 64.3;hTERT-RPE1: 55.8;LHCN-M2: 64.3;TIME: 207.9;U-138 MG: 96.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057437, HPA074973"	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA		28000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA057437: AB_2683440, HPA074973: "	"unprognostic (4.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.01e-4)"	"unprognostic (3.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.50e-2)"	3.9	5.5	1.0	1.9	0.9	0.0	2.4	1.7	1.1	3.8	0.0	3.0	1.8	13.3	1.1	5.4	4.0	4.9	1.0	3.6	1.8	2.1	0.9	1.2	0.8	2.1	3.3	1.5	1.4	0.2	1.8	0.6	0.5	8.1	2.9	0.4	1.3	1.6	0.4	0.9	1.8	11.2	1.4	0.7	5.1	1.0	9.6	0.5	0.9	0.8	0.9	2.6	2.0	1.0	6.4	0.5	1.2	0.0	17.5	118.3	0.0	3.6	16.3	14.8	33.3	0.0	0.1	0.1	0.1	44.1	5.5	0.0	6.6	1.1	41.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	61.2	0.0	64.3	0.2	55.8	27.1	0.0	0.1	0.3	64.3	0.0	0.2	0.1	5.6	0.0	0.3	0.0	10.1	0.2	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	207.9	96.9	2.5	2.6	15.8	0.0	0.0	0.0	31.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	1.7	1.1	3.6	1.8	2.1	3.3	0.5	1.4	9.6	1.0	1.6	0.0	0.0	5.2	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.4	1.4	0.0	0.6	0.0	0.0	0.0	0.0	3.1	0.0	0.1	7.2	0.3	1.1	8.9	0.0	0.0	245.4	0.0	0.0	15.1	0.5	0.5	0.0	0.1	1.1	0.0	0.1	0.0	39.5	0.4	0.0	0.0	0.8	2.9	5.0	0.1	0.0	1.9	0.0	0.0	0.0	9.0	5.7	0.0	0.4	1.2	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.1	1.2	2.9	1.6	0.1	0.1	0.1	0.0	0.1	1.7	0.1
ADAMTSL5	THSD6	ENSG00000185761	"ADAMTS like 5"		19	1505022-1513604	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"cervix: 33.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 9.8;Cardiomyocytes: 9.6;Leydig cells: 19.3;Peritubular cells: 18.0;Proximal enterocytes: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044050			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA044050: AB_10962625"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.37e-3)"	1.8	1.5	1.7	0.7	2.2	0.3	2.2	2.3	2.0	33.0	8.3	3.2	9.8	19.8	5.0	15.1	9.5	0.5	20.7	1.8	0.4	1.5	4.2	1.4	0.6	0.8	1.0	1.3	1.0	1.4	2.6	4.2	0.6	4.5	1.1	0.9	3.9	3.3	15.1	2.1	8.4	12.5	0.2	0.8	1.4	3.6	1.6	0.2	1.5	5.9	1.5	3.8	22.5	1.4	8.1	3.5	0.1	0.1	4.1	3.0	3.8	14.7	9.8	5.6	8.1	20.7	4.0	0.0	3.6	12.3	1.6	6.7	3.5	4.2	4.2	7.9	0.4	1.7	11.0	3.8	4.6	0.2	10.2	1.8	4.6	1.3	3.5	7.4	0.0	2.5	5.0	9.8	0.6	7.5	0.4	0.4	0.1	2.3	1.8	0.2	0.8	2.1	4.5	0.0	0.1	0.3	3.5	0.4	4.4	1.9	9.2	3.0	0.9	0.0	5.4	10.9	0.6	6.2	4.2	1.0	0.1	0.8	2.4	0.2	0.0	0.4	1.4	0.5	0.9	0.0	1.6	1.1	0.0	0.0	2.0	1.3	0.1	0.0	0.9	0.0	0.5	0.5	1.7	2.2	2.3	2.0	1.8	0.4	0.8	1.0	0.6	0.2	1.6	1.4	0.2	0.0	1.1	3.6	0.3	0.4	2.4	9.8	6.2	0.3	1.9	0.8	9.6	0.0	3.4	0.0	0.0	0.8	0.7	0.6	0.0	0.6	0.6	0.3	4.5	0.4	0.0	0.0	0.1	1.7	2.1	5.8	1.1	0.4	0.0	0.5	0.0	1.8	0.3	0.0	0.1	1.8	4.1	0.0	0.4	2.6	19.3	0.4	1.8	1.0	0.0	3.7	0.0	0.0	0.1	7.0	1.5	18.0	1.8	2.7	12.5	0.5	1.3	2.1	0.0	0.9	3.3	0.6	1.9	8.4	0.4	0.7	1.2	0.3	1.6	3.5
ADCY4	AC4	ENSG00000129467	"Adenylate cyclase 4"	Q8NFM4	14	24318349-24335093	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 90.9;Endothelial cells: 74.6;Hepatic stellate cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 2.9;TIME: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005070, HPA048344"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB005070: AB_2273639, HPA048344: AB_2680366"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-4)"	"prognostic favorable (8.20e-4)"	"unprognostic (4.06e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.75e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (8.02e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	18.0	2.6	2.8	2.3	2.2	0.0	16.1	2.2	2.8	9.2	2.0	3.9	0.9	8.8	0.5	3.7	8.2	2.9	16.9	2.0	2.1	10.2	1.4	9.9	1.6	2.7	2.5	2.4	2.3	1.0	1.7	9.9	2.6	5.3	0.7	0.0	3.7	1.4	4.3	4.7	4.5	1.9	2.4	9.9	3.7	1.1	3.0	0.4	7.7	2.8	0.8	5.9	6.7	2.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	2.2	2.2	2.8	2.0	2.1	2.7	2.5	2.6	2.4	3.0	2.3	90.9	0.0	1.8	0.3	1.0	3.6	0.4	0.3	3.4	0.0	1.5	1.5	10.6	0.0	0.9	1.8	0.0	0.2	1.6	2.9	0.0	1.2	1.3	0.5	1.1	74.6	1.2	0.4	0.2	3.1	0.1	4.7	7.1	0.6	1.3	0.0	50.3	0.2	1.4	1.7	0.2	7.9	0.0	5.0	3.1	6.9	0.0	1.5	7.2	12.2	2.5	0.9	1.0	0.0	0.0	2.1	3.8	0.0	1.4	0.4	2.4	0.0	1.1	0.2	6.6	1.7	5.7	0.3	0.8	0.6	2.8	0.0	1.6	0.5	2.1	0.2
ADGRL2	"KIAA0786, LEC1, LPHH1, LPHN2"	ENSG00000117114	"Adhesion G protein-coupled receptor L2"	O95490	1	81306147-81992436	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"Excitatory neurons: 902.7;Inhibitory neurons: 646.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 252.8;hTEC/SVTERT24-B: 130.3;NTERA-2: 100.0;SH-SY5Y: 168.3;U-2197: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043447			Approved	"Plasma membrane"		NA	NA		700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA043447: AB_2678486"	"unprognostic (2.54e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.81e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.76e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.41e-2)"	19.8	19.9	11.0	8.2	13.4	0.0	17.8	6.5	26.3	16.4	5.0	15.3	5.8	12.4	15.0	23.6	23.1	23.1	28.5	13.9	14.6	21.4	38.5	64.9	8.9	8.6	10.7	36.3	9.7	27.5	20.5	48.8	7.6	30.0	10.9	25.2	36.7	19.4	4.4	12.9	13.4	12.7	7.0	19.9	15.5	4.2	15.5	10.4	43.2	19.7	8.7	13.2	23.4	15.0	18.2	9.9	252.8	0.0	30.3	35.3	3.4	6.4	14.8	2.5	2.9	0.0	0.0	0.1	69.6	34.6	7.1	10.1	20.3	28.0	2.3	0.5	41.5	0.0	7.0	16.6	11.8	0.0	0.4	32.5	1.8	130.3	12.9	17.8	42.9	0.0	0.0	0.0	3.4	0.2	0.0	0.1	100.0	0.0	7.1	0.0	34.9	0.0	56.9	3.8	11.7	168.3	0.0	6.3	0.0	73.5	0.4	74.7	27.5	26.0	28.9	118.9	9.3	0.0	0.0	0.2	14.9	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	13.4	6.5	26.3	13.9	14.6	8.6	10.7	7.6	7.0	15.5	15.0	25.3	3.2	2.2	23.8	0.2	0.0	7.0	0.0	2.2	48.5	6.6	11.2	44.1	10.0	3.1	5.5	6.2	0.4	0.1	2.1	0.0	4.7	1.4	11.7	10.3	36.9	0.0	0.0	902.7	1.6	0.4	19.6	0.5	25.4	0.0	32.3	30.0	39.3	0.9	33.7	646.8	2.0	0.0	3.1	0.0	1.4	23.3	1.1	0.0	69.3	0.0	19.0	0.0	11.1	13.0	0.8	3.6	17.7	0.0	10.4	0.0	7.8	0.0	3.9	19.7	2.5	19.8	1.5	3.5	4.1	0.0	0.4	0.5	43.1	3.5	3.0
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3"	"Group enriched"	"Detected in many"	11	"Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	7.1	6.2	25.1	1.1	25.7	0.0	2.5	14.0	30.7	5.5	0.0	4.0	2.5	3.9	1.8	1.0	2.4	1.6	2.6	30.4	25.0	1.6	0.4	2.6	0.4	15.3	24.6	1.1	0.3	6.7	0.9	1.2	15.9	1.3	3.9	10.0	0.6	4.2	0.7	3.0	3.6	3.0	12.5	0.3	3.2	4.1	32.3	0.4	0.7	0.3	0.1	1.6	3.4	15.7	0.0	0.1	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	4.0	0.5	0.1	0.1	0.0	4.8	0.2	0.0	6.3	0.3	0.0	0.0	0.0	7.6	0.1	3.2	0.0	0.2	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	25.7	14.0	30.7	30.4	25.0	15.3	24.6	15.9	12.5	32.3	15.7	0.4	0.0	0.0	584.1	0.0	0.0	0.0	0.0	0.6	12.4	4.9	1.8	3.3	0.0	0.0	0.0	4.2	1.0	0.0	0.0	9.8	0.0	46.4	1.3	17.7	1.9	0.0	0.0	696.1	0.0	1.3	3.3	0.0	0.4	0.0	0.4	2.5	0.2	0.1	1.7	737.4	0.0	0.0	0.0	0.0	33.2	0.0	0.5	0.0	70.3	0.0	31.3	0.0	1300.8	592.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.4	6.6	0.3	18.5	0.9	3.5	1.2	0.0	2.2	0.2	0.1	0.0	0.1
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044578, HPA061919"	Approved					NA	NA		5300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	141.5	71.3	48.3	52.5	48.2	28.5	111.9	48.0	56.0	92.7	55.8	158.8	94.2	134.8	142.2	114.4	95.9	69.3	124.3	45.9	54.6	175.4	264.1	73.5	51.3	47.6	48.5	118.4	49.4	50.1	41.4	60.9	47.9	116.2	100.8	36.0	65.4	124.6	80.9	54.8	94.3	118.0	49.7	51.6	91.3	52.2	48.6	83.3	79.2	75.8	55.5	158.9	73.9	51.4	84.0	66.9	194.8	110.0	344.7	316.0	116.6	136.6	237.6	143.8	125.2	77.1	96.7	96.5	77.5	197.8	92.8	69.8	135.0	188.7	137.7	69.9	56.6	67.1	83.3	306.7	332.2	118.4	51.9	287.3	143.1	108.3	84.7	151.0	112.8	99.8	125.8	53.3	192.3	94.9	160.4	105.4	156.7	20.6	79.8	115.4	108.9	50.9	230.2	96.0	74.0	97.0	82.7	96.6	155.9	141.8	78.2	82.2	85.4	130.5	82.9	86.4	95.2	55.9	74.4	135.4	134.2	77.4	135.7	21.8	21.2	35.8	32.6	18.9	29.5	26.0	35.3	30.4	23.8	26.2	34.0	31.9	3.0	51.3	14.1	20.5	49.5	32.8	48.3	48.2	48.0	56.0	45.9	54.6	47.6	48.5	47.9	49.7	48.6	51.4	69.0	105.8	78.2	22.9	48.1	39.6	85.9	257.5	109.3	31.8	32.1	74.3	127.4	78.6	94.3	55.2	10.4	290.1	51.8	80.4	197.6	94.8	24.0	146.9	159.1	56.3	79.7	45.8	14.3	83.8	277.2	131.2	37.8	113.0	26.6	83.3	47.2	188.0	118.1	38.7	12.0	101.8	87.5	48.6	27.1	22.0	187.4	43.4	53.4	15.9	63.2	152.4	77.2	27.6	13.9	78.4	86.0	255.1	41.5	34.9	95.2	316.0	56.8	46.5	111.7	55.6	127.7	30.5	48.5	74.9	23.0	83.0	58.5	147.0	104.8	68.1
ADIPOR2	"ACDCR2, PAQR2"	ENSG00000006831	"Adiponectin receptor 2"	Q86V24	12	1688574-1788674	"Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 321.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043737	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA043737: AB_10964205"	"unprognostic (1.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.85e-2)"	55.1	72.3	36.6	10.6	49.8	9.6	44.2	46.4	48.7	25.8	28.3	32.2	22.2	24.4	8.1	45.2	23.3	9.7	33.3	35.3	40.6	22.4	79.6	44.6	9.8	50.9	46.9	25.1	31.1	16.9	26.1	13.0	49.5	20.7	17.7	13.1	22.2	11.9	42.9	31.9	32.7	12.0	41.6	19.9	44.7	27.7	44.5	12.8	28.0	19.9	12.6	21.4	29.3	67.0	34.3	28.0	23.1	21.4	21.4	25.6	30.9	24.6	28.4	31.5	44.5	42.1	51.6	24.1	7.8	23.0	56.7	26.1	34.7	35.8	44.9	62.7	28.7	47.3	22.7	30.3	21.2	36.1	29.3	22.6	35.5	39.8	45.6	28.7	23.1	25.8	31.7	50.9	23.7	48.8	23.6	32.8	46.3	28.4	14.8	19.5	43.7	18.3	31.4	19.9	6.9	16.4	22.7	43.8	51.5	39.7	24.6	46.5	23.2	17.8	37.5	28.6	36.2	12.3	16.5	39.5	21.7	32.3	24.7	0.7	0.7	1.8	0.9	0.7	0.7	0.5	0.5	0.8	0.5	0.5	0.6	0.7	0.9	0.6	0.6	0.9	0.7	0.3	36.6	49.8	46.4	48.7	35.3	40.6	50.9	46.9	49.5	41.6	44.5	67.0	81.5	12.8	32.4	39.2	21.8	23.7	25.0	26.6	22.8	11.3	29.9	20.3	22.3	31.5	36.6	14.7	18.8	13.9	32.4	91.4	11.7	22.6	56.3	17.8	15.4	41.1	37.5	38.1	35.7	31.4	42.2	21.1	61.7	30.2	36.3	28.8	28.9	113.4	18.2	18.5	41.3	49.0	32.6	27.3	18.9	77.0	15.8	32.6	26.6	124.6	27.0	32.5	27.8	32.2	321.0	39.6	49.4	22.6	30.2	27.8	41.5	10.8	21.7	16.0	6.6	21.3	25.7	45.0	42.2	29.7	34.4	29.3	26.1	39.6	33.5	29.8
AFAP1L1	FLJ36748	ENSG00000157510	"Actin filament associated protein 1 like 1"	Q8TED9	5	149271859-149343637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 62.4;Cardiomyocytes: 39.3;Early spermatids: 105.4;Endothelial cells: 72.0;Extravillous trophoblasts: 47.1;Hepatic stellate cells: 47.2;Late spermatids: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 42.6;HUVEC TERT2: 20.8;TIME: 33.9;WM-115: 79.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.91e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.52e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.88e-2)"	23.9	2.8	1.7	2.1	0.9	0.1	15.2	1.1	1.3	4.2	1.0	3.5	0.8	7.1	0.6	4.3	10.1	4.0	26.1	0.9	1.0	4.1	2.1	13.3	2.3	1.4	1.1	3.3	1.0	6.1	2.4	14.4	1.4	3.3	0.7	1.3	3.4	1.9	31.6	6.0	3.4	3.5	1.1	2.9	2.4	2.3	1.8	3.4	7.4	16.6	0.8	4.6	3.7	0.9	7.0	2.4	0.1	0.3	9.9	2.1	42.6	1.5	5.5	5.4	8.9	0.1	4.1	0.0	3.3	2.5	13.7	1.4	0.8	6.2	2.2	0.0	1.0	1.6	0.9	0.0	5.2	0.0	0.1	7.3	1.0	3.0	11.6	4.3	20.8	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.0	0.0	5.4	0.0	0.0	0.0	3.5	1.1	0.7	1.1	4.4	0.1	14.8	1.5	0.2	0.4	33.9	2.5	7.7	0.1	1.2	0.0	0.0	0.0	0.5	0.1	79.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.9	1.1	1.3	0.9	1.0	1.4	1.1	1.4	1.1	1.8	0.9	62.4	0.0	1.3	0.3	0.2	1.5	1.4	4.6	0.0	0.3	0.4	0.5	39.3	1.5	4.1	0.0	0.0	14.2	0.2	0.0	0.0	0.3	105.4	0.3	0.4	72.0	0.0	0.0	2.9	0.0	47.1	4.5	0.0	0.2	1.3	0.0	47.2	0.6	2.7	0.0	1.2	0.0	0.0	4.2	1.3	50.4	9.6	0.7	7.2	10.3	0.0	0.5	0.0	2.0	0.3	0.0	0.0	15.8	0.0	4.0	0.0	0.8	6.4	5.3	13.1	4.6	4.0	0.5	4.8	0.3	1.4	6.4	0.5	1.8	0.0	5.4
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294991-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 6.4;Distal tubular cells: 9.8;Hofbauer cells: 5.7;Proximal tubular cells: 6.3;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	1.8	2.1	2.2	1.3	2.7	2.1	2.2	2.0	3.3	1.7	2.7	2.6	4.2	1.5	1.9	1.6	2.2	1.5	4.6	1.7	1.9	5.0	3.7	1.7	1.8	1.8	2.0	1.7	2.1	5.4	1.5	2.2	2.0	1.6	3.1	3.1	1.8	1.7	3.7	1.2	3.0	1.7	1.7	2.0	2.8	10.7	2.7	2.3	3.0	4.0	2.1	1.7	1.1	3.2	2.7	1.4	3.4	6.1	3.5	5.1	3.3	3.0	4.4	4.8	4.7	5.7	3.3	4.8	3.8	4.7	5.8	1.5	4.4	4.5	5.4	2.8	2.6	5.7	1.8	6.6	3.5	5.3	2.7	4.7	3.6	3.6	5.8	3.1	2.6	3.5	5.9	2.2	4.5	2.6	0.9	4.8	2.2	4.6	2.8	3.3	4.6	2.8	6.1	2.9	3.7	3.2	2.4	3.5	6.4	4.5	2.8	9.8	3.2	2.9	0.7	2.6	3.4	1.5	2.6	3.7	3.6	6.0	4.5	0.0	1.6	2.8	1.0	1.2	1.3	2.5	1.5	1.9	1.4	3.4	2.1	1.4	0.4	2.4	4.3	1.6	2.3	0.7	2.2	2.7	2.0	3.3	1.7	1.9	1.8	2.0	2.0	1.7	2.7	3.2	2.4	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	5.0	3.7	0.0	6.4	1.1	0.0	9.8	3.1	0.0	2.6	2.6	2.2	0.0	0.0	0.0	3.8	4.6	1.2	0.0	1.8	2.5	5.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	6.3	5.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	0.9	4.5	0.0	0.0
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377227	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	26.1	25.9	16.4	21.9	17.0	32.4	29.2	18.2	19.0	24.1	30.8	60.8	79.9	22.1	17.5	41.5	23.8	18.3	88.0	17.0	18.7	62.7	51.0	21.8	23.7	17.7	16.6	24.1	41.1	76.0	18.6	23.5	18.8	24.6	54.1	20.3	30.8	24.4	145.4	29.8	58.7	25.4	15.8	18.5	39.1	18.5	19.0	24.3	39.2	155.8	31.0	30.9	19.6	17.6	56.5	56.6	39.7	44.8	45.2	48.6	52.7	61.9	61.1	86.6	63.1	88.1	34.1	161.3	66.3	56.6	76.8	55.6	101.4	71.3	70.3	38.1	43.5	48.5	59.3	83.5	61.1	185.0	69.8	54.3	76.3	82.1	107.7	47.8	64.0	57.0	111.3	92.8	43.6	89.0	66.7	58.5	55.3	277.4	41.9	74.0	125.1	135.2	74.9	123.6	73.7	51.3	97.0	103.8	90.0	50.5	47.8	84.5	49.0	102.4	88.6	98.7	81.7	64.7	80.7	104.1	56.2	71.4	48.0	3.8	16.5	12.4	11.6	17.6	13.9	14.0	13.8	17.9	21.8	10.3	17.2	20.2	1.1	28.4	16.2	11.5	9.5	13.4	16.4	17.0	18.2	19.0	17.0	18.7	17.7	16.6	18.8	15.8	19.0	17.6	24.3	41.7	49.2	23.2	36.6	22.2	45.3	21.5	42.7	50.2	36.5	36.2	74.9	50.1	28.1	35.0	50.1	58.5	29.1	85.2	72.4	39.5	5.5	37.8	52.3	27.7	39.1	61.0	21.1	37.4	37.9	31.2	53.5	46.1	14.5	41.3	21.8	85.6	37.0	30.3	26.8	82.6	18.3	32.6	14.4	5.5	32.9	34.2	23.2	12.2	27.6	26.9	40.2	14.1	17.7	47.8	43.1	30.1	38.8	43.1	88.7	100.0	22.1	58.3	26.3	53.6	26.9	50.9	65.0	75.8	31.3	92.8	28.4	60.8	94.9	38.2
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 219.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 219.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	6.3	2.5	85.4	10.0	69.0	14.5	1.8	0.6	219.9	0.8	0.0	2.2	2.9	2.0	0.3	2.3	1.0	4.3	23.5	162.1	0.0	0.8	1.1	3.4	16.9	0.0	0.0	1.5	3.7	1.8	7.5	2.5	0.0	1.9	1.5	4.6	2.3	0.8	15.1	3.2	5.8	1.0	0.0	11.4	3.3	1.0	0.0	15.0	2.5	9.9	11.3	3.2	1.0	38.7	7.3	10.5	19.8	5.8	0.0	0.0	11.3	4.8	0.9	0.1	0.5	1.2	6.6	18.4	1.5	0.0	3.6	4.4	0.1	0.2	0.0	20.3	3.1	20.5	1.6	3.4	0.1	21.2	40.3	0.0	0.0	0.1	0.1	8.4	0.0	21.3	0.0	39.8	0.0	12.6	37.4	13.5	3.2	2.3	10.6	15.5	98.8	13.4	0.0	6.0	5.6	20.5	2.6	3.6	4.3	0.1	2.6	14.8	11.2	5.5	9.0	10.5	3.6	16.8	10.9	9.4	9.8	13.9	9.4	3.8	0.5	0.6	2.7	0.8	2.9	1.2	2.8	3.0	0.8	0.8	1.1	1.7	3.8	1.4	0.4	0.8	4.2	1.1	85.4	69.0	0.6	219.9	162.1	0.0	0.0	0.0	0.0	0.0	0.0	38.7	3.6	3.2	1.1	0.0	5.7	0.0	0.3	0.0	0.0	10.0	0.8	0.5	5.8	1.5	0.6	0.0	0.0	0.1	16.4	0.2	0.0	0.1	0.4	0.1	0.7	4.2	0.0	2.1	22.2	0.0	0.2	0.9	2.0	0.2	2.5	0.0	1.1	0.1	1.3	8.4	12.3	0.5	0.0	2.2	1.1	1.1	0.0	3.0	0.0	1.9	3.9	0.5	17.5	5.0	1.2	0.1	0.1	0.7	11.4	0.3	0.3	0.1	0.0	2.3	32.9	2.2	16.2	0.8	0.4	0.2	0.4	0.0	16.4	0.3	0.2	0.0
AGPAT3	"LPAAT-gamma, LPAAT3"	ENSG00000160216	"1-acylglycerol-3-phosphate O-acyltransferase 3"	Q9NRZ7	21	43865223-43987592	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 183.5;Early spermatids: 219.0;Late spermatids: 219.3;Rod photoreceptor cells: 184.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 9.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (2.36e-2)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.50e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.50e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.60e-2)"	20.9	20.9	41.5	19.2	47.1	11.1	15.1	42.3	34.9	11.7	14.8	22.0	44.7	10.3	12.6	25.7	12.3	13.8	27.8	38.4	36.0	53.4	53.2	18.8	16.4	52.1	41.8	10.4	21.3	24.6	14.7	12.2	39.2	13.8	11.9	61.9	30.5	11.6	62.3	24.3	52.4	8.7	47.8	19.1	18.0	26.4	48.1	15.4	21.4	50.2	10.3	15.4	15.0	48.2	73.0	40.0	10.0	27.5	17.8	20.4	7.7	32.6	40.6	40.8	25.1	40.3	51.4	24.5	24.3	39.3	38.4	27.8	17.3	36.5	11.8	117.2	45.8	10.8	24.4	54.8	33.6	39.6	23.5	25.1	30.4	36.1	15.0	35.1	31.2	8.0	61.4	39.1	15.0	31.2	0.4	22.9	4.7	28.2	28.5	40.6	11.3	65.9	29.7	70.2	34.0	24.7	40.0	45.0	29.9	3.9	31.3	42.9	46.6	25.9	0.3	39.1	34.0	31.0	50.3	15.3	33.3	78.3	23.9	0.0	3.3	2.2	1.1	7.4	1.2	0.9	1.6	1.7	3.8	1.1	1.3	1.5	0.9	0.6	9.6	0.9	3.0	1.8	41.5	47.1	42.3	34.9	38.4	36.0	52.1	41.8	39.2	47.8	48.1	48.2	17.0	12.8	25.4	33.0	7.0	8.0	9.3	14.5	7.4	40.3	19.8	12.3	33.4	25.8	21.0	25.8	183.5	15.9	10.8	45.1	9.8	25.7	219.0	17.7	16.6	16.3	13.8	12.8	34.3	29.5	1.1	10.4	19.9	18.5	5.1	24.6	15.4	68.7	19.0	65.6	37.9	19.7	12.2	32.6	27.3	219.3	7.8	25.7	1.8	17.8	38.5	34.1	9.2	19.1	28.7	26.8	18.8	5.7	11.8	18.6	60.5	52.6	31.0	184.0	6.6	14.9	24.4	7.0	2.4	17.4	11.1	12.0	14.4	22.0	22.5	15.7
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129967-161274061	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 51.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 407.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 25.5;HEL: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	4.8	2.1	14.7	1.8	30.5	5.2	4.5	24.6	22.5	7.2	5.6	6.4	1.2	7.8	2.2	3.7	6.1	4.2	2.6	14.9	22.7	6.0	0.8	6.7	0.9	47.1	26.3	7.4	2.1	0.3	11.4	8.7	34.3	3.6	2.1	2.2	2.7	2.4	1.0	2.3	2.6	4.7	25.5	4.6	2.3	2.8	28.6	1.3	4.1	1.0	1.0	3.0	5.0	51.3	0.5	1.0	25.5	5.1	4.7	9.5	1.1	0.9	0.3	1.9	3.2	1.5	4.6	0.7	1.8	4.2	11.8	0.5	4.8	4.0	1.8	2.9	8.1	19.4	4.9	0.1	3.7	0.2	2.8	11.4	1.9	5.0	2.7	9.1	6.1	3.1	9.8	8.9	2.4	0.0	1.4	2.2	6.2	0.0	9.7	0.0	1.1	0.5	5.6	0.4	14.8	5.6	4.0	2.1	1.1	9.9	1.1	1.2	6.8	2.6	3.3	1.8	4.4	0.7	1.0	0.0	9.9	1.0	1.6	0.0	1.8	0.0	3.4	1.5	1.1	0.2	1.6	2.1	1.0	0.5	0.8	1.2	0.3	2.9	1.3	0.8	1.7	1.3	14.7	30.5	24.6	22.5	14.9	22.7	47.1	26.3	34.3	25.5	28.6	51.3	12.0	3.2	5.5	7.5	4.5	3.2	5.5	9.7	6.2	2.4	3.5	2.7	5.6	5.7	6.9	5.5	0.0	20.3	31.1	6.1	0.0	5.2	52.1	23.8	12.5	13.5	1.8	31.5	87.9	8.2	12.0	17.8	4.6	5.1	11.4	20.6	10.4	0.2	18.2	0.0	95.8	0.7	10.2	7.2	16.4	72.8	5.9	17.0	3.6	23.4	9.4	4.0	9.2	56.3	407.6	5.5	18.7	8.6	15.7	1.3	0.0	0.6	21.4	1.2	19.7	5.3	6.9	4.9	2.8	1.1	2.6	22.2	14.1	3.7	1.4	3.6
AHNAK	MGC5395	ENSG00000124942	"AHNAK nucleoprotein"	Q09666	11	62433542-62556235	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 561.4;fHDF/TERT166: 554.5;TIME: 582.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 395.4"	"HPA019010, HPA019070, HPA026643"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA		10000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.47e-6)"	243.1	27.9	62.6	43.4	50.2	44.1	190.3	33.7	45.4	183.3	61.0	276.2	49.0	183.3	51.7	248.2	145.5	74.8	115.1	65.0	98.0	59.7	60.1	144.1	36.7	76.2	48.3	125.8	30.3	26.3	16.9	97.3	62.9	88.5	96.6	10.1	127.5	105.7	188.5	334.7	136.6	113.1	60.8	59.5	133.5	18.0	49.0	27.9	64.9	172.2	63.7	142.0	213.3	78.4	188.2	107.9	9.8	44.1	421.8	561.4	70.3	166.0	201.4	103.0	57.4	93.7	64.9	0.2	61.7	554.5	79.8	244.1	41.2	203.7	130.7	154.2	7.3	22.6	173.4	27.9	80.8	31.5	142.2	204.2	233.0	202.4	183.6	131.5	215.4	2.7	21.8	138.8	211.7	72.1	0.4	60.7	3.0	59.6	171.7	0.4	45.1	113.9	227.1	120.2	0.3	9.2	167.5	69.3	69.0	198.8	133.7	28.4	582.1	182.4	119.8	229.8	74.4	25.0	5.4	0.6	138.2	10.1	60.9	44.1	75.6	0.3	38.7	45.0	25.8	20.0	24.8	31.7	73.8	16.1	3.2	17.3	1.1	31.5	37.8	20.2	21.5	36.8	62.6	50.2	33.7	45.4	65.0	98.0	76.2	48.3	62.9	60.8	49.0	78.4	413.1	439.1	106.3	49.3	171.4	479.4	133.8	285.0	253.2	1.4	173.0	226.8	199.9	195.9	224.1	193.1	0.0	110.8	194.3	400.8	13.7	99.6	10.6	188.5	195.0	282.5	47.6	43.7	0.9	64.1	145.6	312.9	538.2	351.2	238.9	4.3	201.4	88.5	79.4	1.7	0.8	164.8	138.4	329.8	458.3	33.2	451.4	292.3	318.4	43.1	284.8	30.7	138.0	0.5	0.4	262.5	195.5	466.0	329.0	202.4	262.3	6.8	149.3	1.2	177.5	349.5	244.4	3.1	8.1	596.4	610.3	102.2	256.5	3.0	101.8	198.0
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282019-77559966	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 121.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.5;Excitatory neurons: 403.7;Inhibitory neurons: 167.3;Oligodendrocytes: 706.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 13.6;naive CD4 T-cell: 16.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 13.6;T-cells: 16.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;BJ: 67.8;fHDF/TERT166: 77.5;LHCN-M2: 189.9;U-2 OS: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: AB_2683383"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.0	1.6	75.9	1.5	101.2	3.9	18.9	19.4	115.0	1.3	0.8	2.6	1.0	0.7	0.6	1.0	1.0	1.0	1.0	121.0	31.5	1.4	0.1	0.4	2.3	27.2	30.2	0.5	1.6	0.7	3.4	1.2	25.6	2.3	1.0	3.0	3.0	2.1	0.3	2.0	1.0	0.8	31.0	2.1	2.4	9.4	31.7	0.8	1.1	0.8	1.5	0.7	0.7	81.1	0.2	3.6	2.9	0.1	34.8	93.7	1.2	67.8	14.4	10.8	4.6	0.5	1.7	0.6	0.5	77.5	4.4	0.4	0.2	0.0	5.5	2.6	0.7	0.5	1.2	0.4	1.8	0.6	0.2	11.6	0.5	2.1	4.3	37.9	31.5	0.3	0.9	0.7	189.9	0.7	0.0	0.6	3.9	18.4	24.5	1.7	7.1	1.6	29.3	1.1	15.3	3.5	0.2	0.2	4.4	0.3	0.3	0.5	7.9	26.1	58.4	1.6	2.2	15.2	14.7	0.3	5.2	3.5	9.8	1.2	0.8	0.1	3.8	0.2	0.5	0.9	3.6	1.9	13.6	0.9	16.3	9.1	0.6	0.2	0.2	1.5	1.7	2.3	75.9	101.2	19.4	115.0	121.0	31.5	27.2	30.2	25.6	31.0	31.7	81.1	0.7	0.0	0.0	10.7	0.4	0.3	0.4	0.0	1.2	1.3	54.0	27.3	1.1	0.0	0.0	1.8	0.0	1.9	5.6	0.3	7.9	0.3	150.5	1.1	0.1	1.3	12.0	0.8	403.7	0.6	56.3	1.5	1.1	1.7	0.0	0.0	0.4	0.0	2.4	13.5	167.3	0.3	0.0	0.0	0.6	29.2	1.2	0.4	3.6	41.2	1.9	0.0	47.4	60.8	706.6	0.1	1.1	0.7	0.1	2.9	0.0	7.8	0.0	0.3	0.0	1.2	6.3	10.2	91.0	0.0	0.3	2.9	4.2	0.1	0.2	0.1
AK8	"C9orf98, FLJ32704"	ENSG00000165695	"Adenylate kinase 8"	Q96MA6	9	132725578-132878777	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.3;fallopian tube: 25.8;testis: 15.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 102.3;Endometrial ciliated cells: 26.1;Late spermatids: 134.1;monocytes: 49.2;Respiratory ciliated cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 6.2;naive B-cell: 4.9;NK-cell: 3.1"	"Group enriched"	"Detected in many"	30	"B-cells: 6.2;NK-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.1;RPTEC TERT1: 3.6;T-47d: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021443, HPA023894"	Enhanced					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 3: Monocytes - Immune response regulation"			"HPA021443: AB_1845852, HPA023894: AB_1845854"	"unprognostic (4.14e-2)"	"unprognostic (1.20e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.43e-1)"	0.7	1.2	2.2	0.5	2.5	0.1	1.0	1.7	2.3	2.5	5.6	0.5	0.0	1.3	19.3	0.9	25.8	1.3	0.2	2.5	3.1	2.3	0.1	2.1	0.6	4.2	6.8	1.6	0.7	3.1	1.8	0.4	4.5	0.9	0.3	2.7	1.7	2.7	0.0	1.6	0.1	0.7	3.7	0.1	0.8	15.9	3.3	1.5	4.7	0.2	4.3	0.5	0.5	2.5	1.1	0.7	0.3	1.6	0.2	0.4	0.3	0.1	0.1	0.1	0.0	0.3	1.2	0.0	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.7	0.0	0.0	1.0	0.5	0.3	0.4	0.4	0.0	0.8	0.0	0.0	0.3	3.1	0.7	0.3	0.1	0.4	0.5	0.0	0.0	0.0	3.6	0.0	0.6	0.6	1.5	0.0	0.2	0.3	2.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	4.9	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.1	2.2	2.5	1.7	2.3	2.5	3.1	4.2	6.8	4.5	3.7	3.3	2.5	0.2	3.2	1.7	9.4	1.5	0.5	0.5	3.9	0.6	0.3	0.8	0.5	1.2	0.0	3.4	3.7	0.0	0.4	0.1	0.3	0.0	2.8	102.3	26.1	1.1	1.1	0.0	0.4	4.9	0.5	0.3	0.8	0.0	1.3	0.0	0.4	0.7	0.0	1.7	0.0	5.1	0.9	2.0	0.3	0.3	134.1	6.2	1.8	1.8	0.0	49.2	0.8	0.0	4.5	5.0	1.2	0.3	4.1	0.0	0.6	0.0	6.0	36.7	1.8	0.0	0.8	2.7	24.3	5.6	0.4	1.6	0.4	0.2	1.0	0.5	0.7
AKIP1	"BCA3, C11orf17"	ENSG00000166452	"A-kinase interacting protein 1"	Q9NQ31	11	8911139-8920084	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061391			Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA061391: AB_2684499"	"unprognostic (7.79e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.58e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.24e-9)"	"unprognostic (1.03e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.77e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.19e-1)"	16.0	33.0	21.3	12.4	21.6	11.0	14.9	20.8	21.9	22.1	21.4	22.2	13.7	22.7	17.3	22.4	19.2	13.5	27.1	21.2	22.8	22.7	15.5	17.2	11.3	21.8	24.6	19.6	13.0	13.9	18.7	16.0	21.9	17.3	11.3	16.4	14.6	14.9	37.7	10.3	14.2	14.9	22.4	25.5	16.7	17.6	22.2	16.0	18.6	22.1	9.1	18.8	17.3	22.7	81.5	73.2	31.1	30.4	29.2	37.0	25.0	58.6	45.6	35.0	33.4	39.2	48.1	14.7	45.2	42.5	36.9	53.4	15.6	28.3	24.2	72.4	40.3	25.1	39.7	34.9	34.3	33.6	29.1	31.7	37.8	17.2	62.9	26.8	32.2	29.0	52.2	15.3	65.3	26.6	27.3	31.2	26.3	39.3	54.6	28.5	22.9	18.7	35.7	33.4	22.0	21.6	67.2	29.3	31.7	20.1	33.7	27.6	53.1	49.0	44.5	84.2	56.7	23.0	63.0	3.6	51.0	40.5	52.6	3.1	31.5	1.4	15.3	29.0	16.1	9.2	17.8	17.4	41.1	8.5	11.9	21.0	1.9	13.1	14.5	43.7	58.8	18.1	21.3	21.6	20.8	21.9	21.2	22.8	21.8	24.6	21.9	22.4	22.2	22.7	16.1	19.2	9.9	6.8	7.8	10.7	15.1	54.0	16.5	15.9	13.2	17.0	11.7	20.0	22.2	20.2	10.4	40.9	12.5	7.0	25.4	41.4	54.6	7.6	20.6	24.5	2.4	15.3	8.3	36.0	41.5	22.0	9.2	10.7	49.4	25.9	22.9	15.2	65.9	25.2	10.3	9.8	75.3	25.5	17.3	28.0	22.1	25.6	16.0	8.4	33.4	32.3	7.2	9.5	5.2	33.1	18.6	48.2	9.0	8.3	11.5	21.0	15.7	15.5	19.7	15.4	22.2	39.8	35.1	18.5	7.1	11.8	14.7	48.9	13.7	11.8
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108963484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 4.8"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 80.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;hTCEpi: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030270, HPA030271, HPA030272"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.0	0.0	1.6	0.0	1.5	0.1	0.0	1.8	2.5	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	80.6	0.3	5.1	1.4	0.0	0.0	1.0	0.2	0.8	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.7	0.0	0.0	0.3	17.8	2.5	0.1	1.8	0.0	0.0	0.4	0.0	3.5	3.1	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.9	0.6	1.4	0.1	0.1	0.7	0.1	0.7	0.5	0.0
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386312-113401290	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 209.8"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 147.8;Granulosa cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced		Approved	Cytosol		NA	NA		44000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (7.33e-5)"	"prognostic favorable (5.64e-4)"	"unprognostic (4.16e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (8.80e-5)"	"unprognostic (2.87e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.31e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-2)"	54.7	153.9	73.5	16.8	82.7	82.2	23.2	75.2	84.7	18.4	53.6	25.7	29.5	16.3	26.6	35.0	15.6	27.4	51.9	66.0	74.5	73.2	209.8	20.6	15.6	85.4	83.5	28.9	46.5	73.2	15.9	24.9	84.5	34.1	24.5	19.0	98.6	24.2	28.8	38.9	26.6	17.6	80.1	13.6	50.4	13.1	81.1	20.3	25.9	23.9	18.7	18.4	19.3	83.7	8.1	14.8	11.0	15.7	71.2	48.4	67.8	21.9	35.4	13.7	17.2	19.2	16.7	11.7	12.7	30.3	11.0	29.1	8.1	14.6	8.3	29.5	10.2	22.0	18.2	26.2	16.4	21.2	19.0	41.2	10.8	12.7	5.5	53.9	27.1	18.6	8.9	16.5	23.7	61.8	23.8	21.2	5.4	57.9	27.4	19.5	18.7	19.8	21.4	16.6	10.2	9.4	27.2	32.5	20.1	19.2	34.1	23.7	30.7	12.5	9.3	25.1	12.4	23.8	26.0	9.8	34.1	18.9	13.6	10.2	13.7	23.6	11.3	15.5	6.0	6.8	9.3	6.0	14.6	10.2	8.7	9.9	6.2	6.9	17.4	6.0	10.8	9.7	73.5	82.7	75.2	84.7	66.0	74.5	85.4	83.5	84.5	80.1	81.1	83.7	7.2	16.0	15.6	18.6	10.4	7.0	8.9	7.1	8.0	12.9	16.7	11.6	50.3	25.8	12.0	14.7	27.1	48.2	7.4	27.7	13.7	20.3	5.4	17.7	9.2	11.5	9.1	147.8	10.0	26.3	23.2	10.2	15.3	27.7	14.5	86.5	11.0	70.0	17.0	5.0	10.7	12.5	10.2	15.1	6.4	10.8	11.8	12.4	12.4	9.4	12.4	6.4	8.2	7.1	20.0	15.0	35.3	14.7	11.0	7.6	32.6	59.0	10.6	15.7	6.6	8.9	24.6	6.8	9.5	22.6	9.1	11.4	8.8	11.7	16.7	9.2
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605941-95656711	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 120.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	15.3	16.1	12.2	21.2	12.6	16.7	20.2	12.4	13.1	33.4	21.0	51.9	89.3	18.5	30.9	21.0	21.9	25.2	11.5	12.2	13.6	17.7	24.3	10.8	22.0	12.4	14.7	16.7	61.8	33.5	28.2	26.3	13.1	24.2	49.3	11.4	120.1	24.9	4.3	22.4	73.1	26.3	12.7	12.1	40.5	11.7	14.0	17.2	37.5	5.5	26.9	25.2	14.3	13.1	66.5	61.6	57.9	152.7	76.0	72.9	62.2	75.6	112.8	75.1	93.7	124.4	51.6	223.7	68.9	119.7	36.2	85.6	117.1	77.8	84.6	64.0	92.0	71.2	40.5	177.9	49.7	125.6	76.1	77.0	46.8	61.5	119.1	124.5	79.9	82.6	67.5	46.0	57.1	95.0	114.5	80.5	68.6	109.2	60.7	105.9	66.3	76.9	88.3	49.7	57.5	56.9	60.1	47.1	56.9	66.0	70.5	57.9	66.7	31.1	49.0	80.9	88.2	52.4	41.7	135.8	60.4	142.8	40.7	0.1	2.6	0.2	27.3	5.2	28.7	23.0	24.5	28.3	9.6	16.1	20.7	23.1	0.5	26.3	8.3	5.9	25.8	15.5	12.2	12.6	12.4	13.1	12.2	13.6	12.4	14.7	13.1	12.7	14.0	13.1	4.6	6.4	9.2	7.2	12.6	11.2	8.3	8.9	14.2	6.3	15.6	12.4	4.6	11.5	14.3	20.2	0.0	43.9	6.7	80.5	1.9	13.7	1.3	12.7	18.1	8.0	19.8	17.9	15.7	21.1	31.6	16.2	18.8	16.9	8.2	81.6	5.3	27.3	11.5	10.1	13.6	41.3	8.2	3.5	3.8	1.6	9.3	3.5	16.0	11.2	2.6	7.1	8.2	17.6	12.8	11.7	56.4	12.0	30.1	18.4	79.4	8.4	15.2	3.4	0.0	10.5	10.1	8.2	9.9	17.6	8.1	30.2	9.0	10.8	38.7	9.4
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900671-73080442	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1500.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"classical monocyte: 87.3"	"Lineage enriched"	"Detected in many"	33	"monocytes: 87.3"	"Cell line enhanced"	"Detected in many"		"A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"midbrain: 378.3"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	109.4	182.4	51.3	28.4	71.9	31.8	64.3	125.1	72.4	121.8	35.7	218.2	549.7	139.3	583.4	41.3	184.3	175.4	53.7	64.6	62.1	335.4	1500.8	142.6	31.2	93.4	370.7	222.7	498.1	24.3	164.4	32.0	84.7	57.2	88.8	0.4	104.5	245.4	66.7	17.2	304.3	117.0	104.2	77.5	568.5	149.5	74.5	19.8	211.7	83.0	21.6	31.6	90.7	106.1	0.0	4019.8	0.4	0.0	22.4	0.2	1.4	139.6	0.0	0.1	0.1	136.2	0.0	0.1	50.5	0.0	0.3	2.6	0.0	0.2	0.1	0.4	0.1	232.1	0.6	1269.3	13.7	0.6	0.3	6.7	0.1	0.0	0.0	0.3	143.0	0.0	16.9	0.0	153.3	7.2	0.2	1.8	0.7	7.2	0.4	0.5	44.0	1.8	710.6	1.1	0.3	1.4	0.3	0.4	2.9	0.2	0.0	0.5	0.7	0.0	3.5	0.5	0.3	0.4	0.2	1.0	0.0	1.7	0.4	0.0	87.3	1.4	0.0	14.9	0.0	0.0	0.2	0.1	1.4	0.7	0.0	0.0	2.6	0.0	1.1	1.0	0.0	30.3	51.3	71.9	125.1	72.4	64.6	62.1	93.4	370.7	84.7	104.2	74.5	106.1	4.9	96.1	107.6	31.3	6.9	2.7	18.3	168.3	1.2	0.4	12.6	1.7	4.3	187.3	361.1	115.8	0.0	1.7	0.1	20.2	389.4	71.6	12.6	6.3	125.2	26.4	54.9	96.1	3.5	349.7	1.0	102.7	258.4	8.1	158.9	0.2	133.5	624.4	134.4	0.0	0.5	168.9	138.4	109.6	5.1	37.8	406.4	61.7	7.2	17.8	46.0	0.0	2.1	0.0	0.7	128.4	77.4	207.3	1.3	2.0	267.4	375.4	583.7	0.3	26.3	334.2	28.6	8.6	4.6	21.5	3.1	2.5	8.8	129.6	131.7	26.5
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494867-24537207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 136.6;U-698: 173.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		50000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	9.4	6.1	27.8	5.9	28.9	4.4	5.2	25.0	32.7	5.4	18.8	8.5	11.8	4.8	3.7	7.3	19.0	5.1	14.5	26.5	32.8	27.8	98.8	6.4	13.6	26.7	35.0	7.3	8.2	19.4	5.8	2.4	27.3	8.2	7.1	11.0	5.2	5.2	57.9	9.5	8.0	3.1	29.4	6.8	7.7	4.5	34.0	26.8	17.0	33.8	12.9	6.7	8.4	24.9	11.5	9.3	6.5	10.1	0.1	0.0	11.7	0.8	2.0	2.4	1.6	35.1	2.5	136.6	21.1	1.0	2.2	0.1	10.5	1.3	1.5	14.7	20.2	20.7	5.9	42.4	1.6	32.2	2.7	1.0	4.4	0.2	0.0	7.1	0.1	34.7	10.4	0.0	1.8	23.3	40.4	19.0	2.7	18.4	5.5	46.1	1.4	1.3	7.7	19.6	11.7	10.5	12.1	1.2	13.2	2.8	19.4	17.5	0.2	1.1	6.7	0.3	7.1	19.4	32.2	173.7	0.2	9.8	1.4	0.3	0.0	0.1	1.0	0.0	1.9	2.2	1.4	1.5	0.1	2.0	3.8	3.4	0.2	0.8	0.1	2.4	0.9	0.7	27.8	28.9	25.0	32.7	26.5	32.8	26.7	35.0	27.3	29.4	34.0	24.9	2.9	16.0	25.3	14.0	9.7	1.7	5.6	8.2	2.2	12.9	7.5	3.4	34.8	11.5	9.4	7.3	16.7	6.1	7.4	6.1	1.9	1.6	0.8	15.2	5.0	3.7	8.4	16.0	18.1	1.0	5.2	3.5	5.6	5.4	7.0	13.5	6.8	90.7	3.9	16.8	32.4	11.7	2.0	3.8	1.8	0.3	3.4	1.7	1.8	8.4	0.2	11.8	3.1	11.6	2.4	1.3	7.7	4.5	12.2	4.1	13.4	26.8	12.8	6.9	0.0	6.9	2.3	1.7	6.6	8.7	3.0	1.9	5.4	8.0	17.0	13.1
ALKBH7	"MGC10974, SPATA11"	ENSG00000125652	"AlkB homolog 7"	Q9BT30	19	6372794-6375250	"Predicted intracellular proteins"	Necrosis	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 517.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 3004.6;Late spermatids: 8717.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008539, HPA039571, HPA039872"	Approved		Supported	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710"	"unprognostic (5.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (7.83e-6)"	"unprognostic (7.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	48.9	64.5	59.8	19.2	62.3	31.1	51.3	65.7	74.2	54.6	69.5	72.5	65.8	48.4	14.6	66.1	55.4	19.2	157.2	56.6	61.3	86.0	152.9	40.4	26.9	64.0	61.3	68.8	112.3	44.9	67.5	14.3	61.0	70.1	20.0	15.8	65.2	30.5	154.4	61.0	61.5	12.8	63.6	46.6	68.4	517.8	61.6	28.1	73.0	67.4	15.9	52.1	51.6	68.5	28.9	25.2	21.4	37.1	11.8	32.7	30.9	20.5	18.0	18.1	19.1	44.0	18.3	42.1	68.4	26.2	12.8	22.1	9.6	17.1	3.5	40.9	38.9	24.5	17.6	41.4	34.5	12.4	31.3	37.6	33.8	15.7	12.3	17.5	22.5	40.7	26.2	80.0	13.9	58.3	63.5	42.6	30.8	33.9	106.1	46.6	13.4	84.2	20.4	22.1	30.3	46.3	13.8	36.1	76.4	10.1	41.0	44.7	20.3	18.0	25.0	66.9	20.1	129.2	98.1	27.7	33.9	41.9	15.9	38.3	106.4	17.3	52.7	91.6	72.9	113.4	91.4	72.5	127.6	103.0	137.4	111.1	64.4	66.1	72.0	143.9	85.7	91.5	59.8	62.3	65.7	74.2	56.6	61.3	64.0	61.3	61.0	63.6	61.6	68.5	84.8	60.9	74.4	3.3	109.0	83.7	154.4	129.1	160.5	93.1	221.6	335.4	106.3	112.9	83.9	66.2	66.7	97.6	79.3	516.1	313.1	110.1	3004.6	76.1	73.0	84.8	220.4	54.0	2.4	245.2	149.6	88.0	77.5	85.1	66.0	108.3	113.2	302.0	196.8	42.1	3.5	400.4	71.2	168.6	96.2	8717.7	103.2	128.6	133.4	1.9	192.6	166.1	69.0	3.0	9.3	116.0	528.2	88.8	121.0	121.1	856.4	433.6	52.7	152.4	92.1	97.2	104.1	1180.3	76.7	171.2	100.6	108.9	87.4	143.4	410.5	215.6
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 72.8;lymphoid tissue: 93.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 63.7;granulocytes: 201.3;Hofbauer cells: 85.0;Kupffer cells: 78.5;Macrophages: 86.5;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 13.9;Daudi: 40.9;HMC-1: 24.0;U-266/70: 30.8;U-698: 11.0"	"Region enriched"	"Detected in single"	4	"white matter: 2.9"	"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	16.8	8.4	1.4	8.4	1.1	31.1	12.7	2.8	2.9	6.1	1.0	11.0	3.0	6.9	0.3	10.7	11.1	3.4	6.7	1.2	1.8	8.3	5.5	72.8	6.7	4.1	2.5	2.6	23.2	0.9	3.2	3.6	2.7	11.8	2.3	0.1	14.1	1.5	2.1	5.6	35.8	4.9	2.5	93.9	9.3	2.1	2.2	2.6	4.7	3.7	8.9	40.0	7.9	4.2	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	7.4	40.9	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	8.6	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	2.7	0.0	5.2	0.7	0.0	0.0	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.2	0.0	0.0	30.8	2.8	11.0	0.0	0.1	0.0	462.5	225.6	317.6	0.3	198.4	0.6	133.9	5.3	1.7	119.7	98.5	0.7	0.5	457.8	0.2	210.5	2.4	1.2	136.1	1.4	1.1	2.8	2.9	1.2	1.8	4.1	2.5	2.7	2.5	2.2	4.2	0.7	16.0	38.4	1.3	63.7	1.1	7.3	0.2	1.2	1.3	7.3	4.3	2.2	12.8	9.5	9.2	2.1	0.7	1.7	1.7	0.0	20.9	0.5	0.7	0.5	3.0	7.1	1.7	2.8	21.6	2.0	1.7	13.7	4.4	201.3	2.2	3.6	1.1	85.0	0.0	1.1	2.0	14.2	78.5	17.8	1.1	0.3	86.5	0.0	47.8	59.5	0.7	4.1	4.0	1.4	18.4	0.6	0.0	13.8	4.0	9.4	0.2	2.6	0.3	13.1	0.3	1.1	0.3	1.1	9.2	1.4	4.1	5.9	0.7	3.2	45.3
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986165-34008104	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 134.3;liver: 180.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5"	"Group enriched"	"Detected in all"	4	"liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 175.4;U-266/84: 98.0"	"Low region specificity"	"Detected in all"							"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		70000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	8.6	15.0	5.9	5.0	5.5	3.0	6.4	4.6	6.0	6.5	4.6	40.0	18.0	4.7	9.6	15.6	6.2	20.5	10.1	5.4	7.8	134.3	180.6	9.2	3.6	5.9	6.4	7.8	13.8	13.0	5.7	7.7	6.6	39.3	42.9	12.0	60.7	12.5	19.2	4.9	15.9	7.0	5.8	5.4	34.8	4.3	8.4	4.8	8.3	14.9	5.6	8.8	8.5	5.8	12.7	20.2	11.1	14.3	7.7	11.9	19.1	16.6	12.2	7.6	5.7	66.1	15.1	4.1	8.7	23.6	28.6	5.8	2.8	12.0	7.7	12.7	10.9	9.8	13.7	19.0	5.4	6.0	3.0	18.1	6.0	9.7	3.6	10.7	8.5	8.3	3.8	14.7	22.4	9.6	5.0	7.6	10.0	9.4	32.9	6.0	18.6	6.5	33.2	62.4	6.1	8.7	27.6	19.3	16.9	9.1	14.9	5.9	15.6	24.6	5.4	6.2	13.6	175.4	98.0	7.4	7.0	12.1	18.8	0.3	6.0	9.3	8.3	8.0	7.0	7.1	7.2	6.4	8.9	5.2	6.6	4.8	10.0	8.7	14.2	4.6	7.9	6.0	5.9	5.5	4.6	6.0	5.4	7.8	5.9	6.4	6.6	5.8	8.4	5.8	0.8	3.2	4.1	0.0	2.2	0.4	0.4	0.9	1.8	4.3	1.4	0.9	1.1	8.6	3.7	1.8	0.0	1.0	2.2	19.7	5.9	0.8	8.9	2.3	1.2	3.0	4.2	2.1	0.0	3.8	1.0	2.9	4.1	1.5	0.0	1.2	1.1	21.6	1.1	5.0	0.0	5.1	4.1	0.9	0.2	21.6	0.6	1.2	0.0	0.0	1.5	9.3	3.1	0.0	0.0	2.6	4.5	2.2	1.6	0.6	4.7	38.5	3.1	0.9	0.0	1.7	3.7	0.7	0.7	3.4	0.6	0.3	1.5	1.2	4.4	0.4
AMPD1	"MAD, MADA"	ENSG00000116748	"Adenosine monophosphate deaminase 1"	P23109	1	114673090-114695618	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 559.2;tongue: 211.4"	"Group enriched"	"Detected in some"	6	"Plasma cells: 43.8;Skeletal myocytes: 13.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"U-266/70: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026478, HPA028080"	Enhanced				"Intracellular and membrane"	NA	NA		38000	"Cluster 37: B-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA026478: AB_10599969, HPA028080: AB_10600776"	"unprognostic (1.98e-3)"	"unprognostic (1.43e-3)"	"unprognostic (8.75e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.95e-2)"		"unprognostic (5.61e-3)"	"unprognostic (8.21e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.36e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.02e-1)"	0.1	0.1	0.0	0.5	0.0	0.3	3.0	0.0	0.0	0.2	0.0	5.6	16.4	0.2	0.0	5.8	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.0	3.5	5.5	0.0	4.4	0.9	559.2	0.0	7.5	0.1	0.0	1.6	3.7	0.1	0.0	0.4	0.1	211.4	2.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.8	1.9	0.0	0.0	0.0	3.0	4.2	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
ANGPTL6	"AGF, ARP5"	ENSG00000130812	"Angiopoietin like 6"	Q8NI99	19	10092338-10102796	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 30.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.1;Hepatic stellate cells: 5.7;Hepatocytes: 8.2;Smooth muscle cells: 15.8;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	450000	23000000	"Cluster 24: B-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.28e-1)"	"unprognostic (2.18e-6)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.26e-10)"	"unprognostic (8.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	0.3	0.3	0.8	2.1	0.7	2.8	0.3	0.8	1.1	0.2	0.4	0.6	0.7	0.1	0.2	0.3	0.7	0.4	0.2	0.7	0.8	0.5	30.2	0.5	3.3	1.7	1.1	0.3	1.1	0.1	0.4	2.2	1.3	0.2	0.4	0.1	0.2	0.0	0.0	0.3	3.5	0.2	1.2	3.4	1.6	1.6	1.0	0.8	0.3	0.0	3.3	0.5	0.2	1.7	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.2	0.0	0.1	7.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	2.0	0.2	0.2	0.0	0.5	58.9	0.0	0.2	0.1	0.1	0.3	0.0	0.6	0.4	0.3	0.0	0.0	1.3	4.7	0.2	0.4	1.1	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	5.0	0.0	0.1	0.1	0.0	0.0	5.1	1.4	2.9	0.2	0.7	0.7	0.0	0.3	0.0	0.6	0.4	0.4	0.7	0.4	0.4	0.1	0.9	0.2	0.4	0.0	0.4	0.2	0.1	0.5	0.2	0.8	0.7	0.8	1.1	0.7	0.8	1.7	1.1	1.3	1.2	1.0	1.7	0.3	0.0	0.0	0.0	4.1	0.3	0.1	0.4	0.0	0.1	0.4	0.3	0.4	2.8	0.3	0.0	0.0	0.2	1.7	0.1	1.9	0.3	0.3	0.0	0.3	0.2	0.0	0.4	0.9	0.0	0.2	2.5	0.5	0.1	0.0	0.1	5.7	8.2	2.3	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	2.1	0.0	0.2	0.5	0.2	0.2	0.0	0.1	15.8	0.5	6.3	0.0	0.0	0.3	1.0	0.9	0.1	0.1
ANKRD34C		ENSG00000235711	"Ankyrin repeat domain 34C"	P0C6C1	15	79293285-79298235	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"brain: 5.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 3.0;Inhibitory neurons: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"SCLC-21H: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045329			Approved	Mitochondria		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA045329: AB_2679291"	"unprognostic (3.20e-1)"			"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"						"unprognostic (1.81e-1)"		"unprognostic (3.42e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.48e-1)"			0.1	0.1	1.4	0.0	0.5	0.0	0.0	2.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	3.0	0.0	0.0	0.1	0.0	2.2	2.8	0.0	0.2	0.0	0.7	0.0	3.4	0.0	0.0	0.5	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	2.0	1.9	0.4	3.0	2.2	2.8	3.4	0.2	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD46		ENSG00000186106	"Ankyrin repeat domain 46"	Q86W74	8	100509752-100559784	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013758	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA013758: AB_10962626"	"unprognostic (3.71e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.08e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-3)"	19.2	38.7	29.1	8.4	30.2	2.2	14.6	25.1	33.6	15.1	15.6	9.2	10.2	12.7	16.3	12.7	11.4	7.7	20.1	30.1	25.8	32.7	41.6	10.7	9.9	22.3	22.2	22.6	18.5	16.1	10.3	20.8	24.4	13.5	9.1	35.2	17.1	13.2	62.2	11.2	11.0	12.4	24.9	11.1	11.6	8.3	24.0	15.4	20.0	36.2	10.9	9.5	9.9	28.7	10.0	12.2	17.9	10.1	13.6	8.0	20.0	12.8	5.8	9.6	8.1	17.8	5.9	31.2	23.3	4.4	3.1	7.5	18.5	9.5	10.1	11.2	16.3	39.0	6.4	14.1	7.7	9.3	4.7	5.8	17.1	6.1	10.2	10.3	11.9	21.4	20.8	9.9	9.3	11.4	43.3	16.8	13.1	25.6	9.0	33.1	6.0	21.0	14.1	10.6	19.8	20.1	5.5	9.9	8.5	21.5	14.8	15.7	9.0	4.4	4.9	6.5	5.1	23.0	23.8	25.7	4.8	29.6	7.2	16.4	7.3	7.6	14.4	3.7	17.1	12.7	13.5	12.4	9.6	11.1	17.5	15.2	1.8	16.9	6.8	8.8	13.8	10.9	29.1	30.2	25.1	33.6	30.1	25.8	22.3	22.2	24.4	24.9	24.0	28.7	11.5	6.4	3.9	17.9	14.2	10.8	11.3	9.0	19.4	30.1	10.7	7.4	13.1	12.8	4.8	22.0	18.8	32.1	12.2	5.7	29.4	8.3	1.2	4.6	6.7	12.5	7.3	12.2	41.5	6.0	14.1	11.9	9.7	4.7	4.5	13.8	21.8	34.6	11.4	67.3	36.9	7.6	2.0	6.7	9.3	2.2	21.1	4.0	10.6	24.4	8.1	46.4	10.3	24.1	23.4	3.3	9.1	26.4	13.8	10.5	20.3	61.8	6.5	31.5	26.3	15.1	12.8	14.4	17.2	13.9	14.2	23.4	9.3	11.9	8.5	9.6
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039233-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5"	"Group enriched"	"Detected in all"	6	"B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3"	"Cell line enhanced"	"Detected in many"		"HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	4.7	1.3	3.2	12.1	3.2	19.8	3.9	3.0	3.8	3.5	3.5	2.5	3.3	2.4	1.7	1.8	3.3	3.5	2.9	2.8	2.9	2.0	1.3	4.6	26.1	3.4	3.3	1.2	0.8	0.6	1.1	3.2	3.2	2.7	2.7	0.1	1.7	1.2	2.5	2.1	8.2	2.1	3.5	15.8	3.3	1.5	3.3	25.2	2.7	3.0	17.2	3.2	3.8	4.0	2.1	2.1	1.6	1.2	2.6	8.0	0.4	0.5	0.3	0.5	0.6	3.9	1.9	6.8	6.5	1.6	2.2	0.8	5.0	0.5	0.5	13.3	4.0	2.2	5.9	1.8	4.1	2.6	0.8	27.7	0.2	2.4	0.2	0.1	16.2	33.1	1.5	8.9	2.1	3.1	30.0	4.1	0.0	1.7	14.8	30.9	3.6	3.9	0.7	1.1	5.7	0.0	2.7	0.7	0.7	0.2	0.7	4.9	9.9	0.5	0.0	0.8	2.5	4.4	6.7	3.3	3.6	117.7	1.4	5.6	3.5	1.7	53.9	2.5	63.5	34.3	56.1	59.9	3.5	32.9	96.3	72.1	3.2	24.8	8.1	5.2	66.5	26.6	3.2	3.2	3.0	3.8	2.8	2.9	3.4	3.3	3.2	3.5	3.3	4.0	32.2	0.0	9.9	0.0	23.8	3.7	1.4	0.3	2.2	0.1	1.9	2.2	1.3	4.3	1.5	0.0	0.0	0.4	36.4	0.5	0.0	0.1	4.0	1.1	5.0	24.8	1.8	8.2	0.0	0.0	1.1	7.2	1.5	0.8	15.2	4.1	38.2	1.4	8.7	0.0	0.0	0.1	2.0	18.2	5.6	1.5	1.5	7.5	7.2	0.0	7.1	0.2	47.4	0.0	0.0	0.1	0.0	0.4	7.8	1.2	1.0	0.4	2.0	0.0	0.0	3.4	3.7	0.7	1.6	1.2	2.3	0.4	66.0	0.3	0.5	1.4
ANXA4	ANX4	ENSG00000196975	"Annexin A4"	P09525	2	69644425-69827112	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 569.9;pancreas: 356.8"	"Cell type enhanced"	"Detected in all"		"Cholangiocytes: 2344.8;Ductal cells: 1469.8;Proximal enterocytes: 657.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 414.2;Hep G2: 456.9;RPTEC TERT1: 623.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005076, HPA007393, CAB017560"	Enhanced		Approved	Cytosol		NA	NA		550000	"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168"	"prognostic unfavorable (8.55e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (7.23e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.97e-2)"	48.2	21.6	14.5	33.6	15.4	30.8	45.9	14.9	18.9	62.4	52.4	101.7	271.3	50.9	30.3	43.0	68.6	569.9	26.1	14.4	15.2	104.0	120.9	81.6	21.1	15.6	15.1	38.8	356.8	78.0	11.9	52.7	15.8	46.3	92.3	30.0	39.2	52.1	17.2	61.0	232.4	52.0	15.7	24.2	108.2	9.7	15.2	23.0	43.6	20.4	24.0	61.3	50.2	16.6	69.6	249.4	3.4	31.0	185.0	158.3	11.3	66.0	101.5	27.1	38.0	37.9	121.7	22.8	414.2	109.5	78.9	104.7	23.8	108.1	27.6	65.2	20.3	35.0	20.5	456.9	131.2	12.5	43.0	95.9	104.8	36.5	87.3	62.9	71.1	11.0	2.0	20.1	74.7	63.8	18.3	22.8	6.1	280.0	34.3	19.4	6.8	28.3	623.2	99.1	5.1	22.9	72.9	99.5	103.8	35.6	33.3	156.3	100.9	49.2	23.8	65.5	37.7	8.2	9.7	1.3	75.8	59.7	34.1	80.4	34.7	29.6	23.1	42.5	17.5	40.6	11.7	17.5	50.6	46.7	2.0	12.5	4.9	9.5	58.7	15.5	14.5	24.2	14.5	15.4	14.9	18.9	14.4	15.2	15.6	15.1	15.8	15.7	15.2	16.6	66.4	205.1	154.8	47.3	27.3	74.2	98.5	148.2	68.9	8.2	36.8	36.4	10.6	2344.8	139.4	84.6	6.2	86.4	27.2	315.1	221.1	1469.8	14.6	257.9	79.0	49.1	18.6	12.6	29.9	344.4	370.1	103.6	196.7	488.8	111.5	24.3	33.9	68.5	227.6	8.4	17.7	193.8	240.1	46.1	80.4	11.2	64.7	54.5	92.5	63.7	87.2	48.7	45.3	17.6	106.0	245.7	268.6	92.2	6.9	55.6	657.1	400.4	230.2	59.9	6.6	27.6	64.6	15.8	3.7	61.3	79.6	439.6	32.5	19.1	174.1	96.9
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674014-49683971	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		2300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	21.7	43.6	18.0	30.7	18.0	42.3	26.8	17.9	22.8	24.8	27.7	48.5	48.6	19.7	24.7	40.2	33.7	22.3	40.6	17.7	19.9	65.8	63.3	26.8	35.2	19.2	21.3	24.6	34.8	63.0	38.3	31.9	24.3	31.0	51.7	12.9	34.0	29.5	103.8	32.8	35.1	28.1	16.8	27.2	35.5	18.7	20.0	37.3	48.6	103.9	43.4	35.0	21.2	16.7	101.2	79.2	84.2	110.8	71.3	48.3	113.6	64.2	79.3	87.4	91.2	130.1	101.7	127.1	70.0	71.7	78.9	89.8	95.1	143.4	64.2	61.9	41.0	138.8	123.4	105.1	72.0	145.5	204.7	55.0	106.5	49.2	101.4	85.5	78.7	86.4	86.6	59.8	86.0	90.8	105.3	76.6	50.4	140.5	75.3	38.4	72.8	165.1	169.9	226.7	40.4	71.2	72.4	166.7	78.9	61.0	112.1	77.2	36.1	53.8	93.0	83.6	86.8	69.8	54.5	77.7	91.7	104.1	78.7	57.9	43.0	52.8	44.8	47.6	34.8	33.3	36.3	41.9	43.6	27.6	37.9	37.4	13.6	39.0	47.6	35.1	50.4	51.9	18.0	18.0	17.9	22.8	17.7	19.9	19.2	21.3	24.3	16.8	20.0	16.7	5.4	41.7	25.3	7.5	20.1	8.7	23.3	50.2	11.4	6.8	20.8	15.9	46.8	30.0	39.4	27.6	12.5	83.7	16.5	83.2	43.0	44.4	6.4	16.6	13.8	9.0	26.5	43.8	4.8	34.7	64.8	16.4	41.8	20.5	23.5	20.0	13.2	74.7	51.1	8.4	4.7	47.1	63.1	35.9	11.9	10.9	15.2	23.2	21.4	2.8	26.8	30.4	27.8	3.0	2.0	39.0	35.8	13.5	39.4	18.0	85.4	80.7	19.4	11.1	13.1	10.6	25.2	33.2	28.5	30.6	9.2	62.1	23.9	28.5	74.0	23.7
APOBEC3F	"ARP8, BK150C2.4.MRNA, KA6"	ENSG00000128394	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3F"	Q8IUX4	22	39040604-39055972	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.9"									HPA073637			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA073637: "	"unprognostic (1.38e-3)"	"unprognostic (1.28e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (8.28e-4)"	2.2	6.3	2.2	9.2	2.1	3.3	2.5	2.2	2.7	4.0	3.4	3.5	3.7	4.1	6.3	2.4	8.3	3.5	5.5	2.0	2.2	3.4	2.9	3.4	15.7	3.1	2.6	8.8	3.0	5.2	3.4	2.2	2.8	4.8	2.8	1.1	4.9	5.2	0.6	1.6	3.8	4.5	2.3	11.9	4.8	8.2	2.5	5.3	3.0	1.3	14.5	4.5	3.2	2.9	4.9	4.2	1.8	6.2	4.9	7.1	2.2	4.2	6.9	8.8	14.0	3.9	9.1	12.9	4.1	8.9	7.7	6.5	1.7	6.0	3.8	11.7	5.3	16.5	0.5	2.5	8.6	3.6	7.0	9.5	3.0	5.0	1.5	5.1	8.5	3.5	1.3	19.9	4.8	3.9	4.0	2.7	0.8	0.5	0.7	6.1	0.7	2.5	8.1	6.6	0.9	1.5	4.7	1.2	2.5	3.5	4.7	1.9	2.3	2.0	5.0	0.4	2.0	3.4	1.7	0.5	5.6	1.9	3.1	3.2	4.7	9.4	8.5	9.1	9.8	27.7	5.6	9.0	6.0	34.2	3.4	5.6	3.1	14.6	14.5	4.6	8.4	7.4	2.2	2.1	2.2	2.7	2.0	2.2	3.1	2.6	2.8	2.3	2.5	2.9	1.6	0.0	0.5	0.0	9.8	0.9	4.9	6.3	2.2	0.0	2.1	2.2	5.9	8.6	4.2	0.0	0.0	2.0	7.6	0.8	1.9	7.4	2.4	4.8	3.8	2.6	1.2	2.1	0.1	3.9	1.4	2.9	2.6	3.6	2.5	11.0	3.6	1.6	5.9	0.0	0.0	2.2	4.1	2.2	1.4	5.2	5.0	2.8	5.4	2.8	5.3	2.2	8.2	0.5	0.0	4.8	3.6	6.4	9.6	4.5	0.5	5.3	4.6	0.2	0.0	1.0	2.6	0.3	0.4	1.6	0.9	1.6	5.4	7.8	1.5	5.9
APOBEC3G	"bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019"	ENSG00000239713	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3G"	Q9HC16	22	39077067-39087743	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 145.4;monocytes: 69.1;NK-cells: 251.3;Plasma cells: 69.5;T-cells: 120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.0;Daudi: 38.3;HDLM-2: 31.8;Karpas-707: 44.2"									"HPA001812, HPA073637"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA001812: AB_1078175, HPA073637: "	"prognostic favorable (4.78e-4)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.18e-3)"	"prognostic favorable (6.03e-5)"	"unprognostic (2.37e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.13e-3)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.66e-13)"	"unprognostic (3.41e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.91e-2)"	"prognostic favorable (6.30e-4)"	5.5	8.1	3.3	21.7	3.2	15.9	8.6	3.4	4.6	7.7	2.9	7.6	5.5	10.3	10.4	6.1	21.1	11.1	4.3	3.0	4.0	4.1	5.7	14.5	45.9	3.9	3.7	22.7	1.7	4.8	3.5	5.0	3.9	7.8	9.4	1.4	8.5	22.4	1.2	1.6	9.6	9.6	4.0	28.2	10.0	20.1	3.4	25.9	5.8	2.7	35.1	15.7	6.4	4.5	4.5	0.1	0.0	0.0	5.0	9.7	0.3	1.0	16.8	19.9	30.0	1.6	22.6	38.3	0.5	7.3	11.6	0.1	0.2	1.3	6.0	31.8	0.1	23.1	0.0	0.2	21.8	7.1	10.1	14.3	0.5	10.9	2.4	0.0	2.4	1.2	1.9	44.2	3.1	0.0	7.6	7.7	0.6	0.0	1.7	15.3	0.0	25.8	0.0	19.6	0.0	0.0	0.5	0.0	2.0	1.7	0.0	13.2	0.0	2.8	0.2	0.0	0.0	0.0	3.5	0.5	3.2	6.9	5.0	30.7	42.3	28.7	363.8	98.1	207.6	84.9	108.8	281.7	52.4	66.1	34.3	160.2	34.8	232.2	123.0	28.1	92.3	297.8	3.3	3.2	3.4	4.6	3.0	4.0	3.9	3.7	3.9	4.0	3.4	4.5	8.4	3.2	8.9	1.0	55.7	1.8	15.5	27.0	4.6	0.4	3.0	6.6	3.7	7.2	14.4	0.0	2.1	3.9	145.4	0.6	5.9	11.7	47.2	5.7	6.4	8.9	6.0	8.6	0.1	2.3	1.1	10.0	2.0	3.9	12.6	62.5	11.4	0.9	30.6	0.0	0.1	1.9	10.2	20.4	9.8	13.7	19.0	21.3	7.2	3.7	69.1	8.1	251.3	0.5	0.0	2.2	1.8	9.1	69.5	16.0	0.1	2.1	12.1	1.2	19.7	4.7	10.1	1.3	1.6	2.0	1.3	1.0	120.5	20.3	1.5	18.0
ARAP3	"CENTD3, DRAG1, FLJ21065"	ENSG00000120318	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3"	Q8WWN8	5	141653401-141682230	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.2;Endothelial cells: 28.3;Hepatic stellate cells: 28.5;Horizontal cells: 38.7;Microglial cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.3;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.4;HUVEC TERT2: 74.3;TIME: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042887	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042887: AB_10796681"	"unprognostic (1.98e-1)"	"unprognostic (4.88e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.77e-3)"	"unprognostic (9.76e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.98e-2)"	11.4	4.1	4.6	5.4	4.7	6.2	10.1	5.2	5.4	9.5	1.5	4.5	3.2	7.5	5.4	3.2	7.8	6.7	14.1	3.3	2.9	7.8	2.1	15.8	2.3	4.1	4.4	3.7	2.5	5.3	5.1	11.9	4.4	7.4	2.6	3.9	3.9	5.8	7.0	2.6	4.6	5.9	3.1	7.3	4.3	1.6	6.3	0.7	8.5	9.2	1.2	7.8	7.3	2.9	11.9	7.5	29.4	0.0	1.8	4.5	0.3	7.0	7.9	7.2	9.2	4.7	0.9	0.1	39.4	2.6	11.7	12.8	5.0	16.8	5.5	0.2	2.1	11.0	12.6	0.1	8.2	0.9	0.4	8.3	7.6	3.9	8.9	20.1	74.3	0.0	0.8	0.1	1.0	0.3	0.0	9.5	17.4	3.9	9.4	0.2	2.3	0.0	0.8	5.4	0.5	24.7	15.1	0.8	12.7	10.6	0.4	2.8	53.3	4.8	10.8	1.3	14.7	0.0	0.1	0.1	12.4	12.6	24.3	0.3	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.1	0.2	4.6	4.7	5.2	5.4	3.3	2.9	4.1	4.4	4.4	3.1	6.3	2.9	33.2	3.2	8.6	0.3	0.3	0.5	1.7	3.1	0.0	6.1	0.9	2.2	5.2	0.0	2.6	1.8	0.0	0.1	1.6	1.3	0.0	1.2	0.0	0.7	2.3	28.3	0.0	0.0	2.4	0.7	0.1	2.2	1.1	1.2	1.3	0.0	28.5	0.3	1.3	38.7	3.2	1.3	2.0	4.4	2.1	0.6	0.3	2.2	0.0	15.0	2.7	3.6	2.1	1.5	0.1	4.6	1.8	1.5	1.6	2.8	0.0	0.1	0.9	0.9	0.0	1.2	3.3	0.5	0.9	0.8	0.4	0.1	1.5	0.4	2.7	3.6
ARF3		ENSG00000134287	"ADP ribosylation factor 3"	P61204	12	48935723-48957487	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.99e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	63.1	73.4	113.5	79.9	151.8	66.7	53.1	53.9	154.2	66.9	31.4	98.0	57.7	59.8	71.0	79.5	59.2	46.6	45.2	167.5	102.3	85.6	45.9	71.0	50.6	70.1	77.1	47.3	46.3	138.1	75.2	58.6	71.7	55.2	89.0	78.0	55.1	59.2	16.9	68.2	65.4	72.0	70.2	60.7	55.3	48.9	128.4	73.3	69.5	16.7	69.8	64.8	51.0	100.4	212.1	305.2	131.0	116.7	106.5	77.4	124.8	137.8	173.0	158.5	136.4	407.0	272.1	168.6	201.4	151.2	124.4	171.7	182.9	186.8	142.4	206.8	94.2	274.5	243.0	118.3	66.5	212.1	213.5	87.4	145.2	172.8	102.3	172.1	170.9	111.8	170.4	89.0	137.1	256.7	158.1	116.7	185.4	338.5	162.4	150.4	75.0	111.6	173.3	265.7	134.7	122.7	148.6	171.2	129.7	144.4	290.1	167.1	238.8	117.3	187.1	74.2	87.3	86.0	210.4	123.0	154.7	162.0	68.4	5.7	39.0	27.7	13.5	25.2	10.6	13.1	15.6	16.8	52.1	12.7	8.4	9.8	54.8	18.7	17.1	40.2	14.0	21.3	113.5	151.8	53.9	154.2	167.5	102.3	70.1	77.1	71.7	70.2	128.4	100.4	35.8	25.6	33.2	19.6	31.4	60.3	41.5	92.2	61.5	34.5	60.2	40.6	10.1	54.3	47.4	99.3	10.4	56.4	54.4	228.4	66.5	114.8	49.9	41.3	31.8	55.0	70.8	26.5	44.3	90.7	119.8	42.7	34.1	48.9	27.9	59.5	57.5	48.7	132.8	43.7	36.8	71.5	75.3	86.9	81.2	101.9	40.7	79.9	44.4	18.7	128.1	57.4	50.4	14.6	20.6	103.2	176.3	37.2	37.6	60.5	78.9	143.3	45.8	24.1	32.9	24.0	52.3	52.6	63.8	61.6	65.8	69.0	31.3	43.2	67.3	56.7
ARFIP1	HSU52521	ENSG00000164144	"ADP ribosylation factor interacting protein 1"	P53367	4	152779937-152918463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005080, HPA037375, HPA063759"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.49e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (2.83e-10)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.22e-3)"	16.8	14.8	7.9	15.8	8.7	3.7	23.4	9.9	10.8	22.5	9.9	28.1	23.2	21.7	20.5	20.9	18.5	19.9	10.2	7.3	9.3	19.8	15.4	16.8	15.1	9.3	8.0	17.6	10.5	22.4	10.5	18.0	9.5	21.1	27.8	20.2	13.7	17.2	6.6	17.3	21.3	19.8	9.4	18.3	22.7	12.1	8.3	12.0	20.1	10.4	14.8	23.5	15.2	11.4	25.8	18.4	25.1	25.7	37.2	37.9	30.6	29.5	40.5	28.7	26.9	21.3	51.3	20.6	9.9	40.5	22.7	18.1	26.3	29.1	35.3	16.9	16.2	20.0	18.0	20.5	26.1	38.2	41.7	26.6	30.9	24.8	23.8	30.7	26.4	11.8	23.5	43.3	39.8	28.6	22.7	19.8	21.8	29.9	18.5	12.6	14.7	19.2	50.7	32.1	32.8	26.0	22.1	40.7	30.2	23.5	37.7	19.6	17.3	27.8	20.1	26.8	21.4	48.2	42.8	28.1	35.3	38.2	40.0	31.5	27.3	42.2	14.5	31.1	14.6	19.0	11.2	12.2	24.8	17.7	8.7	11.8	81.6	29.1	30.7	3.1	18.5	18.7	7.9	8.7	9.9	10.8	7.3	9.3	9.3	8.0	9.5	9.4	8.3	11.4	28.5	6.4	31.8	40.5	20.3	29.6	18.4	30.7	34.1	17.2	26.2	19.7	10.2	20.0	29.1	38.6	0.0	28.6	15.6	40.9	27.4	27.4	46.3	42.2	33.0	23.8	38.9	12.0	44.5	18.3	27.0	28.8	40.2	50.7	22.8	14.2	17.2	19.8	22.1	18.5	42.8	39.1	34.6	23.8	18.0	21.6	22.4	24.5	21.4	89.9	19.5	35.9	23.7	76.4	75.6	24.4	28.2	21.8	11.8	23.6	23.8	34.2	31.9	24.2	32.9	20.6	27.8	31.7	29.5	31.9	34.0	43.9	17.7	89.2	31.7	30.3
ARHGAP21	"ARHGAP10, KIAA1424"	ENSG00000107863	"Rho GTPase activating protein 21"	Q5T5U3	10	24583609-24723887	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 111.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 266.5;Oligodendrocyte precursor cells: 336.7;Oligodendrocytes: 827.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036610, HPA057861"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Cell Junctions, Actin filaments"	"Plasma membrane"	"HPA036610: AB_10669910, HPA057861: AB_2683546"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	28.4	18.0	44.3	10.3	77.7	7.2	16.1	56.7	58.1	19.7	0.0	16.6	12.9	19.9	8.6	10.8	17.5	17.9	21.2	49.1	48.3	11.0	13.1	21.7	5.3	76.3	63.1	31.9	14.9	14.6	12.1	16.6	66.7	10.8	18.5	41.3	24.5	11.5	17.7	6.8	16.3	17.8	48.4	8.9	27.1	14.6	58.0	11.4	12.8	23.0	6.0	13.8	9.0	111.2	59.0	25.1	60.9	52.3	42.2	59.1	21.6	41.6	26.6	24.5	34.0	18.4	36.8	10.9	14.0	64.3	37.7	38.1	31.6	40.4	35.9	38.0	20.5	64.9	54.7	13.8	25.5	0.0	9.9	24.4	45.0	32.1	34.4	36.9	42.3	16.1	27.9	96.3	50.0	11.6	30.2	2.3	9.7	20.8	13.6	7.0	21.4	6.2	17.2	10.2	10.5	10.9	27.9	16.0	32.6	18.1	16.3	9.1	47.8	35.3	22.7	40.0	30.6	11.0	20.3	7.8	36.2	11.4	24.7	0.9	0.2	0.4	0.1	0.4	0.1	0.0	0.2	0.3	0.3	0.0	0.6	0.3	0.0	0.2	0.2	0.4	0.4	0.2	44.3	77.7	56.7	58.1	49.1	48.3	76.3	63.1	66.7	48.4	58.0	111.2	47.9	86.6	33.1	246.8	6.5	29.6	13.2	23.6	14.8	144.0	17.5	26.0	37.4	24.3	45.0	5.5	68.8	23.8	6.9	44.6	1.9	21.4	5.0	36.2	148.7	34.9	16.2	15.2	266.5	27.6	21.0	73.0	82.0	54.2	17.1	135.8	26.0	20.9	14.6	132.9	153.8	28.3	14.2	32.8	31.8	8.3	92.9	38.9	19.6	171.4	11.0	194.0	2.1	336.7	827.4	37.1	34.6	59.5	15.2	27.4	21.9	6.5	30.3	53.5	26.3	60.4	43.2	27.4	35.6	18.1	20.2	12.6	11.8	62.2	29.0	29.5
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.7;granulocytes: 210.8;Microglial cells: 88.1;NK-cells: 103.0;T-cells: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 657.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 66.7;HMC-1: 256.1;NB-4: 47.3;U-266/70: 50.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	11.1	5.2	5.2	38.8	5.4	37.4	8.0	5.6	7.9	6.0	5.1	7.2	6.2	6.7	22.7	4.3	4.7	11.7	6.7	5.2	5.6	7.1	10.1	21.3	71.4	7.6	6.0	16.7	2.1	2.3	3.5	10.7	6.7	5.0	9.6	0.6	5.1	3.8	3.2	6.2	23.3	8.3	7.1	72.8	8.8	2.5	7.0	27.3	5.1	8.4	67.3	11.9	4.7	8.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	20.8	0.5	0.0	0.1	2.5	0.0	20.5	0.0	2.3	0.0	66.7	0.0	0.0	1.0	14.8	256.1	0.2	2.4	0.4	8.1	0.0	0.0	22.2	0.4	23.6	0.0	0.0	17.2	47.3	1.2	0.2	0.0	18.7	4.3	0.8	0.0	5.4	4.1	0.6	0.2	0.0	1.4	1.4	0.0	12.3	3.5	0.1	0.9	0.1	0.5	50.8	29.0	16.8	0.2	33.3	0.3	234.8	60.8	528.7	171.3	75.9	107.0	156.4	76.2	150.0	37.4	100.8	54.2	95.2	657.3	170.6	94.8	52.3	102.0	132.0	5.2	5.4	5.6	7.9	5.2	5.6	7.6	6.0	6.7	7.1	7.0	8.4	14.1	3.2	15.0	0.3	88.7	5.6	12.4	2.9	5.7	0.8	0.7	6.1	1.4	1.5	2.0	0.0	0.0	0.5	35.1	0.1	1.9	0.1	1.8	0.7	0.6	16.6	3.0	11.6	15.5	0.2	0.4	3.5	2.0	0.4	210.8	0.1	15.4	1.0	48.6	0.0	0.9	0.5	2.0	27.3	12.8	3.6	1.5	22.6	1.8	88.1	40.9	0.5	103.0	0.5	0.9	0.0	0.1	2.6	34.7	1.2	0.0	0.2	5.2	0.2	6.6	0.8	2.1	0.6	1.3	2.5	1.4	0.3	53.7	1.8	0.2	2.5
ARHGAP35	"GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP"	ENSG00000160007	"Rho GTPase activating protein 35"	Q9NRY4	19	46860997-47005077	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, GTPase activation, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 186.4;Late spermatids: 651.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037311, HPA055184, HPA056470"	Approved		Supported	"Nuclear bodies,Aggresome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	Aggresome	"CAB037311: AB_477435, HPA055184: AB_2682730, HPA056470: AB_2683142"	"unprognostic (5.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.78e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (5.55e-8)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	13.6	10.1	35.7	8.0	31.5	5.3	16.1	16.8	31.1	12.9	9.2	14.8	12.9	12.8	10.6	15.7	12.8	9.1	25.8	37.0	27.3	19.1	22.3	14.9	8.7	26.0	32.3	17.3	13.6	31.3	14.1	7.8	34.5	13.4	12.3	16.6	15.7	15.7	29.4	11.6	16.3	12.9	19.8	8.8	10.9	40.3	33.3	10.8	20.2	24.2	9.0	13.1	9.0	25.1	52.0	56.7	37.9	34.0	33.9	27.9	6.4	27.3	38.7	27.1	31.0	30.6	18.0	27.4	19.1	112.0	41.2	30.8	34.8	35.3	36.9	19.3	14.7	37.2	40.1	24.1	31.7	22.3	30.4	28.3	35.1	30.6	32.5	37.9	24.7	18.2	25.2	9.9	31.4	30.3	21.8	35.4	19.9	37.4	20.8	24.1	26.0	8.5	23.0	100.0	37.9	36.1	50.5	47.5	20.0	23.4	44.6	27.1	31.3	23.9	18.9	26.2	33.0	10.1	19.6	21.7	53.6	22.8	59.7	0.3	0.2	0.2	0.6	0.2	0.6	0.1	0.6	0.7	0.3	0.2	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.3	35.7	31.5	16.8	31.1	37.0	27.3	26.0	32.3	34.5	19.8	33.3	25.1	15.7	44.8	38.4	47.7	8.6	15.2	13.9	20.1	19.4	31.9	35.2	23.0	58.2	27.1	21.4	25.8	25.0	3.7	14.8	61.0	7.9	14.6	186.4	17.8	19.0	19.5	31.2	16.6	42.4	20.0	1.0	19.1	19.9	34.1	9.5	30.9	27.8	89.7	15.0	69.0	48.8	18.5	14.2	19.5	7.8	651.3	23.3	11.0	21.4	32.8	14.2	28.2	18.6	37.2	58.2	20.9	21.4	25.6	6.7	23.3	44.5	22.6	10.4	22.0	19.7	22.6	24.9	45.9	23.5	24.4	16.6	1.6	16.1	29.5	25.7	17.0
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 119.1;lymphoid tissue: 120.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.3;dendritic cells: 70.0;Hofbauer cells: 86.6;Kupffer cells: 77.2;Macrophages: 76.0;NK-cells: 70.0;T-cells: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 103.0;HL-60: 76.7;Karpas-707: 90.8;MOLT-4: 93.0;RPMI-8226: 180.7;THP-1: 83.7;U-698: 90.4;U-937: 79.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA000301, HPA001012, HPA001083"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA000301: , HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favorable (3.94e-5)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	20.0	12.5	5.2	52.2	5.4	119.1	13.4	6.9	6.5	9.9	15.0	18.6	14.2	9.7	3.1	7.0	12.9	14.4	10.3	5.7	6.3	22.6	8.6	36.2	73.8	10.9	8.3	5.4	5.9	1.7	8.6	21.2	9.3	11.1	6.9	1.2	9.2	3.8	4.3	5.0	49.7	6.5	8.2	120.9	12.6	7.2	8.5	42.7	10.9	1.5	33.7	11.6	9.2	10.0	1.5	0.6	1.0	5.9	0.2	0.0	2.5	1.0	0.4	0.1	0.2	0.4	42.8	103.0	5.9	0.1	0.8	1.2	4.6	0.2	0.0	27.8	3.4	44.4	0.5	1.7	3.6	76.7	59.7	0.2	0.4	0.0	0.3	0.5	9.1	22.4	0.5	90.8	0.5	4.6	93.0	1.5	3.7	0.4	0.3	44.6	12.0	180.7	0.4	0.7	8.4	12.1	0.9	2.1	0.9	1.2	19.0	83.7	1.9	0.3	1.3	0.9	0.5	60.1	55.8	90.4	0.7	79.9	0.2	10.9	26.1	35.4	26.2	42.4	18.6	18.0	18.8	21.1	25.5	16.9	17.4	17.4	22.4	16.0	59.4	31.6	23.5	26.1	5.2	5.4	6.9	6.5	5.7	6.3	10.9	8.3	9.3	8.2	8.5	10.0	16.0	9.6	22.7	2.6	65.3	3.4	0.6	0.2	0.0	13.7	2.4	6.1	48.3	1.5	2.7	18.4	4.2	1.9	70.0	9.5	5.9	0.9	0.1	2.4	1.4	13.0	4.8	11.3	2.1	0.6	1.9	3.5	7.1	1.5	34.2	7.7	4.2	0.5	86.6	3.3	1.4	6.6	0.0	77.2	31.5	0.2	0.9	76.0	10.6	19.7	42.5	1.9	70.0	2.0	0.7	0.2	0.5	0.0	32.9	0.5	3.0	0.8	8.7	4.6	0.0	7.1	2.6	0.7	5.2	1.6	1.7	1.4	69.5	1.1	5.0	0.4
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472264-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 119.7;lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 171.0;Early spermatids: 96.8;NK-cells: 123.6;Spermatocytes: 89.0;T-cells: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 388.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 27.6;HMC-1: 116.2;MOLT-4: 22.5;NB-4: 22.1;THP-1: 34.9;U-937: 27.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	10.8	4.2	4.2	34.3	6.1	119.7	4.1	8.1	11.1	2.6	4.7	7.7	8.2	3.4	1.6	4.6	7.4	10.5	3.9	4.4	5.3	5.1	7.5	22.0	56.9	7.8	5.8	1.6	3.5	0.6	2.2	5.2	8.8	4.3	10.7	0.5	4.7	1.8	1.3	2.2	37.6	5.9	5.6	100.7	8.8	19.3	6.1	34.9	4.5	6.4	60.7	9.5	3.6	6.4	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.4	0.5	0.1	0.2	0.1	0.0	14.3	0.3	0.3	0.0	0.2	0.4	0.0	0.0	0.7	0.0	27.6	0.1	0.0	1.1	16.4	116.2	0.7	0.0	0.0	0.3	0.2	0.0	14.3	0.5	7.9	0.0	0.0	22.5	22.1	1.0	0.0	0.0	9.1	10.2	4.6	0.0	0.1	3.9	3.0	0.0	0.0	0.4	0.5	0.0	34.9	0.9	0.2	0.3	0.1	0.1	9.2	7.2	13.3	0.3	27.3	0.5	51.9	86.1	243.4	43.3	89.2	30.0	35.9	47.3	39.6	72.1	44.0	61.9	46.0	388.9	68.2	71.0	97.4	63.6	70.8	4.2	6.1	8.1	11.1	4.4	5.3	7.8	5.8	8.8	5.6	6.1	6.4	2.2	0.0	14.2	1.0	49.1	1.5	0.2	0.0	1.8	0.2	1.6	2.9	2.1	1.5	1.3	0.0	2.1	0.4	171.0	0.6	0.0	0.2	96.8	0.6	0.8	1.5	0.0	11.6	3.7	0.0	0.6	2.4	4.6	0.8	12.0	0.0	3.6	1.2	43.5	0.0	1.9	0.5	0.0	39.0	19.7	44.8	1.8	35.1	0.0	8.4	34.8	0.0	123.6	0.0	0.2	0.2	0.1	0.0	50.8	0.2	0.0	0.3	2.2	0.7	0.0	0.6	1.2	89.0	17.5	0.4	1.4	0.3	108.2	0.3	0.4	0.1
ARHGDIG	RHOGDI-3	ENSG00000242173	"Rho GDP dissociation inhibitor gamma"	Q99819	16	280450-283010	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 249.4;pancreas: 112.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 12.1;Excitatory neurons: 27.8;Inhibitory neurons: 32.1;Proximal enterocytes: 64.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.6;HEK 293: 26.6;MCF7: 34.9;SCLC-21H: 10.9;SH-SY5Y: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078260			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA078260: AB_2732375"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.86e-6)"	"unprognostic (2.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.32e-2)"	4.5	2.8	116.5	1.1	138.7	0.2	1.3	118.2	249.4	0.5	49.9	5.9	16.7	0.1	0.9	0.5	0.5	0.1	10.2	130.1	121.2	0.3	0.2	0.5	0.0	110.3	106.1	0.3	112.7	0.6	10.1	2.2	109.8	0.9	0.4	4.0	0.4	0.3	1.9	0.2	6.9	0.6	84.9	0.1	26.8	3.6	112.6	0.0	0.3	1.4	0.4	0.4	1.1	134.9	0.0	0.8	0.2	2.9	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.0	0.9	0.1	0.0	0.1	7.6	0.0	0.0	0.0	26.6	0.0	0.4	0.2	0.7	0.0	0.1	0.2	0.0	0.0	0.0	1.3	0.3	0.0	1.8	0.1	0.0	34.9	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.3	0.0	0.0	10.9	13.9	0.2	0.1	0.0	0.4	2.6	0.0	0.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.5	138.7	118.2	249.4	130.1	121.2	110.3	106.1	109.8	84.9	112.6	134.9	0.1	0.0	0.0	12.1	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.3	1.4	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	0.2	0.4	0.0	0.4	0.1	1.2	2.7	27.8	11.7	0.2	2.5	6.1	0.0	0.0	0.2	1.4	0.0	0.4	0.0	32.1	3.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	8.4	0.0	2.2	0.0	6.6	10.9	3.9	3.9	0.0	0.0	0.1	64.0	0.1	0.0	3.7	0.0	0.0	0.4	0.2	3.9	0.0	0.0	0.4	0.0	0.0	7.0	0.1
ARHGEF25	"GEFT, p63RhoGEF"	ENSG00000240771	"Rho guanine nucleotide exchange factor 25"	Q86VW2	12	57610180-57617245	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 151.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 20.8;Leydig cells: 24.8;Peritubular cells: 45.9;Sertoli cells: 26.3;Smooth muscle cells: 38.9"	"Cancer enhanced"	"Detected in all"		"glioma: 23.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 59.1;RH-30: 129.7;SH-SY5Y: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052016	Approved					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA052016: AB_2681695"	"unprognostic (8.43e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.13e-3)"	"unprognostic (6.95e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.20e-7)"	"unprognostic (1.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.22e-3)"	34.4	12.0	30.7	10.7	38.7	0.1	29.1	38.5	72.1	64.5	12.6	151.2	10.3	92.8	44.3	29.6	85.5	23.6	24.6	72.0	21.7	17.7	5.0	21.7	6.2	20.6	21.1	58.2	8.5	9.4	26.4	9.4	20.8	60.6	19.5	13.2	13.9	80.4	11.4	12.0	34.4	68.8	17.3	20.1	45.0	10.6	22.5	2.1	14.1	13.8	4.9	84.3	51.4	40.5	0.8	8.9	41.6	26.1	0.1	0.0	3.3	12.7	37.4	16.5	20.2	5.2	8.1	3.5	10.7	23.4	7.7	0.4	16.2	0.7	13.9	11.7	13.9	7.4	6.1	11.4	11.6	0.2	19.2	11.5	3.5	7.5	1.1	59.1	6.5	2.0	15.5	16.0	12.2	3.0	2.7	0.3	26.5	0.4	0.4	0.0	129.7	0.7	0.7	0.7	24.1	58.7	2.4	1.2	4.8	14.8	4.3	8.9	0.0	14.8	14.0	9.7	4.7	33.5	5.4	0.1	12.4	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	38.7	38.5	72.1	72.0	21.7	20.6	21.1	20.8	17.3	22.5	40.5	5.6	0.0	0.0	8.5	0.0	2.0	1.8	0.2	4.6	17.7	1.8	8.6	11.6	0.0	0.6	0.0	2.1	0.2	0.6	0.0	0.0	0.5	0.2	1.1	20.8	4.4	0.0	0.0	15.3	1.4	0.5	12.6	0.5	0.6	0.0	2.6	6.8	0.0	0.5	8.4	8.5	0.0	0.0	0.0	1.7	1.5	24.8	0.2	0.0	8.4	0.0	5.4	2.1	3.0	1.6	0.3	0.0	45.9	0.3	0.8	0.0	0.4	0.0	2.8	26.3	6.3	38.9	1.4	1.4	0.9	1.1	0.3	0.5	9.6	0.0	0.4
ARHGEF40	"FLJ10357, solo"	ENSG00000165801	"Rho guanine nucleotide exchange factor 40"	Q8TER5	14	21070273-21090248	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030745, HPA030746, HPA030757"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.95e-2)"	21.0	47.2	9.6	5.3	11.1	1.6	18.5	10.0	9.2	24.8	6.2	14.5	3.7	18.9	12.2	3.5	13.2	14.8	12.3	8.9	11.1	10.1	26.9	14.2	2.3	13.5	10.5	19.3	24.0	10.7	9.0	6.5	10.5	12.3	6.2	2.8	20.2	18.6	10.5	7.4	7.9	9.7	10.1	27.8	9.5	4.3	12.1	3.1	15.8	6.1	1.7	13.8	13.3	12.1	3.3	2.9	30.8	5.8	24.5	37.1	1.1	11.4	28.1	12.1	9.4	1.4	7.5	0.0	1.8	20.9	12.2	5.0	2.6	3.7	4.3	6.6	1.1	4.6	3.4	9.0	3.5	3.0	16.5	15.5	2.4	10.3	3.1	22.6	0.0	0.0	1.4	1.3	9.6	0.3	0.0	8.6	8.1	0.8	0.5	1.0	23.2	1.4	7.6	4.1	0.7	11.6	6.4	0.6	8.9	6.0	2.7	10.1	5.9	25.4	17.5	11.9	5.9	2.6	0.0	0.0	8.8	4.2	7.5	0.0	1.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.0	0.4	9.6	11.1	10.0	9.2	8.9	11.1	13.5	10.5	10.5	10.1	12.1	12.1	12.7	6.4	5.0	32.0	2.5	4.8	8.0	5.8	1.8	9.2	6.6	11.3	13.4	47.1	3.2	14.7	0.0	1.4	0.5	10.0	19.6	21.2	1.0	17.6	13.1	11.0	7.8	1.7	0.3	10.2	0.9	20.4	18.3	3.5	38.0	11.6	8.2	31.5	14.1	5.0	6.2	9.1	4.1	46.9	14.6	2.3	24.2	22.0	23.2	17.8	23.6	24.6	1.0	21.1	8.9	16.4	6.6	24.0	3.1	6.3	1.0	7.1	1.7	6.8	26.3	18.6	21.9	3.1	2.8	0.6	4.4	1.2	3.5	14.6	18.7	6.1
ARHGEF5	"GEF5, P60, TIM, TIM1"	ENSG00000050327	"Rho guanine nucleotide exchange factor 5"	Q12774	7	144355288-144380632	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 47.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 61.7;Glandular and luminal cells: 47.4;Paneth cells: 53.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 29.4;CAPAN-2: 21.9;HaCaT: 16.7;hTCEpi: 18.0;RPTEC TERT1: 17.5;WM-115: 17.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA020980, HPA029504, HPA044188, HPA045619, HPA045699"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.45e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.95e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (3.28e-7)"	"unprognostic (4.67e-2)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.76e-2)"	5.1	2.6	1.8	1.6	2.4	2.4	12.3	1.5	1.7	11.5	5.7	16.4	10.1	3.4	6.9	36.6	4.7	4.7	3.5	0.9	1.8	20.9	14.4	8.4	2.2	2.1	2.7	5.6	19.0	7.3	9.5	3.2	1.8	14.7	5.6	1.8	18.1	2.0	0.7	47.1	13.1	1.2	1.3	3.8	13.8	2.0	2.0	1.8	24.0	0.2	3.1	5.3	17.6	1.4	29.4	3.3	0.0	0.0	0.0	0.0	8.7	3.8	2.3	1.5	1.9	11.5	21.9	0.1	10.3	0.9	0.3	16.7	0.0	10.6	1.5	0.1	3.8	0.0	4.2	0.8	3.1	0.0	0.0	5.5	18.0	0.7	9.9	4.8	0.1	0.0	0.0	0.0	1.5	9.7	0.1	0.0	4.5	7.9	5.2	1.1	0.0	0.4	17.5	1.3	0.1	0.1	11.5	13.4	5.1	2.3	6.8	0.3	0.2	0.5	0.8	0.0	0.1	0.0	0.1	0.1	0.6	0.0	17.7	0.0	0.0	0.0	0.3	0.0	0.4	0.8	0.8	0.7	0.0	0.9	0.9	0.2	0.3	0.0	0.0	0.0	1.5	0.1	1.8	2.4	1.5	1.7	0.9	1.8	2.1	2.7	1.8	1.3	2.0	1.4	3.0	6.4	14.8	0.3	2.3	18.5	37.3	9.4	26.2	0.0	17.5	18.7	1.4	11.5	12.1	22.0	4.2	11.8	1.4	61.7	5.9	14.8	2.3	28.9	5.5	1.6	9.6	2.7	0.0	16.5	15.2	3.6	37.2	47.4	0.0	4.0	1.8	7.5	1.8	0.0	0.0	24.0	6.1	0.3	1.9	0.6	1.5	1.2	5.4	0.0	0.0	2.7	0.0	0.5	0.1	27.7	53.7	1.5	3.1	14.3	42.0	5.4	13.5	3.1	0.0	1.1	1.8	0.7	1.5	28.7	16.8	14.2	2.5	1.1	23.5	33.6
ARL11	"ARLTS1, FLJ33930"	ENSG00000152213	"ADP ribosylation factor like GTPase 11"	Q969Q4	13	49628507-49633872	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.2;Hofbauer cells: 31.3;Kupffer cells: 34.8;Macrophages: 18.2;monocytes: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 38.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.9;HMC-1: 10.7;NB-4: 11.1;THP-1: 14.5;U-698: 6.6;U-937: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040855, HPA040887"	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Intermediate filaments, Cytosol"		"HPA040855: AB_10793864, HPA040887: AB_10796229"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.72e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.14e-2)"	0.8	0.8	0.5	3.9	0.5	3.5	0.7	0.6	0.7	0.6	0.8	1.0	1.2	0.2	0.2	1.0	0.3	1.1	0.4	0.4	0.6	0.1	0.6	2.2	6.9	1.0	0.7	0.2	0.1	0.3	0.3	1.9	0.8	0.2	1.5	0.1	0.6	0.2	0.3	0.6	1.9	0.7	0.7	4.8	0.6	0.3	1.0	3.7	0.4	0.4	3.9	1.3	0.8	1.2	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.6	0.0	5.2	10.7	0.1	0.1	0.0	0.0	0.0	0.4	5.1	0.3	0.1	0.0	1.3	4.9	11.1	0.1	0.0	0.0	5.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	3.5	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.6	0.0	6.3	0.0	21.8	15.3	16.3	0.1	17.9	0.2	7.9	0.3	0.3	8.1	10.1	0.8	0.4	38.0	0.8	13.4	8.6	0.3	4.4	0.5	0.5	0.6	0.7	0.4	0.6	1.0	0.7	0.8	0.7	1.0	1.2	0.9	0.0	1.1	0.0	18.2	0.3	0.3	0.2	1.2	0.7	1.0	0.9	0.6	2.8	0.0	0.0	0.0	4.7	3.4	1.7	0.0	0.0	1.7	0.1	0.1	1.2	1.2	6.9	0.0	0.0	5.1	0.3	0.0	0.1	7.6	0.0	1.8	0.6	31.3	0.0	0.0	3.4	0.0	34.8	3.5	1.3	0.3	18.2	0.0	3.7	19.2	0.3	1.0	0.0	0.1	0.1	10.2	0.0	2.9	0.1	4.2	0.1	2.3	0.5	0.0	0.3	0.2	1.5	0.3	4.1	0.0	1.5	1.2	0.5	3.1	0.4
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497081	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 610.9;Langerhans cells: 474.5;NK-cells: 437.7;T-cells: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 149.4;RPTEC TERT1: 284.8;U-2197: 168.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.99e-5)"	15.1	10.6	15.4	31.7	14.6	65.0	17.3	17.8	18.6	11.4	45.3	9.1	6.6	5.8	9.5	23.2	11.9	31.8	5.1	13.1	21.9	12.2	12.8	16.1	55.3	21.9	17.1	2.1	5.5	10.8	7.4	16.5	21.3	10.3	11.2	9.7	21.6	5.4	1.5	24.1	13.2	5.9	12.8	51.0	13.6	1.2	18.5	74.0	3.7	1.7	32.1	25.5	18.0	13.8	32.3	97.4	12.0	1.6	10.4	3.0	31.6	3.2	13.8	3.8	6.6	45.4	60.4	0.1	8.0	7.7	109.0	23.5	12.0	66.4	4.1	30.4	4.2	0.0	0.6	0.6	10.7	0.1	2.8	6.4	42.2	36.6	21.2	149.4	6.4	78.4	0.4	102.4	16.4	4.4	93.7	0.3	12.6	22.5	21.9	0.3	54.1	18.0	284.8	35.2	44.1	8.1	1.1	7.1	4.7	18.2	0.9	1.9	14.8	60.0	23.2	168.2	61.6	51.1	19.7	1.6	101.9	0.1	32.0	79.8	1.2	27.4	86.7	1.6	85.6	18.1	60.0	69.5	10.3	18.3	53.5	59.1	2.2	61.2	0.9	55.2	83.8	30.0	15.4	14.6	17.8	18.6	13.1	21.9	21.9	17.1	21.3	12.8	18.5	13.8	12.3	73.7	15.9	8.8	63.6	124.8	120.7	18.4	145.1	156.6	40.4	64.6	10.9	67.2	27.0	14.7	8.4	30.0	610.9	2.3	0.0	19.6	7.8	73.9	19.2	23.4	1.8	6.1	15.5	5.7	5.4	23.7	19.9	186.3	27.8	1.1	11.0	3.4	31.4	107.7	103.0	2.5	0.0	208.4	474.5	6.5	0.3	182.1	42.7	6.5	41.8	32.2	437.7	6.0	2.5	16.5	0.1	0.0	132.6	60.4	0.1	0.9	4.7	13.1	0.0	7.0	19.3	0.7	1.9	65.4	42.9	14.6	349.8	0.4	1.2	46.6
ARL5A	ARL5	ENSG00000162980	"ADP ribosylation factor like GTPase 5A"	Q9Y689	2	151788984-151828492	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"basophil: 88.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 88.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027002	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA027002: AB_10601685"	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.59e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.55e-1)"	20.4	20.9	13.1	13.1	14.9	11.8	19.7	17.1	12.4	14.7	12.1	17.6	22.1	14.1	7.3	23.9	14.6	17.2	35.8	12.8	18.5	25.1	22.4	20.0	20.3	18.5	14.7	15.3	15.9	17.9	7.5	23.6	17.3	17.2	16.6	17.6	15.5	13.6	32.5	28.8	20.5	18.0	17.7	14.6	17.7	6.3	14.4	17.5	29.6	36.5	24.6	18.3	11.2	18.8	20.2	20.2	29.0	25.7	20.9	35.6	39.1	34.7	26.8	24.8	30.0	59.5	24.7	66.9	36.4	37.2	18.6	12.8	34.6	26.7	40.0	40.4	31.6	73.6	21.9	77.8	28.8	74.0	39.5	27.9	39.3	34.0	36.4	33.3	34.7	41.1	55.7	78.0	26.5	23.4	63.1	29.3	36.8	24.7	21.5	28.5	40.1	27.6	35.7	33.6	13.0	27.0	21.1	21.8	29.5	34.3	17.0	44.0	28.5	19.6	24.1	18.8	37.7	39.3	47.6	64.6	34.7	50.4	34.7	88.3	7.9	8.9	6.9	6.1	6.5	11.0	6.1	8.6	11.2	15.2	6.6	5.1	3.8	7.4	4.7	6.7	7.9	4.5	13.1	14.9	17.1	12.4	12.8	18.5	18.5	14.7	17.3	17.7	14.4	18.8	18.1	57.7	38.6	28.7	104.3	138.7	122.6	120.7	64.3	62.6	24.4	12.6	109.8	91.5	60.6	14.7	14.6	84.3	46.2	44.3	45.0	55.3	11.9	15.3	17.2	62.9	75.6	66.3	29.8	59.9	153.1	79.6	51.5	12.1	48.2	17.9	77.8	76.6	128.0	116.1	31.9	64.3	126.1	135.8	154.7	13.8	74.6	82.9	81.8	51.5	97.5	64.1	132.8	34.7	23.8	52.6	44.1	82.4	160.7	167.4	166.8	42.9	60.3	61.9	72.3	85.9	60.4	72.6	65.0	103.9	163.7	143.0	63.6	9.2	72.7	135.9
ARL6IP5	"DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b"	ENSG00000144746	"ADP ribosylation factor like GTPase 6 interacting protein 5"	O75915	3	69084937-69106092	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015540, CAB019321"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"CAB019321: , HPA015540: AB_1852061"	"unprognostic (8.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.31e-2)"	157.7	130.6	91.0	109.9	95.9	67.8	139.7	100.6	156.0	123.0	83.1	87.3	59.1	72.8	104.4	78.3	90.5	102.1	216.3	91.1	105.6	88.5	80.3	125.5	138.3	100.6	93.4	74.2	55.3	83.4	47.6	88.8	106.8	129.6	85.2	135.0	159.6	90.5	183.2	48.5	66.1	100.4	104.1	100.3	72.5	34.9	98.3	92.3	71.2	186.8	130.0	111.8	61.0	113.3	86.9	59.0	71.1	52.8	361.4	335.2	89.7	87.9	196.5	66.7	77.4	30.1	205.9	17.0	28.9	151.1	124.8	67.0	59.2	100.8	57.0	339.5	55.2	59.6	91.1	45.8	92.9	51.4	280.5	243.6	177.5	61.5	77.3	235.0	206.0	55.7	26.6	156.7	163.6	50.3	56.0	67.0	18.5	200.2	55.1	48.6	65.0	159.1	330.5	143.1	17.8	47.0	87.0	93.5	119.5	69.7	61.7	80.2	203.7	44.1	34.8	112.5	96.1	139.4	208.5	31.7	146.0	126.0	72.8	697.4	388.2	650.2	332.4	357.6	257.1	397.7	462.4	427.6	275.7	336.1	391.2	409.5	162.0	298.4	315.1	176.0	530.4	933.9	91.0	95.9	100.6	156.0	91.1	105.6	100.6	93.4	106.8	104.1	98.3	113.3	101.1	176.3	132.0	34.6	183.6	72.8	70.6	275.5	108.7	201.9	214.9	174.5	422.0	95.8	185.0	93.8	187.7	305.8	212.7	146.7	25.4	281.4	20.8	144.9	79.5	121.4	42.0	89.8	45.9	214.4	379.2	254.8	64.2	233.4	336.6	75.7	150.3	72.5	292.0	122.8	70.7	57.1	270.6	260.0	402.1	18.9	207.2	275.4	272.1	35.6	476.6	235.7	272.9	49.8	97.0	244.2	95.7	261.8	93.4	93.6	91.7	77.8	155.0	272.4	190.7	190.3	125.4	7.3	4.3	207.8	73.9	178.4	292.2	133.6	77.8	94.0
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing X-linked 2"	Q7L311	X	101655281-101659850	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 154.8"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 59.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 164.1;NTERA-2: 117.2;SuSa: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	17.0	46.2	28.7	11.5	29.1	0.5	17.6	22.8	29.7	36.9	26.5	25.4	5.4	30.6	154.8	9.2	28.8	20.6	33.2	29.1	31.6	28.3	3.2	16.8	8.5	25.9	26.2	47.8	18.9	71.2	78.3	26.3	27.5	28.3	7.9	15.3	44.5	67.9	6.2	6.5	13.0	32.3	23.4	21.3	16.3	5.8	28.1	7.7	59.7	7.5	6.5	26.9	20.1	25.4	0.0	0.0	50.8	0.4	43.6	39.4	0.4	56.0	70.4	1.4	1.4	0.0	21.8	0.0	0.0	74.6	0.0	1.5	0.0	1.3	0.6	0.0	2.0	0.2	60.9	0.0	46.4	0.4	0.1	63.7	17.6	43.5	0.4	68.3	59.7	0.0	0.2	0.3	164.1	0.0	0.0	0.6	117.2	3.4	0.3	14.5	88.9	0.3	2.8	0.0	20.4	36.6	0.0	0.2	1.7	90.3	25.9	0.1	13.0	61.9	65.1	38.8	0.4	0.0	0.0	0.2	55.7	0.1	1.2	0.0	0.4	0.0	1.0	0.9	0.4	2.8	0.9	0.9	0.7	4.0	2.4	2.5	0.0	2.8	0.6	0.9	0.7	1.1	28.7	29.1	22.8	29.7	29.1	31.6	25.9	26.2	27.5	23.4	28.1	25.4	10.4	16.0	6.4	8.5	8.2	4.2	16.4	5.8	21.1	12.5	18.0	20.8	28.7	5.7	11.4	33.1	8.4	1.2	2.4	0.1	3.9	9.6	0.2	11.2	23.4	13.3	9.1	3.2	15.4	2.0	0.7	28.4	4.6	15.2	2.5	18.1	19.2	0.7	3.8	1.7	14.3	3.0	2.0	2.4	6.5	1.3	24.2	7.4	5.4	11.2	7.1	9.3	0.0	16.1	14.0	2.2	0.1	24.5	2.8	16.5	0.3	4.3	4.9	11.3	59.2	31.8	23.9	1.4	1.9	3.8	3.0	5.1	2.5	4.6	1.6	7.2
ARMCX3	"ALEX3, GASP6"	ENSG00000102401	"Armadillo repeat containing X-linked 3"	Q9UH62	X	101622797-101627843	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000325, HPA000967, HPA001530"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349"	"unprognostic (1.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.23e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-2)"	34.9	58.9	30.8	24.4	33.0	14.7	32.2	35.4	35.7	45.0	27.6	31.5	20.2	40.9	105.3	18.1	27.7	34.0	51.0	34.1	38.7	37.2	24.6	29.5	21.8	34.5	33.7	38.3	57.4	103.6	47.7	45.4	34.8	44.5	21.8	19.0	59.6	46.7	30.7	11.9	21.5	36.3	35.4	41.3	29.7	12.9	35.5	20.1	49.9	63.6	21.5	31.9	22.5	37.7	26.4	18.8	48.8	23.9	109.4	118.3	10.0	56.5	54.3	23.2	68.3	20.7	21.5	9.5	31.7	64.7	50.8	5.0	34.9	20.2	28.7	21.6	23.2	18.7	64.9	30.2	85.2	18.2	41.5	67.0	27.4	30.9	30.3	65.1	47.6	11.6	15.2	78.9	67.4	10.9	15.0	0.8	24.4	49.5	4.3	19.1	62.2	8.9	36.0	10.1	22.1	18.9	28.3	1.5	63.9	67.7	19.2	19.0	67.5	29.8	18.9	70.8	11.2	69.7	20.9	0.1	50.4	14.5	25.5	43.6	15.3	13.6	14.6	15.8	18.3	15.0	14.0	12.4	15.8	9.8	15.2	10.6	5.6	13.7	16.8	25.8	9.0	14.4	30.8	33.0	35.4	35.7	34.1	38.7	34.5	33.7	34.8	35.4	35.5	37.7	67.4	44.8	36.1	16.3	61.1	37.9	81.2	40.6	42.7	63.1	70.9	42.3	114.6	50.1	48.4	75.4	58.4	55.3	61.1	20.4	37.2	53.9	0.6	42.2	80.9	69.2	82.4	25.6	35.9	30.6	27.4	85.8	33.1	78.8	79.1	45.5	58.2	48.6	50.7	62.2	41.8	67.6	40.7	52.5	84.9	2.8	64.7	72.3	97.8	18.7	27.2	86.6	34.0	28.6	31.0	30.6	22.1	72.6	122.6	75.2	20.1	43.1	25.1	13.3	32.9	57.1	73.2	2.5	0.4	24.6	21.5	114.9	58.0	70.2	32.1	81.2
ARMH1	"C1orf228, MGC33556, NCRNA00082, p40"	ENSG00000198520	"Armadillo like helical domain containing 1"	Q6PIY5	1	44674692-44725591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 8.2;testis: 11.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.0;Collecting duct cells: 3.7;Endometrial ciliated cells: 13.1;Granulosa cells: 6.2;Hofbauer cells: 11.3;Macrophages: 5.1;T-cells: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 6.9;MOLT-4: 4.9;NB-4: 7.5;U-937: 9.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034769	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA034769: AB_10670979"	"unprognostic (2.01e-5)"	"unprognostic (4.28e-3)"	"unprognostic (7.27e-2)"	"prognostic favorable (8.64e-4)"	"unprognostic (9.23e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.22e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-10)"	"unprognostic (1.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-3)"	0.4	1.1	1.7	0.2	2.2	2.2	0.7	1.1	2.6	0.8	4.5	0.5	0.2	1.7	3.5	0.5	8.2	0.7	0.2	2.3	1.3	0.9	4.2	1.0	0.6	2.6	4.0	2.6	0.5	1.9	3.3	0.3	2.1	0.8	0.3	4.2	0.7	0.6	0.1	0.8	0.3	0.3	1.8	0.3	0.7	11.7	1.9	0.4	0.6	0.0	0.3	0.3	0.3	2.2	0.2	0.3	1.8	0.1	0.5	2.1	0.5	0.0	0.2	0.5	0.3	0.4	3.8	0.2	0.2	0.8	0.9	0.5	0.0	0.0	0.0	1.0	0.2	0.9	2.6	0.6	0.2	6.9	4.1	1.7	0.2	0.7	0.0	1.3	0.2	0.3	0.1	0.7	0.2	0.0	4.9	7.5	0.1	0.5	0.0	2.7	0.1	2.2	0.7	0.0	1.2	0.8	0.0	1.2	0.9	1.2	0.3	3.6	0.0	0.3	0.3	0.3	0.0	0.3	0.1	0.2	0.3	9.9	0.4	8.7	2.1	6.1	0.2	0.7	0.1	0.6	1.1	0.8	1.0	0.9	1.6	1.5	1.0	0.4	0.0	4.8	0.0	1.4	1.7	2.2	1.1	2.6	2.3	1.3	2.6	4.0	2.1	1.8	1.9	2.2	0.5	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	3.7	0.0	0.4	1.3	0.0	1.9	0.7	0.0	13.1	0.6	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.7	0.0	6.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	5.2	0.9	0.0	0.0
ARMH4	"C14orf37, UT2"	ENSG00000139971	"Armadillo like helical domain containing 4"	Q86TY3	14	57999735-58298139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8;kidney: 8.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 15.8;Collecting duct cells: 12.9;Endometrial ciliated cells: 10.2;Endometrial stromal cells: 7.7;Granulosa cells: 26.0;Theca cells: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.7;AN3-CA: 6.1;fHDF/TERT166: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001580, HPA001789"	Enhanced		Approved	"Plasma membrane"		NA	NA		1800000		"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"		"HPA001580: AB_2666366, HPA001789: AB_1078328"	"unprognostic (2.56e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.87e-8)"	"unprognostic (5.22e-6)"	"unprognostic (4.93e-2)"	"unprognostic (8.74e-4)"	"unprognostic (3.01e-4)"	1.2	2.5	2.3	0.6	3.6	0.7	0.8	8.5	3.5	1.8	0.0	0.7	0.5	3.0	1.8	0.8	2.1	1.8	3.1	2.6	2.1	8.3	0.8	0.7	0.4	11.5	5.1	4.3	1.0	3.6	1.3	0.4	12.8	1.6	1.0	1.2	0.7	1.4	0.2	1.0	0.7	2.3	1.0	0.5	1.4	2.2	1.6	0.2	1.5	1.9	0.3	1.2	0.9	0.7	0.0	0.0	9.7	6.1	4.7	1.7	0.0	1.9	1.5	0.3	0.3	0.5	0.1	0.0	0.6	10.8	1.2	0.0	2.9	0.0	0.4	0.1	1.0	0.0	0.0	0.5	0.2	0.0	4.8	1.8	0.0	0.2	0.2	2.7	0.5	0.8	0.1	0.3	1.2	0.3	0.0	0.0	4.5	0.0	2.0	1.4	0.3	2.5	3.9	0.3	1.1	0.0	0.1	0.0	0.3	2.7	0.2	0.2	0.1	1.3	3.5	0.5	2.6	0.3	0.2	0.0	3.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.6	8.5	3.5	2.6	2.1	11.5	5.1	12.8	1.0	1.6	0.7	15.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	12.9	0.0	0.2	0.7	0.0	0.0	2.1	0.0	10.2	7.7	2.3	0.0	0.0	0.0	1.3	0.4	3.0	0.0	2.4	0.0	26.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.3	44.5	0.0	0.0
ARRDC5		ENSG00000205784	"Arrestin domain containing 5"	A6NEK1	19	4890437-4902896	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 17.0"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 292.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	18	"REH: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (2.85e-2)"	"unprognostic (3.83e-5)"	"unprognostic (2.53e-1)"	"unprognostic (7.22e-5)"	"unprognostic (1.70e-1)"	"unprognostic (7.16e-5)"	"unprognostic (1.65e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.18e-8)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.79e-2)"	0.1	0.1	0.4	0.6	0.4	1.6	0.1	0.2	0.7	0.1	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.3	0.4	0.1	0.1	0.5	1.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.9	0.1	0.4	2.1	0.2	17.0	0.8	1.6	0.1	0.0	0.6	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	1.1	0.3	0.6	1.0	0.2	0.8	0.5	0.7	1.0	1.1	0.0	0.6	0.1	1.4	0.5	0.3	0.4	0.4	0.2	0.7	0.3	0.4	0.7	0.5	0.5	0.4	0.8	0.9	0.0	0.0	0.0	0.3	2.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	8.4	0.1	0.0	0.0	292.2	0.3	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.4	0.0	0.0	3.5	0.6	61.0	1.2	2.2	0.0	13.1	3.0	0.0	15.5	0.0	0.3	0.1	0.0	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	5.9	1.0	0.0	0.1	0.0	4.1	0.0	0.0	0.4
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555101-95605102	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 19.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	3.0	3.7	2.1	2.2	2.3	2.3	3.3	2.8	3.0	3.8	2.1	2.7	2.2	3.6	4.2	2.9	3.2	3.1	2.6	2.4	2.1	5.4	3.7	2.9	2.7	1.9	1.9	5.8	4.9	19.1	2.6	5.5	2.3	4.9	2.5	3.6	2.8	4.9	2.3	3.3	2.2	3.0	1.7	2.4	4.2	1.6	2.6	3.7	5.0	2.7	2.0	3.2	3.3	2.2	5.1	3.2	6.6	6.6	32.4	16.8	9.5	15.9	9.2	6.1	12.4	3.9	7.8	6.9	8.1	5.5	10.9	4.6	5.8	10.1	13.3	7.4	8.5	5.5	7.7	6.7	9.4	3.1	4.4	12.4	8.9	9.2	5.9	12.8	10.0	9.3	5.6	7.4	13.7	2.5	8.5	5.9	8.6	1.6	15.3	5.2	10.6	11.0	14.1	1.2	4.7	4.8	9.7	3.1	10.0	9.1	8.9	3.2	18.1	9.6	7.8	15.0	9.9	6.2	11.2	8.4	9.6	8.0	36.5	12.9	1.1	2.1	4.0	1.2	4.7	4.9	4.7	5.4	0.6	5.0	7.0	5.2	0.9	3.3	0.7	2.2	3.9	1.8	2.1	2.3	2.8	3.0	2.4	2.1	1.9	1.9	2.3	1.7	2.6	2.2	6.8	3.2	2.2	9.1	6.6	4.5	6.8	7.4	5.7	7.3	4.4	7.2	4.6	1.5	3.7	7.3	12.5	11.8	6.6	1.9	3.9	4.1	9.2	7.1	10.3	6.2	3.0	10.1	11.0	2.5	47.4	13.6	2.0	5.7	22.9	8.1	6.8	16.5	4.6	10.1	9.7	2.0	10.2	3.2	5.4	2.9	10.8	4.9	5.4	7.5	5.1	12.7	14.4	7.1	10.0	2.6	3.2	11.7	7.1	3.9	3.2	4.8	6.8	10.4	0.0	10.2	10.9	7.4	8.6	5.1	7.0	5.1	9.8	11.8	3.4	2.1
ART4	"ARTC4, CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)"	Q93070	12	14825569-14843526	"Blood group antigen proteins, CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.3;lymphoid tissue: 19.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Endothelial cells: 12.9;Erythroid cells: 51.3;Hepatic stellate cells: 66.0;Hepatocytes: 30.2"	"Group enriched"	"Detected in some"	5	"liver cancer: 3.8;pancreatic cancer: 1.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;HEL: 12.1;Hep G2: 7.3;HUVEC TERT2: 27.0"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.8"	"Low region specificity"	"Detected in all"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"	NA	NA		17000000		"Cluster 85: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"	"Rods & Rings"		"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.6	2.7	0.3	1.1	0.5	4.6	1.8	0.1	0.4	0.9	0.4	0.6	0.0	0.8	0.3	0.9	2.1	9.0	9.0	0.3	1.1	3.6	53.3	3.2	8.6	0.5	0.4	0.5	2.3	0.3	0.1	7.0	0.4	0.3	0.5	0.3	0.7	0.4	0.3	0.3	0.6	1.1	0.2	19.0	0.3	0.2	0.4	1.9	3.6	0.2	2.3	0.6	0.5	0.6	0.0	0.0	0.2	6.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	7.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.3	1.1	0.5	0.4	0.4	0.2	0.4	0.6	0.7	0.0	1.1	0.7	0.2	0.3	0.8	0.0	0.0	2.4	0.2	0.1	1.5	15.7	0.0	1.8	12.5	0.9	0.1	0.0	0.0	0.9	0.4	0.2	0.1	12.9	0.0	51.3	0.2	1.9	2.5	1.9	0.0	0.1	0.0	0.0	66.0	30.2	0.1	0.0	0.2	0.0	0.0	4.7	1.3	0.3	1.8	0.1	1.8	0.0	0.0	0.3	1.0	0.0	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	11.8	6.6	0.5	1.2	0.1	0.1	0.0	0.1	0.3	0.2	0.0	0.0	0.4
ASB2	ASB-2	ENSG00000100628	"Ankyrin repeat and SOCS box containing 2"	Q96Q27	14	93934166-93976739	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 522.2;tongue: 157.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 51.1;Early spermatids: 26.4;Late spermatids: 29.9;Skeletal myocytes: 27.6;T-cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 50.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.8;RPMI-8226: 12.4;SK-MEL-30: 5.9;U-266/70: 42.1;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001546			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA001546: AB_1078224"	"unprognostic (5.65e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.62e-6)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.49e-7)"	"unprognostic (2.51e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.27e-1)"	2.9	0.8	0.8	5.6	2.1	0.5	1.5	0.0	1.9	12.0	0.0	66.5	4.0	31.6	0.3	4.0	26.6	0.5	78.5	0.6	0.0	0.5	0.5	3.0	7.4	0.1	0.0	2.9	0.3	0.2	0.2	0.2	0.3	14.4	0.4	0.0	6.6	0.9	522.2	2.3	18.3	1.6	0.0	4.2	17.2	0.4	0.3	0.4	1.2	157.6	3.2	30.4	8.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.4	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.0	12.4	0.0	0.2	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.9	0.0	0.0	0.0	0.2	0.0	42.1	8.6	1.7	0.5	2.6	0.5	0.0	0.2	50.8	1.9	2.7	0.3	1.9	1.7	3.8	4.2	0.4	0.2	0.5	0.1	0.0	7.8	0.4	2.3	1.3	0.8	2.1	0.0	1.9	0.6	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.0	0.3	3.3	0.4	0.1	8.4	0.0	0.2	0.2	0.9	51.1	0.0	2.9	0.0	0.0	0.1	3.0	0.0	0.0	1.4	26.4	1.7	0.3	0.5	0.0	2.7	4.7	0.0	0.5	1.9	1.1	2.5	0.0	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	0.0	0.3	29.9	0.3	5.3	1.8	1.9	5.8	0.8	2.1	0.0	0.7	0.2	0.0	0.4	10.7	0.1	0.0	0.0	0.4	1.1	0.0	27.6	5.0	0.8	8.4	0.1	0.1	2.9	14.5	0.1	0.1	0.3
ASB9	"DKFZP564L0862, FLJ20636, MGC4954"	ENSG00000102048	"Ankyrin repeat and SOCS box containing 9"	Q96DX5	X	15235288-15270467	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 16.8;liver: 17.4;lymphoid tissue: 11.7;pancreas: 9.5;testis: 25.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 41.1;Proximal tubular cells: 38.1;Spermatogonia: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.8;EFO-21: 20.1;PC-3: 53.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA003014, HPA003060, CAB004997"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"CAB004997: AB_426132, HPA003014: AB_1078226, HPA003060: AB_1078225"	"unprognostic (8.26e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	2.3	0.8	0.7	0.4	0.6	2.4	1.5	0.9	1.0	2.3	0.6	1.7	1.6	1.3	0.8	1.5	2.2	1.9	2.5	0.6	0.5	16.8	17.4	3.5	0.9	1.0	0.6	0.6	9.5	0.6	0.5	3.1	0.8	1.0	2.3	0.1	3.8	0.8	0.5	1.8	1.0	2.3	0.6	11.7	4.0	25.8	0.7	4.1	2.2	1.4	1.2	1.4	0.8	0.7	1.5	25.8	0.2	2.4	0.0	1.1	0.7	0.6	2.7	2.9	1.1	5.8	0.1	0.3	20.1	0.9	14.1	7.5	0.0	1.2	1.9	5.4	0.6	6.2	12.6	12.5	0.0	0.0	0.0	6.6	0.2	0.2	0.1	0.3	9.4	1.9	0.1	5.9	1.7	1.8	5.4	0.1	12.2	3.6	53.5	0.1	11.1	5.8	8.0	4.2	2.6	2.6	0.7	1.4	9.0	1.3	0.1	0.7	8.1	0.1	1.8	1.3	3.9	0.4	5.1	0.2	0.8	0.0	14.2	0.5	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.6	0.1	1.2	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.7	0.6	0.9	1.0	0.6	0.5	1.0	0.6	0.8	0.6	0.7	0.7	10.7	0.0	0.0	0.0	1.1	1.9	1.1	0.7	2.2	0.0	0.8	0.9	0.5	12.8	1.0	0.0	0.0	0.1	0.1	0.9	41.1	1.1	2.4	1.2	0.3	11.1	10.7	7.2	0.1	2.0	0.1	1.2	2.6	0.3	1.3	3.4	20.0	12.6	4.7	0.0	0.3	0.3	2.0	4.6	4.4	8.0	1.8	3.3	16.0	1.0	0.3	0.0	0.0	0.0	0.1	0.9	0.5	0.7	0.0	0.6	0.0	38.1	4.8	0.0	0.0	0.0	0.6	1.6	126.5	2.4	3.1	0.1	0.3	5.7	1.6	0.6
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957674-102960513	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;choroid plexus: 13.7;liver: 11.1;pituitary gland: 30.1"	"Group enriched"	"Detected in some"	5	"Astrocytes: 17.0;Enteroendocrine cells: 36.4;Oligodendrocyte precursor cells: 42.7"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"SCLC-21H: 53.7;SH-SY5Y: 29.0"	"Low region specificity"	"Detected in all"							"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA029217: AB_10669595, HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.0	1.1	18.7	0.0	18.3	0.0	0.0	18.9	23.0	0.5	13.7	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.0	18.2	16.8	0.0	11.1	0.5	0.5	20.1	18.1	0.4	0.2	0.0	30.1	0.0	18.5	0.3	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	1.2	0.1	18.7	5.5	0.1	0.0	0.0	0.0	0.3	19.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	29.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.3	18.9	23.0	18.2	16.8	20.1	18.1	18.5	19.9	18.7	19.4	0.1	0.0	0.0	17.0	0.3	0.0	0.3	0.0	0.0	4.3	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	36.4	0.0	1.7	0.0	0.0	0.2	4.6	0.1	0.0	0.0	0.0	1.8	0.1	5.0	4.1	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.4	0.0	42.7	0.3	0.2	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 386.9"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 890.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	386.9	160.3	64.7	50.6	69.2	16.9	106.9	102.3	88.9	65.6	84.4	78.8	45.6	49.3	44.7	71.4	46.9	61.0	111.3	64.5	58.4	59.5	74.9	74.1	20.3	54.0	69.2	62.2	44.7	38.7	36.3	47.9	52.2	48.3	84.9	219.5	101.9	70.2	357.6	35.2	45.5	67.5	44.8	28.6	105.0	16.5	71.8	16.7	97.0	182.7	28.5	112.2	43.8	60.4	460.3	652.3	89.9	55.1	392.1	370.1	31.2	804.0	741.3	336.3	350.1	113.1	594.2	35.3	54.3	474.6	270.3	167.5	56.2	281.1	570.0	13.6	57.0	81.1	372.5	310.3	251.2	12.5	12.9	306.5	61.9	187.6	237.4	657.2	144.8	18.0	22.2	32.1	300.2	97.4	3.3	16.6	51.7	441.6	383.4	22.3	97.0	7.3	206.2	374.0	93.1	32.1	249.9	116.1	101.7	49.0	47.7	22.2	456.7	338.0	174.3	313.0	288.0	20.2	27.1	1.5	890.1	7.5	231.4	1.9	8.3	0.3	2.5	2.9	4.7	5.5	3.5	2.4	10.0	5.0	4.9	2.5	25.4	8.7	1.8	34.0	4.0	4.1	64.7	69.2	102.3	88.9	64.5	58.4	54.0	69.2	52.2	44.8	71.8	60.4	79.1	195.5	244.0	366.6	13.8	47.0	160.7	126.0	68.9	138.3	83.7	58.4	228.6	37.1	157.5	86.5	294.0	118.1	40.3	57.0	15.6	144.2	1.6	51.4	65.8	85.9	116.5	13.0	93.1	180.4	107.1	132.0	73.9	115.4	8.2	34.5	42.8	62.6	72.2	127.9	98.9	215.1	52.9	26.6	44.1	3.1	70.8	48.1	42.7	61.8	20.0	468.8	2.1	154.8	53.5	257.7	32.3	57.6	15.9	148.2	34.3	34.6	66.6	158.8	46.0	114.4	92.7	3.4	16.8	101.7	50.3	48.0	13.6	131.2	67.3	254.2
ATAD1	"FLJ14600, Msp1"	ENSG00000138138	"ATPase family AAA domain containing 1"	Q8NBU5	10	87751512-87841361	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 987.5;Late spermatids: 1846.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037569	Uncertain		Approved	"Nucleoli rim,Mitochondria"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli rim"	Mitochondria	"HPA037569: AB_10672496"	"unprognostic (9.92e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.67e-2)"	"prognostic favorable (3.98e-6)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.22e-2)"	15.7	17.4	9.9	9.0	10.3	4.9	16.3	11.3	12.6	16.0	10.7	18.2	10.9	16.8	13.7	16.2	13.8	10.5	36.1	10.4	11.5	16.7	18.0	14.5	11.8	10.7	11.5	15.9	12.7	28.5	13.4	15.2	11.1	18.7	14.5	28.0	14.9	16.1	37.2	15.1	12.5	13.6	10.0	10.0	13.6	26.4	11.0	13.8	17.4	31.8	12.1	15.5	16.0	10.2	18.8	18.2	20.8	18.2	27.4	29.5	14.4	19.7	33.4	19.6	20.6	14.6	53.8	17.6	15.4	17.3	9.8	31.3	18.9	14.4	21.2	18.6	26.4	15.3	24.0	18.8	30.5	41.7	8.0	23.0	45.4	20.7	42.1	37.2	12.7	14.1	15.9	20.7	22.7	11.2	23.1	22.9	16.4	13.9	10.0	15.8	13.2	19.2	28.9	13.4	14.2	31.5	20.3	12.3	32.0	21.0	29.1	18.0	19.3	16.2	13.9	11.2	24.5	25.4	39.4	22.5	20.8	23.7	11.5	8.4	2.8	4.9	6.3	4.9	10.3	7.2	7.3	8.3	5.4	5.7	9.1	8.6	1.7	8.6	6.9	4.6	7.6	5.7	9.9	10.3	11.3	12.6	10.4	11.5	10.7	11.5	11.1	10.0	11.0	10.2	31.0	54.5	28.0	46.4	41.4	26.8	42.9	46.2	44.3	50.4	29.8	20.8	81.3	27.1	44.9	22.0	35.5	37.7	35.2	33.8	23.5	37.0	987.5	22.3	38.3	21.7	22.8	24.6	69.0	28.0	33.2	35.6	32.6	28.7	29.2	23.1	20.0	28.9	27.3	70.7	73.1	22.9	50.8	18.0	20.1	1846.8	35.8	25.1	32.0	37.5	16.1	59.6	23.7	58.8	52.7	39.0	25.2	47.0	32.3	42.3	20.5	29.5	44.8	54.8	59.2	29.5	43.8	77.2	29.8	34.6	30.1	88.4	40.0	34.8	23.7	54.6
ATF2	"CRE-BP1, CREB2, HB16, TREB7"	ENSG00000115966	"Activating transcription factor 2"	P15336	2	175072250-175168382	"Predicted intracellular proteins, Transcription factors"	"DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003769, HPA022134"	Supported	Supported	Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB003769: AB_562241, HPA022134: AB_1845138"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.21e-3)"	"unprognostic (6.70e-2)"	16.8	20.2	15.6	15.2	17.6	16.4	19.5	23.3	25.7	25.7	4.1	15.1	13.0	21.8	21.6	14.3	18.9	17.8	12.1	19.3	15.5	22.5	27.8	15.4	19.7	16.2	14.9	26.0	18.9	24.0	13.9	20.4	17.2	18.3	15.7	21.8	17.9	17.7	12.5	10.0	13.6	18.1	12.3	17.6	14.3	21.0	13.3	30.2	32.3	23.1	21.1	18.8	13.0	19.8	14.1	12.1	35.1	23.4	30.6	32.3	16.1	22.3	38.1	26.6	38.1	26.6	25.4	21.1	23.9	26.6	31.2	13.3	26.9	13.5	41.2	26.6	15.6	29.3	19.8	58.3	34.4	27.8	29.7	24.4	29.8	34.4	40.5	35.0	37.0	19.4	24.4	31.6	30.1	10.5	45.2	34.4	32.7	23.6	27.2	38.3	16.1	32.5	39.1	11.8	29.3	23.9	27.9	8.6	33.0	28.2	19.3	30.4	23.5	30.8	16.1	16.9	13.6	30.3	48.9	26.9	24.2	26.0	21.2	35.5	16.9	20.1	20.1	15.1	24.3	16.6	17.0	20.9	21.9	14.1	19.6	21.5	10.8	19.8	19.1	12.1	24.4	18.0	15.6	17.6	23.3	25.7	19.3	15.5	16.2	14.9	17.2	12.3	13.3	19.8	43.4	16.0	13.2	47.7	33.5	33.0	15.4	15.6	52.9	22.7	34.0	24.4	22.5	20.0	15.5	23.9	10.4	14.1	37.4	16.5	13.7	12.1	115.4	19.5	30.5	33.8	16.3	20.8	86.6	7.0	13.0	32.2	18.3	28.4	29.8	27.1	17.2	27.0	18.9	40.4	71.3	14.4	18.3	23.3	30.2	153.0	32.6	23.6	30.2	54.4	20.4	32.3	24.7	75.9	84.9	11.9	9.1	28.6	38.8	15.6	11.5	21.6	19.3	27.3	13.1	31.5	33.9	36.3	17.6	30.4	25.3	6.3	32.9	23.7	16.1	13.6
ATL1	"AD-FSP, FSP1, SPG3, SPG3A"	ENSG00000198513	"Atlastin GTPase 1"	Q8WXF7	14	50532509-50634017	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.6;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 136.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 22.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.8;SCLC-21H: 17.1;SH-SY5Y: 15.4;SiHa: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027550	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA027550: AB_10600983"	"unprognostic (2.06e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.23e-2)"	4.1	5.6	29.1	3.3	33.2	0.2	11.3	18.8	42.8	5.7	2.2	8.1	3.9	9.0	2.9	5.3	6.5	4.8	2.1	37.1	30.3	4.0	0.3	4.3	1.7	25.2	21.5	10.5	3.7	1.9	7.7	0.5	29.6	8.3	5.6	9.5	13.2	8.6	1.1	9.6	4.9	15.6	24.9	1.1	4.6	8.7	25.0	1.1	2.5	2.2	1.8	6.7	5.3	30.0	1.2	1.1	4.8	4.6	0.3	0.0	3.4	5.7	9.6	6.2	7.4	0.0	4.1	3.7	2.5	0.1	4.5	1.4	8.4	1.1	2.4	19.8	1.8	1.2	0.8	0.3	0.2	0.2	3.1	3.6	1.9	8.6	1.6	0.3	0.4	4.2	0.1	0.5	8.7	0.4	1.2	0.6	4.4	1.4	1.5	0.6	12.1	0.4	1.7	2.5	17.1	15.4	18.9	1.1	0.6	0.0	0.0	2.1	1.3	6.0	4.6	0.0	2.9	0.9	4.7	1.7	3.9	0.2	0.2	22.9	0.1	4.9	2.5	0.0	0.5	3.8	0.9	2.1	1.2	1.1	2.1	4.2	0.3	0.6	0.5	2.8	0.4	2.0	29.1	33.2	18.8	42.8	37.1	30.3	25.2	21.5	29.6	24.9	25.0	30.0	3.0	6.4	2.6	31.6	3.7	5.1	6.2	10.3	6.2	27.8	18.1	16.3	1.9	5.7	6.6	5.5	0.0	0.4	6.7	9.3	0.0	10.6	31.4	4.2	5.4	4.8	7.2	0.4	138.6	13.1	1.1	14.6	5.6	2.3	6.3	1.2	5.0	0.0	1.6	11.8	95.5	1.9	2.0	0.0	3.6	5.7	13.4	5.5	8.8	20.6	1.3	23.0	2.1	81.4	136.7	7.2	6.0	17.0	5.2	3.9	13.2	3.4	14.2	8.6	19.7	4.5	10.8	31.9	5.7	4.1	5.5	0.1	3.8	0.2	3.6	3.3
ATMIN	"ASCIZ, KIAA0431, ZNF822"	ENSG00000166454	"ATM interactor"	O43313	16	81035842-81047350	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 180.6;Late spermatids: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054967, HPA066900"	Approved		Supported	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA054967: AB_2682654, HPA066900: AB_2685744"	"unprognostic (9.92e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-1)"	15.9	12.7	18.9	11.4	19.6	7.9	14.4	18.2	23.5	13.5	14.6	12.9	12.8	13.8	18.0	18.9	11.4	11.5	14.2	19.6	21.6	19.7	17.9	10.7	13.9	19.6	21.7	14.3	16.1	27.0	13.1	20.4	22.8	17.6	13.7	10.3	12.8	14.8	16.0	17.6	12.9	13.7	17.6	12.9	12.7	22.6	21.5	15.6	20.6	17.0	15.0	14.2	12.0	18.4	26.7	22.0	28.6	33.7	30.6	21.3	42.8	17.1	24.8	15.9	8.8	14.9	14.9	20.8	21.8	25.6	18.3	25.3	28.1	14.7	20.3	13.8	15.6	14.3	13.3	17.4	28.3	24.7	21.6	22.7	24.7	15.4	24.7	26.7	16.6	20.0	22.8	12.4	22.9	42.9	19.9	18.0	33.6	16.6	16.3	34.5	13.8	12.2	25.0	27.5	22.8	29.5	54.3	16.8	14.3	23.7	28.5	22.0	22.0	20.3	20.6	19.9	16.2	19.7	31.6	50.4	18.7	16.1	19.3	0.5	0.8	0.5	1.9	0.6	1.4	1.5	2.0	1.7	0.8	1.6	1.7	1.9	0.2	1.9	0.6	1.0	2.2	0.6	18.9	19.6	18.2	23.5	19.6	21.6	19.6	21.7	22.8	17.6	21.5	18.4	38.6	9.6	19.2	10.7	11.7	12.0	16.3	10.0	10.2	24.9	20.7	16.9	18.6	20.0	15.5	23.9	20.9	42.3	25.8	21.4	11.7	12.6	180.6	13.3	37.2	19.3	11.5	7.4	16.1	14.0	38.4	17.9	15.8	22.4	16.5	15.2	22.9	21.6	29.7	13.5	17.7	13.7	6.1	23.9	6.0	288.9	19.9	14.3	14.2	3.7	19.2	32.5	12.3	8.0	16.9	18.5	11.2	19.5	15.0	15.1	19.9	20.8	7.5	16.6	13.1	24.2	18.0	28.6	25.4	17.2	15.3	30.1	15.5	21.6	16.0	18.4
ATP1B2	AMOG	ENSG00000129244	"ATPase Na+/K+ transporting subunit beta 2"	P14415	17	7646627-7657770	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	11	"brain: 395.1;retina: 614.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 207.3;Bipolar cells: 330.2;Cone photoreceptor cells: 250.2;Muller glia cells: 303.2;Rod photoreceptor cells: 226.1"	"Cancer enriched"	"Detected in many"	17	"glioma: 200.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;HAP1: 2.9;K-562: 4.5;SuSa: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010698	Supported					NA	NA		160000		"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"HPA010698: AB_1845174"	"unprognostic (9.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.96e-3)"	"unprognostic (3.90e-3)"	"unprognostic (9.33e-2)"	"unprognostic (4.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.79e-2)"	6.1	10.1	212.3	0.9	251.6	11.4	5.0	268.1	288.8	13.3	25.8	9.1	1.2	8.8	17.4	2.2	12.3	3.6	8.6	196.9	250.0	10.1	2.7	4.2	1.7	353.9	395.1	29.5	2.5	4.5	45.3	4.5	282.6	6.6	2.7	614.8	1.9	7.5	4.3	2.3	3.5	5.5	256.3	5.0	3.8	5.5	364.8	0.8	4.6	5.3	1.1	4.6	7.7	174.7	0.0	0.0	9.6	0.4	0.3	0.2	0.1	0.1	0.0	0.3	0.2	0.4	0.0	0.3	0.2	0.1	0.2	0.3	2.9	0.2	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.0	0.9	0.5	0.0	0.3	0.0	0.1	0.0	0.2	4.5	0.5	0.0	0.2	0.2	0.3	2.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	1.8	0.0	0.1	0.0	5.7	0.1	0.2	0.0	0.1	0.7	0.0	0.2	0.4	0.1	0.0	0.9	0.2	0.2	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	212.3	251.6	268.1	288.8	196.9	250.0	353.9	395.1	282.6	256.3	364.8	174.7	8.5	0.0	0.0	207.3	1.8	1.9	0.4	0.0	1.8	330.2	2.3	6.2	3.7	2.8	0.0	0.0	250.2	0.0	1.1	6.7	0.0	0.2	0.2	0.8	8.3	7.7	0.0	49.2	2.9	0.0	0.1	5.9	7.7	0.6	0.0	1.0	11.4	0.2	0.3	18.5	38.8	2.4	2.0	0.8	0.9	2.3	18.6	1.6	0.0	7.5	0.2	303.2	0.0	45.8	1.6	0.0	0.0	46.3	0.8	0.5	0.5	0.2	0.0	226.1	26.3	2.4	50.0	1.2	6.1	1.6	1.1	0.3	1.6	0.5	2.6	0.2
ATP5F1A	"ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM"	ENSG00000152234	"ATP synthase F1 subunit alpha"	P25705	18	46080248-46104334	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1760.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 784.3;Distal tubular cells: 1173.9;Extravillous trophoblasts: 463.0;Proximal tubular cells: 939.6;Syncytiotrophoblasts: 578.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013067, HPA040622, HPA044202"	Enhanced		Supported	Mitochondria		NA	NA		8800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855"	"unprognostic (3.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (4.60e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.87e-3)"	251.3	453.6	198.6	177.7	209.2	210.5	260.4	233.0	251.4	195.5	401.9	414.0	438.9	192.6	225.6	362.6	227.2	146.3	1498.3	207.7	246.0	730.4	441.6	175.1	223.7	234.6	237.8	211.1	299.9	868.5	277.4	201.7	226.0	211.4	419.8	465.4	307.4	265.9	1602.0	290.3	335.0	233.0	205.4	226.8	419.1	167.6	226.7	277.3	261.4	1760.3	337.6	244.9	224.7	209.6	355.2	353.0	459.6	434.3	546.0	601.8	508.6	399.5	562.4	601.0	522.8	532.7	271.9	833.2	238.9	487.4	322.3	641.7	801.1	614.1	556.4	373.0	450.3	551.7	413.3	667.2	357.1	1182.7	501.6	559.2	422.3	434.6	448.2	481.3	630.4	442.5	454.0	477.2	521.8	367.6	612.8	579.7	432.3	344.5	367.6	596.5	533.8	1131.4	816.2	849.7	465.7	434.7	293.3	361.5	506.9	428.6	466.3	679.3	370.4	328.7	282.7	174.9	354.9	542.5	501.5	533.0	328.1	698.0	358.7	119.1	573.9	162.7	353.6	511.8	455.9	492.3	422.7	388.4	959.5	392.9	503.3	421.7	55.9	414.5	485.1	468.3	527.4	1339.1	198.6	209.2	233.0	251.4	207.7	246.0	234.6	237.8	226.0	205.4	226.7	209.6	79.2	169.9	167.8	0.0	49.9	0.0	0.0	0.0	0.0	0.0	205.7	169.8	0.0	0.0	100.3	171.0	0.0	784.3	86.3	0.0	1173.9	358.3	0.0	125.3	163.3	73.0	0.0	0.0	0.0	269.7	463.0	97.8	0.0	119.3	89.6	198.7	0.0	0.0	409.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	179.9	0.0	0.0	0.0	0.0	199.1	0.0	0.0	24.0	0.0	0.0	939.6	95.5	0.0	0.0	0.0	87.1	0.0	0.0	0.0	0.0	578.2	54.6	319.2	0.0	0.0
ATP6V0E2	"ATP6V0E2L, C7orf32"	ENSG00000171130	"ATPase H+ transporting V0 subunit e2"	Q8NHE4	7	149872968-149891204	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"brain: 328.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 123.7;Horizontal cells: 114.4;Muller glia cells: 173.0;Proximal tubular cells: 102.9"	"Cancer enhanced"	"Detected in all"		"glioma: 89.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 148.8;SCLC-21H: 169.4"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (8.72e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.57e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (8.26e-7)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.48e-3)"	21.8	30.0	270.4	11.4	284.5	5.7	17.7	242.5	309.4	9.5	149.4	33.6	7.6	9.3	9.2	10.5	21.9	9.4	117.7	328.6	256.5	57.0	118.0	12.9	23.3	305.6	287.9	10.4	22.7	41.5	134.9	4.1	324.6	44.3	8.0	50.4	66.1	30.7	16.4	14.8	19.0	9.9	236.5	24.0	33.8	8.1	300.3	30.9	55.5	15.6	13.5	12.1	8.8	235.7	26.2	72.2	29.6	96.3	11.9	1.9	18.5	13.4	18.2	36.0	36.8	25.7	32.1	53.5	55.2	17.9	37.5	22.9	63.2	22.6	15.4	69.4	70.2	16.7	21.0	148.8	17.8	12.3	35.3	4.1	23.1	39.8	2.4	27.9	30.2	66.3	18.3	25.5	2.6	45.0	8.8	28.2	25.7	33.7	50.6	57.8	1.2	24.7	28.4	28.0	169.4	96.0	17.4	60.0	41.9	7.2	33.9	8.1	5.7	10.4	11.0	109.6	50.3	35.4	49.2	26.5	65.9	21.4	34.4	4.4	9.0	2.2	45.9	17.5	41.7	19.6	56.5	53.4	18.5	17.8	71.9	66.6	1.5	38.6	22.2	8.5	92.9	31.6	270.4	284.5	242.5	309.4	328.6	256.5	305.6	287.9	324.6	236.5	300.3	235.7	3.7	16.0	11.3	35.6	14.1	4.2	4.1	3.4	0.6	123.7	31.1	23.5	29.6	21.5	8.5	27.6	25.0	19.5	23.2	1.9	54.8	45.5	0.4	13.6	1.9	6.7	22.2	9.5	39.9	12.8	4.8	8.8	10.2	20.9	10.8	21.9	11.4	65.1	24.7	114.4	62.3	26.2	22.4	10.2	4.1	1.6	5.3	9.9	44.4	14.0	6.4	173.0	27.8	34.7	34.2	5.6	0.7	11.3	4.5	15.0	0.9	102.9	6.7	78.9	6.6	8.7	10.0	0.9	13.2	6.9	4.4	5.1	38.1	6.6	2.5	5.6
ATP6V1E2	"ATP6E1, ATP6EL2, ATP6V1EL2, MGC9341, VMA4"	ENSG00000250565	"ATPase H+ transporting V1 subunit E2"	Q96A05	2	46490750-46542577	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 28.4"	"Group enriched"	"Detected in many"	10	"Early spermatids: 350.9;Late spermatids: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 19.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075092	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA075092: "	"unprognostic (1.62e-1)"	"unprognostic (9.65e-3)"	"unprognostic (4.31e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.32e-2)"	1.8	2.3	4.1	1.4	4.2	0.9	2.1	3.6	4.4	1.5	3.1	1.7	0.4	1.5	6.4	1.2	1.4	0.7	1.6	3.8	3.7	2.1	1.9	1.2	1.7	4.0	3.8	1.7	2.8	1.7	2.8	1.1	4.0	2.9	0.7	2.4	2.4	1.6	3.4	2.9	1.4	0.8	4.0	2.0	1.6	28.4	3.8	1.2	1.4	1.4	1.6	1.8	1.6	4.0	8.6	5.5	1.8	4.2	1.7	3.1	0.9	2.9	1.1	1.3	0.6	1.7	1.4	5.1	5.2	2.8	4.2	2.0	4.2	2.1	2.8	7.8	3.3	1.2	1.0	1.2	1.9	2.2	2.4	2.6	19.2	1.8	4.0	1.5	1.3	5.4	3.6	8.8	0.9	5.6	1.5	6.6	3.5	4.4	4.6	3.7	4.4	6.4	2.6	1.9	4.8	10.3	1.9	2.0	4.3	3.0	1.3	1.0	1.3	1.4	5.1	2.5	2.1	4.3	3.7	5.3	2.0	6.6	2.3	0.0	0.8	0.2	0.8	0.4	1.1	0.8	1.5	1.6	0.7	1.0	1.1	1.6	0.5	0.3	0.5	1.7	1.0	0.5	4.1	4.2	3.6	4.4	3.8	3.7	4.0	3.8	4.0	4.0	3.8	4.0	4.7	3.2	0.5	5.5	12.9	5.7	11.3	1.7	8.6	11.8	14.8	18.5	6.7	5.7	2.4	3.7	12.5	2.9	4.0	2.5	9.8	3.3	350.9	3.8	7.8	3.1	3.5	2.5	7.2	3.3	2.2	9.8	5.1	3.9	0.0	5.0	5.0	2.7	2.2	18.5	6.8	2.1	0.0	7.7	5.1	196.3	9.9	5.9	5.4	1.0	7.0	16.5	6.2	4.5	7.4	3.3	0.1	6.8	7.0	5.5	0.3	7.1	3.9	25.8	6.6	6.8	7.4	7.7	10.4	5.0	8.1	0.8	7.8	2.7	3.1	3.8
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711487-44718851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	Immunity		"Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 31919.3;NK-cells: 24726.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	1790000000	2100000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	3160.2	3214.7	697.6	5686.5	705.1	7839.2	2606.9	711.8	1145.0	2539.9	789.6	5139.0	5180.7	2192.2	1735.6	2283.9	1648.3	4948.8	2327.2	651.0	769.9	2462.6	6206.2	6159.2	9311.8	889.5	763.2	1945.7	1310.9	1940.5	318.4	3502.0	815.3	2345.0	5593.5	139.3	5657.1	1784.5	931.7	3015.6	5693.3	2545.3	838.3	7896.1	4878.2	615.6	771.9	4217.4	2340.8	2026.5	5333.4	5753.1	549.4	909.5	1735.4	378.9	226.0	633.6	4348.7	4719.4	1662.5	2045.5	4961.9	3609.7	6561.4	425.3	5417.9	554.8	2567.9	1948.8	2410.2	2537.0	497.2	878.7	1226.2	4762.2	435.9	2956.9	2263.6	600.3	3609.3	2074.5	3328.6	2735.9	609.8	1075.7	1044.4	2442.6	1884.1	965.4	611.9	3649.1	2195.5	476.9	1518.4	3213.8	206.5	629.8	1014.3	2240.2	1926.6	4789.2	2425.5	3486.4	254.1	179.1	1288.4	1571.2	1338.5	394.3	655.3	6180.6	2548.7	4531.4	676.5	5389.2	2193.3	4771.7	7118.6	1683.1	5384.6	3783.6	2567.3	48105.4	18117.1	33178.9	20639.1	17775.0	20836.8	15768.0	23783.0	22245.1	9978.8	11988.4	17122.9	22791.8	50453.6	18779.6	19034.9	12052.6	29659.1	56957.2	697.6	705.1	711.8	1145.0	651.0	769.9	889.5	763.2	815.3	838.3	771.9	909.5	12048.3	3387.8	3505.1	28.7	8472.8	7843.7	3197.1	8420.8	1628.8	33.3	2399.5	2015.2	1068.8	3593.1	5347.4	2100.3	27.1	1354.6	14028.8	8753.6	1038.9	13898.6	43.1	2073.7	2414.0	8385.6	2266.0	2087.2	7.3	9034.5	4397.5	3691.1	1981.7	2282.2	3029.5	1270.6	6835.7	3832.6	11985.7	5.0	22.0	5982.6	8701.4	12536.8	14507.0	158.8	3018.0	10687.9	6744.8	368.2	31919.3	322.0	24726.3	95.0	129.2	10115.7	7085.6	1688.8	11026.6	5300.4	18327.7	3122.5	8367.9	52.5	4016.7	2055.2	4107.1	64.2	72.1	1541.4	8619.8	804.8	14266.2	3229.8	3063.4	8248.6
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105411	"Blood group antigen proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 53.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cardiomyocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 8.8;NK-cell: 22.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.8;NK-cells: 22.1"	"Cell line enhanced"	"Detected in many"		"RT4: 128.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041204			Approved	Vesicles		NA	NA		400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	5.3	7.2	20.7	3.9	21.5	4.8	9.8	14.7	19.6	20.1	8.0	2.7	1.9	9.9	8.5	6.8	14.2	9.9	53.3	21.7	26.7	19.4	1.2	14.6	4.9	12.8	21.7	18.8	11.1	8.6	9.8	13.9	18.0	11.6	2.4	26.6	22.3	8.5	1.4	2.5	2.4	9.9	14.1	6.2	10.7	8.4	25.7	2.8	27.0	3.2	5.4	12.3	5.4	13.0	17.3	0.3	7.5	0.1	1.0	2.8	0.1	9.3	8.7	22.3	7.3	11.3	13.2	0.0	35.7	8.0	12.7	3.9	0.0	16.9	7.5	0.0	0.0	9.0	5.7	0.0	11.2	0.2	0.0	23.3	5.4	6.1	1.4	15.6	31.6	0.0	0.0	0.0	8.3	29.4	0.1	0.0	17.4	0.2	38.9	0.1	0.0	0.2	9.3	128.3	15.1	0.1	23.7	8.8	6.3	3.0	35.6	13.3	0.0	0.2	15.5	0.5	0.2	3.6	0.1	0.2	14.7	0.0	0.0	8.8	0.2	0.0	0.4	0.2	0.4	2.3	0.2	0.4	1.7	0.2	0.4	0.9	0.4	22.1	0.1	1.1	0.0	0.7	20.7	21.5	14.7	19.6	21.7	26.7	12.8	21.7	18.0	14.1	25.7	13.0	5.0	19.2	2.2	10.1	2.1	5.0	5.2	5.7	6.2	56.3	7.5	6.2	56.9	0.0	8.0	14.7	12.5	21.2	1.2	0.1	11.7	3.5	0.7	4.9	5.8	7.7	1.8	17.0	22.3	8.5	13.0	13.3	4.6	8.7	10.2	13.0	6.1	0.2	9.8	6.7	27.5	0.1	6.1	2.1	6.8	2.2	7.2	3.4	10.6	9.4	4.3	12.6	1.0	14.6	3.2	9.8	0.1	5.3	0.2	6.2	0.1	15.8	3.1	8.4	0.0	5.3	13.2	6.5	20.7	8.4	2.6	5.1	1.2	4.6	0.7	4.5
B9D1	"B9, EPPB9, MKS9, MKSR-1"	ENSG00000108641	"B9 domain containing 1"	Q9UPM9	17	19334308-19378193	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 226.2;Endometrial ciliated cells: 99.7;Late spermatids: 171.8;Respiratory ciliated cells: 159.5;Spermatocytes: 141.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022957	Approved				"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA022957: AB_1848220"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.18e-3)"	7.7	20.9	20.1	3.9	22.0	5.7	12.2	16.5	23.0	14.3	38.1	10.2	6.0	15.4	54.8	9.3	62.7	11.1	13.5	20.7	19.4	26.0	10.4	9.5	3.8	18.9	20.8	15.7	22.1	34.2	60.9	5.1	15.6	11.3	7.5	21.8	11.4	18.1	5.9	7.1	5.3	11.8	17.0	7.4	10.4	65.3	21.0	3.7	39.4	5.4	4.5	8.1	7.9	17.9	66.7	61.2	14.9	20.9	18.8	29.2	18.6	10.9	55.8	35.4	37.5	14.1	17.6	18.0	13.9	21.3	20.6	27.3	11.2	31.6	22.1	6.2	41.0	1.1	30.8	43.8	30.6	4.3	2.9	23.4	24.4	22.2	42.0	50.3	33.2	21.5	10.5	2.0	33.2	57.6	2.1	5.3	10.7	32.0	21.3	11.6	1.6	29.9	74.9	4.5	43.6	10.8	22.8	5.7	15.5	42.7	47.1	7.2	6.4	9.4	23.2	10.4	11.7	11.6	2.3	5.5	23.0	2.4	15.7	0.0	0.6	0.0	0.7	1.8	0.9	2.2	0.5	0.6	0.2	0.4	0.6	0.4	0.0	0.8	1.6	0.3	0.2	1.0	20.1	22.0	16.5	23.0	20.7	19.4	18.9	20.8	15.6	17.0	21.0	17.9	1.5	16.0	11.9	13.4	8.1	3.8	10.7	23.0	13.1	5.8	10.5	13.6	10.9	8.6	19.9	38.6	12.5	4.4	0.7	2.6	64.6	19.8	226.2	99.7	8.1	4.9	20.4	9.0	14.5	14.6	4.8	14.6	12.2	5.9	0.0	9.5	3.3	4.6	5.4	5.0	10.6	12.8	14.2	1.0	1.7	171.8	13.1	2.3	16.0	1.9	1.3	14.0	1.0	10.1	8.2	9.6	2.9	9.8	27.2	11.1	1.3	82.6	159.5	16.6	6.6	7.3	30.8	141.5	26.8	14.2	2.0	2.6	2.1	25.2	7.3	7.0
BATF	"B-ATF, BATF1, SFA-2"	ENSG00000156127	"Basic leucine zipper ATF-like transcription factor"	Q16520	14	75522455-75546993	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.7;lymphoid tissue: 30.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 105.4;Breast myoepithelial cells: 73.9;granulocytes: 243.7;NK-cells: 103.0;T-cells: 116.5;Urothelial cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"T-cells: 130.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 368.9;MCF7: 134.7;RT4: 83.3;SK-BR-3: 64.8;U-937: 101.6"	"Not detected"	"Not detected"							"HPA059588, HPA064962"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA059588: AB_2684074, HPA064962: AB_2685392"	"unprognostic (3.33e-3)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (8.30e-4)"	"prognostic favorable (5.35e-6)"	"unprognostic (3.02e-2)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (3.74e-9)"	"unprognostic (4.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (4.30e-4)"	5.5	1.3	1.0	20.5	1.8	21.7	7.8	1.0	1.4	2.2	1.1	3.0	2.6	1.3	1.1	2.9	1.9	5.8	2.4	1.0	1.2	1.4	2.9	8.0	30.6	1.5	1.4	0.5	0.9	8.0	0.5	4.1	1.7	5.5	1.4	0.0	6.5	1.8	0.4	2.9	9.7	2.3	1.2	26.9	7.8	0.6	2.2	7.2	1.9	1.0	20.4	18.2	2.9	1.5	4.7	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	368.9	0.0	7.5	0.0	1.6	11.5	10.0	36.3	0.1	0.0	0.0	0.0	0.0	0.0	8.1	2.0	10.3	0.0	134.7	4.7	30.8	0.2	54.9	0.0	1.1	0.0	6.3	0.0	83.3	0.1	0.0	0.0	64.8	2.7	0.0	6.1	18.7	0.0	0.0	0.0	4.4	0.3	32.8	36.9	0.3	0.0	101.6	0.1	3.6	25.5	8.2	55.0	13.7	43.4	21.3	59.7	74.2	25.2	17.5	23.1	50.4	14.4	21.3	13.2	2.9	130.3	27.8	1.0	1.8	1.0	1.4	1.0	1.2	1.5	1.4	1.7	1.2	2.2	1.5	2.9	9.6	29.3	0.0	17.1	5.4	50.8	5.7	0.6	0.0	105.4	73.9	0.3	1.5	13.5	3.7	0.0	0.4	36.9	0.0	0.0	0.8	0.5	0.9	0.6	5.0	0.0	7.2	0.2	2.5	0.4	4.4	10.2	1.9	243.7	0.0	2.5	0.7	61.3	0.0	0.1	0.0	34.6	15.4	10.7	0.6	0.0	21.7	5.4	1.0	16.7	0.0	103.0	0.0	0.1	11.0	0.1	0.0	29.9	22.1	0.0	0.2	12.8	0.0	0.0	1.0	2.0	0.0	0.1	0.4	3.4	1.1	116.5	0.2	0.5	74.3
BBS9	"B1, PTHB1"	ENSG00000122507	"Bardet-Biedl syndrome 9"	Q3SYG4	7	33109557-33877180	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 125.7;Excitatory neurons: 162.6;Inhibitory neurons: 159.0;Microglial cells: 266.1;Oligodendrocyte precursor cells: 238.8;Oligodendrocytes: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021289	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021289: AB_1845286"	"unprognostic (1.18e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.20e-1)"	"unprognostic (6.90e-3)"	6.9	8.0	9.1	2.5	10.7	1.9	6.7	8.8	8.6	10.8	13.7	6.3	0.7	5.8	4.2	4.7	6.9	3.8	6.4	7.9	8.5	6.8	4.3	5.8	3.4	9.9	9.8	9.5	3.9	10.4	13.2	4.5	10.0	6.9	3.0	21.9	6.3	5.7	3.5	5.5	4.1	4.4	9.5	4.8	4.4	9.9	10.6	5.5	11.4	3.6	3.0	6.2	8.5	10.6	3.1	3.2	6.0	6.4	12.1	11.0	2.7	3.7	11.7	3.4	10.1	2.7	5.2	4.7	4.4	8.5	9.6	3.9	3.1	7.0	8.3	2.3	4.8	0.9	5.6	3.2	5.3	1.4	2.1	10.1	3.8	6.6	2.6	10.5	8.8	9.9	2.8	5.5	7.3	2.9	3.0	2.5	3.3	4.6	4.4	3.6	2.0	2.7	4.4	1.4	2.7	5.2	7.6	3.3	6.6	8.8	8.0	0.8	4.0	3.3	4.9	6.9	2.3	6.8	10.3	6.6	8.7	2.3	5.4	4.9	2.9	4.5	4.9	4.6	5.5	4.4	4.5	5.3	2.4	4.4	4.3	5.4	1.1	7.4	2.3	0.9	5.6	2.9	9.1	10.7	8.8	8.6	7.9	8.5	9.9	9.8	10.0	9.5	10.6	10.6	7.3	3.2	3.7	125.7	6.9	3.7	6.7	3.1	7.4	6.8	3.6	3.4	14.2	2.8	5.0	5.5	29.2	3.6	4.3	1.8	3.9	3.7	28.6	17.6	7.2	7.4	3.6	3.8	162.6	1.5	4.6	7.3	5.1	3.6	0.0	5.9	5.3	2.5	3.7	5.0	159.0	2.7	8.2	2.5	2.9	6.6	4.1	3.4	1.8	266.1	2.2	7.8	4.1	238.8	366.6	1.5	0.5	5.7	8.1	1.6	1.8	3.8	15.6	51.2	0.0	6.0	5.5	25.6	14.7	6.0	3.3	2.5	7.1	4.6	2.3	4.3
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810024-24949101	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 58.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 203.2;Early spermatids: 161.4;Exocrine glandular cells: 139.9;Langerhans cells: 265.8;Late spermatids: 370.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 19.0;glioma: 10.7;lung cancer: 7.2;ovarian cancer: 24.0;testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.8;monocytes: 17.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 261.3;NTERA-2: 287.4;RH-30: 310.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					NA	NA		97000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.38e-4)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavorable (8.54e-4)"	6.7	5.9	4.1	7.1	5.7	2.4	2.1	11.1	10.6	3.6	0.0	3.0	0.8	8.6	1.0	2.0	7.2	4.4	1.8	3.0	19.6	1.2	1.3	9.6	6.4	19.4	19.8	7.2	58.2	0.4	6.6	15.2	22.7	0.9	2.6	14.5	1.7	0.8	0.7	0.6	3.6	5.7	6.4	2.0	1.8	7.1	14.0	5.2	1.2	2.0	5.3	4.1	1.3	7.9	30.3	12.1	106.8	0.2	30.5	59.0	54.9	60.9	40.6	33.4	55.2	67.1	83.1	114.0	0.3	100.7	6.5	12.0	77.2	0.5	88.2	261.3	15.4	91.1	2.0	37.3	112.3	105.9	31.6	77.4	2.0	85.1	17.8	73.0	114.3	56.9	88.5	1.1	28.7	0.6	65.2	30.1	287.4	0.0	8.1	0.1	310.3	1.4	0.1	10.4	0.1	60.1	0.1	0.2	0.5	114.8	0.2	45.2	150.8	19.7	72.9	80.4	58.1	13.2	13.9	152.7	69.9	62.4	0.3	0.0	2.3	0.0	0.0	3.6	0.1	1.1	0.0	0.1	5.8	0.0	0.0	0.0	1.0	0.1	17.1	3.4	0.2	1.0	4.1	5.7	11.1	10.6	3.0	19.6	19.4	19.8	22.7	6.4	14.0	7.9	1.7	16.0	26.0	1.6	1.3	8.7	0.1	2.5	0.0	203.2	0.3	0.3	1.6	1.5	2.2	0.0	2.1	61.2	4.3	0.0	1.9	1.8	161.4	41.5	92.6	16.8	0.0	20.8	39.6	139.9	23.2	27.6	0.0	89.1	11.4	117.4	7.9	0.3	72.3	42.1	81.8	0.0	14.2	87.1	265.8	370.3	7.2	59.9	7.2	38.4	22.3	7.1	0.0	84.4	57.4	49.6	0.0	4.1	0.7	0.2	0.0	0.1	3.3	12.2	6.6	14.9	17.4	1.9	1.6	0.5	7.2	22.4	2.8	41.3	0.1	0.1
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"BAF chromatin remodeling complex subunit BCL11B"	Q9C0K0	14	99169287-99272197	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9"	"Group enriched"	"Detected in many"	8	"gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"JURKAT: 38.3;MOLT-4: 47.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 64.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 30.0"	HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.4	0.3	8.0	5.1	21.2	4.9	1.1	0.0	17.2	0.9	0.0	1.2	2.0	0.2	0.5	4.3	0.3	0.9	0.1	18.9	1.1	0.3	0.4	1.1	10.2	0.3	0.8	0.2	0.1	0.0	0.2	0.1	0.0	0.5	1.4	0.0	1.7	0.3	0.2	15.0	3.5	0.2	1.5	4.4	1.9	0.5	2.0	36.6	0.8	0.0	7.5	1.3	2.9	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.0	0.0	38.3	0.0	4.1	0.0	2.8	47.3	0.8	0.5	3.6	0.0	7.0	0.0	0.0	0.0	2.6	3.7	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.2	0.0	2.6	0.1	0.0	2.0	0.7	0.0	0.0	0.0	0.1	2.0	0.0	1.8	0.0	2.8	2.4	0.0	0.0	4.6	3.1	0.0	0.3	0.0	0.0	2.0	0.8	8.0	21.2	0.0	17.2	18.9	1.1	0.3	0.8	0.0	1.5	2.0	3.9	1.3	3.2	0.0	1.3	6.4	62.8	1.6	6.3	73.4	0.4	4.3	4.4	3.8	4.3	1.3	0.0	0.0	0.1	44.2	3.8	1.9	0.2	0.2	0.2	0.2	1.2	1.2	5.3	57.5	0.5	0.0	3.3	2.0	0.3	5.1	0.2	3.3	0.3	0.3	0.0	105.7	4.9	2.0	1.0	11.4	0.4	0.6	4.0	5.4	1.0	4.9	0.0	51.5	32.2	2.0	1.1	5.4	0.0	24.4	0.6	10.1	0.5	0.3	0.1	0.0	0.5	1.9	1.6	5.8	42.7	71.3	0.0	133.4	0.1	9.7	0.6
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 180.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria		NA	NA		100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107"	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	13.4	13.3	8.7	5.7	11.6	10.8	11.5	8.4	12.8	7.7	1.4	10.0	6.0	7.9	8.8	12.3	7.4	6.8	19.7	9.4	9.9	14.0	16.4	8.4	7.6	11.6	13.7	7.5	11.8	14.8	7.8	9.2	12.1	8.2	10.3	43.8	10.0	6.8	59.6	14.1	7.8	7.6	9.2	6.4	9.5	10.7	9.7	9.2	9.6	40.5	8.7	10.3	8.7	9.4	16.2	6.1	10.6	11.1	19.6	18.8	17.2	11.4	21.3	17.1	19.8	8.3	11.7	14.6	7.5	15.4	13.9	21.3	12.6	18.4	20.9	12.2	12.3	14.5	7.5	6.1	22.3	21.3	10.0	14.5	21.1	14.0	40.1	24.2	14.7	11.3	34.5	15.2	18.9	11.6	11.7	8.9	10.7	26.8	9.7	10.9	20.7	5.3	20.1	12.4	15.6	11.5	16.4	15.6	31.0	38.0	11.9	18.0	17.2	9.9	5.0	15.3	10.5	11.9	10.5	14.7	14.9	16.1	16.4	5.1	9.5	2.3	2.3	8.0	2.8	3.1	3.1	2.7	5.4	3.2	2.8	2.3	3.6	6.5	6.4	2.9	4.5	4.7	8.7	11.6	8.4	12.8	9.4	9.9	11.6	13.7	12.1	9.2	9.7	9.4	18.7	22.4	16.7	32.3	21.5	24.6	33.6	22.7	30.1	180.5	21.8	22.4	42.7	12.8	25.3	18.4	12.5	48.5	19.7	31.7	52.8	29.1	34.8	17.7	16.0	17.5	23.4	19.8	41.9	31.6	35.0	20.0	13.3	23.5	8.8	19.7	15.7	36.0	26.0	48.8	38.1	25.4	18.3	30.8	19.8	15.5	14.0	26.3	16.0	27.2	54.7	57.9	12.3	27.6	45.4	36.4	17.8	15.4	15.4	40.3	32.6	44.4	19.6	35.2	0.0	21.3	15.6	33.1	22.6	32.1	27.1	95.9	19.3	22.9	24.0	43.1
BFSP2	"CP47, CP49, LIFL-L, phakinin"	ENSG00000170819	"Beaded filament structural protein 2"	Q13515	3	133400056-133475222	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"B-cells: 6.3;Melanocytes: 5.4;Plasma cells: 10.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"T-reg: 13.4"	"Lineage enriched"	"Detected in single"	43	"T-cells: 13.4"	"Group enriched"	"Detected in some"	6	"Daudi: 2.4;U-698: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038464, HPA062959"	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"		"HPA038464: AB_10672746, HPA062959: AB_2684912"	"unprognostic (1.58e-3)"	"unprognostic (7.47e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.04e-5)"	"unprognostic (8.13e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.4	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.1	5.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.6	0.0	1.0	0.1	0.1	0.0
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494980-153509546	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 795.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 223.5;Peritubular cells: 782.7;Sertoli cells: 1485.7;Smooth muscle cells: 401.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 312.6;BJ hTERT+: 400.8;fHDF/TERT166: 568.9;HSkMC: 283.9;hTEC/SVTERT24-B: 235.2;HUVEC TERT2: 561.2;U-138 MG: 249.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		3300000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	165.8	213.0	54.1	93.1	57.6	0.3	118.0	51.2	91.5	371.0	69.5	69.3	22.0	234.4	83.7	45.8	143.7	326.1	795.8	56.1	48.7	396.5	347.9	477.3	42.4	50.6	50.8	94.9	67.9	26.6	144.1	199.1	53.2	184.2	24.8	1.1	107.7	135.5	32.4	118.9	48.8	213.2	45.5	352.1	51.6	69.9	64.6	15.9	250.0	46.7	35.9	126.8	180.0	65.4	0.0	0.0	29.7	0.1	31.5	70.5	1.1	312.6	400.8	56.7	18.6	39.5	0.0	0.0	56.9	568.9	2.0	0.1	0.0	0.0	10.2	0.0	0.0	0.0	0.6	3.9	27.0	0.0	0.2	283.9	2.2	235.2	10.7	29.0	561.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.5	0.3	0.2	0.0	0.1	0.0	0.6	0.4	0.0	0.0	1.1	11.8	1.3	0.0	120.0	249.5	2.3	1.0	1.5	0.9	0.1	0.0	0.1	0.3	114.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	57.6	51.2	91.5	56.1	48.7	50.6	50.8	53.2	45.5	64.6	65.4	30.5	3.2	5.6	5.9	0.6	104.1	1.3	7.3	5.7	0.2	1.2	5.6	16.1	4.3	2.5	9.2	0.0	15.5	0.7	0.0	1.9	2.7	1.8	1.4	28.3	45.2	0.0	5.3	0.1	0.2	50.0	180.0	7.7	1.1	3.8	8.4	223.5	1.6	4.4	3.3	0.1	0.0	0.0	4.0	43.6	13.5	147.9	3.0	35.6	25.3	2.0	0.1	0.0	20.6	0.0	1.2	0.0	782.7	0.0	3.0	0.0	0.8	1.6	0.2	1485.7	3.1	401.3	0.8	1.2	1.8	54.1	56.9	3.0	7.7	0.0	1.6
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"	Q9UBW5	12	51281038-51324668	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 101.3;lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 213.6;Extravillous trophoblasts: 172.1;NK-cells: 598.3;Syncytiotrophoblasts: 158.6;T-cells: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 82.6;HMC-1: 134.9;Karpas-707: 59.1;NB-4: 140.8;RPMI-8226: 55.4;THP-1: 117.4;U-937: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	7.1	3.7	3.6	32.5	3.5	101.3	3.3	3.6	4.8	3.6	4.2	8.9	6.2	2.1	1.0	3.2	3.1	9.2	2.3	3.2	3.8	3.0	7.3	16.4	41.9	5.9	4.7	1.7	1.3	1.0	1.1	19.5	5.1	2.1	9.2	0.4	3.4	2.0	1.5	1.3	10.7	6.4	4.4	48.7	7.4	7.9	6.4	48.6	2.2	4.3	36.4	10.1	2.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	38.3	0.1	82.6	0.0	0.0	0.0	34.7	134.9	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.1	59.1	0.0	0.5	24.2	140.8	0.1	0.1	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	117.4	0.1	0.0	0.1	0.1	0.1	31.5	0.1	8.0	0.1	76.8	0.0	663.7	199.8	245.9	281.0	311.8	227.7	49.2	188.9	237.2	107.2	74.0	145.4	193.5	380.1	235.6	411.7	39.7	267.1	479.5	3.6	3.5	3.6	4.8	3.2	3.8	5.9	4.7	5.1	4.4	6.4	6.2	1.5	3.2	17.6	1.3	54.0	0.6	0.1	0.0	0.0	0.1	1.3	1.5	0.6	1.5	2.6	1.8	0.0	103.9	213.6	4.5	17.6	0.1	26.5	0.1	0.2	3.5	1.2	16.2	0.7	0.0	172.1	2.7	3.1	0.2	56.3	0.1	8.2	1.2	56.9	0.0	0.6	8.5	0.0	73.0	22.3	25.7	0.6	111.2	1.8	44.0	77.6	0.0	598.3	2.0	0.6	0.0	4.6	0.4	51.3	0.1	0.1	1.6	3.7	0.1	0.0	1.0	0.9	39.6	11.3	0.4	0.6	158.6	165.7	0.1	5.4	0.1
BLOC1S6	"HPS9, PA, PLDN"	ENSG00000104164	"Biogenesis of lysosomal organelles complex 1 subunit 6"	Q9UL45	15	45587214-45615945	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 230.8;Alveolar cells type 2: 292.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039928	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"			"HPA039928: AB_10673538"	"unprognostic (6.90e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.50e-2)"	30.0	31.2	15.3	31.1	17.1	58.2	25.5	15.6	19.1	25.8	13.9	21.2	20.2	30.7	18.4	21.0	18.1	26.5	25.1	17.0	22.7	24.2	26.8	20.4	41.9	14.8	18.6	37.8	20.4	16.8	19.0	26.3	17.7	36.4	21.5	24.6	20.7	20.4	23.6	18.2	21.3	24.3	13.8	27.9	20.1	17.0	19.2	25.2	44.4	23.2	35.4	28.5	15.6	16.8	31.5	15.9	38.9	46.2	70.1	57.0	22.2	59.0	58.4	28.5	30.4	37.6	15.9	78.1	36.2	47.5	42.6	27.6	41.7	43.2	36.6	52.8	22.0	79.8	34.9	26.2	44.1	82.2	112.9	44.6	36.7	30.7	55.9	43.8	42.4	54.7	62.4	78.7	50.7	11.8	40.0	38.6	22.5	31.4	22.4	55.8	60.3	43.9	36.6	47.9	29.3	49.4	32.7	21.2	33.9	36.8	33.8	83.2	49.0	68.6	35.6	68.6	55.7	81.2	134.8	102.4	69.5	57.1	62.5	19.3	12.5	10.5	7.5	12.6	10.5	12.9	7.3	7.7	16.8	12.8	9.0	10.2	6.0	7.0	11.1	8.1	6.7	8.9	15.3	17.1	15.6	19.1	17.0	22.7	14.8	18.6	17.7	13.8	19.2	16.8	42.0	230.8	292.6	13.7	59.6	34.5	38.7	21.5	39.3	59.8	33.5	30.4	38.4	21.5	126.0	18.4	37.5	26.0	58.9	15.9	37.2	29.9	37.2	36.2	81.8	54.8	62.1	57.4	31.8	33.0	25.6	75.9	22.4	58.7	197.7	38.0	35.0	36.6	37.6	50.5	27.3	30.4	12.2	67.9	123.0	28.4	28.0	97.6	26.6	17.8	80.4	54.0	40.2	22.6	31.0	40.1	25.9	37.2	67.7	71.8	21.2	60.4	141.5	46.7	19.7	52.1	39.2	51.8	37.8	36.9	32.8	22.0	56.1	34.5	24.7	34.4
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030708-81057627	"Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.3;lung: 5.5;urinary bladder: 9.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 32.2;Distal enterocytes: 68.9;Granulosa cells: 104.0;Paneth cells: 32.8;Proximal enterocytes: 25.2"	"Group enriched"	"Detected in some"	4	"lung cancer: 4.2;urothelial cancer: 7.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 10.3;Daudi: 16.3;RT4: 13.5;SK-BR-3: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	1.5	0.4	0.3	0.3	0.2	0.8	1.2	0.2	0.3	0.4	0.1	9.3	3.2	0.0	0.1	0.0	0.9	2.0	0.0	0.1	0.6	0.1	0.0	5.5	0.3	0.7	0.7	2.5	0.0	0.0	0.0	0.0	0.5	0.2	6.8	0.5	1.3	0.0	0.0	0.3	7.2	0.5	0.6	0.0	1.1	0.1	1.4	0.0	0.0	0.6	1.5	9.5	0.2	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.5	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.3	0.1	0.6	0.7	0.7	0.5	0.6	1.4	0.0	0.0	3.2	32.2	0.0	0.2	0.1	0.5	0.7	0.0	2.2	0.1	0.0	1.3	0.0	15.1	0.0	0.0	0.0	0.0	68.9	0.0	0.0	0.0	0.9	0.1	0.3	0.0	0.0	1.6	0.0	0.0	2.1	0.0	0.0	0.0	104.0	0.0	0.0	0.0	0.0	5.6	5.0	6.1	0.0	1.2	0.0	0.9	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.2	32.8	0.0	0.0	0.5	25.2	0.1	9.4	0.1	0.0	0.3	1.2	0.2	0.3	0.0	0.4	0.0	0.0	0.1	14.1	3.8
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168753-57266641	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;choroid plexus: 43.8;thyroid gland: 45.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Basal squamous epithelial cells: 51.8;Cytotrophoblasts: 137.4;Oligodendrocyte precursor cells: 74.4;Squamous epithelial cells: 44.2;Syncytiotrophoblasts: 56.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 172.1;MCF7: 202.3;OE19: 94.4;RPMI-8226: 77.8;SK-BR-3: 128.4;U-698: 237.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"	NA	NA	248000			"Cluster 27: Brain & Skin - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA057757: AB_2683518"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	6.5	33.1	1.9	34.6	0.0	1.3	37.2	27.9	8.5	43.8	2.9	2.2	1.2	17.2	23.9	9.5	0.4	13.8	35.6	28.5	6.3	0.0	1.6	1.0	36.2	36.3	0.2	0.5	0.0	2.7	25.7	34.7	5.9	1.7	5.3	3.9	9.2	0.3	22.5	1.9	0.3	32.8	0.6	3.6	0.7	39.7	3.8	45.9	0.0	2.1	6.8	13.0	42.8	0.3	0.7	23.4	5.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	20.0	6.8	172.1	41.3	0.0	8.7	48.3	5.2	0.0	0.0	0.4	17.2	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	202.3	0.0	0.1	12.3	94.4	0.0	0.1	0.1	77.8	0.0	0.2	0.4	17.8	5.5	128.4	0.5	15.2	0.9	0.4	0.4	0.1	10.9	0.0	0.1	0.2	0.3	237.6	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	34.6	37.2	27.9	35.6	28.5	36.2	36.3	34.7	32.8	39.7	42.8	0.6	6.4	2.2	74.1	0.4	13.8	13.4	12.9	51.8	4.7	0.9	4.6	15.1	0.0	4.2	1.8	0.0	137.4	0.1	0.2	0.0	0.0	5.3	1.7	2.4	1.2	2.4	0.0	0.9	0.0	21.0	13.5	2.0	2.5	21.6	0.1	0.0	0.0	11.0	1.7	4.7	1.5	6.1	0.0	1.9	4.9	0.3	0.4	3.6	2.8	0.1	38.4	0.0	74.4	8.7	0.0	0.3	0.4	2.5	6.6	0.2	2.2	1.9	2.4	0.0	1.3	0.8	1.8	3.4	44.2	9.7	56.9	0.9	0.7	1.5	18.1
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376327-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.2;Inhibitory neurons: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA017385: AB_1845397, HPA049014: AB_2680599"	"unprognostic (2.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	18.5	21.6	8.2	10.9	14.1	2.2	13.2	3.2	16.8	22.6	0.3	13.6	8.5	20.0	11.3	12.4	14.9	17.3	21.5	16.0	14.8	17.4	15.6	29.1	7.2	6.2	7.7	16.8	10.4	17.5	8.5	34.0	10.0	17.1	13.0	26.7	11.0	13.9	10.9	10.9	8.6	24.3	3.9	13.1	11.7	11.3	10.6	9.0	18.2	23.1	9.4	20.6	12.4	5.9	13.3	12.3	12.6	19.7	34.2	31.9	23.8	27.2	28.3	23.6	23.9	10.8	19.6	4.7	30.7	58.2	19.9	24.5	16.8	21.4	41.6	13.8	11.2	14.2	12.6	16.8	22.7	4.0	10.7	24.2	21.5	17.1	22.8	40.6	73.9	5.6	9.3	22.5	33.8	24.8	3.4	3.6	6.9	6.6	11.1	9.1	24.3	7.1	21.3	27.9	12.6	12.7	28.9	17.7	32.7	32.0	13.2	9.5	75.9	48.0	24.4	16.3	16.7	3.1	4.1	1.3	11.3	9.0	13.9	0.1	0.6	0.2	0.9	0.5	0.6	0.3	0.3	0.5	0.6	0.4	0.7	0.3	0.1	0.3	0.9	0.7	1.0	0.3	8.2	14.1	3.2	16.8	16.0	14.8	6.2	7.7	10.0	3.9	10.6	5.9	116.9	105.8	40.3	104.5	15.2	33.4	18.0	34.9	13.6	54.3	29.2	29.7	55.5	15.7	38.8	20.2	81.3	16.9	17.8	25.2	1.9	27.2	2.8	23.1	54.5	152.2	25.1	6.9	202.2	28.1	22.6	47.7	16.8	36.4	23.5	155.1	143.1	19.9	18.7	35.3	190.2	16.3	20.3	24.2	31.7	4.6	33.8	23.5	42.7	170.5	20.2	39.9	16.5	152.8	55.1	46.8	21.1	42.9	9.5	23.9	16.4	12.4	28.0	31.7	65.7	48.8	62.4	33.2	25.0	21.2	35.9	20.0	13.1	0.8	15.5	24.8
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025806	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	No		7900000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies, Plasma membrane"	Nucleoplasm	"CAB025806: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.18e-5)"	41.6	5.8	15.8	10.4	15.5	0.2	29.8	13.1	12.1	26.0	33.2	49.1	4.9	46.6	10.1	24.9	63.2	19.3	14.3	17.1	15.2	9.7	1.0	6.6	3.6	53.2	30.1	35.2	16.1	2.7	20.8	2.2	23.2	33.8	4.6	3.2	23.8	21.3	6.3	34.9	18.3	32.6	32.3	4.6	19.0	5.0	26.3	5.7	24.6	9.0	3.1	32.5	25.8	23.4	0.0	7.6	27.6	79.2	113.6	6.0	0.9	12.8	41.9	3.2	2.7	0.0	0.0	0.1	7.8	21.8	1.7	0.0	5.6	2.7	1.1	0.0	3.4	0.0	2.3	0.0	0.6	0.3	0.2	19.7	1.8	1.7	0.2	25.7	0.0	0.0	0.1	0.0	0.6	2.1	0.2	1.4	7.0	0.0	6.9	0.2	12.3	0.0	0.7	0.1	8.2	11.7	0.1	0.5	0.3	8.1	3.4	0.4	0.0	4.5	7.3	0.1	4.2	0.0	0.0	0.0	9.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	15.5	13.1	12.1	17.1	15.2	53.2	30.1	23.2	32.3	26.3	23.4	9.6	0.0	0.5	71.8	0.0	21.2	3.1	3.6	112.1	0.6	3.7	17.3	1.1	1.5	0.7	5.5	0.0	4.8	0.2	0.0	0.0	0.1	1.4	12.6	10.5	5.6	1.8	0.0	8.8	0.0	4.3	55.4	0.5	11.7	0.0	5.7	3.3	0.1	0.8	0.0	2.5	0.0	0.0	0.3	5.5	3.3	84.8	1.0	10.6	6.5	0.0	12.2	0.0	24.1	0.7	0.3	0.0	47.8	0.6	3.3	0.0	0.0	0.3	0.5	0.0	18.0	13.5	1.5	3.2	11.5	11.1	1.9	0.8	1.1	0.0	0.9
BRD7	"BP75, CELTIX1"	ENSG00000166164	"Bromodomain containing 7"	Q9NPI1	16	50313487-50368988	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042389, CAB046458, HPA060171"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214"	"unprognostic (2.10e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.34e-2)"	32.6	34.1	50.8	33.6	55.8	65.9	36.0	53.4	69.4	36.0	49.2	42.8	31.1	36.8	47.0	49.3	34.3	26.7	36.4	49.5	55.3	40.3	30.6	35.3	46.6	55.4	53.4	33.3	47.8	56.0	30.8	43.1	54.8	32.7	38.5	49.6	35.0	33.1	54.4	43.4	35.1	34.5	52.4	37.4	39.5	57.0	53.3	57.2	40.1	44.3	50.0	35.5	35.6	57.6	78.4	67.8	116.4	69.7	48.2	47.7	76.6	62.8	61.7	96.9	43.8	114.3	77.5	116.1	64.2	56.0	60.4	70.7	107.6	63.3	111.1	53.2	89.1	79.0	54.2	159.2	56.7	110.0	83.5	34.9	93.2	49.9	85.5	58.8	65.6	113.0	115.8	36.2	59.9	51.0	125.2	147.0	91.5	82.0	63.5	151.8	109.2	84.8	85.6	54.5	90.0	73.1	76.3	73.2	53.6	99.0	43.9	98.5	66.8	61.3	74.4	51.0	62.0	17.0	7.1	196.9	48.1	78.5	62.2	6.2	5.1	7.6	6.4	4.4	4.9	6.1	6.4	6.0	4.1	6.2	7.1	8.7	2.9	9.8	4.1	8.5	6.9	3.0	50.8	55.8	53.4	69.4	49.5	55.3	55.4	53.4	54.8	52.4	53.3	57.6	73.7	38.5	64.4	16.0	54.6	50.7	41.1	16.9	20.5	89.0	63.4	63.8	35.7	52.9	29.6	49.7	66.7	70.6	124.6	51.1	107.6	22.3	47.4	75.1	62.9	42.0	36.0	76.4	14.6	23.0	49.5	41.3	40.2	89.1	15.2	84.3	38.6	45.8	29.9	90.9	15.8	46.6	20.3	40.3	24.5	22.5	32.6	45.9	26.6	17.8	38.4	81.2	82.4	30.2	32.7	23.9	36.4	28.2	74.2	62.2	32.0	72.3	36.7	120.6	52.6	78.4	46.5	203.6	157.2	44.8	63.2	72.4	55.7	59.3	46.1	66.6
BRI3BP	"BNAS1, HCCR-2, HCCRBP-3, KG19"	ENSG00000184992	"BRI3 binding protein"	Q8WY22	12	124993645-125031231	"Predicted membrane proteins, Transporters"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 20.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 174.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 114.9;U-698: 161.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014957	Approved		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA014957: AB_1845447"	"unprognostic (1.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.44e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.55e-1)"	3.3	2.0	9.2	8.9	10.7	5.5	5.5	8.2	10.7	3.0	7.1	15.5	20.8	2.1	2.2	6.8	4.1	4.8	2.5	9.2	7.9	6.9	4.8	2.8	13.8	9.6	9.7	1.5	5.1	9.1	2.1	2.1	10.2	2.9	15.3	10.0	2.5	2.2	1.7	5.5	18.8	2.6	9.1	5.9	8.2	1.8	9.1	7.0	4.4	2.1	16.2	2.5	2.6	9.4	34.1	43.8	13.8	12.5	10.9	5.6	24.1	22.2	4.6	13.7	7.1	36.1	22.3	114.9	27.8	5.0	8.9	38.7	30.7	17.3	10.9	26.9	25.5	58.4	16.9	24.8	2.2	86.8	72.2	2.5	9.9	15.0	7.1	5.3	5.1	41.0	23.5	8.0	12.0	31.3	45.1	33.3	9.9	29.9	17.3	30.2	23.0	30.7	17.3	46.8	19.0	13.2	27.6	26.9	9.2	4.6	48.8	60.8	5.9	13.0	16.2	12.5	23.4	26.9	49.7	161.8	11.9	28.7	29.1	4.2	2.2	13.1	0.8	1.6	0.8	1.4	0.6	0.7	1.7	1.5	0.5	0.7	2.2	0.9	1.2	4.2	0.7	0.6	9.2	10.7	8.2	10.7	9.2	7.9	9.6	9.7	10.2	9.1	9.1	9.4	3.4	9.6	10.4	13.4	23.6	12.2	9.1	8.2	5.2	37.1	14.9	6.3	7.2	31.5	9.2	9.2	14.6	15.4	24.3	65.5	3.9	9.1	25.6	16.1	7.2	5.1	7.8	21.5	32.6	10.4	24.0	7.1	32.1	18.0	18.4	7.2	4.2	27.4	19.8	25.2	43.8	42.8	8.2	31.5	26.1	174.4	1.2	23.6	10.6	11.2	28.8	12.1	9.2	11.1	23.4	17.1	43.3	4.1	39.5	9.6	60.2	12.7	15.0	27.9	0.0	9.2	6.9	1.1	11.5	20.7	18.3	5.2	11.5	6.8	72.6	9.7
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318421-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 100.3"	"Cell type enriched"	"Detected in many"	9	"Inhibitory neurons: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.0;Hep G2: 13.6;MOLT-4: 17.9;PC-3: 12.3;RT4: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA055898: AB_2682964, HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.4	0.7	7.2	2.7	4.3	4.4	2.9	5.5	10.9	8.1	5.9	0.6	0.7	0.9	1.2	29.4	0.3	0.9	0.6	2.9	13.2	4.2	1.1	0.6	2.9	24.3	16.0	0.1	0.8	100.3	3.5	2.0	24.4	3.4	0.6	1.9	5.6	1.3	0.5	11.1	1.4	0.5	11.4	1.4	0.6	0.7	21.7	17.2	18.9	0.2	3.3	1.7	11.1	5.3	0.1	25.0	5.0	0.0	1.8	0.5	0.0	0.6	0.0	0.2	0.0	0.3	4.0	0.0	6.1	0.1	2.4	9.2	5.1	9.5	0.3	0.0	1.6	0.0	0.1	13.6	0.0	0.2	0.1	2.0	4.0	0.0	2.9	3.8	0.7	10.5	0.0	0.0	0.2	0.9	17.9	2.0	5.3	0.5	12.3	0.0	8.1	0.0	0.0	11.4	6.8	2.5	0.0	0.2	0.0	0.4	0.5	0.7	1.0	0.1	0.2	0.0	2.0	0.1	0.0	0.1	6.4	2.6	0.0	0.9	0.4	0.5	1.0	0.1	3.5	0.0	1.1	0.6	0.7	0.1	1.4	1.3	1.3	0.1	0.3	0.1	0.6	0.6	7.2	4.3	5.5	10.9	2.9	13.2	24.3	16.0	24.4	11.4	21.7	5.3	0.3	0.0	0.0	17.3	0.3	5.2	3.7	2.5	6.8	3.5	0.7	3.2	2.9	0.0	3.0	0.0	0.0	0.2	1.2	0.0	0.0	0.8	0.0	1.2	1.9	0.3	3.5	1.3	8.7	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.0	0.9	0.3	1.7	266.4	0.4	0.0	0.6	4.3	0.0	0.6	1.7	0.0	1.0	1.8	0.2	3.1	12.5	1.9	0.3	0.0	4.1	0.7	2.8	0.2	0.9	0.3	0.4	0.0	0.0	1.1	0.1	0.2	27.5	7.7	0.4	4.5	3.4	0.4	3.4
BTN2A2	"BT2.2, BTF2, BTN2.2"	ENSG00000124508	"Butyrophilin subfamily 2 member A2"	Q8WVV5	6	26383096-26394874	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 30.3;Plasma cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 72.8;U-266/70: 58.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA051504	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria		"HPA051504: AB_2681510"	"prognostic favorable (1.01e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	7.2	13.5	5.4	21.9	6.9	4.3	8.7	14.4	6.0	7.9	21.2	8.0	7.2	10.2	7.5	5.1	8.4	8.5	4.9	6.8	5.9	7.5	6.1	16.2	32.1	7.5	6.9	10.4	5.2	17.5	5.7	4.0	7.8	8.3	10.5	2.9	12.1	6.8	2.8	11.0	11.3	10.9	6.5	21.8	10.4	6.1	6.2	15.2	7.5	4.2	36.6	8.2	6.9	6.9	10.6	6.6	13.2	14.2	4.4	6.8	0.9	11.4	29.7	17.4	30.0	4.2	4.1	9.6	12.1	20.5	14.1	9.5	10.7	8.7	23.1	29.9	17.9	15.0	13.2	8.4	9.1	3.4	5.1	14.5	2.7	33.5	11.3	20.7	16.3	18.5	12.3	72.8	7.9	4.6	12.1	4.4	5.0	0.4	6.6	28.1	18.7	29.8	12.7	5.9	12.6	17.6	7.4	2.8	31.1	7.5	13.5	6.6	19.5	6.4	7.3	5.6	17.7	58.9	38.8	16.9	6.4	13.4	16.3	2.1	13.7	2.4	6.1	14.6	5.8	24.1	5.0	5.7	23.9	29.4	4.1	5.1	12.4	8.7	6.3	9.7	10.3	7.9	5.4	6.9	14.4	6.0	6.8	5.9	7.5	6.9	7.8	6.5	6.2	6.9	8.1	9.6	12.6	0.0	30.3	3.8	7.3	6.5	6.2	0.6	5.2	5.1	2.5	2.8	8.5	3.7	0.0	2.3	15.0	0.6	0.0	8.6	0.4	8.8	4.5	13.1	1.8	3.6	0.0	5.6	0.8	5.0	3.6	7.5	19.6	9.6	6.1	3.8	8.4	0.0	0.0	7.8	12.2	16.0	24.2	0.6	6.5	17.1	7.2	0.0	15.4	14.3	7.2	0.0	0.0	8.3	0.8	4.9	30.7	6.4	2.6	2.3	10.2	0.7	0.0	5.0	4.4	0.3	1.5	4.5	4.5	1.0	10.0	10.6	2.1	4.2
BTN3A1	"BT3.1, BTF5, BTN3.1, CD277"	ENSG00000026950	"Butyrophilin subfamily 3 member A1"	O00481	6	26402237-26415208	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 59.1;NK-cells: 73.2;Plasma cells: 47.6;T-cells: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA012565	Approved		Uncertain	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA012565: AB_1845494"	"unprognostic (2.82e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (2.45e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (4.81e-4)"	19.2	20.7	10.2	44.8	11.1	29.6	20.1	9.8	10.5	21.2	10.3	24.8	28.5	28.0	16.0	11.9	22.5	30.5	12.1	9.1	12.1	12.8	18.9	41.4	63.4	16.4	10.9	35.1	13.1	13.1	13.7	19.2	12.5	16.5	28.8	3.6	23.9	13.5	12.8	24.9	35.1	21.3	12.2	84.0	31.3	5.0	11.4	33.1	11.5	14.5	52.6	20.0	17.4	12.0	7.4	6.2	9.3	9.5	25.9	27.5	1.2	6.2	24.1	13.5	39.4	0.3	16.7	19.7	20.4	11.2	20.9	5.1	3.0	9.7	8.2	19.5	6.4	10.4	8.5	4.7	11.8	9.5	9.3	15.0	5.6	11.8	5.4	20.4	19.3	31.0	2.5	25.3	5.5	0.6	17.6	6.6	1.0	3.3	2.1	24.2	4.0	45.2	8.3	9.4	4.9	9.8	3.4	7.1	13.5	1.4	6.5	4.0	4.8	10.3	2.6	3.1	5.9	41.8	45.9	7.3	15.6	21.4	8.4	53.8	11.1	28.8	44.7	11.7	40.4	18.8	27.8	42.3	9.1	10.5	24.1	32.0	23.9	40.5	12.9	4.3	36.0	28.0	10.2	11.1	9.8	10.5	9.1	12.1	16.4	10.9	12.5	12.2	11.4	12.0	24.8	16.0	6.5	0.0	27.1	4.2	3.9	3.5	2.2	4.3	8.6	8.1	4.2	11.5	8.5	5.5	0.0	5.5	59.1	8.2	0.0	7.4	0.1	5.5	10.4	18.0	4.8	13.3	0.0	3.2	4.3	9.9	9.2	10.3	25.9	14.0	11.7	3.9	7.2	0.0	0.0	17.3	2.0	19.2	6.1	0.8	3.7	15.4	1.8	0.0	13.7	1.9	73.2	0.0	0.0	2.2	6.3	2.6	47.6	5.4	15.9	1.3	6.7	0.4	0.0	6.7	5.5	0.0	0.1	3.6	3.3	1.5	50.1	8.4	7.4	5.0
C11orf58	SMAP	ENSG00000110696	"Chromosome 11 open reading frame 58"	O00193	11	16613132-16758340	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036591, HPA076406"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"	Nucleoplasm	"HPA036591: AB_10669909, HPA076406: AB_2686798"	"unprognostic (8.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.30e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-1)"	142.2	135.1	52.2	129.5	57.8	128.3	94.5	55.3	79.7	91.5	66.5	101.8	89.9	136.1	73.8	172.3	128.0	115.6	159.9	52.0	62.7	114.9	132.9	102.9	162.9	57.6	56.0	172.0	127.8	115.1	78.7	123.9	61.3	111.7	71.7	94.2	128.6	85.3	212.2	99.8	96.5	113.8	56.8	125.8	111.7	89.6	55.4	138.2	162.1	109.6	127.9	125.1	81.3	69.1	416.1	362.9	390.3	197.0	199.5	162.3	272.8	419.2	213.0	276.2	245.5	348.0	397.7	383.1	315.2	253.7	311.4	242.3	275.0	206.9	232.8	485.8	289.9	342.7	286.8	310.1	243.4	492.8	276.2	182.3	230.6	168.9	336.6	209.7	178.4	232.6	435.2	246.5	191.1	247.8	506.5	211.7	291.1	212.7	197.6	404.3	413.6	196.0	158.6	248.7	269.8	267.4	372.4	273.4	501.4	225.0	244.4	315.7	359.5	336.7	268.2	407.1	388.0	164.0	648.6	525.2	297.2	275.3	326.1	587.6	390.4	552.8	407.8	451.9	482.3	621.9	451.4	435.0	429.7	578.9	506.9	440.6	186.9	433.9	490.1	544.7	522.0	896.2	52.2	57.8	55.3	79.7	52.0	62.7	57.6	56.0	61.3	56.8	55.4	69.1	188.3	246.8	222.5	41.8	219.8	257.1	275.3	379.8	167.9	169.5	170.9	168.4	206.4	178.7	259.1	200.5	150.1	312.2	242.8	65.6	428.4	249.7	65.6	204.2	202.0	217.3	159.2	213.7	72.5	228.1	346.8	258.2	73.4	139.8	237.3	151.3	175.6	163.8	227.0	143.0	68.6	133.2	299.1	164.3	261.0	34.3	205.9	180.1	229.5	45.0	249.9	230.5	248.2	61.3	63.5	232.3	104.3	204.2	183.0	324.1	103.4	364.6	237.0	215.7	157.8	164.9	246.8	331.6	245.7	142.5	276.6	453.5	217.3	188.2	118.7	296.6
C11orf68	"BLES03, P5326"	ENSG00000175573	"Chromosome 11 open reading frame 68"	Q9H3H3	11	65916810-65919062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045938	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA045938: AB_10961633"	"unprognostic (3.18e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.50e-3)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.18e-1)"	36.0	29.3	68.1	14.9	70.3	10.1	33.5	74.7	82.3	50.4	59.4	50.1	17.2	56.1	39.0	29.7	40.5	20.7	50.7	71.0	65.1	31.2	28.0	31.9	24.8	69.0	67.0	43.4	27.2	25.6	24.0	23.4	67.6	42.6	15.7	12.5	30.9	31.7	81.1	32.8	31.0	27.0	66.3	41.6	32.8	53.9	67.9	29.1	32.6	51.4	21.3	45.9	39.5	71.4	76.4	33.6	20.4	22.2	70.0	67.3	17.6	59.7	90.2	74.3	45.2	12.6	83.9	15.6	40.6	89.5	118.6	24.0	15.9	36.6	39.8	24.2	16.1	18.5	23.4	33.2	55.7	14.9	23.7	62.9	53.8	53.9	58.9	76.6	56.1	26.1	25.1	37.7	136.2	34.5	19.7	35.9	20.5	16.5	165.8	28.8	23.1	44.4	39.6	14.5	13.9	21.6	23.1	30.1	59.8	21.0	39.0	14.0	61.4	118.0	57.9	162.1	30.9	25.3	11.9	13.1	69.8	11.1	94.1	6.8	2.5	3.7	5.3	3.9	3.8	3.0	3.4	4.4	2.0	5.3	5.2	5.2	9.1	3.8	2.1	2.7	4.2	2.2	68.1	70.3	74.7	82.3	71.0	65.1	69.0	67.0	67.6	66.3	67.9	71.4	17.8	16.0	5.1	6.5	7.3	15.3	32.9	4.2	6.8	11.4	14.7	22.5	16.6	14.3	2.3	16.5	10.4	16.4	14.5	10.8	7.9	14.5	7.9	8.1	17.8	13.8	4.8	2.1	7.9	11.7	16.5	18.5	7.1	11.8	3.8	12.9	18.2	10.5	14.2	16.8	7.5	13.1	4.1	13.9	7.5	24.5	21.5	8.7	10.6	7.5	14.1	26.7	22.6	4.5	8.6	19.3	3.4	35.3	3.6	23.2	11.8	5.4	1.9	9.9	19.7	13.5	16.4	15.0	17.1	6.2	12.8	21.9	8.3	23.3	9.2	31.3
C12orf42	FLJ25323	ENSG00000179088	"Chromosome 12 open reading frame 42"	Q96LP6	12	103237591-103495978	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	11	"testis: 17.2"	"Group enriched"	"Detected in some"	13	"Early spermatids: 398.6;Late spermatids: 372.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.1;naive B-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"				"unprognostic (9.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.83e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-4)"	"unprognostic (4.89e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.30e-1)"	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	17.2	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.1	1.3	1.6	0.2	5.3	1.4	1.5	0.0	0.0	0.0	1.1	2.2	1.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.5	27.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	398.6	0.0	0.0	0.2	0.0	0.0	8.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.2	372.8	2.8	0.9	0.0	12.2	0.3	0.0	0.0	24.6	0.7	0.0	1.1	1.5	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	10.7	2.3	0.0	0.0	0.0	3.3	0.0	0.0	0.1
C14orf180	"C14orf77, NRAC"	ENSG00000184601	"Chromosome 14 open reading frame 180"	Q8N912	14	104579764-104590515	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.8;breast: 26.7;heart muscle: 109.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.7;Cardiomyocytes: 7.6;Fibroblasts: 2.0;Hepatic stellate cells: 3.3;Horizontal cells: 3.3;Smooth muscle cells: 1.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"ASC diff: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (2.48e-2)"				"unprognostic (1.55e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"		"unprognostic (1.60e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.80e-2)"		40.8	3.1	0.0	0.1	0.2	0.0	26.7	0.2	0.2	0.9	13.5	0.9	0.3	1.1	0.0	0.0	1.8	0.2	109.5	1.5	0.0	1.8	4.1	0.4	0.0	0.5	0.8	0.8	0.8	0.0	1.8	0.8	0.5	0.6	0.0	0.1	0.9	0.4	5.7	0.6	1.4	0.0	0.0	0.5	2.2	0.1	0.4	0.0	0.9	0.7	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	1.5	0.0	0.5	0.8	0.5	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	2.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 108.3;thyroid gland: 228.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 268.1;Club cells: 70.4;Distal tubular cells: 113.5;Fibroblasts: 43.8"	"Group enriched"	"Detected in many"	14	"lung cancer: 64.7;thyroid cancer: 145.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;Hep G2: 2.5;HHSteC: 1.3;NTERA-2: 1.7;U-2197: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	NA	NA		1400000	"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA013613: AB_1845584, HPA016934: AB_2732417"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.48e-3)"	17.8	4.2	20.0	6.0	21.6	0.2	12.8	18.8	28.3	20.2	15.0	6.3	17.6	3.5	87.1	6.7	12.4	45.0	18.8	19.4	19.9	16.8	0.3	108.3	0.9	19.9	18.5	2.8	5.4	0.1	5.7	0.9	19.0	4.2	5.0	0.5	35.0	1.1	0.2	0.6	7.9	4.9	19.6	0.6	82.4	1.2	22.6	2.8	228.8	3.9	2.2	14.4	3.2	22.7	0.0	0.1	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.6	2.5	1.3	0.1	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.7	0.3	1.7	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.0	0.0	0.2	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	20.0	21.6	18.8	28.3	19.4	19.9	19.9	18.5	19.0	19.6	22.6	22.7	0.9	44.8	268.1	23.2	0.0	0.4	1.8	0.3	0.6	0.5	23.6	18.0	2.8	0.0	70.4	0.0	0.0	0.1	0.1	0.1	113.5	0.0	1.7	3.7	0.4	1.3	0.0	0.0	0.9	7.8	0.1	43.8	17.3	0.3	5.1	0.0	0.0	0.0	6.0	0.0	0.7	0.6	6.1	0.0	0.4	2.7	9.3	0.7	0.0	11.2	0.0	0.3	0.0	1.0	1.6	0.7	0.4	14.7	0.0	5.0	0.0	1.5	16.9	0.2	0.0	1.9	1.9	0.8	0.1	0.6	0.3	0.3	0.6	0.0	0.7	5.0
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Endothelial cells: 101.3;Kupffer cells: 145.7;Langerhans cells: 282.7;Leydig cells: 95.1;Peritubular cells: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"myeloid DC: 103.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 103.5"	"Cell line enhanced"	"Detected in many"		"AF22: 77.8;AN3-CA: 110.5;ASC diff: 86.1;ASC TERT1: 141.3;HSkMC: 102.1;HUVEC TERT2: 108.4;U-87 MG: 68.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: AB_2732511"	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	37.6	19.1	59.8	26.4	60.7	11.9	30.7	62.0	96.2	27.6	56.2	25.9	13.3	30.1	39.1	17.9	33.2	46.4	34.6	57.6	62.2	28.4	29.7	29.2	62.6	61.9	61.8	7.9	5.1	14.5	10.5	59.2	62.0	28.7	25.9	16.2	8.4	75.6	24.6	11.1	15.0	60.3	63.5	69.4	12.7	13.9	64.2	30.8	13.9	48.3	27.9	36.2	18.2	62.4	1.6	0.3	77.8	110.5	86.1	141.3	2.2	14.0	20.5	3.8	12.0	0.9	1.9	0.6	4.1	12.3	1.5	2.7	0.2	0.5	5.6	1.4	12.2	1.9	2.0	1.3	17.7	3.9	2.6	102.1	5.9	24.8	1.9	13.2	108.4	1.8	1.8	12.2	15.0	4.2	0.7	24.0	5.7	0.1	3.9	18.8	1.7	1.4	1.1	6.1	1.5	1.3	1.4	0.8	7.5	16.4	1.4	58.0	0.7	28.1	2.1	0.8	0.9	5.0	4.8	1.2	68.3	3.1	0.7	0.1	21.2	0.8	0.6	20.8	2.5	0.9	3.8	1.7	103.5	0.7	3.5	2.0	1.0	0.8	5.6	2.1	1.9	6.4	59.8	60.7	62.0	96.2	57.6	62.2	61.9	61.8	62.0	63.5	64.2	62.4	115.7	3.2	4.5	19.6	3.3	6.4	2.2	2.4	1.8	0.8	2.3	3.7	10.6	2.8	2.5	22.0	0.0	1.3	1.5	2.0	76.3	0.7	9.4	3.1	37.6	101.3	1.2	0.4	4.1	2.3	0.8	29.3	5.1	3.1	1.3	0.7	51.8	1.3	45.3	0.0	3.8	1.3	0.0	145.7	282.7	19.6	95.1	65.6	12.4	16.9	24.9	23.4	1.0	0.5	0.3	2.0	1.5	104.2	3.0	4.9	2.7	4.9	0.5	1.6	32.9	7.5	70.4	16.6	1.9	7.5	5.1	3.6	3.3	5.2	1.4	8.4
C1QTNF3	"2310005P21Rik, Corcs, Cors, Cors-26, CTRP3"	ENSG00000082196	"C1q and TNF related 3"	Q9BXJ4	5	34017858-34043213	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.4;salivary gland: 52.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.6;Fibroblasts: 61.5;Late spermatids: 387.6;Muller glia cells: 227.2;Skeletal myocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	211	"U-266/84: 810.2"									"HPA064996, HPA066011"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	44100000	24000000		"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA064996: AB_2685399, HPA066011: AB_2685597"	"unprognostic (7.71e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.83e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.35e-1)"	7.3	0.5	4.1	1.7	5.0	0.6	6.8	6.8	4.0	3.6	2.6	11.2	3.5	2.7	1.0	33.4	3.0	5.9	0.9	3.9	7.0	4.8	1.1	4.1	0.8	5.3	4.3	1.4	1.7	0.3	1.3	0.6	4.5	2.2	10.0	23.7	52.0	4.9	2.2	2.3	8.9	23.3	5.8	0.7	10.7	11.4	4.2	1.0	1.6	9.9	0.4	13.2	3.6	5.1	0.7	0.1	0.2	0.3	0.0	0.1	0.3	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.9	0.2	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.7	0.8	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.8	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.2	1.6	0.0	0.1	0.6	0.1	0.0	3.8	0.6	0.1	1.0	0.0	1.0	0.9	810.2	1.3	0.0	0.8	3.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.1	5.0	6.8	4.0	3.9	7.0	5.3	4.3	4.5	5.8	4.2	5.1	2.3	3.2	2.0	0.0	2.0	5.7	0.6	0.4	1.8	5.1	3.0	2.3	1.0	8.6	0.8	3.7	0.0	0.9	1.5	0.7	1.9	1.2	161.6	2.6	1.0	7.2	1.8	1.3	0.0	1.4	0.5	61.5	1.5	2.6	0.0	1.8	0.4	1.3	1.3	8.4	0.0	1.4	2.0	0.6	9.6	387.6	1.8	1.1	7.2	0.0	0.3	227.2	1.0	0.0	0.0	0.5	1.5	2.6	0.2	0.8	0.8	2.1	1.2	11.9	0.0	77.5	4.5	6.2	2.0	1.1	5.8	0.4	1.3	1.0	2.0	0.5
C1R		ENSG00000159403	"Complement C1r"		12	7080214-7092540	"Human disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"liver: 1425.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 442.3;Fibroblasts: 684.4;Hepatocytes: 1444.2;Leydig cells: 1142.6;Peritubular cells: 388.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1089.8;ASC TERT1: 546.0;BJ hTERT+: 461.9;BJ hTERT+ SV40 Large T+ RasG12V: 303.4;HSkMC: 672.1"	"Low region specificity"	"Detected in many"							"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001251: AB_2666252, HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	540.6	203.6	15.8	122.4	15.9	1.1	400.6	15.9	23.3	470.5	21.7	277.3	38.3	353.8	80.8	119.0	526.3	279.1	458.7	15.4	19.6	148.9	1425.6	340.3	72.4	23.4	19.9	644.3	88.0	11.0	63.9	52.4	18.4	205.2	100.9	5.8	158.3	87.0	69.4	177.7	228.1	157.7	18.1	192.1	242.7	46.7	18.1	34.7	223.4	74.2	75.3	468.4	394.3	18.0	1.2	8.9	0.9	9.1	1089.8	546.0	0.4	108.9	461.9	143.0	303.4	1.4	2.4	0.5	4.5	108.8	11.8	2.3	11.8	5.5	18.3	18.3	1.1	0.5	4.1	3.6	226.5	0.8	2.3	672.1	3.2	74.7	4.7	121.0	2.9	0.5	0.3	20.5	21.2	0.1	8.0	0.8	3.1	0.1	0.9	8.6	3.8	0.8	0.9	5.5	0.4	2.3	95.1	3.7	2.8	1.3	0.2	0.2	0.4	38.3	6.3	152.1	0.8	1.1	3.0	0.2	53.1	1.0	5.4	0.0	0.0	0.6	0.3	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.6	0.6	0.5	0.8	0.0	0.0	0.3	0.1	15.8	15.9	15.9	23.3	15.4	19.6	23.4	19.9	18.4	18.1	18.1	18.0	45.4	22.4	90.5	3.6	7.1	54.7	58.8	76.6	33.6	0.3	5.9	30.9	20.8	183.0	22.9	18.4	2.1	4.1	1.8	0.7	3.9	280.8	4.6	13.3	442.3	45.4	0.0	40.6	0.9	44.5	3.7	684.4	16.3	11.6	10.1	24.9	114.9	1444.2	11.2	0.0	0.3	0.7	0.0	40.9	66.9	29.2	1142.6	7.0	53.4	13.1	1.6	16.0	0.0	2.5	0.1	51.1	1.3	388.1	6.2	17.7	0.3	6.1	5.3	1.4	170.9	87.5	140.4	6.8	6.7	5.6	40.1	5.2	11.5	15.2	0.7	11.2
C20orf202		ENSG00000215595	"Chromosome 20 open reading frame 202"	A1L168	20	1203454-1208279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 3.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Early spermatids: 3.6;Late spermatids: 2.1;Paneth cells: 1.3;Proximal enterocytes: 1.2;Sertoli cells: 6.6;Smooth muscle cells: 1.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 1.0"	"Group enriched"	"Detected in some"	15	"cerebellum: 8.0;olfactory bulb: 2.6"	"Low region specificity"	"Detected in many"			HPA042786	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA042786: AB_10795760"	"unprognostic (8.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.82e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.24e-3)"	0.6	0.1	0.5	0.1	0.5	0.0	0.3	1.0	0.9	0.2	0.3	0.3	0.3	0.1	0.0	0.3	0.4	0.7	0.6	0.4	0.5	0.4	0.1	1.3	0.2	0.5	0.5	0.1	0.3	0.4	0.2	3.3	0.6	0.1	0.3	0.4	0.4	0.6	0.5	0.5	1.1	0.2	0.5	0.2	0.3	0.6	0.7	0.1	0.2	0.3	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.5	1.0	0.9	0.4	0.5	0.5	0.5	0.6	0.5	0.7	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	1.2	0.1	0.0	0.0	6.6	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0
C2CD6	"ALS2CR11, FLJ25351"	ENSG00000155754	"C2 calcium dependent domain containing 6"	Q53TS8	2	201487421-201619178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 39.9"	"Cell type enriched"	"Detected in some"	21	"Theca cells: 41.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;HSkMC: 2.0;hTEC/SVTERT24-B: 2.0;SCLC-21H: 2.3;THP-1: 2.0;U-2197: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"				"unprognostic (2.64e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.77e-3)"	"unprognostic (7.13e-6)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.13e-10)"	"unprognostic (1.95e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-1)"	0.6	0.7	1.5	0.0	2.2	0.0	0.3	2.3	1.2	0.1	0.8	0.1	0.1	0.2	0.1	0.2	0.1	0.4	1.2	0.5	2.2	0.1	0.1	0.3	0.2	5.5	2.6	0.7	0.0	0.0	0.7	0.1	4.5	0.3	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.2	4.3	0.1	0.0	39.9	2.3	0.0	0.1	0.0	0.0	0.1	0.1	6.6	0.0	0.0	0.0	0.0	0.2	1.9	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.2	0.1	0.0	2.0	0.0	0.0	0.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	2.2	2.3	1.2	0.5	2.2	5.5	2.6	4.5	4.3	2.3	6.6	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050275	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 433.7"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 538.3"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 28.4;Hep G2: 30.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029339	Supported				"Secreted to blood"	NA	NA	113000000000	39000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	2.9	1.7	2.5	1.1	3.4	2.2	2.5	2.4	2.6	3.0	3.5	2.8	3.9	2.7	2.7	1.6	3.0	1.5	1.3	2.2	2.6	4.8	433.7	7.0	2.1	2.9	2.9	3.3	14.9	2.6	3.1	0.9	3.2	3.2	1.6	3.5	1.4	2.2	0.5	3.8	3.9	1.9	2.8	1.5	5.8	1.6	2.8	1.2	2.0	1.2	1.7	2.6	2.1	4.5	1.6	28.4	6.4	11.3	8.0	9.2	0.2	3.4	3.5	0.9	2.0	0.8	2.8	4.1	0.1	1.8	3.8	11.0	0.3	0.3	1.5	0.9	0.0	1.8	1.5	30.4	1.5	1.0	0.7	4.1	0.5	2.0	3.7	1.8	1.0	1.6	0.7	3.8	2.2	5.6	0.4	0.2	1.7	7.0	10.9	2.5	2.8	0.4	1.7	0.8	1.6	6.5	1.6	0.0	2.7	4.4	2.2	3.7	1.3	2.8	0.2	7.5	3.4	2.3	1.8	1.7	2.2	3.8	6.8	0.0	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	3.4	2.4	2.6	2.2	2.6	2.9	2.9	3.2	2.8	2.8	4.5	0.8	6.4	28.6	30.0	3.5	1.0	1.0	0.5	1.8	4.8	2.2	1.3	0.8	32.9	7.1	1.8	0.0	0.1	0.1	0.4	1.9	0.2	1.8	1.1	2.2	1.4	0.0	12.0	7.3	0.4	0.0	2.9	2.0	0.8	0.0	3.1	7.5	538.3	1.9	6.7	9.4	1.0	0.0	16.3	1.0	2.8	3.1	3.5	0.0	6.5	2.3	3.2	2.1	25.6	25.4	0.7	3.8	9.1	0.1	0.7	1.0	6.8	3.8	2.6	0.0	4.0	1.6	7.5	2.5	2.0	1.3	0.0	1.4	2.8	2.0	0.6
C7orf50	"MGC11257, YCR016W"	ENSG00000146540	"Chromosome 7 open reading frame 50"	Q9BRJ6	7	996986-1138260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 295.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052281	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA052281: AB_2681784"	"unprognostic (1.64e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	42.3	40.6	74.8	17.5	70.8	13.4	43.2	63.1	103.3	53.3	58.8	74.1	15.4	55.8	12.6	46.7	56.2	12.9	96.1	71.5	64.8	79.1	59.2	45.5	16.8	73.4	66.2	69.8	108.5	19.7	140.0	16.7	65.0	66.0	8.8	8.8	41.2	32.3	70.0	32.9	35.1	15.1	67.5	39.5	60.4	38.6	75.2	11.1	74.7	22.5	10.9	64.1	41.4	65.3	167.9	104.8	34.5	105.2	18.2	25.8	72.2	73.3	35.6	63.8	54.0	74.3	69.9	49.9	47.1	47.4	80.9	104.1	41.6	88.6	12.6	47.7	84.0	45.8	75.1	102.6	73.7	58.7	30.2	37.0	69.3	59.6	54.4	28.0	44.1	41.5	82.7	46.5	29.0	241.6	27.3	156.3	84.2	74.8	153.7	79.4	12.8	83.0	30.2	45.6	78.7	112.8	60.2	70.6	103.9	22.7	169.7	106.6	51.6	36.9	162.9	110.9	97.5	39.3	57.2	45.8	74.1	96.0	119.0	18.1	129.4	400.1	97.1	136.4	69.4	123.7	79.1	82.6	208.0	165.6	59.9	69.8	15.1	44.8	134.1	60.5	104.9	116.7	74.8	70.8	63.1	103.3	71.5	64.8	73.4	66.2	65.0	67.5	75.2	65.3	42.9	35.3	57.2	16.0	115.8	23.2	43.4	81.6	12.5	74.0	89.2	80.9	72.2	44.3	55.9	66.2	18.8	73.5	42.2	40.5	295.4	89.2	8.5	55.9	30.9	44.3	90.8	21.2	34.1	85.5	78.6	51.6	27.0	37.5	55.8	88.1	37.5	37.7	163.1	57.2	30.8	64.6	73.2	67.5	71.0	7.5	37.0	68.8	71.2	15.9	108.9	140.2	66.9	20.6	17.5	64.2	27.0	44.4	52.4	52.4	9.9	152.0	54.4	73.3	26.3	30.8	73.0	20.4	42.8	34.2	24.4	46.5	60.4	48.0	62.2	39.0
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 99.3"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 101.4;Enteroendocrine cells: 214.1;Excitatory neurons: 318.3;Horizontal cells: 249.0;Inhibitory neurons: 372.1;Oligodendrocyte precursor cells: 271.9"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	4	"cerebellum: 99.3;cerebral cortex: 30.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 45.1;U-87 MG: 23.9"	"Low region specificity"	"Detected in all"							"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	1.0	2.3	15.4	0.3	15.8	0.1	0.9	99.3	30.4	0.6	0.0	0.7	1.2	0.8	1.1	0.2	3.2	0.1	0.6	15.1	6.8	0.5	0.2	0.2	0.4	7.2	11.2	0.9	2.6	0.1	4.2	0.0	10.6	0.4	0.4	7.1	0.2	0.1	0.5	0.3	1.7	0.2	9.4	0.6	2.7	2.3	11.3	0.1	0.7	0.1	0.2	0.3	0.7	15.2	0.0	0.1	0.1	6.0	0.2	0.2	0.0	2.2	2.5	0.3	0.0	0.0	0.0	0.2	0.0	0.2	5.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	2.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.1	0.2	1.4	0.1	0.3	0.6	0.0	0.1	0.0	0.1	45.1	0.0	0.0	0.0	0.4	0.1	0.0	1.9	0.1	0.1	0.9	0.2	0.1	0.0	0.0	0.0	23.9	0.1	0.6	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.0	15.4	15.8	99.3	30.4	15.1	6.8	7.2	11.2	10.6	9.4	11.3	15.2	7.7	6.4	3.2	31.3	9.6	0.6	3.4	0.0	0.0	101.4	3.1	7.4	2.8	0.0	1.3	1.8	16.7	0.0	2.9	0.6	0.0	0.5	27.1	1.2	6.3	6.5	214.1	0.4	318.3	0.4	0.2	4.7	10.7	2.6	1.3	5.2	1.8	1.2	0.5	249.0	372.1	5.0	4.1	1.9	1.4	28.0	1.2	2.1	0.0	28.1	1.2	3.0	4.1	271.9	11.5	1.5	0.1	0.4	0.5	0.8	0.2	2.0	3.7	7.0	0.0	5.1	17.6	4.3	7.1	0.4	0.1	0.3	2.0	2.5	1.0	0.9
CACNA1C	"CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS"	ENSG00000151067	"Calcium voltage-gated channel subunit alpha1 C"	Q13936	12	1970786-2697950	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Host-virus interaction, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Brugada syndrome, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 20.7;heart muscle: 27.1;intestine: 29.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 606.7;Horizontal cells: 301.2;Inhibitory neurons: 476.2;Oligodendrocyte precursor cells: 194.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HDLM-2: 87.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039796, CAB079031"	Enhanced	Approved				NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB079031: , HPA039796: AB_10673019"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-7)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.39e-2)"	3.0	0.9	4.5	1.4	0.9	0.0	1.9	0.0	3.0	5.6	0.0	29.9	0.7	20.7	0.5	2.1	4.2	2.3	27.1	2.0	0.5	2.5	0.4	4.6	0.3	0.0	0.5	1.9	0.9	0.1	5.2	2.1	0.0	6.5	1.3	1.7	1.0	3.3	0.9	1.3	5.0	10.2	0.0	3.0	5.4	2.5	1.8	0.2	1.3	0.8	0.3	12.3	3.4	0.1	0.0	0.0	0.1	0.0	3.3	2.0	0.2	3.4	4.1	2.2	1.5	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.8	87.0	0.8	0.1	0.0	0.0	2.1	0.0	0.1	5.1	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	5.4	0.6	5.2	0.0	0.1	0.2	0.0	4.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.5	0.9	0.0	3.0	2.0	0.5	0.0	0.5	0.0	0.0	1.8	0.1	2.2	0.0	0.0	96.6	0.2	0.6	1.0	0.0	0.0	20.7	0.8	8.3	48.8	0.0	0.0	0.0	2.1	0.2	1.3	0.6	0.0	0.1	35.6	5.1	14.6	5.2	36.6	0.8	606.7	0.0	0.4	4.2	2.0	0.9	0.0	2.7	2.2	0.1	0.3	301.2	476.2	0.6	0.0	0.0	1.1	90.3	0.9	0.2	0.0	72.1	0.0	6.0	1.0	194.5	21.7	0.4	1.2	4.1	0.2	1.2	0.0	0.1	0.0	1.3	13.1	1.6	26.7	3.4	5.8	0.1	0.1	0.1	1.1	0.2	0.5	3.1
CACNB3	CACNLB3	ENSG00000167535	"Calcium voltage-gated channel auxiliary subunit beta 3"	P54284	12	48813794-48828941	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.9;U-937: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059515			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus, Vesicles"		"HPA059515: AB_2684047"	"unprognostic (1.77e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (2.12e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	10.1	3.9	67.9	2.8	69.9	1.3	9.0	56.8	84.2	33.7	44.1	18.1	4.1	31.1	8.5	21.5	19.6	7.2	8.4	72.6	56.7	12.4	1.9	11.8	1.8	50.2	56.2	43.7	4.5	5.1	12.3	5.8	53.4	13.7	8.2	4.7	13.0	9.1	2.8	11.5	10.8	23.1	49.9	6.1	9.2	8.6	59.6	7.6	9.6	5.9	4.1	14.5	20.2	58.7	17.3	13.2	21.1	46.1	26.8	18.0	12.9	16.8	39.4	25.6	14.5	4.5	13.4	2.2	21.5	30.7	4.4	17.2	21.6	19.5	10.1	18.4	5.9	8.5	11.7	0.6	11.0	1.7	9.1	11.7	10.6	10.2	5.5	75.9	31.1	18.6	1.2	7.2	16.9	42.6	22.1	2.2	13.3	18.1	10.9	24.0	5.0	6.6	19.9	31.6	32.9	31.8	5.5	37.1	12.0	18.6	25.2	7.7	27.3	15.5	21.7	7.7	9.5	7.1	3.5	0.7	12.9	109.9	5.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.6	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.2	67.9	69.9	56.8	84.2	72.6	56.7	50.2	56.2	53.4	49.9	59.6	58.7	5.6	3.2	4.3	1.0	0.5	2.9	3.2	5.9	4.0	3.2	8.7	5.7	2.8	1.5	5.1	1.8	4.2	0.8	2.1	12.6	1.9	9.5	1.0	10.0	22.0	5.9	10.2	0.8	15.1	4.3	10.4	7.9	6.1	7.1	1.3	12.0	3.6	0.2	1.6	0.0	4.5	9.5	16.2	0.6	2.9	2.7	13.4	2.4	1.8	3.7	3.7	1.0	2.1	2.0	1.1	10.4	4.6	10.9	1.3	2.9	8.7	0.7	9.4	1.0	0.0	1.5	12.2	1.6	8.1	9.6	5.1	1.1	3.5	6.1	14.4	1.9
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832771-152099167	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 16.4;skin 1: 7.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.6;Inhibitory neurons: 470.7;Microglial cells: 136.8;Oligodendrocyte precursor cells: 155.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1;HMC-1: 20.2;U-937: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015601	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 6: Brain - Smell perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA015601: AB_1845873"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.42e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.45e-1)"	0.7	0.7	4.6	0.4	12.0	0.7	1.5	15.2	16.4	0.4	1.3	0.3	0.4	0.4	0.6	1.4	0.3	0.9	0.3	6.2	2.3	1.4	0.1	2.0	0.3	0.2	5.6	0.3	0.4	0.4	1.8	0.9	0.3	2.0	0.5	1.8	1.7	1.9	0.1	7.3	0.3	0.5	0.3	0.4	0.6	2.3	6.8	1.1	1.4	0.2	1.0	2.0	0.5	6.8	0.0	0.0	0.7	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.9	0.0	1.9	0.0	0.1	0.3	3.2	0.0	0.2	4.1	0.0	0.2	20.2	0.2	0.1	0.4	0.0	1.7	0.0	0.8	0.0	0.5	0.1	0.0	0.2	0.3	0.5	0.1	0.6	2.0	0.2	0.6	1.1	0.5	1.3	0.7	0.0	0.0	0.0	0.1	3.3	0.8	0.0	1.8	2.0	0.6	0.4	0.3	0.0	0.0	0.4	5.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.1	4.6	12.0	15.2	16.4	6.2	2.3	0.2	5.6	0.3	0.3	6.8	6.8	1.1	12.8	53.3	80.6	0.8	12.4	16.3	3.5	30.7	9.9	6.8	7.2	1.3	0.0	3.8	3.7	4.2	0.1	0.3	0.3	3.9	0.5	0.9	3.0	3.0	1.3	0.0	0.0	495.6	1.5	0.0	7.9	1.1	5.4	0.0	84.1	0.7	0.0	3.4	20.2	470.7	0.0	0.0	1.2	7.5	2.1	3.4	2.4	1.8	136.8	1.2	2.3	1.0	155.3	31.2	1.0	0.1	4.5	2.0	29.0	0.1	0.9	1.2	3.4	0.0	0.6	1.2	0.7	4.1	3.2	8.2	0.0	1.1	6.6	0.1	16.3
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CAMK4	"CaMK-GR, CaMKIV"	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 70.4;lymphoid tissue: 55.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 70.9;Early spermatids: 306.2;Excitatory neurons: 212.2;Inhibitory neurons: 131.8;Late spermatids: 108.4;Oligodendrocyte precursor cells: 133.2;T-cells: 83.3"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"basal ganglia: 30.6;cerebellum: 70.4"	"Group enriched"	"Detected in many"	4	"MAIT T-cell: 24.3;memory CD4 T-cell: 17.3;memory CD8 T-cell: 13.5;naive CD4 T-cell: 33.1;naive CD8 T-cell: 18.5;T-reg: 21.3"	"Lineage enriched"	"Detected in many"	23	"T-cells: 33.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.9;JURKAT: 61.3;MOLT-4: 27.9;SH-SY5Y: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	0.4	3.8	5.0	4.4	30.6	3.1	0.4	70.4	8.2	0.9	0.0	1.3	1.4	0.6	0.3	0.7	0.3	1.5	0.1	7.6	0.0	0.7	1.4	1.1	8.1	0.0	0.4	0.6	0.4	0.0	0.6	0.2	1.4	3.4	1.4	4.7	0.4	1.4	0.1	0.1	2.3	0.8	0.0	2.6	1.5	9.4	0.8	55.4	0.2	0.0	5.2	1.7	0.4	0.0	0.0	0.0	3.1	2.1	0.6	2.3	0.0	0.8	6.8	8.0	7.8	0.0	0.1	0.0	4.0	0.4	5.4	0.3	6.8	0.8	5.8	88.9	5.2	1.3	2.8	0.0	0.2	0.6	0.3	0.3	0.0	16.8	1.7	4.9	1.4	61.3	0.0	3.3	0.4	0.0	27.9	0.0	4.1	0.0	0.2	4.0	5.0	0.2	2.9	0.1	18.8	33.5	1.2	0.0	5.6	0.2	0.1	0.5	0.1	16.3	9.5	0.1	14.7	2.6	0.3	0.0	8.0	0.0	6.3	0.1	0.0	0.0	4.8	0.0	24.3	1.3	17.3	13.5	0.0	0.3	33.1	18.5	0.9	1.4	0.0	0.1	21.3	5.5	5.0	30.6	70.4	8.2	7.6	0.0	0.0	0.4	1.4	0.0	0.8	0.0	1.8	0.0	1.1	57.8	9.4	1.1	0.3	1.3	8.6	70.9	0.6	0.6	5.3	0.0	0.0	0.0	0.0	0.1	3.1	0.1	0.0	0.1	306.2	0.2	1.6	1.1	0.0	0.0	212.2	0.0	0.2	4.6	3.6	0.4	4.5	0.3	0.7	0.3	0.2	0.0	131.8	0.8	0.0	1.3	2.1	108.4	4.1	2.0	0.0	12.2	2.7	2.8	1.0	133.2	5.4	1.2	0.0	1.5	11.5	0.5	0.0	0.1	0.1	4.3	0.0	0.6	3.8	30.3	6.2	2.4	1.0	0.0	83.3	0.1	0.0	0.3
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	"Calcium/calmodulin dependent protein kinase kinase 2"	Q96RR4	12	121237675-121298308	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 64.8;Horizontal cells: 62.2;Late spermatids: 89.6"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 32.7;eosinophil: 62.1;intermediate monocyte: 42.3;myeloid DC: 15.9;neutrophil: 39.2;non-classical monocyte: 39.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 15.9;granulocytes: 62.1;monocytes: 42.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA017389: AB_1845956, HPA063713: "	"unprognostic (5.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	26.0	16.7	39.6	17.0	56.2	30.8	22.7	135.4	65.5	22.3	14.3	22.8	25.7	22.9	10.8	17.5	27.5	12.9	17.8	44.8	24.8	16.7	30.9	23.6	15.3	20.8	20.1	27.4	16.8	12.4	11.8	15.3	24.9	29.5	19.4	7.1	18.6	23.8	11.5	18.3	26.6	20.7	18.3	39.6	24.0	7.0	23.6	13.4	17.1	11.2	15.6	25.9	21.1	42.7	27.9	20.5	16.3	30.9	46.7	43.0	22.8	22.0	23.8	19.0	17.3	21.4	12.1	43.0	18.1	48.1	14.1	22.7	20.0	25.8	15.1	29.3	35.9	22.0	14.4	21.3	31.1	50.0	20.0	28.2	37.2	18.0	41.4	26.0	45.0	33.5	25.2	23.6	18.4	27.2	55.8	40.6	11.7	24.9	22.7	35.3	18.4	37.7	18.8	32.1	60.2	22.4	31.5	16.5	19.1	12.9	39.7	62.0	32.2	14.8	11.8	13.1	13.0	84.8	55.6	32.7	27.7	34.4	16.0	2.0	32.7	62.1	4.7	42.3	4.6	4.8	3.5	4.2	15.9	2.8	3.2	3.8	39.2	8.6	39.5	3.6	3.3	15.8	39.6	56.2	135.4	65.5	44.8	24.8	20.8	20.1	24.9	18.3	23.6	42.7	25.4	9.6	5.6	9.8	5.7	7.9	6.0	8.1	8.0	22.2	11.6	10.5	8.2	12.8	8.3	9.2	2.1	9.2	10.6	18.2	3.9	9.6	16.0	6.5	19.6	21.9	34.3	12.0	64.8	10.4	8.2	18.0	13.3	10.9	6.3	23.3	15.0	19.7	7.9	62.2	21.4	16.2	8.2	14.8	15.6	89.6	20.5	16.6	8.8	12.2	36.3	5.4	12.3	10.1	19.3	8.5	10.9	31.6	11.9	16.5	26.6	9.6	7.2	7.0	19.7	7.7	20.6	0.8	2.9	13.3	6.0	3.4	7.6	32.7	17.6	6.3
CAPRIN1	"caprin-1, GPIAP1, M11S1, RNG105"	ENSG00000135387	"Cell cycle associated protein 1"	Q14444	11	34051731-34102610	"Predicted intracellular proteins"	Differentiation	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.0;Late spermatids: 289.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018126, HPA063617"	Approved		Enhanced	Cytosol		NA	NA		43000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018126: AB_1849929, HPA063617: AB_2685062"	"unprognostic (3.79e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (8.67e-8)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	45.2	30.6	26.1	42.2	28.6	70.3	56.8	25.0	30.9	56.8	21.8	48.8	46.0	52.7	30.5	47.1	61.8	41.7	44.9	28.7	28.3	49.9	39.9	43.3	42.9	26.1	26.7	60.5	47.5	59.9	21.6	53.8	27.3	45.7	60.5	58.7	38.6	53.5	45.3	30.3	41.1	66.2	32.3	40.1	42.1	123.0	26.9	77.6	53.3	54.0	62.6	58.9	31.8	36.7	134.7	168.8	245.6	137.2	180.9	182.5	117.5	168.0	175.8	202.4	188.2	154.9	80.8	211.1	104.9	213.9	169.4	173.1	311.9	204.3	244.9	134.7	155.5	174.1	153.3	131.9	109.4	282.0	122.8	164.0	109.2	129.1	236.3	174.7	204.2	153.7	228.1	103.6	211.3	114.5	243.7	55.8	114.8	155.3	150.6	191.8	339.2	93.7	120.4	263.1	155.5	147.7	202.6	101.1	88.8	150.5	183.5	104.4	205.3	172.7	116.4	167.9	190.8	110.9	175.5	238.7	117.2	116.3	191.7	25.0	33.3	13.9	18.8	39.7	27.3	19.4	20.9	23.2	39.0	17.8	21.6	21.1	13.5	30.7	43.4	18.2	28.1	31.0	26.1	28.6	25.0	30.9	28.7	28.3	26.1	26.7	27.3	32.3	26.9	36.7	42.1	35.3	43.5	37.9	46.0	77.8	45.5	51.5	68.9	38.1	63.7	43.9	55.4	24.3	37.2	64.4	18.8	46.7	47.2	46.0	31.3	56.6	483.0	90.0	116.5	52.1	71.8	79.0	37.4	60.1	60.2	54.6	65.7	132.2	17.1	63.1	39.7	46.1	57.2	25.2	38.8	51.1	54.9	75.8	72.3	289.3	47.8	57.9	39.2	37.5	57.0	36.7	35.0	44.2	53.1	71.3	40.4	72.6	83.0	72.7	42.9	47.4	49.5	32.3	39.5	40.4	64.3	201.7	74.8	93.2	72.9	45.8	46.5	53.9	65.5	77.7
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 126.0;lymphoid tissue: 91.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 125.3;Langerhans cells: 120.7;Macrophages: 136.6;monocytes: 185.6;Proximal enterocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 112.7;HBEC3-KT: 53.8;HHSteC: 58.2;U-937: 136.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 18.4"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	20.4	10.5	8.7	59.1	8.8	36.3	21.9	9.3	14.6	11.9	9.8	47.7	124.6	8.7	12.0	27.2	12.3	27.4	12.2	8.5	9.6	13.3	21.6	48.3	52.1	11.2	9.4	11.7	6.4	2.7	5.0	30.0	11.1	13.0	49.7	1.1	20.8	12.5	6.2	30.9	126.0	20.8	10.7	91.0	22.5	2.4	10.7	23.2	7.8	7.3	35.5	35.7	19.4	11.9	1.3	0.3	0.0	5.3	5.8	12.1	1.0	5.7	112.7	14.0	38.5	0.2	0.7	18.7	2.3	6.6	25.7	8.1	0.0	53.8	3.3	12.3	0.0	0.9	0.7	1.3	58.2	22.1	0.2	20.9	37.4	11.4	30.3	36.2	6.1	0.3	0.2	0.0	3.4	0.0	0.6	30.7	0.0	0.1	0.3	18.1	0.4	14.9	0.3	8.9	0.4	0.4	16.9	1.1	26.2	0.1	1.2	50.1	7.2	12.8	0.6	1.2	1.6	0.1	5.4	0.1	8.1	136.2	2.7	83.8	246.1	134.9	132.9	359.9	178.5	40.2	92.7	115.8	220.2	35.5	50.2	82.7	220.0	63.0	383.0	7.7	129.0	213.3	8.7	8.8	9.3	14.6	8.5	9.6	11.2	9.4	11.1	10.7	10.7	11.9	26.3	19.2	30.0	0.0	27.2	26.0	42.5	91.5	14.2	0.1	5.8	23.0	2.9	8.6	37.7	11.0	0.0	2.1	34.1	33.1	1.9	23.3	0.2	5.8	2.5	24.0	6.0	10.3	0.2	12.9	1.3	17.8	11.7	3.4	15.8	0.2	22.9	3.1	96.5	0.0	0.0	50.6	14.2	125.3	120.7	1.3	3.4	136.6	5.4	12.2	185.6	0.1	64.9	0.0	0.1	5.3	73.4	3.4	20.0	8.7	116.0	2.2	28.4	0.2	0.0	1.0	8.1	0.0	0.1	17.9	22.3	1.1	58.4	3.3	90.5	43.6
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700021-115768714	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1056.7"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 777.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"HSkMC: 13.6"	"Region enriched"	"Detected in all"	6	"cerebellum: 43.1"	"Low region specificity"	"Detected in all"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.25e-5)"	31.9	3.0	3.5	6.4	2.3	0.0	8.9	2.8	4.0	8.0	2.0	59.8	3.3	17.2	6.5	38.5	14.7	6.6	1056.7	1.8	3.6	3.5	0.6	5.3	0.8	1.9	4.8	5.3	1.2	1.6	0.9	1.6	2.1	13.8	17.0	0.3	7.6	20.2	182.1	4.9	9.1	39.1	1.9	0.8	14.2	1.5	6.4	1.6	4.1	165.0	1.3	43.9	6.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.3	2.8	4.0	1.8	3.6	1.9	4.8	2.1	1.9	6.4	1.9	2.7	0.0	0.0	0.3	0.0	0.6	0.3	0.0	0.6	0.2	0.1	0.4	777.8	0.0	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	15.5	0.3	0.0	4.8	0.0	0.0	0.7	0.0	0.3	17.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	20.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	1.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	92.1	11.0	73.4	0.1	0.4	0.2	0.3	0.0	0.1	0.0	0.0	0.0
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733802-8841808	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 182.7;tongue: 72.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	5.7	0.1	0.1	27.4	0.1	0.1	0.0	0.0	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	2.5	0.2	182.7	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.1	72.8	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	11.0	2.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0
CBLN4	"CBLNL1, dJ885A10.1"	ENSG00000054803	"Cerebellin 4 precursor"	Q9NTU7	20	55997357-56005519	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 17.8;brain: 19.3;epididymis: 8.8"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 8.9;Excitatory neurons: 26.9;Inhibitory neurons: 31.6;Peritubular cells: 38.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	50	"SH-SY5Y: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074497		Supported			"Secreted in brain"	NA	NA		10000000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA074497: "	"unprognostic (3.61e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-3)"	1.6	17.8	14.6	0.1	3.4	0.0	1.4	0.0	9.4	1.9	0.0	0.0	0.0	0.7	8.8	0.1	3.8	0.5	0.0	14.4	5.8	0.6	0.9	0.7	0.0	0.7	19.3	2.0	0.7	0.3	0.1	0.2	2.4	0.1	0.0	0.3	0.1	0.3	0.3	0.0	0.1	0.3	0.0	0.0	0.3	2.0	12.2	0.1	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	3.4	0.0	9.4	14.4	5.8	0.7	19.3	2.4	0.0	12.2	0.2	0.1	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.2	8.9	0.0	26.9	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	1.3	0.1	1.7	31.6	0.0	0.0	0.0	0.0	1.0	2.1	0.2	0.0	1.9	0.0	0.2	0.0	1.0	2.0	0.0	0.0	38.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CBX1	"CBX, HP1-BETA, HP1Hs-beta, M31, MOD1"	ENSG00000108468	"Chromobox 1"	P83916	17	48070052-48101478	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 350.8;Spermatogonia: 304.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012265	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		120000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB012265: AB_297216"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.48e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.73e-2)"	30.9	31.4	60.3	35.5	59.9	16.5	37.2	61.6	73.2	53.6	54.5	40.7	19.0	66.5	47.9	36.8	40.2	27.9	32.1	59.8	63.9	37.9	21.6	26.9	35.0	63.2	59.7	77.5	22.3	43.8	34.8	34.7	64.0	38.0	33.1	59.5	29.7	47.1	68.4	28.8	24.0	55.6	64.9	33.7	26.6	69.1	60.3	73.6	39.5	46.0	46.9	36.4	37.9	67.3	217.3	121.1	392.4	185.6	78.0	69.3	217.7	197.0	95.1	188.0	200.6	319.2	84.5	148.4	204.5	155.6	144.8	85.3	146.3	124.6	329.2	273.8	118.1	119.8	121.1	119.3	47.5	115.5	71.9	49.8	68.4	140.3	178.3	144.7	157.1	176.6	152.0	67.2	153.8	135.7	325.9	79.8	150.6	118.8	156.9	241.8	322.7	95.8	110.3	121.7	138.5	345.6	135.0	44.6	75.5	281.8	211.0	82.5	110.7	260.2	238.9	112.0	201.1	94.0	227.9	140.4	71.4	50.4	119.0	5.1	12.2	16.0	12.4	12.7	10.0	16.1	11.2	10.4	9.9	15.7	11.5	9.7	33.6	9.5	9.3	10.6	12.4	5.9	60.3	59.9	61.6	73.2	59.8	63.9	63.2	59.7	64.0	64.9	60.3	67.3	32.9	67.3	27.6	7.8	31.4	43.6	30.5	46.1	36.5	46.9	48.0	54.7	70.9	18.6	33.6	42.3	20.9	66.4	27.5	19.2	35.2	68.7	26.8	40.8	78.9	40.2	40.3	34.3	13.0	29.7	86.6	61.5	10.2	39.6	39.9	65.3	30.0	15.6	69.6	50.5	15.5	27.3	42.7	33.5	24.5	59.5	80.2	26.7	40.9	7.5	47.7	106.6	42.2	12.5	13.7	34.7	12.9	91.7	20.0	51.1	9.6	30.9	32.2	36.3	39.5	33.3	71.8	350.8	304.0	26.7	36.2	27.8	25.6	35.8	28.6	20.1
CBY1	"C22orf2, Cby, Chibby, Chibby1, PGEA1, PIGEA-14, PIGEA14"	ENSG00000100211	"Chibby family member 1, beta catenin antagonist"	Q9Y3M2	22	38656636-38673854	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.06e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.42e-1)"	"prognostic favorable (5.22e-5)"	"unprognostic (3.46e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.35e-2)"	25.9	46.3	38.6	11.7	39.5	6.3	29.3	40.0	42.5	36.5	40.8	51.7	16.9	32.9	51.5	27.3	59.3	19.6	53.2	38.8	38.4	38.6	28.4	23.5	12.1	38.9	40.4	40.4	34.8	34.2	33.5	29.2	38.1	39.9	27.8	20.0	29.5	43.7	25.9	27.3	22.2	38.3	38.7	22.9	31.9	25.2	40.0	14.2	32.2	33.5	15.1	37.0	29.7	39.9	31.2	27.8	40.3	56.9	76.4	46.3	19.6	34.3	39.0	34.1	34.6	17.4	28.1	4.3	30.1	39.4	31.1	28.5	32.1	66.7	46.3	13.2	30.0	3.5	22.8	35.2	51.9	10.5	4.6	43.9	52.6	48.8	65.5	62.3	56.1	13.1	19.5	10.6	37.8	51.0	7.2	14.9	22.4	75.7	34.0	6.6	22.9	9.9	88.7	28.1	47.2	12.5	47.2	21.1	43.5	44.6	19.9	9.8	39.3	19.4	24.7	21.8	14.4	11.4	7.4	4.7	28.9	12.3	23.0	4.5	6.3	6.4	10.6	5.0	14.6	6.9	13.4	12.7	6.7	12.0	19.3	13.7	6.3	8.3	6.3	10.6	5.8	6.4	38.6	39.5	40.0	42.5	38.8	38.4	38.9	40.4	38.1	38.7	40.0	39.9	21.9	12.8	18.5	9.4	5.1	13.8	17.8	57.4	15.9	8.5	32.7	41.0	36.6	28.6	28.9	27.6	6.2	86.1	4.2	13.5	35.2	36.0	60.7	106.3	30.3	24.0	21.6	10.8	12.9	19.5	41.9	34.1	10.2	25.6	8.2	33.6	22.5	10.6	20.1	8.4	13.9	22.0	40.7	6.7	10.4	12.4	49.7	4.2	21.4	5.6	5.5	28.4	2.1	3.5	9.2	24.6	13.2	65.8	5.4	19.9	16.8	51.4	89.0	13.7	26.3	22.8	30.6	20.2	20.2	20.1	16.3	49.5	5.8	84.1	29.4	15.1
CCDC102A	MGC10992	ENSG00000135736	"Coiled-coil domain containing 102A"	Q96A19	16	57512181-57536571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040598, HPA040958"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA040598: AB_10794035, HPA040958: AB_10794156"	"unprognostic (3.46e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.40e-3)"	"unprognostic (4.08e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.42e-3)"	5.0	3.7	1.8	2.7	1.6	0.5	4.8	1.7	2.4	10.9	4.1	11.1	2.3	11.0	1.1	3.5	8.8	1.5	6.8	1.6	1.7	5.2	1.5	4.5	3.0	2.5	2.4	8.0	3.3	1.5	2.3	2.5	2.0	8.4	0.5	0.1	4.0	3.8	1.6	4.9	4.7	2.4	2.1	5.1	4.8	3.0	2.4	1.6	5.8	0.5	1.7	11.9	8.2	1.5	6.6	7.9	3.0	4.3	1.0	1.4	6.2	4.2	2.3	2.4	1.2	3.2	7.5	6.0	16.4	1.3	3.2	4.8	1.5	2.2	0.9	4.9	6.8	0.8	3.8	1.3	3.7	0.4	7.7	3.5	1.4	2.0	0.5	5.2	1.9	2.1	4.6	0.0	0.8	2.7	5.4	5.3	7.1	0.7	14.6	4.8	3.4	2.4	3.0	1.0	0.5	7.8	6.6	2.1	3.2	1.1	4.5	2.9	5.2	4.4	14.5	0.4	3.8	6.9	2.7	2.2	2.5	2.1	7.4	0.0	0.0	0.0	1.1	0.0	0.9	0.9	0.2	1.2	0.0	0.5	0.5	0.8	0.1	0.6	0.0	0.3	0.0	0.2	1.8	1.6	1.7	2.4	1.6	1.7	2.5	2.4	2.0	2.1	2.4	1.5	8.8	0.0	3.0	0.7	8.2	12.9	8.0	2.4	14.8	0.0	4.9	10.3	3.1	5.7	2.2	7.3	0.0	1.6	16.3	0.5	9.8	1.9	0.6	6.0	8.5	10.6	0.0	3.4	0.0	0.9	1.1	13.2	2.0	1.8	0.0	14.6	7.1	0.9	0.3	0.0	0.1	1.0	0.0	0.6	2.8	1.3	19.6	1.5	1.8	1.0	0.5	3.5	18.6	0.0	0.0	0.9	0.1	34.6	18.8	10.6	1.1	10.5	3.1	0.2	19.7	10.8	11.8	2.8	8.9	2.3	5.7	0.3	10.5	3.3	1.0	3.2
CCDC102B	"ACY1L, AN, C18orf14, FLJ23594, HsT1731"	ENSG00000150636	"Coiled-coil domain containing 102B"	Q68D86	18	68715209-69055189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 28.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.8;Early spermatids: 138.2;Excitatory neurons: 80.8;Late spermatids: 83.3;Oligodendrocytes: 90.1;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 9.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.2;BJ hTERT+: 29.0;fHDF/TERT166: 26.2;HSkMC: 15.4;Karpas-707: 10.2"									"HPA040623, HPA048194"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Cytosol	"HPA040623: AB_10805715, HPA048194: AB_2680309"	"unprognostic (3.92e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.50e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.50e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (2.90e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.13e-3)"	7.1	2.9	1.5	3.7	1.8	0.7	2.7	0.6	3.5	2.8	0.0	3.8	1.5	1.7	1.1	3.4	1.8	13.6	3.2	1.3	2.0	4.3	1.7	14.3	8.6	2.6	1.6	0.9	1.5	2.6	0.9	28.4	3.1	1.2	4.5	2.2	1.3	1.3	0.6	1.0	2.6	3.7	2.0	2.2	3.6	2.0	2.3	1.5	5.2	1.1	2.0	10.6	1.5	3.6	0.0	0.0	4.0	0.3	3.6	14.2	0.2	0.8	29.0	0.3	0.5	0.1	0.4	0.1	0.6	26.2	0.5	0.4	0.1	0.2	0.4	1.2	0.4	0.8	0.0	1.3	7.0	0.1	0.4	15.4	0.6	0.4	3.5	0.6	0.2	2.0	0.0	10.2	2.4	0.0	0.6	0.3	0.8	0.2	0.5	1.3	0.2	0.5	0.1	0.0	1.7	1.5	0.1	0.0	0.1	1.6	0.3	1.3	4.0	0.6	0.2	0.2	0.3	4.4	0.3	0.8	2.1	1.7	2.5	0.0	0.1	0.3	1.0	0.2	0.9	0.5	0.6	0.8	0.2	0.6	1.8	1.1	0.0	1.0	0.2	9.1	0.3	0.3	1.5	1.8	0.6	3.5	1.3	2.0	2.6	1.6	3.1	2.0	2.3	3.6	11.5	0.0	2.2	72.8	4.4	0.6	0.8	0.8	0.6	6.4	2.7	2.9	10.0	0.0	2.1	3.7	6.2	0.8	12.4	0.4	5.9	0.7	138.2	2.9	6.7	6.8	0.0	3.0	80.8	1.8	0.6	15.3	0.0	1.1	2.5	5.7	8.6	0.8	3.2	6.7	33.6	0.2	0.0	1.9	1.8	83.3	32.3	3.3	0.0	44.0	2.1	11.9	7.2	36.2	90.1	0.2	2.6	9.1	2.2	0.4	0.3	5.3	1.5	13.4	78.9	3.8	37.3	1.9	5.7	0.7	0.6	0.3	3.8	3.7	0.4	0.6
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"		6	138773769-138793319	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Nucleoplasm	"HPA055125: AB_2682705"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	21.8	48.4	41.8	19.6	42.5	40.1	28.1	38.4	48.7	23.8	47.1	23.8	30.4	16.7	38.1	16.4	35.8	23.8	19.1	43.8	43.2	59.9	67.8	26.2	35.4	38.5	38.8	21.8	35.5	53.0	29.5	32.1	39.3	25.0	24.3	25.6	52.3	20.2	15.7	18.0	30.7	15.9	37.8	29.8	29.3	23.8	41.1	46.5	54.2	21.3	33.6	26.2	17.2	39.0	7.2	12.9	9.5	17.4	17.5	24.4	19.4	11.7	20.3	15.2	24.6	11.1	14.1	31.1	22.3	11.8	21.3	12.3	15.6	16.2	24.4	35.9	35.7	25.3	16.3	22.1	27.6	43.8	25.6	15.7	20.2	10.9	32.0	31.0	25.1	43.1	25.8	42.2	17.1	15.9	36.3	58.0	8.9	28.9	13.2	21.7	9.5	29.2	18.3	10.6	11.8	18.4	15.6	13.8	34.9	18.6	6.7	47.6	19.5	11.9	13.5	22.3	18.0	55.8	53.0	23.1	12.7	27.1	10.6	137.8	91.6	120.6	84.5	96.5	76.4	107.1	88.4	92.8	102.1	106.6	101.5	93.3	249.6	115.8	85.0	90.0	159.8	93.6	41.8	42.5	38.4	48.7	43.8	43.2	38.5	38.8	39.3	37.8	41.1	39.0	24.5	32.1	35.4	12.7	36.5	13.4	25.0	36.9	29.0	16.0	24.6	25.1	11.0	24.3	31.6	36.8	18.8	82.7	42.7	31.7	123.3	19.3	146.8	83.5	11.4	20.7	24.7	39.2	25.6	31.6	49.2	23.2	16.3	15.6	43.1	25.3	29.3	50.8	38.0	10.1	22.3	30.6	38.7	41.5	31.5	99.9	16.8	36.1	32.0	3.7	39.5	24.6	42.2	5.5	17.9	16.8	35.9	15.1	29.7	31.2	81.0	130.9	89.0	14.2	13.1	14.0	15.8	48.6	27.2	15.5	14.9	108.9	35.4	18.1	23.1	36.2
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745255-63776351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	57.9	67.3	24.3	42.5	33.6	29.0	57.1	28.8	39.2	47.7	46.9	83.4	87.1	39.1	53.7	52.6	43.9	48.2	65.5	29.3	27.9	72.0	102.2	52.7	33.5	28.8	27.4	35.3	59.8	84.6	21.9	54.8	29.9	60.2	80.6	46.9	62.4	52.0	115.3	52.2	78.2	42.1	30.1	35.6	78.5	32.1	26.0	29.9	62.0	83.7	40.5	58.5	29.3	34.3	143.3	133.8	81.4	71.9	112.4	74.0	158.0	141.9	92.6	96.1	112.4	118.7	127.0	112.9	74.3	100.9	110.8	114.3	99.3	88.1	168.9	39.4	101.2	160.9	106.4	117.3	107.6	129.9	81.3	78.5	121.3	132.4	113.2	67.9	81.3	55.3	183.5	95.5	79.4	116.1	100.5	48.1	70.8	179.4	134.0	92.2	157.9	154.6	115.3	161.1	74.2	101.5	95.2	242.8	120.3	103.0	159.8	70.4	104.0	177.6	112.9	130.6	166.0	93.9	119.9	112.8	103.9	81.4	147.3	53.2	59.7	75.6	40.7	61.5	47.9	38.4	39.8	37.9	82.5	31.7	41.1	36.2	47.6	43.4	65.9	54.7	49.0	52.0	24.3	33.6	28.8	39.2	29.3	27.9	28.8	27.4	29.9	30.1	26.0	34.3	96.9	144.2	122.2	16.3	46.6	100.8	108.5	95.9	98.4	40.9	65.9	53.6	129.0	72.9	128.3	60.7	14.6	111.1	59.0	99.8	9.8	115.3	17.9	80.3	73.9	83.9	52.2	76.6	26.2	105.1	98.3	85.3	65.7	126.0	45.5	31.2	68.2	96.3	57.5	57.2	25.9	95.1	83.4	56.9	58.3	11.5	47.8	60.7	39.2	13.1	52.9	55.3	25.7	22.6	25.5	92.0	62.6	56.1	56.0	89.6	87.5	32.6	83.0	27.9	72.3	117.2	92.1	82.0	44.7	90.1	90.8	144.1	42.7	53.0	110.5	83.3
CCDC74A	FLJ40345	ENSG00000163040	"Coiled-coil domain containing 74A"	Q96AQ1	2	131527675-131533666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 73.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 424.4;Late spermatids: 274.9;Respiratory ciliated cells: 166.1;Spermatocytes: 154.2;Theca cells: 211.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 28.6;SCLC-21H: 23.2"									HPA060727			Uncertain	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA060727: "	"prognostic favorable (5.11e-4)"	"unprognostic (2.89e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.70e-7)"	"unprognostic (7.28e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.53e-2)"	3.3	32.7	10.6	1.2	9.6	0.1	9.6	7.3	11.3	17.6	29.3	6.9	1.1	12.8	8.9	3.0	34.5	7.0	3.5	11.1	12.2	8.9	1.2	6.2	1.3	12.1	12.8	14.8	2.6	20.4	34.7	1.1	10.5	15.8	1.7	2.0	3.1	6.3	0.5	4.9	2.5	3.0	10.5	1.2	3.2	73.5	15.1	5.3	7.3	0.8	0.8	14.5	8.0	8.0	0.0	5.9	6.0	0.3	8.4	20.2	0.5	5.1	8.4	4.6	3.4	0.2	8.9	2.3	3.1	7.9	7.7	4.6	2.6	1.5	1.9	6.1	11.1	0.0	6.2	0.2	1.0	0.2	0.5	6.6	0.6	4.5	0.0	9.0	1.8	12.7	3.4	6.5	4.2	3.8	13.3	3.6	28.6	2.3	3.8	6.4	0.0	2.7	11.8	0.1	23.2	16.9	0.6	0.8	0.9	2.3	8.2	1.3	1.9	1.4	4.3	18.0	3.9	1.3	1.2	0.8	19.0	0.6	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	9.6	7.3	11.3	11.1	12.2	12.1	12.8	10.5	10.5	15.1	8.0	0.8	0.0	0.5	1.6	0.3	5.1	12.2	21.6	14.2	1.0	34.8	28.4	0.5	4.3	15.8	7.3	0.0	0.5	1.1	0.8	7.9	9.4	424.4	88.2	7.6	1.4	7.7	0.0	3.7	0.7	0.4	11.1	1.1	4.7	0.0	30.4	1.4	0.1	0.3	0.0	2.4	0.6	16.2	0.0	5.9	274.9	37.0	0.8	1.8	1.0	0.0	14.2	0.0	1.0	0.5	2.7	0.5	68.4	0.9	7.4	0.1	2.6	166.1	1.1	0.0	2.5	14.2	154.2	18.8	7.2	6.0	0.3	1.2	211.1	2.4	7.2
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 37.0"	HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	4.5	1.4	5.9	19.4	23.9	31.2	6.9	3.2	7.1	4.0	2.5	9.4	13.3	3.1	1.6	12.5	12.2	6.2	4.0	3.6	3.9	6.8	3.6	9.7	33.9	5.6	6.7	1.0	8.3	5.3	5.2	2.4	4.6	9.4	7.0	1.0	10.1	3.9	2.3	7.0	11.7	2.3	4.3	21.7	12.4	8.0	7.8	20.4	2.5	2.7	20.4	8.1	7.6	3.2	8.5	6.9	7.5	9.5	0.0	0.0	34.9	0.0	0.0	0.0	0.0	6.8	13.4	45.1	6.1	0.0	0.4	0.4	11.3	6.4	0.0	28.8	4.7	10.0	4.8	9.9	0.7	23.0	8.4	0.0	11.4	0.0	0.0	0.7	8.6	55.6	11.2	50.1	0.1	24.9	24.2	29.6	7.1	6.2	11.5	19.5	0.2	14.2	2.6	10.2	53.6	11.6	4.6	16.9	4.6	5.6	10.2	20.7	2.6	0.0	0.2	0.1	0.1	58.5	76.2	22.8	0.0	20.1	0.1	7.8	3.3	1.3	9.4	1.9	8.8	2.5	6.0	9.2	1.8	2.1	3.8	5.8	2.3	4.0	3.0	2.0	10.7	4.1	5.9	23.9	3.2	7.1	3.6	3.9	5.6	6.7	4.6	4.3	7.8	3.2	26.6	3.2	28.8	7.8	54.1	9.3	15.9	19.0	27.9	0.0	15.3	7.6	19.8	10.0	22.1	14.7	0.0	3.6	80.1	29.6	0.0	4.4	9.6	62.6	1.4	17.3	23.9	20.6	7.1	5.9	2.2	4.2	20.4	12.1	2.5	1.3	20.3	1.6	6.3	0.0	2.5	15.3	22.4	21.0	12.4	18.7	4.1	18.9	1.8	9.4	20.1	8.0	142.2	8.0	5.2	7.8	18.2	3.0	93.2	16.8	13.1	13.2	112.5	0.1	0.0	2.9	4.4	4.7	17.4	31.2	9.5	1.8	89.2	3.3	19.4	19.8
CCDC90B	"MDS011, MDS025"	ENSG00000137500	"Coiled-coil domain containing 90B"	Q9GZT6	11	83259097-83286407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 447.3;Late spermatids: 233.9;Spermatocytes: 333.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011130, HPA011931"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA011130: AB_1846170, HPA011931: AB_2072332"	"unprognostic (5.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.57e-3)"	"unprognostic (5.76e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.41e-1)"	16.4	37.3	23.2	13.0	24.5	16.1	21.3	24.2	29.8	17.1	23.3	18.1	14.7	14.7	33.8	16.2	15.6	18.2	22.1	22.9	25.4	18.4	38.9	13.5	20.5	25.3	25.0	22.3	18.3	14.9	19.4	22.2	25.0	16.0	17.3	12.6	17.1	16.3	16.2	14.1	16.6	16.7	25.2	15.5	16.9	54.5	24.4	17.2	25.6	17.7	17.0	15.3	14.2	27.1	19.1	27.3	46.1	15.2	59.6	44.7	27.7	37.4	31.6	22.7	24.3	32.2	63.0	46.7	47.7	55.0	47.5	23.5	20.1	47.3	30.3	31.9	16.0	28.2	17.7	27.3	50.1	29.2	23.5	50.2	62.3	29.5	83.8	45.3	52.3	49.6	41.9	37.9	83.7	33.5	29.4	36.7	37.9	80.2	33.4	33.1	40.9	39.3	47.3	27.5	22.2	50.9	26.4	21.0	26.1	60.8	53.9	26.4	51.6	44.8	28.8	85.9	26.0	36.3	51.2	46.8	18.1	23.2	45.5	77.7	18.7	71.6	24.2	41.3	31.2	39.8	34.7	34.2	27.0	37.9	30.2	30.2	9.8	50.7	43.8	20.4	46.0	27.4	23.2	24.5	24.2	29.8	22.9	25.4	25.3	25.0	25.0	25.2	24.4	27.1	50.8	12.8	13.1	14.0	40.5	23.6	49.6	102.8	26.7	36.3	33.5	49.7	58.0	28.6	48.3	36.8	14.6	74.0	41.4	21.0	68.4	59.4	447.3	39.5	38.0	45.8	33.6	36.2	16.0	48.5	55.4	44.5	26.5	31.4	49.4	83.0	35.7	43.3	63.7	42.1	23.3	35.2	52.9	34.6	32.4	233.9	42.6	38.6	21.4	10.3	52.8	35.3	53.5	31.2	48.2	67.6	32.9	25.6	44.6	38.9	44.1	78.0	32.6	50.0	26.3	40.3	43.5	333.0	107.8	32.5	29.0	51.7	37.1	86.8	31.2	49.9
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103827-36105621	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 3753.7;Hofbauer cells: 849.7;Macrophages: 1168.2;NK-cells: 1232.8;Plasma cells: 974.5;T-cells: 1948.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 414.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 135.0;T-cells: 414.7"	"Group enriched"	"Detected in some"	6	"U-266/70: 51.6;U-266/84: 13.3"									CAB007805	Approved				"Secreted to blood"	NA	NA	144000		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.54e-4)"	"prognostic favorable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	38.9	28.0	2.0	32.0	2.0	192.9	10.5	3.4	5.5	16.0	4.1	9.9	7.6	10.3	6.4	15.0	8.2	45.1	4.4	2.0	1.9	6.8	84.2	33.9	34.3	3.2	2.9	5.0	15.6	12.0	2.5	17.8	2.8	7.6	11.1	0.1	5.1	3.4	1.0	0.9	11.4	18.0	2.5	65.3	10.3	2.7	2.1	24.1	5.9	4.5	15.4	56.4	4.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	51.6	13.3	0.2	0.2	0.1	0.0	14.4	3.4	135.0	414.7	4.8	101.6	8.4	46.0	240.6	2.3	17.7	13.8	181.7	55.8	42.8	11.1	2.6	0.5	138.9	2.0	2.0	3.4	5.5	2.0	1.9	3.2	2.9	2.8	2.5	2.1	3.3	52.3	0.0	54.5	0.0	135.9	15.6	1.9	0.3	24.5	1.5	26.3	49.3	11.2	14.3	7.2	0.0	0.0	9.7	3753.7	1.2	0.0	0.4	20.8	3.7	4.7	77.6	1.2	60.9	0.0	0.4	11.3	18.9	118.3	5.5	60.8	0.2	21.4	10.5	849.7	1.7	0.0	1.5	0.0	429.4	428.0	32.6	0.9	1168.2	51.6	3.7	10.5	1.1	1232.8	0.0	0.0	0.2	0.1	0.4	974.5	0.8	0.4	2.8	5.8	5.2	0.0	3.9	20.9	0.4	0.4	11.0	14.5	25.9	1948.3	0.0	0.9	1.6
CCNY	"C10orf9, CBCP1, CFP1"	ENSG00000108100	"Cyclin Y"	Q8ND76	10	35247025-35572669	"Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Late spermatids: 3651.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.8;granulocytes: 26.4;monocytes: 23.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036290	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA036290: AB_10600860"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (3.37e-2)"	"unprognostic (6.15e-3)"	"unprognostic (4.06e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	28.6	21.9	35.1	21.2	37.1	35.9	23.7	31.6	35.1	21.8	24.8	28.4	21.5	28.4	26.9	20.5	22.2	22.7	33.1	37.0	32.4	24.8	31.0	25.9	23.4	32.0	33.6	25.2	20.6	17.9	15.5	38.7	31.9	18.3	20.0	19.3	17.0	20.1	25.5	19.3	22.2	25.7	32.3	24.4	26.3	81.2	35.5	22.5	29.6	22.9	21.0	25.4	17.3	33.4	52.3	22.2	29.3	28.2	41.6	56.5	38.2	27.4	27.7	26.0	24.9	32.4	51.7	33.2	38.1	44.1	22.7	27.1	26.3	34.6	27.7	105.0	17.3	62.0	16.0	42.4	45.8	22.7	28.3	40.3	48.1	39.9	27.1	57.6	63.3	38.3	49.1	27.3	51.6	33.2	39.9	19.6	11.2	29.6	46.2	33.0	54.4	20.7	33.2	24.6	25.8	39.3	21.5	42.7	38.6	25.4	36.9	41.8	75.5	32.1	38.6	49.4	23.9	18.3	16.6	24.4	56.0	46.6	15.1	1.7	23.4	5.2	3.3	6.5	3.6	3.1	3.2	3.5	7.8	2.4	3.2	3.6	26.4	2.9	3.4	4.0	2.3	7.6	35.1	37.1	31.6	35.1	37.0	32.4	32.0	33.6	31.9	32.3	35.5	33.4	102.2	32.1	25.9	91.1	23.4	26.9	14.1	29.0	13.6	43.5	30.2	28.7	33.1	41.5	32.1	38.6	20.9	12.0	35.2	25.8	5.9	16.5	709.0	29.5	37.2	59.8	52.8	12.4	205.5	27.8	18.1	34.4	20.4	33.4	16.5	35.3	32.5	85.3	28.9	48.8	130.0	29.0	26.4	80.4	46.9	3651.5	41.3	56.6	16.0	192.0	89.3	62.4	24.7	167.9	445.2	27.9	19.2	38.7	11.7	27.7	31.5	23.1	28.5	39.6	6.6	56.0	26.5	33.8	40.2	17.1	29.5	9.4	26.2	43.2	28.6	20.9
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"parathyroid gland: 330.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.3;Basal respiratory cells: 62.8;Hofbauer cells: 45.0;Squamous epithelial cells: 51.4;Suprabasal keratinocytes: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 206.4;BJ hTERT+: 126.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	8.6	1.1	2.3	2.4	2.5	2.8	5.5	2.1	2.1	9.9	0.7	6.9	1.3	12.5	5.6	10.2	3.2	4.1	5.8	2.0	4.0	7.0	1.1	6.6	1.0	3.2	3.6	0.7	0.5	330.4	0.4	6.5	3.5	3.6	2.9	0.2	3.4	2.5	1.2	18.9	2.2	12.6	3.7	2.1	1.1	1.8	2.5	3.1	1.3	3.3	2.2	4.5	7.4	3.1	35.6	29.4	1.5	0.1	48.2	206.4	0.0	30.5	126.0	9.0	18.4	0.1	20.2	0.0	19.7	63.5	19.5	96.5	3.5	60.9	12.1	8.5	5.5	11.5	21.0	5.8	10.1	0.0	0.3	60.7	52.4	18.6	68.7	34.2	71.6	3.9	0.0	0.2	45.0	0.8	0.8	0.0	2.4	0.3	18.9	2.6	8.4	40.6	4.8	3.6	0.0	0.1	68.6	0.7	30.8	1.3	0.8	5.8	68.7	96.8	10.1	17.2	28.5	0.7	17.9	0.1	40.3	0.1	89.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.3	2.5	2.1	2.1	2.0	4.0	3.2	3.6	3.5	3.7	2.5	3.1	65.3	3.2	1.7	39.8	1.1	41.4	8.4	62.8	35.9	0.3	2.2	2.2	13.0	0.0	16.3	0.0	0.0	0.4	1.2	0.1	1.9	0.1	23.4	10.8	10.5	38.0	0.0	7.6	4.0	0.0	0.5	25.0	0.5	15.0	2.5	0.0	21.0	0.6	45.0	0.0	3.3	0.1	4.1	2.7	28.5	21.0	0.6	13.5	23.2	19.7	3.3	0.0	0.0	1.5	1.0	0.4	0.0	0.0	1.7	10.8	0.0	23.5	16.0	0.2	0.0	7.4	13.2	1.0	3.5	51.4	43.8	1.4	4.6	1.4	0.2	7.2
CD180	"LY64, Ly78, RP105"	ENSG00000134061	"CD180 molecule"	Q99467	5	67179613-67196799	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 53.6;Hofbauer cells: 78.6;Kupffer cells: 23.5;Macrophages: 17.5;monocytes: 13.8;Plasma cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 77.0;naive B-cell: 78.9"	"Group enriched"	"Detected in many"	25	"B-cells: 78.9;dendritic cells: 23.5;monocytes: 34.5"	"Group enriched"	"Detected in some"	10	"Daudi: 45.2;Karpas-707: 41.1;U-266/70: 33.1;U-266/84: 49.0;U-698: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003740	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle"		Yes	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nucleoli, Mitotic spindle"	"HPA003740: AB_1078450"	"unprognostic (9.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.85e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	1.6	0.7	0.7	9.7	0.7	2.4	6.7	0.6	1.2	0.5	0.4	2.1	2.0	0.5	0.2	0.4	0.4	1.6	0.4	0.8	0.7	0.3	2.5	1.6	23.2	1.5	1.5	0.2	0.3	0.2	0.1	3.2	2.0	0.5	2.7	0.3	1.1	0.4	0.1	0.2	3.9	1.8	1.0	12.9	2.2	0.4	1.8	2.5	0.3	0.2	23.3	3.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.2	33.1	49.0	12.3	0.0	2.7	0.0	0.3	11.8	0.9	0.0	20.4	0.0	77.0	0.1	0.1	22.1	78.9	0.0	0.0	0.9	1.8	34.5	23.5	0.1	8.5	0.7	0.7	0.6	1.2	0.8	0.7	1.5	1.5	2.0	1.0	1.8	2.1	0.1	0.0	0.5	0.3	53.6	0.4	0.1	0.0	0.0	0.1	1.8	1.1	0.7	1.5	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	2.2	0.1	0.0	0.6	0.0	1.7	0.0	0.2	0.3	0.4	0.0	0.1	2.5	0.0	0.0	0.3	78.6	0.0	0.0	0.0	0.0	23.5	8.0	1.0	0.0	17.5	0.0	1.9	13.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	39.6	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.7	2.2	0.0	0.1	0.1
CD1C	CD1	ENSG00000158481	"CD1c molecule"	P29017	1	158289923-158294774	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 130.4"	"Cell type enriched"	"Detected in some"	6	"Langerhans cells: 551.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 84.1;myeloid DC: 324.9"	"Group enriched"	"Detected in many"	8	"B-cells: 84.1;dendritic cells: 324.9"	"Group enriched"	"Detected in some"	10	"JURKAT: 14.8;MOLT-4: 49.4"									HPA068359			Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA		200000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"	"Endoplasmic reticulum"	"HPA068359: "	"unprognostic (2.55e-3)"	"prognostic favorable (1.79e-5)"	"unprognostic (1.75e-5)"	"unprognostic (3.09e-5)"	"unprognostic (3.12e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.80e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.99e-1)"	2.7	0.8	0.0	17.3	0.0	1.1	5.0	0.0	0.2	2.3	0.0	3.4	2.0	2.4	0.6	4.5	1.8	7.7	2.0	0.0	0.0	1.2	4.1	6.5	26.2	0.0	0.0	0.9	0.7	0.6	0.2	0.1	0.0	1.8	9.4	0.0	2.8	1.3	1.0	12.2	12.0	3.1	0.0	23.0	3.7	0.9	0.0	130.4	0.7	1.1	38.2	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	49.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	0.6	26.8	0.1	0.1	24.7	0.3	84.1	0.1	0.0	324.9	49.1	0.2	0.0	1.1	4.1	3.7	1.5	0.5	15.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.2	0.0	26.6	13.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.1	0.0	0.1	1.5	0.0	0.8	0.0	0.0	0.1	1.4	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	7.1	551.4	4.5	0.0	91.2	19.6	0.0	11.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.5	0.0	0.0	0.2	0.4	0.1	0.3	0.0	7.4	0.0	1.9	0.0	0.0	0.0
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 249.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2"	"Group enriched"	"Detected in all"	10	"NK-cells: 1108.0;T-cells: 714.1"	"Group enriched"	"Detected in some"	25	"HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	4.6	4.6	0.6	51.3	0.7	11.4	7.6	0.6	1.0	5.8	0.8	13.9	17.2	3.7	2.8	8.4	4.2	16.8	2.6	0.5	0.8	2.5	7.8	21.0	119.6	1.7	0.7	2.8	2.9	0.9	0.7	1.0	1.1	5.2	16.0	0.0	8.6	2.3	1.4	3.5	28.4	4.4	1.0	44.1	24.1	1.8	1.0	249.8	3.8	1.7	79.1	20.8	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.1	0.0	0.4	0.0	0.0	0.0	0.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.1	0.5	0.0	0.0	166.9	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.4	0.0	11.3	5.2	1.6	421.8	3.7	403.1	3.8	610.2	714.1	95.4	2.5	316.3	486.2	14.1	1108.0	2.8	21.0	655.2	565.1	0.6	0.7	0.6	1.0	0.5	0.8	1.7	0.7	1.1	1.0	1.0	1.1	5.0	3.2	17.5	0.0	12.3	5.0	0.4	0.0	2.2	0.0	4.0	4.7	2.1	0.0	2.5	3.7	0.0	0.1	158.3	0.2	0.0	0.5	23.5	1.1	1.0	2.9	3.0	24.0	0.0	0.0	0.0	2.5	10.7	0.9	5.1	0.0	8.2	1.5	0.6	0.0	0.0	0.0	0.0	10.9	16.6	7.8	0.6	19.1	1.8	1.0	15.5	0.0	178.2	0.0	0.0	0.0	0.0	0.4	42.3	0.1	0.0	1.7	0.0	0.0	0.0	2.9	4.1	0.3	0.2	0.4	3.7	0.0	476.8	0.0	0.5	0.2
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 20.2;parathyroid gland: 62.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.6"	"Group enriched"	"Detected in some"	6	"HEL: 100.0;HMC-1: 42.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		20000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.1	0.6	1.1	5.7	6.4	4.4	1.5	1.5	2.4	1.1	0.0	1.8	2.3	1.3	0.5	1.6	1.3	3.0	0.5	0.7	2.0	1.5	4.2	4.2	9.7	3.1	3.3	0.9	0.5	62.4	0.6	0.5	3.2	1.0	2.4	1.4	1.5	0.4	0.7	0.3	3.1	1.6	2.2	20.2	3.2	1.2	5.5	6.4	0.7	0.6	7.1	3.1	0.4	3.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.4	0.2	5.3	0.1	100.0	0.3	0.1	0.0	0.7	42.6	0.0	1.1	0.2	0.6	0.2	0.0	0.9	0.3	9.3	0.4	0.0	0.8	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.8	0.3	0.1	0.2	11.5	0.4	0.0	0.3	0.2	0.5	0.3	0.1	1.2	36.6	1.0	13.4	0.8	28.8	22.5	2.9	0.1	15.8	17.3	1.6	29.7	1.3	0.1	11.3	13.2	1.1	6.4	1.5	2.4	0.7	2.0	3.1	3.3	3.2	2.2	5.5	3.2	0.6	3.2	3.6	3.3	3.2	0.0	0.3	0.0	0.0	3.4	0.5	0.8	2.5	0.0	0.7	0.0	0.0	0.1	52.1	0.2	0.0	0.0	8.4	0.9	1.7	1.0	0.0	3.2	4.6	0.4	0.0	1.3	3.1	0.5	13.9	1.3	3.3	0.4	1.6	0.0	3.1	0.1	0.0	16.7	2.7	8.2	0.9	24.4	0.0	22.5	14.7	0.8	90.6	2.0	26.6	0.2	0.1	0.7	13.4	0.3	0.0	0.3	1.5	3.6	0.0	1.8	0.6	0.4	0.8	0.0	0.4	0.0	43.2	0.5	0.1	0.2
CD27	"S152, TNFRSF7, Tp55"	ENSG00000139193	"CD27 molecule"	P26842	12	6444955-6451718	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 147.8"	"Group enriched"	"Detected in many"	11	"B-cells: 119.4;Melanocytes: 97.8;Plasma cells: 352.1;T-cells: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in all"		"T-reg: 640.4"	"Group enriched"	"Detected in all"	7	"B-cells: 293.4;T-cells: 640.4"	"Group enriched"	"Detected in some"	107	"Daudi: 238.2;U-698: 141.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002420, HPA038936"	Enhanced					NA	NA		100000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB002420: AB_563539, HPA038936: AB_2676278"	"unprognostic (2.75e-3)"	"prognostic favorable (3.77e-5)"	"unprognostic (8.87e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.65e-7)"	"unprognostic (3.56e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.50e-4)"	"unprognostic (1.31e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.35e-2)"	2.1	2.6	0.3	59.0	0.5	10.6	4.3	0.0	0.5	2.4	0.1	18.0	22.5	1.7	1.0	10.2	1.9	11.0	3.9	0.1	0.1	1.3	2.0	8.2	147.8	0.5	0.2	3.0	1.4	0.0	0.3	0.4	0.8	2.5	11.6	0.4	12.3	1.4	0.6	1.9	34.5	1.6	0.2	73.8	16.6	0.9	0.4	44.7	6.5	0.7	106.3	19.0	1.4	1.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	238.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.8	0.0	0.0	1.7	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.5	0.1	0.0	0.0	0.0	141.7	0.3	0.1	0.0	6.2	1.6	1.4	117.2	1.3	201.2	293.4	283.5	262.6	1.0	114.8	382.8	281.1	6.2	65.0	1.6	2.4	640.4	182.4	0.3	0.5	0.0	0.5	0.1	0.1	0.5	0.2	0.8	0.2	0.4	1.0	1.1	0.0	4.9	0.3	119.4	2.3	0.1	0.0	0.6	1.1	1.1	1.3	0.1	0.0	0.6	0.0	0.0	0.1	7.0	0.3	0.0	0.2	0.0	0.2	0.3	0.9	1.2	8.4	0.2	0.0	0.0	1.5	3.1	0.3	1.3	0.0	2.5	1.5	0.3	0.0	0.3	0.1	0.0	3.2	4.4	0.3	0.3	3.0	97.8	0.0	5.7	0.4	14.4	1.0	1.0	0.0	0.1	0.4	352.1	0.2	0.0	0.9	0.8	1.4	0.0	0.7	1.3	0.1	0.1	0.6	3.1	0.3	109.5	0.0	2.4	0.0
CD276	"B7-H3, B7H3, B7RP-2"	ENSG00000103855	"CD276 molecule"	Q5ZPR3	15	73683966-73714514	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 215.6;Hofbauer cells: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 175.0;U-2197: 231.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009285, HPA017139, CAB017826"	Enhanced		Approved	Vesicles		NA	NA		16000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246"	"unprognostic (1.05e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.57e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.50e-3)"	"prognostic unfavorable (9.81e-4)"	"unprognostic (2.57e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (1.17e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.34e-3)"	24.1	19.1	6.6	12.9	4.3	0.7	15.3	0.4	6.5	22.2	15.6	11.4	11.0	20.2	4.3	5.8	10.0	18.2	14.8	4.2	5.7	5.4	11.8	11.6	3.6	5.9	6.7	13.4	15.3	4.3	6.1	26.2	4.1	16.7	4.2	4.6	15.0	9.6	5.0	16.2	8.4	10.8	2.4	9.0	10.9	6.0	7.5	1.6	8.5	2.2	1.6	14.6	13.0	6.7	43.7	44.6	32.5	82.8	57.7	35.0	102.8	47.5	42.0	33.4	30.4	85.3	90.1	0.6	77.7	39.5	64.1	175.0	31.7	39.9	4.4	30.6	76.3	2.8	47.6	47.1	20.9	0.7	51.8	32.7	17.9	28.3	15.4	19.7	38.7	0.0	15.0	0.8	6.2	66.0	0.3	2.3	84.9	8.6	35.9	0.5	47.9	7.0	27.9	53.8	24.9	59.5	40.1	21.2	88.0	23.0	38.1	26.4	49.8	68.6	60.0	231.6	52.5	0.9	0.8	0.8	114.8	3.4	49.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	6.6	4.3	0.4	6.5	4.2	5.7	5.9	6.7	4.1	2.4	7.5	6.7	4.4	19.2	8.1	6.5	1.2	15.0	11.5	12.5	8.0	20.2	14.1	11.8	9.1	2.8	17.0	11.0	31.3	11.6	0.2	6.7	1.9	48.6	0.9	14.4	26.7	22.0	9.0	0.0	18.4	19.0	215.6	43.7	14.3	31.6	14.7	41.4	4.6	14.6	82.5	10.1	12.9	13.1	4.1	8.8	30.8	2.2	9.9	14.7	24.9	7.5	4.2	8.4	0.0	5.5	1.7	24.7	15.1	17.3	1.7	12.1	3.1	2.7	5.8	27.5	13.1	7.0	32.1	1.8	4.9	3.4	10.2	12.3	1.4	8.4	10.6	8.4
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 30.8;placenta: 14.8"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 34.1;T-cells: 52.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 101.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 101.9"	"Group enriched"	"Detected in some"	14	"Karpas-707: 360.6;RPMI-8226: 173.2;U-266/70: 294.1;U-266/84: 283.7"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"Not detected"	"Not detected"			HPA070003	Enhanced					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA070003: AB_2686226"	"unprognostic (5.54e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.07e-5)"	"unprognostic (9.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.78e-5)"	"unprognostic (4.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-2)"	4.0	0.3	0.0	14.9	0.1	3.3	0.8	0.1	0.1	1.1	0.9	1.7	1.1	0.7	0.3	0.9	0.5	4.1	0.6	0.1	0.1	0.5	1.3	1.9	28.0	0.1	0.0	0.3	0.5	0.2	0.1	14.8	0.1	1.0	1.9	0.1	0.6	0.8	0.3	0.3	3.0	1.4	0.1	7.2	2.5	0.7	0.2	30.8	0.5	0.1	18.6	4.6	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.7	2.0	0.0	360.6	0.2	0.0	19.9	0.0	0.1	0.0	0.0	0.1	0.3	173.2	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.3	294.1	283.7	2.9	0.3	0.1	0.0	1.7	0.6	1.0	8.3	0.5	50.6	0.3	54.5	26.1	0.1	0.3	48.1	18.6	13.8	0.2	0.5	0.2	101.9	14.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.5	0.0	1.3	0.0	2.4	2.9	0.1	0.0	0.6	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.2	3.2	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	1.0	2.0	0.1	1.3	0.0	0.0	0.1	34.1	0.0	0.0	0.0	0.0	0.8	5.3	0.2	0.0	4.4	0.0	1.0	1.5	0.0	2.1	0.0	0.1	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.2	1.6	0.1	52.6	0.0	0.0	0.0
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466399-74484794	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 95.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 103.5;granulocytes: 59.5;Hofbauer cells: 114.0;Kupffer cells: 97.6;Macrophages: 90.9;NK-cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 104.4;NB-4: 45.9;RPMI-8226: 88.7"									"HPA010971, HPA011645"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010971: , HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	10.6	7.5	6.7	31.1	7.1	24.4	4.6	7.1	31.1	2.8	7.5	9.2	11.3	3.5	1.8	3.5	3.1	14.2	4.7	6.9	7.8	3.5	14.6	18.1	27.0	11.4	8.6	1.5	3.2	1.4	3.6	13.9	13.2	4.0	8.6	1.0	4.0	2.5	1.6	4.5	13.5	11.7	9.2	95.2	4.9	1.2	12.1	14.1	2.3	2.7	11.7	9.5	2.6	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	5.5	104.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.5	45.9	0.0	0.0	0.0	0.2	0.0	88.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	17.1	0.0	845.6	170.3	481.9	226.4	374.2	48.3	18.9	45.5	67.5	159.2	6.4	16.7	52.5	560.5	456.5	387.6	149.7	3.1	197.0	6.7	7.1	7.1	31.1	6.9	7.8	11.4	8.6	13.2	9.2	12.1	12.5	1.0	0.0	7.4	0.3	7.8	0.9	0.1	0.2	0.0	0.0	0.6	1.8	0.6	1.5	0.7	0.0	0.0	0.7	103.5	0.1	0.0	0.1	0.0	0.6	0.2	2.5	0.0	5.7	0.1	0.0	1.2	0.8	0.5	0.7	59.5	0.0	2.2	1.3	114.0	0.0	0.3	0.2	0.0	97.6	24.0	0.4	0.0	90.9	3.6	5.6	36.6	0.0	225.6	1.0	0.0	0.0	0.1	0.0	14.5	0.1	0.0	0.4	0.6	0.1	6.6	0.6	0.5	0.0	0.4	0.2	0.6	1.5	33.2	0.0	0.2	0.2
CD300LB	"CLM7, TREM5"	ENSG00000178789	"CD300 molecule like family member b"	A8K4G0	17	74521174-74531475	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 7.8;brain: 16.3;lymphoid tissue: 8.2"	"Group enriched"	"Detected in some"	4	"dendritic cells: 7.1;Hofbauer cells: 6.2;Kupffer cells: 8.7;Langerhans cells: 6.5;Macrophages: 16.6;monocytes: 13.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	5	"cerebral cortex: 16.3"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 75.9"	"Group enriched"	"Detected in many"	53	"dendritic cells: 25.0;granulocytes: 75.9;monocytes: 31.7"	"Group enriched"	"Detected in some"	6	"HL-60: 1.7;NB-4: 2.4;THP-1: 1.9;U-937: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060449			Approved	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA060449: "	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.49e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.01e-2)"	1.7	0.4	0.1	8.2	0.2	7.8	0.7	0.1	16.3	0.4	0.6	0.7	0.7	0.3	0.0	0.3	0.3	2.1	0.2	0.1	0.2	0.2	0.8	1.7	0.8	0.3	0.3	0.1	0.9	0.1	0.2	0.9	3.1	0.4	0.9	0.0	0.3	0.1	0.3	0.1	1.6	1.8	0.2	3.7	0.6	0.3	1.3	0.6	0.2	0.1	0.9	2.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	1.1	0.0	1.5	31.7	75.9	0.1	13.6	0.3	0.0	0.0	0.0	25.0	0.0	0.0	0.2	33.3	0.8	1.9	15.6	0.0	11.8	0.1	0.2	0.1	16.3	0.1	0.2	0.3	0.3	3.1	0.2	1.3	0.4	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.6	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.4	0.2	6.2	0.0	0.0	0.0	0.0	8.7	6.5	0.2	0.0	16.6	0.0	0.0	13.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"	16.6	7.0	7.5	100.2	7.4	155.2	6.5	9.4	13.7	4.2	5.9	13.9	8.2	3.7	0.7	7.3	5.8	13.9	5.2	6.3	11.4	7.6	6.4	46.9	215.0	17.0	12.0	1.7	3.2	1.8	3.4	15.1	16.5	6.9	3.8	0.3	11.5	2.8	1.9	4.1	116.3	3.9	16.7	235.7	14.8	7.4	15.6	57.5	8.3	2.4	88.0	19.1	5.2	28.7	0.2	0.6	1.5	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	306.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	49.5	0.2	53.1	0.0	0.5	0.0	9.4	290.0	0.0	0.0	0.0	0.0	0.2	0.0	18.5	2.6	16.3	0.0	0.0	0.4	5.8	0.2	0.0	0.0	2.9	0.3	110.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	109.0	0.8	0.3	1.0	0.2	0.0	0.3	0.1	69.4	0.2	81.4	0.1	550.2	658.2	829.6	353.2	601.6	357.4	1511.6	426.3	376.2	449.7	1722.2	435.3	368.6	903.8	321.8	747.8	586.3	467.1	816.2	7.5	7.4	9.4	13.7	6.3	11.4	17.0	12.0	16.5	16.7	15.6	28.7	7.1	9.6	14.3	0.3	1643.9	11.7	1.3	0.1	4.6	12.1	4.6	12.1	1.6	2.8	2.5	1.8	6.2	1.9	489.6	2.2	0.0	0.5	94.2	1.2	1.9	9.7	1.2	67.7	0.1	0.0	2.3	6.9	11.7	1.5	264.6	0.3	11.4	4.1	345.3	0.0	0.2	1.7	0.0	272.0	358.4	221.3	2.8	319.7	28.4	21.5	365.0	1.1	394.4	0.0	0.1	0.0	8.0	0.7	119.8	1.1	0.6	2.9	0.9	6.3	0.0	3.2	5.7	1.1	1.3	2.6	11.8	2.9	390.3	0.9	1.9	1.1
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 139.6;T-cells: 294.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	21	"gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.7"	"Group enriched"	"Detected in some"	52	"JURKAT: 70.9;MOLT-4: 193.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	0.7	0.8	0.6	10.5	0.8	1.3	1.0	1.1	0.8	0.7	1.1	2.3	3.3	0.5	0.6	1.4	0.9	2.5	0.5	0.5	0.4	0.6	1.6	2.8	27.9	0.9	0.6	0.4	0.5	0.2	0.0	0.3	0.8	0.9	2.7	0.4	1.6	0.3	10.5	0.9	4.6	0.6	0.3	11.5	4.1	0.4	0.8	94.7	0.6	0.3	20.4	3.0	0.4	1.9	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	70.9	2.5	0.3	0.0	0.6	193.8	1.3	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.7	0.3	0.2	0.2	0.1	9.2	1.2	1.2	229.0	0.6	135.6	0.8	187.3	197.3	0.6	0.9	192.6	241.7	6.4	1.4	1.2	1.5	200.0	90.4	0.6	0.8	1.1	0.8	0.5	0.4	0.9	0.6	0.8	0.3	0.8	1.9	3.2	3.2	6.9	0.0	7.8	2.3	0.1	0.0	1.8	0.2	2.0	2.9	0.8	1.5	1.9	0.0	0.0	0.1	139.6	0.4	0.0	0.3	1.0	0.4	0.4	1.4	0.0	3.4	0.1	0.0	0.0	2.3	13.7	0.4	6.3	0.0	4.2	1.7	0.1	0.0	0.1	0.2	0.0	3.8	5.8	1.4	0.0	7.7	5.4	1.0	8.1	0.0	14.4	0.0	0.3	0.0	0.1	0.0	18.5	0.0	0.0	0.6	0.7	0.8	0.0	1.3	1.6	0.2	0.4	0.6	2.4	0.3	294.0	0.1	0.3	0.0
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609979-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 65.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 95.6;dendritic cells: 18.3;Hofbauer cells: 18.7;Kupffer cells: 25.6;Macrophages: 21.1;NK-cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"memory B-cell: 232.9;naive B-cell: 413.5"	"Lineage enriched"	"Detected in all"	20	"B-cells: 413.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.4;Karpas-707: 14.5;REH: 7.8;U-698: 44.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 4.1"	"Low region specificity"	"Detected in single"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	4.5	2.3	1.9	20.6	2.0	6.7	1.7	2.0	3.3	1.4	4.2	1.9	1.3	1.0	4.8	0.6	1.2	4.1	0.7	1.8	1.8	2.2	6.0	2.8	65.0	2.8	1.8	0.8	2.2	1.1	2.5	3.3	2.4	1.5	1.3	0.4	1.6	0.7	0.6	2.0	8.4	1.6	1.9	53.6	2.6	0.8	3.3	6.9	2.4	0.0	50.2	4.2	0.9	2.3	0.1	0.0	0.6	0.5	0.9	5.2	0.1	0.3	0.1	0.4	0.7	0.0	0.2	21.4	0.1	0.3	0.1	0.0	0.0	0.1	0.5	1.8	0.4	0.6	0.2	0.0	0.5	0.3	4.1	1.5	0.0	0.2	0.4	0.9	0.0	4.9	0.0	14.5	1.1	0.0	0.3	2.7	0.2	0.0	0.1	7.8	0.0	5.5	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.3	0.2	0.2	0.1	0.7	0.2	0.2	0.0	0.3	0.3	44.4	0.8	0.5	0.0	0.6	2.0	0.3	3.1	3.5	4.3	232.9	1.5	2.2	20.2	413.5	0.7	2.4	1.4	10.6	0.5	11.0	1.7	14.8	1.9	2.0	2.0	3.3	1.8	1.8	2.8	1.8	2.4	1.9	3.3	2.3	0.7	0.0	0.6	5.9	95.6	1.0	0.5	0.9	0.6	0.0	1.3	1.3	1.1	1.5	0.4	3.7	0.0	0.2	18.3	0.7	0.0	0.8	0.2	0.4	0.6	0.9	1.8	2.7	1.0	0.7	0.3	0.9	1.1	0.4	0.0	0.8	0.7	0.2	18.7	0.0	1.2	0.2	0.0	25.6	14.6	0.3	0.9	21.1	0.0	0.0	3.0	0.6	19.6	2.0	4.4	1.1	0.0	0.4	2.7	0.5	0.6	0.7	1.3	0.7	0.0	0.5	0.9	1.1	1.7	0.2	1.1	0.3	5.9	0.5	0.4	0.4
CD79A	"IGA, MB-1"	ENSG00000105369	"CD79a molecule"	P11912	19	41877279-41881372	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 152.3;lymphoid tissue: 545.2"	"Group enriched"	"Detected in some"	5	"B-cells: 1186.4;Plasma cells: 956.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	38	"memory B-cell: 1273.8;naive B-cell: 1457.5"	"Lineage enriched"	"Detected in all"	40	"B-cells: 1457.5"	"Group enriched"	"Detected in some"	22	"Daudi: 1598.7;REH: 491.0;U-698: 1366.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000019, HPA056444"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB000019: AB_2244527, HPA056444: "	"prognostic favorable (8.45e-5)"	"unprognostic (1.63e-3)"	"unprognostic (4.13e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.23e-2)"	"unprognostic (8.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (6.08e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	4.8	4.9	0.2	213.4	0.2	47.2	9.5	0.2	0.4	3.6	0.1	47.3	37.9	2.4	1.4	9.9	1.8	13.0	2.9	0.1	0.1	3.4	2.6	8.9	482.4	0.3	0.2	3.7	0.6	0.1	0.3	1.2	0.2	4.3	28.9	0.0	28.5	2.2	0.7	0.4	152.3	2.2	0.6	286.5	76.9	2.4	0.2	93.7	8.1	0.4	545.2	32.3	1.9	0.3	1.1	0.8	0.3	0.1	0.2	0.7	0.2	0.2	0.0	0.3	0.0	0.0	0.1	1598.7	1.2	0.0	0.1	0.0	0.2	0.2	0.0	0.5	0.7	2.7	0.0	1.7	0.2	2.6	1.8	0.5	0.6	0.2	0.0	0.0	0.0	8.0	3.1	0.4	0.1	1.1	1.6	9.9	0.1	0.1	0.4	491.0	0.8	2.5	0.1	0.0	0.5	0.5	0.8	0.5	1.3	0.0	0.0	4.8	1.6	0.1	4.3	0.3	0.8	7.8	1.4	1366.7	0.0	52.1	0.1	12.4	1.5	6.9	1.7	1.8	0.7	1273.8	4.1	2.1	2.5	1457.5	4.9	26.3	4.6	2.6	4.3	36.3	10.4	62.7	0.2	0.2	0.2	0.4	0.1	0.1	0.3	0.2	0.2	0.6	0.2	0.3	0.2	0.0	2.4	0.0	1186.4	1.8	0.5	0.5	0.6	0.0	0.7	0.9	0.2	1.5	0.2	0.0	0.0	0.2	18.2	0.7	0.0	1.8	0.2	0.1	0.3	0.5	0.0	10.5	0.0	25.6	0.4	2.2	6.6	0.2	0.0	0.4	2.2	1.0	0.8	0.0	0.0	0.4	0.0	4.1	1.4	0.0	0.3	5.3	138.7	0.0	6.3	0.0	15.5	0.0	0.0	181.7	0.4	0.4	956.7	0.3	0.2	0.9	0.0	0.0	0.0	0.2	0.7	0.3	0.6	0.9	1.4	0.1	23.5	0.2	5.3	0.2
CD86	"B7-2, B7.2, CD28LG2"	ENSG00000114013	"CD86 molecule"	P42081	3	122055362-122121139	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 121.3;Kupffer cells: 107.8;Langerhans cells: 148.3;Macrophages: 151.8;Microglial cells: 78.7;monocytes: 489.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 79.9;intermediate monocyte: 79.0;memory B-cell: 41.0;myeloid DC: 78.8;naive B-cell: 28.5;non-classical monocyte: 85.2"	"Group enriched"	"Detected in many"	18	"B-cells: 41.0;dendritic cells: 78.8;monocytes: 85.2"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 296.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004319, HPA026802"	Approved		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		160000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	"Centriolar satellite"	"CAB004319: AB_627200, HPA026802: "	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (9.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.67e-2)"	7.8	5.3	3.5	34.5	3.4	10.3	4.4	4.0	3.6	3.5	4.8	6.3	3.7	2.4	1.0	4.0	2.1	14.3	2.7	3.2	6.1	1.9	11.2	18.6	28.8	7.2	5.5	2.1	2.6	2.9	1.1	15.0	7.0	2.4	7.7	0.9	2.3	2.5	0.8	2.0	6.8	7.4	5.3	23.4	5.2	3.1	5.0	10.6	1.3	0.8	22.0	14.9	1.0	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	296.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.2	0.0	32.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.4	0.0	0.1	0.0	0.1	15.1	0.6	35.1	0.0	0.9	0.0	0.1	79.9	0.8	0.0	79.0	0.0	41.0	0.2	0.3	78.8	28.5	0.2	0.1	0.9	3.7	85.2	8.3	1.6	33.4	3.5	3.4	4.0	3.6	3.2	6.1	7.2	5.5	7.0	5.3	5.0	10.2	0.9	0.0	7.7	0.3	36.5	3.6	0.1	1.3	0.0	0.0	0.4	1.3	0.3	1.5	3.2	1.8	0.0	1.8	3.3	0.0	0.0	0.2	3.7	0.1	0.0	2.6	0.0	1.3	0.2	3.5	0.8	0.8	0.5	0.0	2.5	0.1	1.8	0.8	121.3	0.0	0.3	0.0	0.0	107.8	148.3	2.7	0.0	151.8	7.2	78.7	489.4	0.0	0.0	0.5	0.1	0.3	0.0	0.0	20.6	0.3	0.0	0.1	0.1	0.4	0.0	0.3	0.7	0.2	0.3	0.2	4.0	1.9	2.1	0.1	0.0	0.3
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2822.0;Ionocytes: 4461.6;Urothelial cells: 2594.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"basophil: 1957.3;eosinophil: 1156.4"	"Lineage enriched"	"Detected in all"	32	"granulocytes: 1957.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1521.6;RT4: 1126.8;TIME: 2266.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.26e-2)"	204.4	287.8	116.9	96.5	162.9	17.3	298.9	139.8	193.3	399.5	157.3	496.9	127.2	242.4	270.9	1000.2	242.3	102.4	267.5	124.3	132.3	294.2	79.4	403.0	37.4	165.8	141.0	69.0	93.4	881.8	98.1	85.4	160.2	488.5	466.2	32.6	614.5	456.4	74.4	455.3	211.2	197.0	139.2	69.5	178.2	26.4	146.5	66.1	338.0	116.6	289.4	373.1	566.4	207.1	417.6	173.7	3.5	108.7	167.7	170.8	150.1	241.1	477.8	80.8	121.9	128.5	1521.6	1.4	59.2	51.4	239.0	885.6	92.7	475.5	62.7	21.5	63.1	2.0	117.1	26.6	71.3	1.1	497.0	0.6	347.0	147.3	126.0	225.3	976.3	28.9	19.3	1.7	51.5	578.6	1.8	45.4	136.0	504.3	175.7	4.1	290.1	529.7	802.1	1126.8	0.5	34.0	240.9	195.8	215.8	789.0	91.1	42.1	2266.0	8.6	214.6	8.8	29.5	1.7	1.3	63.2	137.2	1.0	221.7	1957.3	61.1	1156.4	1.3	23.6	2.2	5.5	1.4	1.6	10.2	20.5	4.2	11.5	30.9	2.6	0.6	3.7	0.4	71.7	116.9	162.9	139.8	193.3	124.3	132.3	165.8	141.0	160.2	139.2	146.5	207.1	250.0	794.9	403.1	35.6	27.8	1037.8	1864.4	2822.0	804.1	4.9	433.5	379.5	20.9	84.4	1403.7	1075.9	0.0	21.5	8.7	929.9	137.0	599.1	3.0	457.8	66.8	496.5	172.9	10.5	0.4	178.2	271.0	356.9	60.6	722.6	653.4	42.3	522.6	43.1	618.0	0.0	0.6	744.8	4461.6	35.2	685.3	13.1	32.0	253.4	940.9	11.2	151.7	375.1	2.1	56.3	169.5	352.9	896.4	70.7	59.3	1576.4	330.0	21.7	1409.8	14.7	664.0	322.6	397.5	7.3	74.1	1214.3	1279.8	54.0	77.8	838.5	761.1	2594.9
CDC14B	"Cdc14B1, Cdc14B2, CDC14B3, hCDC14B"	ENSG00000081377	"Cell division cycle 14B"	O60729	9	96490241-96619843	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.5;Excitatory neurons: 83.5;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 156.9;Oligodendrocytes: 273.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064747			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA064747: AB_2732719"	"unprognostic (5.69e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (2.97e-10)"	"unprognostic (2.01e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (7.40e-2)"	4.3	2.3	11.1	1.1	15.8	3.0	3.0	6.1	11.7	2.9	1.4	3.1	2.8	1.3	2.0	1.4	4.2	2.9	5.0	5.2	6.9	5.5	10.3	3.0	0.9	11.0	12.1	3.4	4.6	6.9	1.1	2.0	11.4	3.3	3.3	1.7	1.8	4.1	0.7	0.8	3.3	1.7	10.4	0.8	6.1	9.3	11.4	2.9	8.5	1.4	1.2	4.1	0.8	27.3	7.4	4.1	4.2	4.4	20.2	30.1	11.6	5.3	7.0	3.5	5.6	14.0	11.6	0.0	5.0	11.3	8.4	8.1	6.1	4.0	4.1	1.9	5.8	1.1	1.5	11.2	3.3	0.0	0.2	12.4	2.1	3.7	3.4	4.0	0.7	0.0	4.4	0.8	4.8	3.5	0.0	1.2	7.9	8.4	3.6	0.0	2.6	0.2	5.4	11.3	1.3	6.6	3.7	1.1	2.0	14.2	0.9	2.3	2.2	3.5	4.1	9.0	3.9	0.1	0.0	0.0	3.7	0.0	8.3	10.4	0.0	2.2	2.0	0.0	1.0	1.1	0.8	1.5	0.0	0.4	1.4	0.9	0.0	0.1	0.0	0.0	1.1	0.6	11.1	15.8	6.1	11.7	5.2	6.9	11.0	12.1	11.4	10.4	11.4	27.3	4.0	6.4	8.8	86.5	3.7	9.1	8.9	4.4	9.1	7.2	8.4	6.1	17.9	11.5	11.4	9.2	8.4	6.4	2.3	7.1	7.9	5.5	36.9	27.4	7.5	6.2	2.4	0.4	83.5	6.5	3.0	17.3	21.4	33.9	14.5	2.9	6.8	31.2	11.3	8.4	110.2	9.0	8.2	1.6	6.7	33.3	9.0	5.5	8.8	56.2	2.4	12.8	2.1	156.9	273.9	8.6	7.3	11.7	8.3	10.8	16.9	17.0	15.7	12.4	26.3	18.6	15.7	10.8	7.3	4.7	7.7	3.4	4.4	1.2	8.6	13.2
CDC23	"ANAPC8, APC8, CUT23"	ENSG00000094880	"Cell division cycle 23"	Q9UJX2	5	138187650-138213343	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039593	Approved				"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA039593: AB_10795146"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.26e-3)"	"unprognostic (3.46e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.68e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.46e-1)"	12.4	11.8	12.3	13.6	12.7	14.1	17.4	14.5	15.7	12.7	10.0	14.0	11.4	15.1	17.2	14.5	12.4	10.6	15.3	12.5	11.7	19.8	18.3	13.3	17.9	11.6	11.6	14.8	9.5	18.4	10.0	26.2	11.8	15.5	15.6	14.0	11.8	13.6	10.1	16.5	10.9	16.9	12.0	14.4	12.8	15.1	11.8	20.3	16.1	12.2	19.4	14.6	11.7	13.1	42.7	35.8	51.2	62.7	22.2	24.8	59.8	34.8	26.8	70.0	72.3	83.9	46.7	52.0	52.3	32.6	71.9	41.6	67.5	54.0	64.4	40.3	61.9	41.5	30.6	37.7	30.8	33.1	39.4	26.0	36.4	43.9	37.0	29.1	47.3	55.1	43.7	39.1	34.9	28.6	65.6	40.3	32.6	52.6	28.6	58.3	60.8	36.0	38.8	26.9	40.7	36.8	51.8	33.1	61.1	97.3	49.3	41.2	32.6	42.0	27.6	37.1	56.7	43.6	46.7	67.7	28.9	57.2	37.2	41.4	15.1	21.6	18.3	16.5	22.2	16.8	17.9	19.3	14.4	16.2	23.4	20.7	2.9	27.0	12.3	10.4	18.1	16.0	12.3	12.7	14.5	15.7	12.5	11.7	11.6	11.6	11.8	12.0	11.8	13.1	11.7	19.2	9.5	9.8	9.7	8.0	13.9	18.8	11.4	10.5	11.8	10.5	19.0	5.7	23.3	9.2	25.0	31.9	10.3	8.2	39.2	12.5	0.8	9.1	15.1	13.2	6.1	19.8	14.0	7.2	20.4	11.9	8.6	12.3	9.5	13.5	11.0	20.0	15.7	16.8	12.8	9.0	26.4	13.0	4.7	1.1	8.7	8.8	12.4	5.6	12.6	16.4	9.2	10.6	13.5	9.7	4.6	6.4	11.4	11.3	5.6	26.4	10.4	13.1	6.6	9.7	13.2	14.5	25.3	15.9	10.1	40.8	11.2	13.1	9.8	13.8
CDC42SE2	"FLJ21967, SPEC2"	ENSG00000158985	"CDC42 small effector 2"	Q9NRR3	5	131245493-131398447	"Predicted intracellular proteins"	"Cell shape, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-cells: 242.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038624	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA038624: AB_10670783"	"unprognostic (1.26e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (4.50e-5)"	"unprognostic (2.37e-3)"	"unprognostic (7.38e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.65e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (7.50e-4)"	16.5	10.6	30.7	53.6	32.5	78.7	22.8	26.8	42.3	22.1	20.2	46.6	39.2	18.7	21.0	13.2	16.6	27.4	11.2	35.5	27.8	31.3	21.7	24.7	81.2	28.5	29.6	18.9	27.3	23.9	12.3	15.2	27.7	20.4	48.4	7.1	16.5	16.0	12.9	16.8	45.5	17.2	30.0	57.8	32.0	30.9	28.2	48.6	36.7	11.0	66.4	29.3	9.8	37.0	31.6	33.8	22.4	33.4	22.4	11.5	42.2	23.0	14.8	15.4	15.9	37.4	86.7	49.5	50.5	16.4	25.9	22.1	17.6	43.4	22.4	88.2	11.1	39.9	13.9	24.0	27.9	48.2	51.5	15.2	81.2	21.0	46.7	15.9	23.3	56.5	27.2	67.1	26.5	20.4	84.1	51.8	18.2	21.6	10.1	43.5	38.1	63.2	67.6	51.3	23.8	18.1	32.1	20.4	29.6	31.9	24.4	55.9	29.3	21.3	18.4	12.8	28.9	42.1	66.4	62.4	19.1	54.0	18.9	233.4	42.8	134.4	111.5	44.7	131.1	74.9	131.4	137.7	64.1	51.5	131.6	148.6	114.7	113.4	44.6	54.6	117.9	181.4	30.7	32.5	26.8	42.3	35.5	27.8	28.5	29.6	27.7	30.0	28.2	37.0	38.0	32.1	20.6	44.1	166.8	54.2	38.5	45.6	21.6	9.2	30.6	22.4	14.4	52.9	30.0	104.8	8.4	35.4	211.5	148.6	99.7	50.9	29.2	73.7	27.2	33.7	85.6	37.5	84.3	51.0	106.0	18.3	33.6	104.1	54.5	30.6	35.0	35.5	37.9	6.7	78.8	65.7	40.7	111.9	192.3	21.9	14.0	77.6	46.2	72.1	119.9	21.7	134.9	51.8	149.2	66.3	60.6	17.3	113.1	54.4	79.3	148.0	27.3	7.5	0.0	17.7	22.1	58.7	57.7	11.8	45.5	24.8	242.7	15.7	67.2	60.8
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121983-193254815	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002326, CAB016359, HPA069324"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA002326: , HPA069324: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	11.3	9.5	5.8	7.3	6.9	8.9	10.7	6.1	7.3	11.1	4.5	10.2	5.6	10.3	8.5	8.4	7.2	5.9	9.6	4.6	8.1	10.4	9.2	7.9	7.5	6.9	7.2	11.5	6.4	12.9	5.6	9.4	7.9	15.1	9.0	10.1	7.7	9.7	12.2	7.0	7.7	10.3	7.9	8.6	7.0	5.9	6.5	10.6	13.1	5.6	7.9	9.7	8.5	8.3	9.3	2.4	16.6	11.5	18.3	18.9	4.9	6.7	16.1	19.5	16.4	6.5	12.3	10.5	5.2	20.4	8.8	10.7	16.8	14.9	24.7	6.1	4.1	7.3	8.1	7.2	16.1	16.0	11.6	13.7	16.0	14.9	17.7	20.6	17.8	11.1	8.1	14.2	28.8	3.5	13.9	9.2	11.9	21.9	2.5	10.6	7.0	15.0	26.6	8.2	3.9	12.3	8.6	26.8	22.3	21.0	18.3	14.0	9.2	19.3	2.2	16.4	12.6	12.2	7.2	7.6	11.9	10.2	30.1	2.2	0.5	0.7	0.8	1.0	1.2	0.9	1.1	0.6	0.6	0.5	1.4	1.2	0.3	1.3	0.8	1.0	0.9	0.4	5.8	6.9	6.1	7.3	4.6	8.1	6.9	7.2	7.9	7.9	6.5	8.3	44.5	35.3	25.4	54.5	44.9	37.2	35.6	38.4	36.5	30.4	24.4	21.8	44.5	25.8	27.2	33.1	35.5	25.0	48.0	18.2	33.2	37.5	19.7	24.6	39.6	38.0	11.4	40.8	71.9	32.2	42.0	39.1	28.1	30.8	41.1	17.6	25.4	17.2	31.6	21.9	76.4	15.8	34.6	27.4	49.1	8.5	33.5	38.3	28.4	54.4	46.0	35.2	41.2	78.4	112.3	35.5	16.9	36.1	50.3	34.9	19.2	36.3	20.6	36.7	26.3	49.0	48.3	55.6	33.0	36.8	34.9	38.0	44.4	30.3	18.6	27.9
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900899-21945903	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 51.0;Spermatogonia: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 101.0;naive B-cell: 124.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory bulb: 10.1"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	5.9	1.4	3.9	15.0	9.1	51.7	15.7	5.7	5.2	8.7	17.8	17.0	10.7	13.8	5.5	11.2	11.5	8.1	25.3	3.9	3.5	2.8	4.8	14.0	37.1	6.9	4.8	21.8	13.0	1.8	1.1	4.7	3.8	7.3	19.0	5.1	9.0	7.6	6.2	18.5	13.6	11.9	5.0	13.3	17.8	18.5	7.8	49.0	29.8	3.4	31.8	6.3	8.1	9.8	84.5	27.6	26.0	0.6	14.5	17.9	0.0	65.9	58.2	51.8	73.5	11.3	75.4	173.6	21.8	59.3	102.4	51.1	41.4	69.4	103.6	0.3	28.6	42.3	83.8	7.4	21.1	111.1	0.4	35.2	12.7	40.0	116.9	54.9	104.8	133.5	58.3	0.1	41.4	34.5	146.1	46.1	153.2	17.4	36.2	141.0	94.0	119.8	15.4	14.8	96.9	79.7	30.3	19.9	29.9	34.4	45.6	54.6	43.0	57.1	68.5	101.3	83.8	90.6	63.6	223.0	55.7	154.6	54.5	1.1	2.3	43.2	2.2	3.8	0.3	101.0	6.4	3.2	14.9	124.5	30.9	12.8	3.8	3.4	4.9	75.9	9.9	12.2	3.9	9.1	5.7	5.2	3.9	3.5	6.9	4.8	3.8	5.0	7.8	9.8	1.0	19.2	31.5	7.5	51.0	27.1	23.7	6.9	17.1	1.5	12.5	20.7	38.7	11.5	19.0	0.0	2.1	0.5	30.7	8.4	3.9	8.9	7.3	5.4	2.7	4.8	10.7	21.9	0.5	6.2	0.3	13.4	18.3	5.3	8.8	14.9	1.4	4.0	10.8	13.5	1.0	26.1	8.2	15.2	3.5	5.2	4.1	7.0	8.8	1.9	1.6	2.4	1.0	15.1	8.7	3.9	7.4	2.6	20.2	14.2	1.5	0.1	4.2	2.7	13.1	6.8	12.4	4.6	63.5	9.6	7.7	0.3	5.4	8.3	23.0	6.2
CDH11	"CAD11, OB"	ENSG00000140937	"Cadherin 11"	P55287	16	64943753-65126112	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 178.2;placenta: 122.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.0;Endometrial stromal cells: 125.0;Excitatory neurons: 122.2;Fibroblasts: 102.2;Microglial cells: 145.2;Oligodendrocyte precursor cells: 158.3;Oligodendrocytes: 106.3;Theca cells: 160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 246.5;BJ hTERT+: 139.3;fHDF/TERT166: 332.3;HSkMC: 217.4;PC-3: 291.2;U-2197: 194.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013072	Enhanced					NA	Yes		4800000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB013072: AB_2533068"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.93e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.75e-2)"	"prognostic unfavorable (2.48e-9)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.07e-3)"	15.1	8.6	12.4	25.7	27.9	0.3	10.7	10.8	15.8	57.7	13.8	11.4	7.0	52.8	9.5	7.4	12.5	58.6	10.2	19.2	21.4	10.2	1.8	45.6	17.5	17.1	24.1	178.2	3.4	2.6	10.4	122.2	17.3	20.0	12.2	14.0	12.7	24.3	2.6	10.9	8.9	54.3	21.1	89.3	11.8	8.0	19.3	3.7	8.1	3.1	13.0	47.6	13.6	21.4	0.2	0.0	51.4	0.1	35.7	77.5	0.3	246.5	139.3	61.0	34.5	4.6	0.2	0.0	0.0	332.3	0.0	0.1	0.1	1.7	43.4	0.0	2.1	0.0	1.4	0.0	29.7	0.0	14.4	217.4	0.1	74.7	14.9	0.0	17.4	0.0	0.0	0.0	33.1	0.3	0.1	0.3	19.2	37.4	291.2	0.8	38.0	0.0	0.0	0.0	0.8	36.0	0.1	0.3	0.2	64.5	0.3	0.1	0.0	124.4	17.2	194.0	70.1	0.0	0.0	0.1	21.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	27.9	10.8	15.8	19.2	21.4	17.1	24.1	17.3	21.1	19.3	21.4	11.4	3.2	0.0	93.0	0.1	3.8	1.0	7.9	0.0	19.9	1.0	7.4	3.1	1.5	3.3	0.0	0.0	2.6	0.2	0.1	0.0	0.1	2.7	3.9	125.0	17.8	0.0	2.7	122.2	0.0	2.3	102.2	0.5	2.7	0.0	60.0	68.9	0.0	4.7	0.0	67.6	0.6	0.0	0.6	6.9	4.2	52.5	0.9	5.4	145.2	0.0	41.9	0.0	158.3	106.3	0.8	0.0	77.5	0.0	1.6	0.0	1.4	0.4	2.1	26.3	12.8	38.0	1.7	1.1	0.5	3.1	5.6	1.1	160.2	0.3	0.5
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193686-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 14.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Excitatory neurons: 67.1;Oligodendrocyte precursor cells: 60.8;Pancreatic endocrine cells: 63.8;Proximal tubular cells: 171.1;Sertoli cells: 46.0;Smooth muscle cells: 69.5"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 477.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		9600000		"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	5.0	1.1	3.2	1.4	9.3	0.2	2.6	2.2	3.7	4.3	0.5	1.3	1.3	2.3	1.8	2.4	6.8	9.2	2.0	2.2	7.4	14.8	0.7	4.5	0.6	4.9	9.5	0.7	0.7	1.1	1.0	3.6	6.0	1.1	0.9	1.5	0.7	1.8	1.2	1.0	1.2	2.6	3.2	0.8	1.0	0.3	9.8	0.4	2.3	1.6	0.7	2.3	1.9	3.9	0.1	1.9	62.2	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.2	0.0	0.1	477.1	0.3	0.0	0.0	49.6	0.1	0.0	0.6	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	17.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	9.4	0.0	0.2	0.0	10.9	0.1	14.0	0.0	1.8	0.0	0.0	0.1	0.2	19.3	0.1	0.2	0.0	0.1	1.8	5.9	1.5	0.1	0.4	1.1	0.1	0.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	9.3	2.2	3.7	2.2	7.4	4.9	9.5	6.0	3.2	9.8	3.9	5.7	0.0	0.5	7.2	2.4	0.9	0.1	36.5	0.0	10.8	0.1	0.4	3.1	48.6	7.0	11.0	0.0	0.0	0.0	0.0	27.4	37.2	0.2	2.9	0.6	5.3	0.0	0.0	67.1	3.0	0.0	2.9	0.0	2.9	0.0	4.1	0.0	0.1	0.1	0.0	33.6	0.0	0.0	0.0	2.5	0.1	0.3	1.3	0.0	39.4	1.0	0.3	0.0	60.8	5.5	63.8	0.0	0.4	0.0	1.2	0.0	171.1	1.1	0.8	46.0	0.6	69.5	0.0	0.4	0.1	1.0	0.0	1.8	0.2	0.0	0.1
CDHR1	"CORD15, KIAA1775, PCDH21, RP65"	ENSG00000148600	"Cadherin related family member 1"	Q96JP9	10	84194537-84219621	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 313.8;skin 1: 214.0"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 379.5;Rod photoreceptor cells: 240.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"NK-cell: 7.5"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 7.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.2;HEK 293: 5.2;HEL: 6.3;K-562: 4.6;NTERA-2: 4.4;RPTEC TERT1: 16.3"	"Region enriched"	"Detected in many"	21	"olfactory bulb: 333.0"	"Low region specificity"	"Detected in all"			HPA036819	Enhanced				"Intracellular and membrane"	NA	NA		55000	"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA036819: AB_10671750"	"unprognostic (8.91e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.69e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.07e-2)"	0.2	1.9	7.4	1.0	18.3	0.4	4.5	2.3	8.7	5.3	46.2	29.2	0.1	0.6	4.4	10.7	0.5	0.4	1.2	6.6	7.5	0.4	0.5	0.2	0.9	13.4	2.3	1.1	0.1	0.0	3.0	0.2	13.9	1.4	53.2	313.8	1.5	4.2	1.0	214.0	12.2	1.2	0.1	7.0	0.2	0.3	3.2	3.3	0.2	0.0	1.1	0.1	3.5	3.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	10.2	2.0	0.0	0.0	5.2	6.3	0.0	0.0	0.2	0.0	0.2	0.0	2.2	0.0	0.7	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.5	4.4	0.0	0.0	0.0	0.0	1.4	16.3	0.0	3.4	0.8	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	7.4	18.3	2.3	8.7	6.6	7.5	13.4	2.3	13.9	0.1	3.2	3.5	0.0	0.0	0.5	1.3	0.1	51.2	0.3	1.4	3.4	24.1	0.0	0.1	1.8	0.0	0.7	0.0	379.5	0.0	2.1	47.9	0.0	0.1	0.0	2.7	0.7	1.8	12.7	0.0	4.9	0.0	0.0	0.6	0.0	3.1	0.0	3.7	0.4	0.4	0.0	5.0	7.7	46.9	0.0	0.3	5.2	0.2	0.0	0.1	3.6	1.0	0.0	26.3	1.0	7.5	4.4	0.0	31.2	0.0	0.7	0.3	23.0	0.2	0.1	240.4	0.0	0.2	0.3	0.6	0.3	3.0	67.5	0.0	3.0	0.3	52.9	0.2
CDHR4	"CDH29, VLLR9392"	ENSG00000187492	"Cadherin related family member 4"	A6H8M9	3	49790732-49799873	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"fallopian tube: 59.4"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 74.2;Respiratory ciliated cells: 160.4"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 6.8"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;HeLa: 1.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.2"	HPA076277	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA076277: AB_2732306"	"unprognostic (1.50e-4)"	"unprognostic (4.87e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.35e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-11)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.37e-1)"	0.5	0.1	0.6	0.1	0.6	0.2	0.2	0.4	0.3	5.5	1.0	0.5	0.1	1.7	0.4	0.1	59.4	0.1	0.2	0.6	0.7	0.2	0.1	7.4	0.0	2.7	6.1	0.2	0.0	0.0	0.1	0.1	3.4	0.3	0.1	0.0	0.2	0.2	0.2	1.3	0.1	0.2	1.2	0.0	0.1	7.5	0.8	0.0	0.2	0.0	0.0	0.2	0.3	1.0	0.1	0.5	0.1	0.0	0.1	1.3	0.1	0.1	0.0	0.2	0.3	0.0	0.8	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.7	0.0	0.6	0.4	0.0	1.9	2.0	0.2	0.1	0.7	0.1	0.2	0.1	0.1	0.7	0.4	0.1	0.1	1.0	0.5	0.1	0.2	0.1	3.9	0.6	0.6	0.4	0.3	0.6	0.7	2.7	6.1	3.4	1.2	0.8	1.0	0.2	0.0	3.4	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.1	0.1	0.4	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	74.2	0.9	0.5	0.0	0.0	0.1	0.2	0.1	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	20.3	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	160.4	0.0	0.0	0.2	1.7	4.8	0.8	0.0	0.0	0.0	0.2	0.1	0.2	0.1
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.2;lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.2;T-reg: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003387, CAB003799, CAB079974"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		51000	"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	3.8	1.8	0.9	17.0	1.0	53.2	7.4	0.9	1.5	5.2	0.9	17.6	16.3	7.1	12.2	17.5	3.7	4.3	1.4	0.9	1.0	3.1	3.2	4.7	40.6	1.2	1.2	2.3	0.8	2.5	4.1	19.4	1.1	1.7	20.8	1.3	3.2	5.2	1.4	13.2	14.5	8.0	0.9	9.0	10.1	25.1	1.4	74.0	3.6	2.2	47.5	7.1	6.9	1.0	249.9	93.5	241.1	96.0	15.4	23.6	99.0	183.8	132.7	218.8	209.0	218.9	213.7	226.2	69.6	50.6	79.6	149.9	166.2	106.8	225.8	162.3	121.1	119.4	84.4	128.1	2.8	184.5	117.6	4.7	10.4	142.1	137.0	49.6	133.3	146.2	185.1	270.3	246.9	66.3	234.0	131.1	106.6	149.3	193.1	199.7	224.5	111.3	84.3	81.4	112.7	98.7	123.5	184.9	96.3	130.0	199.9	111.5	55.4	92.8	197.9	99.1	255.8	104.9	180.8	205.6	79.9	203.5	117.6	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.7	1.3	0.3	0.4	0.2	0.7	0.0	3.2	0.1	0.9	3.4	0.9	0.9	1.0	0.9	1.5	0.9	1.0	1.2	1.2	1.1	0.9	1.4	1.0	7.7	0.0	3.2	0.3	7.1	39.8	5.4	29.9	2.8	1.1	5.3	6.1	0.8	0.0	10.2	18.4	0.0	80.9	3.6	8.9	3.9	0.8	18.7	10.8	6.2	10.5	3.0	209.6	0.4	0.0	144.6	13.3	13.3	9.4	0.0	51.5	7.5	1.3	57.2	0.0	0.2	14.6	30.5	20.5	18.1	10.4	2.1	16.5	1.8	1.9	1.0	1.0	3.1	0.0	0.1	0.4	0.7	0.7	32.1	4.3	2.2	3.0	17.6	0.7	0.0	0.5	24.6	110.0	39.6	33.8	18.6	22.0	10.3	2.1	26.6	10.4
CDKN1B	"KIP1, P27KIP1"	ENSG00000111276	"Cyclin dependent kinase inhibitor 1B"	P46527	12	12715058-12722369	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003691, CAB021888, HPA059086"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900"	"unprognostic (5.67e-2)"	"unprognostic (9.76e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.90e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	53.4	44.7	53.6	40.1	70.6	68.1	50.2	73.4	81.3	55.3	43.1	43.9	44.5	41.0	24.5	29.1	47.3	24.6	32.9	47.9	58.9	30.2	35.2	38.9	55.3	58.6	58.3	66.1	23.9	34.4	24.4	41.0	61.2	35.9	32.5	55.3	36.3	33.4	81.4	45.4	40.7	24.8	55.1	55.1	30.0	25.8	58.3	71.8	33.7	63.4	39.9	32.0	44.5	91.2	37.1	16.6	94.5	16.6	32.0	18.0	46.1	31.5	53.8	46.0	56.4	47.7	40.4	0.3	12.5	19.6	16.6	34.2	44.9	16.7	41.1	62.4	31.5	28.8	46.5	53.2	42.5	24.5	18.6	19.8	35.3	15.2	44.0	107.8	27.8	54.5	31.5	101.6	16.6	45.9	32.7	35.3	38.0	32.1	16.8	25.2	30.9	63.1	22.5	38.6	35.6	58.4	48.9	34.8	65.8	33.7	18.6	54.6	19.1	22.6	34.9	20.7	33.3	86.1	59.4	33.2	28.2	36.6	22.5	6.2	3.8	8.6	5.9	3.5	6.1	6.8	7.7	7.2	3.6	5.0	8.0	6.1	20.9	7.3	5.5	3.9	12.3	4.0	53.6	70.6	73.4	81.3	47.9	58.9	58.6	58.3	61.2	55.1	58.3	91.2	64.2	44.8	29.3	6.2	126.2	52.6	20.7	21.0	115.5	45.6	39.5	30.1	39.1	21.5	27.1	9.2	27.1	42.9	92.5	32.3	15.6	10.8	70.0	31.2	35.8	51.1	45.7	70.5	8.1	9.3	47.6	39.3	25.5	34.3	31.0	21.3	47.2	30.7	26.8	10.1	13.4	41.4	24.4	55.3	66.0	67.7	55.9	65.1	74.7	23.4	31.6	182.9	60.8	6.0	29.5	10.1	21.3	26.7	121.2	30.3	33.4	16.9	36.4	29.4	92.1	20.2	53.5	7.7	10.8	102.3	52.6	39.0	166.1	20.9	41.9	22.7
CDKN1C	"BWCR, BWS, KIP2, P57"	ENSG00000129757	"Cyclin dependent kinase inhibitor 1C"	P49918	11	2883213-2885775	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 206.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 155.1;non-classical monocyte: 376.4"	"Lineage enriched"	"Detected in many"	14	"monocytes: 376.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002924	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA002924: AB_1079548"	"unprognostic (5.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.79e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	127.4	182.9	8.2	3.3	38.0	1.7	92.5	43.3	18.7	73.7	6.5	48.1	1.4	70.6	0.2	29.9	70.7	0.8	82.6	11.7	18.8	149.5	8.3	34.5	0.2	55.1	33.5	206.4	28.5	0.2	27.8	28.1	45.0	33.1	0.2	0.5	21.7	1.5	60.3	26.6	25.0	0.4	31.8	20.6	54.1	8.6	34.3	0.2	17.0	0.9	0.4	75.0	49.4	95.3	0.1	0.1	1.6	0.0	0.4	0.5	1.8	0.3	0.6	0.3	0.0	3.3	0.4	0.0	12.0	0.2	0.1	0.5	0.3	0.3	0.1	5.6	1.2	0.1	12.8	0.0	3.3	0.0	1.4	2.4	1.6	0.0	0.2	0.1	0.3	0.1	2.7	0.8	0.5	0.1	0.0	6.0	10.6	0.5	4.0	2.2	0.0	18.7	0.7	0.0	3.5	33.0	25.2	0.3	15.2	0.9	0.2	2.8	0.4	0.0	2.2	0.0	0.1	7.3	0.0	0.1	0.0	1.8	6.8	9.1	1.2	0.9	0.4	155.1	1.8	0.0	0.4	0.6	26.9	0.3	1.0	0.3	2.2	0.0	376.4	0.2	0.7	14.7	8.2	38.0	43.3	18.7	11.7	18.8	55.1	33.5	45.0	31.8	34.3	95.3	357.3	3.2	5.8	1.0	11.6	10.7	81.7	4.9	30.7	11.9	81.0	150.5	45.3	61.5	10.8	31.3	6.2	575.3	46.9	20.3	15.6	9.8	176.5	38.8	101.5	100.8	106.5	0.8	0.6	0.6	1531.7	141.0	17.9	56.2	0.0	31.2	74.6	4.0	91.0	8.4	1.2	25.0	12.2	23.5	23.2	276.4	74.3	54.9	35.6	4.7	14.1	68.3	0.0	3.5	65.7	4.3	4.2	44.4	12.9	64.6	4.0	78.5	7.5	27.4	32.9	238.3	71.4	2.1	3.5	17.3	11.8	2241.2	25.1	781.8	15.2	71.8
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"CEA cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.5;lymphoid tissue: 10.2"	"Cell type enriched"	"Detected in some"	10	"Granulosa cells: 150.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8"									HPA043411	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.3	0.7	1.4	2.2	0.8	17.5	0.8	0.8	1.3	2.2	0.6	0.8	0.6	2.6	0.3	0.4	0.7	0.5	0.5	0.8	2.8	0.7	1.2	3.8	5.3	1.9	2.7	0.4	0.2	0.1	0.4	1.5	2.2	0.6	0.6	0.0	0.5	3.6	0.1	0.2	2.6	0.5	1.8	10.2	0.9	1.1	3.9	2.2	0.6	0.1	3.5	0.8	0.3	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.8	1.0	1.0	0.0	5.8	0.0	0.1	6.0	27.3	29.7	11.7	20.1	10.8	25.6	20.8	6.9	15.1	21.3	21.0	30.2	19.2	7.0	12.4	26.6	17.9	1.4	0.8	0.8	1.3	0.8	2.8	1.9	2.7	2.2	1.8	3.9	1.2	1.5	0.0	0.0	0.3	5.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.6	1.8	0.0	0.1	7.2	0.0	0.0	0.0	5.4	7.3	0.1	2.0	0.0	5.7	0.1	0.0	0.1	0.3	0.0	2.2	4.5	150.8	10.0	0.3	9.4	0.0	0.7	0.0	0.0	9.0	0.6	10.3	0.0	6.2	1.8	15.0	1.0	0.0	9.2	0.0	0.1	0.0	0.0	0.4	10.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.6	0.0	0.0	0.3	8.8	0.0	0.0	0.0
CEACAM4	CGM7	ENSG00000105352	"CEA cell adhesion molecule 4"	O75871	19	41618971-41627074	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 21.3;lymphoid tissue: 32.6"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 41.1;Macrophages: 20.9;monocytes: 9.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 122.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 122.7"	"Cell line enriched"	"Detected in single"	6	"U-937: 4.1"															NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (1.10e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-9)"	"unprognostic (3.65e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.34e-1)"	2.1	0.5	0.1	4.8	0.1	21.3	0.5	0.1	0.2	0.4	0.2	0.7	0.3	0.3	0.8	1.0	1.0	1.0	0.8	0.1	0.1	0.8	1.0	5.7	0.9	0.2	0.2	0.2	1.2	0.0	0.3	0.3	0.2	1.1	0.2	0.0	0.8	0.0	0.2	0.3	1.8	1.0	0.1	32.6	0.8	0.1	0.2	0.3	0.4	0.6	0.6	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	30.1	5.6	0.0	23.1	0.1	0.7	1.2	0.0	23.3	0.0	0.7	0.0	122.7	0.0	9.9	0.2	11.3	12.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.0	3.9	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.1	0.0	0.0	0.0	0.0	41.1	1.6	0.2	0.0	20.9	1.8	1.9	9.2	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0
CENPM	"C22orf18, CENP-M, MGC861, Pane1"	ENSG00000100162	"Centromere protein M"	Q9NSP4	22	41938737-41947152	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.0;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 116.7;Erythroid cells: 60.0;Plasma cells: 70.8;Respiratory ciliated cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 50.8"	"Group enriched"	"Detected in many"	6	"B-cells: 38.6;T-cells: 50.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042404	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA042404: AB_2677981"	"unprognostic (3.78e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (7.15e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (5.99e-7)"	"unprognostic (9.54e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.73e-2)"	"unprognostic (5.61e-2)"	1.3	1.5	0.6	9.9	0.6	29.0	1.9	1.8	1.1	2.3	0.3	9.9	8.4	1.7	0.1	9.9	10.8	2.0	0.7	0.5	0.7	2.3	1.6	3.8	25.1	0.8	0.8	0.7	0.7	0.3	0.5	3.2	0.8	1.4	5.3	0.1	3.6	0.3	0.9	8.0	8.3	1.8	0.5	10.6	6.1	12.8	1.0	22.6	0.8	0.4	16.3	2.0	4.0	0.5	79.1	79.0	43.5	28.8	3.3	3.3	18.4	37.8	19.4	65.2	66.2	92.3	41.0	101.5	27.8	20.2	42.2	29.5	32.9	38.8	16.2	29.4	137.4	47.8	82.3	64.9	3.2	91.4	51.9	2.7	2.9	42.1	19.3	6.9	24.8	91.5	36.7	95.0	38.8	121.9	91.9	94.8	23.6	47.5	58.1	86.8	43.4	105.6	26.9	46.5	49.3	9.4	58.5	34.5	20.6	7.2	32.8	58.4	12.5	62.8	93.4	42.0	64.1	50.5	38.0	95.2	21.9	75.9	70.0	1.8	0.3	0.0	6.2	0.2	8.8	27.9	18.6	8.4	0.7	38.6	3.5	4.6	1.1	7.4	0.2	0.4	50.8	7.9	0.6	0.6	1.8	1.1	0.5	0.7	0.8	0.8	0.8	0.5	1.0	0.5	0.4	0.0	3.4	0.3	50.7	2.0	4.8	17.8	1.8	1.9	10.9	10.3	0.6	0.0	7.9	0.0	0.0	39.7	5.4	25.3	17.6	2.1	4.5	116.7	4.2	2.6	7.7	60.0	0.5	0.7	38.9	6.4	10.7	18.0	2.5	15.8	3.6	1.3	43.4	3.3	0.8	34.5	28.5	2.9	3.5	6.7	1.2	5.4	7.2	1.0	1.8	0.1	2.1	1.0	0.2	1.5	8.4	0.4	70.8	2.8	4.0	0.3	102.6	0.6	0.0	0.2	7.0	36.4	29.8	13.3	1.0	8.8	18.5	2.9	36.6	9.0
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694085-184734130	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.6;testis: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 489.7;Late spermatids: 900.3;Spermatocytes: 490.2;Spermatogonia: 215.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 20.7;eosinophil: 14.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 157.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centriolar satellite"		"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	1.5	1.1	0.1	5.4	0.3	62.6	5.7	0.6	0.3	2.4	0.1	7.8	5.1	1.5	0.7	10.5	0.9	1.1	1.5	0.2	0.2	0.7	3.7	1.7	16.2	0.2	0.2	0.6	1.0	1.4	0.2	4.8	0.6	1.3	8.0	1.5	2.7	0.4	0.9	15.3	5.4	2.7	0.2	2.3	3.7	29.5	0.4	12.8	1.3	0.1	13.6	2.1	3.9	0.5	57.8	17.1	67.9	35.8	4.3	6.4	37.6	40.8	19.4	32.2	21.2	24.8	32.1	45.9	3.8	18.7	20.2	23.0	52.4	33.2	30.6	23.4	23.0	50.4	17.5	12.6	0.7	71.1	29.3	2.7	2.1	33.3	8.4	9.4	32.1	53.9	44.1	157.3	51.1	38.2	111.4	53.0	33.8	12.7	21.5	74.5	24.3	15.6	17.1	26.7	52.0	49.0	31.4	39.4	23.9	25.0	44.1	50.2	20.9	23.8	31.3	23.5	39.7	26.5	29.5	37.6	37.2	55.4	94.5	20.7	0.7	14.2	0.5	2.0	0.4	0.9	0.7	0.8	0.4	0.9	0.6	0.8	0.1	3.5	2.8	1.9	2.5	0.6	0.1	0.3	0.6	0.3	0.2	0.2	0.2	0.2	0.6	0.2	0.4	0.5	1.4	9.6	3.2	0.3	6.5	13.9	6.0	11.5	3.4	0.9	11.5	7.9	2.3	4.3	8.7	1.8	0.0	31.5	5.4	8.9	3.9	4.8	489.7	9.5	4.0	3.8	0.0	115.7	0.4	2.5	48.4	7.3	9.2	6.6	8.9	27.1	1.1	0.9	21.6	0.0	0.4	10.0	10.2	5.1	7.3	900.3	9.0	15.3	0.0	1.0	5.3	0.2	4.1	0.5	1.9	3.0	1.0	6.8	28.3	2.6	0.9	0.7	5.6	1.4	19.7	2.0	7.2	490.2	215.1	29.1	21.5	7.5	6.3	4.4	18.1	11.6
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109174418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 50.3;Spermatocytes: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	10.5	7.6	5.1	7.8	5.9	10.2	10.2	10.8	7.8	8.2	4.6	8.5	8.7	9.3	10.5	6.2	6.0	9.4	7.7	5.8	4.1	8.0	10.0	6.6	8.9	4.9	4.2	6.5	7.5	16.9	5.6	10.1	5.5	6.4	10.9	12.0	5.2	6.3	6.1	6.8	7.8	10.8	3.9	7.7	7.3	26.2	5.5	14.4	8.7	6.6	7.4	6.4	6.5	7.9	17.9	7.9	23.1	22.9	21.2	35.2	18.1	40.3	22.1	35.8	39.8	11.9	15.3	16.0	18.4	20.9	30.8	9.1	16.1	15.4	56.1	20.3	16.1	34.8	18.9	12.3	19.6	28.5	14.5	21.2	11.0	30.3	29.9	19.2	32.4	52.5	63.9	52.5	32.4	11.8	32.0	24.6	7.6	14.7	14.6	25.7	17.4	15.7	17.0	7.4	17.4	14.4	19.8	14.7	12.9	15.0	18.2	43.9	14.7	23.1	13.6	24.4	42.9	15.4	19.1	25.3	21.8	43.1	18.9	15.9	5.2	6.6	4.7	6.1	5.1	3.3	4.8	6.7	5.7	6.3	4.5	6.7	3.6	11.6	9.6	6.0	6.9	4.6	5.1	5.9	10.8	7.8	5.8	4.1	4.9	4.2	5.5	3.9	5.5	7.9	12.9	6.4	5.3	12.4	6.3	3.3	7.6	7.4	7.4	6.6	6.8	7.2	10.3	2.8	6.8	5.5	20.9	9.8	9.7	4.2	7.9	7.0	50.3	12.8	18.5	10.6	5.4	18.1	31.9	5.4	13.2	15.5	8.2	6.9	5.1	20.5	8.2	6.3	10.2	5.0	31.1	3.1	8.2	4.1	6.8	39.3	17.4	7.7	8.8	27.2	7.7	10.4	8.2	26.2	36.1	6.0	4.5	12.4	13.2	4.4	5.7	13.4	9.8	12.3	13.1	21.8	14.1	75.7	13.0	5.8	4.4	8.5	6.7	13.6	6.1	5.0
CEP63	FLJ13386	ENSG00000182923	"Centrosomal protein 63"	Q96MT8	3	134485721-134575017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Mitosis"		"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 139.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 179.4"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 179.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058154, HPA058313"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA058154: AB_2683624, HPA058313: "	"unprognostic (1.80e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	23.9	15.2	7.4	14.0	9.8	30.2	16.1	10.0	13.7	13.1	6.8	16.4	10.0	12.9	16.9	12.4	12.2	11.3	25.1	7.5	10.9	16.4	21.9	11.8	18.5	9.4	9.1	16.2	17.0	18.8	12.7	14.4	9.7	14.5	14.3	22.0	16.0	15.9	41.5	14.8	11.2	16.4	7.7	16.2	14.7	45.2	9.3	27.5	18.9	29.0	17.4	15.7	12.5	11.7	32.9	12.6	26.2	17.5	36.9	30.7	24.6	35.1	29.1	26.7	21.9	11.8	13.7	36.5	21.0	24.4	26.0	18.6	14.5	18.0	32.3	41.7	7.4	47.9	15.0	16.1	25.3	30.5	22.0	26.4	23.3	14.8	47.1	28.8	27.9	48.2	14.7	31.3	32.4	20.1	37.7	34.5	18.4	20.1	16.9	23.5	38.7	52.8	23.7	20.3	14.8	14.6	31.2	12.1	47.3	30.2	24.7	38.1	30.1	30.1	18.4	30.3	26.9	27.1	21.9	46.7	33.4	30.8	39.2	72.7	20.1	34.3	12.7	20.6	16.9	15.9	12.2	16.5	24.6	22.2	17.2	13.1	179.4	20.3	29.5	16.3	16.8	12.7	7.4	9.8	10.0	13.7	7.5	10.9	9.4	9.1	9.7	7.7	9.3	11.7	19.9	19.2	27.6	39.2	25.5	10.7	14.6	22.6	13.6	31.6	16.8	22.5	84.7	22.8	23.1	7.3	20.9	25.3	16.5	11.8	31.3	25.8	93.2	21.8	23.6	21.0	13.1	26.5	63.5	20.0	26.0	25.8	14.8	17.9	52.6	25.2	14.6	17.3	29.4	32.0	58.3	16.0	16.2	27.7	12.8	54.9	23.9	25.1	17.8	28.1	30.2	26.3	19.6	71.4	67.8	21.0	16.2	25.9	27.3	19.2	12.5	29.6	31.1	43.8	19.7	31.7	25.1	139.1	51.7	17.3	9.8	17.4	20.6	18.8	16.2	16.2
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CFAP92	"FAP92, FLJ43738, KIAA1257"	ENSG00000114656	"Cilia and flagella associated protein 92 (putative)"	Q9ULG3	3	128909866-129002690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 22.1"	"Group enriched"	"Detected in some"	4	"Adipocytes: 1.3;Cardiomyocytes: 1.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"neutrophil: 34.0"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 34.0"	"Cell line enhanced"	"Detected in many"		"AF22: 7.6;HL-60: 13.5;THP-1: 9.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042811, HPA048445"	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042811: AB_2678180, HPA048445: AB_2680397"	"unprognostic (4.17e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.41e-3)"	"unprognostic (2.45e-1)"	"unprognostic (6.74e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.50e-2)"	0.4	0.6	3.1	1.0	2.1	2.1	0.8	3.9	2.2	0.4	4.4	0.7	0.8	0.7	0.5	1.1	3.3	1.4	0.6	3.7	2.5	0.5	0.2	1.1	1.0	3.1	4.7	1.2	0.9	1.7	1.8	1.1	3.2	1.0	0.8	2.7	0.7	0.3	0.7	4.3	0.9	0.2	1.4	1.0	1.1	22.1	3.3	4.2	0.8	0.5	0.3	0.4	0.1	1.3	1.0	1.4	7.6	1.6	0.1	0.2	2.4	0.3	0.3	0.1	0.0	1.2	1.0	1.5	0.3	0.0	0.7	1.1	2.3	0.1	0.0	0.6	1.1	3.3	1.9	1.0	0.0	13.5	0.7	0.0	1.4	0.0	0.1	0.5	0.1	2.9	0.9	1.7	0.2	1.5	1.3	2.5	1.4	2.6	1.4	1.1	0.8	0.9	0.0	1.5	1.5	0.7	0.4	0.5	0.6	1.0	2.6	9.2	0.4	0.8	1.2	0.8	0.5	2.2	2.0	2.5	0.6	5.0	0.6	0.8	0.7	2.9	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.3	0.3	0.5	34.0	0.3	0.3	0.3	0.2	0.2	3.1	2.1	3.9	2.2	3.7	2.5	3.1	4.7	3.2	1.4	3.3	1.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFDP1	"BCNT, CENP-29, CP27, p97, SWC5, Yeti"	ENSG00000153774	"Craniofacial development protein 1"	Q9UEE9	16	75293698-75433503	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 493.3;Paneth cells: 745.2;Proximal enterocytes: 612.2;Proximal tubular cells: 637.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041316, HPA048242"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA041316: AB_10794371, HPA048242: AB_2680327"	"unprognostic (1.45e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (5.81e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.25e-1)"	45.0	51.0	57.4	24.0	58.0	35.0	45.2	60.8	75.3	69.1	57.9	47.5	30.4	58.6	62.3	41.2	55.6	29.7	36.8	57.1	61.7	64.5	43.1	37.3	27.1	58.8	59.3	83.1	41.2	30.8	57.1	63.1	58.8	39.9	40.2	49.6	39.4	38.1	35.7	42.4	36.4	51.0	56.7	30.2	34.7	59.5	59.6	57.0	45.0	34.9	35.8	44.8	50.7	60.8	65.0	47.6	158.9	59.2	141.2	156.3	47.2	63.2	74.1	83.0	119.1	82.5	86.6	61.3	91.1	79.3	92.7	71.5	123.3	101.9	164.9	26.4	58.6	63.0	46.6	177.2	97.3	69.2	51.6	98.4	85.5	100.2	121.4	144.6	91.5	114.0	91.3	28.3	93.9	149.0	102.2	152.6	77.1	110.0	24.8	182.7	64.3	108.5	93.1	35.5	94.5	79.4	105.7	22.3	92.5	136.4	91.8	121.6	53.8	59.2	63.1	63.2	40.8	54.4	89.2	228.6	59.3	89.9	53.3	61.3	45.5	60.8	31.2	47.8	44.5	33.6	42.7	34.7	48.8	35.4	38.7	36.5	38.1	28.5	46.2	48.7	68.5	25.8	57.4	58.0	60.8	75.3	57.1	61.7	58.8	59.3	58.8	56.7	59.6	60.8	87.4	38.5	57.5	37.5	45.5	57.9	116.3	135.9	47.3	87.2	89.5	103.4	34.7	91.5	111.2	115.8	116.7	119.0	50.5	493.3	197.6	79.1	133.7	197.7	118.5	97.6	82.2	78.9	49.5	94.9	114.0	82.9	61.2	121.3	28.5	194.5	62.8	153.9	77.1	62.2	50.5	219.2	59.0	53.1	44.5	69.7	125.2	51.1	33.8	45.9	64.8	60.8	84.5	49.8	75.6	92.4	745.2	112.5	42.3	116.9	612.2	637.6	205.3	112.5	98.6	55.3	88.2	311.2	178.0	49.5	65.6	154.9	51.6	103.5	120.0	130.4
CHM	"DXS540, REP-1, TCD"	ENSG00000188419	"CHM Rab escort protein"	P24386	X	85861180-86047561	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003231, CAB016171"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016171: AB_2229397, HPA003231: AB_1078518"	"unprognostic (6.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.40e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.60e-3)"	9.3	11.1	2.7	7.3	3.4	2.4	7.7	2.7	4.4	9.3	3.6	6.1	4.6	8.8	4.6	6.7	11.0	7.2	7.2	3.9	2.5	12.1	7.7	7.0	7.1	2.9	2.2	7.8	5.9	14.2	3.8	9.5	3.0	7.6	6.4	9.3	5.6	7.1	6.4	4.2	4.7	8.7	1.3	8.1	7.3	4.6	2.9	8.5	10.9	10.5	6.3	7.6	3.5	3.2	16.8	10.9	10.9	7.2	17.4	18.4	6.9	19.3	16.2	13.2	14.4	8.8	15.0	5.7	24.3	14.0	46.1	9.4	23.9	10.9	22.5	10.9	11.4	3.4	14.6	8.4	13.8	14.3	23.8	14.1	10.1	21.4	26.9	14.6	22.9	9.4	11.9	19.0	20.7	4.8	8.8	5.2	16.2	11.6	17.5	9.0	19.5	8.8	12.2	9.5	9.6	14.8	23.3	7.1	18.3	14.9	6.0	6.7	16.4	16.7	11.0	59.0	9.7	7.2	27.7	7.9	18.0	11.9	14.9	2.2	1.9	0.9	1.6	2.3	1.5	1.8	1.3	1.7	1.5	2.1	1.7	1.8	1.0	1.6	1.9	1.4	1.7	1.2	2.7	3.4	2.7	4.4	3.9	2.5	2.9	2.2	3.0	1.3	2.9	3.2	34.5	3.2	11.0	33.6	22.3	6.9	17.6	18.9	15.9	35.2	14.2	10.3	11.9	15.7	15.9	16.5	8.4	9.6	26.5	10.2	19.6	16.3	0.7	13.8	29.5	22.2	18.7	12.6	82.5	12.4	9.6	21.6	15.3	18.4	16.5	18.2	14.6	12.5	15.5	23.5	94.7	11.8	10.2	23.0	9.1	2.1	15.5	21.4	5.4	52.5	19.6	27.5	18.6	78.4	76.5	15.7	11.4	12.4	17.3	18.9	7.5	35.2	17.7	20.9	46.0	28.0	27.8	3.7	12.2	12.8	7.4	18.3	22.1	28.7	9.4	15.6
CHMP3	"CGI-149, NEDF, VPS24"	ENSG00000115561	"Charged multivesicular body protein 3"	Q9Y3E7	2	86503430-86563479	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA015673, HPA073383"	Supported					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA015673: AB_1858761, HPA073383: AB_2732224"	"unprognostic (2.49e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.32e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.64e-1)"	70.0	56.1	39.5	41.0	54.3	30.9	64.2	49.3	45.6	57.9	26.1	72.3	63.1	68.8	56.9	93.0	51.8	54.8	100.2	46.3	39.9	59.9	23.3	64.0	34.0	35.9	36.5	49.0	66.7	70.3	33.1	31.8	37.1	64.3	75.9	30.8	52.9	61.9	97.1	58.6	64.5	73.4	38.7	40.3	60.5	34.2	42.5	31.7	68.0	80.9	39.9	70.2	50.6	38.1	105.3	96.1	54.4	39.6	71.2	136.7	52.5	76.7	103.2	64.4	55.6	86.2	90.2	34.3	71.7	97.7	71.8	82.8	33.3	67.0	70.3	21.0	42.5	45.5	45.5	98.8	62.5	36.4	47.7	82.4	147.7	40.8	64.9	70.4	73.1	34.1	49.1	25.3	104.7	90.7	24.4	32.4	18.8	138.9	73.8	15.3	125.2	27.2	85.7	117.3	65.7	71.4	73.3	68.0	66.1	25.8	58.3	55.7	88.7	114.2	46.8	112.2	86.7	21.0	33.1	22.9	81.5	58.0	61.3	158.5	61.5	171.5	28.0	73.8	33.6	49.5	41.8	33.8	49.9	49.3	48.7	37.9	228.7	35.5	66.5	42.1	46.1	54.4	39.5	54.3	49.3	45.6	46.3	39.9	35.9	36.5	37.1	38.7	42.5	38.1	102.5	147.4	93.5	0.0	49.6	95.3	83.3	94.4	83.6	55.7	115.2	72.6	125.2	147.3	111.4	40.5	41.7	51.1	42.7	222.1	148.7	180.7	206.6	46.7	84.9	96.2	133.5	73.0	0.0	174.8	59.2	67.4	58.6	70.4	147.6	30.0	144.5	59.1	89.5	69.0	0.0	159.2	65.1	126.2	48.4	108.5	71.7	77.2	71.2	0.0	93.6	60.5	78.2	0.0	0.0	186.7	219.4	91.0	25.0	95.9	201.1	173.3	76.1	42.4	65.7	73.6	78.5	100.7	57.3	101.9	94.1	85.0	47.5	57.3	165.4	103.4
CHODL	"C21orf68, FLJ12627, MT75, PRED12"	ENSG00000154645	Chondrolectin	Q9H9P2	21	17901263-18267373	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;lymphoid tissue: 14.1;testis: 31.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 38.6;Oligodendrocytes: 50.1;Skeletal myocytes: 28.3;Theca cells: 26.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.8;U-266/70: 2.8;U-266/84: 7.2;U-87 MG: 7.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.9;hypothalamus: 12.3;pons and medulla: 10.9"	"Group enriched"	"Detected in all"	4	"olfactory bulb: 66.4;spinal cord: 38.6"	"HPA017282, HPA057559"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	Centrosome	"HPA017282: AB_1846687, HPA057559: "	"unprognostic (3.91e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (6.74e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.02e-1)"	3.3	2.0	1.6	1.1	1.4	0.0	1.1	0.7	1.6	0.2	0.8	2.8	1.6	0.6	1.1	0.9	0.5	0.8	3.7	1.7	5.4	3.6	0.0	0.3	0.4	11.5	2.6	0.6	0.1	0.3	2.5	1.9	10.8	5.6	3.5	0.6	0.5	1.8	0.6	2.3	1.0	0.3	1.6	14.1	0.7	31.0	10.2	0.3	1.1	1.7	1.2	0.7	1.1	3.8	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.4	0.1	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.7	0.6	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.8	7.2	0.2	7.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.5	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	1.6	1.4	0.7	1.6	1.7	5.4	11.5	2.6	10.8	1.6	10.2	3.8	1.7	0.0	0.0	5.2	1.0	4.0	0.8	0.8	3.4	1.1	1.0	1.3	0.5	0.0	0.9	0.0	0.0	0.2	0.9	0.0	1.9	0.4	5.0	1.4	38.6	1.5	0.0	0.0	5.5	0.0	0.2	4.6	0.0	0.8	0.0	12.3	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.8	4.0	3.1	0.1	1.8	4.7	0.0	0.4	0.0	12.5	50.1	0.0	0.0	1.9	3.1	0.2	0.0	0.3	0.3	0.1	0.0	28.3	10.5	1.3	1.7	0.5	2.3	0.5	1.3	26.7	0.1	0.3
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;salivary gland: 17.5"	"Group enriched"	"Detected in many"	28	"Excitatory neurons: 802.9;Inhibitory neurons: 624.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 17.2;SH-SY5Y: 53.5;U-266/70: 21.7;U-266/84: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.3	0.4	4.6	0.8	7.3	0.2	0.8	0.0	11.8	0.4	0.0	7.0	1.4	1.9	0.4	7.5	0.8	0.7	0.4	7.5	0.0	1.1	0.4	1.1	0.1	0.0	0.0	4.8	10.6	0.5	0.5	0.8	0.0	1.1	2.8	1.7	17.5	3.0	0.0	1.3	1.5	4.1	0.0	0.7	5.0	2.5	4.1	0.1	2.0	0.1	0.1	7.0	0.4	2.9	0.0	0.1	0.4	0.4	0.0	0.0	0.9	0.6	0.1	0.3	0.1	0.0	0.0	0.0	2.1	0.0	0.0	5.8	0.6	3.8	2.7	0.0	3.7	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	1.1	9.1	0.9	1.4	0.0	0.0	4.6	4.6	9.1	0.0	1.1	17.2	0.7	0.8	0.1	53.5	0.0	0.1	0.1	4.0	1.8	0.0	0.3	2.3	0.8	0.1	0.5	21.7	16.3	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	7.3	0.0	11.8	7.5	0.0	0.0	0.0	0.0	0.0	4.1	2.9	6.1	0.0	3.7	6.2	0.0	0.0	2.1	0.0	0.6	19.0	4.6	3.2	1.2	0.0	0.8	0.0	0.0	3.2	0.3	11.0	1.9	0.4	19.6	0.1	0.1	3.0	3.5	4.6	802.9	17.3	0.7	3.9	11.7	0.2	1.3	7.5	4.2	0.3	0.5	0.0	624.0	6.0	0.0	0.0	0.0	3.9	0.0	0.2	7.2	22.5	0.0	0.3	0.0	8.5	11.2	2.6	25.3	0.4	0.2	2.5	2.2	1.4	1.6	0.6	0.0	0.2	1.1	12.9	3.0	0.2	0.0	0.5	0.1	0.8	15.5	0.2
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175727-101252048	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	27.5	18.6	10.3	18.5	9.8	23.0	21.7	9.0	11.8	19.5	14.4	7.7	6.0	17.3	9.5	10.8	14.9	22.7	20.1	9.2	10.3	13.7	10.0	23.6	11.6	14.2	13.8	19.7	7.3	7.4	8.5	46.7	11.9	14.4	8.2	7.0	10.1	11.4	6.5	15.0	7.7	20.0	11.5	13.9	10.4	8.7	12.5	10.5	10.0	7.4	10.3	34.8	14.0	9.8	9.1	11.2	36.8	18.7	18.9	25.0	24.5	21.8	19.2	25.8	26.2	9.7	7.1	22.0	12.7	36.3	16.8	24.7	24.5	27.7	28.2	24.6	12.4	43.4	12.2	11.4	23.3	66.9	42.9	23.2	22.8	22.3	20.1	29.3	30.8	9.7	16.2	216.3	19.7	7.9	9.2	46.3	42.5	17.7	7.9	20.6	36.9	32.8	18.1	17.7	6.4	34.6	23.0	11.1	40.8	29.8	12.6	81.6	26.2	41.9	24.1	20.0	46.5	38.2	94.5	12.7	32.5	62.2	32.0	0.0	1.3	2.9	1.5	0.8	1.7	0.9	0.9	1.6	0.8	1.0	0.5	1.0	4.9	0.7	0.9	0.5	1.8	0.6	10.3	9.8	9.0	11.8	9.2	10.3	14.2	13.8	11.9	11.5	12.5	9.8	55.0	0.0	15.7	27.7	11.4	57.9	20.7	10.1	20.5	10.7	41.9	29.8	9.3	5.7	9.4	16.5	6.2	6.1	14.6	1.6	1.9	5.3	1.2	10.0	33.4	45.8	3.0	12.0	34.2	2.2	28.8	40.0	5.1	13.8	25.9	51.9	60.0	5.4	16.6	38.7	36.1	3.6	10.2	17.8	37.1	2.5	55.0	41.2	26.6	59.0	10.2	9.2	10.3	21.1	24.2	5.5	2.5	47.0	9.3	19.3	1.2	2.4	8.1	7.5	46.0	47.9	53.5	3.9	7.5	10.5	62.5	13.8	15.2	23.0	3.9	10.2
CLDN10	"CPETRL3, OSP-L"	ENSG00000134873	"Claudin 10"	P78369	13	95433604-95579759	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"		"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 135.2;pancreas: 216.5;salivary gland: 91.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 182.4;Cholangiocytes: 328.8;Club cells: 251.6;Ductal cells: 394.1;Glandular and luminal cells: 220.2;Proximal tubular cells: 285.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.3;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 14.9;NTERA-2: 12.7;RPTEC TERT1: 29.0;SuSa: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012969, HPA042348"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB012969: AB_2533386, HPA042348: AB_2677955"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (1.11e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (4.75e-3)"	1.0	0.1	33.0	0.0	31.3	3.2	3.1	28.6	45.8	30.4	24.1	0.3	1.1	9.3	20.8	7.9	19.2	25.5	0.5	32.6	30.5	135.2	3.7	2.1	0.0	27.9	30.2	0.9	216.5	0.4	3.1	0.8	27.2	1.3	0.4	2.7	91.5	0.4	0.1	16.8	0.2	0.4	27.4	0.7	0.9	1.5	30.1	0.5	0.2	0.7	27.4	0.5	0.4	29.8	0.0	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	2.7	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	1.9	0.0	0.0	2.9	0.0	0.1	0.0	0.5	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	12.7	0.2	0.0	0.0	0.1	0.0	29.0	0.0	0.2	0.1	0.0	0.0	0.0	73.3	0.7	1.8	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	33.0	31.3	28.6	45.8	32.6	30.5	27.9	30.2	27.2	27.4	30.1	29.8	0.6	0.0	0.0	93.4	1.0	0.3	5.5	182.4	0.0	0.3	22.6	5.0	0.8	328.8	251.6	99.3	0.0	15.0	0.4	0.0	135.0	394.1	3.4	83.2	28.5	4.2	0.0	0.0	0.6	82.5	7.9	1.4	0.0	220.2	0.0	0.1	1.1	0.4	1.9	0.0	1.6	0.0	77.3	0.3	0.3	2.5	0.0	2.8	69.4	4.7	1.6	78.7	0.0	33.7	0.4	103.1	0.0	0.4	0.1	22.1	0.0	285.9	43.3	3.8	6.6	0.2	16.8	12.2	19.9	1.5	0.6	23.1	2.2	0.5	0.0	5.0
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723364-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 132.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Fibroblasts: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 363.0;HMC-1: 637.3;NB-4: 901.1;THP-1: 694.7;U-937: 358.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	17.5	17.5	5.0	7.0	5.6	132.6	14.1	7.9	9.1	44.4	2.9	12.0	4.8	31.9	1.6	8.4	37.5	6.2	16.3	4.4	7.2	21.1	12.1	15.0	2.7	10.2	7.9	31.5	7.5	2.4	22.3	5.5	8.1	22.5	1.9	0.7	6.9	4.8	4.4	16.8	9.7	8.1	7.2	14.0	8.0	9.1	6.2	2.6	12.8	1.0	0.8	19.2	28.2	6.0	2.6	3.5	0.0	2.9	33.7	45.3	79.2	139.3	37.9	15.6	15.7	0.1	0.0	0.4	1.7	70.2	0.8	1.6	0.4	0.2	10.7	0.6	22.9	363.0	0.1	0.0	21.3	0.2	637.3	33.7	0.2	1.9	2.3	0.1	17.9	16.1	4.1	2.2	29.0	2.6	3.1	901.1	1.6	0.3	4.6	30.7	0.2	0.2	0.8	0.4	0.0	3.8	4.2	0.0	58.1	0.0	0.9	694.7	100.3	1.1	41.6	0.7	0.7	2.1	2.2	0.5	47.3	358.7	44.2	1.4	24.3	0.4	0.9	11.5	0.1	0.6	0.3	0.2	17.7	0.4	2.0	4.5	1.6	5.7	5.6	4.8	0.2	8.2	5.0	5.6	7.9	9.1	4.4	7.2	10.2	7.9	8.1	7.2	6.2	6.0	12.4	3.2	5.4	10.4	3.9	32.0	32.2	2.9	27.3	20.5	30.8	31.9	3.4	8.6	4.0	29.5	10.4	8.6	5.0	1.7	119.3	11.0	6.5	17.0	70.7	16.9	26.5	36.4	9.0	3.1	72.4	107.2	4.1	14.1	5.7	18.9	51.4	6.3	49.4	21.9	8.3	4.5	10.2	21.5	73.3	19.9	70.8	29.6	78.2	9.4	11.2	70.4	14.4	8.0	12.9	3.1	1.7	67.4	0.9	21.4	0.5	13.7	5.0	20.7	65.7	20.2	59.2	17.2	21.7	26.3	45.9	18.3	5.8	56.7	3.5	17.8
CLEC2D	"CLAX, LLT1, OCIL"	ENSG00000069493	"C-type lectin domain family 2 member D"	Q9UHP7	12	9664969-9699553	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 128.6;dendritic cells: 112.0;Early spermatids: 95.5;monocytes: 81.6;NK-cells: 131.8;T-cells: 215.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"gdT-cell: 188.1;MAIT T-cell: 114.5;memory B-cell: 95.0;memory CD4 T-cell: 183.3;memory CD8 T-cell: 208.7;naive B-cell: 127.5;naive CD4 T-cell: 192.3;naive CD8 T-cell: 223.0;T-reg: 175.2"	"Group enriched"	"Detected in all"	11	"B-cells: 127.5;T-cells: 223.0"	"Group enriched"	"Detected in many"	4	"Daudi: 67.9;HDLM-2: 53.3;Karpas-707: 31.0;U-698: 105.8"									"HPA017649, HPA047584"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA017649: AB_1846912, HPA047584: "	"unprognostic (1.09e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.85e-11)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.68e-7)"	6.1	1.8	3.6	16.7	3.5	16.0	5.6	3.3	4.9	6.4	3.1	4.8	3.3	4.5	11.8	3.2	5.3	5.5	5.3	3.2	3.7	3.9	2.9	8.6	53.5	4.0	3.4	6.0	2.4	0.8	2.3	2.6	3.9	7.3	3.9	2.2	6.5	4.5	2.9	3.7	20.3	2.0	3.5	26.6	5.5	9.5	4.1	31.6	4.5	1.3	41.7	5.7	4.6	4.2	1.2	2.5	3.5	0.3	0.5	1.4	4.0	1.7	2.5	0.6	2.1	1.9	2.1	67.9	0.3	1.8	1.0	0.7	1.2	0.2	1.1	53.3	0.9	2.1	1.6	2.9	5.7	1.7	1.7	2.3	1.7	0.5	2.1	8.0	0.1	1.2	0.5	31.0	1.5	4.5	0.7	5.9	3.2	0.2	0.4	14.9	1.6	2.2	3.4	3.6	0.6	1.3	0.9	2.8	3.0	6.6	0.6	1.8	0.6	1.3	1.8	1.0	1.2	4.4	1.1	105.8	2.8	3.1	2.1	6.8	2.1	1.5	188.1	1.4	114.5	95.0	183.3	208.7	2.3	127.5	192.3	223.0	6.0	16.5	1.3	1.6	175.2	109.8	3.6	3.5	3.3	4.9	3.2	3.7	4.0	3.4	3.9	3.5	4.1	4.2	8.9	6.4	20.7	11.8	128.6	4.1	39.7	2.1	1.8	1.3	6.5	6.1	9.6	4.3	7.1	1.8	4.2	10.4	112.0	0.8	7.9	3.0	95.5	3.6	6.9	13.0	0.0	21.5	6.3	1.9	6.0	12.2	4.6	6.2	20.2	18.1	12.5	2.3	9.2	5.0	6.8	2.5	0.0	20.9	17.8	28.3	8.4	19.4	1.8	56.2	81.6	3.2	131.8	27.6	4.4	2.8	2.0	9.8	71.5	17.2	0.5	2.1	7.4	2.3	19.7	26.2	8.7	5.7	6.3	1.9	4.8	4.8	215.1	7.4	3.5	24.3
CLEC9A	"CD370, DNGR-1, HEEE9341, UNQ9341"	ENSG00000197992	"C-type lectin domain containing 9A"	Q6UXN8	12	10030678-10066031	"CD markers, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.5"	"Group enriched"	"Detected in some"	5	"Langerhans cells: 30.2;Macrophages: 19.5;Microglial cells: 15.9;Spermatocytes: 9.4"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	96	"myeloid DC: 22.0;neutrophil: 7.9"	"Group enriched"	"Detected in many"	96	"dendritic cells: 22.0;granulocytes: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"		"Cluster 41: Macrophages - Immune response"				"unprognostic (1.13e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.00e-3)"	"unprognostic (7.85e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.56e-5)"	"unprognostic (6.58e-4)"	"unprognostic (4.73e-3)"	"unprognostic (9.65e-2)"	"unprognostic (7.45e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-5)"	"unprognostic (2.17e-1)"	0.3	0.2	1.3	1.5	1.4	0.5	0.6	2.0	1.8	0.3	1.1	0.7	0.8	0.5	0.2	0.2	0.2	0.9	0.2	1.6	2.1	0.3	0.8	0.6	7.5	2.7	1.8	0.7	0.3	0.2	0.3	0.2	2.1	0.6	0.6	0.1	1.1	0.4	0.1	0.3	1.5	0.7	2.2	4.8	0.4	3.0	1.9	4.9	0.2	0.2	2.2	1.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.4	1.3	1.4	2.0	1.8	1.6	2.1	2.7	1.8	2.1	2.2	1.9	2.6	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.2	30.2	1.8	0.0	19.5	0.0	15.9	2.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.4	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CLN5		ENSG00000102805	"CLN5 intracellular trafficking protein"	O75503	13	76990660-77019143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041788	Approved				"Intracellular and membrane"	NA	NA		470000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA041788: AB_10962726"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.52e-9)"	"unprognostic (2.35e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.15e-2)"	20.9	19.8	13.9	14.4	12.8	13.3	21.8	27.0	18.9	25.1	17.0	16.1	11.3	19.1	41.9	10.9	24.5	25.2	14.2	13.5	10.5	50.5	35.5	20.5	19.8	12.5	11.6	26.6	16.8	45.6	14.4	23.3	12.2	22.3	16.5	24.1	21.4	22.7	8.4	14.6	13.6	15.9	7.0	16.7	18.8	16.1	13.0	18.3	72.9	10.7	18.5	18.8	12.0	19.0	25.0	11.7	16.4	13.7	74.4	48.5	21.1	23.7	43.3	18.4	31.9	12.3	23.2	9.7	17.3	33.5	21.0	25.0	11.5	25.5	20.0	18.4	21.5	13.9	13.1	12.2	33.8	19.5	20.4	43.6	28.4	8.9	18.7	37.1	33.0	13.5	9.4	17.2	43.2	7.7	11.6	12.5	10.7	48.6	10.4	9.5	14.4	9.0	42.6	13.8	7.3	11.3	14.1	17.4	26.3	21.3	19.0	26.0	31.2	13.2	10.4	15.4	14.2	21.7	30.0	12.2	35.4	13.5	29.2	58.4	15.6	39.4	3.5	22.4	3.1	13.2	17.0	6.0	10.8	14.5	21.5	13.3	11.4	1.0	27.7	11.0	25.6	14.1	13.9	12.8	27.0	18.9	13.5	10.5	12.5	11.6	12.2	7.0	13.0	19.0	30.5	16.0	32.4	16.6	29.2	11.5	32.5	75.1	17.1	19.8	22.3	20.2	8.7	25.8	59.2	68.0	10.4	53.2	15.2	24.0	9.8	39.3	1.6	26.6	25.0	24.1	13.8	7.8	9.7	38.4	128.5	36.9	13.3	24.8	22.2	23.5	25.7	33.0	48.1	6.7	12.6	13.6	97.6	22.4	16.7	4.5	49.7	22.7	24.9	11.2	31.5	50.4	5.2	15.6	21.5	25.0	14.4	47.4	18.8	23.1	23.9	44.1	48.2	25.4	19.7	24.4	27.2	25.8	34.7	14.6	11.5	46.4	15.2	34.0	11.4	21.8
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.2"	"Cell type enriched"	"Detected in many"	5	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 4.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.3	0.2	0.5	0.9	0.4	0.4	0.6	1.5	0.7	0.2	0.5	0.3	0.6	0.4	1.2	0.4	0.2	0.5	0.2	0.5	0.5	6.2	0.9	0.6	3.0	0.4	0.2	0.4	0.1	0.1	1.3	1.0	0.5	0.4	0.4	0.3	0.5	0.3	0.2	0.8	0.9	0.1	0.1	1.5	1.1	0.8	0.5	1.4	0.3	0.0	2.0	0.3	0.0	0.9	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.2	0.1	0.5	0.1	0.2	0.2	0.1	0.1	1.4	0.4	0.1	2.6	1.1	0.1	0.1	0.4	2.0	0.0	0.6	1.8	0.2	0.5	0.4	1.5	0.7	0.5	0.5	0.4	0.2	0.5	0.1	0.5	0.9	0.1	3.2	3.0	1.0	12.9	0.8	0.8	0.0	0.0	1.3	0.3	0.3	0.7	0.0	0.9	0.0	2.1	0.3	4.6	0.1	13.7	0.0	5.3	0.7	0.2	0.4	0.0	5.3	1.7	0.0	2.2	0.5	0.5	0.9	11.4	0.2	0.7	0.3	0.3	0.0	1.6	0.2	73.2	1.9	5.5	5.4	0.3	3.5	1.8	1.9	0.5	0.4	0.0	1.0	0.7	0.1	0.0	2.2	1.1	0.7	0.0	0.2	0.2	1.0	0.0	1.1	0.5	1.9	0.8	0.0	0.4	0.1	6.0	1.3	0.0	0.7
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769978	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low region specificity"	"Detected in many"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	0.5	0.2	0.7	3.2	0.6	11.3	0.5	0.6	1.4	0.2	0.4	1.4	1.0	0.4	0.7	0.9	0.2	0.3	0.1	1.3	0.3	0.2	0.5	0.4	4.9	0.4	0.4	0.1	0.1	0.2	0.0	1.5	0.6	0.2	2.0	6.8	0.2	0.1	0.6	1.2	1.0	0.9	0.2	1.3	0.9	5.7	0.6	7.9	0.2	0.0	5.2	0.6	0.4	0.9	22.0	17.5	37.8	19.9	2.6	4.8	14.1	43.6	12.0	31.0	41.3	27.9	19.6	45.7	13.9	11.8	22.7	21.4	37.1	14.9	48.1	31.6	16.8	64.5	38.1	12.6	0.1	54.0	36.8	1.0	0.6	53.8	3.7	3.7	16.9	27.1	44.2	30.8	30.3	14.1	56.9	13.1	36.0	14.9	12.2	36.0	57.0	13.8	6.4	35.3	14.0	16.2	37.7	11.6	7.4	25.6	10.0	21.1	12.5	44.6	33.8	27.6	49.3	11.1	29.1	47.1	14.1	37.4	37.0	1.1	0.3	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.2	1.0	0.5	0.2	0.2	0.3	0.3	0.7	0.6	0.6	1.4	1.3	0.3	0.4	0.4	0.6	0.2	0.6	0.9	2.6	0.0	0.5	0.3	6.5	5.6	5.7	4.4	1.2	9.4	2.9	3.8	1.4	2.8	2.7	0.0	12.5	19.7	4.6	12.8	0.0	1.6	7.9	1.0	3.6	3.6	1.2	55.6	1.6	0.6	41.1	5.2	4.6	3.3	1.3	12.0	2.2	0.4	16.9	1.7	1.5	9.4	2.0	3.0	8.2	6.1	2.5	5.8	3.6	0.0	9.1	9.4	4.1	0.0	0.6	1.4	9.5	0.4	32.5	1.8	0.4	0.2	0.0	101.0	6.6	5.3	8.7	281.1	263.3	5.8	2.0	10.4	7.2	1.2	12.0	3.9
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15675012	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 486.4"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 885.4"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.5;hTERT-HME1: 5.2;RPTEC TERT1: 8.5;SuSa: 5.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.5	0.8	0.5	0.0	0.6	0.3	2.0	0.7	0.8	1.0	16.6	0.6	1.3	1.5	3.1	0.6	2.4	3.7	1.1	0.7	0.6	486.4	61.5	1.7	0.4	0.6	0.5	3.2	5.3	10.5	0.6	0.5	0.6	1.5	0.3	1.2	0.8	1.3	0.1	1.2	0.4	0.4	0.4	0.2	10.9	1.0	0.5	0.8	4.1	0.1	0.3	0.8	0.4	0.9	2.3	1.8	1.1	0.3	0.7	1.0	0.7	0.0	0.0	0.1	0.1	0.1	0.5	0.1	1.6	0.2	0.2	8.5	0.7	2.3	0.0	0.3	0.7	0.2	0.0	0.8	1.0	0.0	0.0	0.2	2.0	0.3	5.2	0.6	0.0	2.1	0.5	0.4	0.2	2.8	0.1	0.3	2.9	0.8	2.6	0.2	0.3	0.9	8.5	0.1	1.1	1.0	0.6	0.1	1.8	5.1	0.6	0.2	0.0	0.2	0.4	0.3	0.0	0.4	0.2	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.7	0.8	0.7	0.6	0.6	0.5	0.6	0.4	0.5	0.9	0.1	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	1.8	27.6	0.0	2.1	0.0	0.0	54.8	25.1	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.6	0.5	0.3	0.0	3.3	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	885.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	3.7	0.5	0.0	0.0
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	31	"retina: 297.9"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 407.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.3"					"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"	NA	NA		11000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: AB_2732286"	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.4	1.0	2.7	0.5	6.1	3.9	2.3	2.0	4.0	1.5	7.2	0.9	0.5	1.4	0.5	1.2	1.8	2.0	0.3	3.1	4.2	5.3	0.5	1.4	0.7	3.0	3.4	4.9	1.3	3.6	3.9	0.6	3.1	8.5	0.1	297.9	2.3	1.1	0.2	0.7	1.4	0.1	3.1	0.1	3.1	2.6	4.3	1.7	6.8	0.0	0.0	0.8	0.1	9.5	3.6	5.4	10.1	6.8	0.0	0.0	6.1	3.9	0.3	0.0	0.0	4.2	2.1	4.3	1.0	0.0	3.6	1.5	0.0	0.6	0.0	3.6	9.3	7.3	2.9	34.3	0.0	2.5	1.3	0.3	0.0	0.0	0.0	1.7	0.4	10.5	10.5	12.3	0.0	1.2	4.4	7.8	0.7	4.4	2.4	8.8	4.8	15.5	1.1	1.1	8.8	6.2	4.0	2.5	3.4	8.0	3.3	1.0	0.8	4.0	5.7	2.8	2.0	6.9	13.3	9.7	3.2	4.7	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	0.0	2.7	6.1	2.0	4.0	3.1	4.2	3.0	3.4	3.1	3.1	4.3	9.5	0.1	0.0	2.6	0.3	0.1	0.0	3.8	1.5	2.8	29.6	2.8	5.0	0.2	0.0	1.7	0.0	20.9	0.8	0.0	0.1	1.9	0.4	0.7	2.5	0.3	2.0	0.0	0.0	5.2	0.2	0.1	0.4	0.0	3.2	0.0	3.5	0.0	0.0	0.2	16.8	3.8	0.0	0.0	0.0	0.3	0.8	0.9	0.2	0.0	1.0	0.0	58.1	0.0	0.0	4.9	0.0	0.0	1.2	0.0	5.5	0.0	0.5	2.4	407.5	6.6	0.0	0.3	10.6	8.6	0.2	0.1	0.4	0.1	17.3	0.1	1.6
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		1400000	"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	88.2	45.2	47.0	64.2	50.6	53.1	102.2	51.9	73.1	74.8	49.8	134.1	163.9	44.2	42.2	108.2	35.2	88.5	63.3	44.5	56.9	78.7	217.2	63.8	71.8	52.6	52.4	38.1	90.9	57.7	32.9	48.8	54.2	95.0	141.0	29.2	157.4	50.7	71.1	65.1	152.5	56.0	52.6	58.0	109.0	17.5	52.3	61.7	92.0	73.9	87.9	80.6	63.8	55.3	124.9	68.4	86.6	77.9	154.6	179.3	122.5	216.4	129.8	128.6	129.9	61.3	84.1	183.4	108.6	147.9	120.5	82.7	64.8	112.1	174.9	279.5	52.7	142.9	91.0	106.7	100.8	206.2	100.2	101.2	132.7	107.5	119.7	121.1	135.2	67.4	137.3	143.5	169.8	45.9	168.2	96.8	55.1	162.9	93.6	103.4	149.8	138.5	126.5	134.9	78.3	41.3	155.0	177.7	128.9	113.7	44.2	121.0	127.7	159.6	92.7	154.5	180.8	103.8	154.3	124.4	126.3	125.3	111.7	43.3	12.8	24.2	16.1	14.0	20.7	13.6	18.0	20.0	13.5	14.3	16.9	16.4	5.3	19.4	17.0	11.4	20.9	15.6	47.0	50.6	51.9	73.1	44.5	56.9	52.6	52.4	54.2	52.6	52.3	55.3	101.7	70.5	54.4	14.4	148.1	175.5	125.3	88.9	102.4	34.2	167.8	67.7	48.9	147.3	87.0	75.4	16.7	82.3	117.9	280.0	174.1	186.8	1.6	56.2	63.3	83.8	117.5	126.0	28.5	181.6	133.0	91.2	125.4	98.2	94.0	39.7	88.5	235.9	75.9	43.7	30.2	326.6	91.6	122.0	265.0	5.0	59.4	107.1	254.3	31.9	100.5	66.9	124.6	20.6	25.0	146.8	168.6	70.0	119.8	203.5	234.6	254.5	112.3	31.1	85.5	75.9	95.8	14.0	29.8	167.0	195.1	118.3	160.5	49.0	240.2	250.8
CMTM4	CKLFSF4	ENSG00000183723	"CKLF like MARVEL transmembrane domain containing 4"	Q8IZR5	16	66614750-66696743	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 68.0;Granulosa cells: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014704, HPA023890"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA014704: AB_1847005, HPA023890: AB_1847007"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.43e-1)"	"unprognostic (5.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.06e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	4.5	5.0	36.4	2.7	34.1	2.5	5.7	32.8	34.5	3.9	28.3	16.1	11.9	4.4	20.1	6.0	10.6	2.9	4.1	43.1	37.1	26.3	4.1	8.4	0.6	42.1	41.7	3.4	19.2	32.7	14.4	2.1	35.4	7.7	12.6	7.8	11.1	3.8	3.3	7.7	12.9	3.4	41.8	2.0	31.4	6.9	45.5	0.5	38.6	2.1	1.1	3.2	4.1	41.6	16.0	12.9	7.8	19.1	2.6	4.2	31.7	6.6	5.9	3.5	5.6	24.2	17.7	0.7	10.8	3.9	4.8	20.0	19.7	7.8	5.2	1.3	17.2	1.7	5.3	15.2	5.6	1.4	3.0	6.7	13.4	4.2	8.1	11.9	2.0	2.3	8.0	4.1	5.1	18.5	0.1	3.2	8.7	28.6	8.6	3.5	10.6	4.9	15.2	14.2	17.9	7.1	27.4	14.6	9.3	5.6	15.3	3.4	4.3	6.5	7.0	1.8	6.6	1.4	3.3	0.7	8.1	3.2	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	36.4	34.1	32.8	34.5	43.1	37.1	42.1	41.7	35.4	41.8	45.5	41.6	2.6	22.4	11.1	32.7	0.8	5.2	8.8	21.9	4.6	9.5	23.5	10.8	7.1	15.7	19.3	23.9	8.4	5.0	1.6	51.7	13.7	15.9	1.9	20.7	2.7	4.3	39.0	0.8	68.0	24.0	29.6	3.5	27.5	12.3	4.5	67.6	1.8	6.1	2.4	30.3	37.7	24.1	20.3	2.8	0.9	3.0	2.5	1.9	3.6	7.5	4.4	24.2	0.0	37.7	51.3	30.8	19.5	3.0	0.6	29.0	30.7	19.9	40.0	11.1	6.6	3.1	8.8	6.4	7.7	7.5	5.5	2.9	0.9	2.5	43.4	19.4
CMTM5	"CKLFSF5, FLJ37521"	ENSG00000166091	"CKLF like MARVEL transmembrane domain containing 5"	Q96DZ9	14	23376773-23379772	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 182.4;choroid plexus: 49.5"	"Cell type enhanced"	"Detected in some"		"Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2"	"Group enriched"	"Detected in some"	37	"glioma: 8.4;melanoma: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 20.8"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 20.8"	"Cell line enriched"	"Detected in some"	7	"HEL: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052338	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		540000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA052338: AB_2681793"	"unprognostic (2.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.40e-2)"		"unprognostic (8.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.24e-4)"	"unprognostic (3.03e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	1.1	1.0	75.6	0.5	119.1	8.2	0.9	123.8	101.7	2.8	49.5	5.8	0.5	0.8	1.1	1.2	1.2	2.1	22.7	73.9	85.2	0.5	0.3	1.5	0.2	150.9	106.2	0.8	0.2	0.1	0.6	0.7	135.2	2.1	0.8	2.3	2.2	3.2	3.1	0.7	1.7	0.8	113.4	2.8	1.4	0.1	110.2	0.1	0.5	0.9	0.0	1.2	2.6	182.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.2	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.2	20.8	0.7	0.9	0.1	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.4	30.0	75.6	119.1	123.8	101.7	73.9	85.2	150.9	106.2	135.2	113.4	110.2	182.4	0.5	0.0	0.0	6.5	0.4	1.0	0.1	0.0	1.2	0.2	1.3	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.4	0.0	0.0	93.7	5.4	0.0	1.5	32.0	0.0	20.6	106.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	3.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1
CNKSR2	"CNK2, KIAA0902, KSR2"	ENSG00000149970	"Connector enhancer of kinase suppressor of Ras 2"	Q8WXI2	X	21372801-21654695	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 22.6;retina: 17.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.7;Excitatory neurons: 497.7;Inhibitory neurons: 143.6;Oligodendrocyte precursor cells: 93.5;Rod photoreceptor cells: 86.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.9;AF22: 4.0;NTERA-2: 8.9;PC-3: 4.8;RH-30: 8.2;U-251 MG: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001502			Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Plasma membrane"		"HPA001502: AB_1078542"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.13e-2)"	1.5	2.6	8.4	0.3	12.2	0.2	1.4	22.6	16.4	1.0	0.0	0.7	0.1	0.3	0.5	0.0	1.3	0.1	0.8	20.3	0.0	0.1	0.7	1.2	0.9	0.0	0.0	0.6	2.5	0.0	1.6	0.1	0.0	0.7	0.0	17.9	0.5	0.1	4.7	0.8	0.6	0.1	0.0	0.5	1.2	0.6	0.0	0.9	0.9	1.3	1.0	0.6	0.9	5.3	0.0	5.9	4.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	2.0	0.0	8.9	0.0	4.8	0.0	8.2	0.0	0.0	0.0	3.9	1.6	0.0	0.1	0.3	2.1	0.0	0.6	0.0	0.1	1.9	0.0	5.3	3.1	0.0	3.4	0.8	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.9	0.8	0.2	0.0	0.0	0.0	0.0	0.2	0.1	8.4	12.2	22.6	16.4	20.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.3	16.0	1.3	111.7	9.0	1.3	0.5	0.0	1.2	17.8	0.3	0.6	5.7	1.5	5.6	0.0	20.9	0.1	2.1	0.4	0.0	0.3	0.3	1.0	13.6	0.3	0.0	0.8	497.7	2.3	0.0	6.7	0.0	1.3	1.3	1.0	0.0	2.1	0.1	23.5	143.6	0.5	0.0	0.0	2.6	0.0	0.6	0.2	0.0	15.9	0.2	12.7	0.0	93.5	10.6	0.6	0.1	1.5	3.1	2.0	1.3	0.3	0.0	86.1	0.0	0.6	0.9	6.0	7.7	0.1	1.8	0.0	2.9	1.5	0.4	0.0
CNNM2	ACDP2	ENSG00000148842	"Cyclin and CBS domain divalent metal cation transport mediator 2"	Q9H8M5	10	102918294-103090222	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Epilepsy, Mental retardation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 37.9;parathyroid gland: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.1;Excitatory neurons: 112.6;Inhibitory neurons: 146.9;Oligodendrocyte precursor cells: 92.5;Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059954, HPA071631"			Enhanced	Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA059954: AB_2684177, HPA071631: AB_2686427"	"unprognostic (2.18e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.51e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (2.39e-8)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.56e-1)"	3.3	11.5	5.1	2.3	5.5	9.3	2.5	7.9	5.7	3.7	37.9	7.0	3.8	3.6	2.1	1.7	4.8	4.1	2.1	4.2	3.3	9.1	4.8	3.8	1.5	4.9	4.8	4.8	3.6	31.6	5.7	8.7	4.7	2.7	6.4	5.0	3.0	3.0	1.6	4.5	4.5	3.7	1.8	2.1	3.3	4.5	4.6	1.8	5.6	1.5	1.1	3.2	2.9	9.7	5.0	8.1	3.1	8.5	7.8	3.2	8.6	2.3	9.7	3.1	3.9	5.8	4.3	1.9	3.5	3.4	6.0	6.3	6.9	4.6	2.4	3.3	12.1	2.8	4.2	11.8	4.6	2.0	3.6	4.2	6.6	3.2	10.7	7.9	1.9	5.5	4.8	10.9	1.8	8.6	2.3	2.2	5.1	4.9	5.0	5.5	4.0	2.4	2.4	2.9	4.5	5.8	5.9	1.3	6.3	9.1	10.4	3.7	1.6	4.2	6.2	3.0	4.2	11.7	14.1	3.6	7.4	6.6	1.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.2	1.5	0.0	0.3	0.3	0.1	5.1	5.5	7.9	5.7	4.2	3.3	4.9	4.8	4.7	1.8	4.6	9.7	3.0	6.4	8.4	60.1	7.9	2.4	2.3	1.7	6.8	16.4	3.3	2.4	4.5	2.8	5.6	5.5	12.5	18.8	8.1	46.7	1.9	2.2	10.7	7.4	4.2	4.2	6.7	6.7	112.6	5.4	3.4	6.3	12.8	6.4	3.8	13.7	3.3	6.1	3.8	32.0	146.9	5.0	0.0	3.2	2.5	15.1	3.4	4.7	7.2	39.4	2.3	7.0	2.1	92.5	92.3	2.3	9.0	3.4	6.2	2.0	11.7	5.5	9.5	15.8	13.1	5.7	16.7	15.5	6.9	8.1	4.1	39.8	5.1	3.8	11.6	2.2
CNPY4	"MGC40499, PRAT4B"	ENSG00000166997	"Canopy FGF signaling regulator 4"	Q8N129	7	100119634-100125508	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Leydig cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014166, HPA025240"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA014166: AB_1853895, HPA025240: AB_2082630"	"unprognostic (9.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.09e-3)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.35e-2)"	13.7	16.8	13.3	9.6	13.9	6.1	11.0	14.3	14.9	24.6	14.7	14.1	6.4	21.2	14.8	5.7	15.4	16.7	13.1	13.1	13.7	10.4	6.6	9.2	10.8	14.2	13.8	24.5	4.5	12.8	16.6	21.3	14.1	10.8	9.9	17.2	5.7	15.9	5.1	8.3	9.7	21.4	13.8	13.6	7.8	6.8	13.6	14.3	10.4	7.1	9.8	12.4	14.8	14.3	7.9	13.5	33.2	59.6	76.0	36.5	16.6	29.0	31.2	14.9	27.8	7.5	7.0	17.2	32.9	52.5	10.9	7.9	13.0	14.2	15.6	16.2	13.4	7.1	23.3	10.4	21.5	12.1	12.8	33.4	3.8	13.7	6.2	32.7	52.4	8.2	6.0	11.1	21.5	22.9	25.8	15.9	17.1	5.0	19.2	7.5	24.9	9.2	15.4	2.0	8.3	16.9	27.8	22.4	15.4	21.4	11.3	6.7	42.9	47.5	28.5	20.2	13.3	9.4	16.3	15.3	27.8	18.4	19.7	11.8	5.1	8.6	15.1	11.2	19.8	3.9	15.6	19.0	7.2	2.9	12.7	19.0	2.3	12.3	13.9	4.6	13.8	6.7	13.3	13.9	14.3	14.9	13.1	13.7	14.2	13.8	14.1	13.8	13.6	14.3	15.2	6.4	2.6	4.2	3.4	3.6	2.3	7.9	2.8	6.9	3.4	6.2	3.4	5.7	4.0	12.9	2.1	35.3	5.2	3.7	1.9	6.4	0.5	5.1	20.2	15.0	2.4	11.8	3.4	2.5	10.3	28.4	1.1	4.2	9.5	16.1	18.2	1.3	14.0	8.4	4.0	1.9	4.1	2.5	2.4	2.2	35.1	4.7	16.0	2.8	5.1	26.6	8.2	2.0	2.8	2.4	2.8	31.6	1.9	0.5	2.8	3.3	4.4	15.8	13.1	12.7	15.5	1.1	4.5	2.1	3.8	18.3	8.6	30.5	2.3	1.0
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Spermatocytes: 84.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.9"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"HEL: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	4.4	2.4	2.3	2.1	2.4	7.3	3.5	7.7	2.2	5.0	3.3	4.5	1.2	7.1	2.4	2.7	4.3	4.2	2.3	1.7	2.6	2.4	10.5	2.8	2.7	2.7	3.1	8.8	1.7	4.4	2.2	3.6	3.0	2.7	2.2	2.1	1.6	3.2	1.6	1.9	2.2	4.5	2.6	3.9	1.9	5.2	2.5	2.8	3.1	2.5	1.6	3.5	3.5	2.8	8.3	5.6	12.1	6.8	5.8	13.6	0.4	9.5	6.3	7.0	9.5	0.4	2.7	6.0	1.5	6.6	7.5	0.3	14.1	3.9	10.9	0.3	4.9	35.5	11.7	2.0	6.4	4.9	7.4	8.6	2.0	5.8	5.7	6.5	10.0	2.2	1.3	1.1	11.3	0.6	4.0	7.8	9.4	1.4	10.3	5.8	11.2	3.0	4.1	2.0	7.6	7.9	11.6	0.2	3.0	4.8	2.3	12.3	7.5	9.5	3.7	10.4	8.3	4.7	6.1	0.1	4.4	6.1	4.4	0.2	1.3	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.1	0.5	3.9	0.7	0.1	0.2	2.3	2.4	7.7	2.2	1.7	2.6	2.7	3.1	3.0	2.6	2.5	2.8	32.0	6.4	17.6	59.7	1.6	8.8	13.7	6.1	13.1	12.3	3.6	5.8	13.4	7.2	3.4	9.2	0.0	2.5	1.1	2.4	5.9	10.1	16.3	23.4	30.7	24.9	2.4	17.1	20.3	12.0	5.2	29.2	4.1	17.0	7.6	42.4	20.0	38.8	18.4	20.2	37.2	5.9	4.1	40.3	11.6	8.8	45.7	24.0	8.8	91.8	31.0	21.4	1.0	70.4	29.6	4.0	0.8	30.9	1.8	3.8	5.3	8.5	6.7	8.1	13.1	34.2	21.3	84.3	48.9	5.3	5.5	1.0	1.7	31.6	5.5	6.3
CNTN1	"F3, GP135"	ENSG00000018236	"Contactin 1"	Q12860	12	40692439-41072415	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 158.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 763.9;Excitatory neurons: 844.8;Inhibitory neurons: 699.0;Oligodendrocyte precursor cells: 1021.4"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 224.4;HaCaT: 40.3;SCLC-21H: 68.5;SH-SY5Y: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025200, HPA070467"	Enhanced	Approved			"Intracellular and membrane"	NA	NA		450000000	"Cluster 17: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB025200: , HPA070467: AB_2732156"	"unprognostic (3.18e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-4)"	"unprognostic (6.98e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (3.75e-4)"	3.9	33.2	64.0	2.5	75.3	0.2	8.8	119.4	84.2	14.1	0.0	3.1	1.7	11.5	2.6	9.1	2.2	11.7	0.8	93.6	59.8	12.4	1.2	4.4	4.5	72.6	94.7	49.2	6.0	1.4	10.4	0.3	70.0	27.8	3.8	26.8	5.4	27.7	0.8	12.8	3.0	10.6	129.0	8.2	5.0	9.4	79.2	1.0	1.2	1.6	3.9	21.5	6.6	158.2	0.1	224.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.3	0.3	0.1	0.1	0.0	0.0	40.3	6.0	11.2	0.0	0.2	2.4	0.0	0.7	0.0	0.0	0.0	0.7	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.2	1.5	0.2	0.1	0.0	1.0	0.3	0.0	0.0	68.5	40.3	0.1	2.5	2.7	1.0	0.1	0.6	0.0	0.1	4.3	0.1	10.0	2.8	0.1	0.0	0.3	0.0	0.9	2.6	0.5	0.7	0.3	0.2	0.3	0.4	0.2	0.2	0.1	0.4	0.4	0.2	1.2	0.7	0.4	0.9	0.2	0.0	64.0	75.3	119.4	84.2	93.6	59.8	72.6	94.7	70.0	129.0	79.2	158.2	0.3	0.0	5.9	763.9	0.1	5.2	1.1	1.6	4.0	32.1	0.4	1.8	0.7	0.0	4.5	5.5	29.2	0.0	0.0	0.0	1.9	0.0	34.9	4.3	7.1	0.7	0.0	0.0	844.8	0.0	0.0	13.3	0.0	0.3	0.0	5.0	0.0	0.0	0.1	11.8	699.0	0.0	2.0	0.0	4.0	149.5	62.7	0.1	10.6	54.4	0.0	34.6	0.0	1021.4	23.9	0.7	0.0	60.2	0.0	0.3	0.0	0.0	0.4	5.9	0.0	0.5	3.6	0.6	0.8	2.1	13.5	0.0	0.5	0.3	0.0	0.2
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201372-107564261	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: AB_2677564"	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (1.15e-1)"	11.4	12.1	6.7	9.5	7.7	14.2	10.8	7.7	8.5	20.4	8.1	12.0	9.3	17.1	10.0	12.8	9.0	12.9	19.7	7.1	7.5	9.7	6.8	10.2	9.5	7.0	7.5	12.4	14.7	19.4	10.2	10.5	7.6	17.8	12.4	11.8	22.8	11.0	14.0	12.9	10.1	14.4	6.3	9.0	11.7	8.6	7.5	6.2	20.3	15.4	10.4	10.5	16.7	9.4	39.3	14.9	16.1	15.1	14.7	16.2	12.6	27.0	28.2	11.7	20.5	12.0	17.5	7.9	14.9	27.0	26.5	15.5	10.7	16.0	18.2	23.5	9.6	8.7	9.9	15.1	17.4	18.8	19.0	15.4	15.3	20.4	24.0	32.1	31.7	17.1	16.6	25.1	21.5	18.5	19.2	17.8	5.9	30.0	19.1	6.8	13.6	18.6	13.6	17.9	7.6	21.8	16.6	27.2	31.2	23.8	6.2	12.2	36.6	12.6	16.0	39.7	17.2	16.3	16.9	17.3	24.2	21.0	33.9	9.4	6.6	7.5	6.1	7.6	8.4	6.0	7.7	6.9	5.4	5.8	6.4	6.4	3.4	5.1	9.3	3.7	6.5	5.9	6.7	7.7	7.7	8.5	7.1	7.5	7.0	7.5	7.6	6.3	7.5	9.4	14.8	3.2	15.5	124.4	21.7	12.2	15.0	11.1	24.5	23.2	10.0	7.7	27.6	7.2	16.5	14.7	33.3	10.2	16.5	15.8	1.9	10.5	22.6	11.8	21.8	11.0	10.3	5.9	147.0	10.9	8.5	14.4	14.8	19.8	3.8	12.3	9.7	5.8	11.3	11.8	196.1	36.2	18.3	14.8	12.3	22.1	11.8	15.3	12.4	147.1	15.7	9.0	11.3	136.7	183.2	10.8	10.1	12.4	20.7	20.6	14.5	6.5	16.3	17.4	26.3	15.4	10.2	18.2	14.0	19.0	13.4	10.5	18.9	7.5	14.9	16.1
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50184101-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1331.8;gallbladder: 1211.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 2044.3;Fibroblasts: 1944.4;Leydig cells: 556.0;Smooth muscle cells: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1689.5;BJ: 3428.1;fHDF/TERT166: 5206.1;HSkMC: 2490.3;U-138 MG: 2687.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 115.9"	"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		80000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	312.1	39.9	1.8	272.8	5.3	4.5	184.9	1.3	15.9	1331.8	12.0	223.2	37.7	531.4	23.4	110.2	234.1	1211.3	126.6	1.5	1.9	34.7	29.7	139.0	78.1	3.2	1.4	377.3	39.8	14.1	80.5	503.5	2.0	137.5	46.5	0.4	51.3	98.6	21.2	362.0	86.6	801.2	2.2	46.9	109.9	38.2	17.3	14.4	50.8	13.0	21.1	616.3	342.2	6.7	6.0	5.0	16.4	3.2	702.9	1689.5	29.2	3428.1	915.8	826.6	517.6	64.2	14.6	0.6	7.8	5206.1	5.7	9.1	8.3	3.4	150.1	5.2	6.1	0.4	92.2	4.2	1309.3	1.2	0.8	2490.3	45.7	1016.2	4.6	126.9	0.5	4.8	2.2	0.4	425.4	8.5	1.4	1.0	17.0	10.7	10.5	6.1	2.1	2.7	3.9	0.2	2.0	8.8	5.6	5.0	0.2	245.4	39.8	0.6	1.5	2687.4	562.6	405.0	16.2	2.8	5.9	0.7	200.1	1.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.3	1.3	15.9	1.5	1.9	3.2	1.4	2.0	2.2	17.3	6.7	66.9	9.6	13.8	0.0	2.1	188.0	12.4	31.6	10.8	0.2	9.1	10.0	12.5	5.7	13.2	7.3	0.0	45.7	1.7	1.4	0.0	13.3	1.9	64.6	2044.3	33.4	3.0	0.0	0.1	4.2	45.5	1944.4	17.9	49.2	2.5	8.1	378.0	3.4	67.6	0.0	0.3	5.4	6.1	0.3	318.1	18.2	556.0	13.1	188.5	12.2	0.0	2.5	0.0	0.0	0.0	23.8	0.3	268.1	1.3	10.7	0.1	0.7	9.8	0.2	78.9	74.8	1024.9	4.0	2.6	4.3	163.5	111.8	29.4	57.3	2.9	9.1
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981769-46005050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 796.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 578.3;Fibroblasts: 816.1;Leydig cells: 353.0;Peritubular cells: 251.3;Smooth muscle cells: 324.4;Theca cells: 246.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1157.2;ASC TERT1: 2331.5;BJ: 927.1;HHSteC: 1025.3;HSkMC: 1711.4;U-138 MG: 1297.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 46.8"	"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		250000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (4.54e-4)"	285.9	50.1	15.7	153.3	9.0	0.7	173.9	33.9	20.4	499.3	32.1	796.8	73.3	556.3	24.6	91.1	411.5	194.4	155.6	10.3	14.9	66.1	48.3	140.3	37.5	23.1	18.4	491.4	57.8	29.1	117.8	287.1	21.5	246.8	40.5	3.4	97.7	142.3	85.4	123.4	217.7	177.9	11.3	70.7	230.5	32.8	14.9	30.7	92.6	39.5	16.6	478.7	284.7	9.7	2.9	20.2	31.2	99.6	1157.2	2331.5	3.9	927.1	586.3	231.7	80.7	16.2	62.8	0.1	75.1	522.2	183.6	4.3	13.5	2.3	19.5	0.5	14.9	0.0	3.7	5.2	1025.3	0.3	2.2	1711.4	1.0	578.6	7.8	20.9	5.6	0.2	0.7	0.6	60.9	1.4	0.3	3.2	22.4	13.4	263.2	0.1	19.5	4.3	1.6	11.1	1.0	39.9	87.6	1.1	17.9	10.4	4.2	4.2	0.5	1297.6	86.7	362.7	358.1	0.6	0.4	0.4	464.1	6.9	116.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	9.0	33.9	20.4	10.3	14.9	23.1	18.4	21.5	11.3	14.9	9.7	74.6	0.0	5.8	26.1	2.5	122.2	11.0	1.5	18.2	18.9	9.2	35.9	42.7	5.7	4.4	9.2	0.0	11.6	2.3	0.6	3.9	23.2	4.6	20.9	578.3	50.6	1.8	0.0	27.1	3.3	18.6	816.1	6.1	16.1	1.3	48.7	101.0	13.4	22.4	15.2	8.2	0.3	0.0	3.3	134.7	18.6	353.0	7.8	147.7	40.3	2.0	18.7	0.0	30.7	2.4	6.1	2.6	251.3	3.5	6.3	2.1	10.3	1.0	4.3	184.1	152.3	324.4	2.6	6.2	5.5	89.9	20.8	13.7	246.5	1.4	3.8
COMMD10	PTD002	ENSG00000145781	"COMM domain containing 10"	Q9Y6G5	5	116085016-116412762	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 184.6;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 236.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045441, HPA054156"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA045441: AB_10961905, HPA054156: "	"unprognostic (1.14e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.59e-1)"	19.4	24.1	12.5	14.2	12.4	14.9	23.1	12.8	15.9	19.2	14.4	17.0	13.0	16.7	32.2	15.6	12.9	17.3	31.3	11.7	13.3	35.4	24.6	13.9	22.1	12.8	13.2	13.9	24.1	25.4	14.3	19.6	13.4	20.7	20.1	17.1	30.7	17.0	14.3	9.6	13.8	19.6	13.5	18.6	16.3	8.1	13.2	16.3	27.4	17.5	20.3	18.0	13.6	14.7	34.7	36.7	37.5	20.0	27.3	37.1	40.2	26.5	30.0	37.5	31.0	29.2	43.7	17.9	29.0	37.9	75.0	18.6	20.8	42.6	56.9	49.3	14.6	22.1	10.7	22.9	30.8	17.5	37.1	23.7	28.7	22.4	29.2	31.1	37.9	25.2	13.6	12.1	50.2	24.2	32.9	41.9	32.7	26.8	16.9	30.9	40.1	51.2	54.7	21.8	20.2	26.0	31.3	30.5	39.7	28.1	34.6	64.1	20.9	31.5	38.5	15.3	46.0	11.9	16.3	45.8	32.1	63.2	36.5	13.6	24.6	18.3	9.9	29.7	13.7	16.2	12.9	12.8	32.7	11.3	12.5	13.0	4.7	22.7	31.0	24.9	15.3	18.9	12.5	12.4	12.8	15.9	11.7	13.3	12.8	13.2	13.4	13.5	13.2	14.7	25.7	9.6	20.0	97.3	36.7	22.2	30.4	54.0	17.6	15.7	28.1	18.3	48.9	11.5	29.5	23.9	6.2	44.9	16.9	11.5	92.0	26.2	1.9	15.8	22.2	24.0	10.7	18.5	84.8	15.1	53.4	25.0	27.0	22.8	46.3	22.5	26.4	15.1	48.7	16.8	90.5	25.1	46.8	28.7	38.4	3.7	21.1	33.1	32.0	184.6	27.1	30.2	15.5	142.7	236.7	17.1	17.2	20.3	30.6	33.1	17.3	101.3	10.4	20.9	0.0	13.4	22.4	8.7	15.6	20.5	25.1	49.5	28.4	36.3	25.5	32.0
COMMD6	Acrg	ENSG00000188243	"COMM domain containing 6"	Q7Z4G1	13	75525219-75549439	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"				"unprognostic (8.76e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.49e-3)"	"unprognostic (5.90e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.89e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	94.0	166.3	58.1	76.5	61.0	134.1	116.6	61.7	75.2	110.5	63.0	138.5	70.0	119.2	165.0	96.9	115.1	105.0	109.1	57.0	61.8	105.4	101.0	61.0	171.0	60.7	59.7	234.2	84.7	48.7	61.2	48.9	61.6	83.0	88.9	32.0	85.0	72.1	52.2	79.6	79.0	107.3	63.8	88.0	93.7	43.9	60.8	70.1	144.9	38.9	134.4	109.4	87.7	64.9	201.4	62.2	86.5	73.3	188.8	221.2	60.4	137.5	101.2	46.8	82.0	93.0	109.5	79.2	149.1	115.7	92.4	104.4	56.1	107.3	67.1	164.0	104.3	114.3	52.3	66.8	153.4	132.0	97.2	169.0	176.0	63.8	91.2	264.1	101.3	122.7	32.2	73.1	108.0	49.3	79.3	199.1	51.8	259.7	121.1	75.0	73.7	87.2	96.0	63.7	68.9	112.1	68.5	66.2	184.2	148.4	85.6	196.3	157.6	60.4	59.2	77.2	103.9	92.2	88.7	71.3	195.3	131.2	61.2	564.9	306.4	274.0	308.3	311.8	382.3	684.4	542.9	412.2	382.5	597.2	638.6	548.9	135.4	434.8	294.8	996.5	655.4	582.7	58.1	61.0	61.7	75.2	57.0	61.8	60.7	59.7	61.6	63.8	60.8	64.9	372.1	179.5	233.1	10.1	597.3	521.4	589.4	948.8	592.4	45.9	722.0	1331.3	250.4	348.9	388.2	343.9	20.9	339.9	663.2	299.8	1054.6	353.2	170.8	282.7	338.0	331.7	401.9	153.7	19.5	327.6	434.0	330.5	224.3	222.6	412.1	354.1	418.4	554.0	493.7	42.1	23.1	541.7	360.1	510.1	737.5	77.1	491.5	451.8	338.0	14.0	613.0	287.0	677.7	19.6	19.2	327.9	390.7	348.3	172.0	401.7	324.1	903.6	287.7	54.6	164.3	455.4	363.8	181.0	218.8	457.8	599.1	271.3	614.7	190.7	554.5	500.5
CORO1C	"coronin-3, HCRNN4"	ENSG00000110880	"Coronin 1C"	Q9ULV4	12	108645109-108731526	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041737	Approved					NA	NA		13000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA041737: AB_10804115"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.96e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (2.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.90e-3)"	68.5	30.6	36.1	49.7	36.1	52.5	36.6	28.1	36.8	49.9	22.1	116.6	28.9	96.1	24.1	67.7	55.9	54.4	33.7	41.3	39.1	25.8	49.1	76.4	31.6	43.9	37.1	30.4	13.0	36.4	22.0	48.2	39.0	35.8	53.3	10.5	24.6	67.3	30.0	52.1	42.9	142.9	38.3	26.1	45.0	22.5	40.8	47.4	14.2	23.6	33.6	71.5	44.7	53.4	188.2	207.2	274.3	140.8	137.3	186.5	117.3	347.8	372.0	443.2	353.6	245.8	81.5	10.6	88.8	547.9	173.2	85.4	153.3	255.1	558.1	82.8	71.4	313.8	95.3	192.7	123.8	76.6	154.1	173.7	120.3	501.0	376.9	262.3	234.1	51.8	157.0	101.0	473.6	68.4	34.7	90.5	70.5	68.7	197.9	53.3	158.6	121.9	176.0	122.5	75.0	66.3	115.6	16.0	156.6	173.0	83.0	58.0	263.7	316.1	165.1	297.7	296.8	99.4	245.7	232.8	246.3	64.0	215.5	42.3	70.7	32.0	7.4	78.1	3.5	24.6	2.9	4.5	75.7	19.1	1.0	3.3	81.9	12.6	75.2	75.9	7.5	44.7	36.1	36.1	28.1	36.8	41.3	39.1	43.9	37.1	39.0	38.3	40.8	53.4	24.5	54.5	20.7	18.3	27.8	138.0	168.2	47.7	66.0	7.1	18.2	14.1	19.0	18.6	34.6	12.9	2.1	28.4	39.1	41.3	3.9	59.7	58.9	33.6	47.2	51.9	30.9	25.5	32.8	22.7	125.3	38.4	20.4	39.1	41.8	43.3	17.2	49.8	122.2	15.2	39.7	23.4	16.2	71.0	181.4	56.4	22.4	108.8	90.7	37.5	81.7	6.7	8.2	46.3	42.6	76.9	29.8	58.6	31.6	92.8	19.0	30.1	10.5	5.3	13.1	42.8	53.2	26.8	22.9	60.6	167.8	46.8	12.0	9.9	30.7	93.2
COTL1	CLP	ENSG00000103187	"Coactosin like F-actin binding protein 1"	Q14019	16	84565596-84618078	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Chaperone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 273.2;lymphoid tissue: 374.3"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1402.6;Hofbauer cells: 595.3;Kupffer cells: 1015.5;Langerhans cells: 1146.3;Macrophages: 1046.2;monocytes: 949.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 2441.1;eosinophil: 3418.8;intermediate monocyte: 4072.1;myeloid DC: 2395.7;neutrophil: 1758.0;non-classical monocyte: 4579.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2395.7;granulocytes: 3418.8;monocytes: 4579.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 1271.3"	"Low region specificity"	"Detected in all"							"HPA008918, CAB062328"	Enhanced		Supported	Cytosol		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB062328: AB_2084785, HPA008918: AB_2668176"	"unprognostic (2.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.70e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.35e-3)"	87.8	36.8	65.8	296.0	82.1	273.2	54.2	80.6	67.4	31.7	57.7	68.7	90.4	46.7	12.1	32.4	49.5	75.2	25.1	68.8	82.8	140.5	44.6	110.6	374.3	87.5	80.5	24.1	30.3	32.4	47.4	78.0	86.6	44.5	66.0	44.4	24.9	28.5	10.9	20.4	104.8	66.6	78.0	330.5	126.5	20.5	101.5	88.6	38.0	12.2	263.5	118.4	28.3	86.4	546.3	445.0	994.2	1058.1	111.5	305.0	299.5	462.0	295.8	355.8	136.6	609.1	818.7	149.6	137.6	349.7	211.7	266.8	61.3	364.1	355.1	1.1	77.9	281.9	87.7	162.7	314.0	320.1	1069.3	245.6	57.6	344.2	305.0	222.2	172.2	326.4	26.5	60.5	215.3	88.3	99.1	191.7	123.1	178.5	448.8	10.4	33.7	9.3	529.2	227.5	156.7	7.9	430.7	101.9	238.8	116.9	77.1	256.7	445.9	509.0	290.2	165.8	341.4	11.5	58.1	123.7	397.7	154.1	1271.3	740.1	2441.1	3418.8	69.9	4072.1	92.5	546.6	441.0	417.2	2395.7	279.2	192.6	229.6	1758.0	667.2	4579.3	123.7	685.2	2954.6	65.8	82.1	80.6	67.4	68.8	82.8	87.5	80.5	86.6	78.0	101.5	86.4	44.0	3.2	12.2	20.5	331.8	63.5	116.5	7.5	27.3	10.4	22.2	32.9	5.1	17.2	6.2	77.3	244.0	136.4	104.5	47.0	39.2	73.0	6.8	17.6	74.5	94.4	145.6	78.4	6.8	34.5	1402.6	59.9	181.0	29.8	141.8	126.0	189.2	6.6	595.3	25.2	14.1	77.8	2.0	1015.5	1146.3	10.8	8.1	1046.2	96.0	39.4	949.1	31.5	74.2	27.6	2.1	108.2	19.8	16.1	130.1	165.3	52.8	305.3	4.5	43.2	6.6	15.4	75.7	5.1	39.5	9.2	38.2	172.8	354.9	11.9	140.2	179.6
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 156.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 359.0;Alveolar cells type 2: 362.2;Kupffer cells: 368.5;Sertoli cells: 762.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 21.0;intermediate monocyte: 14.5;myeloid DC: 16.6;non-classical monocyte: 7.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 16.6;monocytes: 21.0"	"Group enriched"	"Detected in many"	4	"ASC diff: 71.1;ASC TERT1: 50.0;HSkMC: 91.2;SiHa: 68.9;THP-1: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles		NA	NA		7100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	156.1	11.5	6.4	14.4	13.3	3.5	40.2	10.1	10.5	14.4	3.8	33.5	4.4	23.9	0.9	10.1	16.2	16.1	4.6	7.6	10.2	41.3	26.5	59.3	16.1	19.3	11.5	18.0	13.0	12.0	1.0	70.1	11.9	14.7	26.6	6.7	4.1	2.8	5.8	21.7	5.9	6.4	7.5	19.4	15.3	5.4	28.0	4.3	7.5	9.7	10.5	9.3	5.7	23.5	0.1	4.0	0.1	0.0	71.1	50.0	0.7	9.8	1.1	1.7	2.3	3.2	4.1	0.5	9.6	1.4	4.1	0.0	1.4	2.7	4.1	0.1	2.7	0.0	15.1	0.3	0.4	1.2	1.9	91.2	0.6	1.0	2.0	8.6	0.0	0.3	0.0	0.1	7.3	1.7	0.0	0.7	1.7	0.0	5.2	3.1	0.6	0.0	7.2	5.9	0.4	0.2	68.9	10.7	7.9	5.5	1.2	26.5	0.2	1.2	7.5	0.5	0.2	0.4	0.5	13.1	4.3	13.1	5.9	0.6	21.0	0.1	0.2	14.5	0.0	1.8	1.5	0.1	16.6	3.5	0.9	0.2	1.6	0.5	7.4	1.1	1.9	7.3	6.4	13.3	10.1	10.5	7.6	10.2	19.3	11.5	11.9	7.5	28.0	23.5	83.3	359.0	362.2	34.6	4.9	12.4	3.5	6.1	0.6	3.3	7.8	8.9	2.6	135.8	70.1	51.5	0.0	32.3	1.1	97.5	29.4	57.9	16.6	100.9	8.3	29.0	10.8	3.6	1.2	212.5	59.9	14.1	4.6	237.1	112.5	6.7	73.9	36.6	134.6	0.0	1.3	28.7	0.0	368.5	36.3	17.5	105.0	202.2	10.6	19.7	23.3	68.9	1.0	23.1	161.8	68.0	65.9	79.0	2.4	38.7	1.9	63.7	16.4	5.7	762.6	7.2	126.9	0.6	3.9	2.4	9.9	172.4	14.5	46.3	32.7	2.8
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 13.2;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 32.6;Erythroid cells: 20.4;Kupffer cells: 59.1;Macrophages: 24.9;monocytes: 13.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.7;eosinophil: 17.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 53.7"	"Group enriched"	"Detected in some"	9	"HL-60: 9.9;HMC-1: 21.8;NB-4: 9.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					NA	NA		33000000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723"	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	13.2	0.8	0.1	27.2	0.5	10.5	0.6	0.1	2.9	1.2	1.3	1.5	1.3	0.5	0.2	0.9	1.4	2.1	0.6	0.2	0.2	2.5	2.6	3.2	20.1	0.7	0.5	0.2	0.3	0.1	0.2	9.1	1.6	0.2	1.5	0.0	0.4	0.4	0.2	0.1	4.4	6.3	0.1	24.4	1.7	0.6	2.1	1.6	0.3	1.0	17.9	6.7	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	9.9	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.7	4.2	17.2	0.0	2.4	0.7	4.5	0.9	0.4	0.3	2.2	0.2	0.1	15.6	0.0	2.3	0.0	0.0	1.3	0.1	0.5	0.1	2.9	0.2	0.2	0.7	0.5	1.6	0.1	2.1	1.8	0.3	0.0	4.2	0.3	32.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.0	20.4	0.3	0.0	0.1	0.6	0.0	0.2	1.3	0.3	0.0	0.4	9.7	0.0	0.4	0.0	0.0	59.1	1.4	0.0	0.0	24.9	0.0	1.9	13.3	0.0	0.0	1.5	4.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.0	0.0
CRABP1	"CRABP, CRABP-I, CRABPI, RBP5"	ENSG00000166426	"Cellular retinoic acid binding protein 1"	P29762	15	78340353-78348225	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 544.1;thyroid gland: 173.2"	"Cell type enriched"	"Detected in some"	24	"Muller glia cells: 4845.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 117.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 1022.7;NTERA-2: 307.4"	"Group enriched"	"Detected in many"	5	"amygdala: 6.4;basal ganglia: 23.4;hypothalamus: 13.3;olfactory bulb: 12.8;pons and medulla: 7.4"	"Low region specificity"	"Detected in all"			HPA017203	Enhanced	Supported				NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA017203: AB_1846512"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.35e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-1)"	0.9	1.7	14.2	2.5	24.8	0.2	56.1	25.6	26.4	1.3	28.5	6.9	0.8	2.3	2.0	0.6	0.3	1.6	0.4	9.6	39.6	15.5	0.0	0.7	0.2	61.7	62.6	0.4	0.7	0.0	27.6	15.0	58.4	2.6	1.7	544.1	1.1	47.4	0.2	26.7	5.0	1.8	23.8	75.2	7.1	0.5	86.2	1.7	173.2	0.2	1.2	0.6	2.5	13.7	0.0	0.2	1022.7	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	65.3	0.9	0.0	6.3	0.0	0.3	0.0	9.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	57.9	0.4	307.4	1.0	0.8	0.0	0.0	0.0	0.0	1.5	85.5	58.0	0.0	0.2	0.1	24.8	1.4	35.9	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	24.8	25.6	26.4	9.6	39.6	61.7	62.6	58.4	23.8	86.2	13.7	1.0	0.0	0.0	0.3	0.8	9.7	0.1	0.0	0.0	31.1	112.6	199.0	0.0	0.0	0.0	0.0	33.3	1.1	2.9	1.1	70.5	0.0	0.0	0.1	0.1	4.8	0.0	0.0	0.2	0.0	0.8	11.3	0.0	0.1	0.0	4.2	0.0	0.0	1.5	10.1	1.5	0.4	0.0	0.0	5.3	0.0	0.0	0.5	192.1	0.0	0.0	4845.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.4	0.5	0.0	91.2	0.0	0.0	1.0	0.1	2.2	0.0	2.6	1.4	0.9	0.0	1.6	0.1
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1189.7;vagina: 604.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 485.4;Breast glandular cells: 224.2;Club cells: 266.7;Squamous epithelial cells: 714.0;Urothelial cells: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1592.5;MCF7: 625.9;T-47d: 1201.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 36.0"	HPA004135	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		76000	"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	22.2	8.0	9.6	4.8	11.5	5.7	104.5	10.5	18.8	273.7	29.4	13.3	0.9	76.3	4.7	1189.7	83.1	18.2	5.5	10.7	12.8	12.0	2.3	6.4	3.9	8.0	8.2	6.2	3.4	55.1	43.5	40.5	7.8	34.8	4.8	4.5	93.5	57.1	5.0	179.0	3.9	57.0	7.4	7.9	5.6	5.3	12.0	15.5	14.5	1.8	76.2	81.2	604.9	10.1	103.4	5.4	115.3	1.6	147.1	218.0	0.4	215.4	1592.5	17.3	21.3	184.9	369.8	1.6	103.1	234.0	2.2	131.2	28.1	0.8	5.1	2.9	8.1	0.1	13.5	1.6	29.0	0.3	2.5	69.3	10.6	25.4	0.5	13.8	0.7	2.0	1.0	2.2	1.9	625.9	1.7	1.9	136.5	12.3	57.3	1.7	0.8	3.4	2.3	4.0	280.7	20.2	3.0	366.2	1.5	214.9	1201.3	0.7	0.2	4.2	63.1	35.5	13.4	9.8	23.8	1.3	28.6	1.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.6	11.5	10.5	18.8	10.7	12.8	8.0	8.2	7.8	7.4	12.0	10.1	7.0	0.0	2.6	1.3	1.8	65.0	131.2	485.4	104.2	1.8	224.2	96.8	0.7	1.5	266.7	16.5	2.1	53.9	4.9	0.9	0.0	12.6	2.2	18.0	51.9	10.3	0.0	0.0	3.1	5.2	6.2	168.4	1.1	29.3	0.0	0.5	6.4	0.2	10.0	0.0	1.8	0.9	40.7	0.0	55.4	1.0	19.9	3.9	62.2	0.0	0.0	1.0	0.0	1.5	0.3	18.1	0.2	37.6	0.2	194.9	0.1	0.3	28.2	0.6	0.0	4.3	40.0	2.0	6.1	714.0	190.7	18.1	7.6	4.8	1.7	506.4
CREBL2		ENSG00000111269	"CAMP responsive element binding protein like 2"	O60519	12	12611827-12645108	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 130.6"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043738	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA043738: AB_10795041"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.53e-1)"	39.8	130.6	24.7	30.4	26.3	5.3	31.9	22.8	29.2	26.4	29.5	23.4	23.1	19.0	28.8	17.1	24.6	28.2	22.5	26.2	28.8	49.7	50.1	32.5	37.5	24.6	24.5	37.2	24.7	56.3	32.2	24.2	24.6	28.2	23.8	35.2	26.4	23.0	10.1	24.6	23.6	18.9	24.8	37.5	25.1	20.9	29.1	24.7	44.3	15.6	29.8	28.0	15.1	27.7	12.5	15.9	13.6	15.5	46.9	47.0	26.3	24.0	40.4	17.3	23.7	11.5	17.9	10.8	9.1	29.3	26.2	10.3	20.7	18.4	29.1	61.0	12.6	8.5	15.1	14.2	30.7	12.2	15.2	30.8	32.2	20.3	33.1	58.7	25.7	8.5	8.7	16.5	29.4	20.1	6.4	9.9	40.8	11.9	14.4	8.7	23.6	6.9	33.1	35.7	16.0	18.2	24.4	11.7	43.3	58.5	6.5	13.6	20.8	23.7	15.1	23.7	23.9	13.9	19.7	2.7	28.1	10.3	24.9	1.1	2.5	2.6	1.7	5.6	3.1	0.9	3.4	2.7	2.8	1.1	3.3	2.7	0.4	1.1	2.6	1.4	5.6	1.5	24.7	26.3	22.8	29.2	26.2	28.8	24.6	24.5	24.6	24.8	29.1	27.7	18.0	25.6	26.5	23.5	14.8	22.2	18.6	11.1	18.8	17.5	23.5	15.9	14.6	30.0	12.2	33.1	2.1	18.1	15.7	17.7	41.1	21.6	40.4	14.2	10.4	19.1	30.0	27.8	15.9	21.8	19.3	25.3	17.9	10.6	10.2	12.1	23.2	48.4	39.3	37.0	17.7	16.4	26.4	120.0	83.0	12.1	36.1	58.2	33.8	33.7	45.6	38.0	10.3	28.6	18.6	21.8	15.0	35.3	17.3	29.5	29.3	58.8	19.9	11.8	39.5	13.7	12.4	45.8	20.8	18.0	29.1	27.5	23.3	11.5	17.6	28.1
CRIM1	S52	ENSG00000150938	"Cysteine rich transmembrane BMP regulator 1"	Q9NZV1	2	36355778-36551135	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 163.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 262.9;Hepatic stellate cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 466.5;fHDF/TERT166: 462.5;TIME: 651.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000556	Enhanced				"Intracellular and membrane"	NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA000556: AB_1078567"	"unprognostic (2.15e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.51e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.67e-2)"	88.3	14.6	27.0	18.8	28.1	3.5	58.9	9.4	23.5	26.7	51.4	28.7	14.9	26.6	16.7	30.5	34.4	32.2	34.5	20.3	28.8	70.0	16.0	50.1	14.8	23.5	21.9	36.9	23.5	29.2	7.4	163.8	21.2	25.8	23.2	29.5	31.1	32.6	50.1	27.2	18.2	35.7	22.1	47.1	17.5	12.4	36.1	9.9	33.8	36.5	8.7	38.9	22.2	17.1	100.9	75.4	15.2	17.5	69.1	78.0	125.0	466.5	244.7	255.4	133.4	95.3	34.2	0.2	297.9	462.5	166.1	42.8	11.4	75.2	206.5	1.1	8.7	3.2	96.7	55.5	221.5	2.2	0.6	110.1	55.2	102.4	182.4	238.4	361.9	1.9	4.7	0.7	271.6	9.2	0.2	1.2	11.9	5.2	22.1	5.4	19.6	15.5	159.8	41.1	1.8	0.2	81.5	26.4	3.4	56.2	72.3	2.0	651.1	321.7	116.1	40.4	229.1	25.5	0.5	0.9	94.7	0.4	100.8	1.4	0.1	0.5	0.6	0.0	0.4	0.3	0.2	0.3	0.1	0.2	0.0	0.3	0.2	0.4	0.6	2.1	0.2	0.0	27.0	28.1	9.4	23.5	20.3	28.8	23.5	21.9	21.2	22.1	36.1	17.1	262.9	12.8	43.3	100.2	5.4	66.0	38.5	30.1	43.9	12.0	55.6	72.9	34.4	47.1	26.5	132.4	2.1	111.9	27.1	49.5	3.9	33.5	1.0	37.1	27.7	159.8	31.8	10.7	85.1	2.6	40.6	41.0	10.2	75.9	1.3	27.4	207.1	3.6	27.7	0.0	57.5	37.7	36.7	7.7	32.5	2.0	19.0	8.2	39.2	135.9	7.1	18.5	6.2	65.9	17.2	26.5	30.9	19.9	6.9	75.5	11.5	38.4	28.9	42.5	46.0	18.4	164.6	2.1	9.4	22.0	30.1	173.5	17.1	5.7	33.2	58.3
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 980.8;Endometrial ciliated cells: 1761.1;Proximal enterocytes: 2548.8;Respiratory ciliated cells: 1702.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 699.8;CAPAN-2: 415.5;HaCaT: 464.1;HDLM-2: 329.5;OE19: 1305.8;T-47d: 586.0"									HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"		NA	NA		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	265.2	21.7	19.2	61.1	19.7	29.4	180.8	20.0	36.4	147.4	20.3	133.9	121.7	108.0	206.6	118.7	118.2	28.1	262.6	18.5	20.3	109.7	17.8	254.6	83.9	26.9	29.1	49.8	18.3	21.2	41.5	28.3	24.6	49.6	55.4	0.2	135.7	87.9	44.7	301.1	312.5	42.4	24.7	94.5	94.2	14.3	21.0	79.6	182.1	50.2	135.7	113.7	98.9	20.3	0.0	699.8	4.8	0.6	12.1	8.3	66.8	1.3	0.4	9.0	0.1	21.0	415.5	228.0	2.4	191.0	2.6	464.1	0.1	0.0	0.0	329.5	0.0	17.7	294.7	116.3	1.8	0.1	0.2	3.8	0.0	23.1	0.0	0.9	0.5	64.6	0.5	0.9	0.0	3.7	8.1	1.6	7.4	1305.8	36.4	181.3	0.0	45.5	0.0	0.0	18.5	1.3	2.6	1.2	0.0	0.5	586.0	106.4	1.5	0.4	0.4	5.5	0.0	0.3	0.2	17.9	0.0	0.0	0.6	121.8	218.6	313.1	209.2	214.4	135.1	697.0	442.0	222.1	442.9	384.2	85.4	100.2	13.9	323.5	283.9	291.3	694.8	465.6	19.2	19.7	20.0	36.4	18.5	20.3	26.9	29.1	24.6	24.7	21.0	20.3	50.2	980.8	256.2	0.3	350.7	186.5	1.2	79.5	67.2	0.0	88.1	18.3	1.0	2.8	501.3	51.5	0.0	2.1	287.8	360.4	1.9	20.5	3.6	1761.1	124.5	86.4	76.5	27.3	0.0	3.1	4.3	313.3	210.0	491.9	521.5	0.1	24.7	1.3	52.2	0.0	0.0	243.1	30.5	168.0	577.3	26.2	25.1	523.7	370.0	1.9	461.4	0.2	83.4	0.0	0.1	34.2	659.2	9.4	584.3	0.7	2548.8	2.5	1702.1	0.0	223.5	8.2	448.0	1.0	11.4	29.4	251.6	1.5	524.7	0.1	190.7	3.0
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.7;pituitary gland: 67.3;retina: 57.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 148.9;Excitatory neurons: 40.8;Horizontal cells: 210.3;Inhibitory neurons: 44.5;Muller glia cells: 78.4"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.0;HAP1: 117.2;NTERA-2: 84.3;REH: 229.4;RH-30: 129.6;SCLC-21H: 167.2;SH-SY5Y: 105.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 14: REH - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	9.8	53.0	2.7	55.9	0.1	0.9	45.0	58.0	9.6	10.7	4.4	1.3	21.9	0.1	2.7	4.9	5.1	2.8	59.7	57.9	2.1	0.3	5.7	1.9	31.0	35.2	7.9	5.7	0.7	67.3	5.4	41.0	3.2	1.6	57.6	2.7	3.1	0.5	3.7	2.9	14.5	30.8	1.1	3.7	3.0	47.1	1.2	2.4	1.1	1.0	2.6	2.9	38.2	1.3	2.7	81.0	2.8	0.1	0.0	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	27.2	1.9	117.2	0.0	0.0	2.2	0.9	0.0	4.0	0.6	1.4	0.1	0.7	1.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.3	1.3	0.0	0.4	0.0	84.3	0.0	2.6	229.4	129.6	20.2	0.0	0.2	167.2	105.8	0.0	0.6	1.4	54.2	0.8	0.1	6.8	3.8	27.3	2.3	2.6	14.8	2.2	0.1	9.8	0.9	69.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	55.9	45.0	58.0	59.7	57.9	31.0	35.2	41.0	30.8	47.1	38.2	1.0	0.0	1.1	23.8	0.0	0.4	0.0	1.5	0.0	148.9	0.0	0.0	1.5	0.0	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.1	2.2	0.4	13.6	6.3	2.4	1.3	40.8	0.0	0.2	3.5	3.1	0.5	0.0	2.4	0.0	0.0	0.5	210.3	44.5	0.0	0.0	0.0	0.0	5.5	0.6	0.2	1.8	6.5	0.0	78.4	0.0	33.2	2.9	0.4	0.0	0.4	0.0	0.4	0.0	0.0	0.0	22.8	6.6	0.4	6.2	1.0	12.4	1.1	0.1	0.3	0.2	1.5	0.0	0.1
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 329.8;liver: 254.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040403, HPA058848"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632, HPA058848: "	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	33.7	31.8	69.5	15.4	81.3	11.2	27.1	75.4	78.1	33.0	65.6	62.1	190.2	30.5	51.7	24.7	26.5	30.0	30.4	65.2	79.0	329.8	254.1	19.9	19.4	76.3	71.9	19.8	46.9	31.4	38.1	16.1	76.1	32.2	49.3	20.7	41.6	36.5	17.0	16.3	131.6	22.8	77.2	23.3	45.2	4.9	71.9	18.0	35.0	20.7	16.3	20.9	23.6	89.8	8.1	6.9	6.4	42.7	31.6	36.1	5.8	11.1	20.0	4.8	3.9	2.6	7.8	0.1	20.6	15.5	10.9	1.9	5.7	9.9	4.9	19.4	4.7	14.2	0.8	55.1	18.1	4.6	12.2	21.5	6.4	3.9	22.0	17.1	51.7	20.3	1.0	5.8	12.7	29.2	12.7	7.2	0.4	68.7	10.2	6.4	3.8	1.0	40.8	16.9	4.2	5.0	6.6	3.1	51.0	3.0	21.2	18.0	50.1	5.8	2.6	14.3	7.1	7.6	1.6	0.0	11.1	7.9	24.5	5.8	50.7	3.2	23.2	59.6	18.9	20.5	30.6	22.1	60.5	23.1	23.5	22.2	1.7	15.6	50.6	6.4	37.5	43.8	69.5	81.3	75.4	78.1	65.2	79.0	76.3	71.9	76.1	77.2	71.9	89.8	29.2	6.4	10.3	57.8	17.7	10.3	15.9	29.7	6.2	6.1	22.0	11.6	10.5	35.8	25.6	77.3	12.5	22.0	10.0	138.5	485.2	26.1	3.6	32.5	8.8	29.1	9.1	6.9	54.5	31.6	11.2	29.8	34.1	27.2	25.3	8.8	50.7	306.1	71.4	1.7	35.3	89.0	32.6	91.6	34.3	4.3	26.1	51.3	37.4	13.1	19.3	112.2	9.2	33.7	114.1	43.2	219.1	24.0	14.3	23.0	509.9	1033.9	20.9	12.6	19.7	23.4	14.7	1.0	2.7	13.0	9.2	20.8	20.1	20.7	105.2	15.0
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.7;heart muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.0;Ionocytes: 114.0;Muller glia cells: 640.7;Proximal tubular cells: 190.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 82.0"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 82.0"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 100.3"	"Group enriched"	"Detected in all"	11	"amygdala: 124.0;basal ganglia: 275.1;cerebral cortex: 124.7;hippocampal formation: 324.3;white matter: 128.4"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		NA	NA		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.9	0.8	37.4	0.9	78.7	1.0	2.7	40.6	62.2	3.7	13.6	6.9	1.6	1.0	0.2	7.6	1.1	7.0	175.3	54.0	31.6	64.4	14.2	8.5	1.1	13.9	19.8	0.3	1.8	8.9	55.6	0.4	15.6	35.4	8.4	54.7	20.6	0.2	13.4	4.1	2.6	0.3	14.1	0.3	1.3	5.1	20.5	0.3	0.4	0.9	3.8	21.8	3.6	31.3	0.2	4.0	0.0	0.0	0.2	0.4	0.7	0.0	2.1	0.1	0.2	0.2	0.2	0.3	1.0	0.0	1.8	0.6	5.4	0.0	0.0	0.0	0.8	23.2	0.1	2.3	0.0	0.1	2.2	0.8	0.0	0.8	1.0	0.0	0.0	0.5	0.0	0.4	0.7	0.3	0.0	0.9	9.7	1.6	0.1	0.1	0.0	0.5	100.3	0.1	3.7	5.2	0.2	0.1	2.6	4.8	0.1	0.0	0.0	0.5	0.7	6.8	0.0	0.2	0.0	0.5	16.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.1	3.9	0.0	0.0	0.3	0.0	0.0	82.0	0.0	1.2	37.4	78.7	40.6	62.2	54.0	31.6	13.9	19.8	15.6	14.1	20.5	31.3	0.3	0.0	20.1	5.2	4.1	2.3	25.4	16.3	0.0	6.3	0.4	11.7	126.0	2.8	56.1	14.7	4.2	0.0	11.4	7.1	17.6	0.1	19.7	3.2	1.5	3.0	13.1	4.8	43.8	0.0	0.0	7.1	6.1	7.7	1.3	1.3	0.4	8.3	0.1	1.7	5.9	20.6	114.0	1.6	0.7	12.4	0.0	1.5	33.8	10.3	0.7	640.7	0.0	7.1	6.6	0.4	2.8	0.0	0.3	19.0	7.5	190.1	19.9	26.2	0.0	0.2	4.3	6.7	7.3	0.2	1.3	0.1	1.1	0.1	8.2	68.0
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1408.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 2403.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: AB_2681767"	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	412.5	166.8	149.0	170.9	168.8	276.4	241.9	160.5	170.8	193.8	163.5	300.1	187.3	226.7	196.2	247.2	162.9	172.0	414.8	137.6	169.8	228.2	233.6	182.8	172.4	166.4	169.5	258.8	216.2	273.8	85.8	182.4	172.6	229.8	199.6	177.6	230.0	245.6	1408.6	201.6	196.1	236.4	172.2	176.5	201.7	257.4	164.7	218.8	262.6	1039.4	208.2	238.4	137.0	187.3	658.8	226.6	395.5	396.1	440.7	561.4	550.1	566.7	420.5	373.0	301.1	334.0	193.7	514.9	465.6	543.1	217.0	272.3	442.4	439.6	539.2	632.1	302.8	506.1	390.3	299.9	388.2	380.7	288.7	414.7	468.2	447.0	583.2	502.2	433.5	426.5	523.3	327.3	458.9	2403.4	513.8	242.0	755.0	274.0	302.5	378.4	1221.9	244.0	295.4	508.4	485.6	320.7	553.9	455.8	433.3	411.9	234.5	599.4	526.9	437.8	597.3	579.6	629.1	495.7	587.9	567.7	564.9	422.2	1365.1	217.2	241.4	230.8	146.4	233.1	199.7	161.6	186.5	180.7	226.8	130.4	219.3	189.1	155.2	191.0	270.8	87.2	222.2	389.4	149.0	168.8	160.5	170.8	137.6	169.8	166.4	169.5	172.6	172.2	164.7	187.3	193.2	198.7	194.2	41.8	198.3	216.2	219.7	149.0	235.6	134.0	218.2	161.5	572.0	160.2	181.1	128.8	58.4	172.4	155.2	160.8	226.9	198.2	405.5	130.4	178.8	191.3	219.9	232.8	70.8	202.9	208.2	181.7	143.2	174.3	219.1	234.7	156.4	189.1	156.8	99.3	73.7	220.3	120.1	277.9	202.0	639.7	161.8	216.8	220.5	55.3	241.8	195.5	117.4	54.3	86.5	213.8	150.6	225.7	283.6	269.0	240.1	235.5	143.2	121.3	164.3	232.4	274.2	263.3	189.8	247.2	234.0	272.9	193.3	208.2	210.5	283.8
CSF2RA	"alphaGMR, CD116, CSF2R"	ENSG00000198223	"Colony stimulating factor 2 receptor subunit alpha"	P15509	X	1268800-1310381	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 64.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 248.5;Extravillous trophoblasts: 124.6;Langerhans cells: 365.1;Macrophages: 114.5;monocytes: 575.2;Syncytiotrophoblasts: 312.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 320.2"	"Group enriched"	"Detected in all"	30	"dendritic cells: 170.7;granulocytes: 320.2;monocytes: 161.1"	"Group enriched"	"Detected in some"	7	"BEWO: 194.0;HMC-1: 58.3;SK-MEL-30: 142.0"	"Low region specificity"	"Detected in single"							CAB016148	Uncertain				"Secreted to blood"	NA	NA		13000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"			"CAB016148: AB_626868"	"unprognostic (4.19e-2)"	"prognostic favorable (2.38e-5)"	"unprognostic (5.47e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.48e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (3.60e-1)"	"unprognostic (9.44e-2)"	10.0	5.5	4.2	25.4	4.4	21.7	6.8	5.2	4.8	5.1	5.4	5.8	5.8	2.5	1.7	5.3	4.1	12.6	2.5	4.0	5.4	2.3	4.6	14.2	20.9	8.5	6.6	1.8	3.3	3.1	1.4	64.4	8.3	2.5	7.4	0.7	3.0	3.0	0.6	4.0	6.6	7.1	7.2	14.9	5.0	1.1	9.0	9.4	1.6	2.0	23.5	12.7	1.5	11.9	0.3	11.5	0.5	0.0	0.0	0.0	194.0	0.3	0.5	0.4	0.1	4.2	1.0	0.2	12.6	0.0	10.3	0.2	0.1	0.0	0.0	3.9	0.1	0.2	8.0	0.1	0.0	4.6	58.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.4	18.8	1.6	1.8	0.4	0.2	0.5	0.3	0.0	0.5	0.1	0.3	3.7	0.1	142.0	15.1	9.4	16.8	0.0	0.2	5.5	0.1	0.0	0.1	0.1	0.6	0.0	18.5	0.1	17.4	161.1	200.3	0.4	94.9	1.0	2.3	0.3	0.3	170.7	0.6	0.4	0.3	320.2	7.3	48.7	164.0	1.1	65.5	4.2	4.4	5.2	4.8	4.0	5.4	8.5	6.6	8.3	7.2	9.0	11.9	1.2	0.0	7.3	1.3	5.5	7.8	0.9	0.1	0.6	0.6	6.3	2.5	1.2	2.8	3.6	1.8	0.0	248.5	38.3	0.0	0.0	0.3	0.6	7.8	1.2	5.3	0.0	1.3	1.4	1.8	124.6	3.4	0.0	14.7	10.1	0.5	0.7	0.1	75.5	0.0	1.7	0.0	2.0	74.8	365.1	0.3	0.9	114.5	8.8	66.5	575.2	0.3	0.0	1.5	0.9	0.2	0.0	0.4	1.0	0.5	0.0	0.1	2.7	1.5	6.6	1.8	1.4	0.2	0.4	0.0	5.3	312.5	3.3	0.1	0.0	2.5
CTCF	"CFAP108, FAP108"	ENSG00000102974	"CCCTC-binding factor"	P49711	16	67562467-67639177	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Chromosome partition, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004122, CAB062550, CAB068181, CAB068182"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139"	"unprognostic (2.70e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (3.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-2)"	17.3	14.5	10.6	20.6	12.2	34.6	17.5	17.4	12.7	21.3	7.4	18.9	15.9	20.8	13.8	20.2	19.9	14.6	15.9	10.7	11.9	18.4	18.7	16.4	29.0	10.3	10.2	22.3	18.4	28.3	12.9	20.4	10.3	17.2	21.6	18.4	17.1	17.7	30.5	23.3	19.4	20.3	9.0	22.7	18.3	10.5	10.2	69.6	19.3	28.4	35.4	19.7	20.0	16.2	34.6	51.2	66.9	26.7	29.9	25.5	54.2	32.4	33.6	45.9	43.5	42.3	34.5	106.6	26.0	27.7	26.2	43.8	65.3	35.7	51.5	38.5	44.0	63.9	28.5	49.3	20.4	73.7	59.7	20.8	42.5	34.6	38.2	27.5	35.5	83.1	57.7	43.3	38.6	66.7	156.8	27.4	58.3	38.7	34.5	113.5	54.9	58.7	28.2	48.7	57.0	40.0	57.3	33.2	27.9	35.2	41.0	45.3	33.8	39.3	41.3	30.5	35.7	38.6	52.6	151.2	23.1	43.1	43.1	6.8	2.3	3.4	4.3	2.4	4.1	5.5	4.8	3.5	2.1	7.4	3.8	4.4	6.8	3.5	4.8	5.6	3.9	1.4	10.6	12.2	17.4	12.7	10.7	11.9	10.3	10.2	10.3	9.0	10.2	16.2	38.0	22.4	29.8	19.9	50.4	22.3	24.3	11.4	35.3	35.5	35.6	33.9	32.6	27.1	28.1	23.9	8.4	27.4	54.0	29.2	19.6	31.3	2.1	29.8	43.9	37.3	31.2	52.6	23.0	33.6	33.7	29.9	27.0	40.2	19.6	39.1	23.9	24.0	24.0	45.4	24.2	26.4	16.2	26.7	12.6	3.6	24.8	31.1	12.4	32.8	29.2	32.3	49.4	17.1	32.8	32.5	16.5	28.6	62.6	35.6	18.8	24.5	16.7	27.6	19.7	38.6	41.4	18.4	27.3	38.8	24.7	29.6	47.9	32.6	23.8	30.0
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 177.7;skin 1: 434.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 185.7;Suprabasal keratinocytes: 291.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067089	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA		35000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"	"Nucleoli, Vesicles"	"HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	34.4	11.1	29.7	11.2	28.2	22.4	35.2	37.3	31.2	59.2	13.1	15.0	18.8	11.8	77.4	177.7	12.5	10.3	43.8	29.5	30.0	17.6	15.7	26.4	8.7	33.8	29.0	14.6	35.9	10.9	19.7	28.2	36.4	24.5	10.2	27.5	53.1	14.1	39.0	434.9	14.9	10.9	27.1	9.3	22.8	27.0	37.5	19.6	21.0	22.3	25.1	13.3	85.1	27.3	74.8	10.9	65.9	50.4	9.8	16.2	21.1	14.4	25.2	20.9	13.3	5.4	92.6	22.9	41.0	18.7	21.6	37.3	7.7	85.9	9.6	58.0	11.9	14.9	3.4	69.3	20.3	11.3	8.4	18.2	83.5	26.7	27.0	17.7	57.2	42.4	26.8	10.5	13.0	45.6	25.3	41.6	35.0	60.0	18.7	28.4	19.3	14.7	10.7	25.2	72.1	45.4	32.9	29.4	44.4	22.3	36.3	27.2	37.7	13.4	16.4	20.4	32.2	22.9	32.5	27.0	5.0	56.6	54.5	2.6	5.2	13.8	2.6	1.8	1.6	1.7	1.3	2.1	6.4	1.5	1.3	1.2	3.7	8.6	1.2	2.0	1.3	2.6	29.7	28.2	37.3	31.2	29.5	30.0	33.8	29.0	36.4	27.1	37.5	27.3	150.6	28.9	13.9	30.0	9.6	103.1	42.3	16.1	40.5	9.0	39.9	33.3	14.0	24.3	17.0	18.4	8.4	71.3	23.5	20.5	33.2	20.9	116.3	20.0	17.9	42.7	49.1	20.0	18.0	18.7	43.2	15.7	30.1	38.5	0.0	27.2	20.0	25.6	58.0	16.8	14.1	37.5	12.2	43.0	97.4	34.8	14.9	38.3	48.0	12.2	33.6	185.7	71.1	17.1	24.1	37.6	28.3	23.0	13.3	53.5	28.6	30.5	5.2	12.8	46.0	15.0	24.5	72.1	43.6	154.0	291.5	48.4	17.2	14.3	28.6	60.5
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150794880-150809577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 420.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 18.1"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.8"	"Group enriched"	"Detected in many"	9	"ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	224.1	12.5	2.7	33.1	2.8	3.1	227.7	2.9	18.1	420.6	16.4	68.6	13.8	334.0	44.9	46.0	74.0	299.2	35.8	2.7	2.6	12.7	9.0	36.4	42.1	2.7	2.7	78.4	10.6	6.1	14.6	18.9	2.6	34.1	61.8	6.9	53.3	38.0	15.7	219.8	63.8	141.6	2.8	20.2	41.7	15.1	2.7	12.3	34.7	46.3	48.7	210.5	176.2	2.9	0.7	0.3	1.4	0.8	2284.0	813.2	1.0	55.2	1949.1	3.3	8.3	0.3	0.3	0.4	0.6	129.8	0.0	0.6	0.3	0.4	1.2	0.4	0.4	1.4	0.5	0.0	11.0	0.2	1.3	156.5	1.7	50.5	0.7	137.6	4.2	0.6	0.4	1.4	1.5	1.4	0.0	3.0	10.2	1.0	0.0	0.2	0.1	0.1	3.2	0.1	0.6	2.9	0.4	0.0	29.3	3.9	1.0	1.5	1.0	0.7	0.5	0.6	0.6	2.3	1.7	3.6	184.1	0.0	9.9	0.0	1.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.4	0.6	2.7	2.8	2.9	18.1	2.7	2.6	2.7	2.7	2.6	2.8	2.7	2.9	17.9	3.2	4.6	2.6	1.1	68.8	0.5	1.6	2.2	12.1	3.7	9.5	2.0	1.5	3.9	3.7	4.2	1.3	2.8	1.5	0.0	1.0	0.9	2.5	59.0	10.2	1.2	0.8	5.0	0.2	2.5	372.4	11.2	3.8	0.0	77.5	14.6	0.5	21.4	3.3	7.7	1.6	8.2	4.6	123.6	4.4	119.0	8.7	97.8	7.5	4.9	2.7	3.1	7.1	2.5	1.4	1.4	149.7	0.8	1.0	1.4	0.1	2.2	7.7	13.1	4.5	33.9	1.4	1.0	2.6	59.1	1.0	5.4	80.9	1.0	0.7
CTTNBP2NL	DKFZp547A023	ENSG00000143079	"CTTNBP2 N-terminal like"	Q9P2B4	1	112396214-112463456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007301	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center, Cytosol"		"HPA007301: AB_1847693"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.21e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (8.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (5.12e-2)"	14.5	4.8	5.6	10.3	4.6	0.5	11.3	4.4	6.1	11.8	3.1	15.5	7.5	15.2	4.7	19.5	8.4	16.5	6.3	4.4	7.6	9.1	5.6	13.0	6.2	7.3	6.6	9.4	4.6	7.4	3.5	20.2	7.1	8.9	14.8	8.2	7.0	9.2	3.0	15.4	10.5	13.5	5.7	10.6	8.6	5.8	5.9	4.3	8.3	6.9	8.2	15.6	11.8	7.6	21.8	7.9	25.7	12.2	17.0	22.3	8.6	33.6	31.4	21.4	21.1	6.1	10.7	3.4	13.2	25.4	10.5	17.4	16.9	23.2	24.9	7.1	8.1	4.6	13.1	4.9	19.7	1.6	7.8	26.4	14.0	26.5	23.0	24.5	52.7	5.7	4.2	3.0	29.9	6.4	3.0	0.6	16.6	6.1	12.3	5.3	24.0	0.0	32.6	15.9	12.6	13.2	26.0	5.3	13.3	24.5	4.3	1.8	68.5	21.3	24.9	22.0	15.8	0.4	3.1	0.1	22.1	2.0	57.0	0.0	2.6	0.0	0.0	2.1	0.0	0.1	0.0	0.0	8.6	0.3	0.0	0.0	0.1	0.0	0.4	3.7	2.0	0.4	5.6	4.6	4.4	6.1	4.4	7.6	7.3	6.6	7.1	5.7	5.9	7.6	100.4	57.7	22.4	17.6	4.4	38.7	30.2	32.0	24.5	10.2	12.3	9.5	9.7	7.2	41.4	22.0	6.2	17.6	4.6	64.0	3.9	39.1	3.3	29.1	30.7	71.6	8.3	3.6	44.1	21.6	12.8	24.2	14.8	58.5	19.0	17.8	41.7	1.6	13.5	5.0	31.2	27.4	30.5	29.7	131.7	4.0	10.5	40.8	16.0	81.5	30.5	11.0	0.0	30.2	25.1	47.7	52.7	11.3	0.7	25.4	21.7	22.6	17.5	7.9	19.7	20.1	29.2	16.8	16.7	25.0	60.7	25.4	2.7	9.1	24.4	69.3
CUL3		ENSG00000036257	"Cullin 3"	Q13618	2	224470150-224585397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, ER-Golgi transport, Mitosis, Transport, Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 224.8"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 309.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002678	Supported					NA	NA		65000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB002678: "	"unprognostic (1.22e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.74e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.87e-2)"	30.6	33.6	26.7	36.3	28.2	62.5	40.6	30.4	34.7	35.3	31.0	38.2	36.1	33.6	41.8	54.2	28.7	32.8	39.0	28.6	30.2	49.4	52.4	31.2	55.5	25.9	26.0	33.2	34.3	56.5	25.2	37.1	26.2	33.4	39.4	46.3	36.1	28.6	112.6	54.1	34.2	33.5	27.0	33.8	35.5	224.8	26.6	48.4	45.7	81.8	75.7	40.6	36.5	31.1	61.7	61.3	87.8	72.6	71.9	62.7	82.7	73.9	74.3	72.6	67.7	72.7	60.2	67.0	44.5	76.1	70.3	53.6	99.8	85.0	112.0	66.5	54.5	95.9	61.3	100.7	87.6	95.1	69.3	62.6	68.9	67.7	74.0	72.2	74.3	61.9	90.2	67.0	96.9	104.5	88.5	91.5	90.4	100.9	38.0	76.5	109.8	50.0	108.5	141.0	79.9	58.6	51.1	73.7	85.7	124.5	58.6	79.3	66.2	77.2	58.5	52.1	74.1	69.2	55.3	115.3	59.9	58.2	83.7	9.4	2.8	7.6	3.5	3.5	4.6	5.3	3.9	5.4	3.0	6.5	4.7	5.2	6.6	8.7	4.2	3.6	7.6	1.7	26.7	28.2	30.4	34.7	28.6	30.2	25.9	26.0	26.2	27.0	26.6	31.1	48.3	51.3	69.6	92.1	73.9	28.3	67.8	25.1	20.5	48.5	40.8	34.7	39.9	30.0	49.7	27.6	29.2	25.7	85.3	46.7	35.2	20.2	211.2	58.9	66.9	35.2	40.9	30.9	86.7	24.9	17.8	35.0	32.6	76.2	38.0	37.1	28.5	39.6	20.7	60.6	93.4	39.2	20.3	43.2	28.3	309.7	27.4	45.2	24.9	95.5	39.4	48.4	28.8	107.1	126.4	34.5	39.3	27.4	58.1	59.8	43.8	43.2	38.7	41.3	52.6	71.8	41.5	116.4	50.7	35.7	32.7	39.5	61.2	40.1	34.0	90.1
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated cyclophilin"	Q6UX04	5	64768930-65018750	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 255.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561"	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	13.4	13.0	13.6	13.0	14.6	20.5	13.4	16.7	18.4	12.6	10.7	14.3	9.8	15.5	12.3	11.8	11.8	11.2	18.9	13.1	15.5	14.1	10.2	10.7	15.4	14.5	13.7	18.2	9.0	16.9	8.8	14.6	14.4	13.9	15.0	14.0	10.5	12.3	22.2	11.5	10.1	14.3	13.5	12.8	11.1	17.2	14.1	21.7	13.9	26.4	16.0	13.2	11.5	15.4	32.7	21.4	37.5	69.9	31.4	38.2	41.8	33.5	27.7	36.7	38.2	36.0	40.3	48.0	57.0	35.0	41.2	20.2	39.8	60.5	66.2	40.4	32.4	36.2	35.6	30.3	48.0	38.3	23.5	25.6	45.7	46.3	58.3	32.3	39.4	53.9	35.8	30.8	36.8	32.6	53.5	34.7	30.4	16.9	25.6	49.0	50.4	50.3	35.0	28.0	44.4	19.6	40.8	16.4	39.7	35.5	35.9	55.5	32.9	21.4	37.8	34.6	54.2	23.9	33.1	46.5	40.1	65.9	38.8	13.2	13.1	9.6	13.6	13.2	16.8	17.5	15.3	17.4	16.9	13.2	16.2	16.9	2.7	20.4	10.2	13.8	18.0	10.4	13.6	14.6	16.7	18.4	13.1	15.5	14.5	13.7	14.4	13.5	14.1	15.4	24.2	9.6	26.2	64.3	26.0	16.4	27.7	37.5	13.6	31.4	17.4	20.3	63.6	18.6	23.2	14.7	14.6	44.0	16.8	11.6	21.5	44.1	255.6	21.0	27.2	27.2	29.9	37.8	114.1	33.1	54.5	25.1	13.7	20.2	19.6	40.7	16.4	11.4	33.0	20.2	110.3	17.0	40.7	17.1	15.2	57.9	38.5	22.3	14.2	61.8	33.6	34.2	36.0	103.0	103.2	40.4	16.0	36.1	21.0	22.1	13.3	24.4	28.6	51.3	32.9	31.3	33.6	74.2	28.3	20.6	20.0	30.8	26.2	30.7	28.6	23.8
CWH43	"CWH43-C, FLJ21511, PGAP2IP"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986275-49062081	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.0;prostate: 42.8;skin 1: 25.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA042814, HPA048140"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"		"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	6.0	0.0	16.9	0.4	0.6	0.4	21.0	14.5	0.0	0.0	0.0	0.0	9.0	0.7	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	42.8	15.6	0.0	3.0	7.7	0.0	25.5	0.0	0.8	0.1	0.0	9.6	0.0	0.1	0.1	10.2	0.0	1.5	2.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.9	0.1	0.8	0.0	0.0	0.6	0.1	0.6	0.0	2.3	7.3	0.0	0.0	0.0	10.4	1.9	0.0	0.2	41.3	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	10.7	21.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	15.4	0.0	0.0	7.6	0.0	2.9	29.5	0.0	0.0	0.0	0.5	0.0	0.5	3.2	9.1	0.0	0.2	0.0	15.0	0.3
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021118-76023497	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 52.7;Glandular and luminal cells: 23.5;Kupffer cells: 41.1;Langerhans cells: 21.4;Macrophages: 45.7;Plasma cells: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 21.5;intermediate monocyte: 52.4;non-classical monocyte: 36.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 52.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.1;BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.2;GAMG: 5.1;RPMI-8226: 4.3;RT4: 2.4;THP-1: 3.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	253000		"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.0	5.9	1.4	95.5	1.5	1.2	20.7	0.9	2.6	13.2	1.2	10.7	11.2	7.1	0.7	8.0	4.1	10.6	4.4	1.2	1.0	7.8	29.0	35.1	68.0	7.4	1.2	3.0	0.9	17.1	2.1	10.3	10.8	43.9	15.9	0.4	20.1	1.8	1.2	2.0	11.2	15.8	3.4	20.3	19.2	3.0	2.6	35.2	3.7	1.1	17.3	45.1	3.7	1.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	6.1	2.2	2.2	0.2	0.1	2.0	0.2	0.0	5.1	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.3	0.1	2.4	0.0	0.0	0.0	0.4	1.3	0.0	0.1	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.6	0.0	0.0	21.5	0.0	0.0	52.4	0.0	1.4	0.3	0.0	3.5	0.1	0.0	0.0	1.1	0.0	36.9	0.0	0.0	7.6	1.4	1.5	0.9	2.6	1.2	1.0	7.4	1.2	10.8	3.4	2.6	1.5	3.8	0.0	2.2	0.0	2.2	0.9	9.4	52.7	0.6	0.0	2.6	7.0	0.3	1.5	2.8	0.0	0.0	0.1	0.0	2.7	0.0	5.9	2.6	12.5	10.9	8.0	0.0	0.0	0.0	0.0	0.0	6.9	3.1	23.5	1.3	0.0	0.0	0.1	17.3	0.0	0.0	1.0	10.2	41.1	21.4	4.0	0.3	45.7	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	11.4	6.4	2.6	1.3	0.0	0.0	1.3	12.4	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.9	1.4
CXCL12	"PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1"	ENSG00000107562	"C-X-C motif chemokine ligand 12"	P48061	10	44370165-44386493	"Predicted secreted proteins"	"Chemotaxis, Host-virus interaction"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 347.2;Distal tubular cells: 172.1;Fibroblasts: 566.4;Kupffer cells: 191.8;Smooth muscle cells: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 509.6;BJ hTERT+: 303.5;BJ hTERT+ SV40 Large T+: 294.9;BJ hTERT+ SV40 Large T+ RasG12V: 441.2;fHDF/TERT166: 501.8;HSkMC: 1293.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017564	Approved				"Secreted to blood"	NA	NA	1030000	560000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017564: AB_2088170"	"unprognostic (2.41e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	366.8	82.6	19.4	143.8	20.2	35.1	237.4	19.1	28.1	268.4	24.5	124.3	53.6	360.7	54.3	138.5	122.1	263.3	190.3	19.4	18.6	124.8	252.8	71.0	215.8	22.3	21.1	112.3	131.2	126.7	21.3	8.5	19.1	47.8	115.5	2.1	116.3	66.2	158.9	99.4	96.5	343.5	19.9	356.6	45.4	19.4	21.0	142.6	103.4	181.3	119.7	107.0	174.3	17.7	0.0	0.0	0.4	0.6	509.6	78.9	0.4	187.7	303.5	294.9	441.2	0.0	0.1	0.2	1.9	501.8	0.0	0.1	0.8	0.2	97.1	187.2	2.4	0.0	0.0	0.0	172.8	0.4	0.9	1293.8	0.0	63.8	0.1	0.0	0.2	0.1	0.1	0.0	1.0	0.4	0.7	0.6	32.2	0.0	0.6	0.8	0.3	224.3	0.2	0.0	0.6	0.6	0.3	0.7	0.0	63.6	272.2	0.4	0.4	0.4	0.5	205.0	0.2	0.2	0.1	0.1	0.6	0.3	3.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	20.2	19.1	28.1	19.4	18.6	22.3	21.1	19.1	19.9	21.0	17.7	347.2	0.0	1.1	1.3	1.4	76.3	0.3	0.0	9.6	1.5	8.1	14.0	25.0	10.0	0.6	5.5	0.0	0.3	2.1	0.0	172.1	0.8	2.2	1.7	46.8	134.1	0.0	0.0	0.6	20.5	0.3	566.4	1.5	1.0	0.0	0.4	55.6	2.5	2.6	0.0	6.6	3.9	0.0	191.8	110.1	3.7	70.2	27.9	135.2	74.0	0.0	1.9	0.0	12.1	0.1	3.0	0.0	8.6	1.0	1.0	0.1	25.5	0.0	0.8	85.5	43.7	146.1	1.8	5.9	6.3	62.7	0.7	9.6	33.2	0.5	0.5
CXCL13	"ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13"	ENSG00000156234	"C-X-C motif chemokine ligand 13"	O43927	4	77511753-77611834	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 523.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 242.2;Breast myoepithelial cells: 72.4;Endometrial stromal cells: 101.0;monocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA052613	Uncertain				"Secreted to blood"	NA	NA	93700			"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"			"HPA052613: AB_2681885"	"unprognostic (5.25e-3)"	"unprognostic (1.19e-2)"	"prognostic favorable (9.12e-4)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.41e-3)"	"unprognostic (9.82e-3)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.16e-10)"	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.68e-3)"	2.6	0.4	0.1	127.7	0.4	0.1	15.4	0.4	0.3	1.4	0.1	13.3	1.9	3.6	1.6	2.4	0.8	5.8	1.2	0.1	0.1	0.6	28.5	2.9	523.1	1.1	0.1	0.7	0.3	0.2	3.1	0.6	0.1	27.3	16.5	0.2	8.5	1.4	0.0	0.6	68.5	1.2	0.4	338.6	34.9	1.5	0.1	16.2	2.4	0.0	441.3	30.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.3	0.1	0.1	1.1	0.1	0.1	0.4	0.1	0.2	0.9	0.0	0.5	1.3	0.3	0.1	15.8	3.9	0.0	0.0	242.2	72.4	0.0	1.5	0.7	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.6	101.0	1.7	0.0	10.7	1.9	0.2	0.3	6.3	0.5	1.8	1.3	0.0	3.6	21.3	10.2	0.0	3.9	0.0	0.0	3.4	0.0	0.0	0.0	0.9	0.0	1.9	38.8	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.3	7.8	0.0	0.1	4.5
CXCR3	"CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR"	ENSG00000186810	"C-X-C motif chemokine receptor 3"	P49682	X	71615916-71618511	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;intestine: 6.4;lymphoid tissue: 16.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 87.6;NK-cells: 15.5;Plasma cells: 36.5;Proximal enterocytes: 17.6;T-cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 306.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 306.7;NK-cells: 198.9;T-cells: 124.7"	"Cell line enriched"	"Detected in some"	15	"RPMI-8226: 47.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045942	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA045942: AB_2679507"	"unprognostic (4.84e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.61e-1)"	"prognostic favorable (3.44e-6)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.01e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.67e-6)"	"unprognostic (4.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.76e-2)"	0.6	0.8	0.1	5.9	0.1	7.2	0.5	0.2	0.3	0.5	0.0	1.6	5.4	0.4	0.0	0.6	0.5	1.4	0.4	0.2	0.0	0.5	0.5	3.3	16.3	0.2	0.0	0.4	0.5	0.0	0.1	0.1	0.0	0.4	1.0	0.0	1.8	0.3	0.1	0.6	6.4	0.4	0.0	7.5	2.9	0.3	0.1	3.0	0.9	0.1	5.3	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.1	0.0	0.4	0.3	0.2	80.4	0.2	40.9	45.3	90.3	124.7	8.4	9.9	5.5	51.6	1.9	198.9	0.2	306.7	89.4	35.3	0.1	0.1	0.2	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	13.9	0.3	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	87.6	3.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	3.2	0.0	0.2	0.0	0.3	3.1	0.3	1.3	0.0	0.7	0.3	0.3	0.0	0.0	1.8	0.0	0.8	6.1	0.0	0.0	4.0	1.8	0.0	2.1	0.0	15.5	0.0	0.0	0.2	5.3	0.0	36.5	0.0	17.6	0.5	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.6	0.1	48.3	1.5	3.1	0.1
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424619-69466264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 318.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"		NA	NA		99000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	60.2	318.0	52.3	51.4	53.9	20.9	50.4	46.0	69.9	45.8	43.6	92.6	69.5	49.3	72.8	59.3	58.2	45.4	58.0	56.9	51.2	71.9	83.8	54.1	68.8	50.7	48.1	44.0	40.1	77.7	28.6	73.8	50.6	47.6	116.0	49.4	36.3	48.3	65.8	45.8	67.8	61.6	44.7	49.6	49.3	38.6	52.3	74.3	54.1	78.2	76.9	80.4	38.2	48.4	186.2	576.4	232.9	144.9	105.1	139.3	99.5	162.3	224.1	266.0	249.2	406.1	221.3	168.0	159.3	157.9	216.0	214.5	224.4	235.0	300.0	90.2	85.5	81.2	97.1	479.1	154.7	169.1	172.4	120.9	116.3	315.9	149.6	111.8	254.7	190.5	133.6	78.4	165.2	241.2	278.9	204.1	173.5	171.4	78.4	260.0	128.7	184.3	359.3	208.7	135.7	69.7	431.6	82.0	142.2	119.0	159.0	133.2	115.9	152.2	124.5	102.2	145.5	94.7	227.0	516.6	157.0	138.0	180.0	121.1	57.6	71.5	103.8	80.0	85.0	68.8	76.9	81.8	69.8	63.1	62.8	75.5	17.1	96.4	59.7	124.2	134.6	105.6	52.3	53.9	46.0	69.9	56.9	51.2	50.7	48.1	50.6	44.7	52.3	48.4	36.2	44.8	46.8	44.7	47.2	49.8	49.2	84.0	66.0	22.8	28.6	26.0	25.0	30.0	51.4	62.5	6.2	159.8	66.7	112.7	78.2	66.2	18.8	56.4	33.3	61.7	23.4	38.7	40.9	70.4	94.1	38.4	27.5	87.7	60.2	36.6	43.9	54.9	64.8	30.3	30.4	76.6	83.4	30.1	57.5	22.7	44.4	33.4	62.2	24.4	55.8	63.0	96.8	23.6	39.4	70.5	78.8	44.4	28.1	34.9	75.9	62.9	49.5	31.6	46.0	22.2	36.5	48.1	46.6	44.9	42.3	59.8	54.1	84.8	61.6	50.4
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649392	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 830.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		NA	NA		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	404.4	310.5	147.1	87.4	152.9	82.7	272.2	145.7	189.9	237.3	115.0	192.4	94.8	248.4	58.8	152.4	174.0	139.5	374.3	138.7	163.9	182.9	279.4	201.3	76.3	194.7	174.2	218.3	89.1	62.0	137.4	107.8	169.9	181.4	74.9	27.3	149.8	239.3	203.0	233.6	138.1	200.2	154.8	101.4	182.0	142.7	156.7	54.0	157.8	140.5	72.3	216.7	210.0	160.2	125.5	78.6	126.6	78.6	830.9	654.7	74.4	359.2	330.0	262.2	232.4	104.0	95.6	58.8	156.6	668.8	113.8	112.4	85.3	178.0	133.7	63.9	187.3	83.6	127.3	202.4	211.0	118.4	149.5	397.4	138.1	188.9	124.5	190.8	220.0	74.0	73.5	296.3	361.9	137.9	116.8	108.4	51.0	129.2	142.7	84.9	153.8	131.3	202.0	90.6	56.1	73.2	118.6	113.2	134.0	92.6	90.6	112.0	340.9	282.0	175.3	192.3	137.9	78.3	91.2	72.4	328.8	67.8	237.9	126.3	104.0	300.3	75.9	135.3	76.6	110.1	72.8	83.9	154.0	102.7	50.8	54.0	53.8	63.5	176.7	140.8	95.0	86.4	147.1	152.9	145.7	189.9	138.7	163.9	194.7	174.2	169.9	154.8	156.7	160.2	238.5	86.6	62.2	17.0	51.7	110.1	95.5	184.8	27.3	16.7	52.3	73.2	106.4	105.8	100.9	60.7	4.2	110.0	37.0	90.5	49.0	216.4	4.8	51.4	82.9	161.5	83.7	113.9	12.3	107.0	199.3	183.4	38.2	65.4	62.8	57.8	180.2	230.4	108.3	16.8	16.1	45.8	142.4	50.6	112.0	17.0	253.9	67.7	176.1	25.3	112.5	91.0	33.0	7.1	26.4	156.8	85.6	280.6	36.7	82.3	116.9	110.8	53.3	18.4	190.7	62.5	202.5	23.8	45.5	57.5	112.7	117.9	43.0	233.1	55.2	96.4
CYP2U1	"SPG49, SPG56"	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931549-107953461	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 84.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.2;Inhibitory neurons: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	7.7	6.4	6.6	4.0	8.3	0.5	4.5	7.6	7.3	5.1	10.1	5.8	3.4	6.6	3.6	3.5	7.8	5.6	7.7	6.5	8.7	5.3	5.9	5.7	6.3	9.0	7.9	9.5	2.3	10.7	4.7	2.4	8.2	9.9	3.9	5.8	3.4	8.7	3.6	2.7	4.7	10.2	8.1	7.6	3.2	3.0	8.0	84.9	3.6	7.2	4.7	4.7	3.8	9.5	4.0	1.9	5.2	9.5	28.6	13.4	0.8	16.8	25.3	10.2	15.7	0.1	2.5	10.8	1.1	10.1	7.8	0.2	8.1	6.4	15.4	3.0	2.5	2.3	3.5	0.5	11.3	3.2	0.0	15.3	5.3	4.7	3.2	20.8	4.0	12.0	0.1	5.0	8.4	2.9	11.8	0.0	5.4	0.4	4.7	6.5	6.3	0.1	3.3	6.7	10.0	7.6	4.2	7.3	18.6	4.3	3.6	1.5	10.6	6.5	0.8	9.3	6.9	21.1	21.2	3.4	5.5	0.0	7.4	0.0	0.1	0.3	0.4	0.5	0.3	0.8	0.3	0.4	0.9	1.1	0.7	0.5	0.0	0.7	2.8	1.1	0.0	0.2	6.6	8.3	7.6	7.3	6.5	8.7	9.0	7.9	8.2	8.1	8.0	9.5	5.5	3.2	3.9	18.6	12.9	1.1	4.6	2.2	15.4	4.1	2.8	5.8	6.2	1.5	2.4	9.2	4.2	0.4	10.1	1.4	0.0	0.9	13.2	6.9	6.3	5.8	3.0	1.7	30.2	2.0	0.3	12.6	3.1	6.2	4.5	2.5	8.6	7.3	2.3	1.7	34.3	1.2	0.0	6.2	3.3	9.5	17.7	4.7	19.6	5.6	3.7	9.5	1.0	20.1	12.1	0.4	0.1	17.7	4.2	1.5	9.9	3.0	8.6	3.1	0.0	20.0	8.1	1.0	4.2	2.0	1.4	0.3	3.6	5.1	3.1	0.8
CYP4F12		ENSG00000186204	"Cytochrome P450 family 4 subfamily F member 12"	Q9HCS2	19	15673018-15697174	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.5;liver: 40.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 58.8;Gastric mucus-secreting cells: 57.6;Paneth cells: 51.9;Proximal enterocytes: 125.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	54	"basophil: 6.1;eosinophil: 14.8"	"Lineage enriched"	"Detected in single"	88	"granulocytes: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 17.6;HaCaT: 32.0;Hep G2: 9.8;Karpas-707: 20.9;OE19: 46.3"									HPA058960	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"			"HPA058960: AB_2683862"	"unprognostic (4.30e-4)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.84e-3)"	"unprognostic (9.13e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (2.33e-4)"	3.2	1.1	0.6	1.2	0.9	0.9	2.7	0.6	1.5	6.0	0.4	15.1	39.1	1.5	0.5	18.1	3.2	2.4	1.5	0.9	2.4	1.8	40.1	1.2	0.5	0.9	1.1	1.6	0.3	0.0	0.5	0.5	1.1	5.0	7.8	0.1	4.3	1.0	0.6	21.1	41.5	1.9	0.7	1.0	12.0	0.2	0.7	0.8	0.9	0.9	2.6	10.5	11.2	1.9	0.0	4.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.6	0.5	0.0	0.0	0.3	32.0	0.0	0.0	0.0	2.0	0.0	0.0	1.7	9.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.1	0.0	46.3	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.1	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.1	0.0	14.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.6	1.5	0.9	2.4	0.9	1.1	1.1	0.7	0.7	1.9	6.3	0.0	1.8	2.6	0.5	14.0	10.0	8.3	13.1	0.0	0.5	0.3	1.0	5.7	7.1	0.0	0.0	0.1	0.0	58.8	0.0	0.6	1.6	0.2	0.1	3.0	7.8	8.0	0.2	0.0	0.1	3.8	57.6	0.3	0.0	0.0	1.4	30.3	0.4	0.0	0.2	24.8	2.0	0.9	1.6	3.2	4.1	0.3	1.8	0.0	0.0	2.7	0.0	0.0	0.4	1.9	51.9	1.2	0.2	3.5	125.3	2.2	4.9	0.1	0.0	0.3	2.5	0.4	0.1	20.5	21.2	0.3	0.5	0.1	29.6	24.8
DAAM1	KIAA0666	ENSG00000100592	"Dishevelled associated activator of morphogenesis 1"	Q9Y4D1	14	59188646-59371405	"Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 467.3;Suprabasal keratinocytes: 332.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026605, HPA064789"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA		9700	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA026605: AB_1847464, HPA064789: AB_2685352"	"unprognostic (2.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	14.5	6.2	13.0	6.8	13.6	5.4	10.4	12.6	12.8	13.6	22.8	13.5	4.8	13.5	5.6	19.0	7.7	5.9	19.3	11.8	14.8	6.9	12.6	10.5	11.1	7.9	8.1	8.0	9.3	20.6	5.3	9.1	8.3	11.9	8.5	24.9	9.4	11.0	5.6	30.9	7.2	10.9	7.8	13.1	7.0	6.9	11.2	4.8	7.4	4.7	15.6	9.5	15.1	10.7	18.2	1.9	13.1	3.5	7.8	5.8	17.1	2.5	2.3	4.7	4.8	9.4	16.6	20.4	4.4	5.6	9.6	39.7	11.8	10.0	4.0	9.0	4.1	6.8	4.8	11.8	4.8	7.9	3.8	3.9	10.6	3.9	4.7	10.8	11.3	10.2	11.9	9.9	2.8	17.0	6.9	4.9	7.5	12.9	5.6	6.3	11.1	2.0	6.8	13.5	20.3	4.8	15.8	23.1	16.1	8.7	30.5	2.1	10.8	3.9	7.4	8.4	2.2	2.2	2.7	22.1	5.0	1.5	8.7	7.7	2.0	2.6	2.3	2.4	3.0	10.8	3.0	2.3	2.2	4.6	2.4	2.6	2.8	6.7	3.5	18.3	4.0	1.9	13.0	13.6	12.6	12.8	11.8	14.8	7.9	8.1	8.3	7.8	11.2	10.7	62.2	35.3	27.0	160.6	37.8	467.3	172.4	128.6	30.7	110.7	56.8	40.6	149.3	38.6	82.3	29.5	308.6	33.0	66.9	47.0	23.5	63.8	40.0	68.4	142.9	71.9	87.7	140.0	143.7	93.1	27.6	67.3	21.9	54.6	26.0	155.2	102.4	47.2	32.8	195.2	202.0	56.7	73.2	16.3	55.8	16.6	60.3	36.1	90.7	66.5	25.2	96.5	16.5	74.9	24.3	191.4	45.1	74.1	30.8	104.2	24.7	12.8	102.4	168.7	32.9	84.6	66.3	51.3	46.3	52.8	332.0	34.2	25.1	25.1	38.1	84.2
DCAF12L2	WDR40C	ENSG00000198354	"DDB1 and CUL4 associated factor 12 like 2"	Q5VW00	X	126163499-126166289	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.3;epididymis: 21.4"	"Cell type enriched"	"Detected in some"	7	"Granulosa cells: 11.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HAP1: 2.6;NTERA-2: 2.2;U-2 OS: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054"	"unprognostic (1.16e-4)"			"unprognostic (8.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.52e-2)"		"unprognostic (2.72e-1)"		"unprognostic (3.02e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.47e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.51e-1)"	0.8	0.9	1.9	0.0	2.0	0.0	0.4	0.1	2.2	1.4	0.0	0.7	0.0	2.4	21.4	0.1	2.3	0.1	0.0	2.5	3.5	0.2	0.0	0.0	0.1	9.3	1.5	1.4	0.0	2.5	1.3	0.0	4.2	1.5	0.0	0.2	0.3	4.3	0.1	0.2	0.2	1.3	1.6	0.0	0.3	5.5	3.1	0.0	0.1	0.9	0.2	1.2	0.5	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.0	0.1	2.2	2.5	3.5	9.3	1.5	4.2	1.6	3.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
DCC	"IGDCC1, NTN1R1"	ENSG00000187323	"DCC netrin 1 receptor"	P43146	18	52340197-53535903	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.9;testis: 7.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 205.7;Excitatory neurons: 439.7;Inhibitory neurons: 455.8;Late spermatids: 174.9;Oligodendrocyte precursor cells: 1305.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 36.4;U-266/70: 112.5;U-266/84: 57.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055376, HPA069552"	Enhanced		Approved	"Golgi apparatus"		NA	NA		64000		"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA055376: AB_2682798, HPA069552: AB_2686151"	"unprognostic (1.96e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.22e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-3)"	0.0	0.6	1.2	0.2	6.3	0.0	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	6.9	3.6	0.2	0.0	1.4	0.0	0.7	4.7	0.1	0.3	0.0	0.6	0.0	1.5	0.3	0.1	0.3	0.1	1.2	0.0	0.1	0.1	0.0	0.0	0.2	0.2	7.6	1.1	1.0	0.0	0.0	0.3	0.1	0.1	0.9	0.1	0.1	36.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	112.5	57.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.3	0.0	3.9	6.9	3.6	0.7	4.7	1.5	0.0	1.1	0.9	1.4	0.0	6.0	10.1	0.3	0.0	0.1	0.0	0.0	2.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	205.7	0.0	0.0	0.1	0.0	0.0	439.7	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	455.8	0.0	0.0	0.0	0.0	174.9	1.2	0.2	0.0	54.4	0.0	0.2	0.0	1305.9	58.6	0.0	0.0	1.2	5.7	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.1	2.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1
DCDC2C		ENSG00000214866	"Doublecortin domain containing 2C"	A8MYV0	2	3703575-3848008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.1"	"Group enriched"	"Detected in some"	7	"Early spermatids: 171.3;Late spermatids: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045848	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA045848: AB_10961120"											"unprognostic (2.63e-2)"	"unprognostic (1.81e-1)"		"unprognostic (3.81e-3)"	"unprognostic (6.98e-2)"			0.1	0.0	0.6	0.0	0.5	0.4	0.1	0.9	0.9	0.0	1.2	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.5	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.4	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	4.1	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.9	0.9	0.5	0.5	0.1	0.1	0.2	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.3	0.0	0.4	2.3	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	59.9	5.6	0.1	0.0	15.9	0.0	0.0	0.0	0.0	0.2	0.3	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 131.8;kidney: 124.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 364.4;Excitatory neurons: 197.4;Oligodendrocyte precursor cells: 182.4;Proximal tubular cells: 283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 239.4;LHCN-M2: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		350000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	10.3	28.6	95.9	12.8	100.9	0.6	18.8	61.5	131.8	22.4	73.4	45.1	40.1	10.8	76.5	12.6	36.5	25.5	17.4	102.0	77.3	124.8	79.5	26.4	2.6	58.6	84.8	2.9	27.5	21.1	6.3	11.6	62.6	28.5	45.3	34.6	17.7	18.6	30.4	5.6	39.7	16.5	59.5	10.6	29.7	19.1	106.6	1.0	28.9	14.0	2.0	19.2	2.6	80.3	63.1	7.6	36.0	6.9	84.1	78.0	9.2	155.9	120.0	63.6	75.6	89.9	16.5	0.1	39.2	239.4	38.3	17.8	79.7	15.0	93.0	0.3	29.5	0.2	22.3	31.8	40.9	57.6	3.2	60.5	2.0	50.4	24.9	85.5	75.9	0.0	0.1	6.0	179.7	7.5	3.0	0.3	25.5	124.6	22.6	0.0	63.1	0.9	113.4	46.3	59.2	115.0	18.0	56.3	9.1	38.7	29.6	4.9	107.7	31.6	27.0	11.7	57.8	0.0	0.1	0.2	1.6	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	100.9	61.5	131.8	102.0	77.3	58.6	84.8	62.6	59.5	106.6	80.3	14.1	35.3	43.4	364.4	2.6	13.8	4.6	6.8	5.7	4.5	31.2	13.8	11.8	61.5	13.6	69.9	4.2	2.7	0.4	75.3	125.2	15.9	22.5	36.9	9.8	7.5	34.2	2.7	197.4	31.2	0.9	13.9	47.9	24.2	0.0	59.3	8.2	102.8	1.1	0.0	51.0	86.9	8.2	2.2	5.5	25.6	15.8	2.4	12.4	23.4	0.6	68.4	0.0	182.4	9.6	44.5	69.4	74.9	0.0	33.6	68.7	283.3	36.5	9.4	13.1	15.3	18.6	4.6	5.4	32.6	14.3	0.8	2.5	13.5	106.7	8.3
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901286-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	21.5	16.9	12.3	19.0	12.4	17.3	25.5	14.6	13.9	24.5	14.2	25.1	13.1	27.3	18.1	19.9	22.5	17.4	18.6	12.5	13.5	19.1	16.3	15.9	27.7	12.1	12.2	30.4	20.9	23.1	21.9	22.1	12.3	19.7	17.9	23.3	15.8	22.5	20.9	17.7	16.3	27.3	12.5	19.7	17.5	25.8	13.3	30.6	25.7	20.7	27.4	23.7	20.0	14.0	48.3	30.6	53.8	67.0	45.4	58.6	33.5	50.2	56.7	45.7	42.5	69.3	41.3	62.4	29.4	45.7	27.9	41.5	53.4	38.0	58.0	54.6	38.5	33.6	30.0	31.0	45.6	71.7	40.5	45.9	38.2	43.7	120.7	79.3	37.3	52.8	60.8	37.5	57.0	39.7	67.6	67.7	31.3	46.7	67.3	58.0	60.6	11.4	35.5	28.7	36.9	50.2	36.5	43.0	57.1	50.2	50.6	45.3	32.0	35.1	40.0	39.5	69.5	49.7	47.6	52.8	37.6	72.8	20.9	9.2	10.6	15.0	18.5	16.7	22.9	16.8	22.8	19.4	14.0	17.1	24.1	21.9	3.4	20.6	13.6	12.4	21.8	15.0	12.3	12.4	14.6	13.9	12.5	13.5	12.1	12.2	12.3	12.5	13.3	14.0	27.8	19.2	21.7	21.2	50.5	11.9	35.4	34.6	36.5	44.2	21.1	23.1	27.4	30.0	31.5	20.2	39.6	40.6	36.0	11.4	56.7	28.7	80.3	25.2	41.6	30.3	16.2	29.5	37.5	25.1	39.3	32.2	22.4	22.8	43.0	30.3	23.2	16.2	23.2	37.0	36.4	19.2	26.4	21.6	9.1	20.0	36.4	21.3	12.4	22.5	41.2	22.7	51.5	28.1	29.5	22.8	14.3	39.1	46.3	30.1	11.1	41.3	26.7	55.1	19.7	35.8	53.5	72.8	58.4	31.7	14.3	41.2	40.8	35.4	21.4	20.7
DENND10	FAM45A	ENSG00000119979	"DENN domain containing 10"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 36.5;Cytotrophoblasts: 53.8;Extravillous trophoblasts: 27.7;Hofbauer cells: 56.0;Syncytiotrophoblasts: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	16.7	14.3	18.7	14.0	20.2	32.4	14.0	18.7	23.6	14.2	17.4	17.9	12.6	13.3	16.7	20.5	11.4	12.7	15.5	18.8	19.2	26.1	31.1	12.6	13.1	19.8	18.9	20.9	9.4	18.0	2.9	15.6	19.8	13.4	14.4	10.6	10.9	10.6	17.6	18.7	15.2	13.2	19.8	14.1	14.2	7.3	19.3	13.1	19.9	11.1	14.6	14.8	9.3	21.7	23.7	24.9	38.6	45.5	75.9	59.1	15.9	32.3	85.9	29.4	30.1	23.7	35.8	16.1	12.8	41.4	33.8	42.2	25.7	28.0	27.0	29.2	24.1	3.8	11.5	32.9	75.4	11.0	10.3	63.7	31.5	20.9	32.6	75.0	36.1	16.8	7.8	22.9	42.0	20.0	17.2	48.5	23.6	22.1	14.6	17.0	40.6	14.3	38.6	25.9	6.9	27.7	21.7	30.2	67.5	36.1	24.9	48.5	36.6	23.3	12.3	28.9	19.4	23.0	10.0	17.7	35.9	54.7	11.2	44.9	26.6	55.6	6.9	31.8	6.6	3.9	10.9	10.0	16.6	3.6	5.7	7.1	40.0	6.1	36.4	5.0	20.4	11.6	18.7	20.2	18.7	23.6	18.8	19.2	19.8	18.9	19.8	19.8	19.3	21.7	9.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	53.8	11.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	27.7	9.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	45.3	1.7	0.0	0.0	0.0
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.5;dendritic cells: 30.1;granulocytes: 15.9;Hofbauer cells: 14.6;NK-cells: 35.0;T-cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 22.5;HEL: 15.1;HMC-1: 44.7;MOLT-4: 14.7;THP-1: 13.8;U-937: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"	2.2	1.0	1.4	21.4	1.3	21.2	1.0	1.5	1.7	0.9	1.5	3.0	4.9	0.9	0.0	1.9	1.3	2.8	1.1	1.4	1.5	1.6	2.1	5.8	32.1	2.4	1.8	0.3	1.3	0.1	0.8	1.8	2.2	1.6	1.2	0.0	3.0	0.5	0.8	1.4	14.4	1.2	1.8	35.1	5.2	0.4	2.8	20.5	1.7	0.3	14.9	3.0	1.3	2.6	0.2	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	22.5	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.0	15.1	0.0	1.6	0.0	7.5	44.7	0.0	0.0	0.1	0.0	0.0	0.0	7.4	0.3	9.4	0.1	0.0	14.7	11.5	0.0	0.5	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	13.8	0.1	0.0	0.0	0.0	0.0	0.4	2.0	10.6	0.1	31.3	0.0	18.3	19.9	32.8	40.1	32.4	35.0	23.8	28.6	35.0	19.5	18.7	35.7	32.1	27.8	23.8	35.0	11.2	35.6	37.1	1.4	1.3	1.5	1.7	1.4	1.5	2.4	1.8	2.2	1.8	2.8	2.6	0.3	3.2	3.0	0.0	27.5	0.4	0.1	0.0	1.2	0.0	0.6	0.6	1.3	2.8	0.0	1.8	0.0	0.2	30.1	0.5	1.9	0.4	0.7	1.5	0.2	0.4	0.0	5.7	0.4	0.0	0.2	0.7	1.5	0.3	15.9	0.5	1.1	0.7	14.6	0.0	0.5	0.9	0.0	11.6	9.2	0.6	0.0	13.8	3.6	2.8	10.9	0.0	35.0	0.0	0.5	0.3	0.4	0.0	13.5	0.2	2.9	6.2	1.6	0.0	0.0	0.0	0.3	0.3	1.2	1.6	0.1	0.3	34.5	0.7	1.0	0.1
DENND2B	"HTS1, p126, ST5"	ENSG00000166444	"DENN domain containing 2B"	P78524	11	8693351-8910951	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 3.2;Cardiomyocytes: 6.2;Cytotrophoblasts: 3.7;Extravillous trophoblasts: 1.8;Fibroblasts: 7.1;Hofbauer cells: 5.8;Smooth muscle cells: 5.7;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 95.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046796	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA046796: AB_2679812"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	26.3	60.0	22.0	19.2	20.4	3.4	26.6	26.6	23.2	72.7	38.2	85.4	28.8	130.3	33.2	62.7	104.6	34.6	35.0	19.1	22.3	29.4	27.4	28.8	12.1	29.7	32.6	69.2	27.5	15.4	21.5	26.4	18.3	45.4	26.7	36.5	37.5	62.9	21.9	22.2	30.3	117.2	21.3	59.7	56.9	41.0	28.0	17.5	36.6	11.1	15.1	65.0	50.4	17.1	32.6	4.9	51.8	9.0	16.8	17.6	2.5	28.9	95.8	27.5	25.4	6.8	34.0	1.0	17.2	52.7	12.1	32.2	10.0	41.7	10.8	4.4	12.7	0.0	16.7	22.8	26.9	0.2	0.2	60.8	11.6	15.6	20.1	56.0	5.5	5.0	6.7	2.8	45.4	3.5	1.8	1.5	7.9	32.2	7.7	1.1	31.5	2.0	37.5	23.4	9.8	31.7	25.7	32.1	19.8	17.7	5.4	1.1	14.9	15.8	24.7	50.6	22.8	8.0	15.5	0.2	24.1	0.2	30.4	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.0	2.9	0.0	0.1	0.4	22.0	20.4	26.6	23.2	19.1	22.3	29.7	32.6	18.3	21.3	28.0	17.1	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.8	7.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0
DENND5A	"FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1"	ENSG00000184014	"DENN domain containing 5A"	Q6IQ26	11	9138825-9265959	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 287.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052923, HPA055009"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"		"HPA052923: AB_2681989, HPA055009: AB_2682669"	"unprognostic (5.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (1.14e-6)"	"unprognostic (9.86e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.40e-2)"	45.8	23.5	72.4	23.2	90.5	21.7	36.3	85.0	80.7	36.1	45.5	44.2	5.8	38.5	14.1	17.4	37.5	23.3	58.0	65.1	85.4	25.5	15.7	46.1	16.8	81.5	86.6	30.2	23.2	18.5	20.5	28.8	77.0	24.5	12.9	34.7	19.5	40.0	26.7	17.3	20.2	47.5	74.9	31.4	23.7	15.8	87.3	28.0	22.0	33.7	15.9	40.4	25.1	81.3	18.8	23.3	63.7	56.1	113.0	92.0	61.7	69.2	99.8	85.7	104.5	16.4	13.6	0.0	30.5	129.0	82.4	12.7	64.3	22.5	111.4	73.0	30.9	6.2	32.2	34.5	61.0	34.4	13.9	76.8	11.5	51.1	74.6	59.7	83.8	21.9	33.6	0.3	101.9	11.0	19.4	15.1	19.7	3.2	28.6	34.2	46.1	0.3	41.6	13.4	15.9	32.1	65.8	29.7	27.2	70.4	15.7	24.6	59.2	63.0	41.0	78.7	47.3	1.4	0.4	18.7	63.4	14.1	51.9	4.4	5.0	5.7	0.1	6.3	0.6	1.8	1.3	1.3	4.6	0.2	3.8	1.9	10.8	1.0	9.2	1.1	0.0	1.9	72.4	90.5	85.0	80.7	65.1	85.4	81.5	86.6	77.0	74.9	87.3	81.3	34.1	19.2	14.5	43.8	7.4	21.7	19.3	10.3	10.2	9.7	15.3	13.8	33.2	14.3	8.0	14.7	60.5	15.9	6.4	0.3	0.0	7.3	1.1	26.3	31.8	31.3	6.6	7.8	47.7	6.7	20.1	27.1	3.1	57.8	2.5	11.6	21.4	10.9	21.8	13.5	74.2	2.2	4.1	36.3	63.4	2.0	21.5	48.9	19.6	68.4	41.1	11.6	3.1	136.2	287.1	8.4	1.4	20.7	0.9	32.5	0.1	10.3	4.8	10.5	26.3	34.4	31.6	7.9	12.3	6.3	8.2	11.2	6.3	16.0	0.8	15.0
DENR	"DRP, DRP1, SMAP-3"	ENSG00000139726	"Density regulated re-initiation and release factor"	O43583	12	122752824-122771064	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 227.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021783	Approved		Approved	Cytosol		NA	NA		200000	"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA021783: AB_2670820"	"unprognostic (3.65e-2)"	"unprognostic (7.00e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (2.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (8.57e-6)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-1)"	25.4	22.6	19.0	27.0	19.6	27.5	29.6	15.3	23.6	22.2	15.1	25.5	26.7	23.7	22.1	32.5	21.7	22.1	24.4	19.4	20.2	25.5	27.6	18.8	36.2	16.8	21.6	19.2	21.2	59.0	17.1	31.6	19.5	28.0	26.0	16.5	28.4	24.8	60.2	29.6	25.0	24.5	15.2	28.0	23.3	14.6	18.9	38.9	29.8	44.7	35.5	30.0	20.4	16.7	113.1	62.1	77.7	80.1	48.7	71.9	67.6	100.5	56.1	87.6	60.6	86.9	40.6	99.9	103.4	72.5	66.6	84.0	93.8	89.5	117.6	90.9	67.3	122.8	36.2	63.8	63.5	139.6	97.4	62.8	86.9	79.3	107.4	81.6	86.4	109.7	129.8	35.8	94.8	74.9	137.7	134.1	159.2	67.2	128.4	120.6	91.2	63.7	85.3	99.9	89.3	63.4	139.2	40.8	107.3	79.1	129.5	78.1	82.2	81.2	95.9	91.7	102.1	58.8	145.8	160.4	76.4	100.1	90.9	227.9	35.0	58.1	38.8	53.3	45.3	45.5	41.9	39.4	47.3	41.4	48.5	43.4	42.2	47.3	69.9	42.1	49.2	44.5	19.0	19.6	15.3	23.6	19.4	20.2	16.8	21.6	19.5	15.2	18.9	16.7	43.4	70.5	40.1	31.0	59.8	71.9	65.9	55.4	59.7	37.7	66.2	69.8	66.3	45.8	47.7	47.8	41.7	73.0	60.8	40.9	64.6	68.6	17.9	67.7	83.5	51.4	84.8	53.8	39.0	61.8	130.3	48.3	40.8	70.7	43.1	50.4	42.1	54.3	57.4	55.5	36.2	53.6	44.7	50.1	42.4	8.0	50.4	49.3	26.6	25.3	60.2	47.3	75.2	48.2	31.3	88.0	44.6	45.9	47.9	73.2	40.3	67.3	49.5	35.9	19.7	46.2	62.5	120.3	136.8	72.8	64.9	60.6	54.7	47.3	58.8	51.3
DGCR6L	FLJ10666	ENSG00000128185	"DiGeorge syndrome critical region gene 6 like"	Q9BY27	22	20314238-20320080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Late spermatids: 2787.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.91e-1)"	"prognostic favorable (3.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"prognostic favorable (5.37e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.29e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.72e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-1)"	34.2	44.8	75.9	15.3	73.2	30.9	36.3	68.7	95.7	38.0	72.4	46.5	19.8	33.6	23.8	41.2	31.7	18.7	67.8	72.9	71.4	57.6	152.6	28.6	24.7	71.2	71.7	36.3	43.1	42.1	43.3	12.5	71.9	51.0	11.4	8.6	45.2	29.0	81.1	54.1	29.8	15.3	71.2	33.8	40.9	132.0	74.1	27.6	45.9	44.1	14.6	39.9	35.3	69.5	34.0	38.0	25.5	64.5	36.6	36.6	26.7	32.4	37.7	58.7	42.6	19.7	16.4	9.1	41.4	35.9	23.7	33.8	19.3	39.0	9.6	43.7	97.6	21.7	26.6	36.8	43.3	46.6	21.0	41.0	35.4	23.0	24.7	22.7	41.4	42.3	99.9	39.4	38.3	79.2	35.1	42.4	18.7	67.2	56.1	61.0	58.5	17.7	31.1	26.3	50.4	36.9	53.3	34.7	60.6	10.3	50.3	37.0	32.5	69.4	80.3	37.1	32.1	34.9	39.5	20.9	56.1	58.5	47.5	115.6	102.0	145.5	104.6	93.3	104.0	81.7	130.7	117.7	93.9	73.5	119.9	113.9	34.0	139.1	92.7	88.2	129.8	120.4	75.9	73.2	68.7	95.7	72.9	71.4	71.2	71.7	71.9	71.2	74.1	69.5	43.6	28.9	30.2	4.9	29.7	43.7	34.2	53.4	33.0	18.6	79.4	106.3	80.3	57.2	41.1	35.0	4.2	67.7	43.1	65.2	133.1	72.2	529.8	28.0	23.2	40.2	52.8	37.2	6.3	63.0	86.4	43.3	26.0	17.5	39.3	38.5	62.4	166.9	80.2	28.6	7.3	64.4	34.6	78.3	52.9	2787.0	70.2	41.7	56.9	1.9	55.5	58.2	95.8	6.0	7.9	51.7	58.5	70.7	44.2	26.2	166.0	164.5	42.5	24.9	46.0	23.6	47.2	117.3	91.0	62.3	60.9	21.9	56.7	36.2	69.0	33.9
DGKA	"DAGK, DAGK1, DGK-alpha"	ENSG00000065357	"Diacylglycerol kinase alpha"	P23743	12	55927319-55954027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 101.5;lymphoid tissue: 198.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 49.0;Squamous epithelial cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 86.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 130.4;hTERT-HME1: 133.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041645, HPA045462"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 58: T-cells - T-cell receptor"	Vesicles	"Nucleoplasm, Mitochondria"	"HPA041645: AB_2677595, HPA045462: AB_2679335"	"unprognostic (1.12e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.02e-2)"	12.7	12.8	7.6	50.0	9.8	31.9	11.0	6.6	9.2	22.9	7.0	25.6	51.2	13.1	9.9	101.5	11.4	15.8	8.5	7.2	5.2	7.9	3.7	18.6	95.5	5.2	5.0	10.9	14.6	12.0	6.9	14.9	5.3	24.8	26.9	2.8	35.5	9.6	2.3	84.7	64.8	14.1	4.8	53.8	12.4	12.3	5.0	198.1	10.5	4.2	101.8	28.4	39.0	6.8	22.2	13.2	9.3	12.4	22.4	29.0	2.8	47.2	47.8	18.2	13.5	6.9	35.2	13.5	11.1	31.5	6.2	38.7	10.3	130.4	21.4	14.4	2.5	21.1	26.8	3.6	19.1	6.7	20.9	25.1	68.4	25.2	133.9	60.6	37.9	78.8	2.4	18.7	49.4	2.3	54.3	8.6	2.0	18.1	15.5	23.8	2.9	2.0	43.7	60.9	1.6	5.6	15.5	0.9	1.7	23.8	9.3	6.4	34.0	12.0	8.4	2.8	1.7	2.9	1.2	32.4	13.8	17.5	3.4	17.0	7.4	15.3	18.5	5.2	35.5	20.4	70.6	33.0	10.5	16.2	86.9	51.5	13.3	14.1	3.5	10.5	86.7	36.2	7.6	9.8	6.6	9.2	7.2	5.2	5.2	5.0	5.3	4.8	5.0	6.8	4.5	3.2	6.5	1.6	25.7	15.0	9.7	21.1	26.7	1.2	4.0	4.6	2.9	4.3	19.1	5.5	0.0	16.3	12.2	35.4	0.0	5.1	9.4	1.9	6.5	5.3	2.4	11.2	11.2	9.4	4.3	8.2	15.3	3.0	7.0	2.4	4.2	0.2	4.2	0.0	5.2	7.7	2.0	6.9	21.6	7.0	3.7	14.0	0.0	5.6	15.7	2.6	10.3	9.0	0.8	25.3	14.4	3.0	14.8	8.2	49.0	0.3	5.2	0.5	6.6	1.5	4.2	6.6	4.2	40.4	13.9	26.4	37.4	1.6	9.7	20.1
DGKI	DGK-IOTA	ENSG00000157680	"Diacylglycerol kinase iota"	O75912	7	137381037-137847092	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 19.2;choroid plexus: 9.2;retina: 6.5;thyroid gland: 15.6"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 606.4;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 329.2"	"Group enriched"	"Detected in some"	4	"glioma: 0.8;melanoma: 0.6;renal cancer: 1.0;thyroid cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 3.0;GAMG: 3.6;hTEC/SVTERT24-B: 3.2;SCLC-21H: 5.0;U-2197: 14.1;U-87 MG: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.01e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.98e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.73e-3)"	0.5	0.3	4.5	0.2	19.2	0.0	0.2	1.0	11.8	0.1	9.2	0.3	0.0	0.3	0.1	0.0	0.1	0.6	2.8	6.1	2.9	0.5	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.2	1.3	0.0	1.5	0.1	0.1	6.5	0.3	0.1	0.0	0.1	0.1	1.3	0.0	0.0	0.1	0.6	6.5	0.0	15.6	0.0	0.0	0.2	0.0	8.2	0.0	0.0	0.4	0.0	0.8	0.6	0.0	3.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.9	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.2	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.3	0.0	0.0	0.5	0.2	0.0	0.0	0.1	1.3	0.5	14.1	0.6	0.1	0.0	0.0	5.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	19.2	1.0	11.8	6.1	2.9	0.1	4.7	1.5	0.0	6.5	8.2	0.3	0.0	0.0	7.5	0.3	1.1	0.2	1.4	0.6	53.1	1.0	0.1	11.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.4	1.3	1.1	0.0	0.0	606.4	0.0	0.0	2.1	0.0	0.3	0.0	0.1	0.4	0.0	0.6	45.4	414.6	0.0	44.7	0.0	0.7	3.6	0.9	0.2	0.0	60.9	0.0	2.1	1.0	329.2	84.4	0.0	0.0	1.5	0.0	0.2	0.0	0.3	0.2	3.3	0.0	0.8	2.2	0.2	0.5	0.2	0.6	0.0	0.1	0.5	0.0	0.0
DHFR2	"DHFRL1, DHFRP4, FLJ16119"	ENSG00000178700	"Dihydrofolate reductase 2"	Q86XF0	3	94047836-94063389	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Ductal cells: 6.3;Respiratory ciliated cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	13	"hTERT-RPE1: 154.6"									HPA051465	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA051465: AB_2681494"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.30e-6)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-2)"	3.3	4.9	3.9	3.8	5.2	1.8	5.3	6.0	5.2	5.2	4.8	4.2	4.1	7.9	6.4	3.5	6.3	5.1	3.7	4.1	4.1	5.9	6.7	4.5	5.7	4.8	4.2	10.1	5.3	6.5	2.5	3.2	5.0	6.4	4.6	3.2	4.4	4.9	1.4	4.2	4.9	5.4	4.2	4.9	4.7	4.7	4.4	5.7	6.7	2.1	4.6	3.3	2.4	6.5	3.8	6.5	4.2	4.4	5.7	7.2	1.7	5.7	6.0	2.8	3.2	1.4	5.7	2.5	3.8	3.0	3.7	5.0	3.3	3.9	4.4	8.5	1.8	3.1	2.9	3.4	6.0	2.2	3.6	7.6	5.1	3.3	4.2	154.6	2.9	11.9	1.6	5.6	3.7	4.5	10.8	1.2	3.7	10.8	6.7	2.7	5.7	4.1	4.1	1.9	5.4	5.3	8.3	2.2	9.6	3.3	5.6	3.1	4.8	4.4	7.4	1.8	2.2	4.1	4.4	3.5	4.4	5.5	6.2	2.2	1.1	2.0	1.8	1.7	3.3	1.8	2.4	2.9	0.7	2.2	3.2	3.0	1.7	1.4	1.8	2.1	3.2	1.3	3.9	5.2	6.0	5.2	4.1	4.1	4.8	4.2	5.0	4.2	4.4	6.5	2.8	12.8	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.6	3.4	0.0	0.0	1.8	3.7	0.0	2.4	2.3	0.0	3.9	6.3	0.0	3.5	4.4	2.5	0.0	0.0	0.0	5.5	1.7	2.5	0.0	2.9	2.5	4.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	5.6	8.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	1.3	3.5	0.0	0.0
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068954-12123221	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 129.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 227.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	10.7	8.4	8.1	6.8	10.4	3.8	8.4	12.6	8.5	8.8	11.9	10.1	7.6	6.2	6.8	7.5	6.1	5.3	13.2	7.6	8.5	42.7	129.5	5.4	8.5	9.5	8.6	10.0	18.0	12.7	5.6	7.7	9.5	12.9	10.8	7.5	13.1	5.7	18.7	5.6	6.9	5.7	8.8	7.8	10.9	4.7	9.1	10.5	11.6	23.1	9.7	6.3	6.1	11.4	27.0	20.4	29.8	23.8	18.2	10.8	35.9	13.3	8.6	23.4	20.6	13.1	15.7	19.3	4.3	8.4	10.8	37.4	31.6	10.4	26.6	10.9	14.2	10.6	7.7	10.1	17.8	4.2	3.8	13.3	7.9	13.7	5.5	9.2	13.0	23.1	16.7	15.1	6.3	52.3	14.4	7.7	16.7	24.9	4.7	24.3	9.7	16.5	15.2	6.4	7.7	34.9	26.3	46.3	15.4	31.7	102.2	15.2	5.8	7.5	5.4	15.8	9.9	13.4	10.3	12.6	9.7	7.4	12.8	23.8	6.8	15.4	4.2	9.2	4.5	13.0	3.2	2.7	11.9	9.9	3.1	4.1	19.4	14.3	17.0	17.3	5.7	4.9	8.1	10.4	12.6	8.5	7.6	8.5	9.5	8.6	9.5	8.8	9.1	11.4	6.9	12.8	38.8	21.5	21.3	5.2	6.7	5.3	10.2	13.3	13.7	8.3	31.1	28.6	7.8	16.5	10.4	35.4	23.2	14.6	19.6	10.9	3.5	8.8	17.3	8.1	11.3	21.9	12.8	11.1	25.1	8.1	21.9	20.8	8.8	45.2	11.0	227.4	10.3	26.9	17.3	18.0	4.1	15.3	10.1	4.2	12.5	13.5	5.4	17.8	13.4	10.4	8.2	15.6	20.5	12.4	9.6	12.0	22.6	9.6	9.4	62.5	5.2	19.2	13.1	10.6	7.4	6.7	3.8	16.2	6.0	13.5	8.4	21.8	16.6	7.8
DIO3	TXDI3	ENSG00000197406	"Iodothyronine deiodinase 3"	P55073	14	101561351-101563452	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 25.0;placenta: 17.8"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 7.8;Fibroblasts: 27.9;Leydig cells: 10.8;Muller glia cells: 8.1;Peritubular cells: 7.5;Skeletal myocytes: 16.3;Syncytiotrophoblasts: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"AF22: 54.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"amygdala: 4.4;hippocampal formation: 5.6"	HPA073684			Supported	Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA073684: "	"unprognostic (4.52e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-5)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-4)"	"unprognostic (9.80e-3)"	5.0	0.4	0.5	1.8	1.2	0.0	3.2	0.2	1.2	25.0	0.2	1.7	0.0	6.5	0.6	1.8	6.7	3.0	0.6	0.6	0.2	0.3	3.9	2.6	1.3	1.3	0.3	13.6	1.5	0.0	0.7	17.8	0.3	3.2	0.4	0.7	1.7	2.2	1.6	3.5	1.7	0.9	0.4	0.6	1.6	1.3	3.3	0.2	4.1	3.0	0.1	5.2	15.4	0.4	0.0	0.2	54.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.0	1.3	0.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.2	1.2	0.6	0.2	1.3	0.3	0.3	0.4	3.3	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.6	0.4	0.0	0.0	0.0	0.0	1.9	0.0	5.9	0.0	0.6	0.3	0.4	4.9	7.8	0.0	0.0	0.1	0.0	2.5	27.9	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.0	0.0	0.7	0.6	10.8	0.1	0.0	0.0	0.6	8.1	0.0	0.0	0.0	0.9	1.1	7.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	16.3	0.7	0.1	0.2	0.2	0.1	28.3	0.2	0.1	0.3	0.4
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997564-79236038	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	18	"kidney: 169.4;liver: 283.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		680000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	8.4	4.5	1.5	0.3	1.7	0.0	2.2	1.4	1.6	1.4	3.0	1.3	0.2	2.8	12.2	1.4	1.3	2.1	1.9	1.5	2.4	169.4	283.8	0.4	0.2	1.5	1.9	2.2	1.8	0.6	2.9	0.1	2.0	1.8	0.4	1.5	0.4	1.8	2.4	0.6	0.6	1.7	1.4	0.1	1.0	2.3	2.9	0.3	4.8	1.5	0.3	1.2	0.5	1.6	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.2	3.6	0.8	1.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	7.6	1.9	0.0	0.0	1.7	2.1	2.2	1.6	1.5	0.0	0.8	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	1.6	1.5	2.4	1.5	1.9	2.0	1.4	2.9	1.6	1.3	0.0	1.1	19.9	2.9	0.1	0.5	1.0	1.8	1.9	1.4	1.8	1.0	2.8	0.8	9.2	2.1	0.3	1.9	0.7	19.6	0.4	40.6	2.6	5.0	1.2	1.2	6.1	5.8	0.7	0.1	2.7	3.6	2.7	0.0	4.1	1.8	104.2	0.1	0.0	1.5	1.2	4.1	1.6	0.4	33.1	2.5	1.7	0.0	4.7	0.2	4.3	3.1	4.5	3.3	0.8	1.4	2.6	4.5	0.9	1.6	83.9	4.7	3.7	0.0	1.7	0.7	4.9	5.3	1.8	0.3	0.3	2.9	4.4	0.9	0.8
DNAJC1	"DNAJL1, ERdj1, MTJ1"	ENSG00000136770	"DnaJ heat shock protein family (Hsp40) member C1"	Q96KC8	10	21756548-22003769	"Predicted membrane proteins, Transcription factors"		"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013432	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum"		"HPA013432: AB_1847797"	"unprognostic (7.00e-2)"	"unprognostic (9.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (4.44e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.22e-2)"	17.6	16.9	9.9	16.3	11.2	18.3	20.0	10.6	13.1	17.8	15.0	20.6	28.3	15.5	13.4	16.3	14.2	17.7	15.8	9.0	12.9	23.0	36.9	24.0	15.6	12.1	11.1	14.0	38.5	45.6	19.6	19.9	12.4	23.7	18.7	7.1	40.7	16.3	12.7	14.3	22.4	15.8	11.5	15.2	28.6	9.4	11.3	13.1	29.0	11.2	13.0	26.5	15.2	12.7	38.5	24.5	53.9	20.1	49.3	34.9	23.4	50.9	22.1	20.8	32.7	33.8	33.1	16.9	21.9	31.2	31.2	36.1	12.3	25.7	11.5	88.6	41.1	40.3	18.8	20.3	119.5	3.0	16.5	35.8	46.5	24.7	28.3	30.4	27.8	16.4	42.7	93.6	23.8	39.2	9.6	12.9	7.1	33.2	20.3	13.8	18.8	62.3	29.1	9.1	11.3	17.1	37.7	62.2	38.1	58.7	19.8	42.8	42.7	20.3	43.5	34.4	29.3	29.8	10.0	11.7	30.3	126.1	12.3	11.8	16.6	7.0	36.2	16.6	36.5	8.4	20.2	29.1	15.3	12.3	12.9	16.5	9.3	34.2	30.9	39.6	15.8	15.0	9.9	11.2	10.6	13.1	9.0	12.9	12.1	11.1	12.4	11.5	11.3	12.7	56.4	35.3	26.9	73.4	46.7	38.7	64.8	26.6	30.1	27.9	67.9	76.1	16.9	57.2	31.0	31.3	45.9	16.7	92.9	52.4	27.4	73.6	47.6	40.9	74.6	54.7	38.3	49.0	134.4	74.2	92.6	67.4	59.7	58.3	41.8	14.3	52.8	84.5	55.0	38.7	77.1	75.8	28.5	43.7	52.5	19.6	94.8	44.2	67.6	112.4	46.9	37.4	99.9	91.5	137.7	80.6	49.2	67.0	202.7	71.2	57.9	80.1	23.9	149.1	59.2	49.3	56.7	232.2	109.5	45.3	44.2	35.3	81.5	41.0	55.8	71.9
DNAJC5	"CLN4, DNAJC5A, FLJ00118, FLJ13070"	ENSG00000101152	"DnaJ heat shock protein family (Hsp40) member C5"	Q9H3Z4	20	63895126-63936031	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Chaperone	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012139, HPA012737, HPA013154"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Plasma membrane"	Vesicles	"HPA012139: , HPA012737: AB_1847293, HPA013154: AB_1847292"	"unprognostic (9.96e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (3.04e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (2.24e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.08e-2)"	12.6	22.1	30.8	10.7	33.0	16.9	11.1	10.2	39.1	11.4	2.1	17.6	11.5	12.1	5.7	42.0	11.6	7.4	25.8	36.2	31.0	17.7	12.8	18.0	9.9	27.9	23.9	8.8	22.7	21.2	28.5	8.4	30.4	16.7	6.9	28.1	16.2	11.5	14.5	19.2	17.5	8.6	13.8	22.2	20.8	10.7	26.8	8.4	16.8	9.5	8.5	13.4	16.9	25.7	25.2	23.7	19.8	18.8	19.4	15.9	14.6	28.6	27.4	49.4	23.8	52.7	30.2	9.8	31.6	28.2	22.7	36.4	15.9	53.6	16.0	8.2	11.3	19.3	17.4	25.8	18.1	19.2	43.5	18.0	39.9	22.9	11.7	19.1	24.2	16.5	19.2	8.9	22.6	17.3	21.1	30.9	7.1	21.0	26.5	21.0	10.9	10.7	16.4	22.6	21.4	13.9	30.8	48.7	17.8	11.6	23.5	75.9	43.7	42.6	14.4	20.4	21.5	11.1	5.6	13.6	42.9	25.3	25.4	0.7	3.2	2.6	3.2	3.7	1.8	1.6	1.8	2.7	2.5	1.4	2.5	2.5	3.1	1.5	3.1	3.9	3.1	2.6	30.8	33.0	10.2	39.1	36.2	31.0	27.9	23.9	30.4	13.8	26.8	25.7	12.8	6.4	17.8	19.2	10.4	20.8	18.5	25.5	20.5	60.7	17.4	14.1	31.7	14.3	23.2	23.9	62.6	18.5	19.1	71.7	13.7	20.5	48.9	23.9	8.5	18.7	32.4	10.3	37.1	37.6	18.4	12.4	27.0	23.5	1.3	12.1	23.9	27.8	43.5	79.1	38.8	33.3	14.2	51.0	24.8	123.5	7.2	31.4	14.2	25.3	36.9	27.9	22.6	19.1	26.2	59.0	41.1	12.4	17.3	39.5	62.0	22.9	29.4	47.0	13.1	9.0	13.1	13.5	13.2	28.0	22.9	30.2	15.0	13.3	28.4	64.5
DNM3	KIAA0820	ENSG00000197959	"Dynamin 3"	Q9UQ16	1	171841498-172418466	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 66.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 365.7;Inhibitory neurons: 631.8;Oligodendrocyte precursor cells: 976.1;Oligodendrocytes: 1970.9"	"Cancer enhanced"	"Detected in many"		"glioma: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 22.9;HMC-1: 10.2;RPTEC TERT1: 19.0;U-251 MG: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064121			Approved	"Golgi apparatus"		NA	NA		70000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA064121: AB_2685193"	"unprognostic (8.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.70e-3)"	4.2	11.9	15.3	1.0	29.9	1.3	4.0	59.4	24.3	5.8	0.0	2.4	0.6	3.2	1.3	1.3	3.2	2.7	2.1	12.2	36.0	4.1	0.4	4.4	1.1	42.8	29.5	2.6	1.1	1.2	6.2	0.4	47.8	2.6	1.1	13.4	2.1	1.6	1.2	2.4	1.4	3.1	10.6	1.8	2.7	3.2	32.3	1.8	3.3	1.3	0.8	2.2	5.1	66.9	0.8	2.5	2.0	0.4	1.5	1.0	0.0	0.5	1.2	1.0	1.3	0.0	3.7	0.0	7.5	1.1	1.2	0.3	1.5	2.9	0.9	1.0	2.9	22.9	3.7	0.0	0.1	0.5	10.2	0.7	0.5	1.2	0.7	1.1	0.5	2.0	0.0	0.3	0.4	0.0	1.5	0.1	5.8	9.5	1.7	1.5	9.9	0.0	19.0	0.1	3.9	0.8	2.7	0.7	0.2	0.7	0.0	0.9	0.3	2.8	3.8	2.3	14.3	3.8	0.7	0.2	2.7	1.2	1.0	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.2	0.0	0.3	0.5	0.3	0.3	0.1	0.0	1.4	1.2	15.3	29.9	59.4	24.3	12.2	36.0	42.8	29.5	47.8	10.6	32.3	66.9	21.8	0.0	6.8	207.3	1.5	2.4	1.5	0.7	3.4	25.1	1.4	1.3	2.4	0.0	0.4	0.0	29.2	0.1	0.7	0.2	3.9	0.3	8.2	7.3	1.3	19.5	0.0	0.8	365.7	0.4	0.1	3.2	7.1	1.0	1.3	0.8	8.2	0.2	0.7	8.4	631.8	0.7	0.0	0.6	3.1	3.9	1.8	13.4	0.0	178.0	0.3	5.9	0.0	976.1	1970.9	2.5	0.1	2.6	0.3	0.7	0.0	0.8	2.2	29.0	0.0	4.5	2.2	5.3	0.4	1.1	1.7	0.3	0.9	10.3	0.8	0.7
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042468	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;lymphoid tissue: 32.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1806.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 45.5;GAMG: 73.4;HDLM-2: 52.7;TIME: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA058106: AB_2683606"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.5	8.2	22.6	18.8	49.2	10.2	3.8	33.7	33.4	8.7	9.7	6.3	4.1	3.2	1.1	3.2	2.4	6.3	1.6	28.7	35.1	3.2	5.5	7.6	27.8	45.5	38.4	17.7	1.7	2.0	1.0	2.3	48.9	1.6	6.5	5.7	2.5	1.7	1.2	5.0	12.5	4.3	32.0	29.8	6.7	2.2	37.9	32.1	2.7	0.8	19.9	6.4	4.4	83.1	0.0	21.4	6.7	0.0	8.5	17.9	0.0	45.5	36.8	21.3	15.8	0.0	0.0	0.6	0.1	28.9	73.4	0.5	0.0	0.1	16.9	52.7	0.0	0.6	4.5	0.0	0.3	4.4	2.1	4.3	0.4	31.0	12.0	8.3	21.4	7.0	0.1	42.1	36.4	2.1	8.0	6.1	2.6	0.0	5.0	10.5	9.8	6.2	1.1	0.1	0.4	5.5	0.0	0.0	4.8	1.2	1.4	20.0	48.2	22.8	5.7	10.9	15.6	0.0	0.0	0.0	32.2	29.6	10.1	3.0	3.3	0.2	6.5	9.2	6.6	7.2	10.9	9.1	6.9	4.5	10.5	9.3	0.1	14.3	11.8	2.8	8.4	4.5	22.6	49.2	33.7	33.4	28.7	35.1	45.5	38.4	48.9	32.0	37.9	83.1	3.7	3.2	9.1	4.2	47.1	4.7	0.6	0.3	8.0	7.9	0.8	4.3	1.2	0.0	2.5	5.5	0.0	0.3	39.5	0.8	1.9	0.1	3.2	0.2	2.3	3.2	2.4	5.5	8.0	0.0	0.2	4.9	5.1	0.5	36.7	64.0	2.5	1.4	30.6	97.6	244.2	3.8	0.0	54.2	39.7	2.8	0.6	51.0	8.8	201.4	38.3	1.2	38.1	400.6	1806.0	0.2	0.3	0.0	43.5	0.5	0.2	0.3	2.6	1.8	13.1	2.5	18.9	0.3	1.1	2.1	4.1	0.8	75.1	31.4	2.5	0.7
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206407	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6"	"Group enriched"	"Detected in many"	4	"Astrocytes: 791.0;Excitatory neurons: 422.8;Microglial cells: 1568.3;Oligodendrocyte precursor cells: 434.3;Oligodendrocytes: 815.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 43.3;HUVEC TERT2: 75.5;TIME: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	7.8	4.4	17.1	6.6	41.6	1.4	4.8	11.4	21.9	5.0	0.0	3.2	1.5	4.6	2.8	2.5	5.2	5.0	4.9	40.6	17.8	4.5	10.0	17.3	2.7	16.5	18.1	8.4	3.2	3.3	3.2	6.9	15.6	4.0	2.8	10.5	3.3	2.5	6.2	2.5	2.4	7.3	14.9	1.8	2.2	2.1	19.2	1.7	3.5	7.3	2.2	3.7	3.5	26.0	0.1	3.5	8.8	7.8	7.2	10.4	5.3	1.0	9.6	1.7	2.8	0.0	0.2	0.8	7.6	2.3	2.0	0.5	1.5	8.8	6.5	2.9	12.9	0.4	5.8	14.3	5.1	1.1	0.4	4.9	1.0	43.3	20.8	3.0	75.5	3.4	0.1	22.6	3.8	1.0	2.0	0.7	5.1	1.5	15.8	0.8	7.0	3.6	6.0	0.5	1.9	7.5	6.2	4.3	5.8	8.2	0.8	0.4	69.0	6.6	3.4	13.7	3.0	1.2	0.5	0.9	0.7	1.8	16.5	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.1	0.1	0.0	0.1	17.1	41.6	11.4	21.9	40.6	17.8	16.5	18.1	15.6	14.9	19.2	26.0	56.4	48.1	6.8	791.0	1.1	5.2	3.3	7.5	8.6	27.4	3.7	6.3	13.1	2.8	16.7	3.7	22.9	0.3	0.1	2.3	0.0	2.1	3.8	1.3	5.5	47.1	10.9	5.3	422.8	0.4	0.2	21.4	0.5	2.2	2.5	5.0	43.9	17.0	14.6	94.2	177.1	0.7	14.2	16.7	21.0	1.5	5.6	27.4	8.8	1568.3	6.1	5.4	0.0	434.3	815.3	1.2	8.0	8.2	0.2	8.2	0.0	1.8	12.2	11.4	13.1	4.2	5.8	0.6	1.9	2.3	2.7	0.0	0.6	26.2	1.5	1.8
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 45.0;lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 506.8;monocytes: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 53.0;granulocytes: 173.6;monocytes: 84.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 52.9;HL-60: 53.3;MOLT-4: 50.1;NB-4: 83.7;REH: 61.9;RT4: 54.3;THP-1: 158.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003218, HPA073349"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695, HPA073349: "	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favorable (6.89e-6)"	11.0	13.3	4.3	35.7	4.4	42.2	7.3	5.2	3.9	4.3	45.0	7.3	7.3	3.0	2.9	7.2	4.3	14.6	2.0	4.0	5.9	16.5	6.1	19.7	51.1	8.8	7.6	2.0	4.2	7.7	2.6	15.3	9.1	5.1	7.3	4.5	4.6	2.8	1.0	3.0	15.4	6.2	9.3	45.6	9.5	7.5	8.8	64.8	4.9	2.5	49.6	14.8	3.3	12.8	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	1.6	1.4	52.9	3.9	0.0	0.0	2.3	0.8	0.3	0.0	18.2	2.3	0.1	0.0	0.2	0.0	53.3	7.1	0.2	9.3	0.0	0.2	0.0	0.0	0.0	11.8	25.9	0.0	3.2	50.1	83.7	0.2	0.2	0.7	61.9	0.1	21.3	0.2	54.3	0.1	0.0	0.0	0.6	3.6	1.0	1.4	158.0	10.2	0.0	0.4	0.7	0.1	10.3	0.1	0.0	0.1	33.3	0.9	65.1	56.9	73.5	12.2	52.0	10.2	25.2	15.7	13.8	53.0	23.2	11.3	11.1	173.6	24.1	84.2	13.8	15.6	22.6	4.3	4.4	5.2	3.9	4.0	5.9	8.8	7.6	9.1	9.3	8.8	12.8	5.0	9.6	33.5	2.3	112.6	6.4	2.5	1.2	45.5	3.6	12.3	10.8	2.3	18.6	4.9	7.3	77.2	70.9	101.9	1.5	1.9	1.0	33.4	1.9	0.7	9.8	8.4	35.1	1.9	6.5	4.3	5.3	12.8	3.2	24.6	12.7	2.9	2.6	58.4	0.0	4.2	12.9	2.0	115.0	49.4	14.8	3.1	107.7	8.8	506.8	134.3	1.1	74.2	4.5	2.2	1.4	24.9	0.4	94.6	1.5	1.2	12.8	8.0	4.2	13.1	30.2	20.6	22.1	13.3	9.4	3.8	42.7	111.6	1.1	1.3	3.4
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501904-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.6;lymphoid tissue: 118.4"	"Group enriched"	"Detected in many"	5	"B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 133.6"	"Group enriched"	"Detected in many"	6	"B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0"	"Low region specificity"	"Detected in many"							HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.0	6.1	5.2	30.2	6.2	93.6	4.4	6.5	7.9	3.2	6.3	8.2	6.5	3.4	1.7	5.5	7.8	4.3	4.1	6.0	7.0	5.0	6.5	27.1	31.5	11.3	6.8	2.1	4.5	0.8	3.4	7.0	10.5	5.5	3.5	2.1	6.6	2.0	3.6	2.6	28.9	4.5	6.7	118.4	5.9	8.9	9.9	4.3	4.4	4.1	32.3	7.1	4.0	8.1	5.2	7.8	5.4	6.3	3.2	0.4	13.0	4.4	1.1	14.0	12.9	11.0	2.2	124.0	3.2	4.0	6.8	8.9	12.2	7.6	6.9	26.1	14.6	21.3	21.4	2.5	1.0	46.1	87.5	1.6	4.5	16.2	1.6	1.5	1.9	11.4	14.8	50.2	5.1	12.9	2.7	52.5	12.2	1.5	12.9	148.6	9.3	1.2	4.4	5.2	7.4	4.9	2.0	2.1	6.2	4.8	11.7	63.4	2.7	12.3	11.3	6.5	5.4	11.1	15.0	122.1	2.7	88.0	2.2	16.8	62.4	57.0	0.3	61.3	0.6	37.2	0.1	0.3	14.5	19.6	0.1	0.1	133.6	0.5	77.6	1.2	0.0	28.7	5.2	6.2	6.5	7.9	6.0	7.0	11.3	6.8	10.5	6.7	9.9	8.1	1.4	0.0	5.6	1.6	31.6	0.3	0.1	0.4	1.8	0.8	1.0	0.9	0.4	0.0	0.2	0.0	0.0	0.5	0.3	0.2	0.0	0.2	0.0	0.4	0.4	1.9	0.0	6.3	4.1	0.2	0.7	1.2	0.5	0.8	18.3	0.2	7.1	0.8	55.7	0.0	3.5	0.3	0.0	51.1	2.3	0.4	0.6	38.3	1.8	3.7	45.4	0.3	2.1	0.5	0.5	0.0	0.7	1.2	38.3	0.2	0.2	0.1	0.1	0.6	0.0	1.8	0.4	3.0	1.9	0.7	0.3	1.0	2.2	0.3	0.8	0.1
DPT		ENSG00000143196	Dermatopontin	Q07507	1	168695468-168729206	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 424.7"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 457.5;Leydig cells: 231.8;Peritubular cells: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 143.3;fHDF/TERT166: 59.9"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"midbrain: 1.0"	HPA065548			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		610000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA065548: AB_2685511"	"unprognostic (1.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.12e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.98e-3)"	334.6	39.6	0.4	28.6	0.5	0.0	251.3	0.5	1.0	177.6	0.5	424.7	18.8	63.2	60.8	86.0	129.1	78.0	241.4	0.5	0.4	13.2	29.0	48.6	58.6	0.5	0.4	30.3	84.8	4.9	2.1	37.5	0.6	55.2	58.2	0.0	72.0	52.7	37.1	39.2	94.2	138.5	0.5	0.9	108.5	15.4	0.5	48.0	75.0	209.3	70.1	103.3	166.9	0.7	0.0	0.0	0.0	0.0	143.3	0.6	0.2	0.1	6.7	7.2	7.4	0.0	0.0	0.0	0.0	59.9	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	4.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	7.6	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.5	1.0	0.5	0.4	0.5	0.4	0.6	0.5	0.5	0.7	18.7	3.2	1.7	0.3	0.3	31.9	0.1	0.0	1.8	0.0	2.2	2.3	7.4	0.0	0.6	0.0	0.0	0.6	0.4	0.1	0.0	0.1	1.2	0.3	10.7	6.9	0.0	0.0	4.8	0.2	0.8	457.5	3.1	0.2	0.0	0.0	8.9	0.0	0.6	0.0	3.4	0.0	0.0	0.0	45.6	4.4	231.8	4.0	39.2	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	123.8	0.5	0.5	0.0	0.1	0.0	0.0	0.0	24.4	18.5	0.5	0.3	3.1	32.0	0.4	5.0	2.2	0.0	0.6
DPYD	DPD	ENSG00000188641	"Dihydropyrimidine dehydrogenase"	Q12882	1	97077743-97995000	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 68.5"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1712.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033241, HPA045210"	Uncertain					NA	NA		1600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB033241: AB_2094323, HPA045210: AB_2679256"	"unprognostic (2.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.25e-1)"	22.2	13.2	7.2	22.6	12.8	10.3	16.7	5.7	10.4	18.8	2.4	11.9	21.9	14.9	8.4	17.1	14.3	25.7	8.9	7.4	12.9	12.6	68.5	29.6	16.6	12.4	9.4	24.0	11.8	9.2	6.2	4.5	12.1	9.9	10.1	3.3	15.0	13.4	5.8	7.1	19.4	18.2	6.9	24.7	8.4	3.7	12.9	17.0	10.3	10.1	12.0	18.2	14.2	24.4	22.2	6.2	7.8	0.2	42.4	72.5	0.1	35.2	31.9	32.1	23.6	0.0	9.2	11.7	50.6	32.9	5.1	5.2	0.0	8.3	58.7	11.6	7.3	10.0	11.1	0.2	18.8	4.5	0.6	57.5	3.0	25.7	29.3	67.7	26.8	6.8	0.4	36.4	17.0	0.0	23.6	6.4	0.9	0.2	7.5	0.1	37.1	18.6	39.4	0.1	11.1	8.8	30.1	2.5	0.3	0.8	0.0	10.2	30.9	69.2	5.0	56.4	70.6	3.0	0.1	0.2	10.2	12.6	56.2	18.2	61.1	4.1	11.6	29.5	14.8	2.2	13.3	11.0	32.7	4.9	12.5	11.1	59.8	13.3	27.1	0.9	15.8	21.9	7.2	12.8	5.7	10.4	7.4	12.9	12.4	9.4	12.1	6.9	12.9	24.4	25.5	16.0	39.1	23.8	15.4	7.6	8.8	9.4	18.8	2.5	8.4	8.3	5.3	40.0	11.5	7.3	0.0	0.2	19.2	3.3	5.9	2.5	7.0	1.5	15.2	14.7	3.0	13.3	258.6	6.4	0.2	30.0	10.7	1.7	9.5	4.5	17.2	54.2	17.1	0.0	30.5	5.5	6.1	130.4	27.0	4.0	33.5	73.7	3.6	105.9	98.1	4.8	27.8	34.2	1712.3	5.3	2.1	18.8	17.0	4.9	21.0	6.6	8.6	0.1	13.1	16.0	17.7	1.2	3.1	19.7	5.5	0.1	31.4	5.1	6.8	9.3
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390808-147510068	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 101.5;Cone photoreceptor cells: 331.5;Granulosa cells: 261.9;Peritubular cells: 205.7;Rod photoreceptor cells: 125.0"	"Cancer enhanced"	"Detected in all"		"glioma: 109.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 685.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Approved	Cytosol		NA	NA		740000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.23e-4)"	58.4	18.6	63.4	54.4	68.6	0.8	37.5	60.3	55.8	66.1	30.4	142.1	18.4	119.9	73.9	69.0	63.4	65.1	59.2	57.0	116.0	7.7	4.4	45.2	18.1	123.7	94.2	88.0	5.5	2.7	12.7	19.8	81.8	104.6	37.6	163.8	24.5	162.0	68.7	23.8	43.3	217.6	115.2	26.4	40.9	19.9	95.2	7.1	22.4	36.0	27.0	118.0	50.6	105.1	0.5	36.1	63.9	0.1	2.3	63.3	1.6	34.1	163.0	71.4	94.4	114.5	3.1	0.0	9.6	100.1	37.4	3.7	13.1	1.4	79.1	16.3	29.2	0.1	30.0	0.2	63.1	0.3	0.2	12.2	0.6	153.8	60.3	178.7	206.9	0.0	0.0	1.3	41.1	0.3	0.2	0.6	135.9	0.2	53.7	0.2	135.1	0.5	63.0	14.2	47.1	685.4	0.3	0.3	10.8	87.9	0.5	1.0	91.1	51.6	38.5	127.0	127.3	113.9	21.7	0.2	47.5	1.4	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	68.6	60.3	55.8	57.0	116.0	123.7	94.2	81.8	115.2	95.2	105.1	59.9	0.0	2.8	101.5	0.0	9.4	3.4	1.5	2.2	14.2	8.1	6.6	7.8	1.5	4.0	0.0	331.5	0.1	0.0	0.2	0.0	9.1	16.8	0.3	4.6	62.6	6.6	0.0	11.3	8.4	0.3	79.8	3.1	1.2	1.3	261.9	57.8	0.4	1.6	5.0	12.9	0.2	24.4	1.2	11.9	19.2	42.9	3.1	19.6	5.6	0.0	28.3	0.0	83.9	0.7	13.7	0.0	205.7	0.3	10.1	0.0	0.1	2.8	125.0	0.0	23.6	40.9	1.8	3.2	3.7	8.2	0.4	1.5	49.6	0.3	4.5
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2368.6;Basal prostatic cells: 1651.4;Basal squamous epithelial cells: 3008.4;Cone photoreceptor cells: 1401.1;Oligodendrocytes: 1410.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 488.1;hTERT-HME1: 371.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	60.9	86.2	206.5	16.2	275.8	3.3	117.3	240.6	221.9	158.8	143.3	173.2	25.4	167.1	38.2	66.1	103.9	32.6	166.0	194.6	230.7	52.2	80.8	108.0	11.3	258.1	250.4	78.2	39.8	36.7	78.8	28.7	263.4	84.5	32.4	87.4	100.3	48.7	143.1	166.2	64.2	106.0	209.1	36.7	68.9	28.4	243.3	31.4	29.8	104.1	15.2	90.4	113.2	325.4	62.4	26.6	41.2	20.8	79.5	103.5	24.6	82.2	89.7	37.8	42.1	17.1	15.5	10.4	32.2	220.7	35.6	46.7	34.4	161.2	73.0	52.3	45.2	17.8	49.5	31.4	65.9	15.0	0.4	58.3	488.1	92.5	371.6	69.1	73.3	9.5	12.6	38.2	113.9	20.2	5.1	6.8	27.7	35.6	21.9	0.1	28.8	16.5	118.8	83.0	47.2	37.8	32.7	11.7	64.1	67.7	18.6	27.2	176.5	77.3	55.9	37.0	68.9	39.6	28.6	5.0	55.8	8.8	40.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	0.3	1.3	0.0	0.1	206.5	275.8	240.6	221.9	194.6	230.7	258.1	250.4	263.4	209.1	243.3	325.4	193.2	336.5	11.8	1048.7	5.6	2368.6	1651.4	250.1	3008.4	673.1	81.0	301.5	862.8	77.2	161.7	55.2	1401.1	61.5	7.8	357.8	7.9	204.3	53.6	133.8	218.4	122.7	44.9	12.4	550.4	66.3	11.6	212.5	71.9	166.8	17.1	478.7	60.7	80.3	21.8	307.9	591.7	100.3	118.0	74.2	124.6	15.5	133.3	56.6	215.3	215.5	46.6	200.8	2.1	630.3	1410.3	194.1	283.0	152.4	27.2	229.8	124.2	10.3	52.0	122.6	65.7	381.8	196.6	20.0	13.7	298.2	857.2	26.5	19.7	30.5	48.1	142.8
DUS4L	"DUS4, PP35"	ENSG00000105865	"Dihydrouridine synthase 4 like"	O95620	7	107563484-107578523	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044301	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA044301: AB_10967460"	"unprognostic (7.95e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-3)"	"unprognostic (7.74e-3)"	"unprognostic (6.72e-3)"	1.5	1.9	1.1	0.5	1.2	0.4	1.5	1.2	1.5	1.6	0.9	1.4	0.6	1.5	1.7	1.7	1.3	0.6	2.7	1.1	1.2	2.7	2.0	1.0	0.8	1.2	1.2	1.8	1.7	1.2	1.5	0.6	1.3	1.5	0.8	1.0	1.6	0.5	1.7	1.5	1.3	0.5	1.2	1.3	1.6	2.3	1.1	0.7	1.6	1.1	0.8	1.7	1.5	1.4	4.1	1.6	1.6	1.0	0.5	1.0	2.3	0.9	1.4	1.7	1.5	2.1	3.6	4.6	2.1	0.6	4.6	1.2	1.7	2.4	2.3	1.2	1.3	1.2	0.9	2.6	1.6	3.0	0.2	1.2	3.5	1.6	5.7	1.8	2.4	3.9	5.4	1.7	2.7	3.0	4.3	5.8	2.8	3.3	3.4	2.3	1.7	5.3	3.2	2.1	1.6	4.4	1.9	4.2	3.6	2.3	1.9	2.6	1.7	2.5	2.0	1.8	2.6	3.0	3.8	4.9	2.3	4.3	2.9	0.0	0.1	0.0	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	1.1	1.2	1.2	1.5	1.1	1.2	1.2	1.2	1.3	1.2	1.1	1.4	4.5	6.4	3.9	4.6	7.6	5.1	11.0	5.6	10.2	10.0	8.6	10.2	9.2	5.7	6.6	11.0	4.2	9.1	4.5	3.3	7.9	13.3	32.8	11.3	7.2	4.6	9.6	5.0	3.5	16.2	8.8	4.6	5.1	11.0	13.4	10.2	4.2	9.3	6.7	3.3	5.1	5.0	10.2	5.0	3.7	24.9	4.4	5.6	3.6	5.6	5.2	15.4	11.3	4.5	9.7	15.7	6.8	3.8	5.6	8.1	7.7	17.3	15.3	9.8	13.1	3.4	5.7	12.4	11.0	11.2	4.0	3.7	6.7	7.6	6.3	6.9
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489891-37513501	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 179.7;Basal prostatic cells: 239.3;Cytotrophoblasts: 162.8;Endometrial ciliated cells: 146.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 36.4;SuSa: 24.9;WM-115: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes		79000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	15.3	14.2	10.9	1.3	11.2	0.3	12.4	11.2	17.0	12.8	10.9	10.3	0.0	9.5	5.5	17.4	7.5	1.2	14.1	11.0	10.9	8.7	15.2	8.6	0.4	11.9	11.1	5.6	6.6	1.0	14.5	0.9	10.6	6.4	1.0	9.9	13.1	0.3	11.0	44.1	5.5	0.8	10.4	2.8	7.6	13.7	10.8	4.4	23.1	4.4	2.7	7.2	17.1	10.7	2.6	0.2	4.9	2.1	0.1	0.6	2.1	10.4	7.8	14.3	15.6	1.2	17.9	0.2	0.9	7.6	0.2	2.8	0.2	6.1	36.4	0.2	0.7	0.0	1.6	6.2	1.5	0.5	3.0	8.5	5.5	4.8	2.5	10.2	0.3	0.2	0.6	3.1	11.4	0.4	9.7	1.7	0.3	3.8	0.0	2.5	0.6	2.5	17.5	2.4	1.9	0.3	0.5	17.6	4.1	24.9	0.8	3.9	1.4	10.8	5.8	0.1	5.8	0.1	0.3	0.1	0.1	0.0	37.5	1.1	0.0	0.7	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.6	0.0	0.2	0.0	0.0	0.2	10.9	11.2	11.2	17.0	11.0	10.9	11.9	11.1	10.6	10.4	10.8	10.7	15.0	6.4	5.4	2.9	8.3	179.7	239.3	74.8	129.1	6.8	42.6	46.0	15.0	4.3	39.6	7.3	8.4	162.8	16.6	0.3	29.4	34.8	36.4	146.9	18.5	21.7	2.4	11.4	12.0	15.1	82.1	30.2	3.1	85.3	87.0	10.6	14.6	15.7	19.7	15.2	5.3	1.2	36.7	2.8	34.8	52.5	13.7	5.9	62.2	4.7	25.3	16.1	15.5	3.0	3.3	74.8	2.9	6.0	9.9	64.9	0.1	16.9	61.3	24.5	0.0	13.2	45.2	26.0	33.4	44.0	92.6	67.9	18.2	26.3	1.1	67.0
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964573-102056443	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol		NA	NA		490000	"Cluster 11: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	22.4	19.3	7.8	4.9	7.2	9.2	18.2	16.1	10.9	17.2	0.0	29.1	3.6	24.6	5.0	18.5	17.5	4.0	29.7	9.2	1.1	12.6	9.4	19.9	4.4	5.2	4.3	21.0	15.8	2.0	20.9	3.0	9.0	14.5	3.1	13.2	19.9	2.9	53.1	27.6	19.2	3.1	0.6	14.2	19.7	13.0	2.1	2.0	17.6	1.2	2.4	23.4	18.0	9.2	3.3	6.6	5.0	4.6	3.0	5.0	3.2	3.0	1.8	5.1	4.5	2.6	4.5	4.2	3.4	5.4	4.9	4.0	8.2	5.3	3.6	3.4	3.5	4.1	15.1	3.3	2.7	3.6	6.4	6.4	6.3	14.1	4.9	3.2	3.9	8.0	3.0	8.9	4.5	4.2	5.6	4.1	5.1	2.1	10.2	4.6	3.3	1.6	5.2	7.6	8.4	2.8	3.2	2.2	3.4	4.9	2.5	1.5	11.5	6.8	4.1	11.5	5.1	4.3	7.6	4.9	9.1	2.9	3.0	1.3	0.6	0.8	0.6	0.4	0.5	0.4	0.4	0.4	0.6	0.5	0.3	0.5	1.2	0.4	0.6	0.6	0.4	0.3	7.8	7.2	16.1	10.9	9.2	1.1	5.2	4.3	9.0	0.6	2.1	9.2	102.1	125.0	84.7	83.9	55.9	52.4	46.4	75.0	51.2	126.4	63.1	55.5	182.9	31.5	89.1	77.3	139.7	49.6	106.3	94.2	13.7	112.6	14.8	123.6	131.0	93.7	71.3	38.1	127.3	81.2	42.9	86.5	86.6	134.6	33.5	117.9	46.1	36.7	40.2	183.4	131.0	68.0	75.3	52.7	123.6	16.8	70.5	90.7	71.2	51.5	99.2	63.3	73.2	51.8	93.3	131.3	73.6	71.5	100.0	47.6	82.6	48.5	90.7	115.4	85.5	81.4	106.1	87.1	72.2	59.2	64.1	37.4	91.3	86.1	64.4	46.5
DYNLT2B	"MGC33212, TCTEX1D2"	ENSG00000213123	"Dynein light chain Tctex-type 2B"	Q8WW35	3	196291219-196318299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 6.2;Cytotrophoblasts: 29.4;Extravillous trophoblasts: 9.9;Hofbauer cells: 16.8;Syncytiotrophoblasts: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 21.9;dendritic cells: 16.2;T-cells: 25.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 101.7"									HPA049555			Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA049555: AB_2680816"	"unprognostic (1.16e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (5.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.61e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	5.0	7.9	15.2	4.5	15.7	5.1	6.5	14.6	18.6	8.7	15.0	9.1	3.4	7.1	7.9	13.0	36.2	5.1	6.3	15.2	16.0	16.9	2.3	7.0	8.8	15.2	16.8	7.3	5.1	7.9	13.8	3.1	17.0	7.0	4.2	15.0	5.2	3.9	3.0	8.4	4.0	3.7	15.7	4.3	5.0	30.9	16.6	14.7	10.1	1.5	6.0	6.7	9.4	15.0	33.1	23.9	45.3	28.0	11.1	22.3	5.4	13.8	9.3	16.8	18.8	7.9	45.0	21.0	23.0	12.1	7.0	33.7	17.8	14.5	16.3	18.4	13.3	8.6	22.3	3.4	12.7	6.4	0.9	12.1	38.2	14.7	17.1	30.5	10.2	44.0	13.3	10.8	32.6	79.0	28.9	29.4	29.6	36.6	41.5	37.3	7.7	8.7	38.9	13.4	50.9	39.7	29.2	17.2	28.0	18.7	101.7	18.3	19.2	15.0	5.8	6.1	18.0	16.9	38.0	48.8	45.0	11.4	25.8	0.0	3.1	1.4	11.7	1.2	7.1	21.9	13.9	9.0	8.8	13.7	9.1	9.4	1.8	4.6	0.8	16.2	25.1	6.3	15.2	15.7	14.6	18.6	15.2	16.0	15.2	16.8	17.0	15.7	16.6	15.0	5.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	29.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	9.9	3.3	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0
DZANK1	"ANKRD64, bA189K21.8, C20orf12, C20orf84, dJ568F9.2, FLJ10600, FLJ30892"	ENSG00000089091	"Double zinc ribbon and ankyrin repeat domains 1"	Q9NVP4	20	18383367-18467281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.8;Endometrial ciliated cells: 35.5;Excitatory neurons: 32.2;Inhibitory neurons: 27.0;Respiratory ciliated cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"THP-1: 25.4;U-266/84: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059478, HPA064255"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"		"HPA059478: AB_2684033, HPA064255: AB_2685228"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.78e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.81e-3)"	1.2	1.3	3.2	0.8	3.1	2.8	2.7	3.2	4.2	2.2	3.3	1.0	0.4	1.0	0.9	1.0	3.5	0.4	0.7	3.0	3.1	3.3	1.0	1.8	1.0	2.9	3.6	2.1	1.7	1.0	5.7	0.5	3.0	1.7	0.6	3.4	1.2	0.4	0.7	1.7	1.2	0.3	2.3	1.8	1.1	4.9	3.0	0.4	3.8	0.2	0.8	1.2	1.1	3.3	0.3	1.7	1.7	1.5	1.6	1.0	0.3	0.9	0.4	2.4	1.5	6.4	0.8	3.3	0.4	0.8	1.0	0.6	5.5	0.6	1.8	0.4	1.1	1.6	0.9	0.8	1.2	2.6	1.1	0.6	1.0	4.4	0.8	0.6	0.8	1.1	0.1	1.1	0.6	2.7	0.2	1.2	3.6	1.0	0.2	0.8	0.7	0.2	3.4	1.5	1.6	2.2	2.6	1.3	3.1	1.3	1.0	25.4	0.1	2.1	0.4	1.8	1.2	3.6	27.9	3.8	0.7	3.1	0.8	2.6	0.3	0.5	0.1	0.9	0.1	1.1	0.1	0.4	0.3	0.3	0.2	0.2	1.0	0.5	0.7	0.4	0.4	0.2	3.2	3.1	3.2	4.2	3.0	3.1	2.9	3.6	3.0	2.3	3.0	3.3	1.7	0.0	3.6	12.1	6.1	1.5	1.1	1.6	1.8	4.3	7.7	9.7	1.6	1.5	8.8	3.7	16.7	0.5	2.3	1.5	1.9	2.1	25.8	35.5	5.1	1.5	0.0	0.4	32.2	1.1	0.8	2.3	1.5	5.1	3.8	3.8	1.4	0.3	2.3	6.7	27.0	1.2	8.2	3.8	1.8	19.3	0.3	2.5	5.4	5.6	1.1	4.0	1.0	9.0	16.7	2.5	0.3	1.9	4.0	0.7	0.6	4.1	41.9	18.0	0.0	2.6	2.6	11.6	12.4	0.8	1.4	0.3	2.6	3.2	1.9	0.6
DZIP1	"DZIP, KIAA0996"	ENSG00000134874	"DAZ interacting zinc finger protein 1"	Q86YF9	13	95578202-95644706	"Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 384.1;Late spermatids: 774.5;Spermatocytes: 222.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054891, HPA057272"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA054891: AB_2682631, HPA057272: AB_2683390"	"unprognostic (6.74e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.89e-3)"	5.0	3.4	8.6	2.5	8.5	0.1	4.4	6.9	9.4	12.4	5.7	10.7	1.0	12.6	7.2	3.2	12.4	5.1	4.3	7.7	8.7	11.4	1.1	4.6	2.2	7.0	8.1	16.3	9.9	0.4	10.3	2.5	6.1	6.4	1.8	4.0	2.3	6.2	1.3	1.6	4.0	6.1	5.6	1.5	4.7	14.8	11.5	0.8	2.4	2.1	1.7	7.9	7.1	7.1	1.1	4.2	17.5	15.5	14.5	16.2	3.6	11.0	13.2	12.7	15.2	0.2	0.0	0.0	2.5	9.4	5.5	0.0	11.7	3.8	14.8	1.1	9.6	15.6	4.4	11.0	9.2	0.1	0.0	11.7	0.4	4.2	5.8	23.1	9.1	1.1	0.0	0.1	11.4	0.0	0.0	0.0	8.6	0.0	0.4	0.0	10.1	0.0	15.4	1.8	4.2	9.9	8.3	0.0	0.6	22.4	0.0	7.3	1.3	12.3	5.3	1.8	8.8	0.0	0.0	0.0	3.5	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	6.9	9.4	7.7	8.7	7.0	8.1	6.1	5.6	11.5	7.1	2.4	0.0	0.0	63.6	0.0	0.6	1.1	3.1	4.6	18.7	0.6	3.4	3.5	2.8	3.9	1.8	4.2	4.5	0.0	0.0	7.9	20.8	384.1	37.2	34.1	2.5	0.0	0.0	86.8	0.2	2.6	19.0	0.5	2.7	0.0	3.1	2.9	0.4	0.7	6.7	95.7	0.0	4.1	0.3	1.5	774.5	38.8	1.2	3.6	19.7	2.0	8.3	0.0	106.6	5.1	0.6	0.0	43.6	0.0	0.8	0.0	24.4	19.4	1.5	19.7	18.2	15.8	222.8	12.6	1.2	1.0	1.8	0.5	20.8	0.0	0.3
E2F7		ENSG00000165891	"E2F transcription factor 7"	Q96AV8	12	77021248-77065569	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 8.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 46.9;Endometrial ciliated cells: 17.2;Late spermatids: 70.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"midbrain: 5.8;pons: 6.4;thalamus: 11.3"	HPA064866			Supported	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA064866: AB_2685374"	"unprognostic (1.21e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.67e-5)"	"unprognostic (1.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-1)"	0.2	0.1	0.2	1.1	0.2	5.0	0.2	0.0	0.3	0.3	0.3	0.9	0.7	0.2	0.0	1.4	0.6	0.7	0.2	0.2	0.2	0.1	0.2	0.3	1.5	0.7	0.8	0.1	0.2	0.1	0.5	1.0	0.4	0.2	1.5	0.2	0.2	0.1	0.0	1.1	0.8	0.3	0.6	0.3	0.6	2.9	0.2	8.3	0.1	0.1	1.6	0.6	0.5	0.2	20.1	9.4	25.7	10.1	0.8	2.5	31.1	27.6	29.8	14.2	17.0	12.8	6.6	11.2	5.4	5.5	29.5	15.1	15.5	29.8	27.1	4.4	10.4	9.8	27.3	7.3	5.9	8.5	8.8	0.8	7.7	37.4	22.9	8.3	14.2	19.0	10.4	8.9	29.5	10.1	31.9	0.1	18.1	6.7	21.9	23.0	22.2	6.2	3.5	16.8	16.3	10.7	22.9	7.9	6.5	10.9	12.6	8.7	39.3	53.5	26.8	23.0	36.7	9.5	5.8	7.1	19.3	3.8	34.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.2	0.2	0.0	0.3	0.2	0.2	0.7	0.8	0.4	0.6	0.2	0.2	0.1	0.0	0.5	2.3	0.5	0.3	1.0	1.4	4.6	0.0	0.6	0.9	2.1	0.0	2.2	0.0	0.0	1.8	0.4	1.5	0.0	0.3	46.9	17.2	0.8	1.5	0.0	7.4	0.4	1.1	3.1	0.8	6.1	3.1	4.5	6.3	0.0	0.0	0.9	0.0	0.2	1.2	2.0	0.3	1.2	70.2	0.3	1.3	0.0	3.7	0.0	1.6	0.0	0.5	0.0	12.0	0.1	0.7	6.9	1.7	0.0	0.0	3.1	0.1	0.0	0.0	1.2	1.2	2.1	6.3	0.6	0.3	0.8	0.4	2.1	4.3
EBF3	"COE3, DKFZp667B0210"	ENSG00000108001	"EBF transcription factor 3"	Q9H4W6	10	129835233-129973053	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.9;brain: 16.9"	"Group enriched"	"Detected in some"	5	"Adipocytes: 29.6;Endothelial cells: 13.1;Fibroblasts: 14.9;Skeletal myocytes: 33.5;Smooth muscle cells: 11.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 16.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;HAP1: 13.6;LHCN-M2: 25.4;NB-4: 35.7;RH-30: 13.2;SCLC-21H: 28.7;THP-1: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (2.96e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.50e-3)"	"unprognostic (8.53e-6)"	"unprognostic (2.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.58e-2)"	23.9	0.6	0.3	1.0	0.1	0.1	13.7	1.4	0.2	4.1	0.4	2.7	0.2	2.3	0.8	1.4	4.8	2.4	9.4	0.1	2.7	0.5	0.5	0.2	6.9	6.5	8.5	1.0	1.3	2.1	0.9	2.5	3.8	2.4	0.5	1.9	3.0	1.1	7.9	3.3	1.0	1.5	16.9	0.2	1.6	1.6	3.2	1.3	7.3	7.7	1.0	3.3	5.5	1.1	0.0	0.0	0.6	0.1	12.5	10.3	0.1	0.8	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.5	0.0	0.0	13.6	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	2.4	0.0	0.0	0.0	0.7	0.0	0.0	25.4	0.0	0.0	35.7	0.0	0.0	0.0	0.3	13.2	0.0	0.0	0.1	28.7	0.4	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	1.3	8.7	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.4	0.2	0.1	2.7	6.5	8.5	3.8	16.9	3.2	1.1	29.6	0.0	0.0	0.3	0.0	1.9	0.0	0.0	0.0	1.8	0.3	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	13.1	0.0	0.0	0.9	0.0	0.0	14.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.5	0.4	0.3	0.4	0.0	1.9	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.7	0.0	33.5	11.7	0.0	3.4	0.1	0.9	0.0	0.2	0.1	0.0	0.1
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115693-4135597	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 422.7"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 293.6;Distal tubular cells: 428.4;Proximal tubular cells: 577.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	53.6	123.6	43.9	21.0	47.7	21.5	65.0	46.5	63.7	60.0	50.5	53.3	64.0	44.9	102.1	26.7	49.2	40.1	150.9	42.4	47.8	236.0	422.7	28.6	20.0	45.0	45.6	71.4	159.8	53.2	52.6	37.7	44.2	45.2	55.4	31.8	29.9	36.3	198.4	22.7	59.6	35.5	45.3	30.1	103.5	30.9	49.0	33.5	37.0	236.4	21.8	31.6	26.8	45.5	82.8	45.1	72.8	161.0	89.7	131.4	8.8	114.0	116.7	122.1	107.7	34.0	12.4	3.6	139.6	126.0	111.0	41.6	83.6	67.4	179.5	30.4	95.8	44.0	59.7	186.8	51.3	40.4	20.7	90.6	40.6	106.2	58.4	166.0	262.9	136.2	146.2	31.1	118.6	33.4	113.9	100.7	49.5	8.1	158.7	108.8	90.8	1.5	67.2	16.8	1.8	33.7	6.8	48.2	107.6	131.0	109.8	18.9	268.6	92.4	49.8	82.7	69.8	46.8	88.7	8.4	47.9	34.7	73.0	19.2	36.4	17.4	41.5	28.4	57.1	45.8	48.8	58.3	58.9	51.9	59.8	59.2	1.2	66.0	43.3	45.3	57.9	41.1	43.9	47.7	46.5	63.7	42.4	47.8	45.0	45.6	44.2	45.3	49.0	45.5	61.0	28.9	25.2	17.0	24.4	18.2	48.6	50.3	22.2	14.3	33.3	41.0	165.8	78.6	40.1	36.8	12.5	293.6	29.3	32.0	428.4	53.2	63.1	60.8	43.1	48.0	52.1	77.6	10.7	175.5	29.0	55.2	34.7	57.0	23.4	68.6	53.9	162.2	64.3	18.5	11.9	41.6	20.3	22.0	19.2	50.6	63.3	23.5	35.6	14.0	34.7	77.7	21.6	8.5	18.2	80.4	37.5	50.8	28.3	24.7	120.6	577.0	83.6	46.4	26.3	46.8	33.9	46.5	35.6	24.9	12.8	101.9	41.2	224.0	60.8	22.3
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 484.1;esophagus: 1370.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 113.3;Fibroblasts: 118.6;Melanocytes: 74.7;Pancreatic endocrine cells: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 402.1;BJ hTERT+: 293.1;fHDF/TERT166: 279.6;hTEC/SVTERT24-B: 195.6;LHCN-M2: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		8700000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	49.3	15.4	7.6	11.8	8.5	0.8	27.1	7.3	14.7	293.8	6.1	17.7	9.4	51.2	484.1	1370.5	20.1	76.5	81.3	8.1	8.3	15.9	61.2	26.3	1.2	17.4	8.9	8.9	4.1	3.5	12.7	44.6	15.4	15.5	18.1	0.9	223.9	14.0	7.0	70.0	12.4	32.6	8.9	11.5	12.4	2.7	9.4	1.3	11.1	7.8	135.0	24.4	360.1	10.7	35.4	3.5	12.6	0.2	73.9	402.1	11.4	126.9	293.1	76.2	99.5	1.9	19.1	0.6	1.3	279.6	8.8	71.5	0.2	15.0	79.3	0.6	0.7	5.7	4.1	0.7	20.4	0.3	125.5	35.7	0.9	195.6	7.2	112.8	21.3	0.7	27.7	0.8	215.2	0.1	0.4	4.2	1.4	147.8	4.1	2.0	92.7	0.5	2.8	0.1	0.8	0.4	28.8	0.9	106.4	5.8	0.3	34.0	5.8	159.3	23.9	18.3	27.9	0.5	1.1	1.5	84.6	11.7	22.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	8.5	7.3	14.7	8.1	8.3	17.4	8.9	15.4	8.9	9.4	10.7	9.1	0.0	1.1	2.9	0.6	14.7	1.9	6.9	0.0	0.7	0.5	0.6	1.8	7.2	7.9	3.7	0.0	2.2	0.6	1.0	0.0	6.2	0.3	3.1	113.3	15.7	0.0	0.0	12.1	4.3	40.9	118.6	7.7	2.5	10.2	1.0	42.5	1.0	17.0	1.7	10.9	1.4	18.3	2.2	22.8	0.3	9.9	10.8	74.7	2.8	0.1	0.5	0.0	1.0	4.4	70.2	1.1	22.2	0.4	1.5	0.1	0.1	0.4	1.2	13.1	4.1	32.3	0.7	0.6	28.1	19.0	10.9	2.1	5.0	0.5	6.9
ECSCR	"ARIA, ECSM2"	ENSG00000249751	"Endothelial cell surface expressed chemotaxis and apoptosis regulator"	Q19T08	5	139448560-139462743	"Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"Adipocytes: 235.8;Endothelial cells: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	122	"EFO-21: 172.1;HUVEC TERT2: 443.7;TIME: 330.9"									HPA063337			Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA063337: AB_2732701"	"unprognostic (5.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.91e-1)"	62.7	12.7	5.5	11.2	5.5	0.2	59.8	5.7	8.5	26.8	5.3	19.4	4.6	29.4	7.4	15.9	33.5	12.1	54.6	5.2	5.9	29.9	6.0	60.1	11.6	6.0	5.9	10.4	6.7	4.7	7.1	33.5	6.3	19.6	8.0	0.8	16.1	7.3	15.1	16.6	20.7	24.4	6.1	23.5	15.2	3.3	6.7	3.5	40.9	17.2	7.2	35.5	26.1	5.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.3	0.0	0.0	172.1	0.3	0.1	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	443.7	0.1	0.0	0.0	1.4	0.0	0.0	0.9	2.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	330.9	0.4	0.4	0.0	1.7	0.0	0.0	0.2	0.0	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.5	5.7	8.5	5.2	5.9	6.0	5.9	6.3	6.1	6.7	5.9	235.8	0.0	3.9	0.0	1.0	14.9	0.4	0.0	0.0	0.0	1.9	2.5	0.0	0.0	0.6	0.0	0.0	0.2	1.0	0.0	0.0	0.6	0.0	0.4	0.5	214.9	0.0	0.0	0.1	1.2	0.1	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	18.3	0.0	0.0	1.7	10.6	5.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	13.9	0.3	1.3	0.9	0.0	1.6
EDA	"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED"	ENSG00000158813	"Ectodysplasin A"	Q92838	X	69616067-70039472	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 84.3;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	5	"monocytes: 1.2;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 5.2;Hep G2: 17.9;OE19: 5.1;RPMI-8226: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA037972, HPA037973"			Supported	"Vesicles,Lipid droplets"	"Secreted - unknown location"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Lipid droplets"	"HPA037972: AB_2675761, HPA037973: AB_2675762"	"unprognostic (3.76e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.25e-4)"	"unprognostic (4.33e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.04e-9)"	"unprognostic (8.63e-4)"	"unprognostic (7.64e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.79e-1)"	4.2	8.5	2.4	0.7	3.0	0.1	2.8	2.2	2.6	4.9	5.2	2.6	0.5	3.0	3.2	1.5	3.8	2.0	10.4	2.1	2.4	3.7	2.1	3.2	0.8	3.2	2.8	4.9	4.2	9.7	1.3	1.8	3.0	3.4	1.1	0.3	2.2	2.2	1.7	4.2	1.1	2.1	2.3	1.4	3.8	1.2	3.1	1.2	6.0	2.0	0.6	2.3	3.9	4.6	0.0	0.6	0.3	2.8	0.5	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.3	5.2	0.2	0.2	0.5	3.8	1.4	0.0	0.0	4.5	0.0	0.0	17.9	1.0	0.0	1.1	1.8	1.3	0.0	0.9	0.0	0.5	3.5	0.0	4.9	0.0	1.2	0.0	0.0	2.8	5.1	0.3	0.0	1.2	6.0	0.1	0.0	1.5	0.0	0.1	0.3	0.1	2.0	0.3	0.1	0.5	1.7	2.2	2.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.0	0.1	2.4	3.0	2.2	2.6	2.1	2.4	3.2	2.8	3.0	2.3	3.1	4.6	3.3	3.2	0.5	21.2	0.3	3.8	2.6	2.0	6.8	0.2	0.9	1.5	12.1	0.0	1.1	5.5	0.0	0.2	0.1	1.0	0.0	1.3	21.3	4.6	1.2	2.2	1.8	0.0	17.9	1.3	0.2	6.0	5.6	12.2	0.0	0.5	11.0	1.2	4.1	0.0	9.6	0.6	0.0	4.8	1.2	9.2	4.7	2.8	1.8	84.3	0.1	1.3	0.0	30.2	45.9	1.1	0.1	2.2	0.2	2.3	0.4	3.1	1.3	0.1	6.6	10.7	5.4	1.7	3.5	3.2	4.1	0.0	2.1	0.4	0.9	1.5
EEF1AKMT1	N6AMT2	ENSG00000150456	"EEF1A lysine methyltransferase 1"	Q8WVE0	13	20728731-20773961	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Breast myoepithelial cells: 19.9;Cytotrophoblasts: 19.8;Distal tubular cells: 27.4;Endometrial ciliated cells: 20.9;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040417, HPA042543"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA040417: AB_2676973, HPA042543: AB_2678045"	"unprognostic (4.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.31e-2)"	9.6	10.3	11.1	5.3	11.6	3.4	9.8	11.8	16.8	11.2	10.5	9.5	4.5	10.8	14.3	5.8	11.1	6.3	9.9	11.2	12.6	9.5	13.5	6.4	6.8	11.1	11.6	10.4	6.3	9.5	9.9	6.5	11.8	10.2	6.0	10.2	7.9	8.9	11.1	5.9	5.6	9.2	12.0	5.8	7.1	4.3	12.0	9.2	9.5	12.2	6.8	8.8	7.5	12.3	11.1	8.5	6.9	11.4	28.3	29.2	16.9	14.4	11.0	12.4	6.4	11.9	12.1	18.0	10.5	15.8	5.8	9.0	9.4	12.2	12.8	11.7	8.4	23.3	3.8	22.8	15.6	46.3	4.6	20.1	10.7	9.2	20.4	13.8	22.4	15.7	13.6	2.4	35.5	30.7	15.6	41.0	12.0	20.2	6.2	19.2	7.6	3.5	17.8	12.7	15.8	9.4	12.5	6.1	16.5	5.9	6.4	42.4	13.3	8.5	0.0	19.1	6.4	3.3	6.7	19.9	7.3	31.4	6.1	0.0	5.2	0.9	8.6	4.1	9.6	13.1	10.3	9.0	8.9	5.4	13.0	11.3	0.7	16.3	4.4	10.8	12.0	6.7	11.1	11.6	11.8	16.8	11.2	12.6	11.1	11.6	11.8	12.0	12.0	12.3	15.0	22.4	9.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.3	19.9	0.0	0.0	8.1	7.3	0.0	19.8	3.1	0.0	27.4	12.6	0.0	20.9	16.2	6.0	0.0	0.0	0.0	10.4	15.2	8.9	0.0	7.0	3.8	13.2	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	36.5	7.3	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	15.7	2.2	9.9	0.0	0.0
EFCAB11	C14orf143	ENSG00000140025	"EF-hand calcium binding domain 11"	Q9BUY7	14	89794669-89954777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 557.0;Late spermatids: 363.3;Oligodendrocytes: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA051209			Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions, Cytosol"		"HPA051209: AB_2681389"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.84e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.45e-2)"	5.0	4.1	8.5	3.2	8.1	6.1	9.1	8.2	10.6	5.3	9.9	5.4	5.1	3.8	6.4	4.8	11.0	3.4	2.6	7.3	7.2	7.6	6.0	3.2	3.7	8.1	8.3	4.8	4.8	8.2	3.3	6.4	7.6	5.2	5.4	6.2	4.7	5.0	2.0	3.3	3.8	3.8	7.6	3.5	4.6	36.8	8.3	4.4	7.8	2.4	4.8	4.7	3.0	8.6	8.4	12.7	11.0	13.5	6.5	7.1	30.5	12.1	10.9	16.1	11.2	15.2	29.1	13.1	22.4	8.1	11.4	17.9	9.3	24.2	23.1	14.9	6.1	9.4	11.0	24.6	1.5	12.1	22.0	4.9	5.9	10.5	11.9	9.2	13.6	13.8	10.0	12.5	19.3	43.4	9.0	16.3	4.7	34.3	22.7	10.3	17.1	9.6	15.2	23.0	4.5	7.7	15.3	27.9	14.5	22.4	22.7	8.6	11.5	8.7	11.9	9.3	12.0	7.6	23.2	23.0	12.7	5.7	16.1	14.9	1.1	3.0	0.4	2.5	0.2	2.2	0.7	0.8	1.8	2.4	1.1	1.1	2.7	2.9	5.0	1.6	1.0	0.6	8.5	8.1	8.2	10.6	7.3	7.2	8.1	8.3	7.6	7.6	8.3	8.6	5.8	0.0	1.1	30.3	6.2	5.1	7.0	14.2	2.2	8.6	8.8	7.9	4.2	11.5	9.7	18.4	2.1	15.7	3.0	3.3	9.8	12.1	557.0	37.7	6.3	7.4	0.0	9.5	16.8	16.9	28.9	6.3	1.5	10.5	5.1	8.0	6.4	6.3	11.7	3.3	19.1	6.1	10.2	4.0	6.6	363.3	5.6	5.7	3.6	18.7	8.0	6.8	2.1	40.2	139.9	6.5	9.7	7.5	6.4	2.6	3.6	20.4	47.7	13.2	0.0	5.3	6.0	62.8	14.7	5.4	3.3	7.7	2.5	10.2	12.2	5.9
EFCAB14	KIAA0494	ENSG00000159658	"EF-hand calcium binding domain 14"	O75071	1	46674659-46719146	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 159.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011224, HPA011938"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA		110000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoli, Golgi apparatus"	"HPA011224: AB_1852314, HPA011938: AB_1852317"	"unprognostic (2.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-1)"	49.8	23.8	26.0	25.4	35.5	8.5	30.5	31.9	21.3	42.4	15.5	37.4	30.2	31.7	24.7	39.6	38.4	33.3	36.1	21.3	28.1	44.2	30.6	43.0	26.2	37.5	33.7	35.8	23.1	159.5	18.0	43.6	33.4	30.7	39.3	12.3	30.5	40.1	34.6	28.7	31.5	38.9	29.9	31.7	65.9	27.3	29.9	34.1	43.9	45.9	35.2	40.1	27.1	38.2	34.9	20.3	13.4	23.8	75.2	48.6	37.3	35.4	56.7	40.3	40.6	22.4	23.1	26.5	38.5	51.6	53.7	41.0	28.1	41.3	51.7	62.4	16.9	33.8	15.1	8.7	26.9	44.3	67.1	43.9	61.5	31.4	28.2	37.4	52.6	26.3	23.5	37.9	37.7	12.4	30.6	10.6	22.2	39.8	21.1	22.1	45.9	25.2	37.6	68.4	7.4	9.9	47.7	64.2	29.9	43.3	29.0	38.6	46.0	33.1	16.8	38.1	37.0	38.0	65.2	22.7	43.6	34.5	25.9	23.4	22.6	36.8	25.3	28.0	34.0	18.0	23.0	22.9	19.5	17.0	21.0	21.7	15.4	21.8	26.3	14.1	21.1	24.3	26.0	35.5	31.9	21.3	21.3	28.1	37.5	33.7	33.4	29.9	29.9	38.2	152.3	73.7	84.6	31.3	45.9	31.7	52.3	32.0	44.9	31.6	56.3	34.0	44.9	47.1	46.1	114.0	31.3	40.6	64.4	80.8	31.3	36.2	70.6	36.1	37.4	74.8	37.8	31.1	20.3	38.4	32.0	48.8	79.0	52.2	101.8	27.4	50.7	57.9	42.2	47.1	27.8	64.6	54.9	75.5	44.0	18.9	47.2	52.0	26.6	29.0	65.0	50.6	84.5	29.7	46.2	48.5	61.3	49.7	34.8	73.8	50.5	34.4	49.9	18.6	26.3	50.2	49.9	51.3	27.7	46.5	43.5	59.0	52.0	30.4	46.2	128.4
EGFLAM	"AGRINL, AGRNL, FLJ39155, PIKA"	ENSG00000164318	"EGF like, fibronectin type III and laminin G domains"	Q63HQ2	5	38258409-38465480	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 121.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 120.9;Early spermatids: 50.7;Late spermatids: 49.1;Leydig cells: 155.4;Sertoli cells: 85.5;Smooth muscle cells: 70.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 10.2;HBEC3-KT: 12.6;hTERT-HME1: 16.4;HUVEC TERT2: 16.1;LHCN-M2: 37.0;U-2 OS: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066577	Approved				"Secreted - unknown location"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA066577: "	"unprognostic (2.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (7.02e-6)"	"unprognostic (2.60e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.04e-2)"	41.7	19.8	2.0	2.8	2.5	0.2	47.1	1.9	2.3	15.6	3.5	6.1	1.9	5.6	6.8	4.0	8.2	4.9	26.2	1.5	2.4	6.9	4.7	2.9	14.2	3.2	4.2	23.7	3.1	4.0	5.8	51.6	3.6	14.2	3.2	66.7	6.9	20.6	72.0	5.9	4.7	6.7	1.6	9.8	3.4	15.0	3.6	20.4	9.0	121.2	9.1	7.7	13.0	2.5	3.2	0.0	6.5	0.2	0.8	0.2	0.0	2.9	0.0	0.5	0.1	0.0	0.0	0.1	10.2	0.1	0.1	0.0	0.0	12.6	0.0	0.0	1.6	0.0	6.1	0.0	2.8	0.0	0.1	5.4	0.0	0.1	16.4	0.0	16.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	3.9	0.0	3.7	0.1	1.3	0.0	0.2	0.0	0.1	15.6	0.6	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.5	1.9	2.3	1.5	2.4	3.2	4.2	3.6	1.6	3.6	2.5	11.4	0.0	0.0	0.3	0.0	2.7	0.3	0.0	0.0	1.3	2.4	9.8	2.6	0.0	0.0	0.0	120.9	0.3	0.4	0.0	3.9	0.5	50.7	0.2	3.2	5.4	0.0	0.0	0.6	1.0	0.5	17.8	0.0	0.3	0.0	1.6	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	4.2	49.1	155.4	0.6	5.4	1.9	0.0	3.4	0.0	1.0	0.1	1.3	0.0	30.9	0.0	0.2	0.0	6.5	0.0	33.1	85.5	22.0	70.9	9.8	3.3	0.3	2.0	0.5	0.4	23.5	0.0	0.3
EHBP1	"KIAA0903, NACSIN"	ENSG00000115504	"EH domain binding protein 1"	Q8NDI1	2	62673851-63046487	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 203.4;Early spermatids: 220.3;Excitatory neurons: 262.3;Inhibitory neurons: 245.4;Late spermatids: 495.6;Oligodendrocyte precursor cells: 226.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035468, HPA035469"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Cytosol	"HPA035468: AB_10671513, HPA035469: AB_10601365"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (8.78e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (1.95e-8)"	30.0	17.2	15.1	10.7	16.3	6.4	17.4	27.7	19.3	29.0	11.7	41.9	9.7	31.1	7.9	29.5	21.3	20.4	11.7	20.0	16.5	17.1	53.9	11.6	8.8	13.3	22.1	48.0	15.9	15.2	12.2	11.9	14.1	16.0	14.2	20.9	15.7	18.6	8.0	13.0	14.9	30.0	10.9	8.1	17.5	37.4	22.6	13.4	14.4	13.1	10.2	18.1	21.6	16.2	49.7	66.9	26.8	16.4	46.1	89.0	27.2	43.6	42.4	31.6	25.9	80.4	36.2	34.2	15.4	79.8	47.5	29.1	35.1	30.5	51.9	36.3	16.5	29.7	22.9	95.2	31.5	17.5	21.5	40.9	54.1	31.6	61.9	31.3	20.5	26.7	20.6	19.1	51.1	19.4	20.0	10.9	26.3	40.8	26.2	17.8	33.8	14.9	20.8	16.1	29.6	23.6	35.1	25.9	43.0	28.5	12.6	17.0	15.2	33.3	34.4	55.8	23.0	21.5	16.2	32.7	33.3	26.3	69.4	0.2	2.2	2.5	4.1	2.4	4.0	6.3	4.2	3.9	3.7	4.9	4.2	3.6	0.8	3.4	1.3	2.4	2.5	2.2	15.1	16.3	27.7	19.3	20.0	16.5	13.3	22.1	14.1	10.9	22.6	16.2	29.0	38.5	18.8	203.4	10.4	15.6	12.0	27.1	43.3	39.7	10.5	12.8	15.2	22.8	20.7	14.7	4.2	10.9	9.9	5.3	15.6	22.1	220.3	10.3	45.4	19.9	16.2	8.8	262.3	40.5	30.1	36.6	9.2	12.1	2.5	15.2	30.0	59.6	5.0	18.5	245.4	5.4	6.1	8.6	11.4	495.6	58.4	7.6	10.6	119.0	6.5	20.1	13.4	226.7	98.7	41.7	5.0	40.3	9.6	13.9	11.4	15.1	14.5	17.8	6.6	33.1	19.4	53.7	31.1	55.4	14.2	2.9	12.7	18.2	8.1	13.1
EID1	"C15orf3, CRI1, EID-1"	ENSG00000255302	"EP300 interacting inhibitor of differentiation 1"	Q9Y6B2	15	48878134-48880173	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA051122, HPA051123"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA051122: AB_2681350, HPA051123: AB_2681351"	"unprognostic (1.38e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-1)"	128.6	206.3	96.9	95.4	103.7	61.0	112.0	98.7	153.6	149.8	107.2	143.9	81.6	161.0	132.1	96.6	134.9	120.9	280.1	103.9	111.3	147.9	125.1	99.5	112.0	102.6	101.7	186.7	102.0	144.8	130.1	93.3	100.5	156.1	71.3	158.4	98.3	147.3	278.8	57.6	79.0	141.8	102.1	115.3	84.2	67.9	104.5	117.2	138.5	227.6	83.9	113.1	81.4	123.2	131.5	109.1	260.9	231.6	239.9	316.9	16.4	337.6	304.5	220.3	294.3	95.0	58.0	174.9	305.3	207.0	155.5	115.4	130.2	130.8	247.9	484.1	127.1	300.6	235.8	4.1	186.0	183.0	132.2	278.1	115.1	146.1	91.9	221.4	262.8	151.2	182.3	162.6	258.5	188.7	134.6	174.1	0.5	98.9	97.4	185.1	302.6	290.6	287.4	142.3	233.8	234.6	210.2	80.2	401.2	212.7	145.0	240.6	262.9	322.4	177.7	305.6	299.3	208.4	616.7	125.1	264.6	410.0	230.0	345.0	311.5	275.5	221.3	285.3	209.2	168.3	249.4	231.8	358.1	183.2	179.6	165.3	40.4	230.0	297.5	354.9	332.4	440.1	96.9	103.7	98.7	153.6	103.9	111.3	102.6	101.7	100.5	102.1	104.5	123.2	327.4	387.8	207.7	31.3	127.5	175.5	139.9	459.5	138.9	345.3	188.5	286.4	480.8	183.0	329.9	261.1	120.9	351.6	168.0	46.0	606.5	386.5	17.5	116.0	324.4	356.8	233.7	219.2	38.0	268.0	151.2	443.4	88.2	116.7	188.0	173.8	339.8	166.2	211.3	238.9	43.5	114.0	301.1	208.1	262.0	49.2	702.4	189.7	487.4	30.9	302.2	844.1	213.1	28.6	80.9	191.0	102.1	651.4	134.3	81.4	91.9	446.5	240.2	329.9	322.1	350.7	379.1	98.6	75.0	125.9	145.6	109.6	180.7	463.2	101.5	96.9
EIF4G3	eIF4GII	ENSG00000075151	"Eukaryotic translation initiation factor 4 gamma 3"	O43432	1	20806292-21176888	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 515.2;Inhibitory neurons: 464.4;Microglial cells: 255.8;Oligodendrocyte precursor cells: 425.8;Oligodendrocytes: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025031, HPA025039, HPA025041"	Enhanced		Approved	Cytosol		NA	NA		68000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104"	"unprognostic (1.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.60e-7)"	"unprognostic (1.02e-1)"	"unprognostic (6.95e-3)"	"unprognostic (8.36e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	21.3	20.7	5.2	20.5	6.2	32.3	17.9	1.6	19.7	18.5	57.9	22.7	15.0	21.1	17.1	19.8	18.8	19.9	18.3	4.8	12.7	16.1	14.9	16.4	17.4	5.0	1.5	17.2	12.1	39.5	26.5	15.6	4.9	17.4	24.4	26.4	12.6	20.6	42.2	18.5	17.4	27.5	0.0	17.1	17.3	74.3	3.7	17.1	35.7	23.4	19.9	22.6	16.7	16.6	31.8	25.2	78.3	32.0	80.1	77.9	16.4	66.8	70.4	46.5	46.1	27.2	33.4	60.7	41.1	73.2	42.6	34.5	48.4	53.9	64.3	50.4	48.2	31.6	47.7	18.9	38.5	53.1	56.5	86.4	39.9	47.8	61.2	69.0	59.2	22.3	23.9	42.0	66.3	25.1	16.6	19.2	23.3	36.7	21.3	31.7	29.8	21.4	40.8	16.4	46.1	35.4	70.0	29.6	35.9	46.3	20.7	58.0	60.7	51.4	19.1	73.5	30.2	18.8	22.5	0.3	63.5	78.7	48.4	0.5	0.5	0.9	0.7	0.0	0.3	0.6	0.3	0.3	1.0	0.8	0.2	0.3	1.2	0.4	0.3	0.6	0.5	0.5	5.2	6.2	1.6	19.7	4.8	12.7	5.0	1.5	4.9	0.0	3.7	16.6	50.9	19.2	30.5	181.5	29.5	20.6	19.9	15.0	17.1	52.0	19.2	17.4	44.5	14.3	28.2	16.5	66.7	4.6	51.1	51.3	0.0	20.6	173.9	66.6	81.2	42.7	16.3	26.1	515.2	19.4	8.8	33.8	46.4	46.8	26.6	44.9	46.1	14.7	23.1	50.5	464.4	21.6	4.1	31.5	11.3	121.8	44.7	39.3	14.2	255.8	18.0	18.6	28.8	425.8	483.4	24.8	32.1	44.8	27.3	21.0	15.7	10.3	51.1	40.5	32.9	36.6	31.3	100.6	51.2	33.8	26.3	3.4	23.7	68.4	29.6	28.0
ELF2	"EU32, NERF, NERF-1A, NERF-1B, NERF-2"	ENSG00000109381	"E74 like ETS transcription factor 2"	Q15723	4	139028112-139177218	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006057, HPA071166"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA006057: AB_1078733, HPA071166: AB_2686351"	"unprognostic (7.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	23.7	14.2	12.1	15.2	17.3	47.3	24.5	19.2	16.1	21.8	9.6	24.6	15.0	24.7	18.5	17.3	20.7	17.8	20.1	11.1	15.6	15.5	20.4	19.0	19.9	15.6	14.9	28.2	16.7	20.0	22.6	26.8	15.9	21.5	19.2	30.7	21.4	21.7	36.0	23.2	17.6	23.0	13.2	19.6	17.4	37.4	14.5	32.8	23.0	33.6	21.4	19.2	18.4	20.2	15.9	11.3	27.9	21.4	28.2	31.7	26.9	18.4	31.8	19.6	21.8	22.2	31.2	32.3	18.5	25.7	10.4	16.8	41.2	26.3	20.5	20.2	18.6	28.5	26.4	20.0	20.7	32.1	22.1	31.1	24.8	19.3	23.3	25.7	29.5	18.0	46.8	18.4	17.7	27.8	37.8	28.6	17.0	36.4	13.1	36.0	36.8	30.1	25.1	27.2	28.4	32.6	23.1	28.5	17.6	32.4	19.7	38.5	25.0	18.3	15.9	16.7	12.4	40.8	48.6	28.3	13.5	32.4	17.2	13.3	8.3	14.1	12.0	7.2	13.2	17.5	11.8	10.8	9.9	19.3	14.6	13.5	9.1	12.9	7.9	18.0	9.4	5.3	12.1	17.3	19.2	16.1	11.1	15.6	15.6	14.9	15.9	13.2	14.5	20.2	103.0	48.1	22.5	64.0	57.6	53.2	41.1	36.1	120.1	42.0	50.3	40.4	37.0	40.0	39.1	40.5	75.0	32.6	71.9	31.0	43.0	26.4	26.0	60.0	54.3	67.1	47.3	43.5	73.6	24.2	32.3	63.7	35.7	56.3	34.8	44.0	53.2	46.9	22.2	67.3	75.3	38.1	42.7	52.2	40.1	24.6	52.5	59.5	30.2	98.4	49.2	37.3	77.2	83.9	279.4	24.1	33.5	38.0	51.0	52.6	35.9	23.1	48.2	57.7	39.5	81.4	59.2	59.7	42.0	79.0	47.6	23.7	50.7	33.6	27.7	39.6
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 70.4;Fibroblasts: 115.9;Leydig cells: 110.6;Peritubular cells: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 97.6;BJ: 143.7;fHDF/TERT166: 205.6;U-2197: 817.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2900000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280"	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.62e-3)"	147.2	21.6	11.6	40.8	14.3	0.1	94.2	19.9	17.6	100.2	24.3	57.6	8.8	73.6	18.4	53.0	70.7	76.7	184.1	13.1	15.3	12.8	13.4	214.1	14.5	15.4	20.1	37.0	90.9	2.8	24.9	58.9	13.8	106.4	11.3	2.8	66.9	35.1	17.9	91.3	40.6	90.0	14.9	40.9	63.2	13.1	14.0	5.1	48.4	16.9	4.5	85.3	84.3	17.9	0.0	2.0	0.8	0.0	97.6	0.6	0.6	143.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	205.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.5	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.6	0.6	8.3	0.8	0.8	0.4	58.0	1.0	0.0	0.0	28.0	68.9	0.0	1.2	0.1	10.0	0.6	0.0	0.0	0.2	0.3	817.9	0.0	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	14.3	19.9	17.6	13.1	15.3	15.4	20.1	13.8	14.9	14.0	17.9	34.6	0.0	6.4	34.9	0.1	11.0	13.5	33.9	4.0	2.8	0.9	1.1	9.7	2.8	4.3	7.3	2.1	0.1	0.3	0.2	0.0	0.3	3.5	3.5	70.4	28.4	1.8	0.0	4.6	3.9	0.3	115.9	7.1	2.3	0.0	0.2	47.2	4.2	0.5	6.7	8.1	1.3	0.0	0.6	20.4	7.5	110.6	1.2	14.2	23.4	0.0	15.9	0.0	14.1	18.5	1.1	0.2	148.2	0.4	1.4	0.0	0.1	3.0	0.8	0.0	12.2	34.1	1.1	1.2	2.1	10.9	0.1	1.2	0.6	0.2	1.1
EMC3	TMEM111	ENSG00000125037	"ER membrane protein complex subunit 3"	Q9P0I2	3	9962537-10011116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 360.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042372	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA042372: AB_10795609"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.81e-6)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.58e-2)"	71.1	41.1	26.5	28.9	27.6	65.7	33.3	28.5	29.9	26.1	29.7	40.6	37.4	23.2	26.9	46.1	28.9	27.9	34.3	29.2	29.4	40.3	65.7	36.1	22.7	31.0	29.5	22.5	43.6	70.5	17.2	20.3	30.4	25.8	36.0	24.2	42.8	32.0	78.5	33.6	37.3	32.0	28.3	23.1	35.3	48.5	28.8	27.2	39.9	46.7	28.5	40.7	25.1	30.4	48.9	100.7	37.4	22.5	232.6	90.3	125.1	98.1	84.6	60.1	64.8	69.5	75.6	38.7	69.8	111.9	115.2	66.7	64.2	58.3	61.7	105.2	64.3	63.6	69.9	46.5	100.4	71.8	68.2	107.4	102.5	104.9	60.1	76.5	75.6	41.8	82.0	109.2	90.2	119.5	38.3	35.6	41.5	103.2	68.7	49.0	52.4	115.7	72.8	86.7	26.4	53.1	69.9	103.3	63.4	39.1	87.5	58.0	87.6	59.8	49.6	65.0	100.8	58.3	165.6	79.0	126.2	52.0	76.4	119.7	115.1	108.5	64.5	93.6	66.8	65.6	63.7	74.5	88.3	71.2	45.8	61.5	103.5	77.3	95.3	79.1	107.3	156.1	26.5	27.6	28.5	29.9	29.2	29.4	31.0	29.5	30.4	28.3	28.8	30.4	59.1	54.5	72.9	19.9	45.3	50.6	59.9	178.0	24.5	40.6	43.0	39.9	108.1	57.2	121.4	46.0	39.6	49.5	52.7	58.6	46.9	100.6	360.7	61.6	50.2	59.2	21.1	240.2	25.4	119.9	51.8	51.1	38.7	64.0	34.1	36.5	46.1	105.0	97.8	23.5	21.1	40.2	109.9	51.0	66.6	109.3	50.4	101.7	58.7	9.4	97.5	65.2	57.7	21.1	17.8	107.4	71.3	37.6	55.6	58.7	92.6	76.9	99.1	63.5	59.2	44.7	60.7	199.7	63.0	49.6	60.7	85.8	52.7	60.6	52.0	80.2
EMCN	MUC14	ENSG00000164035	Endomucin	Q9ULC0	4	100395341-100880126	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"Adipocytes: 409.0;Endothelial cells: 261.7;Hepatic stellate cells: 175.3;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005928	Approved				"Intracellular and membrane"	NA	NA		470000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA005928: AB_1078735"	"unprognostic (8.01e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (3.65e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.75e-2)"	46.3	20.2	6.7	9.6	7.1	0.2	38.2	7.1	11.2	37.1	7.8	10.3	6.8	27.9	9.9	12.7	19.2	31.4	38.5	6.3	7.5	79.7	7.5	48.4	6.6	8.1	7.0	6.9	6.2	19.2	9.6	0.8	9.0	12.7	8.1	1.5	9.2	25.6	18.5	9.0	8.3	38.8	7.0	3.5	8.2	2.3	9.4	8.7	43.6	40.2	4.9	24.9	13.9	7.4	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.1	0.0	30.6	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	7.1	7.1	11.2	6.3	7.5	8.1	7.0	9.0	7.0	9.4	7.4	409.0	6.4	6.0	0.3	14.0	16.6	0.5	0.1	6.2	0.1	2.1	3.0	14.1	0.0	0.7	0.0	0.0	0.1	1.7	0.0	0.0	0.1	0.7	0.6	0.6	261.7	0.0	8.0	1.3	0.0	0.0	16.2	0.0	0.3	0.0	0.1	175.3	1.1	0.2	0.0	0.2	0.0	0.0	5.5	21.4	1.3	1.2	1.7	16.0	111.5	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.4	2.6	1.0	0.0	0.2	0.0	0.4	0.0	5.8	21.4	0.2	0.5	1.1	14.6	0.3	2.4	0.7	0.0	1.0
EML1	"ELP79, EMAP, EMAPL, HuEMAP"	ENSG00000066629	"EMAP like 1"	O00423	14	99737693-99942060	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Excitatory neurons: 57.5;Late spermatids: 61.3;Microglial cells: 69.3;Oligodendrocytes: 61.8;Rod photoreceptor cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 67.3;HDLM-2: 89.5;U-2197: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033137, HPA049105"	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB033137: AB_2098052, HPA049105: AB_2680633"	"unprognostic (9.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.09e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.89e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.81e-3)"	"unprognostic (7.03e-3)"	15.5	6.4	8.6	9.1	25.5	0.3	9.7	7.3	12.7	13.2	15.0	35.5	6.8	16.1	10.8	24.1	15.1	18.6	17.2	8.6	7.9	8.6	5.5	13.2	3.3	9.2	9.0	3.8	8.7	28.3	9.2	27.2	10.7	9.6	14.9	50.1	5.0	16.9	47.5	9.4	10.1	31.0	9.4	3.9	14.9	8.0	8.9	1.3	14.8	34.4	4.4	17.1	10.3	22.8	0.0	44.9	36.8	12.9	20.1	39.5	0.3	35.9	67.3	25.2	8.4	5.1	0.9	0.0	22.2	22.6	30.3	0.2	26.7	3.1	11.5	89.5	13.6	0.0	7.9	0.8	4.8	0.1	0.9	11.6	4.9	31.0	11.7	16.0	44.5	0.7	0.1	0.0	10.4	21.3	0.1	0.1	14.5	0.1	17.2	5.4	13.5	0.2	56.2	0.6	14.1	20.9	11.8	1.8	0.0	24.1	13.7	1.2	42.3	22.8	4.1	104.3	14.9	0.5	0.0	0.3	57.3	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	25.5	7.3	12.7	8.6	7.9	9.2	9.0	10.7	9.4	8.9	22.8	22.8	16.0	7.0	17.3	0.3	2.8	1.2	0.4	1.2	9.2	1.0	1.3	15.0	1.5	4.5	3.7	158.4	2.7	0.1	0.1	0.0	4.6	29.1	15.9	14.2	30.1	0.0	0.0	57.5	4.9	0.6	20.6	4.1	4.7	0.0	1.6	40.0	1.3	1.3	1.7	29.9	0.6	0.0	2.5	4.7	61.3	7.2	1.9	7.2	69.3	0.6	8.8	1.0	17.6	61.8	0.8	0.0	6.0	1.2	1.4	0.0	2.5	11.8	113.6	0.0	20.8	8.7	4.8	11.3	0.4	4.0	2.9	0.7	1.2	0.0	0.7
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580632	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 230.6"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	56.8	9.7	15.5	12.4	15.5	0.7	49.5	14.8	17.1	51.0	18.6	48.0	15.5	25.9	45.5	152.1	35.5	17.7	64.1	13.6	15.6	20.3	83.2	230.6	5.7	16.1	16.8	54.9	13.7	32.8	13.3	23.0	16.0	38.8	34.1	2.0	39.2	17.3	22.5	140.6	28.3	22.3	15.2	16.0	39.1	7.2	18.8	5.3	27.7	25.4	32.8	39.6	72.9	15.7	28.7	39.1	15.9	18.9	35.0	30.0	31.3	40.0	36.8	23.9	35.7	128.5	98.2	0.2	12.6	48.4	17.2	123.9	41.1	49.8	31.3	0.1	26.1	0.1	76.6	72.1	6.1	0.2	0.4	18.4	13.1	31.9	3.2	5.4	10.1	0.1	9.6	2.6	66.9	268.1	0.4	0.6	18.3	46.4	9.5	7.5	18.2	61.7	5.5	182.0	22.0	25.0	49.6	256.2	15.2	45.2	156.6	6.2	5.7	75.5	32.2	25.6	22.7	0.8	1.0	0.2	33.2	0.5	75.7	1.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	1.1	0.3	0.3	0.3	0.2	0.1	15.5	15.5	14.8	17.1	13.6	15.6	16.1	16.8	16.0	15.2	18.8	15.7	239.7	4163.5	368.4	13.1	3.1	356.9	137.9	172.2	111.0	2.3	105.0	94.0	53.1	100.1	255.8	42.3	0.0	74.2	3.1	119.5	0.0	3.8	8.0	78.8	30.9	183.9	104.9	0.0	0.7	67.0	17.8	152.7	46.4	51.9	36.7	68.7	161.0	235.1	10.1	0.0	0.6	207.8	81.4	19.6	136.5	9.3	190.7	17.0	87.2	41.2	33.6	5.7	0.0	22.6	0.6	32.9	158.4	276.1	1.6	86.0	21.0	0.2	142.8	2.2	52.6	256.3	129.3	5.7	12.9	319.5	1174.3	48.0	9.3	73.3	178.5	221.4
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542445-117549546	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 79.0;epididymis: 104.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 239.1;Distal tubular cells: 90.1;Endometrial ciliated cells: 75.6;Endometrial stromal cells: 126.5;Glandular and luminal cells: 68.6;Granulosa cells: 88.3;Proximal tubular cells: 185.0"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 25.4;fHDF/TERT166: 31.6;RPTEC TERT1: 31.1;RT4: 9.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 14.2;cerebral cortex: 17.8;hippocampal formation: 22.8;white matter: 8.1"	"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favorable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	10.4	0.1	23.2	0.2	25.6	0.2	2.8	16.9	31.3	58.2	16.7	0.4	0.1	79.0	104.3	0.4	53.0	1.5	0.8	26.9	16.5	39.1	0.1	0.1	0.6	15.8	18.0	11.9	0.0	0.1	1.8	0.4	16.4	1.1	0.1	0.3	2.4	52.6	10.8	10.5	0.1	45.0	14.7	0.2	0.1	1.2	19.6	0.1	0.3	5.2	0.4	4.7	4.4	22.9	0.0	0.0	0.0	2.6	0.0	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	25.4	31.6	0.0	0.1	0.6	0.0	0.0	0.1	2.8	0.8	0.1	0.2	0.0	0.1	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.1	0.2	31.1	9.4	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	2.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	23.2	25.6	16.9	31.3	26.9	16.5	15.8	18.0	16.4	14.7	19.6	22.9	4.6	0.0	0.0	43.4	1.0	10.7	2.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	239.1	0.0	0.2	0.0	0.1	90.1	0.0	1.4	75.6	126.5	3.1	0.0	0.0	0.1	0.0	0.3	18.0	0.0	68.6	0.0	88.3	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	8.0	2.6	60.3	2.5	21.4	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	41.0	0.0	2.5	0.1	185.0	0.0	0.1	52.6	8.6	32.1	0.3	0.3	0.0	7.5	0.1	2.2	2.2	0.3	1.7
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95877266	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 17.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 102.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0"	"Group enriched"	"Detected in many"	7	"HDLM-2: 147.5;Karpas-707: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002494, HPA014067, CAB079986"	Enhanced		Uncertain	Microtubules		NA	NA		19000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	11.8	8.3	5.9	24.7	5.5	27.5	10.8	5.0	6.3	17.5	5.0	14.3	9.3	28.0	19.3	19.2	14.0	27.7	8.5	5.3	6.3	7.6	5.4	16.1	20.2	7.1	6.5	5.5	2.8	3.4	3.9	11.4	7.7	11.2	12.8	6.8	6.0	18.1	4.0	6.3	11.7	49.7	6.2	21.5	7.3	4.5	7.5	6.8	20.0	8.7	25.6	30.6	11.0	6.3	1.4	2.7	5.4	7.1	0.1	0.1	5.0	4.5	1.2	0.0	0.0	4.0	1.6	8.2	3.1	0.0	5.3	2.2	0.0	0.0	0.0	147.5	5.2	7.2	4.0	4.3	0.0	12.5	4.1	0.1	0.0	0.6	0.0	2.4	18.2	2.0	5.3	135.4	0.1	4.4	4.7	5.8	5.9	3.6	2.8	15.3	2.4	4.4	1.7	2.2	5.1	6.2	3.6	3.7	3.9	3.6	5.5	5.9	3.9	3.9	2.8	3.8	5.3	21.6	7.2	0.6	4.3	13.9	2.7	0.7	41.0	102.2	0.6	27.2	1.1	13.7	1.6	1.1	31.9	11.4	0.6	0.6	49.4	1.5	6.7	2.1	13.1	15.5	5.9	5.5	5.0	6.3	5.3	6.3	7.1	6.5	7.7	6.2	7.5	6.3	19.6	0.0	1.1	74.1	40.9	8.9	0.3	0.0	0.6	1.4	0.8	1.5	10.1	0.0	0.7	1.8	2.1	0.6	3.7	0.3	1.9	0.0	10.3	0.6	3.6	60.6	0.0	4.4	2.8	2.0	1.9	15.7	6.1	0.6	3.8	0.3	31.4	0.8	26.6	0.0	5.2	0.1	0.0	110.4	161.3	7.3	0.6	62.1	16.0	217.4	112.2	0.4	0.0	20.6	5.0	0.2	1.2	3.0	80.1	0.5	0.1	0.3	0.8	0.8	6.6	1.0	22.7	10.1	4.4	0.8	11.2	15.7	26.9	15.1	1.0	0.5
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107621-89482134	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 31.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 70.6;Inhibitory neurons: 106.6;Microglial cells: 103.0;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	5.4	1.0	2.1	1.8	1.3	0.0	2.3	0.2	3.8	12.3	0.1	3.8	2.3	5.5	0.2	3.2	1.3	18.8	8.2	2.2	0.7	1.3	4.9	2.4	3.6	3.3	0.9	4.1	2.1	1.0	0.9	20.1	4.0	31.5	6.2	8.0	2.2	7.1	0.8	0.7	2.4	7.9	0.8	0.9	2.5	1.0	1.7	1.0	11.0	6.3	3.2	14.3	6.4	2.2	0.0	0.0	197.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	11.2	0.2	0.7	0.0	2.4	0.0	0.0	11.8	0.0	0.0	1.7	2.0	0.0	3.9	0.0	0.0	0.6	0.0	2.5	0.1	0.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.5	0.1	0.1	36.1	0.1	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.2	3.8	2.2	0.7	3.3	0.9	4.0	0.8	1.7	2.2	2.2	0.0	0.0	5.5	0.0	0.5	0.3	0.0	0.6	6.4	0.0	0.1	2.4	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.5	1.8	0.0	0.0	70.6	0.0	0.1	18.1	0.5	0.0	0.0	0.0	1.1	0.0	0.1	20.2	106.6	0.0	0.0	0.0	0.7	1.6	2.1	0.1	0.0	103.0	0.0	4.7	0.0	2.5	48.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	18.7	6.6	0.7	19.2	0.1	0.0	0.3	0.3	0.5	0.2	1.3	0.0	0.1
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 24.2;ovary: 6.3;testis: 8.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 421.5;Early spermatids: 401.8;Excitatory neurons: 423.8;Inhibitory neurons: 879.2;Late spermatids: 208.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 24.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 9.3;U-266/70: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA007397: AB_2667821, HPA058047: AB_2683588"	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.2	0.0	6.5	0.0	12.7	0.0	0.2	24.2	10.9	0.8	0.0	3.2	0.1	0.9	0.3	0.8	1.9	0.9	0.3	11.4	0.0	0.4	0.0	0.1	0.0	0.0	0.2	6.3	0.5	0.1	0.1	0.0	1.1	1.0	0.7	1.1	0.1	0.6	0.0	0.0	0.3	1.4	0.1	0.0	0.6	8.4	3.5	0.2	2.0	0.1	0.1	1.4	0.6	0.0	0.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	9.3	0.0	2.2	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.9	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.4	0.0	0.9	28.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	12.7	24.2	10.9	11.4	0.0	0.0	0.2	1.1	0.1	3.5	0.0	0.0	0.0	0.0	421.5	0.1	0.3	0.3	0.0	5.2	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	401.8	0.1	1.4	0.1	0.0	0.0	423.8	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	879.2	0.0	0.0	0.0	0.0	208.7	3.1	0.2	0.0	30.0	0.0	1.0	0.0	31.2	9.0	0.1	0.0	1.5	0.0	0.1	0.0	1.7	0.0	0.3	0.0	0.2	0.1	14.7	2.7	6.0	0.0	0.1	0.0	0.4	0.0	0.1
EPSTI1	"BRESI1, MGC29634"	ENSG00000133106	"Epithelial stromal interaction 1"	Q96J88	13	42886388-42992271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 168.1;monocytes: 144.2;Proximal enterocytes: 156.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 95.8;BJ hTERT+ SV40 Large T+ RasG12V: 99.6;HDLM-2: 74.2;RPMI-8226: 35.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017362	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"			"HPA017362: AB_1848226"	"unprognostic (2.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (7.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.13e-2)"	7.5	7.7	3.7	31.6	4.1	33.6	4.8	3.1	5.1	5.7	2.8	12.6	33.7	6.0	1.6	5.0	3.7	18.1	4.7	3.1	3.6	8.0	12.9	16.8	34.2	7.8	4.6	3.1	3.5	7.6	2.7	16.8	5.2	2.7	11.0	0.3	18.5	4.8	2.2	1.5	32.0	9.7	5.5	31.3	15.8	7.4	4.4	27.7	3.1	2.5	20.7	13.1	3.6	4.5	2.8	0.1	0.0	0.0	0.1	5.2	3.0	2.3	26.0	95.8	99.6	23.2	5.7	3.7	0.8	3.4	10.1	11.4	0.2	3.9	12.2	74.2	0.2	11.9	0.0	0.1	22.9	0.0	2.0	17.4	5.2	7.7	0.5	1.4	1.4	5.7	0.0	17.9	2.5	0.2	19.0	2.9	0.5	1.9	0.1	0.2	0.1	35.7	16.1	0.7	2.0	0.0	0.3	0.0	1.9	0.4	0.6	1.9	3.9	0.0	0.0	1.0	0.0	0.8	0.6	0.0	1.9	0.0	1.0	52.3	34.4	29.4	10.8	59.3	11.4	26.7	22.3	12.3	31.1	23.7	10.4	7.8	16.1	24.4	39.3	3.8	59.0	22.5	3.7	4.1	3.1	5.1	3.1	3.6	7.8	4.6	5.2	5.5	4.4	4.5	26.5	19.2	10.9	1.3	40.0	4.2	1.7	4.1	0.6	0.0	1.2	1.8	2.9	12.8	9.2	5.5	0.0	10.9	27.1	26.5	1.9	40.9	89.0	10.2	18.8	18.8	24.6	31.5	0.3	39.0	168.1	15.9	15.3	20.7	10.8	22.4	12.5	6.3	84.2	0.0	11.6	25.1	2.0	39.2	28.3	27.1	14.9	68.7	10.6	84.3	144.2	0.2	37.0	4.5	0.3	51.2	55.4	4.9	23.6	3.6	156.0	39.1	6.5	0.1	0.0	2.6	10.6	2.6	1.7	2.8	3.8	14.5	37.0	43.9	37.6	3.7
ERBIN	"ERBB2IP, LAP2"	ENSG00000112851	"Erbb2 interacting protein"	Q96RT1	5	65926556-66082546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 119.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;dendritic cells: 61.3;Endometrial ciliated cells: 62.3;Glandular and luminal cells: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048606, HPA059863"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA		39000	"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles, Plasma membrane"		"HPA048606: AB_2680461, HPA059863: AB_2684146"	"unprognostic (4.34e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.45e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.62e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.81e-2)"	15.7	14.5	65.2	29.5	109.6	30.0	24.7	64.2	67.6	23.2	19.0	27.8	24.5	22.6	27.0	20.1	20.0	28.4	16.9	56.2	91.6	29.5	33.3	21.5	40.6	91.3	88.0	20.0	18.8	22.6	8.3	16.4	106.0	26.4	26.3	28.1	21.8	20.2	19.8	32.8	44.1	19.7	64.4	31.4	40.3	27.5	86.6	48.7	29.9	20.7	39.0	28.5	13.0	119.1	97.8	32.2	41.5	49.6	30.0	36.0	31.5	61.5	62.6	85.3	94.3	31.5	113.8	82.2	58.8	95.3	67.2	31.7	26.5	45.1	149.4	36.3	12.0	28.3	41.3	24.7	39.5	22.0	26.3	39.4	29.2	47.2	67.5	50.0	32.1	37.1	29.4	54.6	58.1	33.5	59.0	25.1	10.1	9.7	9.5	53.7	33.0	45.8	49.9	65.6	20.0	18.7	65.0	21.7	46.4	30.9	38.4	53.8	29.8	48.3	85.9	29.8	80.8	47.2	31.7	69.8	31.6	35.9	28.1	13.1	4.1	5.5	5.2	5.8	4.8	4.7	3.9	4.6	3.5	3.7	4.5	4.8	9.2	3.9	5.1	2.2	3.8	2.8	65.2	109.6	64.2	67.6	56.2	91.6	91.3	88.0	106.0	64.4	86.6	119.1	53.0	70.5	57.5	0.0	13.2	0.0	0.0	0.0	0.0	0.0	39.4	24.8	0.0	0.0	31.6	53.3	0.0	6.5	61.3	0.0	11.7	26.7	0.0	62.3	50.0	26.1	0.0	0.0	0.0	24.9	11.2	16.2	0.0	101.9	27.8	47.8	0.0	0.0	40.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	50.3	0.0	0.0	13.3	0.0	0.0	41.7	24.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	8.9	20.0	51.4	0.0	0.0
ERN1	"IRE1, IRE1P"	ENSG00000178607	"Endoplasmic reticulum to nucleus signaling 1"	O75460	17	64039080-64130819	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 53.0;pancreas: 66.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 325.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 17.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 17.9;T-cells: 9.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 74.6;RPMI-8226: 40.2;U-266/70: 77.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009495, HPA027730"	Supported					NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB009495: AB_2098712, HPA027730: AB_10602494"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.55e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.11e-2)"	9.5	53.0	1.5	5.4	1.7	13.4	7.5	2.6	3.2	22.6	2.1	7.7	6.3	10.1	6.4	9.5	14.3	6.2	6.1	1.6	2.4	5.6	23.5	16.5	5.8	1.7	1.0	16.9	66.7	4.3	19.5	5.6	1.3	9.9	4.5	8.8	15.7	7.1	6.8	11.3	10.6	5.6	1.0	15.8	16.2	2.8	1.6	6.8	10.2	2.4	6.6	8.3	11.7	1.7	4.0	4.0	2.2	4.8	4.8	4.4	9.8	4.1	9.7	2.8	1.3	2.5	2.3	6.6	3.2	2.8	3.5	3.6	1.9	4.5	6.1	1.6	1.5	6.0	3.2	2.4	19.6	3.2	2.1	3.8	8.1	6.4	21.5	3.5	5.0	4.7	4.2	74.6	2.8	3.9	4.5	1.0	0.6	3.6	3.2	4.2	4.2	40.2	1.1	5.5	7.1	3.5	4.3	6.1	5.7	3.5	3.8	5.9	5.9	2.5	4.1	6.4	2.7	77.4	23.9	4.8	4.0	2.1	4.2	17.9	0.9	0.4	4.9	0.4	9.0	0.2	3.3	4.1	0.4	0.3	0.9	0.9	4.9	2.5	0.3	7.7	0.8	1.0	1.5	1.7	2.6	3.2	1.6	2.4	1.7	1.0	1.3	1.0	1.6	1.7	31.9	0.0	36.1	7.2	27.8	22.0	54.3	8.3	15.4	4.0	35.0	29.7	8.6	11.5	8.6	12.9	6.2	8.1	106.4	10.0	1.9	12.6	2.3	26.1	49.1	18.3	79.7	11.2	8.6	27.3	8.8	42.2	52.0	79.4	8.2	11.8	13.9	26.8	8.0	3.3	6.1	8.2	8.2	15.7	71.3	1.7	4.7	60.4	74.7	12.2	10.2	3.5	28.8	6.0	4.6	17.9	7.3	6.0	325.8	44.7	7.9	4.4	6.1	26.5	0.0	19.0	25.7	4.0	4.1	27.7	45.0	54.9	88.2	12.0	9.6	60.1
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 569.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	123.8	87.5	83.0	73.0	85.5	95.1	146.7	86.3	110.8	141.0	87.7	125.7	106.7	129.7	160.1	93.6	121.8	96.4	151.5	84.3	98.6	194.4	277.2	92.3	93.5	87.3	85.6	179.0	67.3	109.9	81.5	81.9	89.7	112.5	135.0	122.0	92.8	140.3	149.8	83.3	93.4	166.2	94.3	63.9	83.0	54.2	82.4	155.7	155.0	179.0	110.3	104.9	96.2	100.0	138.4	77.9	229.8	160.4	264.5	441.9	62.5	190.8	280.9	264.7	204.6	131.6	162.8	156.5	56.9	233.3	194.0	137.1	256.8	227.2	333.0	180.4	270.4	200.3	70.7	208.6	220.5	400.1	82.2	304.6	207.0	167.9	229.4	316.2	253.2	260.3	200.3	40.7	433.5	135.1	352.7	260.0	59.8	175.2	148.8	277.1	133.6	106.2	378.4	55.4	115.0	130.1	85.0	72.6	160.3	157.6	137.1	223.0	169.2	94.4	113.0	187.5	181.8	27.6	63.5	135.7	205.3	223.2	131.2	35.0	129.4	55.7	48.5	113.6	80.9	104.1	97.6	76.3	142.8	83.4	114.1	90.5	15.0	109.3	106.1	170.7	90.6	100.3	83.0	85.5	86.3	110.8	84.3	98.6	87.3	85.6	89.7	94.3	82.4	100.0	139.0	54.5	56.8	37.5	77.2	134.1	227.4	300.5	148.0	51.5	114.1	123.2	99.2	167.3	111.7	154.5	41.7	160.4	51.2	59.1	360.0	168.0	135.5	102.2	120.6	112.5	108.8	99.5	22.7	103.2	141.0	162.9	51.0	80.7	96.4	71.1	132.1	154.7	227.5	21.9	19.3	114.6	175.0	140.2	148.0	34.8	267.8	108.2	165.4	25.3	144.3	199.5	36.0	23.6	36.2	85.4	92.3	211.4	35.9	99.1	137.1	569.1	94.2	77.3	151.2	196.0	484.2	61.6	46.3	120.6	129.3	74.4	78.2	151.2	199.8	143.6
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 83.8;endometrium 1: 110.9;fallopian tube: 64.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 86.6;Endometrial ciliated cells: 77.9;Endometrial stromal cells: 79.9;Glandular and luminal cells: 98.9;Hepatocytes: 52.1;Horizontal cells: 62.2;Skeletal myocytes: 56.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 40.2;endometrial cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"MCF7: 46.0;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	4.2	1.8	3.2	1.5	1.3	0.8	29.1	2.9	1.3	83.8	3.2	0.9	0.4	110.9	1.2	0.5	64.9	1.2	1.8	0.6	6.7	2.8	16.9	2.0	1.6	0.4	0.5	9.0	1.0	0.2	6.6	0.4	0.3	6.1	0.5	3.5	0.9	9.8	5.8	1.1	0.8	50.4	0.2	1.7	0.6	2.3	5.9	1.0	3.4	2.6	2.3	2.1	46.9	0.3	0.6	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.6	0.0	0.0	0.0	1.2	0.1	46.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.7	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.2	57.4	0.0	0.1	0.2	0.2	0.5	0.0	5.2	1.1	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.3	2.9	1.3	0.6	6.7	0.4	0.5	0.3	0.2	5.9	0.3	0.6	0.0	1.1	1.3	2.3	1.0	1.7	0.0	0.0	3.9	86.6	16.4	4.4	0.0	1.0	0.0	8.4	0.1	0.4	0.1	1.9	0.0	40.1	77.9	79.9	2.7	1.8	0.0	4.5	0.2	0.1	11.3	0.0	98.9	2.5	36.9	5.0	52.1	0.9	62.2	5.4	0.0	0.0	4.0	3.1	10.3	4.1	2.5	1.8	1.0	0.2	2.4	0.0	25.1	0.6	0.1	0.0	2.2	8.5	0.6	0.0	3.7	1.3	4.6	0.0	56.7	11.7	1.8	1.3	0.4	1.7	0.1	2.2	4.8	0.1	6.8
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 107.2;Suprabasal keratinocytes: 79.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 138.3;BEWO: 101.1;CAPAN-2: 140.8;hTCEpi: 226.5;OE19: 142.6;RT4: 99.1;T-47d: 108.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.2	0.0	0.0	5.2	0.0	0.0	24.2	0.0	0.0	15.5	0.0	57.1	25.2	3.4	29.6	64.2	21.3	8.5	0.1	0.0	0.0	8.5	0.4	15.8	0.0	0.0	0.1	0.1	42.6	28.4	7.2	12.2	0.0	19.9	62.8	0.0	25.9	10.0	0.1	60.6	22.0	2.5	0.0	0.0	38.6	0.6	0.4	5.2	36.6	0.0	15.3	22.5	28.8	0.0	138.3	0.0	0.0	0.2	0.0	0.0	101.1	0.0	0.0	0.0	0.0	44.6	140.8	0.0	3.8	0.0	0.1	81.6	3.8	70.9	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	226.5	0.0	1.4	0.0	0.0	10.7	0.0	0.0	0.0	67.3	1.9	0.4	12.4	142.6	3.4	0.0	0.0	18.3	17.4	99.1	35.1	0.3	0.0	21.0	14.0	21.4	108.0	0.9	0.0	0.1	0.2	0.1	0.3	12.0	13.8	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	38.5	36.7	0.0	0.6	44.6	18.9	30.4	35.9	0.0	29.4	18.0	1.0	21.5	32.4	27.6	0.0	55.1	0.5	76.2	13.7	19.6	12.9	47.1	3.7	0.9	33.1	0.0	2.6	27.5	69.1	0.9	58.1	46.5	1.3	0.0	0.4	0.1	6.0	0.0	0.4	107.2	16.2	0.0	3.2	10.3	0.0	0.5	24.9	0.0	0.6	0.0	0.0	0.5	0.4	21.7	48.1	0.7	1.8	25.1	25.5	0.3	35.0	0.0	0.0	0.0	1.2	0.6	0.9	71.3	79.1	62.1	0.8	0.0	73.9	40.1
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 328.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 352.9;JURKAT: 362.3;U-698: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	101.2	19.2	11.7	145.7	10.4	35.3	65.4	9.8	14.1	35.9	8.9	31.2	26.9	36.5	9.3	21.8	20.2	62.5	43.0	8.9	11.3	30.4	47.6	76.2	277.1	13.1	14.7	27.0	20.1	28.4	7.8	56.3	13.4	17.1	31.4	1.8	16.5	20.7	25.6	18.1	49.3	38.1	11.6	185.8	46.1	8.0	15.2	328.8	39.8	42.3	250.2	67.9	19.2	11.3	87.7	15.7	72.8	0.3	30.7	49.3	0.2	65.7	140.2	80.9	77.3	5.1	91.7	312.1	65.7	109.5	184.7	29.8	7.0	190.0	169.0	66.6	1.1	352.9	6.4	0.3	82.2	36.7	4.0	97.2	15.0	69.6	252.2	46.1	67.9	362.3	0.6	63.3	98.1	0.0	185.7	27.4	27.0	7.9	55.0	50.4	118.7	24.5	64.2	95.6	0.9	5.0	34.5	0.7	73.6	48.5	0.3	17.7	126.1	180.5	57.1	35.5	109.1	46.7	8.9	462.5	32.2	68.0	162.1	51.2	0.1	6.6	20.4	0.3	28.9	12.3	27.0	25.0	0.2	9.2	32.5	26.1	1.1	27.8	1.0	6.2	33.3	9.5	11.7	10.4	9.8	14.1	8.9	11.3	13.1	14.7	13.4	11.6	15.2	11.3	263.1	25.6	26.5	2.9	125.6	114.8	41.0	12.4	1.8	0.0	8.2	7.2	9.0	4.3	24.3	11.0	0.0	0.2	378.9	13.1	0.0	31.9	6.2	26.3	51.0	190.4	15.5	13.7	2.0	22.6	0.5	45.5	17.3	66.2	19.6	1.3	213.8	5.4	7.3	0.0	25.6	15.0	10.2	18.3	48.2	1.5	14.0	12.5	69.4	65.6	16.8	0.2	399.6	55.3	9.5	99.3	6.6	15.4	129.6	26.8	2.2	4.6	5.9	0.2	105.2	55.5	76.6	0.7	1.8	1.5	63.2	0.4	323.2	40.4	5.8	32.6
ETV1	ER81	ENSG00000006468	"ETS variant transcription factor 1"	P50549	7	13891229-13991425	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 119.9;salivary gland: 91.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 137.7;Astrocytes: 67.3;Cardiomyocytes: 87.7;Enteroendocrine cells: 198.1;Excitatory neurons: 66.9;Oligodendrocyte precursor cells: 135.7"	"Cancer enhanced"	"Detected in all"		"glioma: 22.5"	"Group enriched"	"Detected in all"	5	"cerebellum: 119.9;thalamus: 32.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 67.8;hTERT-RPE1: 76.2;SCLC-21H: 79.3;U-87 MG: 157.2;WM-115: 78.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 200.7"	"HPA068389, HPA077249"		Supported	Approved	Nucleoplasm		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA068389: , HPA077249: AB_2686829"	"unprognostic (2.45e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.64e-7)"	"unprognostic (7.08e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	4.9	23.0	13.6	1.9	10.9	0.2	8.2	119.9	12.1	2.3	0.1	4.1	2.2	4.4	2.3	2.7	1.5	17.3	35.6	14.6	5.6	3.2	3.9	28.7	1.4	4.6	14.0	1.4	3.1	11.5	7.4	3.5	9.0	5.5	4.3	4.5	91.6	12.6	0.8	1.9	3.5	3.5	3.1	9.1	2.6	8.9	32.8	4.7	12.2	2.5	1.9	2.7	1.5	8.1	0.1	4.9	35.5	67.8	12.1	35.4	0.1	3.2	12.1	2.0	8.0	0.0	16.6	0.0	3.6	5.6	9.8	0.4	1.5	3.8	4.3	0.9	1.6	2.1	3.1	0.0	7.1	12.3	4.5	10.7	0.0	23.3	1.9	76.2	15.3	1.1	11.0	0.6	14.6	0.0	0.1	0.0	53.2	2.1	36.5	0.0	21.5	2.9	23.7	0.4	79.3	15.6	0.0	1.2	19.6	12.2	1.2	0.5	8.6	7.0	2.2	13.8	13.4	12.2	4.1	0.0	157.2	0.8	78.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	13.6	10.9	119.9	12.1	14.6	5.6	4.6	14.0	9.0	3.1	32.8	8.1	16.0	19.2	137.7	67.3	0.0	1.0	2.8	0.9	13.6	4.9	5.8	23.6	87.7	28.6	0.7	3.7	0.0	0.6	0.1	0.8	5.9	3.6	25.4	1.3	3.9	11.1	198.1	0.8	66.9	0.9	0.4	17.7	1.1	2.0	2.5	0.2	2.9	13.1	3.4	5.0	45.3	2.4	0.0	7.2	1.6	8.7	1.5	0.7	12.4	28.1	0.0	12.6	0.0	135.7	4.3	0.9	0.1	34.6	1.2	0.6	0.0	3.0	1.4	0.6	19.7	17.4	12.6	1.2	2.1	3.1	1.3	0.3	2.2	9.7	1.2	0.3
EVL	RNB6	ENSG00000196405	Enah/Vasp-like	Q9UI08	14	99971449-100144236	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;NK-cells: 591.2;Rod photoreceptor cells: 438.0;T-cells: 373.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 291.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018849, HPA019536, CAB033987"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"		"CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180"	"unprognostic (1.12e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.43e-1)"	38.8	31.3	130.5	91.9	135.1	50.1	58.1	105.0	185.5	44.4	66.3	46.6	29.2	64.8	49.5	30.6	63.7	42.0	53.0	136.9	108.8	42.6	90.3	63.2	159.0	103.1	110.1	51.6	40.8	19.7	98.6	29.1	106.1	52.1	24.2	204.6	41.2	32.0	33.2	41.0	69.9	62.0	92.5	107.7	43.3	31.6	115.5	179.4	37.9	28.8	126.2	43.1	32.8	121.2	15.2	14.2	107.1	30.3	22.4	58.5	59.7	18.9	26.5	14.2	18.7	0.8	11.4	30.9	24.9	19.2	10.5	0.4	49.0	36.3	16.8	30.4	32.6	51.9	11.5	8.4	18.0	16.2	116.7	31.6	18.9	9.1	35.8	29.3	38.3	117.3	25.5	2.3	15.7	22.7	291.7	89.6	19.7	13.1	21.8	65.4	58.7	5.5	17.2	0.6	120.8	73.1	14.3	22.0	7.2	24.6	17.7	47.4	27.7	11.2	16.5	66.9	12.8	55.3	44.1	87.9	14.9	27.1	19.7	2.3	2.6	27.4	20.2	13.9	15.1	9.6	22.6	19.2	4.3	13.2	26.3	24.4	0.6	18.0	16.5	0.8	41.4	10.6	130.5	135.1	105.0	185.5	136.9	108.8	103.1	110.1	106.1	92.5	115.5	121.2	26.4	28.9	42.3	45.1	155.2	20.8	22.2	10.8	12.0	125.4	70.4	50.5	4.7	22.8	14.2	12.9	402.4	22.6	215.3	1.0	31.3	12.9	4.2	40.1	51.9	47.5	8.4	31.1	119.9	14.0	12.0	30.5	20.4	26.2	17.1	45.1	39.3	102.2	144.8	77.4	121.1	3.7	8.2	82.5	76.6	12.0	24.8	92.5	26.6	100.2	42.0	89.1	591.2	86.0	66.1	11.6	2.9	49.7	53.3	17.4	2.6	14.2	41.9	438.0	6.6	29.8	33.9	14.1	28.4	8.7	31.4	14.6	373.3	13.5	3.8	15.9
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.3;lymphoid tissue: 11.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 7.4;Extravillous trophoblasts: 16.7;Plasma cells: 11.8;Spermatocytes: 9.3;Spermatogonia: 9.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	0.5	0.3	0.2	3.3	0.2	17.3	1.2	0.1	0.7	0.5	0.1	3.2	2.9	0.8	0.0	2.5	0.3	0.4	0.2	0.3	0.1	0.3	0.5	0.6	5.8	0.1	0.2	0.2	0.3	0.7	0.1	3.3	0.2	0.2	3.7	0.0	0.5	0.2	0.1	1.8	2.5	1.2	0.2	1.5	1.6	5.7	0.3	11.1	0.4	0.0	6.4	1.2	0.8	0.4	41.3	26.8	43.4	28.6	2.7	6.7	36.5	53.4	17.7	46.7	50.5	33.9	22.5	44.3	25.3	12.6	25.1	40.0	55.5	22.5	54.8	69.5	48.4	41.5	28.8	17.3	1.0	59.8	29.4	1.7	1.1	46.8	12.5	5.7	14.7	43.4	84.6	57.0	37.8	19.0	65.9	33.6	60.4	49.7	26.0	46.2	40.5	47.5	9.6	25.6	48.1	60.9	34.8	27.9	19.5	20.2	25.8	36.6	5.5	44.9	39.5	42.7	72.9	41.5	59.0	71.3	15.6	48.1	54.9	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.2	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.4	0.2	0.0	0.0	0.3	0.7	0.8	0.1	0.7	0.0	0.0	0.3	0.5	2.3	0.0	0.1	0.0	0.0	5.3	0.2	1.2	0.0	0.1	9.3	0.3	0.4	0.7	0.0	7.4	1.0	0.0	16.7	0.9	1.1	0.5	0.0	4.6	0.4	0.0	3.3	0.0	2.9	0.5	0.0	0.3	0.8	2.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	11.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	9.3	9.8	2.7	0.1	4.0	0.8	0.8	1.9	0.3
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819368	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		42000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	88.2	186.6	100.7	98.4	99.5	135.2	59.8	86.0	96.8	77.1	224.4	133.5	158.8	35.6	78.4	260.3	114.6	116.1	116.3	96.2	95.6	159.1	57.9	173.2	185.6	97.6	105.3	44.7	112.6	447.4	42.8	233.0	91.7	81.4	103.6	10.7	89.9	72.2	46.9	187.8	257.1	36.6	99.3	75.6	273.7	55.9	98.9	108.8	126.1	25.5	216.3	219.0	98.6	91.1	668.3	355.4	86.5	125.0	9.3	10.3	502.7	204.7	67.1	225.7	189.2	420.9	357.7	667.1	197.2	235.2	108.5	497.7	172.2	228.0	259.5	235.3	111.2	14.0	204.9	187.5	223.2	167.7	98.9	16.6	172.9	212.9	205.1	191.4	150.2	90.8	134.9	316.7	132.3	175.9	239.3	199.6	144.5	180.6	117.6	176.9	40.7	152.5	462.1	198.6	156.3	127.2	358.5	507.7	37.9	391.5	124.1	218.5	195.3	72.6	233.4	101.1	319.9	216.5	212.8	566.9	45.4	84.9	88.5	177.2	83.4	103.7	195.9	190.8	233.2	466.5	205.6	245.1	181.9	389.7	108.6	146.3	36.2	133.6	202.9	84.5	385.7	298.2	100.7	99.5	86.0	96.8	96.2	95.6	97.6	105.3	91.7	99.3	98.9	91.1	47.4	951.9	547.8	111.3	799.6	614.7	809.5	202.4	247.0	11.2	240.4	144.4	311.0	154.4	726.2	156.3	0.0	406.1	372.4	806.8	97.8	302.3	10.2	782.9	75.4	71.0	159.9	46.5	0.4	256.1	560.3	213.1	500.5	844.5	119.0	40.8	25.4	37.5	113.3	0.0	0.5	415.3	179.0	79.1	820.5	32.8	135.5	297.5	321.9	12.2	110.5	35.7	62.8	2.0	0.7	618.3	631.2	294.2	564.9	416.7	694.2	238.1	1248.4	5.1	249.8	205.5	136.3	52.5	61.7	430.4	726.5	1243.4	483.8	102.3	312.9	1142.8
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.9;Langerhans cells: 43.2;Microglial cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	9.1	3.9	8.1	10.5	9.7	21.2	10.7	5.1	9.2	7.4	0.1	13.3	11.0	6.5	4.2	6.0	5.1	14.7	6.6	9.4	8.6	3.2	4.9	7.8	9.0	4.1	6.8	5.3	3.8	7.5	3.8	5.9	8.1	6.3	14.6	3.6	13.7	7.8	1.3	3.7	11.2	8.8	3.0	8.8	7.6	8.6	5.6	8.7	3.5	6.0	8.2	16.4	4.4	5.0	6.9	4.9	9.7	5.2	17.0	10.2	6.4	4.0	5.4	6.1	10.3	1.8	6.8	7.6	3.6	10.4	6.3	13.1	33.2	1.4	7.8	5.1	4.8	10.6	35.8	0.8	4.3	14.0	19.8	5.5	1.4	9.0	0.5	12.3	4.0	12.5	26.3	41.2	14.4	28.4	9.0	10.0	7.6	16.2	24.6	20.8	24.5	1.6	1.7	7.9	31.4	9.3	15.9	27.4	8.3	6.8	5.8	22.5	0.7	9.8	18.4	8.6	15.5	7.6	1.9	7.1	14.4	10.8	5.3	2.9	0.4	0.4	0.3	0.9	0.2	0.3	0.3	0.4	1.0	0.3	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.1	8.1	9.7	5.1	9.2	9.4	8.6	4.1	6.8	8.1	3.0	5.6	5.0	5.9	0.0	2.2	12.1	6.1	6.1	2.3	1.0	4.6	3.9	10.1	7.2	1.9	10.0	2.2	1.8	0.0	2.4	17.2	15.6	1.9	2.7	15.3	2.1	7.8	5.5	7.2	3.8	54.9	6.1	2.7	16.3	6.6	5.2	7.6	3.6	8.2	1.2	9.7	0.0	27.9	8.1	0.0	25.1	43.2	6.9	14.3	27.5	5.4	52.5	15.2	1.2	11.3	25.1	7.2	4.5	10.5	20.7	11.9	1.9	4.5	1.0	1.8	1.1	0.0	3.2	6.5	4.4	6.4	6.5	3.7	3.4	16.4	36.2	13.8	4.6
FAM104B	"CXorf44, FLJ20434"	ENSG00000182518	"Family with sequence similarity 104 member B"	Q5XKR9	X	55143102-55161310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 134.0;Late spermatids: 238.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049082	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA049082: AB_2680625"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.23e-4)"	"prognostic favorable (1.22e-4)"	"unprognostic (9.35e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.81e-3)"	"unprognostic (9.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-3)"	11.1	16.1	28.1	10.9	30.9	12.6	17.1	29.8	37.8	23.2	26.0	20.4	8.4	20.3	49.0	14.7	46.0	10.3	16.5	28.2	29.3	37.8	18.9	14.1	15.2	29.7	28.8	18.4	10.5	27.7	15.1	11.3	29.9	13.5	16.3	30.6	10.8	16.8	20.5	17.5	10.5	16.4	28.9	10.7	13.5	15.0	29.4	19.9	33.8	22.4	16.3	16.6	13.3	33.0	26.9	20.9	24.3	22.2	16.4	21.3	7.2	13.8	10.2	14.2	12.2	12.4	23.9	12.8	28.5	12.6	25.4	18.6	36.7	21.4	22.7	12.1	36.7	17.5	23.7	14.9	13.2	23.1	14.4	18.6	18.7	22.7	17.5	16.7	17.3	26.3	22.7	17.7	18.2	23.9	30.9	21.7	36.1	25.1	37.4	17.6	30.8	30.5	41.1	29.0	31.3	25.3	23.0	17.9	28.0	35.4	34.4	15.2	17.2	16.5	21.7	40.8	18.2	13.1	12.6	12.2	21.0	40.3	14.5	12.7	16.1	11.0	14.5	22.6	15.7	17.8	16.6	17.5	22.6	14.9	18.9	18.6	7.9	17.9	19.5	21.9	19.1	12.7	28.1	30.9	29.8	37.8	28.2	29.3	29.7	28.8	29.9	28.9	29.4	33.0	13.3	41.7	17.2	6.5	12.2	15.2	19.2	60.3	18.8	8.0	22.6	26.7	49.0	22.8	24.4	25.8	0.0	35.9	10.6	21.3	45.0	35.6	134.0	63.6	19.9	16.7	18.8	51.1	7.4	29.4	52.8	23.0	9.2	18.5	50.0	14.2	16.4	26.0	33.3	5.0	7.3	25.3	26.4	16.2	15.4	238.3	19.6	14.3	26.6	8.4	12.7	27.2	20.6	10.6	10.7	18.4	47.6	22.2	11.5	15.3	12.2	115.4	96.9	12.5	19.7	17.1	23.4	31.6	22.2	23.6	25.3	27.2	13.8	27.7	26.6	20.9
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.0;Oligodendrocyte precursor cells: 157.8;Syncytiotrophoblasts: 279.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	49.2	12.8	8.5	9.9	9.0	12.7	31.8	14.2	11.8	17.6	13.2	18.3	50.5	12.5	7.5	7.6	23.5	16.3	9.9	9.7	7.3	21.9	39.1	11.8	6.3	8.6	8.4	27.8	38.6	49.2	8.4	35.1	9.5	10.6	14.8	15.9	23.4	10.5	9.7	20.4	29.0	13.3	8.3	5.4	16.3	13.9	9.0	5.6	32.8	21.9	4.8	16.9	10.4	8.8	4.5	6.7	9.8	12.8	55.5	22.7	16.0	10.2	12.4	4.0	3.6	5.6	10.3	0.1	4.0	7.4	6.3	2.7	14.5	7.4	8.9	0.6	10.0	7.5	8.9	0.7	16.3	6.3	1.0	21.9	5.9	10.1	3.6	17.5	6.9	2.5	19.7	0.7	8.7	0.2	0.7	2.8	12.1	0.8	6.9	10.2	16.6	4.0	7.4	21.8	24.6	6.5	2.5	7.9	9.9	9.6	5.5	0.2	2.5	11.2	6.2	5.5	5.9	3.4	2.1	0.1	16.6	0.6	5.9	0.0	4.1	0.0	1.0	2.0	0.7	0.0	2.7	0.3	3.5	0.0	2.9	0.7	0.9	0.4	0.6	1.2	1.5	1.6	8.5	9.0	14.2	11.8	9.7	7.3	8.6	8.4	9.5	8.3	9.0	8.8	42.6	12.8	34.9	95.3	4.3	10.1	22.3	20.4	28.5	16.3	29.7	20.6	25.9	38.6	39.3	11.0	35.5	72.9	12.9	50.4	29.4	10.7	3.4	82.0	33.6	14.1	4.9	31.3	178.0	16.9	35.3	42.1	33.1	98.2	1.3	70.2	12.8	143.0	20.7	0.0	46.5	54.1	26.4	29.6	11.9	5.1	45.1	21.7	19.6	104.9	16.9	22.6	5.2	157.8	17.4	20.7	73.4	33.4	10.3	13.6	37.5	50.4	74.6	11.3	0.0	24.7	31.9	5.3	10.2	14.4	7.7	279.5	9.7	41.2	22.3	19.5
FAM13C	FAM13C1	ENSG00000148541	"Family with sequence similarity 13 member C"	Q8NE31	10	59246130-59363181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.0"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 477.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.1;HSkMC: 5.1;hTERT-RPE1: 3.4;NTERA-2: 4.5;SCLC-21H: 8.6;SH-SY5Y: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037888	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA037888: AB_10962981"	"unprognostic (3.68e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.69e-5)"	"unprognostic (8.54e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-6)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.66e-3)"	13.5	16.2	20.8	3.9	45.8	0.0	9.3	33.2	32.4	8.7	3.7	7.7	4.2	8.7	8.0	13.8	14.5	11.5	8.1	21.3	34.3	3.4	2.1	9.9	4.7	49.3	36.3	21.2	2.2	4.7	4.7	2.6	40.9	17.2	6.2	9.9	5.6	7.9	17.1	7.2	5.9	12.2	35.5	5.1	3.8	5.2	37.6	5.2	6.3	22.9	2.3	4.4	7.9	68.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	1.3	0.2	0.1	0.0	1.2	0.0	4.1	1.9	0.1	0.0	0.0	5.1	0.6	0.2	0.0	3.4	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.8	0.0	0.0	1.3	8.6	5.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	2.5	2.2	0.1	2.1	0.0	0.0	0.1	3.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	45.8	33.2	32.4	21.3	34.3	49.3	36.3	40.9	35.5	37.6	68.0	47.8	0.0	0.0	33.6	0.1	4.8	9.3	0.3	8.0	10.5	0.7	2.7	2.5	0.0	0.7	0.0	6.2	0.0	0.4	0.1	7.9	0.0	49.0	18.6	1.5	35.2	0.0	0.0	66.8	0.0	0.0	19.8	0.5	5.3	0.0	26.9	3.9	0.5	0.0	3.3	73.2	0.2	20.3	0.0	2.5	22.1	23.0	0.7	3.6	7.5	0.0	8.8	0.0	56.8	477.1	0.0	0.0	21.1	0.1	5.4	0.0	0.6	20.7	13.6	39.5	23.4	36.2	1.4	0.7	2.4	6.3	0.0	1.2	17.4	0.2	1.1
FAM168A	"KIAA0280, TCRP1"	ENSG00000054965	"Family with sequence similarity 168 member A"	Q92567	11	73400487-73598189	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 125.0;Excitatory neurons: 171.0;Inhibitory neurons: 161.2;Oligodendrocyte precursor cells: 166.9;Oligodendrocytes: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037580	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA037580: AB_10672906"	"unprognostic (2.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (4.60e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.41e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.70e-4)"	13.5	10.9	43.7	10.8	44.9	11.0	13.3	48.8	48.8	14.6	2.3	16.0	8.1	15.3	18.0	8.9	14.1	13.9	13.6	42.6	50.0	12.1	11.3	10.4	9.0	59.1	48.3	16.7	9.7	21.9	12.4	9.8	54.0	12.9	9.6	49.7	12.7	15.7	19.9	8.7	12.0	18.1	49.7	9.4	10.7	8.5	56.0	13.2	14.8	15.3	8.3	12.8	8.8	46.8	13.4	15.6	33.6	19.0	24.2	27.0	5.1	19.6	22.5	21.5	20.5	17.6	17.4	14.9	16.9	34.9	20.1	12.3	19.4	19.3	26.3	10.3	14.3	17.1	17.3	9.6	9.4	9.2	30.8	25.3	13.5	21.3	11.2	29.2	13.8	23.9	4.3	10.9	22.3	20.2	21.4	9.4	11.5	27.4	19.7	30.3	56.7	8.1	12.8	12.0	22.3	34.6	23.1	17.5	37.8	12.3	28.4	10.7	17.8	24.5	20.6	31.9	16.2	24.9	18.7	25.7	13.0	11.3	22.9	6.0	1.3	0.9	0.8	2.3	0.4	0.4	0.3	0.6	1.1	0.5	0.6	0.6	2.9	0.5	1.5	1.4	0.6	0.3	43.7	44.9	48.8	48.8	42.6	50.0	59.1	48.3	54.0	49.7	56.0	46.8	18.3	3.2	8.2	125.0	4.0	3.8	2.3	7.1	3.4	21.8	11.0	9.7	20.3	15.7	9.9	7.3	45.9	2.3	5.7	5.2	0.0	3.3	22.4	13.1	12.5	9.7	12.7	2.1	171.0	2.7	3.6	9.4	5.6	19.2	22.9	31.9	11.0	16.6	9.8	3.3	161.2	8.6	2.0	14.8	6.8	25.4	7.5	10.0	5.4	59.0	7.3	26.7	5.2	166.9	149.1	3.4	2.8	12.8	2.9	1.8	8.4	4.2	7.2	24.4	6.6	12.3	19.1	7.0	6.1	5.3	3.8	2.7	4.9	6.9	6.7	1.7
FAM220A	"ACPIN1, C7orf70, MGC12966, SIPAR"	ENSG00000178397	"Family with sequence similarity 220 member A"	Q7Z4H9	7	6329411-6348981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 89.7;testis: 55.9"	"Group enriched"	"Detected in many"	13	"Early spermatids: 280.0;Late spermatids: 363.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055050			Approved	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA055050: AB_2682684"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (3.71e-2)"	7.1	8.6	13.6	6.9	14.7	2.6	8.3	17.5	17.0	9.1	9.3	6.2	5.4	10.3	7.4	11.5	7.6	7.6	13.8	15.3	13.6	8.2	6.4	6.2	9.9	11.7	12.7	10.7	9.8	19.2	0.6	7.9	12.4	8.0	5.3	11.5	8.4	8.3	89.7	10.1	4.9	9.3	12.5	7.9	6.1	55.9	13.7	12.0	11.7	39.1	10.4	9.6	0.5	13.4	26.9	16.6	11.9	28.0	27.0	22.7	13.1	13.4	16.6	15.9	18.5	10.5	14.6	22.2	15.1	15.9	31.8	19.2	18.2	11.3	20.6	15.5	11.7	7.3	10.0	12.6	29.2	13.5	10.8	12.7	37.5	11.9	28.5	15.3	15.0	16.4	14.6	20.7	13.9	20.9	8.4	24.7	27.8	14.0	21.4	21.6	17.9	18.7	14.7	9.6	12.1	21.0	18.8	23.0	28.6	23.9	22.1	34.9	11.4	12.5	28.5	20.6	17.5	19.7	37.2	23.2	14.6	24.1	39.3	6.6	4.2	8.0	4.7	3.5	4.4	9.1	5.4	6.5	7.7	7.7	8.4	6.8	2.0	12.9	3.8	6.8	6.6	3.7	13.6	14.7	17.5	17.0	15.3	13.6	11.7	12.7	12.4	12.5	13.7	13.4	4.1	3.2	1.1	1.3	8.1	7.8	4.9	6.2	12.0	2.9	6.0	6.9	9.2	0.0	8.2	1.8	6.2	6.3	5.4	3.8	1.9	4.9	280.0	6.0	5.5	4.6	6.1	7.8	4.7	4.8	7.5	6.8	7.7	4.8	1.3	4.4	6.4	3.5	6.2	0.0	4.7	4.2	4.1	6.8	10.5	363.4	8.4	7.4	3.6	2.8	7.1	5.2	6.2	4.0	3.9	4.8	2.1	13.2	3.9	5.5	3.3	2.8	3.4	2.3	0.0	6.3	5.4	23.7	11.4	10.3	10.1	8.2	5.2	3.9	3.4	6.7
FAM53B	"bA12J10.2, KIAA0140, smp"	ENSG00000189319	"Family with sequence similarity 53 member B"	Q14153	10	124619292-124744378	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037751, HPA037752"	Approved		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA037751: AB_2675645, HPA037752: AB_10672285"	"unprognostic (7.88e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.91e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (7.00e-6)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.81e-7)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.41e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.45e-2)"	12.6	19.2	21.6	14.3	33.3	25.8	8.3	18.1	30.5	12.8	8.4	12.4	15.4	23.6	3.9	13.2	11.2	5.7	18.9	21.1	16.5	10.6	4.2	10.7	31.0	30.3	25.6	19.1	7.2	12.4	12.7	4.9	22.7	8.9	7.1	6.3	15.2	7.0	55.0	14.4	17.1	12.8	17.3	20.1	9.6	15.6	35.9	32.9	16.2	22.3	21.7	8.6	8.0	51.7	10.7	12.5	9.6	27.5	11.3	5.8	26.2	4.8	6.7	5.6	4.9	6.6	6.7	37.2	9.7	6.5	5.5	20.8	12.7	15.4	2.4	44.6	13.2	18.1	6.3	16.7	7.6	16.6	11.8	5.6	16.2	5.2	8.3	7.0	9.1	21.2	13.2	17.0	5.5	20.4	18.7	22.4	5.9	9.5	10.9	32.9	3.6	18.2	4.6	19.3	12.8	12.2	4.7	17.8	60.2	3.8	7.2	21.8	5.0	6.7	5.5	6.6	10.7	2.7	5.3	23.8	5.1	13.6	3.8	0.8	2.2	2.2	6.9	2.1	3.3	3.5	3.0	3.7	1.4	6.0	1.2	2.0	3.2	0.7	2.6	1.9	3.6	3.4	21.6	33.3	18.1	30.5	21.1	16.5	30.3	25.6	22.7	17.3	35.9	51.7	13.4	9.6	12.6	14.0	22.4	3.6	5.9	8.5	12.5	6.1	4.3	2.4	17.9	1.5	6.7	3.7	10.4	4.7	31.5	25.9	1.9	3.1	19.4	12.9	18.6	8.7	15.0	8.6	27.1	4.0	4.9	6.0	6.6	8.3	5.1	9.0	16.8	3.7	13.3	1.7	15.0	17.4	10.2	27.8	5.1	6.2	5.6	16.4	8.8	24.4	14.5	4.5	30.9	16.1	79.4	2.8	12.2	10.5	20.0	3.7	22.4	4.3	14.1	25.6	0.0	9.8	4.6	7.0	8.6	12.1	5.7	0.8	21.4	6.9	15.3	6.7
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA		20000	"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	12.7	11.4	9.5	12.8	10.2	9.8	12.9	16.4	12.6	9.7	7.2	15.4	9.6	13.3	9.0	9.0	8.1	7.0	12.4	10.8	10.9	13.1	7.8	8.1	13.8	9.4	9.7	11.2	6.1	19.3	6.4	12.0	10.0	12.1	11.6	19.8	6.3	10.0	13.8	8.8	10.0	9.5	10.1	11.2	9.5	8.5	9.6	28.6	11.7	16.3	13.3	11.9	7.0	12.6	30.7	16.2	77.7	40.0	14.1	25.7	37.9	38.6	28.2	37.4	37.5	35.8	14.4	21.1	41.4	32.2	37.9	31.8	47.4	39.5	52.2	21.8	25.7	62.6	33.9	27.8	20.4	59.8	34.6	23.9	24.1	33.3	38.5	27.4	38.9	45.7	45.6	25.7	36.0	13.8	50.7	31.8	42.0	34.8	22.3	53.3	42.0	17.7	32.8	39.9	47.8	48.9	42.5	27.0	19.8	34.6	33.0	36.6	32.7	42.1	51.5	28.2	44.0	47.6	46.1	78.3	23.1	38.9	44.8	2.3	0.5	1.4	2.8	0.4	2.4	1.6	2.8	2.3	0.6	1.9	3.4	2.6	0.4	2.2	0.6	1.4	1.9	0.4	9.5	10.2	16.4	12.6	10.8	10.9	9.4	9.7	10.0	10.1	9.6	12.6	17.9	16.0	21.4	16.3	16.8	14.7	12.7	14.1	14.2	36.8	15.2	11.6	48.9	12.8	18.1	16.5	16.7	30.6	16.4	11.0	7.9	16.4	3.4	19.1	21.5	16.9	12.6	16.6	22.5	19.8	22.4	16.6	16.8	17.0	13.3	18.4	16.8	13.1	12.6	20.2	20.5	22.6	12.2	15.8	12.2	2.5	12.5	10.9	5.4	18.7	21.4	18.5	21.6	12.1	23.8	14.3	9.8	17.0	18.2	12.4	11.1	12.7	18.8	27.9	6.6	21.5	16.2	27.2	17.1	19.7	14.8	21.5	15.3	14.7	19.3	14.1
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4;smooth muscle: 26.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 67.6;Fibroblasts: 43.4;Microglial cells: 17.8;Muller glia cells: 57.5;Smooth muscle cells: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 192.2;ASC TERT1: 202.3;BJ hTERT+: 167.8;hTERT-RPE1: 209.1;U-138 MG: 167.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.1;hippocampal formation: 2.4"	HPA059739	Uncertain				"Secreted to blood"	NA	NA	108000000	56000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA059739: AB_2684117"	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	5.8	0.2	0.9	5.2	0.9	0.0	10.1	0.4	0.9	15.2	0.0	3.5	0.5	31.4	8.5	3.6	4.8	22.3	4.9	0.3	1.4	0.7	0.2	4.0	1.5	0.6	0.5	3.0	2.5	0.7	0.5	23.1	0.6	1.9	2.5	6.4	4.7	5.8	4.4	2.8	0.9	26.4	0.2	0.4	1.0	1.5	1.0	0.5	2.8	7.5	1.5	15.5	3.6	0.7	0.0	0.0	0.0	0.0	192.2	202.3	0.4	82.8	167.8	16.6	25.4	0.0	0.0	0.0	0.6	31.3	0.0	0.1	0.0	5.1	8.0	0.0	0.0	0.1	1.2	0.0	19.5	0.0	0.0	66.2	1.2	28.1	5.2	209.1	0.1	0.0	0.0	0.0	53.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.5	0.0	9.0	0.2	0.1	0.0	84.3	167.3	3.1	41.4	0.4	0.0	0.1	0.0	37.5	0.1	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.4	0.9	0.3	1.4	0.6	0.5	0.6	0.2	1.0	0.7	3.9	0.0	0.0	5.5	0.2	4.5	0.1	7.0	0.0	1.8	0.3	0.5	0.4	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.2	6.7	3.4	67.6	6.4	4.9	0.0	13.3	0.2	1.9	43.4	0.0	6.2	0.0	0.0	1.4	0.0	0.9	1.7	0.3	1.4	0.0	0.0	2.6	4.1	8.4	0.8	3.6	17.8	0.0	57.5	0.0	0.5	4.2	1.0	0.0	0.0	0.3	0.0	0.0	1.2	0.2	2.0	0.0	4.7	25.2	2.3	0.4	0.4	4.3	1.8	0.8	1.3	0.2	0.0
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078338-82098294	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 372.8;breast: 271.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.0;Breast glandular cells: 442.9;Breast myoepithelial cells: 165.4;Hepatocytes: 244.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		3400000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	372.8	30.9	25.0	14.9	44.2	18.7	271.6	67.3	49.9	31.7	0.0	25.5	11.5	18.0	6.2	63.6	15.2	6.6	21.9	39.9	15.0	11.8	191.4	54.1	7.2	84.4	75.7	16.3	18.6	8.5	72.4	12.1	101.7	69.0	3.0	4.3	38.3	14.3	27.9	89.4	28.8	5.3	12.5	8.8	63.6	11.9	33.7	9.6	21.2	2.3	3.0	27.0	31.8	60.8	179.1	182.0	81.7	56.7	130.1	87.2	176.9	34.3	43.3	35.5	64.6	190.6	116.7	58.8	29.2	26.3	99.5	144.0	79.2	157.8	6.5	30.0	358.0	123.9	140.0	257.2	36.8	67.5	19.2	84.2	40.4	90.8	21.0	12.1	40.1	54.8	193.2	50.7	12.6	304.1	78.9	105.5	161.1	28.1	107.1	64.1	47.8	116.5	40.3	220.7	205.0	117.0	50.6	1109.2	93.6	29.5	199.4	123.4	71.1	52.3	107.0	45.2	88.4	68.5	17.1	60.6	31.2	71.1	79.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	25.0	44.2	67.3	49.9	39.9	15.0	84.4	75.7	101.7	12.5	33.7	60.8	9.6	25.6	126.0	28.4	7.4	7.8	12.7	33.2	8.0	28.7	442.9	165.4	5.9	21.5	28.4	11.0	6.2	32.0	12.8	35.7	3.9	19.2	1.5	19.6	19.8	10.8	18.1	20.6	11.9	29.2	77.7	13.4	33.6	17.1	12.7	29.9	10.8	244.1	13.9	30.3	12.5	22.3	22.4	9.8	6.2	3.4	16.4	7.0	17.8	4.7	6.2	14.1	8.2	11.6	17.6	19.1	23.6	11.3	9.7	60.4	6.5	5.9	23.7	13.1	0.0	9.0	14.9	1.8	11.7	34.1	13.8	29.6	10.6	27.9	27.4	19.6
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	359.3	123.1	17.3	72.3	29.5	1.7	318.2	27.8	27.5	1131.0	802.4	200.7	75.5	410.6	126.0	305.8	497.6	676.1	773.7	47.0	11.9	61.3	15.7	414.9	16.1	21.8	24.5	214.1	106.3	216.9	90.3	505.7	23.1	466.8	83.6	3.1	121.2	158.5	36.0	296.3	174.5	180.3	15.9	24.9	269.1	21.9	24.7	20.5	195.3	47.5	13.0	704.6	940.5	14.6	17.7	41.6	122.9	258.0	1839.4	809.8	559.8	1029.3	1615.9	89.8	33.8	179.2	5.2	0.4	42.8	38.6	2.5	90.9	78.0	2.7	10.8	0.9	21.0	0.4	209.4	121.5	243.2	1.0	1.0	1345.8	15.8	89.6	32.7	1.8	0.2	1.4	0.9	2.1	63.3	2.4	0.8	3.2	173.8	3.7	15.4	1.4	0.9	2.1	41.1	1485.2	8.7	162.7	127.5	589.6	0.6	344.3	3.7	5.4	8.0	17.4	109.3	465.8	1.0	1.6	0.8	1.4	1.2	1.0	43.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.0	2.4	1.2	0.0	0.1	17.3	29.5	27.8	27.5	47.0	11.9	21.8	24.5	23.1	15.9	24.7	14.6	34.4	6.4	1.3	34.3	1.2	170.9	113.4	54.8	21.1	0.1	5.3	11.6	20.1	10.0	28.3	1.8	0.0	666.3	1.6	0.1	0.0	1.3	10.5	61.5	628.2	34.5	0.0	0.0	0.5	0.2	651.6	1506.5	38.7	256.5	1.3	29.0	22.1	0.6	82.4	0.0	0.8	0.3	6.1	0.0	222.9	25.4	92.2	11.4	170.7	41.2	0.0	0.1	0.0	0.0	0.4	1.0	0.1	30.5	4.5	47.4	0.0	0.3	10.2	0.6	118.3	37.1	81.5	42.2	68.7	23.8	130.3	1215.9	18.2	2.3	0.4	86.9
FBXL7	"FBL6, FBL7, KIAA0840"	ENSG00000183580	"F-box and leucine rich repeat protein 7"	Q9UJT9	5	15500180-15939795	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 976.2;Inhibitory neurons: 295.1;Oligodendrocyte precursor cells: 335.8;Oligodendrocytes: 766.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA055464	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055464: AB_2682822"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.94e-3)"	17.5	22.7	16.9	3.7	19.5	0.0	13.9	16.0	15.9	19.1	15.9	17.2	2.0	26.4	10.3	9.7	15.8	8.4	17.0	15.5	14.2	4.7	2.1	9.6	2.6	19.7	16.5	26.8	1.9	1.0	4.7	6.6	16.1	13.3	5.2	4.3	5.6	19.5	4.0	5.0	6.8	24.6	15.1	5.0	10.2	4.4	18.4	2.4	8.2	5.7	2.1	16.6	13.1	22.3	0.1	1.4	16.1	23.5	13.1	10.0	0.0	14.1	17.0	9.9	10.3	0.0	0.0	0.0	0.0	21.7	10.2	0.0	8.1	5.2	9.8	0.0	1.1	0.0	0.0	0.0	5.1	0.0	0.0	11.8	0.0	8.0	0.7	12.1	23.2	0.0	0.0	6.1	7.5	0.0	0.0	0.0	5.4	0.0	2.6	0.0	11.4	0.1	0.0	0.0	4.7	15.9	0.0	4.9	15.3	14.5	0.0	0.0	22.9	20.6	4.1	11.7	6.3	0.0	0.0	0.0	11.4	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	19.5	16.0	15.9	15.5	14.2	19.7	16.5	16.1	15.1	18.4	22.3	21.4	3.2	1.9	976.2	0.3	2.4	2.7	2.4	2.2	3.2	0.9	1.1	11.8	0.0	1.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	2.0	11.8	16.7	0.0	0.0	3.7	0.0	0.1	15.9	0.0	2.0	1.3	13.1	15.4	0.2	0.8	30.3	295.1	0.0	0.0	0.6	2.7	0.7	30.1	0.5	5.4	146.1	0.0	2.4	0.0	335.8	766.0	0.0	0.0	41.3	1.2	3.1	0.0	1.2	3.8	2.5	6.6	16.1	8.1	1.4	2.1	1.5	1.7	0.0	0.3	20.7	0.0	2.4
FBXO17	"FBG4, Fbx17, FBXO26, FLJ11798, FLJ25205, MGC9379"	ENSG00000269190	"F-box protein 17"	Q96EF6	19	38941401-38975742	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 67.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 56.7;Hepatocytes: 58.5;Leydig cells: 83.0;Peritubular cells: 74.1;Proximal tubular cells: 70.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (6.97e-3)"	"prognostic unfavorable (5.67e-4)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (5.34e-2)"	"unprognostic (4.06e-4)"	"unprognostic (2.77e-3)"	22.9	5.2	5.7	1.7	5.1	0.4	17.5	7.7	5.5	28.1	4.6	18.7	2.1	25.1	5.9	7.3	20.8	4.7	12.8	4.9	4.7	42.8	67.9	10.3	1.5	4.3	4.3	33.6	11.7	4.8	9.1	2.9	4.4	18.5	1.5	3.8	7.1	7.6	3.1	13.9	6.9	9.2	3.9	4.4	10.2	4.4	5.6	0.8	5.5	1.9	1.2	18.1	18.8	4.0	19.7	37.3	0.1	23.4	16.7	11.7	0.5	7.7	7.8	9.8	11.8	17.0	0.3	0.4	6.3	12.6	19.2	5.3	4.2	5.5	8.9	0.1	14.9	0.1	2.8	19.5	10.9	0.2	0.6	10.2	4.6	16.5	7.7	18.9	13.1	0.1	21.5	0.1	10.1	9.8	0.1	0.3	7.9	0.0	0.1	0.0	0.1	0.1	11.8	0.1	0.2	15.3	10.9	0.0	9.1	5.4	9.5	0.3	3.9	24.4	17.8	10.1	10.5	0.3	1.1	0.1	21.7	0.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	5.7	5.1	7.7	5.5	4.9	4.7	4.3	4.3	4.4	3.9	5.6	4.0	5.3	0.0	1.1	15.0	0.2	18.7	11.3	9.9	33.0	4.1	3.0	14.4	3.1	17.2	5.4	14.7	35.5	6.9	0.2	0.1	56.7	6.7	4.1	0.6	29.6	8.1	0.0	0.0	14.5	2.0	5.4	34.1	0.0	0.5	0.0	20.1	14.6	58.5	38.8	5.0	19.2	0.0	8.2	0.8	8.5	3.4	83.0	1.9	19.6	13.1	0.0	10.2	0.0	16.1	2.0	2.0	0.0	74.1	1.2	15.8	0.0	70.3	2.0	13.0	52.6	20.6	19.8	0.7	4.4	10.0	17.5	5.1	0.9	16.1	0.0	4.1
FCGRT	"alpha-chain, FCRN"	ENSG00000104870	"Fc fragment of IgG receptor and transporter"	P55899	19	49506816-49526428	"Predicted intracellular proteins, Predicted membrane proteins"		"IgG-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1362.6;Kupffer cells: 877.7;Paneth cells: 883.9;Proximal enterocytes: 1787.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2346.7"	"Group enriched"	"Detected in all"	17	"dendritic cells: 922.9;granulocytes: 2346.7;monocytes: 1364.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 153.7;Hep G2: 144.0;OE19: 165.4;THP-1: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012122, HPA015130"	Enhanced					NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA012122: AB_1848474, HPA015130: AB_1848475"	"unprognostic (2.19e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-3)"	263.1	127.7	67.7	99.6	73.3	147.3	198.8	68.0	102.5	217.2	111.1	209.6	304.4	143.1	48.8	60.2	155.5	144.6	123.0	66.3	75.1	177.6	401.6	177.5	143.3	74.0	69.5	193.2	129.4	114.5	79.8	137.5	74.3	104.6	149.3	4.8	106.2	94.7	64.4	112.3	299.3	91.6	73.6	318.9	126.6	28.3	78.8	62.9	111.9	77.8	39.1	136.7	132.0	78.2	0.4	37.1	4.3	123.7	153.7	78.2	6.0	32.1	73.4	20.9	22.9	50.5	22.5	0.2	59.4	45.9	10.8	8.5	1.2	1.1	11.7	0.3	45.5	74.2	0.6	144.0	95.8	1.1	14.2	95.1	1.9	17.5	0.2	86.5	81.3	48.0	12.2	10.9	53.7	0.8	0.6	14.3	2.1	165.4	22.0	2.6	35.3	3.7	96.0	9.3	2.6	23.1	5.6	0.2	4.5	18.3	26.5	196.1	28.1	52.8	11.8	0.9	1.3	2.4	13.5	9.8	10.8	70.2	7.9	566.8	1364.4	1011.5	24.7	904.8	29.8	58.0	39.8	39.7	922.9	62.5	89.4	51.0	2346.7	28.6	630.2	536.4	28.2	1276.9	67.7	73.3	68.0	102.5	66.3	75.1	74.0	69.5	74.3	73.6	78.8	78.2	479.6	67.3	89.3	21.2	44.2	126.1	130.4	130.7	52.9	0.7	125.5	151.3	30.7	158.7	79.9	73.5	4.2	12.7	83.8	652.3	60.7	86.3	6.5	29.1	89.6	259.2	158.1	55.8	0.2	61.6	24.9	269.9	108.6	24.8	70.5	181.2	587.6	343.9	1362.6	0.0	0.2	349.0	57.0	877.7	438.1	21.8	362.2	608.6	186.7	24.4	190.6	13.4	11.3	10.1	0.2	90.6	883.9	183.6	63.2	87.9	1787.7	329.5	53.4	5.2	216.9	149.2	105.6	21.1	17.6	27.7	107.1	20.7	32.4	129.9	565.1	115.4
FCHO1	KIAA0290	ENSG00000130475	"FCH and mu domain containing endocytic adaptor 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.5;lymphoid tissue: 24.3;skin 1: 22.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 16.8;dendritic cells: 19.1;Oligodendrocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.4;RPMI-8226: 43.3;U-937: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	1.8	24.9	14.7	33.7	20.2	1.5	21.7	32.6	1.0	8.6	2.5	3.2	1.3	1.4	1.1	1.5	4.2	0.8	24.1	25.6	1.4	2.2	3.7	24.3	27.5	28.6	1.7	0.7	1.1	3.9	1.1	29.7	1.0	2.2	3.4	1.3	0.8	0.6	22.2	8.1	1.7	19.9	15.5	3.4	4.4	29.2	17.6	1.0	0.8	17.4	3.0	1.0	59.5	0.9	11.9	7.5	5.2	0.2	0.2	7.5	1.1	0.3	0.3	0.5	1.5	1.4	62.4	17.1	0.5	1.4	2.3	3.7	2.3	0.2	27.6	2.1	4.9	1.4	6.4	0.6	15.7	10.2	0.1	0.3	0.0	0.4	0.4	1.6	30.2	24.9	28.9	0.0	17.4	36.2	27.8	3.6	14.7	28.7	30.2	0.2	43.3	0.2	1.2	1.3	2.5	0.3	5.9	0.9	0.9	6.0	15.4	1.3	0.1	4.1	0.9	0.4	18.2	9.0	33.4	0.9	38.5	0.5	13.2	9.6	10.1	7.0	14.3	6.0	12.4	7.9	6.3	14.5	12.3	7.4	6.1	37.8	6.4	11.5	15.3	7.6	7.4	24.9	33.7	21.7	32.6	24.1	25.6	27.5	28.6	29.7	19.9	29.2	59.5	0.4	0.0	1.5	0.7	16.8	0.0	0.4	0.2	0.6	7.8	2.0	4.3	0.9	2.8	0.4	1.8	0.0	2.9	19.1	2.0	0.0	0.5	1.5	0.8	0.2	2.4	1.2	2.5	15.0	0.0	4.6	2.5	1.5	1.0	9.5	2.9	2.5	0.0	6.8	0.0	13.0	1.7	0.0	8.7	14.3	0.7	2.5	11.0	1.8	6.5	12.3	0.1	13.4	3.0	46.9	2.1	0.5	8.6	4.5	0.3	0.1	0.1	0.7	0.8	0.0	0.2	0.6	0.9	5.5	0.2	0.6	0.8	9.8	12.2	1.8	0.3
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223891	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.6;lymphoid tissue: 130.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.3;granulocytes: 96.4;Hofbauer cells: 193.1;Kupffer cells: 95.8;Langerhans cells: 88.0;Macrophages: 232.9;monocytes: 142.9;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 306.9;HL-60: 135.9;HMC-1: 314.2;Karpas-707: 127.6;MOLT-4: 121.8;NB-4: 174.1;U-937: 138.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065231			Approved	Vesicles		NA	NA		160000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA065231: AB_2685439"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	25.1	14.5	9.4	63.3	11.6	180.6	13.0	11.2	18.1	8.5	12.2	17.3	22.0	8.4	0.7	6.4	13.6	15.6	12.0	9.8	11.6	11.1	12.5	46.2	89.2	17.9	12.2	5.1	7.0	1.3	5.9	15.0	13.2	8.2	8.1	0.6	10.7	4.4	6.0	7.1	34.1	9.4	13.3	130.1	29.6	4.5	17.1	48.7	10.0	4.6	41.8	19.8	7.3	15.3	1.2	1.6	0.5	0.9	0.3	0.8	2.0	1.4	0.2	0.4	0.3	2.6	2.3	32.6	3.2	6.3	0.7	2.4	1.0	0.5	0.5	83.9	0.6	306.9	1.6	0.1	10.8	135.9	314.2	1.2	1.1	5.2	0.0	0.5	81.2	77.0	7.3	127.6	8.6	3.5	121.8	174.1	1.2	1.0	2.3	72.4	8.8	0.7	0.3	0.7	1.9	0.5	0.7	4.5	1.7	0.7	2.0	92.6	7.8	1.1	2.5	1.9	0.9	1.5	3.3	59.4	19.5	138.9	86.6	204.1	207.0	236.5	120.0	192.6	114.9	54.5	94.1	112.0	162.0	53.1	60.9	80.6	184.6	102.4	151.2	195.7	120.9	292.6	9.4	11.6	11.2	18.1	9.8	11.6	17.9	12.2	13.2	13.3	17.1	15.3	3.8	9.6	14.7	0.7	52.1	4.7	0.9	0.3	3.4	0.5	3.3	5.2	2.4	4.3	3.9	0.0	0.0	1.2	118.3	6.1	0.0	0.8	0.4	4.3	5.6	7.9	0.0	62.5	1.2	2.4	1.4	5.4	19.9	7.3	96.4	0.4	19.6	1.4	193.1	0.0	1.5	32.1	0.0	95.8	88.0	0.9	0.9	232.9	17.8	5.6	142.9	0.3	93.7	1.0	1.5	4.3	10.9	2.6	35.2	0.9	8.2	0.4	1.0	0.3	6.6	13.7	6.6	1.2	0.8	1.9	4.5	2.6	78.5	1.4	15.0	0.7
FEZ1	UNC-76	ENSG00000149557	"Fasciculation and elongation protein zeta 1"	Q99689	11	125442881-125592568	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 176.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 109.8;Horizontal cells: 166.5;Oligodendrocytes: 246.6"	"Cancer enriched"	"Detected in all"	10	"glioma: 68.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 23.4;MAIT T-cell: 15.5"	"Lineage enriched"	"Detected in many"	23	"T-cells: 23.4"	"Cell line enhanced"	"Detected in many"		"AF22: 48.3;HBEC3-KT: 66.0;NTERA-2: 68.6;SCLC-21H: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038490, HPA076844"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	"Microtubules, Cytosol"		"HPA038490: AB_10672647, HPA076844: "	"unprognostic (5.68e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	16.9	5.4	96.8	2.9	144.0	0.9	11.3	145.5	120.6	21.8	53.1	39.3	1.7	23.5	2.3	6.2	14.7	6.9	37.4	95.5	120.4	6.8	5.5	34.2	1.9	145.6	136.9	12.7	2.5	1.9	17.6	3.8	138.9	15.4	3.3	18.7	6.4	7.6	5.9	7.9	12.6	8.3	134.8	8.8	15.9	12.7	126.7	0.5	10.2	3.0	1.4	26.5	16.9	176.6	0.3	0.0	48.3	0.2	39.2	25.3	0.0	10.3	14.6	3.8	0.6	0.2	0.3	0.1	16.3	21.1	11.4	0.5	31.2	66.0	2.4	2.3	0.5	37.6	0.1	0.0	25.3	0.0	0.6	23.1	17.6	11.5	29.3	0.4	32.0	0.0	4.5	0.6	3.8	1.5	0.2	0.0	68.6	0.5	1.2	0.0	0.1	0.2	0.0	30.3	54.3	5.5	0.3	0.1	1.4	27.3	4.9	26.4	19.3	0.4	2.4	0.2	11.1	0.6	0.5	0.1	7.9	0.0	26.6	0.2	0.8	0.0	23.4	0.1	15.5	0.1	0.9	5.1	0.4	0.0	0.6	5.5	0.2	1.0	0.0	0.1	0.0	4.4	96.8	144.0	145.5	120.6	95.5	120.4	145.6	136.9	138.9	134.8	126.7	176.6	4.9	0.0	5.2	53.2	0.8	8.0	4.9	96.9	6.2	23.1	0.5	10.3	109.8	2.8	9.6	0.0	2.1	8.0	23.3	0.1	27.4	2.8	68.6	0.8	14.2	13.9	5.4	0.0	41.0	0.4	1.2	43.0	0.5	0.5	0.0	11.1	58.9	1.0	91.6	166.5	48.7	0.0	16.2	24.9	15.5	65.9	25.4	2.3	78.2	12.2	1.9	97.1	74.2	32.2	246.6	0.3	0.0	35.3	0.9	12.7	0.0	2.1	3.8	17.8	19.7	25.4	35.6	28.8	7.7	0.2	5.5	4.2	7.8	5.5	0.1	3.5
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Differentiation, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 11.4;pituitary gland: 11.0"	"Cell type enriched"	"Detected in some"	4	"Intestinal goblet cells: 125.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042563			Uncertain	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"		"HPA042563: AB_10794762"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.98e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	4.1	0.4	1.2	0.7	1.3	0.1	1.3	0.6	1.2	0.1	0.3	8.3	0.5	0.0	0.0	0.2	1.0	0.5	0.3	1.0	1.8	0.1	0.4	3.6	0.2	0.6	0.8	0.0	0.6	0.1	11.0	0.1	0.5	0.1	11.4	0.2	0.1	0.0	0.3	0.9	0.6	0.2	0.3	0.1	0.5	1.5	2.6	0.3	0.1	0.1	0.1	0.1	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	1.2	1.3	0.6	1.2	1.0	1.8	0.6	0.8	0.5	0.3	2.6	0.7	0.2	0.0	0.5	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.2	0.8	0.4	7.2	0.6	0.0	0.0	0.2	0.0	28.1	0.0	0.8	27.8	0.1	0.0	0.3	20.9	0.0	3.2	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	2.0	125.7	0.0	7.2	4.4	16.7	0.6	7.6	1.8	3.7	0.5	0.0	0.0	0.0	0.3	0.9	23.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.3
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 295.2;choroid plexus: 125.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.1;Cardiomyocytes: 62.4;Muller glia cells: 69.4;Oligodendrocytes: 119.8"	"Cancer enriched"	"Detected in many"	12	"glioma: 33.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.6;BJ hTERT+: 33.0;BJ hTERT+ SV40 Large T+: 35.9;BJ hTERT+ SV40 Large T+ RasG12V: 45.0;HBF TERT88: 64.3;hTEC/SVTERT24-B: 45.4;LHCN-M2: 30.6;U-2 OS: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (1.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (3.72e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (3.01e-4)"	17.9	3.3	206.3	1.6	259.3	1.1	12.5	213.9	295.2	1.3	125.8	2.4	1.0	3.1	7.9	2.0	1.7	2.5	50.2	183.5	245.5	66.5	1.7	2.8	1.2	236.2	237.7	0.9	0.8	4.3	6.5	2.1	259.9	1.8	1.3	18.8	7.3	2.3	2.2	1.7	1.2	2.5	225.4	6.9	0.8	2.0	244.3	1.5	5.6	7.8	2.0	1.2	1.0	272.8	5.6	0.3	0.3	1.5	1.1	3.3	1.8	44.6	33.0	35.9	45.0	0.2	0.2	1.3	3.1	15.4	2.1	0.7	0.0	3.5	64.3	0.2	0.0	0.0	0.8	0.4	0.6	0.0	0.4	1.6	1.1	45.4	2.7	9.7	0.0	0.2	0.0	1.6	30.6	0.7	0.1	0.9	1.4	0.1	1.4	0.2	1.5	0.6	1.5	0.2	1.1	2.3	0.1	0.9	0.6	8.0	0.0	0.2	1.1	5.8	33.0	0.8	21.3	0.8	0.4	0.3	8.2	0.3	1.6	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.3	0.0	0.1	0.2	0.1	0.0	206.3	259.3	213.9	295.2	183.5	245.5	236.2	237.7	259.9	225.4	244.3	272.8	1.4	0.0	0.0	75.1	0.1	0.4	5.0	5.7	7.4	3.5	1.2	25.4	62.4	0.0	2.1	20.2	16.7	1.1	0.1	0.0	0.0	1.1	0.4	0.0	0.7	4.8	0.0	0.0	13.0	0.0	0.5	4.7	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	14.6	0.0	12.2	0.0	0.0	1.4	0.0	0.2	3.6	29.0	0.0	69.4	0.0	15.1	119.8	0.6	0.0	0.4	0.0	5.3	0.0	0.3	0.1	11.6	6.6	0.5	23.4	0.1	0.1	0.6	0.0	0.8	0.4	0.0	0.0	0.7
FGF16	MF4	ENSG00000196468	"Fibroblast growth factor 16"	O43320	X	77447389-77457278	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.8"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 1.5;Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 22.5"	"Group enriched"	"Detected in some"	6	"basal ganglia: 3.6;hippocampal formation: 2.0;olfactory bulb: 6.7"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (4.01e-2)"					"unprognostic (5.30e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"			"unprognostic (2.31e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.49e-2)"		0.6	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.1	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193369-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 162.5"	"Group enriched"	"Detected in many"	4	"Kupffer cells: 466.3;Langerhans cells: 571.0;Macrophages: 430.3;monocytes: 463.1;Skeletal myocytes: 166.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	45	"classical monocyte: 256.5;eosinophil: 226.3;intermediate monocyte: 380.6;myeloid DC: 160.0;neutrophil: 294.7;non-classical monocyte: 379.8"	"Group enriched"	"Detected in all"	59	"dendritic cells: 160.0;granulocytes: 294.7;monocytes: 380.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;LHCN-M2: 2.9;NB-4: 2.9;RPTEC TERT1: 5.0;THP-1: 2.1;U-937: 5.0;WM-115: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	NA	NA	38800000	7800000	"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	48.5	24.4	3.3	89.4	2.7	5.8	35.1	5.3	3.5	17.2	6.1	44.9	43.7	17.8	7.6	38.5	22.1	45.4	21.6	2.4	5.4	44.9	43.5	32.7	56.5	7.7	5.9	10.9	8.3	5.2	7.9	21.6	6.7	10.5	57.2	0.8	14.8	11.7	8.8	13.9	69.8	45.7	6.2	162.5	23.5	6.2	3.9	30.1	18.8	24.6	27.5	73.3	7.1	9.8	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.2	0.3	5.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	5.0	5.7	2.8	256.5	226.3	3.9	380.6	1.2	4.3	2.5	3.4	160.0	2.0	1.8	3.0	294.7	2.5	379.8	6.2	4.7	174.0	3.3	2.7	5.3	3.5	2.4	5.4	7.7	5.9	6.7	6.2	3.9	9.8	102.0	6.4	12.1	0.0	26.2	38.1	1.1	0.1	3.4	1.1	1.4	3.0	4.4	0.0	5.0	88.3	10.4	1.3	60.3	17.3	5.9	1.9	7.5	2.6	0.7	50.6	0.0	7.0	0.3	0.0	1.4	102.8	2.0	5.0	10.1	0.6	45.3	5.2	36.2	1.7	0.4	0.3	0.0	466.3	571.0	9.4	27.7	430.3	49.8	33.7	463.1	13.6	39.1	0.0	0.9	0.1	10.9	19.5	82.6	1.1	42.5	5.9	2.2	7.4	0.0	166.2	8.2	0.4	0.4	2.1	31.3	3.7	24.1	0.2	0.8	1.5
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 11467.1;tongue: 9770.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1145.1;Early spermatids: 373.8;Late spermatids: 1206.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 88.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 36.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 36.1;T-cells: 18.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 303.7;fHDF/TERT166: 258.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavorable (2.11e-4)"	938.4	65.8	120.8	75.5	117.2	11.7	441.8	95.9	126.3	315.5	85.8	672.0	83.2	464.6	107.7	538.1	281.6	127.6	1462.3	130.8	144.9	45.2	43.1	285.6	41.7	103.9	125.4	102.8	39.4	196.5	92.9	106.6	115.9	408.8	161.4	76.2	161.3	541.1	11467.1	101.3	235.5	486.5	114.8	43.0	368.4	60.2	130.1	25.1	310.1	9770.8	32.1	469.6	253.1	102.9	0.4	44.3	60.7	57.8	127.2	52.3	1.5	183.7	303.7	34.8	81.3	0.3	12.7	0.7	55.8	258.8	95.0	0.5	119.2	148.0	28.2	0.4	136.7	0.7	34.4	0.0	121.6	0.3	26.8	96.6	24.4	41.2	128.7	14.1	36.6	34.5	0.1	26.0	81.9	2.5	26.1	1.6	19.1	0.2	52.2	69.8	2.6	38.2	1.1	0.1	43.5	63.8	6.6	0.2	12.4	24.1	0.3	2.4	102.5	150.2	71.0	5.9	44.7	6.8	16.0	1.1	11.9	1.4	18.2	0.1	0.7	0.0	5.2	0.1	13.8	5.8	18.2	7.2	3.1	3.6	12.0	4.0	1.2	36.1	0.0	19.4	2.2	11.1	120.8	117.2	95.9	126.3	130.8	144.9	103.9	125.4	115.9	114.8	130.1	102.9	203.0	48.1	11.7	32.0	8.1	56.5	26.9	15.1	14.2	36.2	1.4	8.3	1145.1	0.0	4.9	11.0	8.4	0.6	8.6	0.5	1.9	3.0	373.8	4.3	32.3	61.1	13.8	17.9	70.2	0.2	1.1	236.0	2.0	2.0	15.8	41.0	113.6	6.1	4.3	99.3	55.6	0.8	0.0	5.1	47.0	1206.9	123.9	35.6	32.0	16.9	7.4	209.6	2.1	35.2	8.2	0.6	7.6	152.4	15.5	20.1	0.6	11.6	4.8	19.4	105.2	248.1	235.7	7.4	88.6	2.7	44.8	2.7	15.5	9.6	2.0	2.6
FHL5	"ACT, dJ393D12.2, FLJ33049"	ENSG00000112214	"Four and a half LIM domains 5"	Q5TD97	6	96562548-96616636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 65.5"	"Group enriched"	"Detected in some"	20	"Early spermatids: 1160.3;Late spermatids: 1540.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"ASC diff: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (4.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.48e-3)"	35.7	10.3	5.4	4.4	8.5	0.0	16.0	5.8	7.5	27.8	6.2	5.8	2.5	15.0	17.6	9.6	21.5	12.9	5.6	4.9	5.3	6.4	0.4	14.0	1.8	6.3	5.8	11.4	4.6	3.3	1.2	0.6	7.1	4.9	5.0	0.4	2.1	11.1	8.9	5.5	5.1	9.6	5.4	3.5	4.0	65.5	7.2	1.2	8.9	14.6	0.8	6.8	10.3	5.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	8.5	5.8	7.5	4.9	5.3	6.3	5.8	7.1	5.4	7.2	5.5	5.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1160.3	0.0	0.1	3.8	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1540.1	52.5	1.1	5.4	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.2	0.0	0.0	0.0	0.0	52.6	1.9	67.4	13.2	4.4	0.0	0.3	0.0	0.6	0.1	0.0	0.2
FKBP7	FKBP23	ENSG00000079150	"FKBP prolyl isomerase 7"	Q9Y680	2	178463664-178478600	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.1;Endometrial stromal cells: 54.8;Fibroblasts: 67.6;Leydig cells: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 155.0;ASC TERT1: 96.7;fHDF/TERT166: 60.9;HSkMC: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.3	5.4	1.5	3.9	1.6	1.4	11.9	2.6	2.8	23.1	1.5	8.3	2.8	27.8	11.3	5.9	15.1	15.4	12.3	1.6	1.8	5.2	8.3	7.8	2.9	1.6	1.5	50.0	2.8	2.7	5.0	13.0	1.5	9.3	6.2	2.1	5.0	13.3	3.8	4.2	4.4	19.2	1.2	3.0	5.4	4.4	1.5	2.5	6.6	6.5	2.8	11.6	10.2	2.1	0.2	1.9	18.5	27.8	155.0	96.7	1.7	33.3	55.0	5.9	19.0	0.3	1.9	5.4	7.3	60.9	5.5	0.3	7.1	2.8	10.3	4.5	3.9	5.7	7.3	5.5	23.7	3.5	3.8	64.7	1.4	24.0	3.4	44.2	19.8	6.6	2.5	3.4	25.2	0.3	6.1	6.0	3.6	3.5	2.9	7.8	31.9	7.7	8.4	0.6	9.7	32.0	7.0	0.2	6.2	12.7	0.5	6.8	18.2	11.0	6.8	12.8	3.2	6.3	7.2	2.6	19.9	8.7	24.3	0.0	0.4	0.0	1.0	0.7	1.2	1.1	0.9	0.7	2.6	0.7	0.9	1.0	0.0	0.6	0.0	2.1	1.1	0.4	1.5	1.6	2.6	2.8	1.6	1.8	1.6	1.5	1.5	1.2	1.5	2.1	16.2	6.4	4.1	2.9	5.4	7.0	9.3	19.6	7.4	4.2	6.7	13.6	16.1	2.8	5.2	7.3	0.0	7.6	2.7	0.7	1.9	10.9	149.1	3.4	54.8	19.3	1.2	4.2	1.6	8.4	22.4	67.6	4.1	3.5	14.0	19.0	15.7	11.9	5.8	5.0	3.7	5.6	14.2	4.4	13.6	27.1	64.0	3.8	17.8	4.7	1.6	4.2	1.0	7.1	4.2	3.9	0.7	48.5	10.3	3.4	0.4	3.7	2.1	3.6	6.6	31.1	37.7	8.5	5.1	3.7	5.8	5.1	5.5	30.4	3.1	4.1
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FKBP prolyl isomerase like"	Q9UIM3	6	32128707-32130288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 51.2;Squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.3	4.2	2.9	2.0	2.5	2.8	4.0	2.2	3.2	3.8	2.2	4.1	1.6	3.1	6.1	10.7	4.3	1.6	2.9	2.6	2.4	4.0	5.2	3.2	3.1	2.9	2.4	3.2	5.5	4.0	2.9	1.7	2.6	3.2	3.4	1.8	6.4	1.1	4.5	9.8	3.6	3.6	2.1	4.7	6.1	6.2	2.5	5.5	5.6	4.4	1.1	2.9	5.1	3.6	0.0	0.9	8.1	13.8	11.6	8.2	3.4	5.4	6.1	10.0	9.7	17.5	7.3	0.0	1.8	9.3	13.1	4.2	11.3	10.5	6.9	0.0	13.7	0.0	11.9	10.2	6.5	0.0	6.6	8.0	5.6	19.3	6.1	7.3	10.6	15.8	11.9	15.0	10.2	6.0	6.9	5.9	6.0	16.1	3.0	0.0	5.0	13.6	10.4	1.5	15.3	1.0	5.5	9.6	10.2	2.4	16.8	11.8	4.7	14.3	4.1	7.5	13.3	7.7	1.5	5.7	5.6	7.1	9.1	6.6	1.8	0.5	0.7	2.5	0.7	2.1	1.1	1.3	1.9	0.5	1.0	1.0	2.6	3.4	0.8	1.6	0.3	1.5	2.9	2.5	2.2	3.2	2.6	2.4	2.9	2.4	2.6	2.1	2.5	3.6	8.8	6.4	5.9	0.3	7.8	11.2	4.7	6.7	51.2	2.9	11.5	8.5	2.0	7.2	6.2	1.8	0.0	9.9	6.1	9.3	5.9	8.1	4.2	11.6	6.1	9.6	6.0	19.8	0.7	6.7	13.3	5.6	6.1	8.1	2.5	12.4	5.0	3.3	5.0	10.1	0.6	7.0	8.2	2.8	8.8	5.5	2.8	4.2	7.2	1.0	3.7	7.3	3.1	0.0	0.5	6.0	6.2	3.4	7.7	5.2	10.3	9.9	3.2	4.9	0.0	5.4	17.4	11.1	8.8	34.1	10.2	14.1	6.8	14.9	6.5	4.1
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	10.2	1.9	3.7	10.9	2.3	12.2	6.0	2.1	2.8	5.7	1.2	3.7	3.2	4.6	1.1	2.8	2.7	6.1	6.2	1.8	2.9	2.1	2.8	10.8	12.3	4.7	2.7	1.2	1.7	3.5	0.7	12.5	4.3	1.9	2.9	0.5	2.2	2.2	2.8	1.7	4.0	5.9	3.5	35.8	4.3	0.9	3.9	17.2	2.9	6.6	10.4	6.7	1.9	2.8	0.2	0.0	5.6	0.0	0.8	1.0	0.1	3.3	9.2	3.8	3.1	0.0	0.0	18.5	31.7	11.1	1.1	0.1	0.8	13.5	4.1	9.0	0.2	113.9	0.5	0.0	6.0	13.7	14.6	0.8	1.1	7.7	17.3	11.1	60.5	25.6	0.0	23.3	0.8	0.0	13.3	8.1	1.8	0.0	3.1	49.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	20.4	63.0	0.7	0.0	0.2	3.5	7.3	16.4	16.6	0.1	31.8	5.2	34.5	15.5	24.5	10.1	15.3	11.9	6.8	8.9	8.2	19.1	6.0	3.7	8.2	11.8	12.3	19.1	3.3	11.1	20.1	3.7	2.3	2.1	2.8	1.8	2.9	4.7	2.7	4.3	3.5	3.9	2.8	53.4	6.4	5.3	0.3	65.7	5.1	0.3	1.7	2.2	0.0	0.7	1.3	5.5	5.7	0.1	1.8	0.0	0.4	43.1	0.0	0.0	0.0	0.5	0.4	0.6	84.2	0.0	23.4	0.3	0.0	0.4	5.9	2.0	0.3	22.8	0.0	64.6	1.3	43.2	0.0	1.5	0.1	0.0	86.4	24.7	0.5	1.8	60.3	7.2	231.4	68.4	0.1	93.7	4.0	0.7	0.0	0.0	0.7	56.9	0.3	0.0	0.4	0.8	0.4	6.6	2.1	3.1	0.2	0.1	0.6	4.1	0.3	52.8	0.9	0.2	0.4
FMO1		ENSG00000010932	"Flavin containing dimethylaniline monoxygenase 1"	Q01740	1	171248471-171285978	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"kidney: 199.0"	"Group enriched"	"Detected in many"	7	"Proximal enterocytes: 97.9;Proximal tubular cells: 196.9"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HSkMC: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078132	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA078132: "	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.49e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.37e-1)"	5.1	5.6	0.1	0.5	0.1	0.0	10.0	0.1	0.3	6.3	0.3	0.4	0.1	3.1	0.1	3.5	4.2	5.2	0.7	0.1	0.1	199.0	2.9	1.5	0.4	0.1	0.1	5.0	2.4	1.1	1.8	2.3	0.1	0.4	0.2	0.0	5.4	0.7	0.1	10.4	20.2	4.2	0.1	0.0	0.9	1.6	0.1	7.4	2.3	0.8	10.8	2.5	1.7	0.1	0.0	0.0	0.0	0.0	2.7	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.0	0.0	0.0	0.3	3.0	3.2	0.5	0.0	12.5	0.0	0.5	1.1	10.0	2.8	0.0	3.7	0.0	0.3	0.0	0.0	13.7	0.0	0.7	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.1	18.7	0.0	0.0	0.0	3.2	0.0	0.3	0.4	0.0	0.1	2.9	0.0	0.0	0.0	1.5	10.8	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	2.6	0.0	0.1	97.9	196.9	0.0	0.0	6.6	0.5	4.7	0.0	0.1	1.4	2.3	0.8	1.0	2.6	1.4	0.1
FMO4	FMO2	ENSG00000076258	"Flavin containing dimethylaniline monoxygenase 4"	P31512	1	171314183-171342084	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 48.6;liver: 61.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Hepatocytes: 22.1;Oligodendrocytes: 18.5;Proximal enterocytes: 16.5;Proximal tubular cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 5.7;HSkMC: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favorable (1.09e-4)"	"prognostic favorable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	3.7	2.6	2.2	1.9	3.1	0.9	4.1	2.8	3.0	3.3	3.1	5.0	5.4	2.7	6.3	2.3	3.5	4.9	5.2	2.1	2.6	48.6	61.3	3.2	2.9	3.1	2.8	3.8	2.4	4.7	1.9	2.3	3.3	3.1	4.8	0.7	2.0	2.2	1.0	3.4	9.2	2.0	2.6	3.1	5.0	1.7	3.1	3.6	3.2	2.1	3.3	2.4	2.9	3.5	0.1	0.1	0.3	0.4	4.1	3.4	0.2	0.8	3.7	1.1	1.2	0.6	5.3	3.7	5.7	0.1	2.0	0.2	0.7	1.0	1.6	1.6	0.8	0.0	0.0	0.0	0.6	0.7	0.8	6.6	2.4	0.4	1.0	0.4	0.2	1.7	0.2	2.3	0.5	0.7	1.6	1.3	0.4	0.9	1.2	0.4	0.4	2.1	2.6	0.0	0.1	0.0	1.2	1.0	2.4	4.1	2.2	1.0	0.1	0.9	0.3	1.0	0.7	2.9	1.0	2.2	1.8	1.1	0.8	0.2	1.0	0.3	0.9	1.6	0.7	1.2	0.8	1.3	0.9	1.8	1.2	0.9	0.1	1.7	1.1	1.2	2.1	0.8	2.2	3.1	2.8	3.0	2.1	2.6	3.1	2.8	3.3	2.6	3.1	3.5	2.2	0.0	2.6	7.2	3.2	2.8	4.6	5.0	2.8	0.0	2.3	2.0	3.7	2.8	3.7	9.2	0.0	2.8	0.6	7.1	29.4	2.3	5.7	3.8	1.7	1.4	1.2	0.0	0.1	1.4	1.2	6.6	8.2	1.7	1.3	1.5	2.9	22.1	3.7	0.0	0.1	3.2	2.0	5.9	1.3	1.3	1.5	2.7	5.4	2.8	1.6	1.8	1.0	0.0	18.5	1.1	0.7	0.4	1.1	0.9	16.5	49.5	7.3	0.0	0.0	1.8	2.1	0.3	0.5	1.9	1.6	1.9	1.7	2.0	2.8	1.8
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49145092-49208638	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 266.4;prostate: 76.0"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 367.6"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;RPMI-8226: 1.7;SK-BR-3: 1.8;TIME: 1.3;WM-115: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.8	1.1	17.3	0.9	37.3	0.7	4.8	27.1	27.7	1.9	7.9	0.7	266.4	1.7	0.9	1.5	3.5	10.2	0.5	18.3	22.4	13.5	35.5	1.3	0.9	32.7	28.4	1.0	0.3	0.2	0.0	0.3	31.5	76.0	0.5	4.0	52.8	0.6	0.2	1.7	82.9	1.0	24.1	2.4	1.1	0.8	31.1	0.1	1.0	0.2	0.6	1.4	0.3	59.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	2.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.2	0.7	0.0	1.8	0.3	0.2	0.3	0.0	1.3	0.1	0.9	0.2	0.1	0.0	0.2	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.3	37.3	27.1	27.7	18.3	22.4	32.7	28.4	31.5	24.1	31.1	59.3	0.5	0.0	0.6	0.0	0.0	0.3	0.7	0.1	0.6	0.0	8.2	7.0	0.3	0.0	1.9	0.0	0.0	0.0	0.5	0.0	7.9	0.0	5.2	2.1	0.5	5.0	0.0	0.0	0.5	0.0	0.0	2.2	0.0	2.8	0.0	0.0	2.9	25.9	0.1	0.0	1.0	1.1	0.0	0.3	0.0	1.4	1.5	0.2	3.6	1.0	0.0	17.4	0.0	0.0	367.6	0.0	1.2	0.4	0.0	43.0	0.8	32.4	0.1	0.6	0.0	0.0	0.4	1.1	1.5	1.5	0.9	0.0	0.2	0.5	0.2	0.6
FOLR1	"FOLR, FRα"	ENSG00000110195	"Folate receptor alpha"	P15328	11	72189558-72196323	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 480.2;fallopian tube: 187.2;lung: 193.5;salivary gland: 219.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 496.8;Alveolar cells type 2: 213.3;Breast glandular cells: 211.3;Club cells: 276.3;Collecting duct cells: 318.2;Cytotrophoblasts: 462.2;Proximal tubular cells: 366.0;Syncytiotrophoblasts: 259.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 444.2;RPTEC TERT1: 476.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA	448000	140000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.1	1.7	2.7	0.2	1.8	0.1	28.3	11.8	1.8	123.5	480.2	0.5	0.3	1.9	7.6	3.4	187.2	2.4	0.6	14.1	4.1	153.0	0.2	193.5	0.0	5.7	7.8	0.7	7.1	17.5	8.1	36.2	3.8	1.5	0.4	0.5	219.5	15.2	0.1	2.5	0.4	0.2	3.2	0.2	33.0	0.2	7.7	0.2	45.9	0.0	0.4	0.1	0.1	2.7	0.2	0.2	0.0	0.2	0.0	0.0	64.7	0.1	0.1	0.1	0.1	44.5	46.0	0.0	45.5	0.8	0.0	0.9	2.4	2.1	0.2	0.1	1.4	1.0	444.2	1.3	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.5	0.1	0.1	2.2	0.7	0.0	0.5	15.1	0.0	476.5	0.0	0.1	3.0	1.4	7.1	0.1	38.5	65.7	0.5	0.0	0.0	8.4	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.8	11.8	1.8	14.1	4.1	5.7	7.8	3.8	3.2	7.7	2.7	1.0	496.8	213.3	0.0	1.3	0.9	7.9	80.3	0.0	0.0	211.3	62.9	0.2	34.3	276.3	318.2	0.0	462.2	1.1	0.0	133.1	14.3	0.1	33.6	2.3	3.4	1.8	0.0	0.0	1.4	110.9	4.3	9.7	33.7	5.1	0.0	0.0	0.0	29.5	0.0	0.0	0.1	87.5	0.0	0.4	0.0	0.6	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	6.3	0.0	366.0	149.1	0.1	0.0	0.1	6.3	0.0	0.5	3.2	0.1	259.0	2.2	0.3	0.3	10.4
FOXD3	"Genesis, HFH2"	ENSG00000187140	"Forkhead box D3"	Q9UJU5	1	63322567-63325128	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.2"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 5.4"	"Group enriched"	"Detected in some"	6	"melanoma: 9.9;testis cancer: 3.5"	"Region enriched"	"Detected in single"	4	"medulla oblongata: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 13.1;SK-MEL-30: 11.2;WM-115: 15.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 3.4"	"Group enriched"	"Detected in some"	13	"olfactory bulb: 8.6;spinal cord: 2.2"	CAB022455	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"			"CAB022455: "	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.33e-3)"		"unprognostic (4.63e-2)"	"unprognostic (7.79e-2)"		"unprognostic (8.22e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.28e-1)"		"unprognostic (3.00e-2)"	"unprognostic (8.56e-2)"		"unprognostic (5.83e-2)"	0.4	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.8	0.0	5.2	0.2	0.2	0.0	0.4	0.4	0.1	1.6	0.0	0.0	0.1	0.1	0.0	0.0	1.9	0.1	0.2	0.1	0.0	0.1	0.0	0.4	1.4	0.2	0.0	0.4	0.5	1.4	0.6	1.3	0.1	0.2	0.0	1.1	1.5	0.0	0.0	0.2	0.2	0.0	1.5	1.5	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.3	0.0	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.7	0.0	11.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.0	0.3	0.2	0.3	0.0	0.0	0.0	0.2	0.0
FOXJ1	"FKHL13, HFH-4, HFH4"	ENSG00000129654	"Forkhead box J1"	Q92949	17	76136333-76141245	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 43.4;choroid plexus: 80.1;fallopian tube: 53.2"	"Group enriched"	"Detected in many"	8	"Endometrial ciliated cells: 234.7;Respiratory ciliated cells: 124.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 29.9;CAPAN-2: 25.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 43.1"	HPA005714	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA005714: AB_1078902"	"prognostic favorable (9.39e-4)"	"unprognostic (4.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.71e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-1)"	0.0	0.0	12.2	0.1	12.7	0.3	0.0	13.0	10.8	6.6	80.1	0.6	0.3	2.2	0.5	0.3	53.2	0.0	0.0	14.6	18.3	3.4	0.0	10.4	0.0	36.7	43.4	0.2	0.9	0.0	2.2	0.0	25.2	0.5	0.2	0.4	0.1	2.5	0.4	0.8	0.2	0.0	23.3	0.0	0.5	16.7	22.6	0.2	3.0	0.0	0.0	0.9	0.1	14.9	0.0	0.5	1.7	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	3.1	25.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	12.2	12.7	13.0	10.8	14.6	18.3	36.7	43.4	25.2	23.3	22.6	14.9	2.2	9.6	3.1	1.0	2.3	0.8	1.0	4.4	0.0	0.4	5.6	4.2	0.9	1.5	12.0	9.2	4.2	0.2	4.8	1.0	0.0	0.6	21.4	234.7	4.5	0.7	1.8	3.0	0.0	0.0	0.6	1.6	4.1	10.7	1.3	0.1	0.4	0.0	0.1	0.0	0.1	3.2	4.1	0.6	0.0	19.1	0.3	1.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.8	0.4	1.3	0.5	0.2	3.5	124.0	8.7	0.0	1.8	3.5	20.7	2.0	0.8	0.9	0.3	3.5	1.1	2.3	0.7
FOXL1	"FKH6, FKHL11, FREAC7"	ENSG00000176678	"Forkhead box L1"	Q12952	16	86576368-86583478	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Pancreatic endocrine cells: 10.4;Peritubular cells: 7.9;Sertoli cells: 6.6;Smooth muscle cells: 4.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.4;CAPAN-2: 31.9;hTEC/SVTERT24-B: 21.2;PC-3: 46.7;REH: 27.9;U-87 MG: 86.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"spinal cord: 5.0"							NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.21e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.79e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.36e-8)"	"unprognostic (1.50e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.17e-3)"	1.4	0.4	0.4	0.7	0.6	0.0	0.7	0.3	0.6	0.9	0.9	2.0	2.5	0.6	0.3	0.2	1.0	4.2	2.3	0.3	0.4	1.9	0.2	1.5	0.1	0.4	0.4	0.5	0.1	0.0	0.6	0.0	0.4	1.0	1.9	0.0	0.6	0.3	2.7	0.5	2.6	0.3	0.3	0.0	2.7	1.0	0.5	0.1	0.6	1.3	0.0	3.5	0.9	0.3	2.0	0.2	0.1	0.0	3.1	10.5	0.0	7.9	24.4	6.2	2.3	0.0	31.9	0.0	1.9	2.0	3.0	0.9	0.0	2.3	7.4	0.0	0.1	0.0	7.5	0.0	3.0	0.0	0.0	2.5	0.8	21.2	5.3	2.5	3.1	0.0	0.0	0.1	3.1	0.0	0.1	0.0	0.3	0.7	46.7	27.9	1.7	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	5.7	11.3	0.0	17.6	4.7	0.0	0.0	2.2	86.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	0.6	0.3	0.4	0.4	0.4	0.4	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	7.9	0.0	0.2	0.0	0.0	0.1	0.0	6.6	0.4	4.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3
FOXP3	"AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID"	ENSG00000049768	"Forkhead box P3"	Q9BZS1	X	49250438-49270477	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.2;lymphoid tissue: 7.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hepatocytes: 1.4;Horizontal cells: 3.3;Melanocytes: 1.8;T-cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	11	"T-reg: 53.3"	"Lineage enriched"	"Detected in single"	394	"T-cells: 53.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.9;MCF7: 5.2;SiHa: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026301, HPA045943"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB026301: , HPA045943: AB_2679508"	"unprognostic (2.46e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (4.95e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (2.55e-4)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.73e-14)"	"unprognostic (5.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-1)"	0.2	0.2	0.9	7.4	0.7	1.3	0.7	1.5	0.8	0.4	0.0	0.6	0.7	0.2	7.2	1.2	0.2	1.6	0.2	0.8	0.6	0.3	2.4	0.9	6.1	0.7	0.7	0.4	0.2	0.4	0.5	0.1	0.8	0.6	0.7	0.7	1.1	0.8	0.3	2.3	1.9	0.3	0.5	2.4	1.6	1.3	0.8	7.2	0.6	0.1	5.2	2.8	0.3	0.7	0.1	0.3	0.2	0.9	0.1	0.0	1.1	0.2	0.2	0.1	0.4	0.8	0.2	0.6	0.3	0.5	0.6	0.3	0.8	0.0	0.1	2.9	0.5	0.2	0.3	0.2	0.4	0.3	0.4	0.1	0.8	0.9	1.7	0.0	0.0	0.9	0.9	0.7	0.0	5.2	0.1	0.3	0.8	0.1	0.7	0.4	0.3	0.2	0.2	0.2	0.6	0.5	4.7	0.5	2.0	0.5	1.5	0.8	0.8	0.3	1.4	0.5	0.1	0.4	1.1	0.4	0.2	0.8	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	4.7	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	53.3	1.3	0.9	0.7	1.5	0.8	0.8	0.6	0.7	0.7	0.8	0.5	0.8	0.7	0.1	0.0	0.6	0.3	0.4	0.5	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.1	0.0	1.4	0.1	3.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.8	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.0	0.4	0.0	5.3	0.2	0.0	0.0
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844303-31845604	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Peritubular cells: 56.8;Sertoli cells: 131.5;Smooth muscle cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;hTERT-RPE1: 13.1;RH-30: 10.9;U-2 OS: 14.1;U-251 MG: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	4.5	1.6	2.4	1.4	2.4	0.0	2.8	2.6	3.8	3.7	1.7	1.4	0.3	3.9	2.4	1.0	1.9	2.0	9.7	2.2	2.3	5.4	0.8	5.3	2.5	2.6	2.5	2.0	0.9	0.6	2.3	4.8	2.7	2.4	0.6	0.0	1.1	3.1	1.7	1.5	1.4	1.2	2.2	3.0	1.2	5.5	2.6	1.0	3.5	1.7	0.9	2.6	2.4	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.9	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	14.1	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.4	2.6	3.8	2.2	2.3	2.6	2.5	2.7	2.2	2.6	2.3	4.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	1.1	2.6	0.0	0.0	0.0	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.9	4.9	5.0	0.2	1.8	8.4	0.0	0.0	0.0	0.0	0.0	5.7	0.0	56.8	0.0	0.1	0.0	0.0	0.0	0.1	131.5	0.4	31.5	0.6	0.5	0.1	0.3	0.3	0.1	6.6	0.0	0.1
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.0;Hofbauer cells: 12.7;Kupffer cells: 18.8;Late spermatids: 26.8;Macrophages: 61.3;monocytes: 23.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1187.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1187.9"	"Cell line enriched"	"Detected in some"	20	"U-937: 32.7"	"Not detected"	"Not detected"							HPA029154	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	13.6	1.2	0.3	56.1	0.6	16.6	0.6	0.3	2.6	0.5	0.9	0.8	1.0	0.5	0.1	1.8	1.8	5.9	0.9	0.3	0.3	0.4	4.9	9.4	1.9	0.6	0.5	1.5	2.3	0.3	0.2	7.6	0.9	0.4	0.5	0.1	0.5	0.3	0.3	0.4	1.3	6.7	0.3	17.2	0.7	2.4	1.2	1.6	0.7	4.2	0.8	15.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.9	32.7	0.0	3.6	122.0	5.8	0.2	122.7	0.7	0.1	0.2	0.2	16.6	0.2	0.1	0.2	1187.9	0.2	85.0	3.3	0.1	46.0	0.3	0.6	0.3	2.6	0.3	0.3	0.6	0.5	0.9	0.3	1.2	0.5	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	9.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	5.1	0.0	0.4	0.4	12.7	0.0	0.0	0.0	0.0	18.8	0.8	26.8	0.0	61.3	0.0	0.0	23.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0
FPR3	"FMLPY, FPRH1, FPRL2, RMLP-R-I"	ENSG00000187474	"Formyl peptide receptor 3"	P25089	19	51795157-51826190	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.2"	"Group enriched"	"Detected in some"	15	"Hofbauer cells: 56.5;Kupffer cells: 97.4;Langerhans cells: 223.6;Macrophages: 66.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"classical monocyte: 2.3;intermediate monocyte: 6.7;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	44	"dendritic cells: 2.4;monocytes: 6.7"	"Group enriched"	"Detected in some"	5	"HEL: 10.0;hTERT-RPE1: 2.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (1.96e-1)"	"unprognostic (4.28e-2)"	10.6	12.1	0.6	23.9	1.1	0.4	5.3	0.5	2.4	5.5	2.2	12.6	11.2	3.7	1.5	5.7	2.0	18.8	3.8	0.6	0.7	3.2	21.3	28.2	13.9	3.1	1.0	1.7	2.3	2.2	0.9	5.6	2.8	2.5	18.2	0.3	2.4	2.9	0.9	2.7	14.4	8.9	1.2	16.3	7.1	2.7	6.0	8.1	2.2	2.0	11.0	17.4	1.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.6	1.1	0.5	2.4	0.6	0.7	3.1	1.0	2.8	1.2	6.0	3.9	0.5	0.0	1.7	0.3	2.7	5.6	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.0	2.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	1.1	1.5	56.5	0.0	0.2	0.0	0.0	97.4	223.6	0.2	0.3	66.6	7.2	1.0	3.7	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.4	0.1	0.0	0.0	1.5	0.1	0.0	0.3	0.5	0.0	0.1	0.4	4.5	0.8	0.6	0.0	0.0	0.1
FTCDNL1	FONG	ENSG00000226124	"Formiminotransferase cyclodeaminase N-terminal like"	E5RQL4	2	199760544-199851192	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Excitatory neurons: 43.5;Oligodendrocytes: 115.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA065748			Approved	Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA065748: "	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (3.92e-2)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.21e-2)"	2.4	4.9	4.4	0.9	7.9	2.3	2.1	5.4	5.5	0.6	1.8	1.1	1.0	0.4	1.8	1.3	1.9	0.9	2.9	4.5	4.8	4.2	10.0	1.4	2.0	6.1	6.7	1.0	2.2	1.5	0.9	0.6	5.7	1.2	1.1	1.4	2.4	0.6	8.1	1.2	0.8	1.1	6.1	4.6	0.9	1.0	6.0	0.7	5.7	8.4	0.8	0.7	0.9	7.6	0.6	1.9	0.1	0.0	1.9	1.1	1.4	0.7	0.7	1.0	0.4	0.0	3.5	2.0	0.2	0.8	5.7	0.0	0.9	5.3	1.2	2.3	0.5	1.5	0.8	1.7	0.7	5.5	6.5	0.8	0.2	0.4	0.1	0.7	0.0	4.9	2.7	0.1	0.7	6.0	1.9	2.1	1.6	0.5	4.0	0.3	0.2	0.0	0.4	0.0	2.3	0.0	3.4	3.2	3.2	1.3	4.8	7.1	0.6	2.7	0.0	1.8	1.1	4.7	2.9	1.1	5.2	2.7	1.3	0.0	4.1	1.7	0.4	5.5	1.7	3.4	1.7	0.6	5.8	2.1	1.1	1.8	0.0	1.1	5.1	8.7	0.0	1.4	4.4	7.9	5.4	5.5	4.5	4.8	6.1	6.7	5.7	6.1	6.0	7.6	0.8	0.0	0.0	39.8	3.2	2.7	2.9	0.0	13.6	3.3	6.2	5.5	5.7	4.3	1.3	3.7	4.2	1.5	3.3	0.3	1.9	0.2	2.4	8.4	0.8	1.5	0.0	5.9	43.5	0.7	1.4	1.4	4.6	3.3	0.0	5.9	2.2	6.9	7.4	1.7	23.5	1.2	0.0	8.1	4.7	1.0	0.3	8.2	7.2	17.8	2.1	1.7	0.0	24.6	115.4	0.3	0.1	0.4	1.4	2.6	1.0	10.6	0.0	6.5	0.0	2.4	3.4	0.4	2.0	6.9	2.3	0.3	1.5	10.3	1.1	1.2
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
FXYD7		ENSG00000221946	"FXYD domain containing ion transport regulator 7"	P58549	19	35143250-35154302	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 273.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.0;Excitatory neurons: 42.0;Inhibitory neurons: 12.9;Microglial cells: 9.4;T-cells: 19.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2;ovarian cancer: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 52.1"	"Group enriched"	"Detected in many"	23	"B-cells: 19.0;NK-cells: 52.1;T-cells: 23.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HMC-1: 5.3;Karpas-707: 2.0;NTERA-2: 1.5;WM-115: 3.1"									HPA026916	Approved					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA026916: AB_1849217"	"unprognostic (1.25e-3)"	"unprognostic (8.73e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.95e-4)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	2.1	0.4	119.1	1.7	140.3	0.6	1.1	45.1	273.1	5.8	37.8	2.7	0.6	1.9	0.0	0.4	0.9	0.4	0.7	153.8	75.1	0.4	1.1	1.1	2.8	124.3	83.1	1.0	0.2	0.0	2.1	0.1	129.5	1.0	0.2	1.6	0.5	0.3	2.7	1.3	2.0	0.2	70.1	2.8	1.0	1.3	101.6	0.2	0.5	0.1	1.5	0.8	3.1	185.5	0.6	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.2	1.8	0.0	0.2	0.3	0.1	0.2	0.6	0.0	0.1	0.0	5.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.5	2.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.2	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.1	0.0	0.0	0.0	15.0	0.0	9.5	19.0	23.7	17.2	0.1	14.6	7.5	13.8	0.6	52.1	0.1	1.3	7.5	4.9	119.1	140.3	45.1	273.1	153.8	75.1	124.3	83.1	129.5	70.1	101.6	185.5	1.1	0.0	1.3	7.2	8.0	2.0	0.1	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	1.8	0.0	0.0	14.0	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.4	42.0	0.2	0.1	1.1	0.0	0.0	1.3	0.1	0.7	0.2	0.1	1.7	12.9	0.0	0.0	0.0	4.4	0.2	1.2	0.7	3.6	9.4	0.2	1.5	0.0	3.5	6.2	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	6.6	0.7	1.1	3.1	5.0	0.1	1.1	0.3	19.2	0.0	0.0	0.0
FZD2		ENSG00000180340	"Frizzled class receptor 2"	Q14332	17	44557484-44561262	"Cancer-related genes, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 10.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Kupffer cells: 9.8;Leydig cells: 23.3;Peritubular cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;myeloid DC: 1.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 53.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057667	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"HPA057667: AB_2683497"	"unprognostic (6.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.6	1.0	1.4	1.5	0.2	1.3	0.9	1.2	5.9	10.5	1.8	0.9	5.3	1.3	0.9	3.8	1.8	2.8	1.1	1.3	2.8	0.2	2.9	0.8	1.3	1.9	3.3	1.5	2.1	1.1	3.6	2.0	1.7	0.4	0.7	1.0	1.9	0.4	0.6	1.6	1.5	1.3	2.1	1.2	1.5	1.4	0.3	2.4	0.7	0.7	2.0	2.5	1.6	12.9	37.7	38.3	13.8	8.7	6.4	0.4	39.5	30.4	53.4	38.2	28.4	6.2	0.0	8.9	13.9	13.1	5.5	3.6	2.8	30.2	2.9	7.2	1.7	6.6	0.1	7.7	0.2	7.5	10.7	2.8	9.6	8.8	40.8	1.8	4.9	2.5	0.3	20.9	5.9	6.7	3.6	26.8	0.1	6.7	18.1	8.6	1.9	7.7	0.6	3.8	10.9	5.2	1.1	2.3	32.4	14.6	8.4	0.7	24.1	17.5	4.4	22.6	0.8	0.7	3.0	4.0	2.4	11.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	1.0	1.5	0.9	1.2	1.1	1.3	1.3	1.9	2.0	1.3	1.4	1.6	0.5	19.2	0.0	1.6	0.6	0.6	0.3	0.9	0.0	0.0	0.9	2.9	1.9	0.0	0.2	1.8	0.0	1.6	1.8	0.0	0.0	0.3	0.6	1.1	8.4	0.7	1.2	1.3	0.0	1.8	0.5	5.9	0.0	1.5	0.0	1.4	0.7	0.0	4.8	0.0	0.0	0.3	0.0	9.8	6.0	0.4	23.3	5.6	0.0	6.5	6.2	6.0	0.0	0.0	0.2	0.7	0.0	18.0	0.3	0.1	0.0	0.3	0.2	0.4	0.0	0.4	5.3	0.3	1.2	0.3	0.4	2.3	0.2	2.4	0.0	0.0
GAB1	DFNB26	ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 162.7;Microglial cells: 192.0;Oligodendrocyte precursor cells: 288.0;Oligodendrocytes: 1013.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center, Plasma membrane"	Cytosol	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	7.9	8.6	23.3	6.7	69.9	11.5	9.9	35.5	30.0	10.6	2.5	19.7	12.1	18.1	14.2	20.4	9.2	12.5	30.5	20.4	34.6	13.9	9.1	17.9	6.1	57.3	45.4	19.5	8.1	11.3	4.3	21.0	47.9	8.5	22.8	6.9	8.9	14.7	13.4	10.7	12.3	17.7	26.4	7.5	11.3	9.2	45.7	5.4	7.5	16.5	8.7	7.1	9.7	114.8	6.7	1.4	16.7	12.1	8.3	7.9	22.0	4.6	15.2	5.4	9.4	12.8	11.2	0.2	1.4	6.5	3.7	3.8	16.2	5.3	6.2	1.0	3.9	12.2	3.7	6.1	5.7	1.6	2.3	9.7	9.5	6.6	4.3	11.5	7.2	0.2	4.1	21.7	3.8	9.7	0.9	0.0	4.8	3.5	5.3	74.6	8.2	8.8	8.4	8.0	3.9	11.8	3.1	13.3	5.6	11.2	8.5	1.6	5.5	6.9	5.4	3.4	3.5	34.6	18.2	26.3	4.7	4.8	5.7	4.1	0.4	0.5	0.0	0.5	0.2	0.9	0.0	0.0	0.5	1.8	0.0	0.0	2.6	5.0	1.7	2.2	0.0	0.3	23.3	69.9	35.5	30.0	20.4	34.6	57.3	45.4	47.9	26.4	45.7	114.8	13.4	28.9	19.0	89.5	13.1	20.3	8.8	3.3	12.0	2.1	11.6	8.9	34.0	8.6	5.3	12.9	0.0	23.5	10.9	26.2	0.0	6.6	0.9	8.8	9.3	16.3	22.2	40.8	162.7	2.6	10.6	14.4	11.2	21.6	2.5	9.6	13.9	7.0	6.1	3.3	62.2	27.8	4.1	11.6	10.2	3.8	20.8	8.8	16.0	192.0	5.6	15.4	1.0	288.0	1013.6	4.9	10.7	18.8	94.4	7.2	9.3	5.4	3.4	0.8	13.1	7.0	14.3	2.0	5.3	19.9	24.9	10.4	2.7	4.4	13.6	13.5
GABARAPL2	"ATG8, ATG8C, GATE-16, GATE16, GEF2"	ENSG00000034713	"GABA type A receptor associated protein like 2"	P60520	16	75566375-75577881	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036726	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA036726: AB_10672476"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.58e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.95e-8)"	"unprognostic (3.11e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.85e-1)"	129.2	166.9	269.1	68.0	278.1	101.6	122.3	297.7	310.8	105.9	237.2	118.5	67.1	101.3	158.1	91.9	106.0	84.1	279.9	259.7	294.9	153.8	113.6	111.3	94.7	280.8	278.4	108.7	81.4	209.5	169.0	113.8	289.2	113.7	81.4	201.4	100.8	102.2	262.9	135.0	90.1	98.6	306.0	112.0	99.7	78.3	282.4	102.1	124.5	186.7	98.9	95.3	104.8	320.2	103.4	85.9	142.7	67.7	217.1	189.9	72.6	118.2	169.9	158.0	176.4	79.8	129.1	148.1	143.0	135.3	95.2	86.6	107.6	110.6	193.9	64.8	208.7	86.9	72.2	119.1	118.2	84.1	151.3	132.0	153.5	133.3	98.6	143.0	130.5	130.5	130.3	58.4	160.2	145.7	125.4	161.0	85.8	114.5	95.8	139.4	69.0	179.6	166.2	66.4	167.7	175.5	184.7	43.7	177.4	113.3	140.1	130.4	119.5	67.9	104.7	100.0	64.5	166.2	172.8	310.6	163.6	80.6	102.6	345.1	148.8	370.8	128.4	140.3	163.0	215.0	135.2	146.8	176.8	199.0	121.4	114.6	502.5	115.3	157.0	274.1	208.1	241.5	269.1	278.1	297.7	310.8	259.7	294.9	280.8	278.4	289.2	306.0	282.4	320.2	341.0	86.6	136.2	30.7	163.9	274.9	278.8	311.4	141.7	247.9	196.5	236.2	361.4	145.8	212.5	174.7	45.9	251.3	188.5	201.5	686.7	183.9	48.2	209.6	112.8	270.1	277.8	457.6	37.0	175.4	120.6	203.5	80.5	162.4	110.1	85.9	239.8	128.5	223.9	307.9	39.6	156.4	297.0	169.6	428.8	59.7	243.5	197.2	257.9	21.5	404.6	491.0	145.2	27.6	63.6	223.6	237.0	261.1	137.5	306.1	195.7	552.4	263.0	208.1	157.8	182.1	187.9	288.1	219.9	136.6	273.9	390.1	159.3	182.5	121.2	328.6
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168617	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 27.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 37.2;Microglial cells: 23.4;Oligodendrocyte precursor cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 4.5;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.6;plasmacytoid DC: 4.7"	"Group enriched"	"Detected in many"	29	"dendritic cells: 4.7;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	4.3	4.9	9.2	3.9	9.3	0.7	3.7	8.4	12.6	11.0	7.6	6.1	3.8	9.1	3.1	7.8	6.0	5.6	5.0	9.1	9.5	1.4	0.9	5.2	2.9	13.4	9.5	6.3	1.4	3.0	4.2	5.1	10.1	4.8	6.3	0.5	25.6	3.6	1.9	27.7	5.0	9.9	10.7	2.7	2.4	4.8	15.9	22.3	1.9	1.9	3.2	6.7	10.6	13.1	0.1	0.9	5.4	2.3	4.7	9.6	10.9	3.2	3.2	1.8	2.6	0.6	0.2	1.1	0.7	10.4	3.3	12.2	0.3	1.8	0.6	0.1	0.6	0.4	0.2	0.4	3.4	0.3	2.7	11.7	4.6	5.5	0.6	4.0	3.7	4.3	1.6	0.2	3.4	0.4	4.2	0.2	1.9	11.5	1.3	2.7	2.4	0.2	0.0	0.4	0.3	2.2	1.0	0.0	6.7	1.0	0.0	0.3	3.4	0.3	1.6	0.5	0.1	0.2	0.2	2.5	1.9	0.4	43.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	4.5	0.3	0.0	0.1	15.0	4.6	0.3	0.2	0.1	4.7	1.3	2.2	9.2	9.3	8.4	12.6	9.1	9.5	13.4	9.5	10.1	10.7	15.9	13.1	0.7	0.0	0.5	2.9	0.1	4.2	2.0	3.3	7.4	0.0	2.2	2.4	1.0	1.5	0.9	0.0	0.0	0.3	0.3	1.5	0.0	0.6	0.2	0.2	2.1	1.2	0.0	2.7	0.5	0.0	0.4	7.5	0.0	0.3	0.0	1.2	1.4	0.0	37.2	0.0	0.3	1.3	4.1	1.3	0.8	0.0	4.7	9.6	5.4	23.4	0.7	0.4	0.0	24.6	0.5	0.3	2.5	5.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	3.7	3.3	0.6	0.3	4.2	8.1	0.8	0.7	0.1	4.1	1.4
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 68.4;Kupffer cells: 72.1;Late spermatids: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 84.3;HMC-1: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	NA	NA		53000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	15.0	17.2	20.0	14.9	23.3	23.2	13.3	22.1	26.1	12.0	20.8	15.1	33.3	11.1	12.2	6.6	20.7	18.4	13.5	18.5	21.6	21.3	12.1	23.9	11.7	23.0	22.6	15.8	10.8	9.4	9.8	16.8	23.9	14.3	17.3	18.4	8.1	9.3	8.0	9.1	34.4	9.6	22.3	15.4	16.4	24.0	20.8	9.7	24.5	12.9	7.9	13.6	7.5	30.6	0.0	19.5	7.2	0.0	23.8	21.3	0.0	9.1	17.9	8.3	9.9	10.8	84.3	5.3	26.4	8.7	0.0	1.3	0.0	1.0	10.2	2.7	0.6	29.8	0.7	0.0	19.5	0.1	78.4	20.7	6.6	5.6	0.0	3.4	22.6	0.0	10.0	3.9	14.4	1.9	0.0	4.5	6.5	35.4	2.2	0.0	0.5	0.3	13.4	7.8	6.7	15.6	24.6	4.0	0.2	17.2	20.4	20.5	19.7	0.0	12.9	5.6	0.2	4.2	8.0	0.0	2.3	6.8	19.2	25.3	15.2	34.2	11.1	16.6	24.0	2.5	8.3	10.8	8.9	1.2	6.0	7.0	11.9	16.3	13.4	1.6	5.3	11.7	20.0	23.3	22.1	26.1	18.5	21.6	23.0	22.6	23.9	22.3	20.8	30.6	11.3	25.6	19.0	26.8	8.0	8.4	5.6	9.4	3.4	10.1	9.1	5.2	9.2	10.0	8.9	14.7	12.5	6.2	27.6	15.3	3.9	9.8	51.6	17.3	10.9	11.4	6.1	13.7	17.8	11.4	12.7	15.2	7.7	5.8	68.4	15.9	18.2	6.1	26.6	3.3	21.2	10.2	4.1	72.1	11.8	77.9	16.1	25.0	10.6	8.4	26.7	7.3	40.2	33.2	42.6	14.1	20.0	10.1	9.3	6.1	15.9	6.7	22.1	10.4	0.0	9.8	10.6	14.9	10.0	3.5	11.5	6.6	21.2	12.9	16.7	7.9
GALNT1	GalNAc-T1	ENSG00000141429	"Polypeptide N-acetylgalactosaminyltransferase 1"	Q10472	18	35581117-35711834	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 331.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012628	Uncertain				"Intracellular and membrane"	NA	NA		2600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA012628: AB_1849439"	"unprognostic (9.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.60e-2)"	28.9	20.6	11.9	27.4	12.1	26.0	37.2	12.3	14.2	26.5	15.1	42.8	42.9	19.4	19.7	57.6	15.9	28.9	23.8	10.9	14.4	17.4	45.9	23.3	33.5	13.1	13.2	16.9	24.6	12.2	13.5	52.0	13.5	25.4	41.1	17.1	46.8	18.0	29.0	52.4	49.3	22.7	13.1	25.4	27.1	16.9	13.1	18.6	30.0	37.3	40.8	70.5	27.0	13.9	32.5	34.9	40.5	37.6	78.5	74.0	53.4	33.2	35.4	30.3	27.4	21.0	61.9	38.3	34.9	36.0	28.7	24.4	20.2	63.8	48.1	45.0	18.5	48.7	62.8	48.8	39.2	106.6	62.1	50.7	59.7	47.6	52.1	90.1	331.4	30.8	14.8	49.3	118.9	26.1	31.6	40.5	41.6	33.5	16.4	38.9	53.0	18.5	124.8	148.9	21.8	42.9	59.4	43.0	36.2	77.1	32.9	82.8	116.3	55.7	22.5	37.0	37.1	70.1	35.7	72.5	39.1	72.1	29.5	7.2	3.4	7.6	3.2	4.5	3.6	4.1	2.2	2.9	4.0	2.4	2.0	3.0	4.3	4.6	6.6	4.4	2.5	1.4	11.9	12.1	12.3	14.2	10.9	14.4	13.1	13.2	13.5	13.1	13.1	13.9	85.6	80.1	44.1	35.9	33.4	29.8	28.4	28.8	22.2	31.3	77.2	43.8	43.3	48.6	39.9	16.5	12.5	31.0	44.8	109.1	7.9	42.6	1.4	77.6	44.7	41.7	38.9	30.9	57.5	39.9	92.7	49.8	26.0	73.0	20.3	51.7	35.7	71.3	77.9	85.8	56.3	59.0	16.2	58.8	37.1	2.9	19.0	56.7	19.6	57.1	41.3	105.9	28.8	54.3	56.8	58.5	51.4	18.0	36.7	54.4	76.8	22.0	33.5	28.5	13.1	55.2	28.7	6.5	12.2	26.3	82.1	33.2	33.7	50.3	85.3	52.8
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 65.8"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 74.0;Oligodendrocyte precursor cells: 156.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 284.9;TIME: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	12.1	15.6	10.7	14.4	14.5	19.3	13.5	12.1	10.0	24.1	33.0	16.1	14.4	6.3	6.0	4.9	14.6	16.7	9.0	9.5	12.5	9.7	4.4	15.5	9.9	16.1	13.9	65.8	9.8	13.6	11.5	4.7	12.3	9.1	14.7	7.8	13.5	3.7	5.4	6.0	12.6	11.6	9.9	15.8	22.0	4.5	13.9	7.8	16.6	8.2	9.4	11.1	5.2	12.6	25.6	85.3	20.3	17.8	42.2	37.3	15.6	71.7	39.9	27.9	26.7	12.1	56.7	16.6	49.3	121.4	49.9	4.4	9.4	56.0	25.4	43.2	6.7	45.4	16.0	16.5	32.4	9.9	42.3	46.7	12.9	22.7	33.2	284.9	54.4	12.5	10.5	50.9	48.4	26.4	1.1	6.8	8.0	71.1	17.3	5.1	10.7	16.6	38.6	17.1	2.7	6.6	31.8	117.0	9.4	29.6	45.6	7.4	161.2	67.5	15.9	16.8	77.7	14.5	15.0	8.7	44.2	19.3	21.1	2.0	1.2	2.4	3.1	1.6	2.8	1.9	1.8	2.0	1.4	2.1	0.8	2.1	2.5	1.9	1.8	1.1	1.6	1.0	10.7	14.5	12.1	10.0	9.5	12.5	16.1	13.9	12.3	9.9	13.9	12.6	17.4	9.6	46.4	32.7	17.4	4.8	3.9	5.6	1.8	4.6	12.4	8.6	5.0	5.7	8.7	14.7	4.2	0.7	27.7	23.0	9.8	9.1	10.3	12.4	7.4	14.1	3.0	21.4	14.3	30.1	1.5	13.7	30.5	22.3	10.2	10.5	23.9	5.3	8.5	0.0	15.9	20.4	6.1	19.5	7.8	22.5	38.2	12.4	0.0	74.0	11.9	17.4	44.3	156.9	66.9	36.8	13.6	50.0	15.4	8.2	15.3	2.7	0.7	10.5	6.6	5.6	7.8	2.0	4.0	1.2	3.7	0.8	21.7	27.3	12.2	4.2
GALNT11	GalNAc-T11	ENSG00000178234	"Polypeptide N-acetylgalactosaminyltransferase 11"	Q8NCW6	7	152025674-152122340	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Notch signaling pathway"	"Glycosyltransferase, Transferase"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 408.0;kidney: 229.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 131.1;Inhibitory neurons: 130.7;Proximal tubular cells: 196.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039330	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039330: AB_10795249"	"unprognostic (6.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.24e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.51e-2)"	32.4	25.4	27.9	15.2	30.7	12.7	29.0	24.1	29.3	23.7	408.0	21.9	14.5	23.8	24.6	26.3	22.4	26.1	26.4	39.1	25.1	229.5	19.9	27.5	16.1	20.8	23.9	28.1	84.1	58.0	24.4	45.8	21.6	32.3	17.6	40.6	22.8	25.6	28.4	23.8	15.0	24.2	16.9	20.5	22.0	11.8	30.3	23.8	34.4	26.0	17.8	24.2	24.0	27.0	28.9	25.4	36.8	41.2	83.1	81.3	37.7	22.6	25.6	18.6	17.4	20.7	29.7	0.1	57.8	36.8	51.8	13.3	17.6	31.9	22.8	23.5	26.3	5.8	23.4	18.2	27.3	26.2	29.3	72.1	40.3	15.5	13.0	32.3	34.1	19.9	29.5	0.2	47.0	24.9	22.7	23.6	30.4	45.1	20.2	0.1	16.1	0.9	61.1	43.8	32.6	43.3	37.5	18.0	31.0	39.0	26.8	22.3	31.1	24.8	8.8	31.6	25.1	8.4	11.4	0.5	51.6	25.1	86.6	10.2	12.7	13.5	28.1	15.2	27.8	9.5	15.4	25.8	13.0	5.7	13.1	19.9	6.6	26.2	21.3	4.0	12.7	14.4	27.9	30.7	24.1	29.3	39.1	25.1	20.8	23.9	21.6	16.9	30.3	27.0	28.7	12.8	25.2	44.4	12.9	10.5	24.6	20.5	13.1	123.9	23.5	20.7	30.7	15.7	16.1	35.0	27.1	84.0	49.1	8.7	60.7	17.8	4.8	31.5	38.8	22.8	22.8	7.8	131.1	18.7	13.5	33.8	11.7	57.1	14.5	26.0	22.1	15.8	25.3	75.7	130.7	10.0	8.2	19.7	12.5	3.5	19.9	21.7	17.8	46.9	18.0	37.8	43.3	54.3	42.0	13.0	8.3	36.1	20.3	26.3	9.6	196.7	21.2	39.4	0.0	36.3	25.0	38.7	27.5	24.7	11.8	36.3	29.1	24.3	9.3	19.1
GALNT16	"GalNAc-T16, GALNTL1, KIAA1130"	ENSG00000100626	"Polypeptide N-acetylgalactosaminyltransferase 16"	Q8N428	14	69259277-69357033	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.8;heart muscle: 45.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.6;Cardiomyocytes: 46.7;Excitatory neurons: 27.6;Fibroblasts: 24.0;Inhibitory neurons: 23.8;Smooth muscle cells: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.5;ASC diff: 11.7;hTEC/SVTERT24-B: 17.0;hTERT-RPE1: 17.2;SCLC-21H: 8.7;U-2 OS: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059136, HPA075325"	Approved		Approved	Vesicles,Cytosol		NA	NA		370000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Cytosol"		"HPA059136: AB_2683919, HPA075325: "	"unprognostic (9.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.62e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (5.23e-6)"	"unprognostic (5.38e-3)"	"unprognostic (3.34e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.96e-5)"	14.4	11.6	25.7	2.0	24.4	0.1	12.0	14.7	28.4	7.6	6.5	6.5	2.2	7.3	2.8	3.6	5.6	3.4	45.0	27.0	35.5	7.7	2.0	3.4	3.2	19.6	22.5	2.1	4.3	2.5	4.7	0.4	19.9	4.0	2.2	1.3	23.5	4.6	4.4	7.5	3.7	8.6	16.4	12.1	3.2	3.5	40.8	2.2	4.9	5.8	1.3	3.1	5.0	21.3	0.0	0.8	8.5	0.3	11.7	5.3	0.0	1.3	0.1	1.5	2.3	0.4	0.0	0.0	0.2	1.4	0.8	0.0	3.0	0.0	0.3	0.1	6.0	0.0	0.2	0.5	0.1	0.0	0.5	0.5	0.0	17.0	0.0	17.2	0.9	0.0	0.0	0.0	2.8	0.5	0.0	0.0	1.7	0.0	0.1	0.0	4.8	0.0	0.5	0.0	8.7	3.0	1.8	0.4	0.0	0.3	0.3	0.0	0.1	1.7	19.9	2.2	2.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	24.4	14.7	28.4	27.0	35.5	19.6	22.5	19.9	16.4	40.8	21.3	4.0	0.0	0.0	16.6	0.0	4.1	0.4	0.0	0.0	2.8	3.1	3.0	46.7	0.0	0.0	0.0	2.1	0.1	0.2	0.0	3.9	0.1	9.7	0.2	0.4	1.7	0.0	0.0	27.6	0.0	0.0	24.0	0.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	23.8	0.1	0.0	0.0	6.1	11.2	0.9	0.3	3.6	5.6	0.0	0.1	0.0	8.0	1.6	0.0	0.0	3.8	0.0	0.5	0.1	0.1	0.0	0.8	6.6	10.1	14.8	0.6	2.1	0.3	3.3	0.0	0.3	11.2	0.6	0.4
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.1;Excitatory neurons: 178.4;Inhibitory neurons: 184.7;Microglial cells: 48.7;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 165.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 5.3;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	3.1	6.0	5.7	0.3	5.7	0.0	4.4	11.6	6.0	6.0	2.0	2.9	1.8	7.4	5.2	4.4	5.4	3.7	11.3	6.9	5.2	2.1	1.8	2.4	1.3	4.7	4.5	4.5	2.1	6.6	2.0	1.4	5.8	6.2	1.9	1.3	5.0	4.0	1.5	2.8	1.8	6.7	4.6	1.8	1.8	2.9	4.2	0.6	5.7	1.8	1.3	4.6	3.3	11.2	0.5	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	1.0	1.2	0.3	0.0	1.0	0.1	0.4	0.6	1.8	0.0	0.1	0.0	0.8	0.0	1.9	1.2	0.4	0.4	0.1	0.1	1.5	0.0	0.0	1.5	0.7	1.9	0.8	0.7	0.1	0.5	0.0	0.3	0.4	5.3	1.6	0.1	1.1	3.4	1.9	2.5	1.2	3.9	0.8	2.7	0.4	0.6	0.9	0.0	0.0	0.2	1.0	0.0	0.4	2.3	2.4	1.0	0.4	0.5	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	5.7	5.7	11.6	6.0	6.9	5.2	4.7	4.5	5.8	4.6	4.2	11.2	1.3	0.0	0.0	77.1	0.5	2.7	1.7	0.4	2.8	8.0	3.1	4.3	6.8	4.3	2.0	3.7	0.0	0.6	0.2	0.9	1.9	0.3	2.2	1.0	21.1	1.5	1.2	0.4	178.4	0.6	0.1	4.8	5.6	1.2	0.0	2.4	1.8	2.5	0.8	1.7	184.7	0.8	0.0	1.3	1.9	1.0	7.5	1.3	1.8	48.7	0.0	4.0	0.0	45.2	165.3	0.4	1.6	3.4	0.5	3.3	0.6	1.8	0.1	1.0	0.0	7.1	4.0	3.5	3.9	2.7	2.0	0.3	0.7	1.0	0.8	1.2
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2099.3;liver: 2804.2;pancreas: 2935.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.4	21.4	133.9	12.4	138.4	1.8	25.4	152.5	216.5	9.9	94.3	19.6	175.5	8.4	10.5	25.1	11.6	47.7	57.2	131.1	140.9	2099.3	2804.2	7.3	18.4	148.0	135.4	165.2	2935.3	2.7	8.3	74.7	153.4	12.4	11.5	7.5	57.5	15.1	142.5	137.6	110.2	14.5	149.2	33.6	99.2	78.2	140.4	12.6	63.0	46.9	29.7	18.0	15.5	181.2	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	133.9	138.4	152.5	216.5	131.1	140.9	148.0	135.4	153.4	149.2	140.4	181.2	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 73.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.2;NK-cells: 75.2;Plasma cells: 22.9;T-cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 243.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.5;NB-4: 10.0;U-266/70: 20.7;U-937: 31.5"	"Low region specificity"	"Detected in many"							HPA028656	Supported					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"	3.7	3.3	0.4	73.9	0.5	34.9	4.6	0.4	1.7	3.1	1.5	6.9	5.8	2.3	1.4	2.6	3.1	11.5	2.0	0.4	0.5	2.0	11.1	19.1	54.4	2.9	0.7	2.7	1.1	0.7	1.0	2.8	1.2	2.3	8.0	0.2	4.8	1.2	0.7	1.0	9.0	6.1	0.5	42.7	9.2	4.0	0.8	12.4	2.3	0.9	23.3	12.7	1.4	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.7	1.2	1.2	0.0	0.1	0.1	6.5	5.3	2.6	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.9	0.6	3.0	0.3	0.0	0.0	10.0	1.4	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.6	1.3	0.1	0.0	0.0	4.0	0.1	0.5	0.5	0.0	2.2	20.7	0.5	0.1	0.2	31.5	0.0	0.9	15.3	1.1	97.5	38.0	150.4	4.8	63.1	89.3	6.7	6.0	23.2	35.8	97.9	53.4	44.9	0.7	243.8	38.4	0.4	0.5	0.4	1.7	0.4	0.5	2.9	0.7	1.2	0.5	0.8	0.7	2.1	6.4	5.1	0.0	12.4	0.0	0.2	0.5	0.6	0.0	0.4	0.4	0.7	1.5	4.2	0.0	4.2	0.1	39.2	0.1	0.0	0.0	0.4	3.7	0.4	2.8	0.0	0.8	0.0	1.1	0.0	1.5	2.0	3.9	10.8	0.2	4.6	0.6	4.0	0.0	0.7	0.0	0.0	18.9	1.4	0.2	0.0	17.1	0.0	2.8	10.4	2.9	75.2	0.0	0.0	1.3	0.0	0.0	22.9	0.4	0.0	0.3	8.0	0.4	0.0	0.9	0.9	0.1	2.9	0.9	0.0	0.1	72.9	11.0	0.1	0.1
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44143213-44198170	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 12.6;choroid plexus: 7.4;heart muscle: 8.8;liver: 21.5;pituitary gland: 23.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.3;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	0.8	0.3	8.9	0.3	8.3	0.2	0.7	8.1	9.5	2.8	7.4	0.5	0.1	1.2	0.8	0.4	1.2	0.5	8.8	8.2	11.0	1.2	21.5	0.4	0.2	9.0	9.9	1.4	1.8	0.1	23.9	1.6	9.1	1.2	0.2	1.0	0.3	0.7	0.2	0.7	0.5	0.3	8.3	0.6	0.6	0.4	12.6	0.1	0.5	0.1	0.2	1.1	2.0	7.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.2	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.3	2.3	0.7	0.1	0.1	0.3	2.0	0.4	0.8	0.1	0.0	0.1	0.0	0.3	8.9	8.3	8.1	9.5	8.2	11.0	9.0	9.9	9.1	8.3	12.6	7.9	0.3	0.0	0.0	0.7	0.3	1.1	0.7	0.0	1.2	5.0	0.1	0.8	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.5	2.4	0.0	1.8	0.0	0.2	5.2	0.0	0.0	0.0	2.4	0.0	0.4	0.7	5.0	2.4	0.0	0.0	0.0	0.7	0.3	0.9	0.1	0.0	1.0	0.0	2.8	0.0	0.5	1.0	0.1	0.1	2.2	0.2	1.7	0.0	0.1	0.0	0.8	0.0	0.6	3.7	0.5	1.1	0.0	0.1	0.8	0.3	0.5	0.0	0.7
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885199-93909456	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 48.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 207.9;Erythroid cells: 301.9;Prostatic glandular cells: 762.3;Urothelial cells: 374.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	12.2	13.1	5.4	6.6	4.7	15.0	6.6	5.1	5.4	4.5	5.6	6.2	19.2	3.6	4.0	6.6	14.3	14.1	4.7	4.7	7.5	11.3	48.5	5.9	4.6	6.4	6.9	2.8	7.7	6.7	3.4	10.3	7.1	5.6	5.5	3.6	4.5	5.9	16.0	3.0	12.7	3.6	5.1	6.8	5.7	3.2	5.7	5.0	16.8	11.8	10.1	6.9	3.7	6.1	37.7	58.6	6.4	12.6	20.9	13.0	24.4	43.7	27.3	32.8	24.3	9.9	21.7	14.2	84.8	28.8	106.7	37.3	9.6	18.0	26.2	38.6	12.7	98.9	37.4	42.8	39.1	36.8	15.2	16.1	6.7	67.0	10.7	13.2	36.4	16.0	40.0	20.5	24.0	7.3	26.8	8.5	21.5	36.0	27.4	12.3	19.0	20.9	23.6	43.4	14.8	6.1	41.3	32.2	15.4	71.8	7.2	22.7	38.4	34.1	20.1	64.5	66.7	18.1	25.0	14.7	28.2	20.4	12.2	2.1	0.3	0.7	2.6	0.2	1.5	1.3	2.5	3.4	0.3	2.0	1.5	1.6	1.5	2.3	0.3	1.0	0.7	0.7	5.4	4.7	5.1	5.4	4.7	7.5	6.4	6.9	7.1	5.1	5.7	6.1	28.7	41.7	19.1	16.0	14.6	11.5	207.9	33.2	24.5	24.8	24.2	34.2	16.4	61.5	29.0	29.5	6.2	63.5	39.3	21.7	25.4	25.1	3.9	66.3	27.6	55.5	52.5	301.9	32.0	12.3	19.6	44.5	15.8	50.1	19.7	17.3	31.4	102.4	19.9	33.7	30.7	19.9	22.4	20.7	51.4	4.0	21.5	32.0	8.8	15.0	9.3	21.2	34.0	11.1	11.6	24.2	8.0	12.4	21.6	762.3	47.2	65.1	64.3	13.1	0.0	48.4	37.1	32.0	36.7	33.5	9.2	45.0	34.1	26.5	17.8	374.9
GDAP1	"CMT2K, CMT4, CMT4A"	ENSG00000104381	"Ganglioside induced differentiation associated protein 1"	Q8TB36	8	74320613-74518007	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.9;Cone photoreceptor cells: 47.9;Excitatory neurons: 75.7;Horizontal cells: 47.1;Inhibitory neurons: 67.3;Oligodendrocyte precursor cells: 67.8;Rod photoreceptor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014266, HPA024334"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Cytosol	"HPA014266: AB_1849581, HPA024334: AB_1849583"	"unprognostic (3.19e-2)"	"unprognostic (1.52e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (2.68e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.17e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.73e-1)"	2.7	9.6	19.0	3.3	22.5	1.2	4.0	15.2	26.0	2.9	4.9	2.5	2.4	3.9	1.9	4.0	2.8	2.5	2.1	25.3	19.7	4.2	1.5	2.4	3.3	14.5	17.0	6.0	7.4	12.4	20.6	1.2	18.1	4.1	2.4	19.0	2.4	4.1	2.7	1.7	2.3	2.8	12.2	1.9	2.0	4.7	16.7	4.5	6.6	3.1	2.8	3.9	2.6	20.5	3.5	16.8	17.7	4.8	1.2	1.6	1.5	1.8	8.2	8.3	9.5	7.8	5.0	14.8	2.5	1.2	10.6	6.6	12.4	7.0	16.2	19.7	3.6	7.4	8.9	14.0	0.7	7.6	15.8	4.7	2.3	5.3	8.2	0.9	1.1	7.3	3.4	0.3	4.8	5.7	12.6	0.4	20.1	24.5	17.9	8.7	9.2	3.2	2.9	15.3	18.2	38.9	13.1	3.4	9.7	4.9	14.9	2.6	0.0	11.7	6.2	2.9	5.5	9.3	15.7	6.8	7.3	0.3	13.8	0.5	0.9	1.0	0.8	3.1	1.0	1.4	0.8	1.3	0.8	1.3	0.6	0.6	1.8	0.7	5.5	0.2	4.0	0.8	19.0	22.5	15.2	26.0	25.3	19.7	14.5	17.0	18.1	12.2	16.7	20.5	6.4	6.4	5.1	27.1	5.9	1.8	7.4	4.2	6.2	46.9	6.2	6.1	5.9	5.7	3.6	3.7	47.9	0.4	3.9	2.1	9.8	5.2	5.4	15.4	7.0	6.7	20.4	2.1	75.7	5.8	0.3	4.8	3.1	2.8	17.2	2.1	6.4	1.8	4.7	47.1	67.3	1.7	12.2	6.3	2.5	1.3	4.1	4.6	1.8	15.0	2.9	23.5	4.1	67.8	41.9	3.7	1.4	5.7	2.6	2.6	3.6	6.6	4.9	47.7	0.0	8.0	5.5	14.7	13.1	3.7	1.3	0.0	3.1	6.5	1.7	3.8
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92473043-92486925	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 53.7;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 14.2;Intestinal goblet cells: 12.4;NK-cells: 11.3;Plasma cells: 8.6;T-cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 61.9;HMC-1: 47.5;NB-4: 64.7;THP-1: 127.7;U-937: 261.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favorable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"	1.0	0.5	0.1	5.1	0.2	53.7	0.9	0.1	0.1	0.6	0.3	3.6	4.7	0.6	0.5	0.5	0.7	1.9	0.3	0.1	0.1	0.5	1.0	2.8	6.9	0.3	0.1	0.5	9.4	0.2	0.5	0.2	0.2	0.8	4.5	0.0	1.0	0.3	0.2	0.3	5.7	0.4	0.2	7.0	3.2	0.9	0.2	31.2	0.9	0.0	4.4	1.7	0.6	0.2	1.4	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.1	0.1	1.0	10.3	0.1	0.7	0.0	0.5	0.4	1.2	0.0	0.2	0.0	2.5	1.6	0.2	5.3	0.1	61.9	47.5	0.0	0.0	0.1	0.1	0.3	0.1	17.1	0.4	15.3	0.1	2.1	39.5	64.7	0.0	0.1	0.2	7.8	2.7	3.4	0.0	0.7	0.1	0.1	0.3	0.1	0.3	0.1	0.0	127.7	0.0	0.0	1.5	0.1	0.2	22.2	1.6	4.0	0.0	261.3	0.0	0.0	0.0	0.4	2.1	0.0	1.0	0.0	0.9	1.4	0.0	0.0	0.3	1.9	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.1	0.2	0.0	0.1	1.4	0.0	0.1	0.0	0.1	12.4	0.0	0.8	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	11.3	0.0	0.1	0.4	0.0	0.0	8.6	0.0	0.7	0.1	0.1	0.0	0.0	0.1	0.2	0.5	3.9	0.0	0.0	0.0	16.4	0.1	0.4	0.0
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273284	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		140000		"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	10.9	3.4	7.2	4.2	14.9	0.0	23.2	2.6	9.5	9.9	0.3	18.3	1.7	4.9	20.5	6.9	17.2	5.6	4.8	9.7	18.0	6.0	16.0	2.8	4.0	7.8	28.5	4.5	6.6	2.7	3.2	0.0	7.2	4.5	3.9	3.2	6.0	5.4	4.3	7.2	8.2	4.8	6.2	3.9	8.2	3.1	7.6	4.1	2.8	13.9	6.4	7.0	9.2	6.1	0.1	3.7	12.2	0.0	0.0	0.1	0.0	7.9	0.4	44.7	77.2	0.0	0.0	0.0	46.5	89.3	0.0	0.0	0.1	0.0	63.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	11.5	0.0	3.9	0.0	9.1	0.0	0.0	5.6	59.5	7.6	0.0	5.0	0.0	0.0	0.0	1.9	0.0	5.0	0.0	1.6	0.1	0.0	0.0	0.1	2.1	0.4	0.0	0.4	0.0	0.4	0.1	53.5	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	14.9	2.6	9.5	9.7	18.0	7.8	28.5	7.2	6.2	7.6	6.1	6.1	0.0	0.0	40.5	0.5	5.7	0.0	0.0	1.8	4.1	33.1	11.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	13.2	0.0	0.2	3.2	6.0	0.0	5.1	13.5	0.0	51.2	3.1	0.0	6.3	0.1	0.4	42.2	0.0	0.0	6.6	0.0	0.0	1.0	9.6	12.8	8.1	1.0	5.4	1.9	0.0	12.6	0.0	91.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	100.1	16.7	0.1	10.4	0.7	4.5	0.0	0.7	0.1	0.0	0.2
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 212.7;Late spermatids: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029472, HPA050727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA029472: AB_10696206, HPA050727: "	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.0	23.5	20.4	17.3	21.4	7.8	34.1	23.0	27.6	24.5	18.5	24.8	21.2	23.3	30.4	22.4	21.2	20.0	23.5	21.1	22.5	27.8	21.7	20.1	21.3	21.8	20.6	23.3	16.4	21.1	17.6	19.2	22.3	29.4	23.9	38.8	31.2	19.7	29.8	20.3	20.6	25.7	22.3	20.5	20.4	48.2	20.9	27.6	27.4	28.9	21.9	23.6	17.0	25.7	41.3	22.3	54.5	41.5	41.7	59.9	20.5	36.2	50.7	23.6	33.1	17.5	64.5	28.1	51.3	40.6	38.1	33.5	29.4	37.8	31.2	28.8	54.4	24.0	19.7	29.9	46.9	30.0	19.7	39.3	66.5	32.2	43.0	41.8	42.5	46.2	58.5	24.7	31.5	24.6	37.0	35.7	46.4	109.9	11.5	22.6	17.3	32.6	66.2	22.4	43.3	59.8	27.3	61.5	54.7	20.1	76.7	46.5	35.9	27.9	20.8	47.6	34.7	42.0	55.8	34.3	35.4	33.3	51.4	43.7	31.0	48.5	31.5	37.3	32.1	38.6	39.5	33.8	30.4	32.8	36.2	33.4	27.8	31.9	54.2	25.2	42.5	36.8	20.4	21.4	23.0	27.6	21.1	22.5	21.8	20.6	22.3	22.3	20.9	25.7	18.3	32.1	34.5	16.3	27.2	39.9	60.4	64.6	27.9	32.1	29.1	22.4	24.5	17.2	39.5	20.2	43.8	30.7	24.1	21.4	72.4	37.5	212.7	16.8	15.1	29.4	17.4	12.0	26.5	28.3	43.7	31.0	14.3	12.9	24.6	16.4	28.9	13.0	26.8	48.8	25.7	26.1	69.2	26.9	49.0	290.7	35.8	24.3	67.6	20.6	36.7	55.4	36.0	15.6	23.2	31.8	23.3	35.0	8.5	65.6	29.3	61.3	30.4	51.2	26.3	26.1	32.5	111.6	50.0	18.7	40.6	47.1	33.0	30.9	22.7	55.9
GGTA1	"GGTA, GGTA1P, GLYT2"	ENSG00000204136	"Glycoprotein alpha-galactosyltransferase 1 (inactive)"	Q4G0N0	9	121444991-121499844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 133.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Endothelial cells: 2.2;granulocytes: 3.8;Macrophages: 2.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"classical monocyte: 22.7;intermediate monocyte: 17.9;myeloid DC: 12.7;plasmacytoid DC: 27.5"	"Group enriched"	"Detected in many"	19	"dendritic cells: 27.5;monocytes: 22.7"	"Group enriched"	"Detected in some"	6	"AN3-CA: 4.3;HEL: 1.3;SH-SY5Y: 4.9"									HPA023262	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"		"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"			"HPA023262: AB_1849651"	"unprognostic (1.71e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.49e-2)"	"prognostic favorable (5.33e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.85e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.87e-2)"	33.4	18.5	15.4	10.1	18.9	68.2	40.4	12.7	19.9	17.2	14.4	14.9	12.0	10.7	7.4	24.2	10.1	23.1	18.7	16.4	15.3	5.7	15.0	21.9	25.7	13.9	15.2	7.6	5.0	4.8		41.7	13.7	6.5	15.4	0.5	133.2	15.3	5.0	13.6	16.1	12.5	14.1	40.4	8.7	4.1	16.0	9.9	5.1	13.4	10.4	21.4		14.9	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	17.9	0.0	0.7	0.0	0.0	12.7	0.0	0.0	0.0	1.2	0.1	0.4	27.5	0.0	7.2	15.4	18.9	12.7	19.9	16.4	15.3	13.9	15.2	13.7	14.1	16.0	14.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GHDC	LGP1	ENSG00000167925	"GH3 domain containing"	Q8N2G8	17	42188799-42194532	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031650	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA031650: AB_10601014"	"unprognostic (2.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.21e-4)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (5.13e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (2.08e-1)"	"unprognostic (7.93e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-2)"	15.7	32.9	14.3	10.1	15.2	11.8	15.8	15.1	16.2	18.6	15.2	15.3	15.8	15.1	11.0	8.8	15.9	10.6	12.3	13.9	15.8	24.5	18.6	15.9	13.2	18.3	15.7	22.2	26.4	12.8	16.7	9.3	16.7	20.7	5.3	3.8	24.1	14.2	7.8	9.8	19.4	5.3	15.0	32.2	19.5	5.9	15.5	7.4	26.8	5.7	6.5	15.5	13.3	16.3	7.5	26.1	1.8	20.5	6.8	6.0	16.1	9.9	7.7	5.0	6.5	8.4	35.4	11.4	34.9	9.2	6.1	0.6	5.8	0.2	1.2	18.8	21.1	17.3	11.9	18.0	17.7	13.9	70.4	9.1	5.3	13.7	4.2	6.1	7.8	6.9	16.8	50.0	2.6	9.2	9.0	27.1	4.4	28.1	0.0	8.7	9.5	49.8	13.8	6.0	4.0	13.9	0.3	46.1	34.4	0.4	31.8	22.0	6.7	23.3	9.2	20.4	4.7	37.3	31.3	7.7	19.7	17.3	9.6	0.8	3.2	1.8	2.3	3.0	1.0	2.5	1.5	2.3	2.7	4.1	1.5	1.8	1.6	1.1	4.1	2.4	1.4	2.6	14.3	15.2	15.1	16.2	13.9	15.8	18.3	15.7	16.7	15.0	15.5	16.3	16.2	0.0	9.6	4.9	9.9	2.9	9.3	8.8	2.2	7.6	8.8	7.1	2.1	14.3	6.7	16.5	6.2	13.1	8.7	5.1	3.9	12.9	1.0	5.6	8.5	12.6	13.8	4.6	2.6	19.3	11.6	10.0	6.1	8.9	13.3	6.5	28.5	15.3	27.9	8.4	4.3	10.7	8.2	25.5	5.4	1.3	11.5	12.6	8.8	2.8	9.3	16.2	13.4	1.0	3.5	10.3	4.8	13.9	4.7	6.5	25.6	16.5	7.8	5.5	0.0	12.8	6.3	2.8	0.5	2.2	1.8	7.3	9.5	15.9	9.4	5.4
GHITM	"DERP2, HSPC282, My021, PTD010, TMBIM5"	ENSG00000165678	"Growth hormone inducible transmembrane protein"	Q9H3K2	10	84139509-84153568	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1114.2;Late spermatids: 2559.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016464, HPA061664"	Approved		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA016464: AB_1849656, HPA061664: AB_2684579"	"unprognostic (6.26e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (5.71e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (2.32e-10)"	"unprognostic (2.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	113.9	179.5	124.3	87.0	133.3	110.6	93.8	138.6	147.7	73.1	150.6	171.2	163.5	76.8	86.1	114.4	71.4	68.9	365.3	136.1	146.1	300.7	271.1	74.1	87.3	136.6	128.1	72.7	77.7	197.3	88.8	70.3	138.5	80.6	166.4	144.3	94.4	84.2	369.3	79.7	137.1	85.7	125.4	73.8	123.1	115.7	137.5	86.5	105.9	456.6	103.3	92.3	76.5	123.1	228.2	230.8	97.1	223.5	162.6	143.3	171.6	153.3	267.4	193.7	180.2	283.1	183.8	178.9	167.7	203.2	170.9	199.9	208.4	200.0	185.9	179.8	157.4	127.7	227.3	281.0	306.5	402.0	200.0	162.7	384.1	200.4	577.8	201.8	169.9	150.5	299.9	324.3	180.4	197.4	143.6	318.9	98.3	184.8	203.2	128.3	89.4	270.5	271.4	179.2	79.4	92.4	154.7	134.1	325.1	111.2	273.7	254.2	145.3	94.0	126.5	138.5	251.1	227.9	265.7	199.9	246.8	364.4	67.1	293.7	284.9	276.5	173.9	304.7	194.2	211.0	178.9	186.0	279.9	177.9	166.6	178.8	223.7	206.7	281.3	145.3	235.3	578.0	124.3	133.3	138.6	147.7	136.1	146.1	136.6	128.1	138.5	125.4	137.5	123.1	94.1	96.1	87.6	23.2	138.0	170.3	185.1	440.9	87.0	135.9	102.2	71.8	689.3	140.2	235.8	158.2	70.9	260.4	134.0	376.0	579.2	295.3	1114.2	58.7	68.6	120.7	125.6	242.9	33.6	232.3	234.9	119.6	107.6	67.1	102.0	79.3	88.5	326.1	267.7	101.0	34.5	206.0	443.5	156.2	169.2	2559.1	110.3	153.0	163.7	16.9	228.3	269.0	114.4	14.6	24.3	223.3	276.3	136.9	167.3	180.1	343.7	802.9	173.4	159.9	144.7	114.5	219.8	263.1	153.2	150.4	170.3	386.0	141.6	158.4	281.4	212.9
GIMAP5	"HIMAP3, IAN4L1, IAN5"	ENSG00000196329	"GTPase, IMAP family member 5"	Q96F15	7	150722253-150750033	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 106.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.1;Basal keratinocytes: 11.1;Endothelial cells: 29.7;Langerhans cells: 13.9;Suprabasal keratinocytes: 10.7;T-cells: 31.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 41.7"															NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (6.77e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.13e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.47e-2)"	34.4	13.6	13.3	44.8	14.2	5.2	25.5	13.7	16.8	15.9	12.7	16.6	10.6	17.1	8.8	12.4	18.9	17.9	24.2	12.8	13.2	12.7	23.3	39.7	106.2	15.2	14.1	5.9	8.7	9.1	4.1	26.4	14.8	6.6	16.5	0.8	7.2	9.0	12.4	7.2	22.1	30.5	14.2	64.2	15.6	3.5	14.7	25.1	18.3	43.9	66.4	26.7	6.7	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.3	0.0	1.4	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.4	0.0	3.6	70.5	1.1	260.4	106.3	337.2	1.1	436.3	334.0	8.0	0.6	521.5	280.6	8.3	188.3	43.6	1.6	176.9	510.2	13.3	14.2	13.7	16.8	12.8	13.2	15.2	14.1	14.8	14.2	14.7	13.8	22.1	0.0	1.7	0.0	1.4	11.1	0.3	0.0	1.2	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.1	5.8	0.2	0.0	0.0	0.1	0.0	0.1	29.7	0.0	0.4	0.0	0.0	0.4	2.6	0.5	0.1	2.5	0.0	8.9	0.6	3.1	0.0	0.0	0.2	0.0	5.3	13.9	0.1	0.0	7.1	3.6	0.0	2.2	0.0	9.2	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.1	0.1	0.0	0.1	0.0	0.7	3.2	0.2	0.1	0.1	10.7	0.3	31.5	0.1	0.1	0.1
GIMAP6	"FLJ22690, IAN6"	ENSG00000133561	"GTPase, IMAP family member 6"	Q6P9H5	7	150625375-150632648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.3;Endothelial cells: 83.5;Hepatic stellate cells: 92.1;Kupffer cells: 75.2;monocytes: 37.4;NK-cells: 91.6;T-cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"monocytes: 75.1;NK-cells: 217.3;T-cells: 127.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.4;HUVEC TERT2: 124.9;MOLT-4: 43.3;TIME: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026715, HPA050740"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA026715: AB_1849675, HPA050740: AB_2797239"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.91e-4)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.88e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.75e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	42.0	9.4	9.7	33.9	9.7	2.5	21.8	9.7	10.6	14.9	8.0	12.0	13.6	19.3	7.3	8.4	16.9	14.7	29.1	8.0	9.5	12.4	12.7	38.8	50.2	11.4	10.5	5.7	5.2	8.0	3.3	32.3	11.3	6.4	12.2	0.6	7.8	10.0	24.7	6.4	18.7	25.8	10.9	64.0	11.6	3.2	11.6	29.3	14.2	34.7	33.9	16.5	6.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	6.3	0.0	0.0	0.0	0.4	18.4	0.1	0.0	0.0	0.0	0.0	124.9	0.5	0.0	4.6	0.0	0.0	43.3	5.4	0.0	0.0	0.0	4.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.8	35.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	13.0	0.0	11.6	58.1	2.1	112.9	75.1	127.2	0.4	104.3	120.2	22.1	0.3	108.3	103.0	8.0	217.3	60.2	0.7	105.7	163.5	9.7	9.7	9.7	10.6	8.0	9.5	11.4	10.5	11.3	10.9	11.6	10.1	95.3	0.0	1.1	0.0	3.1	3.8	0.1	0.0	0.6	0.0	1.1	1.0	7.4	0.0	0.0	0.0	0.0	0.2	24.5	0.1	0.0	0.0	0.4	0.1	0.2	83.5	0.0	19.4	0.0	0.2	0.3	3.4	0.0	0.2	2.5	0.3	92.1	1.7	30.6	0.0	0.0	0.1	0.0	75.2	6.5	2.2	1.2	20.0	1.8	13.1	37.4	0.1	91.6	0.0	0.1	0.1	0.0	0.0	2.9	0.1	0.0	0.2	0.7	0.4	0.0	2.6	2.2	0.3	0.1	0.4	3.1	0.4	41.2	1.2	0.0	0.3
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236598-219245478	"Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 52.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.5;Spermatocytes: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	4.6	4.8	3.1	4.0	3.4	4.5	5.3	3.3	3.0	5.3	14.7	3.1	3.1	5.9	11.4	2.5	23.1	9.0	2.2	3.0	3.7	13.6	3.1	5.3	3.0	5.5	7.0	7.1	3.1	14.4	6.8	8.5	4.5	5.6	3.7	8.0	4.5	4.8	0.9	4.6	4.1	5.8	4.4	4.9	2.8	52.3	3.7	3.4	8.4	1.0	3.4	5.9	2.1	5.6	2.8	4.8	7.4	5.9	8.0	9.8	3.7	4.6	9.7	5.7	5.3	1.9	7.7	0.9	4.1	4.1	4.3	1.5	1.9	4.6	4.5	2.6	3.6	2.9	6.9	4.5	19.7	1.1	4.4	11.4	2.9	5.4	3.3	13.5	5.3	4.3	1.8	5.3	5.4	4.0	2.5	2.7	1.3	1.0	1.3	2.5	4.1	4.0	11.5	1.6	4.7	4.2	3.9	5.3	4.3	4.9	8.4	2.6	4.1	4.7	5.8	2.8	2.6	5.0	1.7	1.5	8.8	1.2	12.3	1.9	5.1	0.3	0.7	6.4	0.4	0.4	0.5	0.7	2.1	1.0	1.1	0.7	2.1	1.0	5.4	0.9	0.2	1.7	3.1	3.4	3.3	3.0	3.0	3.7	5.5	7.0	4.5	4.4	3.7	5.6	3.2	3.2	5.1	3.3	1.3	1.8	2.6	3.6	0.6	4.7	4.9	5.6	1.9	1.5	6.3	3.7	12.5	3.4	1.9	1.1	3.9	3.8	41.5	15.7	3.9	4.2	4.9	1.3	0.9	1.8	2.2	8.4	1.1	2.2	0.0	2.7	8.6	1.3	14.5	3.3	1.1	3.2	2.0	5.6	2.4	25.6	10.8	4.4	8.8	1.9	2.7	5.0	3.1	1.0	0.5	2.1	3.3	6.4	1.8	2.7	6.5	16.5	23.9	10.2	6.6	3.8	2.2	117.4	9.7	1.8	1.7	1.4	2.0	7.0	2.4	1.7
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.0;Microglial cells: 76.8;Oligodendrocytes: 154.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 35.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 1.9;monocytes: 2.3;T-cells: 2.0"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 119.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		240000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA040481: AB_2677004, HPA048216: AB_2680317"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	9.1	12.2	6.7	5.6	7.8	0.9	8.9	35.8	6.2	8.2	8.4	12.8	14.2	6.4	6.9	10.0	5.5	7.5	6.3	6.0	6.7	13.3	16.8	8.4	3.5	5.7	8.5	12.7	4.7	8.7	6.4	13.4	7.2	5.8	14.2	13.2	10.9	5.8	4.1	10.4	11.5	7.0	7.5	4.4	9.1	3.9	8.8	4.9	4.1	4.9	5.1	6.6	4.6	8.0	9.6	8.5	5.6	9.7	18.6	17.6	2.0	17.6	23.2	13.3	25.2	7.1	23.6	5.8	8.5	14.4	16.8	14.0	12.1	11.4	27.1	2.2	13.4	9.7	15.0	7.2	17.9	4.2	19.0	12.1	7.8	16.6	18.6	9.7	119.4	4.3	3.9	6.0	25.4	5.9	2.6	7.4	2.7	9.7	5.9	5.8	22.6	7.3	12.3	10.1	17.9	3.7	18.0	11.0	38.1	3.8	7.9	5.8	41.8	12.7	15.7	14.3	15.8	2.5	3.7	1.3	12.9	7.0	18.8	0.0	2.1	0.0	0.3	1.6	0.5	0.2	0.8	0.4	1.8	0.2	0.5	0.7	0.0	0.2	2.3	1.9	2.0	0.9	6.7	7.8	35.8	6.2	6.0	6.7	5.7	8.5	7.2	7.5	8.8	8.0	16.9	0.0	15.4	4.9	6.2	4.8	10.1	8.3	26.2	10.3	18.8	19.4	8.1	7.2	8.8	11.0	10.4	22.7	12.1	21.3	5.9	13.0	3.9	4.0	5.4	22.6	20.4	9.4	79.0	13.8	12.7	14.0	28.1	4.9	2.5	11.8	16.4	27.2	16.4	8.4	41.5	27.1	10.2	13.3	4.4	5.1	6.2	10.7	8.8	76.8	13.7	13.1	4.1	35.7	154.9	16.9	28.2	17.7	7.1	5.3	32.4	18.3	18.2	16.6	13.1	6.6	9.4	29.8	25.9	27.9	6.5	33.0	5.9	17.1	26.4	13.3
GLG1	"CFR-1, ESL-1, MG-160"	ENSG00000090863	"Golgi glycoprotein 1"	Q92896	16	74447427-74607144	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010815	Supported		Supported	"Golgi apparatus"		NA	NA		2100000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA010815: AB_2232486"	"unprognostic (3.70e-2)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-3)"	"unprognostic (5.13e-3)"	"unprognostic (9.45e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.85e-2)"	"prognostic favorable (1.56e-7)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-4)"	42.7	36.8	25.0	17.4	26.3	9.0	40.3	24.0	25.7	53.3	17.3	44.5	17.3	57.8	22.4	30.9	46.7	20.4	50.5	24.7	27.5	42.6	25.6	38.2	16.3	27.0	29.0	69.0	58.1	34.3	38.9	24.9	25.2	37.5	18.7	20.3	36.1	24.9	53.8	35.2	36.4	29.9	25.0	35.1	36.3	40.6	29.5	20.0	43.1	16.4	18.9	42.3	40.8	30.0	38.4	52.2	44.7	43.3	113.7	113.2	42.8	45.0	64.2	48.6	68.3	34.4	116.0	22.8	59.8	102.9	35.8	71.1	30.1	62.1	80.1	10.3	26.1	17.9	37.8	54.3	70.5	29.3	12.6	68.0	32.8	63.6	66.3	91.3	100.8	54.8	19.0	24.9	44.2	70.0	14.1	26.0	34.7	81.2	20.6	33.9	32.6	59.5	31.6	17.1	15.8	23.3	87.3	24.9	25.0	47.7	28.2	36.5	79.1	46.1	40.9	48.2	30.3	47.4	51.2	41.1	86.3	22.5	46.6	3.2	16.7	13.3	19.1	15.7	19.2	11.6	23.8	20.9	18.5	10.1	28.2	22.6	7.3	15.4	19.9	18.4	21.0	19.0	25.0	26.3	24.0	25.7	24.7	27.5	27.0	29.0	25.2	25.0	29.5	30.0	52.8	64.1	50.7	114.3	46.4	27.1	27.2	33.0	55.8	68.5	35.6	35.6	79.5	77.2	39.7	51.5	146.0	78.0	75.6	33.5	7.9	39.9	39.7	49.2	79.3	62.0	38.6	25.0	133.4	42.5	43.6	101.4	38.7	58.0	3.8	91.0	75.3	40.7	50.1	70.7	155.3	31.9	24.4	68.8	42.1	28.1	96.9	44.4	42.7	62.8	64.8	59.6	111.2	97.5	137.3	40.8	28.8	114.3	100.2	33.6	47.8	44.2	44.3	57.9	92.1	84.6	59.9	89.2	87.9	30.5	21.6	75.2	72.4	72.4	32.9	26.4
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57459785-57472268	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 11.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 6.5;Leydig cells: 29.5;Peritubular cells: 42.9;Sertoli cells: 13.1;Theca cells: 7.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.2;BJ hTERT+: 16.9;NTERA-2: 14.0;RH-30: 60.6;U-266/70: 16.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122"	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	2.4	1.2	1.3	1.7	1.6	0.5	1.5	3.5	1.9	11.1	0.4	3.0	2.5	9.5	6.6	0.6	3.7	5.5	2.1	1.0	2.1	1.4	0.8	1.6	0.7	1.9	2.4	1.5	0.8	0.0	1.0	0.5	1.7	4.2	4.1	0.0	1.5	2.8	0.6	1.7	3.3	2.4	1.7	0.9	1.9	4.7	4.2	0.3	2.3	1.8	1.0	4.4	3.1	1.1	0.1	9.8	3.2	24.2	0.7	0.1	0.3	0.9	16.9	2.1	2.3	0.3	0.7	3.1	0.0	0.5	2.3	1.7	1.8	1.1	0.4	2.7	0.3	0.1	1.2	0.2	2.7	0.7	1.4	0.8	0.4	3.1	1.0	4.2	0.3	2.2	0.4	7.8	1.0	0.0	0.7	0.5	14.0	0.8	0.9	1.2	60.6	1.7	2.7	0.0	0.1	0.1	0.2	0.1	0.4	2.4	0.0	0.3	0.1	2.2	7.7	0.6	0.3	16.7	1.0	5.7	2.0	1.3	3.8	0.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.1	0.2	0.0	1.3	1.6	3.5	1.9	1.0	2.1	1.9	2.4	1.7	1.7	4.2	1.1	0.4	0.0	0.0	2.0	0.7	0.1	0.4	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.1	3.5	0.5	0.0	0.0	0.1	0.0	0.1	6.5	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	2.5	29.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.1	0.2	0.0	1.3	0.0	0.0	13.1	1.9	1.6	0.3	1.1	0.2	0.6	0.1	0.5	7.8	0.1	0.1
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988987-104064183	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	16.9	10.9	4.2	5.2	4.9	1.5	19.5	2.6	5.1	29.6	11.2	17.6	5.8	27.4	21.6	7.5	22.3	35.8	15.4	4.8	3.7	4.3	2.7	10.2	6.0	2.9	3.1	41.6	4.5	6.6	9.6	9.4	3.1	13.3	11.4	1.0	7.7	16.0	3.2	4.1	7.7	21.8	2.8	1.6	8.4	6.8	3.7	2.2	26.3	11.5	5.8	20.8	18.9	4.4	0.3	0.6	0.7	22.2	28.3	69.3	0.5	32.0	89.4	8.3	10.5	0.4	0.2	0.9	1.8	37.5	0.4	0.1	0.4	11.9	7.0	1.6	10.0	0.6	11.2	0.2	12.7	0.9	0.5	63.2	0.7	10.0	13.8	51.9	4.4	0.6	0.4	1.3	36.5	0.3	0.8	0.5	2.7	0.1	6.7	1.0	33.6	0.2	45.5	0.4	1.3	1.7	33.5	0.8	0.4	2.4	6.0	0.5	0.7	13.2	6.2	1.3	1.9	3.9	0.8	0.3	1.0	0.7	1.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	4.9	2.6	5.1	4.8	3.7	2.9	3.1	3.1	2.8	3.7	4.4	8.0	0.0	4.6	2.9	0.3	2.8	4.2	2.4	0.0	0.8	1.0	26.3	3.9	1.5	0.1	0.0	2.1	4.1	0.4	0.0	0.0	0.1	41.2	0.6	8.3	7.5	1.8	0.0	10.2	0.0	0.8	55.9	1.1	0.4	0.0	0.1	20.7	0.3	0.6	0.0	10.5	1.3	0.0	0.6	2.8	11.5	55.9	0.4	3.6	4.7	0.6	0.5	0.0	1.0	2.6	0.3	0.0	51.9	1.2	1.4	0.0	0.0	0.1	0.5	6.6	25.2	18.0	1.1	1.1	0.2	2.4	1.4	0.6	10.7	0.0	0.1
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182378098-182392206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1443.6"	"Group enriched"	"Detected in all"	4	"Late spermatids: 8544.2;Muller glia cells: 6247.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 365.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 656.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 656.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1150.8;ASC TERT1: 807.6;HSkMC: 702.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	753.5	76.0	694.3	156.9	746.5	232.9	573.5	717.5	1237.1	161.4	583.2	157.8	24.4	116.7	115.7	218.7	224.3	105.4	129.7	676.6	764.7	65.3	280.7	221.7	75.2	891.0	783.7	303.0	204.7	32.3	70.5	176.6	767.0	103.4	92.5	891.1	233.5	96.0	1443.6	231.4	148.2	124.1	725.0	216.4	648.2	87.1	811.4	97.0	257.4	472.0	103.2	185.5	292.0	810.4	26.4	10.8	117.2	0.2	1150.8	807.6	86.0	44.1	141.7	25.9	23.4	64.1	26.7	22.4	46.3	85.5	23.8	59.3	51.8	309.4	21.5	61.2	143.3	296.5	47.6	124.8	61.1	132.6	227.2	702.1	363.3	32.9	384.6	39.1	52.8	71.7	254.3	13.3	92.6	15.0	208.2	126.5	87.3	36.8	55.0	74.3	31.3	38.6	45.8	114.0	79.7	52.5	12.4	157.3	17.4	93.3	153.1	165.9	39.7	0.9	1.9	0.8	10.1	4.8	3.4	0.4	22.3	73.9	5.0	396.5	153.4	409.4	42.3	145.8	17.6	11.5	29.9	35.5	80.0	17.8	15.3	25.3	656.8	27.2	130.5	43.7	13.0	172.0	694.3	746.5	717.5	1237.1	676.6	764.7	891.0	783.7	767.0	725.0	811.4	810.4	127.8	125.0	173.8	599.4	37.6	134.7	533.8	1190.7	260.0	105.6	166.6	99.1	216.2	171.6	855.3	82.8	52.1	161.7	113.4	118.3	74.3	124.2	1491.3	140.2	150.0	191.5	325.9	319.7	3.4	116.6	65.9	404.4	388.4	124.6	786.3	88.0	152.8	597.1	798.0	43.7	22.0	256.7	451.6	907.2	614.1	8544.2	487.4	687.4	136.9	74.9	112.7	6247.0	42.2	38.2	330.0	108.1	105.3	375.0	38.7	421.0	10.3	46.6	569.9	176.0	92.1	481.5	218.5	48.2	63.6	186.5	128.3	235.3	108.6	53.3	173.3	1420.5
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 12.0;cervix: 19.9;salivary gland: 33.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 14.8;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 3.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	4	"breast cancer: 16.7;endometrial cancer: 15.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HAP1: 6.0;SK-BR-3: 14.1;U-2197: 6.6"					"Low region specificity"	"Detected in many"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	Mitochondria		"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favorable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.2	0.1	0.2	0.1	0.3	0.1	12.0	0.2	0.5	19.9	0.0	0.1	0.3	0.4	0.3	0.9	0.1	7.5	0.3	0.2	0.4	0.9	0.1	0.0	0.3	0.7	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.9	0.2	0.3	33.4	0.1	0.0	1.4	0.1	0.3	0.7	0.3	0.1	0.0	0.2	0.1	0.1	0.5	0.4	0.1	0.3	1.1	0.0	0.0	0.4	0.0	0.7	2.6	0.0	1.7	5.3	2.3	3.7	0.0	0.0	0.1	0.0	1.4	1.0	0.4	6.0	0.0	1.9	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	0.2	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	14.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	6.6	2.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.5	0.2	0.4	0.7	0.2	0.6	0.7	0.2	1.1	0.2	0.0	0.0	0.0	0.0	1.0	2.3	1.4	0.0	0.5	14.8	2.2	0.1	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	1.1	0.0	0.0	1.5	1.4	0.0	0.5	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	3.0	0.4	0.1	0.0	0.0	0.0	3.6	0.0	0.2	0.1	0.1	6.6	0.2	0.6	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.9
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847288	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favorable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	34.4	35.0	26.9	43.4	27.9	43.4	27.7	21.2	27.7	31.7	35.9	46.0	43.3	30.1	24.6	37.7	45.4	30.4	41.7	29.3	26.5	46.9	38.3	32.8	41.7	24.2	26.1	24.9	35.8	60.4	31.5	33.7	22.8	40.2	43.9	41.9	43.5	37.5	44.1	33.6	40.4	37.2	22.5	39.2	44.7	20.3	26.6	45.7	40.2	37.8	43.2	36.5	26.9	22.4	43.2	47.5	76.4	47.9	66.1	52.5	73.4	80.0	59.0	59.6	50.7	66.7	75.5	69.8	74.0	74.2	49.0	47.3	96.4	67.0	53.4	114.0	59.4	72.4	57.7	47.7	37.3	117.6	129.6	50.2	52.3	56.3	41.5	57.6	77.2	65.0	122.8	58.8	65.6	69.8	96.6	64.8	91.0	65.0	35.2	123.5	59.9	86.5	73.4	64.0	93.1	47.1	86.4	80.7	37.1	83.1	90.3	123.9	86.1	41.1	46.0	186.2	50.3	49.0	73.1	145.5	29.3	57.9	85.5	10.3	14.1	7.8	9.0	12.7	8.0	6.2	6.0	8.9	9.7	9.6	6.2	5.6	28.1	7.0	20.8	10.8	6.5	8.2	26.9	27.9	21.2	27.7	29.3	26.5	24.2	26.1	22.8	22.5	26.6	22.4	28.6	38.5	47.3	35.6	29.9	19.1	18.7	17.1	19.4	36.8	30.3	23.6	42.3	28.6	37.3	31.3	29.2	28.0	31.1	54.9	66.5	24.4	11.3	58.2	36.7	28.1	46.3	45.6	43.6	19.4	31.6	23.0	26.0	43.0	31.6	27.4	26.7	53.0	32.0	45.4	37.0	41.2	18.3	39.3	23.9	10.3	24.2	35.9	21.4	32.8	54.5	25.0	28.8	28.6	35.8	29.2	38.8	16.1	26.5	29.0	38.9	54.7	73.3	42.6	19.7	24.6	36.1	21.9	24.5	23.4	24.2	35.7	26.1	28.1	38.8	21.3
GMCL1	"BTBD13, FLJ13057, GCL1, SPATA29"	ENSG00000087338	"Germ cell-less 1, spermatogenesis associated"	Q96IK5	2	69829660-69881384	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 264.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 93.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039579	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039579: AB_10805480"	"unprognostic (1.89e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	9.4	6.5	4.4	8.1	4.8	13.6	10.6	5.3	6.7	8.6	11.6	10.7	15.9	7.7	8.8	8.2	7.9	8.5	4.8	5.2	4.4	11.5	10.7	7.7	12.0	4.4	4.7	8.5	9.1	19.1	6.5	9.3	4.3	11.1	12.2	6.1	9.4	8.7	4.1	8.8	13.1	6.4	4.6	9.1	8.6	16.3	4.5	18.5	9.2	5.4	12.2	8.3	6.3	5.3	14.7	10.3	17.2	18.4	15.0	13.1	18.4	12.1	8.0	8.1	13.7	9.9	13.5	30.7	9.7	8.0	9.5	14.2	20.3	10.5	14.1	14.2	21.2	48.0	11.3	22.8	9.9	36.1	32.4	7.2	11.3	6.4	14.9	10.5	14.5	23.2	19.5	21.8	12.9	12.6	37.1	33.7	18.4	24.9	9.6	26.1	22.6	23.6	11.9	22.2	27.0	22.5	13.2	19.1	14.8	13.4	12.6	22.2	9.0	12.4	15.5	19.4	14.7	22.1	28.6	18.9	12.8	29.5	13.0	93.5	8.0	40.1	11.1	6.3	19.1	8.8	10.9	13.7	7.5	8.3	15.6	15.5	26.8	26.8	10.3	7.9	15.5	9.4	4.4	4.8	5.3	6.7	5.2	4.4	4.4	4.7	4.3	4.6	4.5	5.3	17.9	28.9	27.4	22.9	25.9	26.8	21.4	19.5	27.3	22.5	28.3	20.4	7.6	74.4	22.0	18.4	27.1	38.3	42.5	40.0	41.1	36.1	264.8	26.7	21.8	19.5	23.4	29.0	68.1	17.5	51.9	19.4	16.3	18.4	22.2	24.2	26.4	25.4	15.9	21.9	63.8	37.0	44.7	23.8	13.1	50.8	15.8	15.0	16.0	11.2	22.8	44.2	50.4	42.7	45.6	15.2	21.7	22.6	28.2	33.0	42.1	23.2	38.4	37.0	13.1	26.0	21.1	44.2	45.1	38.4	27.7	81.5	36.7	17.5	30.6	25.7
GOLM2	"CASC4, DKFZp459F1927, H63"	ENSG00000166734	"Golgi membrane protein 2"	Q6P4E1	15	44288719-44415758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.9;Cardiomyocytes: 24.0;Cytotrophoblasts: 16.3;dendritic cells: 16.1;Extravillous trophoblasts: 19.4;Fibroblasts: 18.2;Hofbauer cells: 27.3;Syncytiotrophoblasts: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043015, HPA049488"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1200000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA043015: AB_2678271, HPA049488: AB_2680790"	"unprognostic (2.64e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.45e-5)"	"unprognostic (2.15e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.12e-1)"	39.5	84.5	48.5	32.4	47.0	16.5	43.2	43.1	59.2	57.9	62.4	45.7	28.8	50.4	53.5	23.7	53.8	50.5	33.1	42.8	52.6	54.0	60.9	40.9	30.8	49.6	51.5	55.3	37.4	82.0	38.7	34.4	46.9	67.5	43.8	33.7	47.8	56.1	22.3	13.2	29.8	44.4	46.7	35.4	49.4	34.6	52.9	28.9	84.6	26.3	29.5	39.2	24.3	52.7	45.0	38.7	51.9	92.6	141.4	121.8	32.0	78.6	125.2	44.9	57.1	19.3	80.0	13.5	106.4	119.3	47.8	53.8	34.4	25.5	48.2	64.6	19.5	21.4	41.8	35.9	65.1	42.5	68.1	72.1	28.3	49.8	38.4	126.8	53.4	34.2	33.0	103.4	56.2	23.2	36.7	33.2	14.8	60.8	27.5	30.5	29.3	43.3	58.8	54.4	23.3	53.2	60.7	57.0	26.6	28.1	64.1	49.2	76.4	78.1	39.8	112.5	69.5	79.0	145.1	27.9	92.6	58.5	51.7	20.9	14.7	20.8	15.2	9.8	16.3	11.9	12.4	15.2	12.0	10.7	9.5	9.9	37.8	10.5	18.2	10.6	13.2	13.6	48.5	47.0	43.1	59.2	42.8	52.6	49.6	51.5	46.9	46.7	52.9	52.7	19.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	16.3	16.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	19.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	12.7	2.9	0.0	0.0	0.0
GPHN	KIAA1385	ENSG00000171723	Gephyrin	Q9NQX3	14	66507407-67181803	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	"Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 493.0;Excitatory neurons: 686.5;Inhibitory neurons: 866.7;Oligodendrocyte precursor cells: 576.1;Oligodendrocytes: 597.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003116, CAB004419, HPA024694"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		6900	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616"	"unprognostic (8.37e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.89e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (5.25e-12)"	"unprognostic (9.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (4.61e-5)"	13.8	11.1	35.5	3.5	36.0	2.6	13.4	48.4	54.1	9.7	20.9	11.8	7.4	9.9	11.6	12.2	11.1	6.2	17.1	36.1	37.6	25.3	62.4	9.3	3.8	32.7	35.3	8.9	23.9	11.7	13.6	3.6	32.3	11.3	10.1	23.1	9.4	6.6	24.5	15.2	9.0	6.2	32.4	6.7	14.7	6.2	34.6	5.8	11.9	13.8	4.3	11.4	10.7	39.5	39.9	8.8	13.7	15.9	14.2	17.5	9.5	11.1	5.7	12.7	12.2	2.8	17.9	0.0	1.8	7.7	5.5	13.1	17.0	19.9	18.9	15.0	14.9	15.8	9.4	22.3	7.8	9.1	15.8	13.3	13.8	2.9	16.0	4.8	11.8	13.8	9.3	14.2	7.1	19.2	11.9	22.2	5.0	28.3	17.0	0.0	32.5	13.2	16.7	7.5	25.8	10.3	10.2	31.6	12.4	3.3	18.5	11.5	6.7	14.1	24.8	11.3	13.0	22.8	9.1	0.3	10.5	0.8	11.2	0.0	0.7	0.3	2.0	1.2	3.2	1.2	2.5	1.7	1.1	1.9	1.7	1.6	0.0	1.3	1.0	1.5	3.0	0.7	35.5	36.0	48.4	54.1	36.1	37.6	32.7	35.3	32.3	32.4	34.6	39.5	11.5	6.4	13.1	493.0	11.8	4.7	9.2	5.8	27.9	34.3	12.4	6.7	12.7	8.6	10.8	1.8	52.1	3.9	3.5	8.6	13.7	4.0	3.8	7.2	13.5	10.7	6.0	7.6	686.5	5.3	2.3	8.7	19.9	13.6	0.0	3.9	15.7	47.6	3.7	43.7	866.7	15.0	8.2	5.8	1.7	5.0	11.1	4.5	1.8	148.0	1.3	8.9	1.0	576.1	597.5	3.1	7.8	5.7	15.1	11.5	7.1	20.1	2.4	34.9	0.0	12.5	11.8	11.8	8.9	26.7	5.8	2.1	7.9	9.0	10.4	6.5
GPM6A	GPM6	ENSG00000150625	"Glycoprotein M6A"	P51674	4	175632934-176002664	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"brain: 577.8;choroid plexus: 249.3;retina: 147.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 3712.4;Excitatory neurons: 833.0;Inhibitory neurons: 581.3;Muller glia cells: 459.6;Oligodendrocyte precursor cells: 1341.6"	"Cancer enriched"	"Detected in many"	107	"glioma: 110.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 34.8;naive B-cell: 16.6"	"Lineage enriched"	"Detected in many"	12	"B-cells: 34.8"	"Group enriched"	"Detected in some"	10	"AF22: 49.9;Daudi: 43.0;HAP1: 17.4;U-251 MG: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017338	Supported					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA017338: AB_1849933"	"unprognostic (1.36e-4)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.82e-5)"	"unprognostic (2.24e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.60e-3)"	3.8	4.2	366.9	1.4	455.6	0.5	2.5	422.6	577.8	6.8	249.3	25.4	1.9	7.7	2.9	1.9	7.5	4.4	2.8	469.8	268.7	7.1	13.4	20.1	2.6	225.0	265.4	12.3	1.8	0.7	7.7	0.3	222.4	5.7	6.0	147.3	0.9	6.9	0.6	0.8	3.4	11.1	257.9	15.8	1.1	1.5	281.9	0.3	11.9	0.6	1.3	2.6	2.9	336.4	0.3	0.7	49.9	0.5	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.1	0.7	43.0	0.2	0.2	1.8	0.9	17.4	1.5	0.1	0.2	4.0	0.5	3.7	1.4	0.1	0.4	0.7	0.1	0.0	0.1	0.2	2.0	0.0	0.1	0.4	1.7	0.0	1.2	1.6	0.6	1.2	0.0	0.6	0.2	0.2	0.3	0.1	2.1	0.5	0.4	0.2	0.9	0.2	0.3	0.6	0.1	0.2	0.9	0.6	0.6	50.8	1.6	0.1	2.6	1.8	0.4	1.1	0.8	0.1	0.1	0.1	0.1	0.1	34.8	0.1	0.0	0.2	16.6	0.1	0.1	0.4	0.1	0.2	2.9	0.1	0.8	366.9	455.6	422.6	577.8	469.8	268.7	225.0	265.4	222.4	257.9	281.9	336.4	0.6	96.1	8.7	3712.4	9.6	1.8	5.3	0.0	0.0	220.3	0.2	0.1	0.7	1.5	0.6	0.0	14.6	0.0	0.0	0.1	1.9	0.0	11.7	0.4	0.1	29.0	0.0	5.3	833.0	0.2	0.2	2.4	0.0	0.2	0.0	0.2	116.0	2.1	0.3	124.5	581.3	0.0	0.0	4.4	0.4	3.6	3.4	1.6	0.0	208.0	0.0	459.6	0.0	1341.6	37.3	0.0	0.0	1.5	0.1	9.0	0.0	3.4	0.0	30.5	0.0	15.3	3.3	0.5	0.4	0.2	0.9	0.1	1.2	3.0	0.0	6.5
GPM6B	"M6B, MGC17150, MGC54284"	ENSG00000046653	"Glycoprotein M6B"	Q13491	X	13770939-13938638	"Predicted membrane proteins"	"Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 743.2;choroid plexus: 180.7;retina: 207.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 633.3;Excitatory neurons: 361.3;Melanocytes: 357.5;Muller glia cells: 1722.4;Oligodendrocyte precursor cells: 408.1;Oligodendrocytes: 1476.6"	"Cancer enriched"	"Detected in many"	5	"glioma: 192.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	220	"plasmacytoid DC: 77.7"	"Lineage enriched"	"Detected in single"	268	"dendritic cells: 77.7"	"Cell line enhanced"	"Detected in many"		"AF22: 154.8;AN3-CA: 150.1;ASC TERT1: 74.2;HSkMC: 110.0;SK-MEL-30: 154.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002913	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA002913: AB_2263553"	"unprognostic (1.56e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.38e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	7.5	9.3	418.4	6.0	518.8	1.1	26.4	540.4	521.1	27.1	180.7	33.8	5.0	6.3	12.1	11.5	6.5	5.9	15.8	447.8	463.6	7.7	1.1	16.8	2.8	596.3	459.3	4.4	3.2	0.6	17.2	1.3	580.5	21.8	7.8	207.7	14.8	35.2	2.5	13.9	9.2	5.4	533.4	14.5	11.7	3.5	419.9	0.8	5.0	7.5	1.9	9.1	19.7	743.2	0.4	0.4	154.8	150.1	41.6	74.2	0.4	0.9	6.9	0.1	0.0	0.4	0.5	0.7	0.3	0.0	0.6	1.3	7.6	0.8	0.0	0.6	25.2	0.4	10.0	0.4	1.5	0.5	0.9	110.0	0.9	0.0	1.9	0.6	0.0	3.0	0.4	6.8	1.5	0.6	3.4	0.7	48.5	0.1	2.5	2.0	13.7	23.9	0.0	0.5	7.8	4.4	0.8	4.4	154.4	41.9	0.7	3.6	0.3	1.0	1.3	0.3	2.0	0.5	0.3	0.3	1.4	0.3	12.4	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.2	0.1	77.7	0.1	0.7	418.4	518.8	540.4	521.1	447.8	463.6	596.3	459.3	580.5	533.4	419.9	743.2	13.8	0.0	5.1	633.3	15.8	33.0	22.7	5.9	6.8	74.4	37.1	47.1	1.3	1.5	7.8	22.0	87.6	5.0	50.7	3.0	0.0	5.4	1.5	45.8	32.7	12.5	1.2	5.3	361.3	3.7	3.7	54.2	0.0	30.4	4.5	19.7	10.8	0.4	1.2	26.9	144.0	5.0	8.2	1.9	33.5	3.2	24.2	3.7	357.5	40.3	4.6	1722.4	50.4	408.1	1476.6	2.3	6.0	32.0	7.3	26.5	6.1	1.1	11.0	151.4	46.0	137.7	43.6	9.6	13.3	7.0	17.0	13.7	20.5	8.6	3.2	14.8
GPR183	EBI2	ENSG00000169508	"G protein-coupled receptor 183"	P32249	13	99294539-99307399	"G-protein coupled receptors, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.7;lymphoid tissue: 84.5"	"Group enriched"	"Detected in many"	4	"Langerhans cells: 2572.5;Macrophages: 809.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1050.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	23	"HDLM-2: 157.7;HL-60: 108.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033690, HPA075590"	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB033690: AB_2114269, HPA075590: "	"unprognostic (3.28e-3)"	"prognostic favorable (9.77e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.31e-3)"	"unprognostic (9.86e-3)"	26.2	12.8	1.9	84.5	2.1	112.7	11.2	2.2	3.5	12.6	7.1	14.8	8.0	6.6	2.4	15.2	6.5	40.5	13.1	1.8	5.5	3.8	17.1	20.1	67.7	8.1	3.0	3.5	4.6	3.8	5.1	27.8	5.2	9.4	21.3	2.0	5.2	3.9	2.0	5.9	23.6	21.9	3.9	35.1	15.7	1.5	3.5	31.8	15.2	4.1	75.6	52.3	5.3	7.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.7	0.2	0.8	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.4	157.7	0.0	1.4	0.4	0.0	0.0	108.6	0.3	0.0	0.0	1.5	0.0	0.0	0.0	5.7	2.6	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.8	0.3	0.7	0.0	1050.9	10.4	391.6	43.7	3.8	264.5	364.1	463.0	240.9	77.9	172.1	286.1	39.8	9.9	487.0	3.9	255.2	401.6	255.9	1.9	2.1	2.2	3.5	1.8	5.5	8.1	3.0	5.2	3.9	3.5	7.3	6.0	16.0	26.3	0.0	413.9	61.6	0.8	0.5	2.2	0.3	2.5	3.9	4.6	1.5	6.3	0.0	6.2	1.0	168.8	0.5	1.9	0.2	0.7	0.6	1.3	17.1	0.0	4.4	0.2	2.9	1.5	12.8	11.2	0.9	60.9	0.1	0.7	1.2	113.4	0.0	0.2	0.0	18.3	119.1	2572.5	2.8	0.3	809.4	145.9	46.9	248.7	0.1	1.0	0.5	0.3	1.0	0.0	0.0	85.5	0.4	0.0	0.8	3.8	0.9	6.6	2.1	9.1	0.4	0.2	1.3	53.4	1.8	245.2	0.0	0.3	0.6
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71753855-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 10.3;Breast myoepithelial cells: 7.5;Collecting duct cells: 12.9;Glandular and luminal cells: 8.1;monocytes: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.8;neutrophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 17.9;HL-60: 17.5;MCF7: 14.6;NTERA-2: 28.9;RPTEC TERT1: 13.6;SH-SY5Y: 10.9;T-47d: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favorable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.4	4.0	21.3	1.5	22.9	15.7	3.9	13.0	19.7	3.5	7.4	1.6	0.3	5.0	2.8	3.7	6.8	1.0	3.4	19.9	20.6	3.2	0.1	1.4	0.2	18.0	18.3	4.4	3.1	17.3	9.2	1.2	16.2	5.1	0.5	1.8	1.4	4.3	0.7	2.1	0.7	2.9	19.7	3.3	2.0	4.7	22.9	0.5	6.2	1.9	0.2	2.0	2.3	18.9	0.0	1.1	1.9	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	17.9	0.0	0.8	0.1	4.3	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	17.5	0.9	0.0	2.9	0.0	1.2	0.0	0.0	3.7	0.0	0.0	0.0	14.6	1.2	0.2	28.9	0.0	0.0	0.0	0.0	0.0	13.6	7.8	3.0	10.9	3.8	0.0	0.0	3.6	9.9	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	7.2	0.0	0.1	0.0	0.0	0.1	21.3	22.9	13.0	19.7	19.9	20.6	18.0	18.3	16.2	19.7	22.9	18.9	0.2	0.0	1.1	0.0	0.1	1.9	4.2	0.0	4.0	10.3	6.5	7.5	3.5	2.8	1.3	12.9	4.2	1.4	0.4	0.2	1.9	0.7	0.2	2.1	4.9	0.4	1.2	1.7	0.0	0.0	1.3	1.2	1.1	8.1	0.0	2.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.9	3.2	0.0	0.0	8.6	0.5	1.0	0.0	0.0	0.3	0.1	1.2	0.0	5.6	0.0	0.1	1.5	0.4	0.0	2.3	1.7	0.2	4.8	4.7	1.7	0.3	0.7	0.5	0.3	2.0
GPR65	"hTDAG8, TDAG8"	ENSG00000140030	"G protein-coupled receptor 65"	Q8IYL9	14	88005135-88014811	"G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.6;lymphoid tissue: 9.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 256.1;granulocytes: 317.8;Kupffer cells: 112.5;monocytes: 90.9;NK-cells: 319.3;T-cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;HEL: 6.2;HL-60: 7.5;HMC-1: 9.0;RH-30: 11.5"	"Not detected"	"Not detected"							"HPA072624, HPA077397"	Enhanced		Approved	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Nucleoli, Cytosol"	"HPA072624: , HPA077397: "	"unprognostic (8.56e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.80e-1)"	2.0	1.1	0.5	9.1	0.6	12.6	0.9	0.5	0.8	1.1	0.6	1.2	1.6	0.7	0.4	0.9	0.7	2.8	0.6	0.4	1.0	0.8	2.7	4.3	8.8	1.9	1.0	0.3	0.4	0.4	0.4	1.7	1.6	0.8	1.5	0.1	0.7	0.5	0.2	0.3	2.4	2.3	1.0	9.6	1.6	0.6	1.2	4.2	0.4	0.5	6.6	3.4	0.5	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.2	7.5	9.0	0.3	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	39.0	19.8	43.6	33.8	28.4	62.4	9.3	16.9	26.2	13.0	8.1	8.6	19.4	15.2	49.1	32.1	5.9	9.0	24.5	0.5	0.6	0.5	0.8	0.4	1.0	1.9	1.0	1.6	1.0	1.2	2.3	2.9	3.2	21.6	0.3	77.8	4.2	0.5	0.0	0.0	0.2	1.9	3.2	0.4	7.2	1.3	0.0	0.0	0.2	256.1	0.5	0.0	0.0	9.1	0.2	0.4	2.1	0.0	6.6	0.0	0.0	0.3	2.3	6.6	0.5	317.8	0.0	3.9	1.4	62.8	0.0	0.0	0.6	0.0	112.5	73.1	1.4	0.6	88.6	3.6	4.7	90.9	0.0	319.3	0.0	0.1	0.0	0.0	0.0	25.6	0.2	0.1	0.3	0.7	0.2	0.0	0.9	2.0	0.1	0.1	0.7	5.3	0.4	192.8	0.9	0.4	0.2
GPR82		ENSG00000171657	"G protein-coupled receptor 82"	Q96P67	X	41724181-41730130	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.7;lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 16.5;Cone photoreceptor cells: 20.9;Kupffer cells: 37.0;Rod photoreceptor cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	10	"eosinophil: 40.2;NK-cell: 10.9"	"Group enriched"	"Detected in many"	10	"granulocytes: 40.2;NK-cells: 10.9"	"Cell line enriched"	"Detected in single"	30	"HMC-1: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035914	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA035914: AB_10670671"	"unprognostic (5.62e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.41e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-1)"	0.1	0.9	0.7	2.3	0.5	0.1	0.6	0.8	0.7	0.3	0.4	1.1	1.7	0.3	0.1	0.4	0.3	0.6	0.1	0.5	1.0	0.3	0.7	0.2	3.2	1.4	0.7	0.2	0.1	0.2	0.1	0.0	0.7	0.2	1.1	0.0	0.4	0.4	0.0	0.4	2.7	0.3	0.6	1.1	0.9	0.0	1.3	0.5	0.3	0.0	6.9	0.8	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	40.2	0.0	2.5	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.3	10.9	2.4	0.0	0.0	0.2	0.7	0.5	0.8	0.7	0.5	1.0	1.4	0.7	0.7	0.6	1.3	0.8	0.7	0.0	7.2	2.0	5.5	4.7	5.2	2.8	0.6	16.5	1.2	0.3	0.4	4.3	5.9	1.8	20.9	0.9	3.7	3.1	0.0	2.0	0.2	1.0	3.4	3.1	1.2	0.8	1.7	1.1	0.2	2.9	1.5	1.4	0.0	1.4	3.3	1.3	1.3	13.5	2.2	2.0	2.0	37.0	7.7	0.2	4.1	13.9	3.6	0.0	3.4	1.7	12.3	10.6	1.1	2.8	5.1	3.0	1.3	3.6	6.9	0.3	1.1	17.2	0.0	3.4	2.3	1.6	1.1	0.3	2.7	0.7	12.6	3.9	3.4	3.8
GPR83	GPR72	ENSG00000123901	"G protein-coupled receptor 83"	Q9NYM4	11	94377316-94401419	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	9	"brain: 11.5;thyroid gland: 3.0"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 2.7;Excitatory neurons: 2.6;Inhibitory neurons: 4.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 67.5"	"Low region specificity"	"Detected in many"									NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (6.74e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.88e-1)"	"unprognostic (6.36e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.47e-12)"	"unprognostic (3.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-2)"	"unprognostic (8.28e-3)"	0.1	0.7	1.3	0.1	3.0	0.4	0.0	11.5	3.4	0.3	0.1	0.4	0.1	0.1	0.2	0.0	0.1	0.1	0.4	4.4	4.1	0.3	0.2	0.0	0.2	0.3	4.9	0.1	0.1	0.0	0.3	0.0	0.9	0.1	0.1	0.7	0.1	0.0	0.3	0.2	0.1	0.1	0.8	0.2	0.1	0.4	2.2	0.1	3.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	1.3	3.0	11.5	3.4	4.4	4.1	0.3	4.9	0.9	0.8	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	2.7	0.1	0.0	0.0	0.0	2.6	0.4	0.0	0.2	0.0	0.2	0.0	0.1	0.4	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492439-101669726	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Respiratory ciliated cells: 28.8;Squamous epithelial cells: 27.1;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 39.3;CACO-2: 28.0;HaCaT: 46.3;hTCEpi: 35.5;MCF7: 32.7;OE19: 37.9;RT4: 68.9;T-47d: 79.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.1	0.0	0.0	1.0	0.0	0.0	12.3	0.0	0.3	6.9	0.0	8.0	4.0	1.7	16.1	20.4	8.5	3.3	0.0	0.0	0.0	6.3	0.4	5.6	0.0	0.0	0.0	0.0	11.1	9.3	0.8	6.7	0.0	23.2	9.2	0.0	14.8	7.2	0.0	28.6	4.3	0.4	0.0	0.1	9.8	0.3	0.0	2.9	10.2	0.0	4.6	7.7	10.4	0.0	39.3	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	28.0	18.9	0.0	0.0	0.1	0.0	46.3	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.3	0.2	37.9	0.0	0.0	0.0	0.1	0.0	68.9	1.9	0.0	0.0	15.0	0.0	4.4	79.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.1	13.0	0.3	0.0	24.3	10.5	7.6	20.5	0.0	14.4	6.1	0.7	17.2	20.8	11.0	0.0	14.0	0.2	10.3	5.9	7.5	2.4	20.0	1.5	0.8	1.2	0.0	0.8	5.5	7.1	0.8	15.3	20.7	0.0	0.0	0.0	0.0	1.4	0.0	1.3	9.8	2.0	0.0	1.1	9.3	0.0	0.3	1.8	0.0	0.6	0.0	0.0	2.0	0.5	8.8	8.5	0.0	1.3	9.3	5.7	0.1	28.8	0.0	0.0	0.5	1.0	0.1	0.0	27.1	26.0	19.8	0.3	0.1	11.0	6.3
GRIA1	"GluA1, GLUR1, GLURA"	ENSG00000155511	"Glutamate ionotropic receptor AMPA type subunit 1"	P42261	5	153489615-153813869	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 83.7;retina: 32.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 322.4;Inhibitory neurons: 608.8"	"Cancer enriched"	"Detected in some"	15	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.6;ASC diff: 3.5;BJ: 5.5;BJ hTERT+: 2.9;LHCN-M2: 8.1;U-266/70: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035202	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035202: AB_2674516"	"unprognostic (2.51e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.14e-4)"	"unprognostic (7.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.61e-2)"	1.2	0.4	38.7	0.1	42.8	0.0	0.4	43.5	79.8	0.2	0.0	0.6	0.2	0.1	0.7	0.1	0.1	0.0	0.8	83.7	23.2	0.1	0.0	9.3	0.0	3.4	3.6	0.2	0.3	0.2	1.2	0.0	2.7	0.1	0.1	32.6	0.1	0.5	0.2	0.3	0.3	1.0	5.3	0.0	0.6	0.9	27.9	0.1	0.3	0.4	0.0	0.1	0.3	18.1	0.0	0.0	11.6	0.0	3.5	2.3	0.0	5.5	2.9	0.3	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	42.8	43.5	79.8	83.7	23.2	3.4	3.6	2.7	5.3	27.9	18.1	0.2	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	36.3	0.3	0.0	1.2	0.0	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	5.1	0.1	5.6	0.4	0.0	0.0	322.4	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.7	608.8	0.0	0.0	0.0	0.0	3.4	0.0	0.9	0.0	7.5	0.0	49.0	0.0	94.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182928	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 31.7"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 839.8;Inhibitory neurons: 904.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 31.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.4;RPMI-8226: 1.8;U-138 MG: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.3	0.3	4.7	0.0	8.4	0.0	0.1	0.0	31.7	0.3	0.0	0.2	0.3	0.3	2.5	1.1	2.1	0.1	3.0	20.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.2	2.2	0.2	0.3	0.0	0.5	0.2	0.4	0.0	0.0	0.4	2.1	0.1	0.6	0.2	0.2	0.2	0.1	0.4	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.3	1.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	8.4	0.0	31.7	20.0	0.0	0.0	0.0	0.0	0.0	0.1	10.3	0.2	0.0	0.0	16.0	0.0	1.9	2.2	0.5	3.4	10.3	0.3	0.0	18.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	2.1	17.2	0.3	0.1	0.5	0.0	0.0	839.8	0.2	0.0	2.7	0.0	0.7	0.0	3.3	0.0	0.3	0.1	1.7	904.7	0.0	0.0	0.3	0.4	15.1	0.9	0.1	0.0	15.9	0.0	15.6	0.0	27.6	65.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.9	0.0	0.0	5.4	8.2	10.0	0.2	0.4	0.0	0.0	0.0	0.1	0.3
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"	Q9C0E4	3	14489107-14556075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13.3;skeletal muscle: 35.8;tongue: 12.5"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 89.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;NTERA-2: 2.1;PC-3: 6.1;SCLC-21H: 3.4;U-2 OS: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA035673: AB_10669776"	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	1.1	1.1	3.0	0.7	2.7	0.0	1.0	0.0	6.2	1.1	0.0	0.8	0.4	1.1	0.4	2.2	0.8	1.2	13.3	0.2	3.5	2.3	0.3	0.4	0.4	2.9	5.8	3.4	0.5	0.3	1.0	3.9	2.1	0.9	1.0	0.3	0.9	0.4	35.8	2.0	1.0	1.0	1.7	1.6	4.5	0.7	9.6	0.3	0.8	12.5	0.7	1.0	1.2	1.8	0.1	0.9	0.0	0.0	0.3	0.2	0.0	0.3	3.1	0.3	1.9	1.2	0.0	0.0	0.7	0.2	0.5	0.2	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	1.5	6.1	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.3	0.0	1.0	1.1	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	6.2	0.2	3.5	2.9	5.8	2.1	1.7	9.6	1.8	2.3	0.0	0.5	2.3	0.1	0.0	0.1	0.0	1.2	14.9	0.1	1.3	8.5	0.0	0.6	0.0	14.6	0.0	0.7	0.1	0.0	0.0	3.0	2.1	1.4	0.8	4.2	0.0	3.0	0.2	0.0	2.0	2.0	4.9	0.0	0.0	1.1	0.0	0.1	0.0	89.0	0.1	0.0	0.0	0.0	5.2	4.1	0.7	0.0	2.8	0.0	0.5	0.0	0.5	0.9	0.0	0.0	2.2	0.3	0.1	0.0	0.2	0.0	21.9	19.7	4.3	14.7	0.1	0.8	0.2	0.0	0.1	0.3	1.1	0.0	0.0
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698355-24757940	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	13.5	7.8	16.4	2.9	16.7	0.5	7.6	13.3	18.0	17.3	9.2	6.4	7.7	24.8	15.3	3.6	14.3	8.5	9.7	18.1	15.0	13.3	4.5	4.4	5.8	19.4	18.7	16.9	2.6	7.3	7.0	35.0	16.1	7.5	2.4	6.3	3.1	21.1	7.8	3.0	26.8	15.1	16.5	1.8	3.9	12.9	14.1	5.8	14.5	5.2	3.8	15.0	10.1	26.6	31.4	21.7	9.6	41.2	51.4	28.6	16.4	24.1	63.6	24.5	34.3	22.9	1.1	0.5	20.6	66.4	81.7	20.5	5.8	105.4	42.8	0.1	2.1	0.8	39.3	48.0	43.0	0.1	1.5	31.3	75.3	43.5	103.1	73.0	42.3	13.8	3.0	5.2	55.3	0.4	1.9	0.8	10.2	0.1	15.7	0.2	33.6	0.0	74.5	21.9	0.4	60.0	36.5	0.6	42.3	24.3	2.2	2.8	27.9	23.1	39.7	31.6	29.2	2.4	0.6	15.5	69.8	0.1	5.8	0.0	1.9	0.0	0.0	0.2	0.0	9.0	0.1	0.0	5.9	8.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	16.4	16.7	13.3	18.0	18.1	15.0	19.4	18.7	16.1	16.5	14.1	26.6	1.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.0	0.0	0.6	5.5	0.0	168.1	0.0	0.0	41.1	1.9	0.0	0.7	16.9	1.3	0.0	0.0	0.0	0.9	26.5	4.3	0.0	1.0	0.0	4.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	8.8	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	104.7	0.7	0.9	0.0	0.0
GSK3B		ENSG00000082701	"Glycogen synthase kinase 3 beta"	P49841	3	119821321-120094994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 218.7;Inhibitory neurons: 246.3;Microglial cells: 197.7;Oligodendrocyte precursor cells: 241.8;Oligodendrocytes: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016263, HPA028017"	Approved		Supported	Nucleoplasm		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB016263: AB_2279451, HPA028017: AB_10600708"	"unprognostic (1.09e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (3.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.79e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.16e-1)"	11.0	13.6	9.2	11.7	9.5	15.1	11.2	16.6	16.9	10.0	0.0	11.7	12.3	10.3	11.1	13.8	10.1	11.1	18.2	8.2	13.8	12.0	14.8	13.9	10.4	15.2	15.3	9.3	10.7	17.3	7.1	16.3	16.5	10.0	12.4	23.6	13.2	9.3	17.5	16.3	15.3	13.3	4.9	12.9	12.6	23.1	9.6	20.0	15.1	18.0	11.7	12.0	9.5	12.5	59.3	22.7	46.8	25.5	31.9	29.5	50.3	36.6	57.6	28.3	29.3	25.9	23.8	24.1	19.1	43.0	33.8	46.0	22.2	59.1	45.8	15.5	6.6	42.2	18.4	16.6	35.6	31.6	49.9	34.3	39.5	27.0	56.8	27.3	31.5	29.3	13.6	34.6	40.5	25.1	44.0	10.7	25.2	23.3	28.3	16.9	41.0	22.2	25.1	45.3	37.1	22.6	38.5	29.0	44.1	41.1	30.9	27.0	40.0	45.5	55.1	12.7	20.6	31.9	35.2	44.8	29.4	22.0	33.9	1.0	1.8	6.3	0.7	1.6	1.2	0.5	1.0	1.7	1.4	0.7	0.9	0.8	6.6	0.5	2.1	1.1	1.2	0.8	9.2	9.5	16.6	16.9	8.2	13.8	15.2	15.3	16.5	4.9	9.6	12.5	39.3	32.1	26.7	113.6	28.3	50.9	37.8	22.2	46.1	63.2	21.9	17.0	39.7	20.0	21.4	18.4	60.5	27.0	29.0	37.3	11.7	26.9	138.2	25.2	31.6	31.5	26.9	15.4	218.7	32.0	49.3	25.1	46.4	32.5	17.2	18.1	25.0	22.9	21.5	143.0	246.3	22.3	20.3	27.3	29.2	48.1	13.1	33.4	35.6	197.7	35.5	31.6	22.6	241.8	202.5	49.0	23.4	19.9	29.0	28.7	35.8	17.3	16.3	42.4	13.1	24.4	38.2	38.8	29.3	50.8	41.1	43.0	36.4	32.7	25.9	41.6
GSN	DKFZp313L0718	ENSG00000148180	Gelsolin	P06396	9	121207794-121332843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cilium biogenesis/degradation"	"Actin capping, Actin-binding"	"Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 2486.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 1649.5;Fibroblasts: 4145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 1135.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1313.9;HaCaT: 533.6"	"Region enriched"	"Detected in all"	4	"white matter: 869.2"	"Low region specificity"	"Detected in all"			"CAB010823, CAB016728, CAB036009, HPA054026"	Supported		Supported	"Actin filaments"	"Secreted to blood"	NA	NA	112000000000	240000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments"		"CAB010823: , CAB016728: , CAB036009: , HPA054026: AB_2682347"	"unprognostic (3.25e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.79e-5)"	1892.9	162.5	169.7	109.7	317.4	175.0	1244.6	291.2	213.0	577.4	155.6	867.4	152.0	767.7	108.2	435.1	663.2	226.1	2486.9	163.4	219.8	153.1	40.6	308.7	93.2	380.9	284.6	303.8	140.7	70.9	260.6	79.0	354.7	344.0	204.6	57.8	508.7	400.9	420.4	612.9	384.1	350.0	270.6	136.5	469.7	78.1	279.0	99.7	702.6	687.8	87.3	897.2	655.5	376.1	38.4	60.9	39.0	129.8	1313.9	351.8	26.4	130.9	264.7	30.1	56.5	64.2	130.1	3.0	36.6	182.8	48.5	533.6	3.2	84.3	16.9	6.5	7.6	31.2	57.1	167.5	32.0	7.0	146.0	140.0	84.9	51.7	34.4	83.1	120.4	6.1	10.4	5.3	137.0	81.1	0.4	304.4	12.7	76.2	45.1	8.4	13.1	4.3	156.4	63.4	7.7	10.4	60.9	62.5	197.2	84.6	245.3	158.8	217.4	100.0	33.2	10.4	12.8	1.8	2.0	3.2	105.3	18.2	278.1	302.9	122.0	1135.9	1.9	84.9	0.8	17.6	0.8	1.4	345.3	6.7	0.8	0.7	307.1	217.8	23.7	243.2	4.2	105.4	169.7	317.4	291.2	213.0	163.4	219.8	380.9	284.6	354.7	270.6	279.0	376.1	1649.5	147.4	55.7	82.3	22.7	341.2	278.1	252.7	103.0	7.5	120.8	212.0	272.0	85.8	354.3	121.4	77.2	55.8	74.9	557.7	105.7	258.5	9.9	141.9	163.1	724.8	63.1	17.2	17.1	202.3	94.3	4145.2	322.7	220.6	104.0	31.8	273.5	16.5	492.6	1.7	9.0	762.9	512.7	139.0	798.7	20.2	588.7	273.7	537.2	155.5	487.5	220.6	55.6	33.2	443.1	315.8	590.5	671.8	24.1	91.4	77.4	39.8	583.7	86.5	611.4	362.4	740.4	8.7	13.7	175.9	299.1	84.0	58.7	34.3	52.2	144.7
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 61.0;Plasma cells: 28.4;Squamous epithelial cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 116.0;HSkMC: 115.6"	"Low region specificity"	"Detected in all"							"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		1200000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	73.7	84.4	92.3	11.9	109.9	10.7	81.2	86.7	104.6	165.9	111.5	115.2	26.3	70.6	43.7	61.6	102.7	22.0	99.7	93.5	104.7	86.8	35.6	45.2	14.3	94.3	97.1	240.9	54.5	53.6	113.7	9.3	91.9	159.0	17.7	25.1	55.2	80.7	218.4	88.2	65.5	34.2	93.9	52.6	88.3	41.9	105.2	15.9	97.9	108.4	12.6	108.3	144.5	90.6	0.0	3.5	37.8	38.9	44.0	116.0	7.2	24.5	42.6	22.1	28.0	6.7	0.0	0.7	25.5	61.1	18.0	0.2	3.1	0.2	28.6	1.5	0.8	14.0	0.4	9.3	29.6	1.1	25.2	115.6	1.0	32.7	0.0	58.5	16.1	11.6	4.2	0.7	48.5	0.3	19.5	24.6	6.7	0.7	32.4	23.8	0.1	0.2	6.6	0.5	8.1	18.7	0.0	1.0	13.0	21.7	38.6	7.0	0.2	24.3	1.2	35.3	1.9	11.9	19.0	1.3	36.7	0.5	0.3	1.8	3.8	29.6	3.1	6.3	3.1	8.8	8.8	3.4	23.0	6.2	34.4	15.1	2.2	18.0	4.1	29.8	9.4	10.8	92.3	109.9	86.7	104.6	93.5	104.7	94.3	97.1	91.9	93.9	105.2	90.6	2.0	0.0	4.8	16.0	4.5	4.8	2.4	0.9	20.5	1.5	4.5	4.3	61.0	2.8	11.5	3.7	0.0	0.5	6.1	0.4	0.0	0.2	1.9	2.8	10.3	5.8	0.0	10.9	1.5	0.0	0.2	19.2	14.8	2.7	2.5	4.4	1.8	0.8	1.5	3.3	2.6	1.3	2.0	0.8	2.3	10.4	15.5	3.4	5.4	11.2	0.7	7.2	8.2	12.5	0.7	0.1	0.0	10.5	28.4	0.8	0.4	1.2	9.9	0.3	6.6	5.6	13.6	0.3	0.8	27.0	2.8	0.5	5.1	4.0	0.7	1.6
GTF3C1	TFIIIC220	ENSG00000077235	"General transcription factor IIIC subunit 1"	Q12789	16	27459555-27549913	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8;dendritic cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 31.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051617, HPA075900"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA051617: AB_2681553, HPA075900: "	"unprognostic (6.46e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (8.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.32e-2)"	"prognostic favorable (9.56e-4)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.06e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.23e-3)"	18.1	28.8	24.2	9.9	24.4	16.6	16.7	21.5	32.6	31.2	40.5	21.2	8.8	26.7	7.8	65.2	24.6	11.5	38.5	24.6	21.8	25.4	21.7	20.3	12.2	20.4	20.8	24.4	35.3	18.6	47.8	11.0	19.6	40.4	9.7	18.3	24.9	12.6	50.2	51.0	18.5	15.5	17.0	21.3	24.7	26.6	22.2	18.6	34.6	20.8	11.2	19.7	35.1	21.7	27.8	60.1	43.3	50.7	37.8	30.4	24.6	29.5	33.0	40.2	34.0	45.0	25.6	30.5	42.3	36.4	30.6	30.3	55.4	37.6	32.9	13.7	53.1	25.2	49.8	63.8	21.3	29.1	32.2	37.5	28.0	49.5	21.8	26.9	40.2	34.6	31.7	24.2	32.0	67.6	32.5	34.8	58.4	15.1	28.3	59.7	53.4	31.4	25.2	28.7	54.4	36.5	29.8	24.9	18.6	34.4	44.8	21.8	43.2	40.2	24.0	25.6	30.7	25.6	24.8	30.2	16.6	31.7	30.2	2.6	3.4	3.5	31.9	3.2	23.0	3.1	3.6	15.8	4.3	2.2	3.7	10.0	2.5	12.2	3.3	6.6	4.0	6.9	24.2	24.4	21.5	32.6	24.6	21.8	20.4	20.8	19.6	17.0	22.2	21.7	16.9	19.2	23.9	29.7	10.8	18.4	7.3	14.3	23.3	45.5	10.6	11.9	27.4	10.0	17.2	12.9	93.8	7.8	86.2	18.4	5.9	11.8	2.8	40.4	37.3	18.0	30.0	7.2	30.2	11.5	4.3	22.5	19.9	22.3	19.0	26.1	13.9	13.7	10.9	26.9	33.9	17.6	18.3	10.3	7.7	4.5	19.3	12.9	3.6	14.0	10.0	15.0	52.5	17.1	23.4	15.8	9.3	15.8	29.6	13.9	10.2	9.0	30.8	35.1	13.1	16.4	15.1	17.2	18.2	34.8	20.6	4.2	32.7	25.7	12.2	6.7
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807811	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.2;Ductal cells: 22.9;Glandular and luminal cells: 15.5;Proximal tubular cells: 22.2;Smooth muscle cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 7.2;non-classical monocyte: 23.9"	"Lineage enriched"	"Detected in many"	13	"monocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 46.0;Karpas-707: 23.7;MOLT-4: 29.9;RPTEC TERT1: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	13.8	7.1	23.6	15.6	30.0	2.2	10.0	5.3	36.6	12.6	0.0	28.9	5.8	16.4	6.0	8.1	13.7	13.3	18.7	30.1	28.2	13.2	7.7	16.5	10.4	9.8	13.9	5.8	10.9	50.3	6.0	43.6	22.8	13.6	8.7	34.7	5.5	12.2	5.9	3.5	11.1	25.0	6.4	11.0	13.8	2.4	14.8	7.2	7.3	14.9	7.3	10.0	11.1	17.0	0.0	0.5	6.5	0.0	2.2	11.4	0.0	2.0	3.6	0.2	0.1	0.0	0.0	0.0	3.0	1.1	5.0	0.1	13.6	0.3	0.8	0.0	4.6	46.0	0.0	0.0	1.2	0.0	0.0	5.1	0.4	0.0	0.2	4.2	0.1	10.2	0.0	23.7	3.0	2.1	29.9	0.1	0.4	0.0	3.2	3.5	0.9	0.7	42.9	4.4	0.7	7.8	0.0	0.2	0.0	6.4	0.0	0.0	0.0	7.3	1.6	12.4	9.5	0.3	0.0	0.0	15.6	0.0	0.0	1.4	0.5	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.5	1.3	23.9	1.6	0.0	5.8	23.6	30.0	5.3	36.6	30.1	28.2	9.8	13.9	22.8	6.4	14.8	17.0	20.2	6.4	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.2	0.0	0.0	0.0	9.2	0.0	1.1	1.1	0.0	5.9	22.9	0.0	3.7	4.3	3.4	0.0	0.0	0.0	4.2	0.2	5.4	0.0	15.5	1.3	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.7	0.4	0.7	0.0	0.0
GULP1	"CED-6, CED6, GULP"	ENSG00000144366	"GULP PTB domain containing engulfment adaptor 1"	Q9UBP9	2	188291669-188595931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid transport, Phagocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 83.0"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 136.5;Inhibitory neurons: 115.5;Muller glia cells: 129.4;Syncytiotrophoblasts: 204.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 106.9;SH-SY5Y: 83.4;WM-115: 228.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020587	Enhanced		Approved	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA020587: AB_1850452"	"unprognostic (1.95e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.23e-1)"	"prognostic favorable (4.25e-6)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.04e-4)"	9.4	24.5	2.0	5.8	6.4	0.2	13.1	0.0	4.3	27.7	33.0	13.3	13.5	35.3	83.0	19.2	18.2	17.5	5.2	3.6	7.3	21.3	0.8	13.3	1.7	22.7	4.1	31.8	22.2	26.1	3.4	19.7	23.2	27.7	7.8	17.7	16.1	28.1	9.6	6.2	15.8	21.7	0.3	5.9	22.6	28.0	4.0	1.7	7.8	16.7	3.3	11.9	14.3	0.1	12.5	26.9	106.9	23.8	17.1	15.5	18.6	16.5	27.0	25.1	19.9	18.9	62.6	0.0	13.2	13.2	28.2	8.3	20.0	1.5	18.9	0.0	13.9	27.0	20.5	0.2	15.1	0.0	0.2	10.1	4.2	13.0	14.2	42.9	12.7	0.0	22.5	0.5	19.3	1.8	0.0	0.4	27.4	18.1	46.0	0.1	25.1	14.0	60.0	4.7	0.5	83.4	0.0	14.6	40.2	47.9	4.7	0.1	5.9	7.8	3.8	26.3	9.6	0.0	0.1	0.0	4.6	0.0	228.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.0	6.4	0.0	4.3	3.6	7.3	22.7	4.1	23.2	0.3	4.0	0.1	22.8	16.0	13.4	43.4	1.6	15.7	23.9	3.6	10.2	1.5	10.6	12.2	1.6	45.8	28.2	23.9	0.0	41.1	0.6	3.7	45.0	33.0	5.0	23.9	35.4	32.1	136.5	0.0	82.7	38.2	5.9	55.3	39.8	52.1	0.0	2.2	10.0	1.5	3.2	1.7	115.5	4.6	14.2	1.0	10.5	7.9	20.5	2.0	35.6	53.4	1.1	129.4	0.0	3.0	3.1	51.3	9.8	61.3	1.4	79.8	30.8	43.2	43.5	3.7	6.6	42.2	27.9	79.6	23.9	38.9	27.6	204.4	2.7	27.0	4.7	34.5
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888046-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Endometrial stromal cells: 45.4;Fibroblasts: 23.0;Late spermatids: 27.1;Oligodendrocytes: 61.3;Skeletal myocytes: 40.0;Theca cells: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 22.3;JURKAT: 22.1;MOLT-4: 36.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	6.0	3.8	2.6	5.2	5.3	1.8	4.0	4.3	3.2	5.7	2.6	3.7	0.6	5.6	2.5	3.2	5.1	10.1	13.6	2.0	2.4	0.9	0.3	3.8	1.5	6.2	5.8	16.5	4.2	2.4	1.9	4.0	4.1	3.3	2.0	0.4	5.3	4.0	0.8	1.7	1.2	5.5	5.3	0.7	1.3	5.8	4.6	6.7	8.8	1.5	1.0	5.7	3.6	6.9	0.2	1.8	0.1	11.2	9.9	19.3	1.7	1.8	4.2	4.0	9.8	0.5	1.2	0.0	3.1	4.9	22.3	0.1	1.0	2.2	3.8	0.0	1.3	0.0	7.2	12.4	12.6	4.9	0.0	18.8	1.1	9.7	1.6	6.0	0.0	22.1	5.8	0.1	2.4	2.7	36.5	0.1	6.6	0.1	2.2	0.2	9.5	0.0	1.3	1.7	1.1	5.0	9.8	0.5	1.3	2.0	3.7	1.5	0.1	4.3	13.5	13.3	6.5	1.0	0.1	0.2	11.1	2.3	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.3	0.0	2.6	5.3	4.3	3.2	2.0	2.4	6.2	5.8	4.1	5.3	4.6	6.9	1.6	3.2	2.6	7.2	0.1	1.9	1.9	5.3	0.0	0.6	1.5	7.6	14.6	2.8	2.3	0.0	0.0	0.2	1.5	1.4	0.0	0.1	47.9	5.7	45.4	0.6	3.5	0.0	8.3	1.1	0.3	23.0	0.0	7.5	0.0	8.0	0.7	0.0	0.4	0.0	9.0	2.9	0.0	0.0	4.0	27.1	8.1	0.5	0.0	12.2	0.0	2.5	0.0	3.0	61.3	0.8	0.4	7.2	0.0	2.0	0.6	0.5	2.1	0.4	0.0	40.0	3.9	2.5	4.2	0.2	0.4	0.8	0.4	22.9	1.6	0.4
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102646-55110252	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.1"	"Group enriched"	"Detected in many"	24	"dendritic cells: 739.3;NK-cells: 1543.8;T-cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	15	"gdT-cell: 941.4;MAIT T-cell: 926.2;memory CD4 T-cell: 250.0;memory CD8 T-cell: 922.7;naive CD8 T-cell: 494.1;NK-cell: 718.8"	"Group enriched"	"Detected in all"	42	"NK-cells: 718.8;T-cells: 941.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.0;JURKAT: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054134, HPA076751"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054134: AB_2682395, HPA076751: "	"prognostic favorable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	5.6	6.0	0.9	16.7	0.9	35.3	7.2	0.9	2.5	7.6	1.2	14.7	29.2	14.7	8.8	4.8	4.6	14.0	4.0	0.8	1.0	3.2	15.2	21.9	68.1	1.6	0.9	4.5	1.0	1.3	1.0	3.1	1.1	3.1	17.8	0.0	7.1	3.0	1.7	1.6	27.6	7.2	1.1	51.1	11.7	2.0	1.1	12.4	2.9	1.3	19.2	13.5	2.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.5	3.8	941.4	2.3	926.2	3.4	250.0	922.7	3.1	1.3	48.5	494.1	19.9	718.8	4.0	3.2	33.1	712.7	0.9	0.9	0.9	2.5	0.8	1.0	1.6	0.9	1.1	1.1	1.1	1.1	5.1	3.2	18.1	0.0	12.3	0.4	0.1	0.0	2.8	0.0	2.7	2.4	1.6	5.7	3.1	0.0	0.0	0.4	739.3	1.4	0.0	1.6	0.0	1.7	2.7	2.8	0.0	36.2	0.0	0.0	0.2	7.8	20.4	2.1	7.6	0.0	17.9	2.8	0.3	0.0	0.1	1.5	0.0	25.8	2.6	0.0	0.0	12.3	3.6	0.0	12.6	0.0	1543.8	0.0	0.1	0.0	3.9	0.0	40.8	0.1	2.8	3.3	2.9	0.0	0.0	2.6	2.6	0.0	0.1	1.1	1.4	0.7	709.4	0.0	1.8	0.0
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2050.2;NK-cells: 1704.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 22.0"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	8.2	1.7	1.2	17.8	1.3	68.2	2.1	1.2	3.9	1.2	1.4	2.5	2.3	7.1	1.6	3.8	1.5	6.5	1.8	1.2	7.9	1.5	4.1	15.3	37.1	1.5	1.5	0.3	1.0	0.7	0.7	3.3	1.6	1.4	2.2	0.0	2.3	1.4	2.0	0.4	4.4	4.3	1.4	28.9	3.5	0.5	1.8	9.7	1.9	1.5	34.6	18.5	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.7	2.8	9.9	3.0	5.3	1338.5	4.0	16.0	7.0	95.2	641.6	6.3	3.1	29.1	607.5	43.1	507.8	6.0	6765.2	2.7	1607.1	1.2	1.3	1.2	3.9	1.2	7.9	1.5	1.5	1.6	1.4	1.8	1.3	4.3	6.4	36.0	0.0	15.9	2.8	0.3	0.0	0.0	0.0	0.9	0.8	1.1	4.3	7.4	0.0	0.0	0.4	2050.2	0.6	0.0	1.6	0.0	0.4	0.5	2.7	0.0	11.8	0.0	0.0	0.1	5.1	9.2	0.5	17.7	0.0	4.2	1.2	0.2	0.0	0.0	0.6	0.0	4.8	9.0	0.2	0.0	27.1	42.7	1.0	11.6	0.0	1704.4	0.0	0.1	0.1	2.3	0.0	86.8	0.2	0.6	3.1	4.4	0.0	0.0	1.3	1.3	0.0	0.1	0.4	4.1	0.3	373.8	0.0	0.6	0.1
H2AZ2	"H2AFV, H2AV, MGC10170, MGC10831, MGC1947"	ENSG00000105968	"H2A.Z variant histone 2"	Q71UI9	7	44826791-44848087	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 238.5;Cytotrophoblasts: 174.1;dendritic cells: 85.4;Extravillous trophoblasts: 435.9;Hofbauer cells: 242.8;Syncytiotrophoblasts: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA057236	Supported					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA057236: AB_2683377"	"unprognostic (2.16e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (8.04e-4)"	"unprognostic (4.86e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.25e-1)"	67.9	82.0	98.4	95.7	106.3	316.8	68.2	115.2	106.2	65.9	75.2	106.5	78.2	71.8	69.7	85.5	64.3	57.3	142.7	91.1	100.5	92.8	90.1	77.1	145.2	94.0	104.7	61.7	72.3	83.3	59.0	65.4	97.6	70.3	103.9	141.7	65.9	66.4	139.3	60.2	96.1	78.0	104.0	90.5	87.3	92.8	110.0	288.1	79.4	134.9	170.7	69.2	64.3	103.9	278.2	280.7	368.9	313.8	147.1	115.0	154.2	184.0	202.9	202.4	245.3	234.7	356.1	349.7	195.1	234.4	393.3	308.2	286.9	237.9	319.6	335.1	175.4	221.8	461.0	298.4	103.6	566.6	296.1	92.3	103.0	236.6	209.2	165.6	248.5	379.1	402.8	383.2	306.3	575.2	536.8	919.1	282.0	342.3	266.2	433.4	411.5	331.0	219.7	244.9	233.7	318.9	330.8	369.3	142.3	363.1	328.6	558.4	220.1	181.9	533.3	168.3	459.5	354.6	401.1	619.7	188.6	448.7	589.5	104.7	62.0	229.9	62.2	54.1	80.5	77.7	86.7	83.4	96.4	76.1	63.2	61.2	74.6	77.0	50.3	147.0	169.1	48.2	98.4	106.3	115.2	106.2	91.1	100.5	94.0	104.7	97.6	104.0	110.0	103.9	34.6	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	238.5	0.0	0.0	0.0	0.0	174.1	85.4	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	435.9	37.0	0.0	0.0	0.0	0.0	0.0	0.0	242.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	106.9	17.1	0.0	0.0	0.0
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 295.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 209.8;Proximal enterocytes: 236.8;Proximal tubular cells: 162.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 23.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 23.2;granulocytes: 19.2;monocytes: 17.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 49.4;REH: 9.9;THP-1: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced					NA	NA		580000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	8.7	5.4	1.8	5.9	2.1	4.1	12.9	2.1	2.5	16.0	3.3	13.2	23.1	10.5	14.5	6.0	10.6	6.1	7.0	1.8	2.3	41.8	295.8	5.7	6.1	2.0	2.5	14.0	26.3	2.9	4.5	8.5	2.3	10.1	11.6	0.3	3.8	11.3	2.4	5.0	40.8	4.7	2.1	5.4	9.6	1.8	2.1	4.0	5.8	3.2	4.5	15.8	9.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	4.6	14.0	0.1	0.0	0.1	0.6	0.0	0.0	4.7	0.0	0.8	0.0	1.4	5.6	0.0	49.4	0.4	1.9	0.1	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.6	0.2	0.0	9.9	1.1	0.3	0.0	0.0	0.1	0.0	0.6	1.0	0.0	1.3	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	7.9	17.4	19.2	0.0	10.5	0.0	3.5	0.0	0.0	23.2	3.9	0.0	0.1	5.5	0.7	2.9	7.7	0.0	5.6	1.8	2.1	2.1	2.5	1.8	2.3	2.0	2.5	2.3	2.1	2.1	2.3	2.5	0.0	1.1	3.6	3.5	4.0	6.3	2.3	14.8	0.1	2.9	7.6	0.6	14.3	1.6	1.8	0.0	1.1	2.9	18.3	17.6	7.4	0.0	0.6	8.1	1.9	6.7	12.0	3.4	13.3	0.5	18.0	1.5	0.3	30.4	1.2	4.6	209.8	21.3	0.0	2.2	14.9	0.0	13.5	4.9	0.2	12.5	8.7	5.4	8.4	8.4	3.6	1.0	5.5	1.0	4.8	28.7	10.5	0.5	2.1	236.8	162.7	0.5	0.3	13.1	37.7	13.8	0.4	0.7	6.0	4.8	1.2	1.2	2.2	25.5	2.7
HABP4	"IHABP4, SERBP1L"	ENSG00000130956	"Hyaluronan binding protein 4"	Q5JVS0	9	96450169-96491336	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.3"	"Group enriched"	"Detected in many"	10	"Early spermatids: 224.6;Late spermatids: 808.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055969, HPA062366"	Enhanced		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Cytosol	"HPA055969: AB_2682991, HPA062366: "	"unprognostic (1.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.62e-2)"	21.9	12.8	62.7	7.0	70.1	1.8	16.8	55.1	73.3	16.1	40.8	19.2	3.0	13.5	7.0	7.6	13.5	8.8	28.1	62.3	63.9	27.0	7.6	10.8	8.3	66.2	65.4	15.6	6.6	12.9	22.6	3.5	66.1	12.5	4.2	16.0	6.2	11.1	16.8	9.5	10.4	9.7	59.5	7.5	12.5	43.9	61.3	4.6	13.7	13.4	5.3	18.4	13.0	68.9	14.8	16.6	20.6	22.3	44.7	37.9	14.6	19.5	21.8	14.5	15.7	24.9	24.0	7.5	9.4	29.4	45.9	10.6	17.4	3.7	11.6	9.0	10.3	2.9	7.8	42.0	22.7	0.7	3.0	15.5	6.7	16.5	13.0	21.9	10.4	8.4	3.4	21.6	26.4	15.2	0.3	4.6	9.6	20.5	15.8	7.6	17.9	0.3	24.8	6.4	13.0	8.8	10.6	6.2	32.5	15.2	4.5	3.2	17.8	19.8	4.6	36.6	16.8	13.2	14.0	3.3	15.9	5.9	29.8	0.0	0.0	0.0	0.5	0.1	0.5	1.9	1.6	1.3	0.0	1.1	1.1	1.1	0.1	0.4	0.3	0.0	1.3	0.2	62.7	70.1	55.1	73.3	62.3	63.9	66.2	65.4	66.1	59.5	61.3	68.9	22.2	0.0	7.4	27.1	5.9	11.5	10.8	0.9	4.0	22.6	3.8	6.9	11.0	14.3	5.5	18.4	0.0	2.5	5.5	0.9	17.6	4.7	224.6	7.3	9.0	14.6	13.1	0.8	47.4	5.8	7.4	13.3	1.5	8.1	1.3	13.0	15.0	6.3	6.6	23.5	33.2	0.9	4.1	1.3	9.3	808.8	13.7	6.0	17.8	10.3	2.7	22.2	3.1	18.6	37.5	6.3	0.0	23.7	5.1	10.0	1.1	43.7	1.8	15.6	6.6	5.8	26.4	26.8	15.4	0.9	8.0	1.4	13.3	3.0	1.3	6.0
HACL1	"2-HPCL, HPCL, PHYH2"	ENSG00000131373	"2-hydroxyacyl-CoA lyase 1"	Q9UJ83	3	15560699-15601852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 117.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 117.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035496, HPA035497, HPA073760"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633"	"unprognostic (6.64e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (5.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.62e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.07e-2)"	14.4	12.0	7.5	8.2	7.8	11.6	14.6	10.4	10.5	9.1	7.9	10.0	56.6	8.3	16.6	7.5	10.8	8.8	11.0	7.6	7.0	26.0	51.8	9.7	14.1	7.4	7.2	7.5	15.2	20.0	7.8	7.8	7.0	10.8	12.0	12.2	9.1	9.1	17.6	10.6	27.7	9.5	7.4	11.4	13.2	26.7	6.8	13.9	20.4	10.6	14.5	10.3	6.4	10.0	15.1	28.6	8.2	30.7	13.4	12.4	82.3	14.2	22.0	26.6	26.3	27.3	14.3	14.6	9.7	18.7	10.5	10.4	18.7	25.3	23.8	13.6	36.4	25.4	17.7	24.7	20.3	30.5	23.1	13.7	16.2	37.9	16.6	8.3	31.4	18.3	24.0	21.2	22.9	28.7	14.0	12.6	19.7	19.7	29.7	14.4	21.5	19.6	26.4	20.2	9.6	12.3	22.4	19.0	25.2	12.8	8.5	25.4	22.5	14.1	14.6	17.4	24.7	27.2	50.9	28.5	27.1	26.4	17.2	117.3	16.0	18.3	14.4	20.1	21.2	15.4	15.5	18.0	16.0	21.2	14.8	16.1	3.4	24.1	24.2	10.2	19.8	13.0	7.5	7.8	10.4	10.5	7.6	7.0	7.4	7.2	7.0	7.4	6.8	10.0	12.4	9.6	17.3	34.9	22.1	10.3	12.0	13.5	20.5	19.3	9.1	10.2	6.4	14.3	15.6	11.0	29.2	27.2	15.7	6.1	13.7	16.0	66.6	12.6	6.0	12.3	9.1	8.2	67.4	25.2	18.0	12.0	11.2	5.4	13.3	12.7	8.9	24.3	13.2	13.5	55.8	7.5	10.2	9.3	8.1	56.8	23.3	8.8	12.4	25.3	19.3	24.8	8.2	40.7	38.8	14.5	11.2	15.4	21.4	9.0	41.9	39.7	29.8	38.3	6.6	9.0	11.2	51.1	24.4	8.6	7.1	18.9	19.4	15.1	10.6	7.9
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 5.3;testis: 7.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	0.2	0.1	0.0	1.8	0.2	6.0	0.4	0.0	0.1	0.2	0.2	1.1	1.5	0.2	0.1	1.3	0.3	0.2	0.1	0.0	0.0	0.1	0.1	1.4	4.2	0.1	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	1.0	0.0	0.4	0.0	0.6	0.7	1.8	0.4	0.0	1.7	0.9	7.3	0.2	5.3	0.3	0.1	5.1	0.3	0.5	0.2	11.3	12.2	11.1	12.5	0.7	1.4	9.3	10.2	7.8	19.7	19.3	9.6	4.6	27.7	5.7	5.7	7.9	18.0	20.1	9.9	18.7	0.1	16.7	13.8	9.9	5.8	0.5	8.1	13.7	0.9	0.8	14.9	9.2	2.4	9.1	21.6	12.4	23.7	10.1	5.9	16.4	4.8	9.8	8.7	8.3	16.8	13.9	7.4	3.0	7.8	4.4	6.5	8.9	6.1	3.5	9.6	6.1	7.5	4.7	8.7	9.9	9.8	18.1	4.5	5.4	13.4	5.1	11.5	10.7	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
HCFC1R1	"FLJ20568, HPIP"	ENSG00000103145	"Host cell factor C1 regulator 1"	Q9NWW0	16	3022625-3024286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 511.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 396.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 376.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059647	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059647: AB_2684094"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.03e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.23e-1)"	82.6	98.5	174.5	20.9	178.9	17.9	74.8	164.1	248.1	124.9	129.3	131.5	30.4	140.6	29.2	59.0	81.7	43.1	138.7	172.0	182.0	180.5	48.2	72.0	24.2	181.5	182.7	86.7	44.0	40.9	97.7	32.1	185.2	102.8	18.8	21.6	50.6	87.4	511.6	76.3	53.1	47.5	154.0	45.9	65.6	36.6	181.0	17.0	68.0	196.2	18.3	85.2	103.0	174.1	59.6	175.6	32.5	38.1	123.0	160.9	33.4	26.0	115.0	57.8	161.2	37.9	75.8	49.2	66.1	108.3	52.8	81.0	32.7	121.5	26.3	62.7	88.4	21.3	132.2	65.5	105.2	37.3	39.5	205.7	73.9	62.1	63.4	376.5	81.5	33.0	30.4	81.6	63.3	63.0	20.1	53.0	70.5	34.7	36.5	70.1	31.3	124.6	209.4	13.7	57.3	48.4	54.7	70.7	78.5	77.5	48.6	28.1	35.5	98.4	256.8	85.8	50.7	53.0	59.1	40.7	42.9	22.1	23.8	5.3	36.3	16.3	20.1	28.2	19.3	23.2	25.5	21.7	44.9	21.7	18.5	22.9	8.0	25.8	26.5	22.1	36.7	17.9	174.5	178.9	164.1	248.1	172.0	182.0	181.5	182.7	185.2	154.0	181.0	174.1	51.3	57.7	15.0	17.9	30.7	85.4	58.0	123.7	92.2	29.3	45.2	80.0	45.8	47.1	37.4	198.6	6.2	116.2	23.7	53.7	240.7	49.7	5.2	38.0	56.0	38.3	43.7	37.0	19.3	26.5	120.7	98.4	34.1	45.3	40.0	26.1	60.3	45.9	117.9	20.2	19.8	40.9	40.7	57.5	57.0	15.8	96.3	42.2	64.0	13.1	51.0	52.6	39.1	6.6	19.0	26.7	55.4	178.3	35.0	37.8	114.2	396.2	28.4	28.1	124.9	39.7	149.2	15.2	44.3	69.5	65.8	53.9	35.0	26.7	45.9	41.3
HEATR9	"C17orf66, FLJ32830"	ENSG00000270379	"HEAT repeat containing 9"	A2RTY3	17	35854946-35868891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 10.1"	"Group enriched"	"Detected in some"	17	"Early spermatids: 88.4;Late spermatids: 36.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA023129	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA023129: AB_1845599"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.44e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.61e-10)"	"unprognostic (6.78e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.61e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	88.4	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.0	36.4	0.6	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.5;Hofbauer cells: 340.2;Syncytiotrophoblasts: 493.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 746.0;GAMG: 646.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	92.2	72.0	22.1	59.7	25.3	59.9	83.0	22.3	32.5	97.6	39.4	105.0	99.0	71.5	321.4	38.5	66.7	99.0	84.3	23.1	26.2	81.6	137.5	111.3	47.0	23.8	22.9	62.4	103.6	94.2	46.6	319.4	24.7	98.7	116.9	33.6	123.4	54.0	43.3	54.3	75.4	76.1	23.2	64.7	88.4	19.6	28.2	29.1	89.6	38.4	40.4	94.6	64.1	30.4	147.3	111.0	39.4	131.8	746.0	232.3	122.3	173.5	590.4	175.0	375.2	130.6	194.5	0.0	133.0	152.2	646.3	115.2	43.2	185.2	228.7	79.2	72.6	19.1	101.4	101.5	216.5	16.2	152.3	206.7	108.0	180.7	121.3	275.9	204.5	47.3	54.3	236.9	194.9	145.7	19.8	36.6	36.8	142.7	47.8	43.9	56.2	191.8	119.8	130.4	24.5	30.4	134.2	92.6	180.0	68.8	99.1	108.6	118.5	112.1	26.6	207.8	165.6	102.6	191.3	0.9	257.9	143.6	209.8	86.2	343.2	99.1	69.3	129.9	80.7	45.2	56.1	64.0	310.8	28.1	52.6	51.3	125.2	42.4	82.5	93.4	73.2	269.0	22.1	25.3	22.3	32.5	23.1	26.2	23.8	22.9	24.7	23.2	28.2	30.4	49.6	41.7	38.4	5.9	31.5	44.0	82.8	103.2	21.6	10.2	26.3	27.6	19.8	82.9	63.8	29.5	8.4	466.5	32.8	68.2	19.6	151.3	1.3	21.0	21.4	56.2	22.8	23.1	32.2	125.6	175.4	107.2	33.6	26.9	69.8	19.8	74.3	70.1	340.2	10.1	24.3	56.7	107.8	127.3	134.3	3.4	85.1	168.8	72.9	17.8	114.2	35.4	29.9	22.6	13.3	65.8	54.8	72.2	71.5	74.2	99.5	79.6	36.3	16.3	46.0	32.6	49.5	0.3	1.4	23.8	32.5	493.6	35.3	31.4	81.8	71.0
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689955-92695647	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 84.7;liver: 91.2;thyroid gland: 102.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5"	"Group enriched"	"Detected in all"	5	"liver cancer: 20.1;thyroid cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	43	"basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7"					"Low region specificity"	"Detected in many"			"HPA003257, HPA051894"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003257: , HPA051894: AB_2681653"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	16.2	18.5	5.0	22.2	5.4	84.7	11.2	5.6	8.8	7.1	5.1	7.8	6.4	6.4	3.5	4.1	6.1	27.4	6.1	4.8	5.2	7.0	91.2	16.9	39.1	6.3	5.4	3.0	38.1	1.9	2.2	14.6	6.4	4.7	6.5	0.3	3.5	4.0	2.9	4.6	19.0	5.8	6.2	39.9	5.2	2.4	6.0	4.4	102.1	6.3	30.4	12.7	5.0	6.7	11.2	20.6	10.5	0.1	0.9	0.7	0.2	5.6	46.4	7.4	6.6	4.0	2.6	10.7	87.7	0.7	0.0	2.1	9.5	0.3	9.1	0.1	11.1	99.9	8.8	67.4	21.0	58.6	105.6	0.3	0.2	6.5	0.0	3.7	106.1	0.3	154.8	0.1	0.5	3.2	0.4	101.8	0.2	30.2	11.8	34.0	3.0	0.1	0.9	4.3	4.9	1.0	6.2	0.0	0.1	0.5	3.3	30.6	37.2	0.0	0.6	0.1	0.1	2.6	1.8	21.2	0.0	79.7	51.4	28.0	41.5	61.8	0.8	45.7	0.3	59.3	0.0	0.1	30.8	65.8	0.1	0.1	31.4	1.0	50.7	36.3	0.4	15.5	5.0	5.4	5.6	8.8	4.8	5.2	6.3	5.4	6.4	6.2	6.0	6.7	31.9	0.0	3.0	0.0	77.2	6.4	2.1	0.9	2.2	0.0	3.0	3.2	3.6	125.8	1.6	0.0	0.0	0.7	57.6	0.4	0.0	107.9	0.3	0.8	0.5	80.0	5.3	28.2	0.0	12.0	0.7	2.2	0.5	1.0	7.0	0.0	88.9	58.3	72.6	0.0	0.0	1.6	0.0	63.5	29.1	1.1	0.3	51.7	7.2	5.6	50.4	0.0	9.2	0.5	0.0	10.5	0.0	1.2	1.6	3.2	0.0	0.2	0.9	0.2	0.0	1.9	2.1	0.3	6.3	1.0	3.7	1.1	8.3	3.4	0.7	1.3
HHIPL1	KIAA1822	ENSG00000182218	"HHIP like 1"	Q96JK4	14	99645129-99680569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 33.3;Bipolar cells: 10.5;Excitatory neurons: 8.3;Inhibitory neurons: 12.2;Muller glia cells: 13.1;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;fHDF/TERT166: 5.6;SiHa: 3.7;THP-1: 3.9"	"Low region specificity"	"Detected in many"												"Secreted in other tissues"	NA	NA		120000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (6.16e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.49e-6)"	"unprognostic (2.52e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.12e-6)"	1.6	0.3	7.0	1.1	8.7	0.1	0.8	4.1	8.4	1.5	3.0	2.0	0.5	2.5	0.4	0.8	1.3	1.2	1.6	7.2	4.6	0.7	0.6	0.7	1.0	4.9	4.7	1.0	0.2	0.3	0.9	0.6	4.5	1.7	0.3	2.1	0.8	0.9	0.3	0.5	0.9	1.8	4.0	0.9	0.8	0.4	6.3	0.1	0.5	0.4	0.6	1.3	1.1	4.2	0.0	0.2	0.4	0.1	0.1	0.0	1.7	1.6	0.4	0.3	0.1	0.1	0.5	0.1	3.1	5.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.9	0.1	1.2	0.2	0.1	1.4	0.1	0.0	0.1	0.9	0.2	0.0	0.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.6	3.7	0.0	0.0	0.6	0.0	3.9	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	8.7	4.1	8.4	7.2	4.6	4.9	4.7	4.5	4.0	6.3	4.2	1.6	0.0	0.0	33.3	0.1	0.0	0.0	0.0	0.0	10.5	0.3	0.8	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	2.0	1.7	0.0	0.0	8.3	0.0	0.1	2.6	0.0	0.0	0.0	0.9	0.7	0.3	1.9	0.0	12.2	0.0	0.0	2.1	0.7	0.2	0.3	0.3	3.6	6.5	0.0	13.1	0.0	13.0	6.2	0.0	1.4	1.9	0.0	0.1	0.1	0.0	0.0	1.7	0.0	0.9	0.9	0.3	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.1
HIC1	"ZBTB29, ZNF901"	ENSG00000177374	"HIC ZBTB transcriptional repressor 1"	Q14526	17	2054154-2063241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 38.6;Fibroblasts: 44.3;Leydig cells: 57.5;Peritubular cells: 48.2;Sertoli cells: 46.0;Smooth muscle cells: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.9"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.9;BJ: 11.9;HSkMC: 7.1;TIME: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043372	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA043372: AB_10795614"	"unprognostic (1.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (2.20e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-2)"	24.5	8.6	5.0	5.7	4.0	1.3	16.5	3.4	3.8	23.9	2.8	16.1	6.5	27.0	1.5	5.7	21.5	4.4	23.4	3.0	3.1	12.4	5.9	15.2	2.1	5.7	4.5	30.0	3.8	0.9	19.7	1.4	4.1	20.1	1.7	0.5	5.2	4.5	8.5	5.3	11.7	3.2	3.9	8.9	9.8	4.9	5.6	2.3	12.6	1.2	0.5	17.9	13.9	2.4	0.6	0.7	0.8	0.6	4.7	6.9	1.4	11.9	6.4	1.6	2.3	0.6	0.3	0.1	0.2	6.2	0.6	1.1	0.7	0.2	0.5	0.4	1.5	0.3	0.8	0.3	4.0	0.2	0.5	7.1	0.8	2.4	0.1	3.3	6.2	0.6	1.8	2.8	0.4	0.0	0.1	0.4	0.2	0.0	0.4	0.7	0.3	0.3	0.2	0.4	0.4	0.7	0.2	0.1	0.0	0.2	0.0	0.1	12.4	4.3	0.1	4.2	6.2	0.4	0.4	0.2	0.4	0.4	1.1	0.0	0.0	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.0	4.0	3.4	3.8	3.0	3.1	5.7	4.5	4.1	3.9	5.6	2.4	25.6	0.0	1.8	1.0	3.9	4.0	2.1	1.5	1.2	2.1	1.9	1.8	5.8	0.0	1.0	1.8	0.0	0.1	19.2	0.1	0.0	0.5	0.5	2.0	38.6	26.9	1.8	0.4	0.2	1.1	0.7	44.3	1.1	1.6	2.5	0.2	23.9	0.3	0.5	0.0	0.3	0.1	2.0	8.5	6.0	1.6	57.5	15.5	3.6	6.5	0.2	0.3	12.3	0.0	0.0	0.2	0.1	48.2	2.3	1.1	0.2	0.1	1.0	1.6	46.0	12.5	30.1	0.8	2.9	1.1	4.1	0.1	13.0	13.3	0.0	2.6
HIRIP3		ENSG00000149929	"HIRA interacting protein 3"	Q9BW71	16	29992330-29996074	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 129.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051897, HPA063205"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051897: AB_2681655, HPA063205: AB_2684963"	"unprognostic (6.99e-2)"	"prognostic favorable (2.74e-5)"	"unprognostic (4.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (8.53e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.35e-2)"	12.3	11.6	24.4	9.0	25.5	15.8	11.8	23.9	24.7	13.3	19.0	16.0	8.3	13.5	10.6	9.6	12.2	7.1	19.2	22.9	23.8	12.6	14.9	11.6	13.1	25.5	24.6	16.8	11.0	15.6	14.5	6.8	25.4	11.9	7.3	20.1	11.1	12.8	33.5	14.6	10.9	8.6	24.1	12.9	10.6	38.7	24.4	25.6	11.7	21.7	12.3	14.2	11.5	25.7	27.4	27.7	44.2	28.5	13.9	14.8	13.4	20.9	16.1	21.2	18.2	24.8	26.8	52.7	42.5	13.7	15.3	19.0	28.8	26.6	15.8	47.8	28.1	56.7	36.2	26.9	11.5	50.3	42.4	7.4	19.4	20.9	32.3	12.4	13.4	50.6	27.2	57.0	12.9	20.0	66.1	26.3	13.0	17.8	15.5	65.9	52.6	52.5	14.9	12.2	28.6	34.7	21.7	16.3	14.5	11.3	24.2	30.6	15.4	28.4	21.8	20.3	20.5	37.1	31.0	31.4	26.8	43.2	38.1	4.6	7.5	15.0	16.7	12.0	11.4	19.1	18.6	15.3	6.3	14.6	19.3	17.9	3.4	14.3	20.8	19.1	22.9	10.8	24.4	25.5	23.9	24.7	22.9	23.8	25.5	24.6	25.4	24.1	24.4	25.7	19.1	67.3	26.3	2.0	14.9	12.7	17.1	11.2	14.8	36.4	14.6	19.6	30.4	10.0	15.8	9.2	14.6	30.6	18.7	12.5	29.4	10.5	27.6	12.6	10.9	15.4	9.6	27.0	2.1	12.1	28.9	14.6	4.6	10.9	31.0	12.1	10.8	16.7	18.7	15.2	2.7	10.8	14.2	8.2	11.9	12.0	20.5	9.8	5.4	1.0	8.8	37.3	32.0	3.5	4.7	6.3	11.4	22.6	22.0	6.7	25.6	19.9	19.9	49.4	13.1	14.7	18.6	129.5	46.2	10.2	11.4	11.5	20.9	12.1	14.0	8.3
HLA-C	"D6S204, HLA-JY3, PSORS1"	ENSG00000204525	"Major histocompatibility complex, class I, C"	P10321	6	31268749-31272130	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1445.7"	"Cell type enhanced"	"Detected in all"		"NK-cells: 3899.1;Proximal enterocytes: 3582.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 760.0;EFO-21: 795.5;RPTEC TERT1: 462.7;U-266/70: 481.6;U-266/84: 401.0;U-698: 289.3"														"Intracellular and membrane"	NA	NA		240000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.16e-2)"	538.6	417.5	0.7	274.6	2.4	122.3	507.4	0.8	0.9	464.4	1.5	594.3	1.6	434.8	259.5	277.6	411.7	103.9	424.3	0.3	1.1	561.0	485.7	1078.3	334.0	1.6	0.9	266.3	245.3	0.2	269.6	34.5	0.9	344.2	27.7	13.7	389.5	0.4	190.6	449.6	750.0	51.0	1.3	1445.7	419.4	62.3	1.2	2.4	382.9	0.3	0.7	372.7	377.5	0.8	760.0	1.1	0.0	0.0	120.1	94.1	1.7	3.1	0.9	1.1	2.3	0.9	0.0	0.4	795.5	190.8	208.7	0.5	0.0	188.1	0.0	1.4	170.4	0.8	8.1	0.1	0.8	0.5	0.5	80.5	0.2	0.5	0.0	272.4	0.0	92.5	0.4	0.0	0.0	0.0	7.8	4.8	0.5	0.0	0.8	1.9	0.3	1.9	462.7	0.0	0.9	1.5	0.2	0.1	2.2	0.3	0.3	3.3	0.6	196.4	65.8	2.3	2.5	481.6	401.0	289.3	0.3	8.2	0.2	1.9	2.8	2.3	0.7	0.8	0.6	0.4	0.4	0.6	0.4	0.4	0.4	0.5	2.8	0.8	0.3	0.1	0.9	46.1	0.7	2.4	0.8	0.9	0.3	1.1	1.6	0.9	0.9	1.3	1.2	0.8	1903.4	227.6	328.1	13.1	1576.5	729.1	757.8	1082.3	236.8	33.4	457.0	342.8	61.2	807.8	662.7	483.7	10.4	39.5	2429.1	1994.0	84.1	1966.4	25.6	233.7	343.8	1466.2	482.2	301.2	3.9	1511.3	1010.7	608.5	648.8	557.2	344.1	256.3	1390.0	469.2	1579.0	99.3	5.8	1375.7	923.7	2050.7	1492.7	32.1	507.3	1595.9	836.0	76.8	2570.1	207.3	3899.1	18.6	3.8	1272.7	2195.7	333.6	2482.6	1038.0	3582.3	232.5	548.5	24.0	1203.0	336.7	558.8	142.0	43.5	192.6	651.7	121.6	2212.1	786.8	1003.1	1160.6
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941028	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.8;lymphoid tissue: 101.5"	"Group enriched"	"Detected in many"	4	"B-cells: 228.5;dendritic cells: 129.4;Hofbauer cells: 274.8;Kupffer cells: 201.9;Langerhans cells: 472.8;Macrophages: 272.4;monocytes: 187.1;Proximal enterocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 128.8;dendritic cells: 85.3;monocytes: 73.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 14.2;Daudi: 27.6;EFO-21: 12.4;U-266/70: 7.8;U-698: 31.9"					"Low region specificity"	"Detected in all"			"HPA012298, HPA077524"	Supported		Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"	38.3	35.9	0.1	13.2	0.2	6.9	25.7	0.3	1.0	21.6	0.1	19.9	0.0	14.6	7.4	9.3	14.6	0.1	11.1	0.0	0.6	41.9	7.8	59.9	17.6	0.3	0.4	9.5	9.1	0.0	9.2	0.8	0.2	13.1	14.9	0.5	14.7	0.0	5.3	14.3	78.8	0.0	0.9	101.5	17.6	2.2	0.1	9.9	45.9	0.0	18.8	14.4	10.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	27.6	12.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	7.8	0.4	31.9	0.0	0.1	0.0	0.5	73.2	16.7	1.2	73.8	2.6	94.0	1.0	2.9	85.0	128.8	0.7	2.4	4.7	16.2	28.1	85.3	6.7	71.4	0.1	0.2	0.3	1.0	0.0	0.6	0.3	0.4	0.2	0.9	0.1	1.1	36.8	9.6	57.0	0.7	228.5	12.0	1.0	5.4	2.2	0.2	2.5	4.7	2.6	5.7	12.7	16.5	0.0	1.7	129.4	3.3	11.7	28.8	0.5	7.5	5.4	37.2	4.2	10.3	0.8	4.4	1.6	3.8	3.1	38.5	15.2	22.7	5.7	0.5	274.8	0.0	0.6	8.5	2.0	201.9	472.8	1.5	3.4	272.4	16.0	27.2	187.1	0.5	21.6	1.0	0.1	2.5	17.8	1.9	3.8	1.3	284.8	7.4	16.8	1.1	6.6	1.6	3.1	0.6	0.7	1.1	10.9	2.7	17.6	0.9	10.3	8.7
HLTF	"HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3"	ENSG00000071794	"Helicase like transcription factor"	Q14527	3	149030127-149086554	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 143.4;Spermatogonia: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015284, HPA049001"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA015284: AB_1857263, HPA049001: AB_2680594"	"unprognostic (3.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.07e-2)"	12.2	23.6	10.3	7.4	11.9	11.5	13.8	20.7	12.0	11.1	17.6	9.9	5.3	13.6	10.2	7.5	11.5	9.3	19.0	10.3	13.4	16.9	18.5	7.8	11.9	13.1	12.6	18.8	13.6	17.2	12.4	8.2	13.9	15.7	7.5	27.6	11.1	11.6	11.6	5.6	6.8	12.1	15.1	8.7	9.9	44.7	12.2	15.8	21.0	11.4	11.2	8.3	6.0	17.5	66.7	31.8	44.3	34.6	29.0	37.3	4.3	44.1	26.2	32.0	37.0	25.8	45.1	42.7	52.3	20.6	62.3	1.9	60.1	17.5	52.9	23.7	29.1	102.6	23.6	10.5	18.1	27.2	40.7	23.7	9.3	23.9	13.9	48.4	18.7	68.1	36.5	26.9	44.2	33.5	56.4	40.9	33.5	33.3	39.3	64.2	49.8	6.6	26.2	21.1	43.5	25.6	66.9	30.4	60.8	23.3	91.5	25.9	13.2	37.1	22.4	53.1	48.5	39.3	23.5	55.4	36.2	36.3	14.6	8.2	1.0	3.5	4.3	1.7	8.0	6.9	3.8	5.8	3.4	4.9	5.6	5.7	0.0	4.7	1.9	7.8	3.9	2.8	10.3	11.9	20.7	12.0	10.3	13.4	13.1	12.6	13.9	15.1	12.2	17.5	19.5	25.6	20.4	56.8	15.6	5.6	8.5	12.9	10.8	99.3	20.1	16.5	46.4	18.6	18.5	31.3	41.7	10.2	29.9	1.9	35.2	10.1	9.9	36.7	31.1	14.3	4.9	71.5	67.5	8.4	10.1	27.6	12.8	11.7	55.7	55.8	13.2	17.2	8.7	47.1	88.7	6.9	18.3	4.6	3.1	12.3	33.8	11.9	5.4	28.1	5.2	35.4	12.3	66.4	68.7	7.4	3.6	32.4	19.3	8.2	2.0	19.2	26.2	76.2	13.1	37.5	23.8	143.4	113.2	11.5	4.3	1.6	22.1	100.6	7.5	6.6
HMGCLL1	"bA418P12.1, DKFZP434G1411"	ENSG00000146151	"3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1"	Q8TB92	6	55434373-55579197	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 49.9;Excitatory neurons: 80.7;Inhibitory neurons: 76.2;Oligodendrocytes: 23.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.74e-3)"		"unprognostic (1.54e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.97e-3)"		"unprognostic (2.12e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.13e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.52e-1)"	1.4	3.6	6.1	0.2	5.9	0.0	1.4	5.9	5.2	0.8	0.0	0.8	0.2	0.2	0.0	1.0	0.4	0.6	1.8	5.5	10.6	0.9	0.7	2.6	0.3	5.6	6.3	0.4	1.6	0.1	4.7	6.2	6.6	3.0	0.8	4.5	0.8	1.0	1.1	0.1	0.9	0.5	9.2	0.0	1.0	2.6	8.3	0.6	0.4	2.8	0.2	0.9	0.7	9.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.2	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.9	5.9	5.2	5.5	10.6	5.6	6.3	6.6	9.2	8.3	9.4	0.6	0.0	1.3	49.9	0.0	0.0	0.0	0.0	1.2	15.1	3.7	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.5	0.0	0.0	80.7	0.0	0.0	5.8	0.0	0.0	0.0	3.5	3.9	0.0	0.1	0.0	76.2	0.0	0.0	0.3	0.0	1.3	0.3	0.1	0.0	15.0	0.0	1.5	0.0	5.5	23.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.9	5.6	1.3	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
HMGN1	"FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425"	ENSG00000205581	"High mobility group nucleosome binding domain 1"	P05114	21	39342315-39349647	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012260, HPA048694"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB012260: AB_304786, HPA048694: AB_2680496"	"unprognostic (4.49e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.21e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (5.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (8.74e-7)"	"unprognostic (3.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.84e-2)"	"unprognostic (8.98e-3)"	56.1	73.7	54.1	120.5	52.3	202.4	121.4	52.0	63.7	115.8	54.6	126.0	121.3	78.8	187.6	124.8	100.2	72.9	39.1	53.3	58.7	114.4	100.8	72.5	219.1	57.1	57.5	72.9	92.2	132.1	73.8	111.6	55.7	93.2	136.2	245.5	97.1	75.2	16.2	82.5	133.6	65.3	57.2	100.9	113.2	64.8	56.4	238.7	117.2	26.3	294.9	114.2	73.8	58.5	517.7	135.9	450.3	316.3	74.5	131.1	299.7	266.6	191.8	261.0	233.0	262.6	420.6	1161.6	246.8	223.7	309.8	106.5	317.4	377.9	336.1	459.5	317.7	883.6	225.7	355.8	187.0	768.2	291.3	167.4	349.9	260.2	350.6	222.4	363.6	513.6	680.2	191.6	436.7	686.7	780.2	691.0	798.0	682.3	237.8	853.2	224.7	466.0	469.5	308.3	386.3	362.2	582.8	364.1	356.0	183.1	479.5	807.5	239.6	127.2	128.7	94.0	279.7	235.6	394.8	690.7	179.4	882.9	341.4	103.7	76.4	282.5	138.0	68.9	153.5	228.9	175.2	143.7	216.5	205.8	195.2	172.2	53.8	174.5	67.7	294.9	221.5	231.4	54.1	52.3	52.0	63.7	53.3	58.7	57.1	57.5	55.7	57.2	56.4	58.5	169.9	93.0	139.7	55.2	420.4	278.5	532.0	674.9	233.9	265.1	650.7	412.6	56.1	307.4	349.0	285.1	331.5	599.2	405.1	306.8	737.6	479.9	642.8	304.4	287.3	223.3	345.2	275.6	34.9	350.5	970.7	196.6	221.7	309.2	219.9	277.8	135.7	176.2	533.9	240.6	55.1	442.1	514.7	176.1	389.6	180.6	175.8	279.6	243.7	45.0	415.1	427.8	358.4	96.5	68.8	381.0	307.4	200.1	335.9	684.7	327.8	625.4	226.8	1301.8	32.9	122.0	179.5	81.9	149.1	399.7	313.7	602.1	326.1	289.2	537.1	699.9
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 612.2"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 327.1;Extravillous trophoblasts: 285.2;Hofbauer cells: 494.9;Kupffer cells: 954.1;Macrophages: 271.5;Syncytiotrophoblasts: 502.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 98.8;intermediate monocyte: 238.8;non-classical monocyte: 329.2"	"Lineage enriched"	"Detected in all"	7	"monocytes: 329.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 869.1;GAMG: 631.2;U-138 MG: 506.2;U-87 MG: 489.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA		170000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	150.2	48.9	40.9	64.6	48.8	99.3	20.6	42.4	66.3	28.2	46.4	35.2	106.0	10.4	7.6	48.4	40.7	52.6	18.2	40.6	46.6	96.2	136.5	113.6	57.2	52.3	46.5	139.0	41.7	7.4	9.6	72.2	56.3	6.7	31.1	1.7	15.1	4.0	107.1	74.1	64.5	38.7	45.9	612.2	19.9	17.8	60.7	25.1	11.3	21.4	49.4	46.2	29.2	56.2	12.2	179.1	1.8	37.7	170.9	49.6	869.1	83.2	57.6	42.9	48.6	82.1	11.3	0.1	18.3	83.3	631.2	10.1	11.4	1.9	16.1	308.6	9.2	4.3	51.5	179.3	218.9	11.5	54.8	146.3	4.2	282.3	19.7	74.6	130.9	0.5	0.0	87.4	152.5	6.9	0.2	4.3	18.1	130.4	20.7	1.2	15.6	28.4	35.2	104.5	2.7	2.4	215.8	19.1	15.5	92.5	8.9	3.0	44.3	506.2	22.1	82.5	82.5	53.5	77.0	9.3	489.4	5.7	8.6	11.3	98.8	7.7	1.1	238.8	0.4	24.8	0.7	1.7	44.6	2.9	0.1	0.5	47.1	5.3	329.2	1.1	1.8	70.9	40.9	48.8	42.4	66.3	40.6	46.6	52.3	46.5	56.3	45.9	60.7	56.2	19.3	3.2	19.0	0.0	11.5	16.4	27.5	11.0	10.8	0.0	25.0	9.1	2.9	24.3	10.5	5.5	0.0	50.5	3.5	59.1	21.5	13.6	2.1	39.6	12.9	327.1	16.0	5.7	0.2	1.5	285.2	64.1	9.2	74.6	11.4	98.4	23.6	23.6	494.9	0.0	0.4	8.3	18.3	954.1	175.8	4.1	31.1	271.5	35.6	1.9	184.7	0.4	9.2	0.5	1.4	8.3	26.1	5.3	2.5	110.6	61.5	157.9	7.1	0.6	0.0	40.8	52.7	0.9	4.4	5.5	15.6	502.0	6.8	6.9	6.1	118.3
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 299.3;Kupffer cells: 263.7;Proximal tubular cells: 268.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"classical monocyte: 110.9;intermediate monocyte: 89.8;myeloid DC: 68.3;non-classical monocyte: 52.2"	"Group enriched"	"Detected in many"	23	"dendritic cells: 68.3;monocytes: 110.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 227.2;HSkMC: 87.9;RT4: 117.1;SuSa: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		130000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	70.4	18.2	13.0	41.7	13.3	12.6	62.3	13.1	18.8	57.3	19.2	53.9	29.3	62.8	27.1	17.5	34.5	68.7	21.7	15.6	19.1	109.7	245.9	49.0	35.1	16.0	15.3	91.0	29.0	40.2	9.5	46.8	18.1	37.0	56.4	6.1	30.5	44.3	5.9	17.4	29.1	33.1	16.1	37.5	29.1	10.3	14.5	8.2	14.6	11.9	16.4	49.7	24.5	22.2	0.7	0.9	5.6	14.6	61.9	64.6	0.4	3.9	6.2	0.4	2.3	29.7	15.7	0.9	50.2	17.0	0.8	1.1	11.9	0.0	0.1	0.7	4.9	0.2	44.5	227.2	28.0	0.3	0.6	87.9	0.1	21.5	0.0	4.7	15.9	0.1	0.5	0.7	47.4	3.7	0.0	0.5	28.1	39.3	5.6	0.5	1.5	0.2	67.9	117.1	0.1	0.8	22.1	28.4	0.1	107.9	1.0	53.2	4.8	4.8	11.8	6.2	16.3	0.4	0.3	0.7	20.9	27.8	3.3	1.3	110.9	0.7	0.5	89.8	0.3	1.8	0.2	0.2	68.3	0.5	0.3	0.4	3.9	0.5	52.2	1.5	0.7	32.6	13.0	13.3	13.1	18.8	15.6	19.1	16.0	15.3	18.1	16.1	14.5	22.2	15.5	28.9	44.1	9.4	5.0	35.6	81.5	64.6	30.7	0.7	78.1	65.4	2.2	133.0	88.9	60.7	0.0	54.9	2.6	59.4	123.3	122.1	1.5	28.3	50.6	9.4	16.4	16.8	16.8	48.0	81.6	54.2	20.9	115.3	0.0	17.4	19.2	165.7	299.3	0.0	13.8	67.8	24.4	263.7	97.2	4.2	131.4	127.4	56.9	31.9	122.0	25.5	4.1	45.8	14.3	71.0	108.6	105.3	0.2	39.8	31.9	268.3	38.4	0.8	78.9	55.2	55.7	0.5	0.9	33.2	25.9	37.6	4.0	43.9	83.5	126.1
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130780	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.6;Basal squamous epithelial cells: 31.9;Distal tubular cells: 15.6;Hepatic stellate cells: 16.8;Proximal tubular cells: 13.1;Squamous epithelial cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"medulla oblongata: 19.3;pons: 16.1;spinal cord: 15.6;white matter: 14.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.0;HEK 293: 22.2;REH: 21.0;WM-115: 29.1"	"Region enriched"	"Detected in single"	46	"pons and medulla: 11.3"					HPA060088	Approved		Supported	"Nuclear bodies"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA060088: AB_2684200"	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	16.2	10.0	0.0	2.1	0.0	0.7	10.5	0.1	0.1	5.5	0.0	13.2	4.9	5.9	13.0	15.3	22.1	3.6	1.9	0.0	0.0	16.3	1.5	14.7	1.3	19.3	1.6	6.8	1.9	25.8	0.0	0.1	16.1	5.9	2.4	0.0	0.6	5.8	18.8	4.9	8.2	4.6	15.6	6.9	13.4	1.6	0.0	1.9	3.7	8.2	0.4	7.7	4.6	14.1	9.5	3.1	0.0	29.0	0.0	0.0	1.9	0.9	0.9	3.0	3.0	5.9	1.9	2.5	0.1	2.8	2.7	4.0	1.1	0.4	2.3	0.1	22.2	0.0	0.9	13.7	3.3	3.3	5.4	3.2	2.4	10.2	0.8	0.0	10.3	0.8	0.0	0.0	10.0	2.5	0.0	11.2	0.0	3.3	7.2	21.0	4.4	0.2	14.6	2.2	1.4	0.0	2.9	0.0	11.2	1.0	0.7	1.7	13.5	0.0	4.6	7.6	0.2	0.0	0.0	1.0	6.1	5.1	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	19.3	1.6	16.1	15.6	0.0	14.1	11.6	0.0	0.0	0.0	0.1	0.9	3.1	0.0	31.9	0.0	3.6	7.7	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.7	15.6	0.0	0.4	0.2	2.6	5.2	3.0	0.8	0.0	0.0	0.9	5.4	0.5	0.1	0.0	0.4	16.8	0.0	0.2	0.0	0.0	0.9	0.0	0.6	0.3	0.4	0.0	0.9	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.7	1.4	0.7	1.0	13.1	0.0	0.0	0.0	8.3	5.8	0.4	3.2	12.5	1.3	0.1	0.8	1.4	2.0	2.5
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119937	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.6;endometrium 1: 35.9;vagina: 25.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.0;Collecting duct cells: 14.7;Distal enterocytes: 10.6;Distal tubular cells: 15.6;Endometrial stromal cells: 25.3;Endothelial cells: 13.5;Enteroendocrine cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HEK 293: 40.3;RPTEC TERT1: 32.3;SCLC-21H: 11.8;SiHa: 18.4;U-251 MG: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	66	"spinal cord: 6.6"	HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		No	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA065871: AB_2685573"	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	2.0	0.1	0.0	0.5	0.0	0.0	2.6	0.0	0.0	20.6	0.0	18.7	0.0	35.9	0.5	0.5	4.1	0.1	0.0	0.0	0.0	19.9	0.0	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	16.8	5.8	0.0	0.1	6.7	0.1	1.5	0.1	18.1	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.2	2.2	25.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.2	6.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.1	12.0	0.0	0.0	0.5	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.9	0.0	32.3	0.0	11.8	3.1	18.4	0.0	0.1	2.2	0.0	0.0	2.7	0.0	2.1	1.0	14.4	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.0	0.0	0.0	0.0	0.0	0.9	6.2	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	14.7	0.0	0.0	0.1	10.6	15.6	0.0	0.0	1.2	25.3	13.5	24.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.8	0.2	1.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	1.1	0.0	0.2	0.0	4.4	2.9
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122719-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 42.2;endometrium 1: 57.8;kidney: 52.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.4;Collecting duct cells: 23.9;Distal tubular cells: 37.2;Endothelial cells: 39.2;Leydig cells: 34.2;Peritubular cells: 26.7;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.3;HEK 293: 16.1;RPTEC TERT1: 19.0;SH-SY5Y: 21.7;SK-MEL-30: 13.2;TIME: 16.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	80	"spinal cord: 8.0"	HPA068683			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"		"HPA068683: AB_2686018"	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (9.58e-4)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	11.6	6.4	0.0	1.3	0.0	0.0	13.9	0.0	0.0	42.2	0.0	29.3	0.1	57.8	14.8	3.5	16.1	0.9	0.2	0.0	0.0	52.1	0.1	0.7	2.4	0.5	0.0	11.1	0.3	0.3	0.0	0.5	0.1	32.3	2.9	0.0	1.2	8.0	1.6	5.8	3.0	15.2	0.5	2.4	0.5	5.6	0.1	0.5	1.4	0.2	0.8	6.1	35.3	0.8	0.1	0.0	0.0	0.0	0.5	0.4	0.2	1.6	1.1	1.3	1.1	0.0	0.0	0.0	11.3	1.6	0.8	7.6	0.1	0.0	0.9	0.0	16.1	0.0	0.8	0.0	0.1	0.0	0.0	3.6	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	19.0	7.1	4.3	21.7	5.5	0.0	13.2	1.1	0.0	0.0	16.9	0.0	3.6	5.3	6.0	0.0	0.0	0.0	1.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.1	0.8	38.4	0.0	0.0	0.0	0.4	2.4	1.9	0.0	0.0	0.0	0.8	0.5	0.7	0.0	0.0	23.9	0.0	0.0	1.0	8.5	37.2	0.0	0.2	0.8	10.9	39.2	7.8	0.0	0.0	0.0	0.2	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	3.0	1.3	34.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	26.7	0.0	1.1	0.0	3.0	0.0	0.0	39.5	1.9	3.3	2.2	1.4	0.1	1.8	0.0	1.1	13.9	3.8	0.8
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729470-169757944	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 71.0;Distal tubular cells: 92.0;Extravillous trophoblasts: 61.2;Granulosa cells: 56.4;Hofbauer cells: 56.3;Proximal tubular cells: 63.9;Theca cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (5.63e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	19.3	18.6	18.6	16.4	19.9	16.8	21.2	19.6	26.0	19.6	22.0	22.0	12.2	23.3	24.8	15.7	17.1	13.1	22.5	19.2	19.7	18.1	22.1	14.3	21.1	20.2	19.3	22.7	14.4	16.0	19.5	16.8	20.9	17.3	17.7	21.3	13.2	15.7	21.3	19.6	12.8	24.8	19.6	17.5	15.8	14.1	19.6	26.9	18.8	20.9	21.1	16.8	16.8	22.2	33.7	21.0	71.2	37.7	42.6	52.4	30.3	59.9	58.8	72.8	76.7	14.3	35.5	17.5	15.7	39.2	53.3	14.7	49.5	43.6	76.7	55.1	33.7	57.0	30.0	20.5	29.9	48.7	20.1	34.1	43.2	47.1	14.5	44.1	64.1	59.1	43.7	66.2	64.4	27.3	102.7	42.4	29.2	32.2	27.0	44.7	33.8	21.2	41.9	21.9	17.2	63.1	39.7	17.2	56.3	49.1	34.0	43.1	31.3	24.8	39.2	58.4	54.3	31.3	49.8	52.4	68.3	47.0	40.3	19.3	20.0	22.4	28.7	24.0	34.6	22.0	33.0	35.1	26.1	18.1	32.1	33.3	5.3	25.4	23.7	17.9	38.1	21.9	18.6	19.9	19.6	26.0	19.2	19.7	20.2	19.3	20.9	19.6	19.6	22.2	41.6	44.8	26.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	19.9	29.6	0.0	0.0	17.3	27.6	0.0	71.0	14.3	0.0	92.0	45.7	0.0	31.9	36.9	20.1	0.0	0.0	0.0	46.3	61.2	26.1	0.0	21.9	17.7	56.4	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	31.1	0.0	0.0	1.6	0.0	0.0	63.9	15.3	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.3	10.5	56.0	0.0	0.0
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.1;Distal enterocytes: 44.9;Glandular and luminal cells: 41.6;Suprabasal keratinocytes: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	5.7	3.0	5.5	3.1	6.2	0.1	3.4	1.7	6.5	5.0	2.1	8.8	2.7	4.3	4.8	3.3	7.4	7.1	1.5	6.1	5.3	4.2	0.7	4.1	1.2	4.6	2.9	5.9	0.6	0.9	0.5	3.9	3.6	2.4	5.1	0.2	1.8	3.5	0.9	5.1	4.3	5.4	3.2	1.0	1.7	0.8	5.8	1.2	1.2	2.2	1.4	14.3	5.0	4.1	2.6	6.1	0.0	0.0	2.7	28.5	4.2	4.6	15.3	13.3	8.8	1.1	21.8	0.0	13.4	10.6	13.5	17.3	0.0	6.3	17.7	10.1	0.0	1.4	9.7	0.0	8.4	4.5	2.4	10.0	3.7	30.4	10.5	18.4	19.1	0.2	0.0	0.1	5.8	0.0	0.0	1.9	0.0	2.6	5.4	0.4	1.6	0.6	23.2	3.6	0.2	0.0	6.6	4.6	0.0	0.2	0.0	3.5	28.8	14.8	9.4	15.3	23.4	0.0	1.7	0.1	22.5	3.9	13.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	5.5	6.2	1.7	6.5	6.1	5.3	4.6	2.9	3.6	3.2	5.8	4.1	11.5	6.4	1.1	33.3	0.1	46.1	8.9	7.4	6.8	0.0	0.5	0.5	0.5	0.0	19.3	1.8	0.0	0.2	0.0	44.9	0.0	0.6	0.3	20.5	6.9	20.2	3.5	0.0	34.6	0.7	1.0	16.7	8.6	41.6	2.5	28.8	2.5	0.0	27.2	0.0	19.1	15.1	4.1	12.5	12.3	0.2	3.7	9.8	0.0	2.8	0.1	0.0	0.0	2.0	1.1	14.0	21.0	0.0	0.0	6.2	29.1	0.7	5.0	0.2	0.0	6.8	2.8	1.8	3.3	2.2	41.5	0.5	1.0	0.2	15.8	19.3
HS2ST1	KIAA0448	ENSG00000153936	"Heparan sulfate 2-O-sulfotransferase 1"	Q7LGA3	1	86914635-87109982	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.9;Excitatory neurons: 126.1;Inhibitory neurons: 130.1;Oligodendrocyte precursor cells: 95.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043069, HPA043603, HPA075001"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.58e-2)"	8.0	25.7	11.5	9.4	13.8	3.8	8.1	8.0	12.2	10.5	13.2	9.3	9.7	9.1	9.9	7.0	6.7	10.6	7.0	11.9	11.4	13.8	17.2	8.2	11.8	10.1	11.0	12.7	10.1	13.4	6.6	8.3	8.1	9.5	9.0	19.3	6.7	9.9	4.4	8.2	9.3	7.8	8.8	12.7	8.3	9.3	12.2	10.6	12.9	4.7	11.6	9.4	5.9	8.4	24.4	20.4	59.0	38.5	31.9	92.3	20.4	23.3	30.5	19.2	21.2	78.1	30.6	53.3	22.1	16.4	33.2	14.5	27.2	19.5	30.8	42.1	22.2	64.0	21.0	63.0	13.4	33.6	31.0	38.2	17.0	31.0	25.6	30.4	28.8	29.7	44.6	27.4	28.1	8.6	33.8	20.2	19.8	26.5	12.9	41.2	55.7	11.6	23.5	50.3	12.6	19.0	30.6	26.2	27.2	15.2	17.2	15.2	25.7	24.0	29.8	42.2	29.7	25.1	19.9	49.7	14.8	23.6	25.0	6.2	1.1	1.0	1.3	0.6	1.6	1.1	1.5	1.5	0.7	2.8	1.4	0.9	1.2	1.1	2.8	0.7	0.9	1.0	11.5	13.8	8.0	12.2	11.9	11.4	10.1	11.0	8.1	8.8	12.2	8.4	13.0	16.0	12.4	160.9	14.2	16.6	8.6	9.3	19.9	10.9	11.9	7.6	12.8	14.3	15.2	20.2	4.2	8.2	5.7	13.5	13.7	18.2	5.5	7.1	23.6	13.8	23.4	12.2	126.1	11.5	9.3	16.9	11.2	8.0	19.0	74.2	18.2	28.9	37.7	8.4	130.1	12.5	18.3	12.8	13.5	3.8	6.8	15.3	12.4	53.4	8.2	28.8	5.2	95.0	54.5	11.3	7.7	20.3	24.0	7.3	17.6	18.3	11.2	17.7	0.0	21.1	16.8	10.1	15.0	12.8	15.8	4.4	12.9	77.4	13.5	7.1
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452473-119637199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 320.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 225.1;Oligodendrocytes: 221.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 75.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		450000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	74.4	85.0	37.2	41.9	50.2	19.7	44.4	51.1	50.0	68.8	47.2	64.5	79.3	34.1	53.0	50.9	39.1	52.5	68.6	34.9	50.7	84.4	320.0	75.6	33.2	50.6	49.5	34.8	55.2	75.5	26.5	53.4	49.2	56.8	65.9	27.2	44.9	79.0	59.8	51.8	87.6	39.5	44.7	36.6	53.8	20.9	49.9	31.9	133.9	52.8	39.7	57.7	31.5	56.3	68.8	59.8	104.1	143.7	261.8	120.3	57.9	63.4	80.3	57.3	103.0	49.4	112.8	84.4	128.0	70.6	81.0	68.7	77.0	144.4	84.3	94.6	79.8	118.1	62.0	96.9	65.8	38.0	169.9	110.0	56.3	64.9	54.7	69.3	103.9	59.4	41.0	48.9	64.2	64.0	59.2	23.6	82.1	161.1	43.1	68.7	103.0	104.8	92.2	192.7	81.1	70.6	149.0	23.4	78.7	93.3	88.7	68.2	67.6	52.7	38.1	66.5	53.1	26.3	55.3	32.6	63.7	104.4	56.7	75.5	27.3	49.9	6.5	15.5	7.3	11.1	5.8	5.3	21.3	10.3	5.5	5.2	4.9	6.9	17.1	13.8	4.1	12.2	37.2	50.2	51.1	50.0	34.9	50.7	50.6	49.5	49.2	44.7	49.9	56.3	38.9	73.7	125.2	47.3	28.2	14.9	42.5	43.2	24.5	19.7	31.1	22.1	76.4	64.3	52.3	36.8	14.6	64.3	19.1	40.0	84.1	39.9	8.8	29.0	48.9	32.3	33.0	42.1	92.9	35.8	29.3	35.6	48.4	35.8	68.4	25.3	32.2	225.1	77.9	15.2	102.8	45.8	22.4	51.8	13.8	13.4	34.5	46.7	8.8	49.6	85.7	47.3	9.2	78.4	221.5	20.5	29.6	51.1	23.1	24.8	85.7	65.4	33.8	18.6	6.6	29.2	32.2	30.6	22.7	34.7	17.2	65.0	15.7	57.2	55.3	39.7
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204655-33206831	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 125.2;Proximal tubular cells: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 79.5;T-47d: 62.0;U-266/70: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		97000	"Cluster 35: T-regs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	9.6	24.6	10.1	6.5	10.5	9.7	17.0	9.9	11.3	13.7	10.9	18.0	19.7	7.2	29.4	25.5	23.6	7.9	20.3	9.6	10.8	30.7	67.4	11.2	10.5	11.3	11.9	8.6	55.3	42.2	14.1	5.6	12.3	11.3	16.2	11.8	25.1	16.5	20.8	25.9	18.8	7.3	11.4	12.1	15.1	5.9	10.8	13.3	32.9	25.0	15.1	9.8	12.8	11.3	7.0	15.0	6.8	9.3	2.3	4.4	1.3	0.8	4.7	0.1	0.1	5.8	17.5	45.4	11.2	1.2	2.2	29.1	7.2	11.7	1.0	8.6	0.0	2.6	14.0	27.1	20.0	0.0	3.8	5.0	28.9	0.2	49.4	0.4	2.1	13.6	0.3	46.2	4.1	9.4	31.2	1.3	2.1	23.3	2.9	11.0	1.2	79.5	27.8	1.3	12.1	7.6	2.9	34.3	7.6	4.6	62.0	1.8	1.3	0.7	7.3	0.6	0.4	65.5	42.4	16.6	3.1	1.0	1.7	0.1	5.8	2.0	18.7	13.4	30.0	16.6	24.0	29.2	11.6	13.1	26.4	28.5	0.7	16.8	14.6	20.8	21.8	26.7	10.1	10.5	9.9	11.3	9.6	10.8	11.3	11.9	12.3	11.4	10.8	11.3	12.5	19.2	21.6	3.3	18.6	29.7	28.3	55.0	21.6	12.4	31.3	34.8	31.8	48.6	25.9	22.0	6.2	29.9	9.7	21.2	125.2	27.9	6.3	20.0	6.0	10.1	18.0	12.8	0.3	32.4	12.9	9.1	16.3	13.7	7.0	9.8	10.0	83.2	17.4	1.7	0.5	26.6	20.3	10.3	16.4	18.1	7.5	7.9	49.8	1.0	8.1	32.6	6.2	1.0	0.7	21.9	21.1	6.0	47.6	15.4	74.8	137.2	33.3	14.8	0.0	11.3	9.8	8.1	8.5	40.0	37.2	17.4	18.0	29.8	44.4	31.5
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989147	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 42.5;Hepatocytes: 68.9;Hofbauer cells: 53.9;Proximal enterocytes: 45.3;Proximal tubular cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"basophil: 61.8;eosinophil: 27.3"	"Lineage enriched"	"Detected in many"	38	"granulocytes: 61.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 91.0;Hep G2: 66.2;HMC-1: 98.1;U-2197: 96.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Approved		Enhanced	"Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	27.3	25.7	5.7	10.9	6.2	4.4	17.1	14.7	9.1	8.5	3.5	15.9	19.5	9.5	2.1	12.3	9.4	11.5	11.7	5.9	5.9	27.7	136.5	11.2	8.4	6.3	5.4	8.6	25.6	8.0	5.4	4.5	6.6	8.2	5.8	1.6	10.0	4.5	7.0	18.5	18.4	9.8	5.6	16.3	11.1	6.0	7.1	2.8	6.3	4.5	5.5	13.9	8.7	6.9	20.3	23.2	2.4	11.5	7.9	28.5	1.4	24.8	38.7	4.8	10.0	1.7	34.4	1.2	8.1	30.3	0.8	6.1	2.2	3.6	2.4	91.0	5.4	1.6	18.6	66.2	7.4	0.5	98.1	13.7	6.0	23.1	4.6	11.2	2.2	1.2	4.9	1.0	18.3	43.6	0.6	14.4	1.9	8.5	3.2	2.5	7.8	22.3	15.1	1.3	8.4	4.1	3.2	15.9	2.2	1.1	31.1	1.6	11.5	10.0	2.8	96.1	2.7	1.6	15.4	1.1	39.1	2.5	0.8	61.8	1.4	27.3	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.2	0.0	0.1	1.2	0.5	0.0	0.6	0.0	0.7	5.7	6.2	14.7	9.1	5.9	5.9	6.3	5.4	6.6	5.6	7.1	6.9	7.6	3.2	4.2	3.3	1.2	7.9	2.6	4.1	4.0	0.7	13.6	9.8	1.7	27.1	2.2	14.7	0.0	2.0	0.5	10.8	15.6	42.5	37.5	1.9	7.1	11.1	7.8	4.8	0.2	30.3	3.5	26.0	8.2	4.2	9.5	9.0	6.8	68.9	53.9	1.7	0.4	11.4	6.1	7.3	15.9	2.2	6.5	11.4	14.2	0.0	12.8	2.1	0.0	0.5	1.2	20.7	14.0	5.3	1.9	1.8	45.3	46.7	1.3	0.5	13.1	9.4	6.3	0.8	1.2	4.9	12.6	1.4	1.7	6.5	23.5	2.8
HTR2A	"5-HT2A, HTR2"	ENSG00000102468	"5-hydroxytryptamine receptor 2A"	P28223	13	46831546-46897076	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Behavior, Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.2;choroid plexus: 5.6"	"Cell type enriched"	"Detected in some"	8	"Excitatory neurons: 81.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;ASC TERT1: 4.6;BEWO: 1.4;HEL: 1.5;U-138 MG: 2.3;U-2 OS: 1.4;U-87 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014011	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014011: AB_1856709"	"unprognostic (8.01e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.94e-5)"	"unprognostic (4.78e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.28e-2)"	0.9	0.3	6.7	0.8	9.7	0.1	0.5	0.0	15.2	0.6	5.6	0.5	0.4	0.5	0.0	0.5	0.3	1.6	0.7	11.8	8.7	0.1	0.1	0.3	0.0	0.5	1.4	0.3	0.0	0.0	0.2	0.0	2.9	0.2	0.6	0.8	0.0	0.6	0.3	0.1	0.4	2.6	0.1	0.0	0.2	0.6	1.6	0.7	0.1	0.6	0.2	0.8	0.5	5.8	0.0	0.0	0.0	0.0	1.8	4.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	1.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	6.7	9.7	0.0	15.2	11.8	8.7	0.5	1.4	2.9	0.1	1.6	5.8	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.2	8.6	0.1	0.0	0.0	81.7	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.0	10.1	0.0	0.0	0.3	0.0	2.2	0.9	1.9	0.0	3.7	0.0	4.6	0.0	2.5	3.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1
HYAL2	"LuCa-2, LUCA2"	ENSG00000068001	"Hyaluronidase 2"	Q12891	3	50317790-50322782	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 282.8"	"Group enriched"	"Detected in many"	5	"Adipocytes: 497.6;Endothelial cells: 216.3;Hepatic stellate cells: 253.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HUVEC TERT2: 363.3;TIME: 502.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036436	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA036436: AB_10670104"	"unprognostic (9.97e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-3)"	"unprognostic (3.44e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.93e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (7.36e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.62e-2)"	97.4	62.6	24.7	29.1	23.0	3.1	93.9	24.9	28.3	51.6	24.3	34.0	17.9	66.1	10.3	39.7	55.6	47.5	92.2	22.3	24.8	85.1	32.2	186.8	40.0	26.0	24.9	29.1	27.9	25.7	41.6	87.4	27.5	37.2	11.5	3.3	37.5	22.0	30.9	37.1	38.7	37.4	27.1	282.8	38.6	22.0	28.1	9.5	80.9	35.7	14.6	47.0	45.8	24.9	26.8	38.5	63.0	64.1	38.2	32.9	39.6	29.8	41.2	42.0	32.6	44.6	77.3	7.0	102.4	43.6	82.5	27.4	24.6	58.7	12.0	14.2	19.6	9.7	34.9	69.2	33.0	8.1	24.4	51.9	48.8	42.1	13.8	38.1	363.3	18.2	17.6	8.0	35.4	37.0	17.7	16.6	72.0	23.2	55.7	15.5	12.4	26.1	52.4	24.2	16.6	53.3	30.4	31.2	31.8	21.2	34.4	20.3	502.9	50.0	49.7	33.5	47.5	13.9	24.1	21.6	29.4	25.5	73.0	0.0	9.5	10.7	1.4	14.1	3.0	1.1	1.3	3.8	5.3	1.5	0.4	0.7	9.2	2.8	13.6	4.0	1.9	3.3	24.7	23.0	24.9	28.3	22.3	24.8	26.0	24.9	27.5	27.1	28.1	24.9	497.6	19.2	9.9	5.2	3.6	13.0	28.6	45.2	11.4	7.8	17.6	16.6	7.3	32.9	30.9	33.1	6.2	33.6	4.1	13.5	11.7	53.0	4.7	8.5	19.8	216.3	7.3	10.1	1.6	38.7	38.4	26.6	16.8	13.8	0.0	31.5	253.1	9.1	46.2	8.4	1.9	13.0	42.7	12.6	9.3	5.0	24.5	9.4	17.8	15.9	7.6	19.7	5.2	4.0	3.4	45.6	13.5	22.2	4.2	45.3	16.1	11.8	11.0	6.1	39.5	11.2	26.0	11.2	56.0	24.9	12.6	32.7	4.1	50.0	16.6	33.3
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 341.8;Endothelial cells: 180.8;Hepatic stellate cells: 128.5;NK-cells: 106.1;Plasma cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 1260.8;TIME: 319.0"	"Low region specificity"	"Detected in all"							HPA071155			Approved	"Plasma membrane,Cytosol"		NA	NA		730000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	97.4	11.3	39.6	30.4	39.6	20.7	78.7	40.3	48.3	20.3	34.6	26.3	14.1	24.4	6.7	12.1	22.2	18.8	99.7	38.2	40.5	44.3	14.6	84.5	60.5	42.1	40.9	12.7	15.4	9.0	12.4	79.3	42.9	16.1	18.2	1.2	16.0	8.6	37.9	16.3	34.2	29.5	41.4	168.1	18.8	3.5	44.6	31.5	33.6	55.9	41.8	33.0	21.4	40.6	0.0	0.0	0.0	0.0	11.3	10.8	3.2	1.1	0.7	0.3	1.1	2.7	52.2	92.9	16.6	0.0	0.3	0.4	1.2	0.0	1.7	22.3	0.0	82.9	4.4	10.0	1.8	14.2	0.3	0.4	0.0	0.8	0.2	0.0	1260.8	78.8	67.7	50.5	0.3	0.0	101.8	11.8	0.1	0.7	0.0	60.3	0.2	128.7	6.7	12.8	0.0	0.8	0.0	0.2	0.0	0.1	0.0	10.3	319.0	0.2	0.8	6.2	0.0	47.6	18.7	83.4	0.1	17.7	0.0	444.8	191.8	62.1	282.8	464.6	326.0	265.6	371.2	270.7	203.6	328.9	400.3	253.3	23.1	188.5	525.8	67.2	450.8	502.0	39.6	39.6	40.3	48.3	38.2	40.5	42.1	40.9	42.9	41.4	44.6	40.6	341.8	0.0	8.4	0.0	47.8	7.4	4.0	5.2	0.6	0.1	6.1	11.3	0.5	1.5	4.5	7.3	0.0	0.5	41.7	1.7	0.0	1.2	0.6	1.2	2.4	180.8	1.2	28.2	0.1	1.4	0.3	13.8	1.1	0.8	12.0	0.7	128.5	1.9	20.0	0.0	0.0	2.2	2.0	55.6	13.4	1.3	0.3	56.9	28.4	21.5	25.7	0.4	106.1	0.5	0.2	6.8	4.7	1.9	114.4	3.8	0.6	0.5	4.1	0.5	6.6	7.4	11.6	0.2	0.3	0.7	5.4	1.0	60.1	6.5	4.2	2.8
IDS	"ID2S, SIDS"	ENSG00000010404	"Iduronate 2-sulfatase"	P22304	X	149476988-149521096	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 323.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"amygdala: 194.3;basal ganglia: 212.9;cerebral cortex: 323.4;hippocampal formation: 320.5;white matter: 109.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA078003	Approved				"Intracellular and membrane"	NA	NA		17000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA078003: "	"unprognostic (9.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.76e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	32.7	43.3	194.3	29.5	212.9	47.6	27.9	0.0	323.4	37.5	0.0	35.7	21.1	35.1	43.5	26.1	35.7	26.3	42.2	320.5	25.7	22.7	15.8	40.5	31.0	9.7	9.4	45.4	23.3	57.0	67.8	16.3	3.1	29.4	20.8	48.6	24.7	41.0	25.1	37.1	27.9	30.5	0.2	34.1	23.0	6.1	32.3	17.2	27.2	38.9	36.0	32.8	31.5	109.4	46.4	50.7	19.6	12.7	22.1	40.9	9.2	26.6	67.8	23.3	43.9	10.2	32.7	110.0	69.6	38.3	49.1	22.6	21.3	40.5	30.1	40.8	17.7	11.5	14.7	5.7	17.8	18.8	101.3	21.4	19.6	50.9	33.1	95.5	37.8	20.2	5.7	76.6	34.7	57.9	19.6	9.3	17.5	28.8	34.3	12.4	19.4	20.7	27.8	10.5	28.9	67.6	9.8	22.1	32.0	33.2	6.9	7.9	44.3	29.9	31.3	50.1	70.8	54.5	47.3	79.3	138.0	44.3	22.1	117.5	56.9	171.7	70.9	63.0	53.2	35.2	43.1	54.0	48.7	27.0	28.4	42.9	261.1	37.2	73.9	36.8	74.0	63.0	194.3	212.9	0.0	323.4	320.5	25.7	9.7	9.4	3.1	0.2	32.3	109.4	53.7	99.3	64.4	55.8	150.9	33.1	60.6	44.0	20.5	178.3	43.2	43.8	44.1	27.1	58.9	82.8	45.9	34.2	158.5	66.9	21.5	50.2	1.3	59.8	36.8	44.7	168.4	19.6	232.3	74.0	25.7	78.3	31.1	49.5	226.2	25.5	60.3	33.0	44.0	222.1	243.7	29.0	73.2	94.8	109.8	3.7	72.7	98.4	51.6	63.7	120.9	55.0	146.2	39.2	95.8	85.0	50.3	89.5	98.8	71.3	74.6	22.3	112.4	59.5	59.2	68.1	65.2	3.5	6.6	22.2	43.8	143.0	183.9	16.4	17.1	96.9
IFIT1	"G10P1, GARG-16, IFI56, IFNAI1"	ENSG00000185745	"Interferon induced protein with tetratricopeptide repeats 1"	P09914	10	89392546-89406487	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 63.3;Distal tubular cells: 64.6;Muller glia cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 66.7"	"Group enriched"	"Detected in all"	8	"granulocytes: 66.7;monocytes: 21.7"	"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 325.3;BJ hTERT+ SV40 Large T+ RasG12V: 318.1"									"CAB045980, HPA053890, HPA055380"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB045980: AB_11125836, HPA053890: , HPA055380: AB_2682800"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.35e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.82e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.75e-3)"	"unprognostic (6.40e-3)"	17.5	38.0	12.6	4.5	12.4	9.9	14.3	15.2	17.8	17.2	13.0	14.6	3.9	6.9	6.6	5.0	9.5	13.8	22.7	12.4	12.7	23.7	24.9	14.1	3.4	15.1	14.2	9.1	6.1	11.9	20.3	9.9	13.5	6.7	5.0	8.0	42.0	6.2	17.4	4.9	7.5	7.9	29.4	18.7	6.9	5.4	13.9	13.3	9.1	20.6	2.4	7.6	9.4	14.4	10.0	1.2	2.6	17.2	8.1	16.5	0.2	11.7	68.9	325.3	318.1	1.0	10.4	0.7	3.8	14.6	63.4	8.2	1.0	1.0	15.6	0.6	1.1	1.7	8.4	0.9	9.2	1.4	1.7	13.5	0.3	6.2	0.1	6.4	0.4	1.7	0.2	7.7	3.5	0.3	2.3	6.8	0.3	0.1	6.3	3.1	0.8	2.0	7.9	1.2	0.1	0.6	3.1	2.4	69.6	2.4	1.3	1.5	0.5	1.7	1.9	2.5	1.4	1.0	1.3	0.6	2.2	2.3	0.9	9.9	12.6	15.4	1.6	15.6	2.9	3.0	4.1	2.9	3.7	3.2	5.7	3.5	66.7	1.9	21.7	0.2	4.9	6.6	12.6	12.4	15.2	17.8	12.4	12.7	15.1	14.2	13.5	29.4	13.9	14.4	63.3	35.3	5.8	7.2	2.5	2.9	3.3	12.9	3.4	26.4	2.4	5.2	19.1	4.3	7.6	9.2	18.8	4.8	4.7	6.3	64.6	12.6	0.4	21.1	3.2	41.4	0.0	4.0	13.8	5.1	20.8	22.8	0.5	7.2	2.5	11.0	9.3	12.1	36.9	32.0	13.3	1.4	4.1	14.5	3.3	3.0	19.3	13.3	1.8	16.9	13.5	77.9	1.0	12.1	14.4	3.6	4.7	43.6	0.7	1.1	9.8	26.7	17.8	13.4	39.5	18.1	11.4	0.5	3.0	1.0	1.7	1.4	3.1	15.4	0.2	1.2
IFNAR1	"IFNAR, IFRC"	ENSG00000142166	"Interferon alpha and beta receptor subunit 1"	P17181	21	33324429-33359864	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 198.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029226	Approved					NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA029226: AB_2672954"	"unprognostic (2.42e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.38e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.06e-2)"	40.8	22.3	14.3	36.4	14.6	30.8	32.3	15.7	15.2	26.3	9.6	28.9	26.7	22.4	23.2	25.2	23.8	30.2	21.2	15.0	16.2	32.0	76.6	29.7	28.8	17.4	15.6	23.5	29.2	40.5	7.7	49.5	16.9	27.2	30.5	23.6	30.2	24.1	32.7	20.5	27.4	24.0	15.7	33.5	31.6	20.9	17.5	33.1	41.2	24.8	29.7	39.8	9.0	18.6	47.3	24.4	27.4	24.2	55.8	80.8	23.7	44.6	74.2	32.9	36.1	31.7	57.2	42.4	35.4	49.4	36.3	28.4	23.3	37.0	43.8	33.8	26.0	62.8	29.0	20.2	33.9	50.8	43.3	58.2	38.4	43.6	37.7	39.4	63.1	40.3	67.6	198.2	56.5	22.8	38.7	22.2	24.9	46.6	25.6	29.5	75.0	62.4	33.7	44.0	22.5	24.1	50.5	42.4	39.3	20.8	58.2	36.8	61.3	39.3	24.7	58.2	28.2	102.3	132.7	43.2	66.3	64.4	50.5	77.3	45.4	27.7	23.6	64.0	23.1	56.2	31.5	28.6	37.4	57.0	37.0	29.0	166.7	28.0	80.3	54.3	41.2	35.2	14.3	14.6	15.7	15.2	15.0	16.2	17.4	15.6	16.9	15.7	17.5	18.6	101.2	109.0	45.8	17.6	69.3	45.8	57.0	72.3	18.8	51.9	42.5	29.7	33.5	34.3	78.8	44.1	29.2	28.1	43.8	25.3	21.5	73.0	17.7	37.9	58.4	75.5	26.9	27.1	26.3	90.5	92.4	61.1	35.7	44.5	39.2	30.3	53.9	81.3	69.2	58.9	29.4	28.9	46.8	82.1	47.5	10.7	32.6	77.6	37.4	30.9	86.8	34.3	42.2	34.2	27.2	64.7	25.5	30.9	137.3	63.9	37.6	28.7	59.6	30.0	19.7	54.9	44.9	38.5	17.5	21.5	44.9	20.1	38.3	25.1	27.5	72.2
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159740	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.5;lymphoid tissue: 7.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 283.2;T-cells: 200.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010344	Approved				"Secreted to blood"	NA	NA	1470		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 7: Non-specific - Mitochondria"			"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"	0.7	0.7	0.1	3.5	0.2	11.5	0.3	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.0	0.0	0.3	1.5	1.8	7.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.9	0.2	0.0	0.0	0.3	0.2	0.0	1.3	0.4	0.1	0.1	0.5	0.3	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	2.4	6.6	0.0	0.4	0.5	3.7	0.1	0.9	0.0	0.0	0.1	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.7	0.0	0.0	0.0	3.1	3.2	1.3	0.0	0.0	0.0	4.8	5.5	0.2	1.5	0.0	0.0	0.0	0.0	283.2	0.1	0.0	0.0	0.2	1.0	1.1	1.3	0.0	0.4	0.0	0.0	0.0	1.5	6.1	1.1	0.0	0.0	1.4	1.2	0.1	0.0	0.0	0.5	0.0	4.4	5.5	0.0	0.0	10.4	7.2	0.0	0.0	0.0	19.6	0.0	0.1	0.0	1.1	0.0	10.9	0.2	0.0	0.3	0.0	0.0	0.0	1.0	2.9	0.0	0.0	0.8	4.0	0.0	200.1	0.0	0.2	0.2
IFT52	"C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5"	ENSG00000101052	"Intraflagellar transport 52"	Q9Y366	20	43590937-43647299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063367, HPA067423"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA063367: , HPA067423: AB_2685837"	"unprognostic (2.88e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.18e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.30e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	23.5	15.1	12.2	11.7	12.6	29.1	26.1	12.4	15.2	29.3	14.3	16.3	9.2	27.4	29.0	14.8	38.0	19.0	11.8	12.5	13.5	20.5	7.8	16.9	18.3	12.3	12.8	39.2	15.7	22.5	16.5	17.5	12.8	17.5	17.8	15.1	13.6	23.8	4.7	15.5	11.2	24.3	13.3	15.7	12.2	31.8	14.1	22.8	31.3	9.0	18.9	19.5	18.0	14.2	33.9	25.4	50.3	35.8	41.9	46.4	23.9	20.8	46.1	53.6	51.6	70.5	33.7	18.8	32.8	42.6	43.4	27.7	21.3	37.3	58.6	15.6	20.0	24.8	16.2	65.9	51.4	33.4	16.4	37.8	40.2	34.9	27.0	39.0	42.7	41.4	21.3	26.1	39.9	34.0	46.4	51.5	28.4	22.2	24.9	48.6	57.5	27.8	41.8	32.9	38.8	45.3	63.6	46.7	52.2	25.3	21.8	45.1	26.9	47.3	35.1	26.3	31.1	25.3	26.9	32.8	56.8	24.0	34.8	8.0	22.0	16.8	18.4	20.9	15.0	17.5	14.7	17.5	28.4	15.3	15.4	16.0	6.3	17.4	26.2	21.5	18.6	17.3	12.2	12.6	12.4	15.2	12.5	13.5	12.3	12.8	12.8	13.3	14.1	14.2	21.1	6.4	13.1	11.4	13.7	13.0	12.8	22.4	12.0	11.5	14.1	19.2	2.9	11.5	13.2	7.3	0.0	19.9	16.0	14.8	19.6	26.1	78.4	32.1	19.4	18.1	9.5	23.4	20.5	22.2	19.7	25.3	8.2	10.5	14.5	26.7	23.2	2.6	19.4	8.4	22.5	11.0	14.2	18.2	13.9	20.9	28.6	13.3	17.8	12.2	21.3	22.6	18.6	14.6	25.7	14.8	10.1	38.4	13.5	5.9	5.5	18.3	49.0	12.8	13.1	23.9	24.8	57.3	18.5	12.2	14.9	9.6	12.1	30.4	10.3	10.5
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38406528-38424454	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 16.5"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;Excitatory neurons: 2.5;Hofbauer cells: 1.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 2.5;Spermatogonia: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 360.4;NTERA-2: 104.2;RH-30: 97.5;SCLC-21H: 334.3;SH-SY5Y: 332.6;SuSa: 241.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	0.8	1.5	2.4	0.5	4.2	0.5	0.1	3.4	2.8	0.2	1.4	0.5	0.9	0.7	0.1	0.3	0.3	0.6	1.3	2.6	2.0	0.2	0.3	0.8	0.2	1.5	2.3	0.1	0.9	0.0	1.1	0.6	1.7	0.4	0.3	0.3	0.1	1.6	0.2	0.2	0.6	1.1	1.0	0.1	1.6	2.1	2.8	2.9	16.5	0.0	0.1	0.5	0.1	1.8	0.0	8.6	360.4	0.4	0.0	0.0	0.2	2.4	0.0	0.5	0.3	0.1	0.2	0.1	1.3	0.3	0.0	0.1	44.0	0.0	0.5	0.0	2.7	0.1	1.2	0.2	0.0	1.7	1.2	0.4	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.2	2.5	0.1	0.3	0.2	104.2	0.5	0.7	0.1	97.5	0.9	0.0	0.2	334.3	332.6	6.4	0.5	0.0	241.3	2.3	2.3	0.4	0.1	7.7	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.0	2.4	4.2	3.4	2.8	2.6	2.0	1.5	2.3	1.7	1.0	2.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.3	0.6	0.1	0.0	1.8	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0
IGHD	"FLJ00382, FLJ46727, MGC29633"	ENSG00000211898	"Immunoglobulin heavy constant delta"	P01880	14	105836765-105845678	"Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 330.9"	"Group enriched"	"Detected in some"	47	"B-cells: 261.8;Plasma cells: 588.1;T-cells: 474.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 58.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	63	"memory B-cell: 279.1;naive B-cell: 815.9"	"Lineage enriched"	"Detected in many"	93	"B-cells: 815.9"	"Group enriched"	"Detected in some"	7	"Daudi: 82.3;U-698: 95.8"									CAB012703	Approved				"Immunoglobulin genes"	NA	NA		14000000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB012703: AB_10554307"	"prognostic favorable (1.49e-6)"	"unprognostic (1.84e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.30e-2)"	2.8	0.4	0.0	35.4	0.0	39.2	9.3	0.0	0.4	0.9	0.0	2.2	3.4	5.0	0.2	2.8	0.6	19.0	5.7	0.0	0.0	2.1	3.5	34.1	111.6	0.2	0.0	0.3	0.4	0.2	0.0	0.3	0.0	6.4	1.9	0.0	67.1	1.2	0.4	1.5	17.6	0.9	0.0	146.7	43.3	0.3	0.1	8.3	1.3	0.0	330.9	20.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	82.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	12.4	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	2.7	0.5	0.3	0.4	0.3	0.2	279.1	0.3	0.8	0.7	815.9	1.0	0.3	3.3	0.3	0.5	8.7	0.4	39.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	261.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.6	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.3	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	1.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.7	0.0	9.2	0.0	0.0	0.0	0.0	0.0	588.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	474.2	0.0	0.0	0.0
IGHD2-15	"D2, IGHD215"	ENSG00000211918	"Immunoglobulin heavy diversity 2-15"		14	105897957-105897987	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"bone marrow: 2.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"naive B-cell: 39.9"	"Lineage enriched"	"Detected in single"	400	"B-cells: 39.9"	"Cell line enriched"	"Detected in single"	28	"HEL: 2.7"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"																						0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHD3-16	IGHD316	ENSG00000211917	"Immunoglobulin heavy diversity 3-16"		14	105895634-105895670	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	4	"bone marrow: 4.0;intestine: 2.6;lymphoid tissue: 4.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"naive B-cell: 27.0"	"Lineage enriched"	"Detected in many"	12	"B-cells: 27.0"	"Group enriched"	"Detected in some"	16	"HEL: 2.4;HMC-1: 1.3;NB-4: 1.0"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"																						0.0	0.0	0.0	1.7	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	27.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHD3-22	IGHD322	ENSG00000211911	"Immunoglobulin heavy diversity 3-22"		14	105886031-105886061	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 1.6;lymphoid tissue: 2.7;stomach 1: 3.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 48.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 48.9"	"Cell line enriched"	"Detected in single"	13	"SH-SY5Y: 1.3"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"												"unprognostic (4.12e-1)"						"unprognostic (1.53e-1)"				0.0	0.0	0.1	0.9	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.2	3.1	0.0	0.0	0.7	0.0	0.0	2.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	48.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHD3-3	"DXP4, IGHD33"	ENSG00000211930	"Immunoglobulin heavy diversity 3-3"		14	105914359-105914389	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;lymphoid tissue: 2.6;salivary gland: 3.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 62.6"	"Lineage enriched"	"Detected in single"	626	"B-cells: 62.6"	"Group enriched"	"Detected in some"	48	"NB-4: 6.9;SH-SY5Y: 2.6"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"												"unprognostic (1.34e-1)"			"unprognostic (1.69e-1)"			"unprognostic (3.13e-1)"	"unprognostic (1.75e-1)"			0.0	0.0	0.0	0.9	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	1.9	1.6	0.1	0.0	0.1	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHD3-9	"DXP1, IGHD39"	ENSG00000211924	"Immunoglobulin heavy diversity 3-9"		14	105904681-105904711	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.9;stomach 1: 4.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	214	"memory B-cell: 8.9;naive B-cell: 33.8"	"Lineage enriched"	"Detected in single"	339	"B-cells: 33.8"	"Cell line enriched"	"Detected in some"	5	"HEL: 5.5"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"												"unprognostic (1.74e-1)"						"unprognostic (1.50e-1)"	"unprognostic (9.31e-2)"			0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.1	1.6	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.9	0.4	0.0	0.0	2.0	0.0	0.1	2.8	4.8	0.0	0.1	2.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV1OR15-1	IGHV1/OR15-1	ENSG00000270505	"Immunoglobulin heavy variable 1/OR15-1 (non-functional)"		15	22160431-22160868	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 78.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.0;B-cells: 1.1;granulocytes: 1.3;T-cells: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 94.3;naive B-cell: 111.6"	"Group enriched"	"Detected in many"	18	"B-cells: 111.6;T-cells: 60.9"	"Group enriched"	"Detected in some"	4	"JURKAT: 10.3;Karpas-707: 6.9;MOLT-4: 2.5"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"											"unprognostic (2.14e-1)"						"unprognostic (1.13e-1)"				0.6	0.4	0.0	18.2	0.1	7.0	5.8	0.1	0.1	0.8	0.0	15.6	13.8	0.8	0.0	4.0	0.6	14.4	0.6	0.0	0.1	0.4	0.7	2.8	52.0	0.2	0.1	1.0	0.4	0.1	0.1	0.1	0.1	2.3	10.2	0.0	4.8	0.4	0.0	0.1	13.7	0.4	0.2	18.1	11.1	0.1	0.1	58.7	1.1	0.0	78.8	9.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	6.9	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	9.2	0.0	3.3	94.3	54.9	18.1	0.1	111.6	60.9	14.5	0.5	4.8	0.1	3.3	35.9	20.5	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	3.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.2	0.0
IGHV1OR15-9	"IGHV1/OR15-9, IGHV1OR159, VSIG7"	ENSG00000188403	"Immunoglobulin heavy variable 1/OR15-9 (non-functional)"		15	19964666-19965101	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	9	"breast: 4.1;intestine: 8.6;lymphoid tissue: 8.6;stomach 1: 8.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"lung cancer: 5.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 14: B-cells - Humoral immune response"						"prognostic favorable (1.79e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.34e-2)"		"prognostic favorable (6.84e-4)"		"unprognostic (1.64e-1)"			"unprognostic (1.57e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.07e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.11e-1)"	0.0	0.0	0.0	8.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	8.6	3.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	8.3	0.0	0.0	1.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV1OR21-1	IGHV1/OR21-1	ENSG00000277282	"Immunoglobulin heavy variable 1/OR21-1 (non-functional)"		21	10649400-10649835	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 3.3;lymphoid tissue: 6.3;stomach 1: 3.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"lung cancer: 2.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"memory B-cell: 2.0;naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	15	"B-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"					"unprognostic (3.93e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-2)"			"unprognostic (8.48e-5)"		"unprognostic (2.59e-1)"			"unprognostic (3.45e-1)"			"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.32e-1)"		0.0	0.6	0.0	3.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	3.3	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.4	0.6	0.0	0.9	3.4	0.1	0.0	0.5	0.0	0.0	6.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-16		ENSG00000211944	"Immunoglobulin heavy variable 3-16 (non-functional)"	A0A0C4DH30	14	106165205-106165730	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		3200000000	"Cluster 43: B-cells - Humoral immune response"														"unprognostic (1.04e-1)"						"unprognostic (1.04e-1)"				0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-38		ENSG00000211958	"Immunoglobulin heavy variable 3-38 (non-functional)"	A0A0C4DH36	14	106410493-106411021	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.9;lymphoid tissue: 10.4;stomach 1: 5.9;urinary bladder: 7.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"memory B-cell: 3.4;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	34	"B-cells: 3.4"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		2900000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"						"unprognostic (1.03e-5)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.02e-1)"		"unprognostic (1.31e-3)"		"unprognostic (8.40e-2)"	"unprognostic (3.54e-2)"		"unprognostic (2.05e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-8)"	"unprognostic (6.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.52e-1)"	0.3	0.1	0.0	5.9	0.0	1.6	3.3	0.0	0.0	1.4	0.0	7.7	9.9	0.1	0.0	0.9	0.1	0.9	0.2	0.0	0.0	0.1	0.4	1.8	2.2	0.0	0.0	0.6	0.4	0.0	0.0	0.2	0.0	0.2	7.0	0.0	4.1	0.0	0.0	0.2	5.8	0.0	0.0	4.4	5.9	0.7	0.0	0.0	0.0	0.0	10.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3OR15-7	IGHV3/OR15-7	ENSG00000259490	"Immunoglobulin heavy variable 3/OR15-7 (pseudogene)"		15	19987656-19988117	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 2.0;stomach 1: 1.8"	"Cell type enriched"	"Detected in single"	104	"Plasma cells: 10.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.08e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.07e-1)"		"prognostic favorable (1.43e-5)"		"unprognostic (4.56e-1)"			"unprognostic (3.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-4)"	"unprognostic (7.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.24e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3OR16-10	IGHV3/OR16-10	ENSG00000233732	"Immunoglobulin heavy variable 3/OR16-10 (non-functional)"		16	32995048-32995505	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"esophagus: 4.8;intestine: 6.3;lymphoid tissue: 8.3;salivary gland: 7.0;stomach 1: 5.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.1"	"Not detected"	"Not detected"																	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.40e-3)"	"unprognostic (4.22e-2)"	"unprognostic (3.45e-2)"			"unprognostic (3.41e-4)"		"unprognostic (2.20e-1)"			"unprognostic (2.29e-1)"			"unprognostic (1.12e-2)"	"unprognostic (2.30e-1)"			0.0	0.2	0.0	1.0	0.0	1.1	0.7	0.2	0.3	0.0	0.0	4.1	6.2	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.0	7.0	0.0	0.0	0.0	2.1	1.1	0.1	1.4	5.6	3.5	0.1	0.9	0.2	0.0	8.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3OR16-12	IGHV3/OR16-12	ENSG00000270467	"Immunoglobulin heavy variable 3/OR16-12 (non-functional)"		16	33802764-33803217	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	4	"intestine: 13.7;lymphoid tissue: 20.3;stomach 1: 9.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"memory B-cell: 4.5"	"Lineage enriched"	"Detected in single"	46	"B-cells: 4.5"	"Not detected"	"Not detected"																	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"						"unprognostic (1.38e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"			"unprognostic (1.44e-3)"		"unprognostic (1.07e-1)"			"unprognostic (7.10e-2)"			"unprognostic (5.02e-1)"	"unprognostic (1.29e-1)"			0.0	0.0	0.0	7.7	0.0	1.0	3.3	0.0	0.0	1.2	0.0	8.3	13.7	0.0	0.0	1.1	0.1	1.6	0.0	0.0	0.0	0.1	0.3	1.3	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	4.1	0.0	2.5	0.0	0.0	0.0	3.6	0.0	0.0	2.1	9.8	0.2	0.0	1.0	0.0	0.0	20.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3OR16-17	IGHV3/OR16-17	ENSG00000259680	"Immunoglobulin heavy variable 3/OR16-17 (non-functional)"		16	33844784-33845229	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 11.5;lymphoid tissue: 24.4;stomach 1: 11.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"memory B-cell: 1.5;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	26	"B-cells: 2.5"	"Not detected"	"Not detected"																	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"						"unprognostic (1.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.32e-2)"			"prognostic favorable (6.96e-5)"		"unprognostic (1.81e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"		"unprognostic (2.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.58e-1)"	0.2	0.1	0.0	9.3	0.0	4.3	3.3	0.0	0.0	4.0	0.0	11.5	9.6	0.1	0.0	4.0	0.1	0.5	1.0	0.0	0.0	0.0	0.4	1.0	1.3	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	6.4	0.0	4.3	0.0	0.0	0.0	5.6	0.4	0.0	4.1	11.8	0.0	0.0	0.5	0.0	0.0	24.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3OR16-8	IGHV3/OR16-8	ENSG00000271130	"Immunoglobulin heavy variable 3/OR16-8 (non-functional)"		16	33009175-33009620	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 32.0;lymphoid tissue: 49.4;stomach 1: 32.9;urinary bladder: 40.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"memory B-cell: 7.3"	"Lineage enriched"	"Detected in single"	74	"B-cells: 7.3"	"Not detected"	"Not detected"																	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"						"unprognostic (2.58e-4)"	"unprognostic (3.25e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.56e-1)"		"unprognostic (2.43e-4)"		"unprognostic (1.31e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"		"unprognostic (2.60e-7)"	"unprognostic (2.24e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	2.3	0.8	0.0	13.8	0.0	5.9	4.5	0.0	0.0	2.7	0.0	30.1	32.0	0.2	0.0	1.9	0.7	5.3	0.0	0.0	0.0	0.1	0.9	3.2	3.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	14.8	0.0	10.0	0.0	0.0	0.0	9.0	1.8	0.0	5.8	32.9	0.1	0.0	3.0	0.7	0.0	49.4	40.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV7-81		ENSG00000211979	"Immunoglobulin heavy variable 7-81 (non-functional)"	A0A0B4J1V7	14	106874583-106875071	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.7;lymphoid tissue: 18.3;stomach 1: 12.3"	"Group enriched"	"Detected in some"	12	"B-cells: 1.5;Plasma cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 5.5;naive B-cell: 3.9"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;Daudi: 6.1;OE19: 1.2;U-698: 2.0"														"Immunoglobulin genes"	NA	NA		270000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (5.71e-4)"	"unprognostic (3.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.85e-2)"		"unprognostic (2.67e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.07e-1)"		"unprognostic (1.14e-2)"	"unprognostic (6.16e-5)"	"unprognostic (1.69e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.63e-2)"	0.1	0.1	0.0	8.4	0.0	4.6	3.6	0.0	0.0	0.3	0.0	7.6	6.4	0.4	0.0	0.6	0.3	7.9	0.2	0.0	0.0	0.3	0.2	1.8	4.2	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	2.3	12.7	0.0	5.0	0.1	0.0	0.2	6.2	0.4	0.0	2.3	12.3	0.1	0.0	1.4	0.0	0.0	18.3	1.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.3	0.1	0.0	3.9	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV8-51-1	"IGHV(III)-51-1, IGHVIII-51-1"	ENSG00000254167	"Immunoglobulin heavy variable IGHV8-51-1 (non-functional)"		14	106583501-106583807	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	6	"lymphoid tissue: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"MOLT-4: 10.8"														"Immunoglobulin genes"	NA	NA			"Cluster 43: B-cells - Humoral immune response"		"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"												"unprognostic (2.16e-1)"						"unprognostic (4.58e-2)"				0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-17		ENSG00000242766	"Immunoglobulin kappa variable 1D-17"	A0A075B6S4	2	90082635-90083291	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 6.8;lymphoid tissue: 12.5;salivary gland: 5.7"	"Cell type enriched"	"Detected in some"	13	"Plasma cells: 36.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	60	"memory B-cell: 7.7;naive B-cell: 4.1"	"Lineage enriched"	"Detected in single"	78	"B-cells: 7.7"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		1000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.47e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.44e-1)"		"prognostic favorable (5.68e-4)"		"unprognostic (1.19e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.04e-3)"	1.3	0.1	0.1	5.1	0.1	0.9	0.8	0.1	0.2	0.3	0.8	6.8	1.5	0.2	0.0	0.5	0.8	0.6	0.0	0.1	0.1	0.3	0.4	1.5	0.8	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	2.2	0.0	5.7	0.3	0.0	0.4	4.7	0.4	0.1	12.5	2.0	0.0	0.1	0.3	0.5	0.0	4.5	1.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-37	"IGKV1D37, O4"	ENSG00000250036	"Immunoglobulin kappa variable 1D-37 (non-functional)"	P0DSN7	2	89884740-89885216	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.7;stomach 1: 15.0;urinary bladder: 20.1"	"Cell type enriched"	"Detected in single"	11	"Plasma cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	209	"memory B-cell: 13.6;naive B-cell: 29.1"	"Lineage enriched"	"Detected in single"	284	"B-cells: 29.1"	"Cell line enriched"	"Detected in single"	5	"HDLM-2: 2.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		6700000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "														"unprognostic (2.68e-1)"				0.1	0.0	0.0	4.2	0.0	3.3	2.4	0.0	0.0	0.8	0.0	8.6	12.7	0.1	0.4	2.1	0.2	0.5	0.2	0.4	0.0	0.1	0.4	0.8	4.1	0.0	0.1	0.4	1.2	0.0	0.0	0.1	0.0	0.7	1.0	0.0	7.1	0.0	0.2	0.0	6.0	0.2	0.0	6.5	15.0	0.2	0.0	1.1	0.1	0.0	2.5	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-42		ENSG00000211633	"Immunoglobulin kappa variable 1D-42 (non-functional)"	A0A075B6H8	2	90190193-90190681	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.7;lymphoid tissue: 25.3"	"Cell type enriched"	"Detected in single"	93	"Plasma cells: 9.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"memory B-cell: 5.6;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	57	"B-cells: 5.6"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 2.6"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		41000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (8.08e-6)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-2)"			"unprognostic (2.51e-3)"		"unprognostic (1.84e-1)"			"unprognostic (2.10e-2)"		"unprognostic (1.66e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-1)"	0.1	0.0	0.0	7.6	0.0	6.6	10.8	0.0	0.0	0.8	0.0	18.8	7.5	0.2	0.3	1.4	0.2	1.7	0.1	0.0	0.0	0.0	0.3	2.8	2.6	0.1	0.0	4.1	1.1	0.0	0.0	0.0	0.0	0.1	47.7	0.0	8.5	0.0	0.0	0.1	7.9	0.0	0.0	4.2	13.9	0.0	0.0	0.6	0.3	0.0	25.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV2-40		ENSG00000273962	"Immunoglobulin kappa variable 2-40"	A0A087WW87	2	89330110-89330429	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 42.8;urinary bladder: 34.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	48	"memory B-cell: 15.4;naive B-cell: 7.1"	"Lineage enriched"	"Detected in single"	66	"B-cells: 15.4"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.7"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"												"unprognostic (3.31e-1)"						"unprognostic (1.94e-2)"				0.4	0.1	0.0	9.3	0.0	1.1	6.7	0.0	0.1	10.2	0.0	9.7	42.8	0.9	0.0	10.5	15.5	0.1	0.1	0.0	0.0	0.3	1.4	10.9	0.9	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	1.1	7.1	0.0	5.9	2.0	0.0	0.1	6.2	0.0	0.0	17.8	19.6	0.2	0.0	1.9	1.2	0.1	6.2	34.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV2D-30		ENSG00000239571	"Immunoglobulin kappa variable 2D-30"	A0A075B6S6	2	89936859-89937679	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.3;lymphoid tissue: 33.5;stomach 1: 22.2"	"Cell type enriched"	"Detected in some"	222	"Plasma cells: 1314.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 124.9;naive B-cell: 164.0"	"Lineage enriched"	"Detected in single"	430	"B-cells: 164.0"	"Cell line enriched"	"Detected in some"	6	"U-698: 51.7"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.17e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.58e-1)"			"unprognostic (2.98e-4)"		"unprognostic (5.74e-3)"		"unprognostic (3.19e-2)"	"unprognostic (1.10e-1)"			"unprognostic (4.12e-2)"	"unprognostic (3.55e-1)"			0.4	0.4	0.0	6.4	0.0	4.3	5.9	0.0	0.1	0.8	0.0	15.3	11.8	0.4	0.0	1.0	0.4	0.8	0.8	0.1	0.1	1.4	0.7	2.8	6.7	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.5	11.2	0.0	13.0	4.6	0.0	1.2	8.5	2.0	0.0	29.3	22.2	0.1	0.0	1.6	0.8	0.0	33.5	5.6	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	51.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	124.9	0.0	0.1	0.1	164.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	19.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1314.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0
IGKV2D-40		ENSG00000251039	"Immunoglobulin kappa variable 2D-40"	P01614	2	89851791-89852497	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 123.3"	"Cell type enriched"	"Detected in some"	489	"Plasma cells: 1517.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 30.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	494	"memory B-cell: 134.9;naive B-cell: 96.8"	"Lineage enriched"	"Detected in single"	575	"B-cells: 134.9"	"Cell line enhanced"	"Detected in single"		"Daudi: 3.7"														"Immunoglobulin genes"	NA	NA		1900000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (5.01e-4)"	"unprognostic (1.16e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.04e-2)"		"prognostic favorable (9.78e-7)"		"unprognostic (1.87e-1)"		"unprognostic (2.29e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.25e-1)"	1.7	1.4	0.0	21.0	0.0	14.8	13.5	0.0	0.1	10.0	0.0	16.6	6.9	3.0	0.0	35.6	14.4	7.7	2.0	0.0	0.0	1.0	2.9	19.5	65.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.6	21.8	0.0	32.3	21.7	0.0	0.0	31.2	1.6	0.0	44.8	38.6	0.4	0.0	26.3	5.7	0.0	123.3	34.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	134.9	0.0	0.0	0.0	96.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1517.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGKV3OR2-268	"IGKV268, IGKV3/OR2-268, IGKV3/OR2-268A, IGKV3OR2-268A"	ENSG00000233999	"Immunoglobulin kappa variable 3/OR2-268 (non-functional)"		2	87338511-87339035	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 100.4;lymphoid tissue: 85.7"	"Cell type enriched"	"Detected in some"	302	"Plasma cells: 2604.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 220.0;naive B-cell: 78.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 220.0"	"Group enriched"	"Detected in some"	71	"U-266/70: 183.9;U-266/84: 593.2"									HPA047702	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (8.06e-4)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"			"prognostic favorable (1.41e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (2.80e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.41e-1)"	0.4	1.3	0.3	45.8	0.4	11.8	28.5	0.1	0.6	3.4	0.2	100.4	33.9	0.9	0.0	1.3	0.7	24.7	1.3	0.3	0.4	0.6	2.6	7.5	23.8	0.3	0.2	3.3	1.2	0.0	0.0	0.1	0.2	1.6	59.5	0.0	29.4	1.6	0.0	0.6	27.7	4.1	0.1	19.3	34.0	0.4	0.2	10.3	1.2	0.0	85.7	24.4	0.8	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.5	0.2	183.9	593.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	220.0	2.8	0.1	0.1	78.9	0.0	0.1	0.1	0.1	0.0	0.2	30.0	32.7	0.3	0.4	0.1	0.6	0.3	0.4	0.3	0.2	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2604.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
IGKV6D-21	"A10, IGKV6D21"	ENSG00000225523	"Immunoglobulin kappa variable 6D-21 (non-functional)"	A0A0A0MT36	2	90021567-90022185	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	7	"intestine: 67.0;lymphoid tissue: 152.7;urinary bladder: 227.3"	"Cell type enriched"	"Detected in some"	7	"Plasma cells: 234.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	154	"memory B-cell: 14.2;naive B-cell: 16.5"	"Lineage enriched"	"Detected in single"	166	"B-cells: 16.5"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.95e-4)"	"unprognostic (5.47e-3)"	"unprognostic (2.85e-3)"			"prognostic favorable (5.25e-5)"		"unprognostic (1.51e-1)"		"unprognostic (1.86e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.07e-1)"	1.1	0.4	0.0	17.2	0.0	17.2	11.8	0.0	0.1	5.4	0.0	67.0	38.8	1.6	0.0	22.1	0.8	2.7	2.1	0.2	0.0	1.6	2.4	6.3	19.8	0.6	0.0	1.1	1.1	0.0	0.0	0.0	0.1	0.8	31.8	0.0	21.1	17.3	0.0	1.2	37.8	1.0	0.0	45.3	13.4	3.4	0.0	9.1	1.4	0.0	152.7	227.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	234.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGLJ6		ENSG00000211682	"Immunoglobulin lambda joining 6"		22	22918132-22918201	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	6	"intestine: 6.6;lymphoid tissue: 7.9;urinary bladder: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"colorectal cancer: 1.2;endometrial cancer: 1.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	48	"memory B-cell: 31.6;naive B-cell: 38.3"	"Lineage enriched"	"Detected in single"	52	"B-cells: 38.3"	"Group enriched"	"Detected in some"	8	"Daudi: 14.5;U-698: 4.3"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"																						0.0	0.0	0.2	7.2	0.2	0.0	0.4	0.0	0.3	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.0	0.0	7.9	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	5.3	1.0	0.0	0.4	0.0	0.0	0.0	2.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.2	0.2	0.0	0.3	0.1	0.8	0.3	0.4	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLJ7		ENSG00000211684	"Immunoglobulin lambda joining 7"		22	22921390-22921435	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 12.3;lymphoid tissue: 19.0;stomach 1: 17.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.0;endometrial cancer: 1.5"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	222	"memory B-cell: 314.0;naive B-cell: 370.8"	"Lineage enriched"	"Detected in many"	240	"B-cells: 370.8"	"Cell line enriched"	"Detected in single"	21	"U-266/70: 2.0"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"																						0.7	4.1	0.1	14.5	0.1	1.1	0.0	0.3	3.4	0.0	0.0	6.1	12.3	0.0	0.0	2.1	0.0	3.3	0.0	0.2	0.9	0.0	0.0	2.0	3.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.9	0.0	5.9	0.0	0.0	0.0	5.4	0.0	0.0	3.8	17.5	1.8	0.1	0.3	0.0	0.0	19.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.6	314.0	0.0	0.0	0.0	370.8	0.0	0.0	0.0	0.0	1.5	0.2	0.0	27.6	0.1	0.1	0.3	3.4	0.2	0.9	1.2	0.4	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV11-55		ENSG00000211641	"Immunoglobulin lambda variable 11-55 (non-functional)"	A0A075B6I3	22	22201663-22202161	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.1"	"Cell type enhanced"	"Detected in some"		"Late spermatids: 3.5;Plasma cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Daudi: 8.6;U-698: 2.7"														"Immunoglobulin genes"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"											"unprognostic (1.22e-1)"						"unprognostic (6.16e-2)"				0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.5	0.2	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV2-33		ENSG00000211656	"Immunoglobulin lambda variable 2-33 (non-functional)"	A0A075B6J2	22	22588155-22588688	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.3;lymphoid tissue: 2.7;salivary gland: 2.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"memory B-cell: 2.9;naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	30	"B-cells: 2.9"	"Group enriched"	"Detected in some"	9	"RPMI-8226: 1.5;U-266/70: 5.1;U-266/84: 3.4"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"					"unprognostic (1.29e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.30e-1)"		"unprognostic (2.64e-3)"		"unprognostic (2.47e-2)"			"unprognostic (2.06e-1)"			"unprognostic (6.68e-2)"				0.0	0.1	0.0	1.5	0.0	1.3	0.4	0.0	0.0	0.0	0.0	2.2	4.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	2.6	0.0	0.0	0.0	2.3	0.2	0.0	1.5	1.5	0.0	0.0	0.1	0.0	0.0	2.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV3-12		ENSG00000211667	"Immunoglobulin lambda variable 3-12"	A0A075B6K2	22	22771824-22772582	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.2;memory B-cell: 9.2;memory CD8 T-cell: 4.0;naive B-cell: 6.7;NK-cell: 5.6"	"Group enriched"	"Detected in many"	64	"B-cells: 9.2;NK-cells: 5.6;T-cells: 4.2"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		850000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"		"Cluster 57: B-cells - Immune response"				"unprognostic (1.92e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.03e-2)"		"prognostic favorable (8.39e-6)"		"unprognostic (8.44e-2)"		"unprognostic (4.62e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.15e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.52e-1)"	0.8	1.2	0.0	3.9	0.0	2.7	1.9	0.0	0.3	0.3	0.1	7.3	5.5	0.5	0.0	1.0	0.6	3.3	0.0	0.0	0.0	0.1	0.5	2.7	15.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	5.1	1.7	0.0	0.2	2.7	0.1	0.0	4.6	8.2	0.9	0.0	3.9	0.2	0.0	30.1	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	1.1	9.2	1.0	4.0	0.0	6.7	0.0	0.2	0.0	5.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV3-22		ENSG00000211661	"Immunoglobulin lambda variable 3-22"	A0A075B6J6	22	22704265-22704822	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 2.6;lymphoid tissue: 9.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	72	"memory B-cell: 6.6;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	78	"B-cells: 7.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		1100000000	"Cluster 37: B-cells - Transcription"	"Cluster 63: T-cells - Adaptive immune response"													"unprognostic (2.00e-1)"						"unprognostic (9.93e-3)"	"unprognostic (3.73e-1)"			0.0	0.7	0.0	1.0	0.0	1.5	2.6	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.8	0.3	0.0	0.0	1.4	0.0	0.0	1.4	0.8	0.3	0.0	9.5	0.0	0.0	5.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV4-3		ENSG00000211672	"Immunoglobulin lambda variable 4-3"	A0A075B6K6	22	22871507-22872035	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"lymphoid tissue: 15.7;stomach 1: 28.9"	"Cell type enriched"	"Detected in some"	23	"Plasma cells: 50.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	98	"memory B-cell: 11.7;naive B-cell: 7.8"	"Lineage enriched"	"Detected in single"	118	"B-cells: 11.7"	"Cell line enriched"	"Detected in single"	5	"Daudi: 1.3"														"Immunoglobulin genes"	NA	NA		1600000	"Cluster 37: B-cells - Transcription"	"Cluster 4: Stomach - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (7.22e-2)"	"unprognostic (5.51e-3)"	"unprognostic (2.71e-1)"			"unprognostic (4.37e-4)"		"unprognostic (1.87e-1)"			"unprognostic (2.74e-1)"			"unprognostic (1.49e-1)"	"unprognostic (1.36e-1)"			0.2	0.0	0.0	2.1	0.0	1.4	1.6	0.0	0.0	0.3	0.0	5.1	4.5	0.3	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.1	1.0	10.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	3.3	0.0	2.8	0.0	0.0	0.0	3.0	0.0	0.0	5.3	28.9	0.2	0.0	1.4	0.4	0.0	15.7	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV4-60		ENSG00000211639	"Immunoglobulin lambda variable 4-60"	A0A075B6I1	22	22162199-22162681	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 193.1;lymphoid tissue: 116.3;urinary bladder: 185.2"	"Cell type enriched"	"Detected in some"	152	"Plasma cells: 1125.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	78	"memory B-cell: 79.4;naive B-cell: 48.9"	"Lineage enriched"	"Detected in single"	96	"B-cells: 79.4"	"Group enriched"	"Detected in some"	4	"Daudi: 7.8;HEL: 13.3;U-698: 3.9"														"Immunoglobulin genes"	NA	NA		120000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.57e-4)"	"unprognostic (5.46e-3)"	"unprognostic (9.43e-3)"	"unprognostic (1.26e-2)"		"prognostic favorable (1.89e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.60e-1)"	1.8	1.9	0.0	32.9	0.0	18.1	36.6	0.0	0.2	3.3	0.1	70.7	193.1	1.5	0.0	12.3	1.9	3.4	11.4	0.0	0.0	3.1	3.9	43.5	116.3	0.0	0.0	4.6	1.1	0.4	0.2	0.2	0.1	1.1	73.3	0.0	37.9	0.8	0.1	0.1	86.8	2.1	0.0	80.3	37.7	1.7	0.0	18.3	1.7	0.0	112.0	185.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	3.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.1	0.0	0.0	48.9	0.0	0.0	0.8	0.0	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1125.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGLV5-37		ENSG00000211654	"Immunoglobulin lambda variable 5-37"	A0A075B6J1	22	22427540-22428035	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 24.7;intestine: 10.5;lymphoid tissue: 41.5;salivary gland: 11.5;stomach 1: 16.5"	"Group enriched"	"Detected in some"	4	"B-cells: 2.5;Late spermatids: 1.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	54	"memory B-cell: 6.1;naive B-cell: 7.0"	"Lineage enriched"	"Detected in single"	58	"B-cells: 7.0"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		14000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 57: B-cells - Immune response"				"prognostic favorable (4.69e-4)"	"unprognostic (2.44e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.26e-1)"		"prognostic favorable (4.71e-4)"		"unprognostic (4.97e-2)"		"unprognostic (3.56e-2)"	"unprognostic (3.15e-1)"		"unprognostic (5.34e-6)"	"unprognostic (1.66e-1)"	"unprognostic (4.32e-1)"		"unprognostic (1.25e-1)"	0.7	0.0	0.0	9.5	0.0	1.0	3.2	0.0	0.0	1.8	0.0	10.5	10.1	0.2	0.0	4.2	0.9	24.7	1.1	0.0	0.0	0.9	0.7	3.6	4.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.6	8.0	0.1	11.5	0.0	0.0	0.0	8.8	0.2	0.0	22.7	16.5	1.2	0.0	8.4	0.6	0.0	41.5	3.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV5-48		ENSG00000211647	"Immunoglobulin lambda variable 5-48 (non-functional)"	A0A075B6I7	22	22352940-22353433	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.3;lymphoid tissue: 5.5;urinary bladder: 2.7"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 19.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	61	"memory B-cell: 5.4;naive B-cell: 6.7"	"Lineage enriched"	"Detected in single"	68	"B-cells: 6.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (3.76e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.43e-2)"			"unprognostic (3.36e-4)"		"unprognostic (1.38e-1)"			"unprognostic (1.90e-1)"			"unprognostic (1.74e-2)"	"unprognostic (2.97e-1)"			0.0	0.0	0.0	0.9	0.0	1.3	0.9	0.0	0.6	0.4	0.0	3.3	3.3	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.0	0.1	0.1	0.3	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.5	0.0	0.0	0.0	1.3	0.2	0.0	5.5	0.7	0.0	0.0	2.5	0.1	0.0	5.3	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV9-49		ENSG00000223350	"Immunoglobulin lambda variable 9-49"	A0A0B4J1Y8	22	22343187-22343732	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 125.5;lymphoid tissue: 118.0"	"Cell type enriched"	"Detected in some"	20	"Plasma cells: 46.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	672	"memory B-cell: 70.3;naive B-cell: 88.1"	"Lineage enriched"	"Detected in single"	747	"B-cells: 88.1"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		43000000	"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.04e-5)"	"unprognostic (4.30e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.61e-2)"		"prognostic favorable (2.00e-5)"	"unprognostic (6.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.12e-8)"	"unprognostic (1.66e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.16e-2)"	2.4	125.5	0.0	14.7	0.0	9.8	6.1	0.1	0.5	3.3	0.0	33.6	36.5	2.2	0.0	6.0	3.2	1.1	1.2	0.2	0.0	1.2	4.4	43.8	118.0	0.2	0.0	3.3	1.4	0.0	0.1	0.1	0.2	0.9	15.1	0.0	29.7	1.0	0.1	0.1	28.2	0.4	0.0	65.9	46.3	2.0	0.0	14.0	3.4	0.1	97.9	39.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.1	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.1	0.5	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IHO1	"CCDC36, CT74, FLJ25320, LELA1"	ENSG00000173421	"Interactor of HORMAD1 1"	Q8IYA8	3	49198428-49258106	"Predicted intracellular proteins"	"Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 7.5;testis: 26.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.7;Cardiomyocytes: 1.4;Fibroblasts: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.9;hTEC/SVTERT24-B: 9.2;LHCN-M2: 4.0;NTERA-2: 2.5;U-2197: 5.1;WM-115: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA045690, HPA069534"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA045690: AB_10964634, HPA069534: AB_2686146"	"unprognostic (1.54e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.51e-4)"	"unprognostic (3.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.33e-2)"	3.2	1.4	0.2	0.3	0.2	0.2	1.8	0.9	0.5	1.3	7.5	1.1	0.2	1.2	0.4	0.4	1.3	0.7	1.1	0.4	0.0	0.3	0.1	0.5	0.3	0.1	0.3	3.8	0.2	0.1	0.2	0.9	0.1	0.4	0.1	0.7	0.3	0.5	0.9	0.6	0.4	1.0	0.1	0.5	0.3	26.5	0.5	0.1	1.0	0.8	0.1	0.8	0.6	0.1	0.0	0.1	0.0	0.0	1.9	2.2	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.1	1.7	0.0	9.2	0.0	0.0	1.2	0.0	0.0	0.1	4.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.5	0.4	0.0	0.1	0.3	0.1	0.1	0.5	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 173.0;lymphoid tissue: 112.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	5.0	3.2	3.5	53.0	3.4	173.0	4.4	4.0	3.9	3.6	3.3	7.6	7.0	2.5	2.3	4.8	2.2	7.7	1.5	3.0	4.0	1.4	4.9	11.6	87.1	7.7	5.2	1.6	0.8	0.8	0.6	3.6	7.5	2.3	6.8	0.2	4.6	1.9	1.0	2.0	15.6	4.0	7.3	48.6	12.0	1.7	8.7	112.5	2.1	1.2	73.8	9.6	1.8	10.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	258.6	0.2	52.1	0.0	0.0	0.0	84.5	220.4	0.0	0.0	0.0	0.0	0.0	0.0	128.9	72.4	15.4	0.0	0.0	184.3	80.9	2.4	0.0	0.0	192.3	0.3	39.6	0.0	0.0	1.6	2.0	0.8	1.0	0.8	0.4	0.2	112.1	0.2	0.0	1.9	0.2	0.4	80.8	49.4	342.7	0.5	89.5	0.5	21.2	14.2	25.0	35.4	43.9	29.1	46.7	36.3	35.0	15.1	40.7	48.2	35.7	20.2	24.3	43.3	23.4	32.6	26.4	3.5	3.4	4.0	3.9	3.0	4.0	7.7	5.2	7.5	7.3	8.7	10.3	2.8	3.2	12.2	0.7	120.5	2.8	0.1	0.0	0.0	0.0	2.8	1.9	1.5	2.8	1.8	1.8	0.0	0.4	221.4	0.3	0.0	0.4	3.8	0.5	0.4	2.6	0.0	89.8	0.2	0.0	0.4	2.5	4.6	0.6	23.4	0.2	3.9	2.0	30.6	0.0	0.3	0.0	0.0	64.3	61.0	5.3	0.0	72.1	19.6	91.8	106.6	0.0	150.4	1.0	0.3	0.1	0.4	0.0	128.9	0.1	0.0	1.0	1.5	0.1	0.0	1.5	1.6	0.1	2.1	0.5	2.7	0.7	182.8	0.1	0.1	0.1
IL11RA		ENSG00000137070	"Interleukin 11 receptor subunit alpha"	Q14626	9	34650702-34661902	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Craniosynostosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 57.8;Late spermatids: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 36.8;HSkMC: 38.2"					"Low region specificity"	"Detected in all"			"HPA013162, CAB032830, HPA036652"	Supported				"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB032830: AB_2123745, HPA013162: AB_2668790, HPA036652: AB_2675229"	"unprognostic (7.76e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.71e-2)"	26.6	14.8	20.0	15.5	22.9	13.7	30.2	23.9	23.8	44.6	17.2	58.0	21.7	32.9	12.2	16.3	36.8	19.5	66.4	20.6	20.4	21.9	50.7	22.6	32.0	21.4	21.5	38.0	12.9	29.2	21.8	10.3	20.4	30.3	11.4	18.7	26.1	15.7	30.0	61.3	37.9	19.6	20.8	33.3	26.0	18.3	21.6	16.9	48.0	28.5	21.1	32.2	34.1	22.9	2.5	5.5	11.7	11.7	16.5	28.9	5.5	13.8	19.1	8.8	11.9	2.0	4.6	2.6	3.7	36.8	3.3	5.0	3.4	5.0	3.5	23.8	9.2	7.9	23.4	1.0	8.4	2.7	4.3	38.2	6.1	4.9	1.7	11.9	5.6	16.4	3.3	5.4	11.3	1.6	3.6	18.6	2.5	2.0	3.7	5.6	2.3	2.7	2.9	2.5	3.4	12.3	1.7	3.7	5.3	6.1	10.1	10.2	5.2	4.1	10.0	3.2	0.0	3.7	2.6	1.0	10.9	3.1	20.1	2.1	1.0	0.0	1.4	1.4	2.1	0.8	2.7	2.2	1.3	1.0	2.5	1.8	0.3	1.0	0.3	0.5	1.7	1.7	20.0	22.9	23.9	23.8	20.6	20.4	21.4	21.5	20.4	20.8	21.6	22.9	15.8	3.2	14.3	26.8	2.6	17.5	5.8	3.6	6.2	19.6	6.4	25.1	37.9	1.5	3.6	3.7	14.6	11.3	5.1	3.7	0.0	1.9	18.3	0.7	4.4	15.2	9.1	0.8	4.3	0.7	4.1	42.7	3.1	1.3	0.0	57.8	17.5	32.1	4.6	23.5	9.0	5.0	0.0	3.5	19.6	97.2	11.1	3.6	32.0	4.7	2.6	15.2	6.2	5.0	7.3	0.3	4.3	5.7	2.4	2.9	7.0	2.4	1.4	9.0	0.0	32.9	8.9	4.6	21.6	1.4	14.1	12.4	6.0	12.2	5.2	1.7
IL18RAP	"AcPL, CD218b"	ENSG00000115607	"Interleukin 18 receptor accessory protein"	O95256	2	102418689-102452565	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 104.6;lymphoid tissue: 46.7"	"Group enriched"	"Detected in some"	6	"dendritic cells: 42.2;NK-cells: 66.9;T-cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 118.1"	"Group enriched"	"Detected in many"	107	"granulocytes: 67.6;NK-cells: 118.1;T-cells: 65.2"	"Cell line enriched"	"Detected in some"	11	"U-937: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025270	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025270: "	"unprognostic (1.73e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.07e-3)"	"unprognostic (4.64e-6)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.86e-5)"	"unprognostic (5.09e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.73e-2)"	6.8	0.6	0.4	12.0	0.4	104.6	1.5	0.3	1.1	0.7	0.7	2.0	2.3	0.5	0.3	1.1	5.5	3.0	1.6	0.3	0.4	1.5	3.5	16.2	2.6	0.4	0.4	0.4	0.6	0.1	0.6	1.4	0.7	1.1	1.7	0.0	0.8	0.6	0.5	0.4	6.3	1.0	0.5	46.7	2.6	0.1	0.6	0.8	1.1	1.1	2.8	2.5	1.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	2.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.3	0.2	0.1	19.3	46.2	0.1	65.2	0.0	5.9	12.6	0.5	0.0	0.2	1.5	67.6	118.1	0.0	0.7	0.4	6.4	0.4	0.4	0.3	1.1	0.3	0.4	0.4	0.4	0.7	0.5	0.6	0.4	0.4	3.2	1.1	0.0	0.8	0.3	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.1	1.3	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.8	5.3	0.0	0.0	1.9	0.0	1.9	0.6	0.0	66.9	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	22.5	0.0	0.0	0.0
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Cytokine, Growth factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Melanocytes: 3.6;T-cells: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010310	Uncertain				"Secreted to blood"	NA	NA	20300					"Cluster 7: Non-specific - Mitochondria"			"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.4	0.0	0.0	0.0
IL21R	CD360	ENSG00000103522	"Interleukin 21 receptor"	Q9HBE5	16	27402174-27452042	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.6;lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 15.5;dendritic cells: 21.8;Langerhans cells: 11.4;NK-cells: 23.7;Plasma cells: 13.4;T-cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.9;HDLM-2: 110.8;Karpas-707: 49.3;RH-30: 37.2;RPMI-8226: 63.0;U-266/70: 24.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042296	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA042296: AB_10806236"	"unprognostic (2.91e-2)"	"unprognostic (2.65e-3)"	"unprognostic (6.64e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.50e-6)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-10)"	"unprognostic (8.79e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.58e-2)"	0.5	0.4	1.4	11.9	1.0	7.6	0.2	1.1	2.6	0.2	0.9	0.8	0.6	0.3	0.2	0.3	0.2	1.1	0.7	0.9	2.3	0.9	0.4	2.9	24.7	2.1	2.3	0.2	0.3	0.0	0.5	0.8	3.3	0.4	0.9	1.1	0.6	0.1	0.3	0.8	2.1	0.7	1.2	5.5	1.5	1.1	1.2	14.4	0.6	0.0	18.8	2.2	0.2	1.6	0.1	0.2	0.3	0.2	0.0	1.3	0.8	0.8	0.1	0.1	2.2	0.2	0.2	25.9	0.2	2.1	1.4	0.1	0.0	0.1	0.1	110.8	0.1	5.4	0.2	0.7	3.4	0.2	1.5	3.8	0.0	6.8	0.1	0.7	0.0	0.6	0.3	49.3	3.8	0.2	0.1	0.5	0.9	0.1	0.0	0.4	37.2	63.0	0.0	0.1	0.2	0.2	0.1	0.1	2.7	0.2	0.1	1.3	2.8	1.9	0.7	0.6	0.2	24.7	9.4	5.9	5.2	1.4	0.2	0.5	0.4	0.1	13.4	8.3	4.9	1.8	8.6	14.2	2.3	14.2	9.2	9.3	0.9	9.5	27.0	1.1	10.8	7.3	1.4	1.0	1.1	2.6	0.9	2.3	2.1	2.3	3.3	1.2	1.2	1.6	0.2	0.0	1.3	0.0	15.5	0.4	0.1	0.0	0.0	2.0	0.2	0.1	1.9	0.0	0.0	0.0	4.2	0.1	21.8	0.1	0.0	0.0	6.5	0.1	0.2	0.9	0.0	0.0	0.4	0.0	0.1	0.3	1.5	0.2	0.0	0.0	1.1	0.2	8.2	0.0	0.5	0.0	0.0	5.0	11.4	5.7	0.0	3.6	1.8	2.8	1.8	0.2	23.7	0.5	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.0	0.5	0.0	0.8	0.8	0.2	0.0	0.0	0.9	0.1	25.1	0.1	0.1	0.1
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 50.8;lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.5;dendritic cells: 95.8;Kupffer cells: 65.6;Microglial cells: 181.8;NK-cells: 193.6;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 44.7;HEL: 94.6;HMC-1: 94.8;hTCEpi: 87.1;NB-4: 89.4;THP-1: 62.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016300, HPA070455"	Enhanced		Supported	Cytosol		No	No		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	15.5	5.8	6.7	19.8	7.3	32.7	11.4	7.6	6.5	9.2	6.7	9.5	3.7	6.3	2.8	7.5	9.2	6.0	8.2	6.0	8.5	9.5	6.5	25.2	34.1	10.8	9.4	3.2	3.1	1.2	6.9	8.4	11.2	11.8	4.7	0.3	26.3	2.9	3.9	7.9	50.8	3.5	9.3	99.4	6.3	3.5	10.4	14.5	7.8	1.7	31.9	9.8	8.4	10.3	0.1	0.1	0.6	0.0	0.0	0.2	4.8	0.1	0.2	0.1	0.0	0.0	1.2	17.9	0.0	0.0	0.0	0.1	0.0	44.7	0.1	15.4	0.2	94.6	0.1	9.0	0.7	28.7	94.8	1.6	87.1	0.3	9.6	0.3	12.7	2.6	0.4	8.0	0.4	0.0	13.2	89.4	2.9	0.0	0.1	27.5	0.1	6.5	0.1	5.5	0.1	0.1	0.0	1.7	0.0	11.1	0.0	62.9	10.7	0.0	1.5	0.0	0.0	0.2	5.2	26.7	0.1	36.5	0.2	13.2	10.8	11.4	16.0	15.8	10.9	14.0	7.1	12.0	12.3	12.6	5.8	8.4	10.3	12.5	20.0	6.1	10.5	17.9	6.7	7.3	7.6	6.5	6.0	8.5	10.8	9.4	11.2	9.3	10.4	10.3	18.1	3.2	15.5	3.3	94.5	1.7	1.6	5.4	9.1	0.5	3.2	5.8	3.6	4.3	5.2	3.7	0.0	0.6	95.8	1.1	0.0	0.5	13.0	0.8	0.3	20.8	0.0	35.7	2.6	0.5	0.8	1.7	2.0	0.5	15.2	0.1	15.0	2.2	29.2	0.0	1.1	0.2	0.0	65.6	17.1	13.4	0.0	51.5	0.0	181.8	51.4	0.0	193.6	4.0	1.8	0.4	2.5	1.2	34.0	0.6	0.1	0.4	5.7	0.0	0.0	2.0	1.7	0.5	1.0	3.1	1.1	1.1	60.6	0.1	0.5	1.5
IQCH	FLJ12476	ENSG00000103599	"IQ motif containing H"	Q86VS3	15	67254786-67502260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.4;Early spermatids: 59.4;Excitatory neurons: 26.5;Late spermatids: 37.3;Respiratory ciliated cells: 30.3;Spermatocytes: 48.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040845	Uncertain		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA040845: AB_10672898"	"unprognostic (2.69e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.89e-5)"	"unprognostic (2.48e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.16e-3)"	"unprognostic (6.42e-2)"	0.3	1.1	0.7	0.3	0.8	0.1	1.6	0.7	1.4	0.9	4.2	0.5	0.2	0.8	2.6	0.5	6.8	0.6	0.9	0.7	1.8	2.2	1.0	0.9	0.4	2.5	2.2	0.3	0.7	3.7	2.0	0.4	1.6	0.6	0.7	5.0	0.6	0.8	0.5	0.6	0.1	0.3	2.0	0.4	1.1	11.5	1.9	1.0	4.1	0.0	0.2	0.7	0.3	1.4	1.7	1.6	0.8	1.3	1.1	2.6	0.6	0.9	0.7	1.3	0.9	0.1	1.9	1.2	0.8	1.5	1.5	2.8	2.6	1.0	2.3	0.2	1.2	0.3	1.6	0.2	1.7	0.5	0.3	1.7	1.1	2.9	2.8	1.3	0.5	3.1	2.6	1.1	1.0	1.8	0.4	0.4	0.9	1.0	1.1	0.3	1.2	1.3	1.6	0.7	2.6	0.7	1.2	1.6	4.8	1.6	4.3	0.3	1.2	1.5	0.7	2.4	1.0	2.5	3.2	0.3	3.1	1.3	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.8	0.7	1.4	0.7	1.8	2.5	2.2	1.6	2.0	1.9	1.4	0.7	3.2	1.1	27.4	0.3	1.3	1.0	1.6	1.8	1.5	2.7	2.2	1.1	0.0	2.8	1.8	8.4	0.2	0.3	0.4	0.0	1.0	59.4	15.9	1.1	0.9	0.0	0.4	26.5	0.8	0.5	0.7	8.2	2.0	0.0	0.7	0.0	0.0	0.3	1.7	18.2	0.5	4.1	0.0	0.7	37.3	0.9	0.3	0.0	8.4	1.0	1.1	0.0	9.0	9.5	0.7	0.0	0.7	0.5	0.3	0.2	2.2	30.3	5.4	0.0	1.5	0.6	48.8	18.2	1.2	0.4	0.3	0.4	4.2	0.4	1.0
IRF1	MAR	ENSG00000125347	"Interferon regulatory factor 1"	P10914	5	132440440-132508719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.1"	"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 516.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 138.1;REH: 114.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011662, HPA063131"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB011662: AB_775784, HPA063131: AB_2684945"	"unprognostic (1.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.09e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.53e-3)"	53.7	19.1	8.2	88.0	7.6	142.1	29.5	8.1	9.4	21.3	7.7	46.3	84.8	21.3	11.7	24.3	24.4	32.6	25.8	7.3	7.5	32.9	54.4	119.0	86.3	17.2	8.1	18.4	15.6	7.4	17.3	22.2	15.8	36.4	38.1	2.8	28.7	16.2	16.7	19.7	68.8	33.1	8.8	117.4	47.4	13.5	10.5	66.4	25.8	13.3	45.3	63.9	24.1	8.0	26.7	22.8	2.3	8.1	22.1	18.9	42.5	14.7	58.8	41.6	52.2	11.3	79.4	26.7	15.8	18.4	64.8	35.7	7.4	33.7	14.3	54.2	7.1	33.2	8.1	6.9	138.1	14.6	34.3	36.9	9.4	31.7	32.2	26.5	22.4	19.1	6.9	97.5	13.1	15.9	87.6	32.7	3.4	9.3	14.6	114.5	23.2	31.7	22.5	27.8	6.4	3.6	14.6	30.8	13.4	10.1	4.7	24.2	13.0	20.5	8.1	12.8	19.8	74.8	27.0	19.3	24.9	27.2	15.5	175.3	167.1	257.0	157.2	244.1	106.9	68.4	104.2	129.9	95.7	62.5	63.5	91.7	621.0	136.9	272.4	52.4	122.1	160.0	8.2	7.6	8.1	9.4	7.3	7.5	17.2	8.1	15.8	8.8	10.5	8.0	369.9	102.5	114.3	1.0	216.5	88.1	129.4	66.3	306.7	14.7	216.5	186.6	17.0	47.1	58.0	22.0	33.3	24.0	396.3	183.6	19.6	112.1	92.5	242.3	170.8	223.1	87.1	36.6	1.1	114.3	42.6	224.4	212.0	288.1	105.2	32.0	58.2	14.6	49.7	1.7	1.2	137.4	57.0	73.9	228.7	9.1	27.4	134.1	72.9	7.5	257.2	16.7	399.6	2.5	1.1	88.6	140.6	7.9	248.6	270.9	155.5	22.4	110.9	46.5	13.1	516.2	225.0	1.3	6.8	118.8	82.7	11.2	301.4	20.5	94.6	95.0
IRF2BP2	IRF-2BP2	ENSG00000168264	"Interferon regulatory factor 2 binding protein 2"	Q7Z5L9	1	234604269-234610178	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 277.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027815, HPA062269"	Approved		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA027815: AB_10609994, HPA062269: AB_2684732"	"unprognostic (1.15e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	35.6	39.6	43.3	25.6	50.2	157.2	45.0	48.5	49.1	50.0	43.3	42.5	39.6	55.8	26.5	47.0	45.1	40.7	45.0	40.5	45.4	34.2	53.6	43.7	36.3	55.2	49.0	54.8	49.5	45.5	24.1	29.6	51.1	39.2	49.3	26.9	55.0	33.5	47.4	64.2	42.2	31.7	48.9	28.4	44.4	18.0	44.7	29.6	57.3	40.5	30.3	38.7	43.7	61.1	28.0	41.5	29.8	45.7	61.2	48.1	35.1	21.8	18.4	12.7	14.2	24.5	33.5	0.0	49.4	21.2	43.3	37.4	16.2	28.3	20.2	45.2	36.8	26.7	32.9	72.3	49.4	101.0	91.0	57.0	65.8	28.3	53.4	74.4	33.0	24.5	23.0	55.6	33.2	8.4	25.5	107.2	27.1	65.1	15.7	49.6	13.8	66.8	25.1	22.9	58.8	41.8	35.2	46.7	72.7	29.8	45.1	277.5	36.8	45.5	19.0	34.7	41.6	122.9	33.8	9.1	23.1	89.6	63.4	10.1	4.5	8.5	3.9	3.6	4.0	4.3	4.8	4.6	4.7	4.0	4.9	4.1	2.3	3.0	1.9	17.8	4.0	2.5	43.3	50.2	48.5	49.1	40.5	45.4	55.2	49.0	51.1	48.9	44.7	61.1	96.0	134.6	191.3	28.1	75.6	325.9	440.4	142.3	139.5	34.6	126.6	109.7	63.6	133.0	143.8	51.5	10.4	44.6	168.3	84.2	13.7	65.8	24.9	180.8	126.2	101.9	145.5	76.6	14.3	50.0	58.0	97.3	47.4	285.2	107.5	39.6	117.4	185.7	88.9	58.9	22.9	117.1	71.2	131.8	271.2	27.1	69.6	159.7	110.3	30.9	83.2	87.7	38.1	20.6	64.2	68.9	92.0	81.3	39.2	138.2	81.7	40.2	95.1	19.5	78.9	117.1	102.9	29.5	24.1	182.1	396.2	79.4	91.3	15.5	162.7	370.6
ISCA1	"HBLD2, hIscA, ISA1, MGC4276"	ENSG00000135070	"Iron-sulfur cluster assembly 1"	Q9BUE6	9	86264546-86283102	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 994.9;Erythroid cells: 315.5;Late spermatids: 804.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			HPA042789	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA042789: AB_10797022"	"unprognostic (1.14e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (4.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.31e-1)"	38.3	48.0	45.6	16.6	47.4	75.6	33.6	50.6	52.1	25.1	45.1	29.8	28.6	29.3	23.4	19.9	29.1	25.8	62.3	47.2	49.5	60.1	45.9	22.4	17.3	46.9	48.4	34.7	27.8	54.8	32.8	35.5	49.4	26.5	26.1	43.3	21.3	31.5	91.7	20.6	24.7	28.5	44.5	19.5	24.9	46.0	47.6	22.1	39.3	105.7	15.7	27.1	19.1	45.7	43.2	30.5	43.6	59.5	83.7	36.9	53.8	45.3	31.9	44.9	26.0	23.7	23.5	28.9	30.5	37.1	33.7	38.2	42.7	35.0	32.5	66.3	29.5	48.2	34.0	44.1	39.4	42.9	25.0	41.7	54.9	30.1	28.8	38.3	36.0	42.4	25.3	54.2	38.9	43.7	48.6	23.5	85.4	62.5	64.4	32.3	57.9	39.6	63.8	41.4	62.7	46.0	39.1	63.0	54.4	41.4	21.5	24.6	29.3	25.7	31.0	45.1	59.7	41.8	87.3	20.5	51.4	29.5	32.1	45.8	14.8	29.5	19.5	12.7	23.1	18.0	23.1	20.2	10.6	14.8	25.1	24.3	24.3	19.7	13.9	17.5	28.8	21.7	45.6	47.4	50.6	52.1	47.2	49.5	46.9	48.4	49.4	44.5	47.6	45.7	61.3	28.9	15.0	14.7	71.2	60.9	78.0	41.2	38.7	52.9	51.7	57.1	44.0	55.8	19.0	29.5	20.9	75.4	107.0	41.7	140.8	67.0	994.9	93.0	40.1	43.6	53.8	315.5	29.0	43.8	90.0	48.8	31.1	54.2	16.5	45.5	44.3	88.3	45.7	67.3	28.1	36.4	46.8	34.7	42.0	804.2	56.5	56.6	55.2	10.3	37.0	58.6	34.0	18.6	22.7	62.2	38.0	48.9	62.7	81.7	64.1	121.4	44.4	49.4	32.9	47.2	56.9	84.3	65.6	41.1	52.6	114.0	85.0	75.9	41.2	56.9
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438167	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 223.6;testis: 223.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1141.3;Sertoli cells: 315.5;Syncytiotrophoblasts: 1034.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;NK-cells: 14.4;T-cells: 8.9"	"Cell line enriched"	"Detected in many"	4	"BEWO: 492.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	36.0	32.6	15.2	2.8	13.8	5.8	30.5	12.5	19.5	47.3	223.6	14.2	3.6	44.2	4.4	15.2	78.9	3.7	36.1	19.4	24.5	114.4	13.1	22.2	4.4	16.8	18.8	96.0	40.1	12.8	50.7	46.3	14.2	41.4	0.7	0.9	17.7	26.7	13.2	16.2	16.1	2.8	12.7	35.1	11.3	223.8	25.4	3.0	23.7	3.1	1.8	23.5	31.9	11.3	13.9	42.4	98.6	31.0	0.8	0.2	492.7	6.6	1.0	0.6	0.3	24.5	26.1	0.2	33.5	3.2	0.2	36.6	3.0	0.1	0.0	39.8	116.4	52.0	3.1	80.3	10.2	0.6	1.1	9.4	0.4	2.8	0.4	0.4	6.3	1.1	106.0	2.1	0.0	84.1	4.0	3.4	51.7	14.2	33.7	71.2	0.2	24.6	9.5	0.3	30.4	74.3	1.7	9.9	53.1	20.2	68.2	7.1	18.7	0.5	1.1	0.7	1.6	13.9	7.3	3.2	3.0	1.9	17.7	1.0	0.1	0.0	8.1	0.2	6.2	4.5	8.1	6.9	0.8	2.4	6.2	8.9	0.8	14.4	0.1	2.2	6.2	5.0	15.2	13.8	12.5	19.5	19.4	24.5	16.8	18.8	14.2	12.7	25.4	11.3	38.8	3.2	1.1	2.6	9.0	12.0	82.1	74.9	72.8	0.8	26.1	47.0	4.7	20.0	24.0	47.8	2.1	1141.3	8.4	4.1	52.8	39.4	101.3	33.4	10.9	30.5	64.8	21.5	1.0	8.2	114.0	30.2	7.1	14.8	14.0	36.9	25.7	1.1	84.9	0.0	4.3	4.0	28.5	9.0	7.8	230.1	37.3	4.1	23.2	11.2	5.4	8.6	13.4	0.0	0.3	3.4	1.8	50.4	1.8	21.6	0.7	6.1	23.6	0.7	315.5	5.6	163.6	53.7	21.0	10.6	5.7	1034.6	14.9	14.5	6.2	36.8
ITGA1	"CD49a, VLA1"	ENSG00000213949	"Integrin subunit alpha 1"	P56199	5	52787916-52959209	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 264.1;Endothelial cells: 120.5;Hepatocytes: 110.5;Sertoli cells: 98.6;Smooth muscle cells: 143.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.5;HHSteC: 4.5;SH-SY5Y: 1.7;WM-115: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042555	Uncertain					NA	NA		6300000		"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042555: AB_10794281"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.13e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.62e-2)"	13.9	22.4	0.6	1.0	0.8	0.0	10.2	0.7	0.9	5.1	0.4	36.6	1.1	16.3	2.5	5.7	9.9	2.2	10.6	0.5	0.8	11.0	17.1	22.1	0.8	0.8	0.8	3.6	3.1	2.1	2.3	5.8	0.8	12.6	2.7	0.1	2.3	7.2	4.6	2.3	12.5	5.8	0.8	27.9	16.6	0.8	0.8	0.2	9.7	2.5	0.4	17.9	5.1	0.9	0.0	0.0	0.3	0.0	1.4	0.4	0.1	0.3	1.3	0.3	0.7	0.7	0.0	0.0	0.1	4.5	0.5	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.3	0.3	4.5	0.0	0.0	0.7	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.7	0.5	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.7	0.9	0.5	0.8	0.8	0.8	0.8	0.8	0.8	0.9	264.1	54.5	26.8	2.9	1.7	3.2	4.7	1.5	2.8	1.8	3.6	13.8	12.6	5.7	8.7	5.5	2.1	1.5	2.9	5.5	1.9	3.0	21.3	7.7	41.8	120.5	16.4	5.3	3.6	5.4	16.8	40.2	6.1	22.1	10.1	1.0	77.1	110.5	2.2	0.0	19.5	14.0	0.0	7.2	8.2	6.1	9.3	5.6	7.2	63.7	9.1	0.4	0.0	1.5	4.2	19.6	7.7	8.2	2.9	3.2	6.5	15.1	6.3	2.0	98.6	18.6	143.9	0.9	1.1	0.5	3.1	3.4	46.0	13.6	14.0	2.3
ITGA11	HsT18964	ENSG00000137809	"Integrin subunit alpha 11"	Q9UKX5	15	68296532-68432163	"Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 26.3;endometrium 1: 53.1;smooth muscle: 25.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.8;Excitatory neurons: 13.4;Fibroblasts: 30.1;Microglial cells: 18.7;Peritubular cells: 13.5;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 119.5;hTERT-RPE1: 174.5;U-138 MG: 80.6;WM-115: 45.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 7.3;spinal cord: 2.1"	HPA051813	Uncertain					NA	NA		260000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA051813: AB_2681622"	"unprognostic (4.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.22e-7)"	"unprognostic (8.38e-3)"	"unprognostic (2.28e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.33e-2)"	6.5	3.4	0.2	1.1	1.5	0.2	3.2	0.7	1.1	26.3	0.4	2.1	0.8	53.1	13.5	1.5	12.0	2.4	12.7	0.2	0.3	6.5	0.7	1.7	0.5	0.2	0.2	4.6	0.8	0.4	1.8	1.5	0.1	5.2	1.3	0.4	1.2	7.4	2.1	2.7	1.6	25.0	0.1	3.2	1.6	0.9	0.1	0.2	2.0	2.4	0.1	3.9	8.2	0.5	0.0	0.2	0.4	0.9	3.7	0.1	0.1	7.9	15.1	1.6	0.5	0.1	0.2	0.1	0.6	119.5	2.1	0.2	0.0	0.0	0.4	0.0	0.2	0.5	6.8	0.0	10.8	0.2	7.0	1.5	0.0	3.1	0.3	174.5	0.0	0.1	0.2	0.3	20.9	0.1	0.1	0.4	0.7	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	5.5	0.1	0.1	18.5	0.1	0.5	5.0	80.6	0.7	2.1	0.1	0.2	0.0	0.1	13.5	0.2	45.4	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	1.5	0.7	1.1	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.5	2.9	0.0	0.0	0.3	0.3	0.8	0.5	0.0	0.6	3.9	1.0	7.0	13.8	0.0	0.0	1.8	0.0	0.0	0.3	0.1	1.9	0.3	0.3	0.2	0.8	1.1	0.0	0.0	13.4	0.0	0.1	30.1	1.5	0.3	0.0	0.2	2.2	0.5	0.3	0.0	0.7	0.0	0.0	0.6	1.2	0.5	6.8	0.6	0.0	18.7	0.0	0.3	0.0	0.0	0.5	0.2	0.0	13.5	0.2	0.3	0.1	0.3	0.0	1.6	19.7	2.7	5.4	0.0	0.2	0.2	0.4	0.1	0.6	0.2	0.0	0.3
ITGAM	"CD11B, CR3A, MAC-1"	ENSG00000169896	"Integrin subunit alpha M"	P11215	16	31259967-31332892	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Innate immunity"	"Integrin, Receptor"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 182.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 45.4;granulocytes: 35.5;Hofbauer cells: 47.2;Kupffer cells: 117.7;Langerhans cells: 45.5;Macrophages: 83.2;Microglial cells: 41.2;monocytes: 87.4;NK-cells: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HMC-1: 50.0;NB-4: 19.9;U-937: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002274, CAB025091, CAB072870"	Enhanced					NA	NA		1000000	"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435"	"unprognostic (1.82e-2)"	"unprognostic (1.70e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (3.99e-2)"	"unprognostic (5.03e-2)"	13.4	4.7	3.4	24.7	3.5	182.8	3.0	4.5	4.2	3.3	4.8	3.0	2.2	2.0	0.7	2.6	2.3	5.9	2.9	3.6	5.1	1.0	3.5	16.4	7.4	6.7	5.7	1.6	2.3	1.3	0.1	7.7	7.3	1.5	3.4	0.3	2.4	2.2	1.4	1.7	3.5	11.2	6.5	13.1	3.1	1.4	8.6	5.2	1.0	3.1	10.4	8.0	0.2	10.8	0.8	1.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.5	0.8	1.3	0.9	0.0	0.4	0.1	0.0	0.4	0.0	7.6	0.0	1.0	0.0	0.0	0.0	1.8	50.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.3	0.1	1.0	0.0	2.2	0.0	0.0	0.0	0.5	0.4	0.0	0.2	4.3	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	22.6	0.1	93.3	55.7	70.2	31.1	20.9	1.9	4.8	3.3	9.5	9.5	1.0	0.9	7.7	58.4	54.4	3.2	0.6	1.2	27.0	3.4	3.5	4.5	4.2	3.6	5.1	6.7	5.7	7.3	6.5	8.6	10.8	1.4	3.2	9.8	0.7	9.3	1.1	0.3	1.5	0.0	0.0	1.8	3.8	2.3	4.3	1.8	0.0	0.0	0.3	45.4	0.0	0.0	1.2	0.5	0.3	0.4	1.6	3.6	9.4	1.0	0.0	0.7	1.1	1.1	0.5	35.5	0.5	2.2	1.2	47.2	0.0	1.0	0.1	0.0	117.7	45.5	1.8	0.3	83.2	0.0	41.2	87.4	0.0	75.2	3.0	0.3	0.9	0.0	0.0	4.5	0.5	0.0	0.2	0.9	0.0	13.1	1.2	0.5	0.7	0.9	0.5	1.0	0.8	14.9	0.0	0.3	0.2
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 48.1;brain: 33.7;lung: 58.1;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 51.1;granulocytes: 74.0;Hofbauer cells: 45.1;Kupffer cells: 51.5;Langerhans cells: 77.3;Macrophages: 141.7;Microglial cells: 56.2;NK-cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 87.5"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 106.1"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871"	Enhanced					NA	NA		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	12.9	2.3	6.0	42.7	8.1	48.1	4.3	8.8	33.7	2.2	8.4	2.9	2.3	2.8	0.8	2.0	5.9	10.8	3.5	6.2	9.3	2.9	6.3	58.1	23.2	14.6	11.8	1.0	2.9	1.4	2.9	4.6	14.3	3.2	4.3	0.6	4.5	1.5	1.3	2.1	5.5	4.7	13.0	67.5	4.8	0.6	18.4	4.0	2.8	3.2	12.3	9.2	2.1	24.8	0.1	0.6	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	9.0	0.0	0.3	0.1	0.0	0.3	0.1	18.6	0.1	0.1	0.3	0.4	0.0	1.1	106.1	0.1	0.1	1.7	0.2	0.7	1.0	0.0	0.1	0.4	0.0	0.0	0.1	8.8	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.1	0.0	3.3	0.8	0.0	1.6	0.0	0.1	0.1	0.0	0.2	4.9	1.8	0.3	12.8	29.1	27.1	4.8	50.3	0.4	2.1	0.1	0.7	34.7	1.0	0.1	0.7	87.5	41.4	61.0	0.6	0.1	11.5	6.0	8.1	8.8	33.7	6.2	9.3	14.6	11.8	14.3	13.0	18.4	24.8	0.8	12.8	51.1	0.0	9.8	2.8	0.3	0.0	0.0	0.1	0.6	1.3	1.5	0.0	10.5	0.0	0.0	0.4	33.6	0.0	0.0	0.3	0.0	0.4	0.5	4.8	0.0	3.4	0.2	0.0	0.6	4.4	0.0	0.5	74.0	0.0	1.1	0.1	45.1	0.0	0.3	0.0	0.0	51.5	77.3	0.0	0.0	141.7	1.8	56.2	35.3	0.1	68.0	0.5	0.3	0.2	0.0	0.0	5.5	0.2	0.0	0.3	1.5	0.1	0.0	0.6	1.0	0.0	0.2	0.0	1.1	0.4	16.5	0.1	0.0	0.1
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 376.2;lymphoid tissue: 175.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 417.6;Hofbauer cells: 652.4;Kupffer cells: 485.9;Langerhans cells: 259.1;Macrophages: 527.4;monocytes: 463.8;NK-cells: 959.9;T-cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"THP-1: 812.4;U-937: 615.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		3300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	54.5	23.2	8.2	175.2	9.5	376.2	15.4	13.1	9.3	15.5	11.7	25.2	23.8	8.5	2.8	16.2	17.0	36.4	11.8	7.7	14.2	8.4	23.4	78.0	169.1	29.5	19.9	7.2	11.3	5.1	4.6	44.4	28.1	8.8	13.9	1.1	19.5	9.2	6.8	9.3	32.8	46.4	23.9	137.2	29.1	5.9	26.2	87.2	7.3	7.6	68.4	46.3	5.9	50.4	1.9	4.8	0.0	0.0	0.0	0.3	1.7	0.0	2.7	0.1	0.0	0.4	0.4	17.9	128.1	0.2	0.6	0.5	0.0	0.2	0.0	1.5	1.4	18.2	0.0	3.2	0.1	106.6	27.5	1.6	0.1	0.5	0.3	0.1	0.3	58.0	0.7	1.4	7.0	4.0	117.8	126.1	0.4	0.4	2.4	1.5	23.2	64.6	4.7	0.0	0.6	1.3	3.4	2.5	1.7	0.0	0.4	812.4	2.5	0.2	6.6	0.4	3.7	0.8	5.9	2.9	0.1	615.0	0.9	186.6	1848.8	1224.1	726.7	1144.9	326.6	86.1	349.7	506.5	1031.4	115.2	233.1	396.5	1386.1	585.5	1183.5	165.5	288.0	3034.2	8.2	9.5	13.1	9.3	7.7	14.2	29.5	19.9	28.1	23.9	26.2	50.4	7.1	16.0	29.6	0.3	81.7	5.5	0.5	9.6	0.6	0.0	4.1	6.5	4.0	14.3	18.6	5.5	0.0	4.0	417.6	0.3	0.0	3.4	1.0	0.6	0.5	16.8	0.0	19.6	0.5	0.4	4.8	5.3	2.6	0.7	24.1	8.2	9.7	8.6	652.4	0.0	0.3	0.2	2.0	485.9	259.1	2.8	0.6	527.4	5.4	27.2	463.8	0.4	959.9	0.0	0.2	0.6	0.1	1.5	50.5	0.6	1.8	4.2	3.6	0.8	6.6	2.1	3.2	0.2	1.0	0.9	5.1	5.6	254.5	0.0	0.3	0.7
ITIH5	MGC10848	ENSG00000123243	"Inter-alpha-trypsin inhibitor heavy chain 5"		10	7559270-7666998	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"adipose tissue: 112.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 282.7;Fibroblasts: 111.3;Microglial cells: 160.2;Smooth muscle cells: 110.1;Syncytiotrophoblasts: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038305	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Vesicles	"HPA038305: AB_10670662"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.48e-2)"	112.7	3.7	17.9	19.4	18.6	0.2	53.3	19.7	23.2	17.4	28.6	62.7	13.9	24.3	6.3	21.4	10.5	27.7	16.8	14.7	18.0	16.4	1.6	22.4	12.5	18.9	18.1	21.2	15.0	6.3	5.4	86.9	19.7	24.0	16.8	3.5	9.5	46.6	17.8	12.0	21.6	28.8	15.7	3.4	24.0	6.2	22.5	3.8	24.5	22.5	13.4	51.4	15.3	15.2	0.0	0.0	0.0	0.1	0.0	0.0	7.0	18.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.5	14.8	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	102.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	18.6	19.7	23.2	14.7	18.0	18.9	18.1	19.7	15.7	22.5	15.2	74.9	3.2	2.7	1.3	0.2	11.3	3.0	0.1	6.8	2.7	1.6	17.3	8.7	8.6	3.7	0.0	2.1	282.7	0.8	0.1	0.0	25.7	2.0	18.7	1.5	58.8	0.0	0.0	0.5	0.4	70.2	111.3	0.0	34.1	2.5	0.5	1.8	0.1	20.7	0.0	0.7	0.0	8.2	1.2	19.6	2.2	5.3	3.6	14.2	160.2	1.1	21.9	0.0	1.5	1.0	0.3	0.0	15.4	0.9	1.8	0.2	2.1	0.7	3.2	78.9	32.3	110.1	1.7	7.7	0.7	8.8	221.9	3.0	0.3	0.0	1.6
ITM2A	"BRICD2A, E25A"	ENSG00000078596	"Integral membrane protein 2A"	O43736	X	79360384-79367667	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 322.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 390.0;Endothelial cells: 368.4;Fibroblasts: 302.1;granulocytes: 194.6;Leydig cells: 335.5;Muller glia cells: 188.9;T-cells: 239.2"	"Cancer enhanced"	"Detected in all"		"glioma: 51.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 172.6;eosinophil: 88.5;gdT-cell: 107.1;MAIT T-cell: 79.3;memory CD4 T-cell: 204.7;memory CD8 T-cell: 170.5;naive CD4 T-cell: 216.7;naive CD8 T-cell: 101.6;NK-cell: 130.3;T-reg: 168.1"	"Group enriched"	"Detected in all"	7	"granulocytes: 172.6;NK-cells: 130.3;T-cells: 216.7"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 1749.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000296			Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA000296: "	"unprognostic (1.05e-2)"	"unprognostic (5.22e-3)"	"unprognostic (2.77e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-3)"	"prognostic favorable (3.66e-6)"	"unprognostic (1.57e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.30e-1)"	80.2	10.8	103.4	26.8	95.2	45.8	74.5	99.4	172.0	55.3	75.5	30.5	15.1	44.4	18.8	40.1	42.8	28.8	115.3	92.1	105.4	20.6	6.3	52.2	87.2	101.5	102.2	181.4	10.0	14.9	21.0	29.7	102.0	22.8	32.2	11.9	74.9	22.4	41.2	25.0	22.1	56.6	95.2	24.5	24.2	15.9	109.8	322.9	83.1	75.2	46.9	42.3	26.0	95.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	216.6	2.5	0.0	4.4	0.0	69.9	0.0	0.0	0.0	113.1	124.2	19.5	0.0	0.0	0.0	0.1	0.0	333.3	80.2	0.0	0.0	0.0	1749.0	77.6	25.0	0.0	0.0	0.7	0.1	0.3	64.6	0.0	0.2	19.0	0.0	0.9	0.0	17.6	2.2	2.5	3.0	0.0	1.8	0.4	1.1	208.1	0.0	0.0	0.2	0.0	8.7	172.6	0.8	88.5	107.1	1.3	79.3	23.4	204.7	170.5	0.8	23.5	216.7	101.6	3.9	130.3	1.1	6.1	168.1	115.3	103.4	95.2	99.4	172.0	92.1	105.4	101.5	102.2	102.0	95.2	109.8	95.8	390.0	3.2	14.8	1.0	28.0	67.4	13.2	2.1	50.1	3.1	21.1	81.9	29.3	2.8	4.4	1.8	0.0	0.4	64.8	2.1	5.9	0.4	3.1	0.4	2.6	368.4	2.4	42.7	3.5	50.9	0.2	302.1	29.6	0.6	194.6	1.4	135.0	1.0	1.3	1.7	2.3	85.6	0.0	9.5	39.5	7.1	335.5	8.6	62.2	114.3	3.2	188.9	65.9	18.1	60.2	1.0	1.4	117.8	81.8	12.3	0.2	1.4	0.7	12.1	0.0	31.8	22.5	0.5	2.6	24.3	47.0	0.3	239.2	2.0	2.9	2.5
ITPRIPL1	KIAA1754L	ENSG00000198885	"ITPRIP like 1"	Q6GPH6	2	96325317-96330517	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Group enriched"	"Detected in many"	10	"Early spermatids: 170.7;Late spermatids: 145.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 12.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 12.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.9;HEL: 32.0;MOLT-4: 34.5;RPMI-8226: 33.0;U-698: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.26e-3)"	"unprognostic (3.56e-3)"	"unprognostic (4.78e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.56e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.41e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.39e-2)"	3.4	0.4	0.5	2.9	1.0	1.1	3.8	3.2	0.7	0.9	0.3	0.9	1.2	0.5	0.5	1.5	0.8	1.6	1.3	0.5	0.5	0.5	0.5	1.4	3.9	0.9	0.5	0.4	1.4	0.5	0.4	1.2	0.8	2.0	0.9	0.9	7.5	1.5	1.5	0.8	1.7	1.0	0.6	2.6	1.2	27.8	0.6	5.1	0.7	2.0	4.2	1.5	1.2	0.8	0.0	0.0	7.3	0.1	0.8	1.9	8.3	1.6	8.7	7.2	14.1	3.3	0.3	0.0	0.1	3.1	0.1	0.7	25.4	0.0	8.1	15.7	30.9	32.0	0.2	14.4	3.9	0.1	0.0	5.4	0.0	8.3	0.0	0.0	4.7	20.4	0.0	10.6	0.2	0.0	34.5	5.0	10.5	0.0	0.0	22.7	23.1	33.0	0.3	0.0	21.2	14.2	0.0	0.0	0.1	4.4	0.0	5.3	2.4	0.0	0.8	0.1	0.1	15.4	21.4	35.3	4.1	0.0	6.8	0.4	0.2	0.0	10.2	0.2	12.9	1.6	3.3	9.7	1.2	0.4	0.7	4.1	0.1	2.7	0.0	0.5	6.3	2.3	0.5	1.0	3.2	0.7	0.5	0.5	0.9	0.5	0.8	0.6	0.6	0.8	9.4	3.2	0.0	0.0	2.3	0.3	4.8	1.8	2.2	0.7	3.6	2.9	0.7	2.8	3.5	0.0	4.2	0.9	6.9	1.0	0.0	0.1	170.7	0.2	0.6	2.7	0.0	1.7	0.2	0.2	2.3	0.9	0.5	0.1	0.0	0.8	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	2.4	145.2	1.2	1.8	1.8	0.0	0.3	4.3	11.3	0.0	0.0	0.3	0.1	0.7	7.6	3.3	0.0	0.3	0.8	1.7	6.6	0.6	2.9	3.6	2.8	1.7	1.0	0.4	14.8	0.3	0.4	1.3
JAM3	"JAM-C, JAMC"	ENSG00000166086	"Junctional adhesion molecule 3"	Q9BX67	11	134069071-134152001	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 342.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	7	"B-cells: 5.3;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 99.5;RH-30: 122.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003417, HPA050434"	Approved		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA		44000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA003417: AB_1851981, HPA050434: AB_2681126"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.68e-4)"	23.6	18.7	53.4	10.1	86.3	1.3	19.2	68.7	73.4	33.4	52.9	54.6	6.6	40.8	17.5	21.5	28.7	24.5	31.0	56.5	61.3	11.4	3.2	29.6	7.8	73.5	76.8	48.7	5.1	17.7	33.3	102.7	71.0	32.5	12.9	47.3	13.3	44.5	7.0	13.0	22.5	42.8	59.7	13.5	22.4	35.7	73.3	17.6	15.8	14.6	7.5	41.7	23.4	115.2	0.0	1.0	87.9	42.5	85.3	62.7	75.4	37.0	49.1	15.1	14.8	0.3	0.6	0.0	38.7	53.3	56.2	0.5	70.0	0.7	28.2	0.2	29.6	0.3	0.0	6.9	24.9	0.4	36.2	43.2	0.0	10.7	9.6	35.8	99.5	40.8	0.3	0.2	64.5	1.0	27.5	0.2	18.9	0.6	2.9	0.5	122.8	0.0	0.9	0.2	57.5	32.2	0.0	0.2	1.0	35.3	0.2	0.2	0.6	25.1	18.4	40.3	24.7	0.1	0.1	0.4	27.6	1.2	48.0	0.0	0.0	0.1	1.3	0.0	1.6	5.3	1.6	0.9	0.0	3.1	2.3	1.7	0.5	0.0	0.0	0.0	0.0	1.8	53.4	86.3	68.7	73.4	56.5	61.3	73.5	76.8	71.0	59.7	73.3	115.2	22.2	0.0	6.0	12.7	10.9	5.1	5.6	0.9	0.0	21.7	0.3	9.3	15.7	0.0	0.7	5.5	8.4	6.0	1.2	0.1	1.9	0.4	2.1	0.8	23.3	35.5	0.0	0.4	84.3	0.2	71.2	29.6	1.5	0.5	1.3	11.7	12.5	0.0	8.6	8.4	44.2	0.0	12.2	0.6	4.2	4.9	42.9	10.9	17.8	24.4	0.2	20.2	1.0	76.4	342.8	0.3	0.0	64.3	0.9	2.2	0.0	0.2	1.5	75.6	26.3	19.0	24.3	15.5	19.2	0.2	3.8	6.2	3.5	9.7	0.0	1.0
JAZF1	"DKFZp761K2222, TIP27, ZNF802"	ENSG00000153814	"JAZF zinc finger 1"	Q86VZ6	7	27830573-28180795	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid metabolism, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 83.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 160.1;Excitatory neurons: 316.6;Inhibitory neurons: 306.3;Microglial cells: 168.6;Oligodendrocyte precursor cells: 241.3;Oligodendrocytes: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 25.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.7;granulocytes: 25.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 53.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019271, HPA066967"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB019271: , HPA066967: AB_2685758"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-2)"	15.4	83.8	11.1	10.9	12.4	24.4	11.7	11.5	16.5	62.4	12.4	32.8	3.4	41.8	21.3	10.1	16.4	12.4	22.4	13.2	15.3	5.1	15.7	10.1	14.6	7.3	8.3	13.9	6.6	6.3	13.4	16.1	9.1	29.5	8.3	7.8	4.6	35.2	6.9	7.1	8.3	38.6	8.1	14.6	8.3	18.8	17.4	11.5	14.9	6.9	15.9	19.2	27.3	10.0	1.4	0.8	4.8	1.0	35.6	42.9	0.0	11.1	28.6	18.4	22.8	0.1	7.6	33.7	22.6	23.5	12.5	0.7	6.3	8.5	15.0	5.1	10.2	12.2	7.7	0.0	24.2	4.8	3.1	19.4	10.2	13.8	8.9	14.1	11.8	2.2	0.3	53.2	10.3	1.4	1.3	17.5	10.0	0.2	7.7	3.6	2.2	10.1	6.7	0.3	3.0	4.7	9.2	0.3	12.0	14.0	3.5	6.1	11.7	29.0	11.0	8.0	12.9	9.2	2.9	12.5	9.2	12.5	16.2	25.6	3.9	6.9	4.8	3.3	1.3	2.8	1.3	3.2	3.7	3.7	0.5	3.0	1.5	4.1	3.5	13.7	3.2	3.1	11.1	12.4	11.5	16.5	13.2	15.3	7.3	8.3	9.1	8.1	17.4	10.0	10.2	3.2	7.0	57.8	33.4	14.7	3.0	3.8	3.4	6.7	3.5	4.8	25.3	10.0	3.0	1.8	6.2	0.5	37.9	1.3	7.9	14.8	122.1	28.3	160.1	14.5	5.4	115.6	316.6	2.3	1.4	24.6	9.2	18.6	24.1	12.6	3.6	5.5	9.4	16.8	306.3	0.6	2.0	25.7	45.6	89.8	55.0	28.0	23.2	168.6	35.5	4.4	40.2	241.3	262.5	5.3	0.4	34.6	8.7	2.7	0.0	2.4	12.7	4.7	13.1	9.9	15.3	8.7	16.5	3.4	11.2	1.4	25.3	1.6	0.3	1.5
JCAD	KIAA1462	ENSG00000165757	"Junctional cadherin 5 associated"	Q9P266	10	30012803-30115494	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 106.8;Endothelial cells: 30.3;Granulosa cells: 72.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 29.3;HUVEC TERT2: 29.9;LHCN-M2: 24.9;TIME: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017956	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cell Junctions"		"HPA017956: AB_1852408"	"unprognostic (1.78e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.37e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.09e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (2.54e-4)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.34e-2)"	31.2	7.5	13.5	5.2	21.2	0.1	13.0	5.1	13.0	6.5	3.1	36.0	1.4	17.3	7.5	5.9	12.5	10.4	18.3	10.8	7.2	6.7	1.8	24.2	3.5	12.5	8.4	10.9	16.9	4.9	4.5	33.6	10.1	7.8	3.9	13.1	2.4	9.5	9.9	3.7	3.7	17.3	7.3	0.9	4.5	14.0	13.3	6.1	13.6	14.8	1.8	18.3	4.4	8.1	15.3	6.7	5.9	0.0	3.7	0.9	8.6	8.1	8.5	1.2	2.0	2.6	0.1	0.0	0.6	29.3	1.7	0.3	1.6	0.5	3.3	1.7	3.6	0.0	0.0	0.1	16.0	0.0	1.0	9.1	0.2	19.9	1.5	0.5	29.9	0.4	0.0	0.0	24.9	0.5	0.0	0.7	1.2	0.9	10.2	0.0	3.3	0.0	1.2	0.3	0.8	0.1	0.3	0.1	0.0	8.4	0.0	1.4	67.8	14.9	3.6	4.7	0.7	6.2	0.8	0.0	3.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	21.2	5.1	13.0	10.8	7.2	12.5	8.4	10.1	7.3	13.3	8.1	106.8	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	16.4	0.0	1.3	8.5	30.3	0.0	0.0	0.0	0.4	0.9	2.2	0.0	0.8	1.3	72.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.4	0.2	7.1	0.0	0.0
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58776845-58784048	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 295.6"	"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA031174, HPA059474"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030"	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"	331.1	92.7	34.4	36.3	37.0	129.1	308.2	41.6	38.1	172.0	28.0	154.7	34.7	116.4	15.8	100.2	314.1	89.6	158.4	39.1	37.2	94.0	205.2	202.8	52.1	32.7	30.7	197.0	192.2	59.8	75.0	40.1	30.5	153.4	55.0	29.7	154.5	71.7	114.3	286.6	79.1	113.3	34.3	62.0	239.5	20.2	33.8	71.5	189.5	158.8	5.4	156.4	164.5	36.9	49.8	2.8	22.4	2.6	35.3	40.0	0.2	69.4	27.0	57.1	34.3	10.1	3.5	1.7	23.8	57.4	133.6	12.9	2.0	27.7	40.6	29.8	128.9	0.5	1.9	16.9	29.4	5.3	10.2	42.0	74.0	78.1	34.0	27.7	47.2	2.4	15.6	29.6	24.9	8.0	2.5	32.5	13.5	34.6	32.2	1.1	295.6	7.0	60.7	5.8	43.7	12.8	49.9	62.3	26.4	24.5	17.2	3.0	61.6	127.5	37.3	35.3	96.8	37.9	9.8	4.4	133.9	8.4	35.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	34.4	37.0	41.6	38.1	39.1	37.2	32.7	30.7	30.5	34.3	33.8	36.9	2721.4	538.5	543.8	187.7	1018.8	1235.5	2850.5	772.6	2825.1	103.4	1647.1	2067.3	1487.5	1315.4	449.3	104.8	262.7	675.8	651.1	1653.6	50.9	987.0	49.3	1337.1	2845.2	1443.8	1497.4	174.3	12.2	516.4	93.9	2730.7	2663.1	1822.2	541.9	333.4	737.2	158.6	650.5	87.5	4.9	1909.1	836.2	584.9	632.0	48.2	1227.4	1034.9	757.7	65.6	140.1	1234.2	8.2	17.6	10.0	562.8	1529.6	258.8	1540.3	1489.1	1654.1	48.6	216.3	453.5	1538.3	1892.9	2392.5	17.4	20.9	2146.3	964.4	415.6	1065.5	846.5	1199.5	545.7
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 952.2;skin 1: 932.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 1090.1;OE19: 3919.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		64000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	46.5	16.0	13.6	23.6	21.6	20.7	68.6	20.8	18.9	243.7	25.8	94.9	88.1	57.0	15.3	952.2	69.9	39.8	145.1	14.6	14.3	120.7	70.9	57.1	15.7	20.7	16.2	46.2	59.6	19.9	37.3	51.5	19.6	68.0	49.0	4.7	226.4	41.8	110.8	932.4	95.7	23.1	14.8	22.7	86.3	12.5	16.2	29.6	86.4	62.2	92.0	68.7	432.6	33.6	268.8	217.8	21.7	18.5	0.2	0.1	330.6	15.3	89.2	5.9	5.2	332.6	289.0	5.4	157.8	9.7	7.5	1090.1	31.6	242.4	1.0	0.6	74.2	11.6	165.1	74.4	34.7	7.3	113.6	0.5	538.6	0.9	43.9	64.2	96.1	7.0	99.6	94.0	0.0	342.6	1.9	96.5	42.3	3919.9	36.2	313.5	0.2	202.5	165.8	674.0	52.2	38.6	33.8	652.1	1.9	98.6	545.9	8.0	152.4	0.3	14.8	6.8	5.1	8.2	31.2	5.5	1.5	12.7	2.6	3.9	13.1	28.7	0.0	22.6	0.0	13.5	0.0	0.2	14.5	11.7	0.2	0.1	0.6	0.8	43.8	4.5	0.1	5.7	13.6	21.6	20.8	18.9	14.6	14.3	20.7	16.2	19.6	14.8	16.2	33.6	56.9	60.9	36.8	4.6	10.6	196.9	218.5	104.5	100.2	1.9	87.3	77.0	87.8	48.6	80.9	132.4	4.2	98.9	1.1	315.9	27.4	212.2	28.5	112.6	21.1	55.2	66.8	3.4	0.5	135.4	167.3	25.6	136.1	247.0	11.4	16.5	41.4	34.1	14.4	0.0	1.6	125.0	81.4	7.7	32.7	8.3	5.0	10.9	12.4	2.8	6.3	18.2	0.0	7.1	13.6	356.2	223.7	0.0	3.9	220.1	141.1	35.6	45.7	4.3	6.6	37.4	18.8	2.5	4.5	318.3	383.3	185.7	6.1	3.2	129.2	301.6
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236165-62319434	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6;pancreas: 15.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 31.8;Exocrine glandular cells: 8.0;Extravillous trophoblasts: 19.0;Oligodendrocytes: 34.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.8;Hep G2: 13.4;SCLC-21H: 6.2;SuSa: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.7	0.5	1.0	0.5	5.8	0.0	2.6	10.1	3.2	0.3	0.1	1.0	0.3	0.2	0.7	0.2	0.3	0.5	0.3	0.8	4.6	1.4	3.0	2.5	0.0	19.2	13.8	0.3	15.2	5.6	0.1	10.8	22.6	1.5	1.0	1.0	8.4	0.6	0.2	0.5	0.3	0.2	5.3	0.8	2.0	0.9	7.6	0.8	0.3	0.8	0.0	0.2	0.5	8.9	0.0	0.0	1.1	0.0	0.0	0.0	31.8	0.1	0.0	0.1	0.0	4.8	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	2.4	13.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.0	1.0	0.6	0.0	27.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	5.8	10.1	3.2	0.8	4.6	19.2	13.8	22.6	5.3	7.6	8.9	0.1	0.0	0.0	1.3	0.0	0.0	2.4	0.4	0.6	0.3	0.5	7.0	0.9	0.0	0.0	0.0	0.0	31.8	0.0	0.5	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	2.3	8.0	19.0	0.9	0.0	0.1	0.0	0.1	0.4	1.5	2.3	0.0	2.3	1.4	0.0	0.0	0.0	0.3	0.0	0.4	1.8	1.0	0.0	0.1	0.0	0.5	34.3	0.4	0.2	3.8	0.0	0.0	0.0	0.8	0.0	0.5	0.0	1.2	4.2	0.0	1.0	0.2	0.0	5.5	0.1	0.0	1.0	0.1
KATNAL1	MGC2599	ENSG00000102781	"Katanin catalytic subunit A1 like 1"	Q9BW62	13	30202630-30307551	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 144.3;Excitatory neurons: 80.6;Oligodendrocytes: 78.5;Spermatocytes: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 63.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046205			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046205: AB_10965325"	"unprognostic (3.34e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.83e-3)"	8.7	3.8	7.0	5.0	8.8	6.5	4.7	7.5	8.9	9.7	0.0	8.7	1.4	9.3	2.7	5.8	4.8	3.8	17.9	8.0	8.1	4.0	3.9	4.9	6.5	7.2	6.4	4.2	1.9	2.2	2.9	3.0	7.0	4.5	4.1	7.9	2.2	5.9	5.1	2.6	2.8	15.0	7.5	3.3	2.8	20.8	8.4	9.2	3.0	6.6	7.1	5.0	5.2	11.8	11.7	9.6	16.5	8.8	12.3	26.0	0.4	47.5	15.2	24.9	19.4	1.9	11.6	18.8	5.5	63.7	31.3	3.2	11.8	12.2	37.5	16.3	4.4	13.4	11.2	4.4	6.5	6.7	8.7	10.1	6.0	28.0	6.8	23.3	26.4	10.2	7.3	8.1	30.8	2.4	15.2	6.1	7.1	0.2	6.1	16.8	19.4	1.9	8.8	0.8	6.8	14.3	12.6	2.6	9.0	13.6	4.1	4.1	24.2	21.8	32.7	12.1	19.3	4.2	8.2	25.8	8.7	6.5	32.1	1.5	0.7	2.9	4.4	0.4	2.1	1.9	3.4	4.4	1.9	4.5	0.8	1.8	0.2	7.7	0.9	5.5	5.8	1.2	7.0	8.8	7.5	8.9	8.0	8.1	7.2	6.4	7.0	7.5	8.4	11.8	12.9	9.6	1.8	30.3	7.2	5.9	3.9	4.7	6.2	10.2	4.0	5.6	41.4	2.8	2.3	5.5	27.1	0.4	6.6	0.3	3.9	6.5	144.3	10.3	26.5	9.3	10.2	16.4	80.6	1.5	0.8	12.3	1.5	3.6	10.1	10.3	7.9	10.6	2.9	21.9	34.5	1.0	0.0	2.8	8.9	50.7	9.0	5.9	17.8	21.5	21.9	9.6	13.4	29.1	78.5	5.7	0.0	5.3	6.4	1.9	0.3	8.4	14.7	18.7	6.6	11.9	13.7	59.0	24.6	5.2	5.7	0.3	9.8	19.2	0.7	1.7
KBTBD2	"BKLHD1, DKFZP566C134"	ENSG00000170852	"Kelch repeat and BTB domain containing 2"	Q8IY47	7	32868172-32894131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021133	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA021133: AB_1852093"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (3.96e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.96e-1)"	26.4	16.4	23.0	21.7	25.2	54.6	20.9	27.3	24.9	17.2	21.4	16.9	15.9	20.8	10.7	16.1	15.6	25.2	20.3	21.0	24.8	15.3	21.5	22.5	25.6	27.2	25.8	16.4	11.8	17.1	15.0	25.8	27.2	16.3	19.6	25.9	14.4	15.0	57.6	16.3	17.6	23.6	26.3	27.0	14.8	18.1	26.5	30.5	18.6	40.3	24.0	22.0	17.3	28.8	38.3	18.8	47.5	23.5	28.1	28.0	17.1	33.4	33.9	31.2	37.6	18.7	28.6	31.9	22.6	34.7	52.3	27.5	24.5	26.2	39.2	12.6	17.6	27.1	30.6	24.4	28.9	29.3	34.2	30.1	26.9	34.0	32.9	28.9	34.9	28.6	50.3	46.2	46.4	31.4	24.3	47.9	38.6	26.5	17.7	23.4	41.6	26.7	27.6	22.3	24.9	46.4	21.5	29.1	38.6	39.6	20.7	49.5	30.5	29.6	38.7	28.3	46.5	37.5	39.3	57.6	28.8	34.9	77.0	14.5	6.4	21.4	10.9	12.2	9.2	7.1	5.4	9.7	5.6	9.8	4.2	6.9	39.2	10.7	14.6	2.9	7.6	4.1	23.0	25.2	27.3	24.9	21.0	24.8	27.2	25.8	27.2	26.3	26.5	28.8	67.2	28.9	23.9	24.5	27.0	40.4	15.7	13.4	44.3	14.6	20.4	15.6	18.4	20.0	22.1	1.8	10.4	6.9	41.4	18.1	0.0	11.8	7.7	21.6	23.1	48.7	14.9	25.2	21.0	12.2	8.7	22.2	17.9	33.8	43.7	20.4	36.8	14.6	13.3	8.4	20.5	14.0	4.1	24.6	23.1	6.2	13.1	32.5	24.9	34.7	13.0	8.7	15.5	29.7	36.8	16.8	10.3	6.0	25.2	17.1	10.5	5.1	7.3	8.9	19.7	26.4	21.1	19.1	8.8	25.9	36.1	7.5	28.4	10.8	11.4	18.5
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110674940	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 25.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 13.1;Inhibitory neurons: 60.2;Plasma cells: 61.6;T-cells: 20.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 4.9;T-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.1;Karpas-707: 45.6;U-266/70: 32.6;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016625	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	0.5	0.9	3.4	6.4	2.0	4.6	0.9	1.1	4.9	1.1	0.0	2.4	2.5	0.5	0.0	0.5	0.3	1.3	0.4	5.0	7.2	0.2	0.8	5.9	9.4	1.1	3.3	0.7	0.4	0.4	0.4	0.7	5.0	0.5	1.9	0.6	1.4	0.2	0.1	0.2	2.6	0.6	0.2	6.0	4.3	0.5	3.3	25.4	0.7	0.1	7.6	2.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	45.6	0.0	0.0	10.0	0.0	0.9	0.0	0.0	0.0	0.0	9.6	0.0	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.0	0.0	32.6	31.9	11.6	0.0	2.7	0.0	0.0	1.1	0.0	8.9	0.0	10.0	2.8	13.4	14.3	1.4	4.9	10.4	7.9	0.0	1.3	0.1	0.6	13.4	4.4	3.4	2.0	1.1	4.9	5.0	7.2	1.1	3.3	5.0	0.2	3.3	0.0	0.2	0.0	1.9	1.3	11.5	0.4	0.0	0.0	0.0	2.5	0.1	0.0	0.6	0.0	0.0	1.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.3	13.1	0.0	0.0	0.7	1.5	0.0	0.0	0.0	1.8	0.0	0.4	0.0	60.2	0.0	0.0	1.6	2.4	0.0	0.0	3.1	3.6	2.8	2.4	0.3	3.1	7.5	1.3	0.0	0.0	0.0	61.6	0.0	0.0	0.1	0.0	0.2	6.6	0.0	0.1	4.3	0.9	0.1	0.6	0.0	20.3	0.0	0.0	0.1
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273175-120750337	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 47.3"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 690.0;Inhibitory neurons: 1068.2;Oligodendrocyte precursor cells: 1952.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.8;HSkMC: 2.9;NTERA-2: 2.4;RT4: 2.7;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA029068: AB_10601436"	"unprognostic (4.22e-1)"	"unprognostic (2.79e-4)"	"unprognostic (3.79e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-3)"	"unprognostic (9.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.51e-4)"	"unprognostic (4.07e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.83e-3)"	1.7	0.5	8.1	0.5	10.5	0.0	1.0	47.3	8.6	1.1	0.0	0.3	0.3	3.2	0.1	0.1	1.2	4.2	0.2	5.5	10.1	0.0	0.1	0.2	0.1	29.3	15.4	3.3	0.2	0.7	1.9	0.4	26.8	0.2	0.2	1.0	0.3	0.9	0.2	0.1	0.1	2.0	4.9	0.0	0.2	1.7	19.2	0.3	0.4	2.8	0.0	1.1	0.5	2.5	0.0	0.0	0.2	0.0	1.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	2.7	13.2	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	10.5	47.3	8.6	5.5	10.1	29.3	15.4	26.8	4.9	19.2	2.5	0.6	0.0	0.0	108.7	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	1.2	4.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	2.7	1.0	1.9	0.3	0.0	2.7	690.0	0.2	0.0	6.0	0.0	0.8	0.0	6.6	0.7	0.0	0.0	0.0	1068.2	0.0	2.0	0.0	0.0	1.7	3.7	0.1	0.0	40.3	0.0	0.0	0.0	1952.8	9.7	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.3	0.5	0.0	10.9	3.0	5.0	3.4	0.0	0.1	0.0	0.0	4.3	0.0	0.1
KCNIP1	KCHIP1	ENSG00000182132	"Potassium voltage-gated channel interacting protein 1"	Q9NZI2	5	170353487-170736632	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;choroid plexus: 15.1;epididymis: 21.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 57.8;Horizontal cells: 50.5;Inhibitory neurons: 221.4;Microglial cells: 167.7;Oligodendrocyte precursor cells: 196.1"	"Cancer enriched"	"Detected in some"	18	"glioma: 22.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"RPTEC TERT1: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022864, HPA066717"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA022864: AB_1858712, HPA066717: "	"unprognostic (7.75e-5)"	"unprognostic (2.66e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.22e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.46e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-2)"	0.5	4.2	23.5	0.5	26.5	0.0	1.0	19.4	28.3	2.7	15.1	0.7	0.2	1.6	21.6	0.3	1.7	1.8	0.4	21.8	32.6	3.8	0.1	1.0	0.5	24.3	26.6	0.3	1.4	1.3	1.0	1.2	24.7	1.5	0.5	5.8	0.4	5.6	0.1	0.4	0.3	1.1	28.7	1.5	0.4	2.7	32.7	0.1	0.7	0.2	0.4	0.5	0.6	19.6	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	26.5	19.4	28.3	21.8	32.6	24.3	26.6	24.7	28.7	32.7	19.6	0.0	0.0	0.0	57.8	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	2.0	1.2	0.0	0.0	18.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	50.5	221.4	0.0	0.0	0.0	0.6	0.7	5.0	0.1	0.0	167.7	0.0	0.2	0.0	196.1	2.8	0.0	0.0	11.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
KCNIP4	"CALP, KCHIP4, MGC44947"	ENSG00000185774	"Potassium voltage-gated channel interacting protein 4"	Q6PIL6	4	20728606-21948772	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.5;retina: 18.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9816.7;Inhibitory neurons: 1982.4;Oligodendrocyte precursor cells: 5175.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022862, HPA066717"		Supported	Approved	Vesicles		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA022862: AB_1852654, HPA066717: "	"unprognostic (8.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.10e-2)"	0.6	2.2	11.9	1.3	16.4	0.0	0.6	13.8	24.5	11.0	0.0	6.9	1.2	6.2	0.6	4.0	2.5	1.1	0.5	17.8	12.8	8.2	0.2	0.5	0.0	7.0	7.9	1.3	0.5	0.0	4.2	1.0	13.7	0.5	4.1	18.1	0.5	0.3	0.3	0.5	3.8	6.0	4.3	0.3	0.8	0.4	9.0	0.0	6.4	0.0	0.0	1.0	1.5	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	16.4	13.8	24.5	17.8	12.8	7.0	7.9	13.7	4.3	9.0	10.6	0.0	0.0	0.0	148.2	0.1	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.5	0.0	0.0	14.7	0.0	0.1	0.0	0.3	62.6	0.1	9.8	0.2	2.1	1.6	0.0	0.0	9816.7	0.0	0.0	3.1	0.0	0.2	0.0	12.3	1.1	0.2	0.2	0.0	1982.4	0.6	0.0	0.0	0.0	4.2	0.0	0.5	3.6	119.9	0.6	45.9	0.0	5175.8	91.4	0.0	7.8	0.0	0.0	0.0	0.4	15.2	0.0	12.6	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.1	0.1	14.5	0.7	0.1
KCNK2	"K2p2.1, TREK-1"	ENSG00000082482	"Potassium two pore domain channel subfamily K member 2"	O95069	1	215005775-215237090	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"adrenal gland: 53.0"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 19.7;Inhibitory neurons: 53.9;Microglial cells: 30.0;Oligodendrocyte precursor cells: 45.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 79.7;fHDF/TERT166: 76.3;hTERT-RPE1: 49.2;T-47d: 108.5;U-2197: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.81e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-6)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.46e-3)"	1.6	53.0	4.3	0.8	8.5	0.0	6.5	0.0	5.6	2.0	0.0	0.8	0.3	0.4	0.7	0.9	1.2	1.4	0.2	5.0	7.5	1.9	0.0	0.3	0.0	0.7	2.5	3.3	0.5	0.0	0.5	0.0	0.1	0.8	1.3	0.2	0.8	3.5	0.9	3.4	2.2	1.2	2.2	0.0	4.2	0.5	6.1	0.7	9.6	1.3	0.0	2.7	1.2	2.0	0.0	0.0	2.2	0.1	20.3	79.7	0.1	29.8	19.7	9.3	21.6	0.0	1.1	0.0	0.0	76.3	0.1	0.0	13.2	0.1	15.8	0.0	0.1	0.0	0.8	0.0	1.0	0.0	0.0	21.0	0.2	22.7	2.2	49.2	0.0	0.0	0.0	0.1	10.8	0.0	0.4	0.0	2.3	4.1	0.6	0.1	0.0	0.0	0.1	0.0	7.0	0.1	5.1	0.5	0.4	0.2	108.5	0.0	0.0	15.6	0.6	39.2	1.3	1.6	4.1	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	8.5	0.0	5.6	5.0	7.5	0.7	2.5	0.1	2.2	6.1	2.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.3	0.0	0.0	19.7	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	53.9	0.0	0.0	0.0	0.8	0.1	0.0	0.0	3.6	30.0	0.0	0.0	0.0	45.8	0.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.1	0.3	0.0	1.4	0.0	0.1	0.0	0.0	0.0
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783787-40840452	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.1;intestine: 5.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 5.1;Inhibitory neurons: 9.7;Muller glia cells: 4.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HEK 293: 2.2;K-562: 2.6;MCF7: 1.4;REH: 1.3;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	0.9	0.1	0.1	0.3	0.6	0.0	0.6	0.2	1.7	0.9	2.4	5.4	0.4	2.8	0.1	1.0	2.3	0.3	0.6	0.2	0.2	0.1	0.1	0.5	0.0	0.7	5.1	0.5	0.4	0.2	0.3	0.5	0.7	1.1	0.3	0.4	1.4	1.1	3.2	0.6	1.2	1.5	0.8	0.0	1.3	0.2	0.1	0.3	0.2	1.0	0.0	2.3	0.7	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.2	0.9	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.2	0.0	1.1	0.2	0.0	0.6	0.2	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	1.7	0.2	0.2	0.7	5.1	0.7	0.8	0.1	2.0	0.3	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	1.8	1.5	2.1	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	1.2	0.2	0.2	0.1	0.3	1.8	0.8	5.1	0.2	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	2.2	0.0	9.7	1.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.2	0.0	2.5	1.5	0.6	0.5	0.7	0.3	0.2	0.0	0.0	0.0	0.3	6.6	2.0	2.8	0.2	0.7	1.0	0.4	0.0	0.0	0.1	1.1	0.1
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 37.1;lymphoid tissue: 15.8;skeletal muscle: 13.4"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 60.1;Inhibitory neurons: 55.0;Theca cells: 21.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.5;RPMI-8226: 1.8;SCLC-21H: 3.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.8"	HPA059880	Uncertain					NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA059880: AB_2684149"	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	0.4	0.1	3.9	0.1	7.9	0.1	0.3	1.9	37.1	0.3	0.0	0.3	0.1	0.1	0.1	0.2	0.6	0.2	1.2	4.2	0.0	0.0	0.1	0.3	0.0	4.5	0.0	5.0	0.1	0.0	8.7	0.3	2.8	0.1	0.0	0.4	0.2	0.0	13.4	0.1	0.2	0.0	0.0	15.8	0.5	0.9	0.0	0.0	0.1	8.2	0.0	0.2	0.2	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.8	1.8	0.0	0.0	3.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	7.9	1.9	37.1	4.2	0.0	4.5	0.0	2.8	0.0	0.0	12.5	0.0	0.0	0.0	3.6	0.1	0.0	0.3	0.0	0.0	1.3	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	60.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.3	0.0	3.5	2.7	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.1	1.1	0.3	1.0	0.0	0.0	0.0	0.1	21.2	0.0	0.0
KCTD12	"C13orf2, KIAA1778, PFET1"	ENSG00000178695	"Potassium channel tetramerization domain containing 12"	Q96CX2	13	76880175-76886405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 281.2;Endothelial cells: 192.2;Enteroendocrine cells: 386.7;Hofbauer cells: 218.9;Kupffer cells: 395.9;Macrophages: 221.3;monocytes: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 3.9;myeloid DC: 3.7"	"Group enriched"	"Detected in many"	17	"dendritic cells: 3.7;granulocytes: 1.0;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 111.4;HUVEC TERT2: 229.0;TIME: 186.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056987, HPA077376"		Supported	Approved	Mitochondria		NA	NA		21000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria		"HPA056987: , HPA077376: "	"unprognostic (6.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.82e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	76.1	27.8	21.4	55.7	20.1	12.0	52.4	27.0	20.8	44.5	12.4	39.5	22.5	51.3	17.8	38.3	75.0	55.0	22.6	26.9	27.8	31.0	13.9	58.0	39.4	36.2	33.5	47.1	12.5	25.2	6.4	83.9	31.4	14.7	42.5	3.4	20.0	18.5	16.6	22.9	28.1	65.3	37.0	64.8	28.0	26.9	31.4	18.3	16.4	37.1	33.4	39.2	17.4	34.4	1.7	1.5	15.3	0.0	111.4	52.5	4.3	6.9	1.5	4.2	5.5	0.5	0.3	0.0	3.8	18.8	4.9	53.9	6.6	66.4	3.5	1.5	35.1	0.2	38.3	0.0	4.7	18.6	0.1	21.4	21.5	2.7	48.9	8.5	229.0	13.2	0.3	0.2	53.9	1.4	8.5	0.3	7.8	16.6	7.7	0.4	7.4	19.6	17.7	0.2	4.3	7.9	17.3	0.5	2.2	18.5	1.0	12.1	186.0	2.7	4.9	0.4	14.0	2.7	0.5	0.0	42.5	4.0	16.1	0.0	3.9	0.7	0.0	2.5	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	1.0	0.0	1.5	1.9	0.0	0.9	21.4	20.1	27.0	20.8	26.9	27.8	36.2	33.5	31.4	37.0	31.4	34.4	281.2	25.6	8.4	2.9	7.5	40.0	2.7	11.9	28.5	4.4	11.2	27.3	21.8	4.3	16.3	97.5	14.6	3.0	30.4	19.7	17.6	6.5	3.6	4.9	44.6	192.2	386.7	6.1	4.8	0.6	90.6	80.0	12.2	3.3	7.0	53.1	61.1	2.5	218.9	0.0	11.5	71.5	12.2	395.9	75.4	11.8	157.2	221.3	51.6	45.9	206.7	4.8	7.2	0.5	0.9	0.5	15.7	44.8	7.6	4.5	0.7	7.5	72.8	1.5	26.3	153.2	32.2	1.9	7.0	16.9	34.4	4.2	5.5	24.0	46.6	1.9
KHDRBS1	"FLJ34027, p62, Sam68"	ENSG00000121774	"KH RNA binding domain containing, signal transduction associated 1"	Q07666	1	32013868-32060850	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005355, HPA051280, HPA056813"	Supported		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240"	"unprognostic (1.31e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (5.01e-2)"	"unprognostic (2.51e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.03e-2)"	59.8	47.4	36.3	67.0	38.8	93.3	61.7	44.7	37.4	59.5	34.8	62.9	62.3	82.6	47.2	57.3	70.3	48.6	56.8	36.6	39.7	54.0	50.6	52.1	94.1	40.7	38.7	110.6	50.9	61.7	38.3	63.7	38.1	55.1	57.3	58.5	45.2	55.8	45.9	57.3	59.2	65.6	44.1	64.0	52.3	42.2	37.2	112.2	63.8	40.6	96.7	62.2	47.6	46.7	204.6	121.0	272.6	201.6	92.5	115.4	159.5	120.7	152.1	221.5	185.5	136.2	178.1	302.9	131.5	153.5	128.4	139.2	221.9	165.1	225.6	181.7	188.8	191.1	111.8	188.0	121.5	256.2	123.8	127.6	92.7	168.9	132.8	145.6	212.6	183.1	251.0	136.5	172.6	132.6	379.2	218.7	277.0	127.3	144.3	300.1	230.2	257.7	156.0	203.7	185.7	241.7	175.7	148.8	157.2	192.9	177.3	183.7	160.5	143.9	154.5	155.3	205.9	140.3	163.5	296.0	149.2	202.3	112.1	5.8	5.7	5.9	7.8	8.9	11.7	9.9	9.2	8.2	7.8	8.0	9.8	9.5	5.0	8.0	7.5	8.9	9.3	3.0	36.3	38.8	44.7	37.4	36.6	39.7	40.7	38.7	38.1	44.1	37.2	46.7	130.6	38.5	77.4	40.8	181.9	147.6	200.3	58.8	183.2	94.8	111.1	109.9	104.4	97.2	89.8	69.9	50.1	192.7	131.9	87.9	84.1	96.2	24.7	122.5	154.4	125.7	117.8	131.6	46.0	103.1	234.5	132.4	103.5	127.0	128.1	224.5	99.6	64.6	120.8	63.9	48.1	101.1	28.5	141.9	148.4	21.7	111.2	139.2	108.5	36.5	142.6	142.6	105.0	43.7	59.6	107.1	76.2	124.1	141.8	136.4	74.5	123.8	93.3	89.3	92.1	140.4	157.9	198.2	122.7	173.8	130.6	173.5	161.7	138.7	152.0	167.1
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 121.2;kidney: 104.4;liver: 180.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	4.2	3.0	4.3	1.7	2.0	7.1	5.9	2.6	1.2	4.2	112.4	3.8	0.6	2.4	4.3	1.3	1.4	4.8	3.9	104.4	180.5	1.6	1.9	5.4	4.0	3.6	9.4	2.6	1.4	0.5	5.5	1.6	1.2	1.5	4.4	1.4	3.8	2.4	121.2	1.9	3.6	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.3	4.7	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	4.2	4.3	7.1	5.9	4.8	3.9	5.4	4.0	5.5	3.6	3.8	4.7	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
KIAA1671		ENSG00000197077	KIAA1671	Q9BY89	22	24952730-25197448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.4;Excitatory neurons: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"OE19: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018135	Approved		Approved	Microtubules		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules		"HPA018135: AB_1859551"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.68e-2)"	"prognostic favorable (3.19e-6)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.87e-2)"	10.7	13.7	12.4	5.1	13.2	0.8	22.5	2.8	17.9	10.3	8.6	16.0	14.4	6.6	5.2	25.9	20.0	14.8	11.3	20.0	7.7	11.0	34.1	12.2	5.5	6.7	8.3	8.5	10.1	10.3	11.2	4.1	3.9	13.2	14.2	15.5	25.9	15.5	25.1	28.0	16.8	6.8	6.5	3.8	12.4	4.9	13.5	15.6	26.6	22.1	8.9	8.9	18.7	5.6	25.2	15.7	3.3	5.9	0.1	0.1	2.6	0.1	0.1	1.4	0.1	12.6	9.0	0.1	11.7	1.1	6.9	29.8	25.5	25.2	1.0	0.2	10.6	0.1	16.7	16.9	3.3	0.1	1.3	0.6	22.4	7.9	24.3	16.6	28.9	0.5	0.3	0.1	3.4	11.6	0.1	0.1	5.2	39.9	8.3	1.1	26.6	4.9	16.3	10.8	8.0	6.7	20.3	14.0	1.3	10.8	7.6	0.2	19.5	1.4	27.0	16.6	4.5	0.1	0.4	0.1	10.0	0.0	4.3	0.2	0.0	0.0	1.8	0.0	0.2	0.0	0.5	1.3	0.0	0.1	0.2	0.8	0.2	0.4	0.0	0.1	0.1	0.3	12.4	13.2	2.8	17.9	20.0	7.7	6.7	8.3	3.9	6.5	13.5	5.6	27.7	12.8	21.9	74.4	1.1	10.8	21.1	16.2	18.2	4.2	25.4	16.5	11.9	25.8	19.2	5.5	22.9	0.2	3.0	62.9	0.0	18.9	2.6	31.2	3.5	28.5	7.2	5.3	67.8	18.9	0.1	4.9	22.4	30.2	1.3	4.2	29.6	47.8	2.4	16.8	22.9	12.3	6.1	1.9	5.9	3.5	7.2	1.6	10.6	43.1	0.6	21.6	0.0	12.5	3.4	21.4	34.1	9.1	0.6	18.2	34.1	8.8	32.0	17.6	0.0	11.0	9.3	6.8	8.8	27.3	14.5	1.0	6.6	6.6	20.1	29.2
KIAA1841		ENSG00000162929	KIAA1841	Q6NSI8	2	61065871-61138034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 11.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 91.2;Inhibitory neurons: 78.5;Oligodendrocytes: 63.8;Respiratory ciliated cells: 58.0;Rod photoreceptor cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051240	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA051240: AB_2681401"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.71e-8)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.85e-6)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	2.4	1.6	3.2	1.8	3.7	1.1	1.8	4.1	6.2	4.2	1.2	3.2	2.6	1.8	2.2	1.6	3.4	1.3	2.5	3.4	3.3	1.2	1.0	3.6	1.5	5.2	3.2	1.0	1.6	1.3	3.3	1.6	5.7	4.2	3.7	11.2	1.4	1.3	1.8	3.9	2.8	2.4	2.2	1.4	2.5	3.7	5.2	2.5	1.8	2.2	1.6	1.5	1.8	6.1	5.1	10.9	12.5	5.3	6.5	7.7	4.3	10.1	2.2	4.8	4.4	3.4	3.2	2.1	2.6	7.5	9.8	6.3	8.2	3.3	6.7	10.0	3.0	2.2	6.9	8.8	3.5	2.5	2.0	3.7	4.9	8.8	3.1	5.3	7.1	3.0	2.1	1.7	13.5	0.4	2.1	1.7	3.9	5.9	2.5	6.7	10.5	0.5	5.4	10.6	7.5	4.7	11.8	2.6	3.4	9.1	1.8	2.7	9.4	7.8	3.1	6.5	6.8	1.0	3.1	3.0	5.6	1.8	5.5	0.4	0.5	1.8	0.4	0.7	0.4	0.5	0.4	0.2	0.5	0.1	0.0	0.3	1.3	0.5	1.0	0.3	1.5	0.2	3.2	3.7	4.1	6.2	3.4	3.3	5.2	3.2	5.7	2.2	5.2	6.1	12.9	6.4	5.8	26.1	1.5	2.5	3.2	4.4	1.8	14.5	3.5	2.8	7.0	2.8	11.6	3.7	56.3	1.1	4.5	7.5	0.0	3.8	4.0	22.4	8.3	8.0	7.7	5.5	91.2	6.2	2.7	8.0	14.8	4.5	1.3	18.6	7.1	0.9	5.8	8.4	78.5	5.3	4.1	5.9	5.3	2.6	3.7	5.2	3.6	22.5	9.1	5.1	7.2	19.1	63.8	9.2	8.4	1.9	2.0	4.0	4.7	0.8	58.0	45.4	0.0	4.4	7.5	10.5	20.7	4.8	3.3	0.4	4.0	0.9	4.7	2.7
KIAA2013	"MGC33867, RP5-1077B9.1"	ENSG00000116685	KIAA2013	Q8IYS2	1	11919591-11926428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 116.7;Proximal enterocytes: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052677, HPA060536"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Cytosol	"HPA052677: AB_2681911, HPA060536: AB_2684313"	"unprognostic (3.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.51e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.74e-3)"	27.9	25.6	23.6	17.3	28.7	19.3	25.5	28.0	24.1	25.4	24.9	43.7	65.5	35.5	35.7	30.1	27.1	20.6	39.1	23.9	24.3	30.2	59.4	23.8	21.8	32.3	28.8	19.7	42.4	20.0	31.8	20.9	27.7	27.8	20.1	6.1	40.4	25.7	51.9	37.8	61.8	17.2	27.6	35.1	31.4	37.2	27.3	16.8	26.8	23.2	13.1	32.2	25.5	31.6	61.2	44.5	20.5	40.6	34.0	23.2	33.8	38.1	39.8	45.0	46.4	55.1	61.7	39.8	56.9	36.2	35.2	69.3	27.8	37.6	23.8	46.3	71.4	27.4	39.7	95.7	38.4	57.2	54.3	29.7	41.0	44.1	19.4	48.7	43.6	31.2	42.6	51.5	27.2	46.2	36.6	80.1	27.0	27.0	60.6	46.3	37.4	97.6	29.0	16.5	76.1	43.0	30.9	34.1	74.8	20.4	28.6	52.6	42.1	37.9	49.2	56.3	52.6	61.8	47.1	46.0	45.1	91.8	41.1	3.3	4.9	5.1	4.7	4.2	3.7	5.2	2.5	3.6	3.5	6.8	2.5	3.3	11.1	4.1	3.5	8.5	5.5	2.6	23.6	28.7	28.0	24.1	23.9	24.3	32.3	28.8	27.7	27.6	27.3	31.6	26.1	22.4	13.4	12.4	18.7	22.2	9.2	13.6	6.8	20.7	30.5	27.1	18.7	18.6	13.0	25.8	12.5	18.1	32.6	116.7	3.9	15.5	24.4	23.7	18.4	22.9	40.9	11.8	9.9	19.3	30.8	18.7	17.3	27.7	13.3	23.1	27.1	75.2	26.5	32.0	8.8	50.1	22.4	40.3	23.0	41.5	22.7	27.1	19.6	6.5	26.5	18.7	28.8	8.5	22.1	24.7	72.2	23.0	18.4	17.3	139.9	22.3	17.8	22.1	19.7	27.5	15.7	17.6	8.6	15.0	28.1	13.3	16.0	31.1	59.4	17.3
KIF13A	bA500C11.2	ENSG00000137177	"Kinesin family member 13A"	Q9H1H9	6	17759183-17987635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.5"	"Group enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 831.4;Oligodendrocytes: 453.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029253, HPA029254"	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA029253: AB_10611115, HPA029254: AB_10602094"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (2.96e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.77e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.44e-2)"	24.1	20.0	23.9	10.3	29.7	19.4	21.3	25.9	24.4	23.6	31.2	29.4	27.4	25.4	13.1	20.1	18.9	17.7	47.8	21.2	22.9	14.1	16.0	25.3	5.3	24.6	25.8	20.2	14.7	21.2	11.9	11.9	25.3	23.7	25.4	21.6	17.2	18.6	104.5	28.6	23.5	22.4	21.5	8.1	14.5	8.6	27.1	8.3	27.9	72.5	7.4	29.9	24.3	33.9	24.8	18.0	21.3	13.1	28.4	27.0	25.3	33.6	57.0	28.9	29.5	6.5	5.9	0.2	26.3	58.4	36.5	24.3	16.3	42.6	36.2	2.5	9.8	10.6	44.9	32.1	18.9	0.4	10.3	21.5	34.9	31.3	47.1	37.2	23.8	0.1	39.5	0.3	31.8	10.0	0.1	1.5	16.9	5.7	11.0	12.6	29.1	0.2	18.1	62.1	5.8	11.5	27.7	20.6	38.4	36.7	29.9	1.5	16.8	52.6	15.2	17.4	31.8	0.2	0.1	0.2	18.9	0.8	39.2	2.1	1.3	1.2	0.0	1.1	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	5.9	0.1	0.5	0.1	0.0	0.2	23.9	29.7	25.9	24.4	21.2	22.9	24.6	25.8	25.3	21.5	27.1	33.9	29.9	35.3	44.4	149.5	4.3	57.2	39.6	9.2	21.1	32.9	20.5	23.1	67.7	17.2	12.8	20.2	18.8	4.1	2.8	20.3	11.7	5.9	20.9	14.5	27.9	28.6	12.5	20.4	134.4	8.7	4.0	24.0	13.7	16.5	5.1	9.7	15.4	25.5	11.9	5.0	42.2	27.2	6.1	22.3	14.7	10.5	15.5	18.9	17.8	105.9	21.1	37.6	5.2	831.4	453.8	9.2	27.4	24.8	0.6	38.4	18.2	10.9	23.5	26.8	26.3	32.7	35.3	6.8	14.9	8.1	45.6	9.0	2.2	2.9	32.7	38.0
KIF15	"HKLP2, KNSL7, NY-BR-62"	ENSG00000163808	"Kinesin family member 15"	Q9NS87	3	44761721-44873376	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 5.0;lymphoid tissue: 9.2;testis: 7.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 177.5;Late spermatids: 78.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035516, HPA035517, HPA061469"	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA035516: AB_2674664, HPA035517: AB_10671935, HPA061469: "	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.17e-3)"	"unprognostic (6.68e-7)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.14e-4)"	"unprognostic (2.72e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.58e-1)"	0.2	0.1	0.1	1.2	0.1	5.0	0.4	0.2	0.2	0.3	0.0	1.4	1.4	0.3	0.0	1.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	2.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	1.6	0.1	0.2	0.1	0.0	0.8	1.4	0.4	0.1	0.4	0.8	7.3	0.1	9.2	0.0	0.0	2.2	0.3	0.4	0.1	7.5	3.9	17.6	12.8	1.2	1.4	3.9	8.6	5.3	10.8	9.0	6.6	7.2	13.8	2.8	3.1	4.0	6.3	10.1	4.7	13.1	11.6	2.3	14.9	7.7	8.4	0.1	15.6	6.6	0.3	0.2	7.3	7.1	1.6	8.6	18.4	9.3	17.2	8.2	3.9	30.0	5.7	18.2	9.7	7.0	11.9	19.0	7.9	2.4	4.9	8.2	7.8	14.2	4.6	2.9	4.6	7.7	11.7	4.8	10.4	8.5	8.8	11.5	7.2	12.7	17.3	5.5	16.3	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.6	1.6	1.9	0.4	0.9	0.0	0.1	0.5	0.8	1.8	0.0	0.7	0.0	2.1	3.3	0.8	2.5	0.0	0.8	177.5	1.3	1.7	1.2	0.0	28.0	3.2	0.0	5.9	1.9	5.1	1.4	0.0	12.3	0.0	0.2	3.5	0.0	3.8	2.6	0.0	1.6	1.4	78.0	0.0	1.8	0.0	0.0	0.3	0.7	1.0	3.0	4.7	0.5	0.1	0.4	9.7	0.5	0.5	0.1	0.2	0.0	0.0	0.4	1.9	20.2	14.7	6.0	1.0	0.7	3.1	1.1	5.3	0.5
KIF16B	"C20orf23, dJ971B4.1, FLJ20135, SNX23"	ENSG00000089177	"Kinesin family member 16B"	Q96L93	20	16272104-16573448	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 38.1"	"Low region specificity"	"Detected in all"							HPA051198	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA051198: AB_2681385"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.52e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (4.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.61e-2)"	10.1	27.4	5.4	6.4	6.1	5.9	15.8	4.9	8.6	6.3	3.6	24.5	16.7	6.1	12.5	9.4	5.1	8.3	11.5	4.3	6.4	18.1	11.7	8.8	5.3	6.4	5.4	12.8	6.5	31.5	5.2	4.8	6.0	7.3	19.1	9.7	7.3	10.8	17.1	11.9	20.8	7.4	3.9	8.2	12.8	5.1	6.3	5.9	11.1	13.1	4.7	7.9	6.2	7.9	7.7	19.3	9.1	8.3	6.8	5.0	8.8	7.4	4.5	4.6	5.0	9.5	18.5	10.7	4.7	8.0	12.7	6.9	10.8	11.0	6.8	5.7	6.2	4.8	4.7	17.6	4.2	0.0	10.5	8.0	21.4	5.5	10.6	7.0	1.8	8.1	8.7	0.0	7.5	12.2	0.1	2.0	2.6	24.9	8.7	8.1	7.2	18.9	7.2	12.2	4.0	7.9	8.0	38.1	23.9	10.7	11.3	6.3	3.7	7.0	5.9	11.4	3.4	0.0	4.9	3.2	6.6	3.2	14.3	0.0	2.1	0.5	2.0	1.7	2.7	2.7	2.2	1.5	3.4	2.6	2.3	1.7	0.2	4.5	1.8	1.6	1.6	1.7	5.4	6.1	4.9	8.6	4.3	6.4	6.4	5.4	6.0	3.9	6.3	7.9	13.1	19.2	31.7	54.9	9.8	19.1	16.1	11.0	37.5	8.7	30.5	16.0	29.2	4.3	14.8	5.5	18.8	15.7	7.7	60.6	3.9	6.5	12.6	13.2	14.2	13.6	23.4	5.0	67.6	12.3	5.5	15.1	18.3	20.8	9.5	13.6	12.5	15.9	19.1	37.0	84.2	38.9	4.1	12.2	35.7	9.8	11.5	19.8	10.6	59.0	4.9	8.6	10.3	60.3	94.1	13.3	40.9	14.7	6.9	11.1	36.8	21.1	11.6	11.5	6.6	22.7	13.4	12.9	15.0	26.3	22.4	37.5	9.4	12.9	24.8	19.3
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	1.6	0.8	16.1	9.4	16.4	34.1	1.3	0.0	16.5	0.9	0.0	2.4	2.0	0.7	0.4	0.8	1.2	2.1	0.7	21.6	8.3	0.9	1.5	4.8	12.9	5.9	5.7	0.7	0.8	6.0	0.6	0.9	6.5	0.8	1.8	21.4	1.4	0.7	0.3	0.7	6.7	0.8	1.5	12.3	2.5	13.7	9.5	11.8	1.0	0.4	8.0	2.3	0.8	7.9	1.3	1.5	11.8	0.5	0.0	0.0	3.0	0.1	0.0	0.3	0.1	0.7	0.4	39.1	0.5	0.0	3.4	0.3	1.2	0.3	0.4	1.9	0.4	9.7	0.2	0.2	1.0	29.4	41.0	1.0	4.1	0.4	0.7	0.0	1.5	78.8	4.6	49.6	0.0	0.2	24.5	11.2	5.2	3.9	0.0	8.4	0.1	43.8	0.2	0.0	7.2	1.0	0.6	0.5	0.6	2.1	0.2	8.9	2.8	0.0	3.3	0.0	0.2	90.2	44.7	19.3	3.9	12.8	0.3	6.0	0.0	0.6	0.8	0.2	0.9	0.4	0.6	0.8	0.1	0.3	0.5	0.6	1.0	1.3	0.3	0.1	0.6	0.4	16.1	16.4	0.0	16.5	21.6	8.3	5.9	5.7	6.5	1.5	9.5	7.9	1.5	0.0	3.8	22.5	11.0	1.0	0.5	0.2	0.0	25.7	0.4	0.8	1.5	0.0	0.1	1.8	58.4	0.0	17.4	1.2	0.0	0.5	20.4	0.1	0.2	1.8	0.0	4.8	15.6	1.6	0.1	0.6	1.1	0.4	6.3	0.5	1.4	0.3	1.7	1.7	11.8	1.4	0.0	4.4	3.1	82.1	0.9	5.3	0.0	8.4	2.7	20.0	13.4	14.6	4.0	2.4	0.3	0.0	12.0	0.4	0.2	0.0	0.1	26.1	6.6	0.6	1.1	1.9	3.7	0.1	1.0	0.0	18.0	0.1	1.1	2.0
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	13	"granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.0	1.5	0.3	5.7	0.2	21.6	1.4	0.2	0.3	1.5	1.4	4.1	3.9	2.0	0.1	5.3	0.9	1.3	0.6	0.3	0.2	4.6	0.5	1.5	7.9	0.2	0.3	0.7	0.5	0.4	0.1	6.4	0.3	0.9	5.0	0.2	1.1	1.2	0.1	3.7	3.8	4.2	0.2	2.2	2.0	10.6	0.3	15.9	0.3	0.2	9.8	1.8	2.1	0.2	100.7	81.5	64.2	59.0	3.7	7.3	36.3	105.3	57.0	154.8	120.6	50.2	72.4	56.8	31.4	53.1	78.6	110.5	121.6	39.5	158.7	52.9	60.2	55.3	78.8	30.7	2.1	55.6	48.3	3.3	4.2	71.8	60.5	19.4	52.0	46.9	36.0	70.2	95.4	44.1	31.2	28.2	71.6	35.5	33.2	37.0	133.8	31.2	39.3	49.7	32.5	25.3	120.4	51.9	44.9	74.5	50.6	25.3	34.5	90.0	120.8	62.0	157.6	26.3	74.3	48.4	31.5	72.2	78.0	0.0	1.2	4.6	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.4	0.0	0.5	0.0	2.3	1.9	3.7	4.2	0.0	0.2	1.8	2.8	0.8	5.7	4.7	7.3	2.1	24.2	1.4	3.3	3.9	1.8	13.3	13.1	3.6	2.2	1.8	42.3	1.8	0.0	32.4	5.8	3.6	8.7	2.5	22.4	3.9	0.3	8.1	0.0	1.0	3.1	0.0	2.8	3.4	4.8	0.9	3.2	0.0	1.0	8.1	0.2	0.0	0.0	0.2	0.4	0.4	1.9	6.8	1.6	0.8	0.9	3.6	0.1	6.6	0.4	8.2	70.8	20.9	11.3	1.0	2.5	4.2	3.6	8.6	3.3
KIF3B	"FLA8, KIAA0359, KLP-11"	ENSG00000101350	"Kinesin family member 3B"	O15066	20	32277651-32335011	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007119	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA007119: AB_1852498"	"unprognostic (1.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.44e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.42e-2)"	12.2	14.0	25.1	11.1	25.4	8.5	12.1	18.2	25.5	14.5	34.6	18.7	19.9	11.6	17.5	7.7	20.5	14.9	8.1	30.3	20.8	35.4	17.8	12.9	11.5	20.8	22.7	13.5	23.0	46.7	17.3	8.5	18.8	11.7	19.0	30.8	11.1	10.9	8.4	7.8	24.1	12.1	22.4	9.9	17.6	22.2	26.9	8.2	19.2	5.6	11.9	11.4	8.5	21.4	49.9	33.2	22.6	29.1	29.3	46.3	23.0	24.2	33.7	28.7	22.4	56.9	26.7	26.7	28.4	45.8	40.8	31.4	29.3	35.8	36.3	12.7	13.3	23.1	25.6	28.2	18.6	19.6	16.9	28.6	25.2	49.5	19.5	23.5	23.7	10.7	14.5	10.4	23.4	22.8	9.1	8.9	12.2	26.5	28.8	8.3	37.1	9.7	29.2	36.1	37.0	31.1	63.2	16.7	24.7	18.9	36.8	15.1	28.9	53.4	36.4	31.4	30.2	17.3	26.5	13.5	53.2	33.7	22.2	0.7	1.5	1.9	3.2	2.2	2.6	3.2	2.4	3.0	0.9	3.1	1.4	2.2	1.6	1.4	3.2	1.5	2.0	1.0	25.1	25.4	18.2	25.5	30.3	20.8	20.8	22.7	18.8	22.4	26.9	21.4	10.6	22.4	23.4	11.1	12.2	6.6	8.5	12.8	13.6	32.4	14.1	10.7	9.2	40.0	15.0	12.9	106.3	8.1	10.8	67.9	3.9	34.4	67.1	48.5	21.3	16.8	39.4	6.3	31.4	39.1	6.3	14.2	20.9	31.3	8.2	13.7	13.9	28.7	8.1	32.0	37.7	26.3	14.2	7.7	5.5	88.2	13.4	9.0	0.0	8.4	10.9	19.2	8.2	10.1	11.4	32.4	33.4	20.3	16.3	12.1	82.4	23.7	59.1	63.6	0.0	21.0	11.7	33.4	7.4	10.7	5.1	6.6	12.4	17.6	27.3	9.3
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391823-33409896	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 47.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.0;Erythroid cells: 62.3;Extravillous trophoblasts: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	1.1	1.1	0.2	10.6	0.3	39.7	2.2	0.3	1.2	2.5	0.4	8.0	8.8	1.8	0.2	11.7	0.8	1.5	0.6	0.7	0.3	0.8	1.0	2.3	24.6	0.4	0.7	2.0	0.7	0.3	0.6	5.5	0.5	0.9	8.2	0.4	2.1	0.2	0.2	9.8	8.1	4.1	0.2	5.3	4.7	12.3	0.6	47.5	0.7	0.4	24.9	2.7	3.9	0.5	133.5	47.9	120.6	124.2	5.2	8.1	64.0	82.5	48.4	122.6	104.6	80.6	53.3	120.2	38.3	41.5	102.0	88.1	87.1	60.7	79.7	114.3	60.3	93.9	71.6	73.5	0.5	96.0	75.7	2.5	4.7	73.2	38.8	13.8	64.2	87.5	76.0	112.3	81.0	86.2	125.7	103.2	47.5	67.6	48.4	129.7	110.7	61.4	38.4	42.8	100.1	57.2	54.3	91.9	44.1	51.3	78.7	105.4	32.2	74.6	104.6	56.2	128.9	58.2	132.4	126.1	18.8	94.8	101.0	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.0	1.6	0.5	0.2	0.3	0.3	1.2	0.7	0.3	0.4	0.7	0.5	0.2	0.6	0.5	0.4	0.0	2.5	1.0	4.1	5.6	1.5	4.6	2.2	0.4	2.8	2.2	0.5	0.0	1.9	0.0	0.0	18.7	3.7	8.8	0.0	0.7	32.0	2.7	1.9	2.4	0.0	62.3	0.3	0.0	39.6	4.2	4.1	6.1	1.3	15.0	1.8	0.3	14.3	0.0	0.3	8.0	2.0	2.4	9.8	12.0	0.3	4.7	3.6	1.0	3.1	0.3	0.0	1.0	0.6	0.3	2.1	0.7	12.0	0.9	2.1	0.7	0.8	0.5	0.0	2.5	7.5	13.9	9.6	14.4	3.7	6.7	5.7	0.6	12.1	3.1
KIR3DL2	"CD158K, cl-5, nkat4, nkat4a, nkat4b"	ENSG00000240403	"Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2"	P43630	19	54850443-54867207	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.9"	"Group enriched"	"Detected in some"	8	"dendritic cells: 37.7;NK-cells: 14.4;T-cells: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (6.99e-2)"	"unprognostic (1.83e-1)"		"unprognostic (3.64e-1)"		"unprognostic (4.56e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.39e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.62e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0
KITLG	"DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF"	ENSG00000049130	"KIT ligand"	P21583	12	88492793-88580851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Cell adhesion"	"Growth factor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 83.6;Collecting duct cells: 69.9;Excitatory neurons: 46.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 299.8;SK-BR-3: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070395	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		260000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA070395: AB_2686264"	"unprognostic (7.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.61e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.47e-3)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.81e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-2)"	13.2	3.9	2.3	8.2	3.5	0.3	10.6	0.2	3.1	12.9	1.2	18.7	9.6	15.1	2.8	14.3	4.0	18.5	7.0	2.9	0.3	16.0	2.3	31.6	3.3	0.0	2.5	6.0	3.7	3.7	0.2	15.0	0.0	15.1	22.6	2.3	8.8	14.8	3.1	7.1	11.6	18.8	0.3	3.5	17.4	6.3	5.2	5.1	5.9	14.4	10.4	12.3	1.3	6.2	14.3	7.1	7.1	0.9	29.0	61.5	0.0	77.6	60.1	13.5	6.4	299.8	11.0	0.0	2.2	73.3	14.9	49.5	11.5	20.1	14.2	0.1	9.5	0.0	9.5	2.6	4.4	1.9	0.0	53.5	20.6	41.6	26.8	6.3	17.9	0.0	0.0	0.3	6.8	2.5	0.2	0.0	4.8	17.7	17.9	0.0	12.6	0.0	25.0	6.5	2.3	4.8	18.5	118.9	2.2	6.5	57.2	4.3	10.0	60.7	7.4	69.0	6.8	0.0	0.0	0.0	8.4	0.2	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.5	0.2	3.1	2.9	0.3	0.0	2.5	0.0	0.3	5.2	6.2	42.5	19.2	38.3	9.4	0.5	13.5	11.2	7.5	83.6	2.7	12.2	8.1	4.4	1.5	16.5	69.9	0.0	0.1	0.0	12.0	1.9	4.4	0.4	3.1	6.8	43.1	9.5	0.0	46.5	18.2	0.1	34.5	43.3	3.4	0.0	2.1	5.0	0.4	1.2	21.9	61.4	8.5	18.3	3.2	5.7	0.9	14.0	1.9	12.4	18.7	0.0	0.3	0.0	3.0	0.6	8.7	3.0	3.8	1.4	11.2	2.3	1.4	9.8	1.2	13.1	2.2	27.2	0.2	0.5	18.5	5.3	0.0	1.0	4.4	14.7	3.2
KLHDC9	KARCA1	ENSG00000162755	"Kelch domain containing 9"	Q8NEP7	1	161098361-161100346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 29.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 424.7;Late spermatids: 448.2;Spermatocytes: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HDLM-2: 1.5;HEK 293: 1.8;MCF7: 1.4;T-47d: 1.4;U-266/70: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043197			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA043197: AB_2678359"	"unprognostic (1.79e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.31e-2)"	"prognostic favorable (4.20e-6)"	"unprognostic (1.81e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	0.4	3.0	1.3	0.1	1.8	0.0	0.7	1.0	2.9	1.1	2.1	1.4	0.2	1.4	0.5	0.5	2.2	0.0	0.9	1.7	2.2	4.7	1.9	0.8	0.0	1.7	1.8	1.0	2.4	1.1	4.6	0.0	1.6	1.7	0.2	0.4	1.0	0.4	0.7	0.3	0.8	0.0	1.2	0.3	1.3	29.0	2.4	0.0	2.4	0.1	0.1	1.0	0.5	0.9	0.1	1.1	0.4	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	1.5	1.8	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.2	0.9	1.0	0.0	0.7	0.2	0.0	1.0	0.4	0.0	0.4	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	1.0	2.9	1.7	2.2	1.7	1.8	1.6	1.2	2.4	0.9	2.4	0.0	6.7	8.8	1.5	0.9	11.7	11.5	0.6	13.7	15.3	16.3	9.3	14.3	11.7	29.5	2.1	2.3	0.4	7.6	56.7	10.2	424.7	57.5	2.8	3.4	5.4	0.0	8.9	5.5	3.6	3.2	3.1	10.3	1.3	1.6	3.9	9.5	0.6	3.3	6.8	10.6	16.2	0.6	0.7	448.2	8.1	0.9	7.2	2.8	0.6	35.1	1.0	6.0	1.7	3.9	8.2	8.2	2.1	6.4	2.5	47.8	77.8	20.0	13.1	2.8	4.4	198.1	15.6	2.6	0.9	0.8	1.2	1.7	8.7	8.2
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Inhibitory neurons: 29.3;Microglial cells: 30.9;Oligodendrocyte precursor cells: 102.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.3;plasmacytoid DC: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.8;HeLa: 57.3;RH-30: 37.2;RPTEC TERT1: 106.0;SH-SY5Y: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.7	7.3	4.6	2.6	11.1	0.4	24.6	2.7	4.8	20.5	5.5	5.4	3.1	31.4	7.3	5.9	10.7	5.6	7.8	3.2	5.9	16.0	4.7	1.4	0.6	5.9	10.3	7.4	4.6	3.4	2.2	0.8	6.4	6.2	3.9	4.2	2.2	12.3	3.6	1.1	4.8	29.3	4.0	1.6	3.2	3.6	5.9	5.0	0.8	5.6	1.2	7.5	5.0	3.8	1.1	0.4	6.9	14.5	0.1	0.0	0.2	0.5	0.0	0.4	0.0	9.1	0.1	0.0	16.5	0.0	0.7	16.9	33.8	5.6	0.0	0.0	12.9	0.4	57.3	0.1	0.8	1.1	2.2	1.8	2.3	0.2	0.7	6.9	25.8	0.0	0.0	0.0	0.0	1.4	5.9	1.6	13.4	0.0	9.6	0.0	37.2	0.1	106.0	4.0	0.0	94.3	0.5	1.2	0.9	2.7	20.9	0.2	0.7	2.4	2.9	2.0	8.6	0.4	0.0	0.2	10.2	0.0	4.1	2.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.6	0.6	0.0	1.1	0.0	4.1	0.2	0.3	4.6	11.1	2.7	4.8	3.2	5.9	5.9	10.3	6.4	4.0	5.9	3.8	0.7	0.0	0.0	13.7	0.0	0.8	6.8	5.4	12.0	6.2	2.4	19.9	10.5	0.0	4.8	1.8	0.0	0.2	0.1	1.2	29.4	1.1	0.3	8.0	22.7	1.9	1.2	1.3	8.0	3.4	0.1	8.7	0.0	1.3	0.0	10.0	8.6	1.3	0.6	0.0	29.3	2.1	0.0	0.0	1.2	0.9	6.2	1.0	1.8	30.9	0.2	7.2	0.0	102.5	12.3	0.7	3.4	1.9	0.1	2.7	2.9	12.7	22.3	1.2	6.6	18.1	5.3	1.8	10.6	4.8	0.4	0.0	0.6	6.4	4.1	3.6
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672673-32773023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 12.7;thyroid gland: 13.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 21.9;Inhibitory neurons: 9.8;Muller glia cells: 19.4;Plasma cells: 45.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	90	"memory B-cell: 10.5;naive B-cell: 7.3"	"Lineage enriched"	"Detected in single"	106	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;Hep G2: 15.7;REH: 4.2;RPTEC TERT1: 8.4;SCLC-21H: 3.2;U-698: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"hippocampal formation: 14.9;olfactory bulb: 8.1"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.5	0.2	0.2	1.8	0.3	2.4	0.5	0.0	0.6	2.9	0.0	0.2	0.2	1.7	1.0	0.2	6.6	0.3	0.1	0.2	0.3	5.0	0.0	0.3	7.1	1.4	2.3	0.3	0.0	6.9	0.3	0.8	0.7	1.4	0.2	4.7	0.4	12.7	0.0	0.1	2.0	0.8	0.8	8.7	0.2	1.0	0.2	0.3	13.8	0.0	5.3	0.6	0.5	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	15.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.2	1.3	0.0	8.4	0.0	3.2	0.4	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.6	0.2	0.3	1.4	2.3	0.7	0.8	0.2	0.1	1.3	0.0	0.0	0.3	21.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.1	0.0	3.9	0.0	4.5	7.1	0.3	2.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.7	0.0	0.1	1.7	9.8	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.0	0.0	19.4	0.0	1.5	0.2	0.0	0.0	0.0	45.7	0.0	0.5	1.1	0.0	0.8	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.0	0.2	4.7	0.1	0.0
KLHL23	"FLJ37812, MGC22679, MGC2610"	ENSG00000213160	"Kelch like family member 23"	Q8NBE8	2	169694488-169776989	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 132.5;Cone photoreceptor cells: 89.6;Sertoli cells: 170.9;Smooth muscle cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047593			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Actin filaments"		"HPA047593: "	"unprognostic (4.77e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.87e-3)"	6.9	2.1	8.1	6.1	9.6	1.7	6.2	13.2	9.9	9.6	0.2	20.8	11.1	25.6	4.0	12.0	8.9	6.7	8.0	9.8	7.2	6.6	5.9	5.9	3.1	3.7	5.8	17.9	7.2	6.4	3.3	12.8	4.6	13.6	13.9	13.6	8.0	12.5	12.0	1.6	11.8	25.0	4.0	2.8	5.1	10.9	7.6	11.1	8.1	16.3	2.9	8.7	3.9	6.3	17.0	8.6	64.5	18.3	3.6	1.3	43.7	8.0	6.1	14.4	15.8	18.0	14.4	10.6	6.7	0.8	20.9	2.6	67.7	5.8	21.9	37.7	33.2	31.3	16.9	29.9	5.4	44.2	4.7	2.5	4.7	6.0	10.2	9.3	11.2	38.3	43.5	1.4	4.8	8.2	65.0	17.9	52.7	9.0	6.7	20.7	55.1	1.1	13.1	49.9	83.4	57.1	12.7	1.2	7.8	20.3	10.6	14.2	4.2	5.8	18.6	5.7	13.6	4.9	4.9	47.3	4.5	13.0	9.0	0.0	0.0	0.0	0.7	0.0	0.9	0.3	0.6	0.5	0.1	0.3	1.0	1.0	0.0	3.4	0.0	0.9	0.8	0.3	8.1	9.6	13.2	9.9	9.8	7.2	3.7	5.8	4.6	4.0	7.6	6.3	13.7	3.2	8.7	0.0	1.1	1.5	6.9	2.8	7.4	132.5	15.0	17.1	52.9	14.3	6.7	0.0	89.6	5.6	3.8	14.6	3.9	15.6	4.6	2.4	12.8	12.6	31.8	9.7	0.0	30.5	9.6	11.2	4.1	5.5	0.0	27.5	7.5	11.8	0.9	40.4	0.0	21.2	28.5	0.8	1.9	3.7	2.5	1.3	0.0	0.0	0.2	14.6	5.2	0.0	0.0	16.1	13.6	8.6	0.4	17.2	9.7	16.9	4.9	34.8	170.9	11.4	102.6	3.4	20.9	4.7	1.0	1.2	5.5	13.8	20.9	4.1
KLHL30	FLJ43374	ENSG00000168427	"Kelch like family member 30"	Q0D2K2	2	238138668-238152947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skeletal muscle: 149.1"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.5;Skeletal myocytes: 9.8;Smooth muscle cells: 3.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;CAPAN-2: 1.6;EFO-21: 1.5;REH: 1.4;RH-30: 4.5;THP-1: 2.3"	"Region enriched"	"Detected in single"	35	"olfactory bulb: 9.4"	"Not detected"	"Not detected"			HPA062095			Approved	"Centriolar satellite"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	"Centriolar satellite"		"HPA062095: AB_2684680"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.07e-4)"	"unprognostic (6.02e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.17e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	3.8	0.1	0.2	0.1	0.2	0.0	1.4	0.5	0.2	2.2	0.2	1.0	0.2	1.2	0.0	1.0	1.3	0.5	14.3	0.1	0.4	1.0	0.1	0.9	0.0	0.9	0.8	0.4	0.1	0.0	0.1	0.3	0.3	1.0	0.1	0.1	1.0	0.8	149.1	0.8	0.7	0.7	0.1	0.2	0.5	0.1	0.2	0.0	0.6	15.2	0.0	1.6	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.1	0.1	0.0	0.0	1.4	4.5	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.2	0.1	0.4	0.9	0.8	0.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	9.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL32	"BKLHD5, KIAA1900"	ENSG00000186231	"Kelch like family member 32"	Q96NJ5	6	96924620-97140754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 65.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.7;Excitatory neurons: 168.8;Inhibitory neurons: 143.9;Oligodendrocyte precursor cells: 197.5;Oligodendrocytes: 724.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"B-cells: 1.0;T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.3;HDLM-2: 4.5;RPMI-8226: 2.1;SCLC-21H: 1.8;U-266/70: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039150	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039150: AB_2676367"	"unprognostic (1.75e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.22e-2)"	"unprognostic (5.00e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-5)"	"unprognostic (5.82e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.49e-4)"	0.2	0.9	19.6	0.4	40.7	0.1	0.3	24.7	33.3	0.3	1.7	0.6	0.8	0.2	0.4	0.0	6.4	0.3	0.7	21.6	25.9	1.9	0.6	0.7	0.4	31.2	28.2	0.9	1.3	0.7	1.2	0.0	29.9	0.2	0.9	2.5	0.5	0.2	1.2	0.1	1.1	0.1	25.3	0.3	0.5	1.6	29.1	0.7	0.7	0.3	0.4	0.1	0.1	65.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	3.3	0.1	0.0	0.0	0.1	0.3	0.1	0.0	4.5	0.7	0.2	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	1.6	0.0	0.0	0.8	0.2	0.2	0.1	0.1	0.1	0.0	2.1	0.0	0.0	1.8	0.6	0.0	0.0	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.3	0.4	1.3	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	1.0	1.7	0.6	0.0	0.7	1.9	2.6	0.0	0.4	0.0	0.0	1.2	0.8	19.6	40.7	24.7	33.3	21.6	25.9	31.2	28.2	29.9	25.3	29.1	65.2	0.2	3.2	0.0	143.7	1.1	0.0	0.3	0.1	0.0	2.5	0.4	0.5	2.6	0.0	0.1	5.5	0.0	0.1	0.2	0.3	3.9	0.2	6.9	7.5	0.1	0.0	11.3	0.0	168.8	0.2	0.0	0.3	1.5	0.2	0.0	3.2	0.4	1.3	0.1	18.5	143.9	4.1	0.0	0.0	0.0	3.3	0.0	0.1	0.0	13.1	0.0	1.1	0.0	197.5	724.3	0.0	0.1	0.0	0.5	0.2	0.5	2.4	15.3	1.1	0.0	0.2	0.1	0.8	1.8	0.0	0.0	0.0	0.7	1.1	0.5	0.0
KLHL33		ENSG00000185271	"Kelch like family member 33"	A6NCF5	14	20425852-20436166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	29	"skeletal muscle: 73.3;tongue: 20.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 27.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 5.8"	"Cell line enriched"	"Detected in single"	9	"REH: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049985, HPA056560"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA049985: , HPA056560: AB_2683174"	"unprognostic (6.92e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.32e-5)"	"unprognostic (2.32e-1)"	0.9	0.3	0.5	0.2	0.5	0.2	0.6	1.5	0.6	1.2	0.3	0.8	0.3	1.4	1.0	0.9	0.8	0.8	1.0	0.4	0.5	0.5	0.1	0.4	0.6	0.4	0.6	1.2	0.2	0.5	0.2	0.2	0.4	1.0	0.3	0.3	0.5	1.0	73.3	0.1	0.5	0.5	0.1	0.6	0.3	0.4	0.6	1.0	0.4	20.2	0.6	0.5	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	5.8	0.0	0.1	0.5	0.5	1.5	0.6	0.4	0.5	0.4	0.6	0.4	0.1	0.6	0.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412315-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	4	"dendritic cells: 19.2;Oligodendrocyte precursor cells: 36.2;T-cells: 15.9"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 63.1"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 63.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.4;GAMG: 2.8;HEL: 1.3;HeLa: 7.0;HSkMC: 1.2;SuSa: 1.3;U-698: 1.9"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"		0.2	0.1	1.3	0.3	1.4	1.9	0.1	0.7	2.1	0.1	0.2	0.5	0.8	0.5	0.1	0.2	0.2	0.6	0.0	1.3	1.7	0.1	0.5	0.6	1.7	1.7	1.1	0.1	0.1	0.0	0.0	0.1	1.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.3	0.1	1.3	4.0	0.6	0.2	1.3	0.4	0.1	0.0	0.8	0.1	0.1	2.1	0.0	0.0	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.0	0.0	1.3	7.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	7.0	0.0	0.0	0.1	8.7	0.6	63.1	0.0	0.0	0.0	3.6	1.3	1.4	0.7	2.1	1.3	1.7	1.7	1.1	1.2	1.3	1.3	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	0.1	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	1.0	36.2	2.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.1
KLRD1	CD94	ENSG00000134539	"Killer cell lectin like receptor D1"	Q13241	12	10226058-10329608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 740.2;NK-cells: 1316.2;T-cells: 324.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 512.6;memory CD8 T-cell: 217.7;naive CD8 T-cell: 218.7;NK-cell: 737.5"	"Group enriched"	"Detected in many"	68	"NK-cells: 737.5;T-cells: 512.6"	"Low cell line specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069688	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA069688: AB_2686170"	"unprognostic (3.75e-2)"	"unprognostic (2.15e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.53e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.37e-2)"	1.6	1.4	1.5	2.8	1.1	8.4	1.8	2.1	2.1	1.2	0.0	1.6	1.8	1.2	1.5	1.3	1.1	1.6	1.1	1.6	0.7	0.8	4.1	4.7	6.8	0.4	0.2	1.1	2.2	0.5	4.6	1.3	0.4	0.6	0.9	1.3	1.3	0.6	1.2	0.9	3.4	0.7	0.1	17.0	2.1	1.2	1.0	0.5	1.2	0.2	4.0	2.1	0.8	3.0	0.2	0.1	0.2	0.4	0.4	0.2	0.2	0.7	0.0	0.0	0.2	0.4	0.3	0.3	0.2	0.3	0.2	0.3	0.0	0.2	0.0	0.5	0.5	0.4	0.7	0.1	0.5	0.3	0.2	0.1	0.5	0.1	0.3	0.3	0.1	0.3	0.3	1.2	0.0	0.5	0.3	0.3	0.3	0.2	0.4	0.1	0.4	0.3	0.2	0.3	0.6	0.2	0.2	0.6	0.1	0.9	0.2	0.6	0.3	0.5	0.9	0.4	0.1	0.5	0.5	0.3	0.7	0.2	0.4	1.7	0.8	1.1	512.6	2.0	58.1	0.8	3.5	217.7	1.6	0.8	1.3	218.7	9.2	737.5	1.5	2.1	1.3	163.0	1.5	1.1	2.1	2.1	1.6	0.7	0.4	0.2	0.4	0.1	1.0	3.0	7.4	0.0	10.5	1.3	5.8	0.5	1.2	0.2	0.6	0.7	1.7	1.0	2.7	7.2	1.9	0.0	6.2	1.8	740.2	0.4	0.0	0.6	9.0	1.1	1.2	7.7	0.0	24.0	3.1	0.0	1.0	4.5	10.7	1.8	2.5	0.4	15.0	4.3	0.7	1.7	2.0	0.2	0.0	18.3	1.2	12.6	0.3	7.0	5.4	4.7	5.1	0.3	1316.2	1.5	1.8	0.0	0.0	0.7	91.0	1.3	0.2	1.1	1.5	1.0	0.0	2.2	1.7	1.9	3.5	0.3	0.6	0.8	324.9	0.0	0.3	1.4
KLRG1	"2F1, CLEC15A, MAFA, MAFA-L"	ENSG00000139187	"Killer cell lectin like receptor G1"	Q96E93	12	8950044-9010760	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 93.7;granulocytes: 118.9;NK-cells: 164.8;T-cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 390.9;MAIT T-cell: 461.3"	"Lineage enriched"	"Detected in all"	22	"T-cells: 461.3"	"Cell line enhanced"	"Detected in many"		"HEL: 25.1;NTERA-2: 22.1;U-937: 17.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051403, HPA076494"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA051403: , HPA076494: AB_2686800"	"unprognostic (1.54e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.86e-2)"	4.1	1.7	2.4	3.8	2.6	3.0	2.5	4.3	2.9	1.3	1.4	1.5	1.0	1.2	2.1	1.0	1.0	3.3	2.0	2.1	3.2	1.4	3.0	2.2	10.4	2.5	3.4	1.0	0.5	0.4	1.1	0.6	2.3	1.1	1.9	1.3	1.6	0.7	1.7	1.0	2.2	1.6	1.7	8.8	1.6	1.1	2.6	2.5	1.0	1.8	5.0	2.4	0.8	3.8	0.2	3.1	1.6	2.3	3.0	0.7	1.4	0.5	0.3	0.4	1.1	1.1	1.1	4.9	0.1	0.4	2.1	0.2	3.3	0.5	0.4	3.6	1.9	25.1	0.4	1.6	0.8	1.1	1.6	1.4	0.4	0.5	0.0	0.4	7.6	2.5	1.4	0.4	0.2	0.7	1.0	2.0	22.1	1.0	1.7	1.2	1.0	0.0	0.5	0.4	0.4	4.4	1.1	0.5	1.6	4.3	0.3	1.7	0.8	0.7	1.0	0.6	1.4	1.4	4.1	2.6	1.8	17.3	0.2	17.5	2.6	1.5	390.9	2.9	461.3	4.2	85.1	237.7	8.2	5.0	23.5	147.7	5.7	20.9	5.4	3.9	8.7	99.7	2.4	2.6	4.3	2.9	2.1	3.2	2.5	3.4	2.3	1.7	2.6	3.8	12.7	0.0	4.3	2.9	4.7	0.4	0.4	0.0	4.0	5.0	1.0	0.9	2.8	1.5	0.1	0.0	8.4	1.0	93.7	0.1	1.9	0.7	1.6	0.8	0.6	2.9	1.2	24.6	3.8	0.2	0.5	1.3	0.5	0.5	118.9	0.9	25.7	2.0	3.4	5.0	3.6	0.1	0.0	9.1	1.4	3.1	0.6	3.7	1.8	2.8	5.4	1.8	164.8	9.5	6.2	0.3	0.1	0.0	16.9	0.2	0.3	3.1	0.1	3.9	0.0	2.1	1.0	7.8	7.3	1.3	0.0	0.3	109.3	0.7	0.6	0.1
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.4;Erythroid cells: 29.5;Plasma cells: 28.7;Spermatocytes: 40.7;Spermatogonia: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favorable (8.69e-4)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	7.1	7.6	3.7	11.7	3.6	42.3	7.6	4.9	5.3	9.1	3.5	9.8	9.0	5.3	5.2	12.2	6.8	3.4	4.1	3.6	3.4	6.7	6.4	8.0	16.4	3.8	3.4	8.2	6.6	2.9	5.7	5.8	3.9	7.3	11.9	5.5	7.7	2.9	2.5	15.1	14.5	4.6	3.1	18.2	7.2	28.2	4.0	17.8	5.4	1.4	17.4	6.2	8.9	5.0	33.8	27.6	77.8	17.9	5.9	10.8	35.0	30.6	19.8	29.7	27.9	26.2	27.6	40.2	15.6	14.9	19.5	45.4	34.1	19.1	39.1	28.8	23.7	49.7	57.1	27.1	2.0	49.3	32.8	5.8	4.3	30.7	20.2	15.5	20.5	50.5	50.4	29.4	22.6	25.0	40.9	113.0	39.4	16.3	34.5	55.4	37.8	44.8	17.8	35.6	24.1	31.0	55.7	11.7	16.7	46.2	44.4	28.1	15.1	33.7	32.3	33.3	36.3	39.3	42.3	61.0	20.1	31.3	39.6	2.5	0.5	1.8	0.7	0.7	0.6	1.6	1.1	1.3	0.5	0.9	0.8	1.0	1.6	0.9	1.0	0.8	0.5	0.3	3.7	3.6	4.9	5.3	3.6	3.4	3.8	3.4	3.9	3.1	4.0	5.0	4.3	0.0	2.6	3.3	8.1	4.2	1.9	1.9	2.2	2.2	3.1	3.4	1.8	0.0	1.9	5.5	4.2	7.0	3.8	3.0	0.0	1.5	30.4	3.3	3.9	2.9	0.0	29.5	6.2	0.4	5.9	2.9	10.2	5.2	1.3	14.7	2.2	1.3	4.8	0.0	4.5	2.3	0.0	2.2	4.7	17.7	4.7	4.0	1.8	4.7	1.6	1.1	2.1	2.5	4.4	0.8	1.0	3.0	28.7	1.0	1.5	0.5	5.0	5.0	6.6	3.1	2.9	40.7	39.9	4.9	2.3	2.9	5.3	2.1	5.8	1.6
KSR2	FLJ25965	ENSG00000171435	"Kinase suppressor of ras 2"	Q6VAB6	12	117453012-117968990	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.0;pituitary gland: 7.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 161.8;Excitatory neurons: 284.7;Inhibitory neurons: 234.9;Oligodendrocyte precursor cells: 95.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 4.5;SCLC-21H: 3.2;TIME: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035536	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035536: AB_10673485"	"unprognostic (1.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.14e-3)"	"unprognostic (5.74e-2)"	0.0	0.9	2.3	0.0	2.4	0.0	0.2	1.1	10.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.0	7.7	0.0	0.7	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.6	7.9	0.0	0.6	0.1	0.3	1.9	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.3	0.0	0.6	0.0	0.1	0.2	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.4	0.9	3.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	6.9	0.0	0.5	0.0	0.1	0.5	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.4	1.1	10.0	7.7	0.0	0.7	0.0	0.6	0.1	0.3	2.7	0.9	0.0	0.0	17.6	0.5	0.3	1.2	0.1	0.0	55.2	2.8	2.4	2.2	5.7	0.2	161.8	39.6	0.9	0.0	1.3	0.0	2.3	10.8	4.0	0.3	0.5	20.4	5.3	284.7	1.5	0.4	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.1	47.1	234.9	10.3	2.0	0.3	0.4	12.5	0.0	0.0	0.0	5.6	0.0	2.4	0.0	95.0	4.2	0.4	1.5	0.0	0.0	1.4	0.1	0.8	0.3	28.2	0.0	0.3	0.1	0.6	3.1	0.0	0.3	0.3	0.6	0.0	3.0	1.3
LAIR2	CD306	ENSG00000167618	"Leukocyte associated immunoglobulin like receptor 2"	Q6ISS4	19	54497879-54510687	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.6;pituitary gland: 2.6"	"Cell type enriched"	"Detected in some"	7	"Extravillous trophoblasts: 696.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"gdT-cell: 14.0;memory CD4 T-cell: 13.8;memory CD8 T-cell: 19.5;naive CD8 T-cell: 13.2;T-reg: 49.5"	"Lineage enriched"	"Detected in many"	40	"T-cells: 49.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;Hep G2: 1.0"					"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.86e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.68e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.40e-5)"	"unprognostic (6.71e-2)"	0.2	0.0	0.1	0.4	0.3	0.8	0.1	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.1	0.1	0.7	1.6	0.2	0.2	0.0	0.1	0.0	2.6	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.1	0.3	0.3	0.4	0.6	0.1	0.2	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	14.0	0.1	0.4	0.0	13.8	19.5	0.1	0.1	2.4	13.2	0.2	1.2	0.3	0.1	49.5	7.8	0.1	0.3	0.1	0.7	0.3	0.3	0.2	0.2	0.4	0.1	0.4	0.5	0.8	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	10.7	95.4	0.9	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.4	0.0	0.2	696.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.8	1.8	0.0	0.5	0.0	46.4	0.0	0.1	0.6	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	32.2	23.2	0.0	0.0	0.0
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112107931-112254939	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Early spermatids: 114.7;Extravillous trophoblasts: 119.1;Fibroblasts: 149.2;Leydig cells: 166.5;Microglial cells: 124.6;Oligodendrocyte precursor cells: 160.4;Theca cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 330.5;ASC TERT1: 512.5;HSkMC: 405.5;hTERT-RPE1: 256.0;HUVEC TERT2: 441.3;TIME: 404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		320000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	116.2	9.4	17.6	34.0	17.1	0.5	59.9	11.7	12.9	77.0	12.6	82.6	17.2	77.5	18.5	35.6	115.2	37.3	51.2	12.3	17.9	9.9	4.4	80.8	11.5	12.7	16.3	23.2	4.9	8.6	13.6	68.0	14.7	35.4	34.0	1.3	38.4	40.7	10.6	17.7	34.5	107.8	11.4	1.5	36.7	18.7	22.6	5.0	23.2	18.6	8.9	65.1	40.3	11.4	0.3	0.1	18.8	0.6	330.5	512.5	0.3	91.4	55.8	8.9	1.4	0.0	36.1	0.0	58.0	154.9	19.8	0.3	4.0	0.6	1.5	0.3	46.4	0.0	44.4	0.0	69.6	0.1	0.3	405.5	0.1	64.9	0.2	256.0	441.3	0.0	0.4	0.4	1.7	0.0	0.1	0.3	1.1	0.0	15.1	0.2	0.2	0.3	134.0	2.8	0.4	2.1	14.2	0.4	68.5	1.5	0.4	0.2	404.9	145.1	7.6	160.6	29.1	0.0	0.3	0.3	33.5	0.2	191.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	17.1	11.7	12.9	12.3	17.9	12.7	16.3	14.7	11.4	22.6	11.4	115.7	3.2	4.5	45.4	0.1	22.7	1.4	2.9	8.6	1.6	5.4	9.4	53.3	2.8	10.4	3.7	0.0	1.0	0.6	0.0	3.9	0.7	114.7	6.2	24.8	103.5	0.0	2.7	27.4	0.7	119.1	149.2	3.6	10.5	1.3	3.5	36.0	35.3	3.0	0.0	6.3	0.8	20.3	1.6	20.8	47.0	166.5	2.0	56.9	124.6	0.6	0.0	0.0	160.4	2.0	0.7	0.0	81.3	1.5	1.5	0.0	0.1	1.7	0.5	65.7	5.4	98.2	1.3	1.2	5.0	18.6	3.0	2.7	117.4	0.0	12.9
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757774	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1285.7;lymphoid tissue: 672.2"	"Group enriched"	"Detected in many"	4	"B-cells: 872.9;dendritic cells: 340.2;granulocytes: 639.8;Hofbauer cells: 1150.4;Kupffer cells: 942.2;Langerhans cells: 489.6;Macrophages: 925.0;monocytes: 446.1;NK-cells: 562.3;T-cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 554.0;HEL: 1053.2;HL-60: 676.4;HMC-1: 2382.4;REH: 785.2;U-698: 898.1;U-937: 542.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	144.7	82.1	47.6	443.0	49.7	1285.7	60.4	49.7	90.4	53.1	55.7	82.2	68.1	27.3	16.7	49.5	46.8	137.9	31.6	45.2	62.7	30.5	98.6	284.9	672.2	82.4	67.3	16.4	30.2	21.8	22.6	145.2	75.8	31.5	90.6	5.9	38.5	30.9	9.2	24.0	155.9	93.5	69.2	491.1	72.9	10.9	81.1	298.3	38.5	20.9	636.5	161.1	22.8	114.9	1.2	0.0	1.7	0.0	0.1	0.1	0.6	0.9	0.3	0.5	0.1	0.7	1.2	554.0	56.0	1.7	1.9	2.2	0.0	0.8	0.5	62.3	0.0	1053.2	0.0	1.6	0.9	676.4	2382.4	0.6	1.2	0.6	4.1	0.3	124.2	70.7	13.8	34.0	8.8	0.0	117.5	142.2	0.7	0.0	0.0	785.2	99.6	391.6	0.8	0.1	0.6	0.4	1.3	1.3	1.1	1.0	0.5	422.2	145.3	0.6	3.0	0.6	3.4	2.7	0.7	898.1	3.1	542.8	1.8	1094.2	1522.8	1446.7	538.5	1046.1	616.3	823.6	485.5	502.8	825.7	1089.4	481.2	481.2	1709.5	327.0	1075.7	392.7	656.9	2740.4	47.6	49.7	49.7	90.4	45.2	62.7	82.4	67.3	75.8	69.2	81.1	114.9	62.9	25.6	100.4	0.0	872.9	23.8	1.1	1.3	4.0	0.0	6.2	10.4	5.5	14.3	13.9	3.7	0.0	5.8	340.2	0.8	0.0	1.2	2.0	1.4	0.9	60.2	1.2	78.2	0.2	0.7	8.4	12.3	10.2	1.1	639.8	0.2	47.2	9.4	1150.4	0.0	0.8	0.9	0.0	942.2	489.6	4.9	1.5	925.0	49.8	43.1	446.1	0.3	562.3	0.5	0.5	1.4	0.2	0.4	144.8	0.9	0.5	3.0	11.4	1.3	0.0	4.1	5.6	0.3	1.1	1.8	20.0	8.9	432.7	18.2	2.4	1.9
LCP2	"SLP-76, SLP76"	ENSG00000043462	"Lymphocyte cytosolic protein 2"	Q13094	5	170246233-170297815	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 163.9;lymphoid tissue: 115.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 129.6;Kupffer cells: 154.4;Macrophages: 158.2;NK-cells: 91.6;T-cells: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 147.0;HL-60: 152.5;HMC-1: 375.9;Karpas-707: 80.4;MOLT-4: 91.4;THP-1: 80.8;U-937: 99.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004574, HPA036396, HPA036397"	Enhanced					NA	NA		2900000	"Cluster 52: Eosinophils - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436"	"unprognostic (1.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.52e-3)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (1.87e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.07e-1)"	23.0	14.1	5.0	75.7	5.7	163.9	8.4	5.9	22.9	10.3	6.3	14.6	15.8	8.2	4.9	9.6	6.8	28.6	5.7	5.1	6.9	5.6	26.3	31.5	77.5	12.2	8.4	3.7	7.7	3.3	2.2	21.9	11.6	8.0	16.4	0.8	6.6	6.5	3.2	3.9	24.4	16.6	7.9	81.1	17.6	3.9	10.2	115.1	4.7	6.2	47.3	28.2	3.7	12.7	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.0	147.0	0.0	0.0	0.0	152.5	375.9	0.0	0.0	0.0	0.0	0.0	0.1	49.7	1.1	80.4	0.0	0.0	91.4	53.2	0.5	0.0	0.0	14.0	0.0	45.5	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.0	80.8	0.1	0.0	0.1	0.2	0.1	1.4	14.6	0.2	0.3	99.9	1.7	56.8	20.4	76.6	40.5	42.5	40.2	2.7	32.4	38.6	26.6	1.0	29.8	31.0	68.9	41.7	65.8	5.3	39.8	22.9	5.0	5.7	5.9	22.9	5.1	6.9	12.2	8.4	11.6	7.9	10.2	12.7	13.4	16.0	29.2	0.7	12.2	3.2	0.2	0.1	0.0	0.2	0.9	2.8	4.8	1.5	5.6	1.8	0.0	0.5	35.2	0.1	0.0	0.2	1.6	0.4	2.4	14.2	0.0	24.0	2.8	0.0	0.8	9.5	5.1	0.7	129.6	0.0	18.9	2.4	57.9	0.0	7.9	0.7	0.0	154.4	49.4	0.9	2.5	158.2	1.8	31.9	48.2	0.0	91.6	0.5	0.5	0.0	0.0	3.0	12.6	0.4	0.0	0.3	2.9	0.0	26.3	1.3	3.1	0.0	0.2	1.0	1.8	0.8	104.6	0.5	0.0	0.3
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 1825.0"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	11.1	1.4	12.8	2.8	39.6	0.4	6.5	29.8	29.0	10.1	0.1	36.2	2.4	15.1	4.9	54.5	17.3	3.1	1423.0	14.7	23.3	2.0	0.8	5.1	0.5	55.5	36.9	6.4	1.3	0.5	2.4	2.7	46.2	38.1	5.3	0.7	20.8	25.2	2945.6	4.8	8.8	23.7	26.4	0.6	9.0	4.7	38.4	0.7	5.2	1809.4	0.3	7.0	10.3	78.4	0.1	0.1	0.2	1.7	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.4	0.7	0.0	0.0	0.0	0.9	3.0	0.2	0.0	0.0	3.3	0.0	0.3	0.1	1.0	0.0	0.8	0.2	0.1	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.6	4.9	0.9	0.2	0.1	2.4	0.7	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	39.6	29.8	29.0	14.7	23.3	55.5	36.9	46.2	26.4	38.4	78.4	1.5	0.0	0.0	1.0	0.0	1.0	0.5	0.2	0.0	1.5	0.2	0.3	1825.0	0.0	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	23.4	0.1	0.4	15.5	0.0	0.0	4.5	1.1	0.0	31.5	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	2.6	0.0	4.1	0.0	1.2	19.6	11.1	0.5	1.8	1.9	0.0	0.7	0.0	1.5	245.1	0.1	0.0	6.8	0.0	0.3	0.0	0.1	0.1	4.1	39.5	48.0	54.9	1.0	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2
LEFTY2	"EBAF, LEFTA, LEFTYA, TGFB4"	ENSG00000143768	"Left-right determination factor 2"	O00292	1	225936598-225941383	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 74.5;endometrium 1: 170.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 17.4;Endometrial stromal cells: 30.8;Granulosa cells: 43.6;Late spermatids: 34.6;Leydig cells: 18.0;Peritubular cells: 12.0"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 41.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.6;NTERA-2: 44.4;RPMI-8226: 50.9;SuSa: 25.5"									"CAB025801, HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB025801: , HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (3.78e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.79e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.75e-4)"	"unprognostic (2.91e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.90e-4)"	"unprognostic (1.64e-3)"	1.8	1.4	0.2	1.1	0.3	0.0	0.7	0.3	0.3	74.5	15.9	1.2	0.3	170.0	12.1	0.1	3.6	0.4	2.6	0.7	0.2	0.4	0.0	2.4	0.2	0.2	0.3	37.8	0.3	0.0	16.0	3.5	0.2	1.5	0.2	0.9	0.1	12.4	0.7	0.3	0.4	36.9	0.2	0.7	0.3	4.5	0.8	0.2	0.1	0.8	0.0	0.5	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	44.4	0.0	0.0	0.0	0.0	50.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	2.6	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.7	0.2	0.2	0.3	0.2	0.2	0.8	0.3	0.6	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.4	17.4	2.2	30.8	0.6	0.0	0.0	0.0	0.0	0.6	1.4	0.0	0.7	0.0	43.6	0.4	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.2	34.6	18.0	0.3	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	12.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.3	1.7	6.7	0.4	0.0	0.0	0.0	0.2	0.7	0.0	0.1
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 130.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 97.7;Endothelial cells: 80.5;Fibroblasts: 94.2;Hepatocytes: 175.2;Langerhans cells: 66.6;Microglial cells: 129.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"K-562: 114.7;RPTEC TERT1: 52.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported			"Intracellular and membrane"	NA	NA	8240000	14000000	"Cluster 34: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 50: Fibroblasts - ECM organization"			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	24.3	7.2	5.2	3.9	5.1	5.0	20.6	4.9	6.5	21.5	25.0	5.9	3.9	24.6	6.7	9.2	16.1	14.7	6.9	5.3	12.3	7.8	130.4	22.5	9.5	5.2	5.7	25.0	3.0	2.9	11.7	5.3	5.2	9.0	5.1	2.5	11.9	7.3	2.1	15.1	5.6	18.7	6.3	3.2	13.7	3.9	7.7	4.7	10.4	32.1	5.7	9.1	4.8	5.2	3.3	2.0	2.6	2.9	11.5	10.6	9.0	14.2	8.1	4.8	4.5	1.5	7.6	1.4	10.1	18.0	1.3	2.7	2.2	12.3	12.7	17.2	3.7	18.8	7.9	0.3	7.0	1.4	1.6	29.7	6.8	2.9	10.8	36.2	13.9	1.4	114.7	2.2	22.5	0.9	1.4	0.4	4.2	2.0	0.2	0.4	2.2	0.8	52.3	1.4	1.6	26.3	3.5	1.5	4.0	14.9	5.0	5.0	5.3	4.9	10.0	1.1	7.8	3.0	2.2	0.5	10.2	5.3	4.8	4.5	0.8	1.2	0.5	0.6	0.4	0.2	0.4	0.4	0.7	0.1	0.3	0.5	0.4	0.4	0.7	0.5	1.0	0.7	5.2	5.1	4.9	6.5	5.3	12.3	5.2	5.7	5.2	6.3	7.7	5.2	97.7	0.0	11.3	47.0	2.6	35.3	1.9	3.3	2.2	4.0	3.1	3.3	6.6	11.5	4.2	9.2	0.0	1.6	1.6	0.5	3.9	1.5	1.1	2.0	4.4	80.5	0.0	10.3	20.9	1.1	2.6	94.2	2.6	12.8	1.3	2.6	52.5	175.2	2.0	1.7	21.8	0.8	2.0	6.3	66.6	2.3	34.5	6.1	35.6	129.3	3.4	0.4	2.1	29.1	24.5	1.7	1.9	7.5	2.4	7.5	0.7	6.4	2.6	1.0	0.0	41.1	10.3	1.1	1.2	4.1	29.5	2.6	4.7	3.3	0.8	2.1
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675636-37679802	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3949.7;Langerhans cells: 4906.5;monocytes: 7118.4;Smooth muscle cells: 4703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 1649.6"	"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	No	Yes	10000000	20000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (5.10e-4)"	1921.2	778.5	482.4	523.8	520.7	324.7	1490.9	613.5	695.3	1805.7	465.2	1634.7	197.7	2270.1	196.8	387.4	1147.0	556.0	1397.4	457.7	549.0	362.4	277.4	920.2	176.7	694.5	576.1	1440.2	155.5	188.1	254.8	426.1	661.5	903.0	207.2	39.5	397.5	756.3	1172.9	472.8	475.3	1353.4	593.8	460.7	582.7	244.9	624.9	153.9	290.9	691.9	116.9	1059.7	1156.4	782.4	2850.9	1664.3	36.5	1440.9	3314.6	6505.1	32.7	6450.7	7619.4	4761.9	4716.9	189.6	368.3	3.3	649.1	6661.4	1609.2	296.3	58.8	4309.2	1663.3	2917.2	30.9	251.3	1606.3	791.1	2155.3	145.1	3167.7	4031.7	294.2	3785.7	1609.9	4271.1	5325.7	1.7	186.6	1163.4	3771.1	1287.6	5.2	2038.4	14.3	629.6	3914.9	5.4	2388.6	799.7	2000.0	6.4	5.5	843.4	1287.4	224.3	1644.5	66.7	1187.2	1689.0	7122.0	6224.0	3070.2	2788.9	3349.3	701.8	530.6	13.6	7291.9	762.0	2535.9	1086.5	3047.4	110.2	766.5	2320.4	113.6	567.7	694.9	754.2	3653.1	287.5	114.3	478.1	122.2	415.4	2556.7	899.2	1514.7	4667.0	482.4	520.7	613.5	695.3	457.7	549.0	694.5	576.1	661.5	593.8	624.9	782.4	1505.8	166.7	90.4	12.7	294.3	730.3	144.0	2796.6	49.5	10.0	144.2	477.9	986.3	74.4	213.4	163.7	6.2	88.0	466.5	49.9	17.6	690.2	30.9	183.0	3011.6	1063.6	3.0	74.9	7.5	90.4	1573.3	2540.4	28.1	230.3	540.0	172.2	653.2	614.1	3949.7	8.4	5.4	8.4	339.7	2159.0	4906.5	106.4	975.5	1700.0	2856.6	15.9	7118.4	278.0	588.1	4.0	17.1	233.5	6.1	1300.7	590.9	118.8	0.5	28.7	109.8	45.4	1650.1	1873.6	4703.8	33.8	13.1	18.2	588.0	151.5	767.5	197.2	11.6	57.0
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570248-37582616	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 335.5;intestine: 198.0;kidney: 153.0;pancreas: 211.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 779.2;Distal enterocytes: 695.4;Langerhans cells: 982.8;Proximal enterocytes: 2724.7;Proximal tubular cells: 1764.8;Undifferentiated cells: 749.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	27	"classical monocyte: 1464.7;intermediate monocyte: 553.8;myeloid DC: 1207.2"	"Group enriched"	"Detected in all"	50	"dendritic cells: 1207.2;monocytes: 1464.7"	"Group enriched"	"Detected in many"	4	"CACO-2: 109.4;Hep G2: 62.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	7.5	1.4	0.6	23.5	1.4	19.2	5.4	0.2	1.1	1.8	0.2	55.0	41.2	3.6	1.0	5.2	4.4	335.5	1.6	0.5	1.0	153.0	5.0	8.6	60.7	1.6	1.2	0.9	211.5	0.2	0.1	1.7	1.4	2.2	81.1	0.1	2.1	0.7	1.9	9.9	198.0	5.2	0.4	59.2	10.7	0.6	1.1	41.3	1.0	0.7	64.0	8.2	0.5	3.4	2.8	1.5	0.9	1.0	0.0	0.0	1.1	1.7	0.0	0.0	0.0	109.4	0.1	0.4	0.3	0.0	0.3	1.7	0.0	0.0	0.0	0.2	1.1	0.0	0.0	62.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	2.8	0.0	1.0	0.4	21.2	0.3	0.0	0.9	1.3	0.0	0.0	0.0	0.3	1.7	1.9	2.4	0.5	1.6	1.7	6.4	2.0	1.0	4.3	0.8	0.0	0.2	0.3	2.7	0.2	1.3	7.7	1464.7	8.7	1.8	553.8	3.3	9.9	1.8	2.1	1207.2	2.3	2.3	1.9	26.8	2.3	39.7	9.6	3.0	981.5	0.6	1.4	0.2	1.1	0.5	1.0	1.6	1.2	1.4	0.4	1.1	3.4	1.6	6.4	3.9	0.0	16.4	17.1	0.1	0.5	0.0	0.0	13.2	7.5	0.3	779.2	1.4	29.5	0.0	0.2	7.0	695.4	127.2	26.3	0.1	0.1	0.3	2.3	73.7	4.8	0.1	206.7	0.3	3.2	5.6	0.2	2.5	0.0	0.7	1.9	26.4	0.0	0.1	413.0	0.0	100.8	982.8	0.3	0.6	150.8	24.9	0.0	164.8	0.0	4.1	0.0	0.1	291.6	331.6	0.0	0.9	0.3	2724.7	1764.8	2.1	0.0	0.0	0.3	2.3	0.0	0.4	0.1	12.4	0.3	8.6	0.0	749.3	0.3
LGI1	"EPITEMPIN, EPT, ETL1, IB1099"	ENSG00000108231	"Leucine rich glioma inactivated 1"	O95970	10	93757840-93806272	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 39.7;choroid plexus: 44.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 242.9;Excitatory neurons: 57.1;Inhibitory neurons: 74.7;Oligodendrocyte precursor cells: 28.6"	"Group enriched"	"Detected in some"	7	"glioma: 1.8;testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;CACO-2: 2.0;NTERA-2: 6.1;SuSa: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (1.26e-1)"			"unprognostic (4.68e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.20e-2)"		"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.65e-1)"	0.5	1.8	26.8	0.1	31.5	0.0	0.2	23.8	39.7	0.1	44.7	4.0	0.5	0.1	0.0	4.3	0.1	1.0	0.5	29.2	22.6	0.0	2.7	0.0	0.0	29.9	24.2	0.0	0.2	0.0	7.6	0.0	32.9	0.7	2.6	0.4	0.1	0.5	5.9	0.3	1.5	0.6	23.7	0.0	1.8	0.4	26.7	0.0	0.2	3.6	0.1	0.9	0.3	25.2	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	31.5	23.8	39.7	29.2	22.6	29.9	24.2	32.9	23.7	26.7	25.2	0.2	0.0	0.0	242.9	0.0	0.3	0.4	0.0	0.0	0.5	0.4	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.4	0.0	0.0	57.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	74.7	0.0	0.0	0.0	0.4	1.6	1.5	0.0	0.0	10.3	0.0	0.1	0.0	28.6	3.9	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.5	0.6	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.2
LGR4	GPR48	ENSG00000205213	"Leucine rich repeat containing G protein-coupled receptor 4"	Q9BXB1	11	27365961-27472790	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 204.4;Distal enterocytes: 123.3;Glandular and luminal cells: 137.7;Syncytiotrophoblasts: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 83.5;RPTEC TERT1: 100.4;U-2197: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030267, HPA054350"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"		"HPA030267: AB_10610004, HPA054350: "	"unprognostic (5.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.00e-7)"	"unprognostic (5.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.76e-1)"	16.4	16.8	10.2	8.1	10.2	2.4	16.1	13.0	9.2	7.5	10.2	36.8	22.6	10.2	13.3	13.7	10.2	9.0	19.4	7.8	10.5	51.5	55.7	3.2	1.5	14.1	10.4	22.9	59.7	6.4	6.8	34.4	12.8	15.4	36.8	44.4	18.1	16.1	14.4	18.3	24.7	13.2	13.4	11.7	31.0	13.9	10.1	4.4	15.2	8.2	3.0	10.1	11.7	18.0	28.3	50.7	49.5	5.7	4.5	3.1	56.0	15.7	14.8	13.8	11.8	7.6	0.5	0.1	10.1	21.2	23.2	45.8	83.5	31.1	23.5	0.2	37.0	15.3	28.4	36.1	1.4	1.6	0.1	4.1	19.5	9.5	21.0	57.0	7.0	0.0	4.5	0.1	5.7	9.0	0.1	2.7	47.9	76.3	20.4	0.2	33.8	3.3	100.4	12.1	0.7	6.0	7.7	45.7	4.6	37.6	15.1	23.4	22.6	10.2	8.2	82.6	14.6	18.9	15.2	0.0	17.3	0.0	6.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	10.2	13.0	9.2	7.8	10.5	14.1	10.4	12.8	13.4	10.1	18.0	1.7	3.2	0.5	204.4	1.4	30.3	13.5	33.1	38.7	18.6	17.2	14.1	26.6	24.3	15.4	44.1	25.0	55.1	0.4	123.3	3.9	21.4	7.1	75.4	11.5	3.9	16.8	3.4	35.6	50.7	29.2	14.5	43.3	137.7	0.0	78.6	3.6	60.7	8.1	25.2	51.6	47.1	20.3	5.3	5.7	2.2	5.0	1.6	7.2	15.0	2.1	109.8	0.0	36.7	62.1	31.4	48.8	17.0	0.6	11.7	37.9	19.4	14.5	14.8	6.6	6.9	13.0	1.3	1.4	36.8	21.9	128.6	1.8	6.3	55.5	19.7
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39209116-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.2;Endometrial stromal cells: 78.1;Extravillous trophoblasts: 156.9;Fibroblasts: 113.0;Smooth muscle cells: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"myeloid DC: 6.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 255.1;HSkMC: 186.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA058975: AB_2683866"	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (2.30e-4)"	143.2	55.1	46.3	18.6	49.9	1.1	128.7	59.2	45.2	51.6	57.2	51.7	10.8	78.8	47.5	37.0	88.9	74.5	99.7	45.6	57.3	31.9	14.2	82.6	39.1	54.9	56.8	49.6	17.2	18.2	26.9	134.6	51.4	30.8	16.7	11.9	34.7	36.9	32.1	37.9	29.0	68.9	47.8	30.4	27.9	20.4	64.3	17.0	64.2	89.2	17.6	49.1	48.3	44.3	11.5	4.0	118.3	5.1	255.1	115.1	51.6	61.8	88.3	30.8	23.1	0.5	11.6	17.5	1.3	86.6	40.0	17.3	15.0	36.2	25.3	16.9	17.2	47.3	3.7	0.0	26.7	0.8	0.9	186.4	4.7	27.7	45.7	27.6	29.1	1.1	0.0	0.1	59.9	9.9	0.0	14.5	8.8	0.2	15.8	7.7	51.3	0.1	20.9	15.0	0.7	3.8	5.6	7.2	16.8	67.4	6.7	0.1	54.3	77.9	11.7	24.4	33.9	0.9	0.0	48.9	32.4	0.2	57.2	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.3	46.3	49.9	59.2	45.2	45.6	57.3	54.9	56.8	51.4	47.8	64.3	44.3	195.2	3.2	12.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.4	28.6	0.0	0.0	9.9	0.0	0.0	5.0	1.4	0.0	1.9	0.6	0.0	2.7	78.1	32.0	0.0	0.0	0.0	0.6	156.9	113.0	0.0	2.8	2.5	22.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	3.6	2.2	0.0	0.0	0.0	131.6	0.0	0.0	0.0	0.0	6.2	1.2	45.8	0.0	0.0
LILRB5	"CD85c, LIR-8, LIR8"	ENSG00000105609	"Leukocyte immunoglobulin like receptor B5"	O75023	19	54249421-54257301	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 17.9;lymphoid tissue: 49.1"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 61.1;Kupffer cells: 103.4;Macrophages: 40.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012069	Approved					NA	NA		58000000	"Cluster 17: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA012069: AB_1852873"	"unprognostic (3.55e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.86e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.02e-5)"	"unprognostic (6.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	17.9	10.3	0.2	1.7	0.5	0.9	7.2	0.3	1.0	1.6	1.3	6.1	4.6	1.1	0.8	1.8	4.4	2.8	5.1	0.2	0.2	1.6	7.1	5.3	1.8	0.5	0.3	1.3	0.8	0.3	0.7	4.8	0.4	0.6	4.8	0.1	2.9	0.6	1.8	2.3	6.8	2.4	0.2	49.1	2.5	1.1	1.0	1.0	1.4	1.3	0.7	4.2	1.2	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.5	0.3	1.0	0.2	0.2	0.5	0.3	0.4	0.2	1.0	1.1	0.5	0.0	1.1	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	1.7	0.0	0.1	0.2	0.0	2.7	0.0	0.0	0.4	0.7	0.0	0.1	0.0	0.1	8.6	0.9	61.1	0.0	0.0	0.0	0.0	103.4	9.8	1.8	0.0	40.1	1.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.5	0.0	0.1	0.3	1.1	0.8	0.4	0.5	0.0	0.0
LINGO2	"LERN3, LRRN6C"	ENSG00000174482	"Leucine rich repeat and Ig domain containing 2"	Q7L985	9	27948078-28670286	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 7.5;smooth muscle: 8.8"	"Group enriched"	"Detected in some"	29	"Excitatory neurons: 1591.2;Inhibitory neurons: 988.0"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.8"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;hTERT-HME1: 1.5;SH-SY5Y: 9.1;U-87 MG: 1.6;WM-115: 4.1"	"Low region specificity"	"Detected in all"							"HPA016633, CAB025361"	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB025361: , HPA016633: AB_1853362"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-4)"	"unprognostic (9.86e-4)"	"unprognostic (7.55e-3)"		"unprognostic (2.67e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.95e-4)"	0.0	0.4	0.5	0.0	0.8	0.2	0.0	0.0	3.3	0.6	0.0	0.1	0.0	7.5	0.9	0.0	0.4	0.9	0.0	2.9	3.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.6	1.7	0.0	0.6	0.0	2.4	0.0	1.5	0.0	0.1	0.0	8.8	0.1	0.1	0.6	1.7	0.4	0.2	2.9	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.2	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	9.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.8	0.0	3.3	2.9	3.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	17.5	0.4	4.6	0.2	1.8	0.0	1591.2	0.0	0.1	1.4	0.0	0.9	1.3	29.6	0.0	0.0	0.2	0.0	988.0	0.0	0.0	0.0	0.0	16.4	0.0	0.1	0.0	43.1	0.1	0.9	5.2	17.6	20.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.3	2.8	1.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 398.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 123.6;monocytes: 355.1"	"Cell line enhanced"	"Detected in many"		"A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		280000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	76.0	46.3	43.5	66.7	65.2	39.8	47.8	64.1	74.4	54.0	39.0	67.7	167.6	38.8	21.7	28.6	37.8	83.5	24.2	43.5	53.1	44.9	218.9	169.5	159.3	74.7	55.5	32.7	21.4	68.9	12.7	79.1	82.2	30.7	72.0	12.6	22.5	33.8	11.8	18.7	227.5	47.7	65.4	398.4	34.3	13.4	57.0	44.5	31.6	22.5	45.5	58.4	19.3	115.5	354.4	49.4	30.7	367.8	343.5	450.8	10.0	171.4	194.8	65.5	121.5	18.6	176.6	63.9	34.0	264.4	73.7	338.7	13.8	92.8	53.6	86.1	34.7	25.1	19.1	81.5	87.6	48.8	48.9	190.4	69.2	72.9	40.6	88.2	14.9	45.4	0.3	108.5	58.3	28.2	45.7	34.6	22.7	62.4	60.0	26.4	39.0	60.5	69.2	50.9	10.5	21.8	41.4	49.9	133.9	20.4	64.4	65.8	26.2	58.8	15.5	132.1	44.6	60.0	65.7	25.8	71.4	112.9	82.1	4.2	167.3	16.9	40.0	355.1	40.6	31.9	35.8	38.8	123.6	33.4	36.7	40.4	7.1	29.8	198.5	25.0	38.2	159.6	43.5	65.2	64.1	74.4	43.5	53.1	74.7	55.5	82.2	65.4	57.0	115.5	75.5	41.7	33.8	11.1	35.9	17.7	30.3	58.1	25.6	5.4	16.1	14.1	9.6	45.8	31.9	33.1	0.0	34.8	31.4	2.8	21.5	35.1	6.8	11.4	20.4	56.7	21.8	27.4	34.4	36.2	32.9	34.6	21.4	15.5	28.5	10.8	54.7	66.7	515.0	16.8	15.1	8.9	40.7	714.8	69.0	2.7	11.5	303.1	48.0	30.0	71.7	33.1	29.9	15.1	143.0	19.3	12.0	21.8	15.4	11.3	161.0	14.0	28.8	2.2	6.6	19.7	21.0	5.1	13.8	31.9	12.5	20.0	33.1	17.6	9.1	24.0
LIX1L	MGC46719	ENSG00000271601	"Limb and CNS expressed 1 like"	Q8IVB5	1	145933423-145958017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063598			Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA063598: AB_2685055"	"unprognostic (5.21e-2)"	"unprognostic (4.09e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.95e-1)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (5.27e-4)"	21.0	19.0	14.6	15.2	15.1	6.4	16.0	13.8	13.1	27.1	15.6	23.0	6.7	27.6	11.1	9.8	21.1	15.6	16.3	12.9	13.5	9.8	10.2	15.6	20.4	15.0	15.2	36.9	5.8	7.5	16.3	16.2	14.0	16.2	9.2	19.0	9.4	20.8	34.8	8.1	13.3	25.7	13.9	20.8	11.3	6.6	15.8	16.6	10.8	31.5	20.8	21.1	16.9	15.0	7.3	10.3	31.0	34.5	63.4	53.5	0.4	16.3	29.4	24.8	18.1	0.8	6.7	19.6	17.5	33.1	9.3	0.4	14.6	13.6	23.3	18.2	4.5	10.9	11.0	10.4	20.8	26.2	24.8	32.9	6.2	20.3	29.3	39.9	48.7	25.8	16.4	30.6	39.9	0.2	34.6	21.8	9.0	0.1	13.2	23.2	15.6	32.4	25.7	0.2	11.1	31.6	33.5	0.1	24.9	12.8	1.2	20.3	38.0	41.9	11.5	27.6	27.8	24.5	18.7	19.9	29.5	21.4	20.7	4.0	2.2	3.9	5.7	2.2	7.0	3.0	6.6	5.8	2.1	3.1	6.1	8.0	3.7	3.8	3.8	3.3	5.4	2.6	14.6	15.1	13.8	13.1	12.9	13.5	15.0	15.2	14.0	13.9	15.8	15.0	29.7	0.0	5.8	11.1	23.1	11.3	10.6	10.8	11.4	17.1	3.8	7.5	17.5	14.3	4.9	11.0	8.4	1.4	18.6	2.8	3.9	9.6	10.4	2.3	21.6	36.7	12.6	23.5	5.1	10.0	4.3	28.4	2.6	3.5	5.1	10.8	45.7	19.6	21.1	13.5	6.1	1.4	8.2	24.3	43.8	3.6	35.8	18.8	28.4	15.9	27.4	28.1	35.0	8.5	7.0	11.0	1.2	56.4	17.8	7.5	0.1	7.7	3.0	13.6	26.3	16.8	37.9	24.1	4.7	3.1	7.7	0.8	37.4	21.4	2.1	4.2
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501807-8574668	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 573.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 20.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 20.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No		6600	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	131.4	14.3	9.5	45.6	9.5	0.1	97.5	13.5	10.8	27.2	38.8	18.1	9.0	90.3	18.4	36.1	57.8	67.2	90.6	14.0	9.7	33.0	9.7	131.7	17.3	14.0	11.0	65.8	37.7	30.0	8.7	54.5	12.1	34.8	7.0	15.2	42.2	16.8	573.4	28.8	20.1	63.3	13.2	55.6	46.4	11.3	12.6	4.7	18.5	260.9	10.2	110.6	31.5	14.8	9.4	52.0	8.6	6.6	62.0	34.6	8.9	37.9	19.4	20.5	50.0	38.8	11.5	0.0	4.2	44.2	8.8	0.8	4.9	9.9	8.4	16.0	3.6	11.6	3.5	7.6	88.9	0.0	1.1	124.9	0.2	93.8	0.7	11.9	10.1	0.0	0.0	0.0	26.8	6.7	0.0	0.1	16.8	12.0	2.3	0.2	28.2	0.1	19.1	3.6	0.3	21.3	6.4	31.1	20.6	23.9	40.7	0.1	5.0	20.4	40.3	83.0	25.9	5.1	6.2	2.6	4.1	2.9	27.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	2.9	0.6	3.3	0.3	0.0	0.1	0.0	0.0	0.0	1.0	20.5	0.3	9.5	9.5	13.5	10.8	14.0	9.7	14.0	11.0	12.1	13.2	12.6	14.8	287.6	9.6	10.7	2.0	2.1	31.6	42.1	7.4	9.6	13.0	20.4	17.0	14.7	14.3	13.5	5.5	10.4	3.9	1.7	1.4	3.9	122.0	1.1	9.6	77.7	161.9	12.1	0.0	0.8	48.5	4.2	64.5	7.1	4.8	10.2	44.2	30.7	12.6	3.4	97.6	1.2	2.4	4.1	0.8	47.0	2.3	11.5	3.2	53.4	29.0	9.0	38.9	1.0	4.0	8.7	114.1	0.9	32.4	8.0	8.4	0.3	45.5	12.0	8.0	0.0	57.0	112.9	6.4	9.1	29.0	27.1	4.4	5.3	21.5	4.7	7.5
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896456-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 513.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Leydig cells: 125.6;Peritubular cells: 275.3;Rod photoreceptor cells: 70.2;Sertoli cells: 197.2;Smooth muscle cells: 224.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.8;BJ: 21.3;BJ hTERT+: 34.4;fHDF/TERT166: 17.4;HSkMC: 14.5;hTERT-RPE1: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	157.7	52.5	7.8	28.5	9.7	0.0	75.4	5.7	9.1	161.9	5.5	513.9	25.1	309.5	49.7	135.8	194.7	85.5	31.7	6.2	8.0	11.8	5.1	44.3	7.3	13.6	6.5	72.2	8.4	18.2	5.8	35.3	6.8	165.2	46.9	48.0	21.2	242.5	137.5	43.2	115.5	206.6	5.4	18.5	218.6	17.9	9.1	2.5	39.8	45.7	1.6	368.7	111.9	7.2	0.0	0.1	0.4	1.2	15.8	2.0	1.3	21.3	34.4	1.3	1.5	0.1	0.2	0.0	0.7	17.4	0.2	0.3	0.5	0.0	0.4	0.0	1.4	0.0	0.1	0.0	1.5	0.1	0.1	14.5	0.0	1.0	0.0	54.4	0.1	0.0	0.2	0.2	0.7	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.4	0.1	0.3	0.0	0.5	0.4	9.5	0.7	0.0	0.0	0.1	0.8	0.3	0.0	0.7	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	9.7	5.7	9.1	6.2	8.0	13.6	6.5	6.8	5.4	9.1	7.2	16.1	0.0	1.1	8.5	0.3	1.3	1.0	0.3	0.0	4.8	1.6	40.8	25.1	0.0	0.0	0.0	135.5	1.7	0.0	0.1	0.0	0.0	2.1	2.6	64.5	5.8	0.0	0.0	0.5	0.6	0.3	20.4	0.5	1.2	0.0	0.7	9.3	0.4	1.0	3.3	1.0	0.0	0.0	0.0	2.3	8.2	125.6	0.9	3.6	3.7	0.0	7.3	0.0	4.0	1.0	0.0	0.0	275.3	0.0	0.9	0.0	0.1	0.9	70.2	197.2	5.2	224.3	1.2	0.5	0.8	2.3	1.2	1.3	2.1	0.0	0.4
LMX1A	"LMX1, LMX1.1"	ENSG00000162761	"LIM homeobox transcription factor 1 alpha"	Q8TE12	1	165201867-165356715	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"choroid plexus: 20.4"	"Group enriched"	"Detected in some"	16	"Early spermatids: 30.6;Enteroendocrine cells: 41.9;Late spermatids: 23.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA028051, HPA030088"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA028051: AB_10599731, HPA030088: AB_10601106"	"unprognostic (1.73e-1)"		"unprognostic (9.57e-2)"	"unprognostic (7.58e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.82e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.22e-2)"			"unprognostic (2.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.82e-3)"		0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.3	20.4	0.3	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	1.3	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	1.3	2.5	0.0	0.1	1.0	0.0	0.2	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.7	1.3	0.2	2.1	0.5	0.0	2.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.6	0.2	0.0	0.1	41.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	23.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23296897-23425328	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 26.9;Endometrial stromal cells: 26.9;Endothelial cells: 33.1;Extravillous trophoblasts: 22.0;Fibroblasts: 22.9;Hepatic stellate cells: 19.6;Sertoli cells: 26.3;Smooth muscle cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 935.5;BJ hTERT+ SV40 Large T+ RasG12V: 517.3;fHDF/TERT166: 602.7;TIME: 510.7;U-87 MG: 905.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	30.4	3.3	1.9	15.9	2.7	1.2	18.8	4.7	3.0	10.6	0.8	25.3	9.3	12.0	0.9	3.8	4.9	8.0	10.7	1.8	3.2	6.1	3.9	8.3	11.7	7.7	8.1	12.9	6.5	2.5	2.6	36.2	7.0	7.5	5.4	3.0	4.1	13.0	4.5	5.4	10.3	41.3	4.5	5.0	9.0	2.3	4.5	1.8	5.2	2.6	9.5	12.0	7.3	3.7	58.2	147.7	42.7	35.8	112.4	183.8	19.4	935.5	295.9	415.6	517.3	1.1	4.4	10.7	7.5	602.7	193.2	47.6	2.1	79.0	215.3	1.8	8.5	0.9	19.4	1.0	226.8	0.5	3.8	164.6	3.9	155.0	20.8	274.0	350.7	2.4	0.5	2.0	138.1	32.3	0.6	1.4	29.1	0.4	24.5	1.9	36.7	0.4	120.1	0.3	0.9	13.7	122.9	6.1	8.6	131.3	0.8	1.2	510.7	384.6	103.3	163.8	127.3	4.1	0.8	29.9	905.4	1.4	413.5	0.1	0.2	0.8	0.4	0.1	0.2	0.4	0.1	0.3	0.1	0.1	0.2	0.6	0.3	0.1	0.2	0.2	0.1	0.2	1.9	2.7	4.7	3.0	1.8	3.2	7.7	8.1	7.0	4.5	4.5	3.7	12.9	0.0	3.0	6.8	0.6	2.5	0.3	26.9	0.6	1.5	0.6	9.7	2.6	1.5	4.1	0.0	0.0	2.7	0.4	0.0	0.0	1.9	0.6	1.7	26.9	33.1	0.0	0.0	8.1	1.5	22.0	22.9	1.5	2.1	0.0	2.0	19.6	0.2	1.3	1.7	3.2	0.1	0.0	0.3	5.7	0.4	0.9	0.9	3.6	6.5	0.0	1.2	0.0	7.1	11.9	2.3	0.1	0.4	0.9	0.6	0.2	0.2	1.6	3.2	26.3	2.7	48.1	1.3	1.6	0.5	3.1	1.0	1.0	3.1	0.4	0.2
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;ovary: 3.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Fibroblasts: 4.2;Leydig cells: 20.2;Oligodendrocyte precursor cells: 3.5;Skeletal myocytes: 3.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;NTERA-2: 15.2;RH-30: 6.4;U-937: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853"	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	0.5	0.0	1.8	0.4	1.3	0.3	0.8	1.1	1.7	0.6	1.1	0.3	0.0	1.1	0.3	0.6	0.3	0.8	0.7	3.0	1.2	0.1	0.1	0.1	0.0	1.8	1.7	3.6	0.4	0.0	0.1	0.0	1.3	0.2	0.4	0.1	0.3	0.1	0.0	0.5	0.3	0.5	2.6	0.1	0.4	0.3	1.1	0.7	0.1	0.3	0.4	0.3	0.2	3.8	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.2	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.1	2.1	0.0	0.4	1.7	15.2	0.0	0.2	0.8	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	2.6	0.0	0.0	0.2	0.0	0.6	1.2	0.0	0.7	0.7	3.7	1.5	6.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	1.3	1.1	1.7	3.0	1.2	1.8	1.7	1.3	2.6	1.1	3.8	1.2	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.8	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.5	20.2	0.1	1.8	1.0	0.6	1.0	0.0	3.5	0.1	0.0	0.0	2.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.3	1.5	0.4	0.0	0.4	0.2	0.0	0.2
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 118.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 75.9;dendritic cells: 80.7;Langerhans cells: 154.6;Macrophages: 81.7;Plasma cells: 82.2;T-cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 200.7;HMC-1: 329.3;Karpas-707: 285.0;U-2197: 199.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	10.4	8.3	7.5	48.3	8.2	10.2	10.2	7.8	11.8	7.9	4.5	14.5	10.9	7.4	11.9	5.2	7.6	15.1	5.3	7.1	7.8	10.6	14.0	33.5	87.1	9.1	8.8	9.5	8.6	6.5	7.2	5.2	10.2	9.4	19.6	7.0	11.0	7.1	3.8	5.9	26.2	9.7	8.6	44.1	13.0	10.2	10.0	103.3	10.2	5.1	118.5	32.4	6.0	10.9	1.7	2.1	2.0	3.9	7.4	9.3	1.4	50.5	200.7	12.4	22.0	0.4	5.1	149.8	2.0	61.9	9.2	2.0	1.7	137.7	51.4	65.4	0.9	6.8	1.3	1.0	12.8	41.1	329.3	7.2	3.2	170.8	22.0	12.0	80.9	90.0	1.9	285.0	101.5	1.1	144.8	51.6	1.6	2.3	45.8	2.1	2.5	129.2	8.3	71.2	1.0	1.6	2.2	3.2	20.1	2.8	2.7	11.7	79.8	30.8	9.5	199.5	45.9	18.4	18.9	146.5	71.6	36.8	71.6	6.3	74.3	12.2	101.3	41.8	148.9	71.9	102.9	117.6	137.5	46.2	79.6	95.9	14.1	79.2	22.2	124.4	152.1	98.8	7.5	8.2	7.8	11.8	7.1	7.8	9.1	8.8	10.2	8.6	10.0	10.9	4.1	0.0	6.7	22.9	75.9	9.7	6.6	7.2	3.4	4.1	4.0	4.7	2.3	4.3	2.8	0.0	4.2	2.8	80.7	4.2	3.9	2.5	23.0	2.8	1.9	5.9	6.1	13.3	18.2	5.6	1.3	6.6	13.3	2.3	51.5	5.4	2.5	7.6	44.0	1.7	19.8	3.1	6.1	63.7	154.6	8.7	1.8	81.7	19.6	30.0	52.9	2.8	49.4	11.6	27.3	4.1	5.2	3.8	82.2	3.6	6.9	5.7	4.3	4.4	6.6	3.6	3.8	9.2	4.2	2.6	9.7	2.5	90.3	2.9	5.2	27.6
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355249-194369743	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.9;skin 1: 7.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"fHDF/TERT166: 120.6;U-87 MG: 62.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		1700000		"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	1.1	0.1	0.0	1.3	0.0	0.0	3.7	0.0	0.0	2.9	0.0	1.7	0.5	1.9	0.0	0.5	1.1	1.6	0.2	0.0	0.0	0.0	0.1	2.0	0.8	0.0	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.1	3.0	0.0	1.0	0.0	0.1	7.3	0.4	0.6	0.0	1.3	1.5	0.0	0.1	0.2	1.3	0.2	4.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.7	0.1	0.1	0.4	0.0	0.0	1.0	120.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	22.5	3.7	3.0	0.0	0.0	0.0	0.0	62.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.2;thyroid gland: 19.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Bipolar cells: 29.2;Cardiomyocytes: 24.8;Excitatory neurons: 81.2;Inhibitory neurons: 46.5;Leydig cells: 56.2;Oligodendrocyte precursor cells: 61.3"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.5;naive CD8 T-cell: 30.9"	"Lineage enriched"	"Detected in single"	70	"T-cells: 32.5"	"Cell line enhanced"	"Detected in some"		"AF22: 24.7;BJ: 14.7;BJ hTERT+: 31.0;GAMG: 15.6;SH-SY5Y: 43.9;SuSa: 13.6;T-47d: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA043820: AB_2678687, HPA046792: AB_2679810"	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.2	23.2	11.9	1.2	12.8	0.6	1.7	10.4	14.7	2.5	4.3	0.9	0.4	0.5	2.3	1.3	0.7	1.0	8.0	11.9	10.4	0.4	2.2	7.5	3.0	6.8	8.5	6.3	0.9	0.2	3.0	5.8	8.6	2.6	1.0	6.3	1.2	4.9	4.1	0.3	1.4	0.4	7.7	1.4	0.4	14.9	13.2	10.5	19.6	0.5	3.6	0.8	0.9	8.9	0.0	0.1	24.7	3.1	11.2	4.8	0.1	14.7	31.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	15.6	0.1	1.5	0.0	3.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	0.1	0.0	0.1	0.1	6.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.0	43.9	0.0	0.0	0.0	13.6	24.3	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	2.7	2.0	0.0	0.1	32.5	30.9	0.2	0.0	0.1	0.0	0.4	6.1	11.9	12.8	10.4	14.7	11.9	10.4	6.8	8.5	8.6	7.7	13.2	8.9	0.8	0.0	4.3	47.0	0.8	0.0	0.0	0.0	0.0	29.2	0.6	0.8	24.8	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.1	0.3	0.5	1.2	1.8	0.0	81.2	0.0	0.5	13.3	1.5	0.5	1.3	0.0	1.1	0.0	0.8	3.3	46.5	0.0	0.0	0.0	0.4	4.4	56.2	0.2	1.8	7.5	0.8	11.0	1.0	61.3	7.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	3.8	0.0	1.6	1.7	1.1	0.4	0.0	0.1	0.4	10.3	0.5	0.0	0.2
LRRN4CL		ENSG00000177363	"LRRN4 C-terminal like"	Q8ND94	11	62686406-62689530	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 62.1;Leydig cells: 27.1;Melanocytes: 33.8;Peritubular cells: 17.3;Skeletal myocytes: 33.0"	"Cancer enriched"	"Detected in many"	5	"melanoma: 26.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.7;ASC TERT1: 25.3;HHSteC: 19.8;HSkMC: 10.6;LHCN-M2: 13.4"	"Low region specificity"	"Detected in many"							HPA050317	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA050317: AB_2681084"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.95e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-7)"	"unprognostic (2.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-2)"	23.3	6.6	0.4	2.5	0.4	0.5	16.0	1.5	1.3	22.4	2.6	15.1	1.8	29.7	3.7	4.5	18.2	3.6	7.2	0.6	0.6	1.0	0.1	3.5	0.5	0.5	0.3	21.0	1.1	0.3	1.7	0.7	0.4	6.1	2.1	0.4	5.5	5.8	4.8	10.6	7.2	9.1	0.2	0.2	8.2	1.5	0.5	0.4	4.2	5.6	0.3	9.7	16.1	0.7	0.0	0.1	0.2	0.3	7.7	25.3	0.3	2.8	4.0	0.3	1.4	0.2	0.1	0.2	0.3	4.6	0.1	0.3	0.1	0.0	0.4	0.2	0.2	0.5	0.2	0.2	19.8	0.2	0.2	10.6	0.1	0.6	0.0	0.2	0.1	0.4	0.3	0.1	13.4	0.1	0.3	0.6	0.6	0.1	0.1	0.1	1.7	0.3	0.0	0.2	0.8	0.3	0.4	0.3	0.8	0.1	0.2	0.3	0.3	2.4	0.2	2.7	0.1	0.2	0.2	0.3	1.5	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.0	0.4	0.4	1.5	1.3	0.6	0.6	0.5	0.3	0.4	0.2	0.5	0.7	4.0	0.0	1.8	0.0	0.1	6.6	2.1	0.0	0.0	2.1	0.5	0.8	1.5	0.0	0.6	0.0	2.1	0.1	0.2	0.0	0.0	0.0	1.0	0.5	11.0	3.7	1.2	0.0	0.1	0.0	0.2	62.1	0.5	0.4	1.3	0.2	1.4	0.1	0.4	1.7	0.3	0.3	0.0	0.6	8.3	0.5	27.1	1.1	33.8	1.9	0.1	0.2	1.0	0.0	0.1	0.0	0.1	17.3	0.4	1.4	0.1	0.3	0.0	1.0	0.0	33.0	2.8	0.4	0.3	0.5	7.0	0.1	1.1	1.2	0.1	1.3
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 1.9;lymphoid tissue: 5.6;testis: 4.2"	"Group enriched"	"Detected in some"	4	"B-cells: 13.7;T-cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;MOLT-4: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"	NA	NA	8150			"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA007729: AB_1852906"	"unprognostic (3.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.99e-5)"	"unprognostic (3.22e-1)"	"unprognostic (5.13e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.72e-12)"	"unprognostic (2.59e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-1)"	0.2	0.0	0.1	0.6	0.1	0.8	0.1	0.2	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.4	2.4	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	1.9	0.0	0.1	5.6	0.1	4.2	0.1	0.0	0.2	0.0	2.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.0	1.1	2.3	13.7	0.1	0.1	0.0	0.6	0.6	0.5	1.3	2.5	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	1.9	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.4	0.4	0.0	0.3	0.0	1.0	0.4	0.0	1.0	2.5	2.4	0.1	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.3	1.8	0.5	0.5	0.4	0.0	14.5	0.1	0.0	0.0
LTBP4	"FLJ46318, FLJ90018, LTBP-4, LTBP-4L"	ENSG00000090006	"Latent transforming growth factor beta binding protein 4"	Q8N2S1	19	40592883-40629818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 327.1;Leydig cells: 972.3;Peritubular cells: 624.4;Skeletal myocytes: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 120.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015194	Approved				"Secreted to extracellular matrix"	NA	NA		9700000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"CAB015194: AB_2139064"	"unprognostic (3.29e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.41e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.83e-2)"	138.5	48.5	11.3	22.3	10.9	8.3	98.8	1.7	13.3	334.6	9.6	144.5	59.2	309.6	44.7	100.6	246.8	39.3	401.9	10.7	14.2	64.7	37.4	242.5	24.8	16.2	10.3	315.2	37.2	22.6	75.9	38.3	16.4	253.6	38.2	3.7	82.8	126.3	63.0	73.0	135.4	74.4	11.3	80.5	125.3	78.5	14.2	12.9	173.2	156.7	14.0	188.6	374.5	15.3	19.8	21.3	41.7	56.5	15.1	16.0	6.6	7.7	24.9	7.8	6.4	6.4	43.8	22.4	34.9	13.1	12.4	26.3	10.6	26.8	2.6	61.0	3.3	7.3	53.7	2.4	49.4	3.0	23.1	19.9	21.7	15.6	27.8	41.0	4.9	21.6	46.7	120.3	1.9	19.7	3.1	1.3	4.9	56.1	24.9	51.9	1.1	35.6	3.9	1.7	1.8	17.4	28.3	21.5	7.4	6.4	11.9	11.3	20.4	1.3	81.4	2.6	16.7	26.8	24.9	7.1	35.1	28.5	20.4	0.0	1.5	0.4	8.1	2.4	5.5	3.5	7.7	6.5	2.7	2.0	3.2	3.4	0.3	3.0	1.3	5.0	5.5	2.3	11.3	10.9	1.7	13.3	10.7	14.2	16.2	10.3	16.4	11.3	14.2	15.3	84.7	6.4	14.1	2.0	11.6	57.6	30.9	62.8	56.3	60.4	13.0	18.2	15.5	17.2	18.5	22.0	0.0	1.5	12.7	38.2	1.9	6.3	11.1	14.8	154.7	29.9	4.2	12.4	8.1	4.7	2.6	327.1	37.2	24.2	10.2	13.5	102.4	3.3	7.5	40.4	11.3	42.2	6.1	6.4	39.6	39.0	972.3	13.9	58.7	15.0	9.5	3.5	16.5	2.0	14.0	6.9	16.6	624.4	16.5	23.6	97.7	0.3	7.1	3.2	59.2	229.2	52.8	50.7	36.3	38.2	29.1	2.6	24.9	10.2	36.4	27.2
LVRN	"APQ, AQPEP, FLJ90650, TAQPEP"	ENSG00000172901	Laeverin	Q6Q4G3	5	115962454-116027619	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adipose tissue: 11.1;placenta: 21.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 29.3;Extravillous trophoblasts: 33.1;Late spermatids: 68.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"spinal cord: 2.5"	HPA053254	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"		"Cluster 50: Fibroblasts - ECM organization"			"HPA053254: AB_2682092"	"unprognostic (1.47e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-7)"	"unprognostic (1.05e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.31e-2)"	11.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	21.8	0.0	0.0	0.4	0.0	0.2	0.1	0.3	0.4	0.8	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	1.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	29.3	0.0	0.1	0.1	0.0	0.0	2.1	0.0	33.1	7.9	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	68.1	4.7	0.3	0.0	1.9	0.0	0.0	0.0	3.0	1.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.3	0.3	0.1	0.0	10.7	0.0	1.0	0.0	0.1
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 78.4"	"Group enriched"	"Detected in many"	9	"B-cells: 124.9;Hofbauer cells: 191.7;Kupffer cells: 199.1;Langerhans cells: 118.6;Macrophages: 149.8;Microglial cells: 105.9;monocytes: 155.6"	"Cancer enhanced"	"Detected in all"		"glioma: 22.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 426.6;myeloid DC: 426.1"	"Group enriched"	"Detected in all"	43	"B-cells: 335.1;dendritic cells: 426.1;monocytes: 426.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.5;NB-4: 44.7;RPMI-8226: 245.0;THP-1: 103.8;U-937: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	NA	NA		77000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	9.7	10.3	14.0	30.9	13.5	29.2	7.4	14.7	22.0	8.2	14.2	7.6	4.9	3.8	2.8	3.1	4.3	14.6	2.9	13.5	15.8	3.1	13.3	29.7	72.1	17.8	15.4	3.3	3.0	3.4	2.3	14.5	18.7	3.8	11.1	1.2	5.5	6.2	0.7	3.4	16.8	11.1	17.8	52.7	6.2	1.8	18.0	15.1	1.5	1.1	78.4	15.6	1.1	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	44.7	0.0	0.0	0.0	8.0	0.0	245.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	103.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	30.3	0.0	45.8	0.0	4.1	426.6	3.5	1.0	234.9	0.7	335.1	1.1	1.1	426.1	248.8	4.7	2.7	9.1	5.3	88.3	16.3	1.8	221.1	14.0	13.5	14.7	22.0	13.5	15.8	17.8	15.4	18.7	17.8	18.0	24.8	1.2	0.0	15.0	1.6	124.9	2.0	0.0	0.0	0.0	0.0	0.9	3.7	1.5	1.5	1.3	0.0	0.0	1.4	9.8	0.0	0.0	0.0	3.4	0.4	0.1	5.4	0.0	3.8	3.8	0.0	1.8	2.1	0.0	0.0	1.3	0.0	4.2	1.3	191.7	0.0	0.6	0.3	0.0	199.1	118.6	15.4	0.3	149.8	0.0	105.9	155.6	0.0	4.1	0.5	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.7	0.4	6.6	0.4	0.2	5.3	0.2	0.3	2.4	1.9	3.6	0.0	0.2	0.2
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 244.0;dendritic cells: 36.2;Melanocytes: 71.2;Plasma cells: 102.5;T-cells: 44.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.3;JURKAT: 14.1;Karpas-707: 28.0;U-266/70: 70.7;U-266/84: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050917	Approved		Approved	"Plasma membrane,Centriolar satellite"		NA	NA		43000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Centriolar satellite"	"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"	2.4	0.9	0.1	13.7	0.2	11.5	2.0	0.1	0.2	0.8	0.2	3.9	4.0	0.6	0.4	0.9	0.9	2.5	0.5	0.1	0.2	1.1	2.3	3.8	30.2	0.3	0.2	0.6	0.2	0.0	0.2	0.3	0.2	1.1	3.8	0.0	7.1	0.4	0.3	0.8	12.0	0.5	0.3	26.7	6.0	0.2	0.2	25.5	1.4	0.2	31.1	3.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	28.0	0.0	0.0	2.3	0.5	0.1	0.8	0.0	1.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	70.7	29.3	0.3	0.0	4.0	0.0	1.2	0.8	0.4	112.9	1.1	113.5	56.1	97.6	109.8	5.2	52.8	109.6	112.3	2.4	22.2	0.8	72.8	80.3	53.5	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.0	1.8	0.3	244.0	1.0	0.5	0.1	0.0	0.0	0.4	0.8	0.9	0.0	0.0	0.0	0.0	0.1	36.2	0.1	0.0	0.0	0.1	0.1	0.1	0.7	1.2	28.0	0.1	0.2	0.0	1.4	0.5	0.1	0.0	0.0	1.8	0.4	1.9	0.0	0.1	0.0	0.0	3.2	31.9	0.0	0.0	6.3	71.2	1.9	2.1	0.0	22.6	0.0	0.1	0.1	0.0	0.0	102.5	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.1	0.5	1.0	0.1	44.8	0.0	0.3	0.3
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 304.7;Spermatocytes: 191.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: AB_2683779"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	20.6	18.1	20.2	18.8	24.4	19.4	25.5	24.8	23.4	24.3	16.2	28.5	29.0	25.9	16.2	22.9	23.7	18.1	29.6	19.8	21.2	28.9	30.4	17.0	21.9	24.0	24.1	35.0	13.4	29.2	12.3	22.3	24.2	21.9	27.6	25.9	20.9	19.8	27.3	20.1	27.1	24.8	24.2	15.8	16.7	66.9	21.6	30.0	24.6	27.5	23.8	18.1	15.3	28.4	43.0	27.8	52.5	37.2	32.0	51.9	23.3	38.1	32.1	52.8	50.9	34.6	73.4	51.6	42.3	48.1	33.3	31.9	49.7	55.1	78.7	48.5	33.5	75.7	34.9	57.9	30.7	69.7	37.5	34.3	77.0	74.1	69.2	37.6	41.8	67.4	95.6	28.7	49.1	30.5	57.3	33.8	26.6	53.7	44.5	60.7	69.4	41.9	28.5	19.2	26.1	41.2	46.6	20.2	91.2	49.9	33.5	35.1	38.6	36.5	49.6	52.4	40.8	23.2	57.5	87.4	37.3	101.7	49.6	34.9	25.1	40.3	20.5	29.5	17.8	18.4	20.6	20.1	24.8	20.4	20.1	21.2	25.6	23.2	33.2	38.0	29.3	17.5	20.2	24.4	24.8	23.4	19.8	21.2	24.0	24.1	24.2	24.2	21.6	28.4	34.3	6.4	17.3	6.8	20.7	12.7	21.9	24.1	17.6	12.0	22.6	27.3	57.4	10.0	15.9	7.3	6.2	26.9	26.9	25.9	49.0	27.0	304.7	34.7	36.4	19.9	9.1	24.0	11.1	21.2	45.7	27.8	13.3	27.0	30.4	27.2	14.3	23.9	42.7	42.1	14.8	18.1	10.2	22.6	15.7	91.6	26.4	34.9	14.2	14.0	36.8	45.6	20.6	13.6	23.8	22.6	27.8	27.4	22.4	27.6	41.7	53.0	27.4	18.0	19.7	26.6	31.1	191.3	86.2	29.2	16.8	34.5	26.8	21.4	22.5	21.6
MALRD1	"bA265G8.2, C10orf112, Diet1"	ENSG00000204740	"MAM and LDL receptor class A domain containing 1"	Q5VYJ5	10	19048801-19790401	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"intestine: 31.1"	"Group enriched"	"Detected in some"	4	"Astrocytes: 37.9;Oligodendrocyte precursor cells: 76.4;Proximal enterocytes: 69.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9;stomach cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Karpas-707: 44.2"	"Not detected"	"Not detected"							"HPA035732, HPA038106, HPA046848"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837"	"unprognostic (9.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-4)"	0.5	0.7	1.9	0.2	1.9	0.4	0.6	1.0	1.6	0.7	1.3	0.5	30.6	0.6	2.2	0.2	0.2	0.4	1.4	1.8	2.1	1.5	0.1	0.9	0.1	1.5	1.7	1.2	0.1	0.0	1.5	0.4	1.5	0.6	0.1	0.3	0.1	0.3	0.6	0.2	31.1	0.4	1.7	0.2	0.3	2.1	1.9	1.9	0.5	0.1	0.0	0.6	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	44.2	0.0	4.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.9	1.9	1.0	1.6	1.8	2.1	1.5	1.7	1.5	1.7	1.9	1.5	0.0	0.0	1.8	37.9	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.8	1.3	0.0	1.9	0.1	7.9	0.1	0.3	0.1	0.0	4.2	11.6	0.0	0.8	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	11.0	9.5	0.0	0.0	0.3	1.8	0.0	0.0	0.0	5.6	0.0	1.4	0.0	76.4	4.9	0.0	13.8	0.7	0.0	0.2	69.3	0.2	0.0	0.0	0.0	0.1	0.2	9.0	4.1	0.1	0.1	0.3	0.0	1.9	9.7	0.0
MAMLD1	"CG1, CXorf6, F18"	ENSG00000013619	"Mastermind like domain containing 1"	Q13495	X	150361422-150514178	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 33.0;Excitatory neurons: 27.5;Leydig cells: 33.8;Oligodendrocyte precursor cells: 81.4;Peritubular cells: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 23.3;U-2197: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003923	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA003923: AB_10602034"	"unprognostic (4.18e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (9.76e-3)"	4.7	2.6	4.9	1.4	5.6	1.6	3.4	0.1	4.6	4.2	0.0	3.1	0.9	5.3	2.2	1.7	5.0	2.4	2.0	4.3	9.3	1.9	1.7	4.8	1.6	1.8	1.3	12.9	3.1	2.0	4.3	1.7	4.4	3.1	1.1	2.9	1.8	6.6	4.5	1.8	1.3	3.1	1.0	1.4	1.9	10.3	11.1	0.8	1.1	1.9	1.0	3.7	2.3	0.1	7.3	2.9	3.8	7.6	10.9	4.1	0.0	6.8	14.3	10.3	23.3	0.0	0.4	0.0	3.4	16.3	8.1	0.2	4.2	3.2	14.0	10.4	0.3	0.1	8.8	0.2	8.1	0.4	0.0	5.6	0.6	11.7	1.4	5.2	2.2	0.6	0.2	0.0	9.9	1.4	0.0	0.1	0.7	0.0	5.4	0.5	14.7	0.4	1.7	0.1	0.9	0.8	2.4	0.2	3.8	0.9	0.2	0.1	2.8	5.5	6.9	36.8	12.2	0.4	0.5	0.2	15.2	2.9	7.6	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.4	0.3	0.0	0.2	0.3	0.7	0.1	0.1	0.0	0.0	0.5	0.2	4.9	5.6	0.1	4.6	4.3	9.3	1.8	1.3	4.4	1.0	11.1	0.1	3.3	0.0	0.5	33.0	0.4	3.4	0.9	1.2	0.0	1.5	1.9	0.9	1.9	5.7	0.2	0.0	10.4	0.0	0.1	0.0	1.9	3.2	1.1	1.4	5.2	5.5	3.6	3.2	27.5	2.5	0.0	4.8	0.0	3.3	0.0	5.4	4.6	4.8	0.5	13.5	18.3	0.6	0.0	0.8	20.5	4.6	33.8	2.3	3.6	11.2	0.6	2.2	0.0	81.4	5.0	2.2	0.1	24.0	0.3	3.1	0.0	0.4	0.1	0.6	6.6	2.8	3.4	0.3	0.4	0.2	4.1	0.0	1.9	8.3	0.0	0.4
MAMSTR	"FLJ36070, MASTR"	ENSG00000176909	"MEF2 activating motif and SAP domain containing transcriptional regulator"	Q6ZN01	19	48712725-48719725	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 32.4;skeletal muscle: 88.9;tongue: 22.6"	"Cell type enhanced"	"Detected in many"		"Theca cells: 10.1"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 7.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.2;RH-30: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049765			Approved	"Nuclear speckles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear speckles"		"HPA049765: AB_2680870"	"unprognostic (6.00e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.50e-3)"	"unprognostic (4.34e-4)"	"unprognostic (2.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.39e-2)"	4.6	32.4	1.7	0.8	2.0	0.3	1.8	7.9	3.7	6.2	0.0	2.5	0.6	8.0	1.4	3.5	8.0	1.0	4.0	2.0	0.2	2.4	0.4	1.4	0.6	0.6	0.8	8.7	1.9	3.0	3.8	1.6	0.9	2.4	0.7	0.5	2.9	1.9	88.9	2.1	1.2	4.6	0.2	6.1	1.6	9.2	0.6	0.5	1.2	22.6	0.6	2.0	4.6	1.2	0.5	1.3	1.4	3.5	2.7	4.5	1.3	4.8	3.8	2.3	3.6	1.4	0.9	0.7	0.2	4.4	1.3	1.0	0.1	0.8	0.9	0.5	1.6	0.3	0.6	7.2	1.4	0.1	0.9	2.8	0.9	3.2	0.4	3.1	0.8	1.3	0.3	0.9	1.5	0.6	1.1	0.5	0.1	1.1	1.0	1.3	16.6	0.4	0.2	0.3	1.5	2.8	0.7	0.3	0.3	0.3	0.5	0.0	0.3	4.7	0.8	3.8	0.6	1.0	0.6	0.5	1.7	0.5	0.9	0.0	0.2	0.5	1.6	0.4	1.0	1.3	1.7	1.6	0.4	2.1	1.6	1.5	0.2	0.3	0.4	1.3	0.8	0.3	1.7	2.0	7.9	3.7	2.0	0.2	0.6	0.8	0.9	0.2	0.6	1.2	2.4	0.0	0.0	2.6	1.3	0.9	1.8	1.5	4.6	1.8	1.4	2.2	2.9	0.0	2.3	1.8	2.1	0.8	0.5	0.6	5.9	1.7	0.8	0.8	3.5	3.8	0.0	1.3	2.9	1.0	2.9	4.9	1.1	1.6	0.0	6.1	4.6	0.3	1.1	0.0	2.0	0.7	2.0	0.3	2.2	1.7	5.6	1.6	7.2	0.0	1.2	5.3	2.1	1.5	1.2	0.5	0.0	6.0	1.5	0.6	1.1	0.6	0.4	2.9	0.0	5.1	4.7	0.7	1.6	2.4	0.9	1.0	1.8	10.1	0.8	1.6
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766610-43882450	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 317.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 120.6;granulocytes: 137.8;Hepatocytes: 221.1;Peritubular cells: 95.2;Proximal enterocytes: 178.8;Proximal tubular cells: 182.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 41.4;SiHa: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced					NA	NA		110000		"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (1.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.74e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.90e-3)"	78.0	51.1	99.3	6.5	102.8	0.1	45.7	89.1	117.7	32.3	83.5	46.5	73.5	119.4	55.0	31.4	98.0	17.3	97.8	93.9	149.1	124.2	317.6	33.0	6.1	143.8	134.2	155.4	10.9	15.6	25.9	11.2	125.9	82.9	16.5	13.9	78.5	155.5	114.6	9.9	79.0	103.3	115.8	2.4	23.7	9.0	145.2	3.8	5.6	65.1	7.1	28.3	25.4	115.8	0.0	1.0	0.1	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	5.4	4.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	8.1	41.4	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.4	4.0	0.0	0.1	1.1	78.2	0.0	0.5	0.6	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	99.3	102.8	89.1	117.7	93.9	149.1	143.8	134.2	125.9	115.8	145.2	115.8	5.9	0.0	4.1	53.5	0.4	5.5	0.4	1.2	1.8	1.4	3.5	22.4	120.6	52.9	1.9	5.5	4.2	0.4	0.0	10.2	62.6	20.1	0.4	26.4	81.6	10.3	0.0	2.7	36.9	2.8	0.5	17.0	16.3	6.0	137.8	69.6	7.5	221.1	1.5	15.2	7.6	6.4	12.2	4.3	3.6	2.1	46.0	1.8	7.2	9.4	0.0	27.2	0.0	11.6	1.3	7.9	7.8	95.2	0.3	0.6	178.8	182.6	11.8	1.0	13.1	2.6	18.4	0.3	0.4	2.3	4.0	0.4	5.5	0.5	10.5	0.5
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209565	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 431.3;retina: 154.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 717.2;Excitatory neurons: 571.8;Horizontal cells: 647.8;Rod photoreceptor cells: 562.1;Sertoli cells: 769.2;Smooth muscle cells: 461.2"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 301.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		180000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (8.22e-5)"	30.2	19.4	135.6	10.9	127.6	0.1	17.8	181.9	299.9	14.9	0.0	16.9	2.1	16.6	9.5	13.0	11.5	11.0	25.8	138.9	310.5	4.0	2.2	7.1	2.2	392.1	297.1	7.0	3.6	2.5	16.4	10.0	431.3	20.1	5.3	154.9	7.7	25.4	6.0	13.3	7.1	26.4	222.4	1.3	15.3	12.0	332.9	1.5	8.3	9.6	1.3	26.7	11.4	272.0	1.4	62.8	133.5	48.7	80.9	140.1	0.2	32.6	22.7	29.0	34.5	0.5	1.7	0.1	71.8	108.2	87.9	0.6	73.2	2.8	43.3	0.2	12.3	6.7	22.3	18.3	43.6	0.0	5.1	142.1	9.3	116.7	42.8	25.9	91.6	0.2	10.6	0.3	49.5	0.6	0.1	0.0	36.5	0.0	21.3	0.4	16.4	0.1	2.5	0.1	89.9	63.0	28.9	0.3	14.9	109.7	0.2	6.1	301.6	90.7	44.6	69.4	140.3	8.0	0.4	0.2	98.5	0.1	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	135.6	127.6	181.9	299.9	138.9	310.5	392.1	297.1	431.3	222.4	332.9	272.0	45.6	0.0	2.0	85.5	1.5	31.6	71.3	2.3	5.2	240.3	14.3	34.3	366.0	2.8	11.5	9.2	717.2	1.6	0.6	0.0	0.0	12.9	13.2	75.4	116.8	97.8	77.6	0.0	571.8	3.4	1.4	220.6	6.6	27.7	1.3	25.3	42.1	0.8	6.4	647.8	350.7	0.7	18.3	1.3	28.4	23.4	309.7	10.1	80.0	91.8	0.0	406.1	0.0	131.2	269.3	7.1	0.0	384.8	0.5	22.1	0.1	0.9	48.6	562.1	769.2	85.4	461.2	8.9	8.0	1.9	50.6	4.0	4.2	269.9	0.2	20.0
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 85.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.9;HHSteC: 53.7;HSkMC: 51.8;hTERT-RPE1: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	12.6	7.6	12.9	5.4	15.2	3.2	10.3	25.9	19.6	23.5	4.3	13.3	3.2	22.9	4.8	4.0	18.5	14.0	8.6	15.6	11.3	8.5	1.7	11.2	4.4	11.9	11.1	21.6	3.6	7.3	22.7	6.4	13.2	9.6	3.8	13.6	4.9	10.9	2.7	5.7	8.9	14.4	8.0	9.0	7.3	9.0	13.0	6.0	8.6	6.3	2.7	14.0	12.2	13.7	0.5	15.1	8.6	14.2	55.9	28.9	1.2	10.1	18.9	10.8	11.0	0.3	1.8	3.5	5.4	10.8	8.7	0.1	4.3	6.8	4.3	4.9	5.4	3.5	8.3	0.0	53.7	0.1	3.6	51.8	5.2	14.6	7.8	69.1	16.9	7.8	0.1	15.7	10.0	6.7	3.8	0.9	3.2	0.0	5.5	5.4	6.3	1.0	5.4	0.1	9.3	12.4	5.6	6.8	14.9	1.8	4.6	10.3	12.9	10.2	10.8	4.5	2.5	6.1	8.0	0.0	16.8	6.9	10.4	0.0	0.5	0.0	0.4	0.4	0.8	0.1	0.5	0.6	0.2	0.0	0.2	0.3	1.0	0.2	0.1	0.0	0.1	0.1	12.9	15.2	25.9	19.6	15.6	11.3	11.9	11.1	13.2	8.0	13.0	13.7	11.4	6.4	14.6	21.5	8.1	0.8	2.4	0.5	4.6	28.9	5.6	5.2	0.8	7.2	6.4	1.8	37.5	1.9	12.2	4.8	9.8	6.7	1.5	11.5	27.6	10.4	3.5	1.3	21.1	1.8	2.2	11.0	2.0	15.8	12.7	7.0	15.0	7.8	4.1	30.3	19.1	2.8	2.0	10.3	2.2	1.8	8.1	8.6	0.0	8.4	8.5	19.9	5.2	10.6	11.0	4.4	2.1	8.2	6.7	5.3	7.1	14.8	5.5	85.0	6.6	23.5	10.2	2.5	2.1	2.5	1.0	2.2	11.6	12.5	4.1	3.9
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21759657-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 341.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069, CAB079930, CAB079932, CAB079933"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		140000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nuclear speckles"	"CAB004229: AB_627547, CAB079930: , CAB079932: , CAB079933: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (9.41e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.49e-2)"	31.1	33.1	64.8	35.9	84.4	41.2	29.8	37.3	80.9	31.4	32.9	36.1	25.8	29.6	30.1	43.0	29.0	28.9	42.2	91.3	46.4	42.1	34.2	38.5	36.8	29.1	45.1	29.2	38.1	51.7	12.0	33.1	35.9	32.8	36.2	30.3	28.9	32.7	38.1	45.0	29.5	39.1	43.8	40.5	33.9	43.7	60.1	44.4	46.1	41.9	41.9	35.5	18.9	43.2	78.7	48.0	60.5	37.2	75.9	76.7	25.9	84.7	77.5	73.2	72.0	43.8	40.8	45.8	41.3	112.7	67.5	74.6	73.9	67.9	97.8	180.4	72.1	78.9	43.0	67.7	73.5	113.2	80.5	56.9	60.1	89.4	81.6	58.0	101.7	45.4	341.9	50.5	97.5	36.6	72.0	38.5	24.4	104.5	46.8	79.4	149.6	13.2	55.5	62.9	50.0	28.6	91.5	64.2	57.2	60.4	42.4	47.1	90.1	61.5	79.6	71.9	54.2	47.1	59.4	65.8	60.0	60.0	68.4	1.4	4.9	7.2	15.9	6.0	4.9	2.3	3.6	6.0	4.1	2.6	3.5	6.1	16.5	9.3	6.9	4.0	3.4	4.0	64.8	84.4	37.3	80.9	91.3	46.4	29.1	45.1	35.9	43.8	60.1	43.2	36.8	48.1	35.8	97.6	44.0	60.2	28.4	25.1	28.5	25.5	32.5	24.5	41.5	42.9	31.2	51.5	54.2	21.8	151.7	74.4	19.6	28.5	49.0	33.5	40.3	39.9	59.6	63.8	109.2	39.2	23.2	38.4	52.0	45.0	92.8	28.8	52.1	63.5	53.2	28.6	91.2	42.2	26.4	89.0	77.1	14.7	32.6	74.9	40.9	68.4	75.0	35.8	143.2	82.4	75.1	45.3	35.2	44.4	37.0	43.8	32.8	46.0	32.2	22.4	32.9	44.6	37.3	74.1	53.4	44.9	61.8	19.2	91.4	43.3	38.6	38.8
MAPK8IP1	"IB1, JIP-1, JIP1, PRKM8IP"	ENSG00000121653	"Mitogen-activated protein kinase 8 interacting protein 1"	Q9UQF2	11	45885651-45906465	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 166.8;pituitary gland: 118.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.8;Enteroendocrine cells: 40.2;Horizontal cells: 67.3;Late spermatids: 39.2;Muller glia cells: 41.3;Oligodendrocytes: 48.7"	"Cancer enhanced"	"Detected in all"		"glioma: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058921, HPA070332, HPA079657"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: "	"unprognostic (3.96e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.25e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (1.23e-11)"	"unprognostic (7.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.80e-3)"	4.8	23.3	127.9	2.3	131.0	1.3	4.8	122.0	147.7	8.2	29.6	8.3	1.4	10.9	3.5	2.2	11.3	3.5	5.5	166.8	120.6	11.5	5.6	4.0	0.6	154.9	130.9	9.1	43.1	19.2	118.2	1.4	142.6	11.6	1.2	11.5	11.4	6.1	2.4	4.0	3.7	5.7	124.6	2.3	9.0	27.7	139.3	1.0	7.0	2.5	0.4	6.7	4.8	164.4	0.0	7.1	9.4	26.2	3.4	1.8	0.3	5.1	4.6	9.9	7.2	6.3	1.1	0.4	2.5	5.9	16.8	5.8	10.2	4.8	4.4	4.0	13.1	0.1	8.6	4.1	3.1	0.6	4.4	2.4	1.0	6.4	1.3	6.6	2.2	0.9	11.5	1.6	2.8	3.9	0.4	0.6	24.9	3.3	10.5	0.6	15.4	0.3	4.6	0.2	76.4	28.5	8.4	6.8	10.0	3.6	11.0	0.4	2.1	12.5	19.1	19.0	9.3	1.1	1.3	0.5	7.9	0.2	3.8	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	127.9	131.0	122.0	147.7	166.8	120.6	154.9	130.9	142.6	124.6	139.3	164.4	1.7	6.4	4.1	7.2	0.9	2.4	5.8	2.0	2.8	34.4	6.1	5.3	1.1	5.7	3.3	11.0	22.9	1.6	0.4	2.2	13.7	6.9	43.8	23.9	15.9	2.9	40.2	0.0	10.3	28.9	0.6	6.5	4.1	19.9	0.0	2.8	0.4	4.6	0.5	67.3	11.6	1.6	4.1	0.8	3.5	39.2	6.2	1.1	3.6	1.0	1.6	41.3	0.0	3.5	48.7	11.6	0.5	6.4	0.1	6.3	1.4	8.9	10.9	18.3	0.0	14.2	6.0	10.6	8.2	0.9	1.0	5.7	1.3	7.7	0.9	5.5
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894527-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Alzheimer disease, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;skeletal muscle: 79.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.4;Bipolar cells: 314.4;Early spermatids: 199.9;Excitatory neurons: 189.2;Horizontal cells: 361.7;Inhibitory neurons: 153.7;Late spermatids: 416.6;Muller glia cells: 145.7;Oligodendrocytes: 163.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 9.5;glioma: 13.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"HDLM-2: 69.0;SCLC-21H: 21.1;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"	"Secreted to blood"	NA	NA		7100	"Cluster 35: T-regs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	4.7	4.3	26.2	0.3	27.1	0.0	9.1	8.3	67.7	2.4	0.0	8.4	0.5	1.0	0.2	8.4	1.0	0.8	9.4	30.0	20.4	14.7	0.6	0.8	0.3	11.6	11.4	0.6	1.5	2.9	29.5	3.4	22.4	5.4	0.3	17.6	8.5	3.4	79.0	6.3	1.8	0.3	2.7	0.4	1.7	20.3	14.8	0.4	0.9	27.4	0.2	10.2	2.3	19.7	2.9	0.5	0.3	6.4	0.3	0.9	1.8	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.6	0.4	0.5	0.1	2.3	0.3	0.0	69.0	3.4	0.0	0.3	4.2	0.0	0.1	0.1	0.0	0.5	0.1	0.3	0.1	0.0	4.4	0.7	3.6	0.0	7.7	1.0	0.2	0.2	0.7	2.0	0.0	4.0	8.5	0.0	9.1	21.1	9.1	2.5	0.0	1.8	1.0	34.7	0.1	0.1	0.3	0.8	1.7	0.3	0.9	0.3	0.0	0.6	2.0	0.5	0.1	0.0	0.0	0.2	0.7	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.3	0.2	0.1	1.7	0.0	0.7	0.0	26.2	27.1	8.3	67.7	30.0	20.4	11.6	11.4	22.4	2.7	14.8	19.7	1.9	0.0	9.8	142.4	1.0	1.0	1.4	0.2	1.2	314.4	26.7	21.2	35.2	0.0	0.1	1.8	64.6	0.2	0.4	0.1	7.9	0.5	199.9	0.4	1.7	1.8	0.0	0.0	189.2	0.4	9.1	3.7	0.5	1.3	4.5	1.6	1.1	0.5	0.3	361.7	153.7	0.0	2.0	0.6	1.7	416.6	2.8	0.8	5.4	8.4	0.7	145.7	0.0	129.7	163.8	0.6	0.0	2.6	0.1	2.5	0.1	76.1	0.0	28.3	0.0	28.2	6.0	18.4	8.1	22.7	3.3	0.3	1.5	0.8	0.3	0.6
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857345-113863475	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 12.7;neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 405.8;TIME: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	42.8	16.8	65.1	58.2	64.1	104.6	50.2	73.2	78.5	31.9	21.6	75.7	38.9	31.2	13.5	45.1	27.3	35.8	18.2	56.8	89.2	24.6	26.1	35.0	45.4	81.0	87.6	39.0	42.4	7.0	20.6	63.0	73.1	37.8	68.2	22.0	28.0	18.0	15.7	32.1	43.3	30.1	106.8	57.0	62.8	10.3	85.5	44.8	16.2	12.9	45.3	86.2	34.5	102.8	39.2	22.6	405.8	22.3	134.0	86.6	2.2	123.0	171.4	84.9	140.6	40.7	54.1	0.1	25.3	228.0	67.3	118.0	67.9	35.7	109.7	0.3	40.2	0.0	22.2	53.3	89.2	10.3	0.7	90.2	68.8	81.8	77.4	231.9	243.1	0.4	4.6	107.6	122.1	0.4	1.3	0.3	52.7	43.5	29.4	0.2	40.7	4.1	26.9	73.6	56.4	163.4	78.7	39.6	89.6	95.0	2.1	11.3	326.0	78.3	0.5	129.9	212.7	288.3	22.4	11.4	60.2	55.8	153.4	0.0	3.9	0.0	0.0	12.7	0.0	4.6	0.0	0.0	1.1	1.9	0.0	0.0	18.7	0.0	7.5	0.0	0.0	0.5	65.1	64.1	73.2	78.5	56.8	89.2	81.0	87.6	73.1	106.8	85.5	102.8	211.2	9.6	15.5	44.7	139.0	504.1	540.7	232.3	275.4	157.0	213.2	176.7	16.6	57.2	115.0	38.6	29.2	7.2	5.5	629.5	37.2	144.3	55.7	111.2	444.0	271.6	336.3	2.5	33.0	229.9	11.2	372.6	135.1	130.4	2.5	526.1	236.0	8.8	371.6	84.1	21.0	369.4	126.1	286.3	605.5	35.7	120.5	381.3	273.9	60.0	447.2	315.5	2.1	194.5	9.7	208.1	223.1	67.0	105.2	380.1	89.9	6.9	145.0	37.7	39.5	89.8	222.8	22.7	16.2	326.3	638.5	29.4	22.3	62.3	352.3	620.2
MATN2		ENSG00000132561	"Matrilin 2"	O00339	8	97868840-98036724	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033879	Approved				"Secreted to extracellular matrix"	NA	NA		1500000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"CAB033879: AB_2141502"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (6.65e-2)"	54.4	51.0	24.3	30.2	22.5	1.8	43.6	17.6	23.2	194.4	19.3	67.5	58.5	147.0	101.6	32.8	46.9	40.1	110.2	20.0	23.4	39.3	24.6	15.2	18.0	24.1	30.5	116.4	11.3	28.0	9.9	177.9	26.3	104.9	57.8	45.7	42.6	171.9	4.0	62.8	80.6	98.1	18.3	5.9	23.7	31.2	23.4	4.9	271.4	28.5	15.4	103.0	139.2	30.8	24.1	10.8	23.3	2.5	60.7	3.6	15.0	72.5	17.6	78.6	106.7	13.0	8.4	0.1	7.0	29.2	3.5	114.4	2.3	4.4	100.6	0.0	2.9	0.8	6.1	0.9	14.0	0.0	0.0	13.6	9.5	16.1	0.8	22.1	0.5	1.3	0.1	0.2	4.1	11.2	0.0	0.7	7.1	0.3	3.7	0.0	2.4	11.4	5.7	5.3	16.0	1.5	11.5	0.2	19.8	67.3	10.9	1.4	0.6	5.2	31.5	16.1	11.0	0.9	0.2	0.2	18.8	0.4	5.9	0.0	0.1	0.1	0.2	0.4	5.2	0.0	0.7	0.9	0.8	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	24.3	22.5	17.6	23.2	20.0	23.4	24.1	30.5	26.3	18.3	23.4	30.8	27.8	3.2	1.3	11.1	0.3	37.3	10.1	6.2	80.2	6.3	3.8	45.8	29.1	18.6	3.0	16.5	54.2	1.2	0.2	20.6	0.0	9.9	86.0	4.2	22.6	32.4	23.4	3.2	6.4	0.0	1.1	113.1	5.1	5.0	0.0	43.5	201.0	11.0	1.6	0.0	11.5	25.4	0.0	5.0	7.7	108.6	103.5	0.9	28.4	19.7	2.0	8.1	0.0	86.0	59.8	3.2	18.2	258.8	0.0	6.5	118.7	3.4	1.6	52.9	13.1	97.2	17.1	2.5	2.6	7.3	8.5	2.5	2.0	297.5	27.4	1.8
MATN4		ENSG00000124159	"Matrilin 4"	O95460	20	45293445-45308529	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"pancreas: 24.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.4;Fibroblasts: 8.5;Langerhans cells: 6.3;Spermatogonia: 4.9;Suprabasal keratinocytes: 4.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;NB-4: 2.5;U-937: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		14000		"Cluster 25: Pancreas - Digestion"	"Cluster 24: NB-4 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.54e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.53e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.63e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-1)"	"unprognostic (5.38e-2)"	0.7	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	24.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.1	0.1	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	6.4	0.7	1.0	0.0	0.0	1.6	1.9	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.1	0.7	0.2	0.4	0.0	0.0	1.0	2.5	0.0	8.5	1.1	0.8	0.0	0.3	0.4	0.2	0.1	0.0	0.4	0.1	0.0	0.0	6.3	0.5	0.0	0.1	1.8	1.0	0.0	0.0	0.0	3.0	0.4	0.9	0.1	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.4	0.4	1.6	4.9	0.3	4.3	0.3	0.3	0.1	0.2	1.0
MBTPS1	"KIAA0091, PCSK8, S1P, SKI-1"	ENSG00000140943	"Membrane bound transcription factor peptidase, site 1"	Q14703	16	84053761-84116942	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056109	Supported					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA056109: AB_2683040"	"unprognostic (1.50e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	45.8	33.7	12.7	26.2	16.4	24.6	42.8	17.6	13.3	41.2	18.1	38.7	26.0	40.8	25.6	28.2	45.6	32.2	44.6	13.1	17.8	36.7	27.5	35.5	27.5	6.3	8.0	49.4	36.4	58.5	38.8	37.1	8.9	37.3	33.7	108.7	42.4	40.3	18.9	27.8	26.4	41.2	5.9	30.1	30.7	19.6	16.5	33.4	53.9	35.6	29.9	35.2	21.3	8.6	49.4	61.3	53.8	75.2	124.2	100.1	42.2	81.2	124.4	70.2	52.6	43.7	71.0	47.0	82.0	117.3	55.8	52.9	50.2	56.3	77.9	42.6	55.9	34.4	55.8	61.3	59.9	84.2	72.7	103.6	79.9	64.8	55.5	100.3	92.4	62.2	45.6	40.3	43.1	85.0	46.6	46.4	50.3	27.7	43.2	59.6	28.7	34.1	56.1	40.2	41.0	51.2	156.9	42.9	62.1	58.3	134.3	76.4	99.0	72.3	52.5	43.7	38.7	50.5	102.6	90.5	52.6	50.6	45.2	8.0	16.3	15.0	16.3	13.8	16.8	11.3	14.0	15.4	12.8	9.6	16.9	15.3	4.5	17.0	11.6	7.1	9.6	18.3	12.7	16.4	17.6	13.3	13.1	17.8	6.3	8.0	8.9	5.9	16.5	8.6	54.3	48.1	50.7	27.1	33.5	13.8	24.2	25.9	19.9	68.4	62.2	56.1	50.5	44.3	41.9	25.8	166.8	24.4	41.0	28.9	11.7	24.1	0.9	70.4	67.8	39.8	34.9	19.4	50.4	27.5	21.4	48.4	23.0	92.7	29.1	103.1	36.0	33.8	16.7	84.1	53.5	26.6	28.5	21.0	10.8	5.5	53.4	23.3	19.6	36.5	22.5	44.4	29.9	57.8	39.0	30.2	24.8	50.4	59.3	30.1	20.3	17.5	56.4	318.6	26.3	60.9	42.2	12.6	24.2	23.4	15.8	21.6	34.3	75.5	33.8	28.6
MCAM	"CD146, HEMCAM, MelCAM, METCAM, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 128.5;Endothelial cells: 153.5;Muller glia cells: 89.8;Sertoli cells: 322.1;Smooth muscle cells: 384.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 83.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HUVEC TERT2: 1121.0;TIME: 1107.4;WM-115: 869.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Approved	"Plasma membrane"		NA	NA		1900000000	"Cluster 13: T-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (8.75e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.79e-3)"	332.7	30.0	36.6	68.4	46.1	1.2	180.6	45.7	45.3	96.6	25.3	166.3	29.2	175.8	47.0	89.2	136.4	66.8	118.0	35.3	44.7	42.0	10.5	116.4	19.6	59.4	43.1	60.9	22.0	93.9	17.8	168.0	52.2	78.1	32.2	12.2	39.5	148.0	40.7	50.9	73.0	160.9	36.2	35.4	97.7	9.7	50.2	15.5	58.7	37.4	15.4	174.5	79.8	44.8	0.7	5.1	4.7	0.3	21.5	0.3	23.2	3.2	0.3	29.9	13.3	17.9	0.9	1.2	94.5	10.7	44.7	3.2	38.3	8.1	15.0	56.9	14.5	1.2	102.4	19.8	51.0	0.1	0.4	15.2	0.3	40.8	18.7	1.1	1121.0	7.1	38.7	1.5	6.1	0.0	1.2	9.3	19.9	0.2	4.4	0.9	147.8	32.9	27.1	0.0	12.5	3.9	87.1	2.1	249.2	46.2	4.3	0.9	1107.4	3.1	156.7	0.2	89.1	2.4	2.3	0.6	43.1	0.1	869.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	36.6	46.1	45.7	45.3	35.3	44.7	59.4	43.1	52.2	36.2	50.2	44.8	128.5	0.0	2.3	1.3	1.4	4.7	0.6	11.1	8.0	1.2	9.9	19.7	65.8	18.6	1.1	0.0	22.9	0.5	2.5	0.1	0.0	17.3	1.7	7.8	14.0	153.5	0.0	0.0	1.4	0.4	38.7	14.1	1.5	10.3	0.0	18.2	60.0	0.6	0.8	0.0	3.5	0.0	0.0	1.3	7.0	0.7	0.9	2.4	21.4	14.0	0.6	89.8	1.0	18.6	45.2	1.6	0.0	25.2	3.1	1.7	0.0	0.9	1.3	4.0	322.1	9.9	384.6	2.1	1.6	1.7	3.3	0.4	9.3	4.9	0.1	1.8
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.5;retina: 28.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 79.0;Cone photoreceptor cells: 221.0;Early spermatids: 92.9;Excitatory neurons: 177.2;Inhibitory neurons: 149.9;Oligodendrocyte precursor cells: 185.5;Oligodendrocytes: 69.1;Rod photoreceptor cells: 124.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.0;Karpas-707: 5.0;REH: 3.4"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947, HPA061485"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Centriolar satellite, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655, HPA061485: "	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.1	7.7	9.4	0.3	16.5	0.2	0.1	0.3	33.5	0.3	0.0	0.5	0.0	0.2	0.2	0.2	0.2	0.3	0.2	13.5	6.5	0.4	0.0	0.2	0.5	6.9	6.1	0.2	0.2	3.8	5.4	0.0	7.2	0.6	0.3	28.2	0.1	0.4	0.3	0.2	0.3	0.3	0.0	2.5	0.2	2.6	5.6	0.3	0.1	0.2	0.7	0.4	0.3	19.8	0.0	0.4	0.1	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.0	1.2	0.0	0.2	0.1	0.0	6.0	0.9	2.5	0.2	0.0	0.1	0.8	0.5	0.1	0.0	0.0	0.4	0.0	0.4	1.5	0.8	5.0	0.3	0.7	0.8	0.5	0.8	0.0	1.0	3.4	0.0	0.9	0.2	0.1	1.5	0.5	0.6	0.0	1.3	0.3	0.3	0.5	0.3	0.0	0.5	0.0	0.0	2.0	2.3	1.1	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	9.4	16.5	0.3	33.5	13.5	6.5	6.9	6.1	7.2	0.0	5.6	19.8	12.3	0.0	2.2	17.0	0.2	0.4	0.5	0.2	8.6	79.0	0.3	0.6	1.8	0.0	0.1	5.5	221.0	0.2	0.8	2.1	0.0	0.1	92.9	4.6	2.1	2.0	0.0	0.4	177.2	0.2	0.1	2.0	5.1	4.3	1.3	7.7	1.8	0.4	0.5	8.4	149.9	0.3	2.0	0.8	1.2	16.4	0.9	4.3	1.8	43.1	1.6	3.8	1.0	185.5	69.1	0.1	2.2	0.4	0.6	0.3	0.4	0.1	2.8	124.0	0.0	4.1	0.9	1.4	4.2	11.2	0.4	1.4	2.9	2.9	0.2	1.1
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.1;lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.3;dendritic cells: 43.6;Distal enterocytes: 31.4;Early spermatids: 53.1;Langerhans cells: 100.8;monocytes: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.7"	"Group enriched"	"Detected in many"	14	"B-cells: 10.3;dendritic cells: 29.7;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 21.9;HAP1: 14.7;HDLM-2: 26.9;HEK 293: 13.6;THP-1: 28.5;U-698: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019114	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	0.7	8.8	0.2	5.3	0.2	2.9	1.0	1.0	0.4	1.1	0.7	10.2	1.7	1.0	4.0	0.7	2.6	1.6	0.4	0.3	0.1	1.1	0.7	5.4	12.9	0.4	0.1	0.5	0.8	1.1	0.6	2.6	0.3	0.7	15.1	0.1	0.8	0.2	0.2	2.1	5.5	0.6	0.1	6.7	2.1	1.5	0.3	2.3	0.5	0.2	13.1	1.6	0.7	0.5	1.5	1.6	0.0	4.0	0.8	0.2	0.3	1.0	5.5	1.6	2.0	0.0	0.1	21.9	0.5	0.0	2.6	0.1	14.7	1.8	1.5	26.9	13.6	1.9	0.4	0.0	1.3	0.0	1.8	0.3	0.0	1.3	1.0	0.1	0.0	5.1	0.0	0.0	0.3	0.5	0.3	0.0	1.6	0.0	2.9	0.0	3.3	0.0	0.1	0.2	0.9	0.0	0.1	0.2	9.2	0.2	2.4	28.5	0.1	1.3	2.1	0.0	4.2	0.0	0.0	18.5	1.2	0.0	4.0	0.1	0.3	0.0	5.9	1.1	2.1	10.3	5.0	8.9	7.1	3.7	0.6	4.5	0.2	0.4	0.2	29.7	0.2	2.6	0.2	0.2	1.0	0.4	0.3	0.1	0.4	0.1	0.3	0.1	0.3	0.5	0.4	0.0	0.6	0.0	26.3	4.5	0.4	0.1	1.2	0.0	1.1	1.8	0.5	0.0	1.3	1.8	0.0	0.1	43.6	31.4	0.0	0.1	53.1	12.3	6.0	0.4	2.4	1.3	0.9	1.4	0.1	1.5	1.5	24.5	0.0	0.1	0.7	0.0	0.7	0.0	0.5	4.5	0.0	1.3	100.8	19.6	0.0	14.4	8.8	2.8	32.3	0.0	1.0	0.0	1.4	0.4	4.7	0.0	13.8	0.6	0.0	2.3	1.5	0.0	0.0	0.7	0.3	1.6	4.3	0.0	3.3	0.3	21.8	1.6	5.4	0.1
MCU	"C10orf42, CCDC109A, FLJ46135"	ENSG00000156026	"Mitochondrial calcium uniporter"	Q8NE86	10	72692131-72887694	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 53.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 68.3;Inhibitory neurons: 65.6;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016480	Approved		Supported	Mitochondria		No	No		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA016480: AB_2071893"	"unprognostic (2.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (1.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.48e-2)"	6.1	3.8	2.8	7.4	2.5	19.9	5.7	10.4	3.6	8.3	6.4	28.7	27.8	8.9	3.0	14.2	10.8	12.7	7.8	3.9	2.8	10.6	7.0	10.2	4.9	3.4	3.2	4.9	5.5	10.0	1.9	12.8	3.2	5.8	30.8	2.3	6.7	5.7	41.8	6.8	24.5	13.5	3.0	5.0	43.2	4.3	3.3	5.7	6.4	53.7	7.7	14.9	5.1	2.8	41.7	66.1	16.8	12.2	25.0	28.0	17.1	25.0	35.5	24.5	26.0	39.6	38.6	17.7	19.6	30.8	13.3	36.9	22.2	29.8	32.5	19.5	20.8	22.1	23.5	22.1	19.5	56.0	17.9	28.7	24.9	22.0	46.6	38.4	29.8	18.5	14.0	12.9	23.0	24.3	15.2	12.0	18.5	45.2	13.6	15.7	35.8	4.7	32.7	22.4	17.8	7.9	30.8	34.1	7.5	20.2	6.8	14.5	24.3	11.8	19.9	25.7	16.9	9.4	12.8	12.1	15.8	27.5	9.2	1.8	6.7	18.6	3.0	7.3	3.1	3.5	2.9	3.6	5.8	1.7	2.3	2.6	8.8	2.2	8.9	2.0	5.2	4.2	2.8	2.5	10.4	3.6	3.9	2.8	3.4	3.2	3.2	3.0	3.3	2.8	13.7	35.3	17.0	21.2	4.2	11.7	14.4	8.9	10.8	3.0	5.9	3.9	6.6	8.6	22.0	18.4	2.1	7.3	4.8	38.2	1.9	11.1	14.5	23.3	9.9	9.7	8.4	10.8	58.2	25.2	10.1	7.2	68.3	26.4	8.2	3.4	8.9	5.8	6.7	0.0	65.6	28.2	12.2	6.0	2.9	7.2	5.3	6.7	8.8	37.5	5.7	5.4	2.1	72.4	40.3	40.7	15.6	4.1	5.7	9.7	19.8	8.6	22.6	3.9	13.1	6.8	12.1	5.1	5.2	6.2	12.4	9.3	5.0	12.7	24.5	26.8
MDP1	"FN6Pase, MGC5987"	ENSG00000213920	"Magnesium dependent phosphatase 1"	Q86V88	14	24213943-24216070	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003064, HPA070338"	Uncertain		Approved	Nucleoplasm		NA	NA		29000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA003064: AB_10602350, HPA070338: AB_2686256"	"unprognostic (2.70e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-2)"	14.0	18.6	6.8	3.2	6.8	3.9	14.6	7.0	7.5	14.7	6.4	12.6	3.1	11.5	7.9	7.3	12.1	4.0	18.2	7.0	6.9	16.8	10.3	9.2	5.8	6.7	6.8	12.3	15.3	5.8	20.1	4.0	6.9	13.7	3.5	4.1	10.6	4.8	15.0	12.6	9.5	4.5	7.2	11.6	11.9	7.8	6.6	5.3	13.6	4.8	4.7	12.5	11.1	7.8	4.1	9.5	7.2	4.7	6.9	6.3	0.3	4.2	8.9	8.2	8.4	5.0	10.9	15.7	10.4	4.3	2.4	3.7	3.4	8.2	5.0	5.4	3.9	6.0	3.3	12.1	6.7	7.9	4.2	4.5	7.7	4.9	9.4	8.3	5.9	11.1	1.9	11.4	7.4	21.1	11.7	12.6	2.2	7.8	16.9	8.0	5.0	12.6	8.0	5.7	8.7	8.6	6.6	14.3	9.4	3.9	8.3	4.5	3.5	8.8	8.7	3.9	4.4	18.6	8.4	11.7	8.3	3.8	6.9	5.1	13.9	16.5	7.7	15.2	7.3	13.4	9.9	9.0	16.1	12.9	11.7	9.9	4.6	12.4	13.0	29.9	16.3	10.3	6.8	6.8	7.0	7.5	7.0	6.9	6.7	6.8	6.9	7.2	6.6	7.8	6.6	6.4	12.9	0.0	11.0	4.6	3.5	5.6	16.5	3.9	8.2	11.7	0.0	4.3	2.1	5.5	0.0	3.7	7.3	5.9	13.7	13.8	5.7	4.6	5.5	8.2	11.5	7.8	0.0	19.6	5.3	8.1	9.2	4.3	5.1	4.3	8.6	5.8	7.9	3.3	0.0	10.8	12.2	3.3	8.7	3.0	6.2	10.6	17.8	0.0	21.9	5.2	4.1	0.0	0.0	11.7	6.2	7.5	25.8	2.9	23.7	21.7	13.2	2.9	13.1	7.7	8.7	4.4	3.5	11.5	4.5	2.5	9.7	3.4	8.8	2.6
MED4	"DRIP36, HSPC126, TRAP36, VDRIP"	ENSG00000136146	"Mediator complex subunit 4"	Q9NPJ6	13	48053323-48095131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006232	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA006232: AB_1079351"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.79e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.34e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.84e-1)"	44.2	34.1	26.5	34.0	26.0	78.6	46.7	33.6	35.1	37.2	25.2	41.3	40.6	40.3	43.5	41.1	31.2	32.9	49.4	26.5	26.7	38.4	51.4	36.9	46.7	25.7	25.5	31.9	27.4	43.2	31.4	45.6	27.0	36.7	46.4	41.4	33.6	38.5	57.7	39.9	41.1	43.2	25.7	35.9	33.9	55.9	26.2	63.7	41.1	58.4	55.5	43.4	35.8	28.4	40.2	25.8	86.1	47.8	55.8	71.4	59.5	57.1	70.9	66.8	47.1	49.3	66.9	65.2	16.0	60.5	41.3	59.6	63.1	54.2	86.7	85.0	51.9	85.6	49.5	77.6	51.7	128.1	76.4	49.6	75.2	39.7	58.2	65.2	63.1	64.8	61.9	40.7	75.5	40.6	121.3	121.4	85.4	128.2	33.5	87.4	58.3	52.9	87.0	61.7	38.0	61.2	46.5	57.8	63.4	55.5	49.3	94.6	51.1	37.5	43.4	47.0	52.7	39.2	61.7	100.2	32.2	65.9	72.6	105.0	65.5	106.3	74.6	70.0	82.6	65.4	84.2	76.6	64.5	58.0	80.4	77.0	69.8	86.6	74.3	58.5	101.6	91.2	26.5	26.0	33.6	35.1	26.5	26.7	25.7	25.5	27.0	25.7	26.2	28.4	71.3	96.1	53.4	12.7	71.1	91.3	72.8	164.9	34.7	51.5	48.1	42.9	100.8	60.1	116.5	57.0	16.7	116.4	96.0	51.7	152.6	79.4	87.9	46.4	69.8	73.8	26.9	106.9	24.7	63.4	104.4	74.1	31.6	60.5	98.1	43.9	59.3	66.8	70.3	37.0	20.1	51.2	124.1	51.9	65.4	185.6	76.7	51.2	78.2	14.0	136.6	65.2	102.0	20.1	20.4	66.8	67.4	77.5	46.5	69.7	66.1	100.1	62.8	50.2	52.6	58.7	78.7	141.4	162.8	48.6	97.3	134.9	79.4	61.1	56.9	71.5
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.8	9.5	10.2	20.5	11.6	25.1	28.7	10.5	13.8	24.0	8.8	31.8	24.1	25.7	43.7	52.3	24.3	15.1	41.1	11.2	10.0	24.7	24.0	15.6	24.9	9.5	10.1	14.0	19.5	14.0	11.6	16.9	9.4	29.2	33.5	11.3	23.1	29.7	33.8	28.7	23.4	25.7	9.2	17.6	19.6	51.6	10.6	41.9	18.8	28.7	31.2	34.5	30.8	10.4	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	10.2	11.6	10.5	13.8	11.2	10.0	9.5	10.1	9.4	9.2	10.6	10.4	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
METTL24	"C6orf186, dJ71D21.2"	ENSG00000053328	"Methyltransferase like 24"	Q5JXM2	6	110245928-110358272	"Predicted secreted proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 14.2"	"Group enriched"	"Detected in some"	4	"Astrocytes: 30.0;Excitatory neurons: 23.8;Inhibitory neurons: 28.7;Late spermatids: 8.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	29	"T-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 1.0;SCLC-21H: 1.6;SuSa: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037441, HPA037442"	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA037441: AB_10670933, HPA037442: AB_10696931"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.78e-3)"	1.8	1.6	1.4	1.6	2.3	0.0	1.7	2.1	1.9	3.9	8.1	5.9	1.4	7.5	2.2	4.0	6.0	5.8	3.0	1.7	1.8	3.9	0.9	1.6	0.1	1.6	2.2	5.6	1.3	2.5	2.1	0.4	1.4	4.9	4.2	1.4	0.4	7.1	0.0	0.5	2.1	14.2	2.0	0.7	2.4	2.1	1.8	1.0	1.3	1.1	0.6	4.7	1.6	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.3	2.1	1.9	1.7	1.8	1.6	2.2	1.4	2.0	1.8	1.2	0.0	0.0	0.0	30.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.4	1.5	0.1	0.0	0.0	23.8	0.0	0.0	0.8	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.7	28.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	3.7	0.0	0.6	0.0	31.7	5.4	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.3	2.1	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0
METTL7A	DKFZP586A0522	ENSG00000185432	"Methyltransferase like 7A"	Q9H8H3	12	50923472-50932510	"Metabolic proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 440.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 986.4;Kupffer cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 95.7;classical monocyte: 35.7;eosinophil: 70.7;intermediate monocyte: 38.0;memory B-cell: 32.4;myeloid DC: 31.0;naive B-cell: 34.4;non-classical monocyte: 59.5;plasmacytoid DC: 25.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 420.7;Karpas-707: 401.7;RPMI-8226: 238.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA017434			Supported	"Lipid droplets"		NA	NA		18000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	"Lipid droplets"		"HPA017434: AB_1853835"	"unprognostic (2.31e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.48e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.64e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-2)"	143.6	86.7	59.6	35.2	71.9	15.2	54.6	66.1	53.6	43.9	67.7	67.7	62.8	42.9	29.7	39.1	89.1	79.6	28.1	48.4	66.9	144.9	440.5	60.1	49.4	79.6	79.1	90.7	115.6	48.1	17.3	25.4	69.0	28.5	63.3	15.5	60.7	41.6	64.6	26.1	60.5	62.0	61.9	53.6	87.4	19.3	68.8	29.7	243.2	53.2	50.2	50.7	35.4	68.0	1.5	0.2	8.4	61.3	420.7	115.0	130.0	1.1	8.9	1.0	1.5	4.7	5.2	69.7	5.2	4.6	1.0	8.2	6.1	6.9	0.3	7.1	15.4	17.0	11.1	43.2	88.0	4.5	33.7	118.0	0.9	0.9	0.5	2.1	26.9	2.5	10.1	401.7	3.9	0.0	3.3	19.8	44.6	1.6	0.0	3.7	0.5	238.2	20.3	79.1	21.9	37.3	1.5	41.0	1.0	11.5	114.4	4.1	17.1	1.0	1.2	4.8	0.5	18.7	3.7	30.3	7.8	8.4	0.5	95.7	35.7	70.7	2.4	38.0	1.5	32.4	1.0	2.2	31.0	34.4	0.3	1.6	2.1	10.3	59.5	25.3	9.4	17.7	59.6	71.9	66.1	53.6	48.4	66.9	79.6	79.1	69.0	61.9	68.8	68.0	73.5	201.9	125.6	96.0	47.2	8.7	53.4	41.8	30.1	2.9	37.4	26.7	14.1	240.2	72.5	71.7	0.0	76.7	19.9	159.0	43.0	11.9	2.2	64.2	48.1	43.5	67.9	131.8	4.1	37.3	29.6	83.0	75.4	28.4	32.9	16.5	140.7	986.4	37.3	8.4	5.1	64.4	30.5	308.8	23.1	10.6	216.6	73.2	12.4	45.0	59.8	114.2	29.9	43.2	10.6	3.5	59.3	149.0	65.7	30.2	134.6	145.6	263.1	5.3	52.6	57.3	42.2	1.6	1.4	28.3	9.2	38.3	12.9	52.7	74.8	46.2
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 414.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: AB_2682203, HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	63.6	100.6	41.9	31.1	52.7	118.7	54.5	39.5	53.2	62.9	53.1	45.2	28.3	46.3	70.5	67.8	42.4	32.9	42.0	44.9	41.7	140.8	16.5	49.2	36.1	44.7	43.4	48.6	39.7	68.1	44.7	36.8	40.3	45.6	31.1	38.6	49.8	28.0	77.4	51.5	39.2	33.1	47.1	54.7	44.3	11.0	46.5	56.9	52.7	52.9	44.1	49.5	57.5	48.2	50.8	41.8	95.3	77.0	99.5	156.2	36.1	85.7	103.8	58.8	68.5	30.4	79.9	92.4	64.8	132.6	53.3	33.0	61.1	71.4	71.2	70.5	72.0	41.1	34.1	120.6	75.1	35.8	81.0	111.6	76.6	54.3	81.1	119.4	111.4	97.8	61.8	57.6	112.3	60.2	93.7	71.2	87.6	60.8	64.0	124.8	80.8	82.7	116.3	44.5	61.8	116.0	66.1	53.1	195.0	65.6	44.5	16.7	75.0	96.9	43.9	62.2	49.5	72.8	102.8	71.4	107.6	80.8	66.3	111.0	75.7	33.4	11.4	14.3	13.5	18.3	19.0	21.1	42.5	20.6	20.4	16.2	36.1	17.0	12.0	14.3	20.4	28.8	41.9	52.7	39.5	53.2	44.9	41.7	44.7	43.4	40.3	47.1	46.5	48.2	82.4	19.2	26.1	32.3	66.9	71.8	89.5	143.8	51.2	52.6	77.7	61.7	53.6	34.3	81.3	86.5	45.9	79.4	94.3	49.6	281.8	119.5	7.8	56.4	68.9	89.2	84.9	146.9	48.2	122.9	124.2	67.6	42.8	64.7	47.7	70.0	98.6	11.2	95.8	45.4	37.8	80.4	101.7	181.7	103.3	6.3	63.3	124.2	104.9	40.3	270.1	92.9	109.2	34.2	28.3	114.9	51.5	65.1	58.0	149.4	81.1	414.2	50.4	43.7	65.7	48.9	108.8	17.1	25.1	74.7	77.0	139.1	111.4	57.4	80.5	142.9
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387190	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 903.5;Peritubular cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.0;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 394.8;ASC TERT1: 597.9;fHDF/TERT166: 284.0;HHSteC: 275.4;HSkMC: 417.8;MOLT-4: 375.8;SH-SY5Y: 350.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	271.8	81.9	6.5	74.0	10.0	2.7	197.7	7.0	9.5	326.1	13.1	287.5	102.0	237.3	289.0	293.2	227.5	646.2	273.2	6.1	8.3	61.4	45.6	634.7	65.7	7.7	9.0	325.8	71.3	7.0	87.5	156.7	6.6	226.7	139.1	17.3	108.1	129.8	41.6	144.7	187.6	262.7	6.9	59.8	176.1	31.8	8.1	42.4	114.5	249.7	78.6	488.8	244.6	6.9	0.3	0.7	0.6	0.1	394.8	597.9	0.8	44.8	160.0	4.6	3.2	0.2	0.0	0.2	0.1	284.0	0.1	0.2	0.1	0.0	0.8	0.3	1.2	0.0	0.3	0.0	275.4	14.4	0.2	417.8	0.0	2.6	0.1	4.7	0.0	3.9	0.1	0.0	0.4	0.0	375.8	33.8	7.1	0.1	0.4	26.4	24.9	0.7	0.0	0.2	35.8	350.2	0.4	0.2	0.3	2.4	0.4	82.4	0.2	50.9	3.3	2.3	0.1	0.4	0.5	0.1	48.9	15.4	0.1	0.0	0.1	1.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	6.5	10.0	7.0	9.5	6.1	8.3	7.7	9.0	6.6	6.9	8.1	6.9	35.1	3.2	12.1	0.0	0.3	47.5	0.7	0.2	5.7	0.7	2.3	4.2	10.7	0.0	3.1	1.8	0.0	7.2	1.3	0.0	0.0	0.2	0.7	0.3	21.4	15.9	0.0	0.0	0.0	0.0	3.6	903.5	6.1	0.4	1.3	0.1	15.4	0.2	9.4	0.0	0.0	0.0	0.0	0.0	62.9	6.3	78.3	3.9	67.6	14.0	0.0	80.2	0.0	0.5	0.1	0.1	0.0	240.0	2.6	2.2	0.0	0.0	2.9	3.3	19.7	38.6	103.1	0.4	0.5	8.8	41.1	19.4	6.9	0.2	0.0	2.2
MFGE8	"BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10"	ENSG00000140545	"Milk fat globule EGF and factor V/VIII domain containing"	Q08431	15	88898683-88913381	"Cancer-related genes, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 407.0;Cone photoreceptor cells: 385.7;Rod photoreceptor cells: 978.7;Sertoli cells: 1084.7;Smooth muscle cells: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.3;NK-cells: 7.7;T-cells: 14.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1784.6;ASC TERT1: 918.2;fHDF/TERT166: 660.4;HSkMC: 935.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002753, HPA002807"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	2830000		"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	Cytosol		"CAB002753: , HPA002807: AB_1078072"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (6.06e-9)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (4.85e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.41e-3)"	237.2	95.2	44.2	45.2	49.6	3.7	226.7	56.4	61.8	272.8	52.4	113.7	21.2	444.7	77.0	67.6	361.8	120.2	485.8	41.6	47.2	69.0	15.6	137.2	47.4	55.9	47.4	228.5	36.5	18.9	49.3	79.6	55.6	129.3	29.3	68.7	97.1	195.8	264.3	118.9	106.9	162.7	47.0	40.7	124.9	38.3	46.5	18.8	90.6	124.1	36.9	163.6	223.4	55.6	19.7	85.4	78.7	98.7	1784.6	918.2	6.9	482.7	142.4	95.4	110.3	90.5	23.5	0.0	147.5	660.4	144.6	10.2	27.6	95.8	31.1	82.3	64.7	138.1	4.6	10.2	469.8	0.2	50.1	935.7	251.8	73.5	122.5	205.3	37.0	35.3	23.4	41.1	185.1	6.2	22.6	3.2	405.4	8.3	38.4	22.7	74.4	26.4	32.6	7.3	8.2	42.9	28.0	2.5	226.1	165.6	2.4	11.1	42.0	233.2	127.8	62.3	36.3	145.3	30.5	15.9	31.6	12.2	91.5	5.3	0.2	0.4	1.3	0.0	4.2	1.2	4.2	2.9	0.0	0.9	4.3	3.3	0.0	7.7	0.1	0.1	14.9	2.1	44.2	49.6	56.4	61.8	41.6	47.2	55.9	47.4	55.6	47.0	46.5	55.6	72.1	12.8	5.4	39.2	4.0	48.7	32.2	116.3	24.5	22.1	407.0	190.4	92.8	8.6	25.5	3.7	385.7	4.5	13.1	1.6	0.0	15.7	11.0	33.3	202.2	66.9	44.8	3.8	5.1	4.3	18.6	220.0	12.8	29.7	5.1	30.1	22.1	15.5	8.1	16.8	0.4	6.4	36.7	32.9	39.7	27.9	187.0	12.9	119.2	15.0	1.8	75.9	9.2	5.5	9.6	28.3	0.2	109.1	8.8	15.8	0.1	0.2	8.3	978.7	1084.7	51.8	476.0	3.3	9.0	21.7	35.9	5.3	12.5	25.8	2.0	10.2
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604181	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	22.6	44.4	19.3	24.5	21.0	36.3	32.4	23.9	29.7	26.2	24.2	37.6	26.5	22.1	27.8	23.2	25.1	20.2	57.5	20.4	20.4	76.3	32.2	23.0	26.9	21.8	20.6	22.7	21.3	45.9	27.0	24.5	20.2	28.5	34.1	45.7	23.4	22.1	56.4	22.9	27.4	21.1	20.8	22.6	30.6	27.0	19.7	28.8	37.6	61.5	29.7	23.5	18.7	24.2	35.2	20.0	46.2	29.6	40.4	53.8	39.7	58.3	47.5	60.8	42.0	29.0	55.6	54.4	36.8	56.0	31.3	45.9	45.9	49.1	83.4	55.5	46.5	94.2	20.5	34.3	48.7	71.4	52.7	46.8	47.7	34.5	24.4	54.4	41.2	50.5	33.9	23.9	100.3	30.8	47.9	68.1	31.5	123.2	30.3	51.9	117.2	36.6	121.3	28.6	36.9	28.6	39.8	46.4	39.6	40.2	45.3	66.7	51.1	26.4	23.6	54.1	48.9	17.7	24.8	39.6	26.1	59.0	66.8	34.0	24.8	35.1	30.6	30.5	28.0	42.1	26.9	30.9	27.3	24.4	23.7	30.2	23.3	30.2	25.6	25.1	40.3	23.9	19.3	21.0	23.9	29.7	20.4	20.4	21.8	20.6	20.2	20.8	19.7	24.2	22.0	38.5	26.8	70.2	51.3	30.0	39.8	51.9	26.2	27.1	24.0	17.8	74.5	30.0	46.8	51.5	22.9	60.7	31.8	52.2	144.8	43.3	40.7	39.7	28.4	24.3	30.5	65.2	126.1	27.2	42.6	32.0	27.0	28.7	24.7	26.5	17.9	24.0	36.5	42.1	142.5	25.7	57.0	28.8	22.1	16.2	33.8	28.5	48.0	55.3	43.1	63.9	43.3	77.9	121.7	36.9	51.7	36.1	29.3	27.8	31.3	108.4	56.0	49.0	59.2	37.6	30.7	86.9	48.5	23.0	25.6	70.3	45.5	47.4	34.2	30.0
MIGA1	"FAM73A, FLJ35093"	ENSG00000180488	"Mitoguardin 1"	Q8NAN2	1	77779624-77879539	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.2;Alveolar cells type 1: 35.3;Breast glandular cells: 28.1;Glandular and luminal cells: 29.1;Proximal tubular cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017589	Approved		Supported	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA017589: AB_1848409"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.31e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.75e-2)"	8.8	7.9	6.0	5.4	10.3	6.8	14.2	8.2	9.1	7.2	0.0	6.2	7.3	8.8	5.2	6.3	6.5	7.7	6.5	6.7	9.3	14.9	8.5	6.1	5.3	10.8	9.0	9.0	6.1	18.9	3.4	7.7	11.0	9.6	5.7	5.6	9.2	6.6	7.1	4.6	8.1	7.4	9.5	5.9	7.5	5.2	8.5	4.5	16.5	9.4	4.2	6.0	3.6	19.3	11.8	7.5	4.6	5.9	11.1	14.3	12.1	16.7	7.8	9.6	9.8	7.7	8.0	5.1	18.0	11.5	11.6	7.9	6.3	9.9	18.0	7.4	6.4	6.0	8.9	3.9	11.4	5.6	4.5	10.4	10.5	19.7	14.2	13.8	9.8	4.5	3.4	6.7	14.8	1.9	5.5	3.2	3.9	5.8	9.2	2.9	11.3	2.6	11.6	12.5	9.2	7.4	7.7	11.4	21.8	7.6	4.4	3.6	15.8	13.7	6.3	20.9	17.6	4.0	6.0	3.2	12.1	4.8	6.0	3.7	2.2	2.7	2.1	2.7	2.2	1.7	1.6	1.7	1.5	2.1	2.4	2.1	1.2	2.4	1.7	1.1	1.7	1.2	6.0	10.3	8.2	9.1	6.7	9.3	10.8	9.0	11.0	9.5	8.5	19.3	33.2	35.3	26.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	28.1	20.6	0.0	0.0	10.5	23.9	0.0	17.0	16.5	0.0	5.9	16.4	0.0	15.6	27.0	9.9	0.0	0.0	0.0	14.7	14.0	12.9	0.0	29.1	12.6	18.8	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	18.9	0.0	0.0	5.5	0.0	0.0	31.2	8.7	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	13.3	7.5	16.2	0.0	0.0
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632163-1635263	"Enzymes, Predicted intracellular proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 29.9"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 90.5;Leydig cells: 98.2;NK-cells: 64.9;Peritubular cells: 177.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 11.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.4;NTERA-2: 2.7;PC-3: 1.9;U-266/70: 3.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 7.8"	"Low region specificity"	"Detected in some"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	7.1	2.8	0.4	0.3	0.5	1.3	4.1	0.1	1.0	16.7	0.0	5.0	1.9	15.4	0.0	2.8	11.0	2.9	15.0	0.3	0.0	3.2	3.3	14.3	1.1	0.4	0.0	29.9	1.6	0.0	5.7	2.8	0.1	11.8	0.1	0.1	1.0	1.1	0.5	3.1	3.4	1.2	0.0	3.0	4.3	5.2	0.1	0.0	2.4	0.0	0.1	11.9	10.9	0.2	0.6	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.4	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.5	0.2	1.2	4.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.4	0.0	0.2	2.7	0.0	1.9	0.9	0.0	1.1	0.0	0.0	0.4	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.3	0.0	3.9	0.2	1.1	0.0	0.2	0.1	0.0	0.2	0.0	1.5	0.0	0.9	0.0	0.3	1.0	0.0	0.1	0.0	0.7	0.1	2.2	0.1	11.3	0.3	1.7	0.4	0.5	0.1	1.0	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.2	2.2	0.0	0.5	1.0	1.1	13.4	0.8	0.7	0.6	1.3	1.7	1.5	9.6	1.5	0.4	1.8	0.0	4.0	27.4	3.0	0.0	1.2	1.0	4.0	3.5	2.2	3.0	2.7	0.3	0.5	2.2	90.5	4.6	1.0	0.0	1.4	12.1	1.0	5.7	3.3	0.6	1.9	4.1	1.0	18.5	6.2	98.2	1.3	19.6	0.0	1.2	0.5	64.9	0.0	0.2	4.3	0.9	177.9	4.3	0.5	2.7	1.0	0.5	7.7	0.0	0.7	5.3	2.1	10.5	0.7	15.8	10.3	8.1	2.1	1.7	0.9
MNS1	"FLJ11222, SPATA40"	ENSG00000138587	"Meiosis specific nuclear structural 1"	Q8NEH6	15	56421544-56465137	"Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.2;testis: 48.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 504.6;Endometrial ciliated cells: 256.5;Respiratory ciliated cells: 232.5;Spermatocytes: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039975, HPA040382"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear speckles"		"HPA039975: AB_10793858, HPA040382: AB_10794740"	"unprognostic (7.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.20e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.71e-2)"	1.9	1.4	2.6	1.6	2.4	4.6	3.1	10.1	2.9	3.5	12.3	1.9	2.3	3.6	1.3	2.7	21.2	3.3	2.5	2.2	2.4	10.5	1.9	3.4	1.3	7.2	6.8	4.0	2.4	0.6	3.5	1.6	5.1	2.3	2.0	4.7	2.0	1.7	1.0	1.4	2.1	1.3	6.1	1.4	2.2	48.2	2.7	5.6	2.9	1.1	1.2	1.3	2.5	3.9	32.1	7.4	3.8	11.3	3.1	6.7	0.7	7.6	4.4	8.8	18.6	10.5	15.0	17.8	9.4	3.2	12.8	12.3	4.7	4.4	17.9	0.0	1.9	22.9	8.8	1.8	1.1	7.9	2.4	2.7	0.2	17.9	2.6	3.7	1.6	6.8	5.2	0.0	7.6	4.2	0.3	9.8	1.2	16.4	4.3	15.0	22.6	0.2	8.7	6.1	29.5	8.9	12.7	3.8	13.6	0.9	9.1	12.1	0.7	12.0	13.6	11.6	18.8	3.6	11.9	0.3	13.4	18.3	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	10.1	2.9	2.2	2.4	7.2	6.8	5.1	6.1	2.7	3.9	0.7	0.0	4.7	1.0	0.8	3.3	8.8	9.3	1.8	10.5	4.7	8.3	6.0	4.3	28.3	35.0	25.0	1.8	0.2	3.7	11.7	10.9	504.6	256.5	7.8	2.0	1.2	3.0	4.9	1.9	3.9	14.0	5.1	7.2	0.0	11.0	6.8	0.4	7.0	15.2	3.7	4.5	10.2	1.0	5.5	60.8	12.8	2.0	0.0	0.0	0.8	12.4	0.0	1.5	2.8	1.2	0.1	8.6	0.5	3.0	0.3	12.3	232.5	32.6	0.0	21.6	6.5	249.6	25.0	7.1	1.4	0.5	1.0	6.4	6.0	3.5
MR1	HLALS	ENSG00000153029	"Major histocompatibility complex, class I-related"	Q95460	1	181033425-181061938	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048304			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"HPA048304: AB_2680347"	"unprognostic (6.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-2)"	8.6	9.6	3.2	14.2	3.3	11.1	9.7	2.2	3.5	10.2	5.8	6.7	7.4	9.5	9.6	9.6	10.4	12.7	6.2	3.1	3.8	9.9	10.6	18.0	14.6	4.7	3.3	13.6	3.7	14.0	8.9	13.5	3.7	10.9	8.1	1.5	5.9	10.5	2.1	8.7	6.9	12.5	3.8	12.3	8.7	2.6	4.4	20.2	16.7	3.8	15.2	16.3	7.4	4.8	7.9	5.4	0.1	4.6	32.2	38.8	13.9	15.5	42.2	12.7	21.5	2.2	31.9	9.7	31.6	28.1	9.9	20.5	0.7	18.3	11.1	29.6	5.2	14.2	5.6	9.8	10.8	11.5	40.6	25.2	49.6	18.9	20.3	23.7	1.3	17.8	26.7	25.6	24.9	8.8	12.1	8.3	0.1	0.1	0.8	13.7	0.3	27.3	13.9	23.1	0.2	0.3	8.2	14.8	10.9	6.0	15.4	24.6	8.1	12.5	1.7	21.8	7.7	42.2	15.3	17.9	11.7	14.7	1.2	32.6	21.8	22.9	16.3	27.4	14.6	14.3	14.6	14.6	18.8	18.3	10.8	16.2	14.7	19.0	23.6	10.2	17.0	15.2	3.2	3.3	2.2	3.5	3.1	3.8	4.7	3.3	3.7	3.8	4.4	4.8	4.4	19.2	32.4	8.8	14.7	5.0	8.3	32.6	12.0	0.8	7.7	6.1	4.1	8.6	20.9	14.7	0.0	17.5	15.9	1.6	5.9	10.8	0.3	5.9	12.1	4.9	2.4	11.4	3.1	6.4	9.5	12.8	2.6	7.3	17.1	13.5	3.6	8.9	25.8	0.0	1.7	2.7	32.6	25.2	9.1	0.4	10.8	25.3	7.2	11.2	30.8	4.1	26.8	0.0	0.5	7.5	4.5	12.0	9.1	7.4	2.2	2.4	15.3	0.6	0.0	8.6	9.2	0.4	1.6	10.9	5.4	24.5	15.7	22.4	3.5	13.4
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013382	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 171.2;intestine: 159.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8"	"Region enriched"	"Detected in many"	5	"cerebellum: 14.8"	"Region enhanced"	"Detected in some"		"spinal cord: 4.8"	HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	41.7	3.8	2.6	12.8	2.9	0.0	32.5	12.0	3.9	103.6	5.5	159.2	9.3	171.2	14.2	16.2	98.0	16.7	13.7	2.4	3.1	17.1	7.0	18.7	4.5	4.7	2.8	37.0	3.4	0.5	4.1	11.6	3.3	48.3	8.9	0.2	10.8	45.6	5.1	15.2	38.3	59.3	2.8	13.4	44.1	7.3	2.8	0.7	10.7	3.0	1.3	75.2	65.6	2.5	0.0	0.1	0.1	0.0	67.6	30.0	1.4	39.5	99.1	36.8	24.3	0.0	1.8	0.0	0.8	30.8	0.1	0.1	0.1	0.0	6.8	0.0	0.0	0.0	2.8	0.0	8.5	0.0	0.0	22.1	0.0	23.5	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.9	1.5	0.8	0.1	0.0	3.4	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.0	22.4	0.0	46.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	12.0	3.9	2.4	3.1	4.7	2.8	3.3	2.8	2.8	2.5	3.2	0.0	0.0	0.0	0.6	5.0	0.2	0.0	1.2	0.0	0.3	2.3	0.6	2.8	0.0	11.0	0.0	0.7	0.1	0.0	0.0	0.0	4.9	1.1	20.6	2.3	0.0	0.0	1.1	0.0	0.6	33.3	0.5	0.8	0.0	0.0	3.9	3.8	1.1	0.0	0.2	0.0	0.0	0.0	7.3	7.9	66.2	0.2	7.2	3.7	0.0	3.0	0.0	0.0	0.2	0.1	0.0	100.8	0.1	0.3	0.0	0.9	0.0	0.3	52.6	19.1	63.7	1.3	0.5	0.4	3.8	1.1	0.6	0.6	0.0	0.4
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 673.3"	"Cell type enriched"	"Detected in some"	35	"B-cells: 970.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 625.4;naive B-cell: 627.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 627.0"	"Group enriched"	"Detected in some"	26	"Daudi: 731.3;U-698: 364.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	3.6	0.4	0.0	149.7	0.0	19.1	0.8	0.0	0.1	0.5	0.1	9.0	3.0	2.2	1.0	4.2	0.5	8.4	1.8	0.0	0.1	3.4	2.1	4.0	500.4	0.2	0.0	0.3	0.2	7.3	0.3	0.9	0.1	5.1	10.6	0.0	8.9	0.3	0.8	0.1	123.5	1.2	0.1	253.8	18.4	1.2	0.1	50.6	6.7	0.1	673.3	16.3	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	731.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.5	0.2	0.0	0.1	0.0	364.1	0.0	0.2	0.0	0.8	0.5	0.3	2.4	0.1	3.7	625.4	2.8	5.5	0.5	627.0	0.5	2.1	2.0	6.5	0.6	0.5	0.8	32.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	3.8	0.0	970.5	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	4.5	0.7	0.1	0.3	0.0	7.0	0.0	0.0	0.1	1.8	2.0	0.1	2.5	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.0	0.6	0.3	2.0	0.0	4.6	7.2	0.0	2.5	0.0	2.1	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.1	0.8	0.1	0.0	27.3	0.7	0.2	0.0
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802636-21937651	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046915, CAB080036, CAB080037"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3000000	"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB080036: AB_11128130, CAB080037: AB_11129069, HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	5.9	6.5	4.1	5.4	4.8	5.8	8.5	4.2	5.7	7.8	7.6	6.7	4.8	8.8	7.1	8.8	7.1	4.9	7.0	3.8	4.0	6.9	10.9	5.8	6.3	5.0	4.5	12.1	6.6	8.4	2.8	8.9	5.1	7.2	8.0	3.9	6.5	7.0	4.5	7.0	5.9	9.0	4.0	7.3	7.2	2.9	5.4	6.8	7.2	5.4	7.3	10.1	7.4	6.0	30.4	1.0	23.0	19.0	19.4	19.0	28.3	42.3	21.0	21.9	24.3	21.7	14.6	15.3	13.4	21.1	16.3	15.2	24.4	59.5	36.8	0.3	19.8	0.3	56.8	28.8	18.6	24.5	26.3	23.5	0.1	38.6	42.6	24.4	22.6	0.5	0.3	20.1	21.9	3.1	26.8	0.7	27.5	14.7	35.2	0.4	18.0	26.0	18.3	0.4	14.4	15.3	14.4	17.1	21.1	17.9	10.9	0.6	23.8	0.3	15.7	0.2	34.4	13.7	25.5	30.0	0.2	24.3	12.0	1.2	5.6	0.2	3.6	4.5	6.1	5.9	5.3	4.2	6.9	8.4	4.6	4.2	0.7	6.7	2.9	6.3	3.2	2.7	4.1	4.8	4.2	5.7	3.8	4.0	5.0	4.5	5.1	4.0	5.4	6.0	18.8	22.4	19.8	26.1	16.3	14.1	58.4	22.4	16.5	0.0	20.2	23.9	22.4	24.3	27.9	14.7	0.0	52.3	11.4	6.8	15.6	38.6	77.9	28.8	28.5	14.9	9.6	19.1	14.8	28.0	80.0	18.7	15.3	40.6	10.8	30.0	17.5	22.2	27.1	0.0	9.1	14.3	30.5	25.5	11.1	14.8	14.9	15.1	10.6	48.7	15.0	0.0	10.3	40.7	32.9	41.5	6.8	14.7	13.7	45.0	9.2	19.5	19.1	0.0	13.1	20.6	23.1	1.3	13.9	35.1	13.1	22.6	15.1	33.0	20.7	62.9
MTMR11	CRA	ENSG00000014914	"Myotubularin related protein 11"	A4FU01	1	149928651-149936879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 139.2;Intestinal goblet cells: 79.2;Paneth cells: 98.9;Proximal enterocytes: 133.2;Undifferentiated cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.7;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.7;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 17.0;OE19: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030351, HPA072906"	Enhanced		Approved	Centrosome		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"HPA030351: AB_10602185, HPA072906: "	"unprognostic (1.14e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.12e-2)"	3.6	12.3	3.5	2.9	3.6	0.1	4.1	3.2	4.0	11.0	7.3	22.2	20.3	9.5	6.9	4.3	8.4	12.9	3.2	3.1	3.9	6.9	1.4	3.8	0.7	5.1	4.3	15.2	2.1	5.1	5.3	4.2	3.9	4.7	26.7	1.0	2.2	7.7	1.0	9.4	23.4	13.8	4.5	1.8	3.9	4.9	3.8	0.7	1.6	2.7	0.9	6.9	6.9	4.4	3.1	7.3	3.1	2.6	8.6	10.1	6.6	3.1	10.0	4.0	4.9	0.2	12.9	0.0	6.7	10.6	4.9	4.3	0.3	5.2	2.4	0.2	0.1	0.0	2.3	0.9	2.2	0.0	0.2	6.3	1.7	4.1	6.8	17.0	4.8	0.1	0.2	0.3	7.8	9.9	0.0	0.1	0.7	20.5	2.9	0.0	1.0	0.1	5.8	0.9	0.2	0.2	1.7	2.9	1.1	2.0	3.0	0.0	3.3	4.5	5.4	4.0	2.7	0.6	1.5	0.0	3.9	0.0	0.5	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	3.5	3.6	3.2	4.0	3.1	3.9	5.1	4.3	3.9	4.5	3.8	4.4	2.2	0.0	0.6	2.6	0.5	4.1	3.8	8.9	5.2	0.0	3.0	4.1	6.4	5.7	3.6	14.7	0.0	14.1	0.4	139.2	1.9	15.0	0.6	1.7	3.1	4.5	15.7	0.0	4.0	17.0	10.7	7.0	19.4	2.2	0.0	3.0	3.9	1.5	4.8	0.0	4.9	79.2	0.0	11.3	6.1	0.3	5.6	15.7	1.8	1.0	43.8	0.0	0.0	0.0	3.6	45.1	98.9	12.0	0.3	4.9	133.2	18.5	4.5	0.0	6.6	0.5	7.3	0.4	0.6	3.4	6.5	28.5	0.9	6.4	56.5	4.1
MTX2		ENSG00000128654	"Metaxin 2"	O75431	2	176269395-176338025	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 201.5;Spermatocytes: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031550, HPA031551, HPA031552"	Approved	Approved	Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoli	"HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616"	"unprognostic (2.61e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-2)"	20.4	37.4	31.8	15.2	33.6	9.2	27.0	32.8	46.7	22.1	35.9	31.2	22.8	18.7	39.3	38.1	28.9	14.5	49.8	33.3	34.4	46.4	30.8	15.6	14.2	33.9	32.0	21.1	26.3	48.1	29.5	25.8	33.2	26.4	35.5	47.3	20.4	22.6	74.4	23.4	20.2	25.7	34.0	15.6	24.4	64.3	33.5	18.2	20.4	70.9	20.8	25.1	24.7	35.6	52.2	31.0	60.8	37.8	40.0	45.9	58.3	54.5	52.0	49.8	58.3	53.1	55.8	66.4	91.4	49.1	79.9	34.5	67.1	67.6	67.9	66.6	49.4	63.9	39.1	94.9	62.7	98.9	20.7	51.1	83.5	52.2	89.1	60.3	72.0	64.3	86.8	50.2	59.6	47.4	34.9	102.9	58.3	101.8	45.5	0.0	44.0	60.8	142.4	93.3	87.0	74.4	45.7	60.9	120.7	116.4	33.7	64.0	63.5	49.2	43.5	52.1	57.9	55.4	62.1	79.8	61.1	49.7	60.8	8.0	9.3	4.1	9.6	15.8	13.1	18.9	12.4	11.1	14.8	13.7	14.9	15.4	0.0	19.6	14.4	12.1	16.9	9.9	31.8	33.6	32.8	46.7	33.3	34.4	33.9	32.0	33.2	34.0	33.5	35.6	34.4	19.2	22.6	50.6	20.8	31.1	36.2	130.9	37.5	0.0	38.2	43.8	69.2	31.5	63.6	57.0	0.0	78.8	11.1	38.8	201.5	51.8	22.3	60.9	25.7	31.4	41.5	19.5	106.0	39.5	63.3	30.2	28.1	33.9	43.1	25.7	16.4	33.7	47.8	0.0	106.3	47.7	103.7	21.7	15.7	18.8	35.4	19.6	35.6	43.1	26.1	0.0	12.3	93.5	180.2	49.8	26.1	32.7	23.1	48.2	39.6	106.3	63.8	0.0	39.5	24.9	52.4	247.8	127.1	56.5	41.9	65.0	18.8	55.8	52.6	53.7
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 7.2;cervix: 15.9;fallopian tube: 5.9;salivary gland: 6.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 40.3;Club cells: 81.8;Endometrial ciliated cells: 74.3;Glandular and luminal cells: 157.8;Ionocytes: 99.7;Respiratory ciliated cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"ovarian cancer: 21.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 23.3;HeLa: 45.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"	NA	NA		25000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.9	0.0	0.0	0.0	2.1	0.0	0.3	5.9	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	6.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.6	2.8	0.0	0.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.3	0.1	40.3	0.0	0.0	4.1	0.9	3.4	1.5	81.8	0.0	0.0	2.1	0.2	0.0	0.0	0.2	14.3	74.3	14.8	1.2	0.0	0.0	0.4	0.0	0.4	1.0	0.0	157.8	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	99.7	0.3	0.0	16.4	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	197.4	0.0	0.0	0.0	8.6	0.3	0.2	0.0	0.3	3.3	0.6	0.0	0.0	0.7
MUSTN1	Mustang	ENSG00000272573	"Musculoskeletal, embryonic nuclear protein 1"	Q8IVN3	3	52833114-52835019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 1689.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.3;Skeletal myocytes: 1.0;Smooth muscle cells: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.7;Hep G2: 8.0;HSkMC: 4.8;RH-30: 4.4"															NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.79e-2)"	"unprognostic (3.73e-2)"			"unprognostic (4.11e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.88e-2)"	86.1	10.1	107.0	9.3	118.7	6.5	46.4	106.9	177.9	89.1	105.7	27.2	8.4	44.6	49.0	44.9	52.1	42.5	142.5	104.2	105.8	17.5	12.5	31.0	5.4	107.2	107.4	37.6	6.6	1.6	12.1	4.5	110.3	43.8	21.2	0.8	26.3	59.3	1689.2	28.7	26.7	30.6	99.9	10.9	22.1	4.3	118.5	5.7	31.1	305.6	3.9	54.5	65.7	105.1	0.0	0.0	4.7	0.0	0.5	2.1	1.9	0.0	0.5	0.2	0.5	0.0	0.5	0.0	0.0	1.4	0.2	0.4	0.6	1.3	0.4	0.1	0.5	0.0	1.4	8.0	0.3	1.0	0.4	4.8	1.0	0.6	0.7	0.9	1.2	0.9	0.0	0.0	0.3	0.1	0.4	1.6	0.1	0.6	1.0	0.3	4.4	0.0	0.9	0.0	0.2	0.3	0.3	0.4	0.4	2.0	0.1	2.6	0.0	0.6	0.2	1.0	0.2	0.0	0.0	0.3	0.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	107.0	118.7	106.9	177.9	104.2	105.8	107.2	107.4	110.3	99.9	118.5	105.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 203.7;Muller glia cells: 365.7;Rod photoreceptor cells: 163.8;Theca cells: 218.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 663.8"									"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	189.2	244.3	111.9	53.4	175.1	13.5	133.5	114.5	136.5	149.4	263.7	310.7	37.5	268.3	208.8	157.0	181.0	103.6	526.4	123.4	118.4	83.0	29.9	124.9	31.8	130.3	122.7	185.4	90.3	235.7	48.8	102.8	125.3	154.3	76.1	514.6	62.0	314.8	68.8	73.0	89.4	284.4	122.1	149.7	124.0	115.7	115.4	44.6	272.1	75.9	33.3	250.5	123.1	120.4	19.1	56.1	82.4	155.3	424.0	384.4	41.0	263.8	212.8	188.8	182.8	75.1	2.9	0.5	116.8	368.0	196.8	75.7	92.5	146.5	306.4	1.4	91.7	48.7	39.2	126.8	258.4	22.9	5.9	241.1	171.2	219.3	178.7	421.8	282.0	12.3	35.2	1.2	440.8	5.3	2.9	15.9	26.5	30.0	156.7	43.2	322.2	16.5	153.1	4.8	28.8	207.3	78.5	1.0	152.6	231.6	51.5	29.3	348.5	422.7	90.1	174.3	282.6	24.5	4.9	1.4	663.8	9.9	62.5	1.3	2.8	0.5	4.0	0.8	3.1	2.3	2.1	4.5	2.1	0.4	1.3	2.9	1.1	5.4	0.3	2.4	0.5	3.4	111.9	175.1	114.5	136.5	123.4	118.4	130.3	122.7	125.3	122.1	115.4	120.4	128.3	16.0	14.6	8.5	2.0	10.3	27.0	15.0	13.6	142.0	9.4	42.5	117.3	2.8	10.3	31.3	95.9	1.4	62.6	1.3	1.9	25.5	3.5	48.7	203.7	56.1	6.7	0.8	19.3	4.1	8.1	97.2	2.0	63.9	2.5	64.7	52.5	4.2	3.5	111.0	27.9	7.5	10.2	5.0	13.3	12.4	101.2	7.4	14.2	10.3	1.3	365.7	6.2	15.1	8.9	6.5	0.3	143.3	11.0	21.2	1.6	8.1	10.2	163.8	13.1	132.1	83.6	2.3	10.7	6.0	8.8	0.8	19.7	218.5	1.5	21.1
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 149.5;Extravillous trophoblasts: 259.9;Fibroblasts: 183.3;Leydig cells: 176.1;Peritubular cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"naive CD8 T-cell: 6.4"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.0;BJ: 143.6;BJ hTERT+: 66.9;fHDF/TERT166: 71.9;HSkMC: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	103.6	11.7	2.9	8.2	2.5	0.6	70.0	1.1	2.9	100.4	1.7	58.2	6.3	117.2	2.6	17.6	57.4	19.4	42.8	4.0	2.4	26.4	7.4	53.9	2.5	5.9	4.5	81.9	8.7	1.1	21.7	11.6	2.6	39.0	1.7	0.8	32.4	11.4	16.6	41.6	29.5	6.4	2.3	26.4	28.9	14.7	3.2	0.6	46.6	5.0	0.8	52.8	59.3	3.0	4.1	0.8	1.2	1.0	16.5	46.0	42.3	143.6	66.9	16.6	19.9	8.0	3.3	1.7	0.6	71.9	0.1	3.0	1.0	0.0	3.2	3.2	1.3	1.2	3.1	12.8	43.4	0.2	1.6	54.8	0.0	6.2	0.0	32.4	0.0	0.9	17.3	1.4	21.5	0.4	0.4	0.5	14.0	0.3	4.7	0.6	0.3	0.4	0.0	0.7	3.2	8.9	0.5	1.4	0.1	10.4	11.1	0.7	1.3	0.7	23.1	21.8	0.6	3.3	0.3	0.2	5.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.2	2.9	2.5	1.1	2.9	4.0	2.4	5.9	4.5	2.6	2.3	3.2	3.0	22.2	3.2	0.0	7.5	0.5	10.7	1.1	0.7	2.2	0.7	7.0	47.9	3.5	0.0	0.0	9.2	0.0	9.5	1.1	0.0	0.0	5.7	1.7	4.3	149.5	5.1	0.0	0.0	0.3	0.0	259.9	183.3	2.6	3.7	0.0	0.5	6.4	0.1	9.3	0.0	0.4	0.0	0.0	0.0	19.7	11.4	176.1	1.7	10.6	6.5	0.7	50.7	0.0	0.0	0.1	1.1	0.0	183.6	1.4	0.6	0.0	1.4	0.0	1.5	13.1	65.8	74.7	0.7	5.4	1.3	10.5	29.4	2.2	0.8	0.0	0.3
MYADM		ENSG00000179820	"Myeloid associated differentiation marker"	Q96S97	19	53864763-53876435	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 207.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056301			Approved	"Nuclear speckles"		NA	NA		27000	"Cluster 52: Eosinophils - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA056301: "	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (7.71e-7)"	"unprognostic (2.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.14e-3)"	179.4	25.7	21.5	66.5	20.2	196.3	82.4	3.1	21.6	97.4	24.6	155.6	48.9	248.6	22.2	76.8	146.5	124.6	92.3	16.7	22.2	19.8	46.4	110.7	37.2	16.9	24.7	73.4	101.1	31.1	17.9	89.6	13.7	75.0	39.9	3.6	48.8	100.9	36.7	45.2	63.8	180.9	6.4	42.5	79.5	28.4	17.3	37.1	57.8	21.1	15.2	104.6	64.8	18.8	28.8	231.6	29.2	23.3	96.2	66.0	45.3	145.9	105.9	57.0	58.7	94.4	84.1	2.6	53.7	187.4	61.6	56.4	14.6	56.7	48.5	34.9	34.2	38.0	35.8	75.6	219.2	78.4	131.3	72.3	12.7	73.4	10.5	93.4	52.0	14.9	41.5	68.7	36.4	32.0	21.4	60.9	27.9	104.3	65.3	82.1	31.0	13.3	63.8	3.0	0.4	43.8	1.2	44.6	14.1	58.4	44.4	66.8	105.5	125.8	44.5	17.0	66.2	44.7	29.9	0.6	78.4	37.1	2.1	74.3	48.1	165.5	20.9	27.1	19.6	5.4	13.4	15.2	59.5	7.1	12.5	11.0	207.4	17.8	23.5	22.3	5.4	20.0	21.5	20.2	3.1	21.6	16.7	22.2	16.9	24.7	13.7	6.4	17.3	18.8	125.9	163.5	59.1	2.9	138.9	103.0	173.3	73.1	96.8	4.1	141.0	105.8	67.1	97.2	91.5	20.2	4.2	46.2	143.3	43.8	0.0	106.6	2.7	97.0	164.1	117.2	202.4	35.7	9.1	51.8	243.9	279.7	83.1	195.5	347.6	27.0	182.8	18.5	73.5	10.1	8.3	203.9	24.4	120.4	217.2	2.2	90.1	180.3	60.5	11.2	68.0	4.0	19.6	7.1	13.9	71.4	54.7	116.6	189.9	56.6	2.7	0.5	57.0	1.4	151.2	340.1	199.0	35.9	14.5	19.7	59.8	49.5	221.5	20.5	93.8	75.0
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.3	0.5	1.6	5.3	1.7	35.2	20.1	0.0	0.7	1.6	0.4	25.3	10.9	1.0	0.1	3.0	8.4	0.9	0.1	0.3	0.2	0.1	0.4	2.0	6.3	0.9	1.0	0.0	0.3	3.6	0.0	0.4	0.6	1.4	26.5	0.3	0.6	0.9	0.1	3.0	9.4	1.4	0.2	1.2	2.0	0.7	0.3	66.1	0.1	0.0	7.0	1.1	1.3	0.1	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.6	1.7	0.0	0.7	0.3	0.2	0.9	1.0	0.6	0.2	0.3	0.1	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 11.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 127.3;NK-cells: 107.1;Plasma cells: 40.2;Spermatocytes: 35.8;T-cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.9;MAIT T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 82.5;BJ hTERT+ SV40 Large T+ RasG12V: 69.4;Daudi: 87.7;HBF TERT88: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008791	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	1.0	0.7	1.1	6.1	2.2	2.5	1.7	2.0	1.7	0.7	0.3	1.0	1.3	1.1	0.5	0.7	0.8	2.3	3.4	1.0	1.3	0.4	2.0	2.3	20.1	2.9	1.7	0.6	0.2	0.4	0.4	0.9	3.2	1.2	1.4	5.9	0.5	1.6	0.9	1.2	1.9	2.3	1.9	7.6	1.3	11.8	1.6	2.5	0.6	0.8	16.1	1.1	0.8	3.7	35.4	11.9	3.7	10.1	1.0	2.1	2.6	47.7	21.8	82.5	69.4	1.6	34.9	87.7	4.2	40.4	31.0	10.0	3.5	4.0	113.0	10.6	5.5	1.8	13.4	1.6	0.2	0.8	3.4	0.7	0.4	22.7	19.0	14.8	2.7	6.4	0.4	28.3	51.0	3.1	5.8	1.3	2.8	3.3	15.8	1.9	14.1	2.2	19.4	1.2	8.2	3.3	8.4	3.0	8.6	5.6	50.6	2.3	14.5	49.4	11.3	11.1	44.2	8.2	12.1	25.7	13.0	5.3	20.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	1.1	2.2	2.0	1.7	1.0	1.3	2.9	1.7	3.2	1.9	1.6	3.7	3.0	0.0	2.3	3.3	4.0	1.8	0.4	0.3	1.8	10.4	4.7	6.6	9.1	2.8	0.1	0.0	2.1	2.0	127.3	0.5	0.0	0.5	3.9	0.8	2.4	1.7	0.0	6.6	3.9	0.0	0.7	2.7	3.1	1.4	0.0	5.6	4.2	0.9	0.7	5.0	2.7	0.4	0.0	1.6	3.2	4.2	0.9	5.1	1.8	8.4	1.6	10.3	107.1	5.5	12.4	0.2	1.1	0.0	40.2	0.3	0.0	0.5	1.5	9.1	0.0	2.5	4.5	35.8	6.8	3.2	0.4	1.5	89.1	1.4	0.8	0.3
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520778-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 96.0;lung: 24.4;lymphoid tissue: 78.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 110.2;Kupffer cells: 235.4;Macrophages: 122.7;monocytes: 195.5;NK-cells: 616.9;T-cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 263.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.4;HL-60: 52.3;HMC-1: 87.9;NB-4: 210.2;THP-1: 154.3;U-937: 84.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055242, HPA056036"	Enhanced		Enhanced	Cytosol		NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA055242: AB_2682754, HPA056036: "	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	9.6	4.5	5.1	38.9	5.2	96.0	3.5	5.7	7.2	2.7	6.3	5.0	7.4	2.0	0.7	3.3	6.5	10.5	4.6	4.7	5.9	3.8	7.8	24.4	20.7	9.2	7.6	1.2	2.4	1.2	2.2	7.1	8.7	3.7	3.4	0.2	3.7	1.8	1.5	2.7	12.2	6.4	7.5	78.1	6.5	1.4	8.6	5.4	3.0	4.2	8.5	10.2	2.8	10.1	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	6.1	0.4	0.0	0.4	0.0	0.0	0.0	52.4	0.2	38.1	0.0	0.0	0.1	52.3	87.9	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.5	23.8	0.1	0.3	0.1	210.2	0.0	0.1	0.3	1.0	0.0	5.6	0.1	0.0	0.1	0.3	0.0	0.1	0.3	0.1	0.8	154.3	12.3	0.1	0.2	0.2	0.1	0.1	1.9	0.3	0.3	84.3	0.0	64.5	107.6	105.7	56.6	78.7	44.5	5.9	22.3	39.7	62.8	2.8	1.6	17.0	263.2	32.3	98.8	8.1	34.0	101.3	5.1	5.2	5.7	7.2	4.7	5.9	9.2	7.6	8.7	7.5	8.6	10.1	1.9	3.2	12.3	2.0	26.5	3.3	2.4	0.8	1.2	0.7	3.1	4.3	2.6	5.7	2.9	1.8	2.1	5.0	110.2	2.0	1.9	1.7	6.0	0.6	2.9	4.1	1.2	14.3	2.3	0.9	8.2	2.7	3.6	1.2	31.6	2.2	10.8	6.7	75.8	6.7	1.5	2.1	0.0	235.4	49.3	6.8	2.5	122.7	7.2	64.6	195.5	1.5	616.9	1.5	3.4	1.3	3.2	1.2	30.0	1.8	3.0	2.9	0.2	0.8	0.0	3.4	2.2	6.0	3.4	3.6	5.4	5.1	100.1	3.9	2.7	1.9
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979088	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.6;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.3;Langerhans cells: 65.1;Macrophages: 74.2;monocytes: 392.2;NK-cells: 252.4;T-cells: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.6;HEL: 64.1;HL-60: 39.9;JURKAT: 85.9;MOLT-4: 97.3;NB-4: 52.1;THP-1: 68.6;U-937: 57.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.2	0.8	0.4	16.6	0.3	43.6	1.0	0.3	0.6	0.8	0.3	2.0	3.3	0.7	0.3	1.5	1.2	3.5	0.9	0.3	1.0	0.9	1.3	12.0	25.1	1.4	0.7	0.3	0.7	0.1	0.5	1.2	0.6	1.1	1.8	0.0	2.3	0.7	0.3	0.9	7.8	2.8	0.6	19.0	3.3	0.4	1.6	27.2	1.6	0.4	14.8	6.1	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	52.6	0.0	64.1	2.7	0.0	0.0	39.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	97.3	52.1	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	57.3	0.0	41.5	58.3	18.5	61.5	95.5	38.4	27.7	40.5	55.6	42.7	18.9	14.1	29.6	6.0	23.9	129.8	4.5	79.9	79.9	0.4	0.3	0.3	0.6	0.3	1.0	1.4	0.7	0.6	0.6	1.6	0.8	0.9	3.2	7.7	0.0	55.7	2.8	0.4	0.0	0.0	0.2	1.2	1.3	1.1	1.5	1.3	0.0	0.0	0.2	81.3	0.2	0.0	0.3	0.6	0.3	0.5	1.0	0.0	6.3	0.1	1.1	0.3	2.3	2.0	0.6	30.4	0.4	2.2	1.4	10.5	3.3	0.0	0.2	0.0	58.7	65.1	1.6	0.0	74.2	3.6	0.0	392.2	0.3	252.4	0.5	0.0	0.2	0.1	0.4	33.4	0.4	0.0	0.6	0.7	0.2	6.6	2.0	1.4	3.8	1.2	0.2	1.7	0.1	87.1	1.2	0.1	0.2
MYOZ3	"CS-3, CS3, FATZ-3, FRP3"	ENSG00000164591	"Myozenin 3"	Q8TDC0	5	150660882-150679368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"skeletal muscle: 234.2;tongue: 198.4"	"Cell type enriched"	"Detected in some"	6	"Peritubular cells: 44.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;NTERA-2: 9.2;REH: 14.8;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039166	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 37: Myocytes - Muscle contraction"			"HPA039166: AB_10671871"	"unprognostic (2.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.77e-2)"	"unprognostic (9.19e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-3)"	"unprognostic (7.31e-9)"	"unprognostic (2.19e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.20e-2)"	0.4	0.5	1.9	0.1	1.5	1.1	0.6	1.3	0.8	1.7	0.1	0.3	0.3	1.5	1.4	5.4	0.8	1.4	5.3	1.4	2.6	0.6	0.1	0.8	0.1	8.0	2.6	0.9	0.2	0.0	1.3	0.1	3.0	4.2	0.2	0.2	3.3	1.0	234.2	0.2	0.7	0.8	5.6	0.2	0.5	3.8	2.7	0.4	0.7	198.4	0.0	0.7	0.5	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.5	0.7	0.0	0.0	0.1	0.0	0.7	1.4	9.2	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	1.5	1.3	0.8	1.4	2.6	8.0	2.6	3.0	5.6	2.7	2.8	3.5	0.0	0.0	1.0	0.1	0.4	0.4	0.5	0.6	1.1	1.7	1.5	2.9	0.0	0.1	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.3	0.5	0.7	2.5	0.0	0.0	0.9	0.2	0.3	1.8	0.0	1.4	0.0	4.3	2.9	0.0	0.2	0.0	3.0	0.3	2.0	0.3	1.1	1.2	3.1	0.7	0.0	1.0	0.1	0.5	1.0	0.0	0.2	0.0	0.1	44.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	7.0	0.8	0.4	1.5	0.0	0.4	0.7	0.5	0.4	0.5	0.1
MYZAP	"GCOM1, Gup, Gup1, MYOZAP"	ENSG00000263155	"Myocardial zonula adherens protein"	P0CAP1	15	57591904-57685364	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"heart muscle: 588.9"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 481.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.4;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 137.3;hTERT-HME1: 24.0;HUVEC TERT2: 28.3;OE19: 47.5;RT4: 25.1;TIME: 33.1"									HPA039827	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA039827: AB_10673364"	"unprognostic (1.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.10e-3)"	"unprognostic (5.19e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.77e-2)"	65.3	54.7	2.0	2.6	2.4	4.0	22.3	6.3	1.8	17.3	1.3	18.1	16.8	29.4	1.8	41.4	4.7	4.8	588.9	1.8	2.5	5.7	2.4	31.8	6.0	6.7	2.8	5.1	35.1	0.6	1.7	56.6	7.7	19.8	11.8	1.3	18.3	38.2	11.6	9.6	15.4	17.2	1.6	12.4	23.4	2.5	3.5	1.4	3.7	15.5	8.6	84.1	26.9	1.7	6.0	1.7	0.0	10.5	2.3	0.1	3.2	0.9	8.6	1.4	1.7	7.3	4.1	0.1	0.7	0.0	8.9	2.6	0.0	4.4	1.7	0.0	0.2	137.3	1.7	0.1	0.4	0.0	0.1	0.0	3.1	0.3	24.0	0.1	28.3	0.2	1.9	0.0	0.7	2.3	0.0	0.1	0.1	47.5	2.4	0.0	11.4	0.3	0.0	25.1	0.0	4.1	0.6	5.9	0.0	1.2	7.9	0.1	33.1	0.1	2.6	0.4	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.4	0.0	0.0	3.4	2.0	0.0	0.5	0.0	0.8	0.0	0.2	2.4	2.0	2.4	6.3	1.8	1.8	2.5	6.7	2.8	7.7	1.6	3.5	1.7	22.9	9.6	0.6	0.0	0.3	0.0	10.2	0.0	0.0	0.3	3.0	1.0	481.4	5.7	0.6	25.8	0.0	4.4	0.0	26.9	7.9	32.5	0.1	1.1	3.0	15.1	1.8	1.3	0.0	18.9	2.4	9.8	7.1	3.5	0.0	65.1	4.6	0.2	1.4	0.0	0.0	7.9	0.0	7.9	0.0	0.7	4.7	8.7	0.0	0.0	3.4	0.6	0.0	0.0	0.0	21.5	24.9	17.0	0.0	11.0	18.1	0.3	0.7	0.2	0.0	0.2	8.1	0.0	1.6	0.0	0.0	1.2	0.2	13.2	6.6	22.4
NAA20	"dJ1002M8.1, NAT3, NAT5"	ENSG00000173418	"N-alpha-acetyltransferase 20, NatB catalytic subunit"	P61599	20	20017310-20033655	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 399.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063344			Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA063344: AB_2684991"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	50.4	53.3	38.9	34.8	40.6	46.5	65.3	41.6	51.6	40.8	54.0	41.9	27.9	41.7	54.2	113.5	41.6	32.6	61.7	40.2	42.9	85.2	82.5	40.2	37.3	40.9	41.3	33.0	62.7	103.9	26.7	53.0	41.9	43.5	42.8	49.6	47.1	46.9	84.9	38.2	33.9	46.2	42.3	31.8	42.1	66.6	41.5	37.1	59.7	73.6	51.0	51.3	44.1	44.5	212.7	139.9	50.1	69.4	95.0	116.6	67.7	149.2	100.3	132.1	123.8	67.0	137.7	108.4	80.6	113.6	125.5	156.3	85.8	233.2	153.2	51.4	75.7	79.4	49.6	132.6	141.2	102.2	65.9	122.4	182.1	132.8	153.9	93.2	139.7	80.4	126.7	115.7	157.6	177.2	128.6	149.9	37.9	181.5	180.7	69.8	191.9	148.3	190.0	70.4	84.1	62.2	81.9	254.1	170.7	42.5	145.4	171.1	113.7	106.6	75.4	137.8	153.8	130.0	171.9	116.9	66.5	76.2	76.7	39.7	86.2	70.1	55.5	97.5	83.6	63.3	65.9	65.4	92.9	56.6	63.5	75.0	12.5	70.3	81.8	77.7	75.6	100.6	38.9	40.6	41.6	51.6	40.2	42.9	40.9	41.3	41.9	42.3	41.5	44.5	60.5	67.3	42.2	17.0	44.9	108.7	113.6	312.4	45.5	52.9	62.9	75.2	73.1	77.2	147.8	104.8	25.0	111.8	51.4	32.6	230.9	194.0	399.9	99.5	87.6	77.4	41.3	28.8	18.0	169.0	102.2	66.4	31.1	75.8	51.3	46.5	50.3	72.9	255.9	69.0	22.7	43.8	164.8	66.8	56.1	60.5	69.9	68.6	71.2	31.9	100.1	91.5	58.7	16.1	25.2	198.0	37.1	74.9	44.2	184.5	45.7	242.6	199.9	60.7	39.5	75.8	90.8	354.2	58.3	122.5	118.8	85.5	40.8	99.5	54.2	141.7
NAAA	ASAHL	ENSG00000138744	"N-acylethanolamine acid amidase"	Q02083	4	75913660-75941013	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 142.2;Kupffer cells: 115.8;Langerhans cells: 109.9;Proximal enterocytes: 167.7"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 31.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 672.4;non-classical monocyte: 583.3"	"Lineage enriched"	"Detected in all"	5	"monocytes: 672.4"	"Cell line enhanced"	"Detected in many"		"U-2197: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026135	Approved				"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"CAB026135: "	"unprognostic (5.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.21e-2)"	19.0	14.6	9.2	30.0	10.0	18.5	37.4	10.9	10.8	23.0	14.1	61.8	30.9	12.9	9.1	28.4	16.4	15.7	19.9	9.5	13.3	40.6	68.4	23.0	48.4	11.2	11.1	8.2	7.6	11.7	7.7	19.4	11.7	70.9	69.9	32.7	31.5	11.4	8.6	22.8	60.7	15.4	9.5	63.8	18.5	3.4	13.2	16.3	15.9	13.0	27.9	20.0	18.4	14.5	11.9	26.6	1.1	0.7	62.4	62.8	1.1	17.5	11.6	11.8	4.0	9.3	41.1	1.0	8.9	43.5	0.4	23.1	34.8	13.4	7.1	17.0	1.3	8.4	19.4	22.6	14.3	31.4	29.6	16.0	10.0	10.3	3.5	18.4	19.1	18.7	9.6	35.9	10.6	43.5	20.2	20.5	13.5	53.4	10.5	13.5	0.4	55.6	12.4	6.7	15.9	2.3	18.1	56.2	5.4	1.8	63.3	54.1	28.8	0.7	1.5	78.6	0.8	8.8	3.8	5.9	14.8	44.5	7.4	48.6	270.1	110.3	62.0	672.4	67.5	58.8	78.4	61.8	143.2	40.4	65.2	54.5	90.3	35.5	583.3	53.2	114.6	233.7	9.2	10.0	10.9	10.8	9.5	13.3	11.2	11.1	11.7	9.5	13.2	14.5	10.6	0.0	7.3	7.2	31.2	11.3	18.8	5.7	4.0	11.5	31.3	14.2	4.4	25.8	10.9	5.5	18.8	24.6	19.5	142.2	13.7	5.7	0.5	12.1	18.1	14.6	48.0	10.8	17.7	8.4	19.2	28.2	3.1	11.9	15.2	3.5	18.5	37.2	39.7	11.8	27.4	45.4	8.2	115.8	109.9	0.0	10.5	80.3	17.8	7.5	77.8	7.7	16.5	5.0	4.8	4.1	46.7	7.5	16.8	55.4	167.7	12.4	27.7	86.9	0.0	31.8	16.7	1.1	0.9	15.9	18.9	13.3	34.8	9.1	24.4	14.0
NBR1	"1A1-3B, CA125, KIAA0049, M17S2"	ENSG00000188554	"NBR1 autophagy cargo receptor"	Q14596	17	43170481-43211689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 276.9;Late spermatids: 909.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022944, HPA022999, HPA023999"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nuclear bodies"	"HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (1.65e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	45.7	52.3	48.4	39.4	54.5	20.1	55.9	52.1	48.2	52.0	51.2	66.2	70.1	48.9	39.9	40.3	53.4	44.5	67.3	43.7	49.9	84.7	91.3	47.3	41.0	52.2	50.4	69.7	43.9	97.1	28.8	60.1	52.9	64.7	70.4	80.1	49.4	52.0	112.2	42.9	73.8	49.3	52.1	53.0	52.6	141.0	51.6	59.0	68.2	116.0	45.4	47.3	34.5	65.2	42.3	49.8	42.6	44.6	93.5	95.2	41.0	77.1	147.2	60.5	50.4	26.6	65.1	22.7	77.8	105.1	62.6	46.1	48.5	97.4	90.3	70.0	51.2	27.1	62.0	60.0	89.4	23.2	40.1	108.4	111.6	67.2	133.7	127.3	96.0	50.8	58.1	58.7	83.7	23.9	48.9	17.7	13.6	50.0	32.8	16.5	65.6	73.3	81.6	48.0	25.9	45.8	53.1	26.1	79.8	70.7	70.7	38.0	82.2	89.9	34.1	42.7	31.5	69.9	61.8	29.1	61.8	31.5	63.6	41.6	25.7	40.1	20.3	23.3	20.7	13.7	18.1	19.6	19.3	9.4	17.0	16.6	34.4	24.3	36.4	12.0	26.4	25.0	48.4	54.5	52.1	48.2	43.7	49.9	52.2	50.4	52.9	52.1	51.6	65.2	36.9	41.7	44.1	24.5	21.9	23.8	29.2	28.1	54.1	37.3	33.8	27.4	86.4	35.8	40.4	36.8	39.6	28.0	34.6	94.2	19.6	25.4	276.9	40.5	30.4	39.0	40.2	53.2	24.7	21.9	19.4	37.6	31.1	33.0	25.9	53.1	45.3	67.8	22.0	20.2	28.2	56.4	20.3	62.9	19.9	909.9	58.7	35.7	26.6	29.0	35.6	49.3	44.3	33.2	41.4	25.8	64.5	44.4	26.1	41.1	100.3	57.4	63.4	56.9	39.5	33.9	36.2	49.6	30.9	26.7	27.3	15.7	31.9	68.6	52.4	38.7
NCALD		ENSG00000104490	"Neurocalcin delta"	P61601	8	101686542-102124907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 100.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 251.6;Inhibitory neurons: 460.2;Oligodendrocyte precursor cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 87.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 87.3;T-cells: 42.2"	"Cell line enhanced"	"Detected in many"		"AF22: 136.4;HDLM-2: 159.9;U-266/70: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043245	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043245: AB_2678385"	"unprognostic (3.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.30e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.00e-2)"	21.4	7.3	30.3	9.4	43.4	1.8	44.0	0.0	62.5	13.5	0.0	22.3	6.0	7.6	4.4	12.6	39.6	12.6	12.1	52.4	11.3	14.9	15.1	19.7	13.6	3.6	13.3	37.5	10.0	1.9	13.7	10.0	15.3	12.3	8.8	15.9	100.6	14.9	15.4	18.0	10.2	11.0	1.2	8.3	11.2	7.3	29.4	5.5	5.2	11.6	11.1	11.1	4.0	21.6	6.9	9.8	136.4	0.5	1.1	22.3	0.0	2.3	0.3	0.1	0.0	0.1	0.1	9.0	3.0	10.4	0.6	0.0	1.0	0.0	0.0	159.9	1.0	0.7	0.0	0.0	0.0	6.1	0.9	4.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	19.3	0.8	0.2	1.2	2.4	1.5	0.0	0.0	3.7	0.0	0.4	22.0	0.3	0.6	13.4	0.0	3.1	5.7	22.5	0.9	4.8	0.2	1.6	0.3	0.2	0.4	39.3	5.6	0.1	0.3	0.1	2.2	0.4	0.3	0.3	42.2	0.2	37.1	0.9	16.0	24.8	5.0	0.6	3.9	20.6	1.3	87.3	0.3	0.4	17.5	13.6	30.3	43.4	0.0	62.5	52.4	11.3	3.6	13.3	15.3	1.2	29.4	21.6	17.3	0.0	2.6	11.8	0.5	4.2	0.5	1.0	0.0	14.6	88.6	74.4	7.5	14.3	3.2	0.0	25.0	3.2	28.9	1.7	7.9	9.6	12.8	32.2	5.0	11.3	21.0	4.0	251.6	1.2	13.0	39.8	4.1	23.8	2.5	20.5	14.6	15.0	1.9	13.5	460.2	4.3	61.1	2.6	6.9	6.6	2.8	2.8	103.2	75.9	0.8	46.6	64.9	281.0	26.5	3.5	0.5	1.5	7.1	1.3	0.0	19.5	26.0	4.7	26.3	91.0	24.5	1.5	1.8	3.0	3.1	3.0	17.4	19.4	0.4	1.1
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998409-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 12.0;brain: 26.0"	"Group enriched"	"Detected in some"	19	"Astrocytes: 713.0;Excitatory neurons: 866.5;Inhibitory neurons: 909.2;Oligodendrocyte precursor cells: 1729.1;Oligodendrocytes: 1526.6"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.6;glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"		No	No		120000000		"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: AB_2673650"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	0.7	12.0	14.1	0.9	19.0	0.0	1.6	8.4	17.5	1.6	0.0	2.0	0.2	1.0	0.5	0.5	0.6	1.2	2.0	21.3	22.7	0.2	6.7	2.8	0.1	8.6	14.4	0.3	0.2	0.6	0.8	0.5	8.8	0.9	1.0	1.2	0.7	1.0	0.4	0.8	0.7	1.4	8.8	0.8	0.6	6.3	26.0	0.1	0.3	0.8	0.2	0.6	1.2	21.6	0.0	0.0	0.5	0.0	4.6	4.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.5	1.3	0.0	2.2	0.0	0.1	11.3	0.0	3.5	0.0	0.4	0.0	0.0	11.4	2.4	0.2	15.4	0.2	0.0	0.4	0.0	0.0	1.0	0.0	4.7	0.0	0.0	0.0	5.3	0.0	0.8	0.6	0.1	92.1	7.2	0.0	1.3	0.9	0.1	0.0	0.6	0.0	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	19.0	8.4	17.5	21.3	22.7	8.6	14.4	8.8	8.8	26.0	21.6	0.4	3.2	1.3	713.0	0.1	0.5	0.3	0.0	0.0	1.0	2.0	1.4	1.8	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	57.6	0.3	6.1	0.4	0.0	0.0	866.5	0.0	0.4	4.8	0.0	0.2	0.0	0.2	2.2	0.0	0.3	0.0	909.2	0.0	0.0	0.0	0.3	24.7	0.9	0.1	1.8	30.9	0.0	1.0	0.0	1729.1	1526.6	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.1	0.0	2.4	1.6	3.7	9.6	0.1	0.1	0.3	0.2	1.9	0.0	0.2
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 467.5;Excitatory neurons: 313.0;Inhibitory neurons: 421.8;Microglial cells: 341.9;Oligodendrocyte precursor cells: 459.4;Oligodendrocytes: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	16.6	15.1	24.0	13.3	25.4	17.3	17.3	24.6	28.2	18.6	13.6	15.9	20.9	19.0	12.8	17.6	15.7	14.0	15.3	29.6	19.5	18.9	15.0	16.0	15.3	17.7	19.2	26.6	17.4	30.0	16.6	17.1	16.0	15.2	16.6	47.3	16.0	20.2	33.4	15.7	18.9	19.0	19.5	16.3	12.5	19.9	21.8	26.1	11.8	36.1	16.3	14.9	15.5	22.3	14.1	10.3	17.7	9.2	19.2	17.3	26.9	7.4	14.7	9.1	8.1	9.6	5.9	10.2	3.1	13.5	17.4	3.4	10.7	6.3	9.8	48.6	15.5	36.5	4.1	4.1	12.0	16.9	29.1	27.9	9.4	8.8	7.1	11.3	9.4	12.9	22.6	16.5	14.0	9.4	15.1	6.0	8.5	8.2	6.8	11.8	81.5	5.1	9.9	18.9	16.2	12.8	17.1	10.2	7.4	9.3	12.3	8.6	10.2	15.2	11.9	10.5	7.5	18.8	17.5	17.2	8.6	10.5	7.7	10.6	3.3	7.0	3.4	2.6	3.8	1.6	3.0	3.8	2.5	2.4	2.9	3.5	13.8	3.5	2.9	5.2	3.7	2.0	24.0	25.4	24.6	28.2	29.6	19.5	17.7	19.2	16.0	19.5	21.8	22.3	41.0	38.5	31.5	467.5	16.7	30.5	11.6	7.8	14.2	96.5	32.3	26.7	41.9	17.2	22.8	14.7	52.1	13.1	47.0	39.0	7.9	16.5	29.7	14.6	37.6	34.9	25.2	29.9	313.0	26.6	18.1	39.8	19.9	28.4	20.2	52.9	36.8	22.8	17.9	62.2	421.8	20.7	20.3	29.8	30.3	7.4	47.2	37.7	19.6	341.9	34.7	66.7	78.2	459.4	305.8	20.1	33.5	43.2	14.3	15.7	30.4	12.5	16.9	71.6	39.5	116.9	34.4	37.7	37.6	16.6	31.0	5.3	33.4	27.2	24.1	21.7
NCR1	"CD335, LY94, NK-p46, NKP46"	ENSG00000189430	"Natural cytotoxicity triggering receptor 1"	O76036	19	54906148-54916140	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.5"	"Group enriched"	"Detected in some"	7	"dendritic cells: 30.2;NK-cells: 110.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Region enriched"	"Detected in single"	7	"cerebral cortex: 1.0"	"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049311			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA049311: AB_2680707"	"unprognostic (3.92e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.87e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.32e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.05e-3)"	0.2	0.0	0.1	0.2	0.0	0.7	0.1	0.1	1.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	6.6	0.4	0.0	0.0	0.1	1.1	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.3	0.0	0.0	0.6	0.3	0.0	0.0	1.8	0.0	1.9	0.1	0.0	110.2	0.5	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.1
NDFIP1	"MGC10924, N4WBP5"	ENSG00000131507	"Nedd4 family interacting protein 1"	Q9BT67	5	142108779-142154440	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 678.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009682	Approved				"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA009682: AB_1079455"	"unprognostic (2.78e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.74e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (6.95e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (2.39e-7)"	"unprognostic (9.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.76e-2)"	62.1	81.6	87.4	33.8	93.8	26.2	56.3	63.1	100.7	54.7	70.8	40.3	49.3	45.2	135.9	30.2	46.4	45.4	55.1	94.2	96.8	94.8	120.2	49.7	39.0	70.7	73.6	61.5	64.5	152.6	51.7	45.2	77.2	67.7	38.4	164.1	99.5	63.5	45.7	26.6	47.6	40.9	75.3	56.4	50.4	40.8	90.8	41.9	103.4	40.9	34.8	48.3	31.1	73.9	53.3	35.2	61.8	83.6	128.2	72.5	41.4	56.6	59.1	48.0	54.6	39.5	87.3	4.8	115.0	62.2	66.4	51.9	39.6	59.6	56.2	61.2	48.8	69.2	30.8	28.7	55.8	38.3	23.9	55.8	55.3	33.8	43.6	68.4	55.9	54.0	23.4	83.3	60.1	27.4	42.9	12.0	33.2	52.0	33.4	16.1	34.2	122.1	119.1	56.0	65.0	67.3	61.9	91.7	88.3	46.0	64.7	37.6	64.5	58.7	22.1	48.0	56.8	53.6	65.8	22.0	62.1	24.9	45.6	70.4	32.1	26.4	22.9	39.9	29.2	12.8	40.6	28.2	37.0	10.4	80.9	63.9	19.5	23.5	40.1	11.2	50.6	62.4	87.4	93.8	63.1	100.7	94.2	96.8	70.7	73.6	77.2	75.3	90.8	73.9	100.3	57.7	62.6	74.7	76.4	111.5	176.4	133.4	82.0	196.4	134.3	68.5	70.0	143.0	101.4	154.5	141.8	146.9	94.0	98.0	140.8	207.4	20.2	69.5	91.5	103.7	137.6	184.9	189.5	145.3	263.8	164.1	62.7	118.2	60.2	365.2	116.0	169.8	154.1	318.0	184.9	81.9	177.0	205.9	154.9	15.4	116.5	137.0	170.7	69.3	176.1	300.6	87.6	114.1	125.4	179.8	100.5	156.9	107.6	262.6	198.5	173.0	67.7	322.9	131.5	74.3	149.3	26.6	33.2	71.1	101.3	191.5	156.4	678.1	83.3	256.2
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395943-72282539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 29.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 1968.8;Inhibitory neurons: 1254.4;Oligodendrocyte precursor cells: 726.3;Oligodendrocytes: 442.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.7;TIME: 28.5;U-2 OS: 22.9;U-251 MG: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"		NA	NA		380000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	16.5	5.8	12.8	3.6	15.9	1.2	5.9	4.4	15.7	7.1	0.0	17.5	2.7	5.2	4.1	10.5	7.2	10.7	11.2	15.1	9.1	6.8	0.3	5.5	1.6	1.9	5.6	6.0	4.5	0.7	3.9	2.9	2.7	7.3	7.8	29.8	2.4	5.4	3.3	5.8	5.1	6.4	3.7	0.6	7.4	3.2	12.4	5.6	3.5	5.1	0.8	13.3	6.6	6.5	0.4	0.1	0.8	0.2	26.7	21.0	0.2	19.4	7.2	10.4	12.7	0.1	0.2	0.3	0.1	21.5	0.2	0.6	0.0	0.0	22.4	0.2	0.1	0.1	3.4	0.1	2.2	0.2	0.4	10.2	0.1	8.9	1.5	15.4	12.5	0.3	0.1	0.8	19.5	0.1	0.2	0.2	3.2	0.3	11.0	13.7	20.4	0.3	1.7	0.3	1.5	1.7	6.8	0.1	0.0	0.4	0.1	0.3	28.5	2.3	22.9	0.9	24.5	0.4	0.2	0.1	5.2	13.0	8.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	12.8	15.9	4.4	15.7	15.1	9.1	1.9	5.6	2.7	3.7	12.4	6.5	6.0	0.0	0.5	170.7	0.0	5.0	0.6	0.1	0.0	51.4	0.2	0.5	4.2	1.5	2.5	0.0	27.1	0.0	4.4	0.1	0.0	2.4	6.2	0.1	1.3	2.6	0.0	0.8	1968.8	0.0	0.0	88.7	0.5	0.1	0.0	0.2	0.0	0.0	0.2	1.7	1254.4	0.6	0.0	0.0	16.7	12.5	210.3	2.4	8.8	58.1	3.1	12.2	0.0	726.3	442.7	0.5	0.0	44.8	0.5	1.3	0.0	1.5	7.1	58.7	32.9	8.3	8.5	0.7	2.5	0.3	3.4	0.0	1.1	0.2	0.1	0.7
NEK11	FLJ23495	ENSG00000114670	"NIMA related kinase 11"	Q8NG66	3	131026850-131350465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.7;Early spermatids: 156.4;Endometrial ciliated cells: 69.2;Excitatory neurons: 91.0;Late spermatids: 109.2;Respiratory ciliated cells: 102.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016908	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA016908: AB_1854364"	"unprognostic (9.15e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.92e-6)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	3.1	4.3	8.3	0.5	8.3	0.1	6.6	6.9	7.7	5.4	26.2	2.1	1.3	4.9	7.1	2.3	21.4	4.6	2.1	7.3	9.0	6.3	0.6	4.3	1.0	14.2	15.5	6.4	2.2	4.8	5.6	2.2	12.4	2.9	2.4	5.6	2.9	3.7	1.1	2.2	1.8	2.7	12.8	1.2	1.6	15.5	9.3	0.9	9.6	0.8	1.2	2.8	2.5	12.8	5.7	2.2	1.6	4.8	6.2	9.3	0.9	2.7	5.0	4.1	3.1	2.1	7.7	0.2	1.9	4.8	3.9	3.0	0.4	4.6	5.6	0.5	0.6	0.8	0.3	1.0	2.1	0.6	1.3	3.9	7.7	4.2	1.9	4.3	0.8	2.4	0.2	0.8	6.9	3.9	0.1	0.4	0.5	0.9	2.1	0.0	0.1	0.1	9.3	2.2	2.0	2.2	1.3	0.1	1.9	0.7	4.4	0.1	0.9	4.1	2.0	3.3	1.3	1.2	2.2	0.1	2.9	0.2	0.7	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.6	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.2	0.3	0.0	8.3	8.3	6.9	7.7	7.3	9.0	14.2	15.5	12.4	12.8	9.3	12.8	2.5	16.0	3.2	60.7	1.5	4.2	3.4	4.5	4.6	2.6	7.3	7.5	1.6	4.3	18.8	1.8	6.2	1.0	1.4	3.3	5.9	6.4	156.4	69.2	6.1	3.5	2.4	0.4	91.0	2.5	1.1	7.7	2.6	6.6	0.0	8.1	5.7	0.6	2.0	0.0	42.0	3.5	6.1	0.3	1.7	109.2	6.8	2.0	0.0	21.5	0.8	6.4	1.0	38.7	38.9	3.7	3.9	6.0	0.8	1.6	1.7	10.6	102.7	7.3	6.6	7.2	3.7	33.4	5.2	2.6	2.0	1.6	1.4	11.5	2.4	2.7
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061545	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1357.5;tongue: 858.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063384: AB_2684998, HPA065424: AB_2685488"	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	154.3	130.5	109.3	75.0	99.3	31.1	91.1	101.6	98.3	103.5	225.0	107.6	106.0	149.4	88.2	126.0	130.6	97.3	430.8	112.4	146.3	159.6	104.0	83.3	63.8	135.0	131.1	148.8	65.2	115.2	82.5	100.6	131.0	95.7	80.1	67.1	92.1	123.5	1357.5	121.1	113.3	141.0	116.3	113.0	79.0	69.3	126.8	62.3	132.6	858.4	59.2	89.7	86.3	138.2	122.2	265.4	172.0	147.4	349.8	168.2	128.6	193.7	269.2	135.1	149.8	327.6	137.6	139.8	379.2	244.6	175.2	245.5	122.5	154.5	144.7	239.9	104.1	78.8	181.0	111.1	418.6	178.0	122.1	232.6	380.7	246.7	267.2	228.7	214.6	93.5	142.5	377.4	169.4	103.3	115.5	56.0	113.0	110.0	101.4	80.1	241.8	136.4	150.0	181.0	105.8	160.2	132.4	89.0	272.4	222.5	175.7	120.5	291.2	324.2	141.4	112.3	197.4	626.6	460.1	134.1	310.4	73.6	191.3	14.2	11.8	4.0	3.4	6.5	2.0	5.2	3.1	3.5	2.6	4.9	2.4	2.7	26.1	3.0	8.7	12.9	1.2	1.3	109.3	99.3	101.6	98.3	112.4	146.3	135.0	131.1	131.0	116.3	126.8	138.2	60.1	57.7	49.4	25.1	15.8	55.7	19.3	45.0	34.1	68.8	39.2	33.8	303.1	50.1	34.4	77.3	35.5	22.7	14.7	150.7	25.4	41.3	8.1	57.9	92.0	66.3	30.1	11.6	24.5	36.2	21.5	47.9	27.5	58.8	28.4	89.3	80.3	126.7	36.0	72.3	28.0	51.5	38.7	32.8	18.9	10.6	102.2	23.8	21.4	20.6	31.5	25.4	15.5	9.0	14.4	51.8	64.8	83.8	17.4	33.8	100.3	39.1	49.5	34.8	59.2	39.3	53.8	30.0	35.5	25.9	48.4	22.3	14.2	44.6	49.4	24.4
NFIX	NF1A	ENSG00000008441	"Nuclear factor I X"	Q14938	19	12995475-13098796	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 145.2;Oligodendrocytes: 140.9;Skeletal myocytes: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 149.5;fHDF/TERT166: 211.3;U-138 MG: 191.5;U-2197: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007533	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA007533: AB_2667855"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.66e-4)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-2)"	76.4	14.9	30.4	19.7	80.2	14.9	48.0	99.8	97.7	67.2	4.0	60.4	20.9	88.5	10.9	72.4	69.5	53.9	60.9	54.0	15.0	8.9	20.3	50.0	6.2	50.9	45.1	73.8	23.8	13.2	18.9	11.8	39.4	85.0	19.7	11.7	150.4	60.0	410.3	99.2	24.3	67.8	45.6	11.3	37.3	16.0	46.9	11.6	31.0	138.2	6.2	45.0	52.7	105.2	39.2	16.2	1.0	119.9	111.7	149.5	1.3	48.1	68.6	45.7	31.8	1.3	3.3	0.6	13.4	211.3	31.4	17.5	12.8	37.4	20.1	25.8	19.7	20.2	7.6	17.2	53.8	8.5	10.3	99.0	10.9	44.1	24.6	80.3	12.4	8.6	6.7	6.2	29.3	12.1	14.9	5.7	0.5	8.6	132.3	43.5	22.2	23.1	0.4	8.5	17.9	47.6	34.5	0.3	43.0	0.0	22.7	17.3	12.2	191.5	23.5	185.1	68.5	4.5	1.7	0.3	49.9	12.1	62.0	0.1	0.1	0.0	0.5	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	30.4	80.2	99.8	97.7	54.0	15.0	50.9	45.1	39.4	45.6	46.9	105.2	19.5	12.8	59.3	62.7	6.8	58.8	45.5	22.4	134.9	13.3	57.9	74.2	33.2	27.1	15.9	14.7	4.2	0.2	3.7	16.5	1.9	24.3	64.0	12.1	40.1	20.0	12.1	145.2	69.0	12.7	0.3	89.7	32.6	3.0	3.8	4.3	17.9	33.9	1.0	0.0	38.1	25.8	2.0	4.1	15.2	43.1	112.2	5.8	26.6	17.8	1.9	93.7	0.0	52.3	140.9	15.2	12.0	126.0	2.5	60.3	8.4	10.0	19.0	3.0	6.6	174.7	38.3	15.6	13.2	99.4	51.4	0.3	3.8	56.0	29.5	31.8
NFKBIE	IKBE	ENSG00000146232	"NFKB inhibitor epsilon"	O00221	6	44258166-44265788	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002692, HPA005941, CAB010272"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478"	"prognostic favorable (1.72e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (8.07e-4)"	6.8	5.8	10.9	19.1	10.8	31.5	5.9	12.1	17.6	4.1	10.7	7.2	7.4	3.7	4.7	5.9	3.3	8.3	5.3	11.3	10.6	16.1	10.5	13.6	19.9	11.5	11.4	2.7	8.3	5.3	4.5	5.5	11.2	8.3	5.9	3.7	7.4	3.3	3.5	9.9	12.1	3.6	11.7	35.0	7.0	10.7	11.8	9.9	5.3	3.9	25.1	16.3	5.0	12.3	28.4	7.9	9.5	15.1	3.7	2.8	5.3	4.9	23.8	14.9	15.4	15.0	12.9	15.7	17.0	5.1	39.7	6.2	10.3	15.4	16.6	26.1	6.0	7.9	3.0	17.0	11.4	26.1	23.0	7.1	6.7	13.8	8.8	12.5	10.7	7.2	7.7	39.2	3.9	14.4	5.2	52.7	5.0	44.1	4.0	9.9	8.5	14.0	34.7	30.3	6.1	7.8	3.4	12.5	20.9	8.0	8.6	29.9	18.1	8.4	9.8	5.3	15.4	25.0	11.4	28.7	7.4	28.4	16.1	8.8	7.5	4.0	1.6	9.4	3.2	8.6	2.2	1.5	6.6	6.5	1.0	1.6	3.0	0.8	11.1	8.1	3.1	1.7	10.9	10.8	12.1	17.6	11.3	10.6	11.5	11.4	11.2	11.7	11.8	12.3	7.5	0.0	9.7	1.0	26.0	38.2	28.7	11.6	14.8	3.4	15.3	9.9	5.4	22.8	9.2	3.7	2.1	5.2	12.5	12.2	17.6	49.5	17.3	10.0	6.2	15.9	14.9	1.7	1.1	21.0	8.0	17.3	10.7	12.8	32.5	2.5	6.1	2.0	57.2	3.3	2.0	11.9	6.1	22.6	151.2	34.1	1.8	48.6	48.0	3.7	55.2	3.3	1.0	0.5	0.9	58.9	33.3	2.6	18.7	32.6	14.3	14.4	6.1	4.1	6.6	11.8	11.0	25.9	12.3	11.6	39.2	5.3	13.8	7.0	8.5	34.7
NIBAN3	"BCNP1, FAM129C, FLJ39802"	ENSG00000167483	"Niban apoptosis regulator 3"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"bone marrow: 15.4;intestine: 16.6;lymphoid tissue: 34.7"	"Cell type enriched"	"Detected in some"	8	"B-cells: 11.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7"	"Group enriched"	"Detected in many"	476	"B-cells: 52.1;dendritic cells: 110.7"	"Group enriched"	"Detected in some"	19	"Daudi: 50.1;REH: 23.8;U-698: 33.2"	"Not detected"	"Not detected"							HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.4	0.0	0.0	10.7	0.1	15.4	0.1	0.0	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.4	0.1	1.0	0.1	0.0	0.0	0.5	0.3	0.4	26.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	16.6	0.0	0.0	34.7	0.7	0.5	0.0	1.8	0.6	0.0	12.2	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	52.1	0.0	0.1	0.0	0.0	0.0	110.7	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NIPAL2	"FLJ13955, NPAL2"	ENSG00000104361	"NIPA like domain containing 2"	Q9H841	8	98189826-98294393	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 124.5;Squamous epithelial cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.5;OE19: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071759	Uncertain					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071759: AB_2686443"	"unprognostic (5.14e-3)"	"unprognostic (6.43e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.72e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.76e-2)"	12.6	12.5	6.1	7.8	6.6	6.4	17.7	4.2	13.5	22.9	5.2	17.8	9.2	14.5	41.0	30.1	12.2	15.4	8.6	7.7	5.1	5.9	7.8	10.3	8.6	3.7	3.5	27.5	16.8	11.7	21.9	8.5	3.8	22.9	24.1	11.7	20.6	15.9	2.3	53.2	11.7	7.8	5.0	8.1	19.7	4.9	4.3	3.4	7.2	2.6	13.0	13.2	21.8	8.8	7.9	3.1	1.0	0.1	45.5	27.5	0.2	13.9	17.6	2.5	3.4	0.0	22.7	14.7	15.7	19.5	3.7	9.2	0.7	8.3	1.9	1.3	2.8	5.4	2.1	1.1	5.8	5.7	5.5	28.4	21.6	2.6	7.6	1.4	3.2	0.1	0.0	29.1	10.2	10.9	0.2	3.1	1.8	38.1	1.1	0.0	0.2	1.7	9.1	17.7	1.5	3.0	10.1	8.6	3.5	1.2	9.2	10.5	9.2	1.9	0.2	7.0	0.1	0.3	0.0	0.1	3.4	18.2	9.5	0.1	2.0	2.9	0.7	1.9	0.0	1.7	0.6	0.6	3.7	2.6	0.0	0.5	0.3	1.7	1.6	1.5	2.0	1.6	6.1	6.6	4.2	13.5	7.7	5.1	3.7	3.5	3.8	5.0	4.3	8.8	6.1	3.2	9.3	3.6	11.0	15.3	8.4	19.2	22.8	16.5	10.4	10.8	5.2	7.2	15.8	3.7	2.1	0.2	3.0	20.6	0.0	8.2	7.3	4.6	21.1	8.0	7.2	11.2	124.5	12.8	1.1	13.2	30.5	5.4	5.7	4.1	8.6	3.6	4.6	21.9	30.5	26.3	6.1	6.8	9.4	4.0	25.7	8.5	3.6	26.2	6.0	9.7	10.3	10.6	3.4	9.4	11.0	23.0	6.6	13.4	8.6	1.2	14.3	2.6	6.6	3.3	6.8	0.8	0.7	57.3	22.9	0.3	3.0	12.4	17.2	22.7
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.1;seminal vesicle: 12.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 19.6;Inhibitory neurons: 12.7;Oligodendrocyte precursor cells: 92.0;Oligodendrocytes: 43.7;Peritubular cells: 17.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.7;NTERA-2: 5.3;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: AB_2732397"	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	0.5	6.6	10.1	0.8	8.5	1.4	0.4	6.4	11.1	1.9	0.0	1.8	0.2	2.7	6.4	0.6	4.3	1.4	1.1	10.3	10.2	0.3	0.1	0.6	0.4	7.3	7.0	4.4	0.3	0.5	1.0	0.6	4.8	6.0	0.5	1.9	0.6	12.5	0.1	0.7	0.7	1.9	5.5	0.6	0.6	2.6	7.3	0.4	0.4	0.4	0.2	0.7	1.2	9.7	0.0	0.5	6.7	0.2	1.6	0.6	1.2	0.0	0.0	0.0	0.1	0.1	0.3	0.5	0.5	0.1	0.0	0.1	0.2	0.0	0.1	0.4	0.9	0.4	0.4	0.0	0.0	0.1	0.4	0.4	0.1	0.2	0.0	0.3	0.1	2.0	0.5	1.5	0.0	0.3	0.5	1.2	5.3	0.0	0.0	0.6	0.2	0.3	0.0	0.8	1.7	2.5	0.2	0.0	0.6	0.8	0.0	0.3	0.1	0.1	0.8	0.2	0.0	1.1	1.1	0.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.1	8.5	6.4	11.1	10.3	10.2	7.3	7.0	4.8	5.5	7.3	9.7	0.3	0.0	0.0	19.6	0.0	0.6	0.3	0.2	1.2	2.6	0.3	0.9	0.4	0.0	0.1	0.0	0.0	1.0	0.2	0.2	0.0	0.1	1.3	0.2	1.1	0.5	0.0	0.0	11.3	0.0	0.2	1.3	0.0	0.4	0.0	1.0	0.7	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.8	3.9	2.1	0.2	0.0	2.8	0.1	2.5	0.0	92.0	43.7	0.2	0.1	17.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.6	0.2	0.0	0.1	0.4	0.3	0.2	4.5	0.1	0.3
NMT2		ENSG00000152465	"N-myristoyltransferase 2"	O60551	10	15102584-15168693	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 93.6;Hepatocytes: 141.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 14.5;eosinophil: 13.6;gdT-cell: 11.0;MAIT T-cell: 19.8;memory CD4 T-cell: 17.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 21.8;naive CD8 T-cell: 14.5;NK-cell: 20.8;T-reg: 29.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.5;NK-cells: 20.8;T-cells: 29.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 102.6;TIME: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001303	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA001303: AB_1079494"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	25.9	4.4	7.3	6.1	8.7	3.7	17.5	12.2	10.0	9.8	4.0	8.8	6.6	12.7	3.5	7.0	8.3	7.0	8.7	7.0	4.9	9.4	16.8	6.3	8.9	5.0	7.6	15.4	5.6	16.5	5.5	4.4	5.1	9.0	9.2	7.0	5.2	7.7	8.3	10.1	10.9	10.5	4.3	9.4	7.9	13.4	9.1	27.0	5.9	8.5	8.0	8.6	7.9	7.3	8.8	11.3	12.7	9.3	33.7	35.9	2.3	18.8	15.3	17.0	23.0	10.9	38.7	0.4	12.7	102.6	46.6	10.6	11.4	10.7	28.3	11.7	13.9	23.4	5.4	15.2	22.4	1.7	84.0	31.9	10.8	23.8	7.2	62.2	65.8	16.3	11.2	1.5	63.7	10.9	18.3	4.4	9.3	10.0	10.5	13.6	18.5	1.8	12.6	1.8	3.9	14.4	22.8	3.7	6.3	10.5	11.7	7.3	147.1	16.7	24.4	75.0	13.7	13.0	14.3	1.0	20.7	6.3	12.4	14.5	0.5	13.6	11.0	0.7	19.8	2.2	17.5	12.9	0.5	2.5	21.8	14.5	1.9	20.8	0.8	0.5	29.5	6.5	7.3	8.7	12.2	10.0	7.0	4.9	5.0	7.6	5.1	4.3	9.1	7.3	52.5	9.6	8.8	25.1	16.0	16.6	23.4	8.3	7.4	20.6	14.7	13.1	13.5	57.2	10.9	27.6	4.2	1.3	16.9	32.8	9.8	33.9	6.6	4.7	20.5	21.7	18.0	15.1	39.6	19.5	3.0	16.3	9.2	10.3	93.6	13.2	25.4	141.9	2.8	20.2	30.1	11.4	4.1	7.9	7.1	14.5	21.8	5.8	12.4	17.8	10.1	12.9	40.2	12.5	15.3	27.1	15.9	20.7	10.0	17.9	38.4	63.2	5.3	17.2	0.0	13.4	21.0	8.1	46.8	6.8	14.8	2.6	33.9	11.0	18.1	16.7
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 239.1;tongue: 384.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 344.3;Hepatocytes: 314.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004829, CAB004975"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Cytosol	"CAB004975: AB_425908, HPA004829: AB_1079495"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	26.0	16.5	12.8	11.8	16.0	15.0	13.7	11.2	21.7	16.4	34.9	25.9	17.2	11.0	16.7	16.8	10.7	15.0	137.7	16.1	11.5	57.0	116.4	13.2	16.5	10.3	12.0	10.1	17.8	55.6	9.6	12.7	9.5	18.3	27.8	12.9	26.6	18.2	239.1	10.4	16.1	20.6	9.3	11.5	31.2	6.2	15.8	26.8	31.1	384.0	17.2	17.3	9.3	15.1	15.4	12.6	30.5	59.6	44.0	50.3	9.9	17.5	39.8	24.8	20.8	19.0	30.4	18.5	21.5	43.9	22.3	16.6	120.5	5.4	27.4	31.1	33.6	24.0	70.7	23.8	27.5	50.2	43.1	37.9	17.5	16.3	18.6	42.6	56.3	22.7	21.4	81.3	60.0	15.1	55.8	35.8	6.4	0.1	15.2	54.7	73.8	70.8	58.0	15.5	44.2	37.7	62.9	1.4	46.7	6.9	47.7	58.3	23.2	29.5	28.3	12.0	8.3	36.1	45.1	26.5	7.1	68.8	22.1	12.5	18.2	16.0	16.7	23.0	17.1	12.0	17.1	15.5	32.0	12.0	15.5	14.7	2.9	23.2	24.7	9.1	22.2	19.3	12.8	16.0	11.2	21.7	16.1	11.5	10.3	12.0	9.5	9.3	15.8	15.1	12.0	54.5	37.8	60.7	19.6	11.5	9.5	19.0	13.1	17.9	9.6	6.3	344.3	38.6	27.0	27.6	35.5	8.7	20.4	34.4	27.4	14.4	16.7	18.5	16.6	19.2	19.9	34.9	124.8	10.7	2.3	27.2	23.9	25.1	25.2	26.8	21.0	314.3	25.0	6.7	110.6	22.6	20.3	40.6	11.9	4.6	14.9	19.8	14.2	45.9	25.9	12.5	35.0	77.9	63.4	9.5	16.7	19.2	20.0	11.7	23.6	21.7	18.1	12.8	0.0	14.0	20.1	4.0	1.4	17.6	8.1	2.1	20.9	18.8	28.9	9.9
NPAS3	"bHLHe12, MOP6, PASD6"	ENSG00000151322	"Neuronal PAS domain protein 3"	Q8IXF0	14	32934396-33820863	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 3405.1;Inhibitory neurons: 1408.3;Oligodendrocyte precursor cells: 1893.0;Oligodendrocytes: 1772.0"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 6.4;glioma: 7.7;ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 9.3;U-266/70: 23.6;U-266/84: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075337	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA075337: "	"unprognostic (6.02e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (3.27e-1)"	0.8	0.8	17.3	0.1	19.9	0.0	0.9	14.6	12.9	6.0	0.0	1.4	0.3	3.9	0.8	0.3	3.9	0.7	0.4	14.0	15.0	0.9	0.1	0.2	0.1	22.8	18.0	2.7	0.4	0.5	1.0	0.5	15.8	0.8	0.3	1.4	0.8	1.3	0.2	0.2	0.4	0.6	18.0	1.1	1.0	1.3	15.9	0.4	1.8	0.2	0.2	0.5	0.5	18.3	0.0	0.0	9.3	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	23.6	7.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	19.9	14.6	12.9	14.0	15.0	22.8	18.0	15.8	18.0	15.9	18.3	5.1	0.0	0.0	3405.1	0.1	1.0	1.0	0.0	0.6	8.9	3.8	5.1	2.1	0.0	0.1	1.8	0.0	1.5	0.1	0.1	1.9	0.1	22.2	24.6	5.7	3.2	1.2	0.0	341.9	0.0	0.1	3.5	0.0	72.3	0.0	0.7	4.2	0.1	0.5	10.1	1408.3	0.0	0.0	0.0	1.4	17.0	7.2	0.7	0.0	116.2	0.0	7.4	0.0	1893.0	1772.0	0.2	0.0	5.3	0.1	0.5	0.0	0.5	1.8	0.7	0.0	11.5	3.1	0.2	0.8	0.1	0.4	0.3	1.0	1.1	0.0	0.5
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	84.6	95.7	81.4	75.9	104.4	32.7	82.6	52.1	176.7	112.4	72.4	133.0	134.9	180.7	150.9	133.9	135.0	97.2	196.4	122.6	65.6	126.5	74.0	110.5	48.7	42.9	42.2	79.1	96.6	167.2	47.1	123.1	39.8	170.8	142.0	135.5	101.0	204.4	51.2	68.1	124.9	298.4	28.5	71.8	96.4	69.2	60.4	42.6	112.4	70.1	69.4	140.6	84.9	87.9	101.9	179.1	100.9	74.5	201.6	180.7	141.1	229.1	373.5	258.3	228.4	122.4	317.7	58.7	133.0	331.2	319.2	411.1	164.4	191.3	147.6	105.6	109.3	46.7	83.3	110.2	143.1	72.6	124.9	149.1	165.2	167.4	100.7	254.8	139.5	52.0	26.7	65.2	187.2	81.2	32.4	45.3	93.5	127.3	63.3	52.1	115.8	49.9	353.7	148.3	61.6	19.2	222.4	122.4	151.3	249.6	110.9	97.7	159.0	199.7	133.8	116.0	135.8	56.5	113.8	51.4	185.8	111.0	140.0	5.9	13.5	13.8	6.4	18.5	5.2	3.8	3.6	5.9	5.3	2.9	3.6	4.2	28.0	3.9	14.8	5.5	4.3	13.6	81.4	104.4	52.1	176.7	122.6	65.6	42.9	42.2	39.8	28.5	60.4	87.9	67.1	76.9	66.0	72.1	18.3	65.0	27.0	43.3	51.2	93.0	50.5	45.7	106.9	48.6	60.6	82.8	50.1	7.0	28.8	133.8	1.9	18.1	3.7	73.4	46.7	44.6	103.0	7.4	216.6	24.0	9.2	64.5	41.3	92.1	28.4	33.9	50.0	43.1	25.0	38.7	162.7	90.9	42.7	77.4	46.6	9.9	15.2	61.8	42.7	86.2	43.4	41.2	12.3	63.8	67.4	41.4	66.7	38.4	20.2	26.9	52.3	20.7	92.1	49.7	19.7	35.5	74.0	11.7	10.8	61.9	54.6	6.8	23.9	35.3	52.6	30.7
NREP	"C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17"	ENSG00000134986	"Neuronal regeneration related protein"	Q16612	5	111662621-111997464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 118.3;Excitatory neurons: 116.1;Theca cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"myeloid DC: 24.6;NK-cell: 6.9;plasmacytoid DC: 25.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 425.3;SH-SY5Y: 461.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 1766.0"	"Region enhanced"	"Detected in all"		"cerebellum: 219.5"	HPA000545	Approved		Approved	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA000545: AB_1845721"	"unprognostic (2.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.76e-3)"	18.9	56.5	50.1	19.4	52.6	36.7	29.3	141.8	71.6	32.3	56.9	28.6	16.9	84.8	17.9	23.0	18.2	65.4	70.9	52.5	44.0	49.5	50.7	27.7	17.3	47.8	52.1	41.8	9.8	8.4	13.3	119.8	50.8	52.7	25.2	107.4	36.1	72.2	179.9	22.1	16.7	54.6	44.6	36.9	25.7	12.7	46.4	168.1	18.6	118.2	18.4	27.5	16.8	54.7	0.6	7.1	425.3	91.5	20.2	46.6	20.3	140.9	83.9	135.7	221.0	0.8	2.8	73.1	44.6	71.3	18.9	0.3	91.0	5.2	69.4	29.5	13.0	57.5	35.2	77.6	28.1	77.0	0.8	45.6	22.5	129.5	44.5	318.6	154.2	81.4	0.6	7.4	143.4	1.6	308.3	53.7	244.1	0.2	33.3	326.3	173.4	19.9	52.2	1.6	96.9	461.8	31.6	2.2	2.9	224.2	17.7	210.6	31.1	163.7	54.1	80.8	15.8	34.6	29.3	92.3	35.6	159.8	32.8	0.0	4.0	0.0	0.0	2.2	0.0	1.6	0.1	0.2	24.6	1.1	1.2	1.6	0.1	6.9	1.0	25.1	0.0	2.2	50.1	52.6	141.8	71.6	52.5	44.0	47.8	52.1	50.8	44.6	46.4	54.7	20.8	6.4	30.8	43.1	3.6	18.1	1.6	4.5	14.2	66.9	12.4	22.6	33.4	8.6	5.7	12.9	87.6	118.3	12.9	2.5	33.2	14.4	2.5	5.4	69.1	38.9	21.6	52.2	116.1	5.5	18.6	31.7	31.1	7.4	5.1	69.9	27.5	10.1	35.5	20.2	51.4	9.3	42.7	10.0	19.0	1.0	8.4	14.9	14.2	17.8	11.5	14.9	5.2	37.2	4.6	8.2	2.0	23.3	0.9	0.7	1.2	61.0	0.5	29.0	13.1	25.4	51.8	0.8	12.6	11.9	12.6	31.5	3.2	150.8	11.3	0.2
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Rod photoreceptor cells: 8.8;Sertoli cells: 26.3;Smooth muscle cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	3.9	7.7	3.6	12.4	4.0	5.1	23.4	10.2	7.0	4.8	5.3	2.4	7.4	7.2	2.4	4.8	5.9	5.2	5.8	10.6	12.0	1.6	1.8	4.1	12.4	10.0	8.4	3.0	0.6	2.8	2.6	12.9	4.1	3.0	3.9	3.6	4.9	4.9	2.6	4.7	4.9	8.1	9.1	3.6	2.1	12.0	3.0	5.5	7.5	2.6	4.3	4.7	13.3	0.4	0.9	1.5	0.8	0.0	0.0	1.8	1.1	0.0	0.0	0.0	2.3	1.1	1.2	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.9	1.3	2.0	2.9	0.2	0.0	2.4	1.4	0.0	0.0	0.0	0.0	2.2	0.0	1.3	1.1	2.7	0.0	1.0	1.5	1.2	1.5	0.9	0.4	0.9	1.6	0.7	0.0	1.5	1.1	1.7	0.8	1.2	0.3	2.7	0.8	0.4	1.2	0.6	0.7	0.9	1.6	0.4	0.1	1.8	1.5	1.1	0.8	3.7	0.3	0.1	0.5	0.2	0.3	0.7	0.4	0.5	0.2	0.6	0.8	0.3	0.1	0.4	0.1	0.3	0.1	0.1	7.7	12.4	23.4	10.2	5.8	10.6	12.4	10.0	12.9	8.1	12.0	13.3	0.6	0.0	1.1	0.0	0.2	0.1	0.5	0.0	0.0	5.0	0.1	0.9	1.3	0.0	0.0	1.8	6.2	0.3	0.3	0.0	0.0	0.0	1.6	0.2	0.9	0.6	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.4	0.0	0.1	3.3	3.3	0.0	0.0	0.6	0.3	1.8	0.3	0.5	0.0	2.8	0.0	0.6	3.1	0.5	4.9	0.0	0.0	5.3	0.0	0.3	0.0	0.2	0.0	8.8	26.3	0.5	23.1	0.1	0.3	0.1	0.1	0.0	1.1	0.4	0.0	0.1
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 78.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 134.4;Hepatic stellate cells: 137.8;Hofbauer cells: 141.3;Langerhans cells: 129.8;monocytes: 224.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 123.6;HUVEC TERT2: 105.7;TIME: 106.3;U-251 MG: 217.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039980, HPA054974"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA		29000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA039980: AB_10795517, HPA054974: AB_2682657"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (7.80e-5)"	18.8	22.2	18.0	17.8	13.8	4.6	12.6	9.3	11.7	18.8	7.0	78.7	5.3	51.8	3.7	13.3	21.1	31.1	6.3	21.7	42.5	4.9	9.6	24.3	8.2	30.4	23.9	46.8	1.9	2.5	9.6	47.0	19.6	13.0	10.5	3.6	3.3	30.9	2.3	4.8	14.9	54.8	13.2	7.5	25.9	1.4	33.9	6.1	10.8	3.4	4.5	38.3	15.9	12.4	2.5	50.4	32.2	0.2	30.1	9.6	9.3	8.5	14.8	10.0	9.5	48.0	123.6	0.0	11.9	25.3	20.5	19.2	1.5	15.9	16.8	0.1	6.8	0.5	2.4	0.4	80.7	0.0	2.1	68.5	12.2	14.4	12.3	64.5	105.7	0.2	0.2	0.1	6.8	0.2	0.0	0.0	41.5	0.1	9.2	0.2	2.0	12.0	21.7	0.0	29.0	1.0	1.1	0.3	75.4	84.9	0.1	0.8	106.3	43.1	0.4	11.3	217.0	0.0	0.2	3.2	96.9	0.3	88.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	13.8	9.3	11.7	21.7	42.5	30.4	23.9	19.6	13.2	33.9	12.4	88.7	89.8	57.5	2.0	3.8	19.4	19.5	30.8	97.9	36.5	1.3	11.3	4.5	5.7	53.2	1.8	0.0	89.7	0.1	0.6	0.0	6.4	6.3	8.8	8.1	134.4	1.2	2.7	4.1	3.8	8.7	47.0	1.5	13.2	3.8	2.7	137.8	1.8	141.3	0.0	9.4	1.1	4.1	28.0	129.8	18.9	2.8	53.7	19.6	53.4	224.8	4.8	0.0	4.0	8.1	53.2	0.0	4.9	0.2	9.1	0.0	0.6	48.1	2.7	0.0	4.6	32.2	1.4	1.4	17.8	12.6	25.7	2.4	48.1	0.4	51.5
NRXN2		ENSG00000110076	"Neurexin 2"	"P58401, Q9P2S2"	11	64606174-64723197	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.4;Horizontal cells: 149.7;Inhibitory neurons: 47.8;Late spermatids: 49.7;Muller glia cells: 60.7;Oligodendrocyte precursor cells: 47.3;Peritubular cells: 59.0"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 47.8;SCLC-21H: 22.8;SH-SY5Y: 10.5;U-2 OS: 26.1;U-87 MG: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		1000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 14: REH - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (3.87e-2)"	"unprognostic (1.54e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.23e-1)"	"unprognostic (5.93e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.97e-3)"	"unprognostic (2.39e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.27e-4)"	"unprognostic (5.46e-3)"	3.8	4.7	61.0	2.0	51.6	0.5	2.6	73.6	65.9	27.0	0.0	17.1	1.0	19.0	1.1	0.4	14.6	2.2	3.7	61.9	21.8	5.8	1.0	1.5	1.0	16.0	18.2	15.5	3.0	0.1	4.3	0.7	11.6	4.9	0.6	13.0	1.6	2.9	1.1	0.9	2.7	2.4	4.6	1.5	2.4	15.3	24.8	0.8	4.0	0.3	0.4	5.9	7.4	18.3	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	2.1	0.0	0.3	0.3	2.5	2.0	0.1	3.3	0.0	0.0	0.3	0.4	6.5	0.0	0.0	0.0	0.0	0.5	1.2	0.0	4.5	0.0	0.0	0.0	0.1	0.0	9.0	3.1	0.0	0.7	0.3	7.6	0.0	0.0	47.8	1.4	1.9	0.0	0.0	22.8	10.5	0.1	0.0	0.0	0.1	0.0	0.0	0.3	1.1	26.1	0.5	0.0	0.0	0.0	0.0	18.6	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	61.0	51.6	73.6	65.9	61.9	21.8	16.0	18.2	11.6	4.6	24.8	18.3	0.5	0.0	0.0	13.1	0.0	0.5	0.1	0.0	0.0	72.4	0.2	0.6	3.2	0.0	0.0	1.8	6.2	0.1	0.6	6.3	3.9	0.0	23.6	0.9	23.5	2.5	6.7	2.1	36.0	2.7	0.2	7.3	0.0	0.6	0.0	0.7	2.9	8.6	0.2	149.7	47.8	1.1	0.0	1.2	0.7	49.7	42.6	1.2	0.0	7.5	0.7	60.7	6.2	47.3	26.0	0.4	2.5	59.0	0.0	0.1	5.1	40.9	0.0	21.7	0.0	27.3	4.0	37.5	15.2	0.0	0.1	0.3	0.7	4.9	0.9	0.0
NSMCE1	NSE1	ENSG00000169189	"NSE1 homolog, SMC5-SMC6 complex component"	Q8WV22	16	27224994-27268772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 275.5;Late spermatids: 420.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041567, HPA043091"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA041567: AB_10964260, HPA043091: AB_10962722"	"unprognostic (6.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	43.8	68.3	58.8	32.2	61.7	35.1	52.5	65.2	71.7	43.3	66.0	53.1	25.3	42.3	55.0	45.5	62.2	35.8	47.6	57.4	63.3	58.3	55.9	42.4	54.5	65.5	61.4	45.0	59.3	86.1	37.3	37.3	64.6	57.4	36.8	24.9	46.2	51.7	45.2	40.7	37.0	45.2	64.0	33.5	51.3	79.8	61.3	56.4	53.0	44.9	54.7	51.4	39.1	67.0	56.5	80.6	53.8	58.6	85.8	114.2	43.1	58.9	60.4	44.5	46.1	62.7	134.1	110.0	137.7	91.1	45.7	59.5	101.9	178.6	57.3	136.3	70.6	51.0	68.6	122.1	149.1	59.9	37.4	112.6	122.3	111.7	211.5	127.8	60.3	104.3	69.6	33.8	82.9	96.7	80.0	67.5	46.8	94.0	54.7	69.1	65.8	174.7	129.9	36.3	56.4	51.0	40.2	55.9	104.3	65.1	92.3	71.9	37.8	53.3	33.2	61.1	57.8	101.0	78.1	85.9	114.0	59.4	23.3	125.3	91.2	86.2	78.9	81.6	86.3	84.2	111.1	95.7	128.4	133.1	126.7	99.7	29.6	213.8	81.5	124.6	113.0	120.3	58.8	61.7	65.2	71.7	57.4	63.3	65.5	61.4	64.6	64.0	61.3	67.0	34.8	35.3	36.4	8.5	38.1	28.3	57.6	110.7	33.0	14.9	60.7	83.8	49.6	62.9	58.5	44.1	2.1	126.2	41.2	45.6	129.1	79.2	209.9	40.3	32.9	33.9	58.7	24.0	5.4	73.0	63.3	44.5	17.3	29.6	275.5	37.4	52.8	64.0	83.2	13.5	6.7	65.8	44.7	53.3	45.6	420.8	24.2	39.5	46.2	12.2	98.1	64.7	43.3	12.5	14.8	40.1	45.7	39.9	28.1	49.0	83.9	173.8	94.6	18.8	26.3	58.1	50.1	119.0	39.4	43.5	32.7	64.3	55.3	39.9	46.7	48.3
NTHL1	"NTH1, OCTS3"	ENSG00000065057	"Nth like DNA glycosylase 1"	P78549	16	2039815-2047866	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 866.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025152	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"CAB025152: "	"unprognostic (1.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.62e-2)"	11.7	9.3	13.8	6.2	14.7	4.7	11.0	14.8	19.7	15.5	11.1	16.8	6.6	15.4	3.1	11.3	13.8	6.0	15.8	13.5	14.2	9.8	21.9	10.7	8.4	15.4	13.9	16.1	9.9	4.8	11.5	5.6	15.6	11.2	5.6	1.8	16.0	11.5	9.7	9.3	11.1	5.3	13.6	16.7	13.2	8.7	15.2	7.6	9.6	6.8	5.9	11.8	12.5	14.2	29.8	74.2	20.8	32.2	8.5	15.9	22.8	12.1	13.2	23.1	14.6	53.0	28.8	63.0	25.2	10.7	15.1	26.2	26.1	29.0	4.0	28.9	63.3	19.5	47.7	60.9	11.5	22.4	22.3	13.2	14.9	12.3	13.2	15.4	33.4	37.0	22.2	22.6	9.0	34.9	33.9	88.3	46.2	37.3	47.3	80.8	22.0	103.5	17.2	10.7	43.9	43.5	13.2	41.0	25.4	7.6	29.6	23.5	12.9	19.9	21.5	17.5	23.1	30.3	38.0	26.9	8.8	31.7	24.9	4.2	15.0	3.4	14.4	26.0	16.2	37.5	17.3	16.7	25.7	32.8	12.8	15.4	0.7	19.1	22.5	26.3	34.0	14.4	13.8	14.7	14.8	19.7	13.5	14.2	15.4	13.9	15.6	13.6	15.2	14.2	47.2	28.9	27.5	2.9	12.9	8.7	16.4	21.6	8.0	8.8	18.9	23.4	14.1	44.3	28.3	3.7	0.0	10.5	8.1	75.6	17.6	16.3	8.1	20.4	19.5	36.5	67.4	26.7	3.0	9.1	18.3	17.6	16.3	23.3	5.7	20.5	51.0	866.4	13.4	6.7	3.6	85.3	54.9	25.5	17.6	23.8	33.8	9.3	21.4	2.8	9.7	10.7	18.6	3.0	4.9	12.1	81.6	25.2	16.0	6.4	12.8	28.8	23.5	8.1	13.1	8.1	23.6	5.4	32.0	11.7	10.1	2.7	12.2	20.6	56.8	21.0
NTM	"CEPU-1, HNT, IGLON2, NTRI"	ENSG00000182667	Neurotrimin	Q9P121	11	131370478-132336822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 321.8;choroid plexus: 89.2;retina: 74.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 608.9;Astrocytes: 2164.2;Cone photoreceptor cells: 950.8;Excitatory neurons: 651.0;Inhibitory neurons: 1056.6;Oligodendrocyte precursor cells: 1930.7;Oligodendrocytes: 1257.6;Rod photoreceptor cells: 1415.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	175	"plasmacytoid DC: 17.4"	"Lineage enriched"	"Detected in single"	175	"dendritic cells: 17.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 122.4;U-138 MG: 47.7;U-2 OS: 81.8;WM-115: 166.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB024875	Enhanced				"Intracellular and membrane"	NA	NA		58000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB024875: "	"unprognostic (1.52e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.99e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (4.60e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.31e-3)"	17.9	4.7	137.2	2.3	138.8	0.0	2.9	165.1	321.8	1.6	89.2	12.0	2.5	1.3	0.6	9.4	0.9	9.6	30.5	136.9	131.5	2.3	0.3	25.8	0.4	144.0	135.4	0.3	0.9	22.1	0.9	0.7	143.6	1.9	3.8	74.8	2.7	2.8	0.9	6.1	4.6	4.5	135.0	0.5	2.0	0.6	154.2	0.5	1.1	5.0	0.4	3.5	1.8	158.4	0.1	0.0	7.5	0.1	0.9	22.2	0.0	36.7	19.5	11.7	6.8	0.1	0.0	0.0	0.0	20.3	0.0	0.3	0.0	43.6	12.6	0.1	0.4	0.0	0.0	0.4	0.4	0.0	0.2	2.0	0.0	38.0	45.0	29.0	7.5	0.0	0.0	0.3	122.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	3.9	20.8	0.0	2.4	3.8	0.0	0.0	0.2	1.3	0.0	0.1	8.1	47.7	81.8	2.2	31.6	0.0	0.0	0.2	0.1	0.0	166.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	137.2	138.8	165.1	321.8	136.9	131.5	144.0	135.4	143.6	135.0	154.2	158.4	1.2	608.9	27.6	2164.2	0.0	1.8	0.0	1.5	2.2	225.3	0.9	4.4	13.7	0.0	29.7	20.2	950.8	0.0	5.4	0.4	0.0	0.6	10.9	0.0	0.5	2.9	0.0	2.7	651.0	0.0	0.0	22.2	0.5	0.0	53.0	0.1	0.7	0.0	0.1	40.4	1056.6	0.1	0.0	0.0	3.8	2.2	0.3	0.7	3.6	139.6	0.0	30.5	0.0	1930.7	1257.6	0.1	0.2	0.4	0.1	0.1	0.0	0.1	1.5	1415.0	0.0	20.6	7.5	0.4	0.9	0.5	4.8	0.0	0.8	0.0	0.8	0.1
NUDT21	"CFIM25, CPSF5"	ENSG00000167005	"Nudix hydrolase 21"	O43809	16	56429133-56452199	"Predicted intracellular proteins"	"Differentiation, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 445.9;Late spermatids: 230.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019863, HPA074228"	Uncertain		Supported	"Nuclear bodies,Centriolar satellite"		NA	NA		12000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"	"Centriolar satellite"	"HPA019863: AB_2670299, HPA074228: AB_2686675"	"unprognostic (4.95e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.80e-3)"	"unprognostic (6.87e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	29.5	32.0	23.4	37.7	27.1	64.4	39.4	27.0	28.7	39.7	19.9	39.3	49.3	39.2	27.4	39.9	35.9	28.4	31.4	28.9	32.2	42.6	37.0	27.7	56.7	20.7	22.5	55.8	32.3	40.2	22.0	38.5	25.3	29.6	40.1	36.0	30.5	32.1	28.0	25.0	34.7	34.7	22.6	34.5	34.0	71.0	22.6	58.3	37.7	37.9	65.7	39.7	26.0	26.9	143.8	79.3	144.3	116.8	78.0	110.0	131.1	96.2	112.2	135.9	94.7	167.7	146.6	193.5	98.5	90.5	84.8	129.8	190.2	116.8	206.0	67.2	78.5	126.6	73.0	146.2	63.6	183.0	124.8	65.5	83.4	113.7	80.3	78.2	127.5	145.8	137.5	69.1	111.2	88.1	195.5	130.1	178.9	106.6	133.0	286.2	196.3	165.4	94.5	121.9	161.1	107.2	184.0	88.0	77.6	99.2	107.6	106.5	74.8	107.4	153.3	93.1	104.1	103.1	120.0	364.7	71.4	117.9	100.1	32.0	24.9	32.9	28.0	26.1	27.7	22.8	29.4	26.1	25.8	20.9	27.1	27.4	27.2	25.5	29.2	19.9	49.6	22.2	23.4	27.1	27.0	28.7	28.9	32.2	20.7	22.5	25.3	22.6	22.6	26.9	30.7	28.9	37.8	23.8	45.5	60.9	52.9	78.4	47.8	19.5	46.3	34.3	39.3	27.1	54.4	42.3	18.8	63.8	29.1	29.2	66.5	63.4	445.9	32.9	40.2	45.2	31.1	69.9	26.5	86.5	90.6	45.8	25.0	38.7	35.5	35.9	48.9	39.1	67.2	35.3	27.9	57.7	20.3	58.8	50.5	230.2	44.7	42.7	37.4	13.1	61.1	25.6	18.6	18.1	34.6	62.5	36.0	41.0	70.0	60.3	49.2	78.3	47.7	24.2	39.5	33.9	59.6	217.4	96.9	67.4	60.0	68.3	49.7	39.5	64.0	70.1
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420322	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.4;lymphoid tissue: 41.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 57.7;Granulosa cells: 70.0;NK-cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.7;U-266/84: 261.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	2.0	5.2	5.3	23.2	5.8	53.4	5.4	7.8	6.5	2.3	4.8	6.4	7.3	2.6	8.4	7.1	4.1	4.6	2.3	5.0	6.2	8.8	19.8	7.6	41.3	6.1	6.7	1.2	13.0	9.7	13.5	6.4	5.5	5.4	5.6	4.8	6.4	2.8	5.2	5.6	22.2	2.4	5.2	32.5	8.5	9.2	5.8	41.7	8.1	1.8	29.0	5.8	2.2	7.3	41.5	72.0	34.8	90.8	0.0	0.0	138.1	0.6	0.0	8.6	0.4	37.2	66.3	167.7	55.6	0.1	3.9	23.8	77.5	0.0	3.2	135.9	57.9	65.2	81.1	39.6	0.0	210.8	22.7	0.0	0.0	0.0	0.0	6.3	0.1	124.1	102.5	174.9	0.0	103.8	112.6	83.4	40.2	12.8	14.8	0.2	0.2	232.7	16.9	38.4	39.8	39.8	51.3	67.7	21.0	15.5	64.8	172.6	0.5	0.1	11.7	0.2	31.8	176.1	261.0	144.9	0.1	116.0	0.3	0.0	2.5	0.9	7.3	3.2	5.8	5.4	5.2	7.2	5.4	3.1	4.3	5.8	0.1	5.5	2.0	5.6	4.8	3.7	5.3	5.8	7.8	6.5	5.0	6.2	6.1	6.7	5.5	5.2	5.8	7.3	0.7	16.0	5.4	16.6	37.3	1.7	1.3	0.5	0.0	25.4	9.6	5.3	11.6	8.6	4.1	5.5	14.6	17.6	57.7	2.9	3.9	5.7	19.2	4.3	1.0	1.0	8.3	41.8	17.9	4.4	5.6	1.1	3.6	8.3	5.1	70.0	3.6	17.0	16.7	35.3	23.4	8.8	4.1	11.3	4.9	23.5	0.6	14.9	1.8	10.3	16.7	3.0	69.0	30.2	17.7	2.6	0.8	0.4	43.7	2.6	2.1	4.5	3.0	19.4	0.0	2.1	1.1	6.4	10.0	3.5	2.4	4.9	37.2	17.8	11.5	1.9
OAZ2		ENSG00000180304	"Ornithine decarboxylase antizyme 2"	O95190	15	64687573-64703281	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 324.9;Sertoli cells: 374.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 418.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047694	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA047694: AB_2680121"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (2.09e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-1)"	65.1	68.5	110.1	49.5	111.8	32.9	55.1	112.2	112.5	61.1	108.0	72.4	28.4	64.7	57.2	44.4	59.8	46.9	79.3	110.1	114.5	68.4	89.3	55.8	50.7	112.6	114.6	56.5	35.9	96.8	75.0	75.1	112.4	53.3	35.8	123.4	45.3	49.1	207.9	45.9	40.9	72.3	114.3	89.8	47.7	80.8	114.4	41.7	65.8	152.5	45.4	56.3	48.3	116.4	71.2	63.5	130.6	43.5	91.8	79.4	24.6	80.5	120.6	113.4	98.5	43.5	62.2	61.6	72.7	113.4	84.5	37.5	126.7	71.6	99.2	82.4	48.3	40.3	48.3	32.5	52.2	35.7	125.7	104.4	49.6	57.0	40.1	147.4	109.2	42.9	30.1	29.6	123.4	45.3	24.5	43.8	223.1	39.1	50.7	57.5	74.5	54.0	102.0	55.7	68.4	125.1	30.4	45.0	80.3	161.6	75.6	52.7	66.0	76.4	102.2	38.0	87.0	65.1	104.6	58.2	87.4	75.2	69.8	22.1	145.3	268.4	29.3	247.8	24.2	30.2	24.6	24.0	91.1	29.1	27.9	25.3	418.0	39.5	209.6	49.4	30.7	115.5	110.1	111.8	112.2	112.5	110.1	114.5	112.6	114.6	112.4	114.3	114.4	116.4	67.5	25.6	43.5	15.3	36.1	121.7	99.5	67.7	47.8	93.8	57.9	40.4	61.9	44.3	41.0	42.3	104.3	114.1	33.4	19.2	168.3	109.5	324.9	35.2	30.0	109.3	81.9	33.3	14.6	66.0	70.9	61.3	14.3	20.5	103.3	36.9	134.6	83.6	133.9	74.0	13.6	26.0	91.6	115.4	238.1	80.9	114.3	86.6	103.2	20.6	114.2	268.2	49.4	12.1	26.9	81.8	25.7	68.1	19.1	88.9	29.2	94.2	51.1	180.8	374.7	68.1	160.9	166.2	83.9	28.0	121.2	68.5	31.7	44.3	27.4	72.4
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	67949349-68433913	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 383.9;Oligodendrocyte precursor cells: 600.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	4.1	5.1	20.8	1.8	18.6	3.9	4.5	14.2	19.5	6.0	1.0	3.4	2.5	5.6	3.7	3.8	3.2	2.7	3.1	18.0	14.6	4.3	1.3	4.4	1.9	9.5	11.9	4.5	3.1	3.6	2.7	5.6	5.8	10.1	3.4	11.5	5.4	5.0	6.5	6.4	2.9	4.0	6.1	2.3	3.8	2.6	16.3	1.2	4.7	4.8	1.4	2.3	3.8	11.5	23.6	5.1	3.2	7.3	7.1	6.8	5.0	4.2	5.6	8.3	10.1	3.3	4.5	1.5	13.7	4.9	3.4	5.7	3.1	2.9	12.6	0.9	2.1	5.2	6.9	3.7	2.4	2.1	5.2	4.6	4.8	6.9	6.4	10.6	5.6	1.1	3.2	3.1	4.3	10.1	0.8	1.8	7.5	10.0	4.8	0.9	7.3	1.3	8.5	7.6	1.7	2.8	7.2	9.1	13.7	7.1	6.2	1.6	6.0	5.0	7.3	18.1	4.5	2.9	3.4	1.0	4.0	2.8	3.5	1.0	1.0	0.4	0.5	0.4	0.4	0.5	0.4	0.3	0.4	0.8	0.4	0.5	4.6	0.5	0.6	1.6	0.3	0.2	20.8	18.6	14.2	19.5	18.0	14.6	9.5	11.9	5.8	6.1	16.3	11.5	13.8	16.0	19.3	383.9	0.0	3.2	5.4	2.0	10.2	5.4	6.7	5.0	3.3	2.8	6.4	18.4	6.2	23.0	2.3	3.9	0.0	1.2	2.0	7.2	4.3	8.1	4.2	1.3	84.6	0.8	11.7	18.0	14.8	12.9	8.8	36.3	5.0	0.2	4.6	0.0	78.8	3.0	2.0	2.1	9.5	1.7	21.1	5.9	8.8	54.4	1.2	16.0	3.1	600.2	41.7	1.3	2.4	12.0	0.1	8.5	3.8	1.8	10.9	5.1	0.0	24.1	5.4	0.3	1.9	8.9	5.1	66.9	1.4	4.2	4.1	4.2
OR2I1P	"HS6M1-14, OR2I1, OR2I2, OR2I3P, OR2I4P"	ENSG00000237988	"Olfactory receptor family 2 subfamily I member 1 pseudogene"		6	29550407-29557721	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Ductal cells: 1.0;granulocytes: 1.3;monocytes: 1.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 3: Monocytes - Immune response regulation"				"unprognostic (7.45e-3)"	"unprognostic (1.69e-2)"	"unprognostic (6.00e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.34e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (4.00e-6)"	"unprognostic (8.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0
OR52N4		ENSG00000181074	"Olfactory receptor family 52 subfamily N member 4"	Q8NGI2	11	5754243-5755905	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.7"	"Cell type enhanced"	"Detected in single"		"Excitatory neurons: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (3.44e-2)"	"unprognostic (2.59e-3)"		"unprognostic (4.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.86e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.41e-2)"	0.7	0.2	0.2	0.5	0.2	0.5	0.7	0.0	0.3	0.6	0.1	0.4	0.1	0.6	1.3	0.3	0.9	0.3	0.4	0.2	0.4	0.5	0.2	0.8	1.3	0.4	0.2	1.6	0.1	0.0	0.5	0.0	0.3	0.7	0.3	0.7	0.4	0.7	0.2	0.3	1.8	0.1	0.2	2.7	0.2	0.4	0.1	0.5	0.4	0.1	1.2	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.2	0.0	0.3	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.2	0.1	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402893	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.8;tongue: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 281.4;Excitatory neurons: 314.2;Inhibitory neurons: 404.2;Oligodendrocyte precursor cells: 134.2"	"Cancer enhanced"	"Detected in many"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.8;hTERT-HME1: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	1.3	1.5	4.1	1.0	6.1	0.2	1.7	3.7	16.3	1.1	0.0	1.0	0.7	0.8	0.7	2.4	1.0	1.1	3.8	6.1	8.0	2.7	5.6	4.0	1.1	5.7	6.9	1.4	1.2	0.8	6.7	0.6	5.3	3.1	1.0	8.4	2.2	1.5	33.8	8.7	3.5	1.4	1.7	1.0	0.8	1.3	7.5	1.6	2.3	20.3	0.8	1.0	1.5	8.3	0.0	1.1	8.3	16.9	6.8	7.5	6.3	13.9	7.2	12.0	14.6	1.4	0.2	0.0	0.5	12.9	6.6	0.3	19.6	11.4	20.2	0.2	10.2	48.8	2.9	0.0	4.4	8.0	0.3	5.0	17.6	26.4	50.8	4.3	5.8	6.2	0.9	5.8	15.9	7.0	0.1	0.0	10.0	0.0	10.2	0.0	16.9	3.2	0.9	0.0	6.3	3.8	6.2	1.8	13.7	9.2	2.4	0.1	11.4	13.7	8.5	9.3	16.3	31.8	13.4	0.0	16.3	0.0	6.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	4.1	6.1	3.7	16.3	6.1	8.0	5.7	6.9	5.3	1.7	7.5	8.3	0.7	0.0	7.2	281.4	0.0	13.3	2.1	1.3	7.4	59.4	2.1	1.7	15.2	4.3	6.5	0.0	25.0	0.2	0.0	0.1	1.9	0.6	1.0	4.4	1.0	1.7	1.8	0.0	314.2	0.8	4.9	4.3	0.0	0.4	7.0	2.0	0.0	6.2	3.9	1.7	404.2	6.0	4.1	3.5	1.0	1.1	0.0	0.7	5.4	62.8	0.0	10.6	0.0	134.2	10.3	0.2	0.0	1.5	1.5	2.2	9.5	6.2	78.2	6.9	0.0	25.4	5.8	0.1	2.1	6.4	20.9	0.1	0.9	14.5	1.4	0.5
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 216.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	27.5	38.1	17.9	18.1	23.8	30.1	32.6	26.3	23.5	25.5	28.3	20.8	17.4	31.1	31.0	17.7	23.3	17.6	37.0	17.6	23.9	42.8	60.8	27.5	25.9	25.0	21.8	30.5	33.3	60.0	21.1	21.8	26.6	27.8	19.1	53.5	22.0	22.4	70.0	19.6	21.7	24.2	23.0	27.2	34.3	28.4	22.2	21.8	24.7	35.2	33.0	23.7	24.7	32.2	66.3	31.7	69.0	11.2	38.1	17.9	90.7	30.1	50.8	54.9	60.0	53.0	46.6	105.8	54.4	34.1	120.9	26.9	59.2	57.4	76.9	71.9	41.9	77.4	62.7	104.7	36.9	81.7	35.5	44.7	55.0	56.8	31.4	66.8	68.9	52.1	154.4	31.1	26.7	45.4	20.3	92.5	97.0	26.8	15.1	58.2	102.8	110.5	74.0	47.4	31.8	45.2	22.4	79.6	93.7	154.7	38.0	82.8	22.9	11.6	51.2	17.2	58.1	80.2	52.5	120.4	39.3	32.8	23.0	52.7	12.2	30.5	20.1	9.9	28.9	32.6	19.7	20.8	25.0	23.9	21.0	22.2	16.9	16.3	9.4	23.2	20.5	16.4	17.9	23.8	26.3	23.5	17.6	23.9	25.0	21.8	26.6	23.0	22.2	32.2	32.5	80.1	56.8	75.4	39.2	17.7	33.8	25.7	34.1	102.0	34.2	33.0	47.9	38.6	50.5	46.0	41.7	89.2	30.4	20.5	125.2	47.6	40.7	36.3	46.3	30.1	29.8	35.7	64.8	47.8	50.2	48.6	54.0	52.9	33.6	75.7	18.2	61.7	40.1	26.9	113.0	18.3	38.7	22.7	16.0	38.3	62.4	25.3	65.8	63.7	50.1	43.8	29.9	62.8	216.4	41.9	14.3	50.0	81.4	38.5	26.4	59.7	32.1	35.3	46.0	36.9	62.9	32.3	18.9	26.9	18.9	75.5	32.0	52.2	21.2	27.4
OSR2	FLJ90037	ENSG00000164920	"Odd-skipped related transciption factor 2"	Q8N2R0	8	98944403-98952104	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 166.1;endometrium 1: 155.1;fallopian tube: 155.3"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 243.1;Leydig cells: 784.1;Peritubular cells: 758.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	16	"ASC diff: 542.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052425, HPA063486"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane"	Nucleoplasm	"HPA052425: AB_2681826, HPA063486: AB_2685022"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.73e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-7)"	"unprognostic (1.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.54e-3)"	45.0	9.9	0.0	2.4	0.0	0.6	26.0	0.2	0.2	166.1	0.0	9.2	0.6	155.1	53.7	15.1	155.3	12.9	4.2	0.0	0.0	1.3	0.3	3.6	2.4	0.0	0.0	93.2	4.2	3.0	2.7	8.2	0.0	40.2	3.8	0.0	6.8	72.2	5.6	27.9	24.9	47.1	0.0	0.2	5.1	35.6	0.0	0.8	5.6	5.1	1.1	27.2	83.8	0.0	32.3	4.5	0.0	4.4	542.4	17.2	4.3	17.6	33.1	13.7	13.6	3.4	3.9	0.0	2.9	26.7	0.8	12.4	2.7	4.7	6.7	1.5	13.0	0.6	3.3	1.6	8.9	0.9	0.6	17.0	9.8	2.3	1.6	0.8	0.0	4.8	4.0	0.4	0.6	14.6	2.9	5.7	0.0	2.6	2.8	13.8	1.6	1.1	1.1	2.7	1.4	0.1	1.9	7.5	0.4	0.3	4.3	7.5	0.2	2.1	0.1	13.9	1.0	0.7	0.5	0.3	0.9	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.9	14.1	6.6	3.4	1.2	0.0	7.9	5.3	0.7	0.0	3.3	0.0	0.0	17.2	0.9	0.7	0.0	0.0	5.8	7.8	243.1	3.7	0.0	0.0	0.0	0.0	138.4	71.7	0.5	5.9	0.0	0.2	0.0	0.0	9.3	0.0	0.0	18.4	10.2	1.9	21.9	24.1	784.1	2.7	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	758.3	4.6	3.6	103.9	0.1	1.7	0.0	32.9	8.8	21.3	5.1	4.5	0.3	9.1	24.2	2.3	95.6	22.3	2.2
OTC	OTCase	ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352586-38421446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	124	"intestine: 112.4;liver: 377.8"	"Group enriched"	"Detected in some"	5	"Hepatic stellate cells: 38.9;Hepatocytes: 99.6;Proximal enterocytes: 82.0;Undifferentiated cells: 25.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		2200000		"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			1.2	0.0	0.2	0.5	0.3	0.0	0.2	0.3	0.4	0.4	0.1	5.0	112.4	0.7	0.0	0.4	0.5	0.4	0.3	0.2	0.3	0.1	377.8	0.9	0.1	0.3	0.3	0.1	1.7	0.0	0.0	0.0	0.4	0.0	2.5	0.1	0.1	0.1	0.0	0.0	87.4	0.5	0.3	0.0	1.9	0.4	0.3	0.0	0.3	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	7.4	0.1	0.0	1.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	38.9	99.6	0.0	0.0	0.5	8.3	0.0	3.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	82.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.3	0.0	25.3	0.0
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696240	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.7;lymphoid tissue: 78.2"	"Group enriched"	"Detected in some"	4	"B-cells: 94.6;Plasma cells: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"memory B-cell: 76.4;naive B-cell: 84.8"	"Lineage enriched"	"Detected in many"	20	"B-cells: 84.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 53.2;Karpas-707: 32.7;RPMI-8226: 59.5;U-698: 47.1"									"HPA021948, HPA067827"	Supported		Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA021948: AB_1854878, HPA067827: AB_2685908"	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.8	0.3	1.8	30.4	2.2	9.4	0.8	0.2	2.7	0.3	0.0	2.4	1.5	0.1	0.0	0.7	0.3	1.3	8.0	2.1	0.9	0.7	0.5	1.4	78.2	0.6	0.5	0.0	0.2	0.2	1.2	0.2	0.7	0.5	1.9	0.4	1.8	0.0	17.5	0.0	24.7	0.5	0.1	54.4	3.4	0.7	1.1	12.1	0.9	4.0	53.9	2.7	0.3	1.4	8.3	6.7	0.0	0.0	0.2	1.3	0.0	8.4	3.9	0.9	2.6	5.5	9.8	53.2	4.9	4.2	2.9	4.3	18.8	0.0	1.7	0.9	3.2	2.7	17.5	6.3	1.2	3.6	4.2	2.1	1.8	0.2	12.4	6.5	0.0	12.2	0.5	32.7	18.2	0.0	23.4	8.1	4.9	4.4	20.5	0.8	0.0	59.5	0.2	6.3	4.3	0.0	7.5	2.5	3.9	0.0	2.0	3.3	0.1	0.0	4.5	0.2	1.5	11.0	25.2	47.1	0.0	5.1	0.5	0.0	0.1	2.0	3.1	0.0	4.2	76.4	2.8	2.2	0.4	84.8	0.3	0.3	0.0	0.0	0.0	0.1	1.9	4.5	1.8	2.2	0.2	2.7	2.1	0.9	0.6	0.5	0.7	0.1	1.1	1.4	0.1	0.0	0.6	0.0	94.6	0.4	0.1	0.0	0.0	0.8	0.1	0.1	2.7	0.0	0.0	1.8	0.0	0.0	13.4	0.0	0.0	0.2	4.8	0.2	0.2	0.7	0.0	11.1	0.0	0.2	0.0	0.3	0.5	0.3	4.5	0.0	1.4	0.4	0.2	0.0	0.0	0.1	0.0	1.2	0.0	3.1	1.5	1.6	3.6	0.0	1.1	0.0	2.1	0.0	0.0	1.5	0.0	0.0	29.7	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.9	1.0	0.8	0.0	0.0	0.0	11.0	0.0	0.1	0.1
PACRG	"FLJ32724, Glup, HAK005771, PARK2CRG"	ENSG00000112530	"Parkin coregulated"	Q96M98	6	162727132-163315492	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 35.7;testis: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 310.9;Excitatory neurons: 124.3;Inhibitory neurons: 174.9;Late spermatids: 369.8;Respiratory ciliated cells: 118.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066293	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA066293: AB_2685652"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.93e-3)"	0.8	2.5	13.6	1.1	15.2	5.7	2.0	5.9	14.2	2.3	13.2	1.2	1.4	5.3	9.7	3.0	35.7	5.1	13.0	11.9	12.5	10.2	4.8	3.8	1.4	15.1	15.7	4.2	4.3	2.0	23.7	0.4	10.9	3.4	2.4	7.5	2.2	3.6	2.1	4.6	0.8	2.1	9.4	1.8	2.3	29.5	13.5	0.7	4.0	1.3	1.0	4.4	0.9	24.2	0.5	1.7	0.7	1.0	0.0	0.6	1.2	0.4	1.6	0.0	0.3	3.5	0.4	3.2	0.4	0.0	0.3	1.4	0.8	0.0	1.7	0.0	1.1	0.0	1.9	0.0	0.0	0.4	0.5	1.0	0.0	0.5	0.0	0.6	0.0	1.1	0.5	0.7	0.3	0.1	0.2	1.2	0.0	2.8	2.9	0.6	0.0	0.0	3.6	3.6	6.9	3.1	0.0	0.0	0.0	0.2	0.0	1.1	1.2	0.7	0.3	0.0	0.2	1.3	0.5	1.2	0.3	0.8	1.3	2.3	0.7	0.7	0.7	0.2	0.5	0.3	1.1	0.4	0.1	0.6	1.4	0.6	2.5	0.0	0.1	0.5	0.5	0.2	13.6	15.2	5.9	14.2	11.9	12.5	15.1	15.7	10.9	9.4	13.5	24.2	0.3	0.0	1.7	61.0	0.1	0.3	4.2	8.7	2.8	1.3	1.3	3.0	41.0	0.0	8.9	5.5	8.4	0.1	0.0	0.1	54.8	3.4	310.9	67.0	3.1	1.2	6.6	0.0	124.3	7.1	0.1	1.2	0.0	1.9	0.0	0.7	0.7	3.9	0.1	0.0	174.9	0.3	10.2	0.6	0.3	369.8	3.7	0.4	0.0	11.2	0.0	6.0	0.0	59.3	20.0	1.6	1.2	2.6	0.1	3.2	0.0	6.3	118.4	8.1	0.0	1.1	2.2	53.4	6.1	1.1	0.3	0.3	0.3	2.9	0.4	2.7
PAGR1	"C16orf53, GAS, MGC4606, PA1"	ENSG00000280789	"PAXIP1 associated glutamate rich protein 1"	Q9BTK6	16	29816152-29822489	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 166.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Plasma cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041440, HPA043608"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"			"HPA041440: AB_10795541, HPA043608: AB_10797144"	"unprognostic (2.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.09e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.39e-2)"	23.5	27.8	10.2	5.5	10.8	6.5	23.2	18.4	12.3	120.8	8.9	48.9	8.7	55.3	7.1	25.7	68.4	6.1	32.0	10.1	9.9	30.4	28.1	23.0	8.7	10.9	10.7	166.5	26.3	7.4	128.9	3.7	10.8	69.3	5.7	6.8	21.4	8.8	24.6	18.0	30.8	4.7	10.5	23.6	26.4	31.2	10.6	9.3	30.2	9.0	6.8	50.7	73.8	12.5	16.7	24.1	13.9	8.7	7.0	6.7	11.8	12.7	11.5	14.5	12.7	17.1	16.9	33.4	12.7	9.1	7.2	15.4	15.2	19.1	9.2	14.8	31.1	14.8	16.4	16.1	7.3	23.6	26.9	7.5	15.1	10.2	10.0	13.4	12.1	31.0	20.1	10.4	9.9	45.2	18.6	27.6	19.3	14.2	20.4	35.4	24.5	24.9	10.8	7.8	34.9	13.2	9.6	22.4	9.7	10.5	20.9	15.0	9.2	12.0	10.9	15.2	12.9	19.4	21.3	13.1	15.8	24.2	15.0	22.5	16.9	33.0	19.7	17.0	22.1	19.7	16.8	20.0	21.3	19.5	21.7	20.1	11.0	13.9	19.6	21.5	12.7	15.2	10.2	10.8	18.4	12.3	10.1	9.9	10.9	10.7	10.8	10.5	10.6	12.5	1.3	0.0	9.8	66.6	15.2	0.0	0.3	0.1	18.2	3.5	4.7	2.9	0.6	14.3	6.9	1.8	0.0	5.6	5.3	5.9	0.0	27.9	0.5	1.0	1.3	3.8	14.6	10.7	16.2	21.7	8.2	4.4	13.3	0.8	7.6	0.3	6.1	2.0	7.5	5.0	16.5	11.1	0.0	5.6	0.0	0.6	0.9	7.7	0.0	9.4	22.5	1.9	4.1	11.6	8.6	13.5	15.8	3.4	34.5	0.7	20.7	2.1	3.0	3.3	0.0	0.9	5.0	3.1	1.6	16.7	0.4	6.7	10.9	0.2	13.2	0.2
PAIP1		ENSG00000172239	"Poly(A) binding protein interacting protein 1"	Q9H074	5	43526267-43557758	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073653, HPA076187"	Approved		Enhanced	"Plasma membrane,Cytosol"		No	No		60000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"HPA073653: AB_2732234, HPA076187: AB_2686784"	"unprognostic (4.70e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	69.5	54.3	47.8	36.6	50.8	56.6	67.4	52.0	64.2	65.1	52.0	57.1	43.3	61.6	57.3	52.0	51.2	53.3	92.5	51.2	52.0	78.0	90.9	50.3	39.4	49.5	49.5	53.7	54.8	74.3	29.3	68.1	50.8	69.1	54.8	95.2	51.3	68.5	155.3	31.1	40.2	65.3	54.3	34.2	46.9	83.6	49.0	47.6	73.6	122.9	45.3	70.1	39.9	56.5	94.5	82.2	158.0	153.7	161.8	127.1	129.1	81.2	180.0	151.5	130.9	77.2	112.8	62.5	136.9	115.5	227.3	60.4	249.3	98.0	153.5	52.2	96.7	49.2	157.1	122.6	142.3	74.2	74.3	135.8	186.1	102.5	191.7	153.1	146.8	45.9	115.9	82.1	153.0	101.7	82.4	101.8	78.5	89.4	104.8	63.8	119.2	88.1	188.8	114.3	89.4	135.3	260.3	99.2	190.0	144.0	141.4	106.3	82.4	136.6	112.5	68.8	103.7	61.7	112.6	94.3	79.7	113.1	120.4	40.4	24.1	46.2	18.9	20.7	25.2	26.4	23.2	26.2	23.7	26.7	28.9	23.2	8.6	24.9	22.5	66.8	23.0	22.1	47.8	50.8	52.0	64.2	51.2	52.0	49.5	49.5	50.8	54.3	49.0	56.5	66.4	32.1	52.2	15.0	39.4	73.3	74.0	78.5	52.3	48.8	78.8	53.1	122.4	78.6	52.7	44.1	20.9	76.3	66.0	33.1	158.5	120.3	182.6	73.8	56.4	71.2	44.9	54.9	30.0	91.6	89.2	64.2	39.3	55.9	24.6	47.4	50.0	49.2	59.4	35.3	25.3	52.1	103.7	40.9	39.7	58.0	76.4	42.0	83.6	20.6	53.8	86.6	24.7	26.7	35.1	116.4	43.8	66.5	43.3	106.4	45.1	148.8	40.9	67.7	26.3	70.2	71.4	171.2	76.6	56.0	66.3	68.1	35.1	49.7	47.7	84.3
PAIP2	PAIP2A	ENSG00000120727	"Poly(A) binding protein interacting protein 2"	Q9BPZ3	5	139341587-139369720	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 834.4;Late spermatids: 2779.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035945, CAB037212, HPA056766"	Approved		Supported	Vesicles		NA	NA		21000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB037212: AB_1841072, HPA035945: AB_10672996, HPA056766: AB_2683231"	"unprognostic (1.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.80e-3)"	"unprognostic (7.70e-3)"	"unprognostic (8.91e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.92e-2)"	103.3	148.6	107.9	77.2	107.9	115.7	90.3	120.0	149.6	77.3	119.9	79.1	44.2	94.1	85.6	68.8	91.6	66.5	173.1	107.8	118.9	104.7	114.2	73.1	109.0	119.5	114.0	112.3	64.2	88.9	96.2	93.7	123.8	84.3	53.9	168.9	92.1	82.4	169.6	48.2	50.0	83.1	119.1	92.1	58.1	169.0	110.0	147.4	74.6	161.9	107.7	81.4	54.3	138.9	91.9	102.7	196.2	118.5	144.0	81.3	95.6	81.9	113.6	104.7	163.6	138.5	86.7	160.7	170.8	62.3	120.1	88.9	173.5	112.5	137.4	155.7	136.4	148.5	145.7	125.8	93.0	92.8	105.4	93.2	92.4	78.5	88.8	112.9	108.7	173.3	143.7	138.6	95.8	121.1	254.3	227.3	118.9	130.5	74.6	140.0	248.1	177.2	84.0	163.2	90.9	165.2	121.2	110.7	251.2	245.4	214.4	192.6	66.9	55.9	67.9	61.3	67.3	200.0	262.6	167.8	98.2	161.6	58.9	569.5	292.2	735.8	286.2	329.3	317.0	378.7	314.7	330.4	292.0	337.7	364.4	356.5	800.5	347.5	380.6	298.7	449.5	577.2	107.9	107.9	120.0	149.6	107.8	118.9	119.5	114.0	123.8	119.1	110.0	138.9	154.8	73.7	87.5	26.4	173.8	159.8	164.3	168.2	79.1	102.4	108.2	98.0	59.7	97.2	100.9	99.3	58.4	198.6	253.1	74.0	170.2	126.4	834.4	228.6	109.2	126.9	97.0	190.0	40.6	115.1	134.1	129.5	38.7	109.0	109.0	108.2	123.1	103.8	142.3	97.6	46.6	57.7	120.1	142.2	196.1	2779.9	160.9	170.6	135.2	29.0	239.2	158.5	247.2	29.7	59.9	122.5	64.7	155.3	146.8	232.8	62.1	256.2	149.4	93.6	170.9	87.7	180.3	432.3	238.1	57.0	208.3	479.7	191.3	145.8	59.5	178.3
PAMR1	"DKFZP586H2123, RAMP"	ENSG00000149090	"Peptidase domain containing associated with muscle regeneration 1"	Q6UXH9	11	35431823-35530300	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Astrocytes: 380.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 86.9;ASC TERT1: 354.7;BJ hTERT+: 357.7;fHDF/TERT166: 86.7;HSkMC: 123.1;U-87 MG: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA		5600000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (3.38e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.00e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.08e-5)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.08e-1)"	"unprognostic (9.98e-2)"	"unprognostic (8.25e-2)"	32.8	14.9	25.1	0.6	27.4	0.0	15.4	22.0	23.2	59.9	13.9	14.9	4.5	58.2	18.3	10.0	22.6	20.3	23.2	22.5	26.2	7.1	12.6	5.9	1.3	37.9	35.9	3.4	5.3	1.7	6.4	55.9	32.4	21.2	6.6	0.9	5.7	17.9	2.7	19.8	9.9	14.9	46.1	5.7	5.4	0.2	34.1	2.8	7.0	9.0	1.7	28.0	41.3	38.8	0.0	0.0	0.1	0.0	86.9	354.7	0.1	42.8	357.7	4.9	8.3	32.7	0.0	0.0	0.0	86.7	0.1	0.1	0.0	0.0	3.3	0.0	0.8	0.0	0.0	0.0	50.1	0.0	0.0	123.1	1.8	9.7	1.3	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.7	0.0	0.2	0.0	0.2	0.2	0.0	8.4	0.1	0.0	0.0	0.0	0.0	14.3	2.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.0	82.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	27.4	22.0	23.2	22.5	26.2	37.9	35.9	32.4	46.1	34.1	38.8	2.5	0.0	0.0	380.3	0.0	19.1	1.4	14.8	1.2	0.1	0.7	19.7	1.3	0.0	2.4	1.8	0.0	2.2	0.0	0.0	0.0	1.4	0.1	4.5	26.2	1.1	0.0	0.0	13.1	0.0	1.4	50.2	1.1	0.8	0.0	0.6	0.0	0.0	2.0	0.0	8.2	0.2	0.0	0.0	5.5	0.1	0.3	0.5	1.8	28.1	0.6	0.0	0.0	9.5	1.4	0.1	0.0	0.0	0.0	0.4	0.2	0.0	1.8	0.2	0.0	1.6	5.8	0.0	0.2	0.1	9.2	3.4	0.6	0.2	0.0	0.2
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845601	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 56.8"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 140.7;Extravillous trophoblasts: 71.9;Muller glia cells: 41.4;Oligodendrocytes: 37.6;Syncytiotrophoblasts: 74.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8;renal cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 19.8"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 5.6"	"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"	NA	NA		2000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.5	0.3	0.3	0.0	2.5	0.3	0.4	6.6	0.0	0.6	0.0	0.6	0.3	0.0	0.2	1.8	0.3	0.5	0.2	6.3	0.6	0.1	0.0	0.5	0.5	0.0	2.5	0.0	1.1	56.8	0.6	0.2	0.5	3.7	0.1	0.6	0.0	0.1	0.2	0.5	0.4	0.0	1.6	0.4	0.3	0.0	0.5	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	4.3	2.1	3.5	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.5	0.5	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.3	1.6	1.3	0.1	0.6	0.3	0.4	0.0	19.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.4	0.5	0.2	0.5	0.5	0.6	0.4	0.3	0.4	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.8	0.0	0.0	5.5	0.0	1.5	0.0	0.1	11.7	0.0	2.6	0.2	0.1	0.3	140.7	0.0	16.3	0.2	71.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.0	10.8	0.2	0.0	0.0	0.0	1.9	11.5	0.0	0.0	2.8	0.0	41.4	0.0	5.0	37.6	0.8	0.0	10.9	0.0	0.0	0.0	0.5	0.0	2.4	6.6	0.0	1.2	1.3	2.2	0.0	0.0	74.0	0.0	0.0	0.2	0.1
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545475-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 490.7;Microglial cells: 183.6;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;BJ hTERT+: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	9.1	2.8	6.0	1.7	7.3	0.0	5.5	5.3	5.3	4.9	9.3	12.6	3.6	5.1	3.7	4.0	6.5	4.5	4.0	4.6	9.2	6.9	3.4	5.4	2.1	9.3	12.2	7.3	4.9	9.2	1.9	4.4	8.3	4.8	5.5	2.5	3.0	5.2	2.7	4.5	4.2	5.2	8.4	3.1	4.5	3.8	8.0	1.4	5.6	3.6	2.5	5.9	4.0	7.4	2.5	2.1	6.3	2.3	17.8	8.9	3.4	3.8	12.5	3.5	3.8	6.2	1.7	0.0	4.3	7.8	2.8	0.3	0.8	1.0	3.6	0.2	2.9	8.8	5.2	0.0	1.8	0.0	0.5	3.4	1.7	1.2	5.2	5.3	5.2	0.8	0.2	0.1	4.5	1.0	0.0	0.0	0.8	0.9	0.5	0.0	2.7	2.1	3.7	2.5	0.7	2.0	2.0	1.9	1.7	6.2	3.1	0.0	10.9	2.7	1.7	5.5	1.8	0.0	0.0	0.0	2.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.3	5.3	5.3	4.6	9.2	9.3	12.2	8.3	8.4	8.0	7.4	9.5	9.6	8.6	490.7	0.5	11.0	3.3	2.4	6.8	0.5	5.6	5.8	10.8	15.7	14.5	29.5	0.0	3.2	0.2	12.4	0.0	8.7	76.6	8.5	4.0	6.8	6.0	0.8	5.6	2.4	0.2	16.2	11.7	7.4	1.3	14.1	8.2	4.5	0.5	5.0	50.8	9.2	2.0	1.0	4.3	26.0	31.1	0.6	7.2	183.6	0.1	9.7	0.0	159.3	104.2	6.5	15.9	57.9	1.4	5.0	9.4	4.8	17.0	0.3	19.7	23.5	9.6	1.4	2.9	3.5	4.7	1.1	1.0	2.3	8.0	5.3
PARD6G	"PAR-6G, PAR6gamma"	ENSG00000178184	"Par-6 family cell polarity regulator gamma"	Q9BYG4	18	80157232-80247514	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 39.6;Oligodendrocyte precursor cells: 25.6;Squamous epithelial cells: 25.3;Suprabasal keratinocytes: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.4;hTCEpi: 34.0;RT4: 27.9;U-2 OS: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047017	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA047017: AB_2679904"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.80e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.85e-1)"	"unprognostic (2.72e-1)"	3.4	1.7	5.8	1.4	5.7	0.6	5.3	3.8	7.9	9.6	6.8	6.0	1.8	6.5	2.7	18.0	6.2	3.3	2.9	9.3	7.8	7.0	3.5	2.9	2.5	6.3	5.8	6.2	2.1	2.1	3.8	5.5	5.5	5.7	2.0	1.8	4.5	5.9	1.9	38.1	3.0	5.4	4.6	2.0	2.7	2.1	8.3	5.3	18.0	1.0	4.3	5.6	12.0	5.9	3.0	4.3	17.7	13.4	0.6	0.7	12.9	3.3	0.7	2.9	0.4	1.2	1.2	0.0	1.4	1.5	5.1	13.4	6.4	19.2	2.8	0.5	5.7	0.2	3.5	10.4	0.8	4.0	36.4	5.7	34.0	0.3	1.8	2.2	1.4	4.2	1.4	0.8	4.3	5.0	3.6	0.4	5.3	1.4	5.2	0.1	11.7	1.5	0.5	27.9	7.4	7.7	4.1	2.2	20.0	8.6	2.6	3.4	1.1	5.9	28.8	2.2	1.6	0.9	1.2	0.3	1.9	0.9	11.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	5.7	3.8	7.9	9.3	7.8	6.3	5.8	5.5	4.6	8.3	5.9	3.3	3.2	0.6	7.5	0.7	39.6	13.7	11.0	18.8	1.3	4.1	10.3	2.8	1.5	2.3	3.7	0.0	0.6	9.7	0.4	0.0	0.4	0.5	9.8	10.1	8.2	0.0	0.0	6.5	0.2	9.5	4.1	0.5	3.3	0.0	3.1	10.8	1.5	0.8	0.0	8.5	0.7	8.2	0.9	6.5	0.7	1.8	0.8	12.4	15.9	0.0	2.0	0.0	25.6	4.8	0.8	0.0	1.9	3.6	6.6	0.0	7.6	2.6	2.5	19.7	1.9	13.6	1.5	6.0	25.3	63.9	0.4	8.0	2.0	0.6	13.4
PARVG		ENSG00000138964	"Parvin gamma"	Q9HBI0	22	44172956-44219533	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.7;lymphoid tissue: 30.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 56.9;dendritic cells: 51.7;granulocytes: 60.1;Hofbauer cells: 66.7;Kupffer cells: 87.3;Langerhans cells: 53.4;Macrophages: 91.9;monocytes: 62.0;T-cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HL-60: 116.4;NB-4: 44.9;THP-1: 64.7;U-937: 53.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031833, HPA031834"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"HPA031833: AB_2674063, HPA031834: AB_10601242"	"unprognostic (9.83e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.89e-2)"	3.5	2.9	3.7	26.7	3.5	49.7	1.8	4.4	7.1	2.6	4.0	3.1	3.6	2.4	0.6	2.5	2.2	6.2	1.3	3.8	4.7	1.8	3.1	10.4	30.1	8.2	4.9	0.8	1.4	0.5	1.3	3.0	6.9	2.1	3.4	0.2	2.6	1.1	1.2	1.7	12.7	2.9	5.9	28.9	4.4	1.7	7.9	18.4	1.9	0.4	26.8	4.7	1.5	9.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	116.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	16.8	44.9	0.1	0.0	0.0	9.2	0.2	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	64.7	0.0	0.0	11.5	0.2	0.0	0.3	0.0	0.3	0.0	53.9	1.9	12.5	62.0	71.3	13.9	57.6	13.9	21.4	8.0	15.2	49.2	20.4	8.9	10.3	72.2	13.1	65.9	33.3	12.1	44.6	3.7	3.5	4.4	7.1	3.8	4.7	8.2	4.9	6.9	5.9	7.9	9.4	1.3	6.4	14.0	1.0	56.9	2.4	0.1	0.0	0.6	0.2	0.7	1.5	1.1	0.0	3.1	0.0	0.0	0.6	51.7	0.1	0.0	0.0	4.2	3.7	0.4	2.9	0.0	10.1	3.9	0.2	0.7	2.3	3.6	2.5	60.1	0.0	3.9	1.3	66.7	0.0	2.9	0.0	0.0	87.3	53.4	2.7	0.0	91.9	5.4	10.3	62.0	0.0	26.8	0.0	1.4	0.0	0.0	0.0	15.9	0.0	0.0	0.5	1.5	0.2	0.0	0.5	0.4	1.1	0.8	0.4	1.8	1.0	48.3	0.0	0.1	0.1
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.2"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		5900000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	22.2	5.2	2.6	7.9	3.0	0.1	13.5	2.8	3.2	25.3	2.6	12.2	9.3	30.4	11.2	6.4	11.7	22.5	6.5	2.5	4.8	7.1	2.1	7.2	1.7	4.1	5.8	21.0	1.5	2.0	2.4	44.2	3.8	17.5	13.8	2.1	6.5	13.5	2.6	4.1	8.7	18.4	3.2	6.4	6.7	4.5	3.9	3.6	5.1	23.2	1.4	10.8	8.4	3.0	0.0	0.3	148.2	0.0	175.0	190.8	0.1	27.4	86.8	5.0	7.7	0.3	0.0	0.0	0.1	143.3	0.4	0.4	34.2	0.7	2.6	0.2	1.0	0.0	0.0	0.0	129.4	0.0	0.1	195.9	0.3	9.4	3.8	4.7	1.0	0.7	0.0	0.6	2.8	0.0	3.9	0.1	0.3	0.0	2.7	11.7	4.1	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.2	38.3	0.9	0.0	0.0	69.3	4.2	13.9	0.5	0.2	0.0	0.0	3.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	2.8	3.2	2.5	4.8	4.1	5.8	3.8	3.2	3.9	3.0	3.4	0.0	0.5	1.3	0.0	4.1	0.4	0.1	2.2	2.5	1.1	1.7	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	1.9	72.3	3.0	0.0	0.0	0.2	0.0	0.3	56.3	0.0	1.7	0.0	6.4	2.5	0.0	3.1	0.0	9.0	0.0	0.0	0.0	7.8	1.3	37.9	0.9	1.8	10.3	0.0	6.8	0.0	0.0	0.6	0.0	0.0	58.6	0.1	0.0	0.0	0.1	0.0	0.2	19.7	6.6	25.5	0.6	0.1	1.2	2.6	0.8	0.7	18.5	0.0	0.1
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 4.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.5;Endometrial stromal cells: 9.2;Horizontal cells: 10.1;Sertoli cells: 6.6;Skeletal myocytes: 5.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 15.8;ASC TERT1: 6.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	1.0	0.6	1.0	0.3	1.6	0.1	1.2	4.9	1.1	2.5	0.0	1.1	0.1	2.0	0.6	0.8	1.4	1.1	1.9	1.2	1.2	0.3	0.2	1.1	0.2	2.2	2.1	2.0	0.6	0.6	0.9	0.6	1.0	1.4	0.3	1.2	0.8	0.9	0.6	0.7	0.4	1.0	1.2	0.2	0.5	0.3	1.2	0.3	0.5	0.7	0.1	1.0	1.3	2.0	0.0	0.4	0.2	0.1	15.8	6.2	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.8	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.5	0.6	0.3	0.5	0.6	0.1	0.0	0.3	0.8	0.6	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.2	1.4	0.0	0.9	0.5	0.1	0.9	0.6	0.1	0.9	0.1	0.3	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	1.0	1.6	4.9	1.1	1.2	1.2	2.2	2.1	1.0	1.2	1.2	2.0	1.8	0.0	1.1	0.0	0.2	0.1	0.8	0.1	0.6	11.5	0.3	0.4	2.6	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.4	9.2	1.9	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.2	1.3	0.6	1.4	0.3	0.1	10.1	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.5	0.0	0.1	0.1	1.3	6.6	5.7	1.7	0.0	0.3	0.3	0.0	0.0	0.6	0.9	0.0	0.4
PCED1B	"FAM113B, MGC16044"	ENSG00000179715	"PC-esterase domain containing 1B"	Q96HM7	12	47079603-47236662	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.1;lymphoid tissue: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.3;Excitatory neurons: 32.4;Granulosa cells: 47.8;Hofbauer cells: 37.6;Microglial cells: 60.0;T-cells: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 63.3;K-562: 48.9;SK-BR-3: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043901	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	Vesicles	"HPA043901: AB_10959888"	"unprognostic (1.71e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.36e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (4.55e-6)"	"unprognostic (4.79e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.74e-2)"	"prognostic favorable (5.36e-5)"	6.5	40.1	3.4	17.9	3.2	10.6	6.1	2.7	3.3	6.7	2.3	10.1	2.2	8.7	2.0	3.1	9.3	5.9	3.3	2.4	3.7	6.0	3.9	9.1	36.0	4.8	5.3	23.4	2.7	1.2	2.3	3.6	4.4	5.8	2.7	0.8	3.3	2.3	1.3	2.7	12.2	4.5	3.6	29.5	3.8	13.7	4.8	7.1	3.4	1.2	24.1	9.6	5.4	5.0	3.4	63.3	1.5	0.0	0.5	0.0	3.0	2.0	3.5	0.7	0.3	3.2	12.3	11.5	3.4	6.5	1.2	9.2	0.0	9.4	0.0	13.5	0.0	0.4	0.6	1.3	1.3	2.7	0.5	0.2	4.1	1.1	7.1	8.8	2.7	0.8	48.9	10.6	4.4	1.5	0.7	2.3	10.6	7.9	0.9	0.2	1.6	8.2	9.7	5.2	0.4	0.0	5.7	31.0	0.0	3.2	5.7	4.0	0.8	0.2	0.9	0.1	2.2	11.4	8.6	20.3	3.0	8.7	0.3	1.7	1.1	2.8	42.5	2.3	48.3	50.1	50.7	54.1	6.4	35.6	88.8	83.5	4.5	30.1	2.6	38.1	59.1	35.4	3.4	3.2	2.7	3.3	2.4	3.7	4.8	5.3	4.4	3.6	4.8	5.0	3.4	3.2	5.6	30.3	23.6	1.1	0.9	4.2	9.1	2.5	4.4	6.2	0.5	0.0	1.5	1.8	0.0	0.5	21.1	0.2	0.0	3.2	0.9	5.1	1.4	3.4	10.2	0.4	32.4	12.8	9.1	3.1	1.5	10.3	1.3	47.8	9.7	0.3	37.6	0.0	2.2	1.4	0.0	4.3	1.8	2.5	3.7	10.7	1.8	60.0	5.3	0.9	23.7	17.6	0.6	11.7	0.8	0.7	28.1	1.4	0.1	0.4	0.8	0.1	0.0	1.3	4.4	0.7	0.2	2.8	0.6	2.1	36.2	22.4	0.3	4.2
PDCD1	"CD279, hSLE1, PD-1, PD1, SLEB2"	ENSG00000188389	"Programmed cell death 1"	Q15116	2	241849884-241858894	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"		"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 6.7;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"Plasma cells: 9.5;T-cells: 34.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Group enriched"	"Detected in many"	5	"gdT-cell: 4.4;MAIT T-cell: 4.8;memory CD4 T-cell: 8.7;memory CD8 T-cell: 12.4;T-reg: 4.3"	"Lineage enriched"	"Detected in single"	55	"T-cells: 12.4"	"Cell line enhanced"	"Detected in some"		"JURKAT: 1.5;MOLT-4: 2.4;RPMI-8226: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035981, CAB038418, CAB076386"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664"	"unprognostic (2.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (7.78e-2)"	"prognostic favorable (9.44e-5)"	"unprognostic (7.18e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.82e-3)"	"unprognostic (3.75e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (5.06e-3)"	1.2	0.3	0.0	3.2	0.2	0.9	0.4	0.0	0.1	0.6	0.2	0.8	0.3	0.4	0.0	0.8	0.6	0.3	6.7	0.1	0.1	0.7	0.4	1.8	16.1	0.1	1.4	0.2	0.3	0.0	1.5	0.0	0.2	0.7	0.1	0.0	1.0	0.2	0.1	0.3	3.8	0.2	0.1	7.0	1.8	0.3	0.4	3.1	1.5	0.0	4.0	1.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	4.8	0.2	8.7	12.4	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	4.3	2.1	0.0	0.2	0.0	0.1	0.1	0.1	0.1	1.4	0.2	0.1	0.4	0.2	0.4	0.0	0.6	0.0	3.6	0.4	0.3	0.0	0.0	0.0	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.6	0.0	34.7	0.0	0.0	0.1
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494397-119628804	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9"	"Group enriched"	"Detected in all"	4	"prostate cancer: 7.0;thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6"	"Region enhanced"	"Detected in all"		"cerebellum: 18.2"	"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		850000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	15.4	11.3	0.9	10.9	3.5	2.1	9.6	4.9	3.7	32.7	12.6	37.0	15.5	14.4	41.5	41.3	22.9	10.4	12.8	1.4	3.6	5.9	1.5	22.1	6.4	4.9	8.2	5.4	12.4	8.3	3.5	13.2	5.2	59.8	25.9	9.6	9.8	49.8	6.9	5.0	18.9	11.4	0.0	5.8	9.6	9.4	3.4	3.7	16.8	5.6	3.5	14.6	15.8	1.9	16.7	0.8	11.0	1.2	3.7	5.5	1.9	10.7	47.5	0.5	1.0	1.0	1.3	1.6	0.5	13.4	3.0	5.8	3.5	1.7	1.3	0.4	7.4	18.5	2.6	0.9	65.9	3.9	1.7	6.1	3.3	1.1	0.1	24.6	1.4	3.7	2.0	2.9	1.6	0.9	5.0	0.6	2.3	1.8	2.8	0.7	5.9	4.3	4.1	4.9	4.3	8.8	13.0	15.3	1.3	8.1	2.7	2.1	2.5	6.2	5.2	3.4	1.5	4.1	2.0	1.5	5.9	1.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.3	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.1	0.1	1.2	0.9	3.5	4.9	3.7	1.4	3.6	4.9	8.2	5.2	0.0	3.4	1.9	7.8	6.4	3.9	19.9	1.3	3.4	2.8	1.1	5.7	8.1	11.0	8.4	5.5	14.3	3.7	1.8	14.6	0.4	0.9	15.5	0.0	15.8	30.6	5.0	12.6	7.8	2.4	0.0	66.1	2.9	0.3	28.1	1.1	3.9	1.3	1.6	0.7	0.9	0.3	5.0	58.3	9.5	2.0	0.0	3.5	11.5	20.8	11.3	5.4	40.3	1.3	28.5	2.1	56.8	41.1	3.9	10.3	104.9	1.4	3.6	7.9	0.5	0.8	5.8	19.7	5.5	80.9	5.4	6.3	3.5	2.4	0.3	1.7	7.0	11.1	2.6
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 2050.3"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 4448.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basophil: 127.0;NK-cell: 220.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 127.0;NK-cells: 220.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.7"	"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	1.5	0.3	0.0	4.7	0.1	7.8	0.9	0.2	0.5	1.0	0.2	1.6	0.6	0.2	0.1	0.8	0.7	2.5	0.4	0.1	0.7	2.1	4.2	3.0	20.6	0.1	0.2	0.0	0.0	0.1	0.1	12.0	0.2	0.2	1.0	2050.3	0.5	0.4	1.2	0.3	1.6	0.9	0.1	19.9	1.7	0.8	0.3	8.3	0.4	0.3	7.1	3.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.8	0.2	0.1	0.2	0.4	0.3	0.0	5.8	8.9	0.0	0.0	11.9	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	6.2	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.1	0.6	0.9	0.4	3.1	0.1	127.0	18.1	30.5	4.1	26.2	1.3	2.7	0.8	2.3	28.9	5.1	2.1	7.4	2.4	220.2	15.5	2.9	0.1	13.5	0.0	0.1	0.2	0.5	0.1	0.7	0.1	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.6	0.3	1.1	0.9	0.0	0.0	0.6	422.5	0.3	0.4	0.2	0.0	0.0	5.5	517.1	0.2	4.3	0.1	1.9	0.4	0.8	1.5	0.3	27.2	0.0	1.7	0.2	0.2	0.4	0.2	0.0	0.5	23.6	0.1	2.9	0.2	22.6	262.5	0.1	0.2	0.0	4.8	8.0	2.3	0.0	4.4	3.6	0.0	13.3	709.0	11.3	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	1.0	0.0	4448.6	0.0	0.1	0.1	1.1	0.2	0.3	1.4	0.3	1.7	2.1	0.0	0.1
PDLIM2		ENSG00000120913	"PDZ and LIM domain 2"	Q96JY6	8	22578279-22598025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 793.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"white matter: 429.2"	"Low region specificity"	"Detected in many"			HPA003880	Approved		Supported	"Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Actin filaments, Focal adhesion sites"		"HPA003880: AB_1855149"	"unprognostic (1.04e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-3)"	"unprognostic (9.33e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.37e-7)"	"unprognostic (6.14e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.08e-3)"	66.0	31.6	40.6	31.9	42.2	23.7	51.0	51.0	56.6	85.1	42.6	86.9	60.9	80.2	9.8	131.4	56.0	52.8	51.4	36.9	43.9	77.7	59.4	88.8	54.4	56.6	52.9	49.6	53.7	9.8	35.3	40.5	59.4	45.5	11.2	2.0	48.6	30.9	201.9	153.1	64.3	23.2	49.9	232.0	38.8	12.2	49.9	20.4	27.4	60.9	24.4	57.5	91.7	54.8	90.3	54.5	36.2	63.9	69.9	118.5	40.9	139.1	102.4	97.6	98.5	62.4	14.7	36.9	38.4	126.4	18.1	44.7	20.5	95.0	19.0	0.1	14.1	11.6	35.2	46.1	88.2	13.0	85.9	127.2	11.6	48.2	13.2	76.8	54.2	20.2	3.3	23.4	67.4	46.5	16.7	15.4	29.8	37.8	5.5	13.3	6.9	3.9	17.3	18.3	11.3	26.9	29.1	78.1	128.7	21.3	27.5	25.8	68.2	105.7	108.6	127.9	64.8	0.4	0.8	12.5	109.0	51.3	79.6	78.2	48.0	162.3	47.0	64.4	42.2	25.0	35.5	46.9	38.4	27.6	23.8	35.4	101.6	28.1	63.8	24.7	40.7	34.6	40.6	42.2	51.0	56.6	36.9	43.9	56.6	52.9	59.4	49.9	49.9	54.8	85.8	76.9	13.1	5.5	45.0	95.1	12.9	48.1	39.9	3.0	34.0	42.5	10.2	18.6	34.2	18.4	0.0	73.1	70.9	92.0	15.6	24.9	1.0	8.8	94.0	48.7	1.2	10.5	3.2	26.1	115.1	98.9	7.7	13.8	27.3	25.7	86.4	49.4	59.0	3.3	2.3	12.6	20.3	59.1	73.8	3.4	132.0	37.9	48.0	8.4	42.5	33.1	122.6	7.1	3.9	93.2	126.1	218.2	6.8	52.7	217.6	146.3	5.2	3.6	59.2	27.1	108.3	0.7	6.3	39.7	100.7	793.0	71.6	21.0	15.0	30.6
PDZD4	"FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L"	ENSG00000067840	"PDZ domain containing 4"	Q76G19	X	153802166-153830565	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 150.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 12.1;Bipolar cells: 18.0;dendritic cells: 14.0;Excitatory neurons: 11.0;NK-cells: 26.8;Rod photoreceptor cells: 14.1"	"Group enriched"	"Detected in many"	4	"glioma: 20.1;testis cancer: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.4;NTERA-2: 12.4;RH-30: 17.3;SCLC-21H: 29.5;SH-SY5Y: 28.7;U-2 OS: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003878	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA003878: AB_2162807"	"unprognostic (9.18e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-2)"	3.7	5.0	98.2	1.9	102.8	2.1	3.4	76.6	150.1	9.5	42.3	23.4	1.6	11.9	1.2	3.8	13.9	2.0	6.1	132.0	46.9	3.9	2.6	4.8	2.0	57.6	48.0	2.7	2.3	2.8	44.1	0.1	59.5	10.4	1.3	14.8	4.1	9.8	3.3	4.3	5.9	4.3	38.2	14.0	7.6	6.0	46.7	1.1	3.5	1.3	0.6	10.0	9.2	89.8	0.0	1.6	24.4	6.4	0.0	0.1	0.0	0.7	0.0	0.7	0.8	0.6	0.0	0.0	0.3	0.0	7.9	0.1	4.5	0.0	0.1	0.0	0.8	0.0	1.9	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.3	5.0	0.2	0.9	12.4	0.0	0.3	0.1	17.3	0.0	0.0	0.1	29.5	28.7	1.3	0.0	9.2	8.2	2.8	0.3	0.0	0.0	14.1	0.3	1.8	0.0	0.1	0.0	0.1	0.0	7.9	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	98.2	102.8	76.6	150.1	132.0	46.9	57.6	48.0	59.5	38.2	46.7	89.8	1.8	0.0	0.0	12.1	0.1	0.3	0.0	0.0	0.6	18.0	0.1	2.4	3.7	0.0	1.3	0.0	6.2	0.0	14.0	0.0	0.0	0.0	0.1	0.2	1.5	3.5	1.8	0.8	11.0	0.2	0.0	0.8	0.5	0.1	1.3	0.2	4.6	0.1	0.0	1.7	8.6	0.0	0.0	1.0	0.0	0.2	0.6	0.1	3.6	4.7	0.2	3.9	26.8	5.5	0.7	0.3	0.0	3.8	3.6	0.2	0.0	0.0	4.4	14.1	0.0	1.7	2.1	0.3	4.1	0.5	0.9	0.0	4.1	0.0	0.0	0.2
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205380-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1106.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 246.3;monocytes: 267.6;Muller glia cells: 315.8"	"Cancer enhanced"	"Detected in all"		"glioma: 466.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 78.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	Nucleoplasm	"HPA028356: AB_10602814, HPA070820: AB_2732166"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	190.2	82.2	863.3	121.7	900.6	16.6	142.7	908.1	949.4	110.1	612.5	146.5	31.7	124.5	83.4	119.2	104.2	88.2	241.9	884.6	939.2	112.0	41.2	147.9	75.5	1028.2	1010.2	80.4	39.6	85.4	80.0	102.3	981.5	112.2	58.5	461.4	80.8	119.4	61.1	105.6	64.8	194.6	933.0	103.2	75.8	80.5	915.2	40.7	83.5	84.5	96.9	133.4	110.2	1106.4	139.2	46.8	190.5	82.5	344.5	191.5	63.6	593.2	503.3	471.6	328.5	103.7	72.3	63.4	210.9	729.4	226.6	146.4	71.5	181.7	365.3	34.4	40.2	52.4	32.5	26.7	423.9	17.8	62.0	161.8	100.7	260.2	328.5	259.6	360.7	45.7	55.1	111.8	640.6	68.3	21.0	41.1	127.0	160.9	134.3	34.4	200.6	43.8	173.0	71.0	38.0	100.0	310.4	207.6	179.9	409.4	128.1	122.6	487.7	311.3	246.4	234.4	254.5	88.1	59.5	118.7	287.1	33.2	450.8	1.3	39.3	5.2	8.4	78.2	6.5	18.9	6.2	6.9	56.7	13.5	3.8	4.2	1.8	7.9	38.7	25.0	7.9	14.9	863.3	900.6	908.1	949.4	884.6	939.2	1028.2	1010.2	981.5	933.0	915.2	1106.4	137.8	16.0	29.9	40.5	38.6	80.2	124.2	21.8	33.6	172.1	76.9	60.2	246.3	11.5	24.7	5.5	73.0	21.8	13.7	12.7	29.4	74.7	65.4	36.4	33.7	125.1	12.0	7.4	24.8	46.3	61.1	81.5	17.9	85.9	31.1	17.2	89.3	6.5	63.3	92.5	19.1	12.0	8.2	42.6	234.6	55.4	66.8	68.9	74.7	14.0	267.6	315.8	8.2	12.1	48.3	102.5	4.7	109.9	14.8	119.4	5.4	18.3	13.8	129.2	46.0	69.4	78.3	16.5	4.1	42.7	73.3	45.3	19.4	18.5	12.8	178.8
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	107.3	51.9	23.8	38.1	25.6	41.7	76.6	25.8	29.8	58.4	34.1	68.1	127.3	52.3	51.3	57.5	44.2	53.4	50.7	25.0	30.2	96.0	173.8	42.7	30.6	25.6	29.6	57.9	74.2	80.5	49.0	85.3	27.7	53.0	65.2	55.1	55.3	73.2	54.4	98.2	121.9	67.4	26.6	32.5	95.8	39.5	28.5	28.0	65.6	44.0	40.8	56.3	51.0	29.8	123.3	44.4	80.3	64.9	339.8	177.6	80.5	164.6	182.7	119.4	158.3	46.4	123.6	86.3	187.8	213.4	138.8	70.1	74.3	81.6	149.3	49.7	42.7	58.0	111.3	88.3	429.1	84.7	41.7	140.9	161.3	100.3	123.3	277.0	109.1	55.0	98.2	105.6	173.7	38.2	78.9	39.2	63.1	148.5	39.7	62.5	64.2	59.8	176.8	42.9	63.3	59.7	92.4	103.1	97.3	131.2	79.7	38.0	203.5	100.0	81.4	103.8	77.3	121.0	106.0	91.3	109.9	74.4	70.1	2.2	1.0	2.0	1.5	0.9	0.7	1.2	1.8	1.5	0.6	0.9	1.6	1.5	0.9	1.1	0.7	2.4	2.0	0.6	23.8	25.6	25.8	29.8	25.0	30.2	25.6	29.6	27.7	26.6	28.5	29.8	95.9	54.5	41.0	16.6	27.0	100.1	49.7	27.8	54.1	22.4	49.2	32.8	60.7	58.6	35.9	44.1	10.4	85.4	41.2	68.2	29.4	57.3	80.9	42.2	59.1	50.0	35.5	104.2	20.4	74.2	146.6	69.9	53.0	64.2	12.0	31.0	47.2	125.1	35.3	11.8	19.1	67.8	40.7	15.7	39.5	49.5	46.3	22.1	67.6	13.1	19.0	98.6	21.6	13.6	25.0	69.7	50.6	37.6	48.9	58.0	177.3	111.0	27.4	41.1	13.1	63.3	53.1	33.3	27.3	51.9	111.8	274.9	32.4	39.4	58.8	34.4
PHLDA3	TIH1	ENSG00000174307	"Pleckstrin homology like domain family A member 3"	Q9Y5J5	1	201464278-201469237	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 269.3;Prostatic glandular cells: 188.7;Urothelial cells: 556.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 284.8;WM-115: 164.3"	"Low region specificity"	"Detected in all"							HPA027601	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA027601: AB_10601389"	"unprognostic (1.51e-1)"	"unprognostic (7.48e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (8.55e-3)"	"unprognostic (4.34e-3)"	"unprognostic (5.55e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (9.32e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.45e-2)"	155.6	30.0	34.9	8.4	50.6	0.3	119.3	51.2	41.9	56.8	21.3	139.4	4.1	52.9	11.6	89.4	40.8	15.3	40.9	31.7	39.4	18.2	8.1	41.6	2.5	73.4	50.3	23.5	23.4	10.7	28.4	8.9	51.3	64.8	5.5	3.0	39.3	26.8	75.9	68.3	29.0	17.8	45.2	10.4	35.1	8.9	52.1	10.1	31.5	11.6	4.9	75.5	68.4	69.2	52.4	60.8	11.1	33.5	50.6	47.7	284.8	75.6	57.3	18.2	21.0	4.0	39.5	0.1	3.1	37.6	15.7	90.0	1.0	61.0	3.6	0.0	22.4	0.0	26.2	47.6	57.4	0.0	1.0	66.7	90.6	29.4	25.8	53.5	26.3	4.5	0.0	0.1	36.7	37.5	8.0	0.8	19.1	0.0	3.8	2.5	51.9	0.0	16.9	115.1	0.7	11.7	26.5	0.8	62.7	42.5	25.0	3.6	39.4	42.2	69.6	36.1	16.2	1.4	0.2	0.1	102.4	0.1	164.3	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.6	0.0	34.9	50.6	51.2	41.9	31.7	39.4	73.4	50.3	51.3	45.2	52.1	69.2	83.3	9.6	9.1	8.8	0.9	78.1	269.3	48.8	93.9	5.2	29.8	42.4	6.2	2.8	30.7	49.7	0.0	84.9	1.8	2.2	11.7	42.0	36.8	42.7	15.2	22.2	5.3	2.7	5.7	18.9	24.4	43.3	7.1	31.8	0.0	11.2	10.4	1.4	18.1	0.0	8.3	2.1	10.2	0.6	28.5	136.5	26.8	7.9	32.0	1.0	18.2	105.4	1.0	4.5	37.1	71.4	2.9	41.8	2.1	188.7	1.2	8.5	22.3	5.2	0.0	38.0	55.8	0.8	4.0	92.1	102.0	37.5	5.7	46.5	3.6	556.5
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11149569	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 58.3"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BJ hTERT+ SV40 Large T+: 16.9;BJ hTERT+ SV40 Large T+ RasG12V: 23.1;HeLa: 38.1;U-266/70: 23.0;U-698: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015986, HPA031974, HPA040616"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	1.2	0.5	7.3	1.3	20.2	0.4	1.7	14.7	14.4	1.0	0.1	3.9	0.3	0.6	1.6	5.1	1.1	5.3	0.3	7.9	8.7	1.1	4.1	6.6	0.9	18.2	14.4	0.7	1.8	0.5	0.9	0.0	18.2	3.0	1.4	0.1	0.3	2.9	0.1	1.1	1.1	2.1	8.5	2.7	1.6	1.2	16.8	0.8	1.5	0.2	0.6	5.3	0.7	58.3	0.0	1.8	15.1	0.0	0.0	0.0	0.0	0.8	4.4	16.9	23.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	10.6	0.0	0.5	0.0	38.1	8.8	5.2	0.0	0.1	0.1	0.3	4.3	1.2	0.1	5.2	0.6	0.0	0.3	2.7	0.0	0.3	0.0	4.5	6.7	0.0	0.0	0.0	7.0	0.0	5.3	12.7	0.0	0.1	0.0	0.8	6.7	0.0	4.5	0.0	0.0	5.8	0.3	0.9	23.0	0.2	16.2	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	20.2	14.7	14.4	7.9	8.7	18.2	14.4	18.2	8.5	16.8	58.3	3.3	0.0	5.3	2.0	0.0	0.8	0.3	0.0	0.0	0.0	2.3	0.8	1.6	10.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	31.7	0.2	0.2	9.9	0.0	0.0	2.5	0.2	0.0	11.2	2.6	0.0	5.1	0.1	17.2	5.9	1.0	0.0	37.0	0.0	0.0	3.2	0.8	11.9	0.0	0.6	0.0	9.4	0.0	0.0	0.0	2.0	399.6	0.1	0.0	0.0	0.4	0.1	0.0	0.1	7.3	0.0	6.6	0.9	4.5	0.3	1.4	0.2	0.9	0.4	0.6	32.9	0.0	0.1
PIGS		ENSG00000087111	"Phosphatidylinositol glycan anchor biosynthesis class S"	Q96S52	17	28553383-28571794	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018149	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA018149: AB_1855373"	"unprognostic (2.29e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.82e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.65e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (5.31e-4)"	25.0	15.5	8.3	15.5	8.5	25.3	11.4	8.2	8.6	12.9	18.6	25.5	30.9	12.0	3.3	23.5	20.1	15.6	25.4	10.5	9.1	16.6	4.9	20.2	18.9	8.8	9.4	13.3	16.8	28.5	3.3	17.4	8.8	17.7	15.7	3.4	14.8	16.2	31.4	18.5	32.2	16.1	7.8	18.2	26.9	13.4	8.7	17.5	24.3	19.7	13.7	17.7	5.3	8.0	34.7	57.4	26.5	67.9	51.1	38.2	40.1	42.3	34.5	44.4	58.1	60.4	33.8	22.3	62.9	57.8	43.1	64.5	32.4	48.2	16.6	65.8	92.5	30.1	45.3	26.2	47.8	58.5	73.8	46.7	33.6	27.8	37.8	44.5	60.3	37.8	89.3	34.1	38.5	42.6	36.9	40.2	13.2	77.9	17.6	31.2	87.8	73.6	30.6	36.9	54.3	37.7	60.3	115.4	32.8	26.4	105.4	69.5	52.2	31.5	32.5	27.1	35.0	56.5	84.0	17.0	56.6	56.8	45.1	86.2	60.4	78.9	34.3	55.0	31.0	23.5	27.5	32.5	64.9	22.3	28.8	24.0	29.4	43.0	39.6	49.8	45.2	46.3	8.3	8.5	8.2	8.6	10.5	9.1	8.8	9.4	8.8	7.8	8.7	8.0	15.7	44.8	21.4	10.7	15.9	8.3	11.3	21.1	13.6	20.5	20.5	17.1	40.7	20.0	18.8	46.0	64.6	35.0	31.6	48.5	11.7	43.5	9.5	15.3	15.7	18.7	40.7	17.9	10.9	26.3	53.4	14.9	18.3	21.5	3.8	17.1	26.4	7.9	31.1	52.2	12.6	28.3	24.4	28.1	8.0	13.1	23.9	22.9	7.2	1.9	66.1	17.5	93.7	9.0	11.7	22.5	21.6	22.6	16.8	15.0	49.0	19.1	14.4	56.1	6.6	12.3	15.9	74.2	62.0	19.3	12.5	36.4	21.8	25.0	27.6	12.4
PIGT		ENSG00000124155	"Phosphatidylinositol glycan anchor biosynthesis class T"	Q969N2	20	45416084-45456934	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (6.06e-2)"	"unprognostic (4.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.18e-3)"	"unprognostic (6.68e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (5.48e-2)"	"unprognostic (7.60e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-2)"	57.4	51.9	30.7	39.4	38.9	70.8	52.7	41.2	37.5	65.5	44.6	75.8	49.9	69.6	89.5	37.7	61.2	48.3	113.5	29.9	37.2	47.1	48.9	45.3	26.6	41.0	38.1	46.1	65.0	105.4	48.9	48.5	38.9	39.5	77.2	13.0	48.2	55.6	61.2	46.0	54.3	69.7	37.6	36.5	62.1	38.1	38.8	25.8	57.0	51.8	27.4	57.0	42.8	47.6	79.0	95.3	35.8	138.7	218.0	152.9	68.5	90.4	172.8	126.8	99.7	179.9	123.6	47.1	122.0	142.9	108.4	152.4	43.6	124.8	67.8	25.2	53.5	49.0	80.8	100.9	99.9	93.5	203.1	117.3	117.0	99.9	108.6	179.4	109.3	39.2	65.0	163.8	107.4	165.3	44.8	74.7	29.4	227.5	162.1	38.0	107.6	168.0	102.5	51.1	60.2	77.0	177.7	173.2	88.7	61.4	150.6	169.8	96.5	301.4	138.1	57.1	128.8	93.9	144.0	30.0	190.7	74.7	140.9	58.9	77.9	66.3	57.4	83.2	43.6	27.2	41.0	53.8	92.2	28.1	35.7	41.8	30.7	57.6	79.2	71.4	61.6	83.1	30.7	38.9	41.2	37.5	29.9	37.2	41.0	38.1	38.9	37.6	38.8	47.6	41.9	41.7	29.5	9.1	43.9	30.0	46.4	86.8	13.6	21.0	43.7	31.4	169.2	41.5	63.7	44.1	14.6	62.1	58.9	106.1	13.7	107.5	31.8	45.2	32.3	46.0	65.5	24.2	7.6	114.5	73.9	94.2	44.9	59.2	33.6	58.5	39.7	41.5	76.8	38.7	9.8	145.3	85.5	49.6	42.6	81.4	60.6	44.3	88.9	4.7	39.8	25.8	37.0	6.0	27.1	79.5	61.8	56.1	69.2	40.7	103.8	26.1	46.2	15.6	65.7	39.4	47.2	88.4	96.9	23.5	27.8	52.1	43.4	47.9	111.6	57.7
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593315-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 83.2;lymphoid tissue: 62.3;salivary gland: 73.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;Hepatocytes: 70.7;Kupffer cells: 127.0;Macrophages: 89.8;Microglial cells: 60.9;monocytes: 57.4;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 44.7;memory B-cell: 48.3;naive B-cell: 44.5;non-classical monocyte: 123.0"	"Group enriched"	"Detected in all"	6	"B-cells: 48.3;monocytes: 123.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;NB-4: 62.1;REH: 183.5;THP-1: 92.9;U-698: 114.7;U-937: 95.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	8.1	4.5	2.1	51.1	2.0	47.5	4.7	2.4	3.2	2.8	2.7	7.3	6.8	2.1	1.7	2.4	2.2	24.8	2.5	1.9	2.9	11.8	83.2	16.7	61.2	6.5	4.6	6.0	22.8	2.0	1.4	14.1	5.3	2.8	8.6	3.1	73.6	2.4	0.7	1.0	7.7	8.3	4.7	62.3	6.9	3.0	5.7	8.7	4.1	3.1	57.8	15.2	0.6	7.6	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.2	2.8	1.5	85.3	8.5	0.0	1.3	0.1	17.7	0.0	0.6	48.0	3.0	13.0	0.0	1.7	0.1	36.1	6.7	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.9	0.1	0.1	0.4	1.1	62.1	0.8	24.3	1.0	183.5	4.3	20.0	0.2	0.1	3.6	2.0	0.2	0.2	1.1	0.3	0.2	92.9	0.0	0.0	2.8	0.1	0.7	0.7	0.2	114.7	0.0	95.2	0.0	6.1	16.0	10.5	13.3	44.7	4.7	48.3	0.3	4.1	12.9	44.5	0.1	3.3	13.5	14.0	123.0	11.3	0.5	14.4	2.1	2.0	2.4	3.2	1.9	2.9	6.5	4.6	5.3	4.7	5.7	7.6	0.5	3.2	3.9	1.3	53.7	1.5	0.1	0.1	0.6	0.6	2.2	2.3	2.6	32.9	2.2	1.8	2.1	0.5	41.5	8.1	1.9	40.0	4.3	0.3	0.1	1.8	1.8	10.3	0.8	29.1	0.9	0.7	0.0	0.2	14.0	0.2	5.7	70.7	47.7	0.0	0.8	2.8	4.1	127.0	32.5	1.0	1.2	89.8	5.4	60.9	57.4	0.2	58.7	1.0	0.3	16.4	21.2	2.2	9.4	0.4	1.6	18.3	1.1	3.4	0.0	0.6	0.8	0.8	0.2	0.3	1.1	2.3	18.3	0.4	3.8	0.3
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651731-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 60.9;lymphoid tissue: 50.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.0;granulocytes: 25.3;Kupffer cells: 35.2;Microglial cells: 29.0;NK-cells: 29.9;T-cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 153.3;NB-4: 65.9;REH: 68.9;THP-1: 65.4;U-937: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	7.2	3.1	6.8	33.4	6.3	60.9	3.9	6.1	7.5	6.2	6.4	5.4	5.2	4.9	1.7	4.9	6.1	7.0	3.3	7.0	5.3	6.4	3.5	12.0	46.9	7.3	6.6	7.0	3.0	2.9	2.8	4.2	7.8	4.6	3.4	0.6	5.1	2.7	1.2	3.0	17.2	4.7	6.6	50.4	5.7	4.0	9.3	24.3	5.5	3.5	32.0	7.4	5.1	8.5	8.1	5.2	0.4	1.4	1.3	1.1	0.7	12.1	24.5	26.0	21.1	0.3	3.3	21.5	4.9	9.8	12.4	2.4	2.0	11.0	16.2	153.3	0.4	2.4	1.3	9.0	5.1	56.0	18.7	4.3	4.5	29.2	9.8	11.4	3.8	14.9	8.0	0.1	15.0	0.6	5.4	65.9	2.2	0.3	1.4	68.9	13.0	0.7	10.9	0.0	1.7	1.5	2.7	4.9	11.9	6.8	0.8	65.4	9.8	7.7	7.9	0.2	11.5	4.9	4.9	30.1	16.7	78.6	4.4	18.0	23.5	40.2	21.6	23.0	22.6	12.8	16.3	19.9	22.5	13.6	20.9	23.1	63.2	25.9	29.2	25.7	13.3	38.3	6.8	6.3	6.1	7.5	7.0	5.3	7.3	6.6	7.8	6.6	9.3	8.5	1.7	9.6	13.4	2.0	22.2	1.5	2.2	1.8	4.0	0.7	2.0	1.7	3.1	0.0	1.1	0.0	2.1	0.3	44.0	0.1	1.9	3.9	3.0	2.0	1.7	2.7	0.0	10.3	6.7	2.0	0.5	2.9	0.0	1.0	25.3	4.2	3.6	0.0	14.7	0.0	13.4	0.1	0.0	35.2	6.0	2.8	1.2	23.1	3.6	29.0	19.3	2.5	29.9	1.0	1.1	11.3	0.0	1.5	8.2	4.1	0.2	3.8	3.3	1.3	6.6	2.0	4.7	1.5	3.4	2.9	1.1	0.3	37.1	1.5	0.2	2.1
PIK3R2	"p85, P85B"	ENSG00000105647	"Phosphoinositide-3-kinase regulatory subunit 2"	O00459	19	18153163-18170532	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Stress response, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 14.4;Undifferentiated cells: 16.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA069291	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA069291: AB_2686109"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.36e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.35e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.00e-2)"	7.2	25.6	26.2	6.9	22.9	9.7	7.6	1.1	41.5	17.6	2.0	13.4	20.5	17.5	12.0	26.0	16.7	12.3	12.8	41.0	6.7	9.5	10.5	9.1	5.2	4.4	7.1	21.5	11.0	20.8	21.5	8.7	4.9	15.5	9.6	7.9	15.0	10.4	12.4	26.3	16.7	9.8	4.7	8.7	15.1	11.5	9.4	11.6	10.5	9.9	6.2	15.3	15.3	16.4	39.1	18.0	25.4	36.8	35.3	36.6	40.5	29.4	38.3	21.6	16.6	18.3	20.4	28.0	48.8	41.9	17.5	28.7	15.6	33.2	11.3	25.0	65.5	10.8	21.3	44.0	29.7	24.6	13.4	45.7	36.4	15.0	21.5	36.8	6.6	11.9	33.6	10.8	30.3	57.0	21.5	17.0	32.9	35.8	48.5	19.6	33.4	23.5	37.7	22.8	63.0	68.0	27.1	28.5	28.9	16.0	19.1	15.8	11.4	40.9	20.8	49.2	27.5	22.9	26.4	10.9	33.9	39.4	26.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	26.2	22.9	1.1	41.5	41.0	6.7	4.4	7.1	4.9	4.7	9.4	16.4	1.0	6.4	1.1	7.2	0.8	1.9	1.3	1.0	1.8	6.3	3.6	3.2	1.5	2.8	1.0	3.7	4.2	1.7	0.8	6.9	0.0	6.0	0.3	1.3	1.7	0.8	6.1	7.4	11.7	6.2	2.9	1.7	1.1	0.8	2.5	1.4	1.4	1.3	2.2	10.1	11.2	10.5	0.0	4.7	1.0	0.0	1.8	1.7	0.0	3.7	1.6	5.7	0.0	10.6	9.2	6.4	7.0	1.9	0.9	1.1	14.4	1.1	0.5	4.3	0.0	1.4	1.4	0.5	2.1	1.3	2.3	1.2	0.9	3.2	16.4	0.6
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802722-8867677	"Metabolic proteins, Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 21.9;eosinophil: 75.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 75.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 148.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	0.4	0.0	1.1	1.8	1.6	2.2	0.4	0.9	1.1	0.6	0.8	0.8	1.5	0.9	0.1	0.5	0.2	1.2	1.3	1.0	1.1	0.0	0.3	1.2	2.1	1.4	1.5	0.0	0.4	0.1	0.0	0.6	1.6	0.3	0.6	0.0	0.2	0.3	0.5	0.8	2.2	0.7	1.1	2.9	1.0	0.4	1.9	2.1	0.0	0.3	1.5	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	19.4	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	2.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	21.9	7.2	75.8	0.5	9.6	0.4	2.7	0.1	0.3	10.8	0.3	0.1	0.2	1.1	1.5	7.8	0.0	0.0	3.3	1.1	1.6	0.9	1.1	1.0	1.1	1.4	1.5	1.6	1.1	1.9	1.6	0.2	0.0	1.3	0.3	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	11.5	0.0	0.1	2.6	0.0	0.4	0.6	0.0	0.1	0.2	0.5	0.0	47.4	0.0	0.4	0.0	7.6	0.0	0.5	0.0	0.0	4.4	1.6	20.6	0.0	3.9	1.8	7.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	1.6	0.1	0.0	0.0
PIP4P2	"DKFZp762O076, TMEM55A"	ENSG00000155099	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2"	Q8N4L2	8	90993802-91040872	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.2;Cytotrophoblasts: 32.6;Distal tubular cells: 49.0;Extravillous trophoblasts: 31.1;Hofbauer cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 76.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014591	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA014591: AB_1858124"	"unprognostic (6.09e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.54e-4)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (3.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.58e-2)"	"unprognostic (4.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.59e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-2)"	11.9	13.9	13.2	6.6	15.7	30.0	7.4	16.5	20.1	9.2	20.2	14.6	2.8	10.5	4.2	5.9	7.2	11.0	20.7	13.3	20.4	10.0	3.8	5.5	6.9	16.5	16.4	10.6	3.3	10.9	7.9	8.8	18.2	8.7	4.8	11.0	7.3	12.2	13.5	6.5	5.3	13.5	16.4	8.3	6.5	6.9	17.5	9.5	6.6	14.8	5.4	9.9	6.6	21.0	4.8	2.9	16.8	10.2	27.2	30.6	3.5	19.3	24.2	10.2	15.1	1.9	8.1	9.4	2.6	19.9	10.3	1.1	4.2	7.0	13.6	8.1	7.3	13.9	2.9	1.5	23.6	3.3	12.2	17.2	4.4	12.8	9.6	27.4	9.8	2.7	7.4	31.0	35.6	3.3	10.4	9.5	8.6	0.0	9.8	3.9	6.9	11.2	14.9	3.0	2.0	9.7	1.5	6.6	28.4	11.4	0.2	6.3	15.1	18.5	7.1	11.2	9.0	12.0	7.0	6.0	31.6	6.4	25.2	0.9	11.6	10.8	1.3	5.9	2.3	2.7	3.1	1.7	10.8	1.9	4.8	1.9	76.9	2.4	2.2	6.0	2.8	6.1	13.2	15.7	16.5	20.1	13.3	20.4	16.5	16.4	18.2	16.4	17.5	21.0	26.2	0.0	2.8	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.5	11.2	0.0	0.0	3.1	9.2	0.0	32.6	7.7	0.0	49.0	18.0	0.0	0.8	11.7	5.2	0.0	0.0	0.0	8.9	31.1	18.7	0.0	1.0	8.8	4.1	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.8	0.0	0.0	2.1	0.0	0.0	13.1	1.5	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	10.9	3.7	14.3	0.0	0.0
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLAC9		ENSG00000189129	"Placenta associated 9"	Q5JTB6	10	80131682-80145359	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 124.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 926.5;Leydig cells: 873.5;Peritubular cells: 659.7;Sertoli cells: 295.9;Smooth muscle cells: 446.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.5;ASC TERT1: 85.3;BEWO: 32.1;HSkMC: 28.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 37.9"	HPA043469	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA043469: AB_10795770"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.57e-3)"	"unprognostic (5.88e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-3)"	112.3	18.4	10.2	6.6	9.2	1.2	85.7	10.3	15.5	77.3	53.3	22.1	4.0	26.9	5.0	21.4	30.4	9.0	124.3	14.3	5.9	17.9	6.4	56.1	2.7	5.9	5.8	11.5	5.7	4.1	4.9	12.5	6.4	35.9	4.6	0.6	20.1	7.6	16.9	47.8	19.7	6.5	6.5	5.0	21.4	14.9	6.9	2.2	44.6	19.2	1.9	54.0	75.7	8.5	0.2	0.0	0.8	0.0	98.5	85.3	32.1	10.3	8.7	0.9	1.2	0.0	0.7	0.0	0.2	6.0	0.1	0.8	0.1	0.0	0.0	0.8	0.3	0.0	0.5	0.0	16.4	0.0	2.3	28.7	0.0	2.1	1.2	10.6	3.4	0.4	0.0	0.4	0.0	0.3	0.1	0.6	1.9	0.4	1.5	0.0	0.1	1.5	0.0	0.6	0.0	1.8	0.0	1.2	0.7	0.2	0.1	0.2	3.6	6.6	3.6	21.0	0.2	0.7	0.9	0.1	1.9	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	10.2	9.2	10.3	15.5	14.3	5.9	5.9	5.8	6.4	6.5	6.9	8.5	246.2	3.2	1.8	0.0	1.6	126.4	0.7	1.1	8.0	0.4	7.4	14.0	24.4	0.0	0.3	0.0	0.0	7.0	3.6	0.1	0.0	0.3	4.6	3.1	75.7	102.5	1.8	0.0	0.5	0.2	17.7	926.5	5.6	4.4	1.3	0.1	115.6	0.3	14.1	0.0	0.5	0.0	0.0	0.0	191.3	26.7	873.5	7.9	136.9	7.5	0.0	50.2	0.0	0.0	0.2	0.7	0.0	659.7	2.1	1.0	0.0	0.2	0.9	1.7	295.9	89.7	446.6	2.6	2.9	4.6	126.3	11.5	14.1	1.1	0.0	1.8
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 252.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 99.0;RH-30: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: AB_2682893"	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.94e-6)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	37.7	74.8	4.1	18.5	5.2	21.7	29.6	1.9	7.0	31.4	5.8	28.8	9.6	29.5	9.0	32.9	20.8	26.9	26.4	3.8	2.9	17.0	3.6	26.7	12.1	3.6	4.1	36.5	27.7	9.5	81.6	252.3	3.9	26.0	21.3	1.6	30.1	12.1	12.2	61.9	20.6	19.7	3.2	15.6	26.9	8.7	6.0	6.6	13.8	22.3	12.1	39.6	34.4	4.0	0.2	5.0	99.0	0.1	39.4	78.0	0.3	32.9	21.6	16.1	33.5	0.3	6.0	2.7	16.0	30.4	4.0	0.0	0.8	12.0	32.2	3.1	4.4	45.2	58.7	0.9	13.9	40.9	8.9	60.5	4.6	15.8	13.8	23.4	33.5	16.1	4.4	0.8	18.0	6.2	16.9	19.8	17.2	0.0	3.7	20.7	94.1	0.1	33.1	1.1	8.7	10.3	51.0	0.1	0.1	29.6	0.1	50.1	19.8	0.2	35.2	77.7	36.4	9.1	9.0	0.6	25.3	16.6	2.0	4.9	12.0	25.1	1.4	9.1	1.4	3.7	1.3	1.9	14.9	5.8	0.9	1.5	21.7	2.2	2.9	6.7	2.0	3.8	4.1	5.2	1.9	7.0	3.8	2.9	3.6	4.1	3.9	3.2	6.0	4.0	19.5	51.3	51.0	28.4	15.2	21.7	14.6	5.3	34.1	2.1	16.8	14.0	8.4	5.7	12.6	5.5	0.0	4.6	19.0	16.1	7.9	11.8	1.8	8.6	91.9	23.8	16.7	19.3	60.3	11.3	15.0	143.6	11.7	13.0	18.4	38.7	8.6	0.2	20.3	8.4	76.6	33.6	18.3	26.8	27.8	5.5	138.5	26.8	8.8	49.6	37.6	0.9	2.1	10.6	5.5	13.0	22.5	97.0	5.7	52.0	4.3	15.3	4.4	0.4	13.1	61.7	31.1	0.9	1.0	24.1	43.3	9.9	10.0	205.8	28.5	19.7
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42174718-42207709	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 246.0;urinary bladder: 181.4"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 763.3;Urothelial cells: 992.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 604.7;HMC-1: 425.2;hTERT-RPE1: 344.9;LHCN-M2: 298.2;U-2197: 441.2;WM-115: 806.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	58.9	44.0	14.0	35.6	13.7	0.1	35.1	14.6	17.4	21.8	10.3	55.3	29.9	49.6	16.8	33.7	49.8	40.4	19.3	12.5	16.6	91.9	5.3	41.3	2.3	15.4	15.4	21.5	16.0	246.0	13.3	44.4	16.6	54.0	25.0	2.1	15.6	29.1	8.8	6.2	34.6	32.9	16.0	2.0	41.8	11.9	18.8	4.4	30.9	9.8	2.7	181.4	33.1	14.0	4.2	1.4	29.0	9.1	43.1	61.9	0.9	125.8	216.4	54.2	43.4	1.4	604.7	0.0	4.4	17.1	28.4	14.5	0.3	23.9	78.5	64.6	8.4	0.7	1.0	0.6	253.9	0.2	425.2	65.6	0.4	140.3	6.0	344.9	103.9	0.2	4.6	0.8	298.2	0.0	0.6	0.5	42.3	0.3	48.2	0.2	103.5	0.3	12.6	0.4	0.3	7.4	0.2	0.4	158.7	39.7	1.0	0.3	189.3	11.6	43.1	441.2	15.6	0.2	1.1	0.2	9.7	0.2	806.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.0	13.7	14.6	17.4	12.5	16.6	15.4	15.4	16.6	16.0	18.8	14.0	63.5	0.0	13.7	0.0	2.9	10.8	763.3	155.9	7.4	4.7	103.9	66.3	7.4	1.5	19.1	0.0	4.2	0.6	0.9	0.1	0.0	9.3	0.9	4.8	104.2	98.2	0.0	0.0	1.6	0.6	1.3	136.5	2.0	5.1	164.0	89.7	36.4	0.8	1.9	1.7	4.0	0.0	4.1	1.0	17.7	1.5	3.7	4.7	23.2	25.3	1.6	2.1	1.0	42.7	0.3	52.0	0.0	2.6	2.8	193.3	0.2	0.3	4.0	3.8	13.1	10.8	48.3	1.1	0.6	13.6	13.5	0.7	6.0	0.5	0.5	992.1
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 688.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 820.7;Langerhans cells: 1833.9;Macrophages: 864.3;Urothelial cells: 2274.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1172.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 1172.3;monocytes: 550.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 311.7;U-251 MG: 413.1;U-87 MG: 346.9;WM-115: 346.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		4100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB073533: , HPA050843: AB_2681255"	"unprognostic (9.28e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.59e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (8.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.83e-9)"	"unprognostic (4.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.33e-2)"	52.1	10.4	7.5	81.7	9.8	688.4	14.5	11.2	32.4	30.9	10.3	26.7	10.0	30.2	4.8	11.6	22.8	78.1	23.0	8.1	10.4	18.2	19.8	69.5	10.6	12.2	9.8	14.9	13.6	5.4	9.1	35.9	13.3	11.5	20.1	2.8	21.7	5.8	3.6	7.8	10.6	26.2	9.7	20.4	28.4	3.1	24.8	10.2	9.5	4.7	8.6	109.7	15.8	13.8	83.9	31.0	26.1	1.9	23.4	83.3	16.2	180.7	189.6	114.6	141.4	2.4	95.1	2.4	43.0	116.9	66.8	35.2	7.0	46.4	127.9	5.3	5.3	15.8	44.7	3.9	30.6	18.8	195.2	87.4	9.0	311.7	46.5	160.6	129.0	19.1	16.4	2.2	107.7	6.1	21.0	55.3	8.7	156.1	64.7	24.0	17.4	5.6	35.9	3.8	1.3	22.2	82.0	17.4	25.0	12.6	3.2	59.4	129.7	230.0	121.1	109.8	413.1	3.0	9.0	0.6	346.9	36.0	346.5	87.7	476.5	745.5	6.8	427.9	8.3	2.7	8.9	5.7	213.6	1.4	3.2	4.0	1172.3	6.7	550.7	69.3	3.6	253.9	7.5	9.8	11.2	32.4	8.1	10.4	12.2	9.8	13.3	9.7	24.8	13.8	23.1	73.7	76.6	2.3	15.5	105.2	820.7	274.2	72.3	0.7	45.8	22.5	4.5	24.3	151.9	20.2	0.0	6.5	17.4	314.5	1.9	219.3	0.9	188.1	68.0	64.9	14.8	5.2	2.5	106.5	58.8	145.4	156.0	519.1	305.2	4.2	19.2	1.7	428.9	10.1	3.3	85.3	22.4	155.4	1833.9	2.0	6.8	864.3	72.9	5.6	52.1	1.2	4.1	1.5	0.9	558.8	435.5	4.1	14.5	479.4	12.7	2.7	52.7	0.7	6.6	38.5	90.0	1.2	4.7	202.6	63.1	13.1	33.2	3.1	29.3	2274.4
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28644142	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 39.0"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 112.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.0;eosinophil: 3.0;intermediate monocyte: 4.4;myeloid DC: 5.7;neutrophil: 8.8;non-classical monocyte: 5.0"	"Group enriched"	"Detected in many"	40	"dendritic cells: 5.7;granulocytes: 8.8;monocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;OE19: 7.8;RT4: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	1.8	5.7	3.4	1.8	3.3	5.0	1.8	1.0	3.0	1.9	2.2	1.5	0.7	1.6	1.7	1.0	1.3	1.5	1.2	2.7	2.6	0.7	0.5	1.6	0.4	2.4	2.3	0.9	0.6	0.3	1.6	2.1	2.0	2.1	1.8	0.1	1.4	1.5	2.0	7.9	39.0	2.7	2.5	4.1	0.9	2.6	2.9	0.6	2.0	0.6	0.3	1.7	1.3	1.6	0.4	0.0	2.4	0.0	0.5	0.3	3.6	0.1	1.0	0.2	0.2	2.5	0.2	0.2	0.2	0.4	1.0	0.5	0.0	1.9	0.2	0.1	0.0	0.2	0.4	0.4	0.8	0.4	0.1	0.4	1.1	0.4	0.5	0.4	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	7.8	0.5	0.0	0.4	0.0	1.1	2.7	1.0	0.2	0.1	0.1	0.2	0.2	0.0	1.3	0.2	0.2	0.7	0.1	0.1	0.5	0.1	0.0	0.8	1.8	0.0	0.0	3.0	3.0	0.0	4.4	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	8.8	0.0	5.0	0.3	0.1	1.1	3.4	3.3	1.0	3.0	2.7	2.6	2.4	2.3	2.0	2.5	2.9	1.6	0.6	0.0	0.6	0.7	0.3	0.4	1.0	0.6	0.6	0.1	1.6	1.5	1.6	0.0	1.5	0.0	0.0	0.5	2.1	6.5	1.9	1.6	27.0	2.4	1.0	1.5	1.2	0.0	3.2	0.9	23.2	0.6	0.0	1.1	5.7	0.1	1.1	0.0	12.5	0.0	3.4	5.4	0.0	17.4	10.1	18.3	1.2	12.5	0.0	15.0	4.8	0.3	0.0	1.5	0.4	1.0	2.6	0.7	0.5	0.4	112.6	0.0	1.5	0.0	0.0	1.1	0.3	1.0	0.9	0.3	0.4	8.2	1.5	0.6	2.5	1.6
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 563.5;Excitatory neurons: 2569.1;Inhibitory neurons: 1774.0;Oligodendrocyte precursor cells: 783.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 74.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 45.5;Hep G2: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		6600	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	9.3	8.9	11.7	5.7	52.3	4.8	7.6	0.0	74.3	8.2	0.0	18.1	7.2	9.3	3.5	5.4	9.6	8.5	11.7	17.4	0.0	13.2	4.3	5.0	1.8	0.0	0.1	3.7	14.7	44.3	4.3	19.6	0.0	13.4	4.1	7.1	29.0	18.8	14.4	2.6	5.7	8.1	0.0	3.6	8.0	3.0	9.8	6.8	3.8	11.0	0.9	15.9	6.7	23.8	0.2	1.2	4.8	0.3	8.7	16.1	6.3	20.2	13.1	5.2	3.1	45.5	5.0	2.2	8.2	3.9	0.3	0.0	3.7	0.0	3.8	0.0	4.4	1.0	3.5	68.7	2.2	1.1	0.7	1.1	0.8	7.1	0.0	6.5	10.6	13.0	7.1	26.0	0.1	6.2	1.0	3.3	15.0	10.6	6.6	14.7	0.0	12.1	4.0	16.8	16.9	7.2	0.1	4.1	0.9	17.1	19.9	6.6	1.9	16.8	7.5	1.3	12.7	19.4	24.5	33.9	8.6	12.6	29.5	0.3	1.3	1.2	1.4	0.3	2.0	0.1	0.4	0.5	0.1	0.2	0.2	0.4	0.8	1.1	0.1	0.3	0.1	0.2	11.7	52.3	0.0	74.3	17.4	0.0	0.0	0.1	0.0	0.0	9.8	23.8	74.8	0.0	3.4	563.5	1.1	1.9	20.8	2.3	8.0	7.6	8.1	23.2	26.9	7.2	2.6	16.5	0.0	2.4	16.8	1.3	33.2	1.2	9.9	42.1	5.1	54.6	0.0	6.5	2569.1	13.4	2.8	25.8	3.6	83.6	1.3	0.2	26.4	2.8	0.8	1.7	1774.0	2.1	0.0	8.2	1.2	4.3	3.4	9.1	7.2	211.7	12.2	18.2	15.5	783.1	34.8	1.8	0.5	3.8	6.1	20.2	0.1	9.4	9.9	4.1	0.0	7.4	13.3	4.7	5.6	2.5	1.7	1.8	15.4	1.1	1.2	18.9
PLCH1	"DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3"	ENSG00000114805	"Phospholipase C eta 1"	Q4KWH8	3	155375580-155745071	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.6;retina: 12.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 93.7;Early spermatids: 206.2;Excitatory neurons: 126.0;Inhibitory neurons: 131.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 12.3;AF22: 39.0;HEL: 10.1;NTERA-2: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036176, HPA057978"	Uncertain		Enhanced	Vesicles		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA036176: AB_10671837, HPA057978: AB_2683569"	"unprognostic (1.08e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.94e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (3.03e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-2)"	0.0	0.0	5.5	0.3	4.8	0.2	2.6	4.5	6.0	1.2	9.3	2.5	2.5	0.7	8.2	0.1	8.1	1.5	1.8	3.8	1.4	1.2	0.1	4.0	0.0	1.3	4.6	0.1	1.4	0.4	1.5	0.4	1.5	0.3	2.4	12.4	1.3	1.9	0.2	0.1	2.5	0.1	1.6	0.0	3.8	11.3	1.3	16.6	5.7	0.0	0.0	0.4	0.1	2.0	0.0	12.3	39.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.4	9.8	0.0	0.8	0.0	0.1	0.0	7.0	0.0	0.0	0.0	3.6	10.1	0.0	1.4	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.3	0.0	0.0	4.4	2.4	9.4	20.8	1.3	1.6	0.9	0.0	0.0	2.4	0.2	3.6	0.9	0.0	9.4	0.0	5.7	4.2	0.0	0.0	0.0	0.2	0.0	1.7	0.4	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	4.8	4.5	6.0	3.8	1.4	1.3	4.6	1.5	1.6	1.3	2.0	0.0	3.2	13.6	93.7	0.3	0.0	0.4	0.5	0.6	10.5	4.0	5.0	0.8	4.3	2.3	1.8	4.2	0.0	0.1	2.7	0.0	2.2	206.2	34.6	1.3	0.6	3.0	0.0	126.0	2.3	0.3	0.3	15.3	13.6	0.0	0.1	0.0	0.0	0.2	25.2	131.5	4.0	0.0	0.3	0.4	21.4	1.2	0.4	0.0	12.2	0.1	16.1	0.0	5.5	5.7	1.5	4.6	0.4	0.0	0.4	2.8	2.1	23.4	3.0	0.0	0.0	0.2	2.4	1.2	0.7	0.1	0.0	0.3	0.1	4.4	0.4
PLD4	C14orf175	ENSG00000166428	"Phospholipase D family member 4"	Q96BZ4	14	104924713-104937761	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;brain: 16.7;lymphoid tissue: 11.3"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 284.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 3621.6"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 3621.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 127.3;RPMI-8226: 85.5;THP-1: 191.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051512	Uncertain					NA	NA		2900000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA051512: AB_2681515"	"unprognostic (4.50e-3)"	"unprognostic (1.78e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.19e-3)"	"unprognostic (3.45e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.41e-1)"	0.4	1.0	5.1	5.7	4.7	13.4	1.5	7.0	7.1	1.0	0.4	0.8	3.8	1.0	0.2	0.6	1.8	2.4	0.5	4.5	7.3	0.8	0.5	1.8	11.3	15.7	6.8	0.5	1.1	1.2	2.1	0.8	10.3	1.7	0.5	0.5	3.5	1.8	0.3	0.6	5.1	0.5	13.9	10.4	2.8	0.6	9.4	2.8	0.6	0.0	9.4	1.9	0.4	16.7	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	127.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.1	10.7	0.1	0.0	0.1	30.0	0.1	85.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	191.5	0.0	0.1	0.3	0.1	0.2	0.4	0.0	0.1	0.2	1.6	0.3	4.6	43.0	699.5	1.0	188.4	1.9	222.7	0.8	1.2	545.8	198.4	1.7	0.4	9.8	25.4	297.9	3621.6	1.0	72.9	5.1	4.7	7.0	7.1	4.5	7.3	15.7	6.8	10.3	13.9	9.4	16.7	0.8	0.0	0.0	0.3	34.7	0.4	0.1	0.0	0.0	2.7	0.6	2.8	1.4	0.0	0.0	0.0	0.0	0.2	284.8	0.0	0.0	0.0	0.7	0.1	0.3	2.7	0.0	5.5	0.1	0.0	0.4	1.1	1.1	0.4	3.8	0.0	0.0	0.0	30.6	1.7	0.1	0.0	0.0	1.3	32.0	4.7	0.0	38.0	5.4	22.5	11.3	0.1	2.1	0.5	0.1	0.0	0.0	0.0	2.3	0.1	0.0	0.1	0.0	1.1	6.6	1.6	0.3	1.6	1.6	0.0	0.4	0.3	2.2	0.0	0.1	0.0
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524697	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 16.2;choroid plexus: 52.8"	"Group enriched"	"Detected in some"	6	"Inhibitory neurons: 319.5;Oligodendrocyte precursor cells: 127.6;Oligodendrocytes: 226.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	5	"cerebellum: 16.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.0;AF22: 10.3;HDLM-2: 5.3;SH-SY5Y: 2.9;U-2 OS: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol		No	No				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Vesicles, Cytosol"	"HPA028389: AB_10602145, HPA050367: AB_2681105"	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	0.4	1.7	1.7	0.0	2.9	0.0	0.4	16.2	2.5	0.6	52.8	0.2	0.0	1.1	0.2	0.4	1.1	0.1	0.1	3.4	2.5	0.4	0.0	0.2	1.1	2.9	2.6	2.1	1.0	0.2	2.4	0.4	2.8	0.8	0.1	0.3	0.7	3.0	0.2	0.1	0.1	0.9	2.0	0.7	0.3	1.5	2.2	0.4	0.2	0.0	0.4	0.1	0.3	2.7	0.0	3.0	10.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.9	16.2	2.5	3.4	2.5	2.9	2.6	2.8	2.0	2.2	2.7	0.1	0.0	0.0	7.8	0.2	0.1	0.0	0.0	1.2	0.5	0.0	1.7	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	9.1	2.9	0.6	0.3	0.0	0.0	35.5	0.0	0.0	3.1	0.0	8.2	0.0	0.7	0.0	0.0	0.0	3.3	319.5	0.2	0.0	0.0	0.0	21.0	5.0	0.1	0.0	5.6	0.0	0.4	0.0	127.6	226.8	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.2	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.1
PLEKHA6	"KIAA0969, PEPP3"	ENSG00000143850	"Pleckstrin homology domain containing A6"	Q9Y2H5	1	204218853-204377665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.0;Distal enterocytes: 66.6;Excitatory neurons: 102.6;Inhibitory neurons: 62.5;Oligodendrocyte precursor cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 60.3;BEWO: 94.6;CAPAN-2: 79.2;OE19: 80.9;RT4: 66.4;SK-BR-3: 58.4;T-47d: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028152, HPA028157, HPA054311"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Vesicles	"HPA028152: AB_10601048, HPA028157: , HPA054311: AB_2682446"	"unprognostic (9.81e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.57e-4)"	5.1	6.6	20.4	6.0	21.6	0.4	13.7	20.9	34.4	4.1	9.1	32.2	25.5	4.8	12.9	17.2	9.3	13.2	20.8	19.6	18.7	27.4	27.5	3.2	0.6	23.1	24.3	4.6	10.2	5.7	31.1	8.8	23.3	13.8	29.3	11.4	9.0	13.9	6.0	4.0	29.5	3.8	17.9	3.1	39.7	5.4	34.6	1.0	4.0	2.4	2.4	12.7	7.5	24.1	60.3	36.8	23.7	0.1	0.3	0.6	94.6	2.1	6.6	0.2	0.3	17.8	79.2	0.3	17.3	1.4	0.3	6.7	0.3	6.5	0.3	0.2	3.8	0.2	15.2	25.7	3.5	0.0	0.1	1.0	19.6	0.0	5.0	7.2	10.4	0.8	0.1	0.2	23.9	26.7	0.1	0.1	7.4	80.9	44.6	0.0	0.2	0.1	23.0	66.4	4.8	48.4	26.6	58.4	0.4	4.9	55.3	0.3	0.7	0.0	1.0	0.3	0.5	0.2	0.0	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	21.6	20.9	34.4	19.6	18.7	23.1	24.3	23.3	17.9	34.6	24.1	0.2	0.0	10.9	111.0	0.3	0.1	4.2	1.9	0.6	41.6	15.7	8.1	16.6	37.1	4.5	9.2	20.9	6.6	0.5	66.6	3.9	8.4	10.4	4.0	1.3	1.2	16.8	2.7	102.6	5.1	2.4	9.0	40.8	6.2	0.0	0.3	5.0	21.4	0.8	18.5	62.5	32.7	4.1	0.6	0.7	4.0	5.3	0.7	0.0	15.0	0.1	1.2	0.0	85.5	41.8	13.3	33.2	3.8	0.1	6.9	15.2	11.7	7.2	7.1	0.0	26.4	1.1	0.6	0.2	1.4	0.6	21.6	0.6	0.1	34.5	13.7
PLEKHG5	"GEF720, KIAA0720, Syx, Tech"	ENSG00000171680	"Pleckstrin homology and RhoGEF domain containing G5"	O94827	1	6467122-6520074	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.4;skin 1: 102.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 57.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 32.1;TIME: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049570	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA049570: AB_2680818"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.50e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.85e-2)"	18.7	15.0	4.4	2.9	2.6	0.6	12.0	57.4	16.6	14.0	0.0	7.3	6.4	7.5	1.9	21.6	8.6	7.3	16.4	13.0	0.0	6.5	1.8	6.0	5.0	0.0	0.0	7.5	5.1	4.4	43.3	12.4	1.8	9.9	3.5	3.4	9.3	7.2	6.8	102.5	8.4	3.9	0.0	50.9	4.4	5.4	0.0	2.0	7.2	3.0	3.3	5.9	14.3	0.0	7.1	2.7	11.9	9.4	1.5	4.2	3.1	8.4	7.0	3.2	2.1	6.9	18.8	0.3	22.6	2.8	4.9	22.6	2.2	23.7	1.3	16.5	3.0	0.0	15.1	2.9	1.9	0.0	1.3	5.5	10.2	8.1	12.5	17.4	24.9	1.7	0.0	1.5	0.6	5.0	0.5	32.1	4.9	2.3	23.8	0.1	2.7	2.3	6.3	3.1	10.5	25.2	1.1	8.2	1.5	5.3	8.2	0.5	30.3	8.1	5.0	0.0	6.6	0.1	0.0	2.4	9.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	2.6	57.4	16.6	13.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.6	0.0	1.5	1.0	0.2	7.4	2.3	4.7	8.0	1.4	1.4	2.2	4.1	1.5	3.6	3.7	2.1	2.6	0.1	4.2	0.0	1.3	8.6	2.5	5.9	9.8	3.5	0.4	17.4	1.3	4.0	1.9	3.1	3.2	0.0	4.0	7.5	0.3	5.3	1.7	9.6	6.4	6.1	0.8	1.3	5.7	1.8	2.4	0.0	7.5	0.0	9.7	0.0	2.0	1.2	5.1	5.6	8.6	0.4	3.8	4.1	0.4	2.7	1.5	13.1	2.1	1.7	2.1	5.1	10.8	14.5	1.9	0.7	2.5	2.8	5.8
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351450-17377342	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 436.2"	"Group enriched"	"Detected in many"	4	"Adipocytes: 439.2;Endothelial cells: 344.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 35.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 35.2"	"Cell line enriched"	"Detected in some"	27	"EFO-21: 549.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		53000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	283.0	51.1	2.7	54.6	3.1	1.7	210.5	2.9	4.2	102.7	18.2	95.7	86.7	90.0	5.1	48.9	83.3	139.2	92.5	3.3	3.1	153.0	6.9	31.0	50.5	3.7	3.5	16.7	96.1	98.6	64.3	48.8	3.6	68.4	22.3	0.0	77.9	38.0	32.7	58.9	103.3	50.5	3.6	166.7	116.6	4.4	3.5	18.9	436.2	12.9	16.2	104.4	80.8	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	549.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	9.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.1	20.0	0.0	2.3	0.1	0.3	0.5	2.2	2.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	35.2	0.0	0.6	2.7	3.1	2.9	4.2	3.3	3.1	3.7	3.5	3.6	3.6	3.5	4.1	439.2	6.4	0.0	0.3	0.7	22.9	1.0	0.0	8.0	0.0	2.7	3.3	3.7	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	3.6	0.4	0.3	344.9	0.0	0.4	0.4	2.5	0.1	48.9	0.0	0.3	0.0	0.4	79.6	0.2	1.8	0.0	0.3	0.0	0.0	3.5	28.8	0.8	0.0	5.5	23.2	6.5	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	7.6	1.5	0.0	0.0	0.0	0.1	0.0	1.4	6.1	0.5	0.7	2.9	16.8	0.1	1.4	0.7	0.0	2.3
PLXDC2	"FLJ14623, TEM7R"	ENSG00000120594	"Plexin domain containing 2"	Q6UX71	10	19816239-20289856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Microglial cells: 1508.4;Oligodendrocytes: 470.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3"	"Group enriched"	"Detected in many"	13	"dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.4;U-2197: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017268, HPA070793"	Approved		Supported	"Nuclear bodies"		No	No		720000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA017268: AB_10965928, HPA070793: AB_2686313"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.66e-2)"	12.4	9.4	13.3	7.3	14.1	5.2	11.5	9.6	13.3	12.7	16.8	5.3	4.2	10.7	3.5	7.5	10.1	17.4	10.2	11.3	25.6	10.7	3.1	17.1	2.4	18.0	17.3	9.4	3.6	16.2	3.3	4.7	19.2	7.6	4.6	18.2	6.2	7.7	5.0	15.5	7.1	16.2	16.2	9.4	3.8	5.9	22.3	2.5	6.8	10.0	2.8	8.5	8.9	29.1	0.0	0.0	5.8	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.7	2.2	1.8	0.0	0.0	0.7	2.8	8.6	0.4	19.4	0.0	0.0	7.7	0.6	0.0	2.3	8.9	0.0	0.0	0.1	1.7	0.9	1.1	0.6	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.2	2.4	0.4	0.0	1.8	0.8	0.9	0.0	7.6	3.9	45.9	0.0	0.1	0.0	0.0	3.5	0.1	0.0	10.7	57.5	11.8	1.3	33.4	2.7	0.0	0.0	0.3	36.0	0.0	0.0	0.0	81.6	4.4	37.3	1.6	0.0	17.7	13.3	14.1	9.6	13.3	11.3	25.6	18.0	17.3	19.2	16.2	22.3	29.1	101.4	16.0	8.9	131.9	2.6	36.8	23.8	12.3	41.5	44.2	14.4	45.3	10.9	15.7	10.9	5.5	8.4	0.9	2.9	7.1	0.0	6.9	2.9	16.5	7.6	45.3	3.0	10.5	190.9	0.0	8.1	97.2	1.1	19.4	31.6	80.9	82.1	4.2	94.3	1.7	59.9	27.3	8.2	91.3	46.3	2.1	19.3	147.7	7.2	1508.4	94.5	25.5	5.2	158.3	470.2	1.0	16.6	57.2	3.8	5.5	16.0	22.2	3.0	73.6	19.7	110.1	12.7	1.6	1.2	35.5	38.1	1.2	4.2	71.4	8.8	11.7
PMEPA1	"STAG1, TMEPAI"	ENSG00000124225	"Prostate transmembrane protein, androgen induced 1"	Q969W9	20	57648392-57711536	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 110.8"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 339.6;Muller glia cells: 325.9;Pancreatic endocrine cells: 827.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 157.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"naive B-cell: 6.3;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	8	"B-cells: 6.3;dendritic cells: 23.9"	"Cell line enhanced"	"Detected in many"		"SiHa: 206.1;U-2 OS: 129.9;U-251 MG: 481.8;WM-115: 237.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072291			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA072291: AB_2686509"	"unprognostic (2.72e-3)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.83e-3)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (2.87e-7)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.87e-3)"	"prognostic unfavorable (7.60e-4)"	50.5	14.5	24.2	14.2	75.5	1.3	25.1	38.8	29.9	94.8	1.8	30.7	6.5	48.4	7.1	7.6	19.9	26.0	29.2	24.0	28.3	16.2	3.8	21.8	7.4	32.9	34.1	14.9	31.3	5.0	13.5	3.9	38.8	110.8	8.4	23.6	30.5	20.6	33.2	18.1	12.6	28.8	27.0	6.6	12.2	5.3	36.1	2.4	13.6	13.6	8.9	13.1	29.6	26.2	32.2	75.4	2.3	3.9	2.4	0.0	0.8	4.9	0.2	1.7	0.8	1.5	97.4	0.2	17.7	7.4	51.8	121.1	1.6	100.8	1.3	1.0	4.1	0.0	23.2	0.1	1.5	0.3	0.8	1.2	55.8	4.4	12.1	16.5	13.0	67.8	0.8	1.2	6.2	66.1	3.8	0.7	9.4	15.0	9.6	0.3	36.0	11.3	24.2	0.0	17.7	13.7	206.1	120.3	15.1	5.6	18.8	4.1	33.1	17.9	129.9	1.9	481.8	5.9	0.8	0.5	8.1	1.1	237.1	0.0	0.4	0.0	0.0	0.0	0.0	2.6	0.8	0.2	0.1	6.3	1.8	1.2	0.1	0.0	0.1	23.9	0.5	0.6	24.2	75.5	38.8	29.9	24.0	28.3	32.9	34.1	38.8	27.0	36.1	26.2	59.4	57.7	32.3	4.9	32.7	167.0	143.1	120.6	30.7	59.0	38.0	23.0	23.2	125.8	31.7	11.0	2.1	0.2	27.8	57.3	3.9	339.6	1.2	33.4	88.8	55.6	10.1	0.0	19.1	62.5	4.1	40.5	5.1	80.2	59.8	17.5	24.7	0.5	6.1	1.7	32.7	16.9	14.2	3.5	68.0	2.7	3.1	13.4	32.0	31.9	5.8	325.9	0.0	17.6	9.0	827.5	54.2	21.8	25.3	203.1	6.2	2.7	10.1	11.5	72.3	43.8	155.2	0.2	8.8	10.0	178.4	0.1	17.8	9.1	19.3	87.5
PMP2	"FABP8, M-FABP, MP2"	ENSG00000147588	"Peripheral myelin protein 2"	P02689	8	81440326-81447439	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Transport		"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	50	"brain: 278.7;choroid plexus: 97.2"	"Group enriched"	"Detected in some"	16	"Astrocytes: 84.9;Muller glia cells: 48.5;Oligodendrocyte precursor cells: 88.4;Oligodendrocytes: 90.3"	"Cancer enriched"	"Detected in some"	59	"glioma: 239.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"WM-115: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	9	"spinal cord: 1313.6"							NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"					"unprognostic (5.87e-2)"			"unprognostic (5.81e-2)"	"unprognostic (1.12e-2)"		"unprognostic (1.95e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.43e-2)"		"unprognostic (7.21e-2)"	"unprognostic (4.41e-1)"		"unprognostic (3.27e-3)"	1.8	1.4	155.1	1.4	168.0	0.0	0.7	231.4	193.1	1.3	97.2	1.4	0.4	0.1	1.8	0.8	0.3	1.1	2.0	146.1	206.4	0.4	0.2	0.1	0.0	278.7	243.1	0.2	0.4	0.0	0.7	0.0	257.4	1.8	0.7	0.2	1.0	3.7	0.3	0.3	0.6	0.3	247.1	0.0	0.6	0.1	214.0	0.0	0.3	0.8	0.0	0.9	1.1	275.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.1	168.0	231.4	193.1	146.1	206.4	278.7	243.1	257.4	247.1	214.0	275.2	1.4	0.0	0.0	84.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.7	0.0	48.5	0.0	88.4	90.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PNOC	"N/OFQ, NOP, PPNOC"	ENSG00000168081	Prepronociceptin	Q13519	8	28316986-28343355	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Neuropeptide, Neurotransmitter, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.3;fallopian tube: 18.2;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 61.5;dendritic cells: 12.6;Inhibitory neurons: 23.3;Melanocytes: 14.2;Plasma cells: 80.4"	"Cancer enriched"	"Detected in many"	8	"ovarian cancer: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"memory B-cell: 231.2;naive B-cell: 260.3;plasmacytoid DC: 194.0"	"Group enriched"	"Detected in many"	20	"B-cells: 260.3;dendritic cells: 194.0"	"Group enriched"	"Detected in some"	6	"Daudi: 38.3;Karpas-707: 29.2;RPMI-8226: 11.2;U-698: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044507, HPA056724"	Enhanced				"Secreted to blood"	NA	NA	12300		"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA044507: AB_10795043, HPA056724: AB_2683216"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.81e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.57e-9)"	"unprognostic (2.19e-2)"	"unprognostic (5.45e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-1)"	0.2	0.8	5.4	9.9	5.1	2.7	0.6	1.3	10.8	0.2	1.3	2.9	4.3	0.1	0.0	0.6	18.2	1.1	0.1	2.9	9.9	0.7	0.2	1.0	25.1	10.4	6.3	0.4	0.0	0.0	0.0	0.0	9.9	0.2	1.5	0.0	1.6	0.1	0.0	0.1	5.8	0.5	14.3	14.4	3.2	0.6	4.3	2.7	0.4	0.0	23.6	3.7	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.0	4.4	23.0	0.1	0.1	0.0	0.2	11.5	2.3	0.2	7.7	0.1	231.2	0.2	0.1	1.1	260.3	0.1	0.1	1.3	1.2	3.2	194.0	0.5	11.1	5.4	5.1	1.3	10.8	2.9	9.9	10.4	6.3	9.9	14.3	4.3	3.0	0.1	0.0	1.9	1.3	61.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.4	0.4	0.2	0.0	23.3	0.1	0.0	0.0	0.3	2.8	0.3	1.7	14.2	1.0	3.0	0.0	1.0	0.0	0.9	0.1	0.0	0.0	80.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	1.1	0.0	0.3	0.5
PODXL2	"endoglycan, PODLX2"	ENSG00000114631	"Podocalyxin like 2"	Q9NZ53	3	127629185-127672802	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6;pituitary gland: 59.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 96.3;Early spermatids: 73.5;Horizontal cells: 82.4;Late spermatids: 153.1;Spermatogonia: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 118.1;SCLC-21H: 167.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024934, HPA042265"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"CAB024934: , HPA042265: AB_2677920"	"unprognostic (2.07e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-3)"	3.8	17.3	45.0	2.7	39.9	1.8	8.8	34.1	50.9	2.9	1.9	9.4	7.2	4.4	2.3	4.2	4.3	4.5	4.1	42.3	65.6	7.2	1.6	2.0	2.2	49.2	50.9	11.2	13.5	5.3	59.0	1.0	54.6	13.1	8.2	21.6	24.9	2.0	3.2	7.6	6.7	1.8	32.9	2.0	14.1	30.8	53.6	1.9	5.5	1.8	2.7	3.1	2.8	40.5	0.3	13.8	37.5	89.2	0.0	0.0	55.2	4.3	0.2	7.9	1.6	28.7	1.5	34.0	33.3	0.6	12.1	0.2	30.9	0.0	0.7	0.2	63.3	0.7	30.9	29.3	1.2	78.1	75.7	1.5	6.6	0.2	0.0	20.9	2.2	0.2	45.6	0.2	2.9	17.6	0.3	0.3	56.2	7.9	66.6	0.2	1.0	118.1	10.9	3.9	167.0	94.0	40.9	86.3	77.2	3.7	22.0	39.2	0.4	0.2	17.2	1.5	27.3	0.2	0.0	26.9	0.9	50.1	25.1	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.6	0.5	0.1	45.0	39.9	34.1	50.9	42.3	65.6	49.2	50.9	54.6	32.9	53.6	40.5	1.6	0.0	1.1	10.4	3.4	5.5	3.7	1.3	9.1	96.3	17.5	18.4	0.5	4.3	1.7	9.2	31.3	2.2	4.4	14.3	1.9	6.8	73.5	8.7	2.5	2.2	63.5	5.5	21.3	20.1	5.9	8.2	25.0	12.3	1.3	9.5	0.7	0.7	1.3	82.4	57.7	23.2	4.1	1.3	2.8	153.1	8.7	1.6	21.4	5.6	8.1	19.0	6.2	29.1	12.5	12.9	16.7	5.7	10.4	9.9	10.8	2.9	1.7	49.9	6.6	3.8	9.8	20.4	80.4	10.0	5.5	1.5	3.3	7.5	21.8	3.1
POGLUT3	"KDELC2, MGC33424"	ENSG00000178202	"Protein O-glucosyltransferase 3"	Q7Z4H8	11	108472112-108498384	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.8;Cardiomyocytes: 13.1;Cytotrophoblasts: 27.6;Extravillous trophoblasts: 14.5;Fibroblasts: 14.7;Hofbauer cells: 18.0;Syncytiotrophoblasts: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039315, HPA039817, HPA066134"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Vesicles	"HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624"	"unprognostic (1.29e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.00e-3)"	"unprognostic (4.08e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (6.27e-5)"	24.6	13.2	5.0	17.3	5.0	7.6	16.2	4.6	5.4	33.6	7.0	16.8	9.4	35.0	27.3	21.0	23.0	21.7	15.2	4.2	5.9	15.6	13.2	16.0	10.4	5.5	6.1	36.5	8.3	25.2	5.4	32.7	5.4	28.4	16.9	5.8	13.9	28.4	5.5	13.7	11.2	37.1	5.3	12.4	11.3	5.8	5.5	16.4	12.1	13.9	9.5	22.5	18.8	6.0	10.9	12.4	46.5	47.8	76.5	88.5	44.8	47.0	43.7	66.0	71.1	58.9	78.1	0.1	28.6	61.6	73.1	7.9	35.6	1.2	69.3	19.4	27.4	18.1	12.1	27.2	30.8	47.7	0.2	51.1	14.6	35.0	1.0	40.1	56.6	0.3	41.5	0.3	101.0	7.9	30.9	27.2	20.3	11.5	34.8	1.5	72.5	0.2	12.3	30.3	9.7	29.5	89.1	6.2	13.3	21.4	42.3	18.0	56.8	127.0	24.9	10.8	49.7	0.4	0.1	0.3	32.6	48.9	103.1	0.1	0.1	0.0	2.0	0.7	1.7	0.2	1.0	1.7	0.5	0.3	1.0	1.5	0.1	1.9	0.4	1.0	0.9	0.5	5.0	5.0	4.6	5.4	4.2	5.9	5.5	6.1	5.4	5.3	5.5	6.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	27.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	14.5	14.7	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	21.2	0.5	0.0	0.0	0.0
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 254.5;Late spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 280.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011616, HPA049104, HPA069013"	Enhanced		Uncertain	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB011616: AB_731977, HPA049104: AB_2680632, HPA069013: "	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.65e-4)"	12.4	17.5	26.6	13.5	27.4	51.3	27.4	82.3	35.5	18.9	24.3	12.3	10.8	12.9	19.7	26.5	13.2	17.4	26.1	28.1	29.0	18.0	33.9	14.2	20.2	27.1	27.8	20.4	16.9	18.8	26.7	11.1	28.9	24.8	13.2	18.0	30.3	11.3	85.3	23.1	10.8	10.6	27.6	17.2	14.0	53.1	30.2	24.8	14.2	70.0	22.2	30.8	18.9	28.9	40.2	23.5	40.6	80.4	21.8	20.7	33.8	25.2	29.3	41.5	37.7	33.1	46.0	36.4	31.1	16.5	43.4	20.0	34.1	29.5	50.3	23.8	36.7	26.5	18.2	45.3	34.1	18.6	280.6	18.8	34.4	30.1	35.4	51.8	32.1	77.2	58.4	22.4	40.3	23.6	78.0	52.6	54.4	48.4	26.7	44.2	40.8	31.4	78.4	32.1	22.7	41.8	29.9	19.9	79.0	41.4	52.5	31.5	17.8	19.1	27.0	48.8	24.6	32.5	58.4	52.2	19.3	39.4	52.2	47.6	15.1	48.1	12.0	18.8	13.3	12.2	12.5	13.0	15.7	11.1	14.1	13.3	63.6	22.2	26.3	84.9	19.3	11.5	26.6	27.4	82.3	35.5	28.1	29.0	27.1	27.8	28.9	27.6	30.2	28.9	13.9	3.2	13.6	6.8	20.2	16.8	30.1	14.2	31.3	2.9	14.3	15.1	21.6	7.2	20.7	7.3	8.4	7.5	51.9	3.1	5.9	11.7	254.5	13.8	7.7	12.5	6.0	7.6	15.8	9.6	7.0	9.7	10.2	9.9	23.4	12.7	8.6	12.7	7.4	6.7	20.3	5.4	4.1	5.7	9.9	133.9	7.2	18.2	7.2	19.7	11.2	8.3	13.4	12.5	16.7	33.6	5.8	3.8	21.9	41.6	4.3	6.8	16.4	4.4	0.0	6.6	12.3	19.4	15.4	27.3	20.0	11.1	16.2	7.8	6.6	31.6
POMGNT2	"AGO61, C3orf39, FLJ14566, GTDC2"	ENSG00000144647	"Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)"	Q8NAT1	3	43079232-43106079	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034870, HPA040989"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"			"HPA034870: AB_10602701, HPA040989: AB_2677238"	"unprognostic (2.37e-3)"	"unprognostic (8.22e-2)"	"prognostic favorable (8.13e-5)"	"unprognostic (2.57e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (8.71e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (4.00e-7)"	"unprognostic (4.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	11.0	13.5	22.1	4.2	21.0	20.7	9.9	22.6	23.1	19.4	19.8	14.9	3.6	50.7	11.3	7.5	30.9	9.0	19.1	22.6	20.8	12.8	9.2	10.2	3.1	21.7	21.0	30.4	15.3	17.7	19.1	5.5	24.9	15.2	2.9	9.0	13.8	14.5	31.5	11.7	7.1	19.7	18.1	6.0	13.8	14.8	26.7	5.5	11.8	18.6	2.3	15.2	13.6	17.8	20.0	14.9	8.5	26.0	32.0	8.2	13.5	5.6	10.0	19.5	22.7	18.2	13.7	0.0	20.6	10.2	23.6	0.4	14.0	16.3	8.5	0.1	39.2	14.0	11.1	17.4	12.1	9.9	15.9	9.5	11.9	13.2	7.7	7.7	7.6	29.7	11.6	0.1	7.6	11.8	18.1	2.6	18.7	12.4	27.7	7.0	6.0	12.3	11.6	14.4	13.4	12.2	11.8	9.4	10.9	5.7	17.8	8.6	3.6	15.7	21.9	23.3	23.3	14.5	23.2	0.1	20.2	19.6	17.0	0.0	0.5	0.5	3.0	0.4	2.7	1.9	1.9	1.9	0.6	0.9	2.3	1.9	0.0	1.0	0.4	0.6	1.7	1.0	22.1	21.0	22.6	23.1	22.6	20.8	21.7	21.0	24.9	18.1	26.7	17.8	4.1	3.2	2.0	11.8	2.6	8.0	2.8	3.8	6.8	15.3	8.2	7.5	17.0	10.0	3.4	14.7	8.4	3.4	3.2	2.4	5.9	9.9	10.4	6.9	6.6	3.9	6.0	28.4	13.2	10.7	5.3	14.3	4.6	2.5	0.0	12.6	5.0	6.6	6.2	10.1	14.1	1.9	4.1	4.2	4.8	24.5	19.9	3.7	5.4	3.7	1.1	10.1	5.2	15.6	7.4	5.5	2.0	29.3	3.1	4.4	1.4	5.2	9.2	5.2	13.1	8.5	8.3	10.0	19.0	6.0	11.6	1.8	3.6	3.2	2.7	2.2
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643994-62935150	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;parathyroid gland: 42.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 123.5;Glandular and luminal cells: 81.6;Inhibitory neurons: 162.1;Microglial cells: 89.9;Oligodendrocytes: 341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 80.6;HMC-1: 62.7;SK-BR-3: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816"	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.2	1.5	12.0	1.2	12.7	3.1	4.9	30.0	16.0	7.5	5.7	2.4	3.1	6.2	6.7	0.6	6.5	6.7	2.4	13.3	15.7	10.6	3.4	2.7	1.2	11.1	11.3	9.6	3.9	42.4	8.2	6.5	14.9	13.4	3.0	26.7	11.4	6.0	1.1	0.8	1.7	1.5	7.8	0.9	5.7	0.9	16.5	4.3	3.2	1.3	1.7	2.1	0.3	16.2	1.2	12.4	2.2	0.2	0.5	0.0	26.5	2.9	2.9	1.8	0.6	80.6	5.7	0.0	2.7	1.4	1.8	1.6	8.7	0.2	1.1	0.2	4.3	15.2	2.4	18.4	0.1	4.6	62.7	0.1	0.3	0.0	0.7	1.9	0.3	2.7	4.0	0.0	1.3	9.5	1.5	2.2	15.9	4.1	5.9	2.1	5.6	23.0	18.1	28.3	6.9	0.0	5.0	35.6	12.1	8.5	19.6	2.7	0.2	0.5	1.5	0.2	0.9	3.3	21.4	4.1	0.2	0.1	1.2	2.9	0.7	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.1	12.0	12.7	30.0	16.0	13.3	15.7	11.1	11.3	14.9	7.8	16.5	16.2	4.6	6.4	4.7	25.5	1.0	0.1	0.3	3.0	0.0	9.4	9.5	3.4	2.4	12.8	5.9	16.5	27.1	22.2	0.0	0.7	3.9	4.2	8.5	27.6	25.3	6.5	9.0	3.8	123.5	6.3	2.1	1.3	7.7	81.6	14.5	0.3	9.7	6.1	6.1	11.8	162.1	2.0	6.1	1.6	2.1	10.1	0.9	2.1	3.6	89.9	2.1	6.4	0.0	41.7	341.4	4.5	2.1	1.5	0.5	4.3	0.1	8.5	14.0	10.9	0.0	0.6	1.7	0.0	0.5	0.5	0.1	6.8	1.3	2.8	2.4	0.5
PPP1R3G		ENSG00000219607	"Protein phosphatase 1 regulatory subunit 3G"	B7ZBB8	6	5085341-5089487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.9;liver: 6.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 18.5;Glandular and luminal cells: 7.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.3;PC-3: 3.9;THP-1: 14.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056393	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA056393: AB_2683115"	"unprognostic (1.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-3)"	"unprognostic (8.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.27e-1)"	2.3	3.0	2.3	0.3	2.1	0.1	1.4	1.5	2.7	2.1	0.9	2.0	0.2	1.2	1.0	1.8	1.0	0.3	5.9	2.0	1.8	0.6	6.2	0.3	0.5	2.3	2.3	0.8	0.1	0.3	0.2	0.7	1.9	1.2	0.5	0.2	0.6	1.4	0.5	1.2	0.5	0.5	1.6	2.8	0.6	0.2	2.2	0.2	0.3	0.2	0.4	2.8	2.1	1.7	0.0	0.2	0.1	0.0	1.6	1.0	0.0	0.3	0.4	0.2	0.3	0.0	0.3	0.0	3.3	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.9	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.3	0.0	14.6	0.0	0.0	0.0	0.8	0.5	2.0	1.7	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	2.3	2.1	1.5	2.7	2.0	1.8	2.3	2.3	1.9	1.6	2.2	1.7	4.2	0.0	0.0	0.0	0.4	0.5	0.5	0.4	0.0	0.5	0.2	0.1	18.5	0.0	0.1	3.7	0.0	0.8	0.0	1.3	0.0	0.3	0.0	1.2	2.0	1.9	1.2	0.0	0.0	0.0	0.4	3.7	0.0	7.2	0.0	1.4	2.9	0.0	4.5	0.0	0.0	0.9	0.0	4.0	4.7	0.2	0.9	1.8	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.6	1.8	3.0	1.8	0.4	0.0	2.1	0.2	0.2	0.0	2.0	2.5	0.1	0.9	0.2	0.3	0.8	0.2	0.5	1.4	1.2
PRICKLE1	"EPM1B, FLJ31937, RILP"	ENSG00000139174	"Prickle planar cell polarity protein 1"	Q96MT3	12	42456757-42590355	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8;Excitatory neurons: 307.7;Inhibitory neurons: 122.2;Microglial cells: 64.6;Oligodendrocyte precursor cells: 114.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.6;naive B-cell: 11.5"	"Lineage enriched"	"Detected in many"	4	"B-cells: 11.5"	"Cell line enriched"	"Detected in many"	18	"HBEC3-KT: 1015.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001379, HPA050037"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA001379: AB_1855703, HPA050037: "	"unprognostic (2.44e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.29e-4)"	"unprognostic (1.12e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.33e-4)"	6.3	3.0	3.7	5.2	5.0	1.7	5.0	0.0	7.2	12.5	0.0	4.2	2.6	12.1	1.6	2.4	6.4	10.0	13.8	4.2	0.0	5.0	1.7	9.5	4.6	0.1	1.3	12.5	2.0	1.4	2.0	5.3	0.0	5.1	2.2	4.2	7.8	5.6	3.9	4.7	2.4	12.7	0.0	14.8	2.9	6.0	3.9	1.6	7.9	4.6	3.4	5.5	6.3	1.0	7.7	4.4	17.0	0.5	12.4	13.1	0.5	11.0	5.2	3.0	5.1	0.5	16.0	0.5	31.4	1.6	0.0	2.9	12.5	1015.4	3.5	0.6	6.4	17.5	0.9	0.4	1.7	0.3	0.2	19.3	7.5	12.7	1.7	1.8	39.7	0.3	1.8	3.1	2.9	0.3	0.1	0.5	56.1	0.1	18.0	0.2	0.7	0.1	21.1	0.7	4.4	3.0	0.3	0.7	0.7	13.7	0.3	35.1	2.9	0.9	13.4	14.0	14.2	0.9	0.6	6.1	0.2	10.7	0.6	2.6	1.8	0.4	0.2	1.0	0.7	7.6	0.2	0.2	1.0	11.5	0.4	0.2	2.4	0.5	0.6	1.6	0.2	0.9	3.7	5.0	0.0	7.2	4.2	0.0	0.1	1.3	0.0	0.0	3.9	1.0	6.9	16.0	8.2	8.8	13.2	2.7	5.3	7.3	4.0	13.5	4.0	2.2	5.7	14.3	2.6	1.8	2.1	0.6	0.2	0.0	0.0	3.8	72.8	5.2	43.0	8.1	0.0	0.4	307.7	2.6	0.2	19.2	3.6	8.6	1.3	59.1	14.6	0.1	0.6	8.4	122.2	0.0	2.0	0.9	2.3	25.4	9.9	1.2	7.2	64.6	1.1	2.7	0.0	114.6	5.3	3.9	0.1	24.8	3.1	1.0	0.0	3.3	0.3	4.5	0.0	3.8	7.9	5.1	4.8	1.9	1.4	0.7	1.1	18.6	0.0	0.8
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 334.4;Inhibitory neurons: 348.8;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		130000	"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	16.5	47.7	79.4	26.1	101.6	16.0	17.7	70.0	113.3	19.8	0.0	55.9	10.8	19.2	38.8	17.8	10.0	26.2	23.8	100.7	107.5	23.8	20.8	15.8	41.8	53.5	44.4	17.8	27.8	23.5	24.7	11.5	65.4	30.6	51.7	71.6	83.7	27.3	4.9	4.1	12.7	28.8	59.9	36.0	34.1	8.1	91.0	63.5	25.2	13.5	36.8	27.6	7.7	110.0	8.6	16.9	26.4	31.8	29.9	26.1	12.3	41.7	31.4	20.8	19.4	0.4	7.5	45.1	28.0	32.8	38.0	5.8	12.6	13.6	22.0	44.1	6.8	99.3	21.3	3.2	29.4	39.8	2.2	15.6	6.0	20.2	11.2	30.2	97.2	16.7	3.2	25.2	34.3	1.6	51.8	21.0	26.1	0.1	11.8	39.6	41.2	27.3	50.5	30.2	8.6	33.4	23.0	8.8	25.6	19.7	8.1	8.2	86.8	28.7	22.4	29.4	31.9	18.6	24.2	45.3	13.7	41.5	36.5	56.3	7.5	16.4	59.3	10.2	47.7	35.2	43.4	52.9	19.4	28.4	65.0	69.5	3.8	73.1	16.2	11.1	44.2	66.8	79.4	101.6	70.0	113.3	100.7	107.5	53.5	44.4	65.4	59.9	91.0	110.0	9.5	0.0	1.5	118.8	56.6	5.1	7.2	3.5	11.4	44.9	11.5	9.1	44.4	21.5	5.2	14.7	35.5	1.9	103.0	115.5	33.2	6.2	2.9	11.4	27.0	13.4	21.7	52.3	334.4	11.9	1.2	17.0	16.3	14.0	58.9	15.2	28.5	17.0	27.1	47.1	348.8	58.1	4.1	62.3	24.4	3.6	14.9	51.6	16.0	95.5	14.6	35.6	96.8	302.6	499.0	20.6	42.2	21.8	53.9	10.0	4.5	25.6	6.3	34.4	13.1	14.1	20.3	13.9	8.0	8.1	2.8	0.7	87.6	11.4	51.1	9.1
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;liver: 86.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	1.6	10.0	11.0	1.4	21.4	0.0	1.8	24.6	18.2	1.0	0.0	2.6	2.1	1.1	1.2	0.6	2.2	1.9	15.7	23.1	12.4	4.7	86.8	1.2	2.8	18.7	17.3	7.4	15.5	0.1	4.0	0.4	13.9	0.5	2.7	21.2	0.3	0.4	3.6	0.7	2.6	0.8	10.6	7.1	2.1	5.4	30.0	0.2	7.6	2.1	0.7	1.0	0.7	38.2	0.0	0.0	0.6	0.0	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.3	0.2	2.3	0.0	0.1	0.0	1.0	0.6	0.0	31.4	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.1	3.5	2.3	5.7	0.0	0.4	0.0	0.4	0.0	1.7	2.0	1.3	0.0	15.9	2.5	0.2	0.5	2.3	77.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.2	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.4	24.6	18.2	23.1	12.4	18.7	17.3	13.9	10.6	30.0	38.2	14.3	0.0	2.3	1.3	1.9	5.9	1.1	0.3	5.7	196.4	4.8	4.7	105.9	102.9	1.3	9.2	2.1	0.0	0.1	3.2	15.6	34.7	52.7	0.1	1.0	36.5	66.9	5.3	2.9	2.7	0.1	8.7	8.6	0.3	0.0	9.3	11.0	285.9	0.9	523.3	66.8	16.5	12.2	4.4	6.6	10.4	1.2	2.2	10.6	8.4	0.0	36.0	0.0	27.2	114.0	3.4	130.6	1.2	0.1	3.9	3.3	0.4	0.9	11.7	0.0	113.6	3.7	2.9	0.4	0.4	4.5	0.0	1.9	29.6	10.5	0.9
PRPF18	hPrp18	ENSG00000165630	"Pre-mRNA processing factor 18"	Q99633	10	13586939-13630859	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037599, HPA047950"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA037599: AB_10795137, HPA047950: AB_2680221"	"unprognostic (5.82e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.63e-1)"	14.6	15.9	8.4	14.4	9.7	43.0	19.6	12.2	10.4	12.8	8.9	16.0	16.9	14.0	28.1	15.8	11.7	15.5	14.3	8.5	10.8	20.7	21.9	14.9	18.2	8.7	8.7	12.9	17.0	18.7	10.7	17.4	8.7	14.3	18.1	10.1	14.3	13.0	23.2	14.3	16.5	15.1	8.6	13.6	15.0	18.8	9.1	25.0	23.6	22.2	19.7	16.4	12.3	10.1	29.5	21.7	18.9	16.4	25.9	24.7	23.5	33.6	16.6	35.9	34.2	20.8	43.8	24.4	18.3	31.1	16.3	23.8	25.1	27.8	41.3	36.3	24.9	28.4	18.5	16.3	30.7	22.6	32.9	19.4	44.3	31.3	15.4	21.9	35.3	35.0	29.9	32.1	33.1	30.5	42.2	15.6	17.8	29.0	10.7	29.8	22.8	30.6	23.9	12.6	13.2	32.7	26.6	18.8	29.1	23.0	29.0	36.6	30.2	22.2	26.1	36.5	25.5	31.2	35.8	34.8	32.8	27.9	15.4	27.2	27.3	36.5	27.7	25.1	24.0	26.9	24.8	23.9	27.4	25.8	26.4	32.6	40.3	39.7	37.4	23.3	33.5	16.8	8.4	9.7	12.2	10.4	8.5	10.8	8.7	8.7	8.7	8.6	9.1	10.1	24.5	19.2	22.4	14.7	32.8	45.6	24.0	35.7	25.0	13.5	22.6	15.0	9.4	30.0	32.9	22.0	10.4	30.5	28.7	21.1	41.1	30.9	29.8	27.5	22.8	21.1	12.6	25.9	27.0	29.1	40.4	18.9	19.4	22.0	27.1	10.5	16.4	28.4	26.0	21.9	25.3	21.8	46.8	20.7	18.0	16.5	17.7	19.4	24.9	18.7	29.7	20.2	36.0	28.1	29.3	33.7	28.9	13.2	27.1	16.2	30.2	50.6	31.8	21.7	19.7	20.8	18.3	105.8	41.1	17.1	46.9	41.7	33.2	11.6	19.0	25.8
PRPH	"NEF4, PRPH1"	ENSG00000135406	Peripherin	P41219	12	49293252-49298686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.6;intestine: 21.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 327.5;Late spermatids: 920.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.6;glioma: 1.7;pancreatic cancer: 1.1;testis cancer: 1.5"	"Group enriched"	"Detected in many"	5	"medulla oblongata: 51.9;pons: 53.6;white matter: 15.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 367.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.4;pons and medulla: 35.1"	"Region enriched"	"Detected in many"	8	"spinal cord: 256.8"	"CAB002437, HPA039277, HPA063887"	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142"	"unprognostic (1.73e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.25e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.86e-3)"	"unprognostic (6.36e-5)"	3.1	14.5	0.9	7.5	1.1	0.0	1.8	0.3	1.8	3.3	0.4	21.0	4.7	0.8	0.1	0.5	3.1	0.6	1.2	0.9	2.2	0.9	0.1	0.9	0.2	51.9	8.0	0.7	1.3	0.1	2.9	0.3	53.6	2.3	2.1	1.5	0.5	1.5	0.4	1.1	8.9	2.0	7.8	1.2	5.2	13.2	0.9	0.1	0.5	0.2	0.1	1.5	8.3	15.7	0.0	0.7	0.0	367.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.7	1.6	0.4	1.3	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.7	0.0	0.2	2.0	0.0	2.2	0.4	0.0	1.6	86.6	1.5	0.2	0.8	0.0	0.0	1.7	0.1	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	1.8	0.9	2.2	51.9	8.0	53.6	7.8	0.9	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	10.8	0.3	0.8	0.4	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	327.5	0.5	0.1	1.4	92.3	0.0	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	25.2	0.1	1.0	0.0	0.0	0.9	920.2	5.9	0.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.8	0.1	38.1	0.0	0.1	14.1	96.1	19.4	0.3	0.4	0.0	0.1	0.0	0.5	0.2
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 147.8;parathyroid gland: 182.0"	"Group enriched"	"Detected in many"	7	"Leydig cells: 1431.5;Peritubular cells: 1995.0;Sertoli cells: 624.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051269, HPA067599, CAB070417"	Enhanced		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nuclear speckles"	"CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869"	"unprognostic (7.50e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	11.0	46.0	6.3	24.5	7.3	24.2	19.7	1.9	12.0	54.5	2.5	30.3	14.0	32.8	26.5	16.1	29.7	28.1	5.4	6.9	2.9	28.0	26.1	13.1	36.8	3.0	6.5	147.8	62.8	182.0	3.4	6.1	2.2	21.9	31.3	1.3	27.9	84.0	2.1	21.9	15.8	24.3	4.4	15.6	32.5	131.1	8.8	44.6	18.1	4.2	31.5	22.5	21.2	6.4	114.2	63.7	22.1	40.3	26.7	31.8	14.6	54.4	26.8	53.1	51.1	46.3	78.7	34.9	24.2	23.5	45.3	79.9	43.1	53.7	61.5	89.7	108.0	41.7	49.6	43.3	24.7	77.3	38.9	30.5	35.0	39.1	51.7	26.9	22.1	86.8	30.4	39.8	45.2	68.5	117.6	34.7	49.9	81.0	107.3	61.5	102.7	79.5	33.0	81.7	46.1	33.6	64.9	2.1	38.9	30.2	58.8	32.4	24.9	41.8	32.0	162.5	55.5	103.6	41.3	76.8	44.4	39.4	67.4	25.9	20.1	9.4	17.2	19.4	19.9	27.8	25.0	16.4	28.2	30.6	31.7	23.0	8.0	24.3	12.3	19.9	22.6	28.2	6.3	7.3	1.9	12.0	6.9	2.9	3.0	6.5	2.2	4.4	8.8	6.4	12.2	3.2	8.7	0.7	25.4	64.0	48.5	16.2	41.5	0.6	53.1	15.9	2.0	11.5	12.4	55.2	0.0	1.1	18.5	21.1	72.4	19.3	12.1	24.7	62.5	14.5	21.8	28.4	14.8	39.2	7.3	25.8	31.1	26.4	27.9	16.2	10.4	13.7	24.4	0.0	6.3	27.9	8.2	21.4	44.3	65.8	1431.5	20.7	40.9	3.7	18.2	1.2	18.6	3.5	5.1	24.6	17.4	1995.0	30.7	52.2	6.0	10.4	20.3	0.2	624.5	9.4	19.2	10.3	8.1	29.2	43.8	0.4	27.2	179.2	50.2	36.9
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 178.4;pancreas: 103.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 203.0;Distal tubular cells: 170.2;Intestinal goblet cells: 127.8;Paneth cells: 226.4;Proximal enterocytes: 263.7;Undifferentiated cells: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 205.6"	"Not detected"	"Not detected"							HPA022918	Approved		Approved	Cytosol		No	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.29e-13)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	2.2	0.1	0.0	7.9	0.1	0.1	38.8	0.2	0.2	13.4	9.5	111.2	178.4	1.4	18.3	12.9	26.5	22.0	0.4	0.8	0.0	28.0	1.9	21.7	0.2	0.1	0.0	0.3	103.9	0.8	8.5	0.0	0.0	17.7	124.3	0.0	51.8	15.8	0.1	10.0	128.5	3.3	0.0	0.0	84.4	2.5	0.0	0.4	67.8	0.0	2.0	2.7	6.7	0.1	3.8	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	8.6	5.8	0.2	0.3	0.0	0.0	20.5	0.0	0.1	0.0	0.4	0.7	0.2	0.0	2.6	0.0	0.4	0.4	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	19.7	0.4	0.4	0.0	205.6	0.7	0.3	0.0	1.4	1.1	2.6	11.7	0.5	0.0	35.7	0.0	0.0	24.1	0.0	0.1	0.3	0.0	0.7	0.1	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	22.4	19.8	0.3	0.1	0.0	2.6	2.4	0.0	0.0	16.7	8.9	0.1	80.1	19.8	16.5	0.0	0.0	0.1	203.0	170.2	35.6	5.5	9.8	0.3	0.2	31.6	0.0	0.1	36.1	0.0	0.4	55.5	3.9	0.0	0.0	0.0	0.8	0.1	0.0	0.1	127.8	24.4	0.0	0.0	9.0	1.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	226.4	0.4	0.2	15.6	263.7	30.0	19.2	0.0	0.0	0.0	1.0	11.1	0.1	7.3	0.0	0.0	0.6	0.0	100.9	9.9
PRRT1	"C6orf31, DSPD1, IFITMD7, NG5"	ENSG00000204314	"Proline rich transmembrane protein 1"	Q99946	6	32148359-32153083	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 40.1;ovary: 11.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.5;Cardiomyocytes: 125.5;Granulosa cells: 181.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 38.4;cerebral cortex: 40.1;hippocampal formation: 37.0;white matter: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.0;SK-MEL-30: 1.6;U-2 OS: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055149, HPA059099"	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA055149: AB_2682717, HPA059099: AB_2732632"	"unprognostic (1.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.08e-5)"	"unprognostic (2.99e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	1.6	2.2	38.4	0.3	6.4	0.0	2.0	0.0	40.1	2.7	0.0	2.9	0.6	2.3	0.0	1.5	3.6	0.1	1.6	37.0	4.8	3.1	0.9	1.3	0.1	3.4	2.1	11.9	0.6	0.3	5.6	0.2	2.2	3.1	0.0	1.3	0.9	0.6	0.4	2.0	1.8	0.0	0.0	0.9	2.0	1.3	6.5	0.0	1.9	0.0	0.0	2.4	2.4	17.5	0.0	0.1	0.0	0.5	0.2	0.1	0.2	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.8	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	6.4	0.0	40.1	37.0	4.8	3.4	2.1	2.2	0.0	6.5	17.5	3.2	0.0	0.0	4.9	0.5	4.0	8.0	3.4	14.8	67.5	1.8	3.0	125.5	10.0	1.2	1.8	10.4	6.7	1.7	2.2	1.9	0.1	1.3	1.3	2.3	6.7	9.0	4.2	12.6	0.0	1.0	7.8	4.6	0.5	0.0	181.6	5.0	3.5	1.0	32.0	10.9	5.5	0.0	0.8	2.1	1.2	6.2	1.9	3.6	6.5	0.2	16.0	1.0	3.5	5.0	0.2	3.4	6.4	0.8	3.6	5.5	0.1	3.7	8.7	0.0	3.6	8.0	0.8	1.6	3.8	2.7	3.6	2.2	8.1	4.1	4.8
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 124.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.3;Cone photoreceptor cells: 31.3;Leydig cells: 36.1;Peritubular cells: 40.3;Rod photoreceptor cells: 37.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"AF22: 24.1;HeLa: 13.8;hTERT-RPE1: 14.0;REH: 17.6;U-138 MG: 14.5"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	13.4	10.5	32.9	2.4	40.4	0.3	10.8	70.7	70.5	79.4	0.0	33.9	5.3	39.5	8.6	6.7	47.0	10.9	15.6	46.0	20.1	8.7	2.4	12.9	3.3	15.6	8.0	124.3	4.7	4.3	85.6	7.0	16.2	39.1	2.3	19.8	5.4	13.9	4.5	5.0	14.5	10.4	24.5	1.7	12.4	14.6	29.2	0.5	10.6	1.8	1.0	34.1	51.0	34.0	0.1	1.5	24.1	8.6	1.2	4.2	0.5	2.5	4.1	1.0	0.8	1.1	1.5	0.2	0.3	4.4	0.5	1.6	3.4	0.2	0.4	4.1	1.4	1.7	13.8	1.6	0.3	0.0	0.3	4.1	0.1	1.9	0.1	14.0	1.0	0.7	0.2	1.5	0.2	3.1	0.6	0.5	5.0	0.1	1.1	17.6	0.9	0.4	0.2	0.8	4.1	4.3	0.2	2.1	0.5	3.5	7.6	0.0	1.3	14.5	5.2	0.7	1.4	3.7	0.5	0.2	5.3	0.2	0.5	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	3.2	0.1	0.0	0.0	0.1	32.9	40.4	70.7	70.5	46.0	20.1	15.6	8.0	16.2	24.5	29.2	34.0	2.3	3.2	0.0	22.9	0.9	1.1	1.4	1.7	0.6	82.3	1.6	1.7	0.8	1.5	1.2	0.0	31.3	1.9	1.9	9.5	1.9	1.1	2.0	4.4	10.4	5.0	6.1	0.0	24.4	1.5	0.8	11.4	2.0	1.6	0.0	1.7	3.3	0.1	0.4	20.2	19.5	4.2	2.0	0.0	2.4	9.8	36.1	0.5	0.0	5.6	0.6	5.7	1.0	8.5	1.6	3.0	9.0	40.3	0.7	1.8	15.2	1.0	5.6	37.1	6.6	2.9	11.7	2.4	3.1	0.4	0.4	2.6	2.7	0.6	2.5	1.3
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512534-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 50.5"	"Cell type enriched"	"Detected in some"	36	"Muller glia cells: 410.9"	"Group enriched"	"Detected in some"	4	"glioma: 2.8;testis cancer: 4.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in single"	195	"T-cells: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.4;CACO-2: 86.3;HAP1: 12.8;RPTEC TERT1: 24.6;SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 2.9;cerebellum: 3.6;cerebral cortex: 5.8;hippocampal formation: 5.3;olfactory bulb: 2.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	1.3	2.4	2.9	0.1	3.8	0.0	0.3	1.7	6.8	2.9	1.5	0.1	0.3	1.3	1.1	0.3	1.4	4.2	4.4	3.2	2.1	3.1	0.4	1.3	0.7	1.8	1.9	10.2	0.3	0.3	1.1	3.6	1.8	1.1	0.3	50.5	0.3	0.4	0.1	0.2	0.1	1.5	1.8	0.7	0.3	3.1	2.6	0.1	0.4	0.1	0.1	1.3	0.5	2.2	0.0	0.5	1.9	0.0	0.1	0.0	0.0	0.3	10.4	1.0	2.0	86.3	0.0	0.0	0.1	0.4	0.0	0.0	12.8	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	0.4	8.2	0.0	0.0	0.0	24.6	0.0	0.0	1.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.5	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.8	1.7	6.8	3.2	2.1	1.8	1.9	1.8	1.8	2.6	2.2	0.3	3.2	0.5	8.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	1.5	0.0	0.0	1.8	0.0	0.3	0.0	0.1	9.8	0.1	0.1	0.0	0.3	0.8	1.8	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.4	6.7	0.2	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	1.0	0.0	410.9	0.0	1.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	11.4	6.6	0.1	3.7	0.1	0.5	0.0	0.0	0.1	0.7	5.1	0.0	0.0
PSAP	"GLBA, SAP1, SAP2"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851325	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease variant, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2792.8;Kupffer cells: 2427.0;Macrophages: 1916.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 11615.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 5104.0;hTERT-RPE1: 6978.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	1068.6	1192.2	831.4	874.2	946.7	834.2	683.8	873.7	831.7	1073.9	1023.0	667.1	475.6	879.3	951.2	605.5	724.7	1115.6	1413.3	830.5	1081.8	860.4	906.4	1118.6	956.1	957.6	894.0	1106.9	544.7	1167.5	563.5	869.3	885.3	773.9	625.5	665.2	580.9	936.8	1409.5	544.4	487.7	1138.6	1025.9	1045.9	664.0	489.1	1048.8	672.3	875.9	987.5	560.4	941.2	578.3	1325.1	455.9	847.4	540.4	1121.0	5104.0	2910.1	1900.2	799.9	2368.3	620.8	735.9	795.4	1131.9	245.6	1608.1	1321.6	1038.9	964.1	207.5	659.1	434.8	481.4	381.8	288.9	352.3	459.6	1970.7	188.8	1596.0	1871.8	1479.1	625.7	1177.6	6978.9	1128.1	345.8	420.5	1158.1	777.0	294.9	843.8	290.1	249.5	575.4	404.0	172.9	301.3	696.7	730.3	764.4	584.4	515.8	751.1	2248.3	3122.2	700.4	454.4	431.1	1467.0	861.8	610.0	587.1	670.5	1289.0	1038.7	435.4	1375.5	374.4	650.0	863.2	10095.9	1127.5	424.2	11615.6	349.8	466.7	342.9	368.8	3481.1	425.5	370.1	350.6	2890.4	365.8	10148.2	1758.2	422.8	15009.0	831.4	946.7	873.7	831.7	830.5	1081.8	957.6	894.0	885.3	1025.9	1048.8	1325.1	263.2	253.2	339.0	136.8	173.9	228.3	253.4	487.0	108.1	193.8	254.6	158.7	664.1	253.1	318.9	476.3	127.2	891.6	260.2	434.8	70.5	1043.6	19.3	147.0	246.6	311.4	261.9	160.5	86.1	456.1	872.6	623.8	187.6	195.2	398.1	210.8	426.9	509.2	2792.8	333.1	93.7	242.2	343.8	2427.0	779.7	54.1	458.6	1916.9	663.5	105.9	1528.9	495.6	182.3	92.5	117.6	357.7	298.3	551.8	503.0	244.8	370.6	311.6	297.2	164.3	276.1	273.6	263.8	55.2	126.3	137.2	198.0	1073.2	138.9	624.1	228.3	223.9
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome 20S subunit beta 8"	P28062	6	32840717-32844679	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No		2700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	62.7	76.9	3.3	11.2	3.4	9.8	56.5	3.3	7.3	42.7	3.4	79.9	12.9	41.3	3.2	59.5	41.6	5.8	34.2	3.4	3.5	63.7	99.2	78.2	18.2	4.3	3.4	32.1	29.5	8.2	26.6	4.4	3.7	45.2	20.4	0.7	44.2	6.4	14.4	58.0	93.9	8.9	4.0	150.4	57.0	5.9	3.6	13.5	40.8	0.1	17.2	41.3	48.1	4.1	15.1	3.9	0.3	0.0	5.1	13.1	11.2	4.9	22.9	29.1	39.3	0.0	20.9	45.7	9.4	10.5	25.5	8.1	6.8	16.6	8.0	19.2	0.0	27.6	5.9	0.3	30.3	5.2	7.5	14.9	10.3	12.9	6.8	1.9	18.1	11.8	1.1	8.1	6.1	0.1	12.9	11.7	0.1	0.0	7.3	29.3	1.3	24.1	21.3	4.9	0.8	0.2	8.6	10.4	8.5	0.1	7.0	41.0	4.3	8.8	7.6	7.8	0.6	21.0	15.9	11.2	2.2	27.7	9.0	56.8	70.3	94.6	58.1	88.0	51.2	73.4	49.1	61.1	67.5	71.1	34.8	49.6	90.2	63.0	78.2	58.5	81.2	156.0	3.3	3.4	3.3	7.3	3.4	3.5	4.3	3.4	3.7	4.0	3.6	4.1	237.0	38.5	55.8	2.9	162.0	84.4	64.1	183.7	54.7	1.8	85.3	92.5	8.7	71.4	103.2	62.5	0.0	2.7	211.2	219.9	86.1	219.4	0.6	63.2	74.9	158.5	65.7	45.0	0.1	247.6	18.3	60.7	93.8	81.5	50.7	51.4	114.5	75.0	165.9	6.7	0.5	243.8	120.1	143.5	94.9	1.9	39.1	128.2	56.9	10.3	214.3	39.9	279.1	3.0	0.7	179.6	287.9	30.5	153.2	100.1	319.8	78.9	103.2	3.0	39.5	33.2	56.8	0.4	1.2	60.5	79.6	2.7	181.6	110.9	222.6	121.6
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome 20S subunit beta 9"	P28065	6	32844136-32859851	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 160.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		NA	NA		340000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	47.0	31.1	4.8	18.4	4.9	6.9	41.4	4.3	5.5	28.8	2.6	38.4	10.2	26.8	2.3	25.7	25.9	4.7	31.6	4.8	5.6	36.3	37.4	60.2	26.2	7.6	4.9	18.1	12.1	1.5	14.0	3.4	5.9	26.5	8.7	1.3	20.3	5.0	11.9	27.7	78.1	5.7	5.7	160.9	26.5	4.9	5.1	15.0	28.7	3.8	22.2	23.6	30.8	5.8	5.5	0.3	0.0	0.2	3.4	8.5	3.0	0.7	11.5	17.3	27.7	0.0	3.1	40.8	1.3	2.9	14.3	10.0	0.2	5.8	2.6	9.3	0.1	17.6	0.7	0.8	17.3	1.8	2.2	2.1	0.3	7.0	1.0	3.3	2.7	10.1	1.4	12.8	1.9	1.0	16.1	8.0	0.0	0.0	0.8	19.0	1.2	7.4	2.1	2.5	0.0	0.0	1.0	2.1	10.7	0.0	4.4	10.3	0.0	2.5	1.6	14.7	1.2	11.3	23.9	9.3	7.5	6.8	4.0	92.7	30.3	75.6	56.1	55.8	45.9	59.7	45.1	55.9	26.6	45.3	41.0	49.6	96.3	61.5	60.9	20.5	61.0	46.2	4.8	4.9	4.3	5.5	4.8	5.6	7.6	4.9	5.9	5.7	5.1	5.8	258.6	41.7	51.1	1.3	197.2	72.5	37.4	155.6	30.1	2.4	25.3	47.0	7.3	50.1	64.8	25.8	0.0	1.5	216.2	88.0	19.6	116.6	1.3	28.9	47.5	146.5	33.5	29.9	0.0	115.6	6.6	45.1	34.1	42.6	77.3	20.0	119.6	26.6	117.2	0.0	0.1	148.0	99.7	126.8	155.7	2.1	29.2	145.2	35.6	8.4	323.0	22.7	495.4	0.5	8.3	67.8	150.3	15.8	136.1	40.4	318.5	40.5	133.7	1.7	32.9	23.1	50.8	1.5	7.4	21.0	58.7	1.4	241.8	45.3	110.6	39.1
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 107.6;Early spermatids: 149.8;Late spermatids: 211.5;Proximal tubular cells: 91.7"	"Cancer enhanced"	"Detected in all"		"glioma: 41.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	4.7	9.4	11.0	3.7	12.4	3.7	3.9	11.8	10.8	4.7	13.3	4.8	4.2	4.9	5.2	8.7	16.1	5.9	8.1	11.0	11.0	10.0	6.8	3.5	5.1	12.3	12.9	8.2	6.7	6.6	9.4	3.7	11.7	6.4	4.4	4.4	4.5	6.4	4.6	4.2	4.1	5.1	12.2	3.9	6.2	7.1	12.1	5.8	7.0	6.0	5.9	5.2	5.7	16.1	130.1	37.6	23.1	93.0	18.9	25.3	16.7	32.5	18.5	18.7	32.7	34.7	23.5	62.9	21.0	29.4	44.5	26.9	52.6	26.9	19.0	48.1	27.9	17.9	11.1	62.2	44.4	18.6	26.8	31.8	50.2	27.7	32.6	25.1	17.7	61.2	44.4	42.4	26.4	17.3	27.7	48.3	38.0	47.5	52.1	35.9	14.4	39.8	17.2	6.8	43.6	49.8	23.5	14.9	68.9	20.9	44.8	41.4	14.5	15.1	24.8	45.5	30.3	26.9	53.0	72.8	21.9	39.9	49.7	2.5	6.2	5.9	3.1	4.4	2.3	5.4	3.0	3.8	9.6	6.1	4.5	4.1	2.9	4.7	7.1	9.3	4.0	4.8	11.0	12.4	11.8	10.8	11.0	11.0	12.3	12.9	11.7	12.2	12.1	16.1	2.1	3.2	1.5	11.4	5.2	6.8	16.9	20.5	8.6	5.2	8.3	5.8	13.1	11.5	11.4	5.5	2.1	12.8	4.5	2.4	107.6	8.6	149.8	62.9	5.4	4.2	4.8	7.2	9.3	8.0	7.5	9.9	3.1	9.4	1.3	16.5	5.0	9.8	9.5	1.7	9.8	5.0	4.1	4.4	5.8	211.5	8.4	4.3	7.2	0.0	5.7	46.8	2.1	7.1	13.8	7.1	3.5	6.0	10.1	6.5	3.1	91.7	28.3	3.1	13.1	5.1	20.0	30.1	22.5	7.6	8.5	4.7	3.9	16.1	7.3	7.7
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.1;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 906.5;monocytes: 256.7"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 36.6;HMC-1: 131.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	10.4	2.4	4.3	30.8	4.7	41.1	3.4	4.7	5.6	3.4	4.1	5.5	4.1	1.7	1.2	7.2	2.6	7.2	2.0	3.8	5.1	2.7	4.1	17.8	13.5	8.9	6.6	1.3	2.0	1.6	0.6	7.3	7.7	1.5	6.7	0.5	2.3	1.5	0.7	5.4	6.3	7.9	8.1	14.4	3.8	1.3	7.2	3.6	1.9	2.6	18.0	14.4	1.9	11.8	20.1	0.2	0.1	0.4	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.2	5.7	1.3	0.1	0.1	0.3	13.5	0.5	36.6	0.8	0.4	0.6	7.7	0.2	0.9	0.1	1.9	131.3	0.0	6.0	0.4	0.4	0.0	0.2	0.1	0.5	0.4	0.0	1.3	0.2	19.3	0.6	0.5	0.2	0.3	0.1	0.1	8.7	2.1	0.3	0.1	0.1	18.1	0.2	0.4	0.4	5.4	0.1	0.2	0.7	0.0	0.2	1.2	1.1	5.6	0.1	2.4	0.6	61.7	256.7	906.5	0.6	77.9	1.2	12.5	0.4	0.4	116.1	6.7	0.5	0.7	747.1	0.7	34.1	1.3	1.2	112.4	4.3	4.7	4.7	5.6	3.8	5.1	8.9	6.6	7.7	8.1	7.2	11.8	2.1	6.4	6.7	0.0	4.1	6.5	2.0	37.9	5.2	1.5	0.8	0.5	2.2	1.5	20.9	1.8	2.1	0.6	2.9	0.4	0.0	18.1	0.4	0.5	0.2	7.3	0.0	4.0	0.9	5.1	0.5	1.3	1.1	0.5	75.4	2.0	2.9	1.0	71.7	0.0	0.7	0.0	18.3	93.0	67.8	0.2	0.6	64.5	0.0	15.0	52.8	0.2	0.0	1.5	6.6	89.8	0.6	0.0	0.5	0.6	0.3	0.2	20.2	0.9	0.0	0.6	1.0	2.3	0.7	3.2	2.8	1.5	2.0	0.0	0.4	9.4
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267698-52276724	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Mast cell degranulation"	"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 7.9;lymphoid tissue: 6.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 50.6;NK-cells: 187.4;T-cells: 31.4"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.0"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 68.0;NK-cell: 90.3"	"Group enriched"	"Detected in many"	33	"NK-cells: 90.3;T-cells: 68.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA049668	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA049668: "	"unprognostic (9.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.60e-8)"	"unprognostic (1.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.89e-2)"	2.0	0.5	0.2	2.1	1.7	1.4	1.2	0.8	0.7	2.1	2.6	5.6	0.7	1.5	1.0	0.4	1.3	1.6	1.9	0.1	0.3	0.5	1.1	1.7	3.2	2.4	0.6	0.8	0.3	0.4	2.1	0.2	0.4	0.8	7.9	0.0	1.1	0.4	0.6	0.6	1.4	0.8	1.5	6.3	1.3	0.2	0.4	0.9	1.1	0.4	1.1	0.9	1.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	68.0	0.0	33.5	0.1	9.0	40.9	0.1	0.0	1.4	22.5	2.3	90.3	0.4	0.2	0.2	12.9	0.2	1.7	0.8	0.7	0.1	0.3	2.4	0.6	0.4	1.5	0.4	0.1	2.9	3.2	0.0	0.0	0.9	0.5	0.0	0.0	0.6	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	50.6	3.2	0.0	0.0	0.0	0.2	0.1	2.0	1.2	2.7	0.2	0.0	0.0	1.5	1.1	0.1	1.3	0.2	2.2	0.5	0.1	0.0	0.2	7.5	0.0	1.9	0.4	0.0	0.0	4.6	1.8	1.0	0.4	0.0	187.4	0.0	0.1	0.0	2.8	0.0	4.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	5.5	0.0	0.0	0.1	0.1	0.0	31.4	2.2	14.6	0.0
PTGFRN	"CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6"	ENSG00000134247	"Prostaglandin F2 receptor inhibitor"	Q9P2B2	1	116909916-116990353	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 66.2;Cardiomyocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 146.8;WM-115: 111.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017074	Approved					NA	NA		340000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA017074: AB_1855888"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-2)"	11.6	21.1	3.2	10.1	3.5	0.0	10.6	3.3	4.8	14.9	8.3	40.6	11.3	31.2	10.6	21.2	23.9	17.2	48.8	3.3	2.6	4.0	6.6	6.6	2.5	2.8	4.5	15.9	13.3	6.3	2.9	5.0	2.2	18.0	21.7	1.4	18.5	23.6	2.9	17.8	14.0	46.6	4.6	3.1	10.5	5.3	4.1	5.3	6.9	3.9	6.2	20.1	15.1	3.2	40.0	10.3	18.4	42.8	3.2	8.3	2.6	2.8	4.4	15.4	5.8	7.2	8.7	0.0	35.7	10.6	12.7	69.7	41.4	74.4	9.7	0.4	25.1	2.9	24.0	11.1	1.1	0.1	3.9	37.3	66.0	2.0	36.4	21.9	30.0	4.2	16.5	0.2	23.5	50.9	0.0	5.5	21.5	3.3	0.1	0.0	100.6	0.2	51.3	32.4	9.0	20.8	80.0	55.9	22.9	32.1	48.8	12.3	77.6	22.4	33.2	37.2	25.1	0.0	0.1	0.1	146.8	0.0	111.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	3.5	3.3	4.8	3.3	2.6	2.8	4.5	2.2	4.6	4.1	3.2	2.3	3.2	5.9	15.0	0.5	66.2	13.4	25.6	22.2	6.5	10.9	11.9	79.4	10.0	12.2	3.7	0.0	0.8	0.3	20.6	1.9	31.2	4.8	10.2	19.3	12.1	13.9	0.0	13.6	31.8	5.5	32.0	10.7	16.9	0.0	22.1	3.9	11.1	4.4	0.0	7.4	18.2	14.2	8.8	9.7	6.3	19.3	4.7	8.8	3.7	3.1	1.2	0.0	31.2	0.9	27.9	11.1	30.1	0.0	15.1	15.8	1.2	13.6	0.2	19.7	48.5	12.5	0.8	5.2	20.3	45.3	0.8	1.4	28.3	26.3	17.4
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568137	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 80.7;urinary bladder: 81.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 28.1;Fibroblasts: 70.8;Hepatic stellate cells: 117.8;Leydig cells: 26.8;Peritubular cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 45.1;ASC TERT1: 45.2;U-2197: 143.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavorable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (9.99e-5)"	43.2	4.7	0.7	9.0	2.5	0.3	24.0	0.3	1.9	29.5	1.8	38.9	3.2	79.0	16.1	16.5	80.7	31.3	40.4	0.5	0.8	4.0	6.0	18.2	0.7	0.6	0.4	38.1	2.5	0.3	0.9	1.1	0.4	22.2	6.6	0.2	7.6	8.3	4.0	7.2	10.5	40.5	0.6	0.5	17.9	5.1	1.0	0.3	7.8	2.4	0.8	81.7	18.2	0.6	0.0	0.1	1.9	0.1	45.1	45.2	0.5	1.0	5.7	0.2	0.0	0.0	0.0	0.1	18.4	13.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.1	3.3	0.0	0.6	0.0	15.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.2	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.2	0.0	8.2	0.1	0.0	0.0	0.8	2.4	143.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.7	2.5	0.3	1.9	0.5	0.8	0.6	0.4	0.4	0.6	1.0	0.6	5.3	3.2	2.7	0.0	0.0	3.7	0.7	0.0	0.0	1.1	2.2	1.3	5.0	2.8	1.9	3.7	0.0	0.3	0.3	0.0	0.0	0.6	1.8	0.0	0.9	28.1	0.0	2.7	2.7	0.0	0.2	70.8	1.5	0.1	0.0	25.0	117.8	1.0	0.3	0.0	2.4	0.0	0.0	3.1	6.7	3.3	26.8	1.0	1.8	6.5	0.1	0.4	0.0	1.0	0.2	1.2	0.0	104.9	0.3	0.4	0.0	0.2	2.2	4.5	0.0	7.9	3.5	0.7	1.4	0.5	4.8	0.3	1.0	0.5	0.0	0.6
PTHLH	"HHM, PLP, PTHR, PTHRP"	ENSG00000087494	"Parathyroid hormone like hormone"	P12272	12	27958084-27972733	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 254.0;Basal squamous epithelial cells: 93.9;Breast glandular cells: 105.4;Breast myoepithelial cells: 56.3;Club cells: 77.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HaCaT: 291.3;HBEC3-KT: 359.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035982	Approved	Approved	Supported	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA035982: AB_10794631"	"unprognostic (1.67e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (1.82e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.87e-3)"	3.1	0.8	1.8	1.2	2.3	0.0	20.1	0.6	3.2	13.6	10.2	3.3	2.3	10.7	1.1	16.2	1.5	7.5	4.2	4.1	3.2	0.4	0.2	1.2	1.1	4.0	8.1	1.8	1.7	22.8	2.9	3.0	0.4	5.2	1.6	0.2	8.5	2.4	0.7	2.0	1.6	3.0	0.2	3.6	1.8	1.3	8.6	0.4	1.8	1.7	1.0	9.2	15.2	0.8	1.7	9.9	0.0	0.0	2.9	2.8	0.1	0.3	1.0	0.5	1.3	0.3	7.9	0.0	0.5	2.6	9.1	291.3	1.3	359.8	0.1	7.4	1.7	0.5	1.8	0.1	0.8	0.1	0.4	0.2	19.7	9.1	34.4	0.9	11.2	0.1	0.0	0.4	0.2	0.1	0.1	0.0	1.4	0.4	16.7	0.1	1.5	0.6	34.3	0.3	0.2	0.1	16.4	0.1	2.1	11.5	0.5	0.1	5.6	1.6	8.9	5.1	77.8	4.7	0.1	12.1	7.5	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	2.3	0.6	3.2	4.1	3.2	4.0	8.1	0.4	0.2	8.6	0.8	1.4	0.0	0.0	0.7	0.4	4.6	1.9	254.0	93.9	0.3	105.4	56.3	0.4	0.0	77.5	0.0	0.0	0.0	0.5	0.0	0.0	3.5	5.9	0.9	4.7	4.5	0.0	0.0	0.6	8.9	0.0	13.6	0.0	0.8	0.0	2.6	0.4	0.2	0.0	0.0	11.2	0.0	4.1	0.3	1.3	2.7	0.9	0.6	23.2	1.0	0.6	1.8	0.0	0.0	0.2	8.6	0.0	0.0	6.2	0.5	0.0	0.3	14.8	0.5	6.6	8.0	6.7	3.6	0.2	7.9	1.4	0.0	0.5	0.2	0.0	0.2
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.3;brain: 102.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 127.4;REH: 141.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (3.33e-3)"	19.7	10.8	46.9	52.6	54.4	106.3	11.5	22.8	102.9	11.5	38.3	29.8	34.1	9.9	8.9	19.2	15.6	12.7	10.6	96.3	8.5	15.9	15.2	28.6	78.3	0.0	26.0	4.7	12.6	7.1	13.7	8.0	0.0	25.5	23.5	4.4	26.6	12.3	5.0	45.2	48.8	10.7	0.2	78.3	22.2	9.5	27.0	86.0	12.5	5.4	73.6	21.0	15.1	37.0	38.2	10.4	2.8	3.0	76.6	5.5	21.5	2.9	1.9	1.9	2.7	9.9	21.5	127.4	4.0	5.8	3.1	34.3	1.1	31.3	1.1	8.7	0.8	26.4	10.6	2.0	15.7	28.5	45.5	41.6	46.0	2.6	17.3	13.0	1.0	36.0	31.7	85.6	2.1	4.0	49.1	57.0	2.2	33.0	2.6	141.2	0.7	88.3	8.5	29.5	19.2	3.5	13.4	9.3	5.0	6.5	11.5	72.1	17.5	1.3	2.8	2.5	1.0	68.0	32.0	68.9	5.2	60.6	2.4	47.3	48.4	36.9	33.9	43.0	22.2	46.0	17.0	24.3	36.1	46.6	20.8	25.9	45.8	29.0	53.5	11.7	18.2	50.1	46.9	54.4	22.8	102.9	96.3	8.5	0.0	26.0	0.0	0.2	27.0	37.0	6.9	3.2	29.8	16.6	64.3	37.7	38.7	19.7	6.8	5.4	5.9	7.7	3.7	8.6	13.0	14.7	0.0	2.9	33.4	65.5	0.0	8.0	1.2	7.1	1.8	9.6	7.8	20.2	109.2	8.3	26.5	3.5	22.4	5.3	28.5	1.1	5.0	24.1	23.1	8.4	9.2	21.9	10.2	68.4	32.1	1.0	1.5	55.3	8.8	22.5	62.5	2.8	70.0	7.5	15.1	13.3	42.0	0.7	68.1	18.6	44.6	16.1	13.9	3.9	0.0	3.3	3.3	4.2	6.4	4.8	30.1	1.9	46.6	1.0	18.1	17.9
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343774	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 280.4;parathyroid gland: 383.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 672.0;Extravillous trophoblasts: 416.0;Horizontal cells: 526.6;Muller glia cells: 548.5;Oligodendrocyte precursor cells: 322.7;Squamous epithelial cells: 439.9"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"AF22: 1717.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1400000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	26.2	18.2	212.9	4.1	206.4	0.1	82.3	217.0	280.4	100.0	182.0	31.4	5.4	76.8	55.3	78.2	19.2	55.9	87.7	209.6	205.2	38.4	8.5	18.4	7.4	220.3	200.5	19.0	8.4	383.5	126.1	36.2	196.3	116.1	21.6	63.4	37.4	52.5	2.2	9.1	10.1	54.0	204.2	40.4	15.7	53.8	207.6	21.4	18.9	18.8	11.4	24.8	65.1	209.1	1.2	0.0	1717.6	21.2	0.4	0.9	140.6	45.3	134.3	25.1	34.3	0.4	0.2	0.0	0.2	60.0	15.6	1.0	0.0	0.0	18.9	0.0	1.4	0.0	0.0	0.0	7.7	0.0	0.5	1.9	0.0	16.6	0.2	24.6	0.0	0.0	0.0	8.2	7.0	0.0	0.0	0.6	133.5	0.0	1.1	0.1	2.8	0.4	0.7	0.0	8.0	116.5	0.0	0.0	0.2	24.1	0.2	0.2	0.0	37.4	32.9	1.8	99.4	0.7	0.0	0.0	119.7	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	206.4	217.0	280.4	209.6	205.2	220.3	200.5	196.3	204.2	207.6	209.1	10.1	0.0	0.0	303.3	1.3	23.2	1.7	85.0	209.5	27.7	244.6	117.3	14.6	2.8	20.9	1.8	6.2	220.0	2.2	0.0	9.8	1.1	24.5	53.4	672.0	32.0	0.0	0.0	4.9	0.0	416.0	248.8	0.5	24.6	0.0	1.1	7.1	0.3	20.4	526.6	18.1	0.0	0.0	0.3	20.6	14.0	172.7	4.0	44.4	102.1	0.0	548.5	0.0	322.7	218.4	0.3	0.0	185.5	2.5	18.6	0.0	7.5	7.2	32.3	59.2	3.0	91.4	4.0	2.4	439.9	13.9	193.3	4.4	144.7	0.0	2.2
PTPN9	MEG2	ENSG00000169410	"Protein tyrosine phosphatase non-receptor type 9"	P43378	15	75463251-75579315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 63.0;Excitatory neurons: 66.1;Inhibitory neurons: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041922	Approved		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA041922: AB_10795269"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.25e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.49e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.39e-1)"	15.9	12.0	14.8	13.0	16.3	10.8	15.1	11.9	18.8	16.6	11.7	18.0	17.9	16.5	13.3	9.9	16.2	12.1	11.0	16.9	18.4	18.2	14.7	15.8	14.5	18.6	14.4	14.0	10.2	17.9	9.7	19.9	15.1	16.6	19.7	8.9	13.0	21.2	6.4	11.0	20.0	18.0	13.6	13.4	13.5	7.2	17.0	16.1	32.8	13.1	15.0	18.1	13.8	14.5	20.3	24.1	36.7	24.6	26.8	29.3	12.0	29.8	46.2	36.9	33.4	14.5	30.0	32.6	23.3	51.1	29.5	30.0	79.9	34.3	37.0	40.5	19.8	18.4	16.2	15.7	40.2	28.2	27.1	38.4	35.2	29.6	45.9	37.7	31.4	21.3	12.4	11.5	42.1	13.5	20.0	26.3	33.6	18.2	12.1	38.9	18.2	9.1	46.6	32.5	14.4	29.9	42.4	23.3	46.3	34.9	12.1	47.8	36.5	35.2	11.3	23.3	32.2	16.9	18.9	30.0	20.5	41.9	35.3	3.2	2.2	2.3	3.4	3.0	2.8	1.7	2.4	3.0	3.0	1.3	1.0	1.8	0.3	3.9	2.9	2.0	1.6	1.7	14.8	16.3	11.9	18.8	16.9	18.4	18.6	14.4	15.1	13.6	17.0	14.5	12.7	6.4	13.4	63.0	9.2	3.3	8.2	6.6	5.7	12.1	8.0	7.1	3.7	10.0	8.1	11.0	8.4	20.0	7.3	25.0	15.6	10.8	3.0	7.9	19.4	10.0	7.2	13.7	66.1	9.9	4.2	20.6	10.7	11.4	15.2	23.6	17.5	12.6	18.8	3.3	63.2	11.5	6.1	18.9	18.1	4.7	12.5	16.5	7.2	46.9	24.2	5.6	19.6	48.7	19.6	18.2	12.6	27.4	9.7	12.1	24.9	14.0	8.1	17.1	13.1	11.7	20.8	10.6	9.4	6.6	3.3	10.1	13.4	11.6	13.2	13.1
PTTG1IP	"C21orf1, C21orf3, PBF"	ENSG00000183255	"PTTG1 interacting protein"	P53801	21	44849585-44873903	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034146, HPA061827"	Uncertain		Supported	Nucleoplasm		NA	Yes		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB034146: AB_1568894, HPA061827: AB_2684620"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (5.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.90e-1)"	127.8	131.8	147.6	98.4	158.9	92.0	114.0	150.8	146.8	131.1	131.1	132.7	123.2	132.4	118.5	89.1	109.4	141.8	164.3	138.1	168.7	157.6	130.5	160.5	75.3	178.8	152.9	110.7	85.6	84.1	68.8	180.1	169.9	108.5	111.5	29.7	118.3	151.4	70.7	88.9	127.3	145.0	152.0	97.7	169.9	66.9	175.3	57.9	127.4	63.2	62.0	139.6	93.3	157.5	245.3	134.6	155.3	148.2	300.6	174.8	127.0	212.9	309.8	174.1	166.6	290.0	323.9	32.9	789.8	344.4	417.0	109.8	73.0	140.2	161.1	56.3	81.0	254.3	80.0	260.1	293.8	97.6	83.5	269.9	225.1	189.1	130.8	346.3	376.6	88.6	131.7	83.1	539.5	106.0	71.0	99.5	166.8	352.9	169.8	70.4	158.4	162.0	735.6	82.7	117.2	182.0	240.0	262.5	482.0	188.7	203.7	163.7	511.8	216.9	126.5	170.6	340.0	78.5	79.4	42.2	146.7	220.6	199.8	336.2	181.2	109.1	48.4	146.7	79.5	25.5	62.7	51.3	203.3	23.6	59.7	41.0	248.8	67.3	167.0	92.5	87.3	223.7	147.6	158.9	150.8	146.8	138.1	168.7	178.8	152.9	169.9	152.0	175.3	157.5	140.9	394.2	169.6	39.8	28.0	50.7	84.1	181.3	61.5	14.6	102.0	96.8	173.0	75.8	248.9	145.3	6.2	218.6	56.8	321.4	49.0	323.0	51.5	115.0	115.0	191.6	79.3	37.8	8.5	120.6	72.7	117.1	140.6	187.7	81.5	181.3	124.2	102.2	109.3	11.8	10.7	89.1	130.2	88.0	69.6	98.7	72.1	136.3	87.2	22.5	91.1	78.8	51.5	20.1	31.9	294.3	255.2	98.9	36.4	112.8	268.1	71.2	192.3	15.2	65.7	61.1	127.9	73.7	43.4	92.4	42.9	366.7	45.6	54.6	100.3	169.9
PUM2	"KIAA0235, PUMH2"	ENSG00000055917	"Pumilio RNA binding family member 2"	Q8TB72	2	20248691-20352234	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030316, HPA049670"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA030316: AB_10610289, HPA049670: AB_2680845"	"unprognostic (2.41e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.87e-2)"	27.6	29.8	29.7	33.4	31.7	33.4	41.7	42.5	32.7	36.2	32.4	36.5	34.4	36.3	32.8	39.2	29.7	27.1	33.1	31.1	30.9	36.8	43.1	33.2	48.6	26.0	29.3	44.6	27.4	41.4	8.3	40.3	26.1	37.3	37.0	66.8	33.0	33.1	21.5	47.2	35.6	32.3	29.1	42.6	35.8	24.9	31.6	70.5	57.6	32.6	47.6	38.0	18.3	37.6	72.4	50.0	65.3	46.1	40.2	40.5	65.9	49.2	53.6	48.4	42.2	43.5	33.0	96.3	11.0	44.9	58.2	38.9	61.4	35.6	71.2	87.0	38.2	105.0	35.3	62.2	43.4	107.2	93.3	29.7	79.7	42.1	77.4	45.5	53.1	57.1	75.0	82.9	57.3	35.5	93.6	65.9	55.8	68.3	31.5	80.6	110.9	73.8	45.0	68.1	55.9	76.6	42.2	58.3	48.1	43.4	33.0	61.5	52.5	58.6	58.5	38.3	64.6	93.3	123.0	181.8	35.3	75.8	51.4	11.5	4.0	5.8	6.0	5.2	7.1	4.8	6.7	7.5	4.2	5.3	7.3	6.0	11.6	7.7	7.3	3.7	5.8	3.7	29.7	31.7	42.5	32.7	31.1	30.9	26.0	29.3	26.1	29.1	31.6	37.6	43.6	35.3	51.6	89.5	57.6	79.7	32.2	26.4	74.0	94.6	46.9	30.5	46.5	32.9	33.8	47.8	62.6	36.3	43.6	44.0	11.7	16.6	10.1	33.9	35.6	45.0	34.6	41.0	134.7	15.5	16.9	36.5	43.8	45.9	20.3	53.0	41.4	56.3	29.1	58.9	153.5	43.2	38.7	70.7	44.2	5.8	34.2	44.9	32.0	144.3	42.7	26.8	43.3	155.3	186.0	22.6	28.1	26.4	54.7	57.8	33.9	29.7	39.5	72.3	32.9	40.5	47.6	16.8	16.6	75.2	106.3	52.0	50.1	31.2	40.2	56.6
PURA	"PUR-ALPHA, PUR1, PURALPHA"	ENSG00000185129	"Purine rich element binding protein A"	Q00577	5	140107777-140125619	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 220.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		260000	"Cluster 15: NK-cells - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (2.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.77e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.09e-1)"	7.6	9.0	29.6	8.1	19.3	2.5	5.2	11.3	18.6	8.5	0.0	6.4	10.0	6.9	5.5	5.7	5.6	5.6	8.4	14.4	22.7	12.2	8.6	6.8	6.0	24.2	21.4	10.1	7.2	13.5	4.8	8.1	23.6	9.5	4.4	12.6	9.7	8.0	9.6	7.3	9.0	5.6	24.0	9.8	9.4	5.2	26.7	5.8	11.7	8.2	5.7	5.9	4.8	25.8	15.1	9.2	3.7	21.5	9.3	13.4	20.1	32.5	13.4	15.0	11.7	19.2	15.5	15.8	25.2	12.7	10.0	13.4	8.9	18.6	12.7	25.7	28.0	11.8	13.1	6.7	5.8	9.6	19.0	6.2	8.9	14.1	8.5	9.7	4.3	11.3	11.1	16.4	7.7	18.6	15.3	12.1	4.7	5.0	23.3	15.4	14.6	11.3	9.4	11.9	11.7	12.1	16.5	19.1	18.7	3.6	17.2	9.2	15.2	26.8	19.5	9.5	23.4	26.0	13.5	16.8	12.7	10.5	22.7	6.4	1.8	3.4	2.8	1.2	2.1	3.0	3.1	3.2	1.6	3.7	2.7	3.4	0.9	5.2	1.5	2.5	2.9	1.0	29.6	19.3	11.3	18.6	14.4	22.7	24.2	21.4	23.6	24.0	26.7	25.8	82.2	51.3	43.3	28.4	43.5	34.3	48.5	15.0	54.1	162.0	58.5	62.2	76.2	62.9	21.7	77.3	125.1	47.2	53.6	48.8	13.7	22.2	25.4	46.2	66.4	71.2	62.9	27.8	45.3	25.4	44.4	57.5	49.5	40.8	25.4	35.9	77.4	62.1	26.4	220.4	46.0	47.9	12.2	32.3	26.2	10.0	76.4	29.2	37.4	34.7	27.0	95.1	49.4	27.2	43.4	26.4	33.9	102.0	43.5	61.7	57.6	48.9	22.5	106.7	72.3	99.8	76.7	38.6	38.7	39.7	45.5	43.4	49.9	52.7	44.0	48.8
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.1;Endometrial stromal cells: 99.4;Endothelial cells: 95.1;Hepatic stellate cells: 71.4;Skeletal myocytes: 120.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 323.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA012375	Approved				"Secreted to extracellular matrix"	NA	NA		9100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA012375: AB_1855965"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	59.5	5.5	4.1	24.3	3.5	0.9	33.7	1.9	4.1	18.2	27.5	36.1	7.9	32.8	4.0	4.9	18.0	22.7	22.7	3.1	7.7	9.0	12.4	27.6	5.0	4.2	6.2	32.7	3.8	3.0	11.7	33.4	4.7	17.5	8.7	5.2	13.6	11.1	7.7	6.9	16.3	61.8	2.6	10.0	13.2	6.4	5.2	2.1	8.4	11.5	2.1	33.8	13.5	3.4	39.9	13.9	72.0	0.1	198.3	180.9	54.6	231.4	182.3	99.0	107.9	0.1	0.5	0.0	323.8	230.3	4.5	8.3	0.3	142.3	125.5	0.6	2.4	0.0	139.3	0.0	196.4	0.6	0.0	200.7	41.0	112.2	83.8	299.5	247.0	35.9	0.1	0.0	142.6	23.6	6.8	8.0	58.3	0.0	52.3	13.2	250.8	0.6	115.9	0.1	0.2	131.9	0.2	73.6	0.4	142.9	27.0	0.9	242.4	162.8	79.7	6.2	180.7	0.2	205.4	1.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.1	3.5	1.9	4.1	3.1	7.7	4.2	6.2	4.7	2.6	5.2	3.4	79.1	6.4	2.3	2.6	0.4	2.9	2.8	12.8	0.6	2.5	17.5	14.1	5.8	17.2	7.0	1.8	0.0	0.6	0.2	0.3	0.0	10.4	33.4	4.2	99.4	95.1	1.8	0.0	6.6	0.0	11.3	45.2	0.0	3.4	1.3	43.7	71.4	1.8	1.9	0.0	7.3	1.3	20.3	5.7	4.4	40.7	26.8	0.7	7.2	8.4	0.6	10.0	1.0	55.8	0.7	0.5	0.1	15.1	0.0	14.0	0.0	0.2	6.7	0.8	46.0	120.1	51.1	22.0	16.0	0.5	2.8	1.4	1.0	33.3	0.5	1.4
RAB18		ENSG00000099246	"RAB18, member RAS oncogene family"	Q9NP72	10	27504174-27542239	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Protein transport, Transport"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025928	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA025928: AB_1855997"	"unprognostic (9.45e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	40.8	55.5	26.3	29.0	26.8	88.9	50.7	28.9	32.1	32.3	26.5	34.3	33.5	30.5	41.0	44.5	25.4	26.7	48.0	26.4	33.4	47.5	52.3	30.0	26.2	28.5	30.2	30.8	31.5	53.2	20.4	36.7	31.8	41.2	35.2	70.6	28.0	34.1	51.2	35.7	30.9	37.4	30.9	30.0	32.0	34.3	30.1	34.9	41.1	50.5	32.9	39.7	31.0	33.5	68.1	47.5	56.8	41.0	94.1	53.3	37.9	102.6	47.0	87.6	83.4	46.2	44.6	27.7	42.7	88.8	44.2	44.9	37.4	65.6	72.0	42.3	34.1	39.2	44.2	59.3	68.0	16.9	45.4	70.5	122.2	55.0	31.4	62.3	68.5	25.7	22.6	55.2	75.0	44.1	37.8	11.6	24.8	38.7	22.1	27.3	93.8	33.7	83.5	37.6	30.5	36.9	50.6	57.1	67.5	59.6	115.6	35.0	68.5	40.0	49.9	76.8	60.1	24.0	47.5	34.7	68.6	97.6	22.6	212.9	54.4	137.4	41.7	50.7	91.5	25.6	35.7	45.1	40.6	26.5	30.1	35.9	193.2	45.2	60.9	26.7	42.7	49.8	26.3	26.8	28.9	32.1	26.4	33.4	28.5	30.2	31.8	30.9	30.1	33.5	50.3	73.7	44.5	37.5	51.4	186.0	105.3	145.9	68.9	74.1	131.7	51.2	131.4	48.6	92.9	90.1	41.7	90.5	64.9	82.3	213.2	105.0	46.7	46.7	55.4	62.1	65.4	41.2	53.9	90.4	114.9	78.7	31.6	51.8	34.9	63.6	62.8	85.1	84.5	48.8	51.2	47.5	152.5	81.0	83.4	33.8	63.0	62.4	99.6	42.2	115.6	117.6	53.5	43.7	54.8	120.5	57.8	69.2	51.3	127.6	73.1	208.6	72.8	91.0	26.3	45.9	76.9	138.7	81.0	80.7	199.0	149.1	60.9	79.1	40.9	132.6
RAB22A		ENSG00000124209	"RAB22A, member RAS oncogene family"	Q9UL26	20	58309715-58367507	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066920	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA066920: AB_2685749"	"unprognostic (4.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.34e-3)"	"unprognostic (6.20e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.01e-3)"	6.4	10.2	8.7	5.3	10.4	4.7	6.4	5.9	11.0	6.9	0.7	6.9	7.1	6.2	7.8	11.6	4.7	5.6	4.2	11.3	9.9	7.5	7.4	6.0	5.8	8.4	8.3	5.6	5.5	11.6	6.1	4.8	9.7	5.2	6.8	5.4	6.4	5.6	4.5	7.5	6.9	5.8	8.0	6.1	7.0	5.4	10.1	6.3	8.5	5.0	7.2	7.0	7.7	8.7	17.5	7.1	8.8	5.7	17.9	16.7	5.2	12.9	14.9	17.4	10.4	11.9	11.8	9.6	15.7	18.2	19.5	13.7	4.5	20.4	19.7	6.5	4.4	6.8	10.0	9.5	13.8	8.5	11.5	11.4	24.4	12.4	12.7	12.3	11.0	7.5	6.0	13.4	18.4	25.1	10.0	8.0	2.2	15.3	17.4	5.2	8.6	8.3	10.9	11.1	6.7	9.1	18.2	34.0	15.6	4.6	12.6	11.5	17.6	28.7	11.9	18.0	15.6	11.5	17.0	6.3	29.5	8.0	10.0	1.5	1.0	0.8	2.2	1.3	2.1	1.5	1.7	1.9	1.4	1.4	1.5	1.8	2.0	2.2	2.1	1.1	1.5	0.8	8.7	10.4	5.9	11.0	11.3	9.9	8.4	8.3	9.7	8.0	10.1	8.7	34.2	22.4	16.2	25.1	34.2	56.0	68.9	21.3	32.5	14.6	32.7	22.5	18.6	32.9	20.9	20.2	8.4	16.6	39.7	39.9	50.9	37.0	6.4	30.1	32.8	29.9	19.2	22.3	27.8	36.0	24.7	39.3	31.1	33.7	11.4	19.9	26.0	25.3	28.0	11.8	26.5	23.5	22.4	23.0	69.7	9.2	31.4	33.6	24.9	35.6	23.0	27.9	34.0	24.6	32.1	75.2	26.2	20.7	29.3	75.4	24.5	44.1	22.4	12.6	13.1	42.4	39.7	22.2	39.7	47.6	68.9	35.4	40.6	30.1	22.5	124.3
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.2;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		6500000	"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	0.3	2.6	7.9	1.1	10.2	1.0	11.9	0.0	11.9	3.0	0.0	4.9	5.1	0.8	0.4	14.0	1.1	3.8	0.1	13.3	5.2	0.3	1.3	7.2	0.5	0.0	0.1	0.2	4.1	2.3	1.0	1.1	0.6	20.5	5.3	1.0	14.0	1.0	0.2	15.6	4.9	0.9	0.1	1.7	44.1	4.5	2.6	1.4	0.3	0.5	5.2	6.2	5.2	3.3	7.8	22.4	0.8	0.0	1.5	19.3	0.0	1.7	13.5	1.8	1.3	0.0	8.6	1.3	0.1	3.9	16.7	14.5	0.2	9.0	0.5	0.0	0.5	63.3	5.0	0.0	2.6	3.4	7.0	15.3	46.6	25.5	56.0	21.1	1.2	0.3	0.0	3.9	16.1	7.9	0.2	7.4	0.2	14.0	14.7	0.0	0.0	0.3	4.1	28.9	0.2	10.3	2.2	13.4	0.0	0.1	8.3	0.3	0.3	18.8	0.6	9.8	2.0	0.4	0.0	0.0	165.2	35.6	0.9	0.6	0.0	0.1	2.2	0.0	0.5	0.0	0.7	1.1	0.0	0.0	0.2	1.0	0.2	2.6	0.0	0.0	0.0	1.6	7.9	10.2	0.0	11.9	13.3	5.2	0.0	0.1	0.6	0.1	2.6	3.3	0.3	48.1	37.6	3.3	0.9	25.6	8.6	18.2	8.0	2.4	59.8	25.3	0.5	8.6	36.9	5.5	2.1	6.5	15.0	5.7	1.9	7.2	259.3	30.9	4.4	1.9	4.2	3.4	101.0	41.0	4.5	2.0	178.4	64.0	246.6	0.4	2.5	0.9	0.6	6.7	75.8	31.3	20.3	0.6	2.7	209.9	2.1	38.1	7.2	2.8	2.1	1.4	29.9	98.5	2.6	34.0	18.6	0.4	3.2	78.9	3.0	0.0	15.8	0.4	6.6	0.3	2.2	7.9	1.4	79.2	49.2	2.9	13.9	0.5	7.9	42.2
RAB38	NY-MEL-1	ENSG00000123892	"RAB38, member RAS oncogene family"	P57729	11	88113251-88175443	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.6;skin 1: 44.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.4;Basal respiratory cells: 74.8;Cytotrophoblasts: 94.5;Melanocytes: 131.6;Suprabasal keratinocytes: 98.5;Syncytiotrophoblasts: 54.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 73.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"NK-cell: 18.0"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 18.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 87.7;hTCEpi: 308.0;hTERT-HME1: 271.4;SK-MEL-30: 175.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	HPA071701			Uncertain	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies, Mitochondria"		"HPA071701: "	"unprognostic (2.85e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	2.6	27.8	0.4	1.4	0.4	1.6	8.6	0.3	0.8	11.8	6.3	1.9	2.4	4.7	6.7	48.6	5.6	6.0	1.1	0.7	0.6	4.5	1.8	5.8	1.7	0.5	0.7	3.3	1.6	1.8	2.8	14.7	0.5	2.4	1.3	2.9	7.7	6.4	0.6	44.3	2.3	3.6	0.4	1.6	1.6	2.5	0.8	3.5	7.9	0.4	17.9	8.7	23.5	0.6	10.7	1.4	0.3	0.5	0.4	2.4	0.6	6.5	26.1	10.4	19.0	4.7	4.8	0.5	6.3	6.9	1.2	71.2	5.7	87.7	14.1	1.3	5.1	54.0	6.2	0.0	1.0	0.6	0.6	2.2	308.0	1.4	271.4	13.0	12.3	1.0	0.3	0.9	0.0	0.0	0.7	18.4	8.2	0.7	0.1	0.5	0.1	0.8	20.0	40.6	1.9	1.2	0.3	0.1	175.6	6.2	15.7	4.6	6.7	0.0	4.6	0.0	1.1	1.5	6.5	0.2	1.7	2.2	1.2	0.0	0.8	0.1	1.5	0.6	0.8	0.0	0.4	1.8	1.6	0.0	0.1	0.8	0.6	18.0	1.3	4.4	1.0	0.7	0.4	0.4	0.3	0.8	0.7	0.6	0.5	0.7	0.5	0.4	0.8	0.6	1.0	0.0	6.7	0.7	0.1	46.4	15.9	74.8	21.1	0.1	6.9	9.7	0.2	8.6	25.0	0.0	0.0	94.5	2.7	0.5	3.9	1.7	0.0	2.1	0.9	2.7	0.0	5.5	0.6	1.1	10.5	9.1	3.1	2.3	16.5	5.3	1.1	0.0	17.5	0.0	0.4	0.3	14.2	1.6	21.2	0.1	3.4	3.9	131.6	3.7	6.3	0.6	1.0	2.0	0.1	2.6	2.6	1.2	0.1	9.5	2.1	5.3	7.4	6.4	0.0	0.6	5.3	0.1	5.9	38.1	98.5	54.7	2.7	5.9	2.5	23.3
RAB3GAP1	"KIAA0066, RAB3GAP, RAB3GAP130, WARBM1"	ENSG00000115839	"RAB3 GTPase activating protein catalytic subunit 1"	Q15042	2	135052292-135176394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034494, HPA034495"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		6300	"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA034494: AB_2674188, HPA034495: AB_10670158"	"unprognostic (1.02e-2)"	"unprognostic (2.43e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.15e-1)"	23.4	21.1	22.5	24.3	24.1	37.5	25.6	18.7	23.1	27.5	22.0	23.7	19.1	29.2	30.6	26.2	22.9	21.6	35.2	24.5	24.1	23.2	20.5	20.4	25.9	23.3	23.2	35.2	35.4	34.0	18.9	23.6	24.3	29.5	27.9	34.1	35.6	28.3	36.9	26.2	21.4	30.9	19.7	21.3	26.1	18.7	23.1	30.3	30.8	36.0	30.4	26.0	22.4	22.0	51.2	20.4	34.8	29.0	67.3	57.0	32.4	76.6	62.6	59.5	58.4	45.3	40.7	75.5	46.2	78.5	22.8	42.2	37.4	70.6	72.1	36.2	37.9	34.3	24.8	39.9	46.9	46.8	39.3	50.2	91.2	54.8	98.2	53.6	43.6	33.7	49.5	42.5	54.7	30.1	24.1	18.2	27.1	30.7	33.8	40.9	45.0	31.9	35.0	44.9	28.3	22.4	52.0	30.7	36.8	30.5	27.2	33.6	53.0	60.0	45.7	26.0	32.5	30.1	18.2	55.8	39.2	27.8	34.3	10.3	4.3	6.7	1.5	5.3	1.3	5.5	3.8	2.1	4.5	6.8	7.9	4.2	1.7	3.1	6.0	2.3	5.4	2.1	22.5	24.1	18.7	23.1	24.5	24.1	23.3	23.2	24.3	19.7	23.1	22.0	34.3	25.6	26.7	86.8	50.4	30.2	46.8	28.8	27.9	28.9	30.2	27.8	58.0	32.9	32.6	31.3	50.1	23.6	15.3	39.4	11.7	20.0	34.8	31.8	33.0	28.5	34.6	24.4	137.8	26.9	17.1	35.5	46.9	31.5	46.3	27.2	32.9	25.7	22.4	30.3	106.8	31.2	28.5	26.7	28.1	23.2	30.7	32.4	23.2	112.4	24.2	18.0	6.2	107.1	123.3	34.6	24.3	35.7	40.0	42.5	29.9	21.1	36.0	33.8	46.0	31.8	34.4	41.8	25.8	37.5	29.7	39.1	28.3	35.0	24.7	51.0
RAB4A	"HRES-1/RAB4, RAB4"	ENSG00000168118	"RAB4A, member RAS oncogene family"	P20338	1	229271062-229305894	"Enzymes, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 32.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"				"unprognostic (9.21e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.72e-2)"	12.1	12.9	29.7	7.6	27.4	7.2	19.4	27.9	35.7	19.4	24.0	17.9	17.0	12.5	13.4	17.7	15.2	15.0	38.5	24.5	27.3	15.8	30.8	10.9	10.9	25.7	31.4	15.6	24.7	14.3	9.1	11.3	26.0	34.3	19.1	17.3	38.8	20.9	34.2	16.9	13.4	13.4	25.7	7.8	26.7	11.4	34.3	12.4	19.8	35.0	11.8	15.4	13.9	27.7	10.3	13.8	22.6	15.7	31.7	35.1	18.9	15.4	18.3	9.2	8.8	25.6	16.8	0.0	25.1	20.7	7.7	11.1	15.2	21.6	12.9	13.1	30.7	13.9	11.8	40.2	20.5	28.2	10.9	27.1	30.4	6.4	8.9	27.1	20.8	14.9	14.8	0.0	16.1	13.3	14.4	18.8	20.4	63.1	19.1	4.6	3.6	7.2	48.6	24.4	19.4	25.3	12.7	19.1	27.6	11.9	18.1	49.5	14.6	0.0	7.3	14.6	21.4	11.9	11.8	0.1	6.4	23.9	21.8	21.4	5.5	32.7	2.2	6.5	2.2	3.0	2.9	2.9	6.8	3.7	1.8	2.4	1.2	2.2	4.2	3.8	3.7	3.5	29.7	27.4	27.9	35.7	24.5	27.3	25.7	31.4	26.0	25.7	34.3	27.7	43.9	16.0	22.1	37.5	48.4	137.0	155.0	135.3	153.1	29.4	82.3	88.8	91.7	154.4	60.5	44.1	47.9	77.7	61.1	81.9	113.5	89.0	158.0	81.7	45.7	45.3	48.6	52.0	23.6	115.4	88.5	47.2	68.3	47.1	24.8	41.5	52.5	119.2	67.8	30.3	24.2	82.6	79.3	78.4	96.3	169.4	46.6	76.0	64.0	16.9	80.4	33.2	50.4	23.6	38.0	84.9	105.7	83.8	47.6	145.2	73.0	128.1	63.2	58.4	46.0	41.6	46.0	92.6	35.2	83.8	122.6	58.0	50.5	39.5	110.5	161.9
RAB6A	RAB6	ENSG00000175582	"RAB6A, member RAS oncogene family"	P20340	11	73675638-73761137	"Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009936, HPA059131"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"CAB009936: AB_2175466, HPA059131: AB_2683916"	"unprognostic (2.84e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (1.79e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (8.67e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.36e-1)"	71.2	69.8	87.7	53.0	96.5	38.4	50.6	85.4	112.8	64.4	79.3	66.2	71.6	66.9	53.0	100.2	54.0	55.6	99.5	101.8	100.9	75.1	85.3	68.5	45.7	106.0	90.1	64.5	49.0	67.5	36.4	91.4	112.9	64.0	70.6	56.1	47.8	64.9	107.5	55.0	83.4	79.8	80.0	56.9	54.9	36.1	97.4	54.2	98.7	101.7	60.8	78.9	62.4	93.4	86.2	66.3	105.8	68.5	135.9	154.3	141.7	130.4	124.6	111.1	100.8	131.5	146.4	73.2	136.6	174.0	94.9	94.6	68.4	135.3	142.5	84.6	25.6	118.2	68.6	110.9	114.2	78.1	113.1	114.7	246.8	113.5	165.0	124.4	135.9	75.7	71.3	111.5	133.3	99.6	85.7	54.7	42.2	192.0	62.3	64.8	193.9	132.5	135.2	146.6	83.0	70.5	136.1	136.7	290.9	104.7	107.2	71.0	165.0	113.3	56.9	193.5	56.6	71.9	89.5	149.5	46.3	63.2	104.6	227.9	81.8	133.2	84.2	87.6	76.2	56.1	70.3	75.5	62.9	50.7	52.0	61.8	61.9	78.6	88.6	33.7	86.3	111.1	87.7	96.5	85.4	112.8	101.8	100.9	106.0	90.1	112.9	80.0	97.4	93.4	66.3	32.1	51.0	79.7	59.2	83.5	49.4	57.2	88.2	53.9	45.8	30.4	64.2	35.8	42.7	68.0	87.6	109.9	55.3	85.2	43.0	66.0	8.8	51.5	41.3	78.7	52.0	47.5	133.6	49.5	162.3	60.5	52.5	51.2	48.8	83.7	72.5	63.7	65.7	40.4	119.0	61.8	75.3	58.4	85.7	9.5	52.8	58.3	72.9	49.6	74.2	47.7	52.5	130.7	109.4	79.0	61.7	61.7	86.3	57.8	102.7	54.1	47.2	54.2	26.3	47.4	65.5	74.2	53.4	106.5	112.7	173.6	63.8	45.0	50.8	69.8
RAC2	EN-7	ENSG00000128340	"Rac family small GTPase 2"	P15153	22	37225270-37244448	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 411.9;lymphoid tissue: 387.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 329.0;dendritic cells: 381.4;granulocytes: 520.5;NK-cells: 717.9;Plasma cells: 287.8;T-cells: 419.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 522.5;HL-60: 734.5;HMC-1: 1427.9;Karpas-707: 684.5;U-87 MG: 618.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022946, HPA047820"	Enhanced					NA	Yes		3300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB022946: , HPA047820: AB_2680167"	"prognostic favorable (1.03e-5)"	"unprognostic (2.91e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.74e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.50e-2)"	24.7	8.4	3.6	207.2	3.8	411.9	11.4	3.9	8.0	12.2	4.4	34.8	35.3	10.1	4.7	15.9	11.7	37.1	6.5	3.8	4.7	10.9	19.3	63.4	387.9	6.5	5.3	5.5	5.3	2.1	3.4	12.4	7.1	10.9	33.9	0.4	21.5	8.3	4.9	7.6	96.9	19.6	5.2	299.9	42.7	3.5	6.1	323.9	9.5	7.2	309.1	54.0	9.9	7.2	136.6	0.2	0.0	0.0	14.3	130.5	0.6	17.9	41.1	14.2	28.8	0.3	44.8	167.4	19.8	52.9	0.8	33.3	1.0	231.6	15.6	522.5	0.6	209.6	3.6	0.6	35.8	734.5	1427.9	96.4	32.3	25.1	84.3	0.9	239.7	159.1	50.5	684.5	1.9	0.2	218.9	291.2	2.8	13.1	87.2	72.3	0.7	193.8	22.6	0.1	2.0	0.6	0.9	23.0	2.7	0.8	9.7	391.8	258.7	0.6	23.5	1.0	2.0	307.0	171.4	176.6	618.6	316.5	35.1	1319.9	519.8	1602.2	972.1	695.5	731.5	761.7	768.6	858.9	494.0	672.8	584.3	759.8	1336.4	972.2	879.5	728.7	1163.4	1566.2	3.6	3.8	3.9	8.0	3.8	4.7	6.5	5.3	7.1	5.2	6.1	7.2	4.4	16.0	47.7	0.0	329.0	5.4	2.2	26.0	16.5	0.0	8.6	9.5	1.1	2.8	12.6	1.8	0.0	0.8	381.4	3.4	0.0	13.6	0.2	1.1	0.8	5.6	4.2	109.7	0.4	2.2	1.5	9.2	33.6	1.0	520.5	0.3	13.6	3.4	150.8	0.0	0.1	6.3	0.0	129.9	63.9	0.9	0.3	147.9	30.2	3.7	125.9	0.0	717.9	0.5	0.0	18.2	18.1	0.0	287.8	0.5	0.6	1.5	4.4	0.0	13.1	2.4	4.5	0.0	1.0	5.1	4.0	2.9	419.6	3.7	11.2	3.6
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.9;lymphoid tissue: 43.0;testis: 45.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 55.7;Extravillous trophoblasts: 49.4;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	5.0	2.5	5.5	13.7	8.2	38.9	7.1	6.9	6.3	5.2	3.2	16.7	10.5	5.3	1.5	21.3	4.4	6.4	2.8	5.0	6.0	9.2	4.7	6.2	23.9	6.7	7.1	2.4	2.7	5.8	1.4	14.0	6.5	3.3	18.7	5.3	4.8	3.4	4.9	14.4	11.6	12.5	5.5	6.5	9.8	45.5	7.6	43.0	3.3	4.8	30.2	7.7	8.0	7.0	193.0	174.5	135.8	86.8	24.8	29.7	113.0	195.0	97.0	207.3	140.3	174.6	144.7	107.5	86.0	108.3	99.9	127.1	137.7	93.6	219.9	203.0	85.4	137.9	165.8	58.1	8.4	146.1	109.0	16.2	17.2	140.7	111.4	60.3	71.7	96.4	101.6	159.6	197.0	136.8	122.5	72.6	96.2	108.9	112.9	113.9	163.5	78.3	54.9	95.7	113.9	97.5	161.7	102.7	53.0	68.8	199.7	64.8	64.9	136.2	119.1	86.8	144.7	83.3	225.2	126.6	67.7	97.0	81.1	24.1	3.2	4.7	6.5	4.1	5.7	8.2	7.9	9.2	2.8	4.3	4.6	6.1	0.7	11.0	2.6	1.8	19.1	5.8	5.5	8.2	6.9	6.3	5.0	6.0	6.7	7.1	6.5	5.5	7.6	7.0	2.0	6.4	6.4	2.9	4.2	12.9	2.5	4.9	6.2	1.5	4.8	5.1	1.5	2.8	3.3	5.5	4.2	21.8	4.4	3.1	19.6	1.9	15.2	2.2	3.1	2.7	0.0	55.7	7.5	2.2	49.4	5.9	7.7	4.0	2.5	14.2	5.3	2.7	13.1	1.7	8.0	5.7	20.3	11.3	8.0	17.7	1.5	7.1	1.8	1.0	4.5	2.7	6.2	6.0	12.3	2.0	1.0	3.8	10.9	2.8	1.1	2.1	2.3	0.8	13.1	3.1	5.5	79.6	32.2	19.5	12.9	8.6	6.9	2.2	11.6	2.9
RALB		ENSG00000144118	"RAS like proto-oncogene B"	P11234	2	120240064-120294710	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Cell division"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 335.7"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 378.4"	"Group enriched"	"Detected in all"	4	"granulocytes: 378.4;monocytes: 176.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026010, HPA065232"	Enhanced					NA	NA		440000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB026010: , HPA065232: AB_2685440"	"unprognostic (5.16e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (2.29e-2)"	"unprognostic (8.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	53.8	35.9	30.6	57.2	30.8	60.0	39.9	32.8	38.7	44.3	33.1	59.2	50.5	37.5	15.8	73.3	45.7	44.8	51.0	32.3	37.7	56.5	34.2	50.7	35.8	30.8	33.6	28.7	25.6	335.7	16.6	63.1	30.6	51.0	51.8	25.8	36.2	31.7	30.1	25.7	44.8	46.5	31.3	54.2	39.3	29.9	37.9	27.5	30.8	43.9	35.0	51.0	49.1	32.8	179.8	47.7	46.8	29.5	71.2	115.5	66.7	121.4	105.8	93.3	70.5	99.4	118.0	7.1	63.9	131.6	88.2	64.1	22.5	93.1	85.7	293.3	25.8	84.4	36.3	71.3	46.0	45.1	144.9	60.3	99.0	97.2	74.0	77.1	272.9	6.3	66.5	28.1	108.2	91.9	5.9	100.0	31.7	71.6	101.9	1.2	59.3	38.1	97.5	45.6	13.3	32.1	50.4	137.9	85.1	39.3	43.3	66.3	168.4	91.1	69.8	93.9	48.8	16.2	9.1	12.8	72.7	57.5	95.6	101.8	80.9	230.5	19.0	117.7	18.5	45.0	18.0	19.0	65.4	59.6	11.9	13.7	378.4	25.5	176.1	6.9	24.6	59.5	30.6	30.8	32.8	38.7	32.3	37.7	30.8	33.6	30.6	31.3	37.9	32.8	69.3	9.6	27.0	6.5	23.8	19.4	30.1	22.4	7.4	4.1	23.2	7.9	55.8	18.6	21.9	11.0	12.5	6.0	11.8	95.3	66.5	84.9	18.8	28.4	22.8	77.8	18.6	8.4	12.9	55.0	128.5	32.7	17.9	26.7	106.1	90.6	78.5	9.8	53.6	13.5	9.7	19.1	18.3	54.3	59.4	23.0	19.9	66.7	35.6	16.9	62.6	26.3	21.6	10.1	5.4	138.1	62.1	31.2	6.7	28.5	44.6	104.4	46.3	7.5	19.7	18.3	33.4	13.1	16.2	16.4	18.9	36.7	19.5	12.9	31.3	32.2
RAMP2		ENSG00000131477	"Receptor activity modifying protein 2"	O60895	17	42758447-42763041	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 1066.8;Endothelial cells: 562.9;Hepatic stellate cells: 344.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 120.4;EFO-21: 80.5;HUVEC TERT2: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052020			Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA052020: AB_2681697"	"unprognostic (8.64e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-1)"	190.0	29.0	60.4	19.2	61.8	0.1	168.9	61.7	72.3	100.7	67.7	35.7	12.5	63.1	27.8	25.1	51.7	39.6	123.2	59.3	65.8	70.5	16.7	163.3	26.2	65.7	68.1	33.0	17.1	23.8	20.8	97.0	72.7	42.1	21.1	4.1	45.9	27.5	43.3	55.9	44.1	72.6	62.7	40.2	33.9	11.9	66.6	11.4	71.7	98.7	24.5	45.9	49.6	62.4	0.1	1.1	4.9	0.1	120.4	6.2	4.0	0.9	2.1	10.2	4.9	11.5	0.1	0.0	80.5	3.0	0.5	0.0	4.6	0.1	8.9	0.0	0.2	0.0	0.7	3.7	3.0	0.0	0.0	4.2	0.1	1.8	0.4	3.5	37.6	1.5	0.1	0.2	0.6	0.0	0.6	0.8	23.3	0.0	0.0	0.1	0.1	0.0	0.6	0.6	4.8	9.8	2.9	0.0	17.3	4.8	1.2	3.2	6.7	19.3	7.1	0.4	2.4	0.0	0.1	0.3	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	60.4	61.8	61.7	72.3	59.3	65.8	65.7	68.1	72.7	62.7	66.6	62.4	1066.8	0.0	5.7	1.6	6.2	34.4	5.4	0.9	9.6	0.6	24.0	24.8	2.2	0.0	1.0	3.7	0.0	1.1	3.7	0.1	3.9	0.6	1.6	22.2	52.8	562.9	4.2	0.0	0.2	0.7	1.7	126.9	3.1	38.5	0.0	1.4	344.8	1.3	3.4	0.0	1.0	0.2	20.3	8.4	40.5	3.6	38.8	4.1	23.2	45.0	2.6	15.5	0.0	1.5	0.3	0.0	0.0	21.8	5.2	4.8	0.0	1.0	0.1	1.8	6.6	10.5	26.3	26.6	59.1	2.6	27.6	1.5	4.0	14.0	0.1	4.3
RAP2B		ENSG00000181467	"RAP2B, member of RAS oncogene family"	P61225	3	153162226-153170627	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 236.8;Squamous epithelial cells: 259.0;Urothelial cells: 269.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		160000	"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (2.44e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	5.2	2.5	4.9	6.0	7.2	15.6	3.4	1.4	7.4	6.0	2.1	3.8	2.6	3.4	2.9	14.9	2.7	6.3	2.1	12.1	5.2	2.7	4.4	5.0	6.3	2.5	4.8	3.6	2.4	2.3	1.2	8.6	2.1	2.4	3.5	0.9	4.8	2.3	1.3	5.0	3.6	3.1	2.9	7.5	8.7	1.4	8.2	4.7	2.1	1.6	5.0	8.2	7.0	5.4	29.0	10.4	5.0	7.4	10.7	9.7	13.7	7.3	10.8	4.9	5.4	5.5	16.6	2.0	8.0	6.8	8.1	28.5	3.9	13.3	5.7	11.7	7.5	11.7	5.6	10.2	5.6	10.9	17.8	10.5	11.1	7.3	13.6	8.6	11.9	5.5	6.8	23.9	9.3	11.5	10.3	15.7	10.4	6.0	16.1	8.9	13.7	26.3	7.7	27.8	0.1	2.7	7.6	6.9	23.5	8.9	5.1	5.6	23.9	7.5	11.6	8.1	18.5	15.3	2.7	5.2	10.0	12.0	7.9	28.0	17.9	7.5	19.5	27.8	14.7	6.4	16.6	17.2	13.1	3.8	9.3	14.7	7.2	14.1	27.6	9.5	12.7	13.8	4.9	7.2	1.4	7.4	12.1	5.2	2.5	4.8	2.1	2.9	8.2	5.4	39.7	12.8	16.5	1.6	26.0	193.0	145.8	61.1	236.8	3.7	41.3	22.4	4.8	30.0	39.4	16.5	2.1	17.3	94.4	135.3	3.9	31.3	0.6	107.8	40.4	21.5	48.6	40.8	8.9	21.7	49.4	30.7	120.8	173.4	26.6	51.3	25.4	14.7	132.1	3.3	3.0	53.5	40.7	170.6	159.9	1.5	19.3	117.0	35.6	4.7	120.1	7.9	110.2	4.5	1.9	60.6	121.3	14.7	27.8	102.1	31.1	12.3	22.1	5.9	0.0	11.1	18.0	3.8	6.1	259.0	195.2	15.2	52.6	12.3	33.6	269.2
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 456.2;Inhibitory neurons: 264.1;Microglial cells: 238.9;Oligodendrocyte precursor cells: 199.0;Oligodendrocytes: 236.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.9;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 104.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068798			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA068798: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	22.7	9.4	8.7	13.4	19.8	87.5	24.1	4.1	32.1	16.7	0.0	21.8	15.9	16.1	9.8	13.8	14.0	20.1	23.2	27.4	0.3	22.7	30.5	26.6	11.9	0.0	0.7	13.5	19.5	23.5	15.3	38.5	0.3	12.2	20.8	35.1	25.3	12.6	21.7	17.5	17.0	19.7	0.6	29.7	19.3	9.8	6.0	17.5	39.5	31.4	11.5	14.8	11.8	18.6	8.9	11.9	55.4	17.2	21.4	23.9	84.9	17.0	21.3	15.2	10.9	36.7	19.4	50.7	6.1	17.0	22.0	8.0	19.1	21.8	18.0	8.6	13.2	79.0	25.3	21.4	15.5	9.7	104.5	14.1	12.1	36.5	12.9	32.0	44.1	20.7	17.6	46.0	19.0	15.6	24.1	1.5	23.7	10.4	11.8	19.7	14.0	2.0	13.6	20.2	15.7	21.0	24.9	12.1	20.0	26.5	6.0	6.3	47.0	23.9	25.2	30.7	14.2	51.0	32.9	0.8	28.3	4.1	14.8	2.2	1.0	0.7	0.5	0.5	0.6	0.2	0.4	0.3	0.5	0.2	0.6	0.3	5.9	3.3	0.6	1.0	1.0	0.3	8.7	19.8	4.1	32.1	27.4	0.3	0.0	0.7	0.3	0.6	6.0	18.6	66.7	57.7	30.1	110.7	12.9	20.4	11.2	7.5	9.6	19.7	23.5	11.9	39.0	11.5	13.8	7.3	41.7	11.1	20.2	24.8	0.0	9.2	5.3	43.5	19.5	49.2	14.4	38.9	456.2	12.6	9.6	16.9	7.7	59.2	51.8	22.9	32.2	30.5	10.8	33.7	264.1	12.0	2.0	24.6	20.1	5.3	7.8	29.5	33.8	238.9	15.6	30.2	2.1	199.0	236.2	22.1	17.7	8.6	40.5	17.6	7.1	8.7	18.7	22.4	52.6	28.1	37.2	3.5	8.9	10.7	20.0	5.9	12.9	7.2	7.9	15.1
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 141.6;skin 1: 121.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 6.7;T-cells: 18.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 101.0;MCF7: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	17.4	16.2	10.2	5.7	9.7	3.7	19.4	13.0	10.9	55.0	10.8	22.7	2.5	23.3	6.0	141.6	27.2	15.7	17.3	9.7	9.5	12.5	3.2	15.2	5.9	10.3	10.0	20.5	8.5	7.2	8.7	9.5	9.3	26.9	7.8	3.9	30.6	16.2	6.9	121.4	10.4	13.0	10.0	10.2	14.5	4.8	9.5	5.1	22.6	10.6	22.5	26.2	69.3	10.0	22.8	24.7	5.5	50.9	55.0	46.8	1.7	23.2	50.0	29.7	23.3	8.3	101.0	0.5	12.5	93.6	16.2	74.3	18.4	44.6	7.4	5.7	9.4	3.3	18.6	7.4	23.2	0.0	9.1	34.8	63.9	28.5	6.4	74.7	12.7	4.6	0.8	9.8	11.9	110.3	1.3	1.1	16.3	30.4	42.7	7.3	1.9	18.1	8.9	37.1	4.4	22.9	47.0	50.6	32.1	6.8	43.9	1.4	13.8	35.4	16.5	23.6	1.5	4.2	2.6	1.8	43.4	3.8	51.3	1.8	3.1	0.9	7.4	0.9	18.8	2.0	6.5	5.4	6.7	0.6	5.2	4.7	0.0	2.3	0.0	0.6	1.8	4.0	10.2	9.7	13.0	10.9	9.7	9.5	10.3	10.0	9.3	10.0	9.5	10.0	10.7	3.2	7.0	21.2	2.5	34.2	24.1	21.6	42.7	0.5	18.0	15.6	3.7	11.5	11.1	3.7	2.1	7.5	6.2	3.2	0.0	10.5	0.1	3.6	14.4	11.0	1.8	0.8	2.5	5.1	1.2	19.6	13.7	3.4	1.3	0.3	20.3	0.1	2.7	0.0	3.0	2.1	12.2	4.1	13.3	0.5	5.3	4.9	8.8	6.5	1.8	3.6	5.2	7.1	0.7	14.3	4.4	5.3	3.0	19.2	0.2	0.5	3.9	5.2	6.6	9.5	22.0	0.8	5.6	69.9	55.8	1.8	7.2	0.4	5.5	45.7
RASGRF1	"CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187"	ENSG00000058335	"Ras protein specific guanine nucleotide releasing factor 1"	Q13972	15	78959906-79090780	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 26.5;lung: 7.5;retina: 7.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010413, HPA041965"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"CAB010413: AB_2238127, HPA041965: AB_10793939"	"unprognostic (2.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.02e-6)"	"unprognostic (2.35e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.81e-2)"	"unprognostic (8.81e-2)"	0.1	0.1	4.2	1.0	4.1	0.0	0.1	24.4	24.4	0.6	0.0	0.2	0.2	0.4	0.1	0.1	0.4	0.1	0.0	12.2	6.4	0.7	0.0	7.5	1.3	13.9	10.2	0.8	2.3	0.6	1.1	0.2	16.4	0.5	0.2	7.4	0.1	0.2	0.0	0.0	1.4	0.1	8.7	0.6	0.2	0.3	14.9	0.5	0.0	0.0	1.4	0.3	0.1	26.5	8.5	0.1	0.1	0.0	0.0	0.0	7.7	0.0	0.4	0.5	1.2	0.0	1.5	0.4	0.2	0.0	0.6	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	10.4	1.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.9	13.0	0.1	0.3	0.8	0.0	0.0	0.1	1.6	0.7	0.0	1.7	0.0	0.0	15.1	0.0	0.3	0.0	3.8	2.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.1	24.4	24.4	12.2	6.4	13.9	10.2	16.4	8.7	14.9	26.5	0.2	3.2	80.6	8.5	4.5	0.6	0.6	0.2	0.0	13.7	0.2	0.1	1.0	0.0	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.6	0.4	0.5	0.0	0.0	80.9	0.0	2.7	0.3	0.0	1.8	0.0	0.0	0.0	0.0	2.0	25.2	91.2	0.0	0.0	0.3	16.1	0.0	0.0	1.8	3.6	5.6	0.6	1.1	0.0	1.5	121.5	0.3	0.0	0.4	2.1	0.2	0.0	6.8	2.0	2.5	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.8	0.1	1.6	0.0	0.4
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 20.8;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 39.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;HMC-1: 24.0;U-937: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	3.2	0.8	0.3	6.7	0.3	20.8	0.7	0.3	0.9	1.1	0.4	1.2	1.2	0.5	0.1	1.0	1.0	1.9	0.6	0.2	0.3	0.3	0.7	3.3	1.1	0.9	0.4	0.4	1.1	0.3	0.2	2.3	0.6	0.5	0.8	0.0	0.4	0.5	0.8	0.5	1.8	2.0	0.7	8.9	0.9	0.2	1.1	1.1	0.2	1.4	0.7	2.5	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	12.5	13.5	20.1	0.0	15.4	0.0	0.1	0.3	0.0	9.4	0.1	0.0	0.0	39.4	0.0	17.9	0.7	1.4	4.4	0.3	0.3	0.3	0.9	0.2	0.3	0.9	0.4	0.6	0.7	1.1	1.0	0.2	0.0	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.3	18.1	0.0	1.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.7	0.0	0.2	0.4	0.0	0.0	26.6	0.0	1.4	0.0	15.1	0.0	0.4	0.0	0.0	32.9	11.6	0.0	0.0	19.1	1.8	0.0	25.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.1
RASIP1	"FLJ20401, RAIN"	ENSG00000105538	"Ras interacting protein 1"	Q5U651	19	48720585-48740610	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 121.8;Endothelial cells: 83.9;Hepatic stellate cells: 94.2;Theca cells: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 14.7;HeLa: 13.9;HUVEC TERT2: 38.5;SiHa: 21.1;TIME: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077251	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA077251: AB_2732337"	"unprognostic (9.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (7.17e-5)"	"unprognostic (8.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.46e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	24.4	7.0	5.9	2.6	4.3	0.7	21.0	4.4	4.6	9.2	1.4	5.6	2.5	11.2	1.1	5.1	9.9	3.8	18.8	3.6	4.0	12.6	2.6	27.9	2.2	4.9	5.3	4.9	13.2	1.6	4.1	7.9	5.9	5.5	0.7	0.1	4.8	2.7	7.7	6.0	5.7	4.2	4.5	16.8	10.3	6.8	7.3	1.5	10.5	4.0	1.4	7.6	7.7	3.6	10.2	0.1	0.2	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.6	1.1	0.8	2.2	0.0	0.0	2.5	0.2	2.2	0.0	0.0	14.7	0.2	13.9	0.4	2.2	0.0	0.7	2.2	1.2	0.0	0.0	0.0	38.5	1.3	1.3	0.1	0.0	0.9	0.0	1.3	0.3	0.4	0.0	0.2	0.0	0.4	0.0	0.8	6.7	0.5	21.1	0.0	0.0	0.1	0.1	0.0	52.4	0.0	0.4	0.2	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	4.3	4.4	4.6	3.6	4.0	4.9	5.3	5.9	4.5	7.3	3.6	121.8	0.0	1.3	0.0	1.2	6.5	5.7	2.0	0.6	1.1	5.9	10.8	7.3	1.5	1.2	1.8	0.0	0.4	0.7	0.1	0.0	0.7	5.9	3.2	4.8	83.9	0.0	2.7	3.4	0.7	1.9	9.5	2.0	3.8	0.0	6.0	94.2	1.9	0.7	6.7	1.1	0.1	4.1	6.3	3.0	5.2	10.2	1.0	19.6	16.9	0.0	2.1	0.0	1.5	1.5	0.8	0.0	11.3	1.4	10.1	0.2	0.3	2.1	0.7	19.7	1.9	6.2	1.0	11.0	3.7	6.0	0.3	1.0	40.2	0.2	6.4
RASL12	RIS	ENSG00000103710	"RAS like family 12"	Q9NYN1	15	65053337-65076690	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.5;Peritubular cells: 57.9;Sertoli cells: 98.6;Smooth muscle cells: 55.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;CACO-2: 14.5;EFO-21: 22.7;NTERA-2: 9.9;SuSa: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (6.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (1.76e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.17e-4)"	27.9	3.9	32.9	5.1	36.8	0.0	15.7	30.8	24.4	49.8	8.5	35.6	3.6	61.6	27.9	19.2	54.7	13.2	53.4	26.0	38.4	6.9	1.1	38.4	3.3	39.4	57.4	16.5	2.4	1.8	7.0	17.0	38.0	52.5	6.7	3.3	8.0	76.4	37.1	12.1	9.4	33.0	38.8	9.6	7.7	15.6	66.1	0.9	8.4	20.6	1.7	40.2	33.5	32.6	0.1	0.1	0.2	0.0	0.6	5.0	0.2	0.0	0.5	0.0	0.0	14.5	0.1	0.0	22.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	17.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	36.8	30.8	24.4	26.0	38.4	39.4	57.4	38.0	38.8	66.1	32.6	7.4	0.0	0.0	22.5	0.0	1.5	3.9	0.0	0.0	0.3	2.0	5.6	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.7	0.3	12.6	3.6	0.0	0.0	0.1	0.0	0.1	15.2	0.5	0.5	0.0	12.3	1.4	0.1	0.3	0.0	0.1	0.0	2.0	0.0	1.3	3.9	13.1	0.2	0.0	2.8	0.0	17.9	0.0	0.0	0.0	0.1	0.0	57.9	0.0	0.4	0.5	0.0	0.0	0.8	98.6	0.9	55.7	0.7	1.1	0.4	0.1	0.3	0.2	0.4	0.2	0.1
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 124.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 124.1"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 145.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	33.1	22.9	13.8	43.3	9.3	17.3	14.9	7.1	9.5	19.4	33.0	106.6	21.1	23.9	15.1	36.8	13.2	29.3	44.3	7.6	9.2	6.9	10.9	32.5	37.0	11.4	20.5	19.6	13.1	3.3	4.6	39.6	13.6	33.0	42.0	1.5	35.6	48.7	45.0	6.8	26.3	60.1	11.4	47.6	34.5	13.5	22.1	15.4	6.5	13.1	33.2	50.3	14.1	13.4	28.1	30.9	9.6	18.6	10.2	14.7	58.3	11.9	61.8	15.8	18.6	22.3	28.9	43.6	24.8	8.6	19.0	12.1	29.6	12.5	19.0	35.5	11.3	28.6	13.0	25.5	27.9	30.5	19.3	10.0	10.7	36.2	26.7	46.1	68.0	20.7	15.4	21.0	18.7	26.5	20.2	19.9	21.4	65.8	18.8	32.5	30.9	18.4	20.8	33.6	21.7	22.7	20.0	3.8	145.5	23.0	17.3	19.0	98.7	12.8	15.6	13.5	13.1	19.5	22.0	28.0	15.4	26.2	37.8	19.6	16.6	12.5	13.2	17.7	11.1	14.1	19.4	14.9	9.1	10.1	19.1	20.3	124.1	12.0	17.7	8.4	22.1	2.8	13.8	9.3	7.1	9.5	7.6	9.2	11.4	20.5	13.6	11.4	22.1	13.4	30.7	3.2	15.4	4.2	32.7	16.3	15.0	5.5	2.8	0.0	12.4	13.7	56.5	30.0	8.9	5.5	0.0	35.5	39.0	67.4	0.0	12.4	0.3	14.4	4.1	31.2	26.4	16.4	8.7	21.2	19.1	14.5	20.9	28.3	6.3	4.7	20.7	4.6	24.1	0.0	16.2	15.8	2.0	69.9	149.3	0.8	2.5	55.7	48.0	49.6	72.7	2.8	32.0	3.5	4.8	24.0	14.5	14.3	9.8	25.5	13.3	1.7	3.9	0.2	13.1	9.2	27.0	0.6	19.3	5.9	11.9	19.7	30.7	1.6	20.7	21.1
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870362	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 440.4;Syncytiotrophoblasts: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	47.1	280.4	28.9	57.0	35.7	99.8	63.8	27.7	39.8	133.1	40.1	73.0	55.0	90.5	293.7	67.1	96.3	49.8	86.5	32.0	31.0	60.9	56.7	42.9	89.8	29.4	25.9	132.8	46.8	194.2	42.5	96.4	28.8	81.9	73.0	61.4	62.1	166.4	132.8	61.2	57.2	101.0	30.1	47.7	64.4	94.5	27.4	88.7	57.9	90.0	106.5	67.9	51.7	34.2	298.0	219.5	159.5	212.2	99.8	116.6	103.0	143.7	144.7	207.7	233.9	128.6	190.4	328.0	215.2	141.6	236.3	153.1	291.5	214.4	275.2	186.2	400.6	138.9	247.7	153.1	83.8	212.1	160.3	91.3	77.8	240.6	174.9	133.3	211.9	134.6	141.5	167.2	166.9	200.2	236.1	194.0	181.7	141.5	199.5	204.3	295.3	386.7	151.9	197.6	149.3	110.7	271.9	128.3	133.9	225.8	426.8	126.5	99.0	99.5	102.1	265.7	162.8	116.6	178.6	429.3	127.7	140.8	123.3	50.9	45.3	62.3	85.1	79.5	82.6	92.0	70.6	89.4	63.6	80.0	73.3	82.9	18.2	89.2	111.7	74.1	72.1	77.2	28.9	35.7	27.7	39.8	32.0	31.0	29.4	25.9	28.8	30.1	27.4	34.2	52.0	51.3	65.0	18.6	69.5	74.8	105.7	98.0	33.6	31.4	53.5	51.1	105.1	42.9	80.8	55.2	29.2	440.4	89.8	41.9	78.2	87.3	14.5	55.0	58.0	50.7	60.7	70.2	26.6	74.3	170.8	87.7	44.9	54.8	57.7	101.8	41.4	36.4	109.3	25.2	20.7	57.4	81.4	33.5	39.6	31.2	113.7	43.7	83.6	16.9	60.4	79.4	72.1	46.3	24.7	75.7	39.0	187.3	89.6	75.3	48.6	64.2	63.8	43.6	138.1	73.8	134.3	109.9	121.1	52.5	61.1	532.2	67.8	81.9	79.3	74.2
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781379-27890681	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 79.0;Proximal tubular cells: 110.9;Respiratory ciliated cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 17.8;RPTEC TERT1: 40.8;U-266/84: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		11000	"Cluster 22: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	5.8	24.8	3.9	2.0	4.3	1.8	3.9	5.2	5.1	3.5	5.0	6.1	25.2	2.8	10.9	3.1	15.5	2.7	5.2	4.1	4.4	27.5	46.5	3.1	1.7	4.4	4.6	8.1	4.6	9.3	11.0	1.8	4.3	2.4	5.2	13.8	2.1	3.4	8.2	1.5	25.6	2.2	3.9	1.7	2.8	9.2	3.9	3.1	9.8	5.9	2.2	2.2	2.3	4.4	6.4	4.9	0.5	0.6	0.4	1.7	3.9	1.3	1.7	1.5	1.1	9.3	2.9	2.4	17.8	3.6	3.0	2.3	0.6	2.7	2.1	0.9	0.3	0.1	0.7	8.2	2.7	1.7	0.2	2.4	3.3	5.8	7.8	1.5	1.2	3.8	0.5	4.0	3.6	8.2	1.5	4.6	0.8	4.6	4.3	1.8	0.3	1.4	40.8	0.5	1.7	2.5	6.1	7.7	2.8	2.3	3.9	9.3	0.2	1.2	0.9	4.3	2.7	13.6	18.2	3.8	3.6	5.6	0.2	1.6	2.5	1.4	1.9	0.9	4.2	4.4	2.7	4.8	3.5	3.7	3.1	2.3	1.0	4.5	0.2	0.4	4.2	2.3	3.9	4.3	5.2	5.1	4.1	4.4	4.4	4.6	4.3	3.9	3.9	4.4	9.9	6.4	5.0	14.7	24.0	2.0	3.1	11.7	26.7	10.7	5.1	7.1	7.1	5.7	9.7	18.4	4.2	4.2	10.5	12.2	46.9	12.6	36.9	35.2	2.4	7.8	3.6	3.0	13.9	12.3	1.3	10.9	8.6	7.4	2.5	4.6	2.9	29.5	6.5	8.4	18.3	4.7	6.1	4.4	3.4	26.4	1.5	50.8	1.8	2.8	2.4	15.5	3.1	15.6	10.3	7.0	14.9	2.6	21.2	1.0	79.0	110.9	59.0	25.6	0.0	3.3	11.2	23.8	20.0	5.2	1.6	1.5	19.6	9.5	10.7	1.9
RBM27	"ARRS1, KIAA1311, Psc1, ZC3H20"	ENSG00000091009	"RNA binding motif protein 27"	Q9P2N5	5	146203605-146289223	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (8.18e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (4.73e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.67e-3)"	"unprognostic (4.09e-3)"	7.3	5.4	4.1	8.4	4.2	19.5	9.4	7.0	4.9	8.3	4.0	7.8	7.5	9.3	8.0	7.3	7.4	5.9	7.0	3.9	4.8	8.0	10.6	6.7	11.7	3.5	4.5	10.9	6.0	8.9	3.6	9.2	4.0	7.6	8.3	9.4	6.3	6.4	7.2	7.2	7.3	7.6	4.3	9.4	8.6	10.1	4.6	12.6	10.9	9.2	11.3	9.3	5.9	4.9	15.0	12.1	15.3	24.8	13.1	12.5	17.7	10.9	12.3	15.7	17.2	21.3	18.9	31.7	8.4	12.5	21.5	15.3	23.1	25.2	27.7	24.3	10.2	21.7	12.9	14.9	14.4	34.3	24.1	11.7	13.0	16.9	29.9	12.1	14.2	14.9	24.3	18.7	15.0	13.5	25.0	17.4	21.2	16.5	13.6	22.2	23.7	21.9	16.0	16.6	19.1	13.1	22.5	21.7	17.8	15.6	25.3	18.7	13.5	16.6	17.6	12.5	17.8	17.7	18.1	36.6	12.5	24.7	15.7	1.7	0.8	1.6	1.4	1.3	1.6	1.2	1.4	1.6	1.1	1.4	1.8	1.5	1.2	1.8	1.5	1.3	1.5	0.7	4.1	4.2	7.0	4.9	3.9	4.8	3.5	4.5	4.0	4.3	4.6	4.9	12.7	16.0	17.6	20.5	13.1	66.2	9.5	52.6	6.2	11.2	13.0	8.6	17.3	5.7	32.3	14.7	10.4	9.2	17.6	10.1	1.9	7.8	32.4	15.1	11.8	15.7	10.8	11.8	32.2	6.8	8.3	17.0	11.2	13.9	22.1	12.2	11.4	12.1	11.2	15.2	31.4	13.8	30.5	20.4	40.6	6.6	11.5	14.1	19.6	28.1	16.9	8.4	12.3	28.6	43.8	11.5	8.7	14.7	7.3	17.4	9.9	7.9	36.8	8.7	0.0	16.5	24.1	31.4	13.2	12.0	62.1	9.7	15.7	9.8	12.5	19.7
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391396-57409333	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 136.4;skeletal muscle: 221.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 110.9;dendritic cells: 156.9;Erythroid cells: 280.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 95.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 140.6;U-698: 150.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favorable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.83e-1)"	11.7	10.7	6.7	26.6	9.4	136.4	12.8	13.3	10.3	18.8	15.1	96.6	8.7	38.4	0.9	16.8	28.9	5.1	72.6	5.9	6.4	16.3	16.4	21.0	43.4	8.6	11.5	27.8	10.8	1.9	12.2	5.5	8.0	27.0	4.1	0.6	19.7	11.9	221.7	9.1	39.8	8.7	6.6	65.8	23.0	38.1	9.4	26.6	9.4	32.7	12.2	42.9	13.6	7.9	20.1	20.4	9.7	25.1	0.0	1.6	56.3	6.5	1.6	13.5	3.5	84.2	20.6	140.6	54.1	1.9	13.2	18.3	8.0	8.0	2.1	29.0	34.5	118.0	7.6	52.6	6.0	57.8	54.2	1.9	3.8	5.7	1.1	1.9	9.2	52.5	100.9	24.6	1.6	87.8	42.7	58.5	36.9	10.7	25.5	82.0	23.6	114.2	10.1	9.2	40.9	26.3	15.2	50.5	24.7	8.7	28.3	79.4	17.0	4.4	42.6	6.0	27.6	60.1	86.8	150.7	1.1	40.3	4.2	0.0	0.5	2.2	3.1	1.8	1.9	3.2	2.5	2.1	1.0	3.3	3.0	2.8	0.7	3.5	1.7	1.3	4.7	2.1	6.7	9.4	13.3	10.3	5.9	6.4	8.6	11.5	8.0	6.6	9.4	7.9	13.9	3.2	5.2	10.1	110.9	9.1	28.3	7.9	13.6	1.0	15.8	21.0	42.5	8.6	6.6	1.8	0.0	1.9	156.9	41.6	9.8	6.2	4.2	54.2	5.2	11.9	62.8	280.4	2.5	5.0	5.8	8.8	12.2	21.5	8.8	31.5	10.4	6.0	9.6	0.0	1.3	56.4	12.2	8.1	18.9	4.0	4.4	27.6	1.8	2.8	5.8	12.8	54.6	4.5	4.6	5.9	35.4	6.0	52.8	18.8	2.8	16.4	22.5	1.4	6.6	20.6	7.6	2.4	13.2	9.1	8.4	2.3	81.0	13.3	34.0	18.5
RBM43	"C2orf38, FLJ45645"	ENSG00000184898	"RNA binding motif protein 43"	Q6ZSC3	2	151247940-151261863	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.4;HSkMC: 18.5"	"Low region specificity"	"Detected in all"							HPA038204	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Nucleoplasm	"HPA038204: AB_10669520"	"unprognostic (3.50e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.94e-2)"	5.2	8.7	2.4	4.2	2.3	6.7	6.9	1.6	2.3	7.5	3.5	4.2	3.0	7.6	9.4	3.2	12.3	6.8	3.2	2.1	2.7	7.0	6.7	6.1	6.9	2.9	2.9	15.4	4.0	5.1	2.9	5.7	2.3	6.5	4.4	1.8	5.2	7.7	3.4	4.7	3.9	5.7	2.8	7.9	4.6	3.6	2.9	7.0	12.3	2.5	4.7	3.8	3.1	3.0	3.5	2.2	3.5	4.7	9.4	20.4	2.3	4.0	9.2	5.0	7.2	0.1	5.7	2.7	1.5	7.3	2.7	1.7	1.1	4.6	2.5	4.2	2.5	6.6	1.0	0.2	9.1	8.2	2.2	18.5	5.0	4.0	3.0	7.4	10.7	2.9	2.7	3.0	6.8	3.5	4.7	3.9	1.3	0.1	4.2	3.2	4.1	1.6	8.4	3.0	1.3	4.2	3.8	2.8	7.8	0.6	4.1	5.2	6.1	3.7	3.3	3.2	1.7	1.1	0.8	0.0	9.7	3.3	2.3	1.0	0.7	3.0	1.2	0.9	2.0	1.2	1.6	1.5	0.5	1.3	2.0	1.5	0.8	2.7	2.4	0.2	0.8	0.6	2.4	2.3	1.6	2.3	2.1	2.7	2.9	2.9	2.3	2.8	2.9	3.0	26.5	3.2	8.9	2.9	9.6	3.3	3.2	5.8	5.7	6.7	8.6	14.9	2.6	11.5	5.7	18.4	0.0	6.8	8.4	1.7	27.4	6.8	3.0	30.9	17.2	16.9	6.1	8.8	1.0	5.9	4.7	21.8	5.6	9.4	3.8	13.4	20.7	9.1	5.1	6.7	1.3	6.9	4.1	10.4	4.3	2.4	28.0	8.2	3.6	2.8	12.3	22.1	13.4	4.0	0.9	4.6	5.6	29.0	5.5	2.8	5.5	18.2	26.3	1.3	0.0	18.4	13.0	0.5	3.6	7.3	3.1	1.4	13.5	30.4	3.7	2.2
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 1366.7;pancreas: 632.7"	"Group enriched"	"Detected in many"	4	"Granulosa cells: 5988.6;Theca cells: 3228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"SH-SY5Y: 835.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 64.4"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		41000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	23.7	377.1	64.6	18.4	65.2	1.3	49.5	64.9	72.7	53.8	251.4	30.3	32.3	180.2	64.2	35.4	390.2	182.9	60.1	65.5	67.8	46.9	140.8	26.8	18.6	83.1	69.0	1366.7	632.7	46.8	257.8	63.6	64.7	44.8	14.2	23.2	50.2	41.3	15.2	31.3	26.2	119.3	68.2	47.0	29.3	56.1	75.2	9.4	23.0	15.5	12.0	65.7	24.3	67.5	7.8	2.9	7.4	164.2	0.3	0.0	0.9	0.1	0.0	0.0	0.1	0.4	76.1	0.0	53.8	0.1	2.6	0.1	38.2	0.5	0.0	0.1	5.3	0.1	2.7	75.5	155.1	0.2	0.1	3.0	0.0	0.1	0.0	160.9	0.0	0.0	0.2	29.9	0.2	0.0	0.2	0.5	18.4	0.2	0.0	0.1	32.0	0.5	0.1	0.1	19.6	835.4	35.3	0.1	0.1	13.9	3.2	1.1	0.0	0.3	120.0	0.2	0.3	0.6	0.5	0.5	1.3	0.0	2.3	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	64.6	65.2	64.9	72.7	65.5	67.8	83.1	69.0	64.7	68.2	75.2	67.5	24.8	32.1	5.9	8.8	3.5	17.6	53.5	91.9	2.8	26.3	70.4	47.8	21.4	77.2	30.3	23.9	2.1	3.2	1.0	0.1	13.7	1013.0	4.8	199.6	961.4	103.8	43.1	13.5	0.5	1042.7	6.2	158.8	19.9	58.1	0.0	5988.6	343.7	6.9	16.5	3.3	0.3	2.3	42.7	10.6	3.4	16.2	27.1	25.1	8.8	5.6	13.5	159.9	0.0	4.0	16.0	563.0	0.0	4.5	2.9	56.6	2.6	4.7	10.3	7.2	26.3	220.9	534.7	11.6	4.9	6.2	34.9	3.8	10.2	3228.5	2.7	32.7
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7115736-7128889	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 443.5;liver: 324.2"	"Cell type enriched"	"Detected in many"	8	"Proximal tubular cells: 3197.2"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.0;Hep G2: 13.4;K-562: 26.3"									HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Vesicles	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favorable (3.68e-4)"	6.4	11.7	0.0	15.0	0.1	1.6	5.1	0.3	0.3	11.2	0.2	8.5	4.6	8.6	3.2	3.8	8.1	5.9	1.4	0.0	0.0	443.5	324.2	3.8	31.2	0.5	0.3	4.9	5.2	1.3	6.2	0.3	0.3	10.0	4.9	0.8	3.7	5.0	0.7	2.4	20.6	5.4	0.0	97.1	5.2	2.2	0.2	14.2	7.9	0.0	21.4	7.4	4.6	0.0	0.9	1.3	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.2	1.1	1.2	1.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	1.6	0.0	6.0	3.9	13.4	0.0	0.2	0.9	0.2	0.0	0.0	0.0	2.4	0.0	0.6	26.3	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.2	1.4	0.9	0.0	0.6	0.5	0.7	0.7	0.6	0.5	2.8	0.4	0.3	0.1	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.5	0.3	0.3	0.0	0.2	0.0	4.9	0.0	0.6	0.7	15.2	1.5	0.5	0.1	0.0	1.2	1.3	1.3	0.1	5.7	0.1	80.9	0.0	0.1	0.3	0.1	352.1	0.2	4.1	0.3	1.7	28.8	0.0	0.0	2.1	0.4	0.0	8.2	0.0	0.5	0.0	0.2	8.9	361.1	0.1	5.0	1.1	0.0	0.0	8.1	2.6	6.7	2.5	16.6	0.0	1.9	0.0	1.4	0.0	0.5	0.1	0.2	0.0	0.4	0.1	0.5	0.0	3197.2	0.9	1.7	0.0	0.1	4.3	0.7	0.4	0.2	2.3	0.0	7.3	2.4	0.1	0.3
RCN2	"E6BP, ERC-55, ERC55, TCBP49"	ENSG00000117906	"Reticulocalbin 2"	Q14257	15	76931738-76954393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 321.5"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 528.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030694, HPA030695"	Enhanced	Supported	Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		92000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum"		"HPA030694: AB_2673573, HPA030695: AB_2673574"	"unprognostic (1.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.67e-2)"	31.3	30.8	42.5	24.9	43.9	24.6	35.8	35.8	57.8	34.1	41.4	33.1	22.2	44.0	321.5	28.5	54.3	32.6	38.8	44.0	55.0	49.3	19.8	28.8	30.0	38.0	45.1	34.2	21.5	80.6	30.8	49.2	46.9	41.2	36.5	43.9	22.7	41.1	56.9	22.6	23.3	39.6	40.0	25.4	26.9	93.4	51.4	40.3	48.0	60.4	32.4	39.0	25.2	40.8	93.9	65.3	284.1	134.9	120.1	135.6	177.3	109.1	147.5	138.7	115.1	81.2	78.2	58.3	154.3	119.3	149.5	139.9	217.4	94.0	176.0	45.3	170.8	28.9	91.4	135.0	143.0	105.4	42.9	123.6	126.8	68.2	87.5	146.1	148.9	98.3	74.2	56.3	146.6	60.3	104.9	71.9	216.6	98.0	72.1	109.4	187.0	37.3	91.6	123.8	161.8	161.1	178.8	98.6	220.5	251.1	96.0	115.0	80.5	162.8	131.2	104.8	228.0	80.4	266.6	69.6	92.8	87.6	151.1	7.5	7.6	16.2	21.7	7.4	24.9	23.4	23.0	28.1	16.1	22.9	25.5	25.1	3.9	23.5	12.3	19.1	18.1	20.0	42.5	43.9	35.8	57.8	44.0	55.0	38.0	45.1	46.9	40.0	51.4	40.8	87.3	25.6	36.8	56.8	111.2	82.1	125.0	85.5	96.2	87.1	75.9	74.8	94.9	62.9	52.5	99.3	37.5	183.1	76.3	23.3	49.0	116.0	44.8	87.0	101.6	64.8	73.5	91.5	48.4	45.1	296.8	106.0	54.6	85.6	28.6	120.9	60.0	32.8	57.3	127.9	72.0	55.0	101.7	30.5	38.3	81.7	61.8	30.0	92.5	19.7	34.1	99.7	89.6	149.8	63.3	56.9	43.2	93.6	85.6	127.5	25.8	56.2	48.7	58.9	59.2	78.9	126.3	528.6	140.8	109.3	70.8	163.6	76.7	131.8	84.4	117.0
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296712	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 155.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		38000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	40.3	155.0	38.0	17.4	57.7	12.0	16.4	50.0	42.7	32.1	32.8	15.2	6.8	28.8	12.9	27.4	19.7	27.2	41.0	35.1	44.7	50.2	68.5	48.8	11.4	52.7	48.2	52.8	52.7	33.2	7.6	35.3	54.3	25.4	11.1	19.2	20.8	26.0	82.1	11.9	7.4	35.0	45.1	26.6	15.0	33.7	47.7	14.3	45.7	59.7	14.6	27.1	10.1	77.6	69.6	35.3	137.3	54.8	78.8	87.4	79.3	85.8	47.6	54.3	59.2	99.7	115.4	0.1	127.4	104.7	84.9	61.5	77.3	80.4	80.5	41.9	44.2	51.5	107.7	74.1	73.6	19.0	33.2	89.7	45.6	68.0	120.1	89.3	149.8	11.1	73.5	29.5	127.0	120.0	11.0	15.6	44.0	4.0	58.4	31.2	96.8	30.1	68.1	33.5	37.2	40.5	148.5	65.9	52.7	102.5	85.0	29.9	92.6	89.5	66.8	43.9	67.4	9.5	17.3	65.9	34.2	11.3	210.9	29.5	14.8	22.0	11.6	12.5	15.5	11.5	10.2	8.8	12.8	8.3	6.8	5.8	2.0	17.6	9.9	10.3	22.0	8.4	38.0	57.7	50.0	42.7	35.1	44.7	52.7	48.2	54.3	45.1	47.7	77.6	248.8	484.0	98.8	53.5	30.0	56.1	51.8	124.6	56.9	85.9	47.4	45.7	159.3	70.1	77.9	75.4	43.8	122.1	21.6	17.7	109.5	128.1	15.5	109.1	117.2	289.2	22.2	104.8	27.1	423.4	189.8	88.4	19.9	135.3	67.2	132.0	319.2	260.1	85.1	101.0	57.6	7.3	61.1	103.2	59.9	43.6	275.2	71.6	72.9	42.2	135.4	77.0	36.0	68.3	229.4	134.3	22.1	266.7	36.1	65.9	0.1	236.9	52.2	94.8	124.9	74.0	143.8	73.9	257.4	52.8	40.5	227.3	29.2	229.9	11.8	45.9
REC8	"kleisin-alpha, REC8L1, Rec8p"	ENSG00000100918	"REC8 meiotic recombination protein"	O95072	14	24171853-24180257	"Plasma proteins, Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 68.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.6;Gastric mucus-secreting cells: 73.9;Late spermatids: 74.5;Respiratory ciliated cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 10.8;HHSteC: 8.7;MOLT-4: 11.7;SH-SY5Y: 47.4;SuSa: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031727, HPA031729"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA031727: AB_10602920, HPA031729: AB_10669915"	"prognostic favorable (2.19e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (5.57e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.40e-3)"	9.8	6.1	3.3	2.1	3.2	6.6	2.5	5.2	3.9	6.3	5.3	8.5	1.3	7.1	0.1	2.7	14.9	8.8	2.8	3.4	4.5	12.4	3.3	9.5	3.1	8.9	4.8	3.9	2.7	0.2	68.9	0.6	8.9	7.3	0.4	1.9	4.7	6.2	0.9	1.7	7.3	2.4	3.6	13.6	25.7	29.9	5.3	10.1	3.5	0.3	3.1	4.0	3.7	4.4	0.1	0.2	10.8	0.1	0.4	0.5	0.6	0.4	0.5	1.0	0.8	0.1	1.2	0.2	0.1	0.0	0.6	0.5	0.3	0.0	0.7	1.0	0.2	0.4	0.7	0.0	8.7	0.2	1.5	4.8	0.5	0.4	0.1	4.1	1.9	0.4	0.1	1.4	0.0	0.2	11.7	1.8	3.4	0.0	0.1	0.2	0.0	0.1	0.4	0.4	0.2	47.4	0.0	0.1	0.4	26.0	0.2	0.5	0.4	0.0	0.2	0.3	0.1	1.7	0.5	0.1	0.0	0.2	0.2	2.2	0.1	9.7	4.7	1.1	5.4	1.6	1.7	2.7	3.2	1.7	0.7	2.4	0.1	2.8	5.8	5.2	2.9	1.2	3.3	3.2	5.2	3.9	3.4	4.5	8.9	4.8	8.9	3.6	5.3	4.4	9.5	12.8	10.8	3.6	6.8	1.9	4.4	15.8	8.6	14.9	2.8	2.0	2.0	25.8	14.8	27.6	0.0	1.4	10.2	5.1	5.9	2.9	150.6	43.5	10.6	4.8	4.8	25.9	3.8	2.7	3.2	10.0	73.9	21.9	3.8	7.9	3.6	2.1	2.3	6.7	5.1	2.5	10.2	5.7	3.9	74.5	4.7	6.6	1.8	2.8	4.0	21.1	2.1	5.5	4.6	5.0	0.7	3.0	11.0	1.5	4.1	24.7	51.4	2.0	0.0	3.7	3.9	8.3	43.4	1.3	2.0	0.4	11.3	33.8	2.4	4.0
REPS2	POB1	ENSG00000169891	"RALBP1 associated Eps domain containing 2"	Q8NFH8	X	16946658-17153272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 117.9;Inhibitory neurons: 142.7;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 204.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 13.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"basophil: 5.8;eosinophil: 4.5;neutrophil: 14.3"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.2;Karpas-707: 11.7;RH-30: 8.4;RPMI-8226: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000565, HPA026073"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 68: Epididymis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA000565: AB_1079800, HPA026073: AB_1856176"	"unprognostic (6.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.70e-3)"	"prognostic favorable (5.36e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.56e-4)"	2.4	11.1	7.6	1.2	9.4	3.0	3.3	2.4	29.1	15.9	1.6	4.3	2.1	4.2	12.6	1.3	2.1	2.1	1.6	11.2	9.2	11.0	7.6	4.6	0.5	2.4	4.4	4.0	10.3	9.4	6.0	2.6	3.4	8.2	4.6	9.3	5.1	7.8	0.9	0.9	2.0	4.2	0.9	1.2	6.3	2.1	9.3	0.7	2.0	1.3	0.6	1.8	0.9	12.5	1.4	0.6	0.0	0.1	0.8	0.5	0.1	0.0	0.0	0.1	0.2	0.1	5.2	0.0	0.6	0.0	3.9	0.2	1.1	2.8	0.5	30.2	0.6	0.0	0.7	0.0	0.7	0.0	0.1	5.3	0.9	0.0	4.7	4.9	1.6	0.0	0.0	11.7	0.3	1.4	0.0	0.4	0.2	4.3	0.9	0.0	8.4	9.4	0.3	2.8	4.2	0.3	2.2	2.1	1.7	1.7	3.9	0.2	0.2	0.0	0.2	0.1	0.4	0.5	0.0	0.4	0.0	0.4	0.2	5.8	0.3	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	14.3	0.0	0.2	0.3	0.0	0.1	7.6	9.4	2.4	29.1	11.2	9.2	2.4	4.4	3.4	0.9	9.3	12.5	11.7	32.1	13.5	6.5	0.9	0.6	9.6	4.4	1.2	49.5	7.9	5.5	6.6	4.3	8.8	14.7	0.0	0.2	1.5	10.4	1.9	3.0	0.2	7.1	4.0	2.3	9.5	4.4	117.9	14.6	9.1	4.1	9.7	9.6	0.0	7.9	4.2	15.1	4.2	38.7	142.7	7.8	0.0	5.7	6.4	0.9	9.3	6.6	1.8	21.5	4.9	0.9	0.0	84.9	204.0	7.9	5.1	12.8	1.3	10.6	2.3	11.6	2.7	2.6	0.0	0.8	2.0	0.7	2.6	0.9	1.3	0.7	0.5	16.3	10.2	6.5
RERGL	FLJ22655	ENSG00000111404	"RERG like"	Q9H628	12	18080869-18320107	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	37	"Sertoli cells: 164.3;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	719	"REH: 230.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041740	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041740: AB_10795694"	"unprognostic (3.53e-2)"	"unprognostic (7.03e-4)"	"unprognostic (6.29e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"		"unprognostic (5.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.66e-2)"	43.5	5.4	14.3	2.5	14.8	0.0	29.1	14.7	41.0	25.3	14.6	14.4	3.0	25.2	37.9	7.2	25.8	10.2	6.6	14.3	16.1	15.9	2.1	4.4	1.2	15.4	15.1	19.8	1.8	1.1	1.6	0.0	15.3	7.1	16.8	0.2	3.8	19.4	6.0	11.9	13.4	16.0	14.6	2.7	7.8	2.9	15.7	1.2	13.4	30.2	1.4	11.2	14.7	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.8	14.7	41.0	14.3	16.1	15.4	15.1	15.3	14.6	15.7	15.0	6.9	0.0	0.0	2.0	0.1	4.5	0.3	0.0	4.0	0.0	2.8	5.2	4.1	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.7	7.2	0.0	0.0	0.1	0.0	0.5	2.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	6.5	0.4	0.3	0.6	5.4	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.3	0.0	0.6	0.0	0.1	164.3	0.6	381.7	0.1	1.1	0.8	2.4	0.1	0.9	0.3	0.1	0.4
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115"	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	15.6	19.0	13.7	16.7	19.2	33.1	22.2	15.4	15.6	16.9	12.0	15.3	13.3	19.2	17.4	13.8	14.6	12.2	16.5	13.5	14.9	20.8	25.5	18.2	30.2	16.5	15.6	26.1	29.0	31.4	14.7	14.6	18.0	17.8	14.8	24.3	16.6	16.1	11.6	14.9	13.8	17.1	15.4	17.0	14.9	11.8	14.8	28.0	23.1	15.9	30.2	13.5	14.1	25.5	43.5	19.4	53.7	44.1	25.4	32.0	27.5	49.1	44.6	49.2	58.2	37.8	43.1	106.5	32.4	33.2	52.8	20.7	49.8	42.6	78.5	19.5	33.9	48.0	35.6	34.7	30.6	67.5	30.7	24.6	33.8	49.9	55.3	39.1	38.8	52.1	48.0	22.1	37.9	17.5	99.7	43.4	33.0	26.8	24.2	78.1	97.8	33.7	21.4	30.1	37.6	36.4	29.1	11.3	37.6	33.4	29.8	37.5	30.0	40.3	49.6	37.8	63.1	31.0	45.8	101.3	33.1	69.3	41.2	8.2	8.6	3.8	13.7	6.9	10.1	14.6	11.7	11.9	6.9	16.1	13.8	12.2	3.9	12.6	8.9	14.3	11.5	5.5	13.7	19.2	15.4	15.6	13.5	14.9	16.5	15.6	18.0	15.4	14.8	25.5	65.5	64.1	120.6	33.0	62.9	20.6	37.9	26.5	47.3	67.8	60.5	62.4	86.1	45.8	37.0	57.0	60.5	43.1	83.8	30.6	72.4	54.8	73.0	45.9	79.1	56.1	30.0	57.9	22.0	66.0	48.5	54.9	28.1	60.0	25.9	82.2	57.8	82.0	30.7	85.8	32.1	58.2	12.2	44.3	16.6	32.3	82.0	35.1	16.0	22.5	58.1	82.7	107.1	38.7	95.7	51.1	34.2	91.7	75.0	50.0	36.1	124.2	32.6	83.3	59.2	61.6	54.6	49.0	66.5	38.2	21.3	32.2	63.7	70.8	49.1	44.5
RFK	"FLJ11149, RIFK"	ENSG00000135002	"Riboflavin kinase"	Q969G6	9	76385526-76394517	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 352.0;Pancreatic endocrine cells: 220.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023259, CAB033887, HPA057163"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357"	"unprognostic (1.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	11.6	20.6	18.0	14.6	18.4	25.0	11.7	12.6	21.1	11.7	12.5	30.8	33.1	12.8	18.2	12.9	13.6	19.9	16.3	20.6	27.2	27.0	29.2	12.4	11.6	16.9	18.4	11.7	16.4	23.8	12.0	13.2	27.0	13.0	22.9	14.7	11.0	9.9	14.9	5.1	28.2	11.9	14.2	10.2	29.0	16.7	21.6	12.0	19.7	18.7	11.2	13.9	5.9	13.5	21.9	23.2	13.9	18.1	20.5	20.3	41.8	25.2	18.6	17.8	13.9	8.2	13.3	35.3	28.7	18.2	32.3	22.9	19.3	16.5	35.3	10.4	18.0	11.2	30.4	26.2	36.7	37.9	25.6	13.5	29.3	21.4	23.2	19.9	58.3	30.4	30.6	28.7	36.1	20.8	49.3	13.3	18.1	51.2	22.7	26.7	18.3	8.9	82.0	10.6	35.0	12.7	26.9	37.2	22.9	18.1	9.4	20.2	35.9	18.5	33.3	40.1	35.6	30.7	32.3	12.4	30.7	33.3	25.9	5.2	9.8	3.6	5.0	19.9	7.5	5.8	7.3	6.0	11.8	4.4	7.0	6.7	1.4	8.5	21.1	4.3	7.4	9.8	18.0	18.4	12.6	21.1	20.6	27.2	16.9	18.4	27.0	14.2	21.6	13.5	27.3	16.0	9.2	5.9	22.9	45.4	23.8	15.3	22.2	50.4	24.5	20.6	37.9	34.3	20.1	42.3	20.9	54.1	18.4	158.8	60.7	64.9	191.7	37.8	18.5	46.2	28.2	48.8	18.0	189.3	352.0	33.5	33.1	42.3	12.0	18.0	124.2	40.9	33.2	11.8	19.3	23.1	40.7	57.6	26.6	118.1	22.1	29.9	30.2	10.3	25.2	44.7	9.2	7.1	6.5	220.6	68.3	65.1	12.7	33.6	79.9	142.8	27.7	28.7	0.0	23.0	21.7	91.8	64.1	18.8	40.5	123.5	23.1	18.8	33.7	22.6
RFTN2	"C2orf11, FLJ30574, Raftlin-2"	ENSG00000162944	"Raftlin family member 2"	Q52LD8	2	197568224-197676045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 70.9"	"Group enriched"	"Detected in many"	7	"Astrocytes: 152.8;Early spermatids: 125.0;Late spermatids: 351.7;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 320.6"	"Cancer enriched"	"Detected in many"	5	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.8;ASC diff: 15.5;ASC TERT1: 8.7;HSkMC: 10.7;TIME: 6.4;WM-115: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035232, HPA043190"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA035232: AB_10601495, HPA043190: "	"unprognostic (1.15e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.77e-2)"	10.8	4.7	30.0	1.9	48.9	0.3	3.2	39.2	32.6	4.4	3.7	1.8	0.7	4.6	1.2	2.5	2.2	4.4	3.4	28.3	29.4	2.0	1.0	2.4	2.5	42.5	36.6	9.9	1.9	0.6	0.7	6.2	49.5	1.7	1.9	4.3	3.3	1.6	1.5	2.3	1.3	3.3	40.2	1.9	1.5	3.0	33.7	0.8	1.9	5.8	1.5	2.7	2.4	70.9	0.2	0.0	19.8	0.4	15.5	8.7	0.7	0.2	1.3	0.0	1.1	0.3	0.4	0.4	0.5	1.8	0.4	0.6	0.0	0.0	0.0	0.8	0.1	0.1	1.0	0.0	2.2	0.3	0.3	10.7	0.4	0.1	0.0	0.1	2.3	0.6	0.0	0.2	0.4	0.9	0.1	0.1	0.8	0.8	0.6	0.1	0.5	0.2	0.0	0.2	0.5	0.2	0.0	0.0	3.0	3.4	0.1	0.0	6.4	1.7	0.3	0.1	0.3	0.5	1.1	0.2	1.6	0.0	9.6	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.1	0.1	0.0	30.0	48.9	39.2	32.6	28.3	29.4	42.5	36.6	49.5	40.2	33.7	70.9	14.8	0.0	0.6	152.8	0.2	2.4	0.2	0.1	0.0	1.3	1.3	1.4	2.2	2.8	0.1	0.0	0.0	0.2	0.5	0.1	0.0	1.0	125.0	0.9	9.7	13.0	0.0	0.0	1.2	0.0	0.1	16.3	0.0	0.4	0.0	8.6	19.6	0.3	0.4	3.3	1.5	0.0	0.0	0.6	3.3	351.7	15.8	0.7	16.0	32.8	0.0	23.5	0.0	198.5	320.6	0.1	0.0	22.2	1.6	0.3	0.0	0.1	0.2	1.5	6.6	16.2	8.3	4.5	2.8	0.5	2.3	0.0	0.6	3.3	0.0	0.1
RGL1	RGL	ENSG00000143344	"Ral guanine nucleotide dissociation stimulator like 1"	Q9NZL6	1	183636085-183928532	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Excitatory neurons: 176.1;Inhibitory neurons: 141.8;Kupffer cells: 109.1;Oligodendrocytes: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;HSkMC: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019788	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA019788: AB_1856215"	"unprognostic (3.08e-1)"	"unprognostic (5.25e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.49e-5)"	"prognostic favorable (4.32e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.88e-2)"	24.7	16.8	22.7	19.9	25.3	1.6	17.1	17.3	27.0	18.6	21.5	11.3	8.7	18.0	6.3	10.6	15.2	22.5	17.0	27.1	21.7	28.6	16.2	20.9	22.9	23.7	20.7	19.2	6.8	8.9	9.5	16.1	17.4	13.2	12.8	15.7	7.7	11.6	2.7	8.9	10.6	22.2	21.1	45.4	6.9	14.7	23.9	8.7	9.1	7.7	10.1	18.7	8.9	28.5	0.3	1.5	26.3	4.0	35.0	16.1	26.7	12.4	20.6	5.5	6.8	12.2	0.7	0.3	11.3	8.8	4.3	0.6	1.8	3.1	5.4	0.4	1.9	0.2	2.6	12.6	9.3	0.4	1.5	54.9	0.7	14.0	3.3	26.2	20.8	2.7	0.0	19.6	11.8	0.1	2.9	0.2	9.6	0.9	0.7	23.7	1.7	24.3	1.5	7.5	3.3	7.9	3.9	4.2	2.1	8.5	0.2	0.3	15.3	7.9	3.1	24.7	6.8	2.0	0.5	0.1	8.3	0.3	22.2	0.0	0.8	0.0	0.0	2.1	0.1	0.0	0.3	0.0	0.9	0.0	0.4	0.2	0.0	0.0	0.8	0.0	0.2	0.5	22.7	25.3	17.3	27.0	27.1	21.7	23.7	20.7	17.4	21.1	23.9	28.5	9.4	9.6	12.3	133.5	1.6	8.2	2.2	2.5	5.2	5.1	6.7	4.6	8.7	5.7	9.0	5.5	0.0	5.1	0.6	2.6	5.9	4.0	13.8	7.9	23.2	19.7	0.0	0.4	176.1	0.9	2.6	22.0	3.6	24.1	3.8	11.0	41.4	2.6	43.3	8.4	141.8	0.8	4.1	109.1	50.4	17.6	13.1	43.7	5.4	76.8	1.7	23.0	0.0	38.7	184.3	1.0	0.1	20.7	0.1	3.5	2.8	30.1	14.2	2.0	26.3	1.2	9.7	4.0	2.5	5.8	4.7	5.2	2.2	13.1	0.6	2.9
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 184.7;liver: 383.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Granulosa cells: 67.8;Hepatocytes: 175.7;Muller glia cells: 54.5;Peritubular cells: 69.6;Proximal tubular cells: 174.4"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 21.7;fHDF/TERT166: 6.9;Hep G2: 32.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103, HPA029104"	Enhanced		Approved	Cytosol		NA	NA		280000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: "	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	7.8	184.7	19.2	0.7	20.8	0.0	3.4	23.0	19.9	12.2	25.9	8.4	13.2	7.2	4.5	3.2	5.4	5.0	13.9	19.0	20.2	56.7	383.7	18.9	1.0	21.6	19.8	21.4	34.0	5.8	8.8	12.1	20.7	13.4	2.1	8.0	14.4	17.3	11.8	1.5	13.6	4.4	21.3	3.7	11.9	3.5	19.3	0.5	18.9	11.3	0.5	7.6	6.0	21.2	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.4	0.8	0.0	0.0	21.7	0.0	0.0	1.1	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	32.8	1.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	20.8	23.0	19.9	19.0	20.2	21.6	19.8	20.7	21.3	19.3	21.2	0.6	6.4	3.6	16.3	0.6	0.5	4.9	0.2	1.8	9.6	2.4	7.0	27.5	8.6	0.7	14.7	0.0	0.1	0.0	0.2	58.7	13.9	0.4	3.4	7.4	2.4	4.8	2.7	10.8	8.9	0.3	11.2	3.1	0.5	0.0	67.8	11.4	175.7	0.1	5.0	4.9	0.2	0.0	5.3	1.2	2.1	24.8	1.2	1.8	4.7	0.0	54.5	0.0	27.2	13.7	5.0	1.2	69.6	0.7	1.1	0.2	174.4	1.7	3.1	13.1	22.3	11.3	0.2	0.2	0.5	0.3	0.3	0.7	14.5	0.7	1.3
RGS1	"1R20, BL34, IER1, IR20"	ENSG00000090104	"Regulator of G protein signaling 1"	Q08116	1	192575763-192580024	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 1398.7;Hofbauer cells: 390.4;Langerhans cells: 1133.6;Macrophages: 860.4;Plasma cells: 902.4;T-cells: 748.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 25.7;T-reg: 21.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 25.7;T-cells: 21.9"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 962.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 85.5"	HPA074572	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA074572: "	"unprognostic (3.68e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.37e-1)"	"unprognostic (3.87e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.91e-5)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.56e-2)"	34.7	88.2	18.2	170.3	17.4	151.6	57.9	22.1	77.4	50.7	42.2	75.4	24.7	19.2	5.2	68.3	22.8	112.8	31.4	14.6	43.7	19.9	59.9	78.9	142.9	39.1	21.7	14.3	19.1	25.6	40.0	22.2	27.9	50.7	112.7	26.6	56.0	13.8	2.9	17.9	72.7	44.9	29.3	74.6	36.6	8.5	25.3	154.2	23.9	5.1	90.7	127.7	39.3	46.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	4.3	0.0	0.0	2.8	4.6	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	220.6	0.0	0.0	0.4	5.6	0.2	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	962.6	4.1	3.5	0.0	0.1	0.2	0.0	0.0	25.7	0.8	0.1	1.9	0.0	5.1	4.5	0.7	0.0	0.4	3.7	0.1	0.7	0.1	4.9	21.9	0.7	18.2	17.4	22.1	77.4	14.6	43.7	39.1	21.7	27.9	29.3	25.3	46.7	10.8	12.8	103.2	0.0	170.6	49.2	6.9	0.3	5.7	0.7	11.7	18.7	1.2	4.3	13.2	0.0	0.0	2.1	148.8	1.4	0.0	1.4	1.8	1.7	2.0	32.7	4.8	16.4	0.0	2.8	2.8	15.4	47.4	2.5	1398.7	0.0	5.3	3.8	390.4	0.0	0.0	1.6	0.0	211.2	1133.6	7.4	3.1	860.4	250.8	7.5	333.9	0.9	2.1	0.0	0.0	0.2	3.5	0.7	902.4	3.7	1.3	1.2	11.3	1.9	19.7	2.0	8.5	0.4	1.2	3.5	40.2	6.0	748.2	0.2	4.0	8.3
RGS11		ENSG00000076344	"Regulator of G protein signaling 11"	O94810	16	268301-275980	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.2;pituitary gland: 56.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;Bipolar cells: 69.7;Cone photoreceptor cells: 120.9;Excitatory neurons: 31.9;Inhibitory neurons: 33.6;Oligodendrocytes: 28.0;Rod photoreceptor cells: 67.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.1;ASC TERT1: 2.2;fHDF/TERT166: 2.0;HHSteC: 3.1;hTERT-RPE1: 2.4;SCLC-21H: 3.0;SH-SY5Y: 2.3;T-47d: 2.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041692, HPA043039"	Uncertain					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA041692: AB_2677619, HPA043039: AB_2678282"	"unprognostic (8.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.91e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-1)"	14.7	4.5	13.4	1.0	14.8	0.0	8.4	21.8	40.2	8.8	7.5	21.7	7.1	4.2	0.3	7.4	4.5	0.9	22.3	13.4	11.2	5.4	2.4	9.0	0.4	15.4	14.2	0.8	16.8	4.4	56.4	2.6	15.3	19.2	0.7	8.9	3.8	2.7	2.2	2.5	6.9	1.1	10.2	3.4	15.0	0.8	12.8	0.0	4.2	1.1	0.0	9.2	8.8	14.4	0.0	0.0	0.0	0.0	2.1	2.2	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.0	0.2	0.0	0.0	3.0	2.3	1.2	0.0	0.5	0.0	2.5	0.0	1.6	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	14.8	21.8	40.2	13.4	11.2	15.4	14.2	15.3	10.2	12.8	14.4	1.8	0.0	0.0	31.0	0.1	0.1	0.2	0.1	0.6	69.7	1.0	0.6	7.5	1.5	0.0	0.0	120.9	0.1	0.3	0.9	0.0	0.1	0.0	1.9	5.2	1.8	10.3	0.0	31.9	1.0	0.2	8.6	3.1	3.3	0.0	0.4	6.1	0.0	0.2	10.1	33.6	0.4	2.0	0.0	1.1	0.0	0.9	0.2	1.8	4.7	0.6	3.3	0.0	18.1	28.0	0.4	7.1	1.9	0.0	0.5	5.8	0.0	0.0	67.5	0.0	1.5	7.2	0.5	1.5	0.3	0.6	0.8	0.3	0.1	1.4	0.1
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Microglial cells: 57.1;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 109.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 73.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	10.3	8.9	11.2	13.6	20.9	11.9	11.5	12.2	13.6	11.6	1.8	11.5	10.3	13.6	12.5	11.5	12.9	10.9	10.3	8.8	15.2	12.0	15.1	9.9	16.1	15.6	15.0	13.6	13.9	16.5	4.4	9.9	17.1	13.1	11.2	7.4	9.6	13.3	8.9	8.8	11.8	14.3	15.7	14.2	11.4	17.4	16.8	37.5	15.6	8.6	16.9	11.5	7.0	22.8	10.7	9.3	9.9	15.1	28.6	28.8	0.0	24.1	20.9	12.6	14.6	8.3	18.7	10.1	19.8	25.2	18.0	11.9	0.1	26.8	23.9	25.1	9.9	15.3	5.9	6.7	31.5	15.2	8.0	25.6	38.2	23.8	51.4	14.3	9.8	26.7	41.7	25.6	13.4	18.9	27.8	8.5	0.0	12.2	10.3	12.0	0.1	14.9	10.3	13.3	9.7	7.3	13.6	5.1	18.8	17.6	14.1	18.9	13.1	5.6	12.2	22.0	7.5	28.8	14.9	73.9	17.8	19.6	16.2	10.4	13.7	12.8	7.3	20.0	11.8	22.1	11.0	8.9	17.2	24.5	12.6	10.6	3.3	11.8	13.8	21.1	16.2	10.8	11.2	20.9	12.2	13.6	8.8	15.2	15.6	15.0	17.1	15.7	16.8	22.8	6.6	12.8	6.4	66.9	28.4	5.2	8.5	7.2	8.0	8.0	7.6	4.2	16.6	4.3	8.1	11.0	16.7	7.6	9.3	6.6	3.9	7.0	16.7	8.3	8.6	6.8	1.8	15.2	28.4	9.3	4.1	9.3	8.2	7.8	8.2	22.7	3.3	14.0	5.2	11.8	41.5	6.1	6.1	8.2	4.4	24.4	5.6	7.6	12.4	57.1	6.2	6.3	9.2	55.8	109.0	8.3	1.9	6.8	48.8	13.2	6.8	3.4	7.1	6.3	0.0	5.6	6.6	15.2	9.5	7.3	5.5	5.6	8.6	25.7	5.7	8.9
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Horizontal cells: 334.8;Oligodendrocytes: 155.5;Syncytiotrophoblasts: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.8	13.9	5.6	4.1	6.6	0.9	7.1	5.2	7.8	15.7	5.3	8.1	6.6	14.5	2.4	3.0	10.9	11.5	13.5	4.6	4.7	30.8	6.8	10.6	2.8	6.1	6.1	10.2	9.2	8.6	3.2	37.1	6.3	7.7	4.8	24.3	2.1	9.9	144.2	3.6	5.6	12.1	4.9	14.9	20.8	15.1	7.6	1.9	3.3	19.6	1.2	7.4	7.5	7.8	0.2	12.0	17.8	0.0	8.3	7.3	0.0	5.3	4.8	4.3	6.4	0.6	0.2	0.0	21.9	28.0	2.0	0.3	5.3	1.6	5.0	0.0	4.8	1.1	8.8	67.3	9.0	1.4	0.4	10.6	3.0	2.6	2.7	16.5	20.6	3.8	10.2	0.0	19.1	0.4	5.2	0.0	7.7	0.2	7.9	4.5	24.9	6.4	14.1	0.7	4.9	19.0	6.3	6.9	6.9	11.1	1.4	2.4	18.5	8.2	21.1	0.2	5.9	0.0	0.0	0.0	4.1	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	5.6	6.6	5.2	7.8	4.6	4.7	6.1	6.1	6.3	4.9	7.6	7.8	13.7	16.0	8.7	3.6	1.0	1.8	1.0	0.5	0.6	3.4	3.7	2.5	29.5	1.5	2.3	1.8	135.5	66.1	0.2	0.7	1.9	3.8	75.2	11.0	14.7	13.6	8.3	3.8	74.3	16.0	3.4	8.6	34.1	4.5	0.0	59.0	17.9	9.6	11.3	334.8	23.1	7.7	4.1	21.5	1.4	35.3	8.1	14.1	1.8	57.1	0.4	16.0	0.0	14.1	155.5	16.4	2.5	4.9	0.1	1.2	1.5	36.4	10.2	25.1	6.6	16.7	11.8	2.8	1.4	0.6	1.4	302.4	0.8	15.2	4.3	0.4
RIPOR1	"FAM65A, FLJ13725"	ENSG00000039523	"RHO family interacting cell polarization regulator 1"	Q6ZS17	16	67518418-67546788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 49.2;Endothelial cells: 23.6;Hofbauer cells: 30.0;Pancreatic endocrine cells: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 11.2;eosinophil: 9.3;intermediate monocyte: 15.6;memory B-cell: 15.8;myeloid DC: 10.2;naive B-cell: 9.4;neutrophil: 6.6;non-classical monocyte: 15.1;plasmacytoid DC: 14.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005923	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Cytosol"		"HPA005923: AB_1078809"	"unprognostic (7.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.82e-8)"	"unprognostic (8.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.46e-2)"	44.4	28.1	27.6	23.4	30.6	27.2	37.7	26.4	38.6	39.9	7.5	36.0	8.8	45.2	6.0	18.5	36.2	21.5	53.6	33.6	16.3	67.6	16.7	55.8	20.8	26.6	17.1	33.2	30.1	20.6	26.5	29.8	25.4	30.6	7.4	43.8	22.8	20.2	34.9	21.4	32.7	25.2	12.3	61.2	25.9	18.6	21.5	10.8	36.4	22.3	17.5	37.1	30.4	18.6	44.0	36.6	16.1	25.3	40.0	35.7	35.7	45.7	44.9	51.6	43.0	75.7	31.5	6.0	62.4	78.8	26.0	24.4	32.7	41.3	33.2	19.3	17.0	57.9	53.6	17.4	44.7	4.6	28.0	35.5	18.8	69.7	47.1	36.8	55.2	10.2	6.5	6.4	38.7	47.7	13.8	14.4	4.4	8.5	29.1	46.8	29.0	31.2	39.0	22.1	12.1	31.9	85.1	13.8	28.6	15.9	30.2	10.7	96.8	58.3	34.2	49.8	32.2	9.0	6.8	17.8	38.8	11.1	31.7	0.1	11.2	9.3	1.2	15.6	1.8	15.8	1.0	0.5	10.2	9.4	0.7	0.7	6.6	1.7	15.1	14.4	0.8	6.0	27.6	30.6	26.4	38.6	33.6	16.3	26.6	17.1	25.4	12.3	21.5	18.6	49.2	16.0	16.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	12.1	8.8	0.0	0.0	1.8	7.3	0.0	0.8	3.7	0.0	0.0	15.8	0.0	9.3	17.9	23.6	0.0	0.0	0.0	12.5	1.3	6.9	0.0	18.5	10.1	7.9	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	37.0	0.0	0.0	2.3	0.0	0.0	5.8	2.2	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	2.1	2.3	16.6	0.0	0.0
RMND1	"bA351K16.3, C6orf96, FLJ20627, RMD1"	ENSG00000155906	"Required for meiotic nuclear division 1 homolog"	Q9NWS8	6	151404762-151452158	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031397, HPA031398, HPA031399"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156"	"unprognostic (1.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.04e-1)"	12.6	13.9	7.7	6.4	8.1	4.4	13.6	7.8	8.9	9.9	8.2	10.3	13.4	8.9	11.7	7.5	11.9	8.0	12.1	7.8	8.6	36.9	30.5	7.5	9.2	8.2	8.1	14.6	9.5	8.9	6.3	9.6	8.4	6.8	11.3	7.1	7.1	7.7	10.9	7.7	12.1	7.5	8.0	7.3	8.0	9.1	8.6	8.1	18.6	10.0	10.1	9.2	8.1	8.2	16.0	7.2	15.1	32.3	20.6	46.7	21.3	24.6	23.4	18.6	25.4	21.5	11.7	14.9	17.4	16.1	23.1	13.5	29.3	14.9	32.1	17.7	23.8	24.1	11.0	44.5	43.4	53.9	7.2	33.4	19.5	26.9	39.7	22.8	25.0	22.6	26.3	11.5	29.0	54.1	18.6	18.1	11.1	16.8	14.3	21.0	19.7	18.2	26.7	7.2	26.1	25.5	17.9	22.2	29.5	18.6	36.6	34.8	13.8	14.6	19.0	30.6	20.0	12.1	17.5	17.6	36.7	42.3	17.5	1.9	5.6	7.1	6.4	8.2	10.4	11.6	7.6	9.1	7.0	8.9	10.1	9.3	2.8	13.3	13.3	3.2	11.8	4.5	7.7	8.1	7.8	8.9	7.8	8.6	8.2	8.1	8.4	8.0	8.6	8.2	11.6	0.0	11.2	12.1	6.9	3.8	6.4	10.2	9.1	8.9	15.4	13.7	11.9	5.7	11.9	12.9	12.5	27.0	7.4	7.6	17.6	15.6	9.4	10.9	18.4	7.8	3.0	8.0	22.4	10.7	21.7	8.8	4.1	12.4	9.5	25.0	10.8	16.7	13.7	5.0	20.6	9.7	6.1	12.5	5.7	6.4	6.8	9.8	3.6	8.4	12.3	7.7	10.3	15.6	21.7	9.9	11.2	6.4	5.8	3.6	33.8	45.1	9.3	6.9	0.0	6.7	14.9	13.0	16.8	8.3	2.7	16.8	8.4	27.3	15.3	5.3
RNASE4	RAB1	ENSG00000258818	"Ribonuclease A family member 4"	P34096	14	20684560-20701216	"Plasma proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 478.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 67.3;Gastric mucus-secreting cells: 47.4;Hepatocytes: 55.8;Intestinal goblet cells: 110.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 92.6;ASC TERT1: 107.2;Hep G2: 136.9;HSkMC: 63.1;OE19: 92.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		61000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"				"unprognostic (1.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.18e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.27e-2)"	106.4	7.8	5.5	8.9	5.7	1.2	96.6	5.4	8.3	95.6	8.5	56.5	22.0	59.2	37.0	20.1	77.3	55.6	44.1	5.5	8.1	40.3	478.8	40.3	12.2	6.9	6.6	111.7	41.0	14.7	12.5	5.7	6.9	76.7	65.2	4.7	74.8	45.8	14.1	47.4	41.9	25.9	6.7	11.8	84.7	10.6	5.3	5.8	26.5	31.5	10.6	65.3	75.9	7.8	2.7	12.1	2.6	0.1	92.6	107.2	0.5	10.5	23.8	1.4	4.5	3.4	4.1	0.1	2.9	24.6	6.2	2.5	1.4	2.6	1.7	17.2	1.8	0.3	2.9	136.9	10.2	1.3	0.6	63.1	5.8	1.6	10.3	34.6	12.6	4.2	0.1	12.2	6.9	1.5	1.0	0.2	0.5	92.3	10.3	0.6	2.1	3.6	2.9	2.4	0.1	0.5	5.0	2.3	2.6	4.2	3.4	0.2	13.3	3.0	1.7	4.1	0.3	2.6	3.5	0.4	4.7	1.3	2.7	0.2	24.1	0.1	0.8	1.2	1.0	5.3	1.5	0.6	13.8	4.9	0.3	0.6	0.6	0.6	0.1	3.3	3.3	8.4	5.5	5.7	5.4	8.3	5.5	8.1	6.9	6.6	6.9	6.7	5.3	7.8	1.8	38.5	19.1	2.0	3.4	2.8	1.7	2.5	11.4	0.0	9.9	2.5	0.2	28.6	4.7	3.7	0.0	0.2	0.3	30.4	0.0	34.4	0.2	0.1	0.8	4.0	67.3	8.4	0.1	22.2	0.4	39.2	47.4	0.8	1.3	0.3	5.0	55.8	1.6	0.0	0.2	110.0	2.0	6.2	4.0	0.3	12.5	3.6	3.6	1.9	2.7	1.3	1.0	0.0	0.9	12.8	33.2	4.1	5.9	1.7	41.7	10.2	11.6	0.3	0.0	2.6	8.1	0.2	0.1	10.2	4.1	0.4	0.8	0.1	39.6	1.5
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812770-149962139	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 591.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 462.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	48.2	41.2	58.1	40.4	95.2	19.9	53.9	88.1	91.5	33.6	63.7	35.0	28.9	33.3	57.2	32.6	30.2	40.6	34.4	55.0	77.3	67.9	73.8	64.1	38.0	101.8	83.9	35.6	36.1	52.3	18.3	64.1	100.8	46.6	37.1	40.4	75.5	39.3	36.5	32.5	30.5	36.9	85.6	53.0	34.3	25.2	75.9	32.0	64.0	42.6	33.2	42.3	28.9	131.0	60.6	39.4	24.4	29.0	92.2	55.2	40.3	32.2	86.2	32.3	47.4	33.4	84.4	26.6	48.7	42.0	58.7	58.0	37.5	41.5	42.9	34.1	24.6	35.8	17.3	31.2	61.5	35.0	41.8	59.9	73.1	26.5	71.8	37.3	37.0	24.9	10.1	49.7	28.0	34.5	26.2	18.8	16.8	58.6	29.1	19.0	26.7	108.5	54.2	29.6	12.6	37.6	28.5	39.9	110.3	19.2	79.2	34.0	37.8	40.8	16.5	45.6	23.4	89.9	61.9	51.5	35.9	30.1	23.6	98.2	130.1	106.5	37.4	153.8	48.8	51.9	41.5	44.8	93.1	48.4	38.0	42.4	462.3	46.3	207.8	68.3	48.7	104.5	58.1	95.2	88.1	91.5	55.0	77.3	101.8	83.9	100.8	85.6	75.9	131.0	100.9	109.0	72.3	78.7	55.3	73.5	68.2	84.3	74.0	44.5	54.5	51.1	27.3	48.6	68.1	47.8	29.2	101.2	61.9	30.2	43.0	63.0	2.5	32.5	34.5	69.4	20.3	32.4	122.1	70.6	83.5	84.8	31.6	39.7	60.8	14.6	80.3	53.7	201.2	21.9	98.8	27.7	67.1	183.9	173.7	6.7	76.1	177.6	103.2	92.8	93.5	98.5	38.1	115.6	591.2	58.7	33.6	88.0	62.4	71.9	38.5	71.5	40.4	37.2	92.1	76.3	55.5	23.6	32.5	52.3	72.5	52.5	49.8	38.2	27.7	55.8
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337309	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.73e-4)"	14.3	15.8	12.7	11.5	12.6	22.0	13.3	13.7	15.1	15.4	10.6	19.2	14.5	23.5	10.3	20.9	16.6	10.5	13.2	12.7	12.5	13.6	23.6	12.4	11.8	15.2	13.1	17.1	13.8	18.5	10.4	14.2	15.5	14.8	12.6	8.4	14.9	18.6	8.5	15.7	17.0	19.0	12.7	14.6	19.1	15.1	14.7	13.3	13.2	7.1	12.8	18.9	14.2	13.1	43.8	47.4	43.4	51.4	41.8	32.8	46.0	46.3	49.7	52.8	41.5	80.6	88.9	38.3	62.5	55.5	80.1	77.2	61.9	69.8	33.0	46.0	34.2	101.0	21.8	67.3	31.9	42.8	40.4	34.3	35.2	66.1	59.0	34.7	40.8	58.1	50.0	58.4	36.9	94.9	39.5	44.3	43.5	50.2	59.8	40.5	44.5	30.4	32.7	31.1	30.8	29.9	37.4	46.8	12.5	41.4	106.1	35.4	27.0	63.5	41.8	33.7	43.0	14.0	24.6	0.4	21.3	71.0	50.6	9.5	21.6	5.6	20.8	19.2	13.4	11.1	15.7	18.4	19.0	16.7	17.5	15.5	1.5	14.0	20.2	11.0	8.7	24.9	12.7	12.6	13.7	15.1	12.7	12.5	15.2	13.1	15.5	12.7	14.7	13.1	5.1	3.2	9.4	1.0	9.1	6.9	13.3	15.4	12.5	9.2	10.9	9.8	0.8	22.8	11.1	11.0	2.1	44.0	6.2	9.3	5.9	20.8	6.6	5.9	7.9	8.6	13.8	18.5	3.2	17.0	66.0	11.5	9.2	5.9	7.6	16.9	11.4	23.4	21.5	5.0	2.9	13.0	8.2	14.8	5.9	8.6	14.0	6.6	1.8	1.0	11.6	11.6	15.5	4.5	2.7	14.1	7.5	17.7	4.3	14.2	15.6	12.5	4.8	9.4	6.6	6.5	10.6	19.9	10.5	14.3	8.5	24.4	8.3	8.8	18.6	9.8
ROBO3	"FLJ21044, HGPPS, HGPS, RBIG1"	ENSG00000154134	"Roundabout guidance receptor 3"	Q96MS0	11	124865432-124881471	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 6.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.3;Muller glia cells: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 5.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"AF22: 18.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Low region specificity"	"Detected in many"			HPA071053			Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Vesicles	"HPA071053: "	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.95e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.75e-8)"	"unprognostic (7.27e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-3)"	2.8	1.8	0.5	0.0	0.3	0.2	1.9	0.0	3.2	0.7	0.0	1.3	0.3	0.8	0.0	0.7	2.0	0.0	1.8	0.7	0.2	1.6	0.4	1.1	0.1	0.9	0.9	6.4	0.7	0.0	0.8	0.2	0.2	1.4	0.0	0.2	1.2	0.0	0.5	0.7	0.9	0.8	0.2	1.6	0.6	1.2	1.7	0.0	1.4	0.0	0.0	0.7	1.2	0.9	0.0	0.0	18.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.1	0.0	0.0	1.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.6	0.9	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.0	3.2	0.7	0.2	0.9	0.9	0.2	0.2	1.7	0.9	13.2	0.0	7.3	32.3	0.4	2.9	14.5	16.2	4.0	1.9	5.9	10.9	2.7	1.5	5.9	12.9	0.0	0.2	8.5	2.1	0.0	9.3	0.4	0.4	0.5	11.4	3.5	2.1	6.9	0.8	0.2	19.0	0.5	0.7	8.9	19.0	7.5	0.3	1.6	0.0	2.3	2.4	10.2	1.6	20.1	0.6	13.4	8.0	3.6	11.2	1.6	45.3	8.2	4.5	9.2	1.2	2.5	8.2	0.7	8.2	1.0	0.8	0.6	2.1	0.0	14.3	4.4	10.1	10.8	2.3	1.0	0.1	3.6	3.5	2.7	6.5
ROGDI	FLJ22386	ENSG00000067836	"Rogdi atypical leucine zipper"	Q9GZN7	16	4796968-4802880	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amelogenesis imperfecta, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 105.6"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 179.2;Rod photoreceptor cells: 149.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 74.6;intermediate monocyte: 62.7;myeloid DC: 61.5;non-classical monocyte: 61.8;plasmacytoid DC: 34.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 61.5;monocytes: 74.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041000	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA041000: AB_10794077"	"unprognostic (1.74e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.79e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.71e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.71e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.08e-2)"	7.5	24.1	82.9	11.6	84.5	78.0	7.3	81.3	105.6	8.8	64.3	17.6	24.8	7.5	6.6	18.1	14.5	14.4	44.2	91.4	83.9	19.3	19.7	15.5	8.6	84.0	84.9	5.9	22.9	26.4	18.2	7.9	80.9	19.0	7.6	61.9	25.3	16.6	63.1	6.5	21.4	11.3	79.4	15.6	21.1	8.2	96.8	10.1	4.6	32.9	8.7	11.2	6.4	97.6	13.5	18.8	9.5	42.4	12.2	6.2	36.4	9.4	4.6	8.2	3.6	12.5	15.3	5.9	15.1	19.9	5.3	26.7	9.9	28.7	3.2	4.8	13.3	8.0	28.9	28.1	19.8	10.4	6.5	8.3	11.7	12.4	8.3	21.6	14.5	11.5	5.7	3.5	14.1	74.9	9.4	51.0	15.3	15.4	14.2	30.1	26.1	30.1	19.8	18.1	55.3	24.5	38.6	42.4	9.9	11.9	50.9	40.8	22.3	7.3	17.0	52.5	6.5	14.2	17.0	5.2	8.6	40.0	6.5	10.5	74.6	8.1	2.1	62.7	6.6	2.5	5.4	4.9	61.5	2.8	4.7	5.5	6.7	6.7	61.8	34.5	6.1	38.0	82.9	84.5	81.3	105.6	91.4	83.9	84.0	84.9	80.9	79.4	96.8	97.6	7.0	19.2	7.8	17.3	6.7	5.1	28.0	84.4	32.5	179.2	23.0	22.5	58.1	21.5	36.7	27.6	110.5	46.9	11.5	23.4	39.2	22.2	30.3	17.6	8.5	12.0	52.0	38.7	33.2	16.0	73.4	15.9	11.7	7.2	5.7	9.8	24.3	19.7	64.8	25.2	19.2	29.7	69.2	28.7	29.0	57.0	6.8	31.0	12.4	10.3	77.0	102.5	6.2	7.5	90.2	13.5	23.7	19.2	4.6	12.7	65.7	80.8	21.3	149.7	6.6	8.2	15.3	6.5	20.7	24.8	5.8	30.6	9.5	64.7	23.1	22.3
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774017-64181498	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 26.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Astrocytes: 81.0;Inhibitory neurons: 69.7;Microglial cells: 36.5;Oligodendrocytes: 109.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 40.5;ASC TERT1: 50.3;CACO-2: 36.8;HHSteC: 38.3;HSkMC: 41.6;NTERA-2: 43.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		7700000	"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	4.4	1.1	0.6	2.2	1.4	0.4	3.7	3.0	0.8	7.5	4.6	4.5	2.2	7.1	1.4	5.2	2.5	5.2	7.5	0.7	0.6	2.3	0.5	7.0	1.2	0.7	0.9	8.3	5.5	26.9	0.5	3.1	0.5	5.4	4.0	1.5	1.2	6.4	2.3	2.3	1.7	7.7	0.3	3.2	6.4	1.5	1.2	2.5	1.4	1.6	1.1	4.2	2.3	1.1	15.5	12.2	5.9	0.8	40.5	50.3	4.0	2.9	8.3	1.6	4.3	36.8	4.9	0.3	6.6	7.2	2.9	3.2	0.1	2.9	1.1	0.0	3.7	0.0	1.6	0.5	38.3	0.0	0.0	41.6	10.9	21.7	25.2	8.4	0.7	0.5	0.0	0.3	11.0	0.2	0.2	0.1	43.0	11.3	6.1	0.2	0.2	9.8	8.7	0.3	3.4	13.6	0.8	0.2	6.4	19.9	0.1	0.0	8.4	3.3	5.7	23.0	6.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.6	1.4	3.0	0.8	0.7	0.6	0.7	0.9	0.5	0.3	1.2	1.1	1.1	51.3	10.5	81.0	1.8	3.8	2.2	0.5	29.0	4.7	3.0	2.0	11.4	1.5	1.3	1.8	0.0	0.2	0.1	1.3	0.0	5.6	9.6	1.2	9.2	1.8	21.5	0.0	11.6	15.2	1.0	14.5	16.8	1.9	0.0	1.1	0.7	0.0	7.6	0.0	69.7	2.2	2.0	0.6	4.9	8.1	27.7	0.5	3.6	36.5	0.0	5.3	0.0	3.5	109.9	15.3	0.8	14.7	0.1	1.4	0.0	3.4	0.8	0.3	6.6	6.8	8.5	1.4	1.8	11.5	4.5	0.3	0.2	0.3	3.3	0.8
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	"Receptor tyrosine kinase like orphan receptor 2"	Q01974	9	91563091-91950228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.4;Endometrial stromal cells: 19.3;Fibroblasts: 14.4;Inhibitory neurons: 18.6;Microglial cells: 15.9;Oligodendrocyte precursor cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 24.5;HHSteC: 63.1;HSkMC: 52.2;U-266/70: 38.3;U-266/84: 27.5"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"cerebellum: 7.2;spinal cord: 3.7"	HPA021868	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA021868: AB_1856406"	"unprognostic (9.38e-3)"	"unprognostic (4.69e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (2.16e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (1.25e-2)"	6.9	5.7	0.8	3.9	0.6	0.1	4.4	0.4	0.5	18.7	28.2	32.7	2.2	23.7	1.5	8.2	11.6	8.6	11.1	1.4	0.8	1.4	0.5	5.5	0.5	1.7	2.1	13.9	1.6	16.6	1.6	3.5	0.9	13.9	2.2	1.0	1.6	13.3	0.3	4.2	7.7	11.0	1.2	3.3	12.8	3.4	1.2	3.0	5.6	0.7	1.0	17.5	10.6	0.7	0.0	0.2	24.5	0.0	5.3	0.5	6.8	0.4	6.3	4.0	7.8	0.0	0.0	0.0	0.1	0.8	3.9	0.2	5.2	0.0	1.7	0.0	4.2	0.0	18.3	0.0	63.1	0.0	0.0	52.2	0.0	5.6	0.0	0.0	0.0	0.2	14.7	0.0	0.0	0.4	0.1	3.6	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	7.2	0.6	0.0	0.0	5.0	14.8	0.0	0.0	0.0	4.8	2.0	0.0	38.3	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.5	1.4	0.8	1.7	2.1	0.9	1.2	1.2	0.7	0.3	0.0	0.0	1.6	0.1	3.1	11.3	0.9	1.2	1.4	3.7	3.0	8.2	1.5	0.2	0.0	0.0	0.4	0.0	0.5	0.0	2.5	4.5	18.4	19.3	1.4	3.0	0.0	1.4	1.5	0.2	14.4	2.6	7.5	1.3	0.1	0.4	0.0	0.8	0.0	18.6	2.8	0.0	0.0	4.8	8.6	5.9	0.4	5.4	15.9	1.6	7.4	0.0	27.6	0.4	0.6	1.6	9.1	0.1	8.6	0.0	0.0	0.2	0.5	6.6	0.0	2.9	2.3	14.3	0.1	2.3	0.4	0.7	0.4	0.8	5.3
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.3;Spermatogonia: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	28.4	25.0	33.3	39.7	35.1	40.7	43.8	33.4	42.4	32.0	37.4	26.6	18.5	33.7	43.4	32.3	49.1	30.6	39.2	34.5	36.1	32.4	31.8	28.7	75.1	33.7	33.2	52.0	21.0	40.7	31.3	30.2	33.9	28.7	30.2	43.8	24.0	31.3	72.3	40.3	26.1	30.7	36.7	42.3	25.6	63.7	34.0	53.4	52.9	63.2	67.6	30.3	24.9	36.7	60.9	57.4	86.4	68.5	59.3	52.8	57.2	106.1	70.3	130.0	113.5	80.2	72.7	148.9	69.4	41.1	48.4	55.8	126.5	60.3	122.4	121.0	126.0	174.3	73.0	71.3	30.9	229.7	115.1	24.6	33.2	123.8	62.3	40.3	59.1	133.1	196.2	127.1	75.7	63.6	163.9	105.1	181.7	115.1	122.0	115.0	128.7	74.2	49.1	65.2	78.3	75.8	123.3	47.3	100.7	68.1	50.9	71.8	36.6	32.2	73.0	186.2	76.3	105.8	251.0	135.8	81.4	213.5	64.3	322.3	97.4	290.0	279.7	80.0	304.4	272.5	252.9	257.4	112.1	232.0	287.4	282.7	100.1	294.1	106.5	172.3	255.5	435.5	33.3	35.1	33.4	42.4	34.5	36.1	33.7	33.2	33.9	36.7	34.0	36.7	26.5	22.4	15.7	10.4	64.0	21.0	28.5	47.1	16.5	28.4	25.7	27.8	29.0	24.3	30.4	22.0	2.1	95.2	77.8	10.1	35.2	35.0	49.0	14.6	18.8	27.9	13.8	39.1	8.8	20.6	67.3	34.8	7.1	15.1	60.9	33.3	26.4	16.6	51.9	8.4	8.4	14.0	71.2	31.5	27.6	22.6	41.3	34.1	37.4	7.5	86.7	100.0	95.8	9.5	14.3	29.5	10.4	46.3	32.6	19.3	11.2	23.6	28.8	34.5	32.9	48.0	24.7	162.3	183.5	20.6	22.4	55.7	59.9	33.9	19.3	20.1
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619969-128681075	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 424.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		730000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	97.9	88.3	56.7	94.5	65.5	97.1	105.5	69.0	63.3	142.0	96.2	124.0	97.1	92.0	352.4	76.6	124.8	90.5	82.6	56.1	71.4	119.5	226.3	112.7	76.8	72.7	65.8	80.8	118.8	143.8	83.7	139.8	69.4	100.2	134.3	46.9	120.4	113.9	89.2	63.5	94.5	111.6	66.7	85.2	115.0	90.9	68.1	86.0	177.7	77.7	102.4	117.2	64.0	77.9	358.5	190.9	156.2	289.8	412.7	273.1	351.3	300.0	393.2	391.4	452.1	399.4	328.2	221.9	274.8	437.3	363.2	349.7	255.4	268.2	374.7	158.8	160.3	392.7	127.9	332.3	454.3	322.5	198.2	229.5	307.3	258.4	377.5	260.9	308.6	164.2	164.2	289.6	260.4	327.8	179.7	353.0	198.1	476.6	170.2	193.6	209.4	540.6	272.7	212.0	238.6	137.4	246.3	253.6	313.6	199.0	271.0	329.0	203.2	200.9	154.7	297.0	226.9	306.1	259.9	234.4	329.4	235.9	296.9	178.0	171.6	137.6	129.3	147.0	154.7	91.5	104.7	117.7	159.5	60.7	63.8	99.3	233.2	90.3	159.3	192.4	114.2	250.8	56.7	65.5	69.0	63.3	56.1	71.4	72.7	65.8	69.4	66.7	68.1	77.9	82.9	60.9	74.1	13.1	72.4	49.5	83.6	102.8	55.2	13.0	53.7	26.9	42.4	51.5	91.6	112.2	8.4	113.7	59.1	126.0	15.6	111.5	19.1	85.3	73.9	72.4	43.3	63.5	11.7	93.3	199.1	91.7	113.2	126.8	43.7	40.2	96.0	180.0	135.7	20.2	16.3	158.4	73.2	154.1	70.8	29.5	94.1	87.6	58.7	11.2	77.0	30.3	39.1	18.1	21.3	104.0	83.1	64.3	424.1	93.3	109.1	90.7	110.2	13.2	46.0	43.9	53.7	65.9	62.6	67.0	53.4	156.7	65.8	54.0	130.2	78.9
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 497.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 588.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 37.8;plasmacytoid DC: 44.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		320000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.38e-4)"	64.2	72.3	27.0	62.8	41.9	28.1	54.6	41.1	32.2	69.1	52.3	98.3	76.1	59.5	55.0	67.8	45.1	71.5	59.1	27.5	35.3	77.4	219.0	80.2	28.2	49.3	42.2	48.3	497.7	72.4	63.4	107.9	45.5	66.5	65.9	17.7	228.2	63.4	21.9	43.6	82.7	46.0	37.7	57.7	123.1	48.4	40.9	14.4	130.4	14.7	27.0	57.6	55.2	49.2	173.5	121.0	35.7	80.4	160.3	172.2	186.2	264.3	221.3	110.0	148.2	271.2	159.3	66.5	87.3	252.2	113.4	170.4	38.7	215.4	89.1	30.9	29.7	76.2	34.9	283.6	229.4	29.0	93.0	228.9	63.8	178.7	104.3	161.7	109.7	23.4	32.6	62.9	167.6	78.8	11.4	65.5	41.6	383.3	115.8	20.1	94.2	231.3	93.0	58.4	18.2	13.7	151.1	353.2	108.4	75.0	62.0	43.5	198.7	232.7	85.9	122.1	88.5	114.6	93.6	21.6	88.1	30.7	121.1	11.7	8.4	37.8	4.3	5.5	3.2	1.0	1.4	2.6	4.6	1.4	1.4	1.6	7.8	10.7	8.4	44.4	1.5	3.1	27.0	41.9	41.1	32.2	27.5	35.3	49.3	42.2	45.5	37.7	40.9	49.2	146.8	96.1	197.1	15.0	72.5	59.1	92.3	90.3	55.2	21.9	127.0	76.3	46.4	144.4	158.2	95.6	31.3	262.0	180.6	588.9	45.0	199.7	47.2	117.5	228.4	155.8	97.0	31.6	3.0	414.6	235.8	219.7	294.6	322.8	118.9	78.1	118.9	279.9	117.4	25.2	4.9	507.9	50.8	62.0	85.7	44.3	127.1	91.6	71.2	17.8	75.1	144.3	79.3	23.1	27.6	357.7	452.3	83.1	570.6	145.6	221.6	57.2	121.8	35.5	32.9	165.1	169.8	77.5	139.9	73.2	55.8	532.9	56.9	114.6	329.3	218.5
RSF1	"HBXAP, p325, RSF-1, XAP8"	ENSG00000048649	"Remodeling and spacing factor 1"	Q96T23	11	77659996-77821017	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022626, HPA046129, HPA057547, HPA064567"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289"	"unprognostic (2.67e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.00e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.19e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	12.5	17.9	10.8	16.5	12.9	25.7	15.4	43.9	13.7	17.1	1.5	12.8	9.4	20.0	8.9	14.1	14.5	16.6	14.0	8.7	15.4	14.3	11.7	13.2	15.3	8.3	8.5	26.3	16.9	17.3	6.5	18.5	8.5	15.4	12.6	25.9	10.2	13.4	11.7	9.3	10.8	17.5	8.0	16.3	13.5	23.8	12.0	22.6	22.3	13.4	13.5	17.0	8.4	15.5	27.7	18.2	62.0	33.3	20.6	25.9	23.3	31.7	31.0	25.5	31.4	48.0	37.5	46.7	33.2	22.3	39.4	28.1	36.8	23.8	47.7	33.4	16.3	43.9	25.1	13.0	19.6	42.2	30.0	21.8	17.5	35.0	55.8	29.7	32.7	15.2	72.8	43.0	29.7	18.7	29.7	23.4	36.1	32.9	24.8	49.1	107.5	30.6	13.5	35.5	37.3	37.6	48.8	19.1	18.5	32.2	34.3	20.6	41.2	45.0	38.8	71.0	23.1	25.7	35.7	106.3	11.9	28.1	34.5	49.3	17.8	32.8	27.4	16.9	18.8	34.3	16.6	17.6	14.2	35.0	22.7	22.9	46.4	23.7	30.1	32.0	17.0	7.5	10.8	12.9	43.9	13.7	8.7	15.4	8.3	8.5	8.5	8.0	12.0	15.5	100.3	118.6	113.5	99.6	98.0	90.5	69.3	89.7	93.9	123.0	68.8	85.1	97.1	54.3	84.3	73.5	75.0	57.8	85.1	53.0	46.9	79.2	112.4	72.9	95.2	96.5	85.6	71.8	129.4	55.3	50.6	90.5	51.0	86.0	95.5	132.5	79.9	46.2	45.6	146.4	129.3	64.7	71.2	62.9	68.5	40.3	126.8	66.5	56.9	98.4	93.9	124.6	120.5	157.8	144.7	73.1	63.4	118.1	74.8	97.6	44.1	38.2	69.7	97.6	105.2	99.3	100.4	114.8	109.4	57.2	84.0	67.5	99.9	141.7	58.1	91.6
RSRC1	"BM-011, MGC12197, SFRS21, SRrp53"	ENSG00000174891	"Arginine and serine rich coiled-coil 1"	Q96IZ7	3	158105855-158545730	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044792	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA044792: AB_10794502"	"unprognostic (1.06e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (7.40e-5)"	"unprognostic (5.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.84e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.48e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.15e-1)"	18.5	17.1	13.2	11.8	12.0	15.1	16.4	16.9	17.2	16.0	6.2	14.8	8.7	14.2	11.6	12.7	10.7	10.2	16.0	8.0	12.7	15.9	16.5	10.6	13.7	14.5	15.5	12.8	15.6	15.6	11.6	11.8	12.6	13.1	13.5	18.7	13.5	12.3	19.3	12.9	10.2	13.8	11.0	11.8	12.1	11.3	17.6	13.2	17.0	11.0	14.2	13.6	13.4	13.8	73.6	37.3	24.1	32.1	60.7	41.4	34.1	36.2	29.3	37.8	41.5	51.8	56.8	68.6	66.9	42.9	47.2	32.8	48.4	31.8	58.3	107.6	40.4	71.0	30.4	41.3	9.3	61.5	43.2	32.3	30.0	32.4	29.1	43.4	17.7	38.8	45.4	50.2	31.6	63.7	43.2	41.5	21.4	44.3	33.4	54.7	45.4	86.1	29.5	23.8	47.4	51.7	40.7	26.6	44.6	27.1	59.2	51.7	20.3	52.6	31.6	63.3	69.4	41.0	51.0	72.6	48.5	79.5	61.2	40.4	36.3	20.3	25.1	38.6	25.9	49.5	25.6	24.3	22.0	45.5	23.9	25.7	25.4	17.7	37.2	62.3	22.4	12.9	13.2	12.0	16.9	17.2	8.0	12.7	14.5	15.5	12.6	11.0	17.6	13.8	36.0	32.1	23.1	51.6	51.1	37.3	36.1	32.3	15.4	78.1	39.4	28.7	44.9	45.8	27.0	82.8	33.3	37.5	41.1	33.2	74.3	52.6	49.9	32.8	48.4	35.5	33.0	68.8	71.3	60.5	52.8	47.5	26.0	29.9	76.5	44.0	32.2	74.5	38.3	63.9	82.4	54.9	40.7	45.6	67.6	11.0	46.3	42.4	44.4	80.6	50.0	52.2	44.3	46.3	142.2	45.8	34.2	35.7	35.4	27.7	21.8	67.8	29.7	95.6	19.7	34.8	49.5	39.5	40.4	27.4	27.4	29.6	37.4	39.8	35.9	29.3
RUBCNL	"C13orf18, FLJ21562, KIAA0226L, PACER"	ENSG00000102445	"Rubicon like autophagy enhancer"	Q9H714	13	46334681-46438190	"Predicted intracellular proteins"	"Autophagy, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 6.1;B-cells: 20.7;Endometrial stromal cells: 6.7;Hofbauer cells: 16.7;Macrophages: 5.2"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"memory B-cell: 161.2;naive B-cell: 155.8;neutrophil: 124.0;plasmacytoid DC: 106.2"	"Group enriched"	"Detected in many"	15	"B-cells: 161.2;dendritic cells: 106.2;granulocytes: 124.0"	"Group enriched"	"Detected in some"	4	"Daudi: 179.1;U-698: 341.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favorable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"	4.2	1.3	3.7	18.0	3.8	14.8	4.0	3.5	4.1	6.6	2.5	11.9	3.0	3.7	1.2	1.0	3.7	4.0	1.0	3.4	6.8	1.1	2.2	5.2	41.2	6.2	4.8	0.6	0.7	0.3	2.0	4.2	6.1	1.5	16.2	3.9	3.0	2.6	10.1	2.0	13.2	3.6	4.9	20.3	2.2	15.7	6.3	22.9	1.9	1.4	40.6	7.5	1.3	5.9	0.5	0.1	3.6	0.2	0.1	0.2	0.3	0.0	0.2	0.2	0.1	7.5	0.2	179.1	1.8	0.0	0.9	0.2	0.1	0.0	0.1	0.7	0.3	0.2	0.2	0.1	0.0	0.2	0.2	4.7	0.0	0.6	0.9	0.0	0.0	8.2	0.3	0.4	0.0	0.1	1.9	1.4	1.5	0.0	1.4	62.6	0.1	6.1	0.0	0.1	3.4	0.1	0.2	0.3	4.4	10.8	0.2	53.0	0.1	0.2	1.6	0.3	0.4	0.9	37.3	341.2	1.1	0.3	0.2	0.5	4.5	0.1	0.1	8.9	0.1	161.2	0.3	0.1	5.1	155.8	0.1	0.1	124.0	3.5	7.1	106.2	0.2	7.5	3.7	3.8	3.5	4.1	3.4	6.8	6.2	4.8	6.1	4.9	6.3	5.9	0.2	3.2	6.1	0.0	20.7	0.0	0.0	0.0	0.0	0.0	2.9	3.9	0.0	0.0	2.5	0.0	0.0	0.3	0.3	0.0	0.0	1.4	0.0	1.3	6.7	0.4	0.0	0.0	0.0	1.2	0.4	1.1	0.0	2.5	2.5	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
RUFY4	"FLJ46536, ZFYVE31"	ENSG00000188282	"RUN and FYVE domain containing 4"	Q6ZNE9	2	218034960-218090581	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;lymphoid tissue: 2.2"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 9.5;Langerhans cells: 4.0;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"Karpas-707: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037980	Uncertain					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA037980: AB_10672501"	"unprognostic (1.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.39e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.41e-14)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.43e-5)"	0.1	0.2	0.5	0.9	0.6	0.8	0.1	0.4	1.8	0.1	0.4	0.2	0.7	0.0	0.0	0.4	0.2	0.5	0.0	0.9	0.4	0.1	0.2	0.4	1.1	0.4	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.1	0.5	0.1	0.5	0.1	0.0	0.3	0.7	0.0	0.5	2.2	0.6	0.1	0.4	1.7	0.1	0.0	0.8	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.4	1.8	0.9	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.0	0.0	0.0	2.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	9.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.3	4.0	0.3	0.0	0.9	0.0	1.0	2.0	0.0	0.0	13.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3
RUNX1T1	"AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2"	ENSG00000079102	"RUNX1 partner transcriptional co-repressor 1"	Q06455	8	91954967-92103286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 93.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 142.1;Excitatory neurons: 196.9;Hepatic stellate cells: 124.2;Inhibitory neurons: 326.3;Oligodendrocyte precursor cells: 262.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 93.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.6;fHDF/TERT166: 16.5;HEL: 35.9;HSkMC: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049852, HPA070951"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA049852: AB_2680914, HPA070951: AB_2686326"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-4)"	"unprognostic (2.29e-4)"	"unprognostic (5.56e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-4)"	"unprognostic (8.98e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.80e-3)"	7.0	2.8	9.4	2.1	13.2	0.2	5.1	93.1	8.7	8.4	0.0	6.5	1.2	7.4	3.6	2.5	4.7	5.0	8.2	13.1	2.3	1.4	0.6	3.8	1.3	1.4	12.8	4.7	1.0	1.0	3.0	5.8	4.6	2.5	2.4	5.2	3.1	2.4	3.9	2.4	2.5	6.5	4.2	1.9	2.7	3.6	3.6	0.5	3.7	4.8	1.1	3.8	3.9	1.2	0.0	0.0	0.4	1.9	5.0	7.2	0.0	7.6	11.6	5.0	7.6	0.0	0.0	19.6	0.0	16.5	0.0	0.0	4.0	0.5	3.3	0.0	3.2	35.9	0.0	0.0	1.9	0.0	0.0	13.6	0.0	8.4	0.4	0.0	10.8	0.0	0.1	0.0	1.3	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.1	6.0	0.0	0.0	0.0	7.8	0.0	0.0	1.2	0.4	0.0	0.9	0.0	3.8	0.0	6.3	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	13.2	93.1	8.7	13.1	2.3	1.4	12.8	4.6	4.2	3.6	1.2	44.9	0.0	1.1	90.8	0.1	6.2	0.2	0.0	0.6	142.1	1.2	5.1	46.0	0.0	0.6	0.0	16.7	1.1	0.5	0.2	1.9	0.0	2.6	1.1	65.8	64.3	47.7	2.7	196.9	0.2	0.3	77.7	0.5	1.1	1.3	2.1	124.2	1.5	1.9	35.3	326.3	0.6	0.0	4.1	9.4	7.5	96.3	1.2	10.6	103.0	0.0	3.9	0.0	262.4	17.3	0.2	0.0	98.9	0.0	0.3	0.0	0.1	0.0	7.2	65.7	24.4	43.1	3.3	16.8	0.9	4.8	1.1	1.1	20.7	0.0	0.1
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"RUNX family transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.8;Early spermatids: 128.3;Inhibitory neurons: 95.2;Microglial cells: 128.4;Plasma cells: 44.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 22.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 39.3;Karpas-707: 62.3;RH-30: 51.8;U-698: 55.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	1.7	0.7	1.1	4.3	1.0	9.7	2.8	1.2	1.4	6.7	0.9	3.7	2.0	1.5	0.8	1.4	0.9	3.4	0.7	1.3	1.5	1.5	0.7	2.7	4.5	1.9	1.8	2.2	0.6	0.6	1.6	1.5	1.9	4.8	3.9	0.1	10.7	2.6	0.8	2.4	6.0	1.6	1.6	3.6	3.2	0.5	2.0	4.5	1.8	0.9	5.6	3.6	4.9	1.9	3.6	1.1	0.8	0.0	3.2	8.3	0.0	3.3	7.9	10.9	15.2	0.0	1.9	0.0	3.8	4.7	4.9	4.3	0.0	3.1	19.7	13.7	1.5	0.0	2.4	0.0	16.7	14.2	0.1	22.5	2.5	9.7	10.9	39.3	0.2	5.6	0.0	62.3	19.7	1.0	0.4	24.7	0.7	3.2	0.5	0.1	51.8	0.0	10.7	7.0	0.0	0.0	2.4	0.1	4.1	9.2	3.6	1.2	0.5	11.1	8.8	17.2	12.1	19.6	0.0	55.2	12.5	5.3	5.0	8.6	0.9	4.5	1.5	0.2	12.9	0.2	3.5	4.0	2.4	0.2	0.6	1.8	6.5	22.1	0.1	15.4	3.2	1.0	1.1	1.0	1.2	1.4	1.3	1.5	1.9	1.8	1.9	1.6	2.0	1.9	0.9	0.0	2.7	4.6	5.7	2.8	16.6	5.3	1.2	0.0	2.0	1.4	2.7	0.0	4.9	3.7	0.0	0.0	55.8	0.3	0.0	0.6	128.3	0.7	3.5	0.8	0.0	3.8	17.4	0.2	0.0	7.0	4.1	0.5	2.5	0.1	1.1	0.8	3.7	0.0	95.2	1.0	20.3	6.7	20.8	20.0	1.2	16.3	7.2	128.4	18.6	0.0	7.2	6.6	5.2	0.4	0.1	2.2	44.4	16.5	0.0	3.3	5.1	0.0	6.6	1.5	6.2	0.8	0.5	1.2	1.6	0.1	21.4	0.2	0.2	28.0
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"RUNX family transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.8;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 336.4;Langerhans cells: 133.9;NK-cells: 251.3;Plasma cells: 87.1;T-cells: 215.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 124.9;Karpas-707: 155.6;SK-MEL-30: 92.4;U-266/70: 54.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	Cytosol	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.5	1.4	3.7	21.1	3.6	68.8	3.5	3.8	4.6	19.7	3.7	3.7	5.0	1.6	0.7	2.6	1.6	5.3	1.1	3.6	3.8	1.6	3.7	9.5	34.7	4.7	4.4	0.6	0.9	0.4	0.7	0.9	4.3	1.9	4.2	0.1	4.7	0.8	3.8	11.5	15.0	1.6	4.1	35.1	5.5	2.3	4.3	11.2	1.8	0.7	29.0	6.5	1.5	4.5	0.3	10.4	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.5	0.0	0.5	0.0	19.3	18.4	16.4	0.1	0.4	11.1	0.0	0.7	124.9	1.9	0.4	1.8	0.1	0.0	4.5	42.8	0.1	0.0	0.0	1.1	0.0	0.0	3.1	0.1	155.6	0.0	0.0	1.5	37.9	0.7	0.0	3.2	0.0	0.1	22.7	0.0	0.5	3.5	0.0	7.3	0.1	92.4	2.9	0.0	25.7	0.0	0.0	1.9	0.0	0.5	54.6	40.4	18.2	0.1	42.0	4.4	0.7	1.1	7.0	21.7	4.5	11.3	6.7	7.9	18.7	1.4	5.7	3.9	14.6	1.3	28.7	7.7	1.5	9.2	5.5	3.7	3.6	3.8	4.6	3.6	3.8	4.7	4.4	4.3	4.1	4.3	4.5	4.4	0.0	3.6	0.0	57.7	7.6	0.8	4.6	2.2	0.0	9.8	11.3	2.4	0.0	1.5	1.8	0.0	0.1	336.4	0.5	0.0	0.2	2.3	1.1	1.2	2.4	0.0	13.7	0.0	0.2	0.1	3.3	13.3	2.3	45.2	0.0	2.2	1.5	4.6	0.0	0.0	0.5	0.0	22.9	133.9	1.0	0.0	55.6	46.2	1.0	51.1	0.0	251.3	0.0	0.1	0.1	0.1	0.7	87.1	1.2	0.0	0.3	0.5	0.0	0.0	3.5	3.6	0.3	4.1	2.3	5.8	0.3	215.4	0.1	0.4	0.4
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151993859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1760.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 3820.4;Langerhans cells: 3945.6;Pancreatic endocrine cells: 4570.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 2005.4;monocytes: 1235.2;T-cells: 1180.0"	"Cell line enhanced"	"Detected in all"		"OE19: 4936.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		270000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	775.1	376.9	71.1	244.8	76.6	133.7	519.6	75.5	139.8	478.0	78.5	867.3	461.4	110.1	56.7	1760.5	188.7	212.4	340.9	72.4	132.8	735.0	157.7	689.8	133.3	148.2	105.0	234.0	145.0	36.3	71.0	326.9	108.5	164.9	924.2	51.3	422.8	105.0	106.0	483.4	448.0	288.2	98.2	111.2	189.1	145.8	138.8	118.3	143.5	145.4	289.8	338.4	803.1	110.3	1251.3	1085.9	3.4	241.6	1351.4	1711.3	972.5	730.1	912.1	613.8	606.5	1975.4	1671.4	2.3	689.1	1208.0	661.7	2227.5	337.0	2786.6	495.3	242.5	127.1	163.8	461.5	468.1	507.0	60.2	126.7	470.8	2195.5	660.6	738.6	487.6	1326.0	78.9	2.9	3.6	753.8	940.0	11.0	376.5	163.6	4936.7	1671.4	1.6	242.4	27.1	2348.3	317.0	11.1	9.5	1259.2	374.3	539.8	1213.0	882.2	130.5	1654.9	285.5	737.2	1362.3	459.2	34.4	7.8	225.2	1709.5	51.7	977.8	359.5	1235.2	299.7	425.7	758.7	443.3	232.4	652.3	539.0	2005.4	140.1	237.7	363.1	43.6	355.0	664.7	329.6	1180.0	1313.4	71.1	76.6	75.5	139.8	72.4	132.8	148.2	105.0	108.5	98.2	138.8	110.3	1197.3	2554.5	537.7	3.9	244.0	1594.8	1171.4	2183.2	795.6	11.6	241.1	281.4	111.2	693.4	994.6	950.9	4.2	1271.5	476.2	3820.4	1524.1	1811.7	314.2	901.0	104.6	1061.2	1078.1	114.2	0.4	2105.0	527.4	1751.3	432.8	1270.7	289.5	840.0	864.5	206.9	1023.1	16.8	0.9	1723.1	272.6	795.2	3945.6	274.2	647.1	1338.1	1632.8	28.1	1544.2	24.8	285.3	4.0	0.6	4570.5	3391.8	64.7	244.5	2782.5	2146.1	495.6	620.3	32.5	144.7	801.6	529.5	30.4	115.9	1940.1	1242.0	375.8	801.0	38.5	1998.0	2290.6
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745409	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	23.5	26.3	13.2	26.2	13.8	21.1	22.0	17.1	16.1	22.1	13.6	24.0	23.3	20.6	23.3	20.2	16.9	19.2	16.3	14.0	18.8	38.1	28.2	28.9	26.8	15.5	14.9	16.2	21.8	35.8	10.9	25.0	14.7	24.3	23.6	20.3	22.9	20.6	8.8	18.4	21.6	21.2	14.6	26.2	25.0	14.2	15.9	32.5	43.5	11.4	25.0	22.9	10.8	16.3	31.0	23.0	38.0	22.0	58.8	39.2	29.6	50.1	43.0	36.9	33.1	30.5	21.8	47.8	24.3	39.8	49.8	22.7	50.4	27.0	48.9	34.3	26.8	50.8	38.2	25.7	37.6	78.0	61.5	26.5	41.1	39.9	29.6	29.9	25.6	43.2	57.9	45.7	60.6	14.0	59.5	41.4	40.1	29.6	40.1	17.2	20.0	48.4	41.2	42.7	15.0	36.1	35.5	36.3	44.7	38.0	31.0	64.1	33.7	36.2	21.1	37.0	44.5	25.3	71.7	32.5	45.1	106.8	36.2	10.3	17.1	27.5	24.6	14.2	27.5	11.0	17.8	26.0	27.2	11.9	17.6	23.5	14.1	65.2	13.0	11.1	16.7	27.6	13.2	13.8	17.1	16.1	14.0	18.8	15.5	14.9	14.7	14.6	15.9	16.3	18.4	28.9	37.3	22.5	22.2	19.6	9.1	14.6	22.2	22.8	15.2	12.3	16.6	14.3	15.7	7.3	31.3	22.9	55.4	16.4	19.6	11.1	1.6	15.9	31.9	17.6	12.0	23.4	44.7	10.0	11.2	19.5	17.3	18.5	17.1	17.2	17.2	15.4	24.5	33.7	42.7	9.4	18.3	23.0	18.7	2.9	16.8	22.6	17.8	30.9	25.5	15.8	46.4	40.7	43.6	12.9	20.7	23.0	33.2	14.6	18.5	22.3	14.1	20.7	6.6	15.8	16.6	12.3	12.0	15.7	17.3	18.3	44.5	19.5	13.6	11.6
SAMD13		ENSG00000203943	"Sterile alpha motif domain containing 13"	Q5VXD3	1	84298366-84389957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;choroid plexus: 26.9;intestine: 22.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 20.3;Intestinal goblet cells: 18.0;Oligodendrocytes: 16.4;Paneth cells: 33.2;Spermatocytes: 22.5;Undifferentiated cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"basophil: 12.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 12.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA058929	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA058929: AB_2683855"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.55e-2)"	"prognostic favorable (1.14e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.65e-6)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.98e-7)"	"unprognostic (3.99e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.56e-3)"	0.9	3.4	22.3	1.5	30.7	2.8	2.4	11.3	25.7	1.6	26.9	19.5	3.4	1.7	4.1	0.8	4.1	1.8	2.4	19.6	29.0	1.4	0.4	0.9	1.2	29.0	29.4	0.3	1.8	1.2	1.0	0.8	27.7	4.0	22.0	0.8	17.6	2.1	6.2	1.2	3.8	2.5	29.9	1.1	6.1	13.1	35.5	2.8	9.8	3.0	0.6	1.8	0.4	32.5	0.5	2.3	1.1	3.5	3.6	3.3	2.3	0.3	0.2	0.3	0.2	0.0	3.4	3.6	6.3	0.1	0.7	0.4	0.4	1.2	0.5	2.0	1.7	1.3	1.7	0.3	0.8	4.4	0.0	1.3	1.6	0.1	1.0	2.5	8.2	7.8	0.5	1.1	1.0	1.1	5.1	0.5	3.5	2.9	2.3	0.5	2.5	1.5	6.5	2.1	1.4	5.1	0.1	0.1	8.1	1.4	1.0	4.1	1.4	1.4	0.3	0.3	1.0	2.4	0.5	6.3	0.3	3.8	1.1	12.5	0.3	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.7	0.7	0.3	0.4	0.1	0.5	0.3	0.8	0.0	0.3	22.3	30.7	11.3	25.7	19.6	29.0	29.0	29.4	27.7	29.9	35.5	32.5	1.7	0.0	0.6	2.0	0.3	0.4	0.7	0.7	0.6	1.2	3.8	2.9	1.0	2.8	1.1	1.8	0.0	4.5	0.1	20.3	5.9	2.1	5.6	5.4	1.6	1.6	11.4	6.1	5.2	0.6	0.6	1.4	3.6	4.7	5.7	2.0	3.3	0.1	1.5	0.0	5.8	18.0	0.0	2.4	1.6	5.8	1.8	1.4	8.8	6.5	0.4	2.7	0.0	7.1	16.4	1.1	33.2	2.6	0.1	2.0	3.8	2.9	1.1	0.1	0.0	1.8	0.7	22.5	5.5	2.2	0.3	0.8	0.7	4.1	21.3	1.2
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36890229-36951843	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 214.2;Endometrial ciliated cells: 173.8;Kupffer cells: 280.2;Macrophages: 326.4;monocytes: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 510.8;BJ hTERT+ SV40 Large T+: 165.8;BJ hTERT+ SV40 Large T+ RasG12V: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		91000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane"	"HPA047072: AB_2679921"	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	79.5	39.9	11.9	94.3	12.4	11.5	65.7	11.6	12.2	39.1	33.2	58.4	29.4	33.0	9.1	45.8	81.8	40.2	60.5	11.4	16.6	12.2	26.1	68.0	78.0	16.8	15.0	38.0	42.2	14.0	21.7	36.0	17.9	26.3	28.8	5.5	32.6	18.1	23.8	27.8	55.2	44.1	17.6	94.2	45.0	12.6	18.0	29.3	31.7	20.7	51.2	55.3	39.9	26.4	29.9	10.9	3.7	15.6	510.8	101.8	5.5	10.8	37.7	165.8	187.8	39.1	11.2	64.4	19.9	14.4	94.9	21.2	34.7	27.8	30.9	17.4	20.6	5.3	18.8	30.9	39.3	28.2	5.1	96.4	1.0	45.3	1.9	13.3	26.4	0.0	13.7	18.8	5.4	12.0	0.0	19.2	7.9	18.3	25.9	2.8	21.7	35.3	15.7	8.2	23.0	4.2	20.2	10.2	28.2	4.7	20.5	125.4	13.9	11.5	13.5	25.1	28.5	7.3	20.3	21.7	14.5	3.2	7.1	1.4	147.7	4.8	52.2	174.4	47.0	4.5	55.7	53.3	278.6	3.1	55.5	47.6	18.5	56.2	167.0	96.4	95.8	144.3	11.9	12.4	11.6	12.2	11.4	16.6	16.8	15.0	17.9	17.6	18.0	26.4	48.7	28.9	25.5	4.2	19.4	6.4	2.3	7.8	5.7	5.5	6.9	5.8	17.3	14.3	35.3	1.8	4.2	2.6	214.2	2.6	0.0	10.3	3.3	173.8	12.7	44.3	6.0	30.7	8.6	10.2	3.3	71.4	13.3	40.6	12.6	10.5	42.5	20.1	137.2	6.7	8.5	5.7	8.2	280.2	52.3	4.8	82.3	326.4	5.4	36.5	257.9	25.1	116.4	14.1	3.5	7.5	31.3	96.3	54.8	1.9	1.1	1.9	104.4	2.9	59.2	9.6	31.9	10.2	4.9	12.1	5.8	2.9	102.6	9.7	5.5	4.9
SCAPER	"Zfp291, ZNF291"	ENSG00000140386	"S-phase cyclin A associated protein in the ER"	Q9BY12	15	76347904-76905444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 55.4"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Oligodendrocytes: 251.5;Rod photoreceptor cells: 710.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046253, HPA048077"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	No			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA046253: AB_2679600, HPA048077: "	"unprognostic (3.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.69e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.89e-3)"	5.5	7.9	9.7	4.0	12.2	7.4	6.9	18.2	10.4	6.2	6.5	6.0	6.5	7.4	7.7	8.9	6.4	5.3	13.8	9.0	12.8	9.0	7.5	6.3	4.7	11.5	10.5	12.1	8.3	14.5	8.2	6.5	11.3	7.0	4.4	55.4	7.9	6.2	13.6	6.9	6.3	6.3	9.2	5.9	6.1	21.0	10.7	8.6	12.2	12.0	6.0	5.0	6.5	16.3	6.3	5.8	7.8	4.5	3.9	7.0	6.5	8.3	5.9	3.8	5.4	6.1	5.0	6.3	7.2	2.8	10.0	6.7	18.5	3.5	5.7	14.7	9.1	3.3	6.8	3.0	4.9	9.0	7.6	5.9	6.0	4.5	7.3	8.2	5.2	12.6	4.8	17.5	6.6	2.6	8.8	2.7	2.3	5.5	3.3	7.9	12.4	2.2	3.5	6.3	18.4	8.9	11.2	3.9	9.0	9.4	5.8	7.3	6.3	8.7	8.1	4.1	7.4	10.5	23.7	8.9	5.1	11.1	5.9	40.8	6.3	17.4	11.4	3.5	13.1	16.3	11.5	10.3	3.6	17.0	18.8	12.1	10.7	17.1	4.2	9.3	9.7	4.2	9.7	12.2	18.2	10.4	9.0	12.8	11.5	10.5	11.3	9.2	10.7	16.3	28.5	99.3	61.5	190.7	33.2	20.6	28.9	10.6	18.8	91.5	13.9	15.5	191.3	12.8	27.4	12.9	252.3	33.8	26.6	17.1	1.9	14.6	59.1	10.6	13.8	23.5	16.2	1.7	151.5	6.0	11.8	22.1	17.3	18.4	22.1	41.9	21.8	9.3	14.3	77.4	201.8	9.0	6.1	13.6	11.3	24.9	20.5	14.4	10.6	135.9	12.8	51.3	34.0	203.1	251.5	6.5	11.4	19.2	28.6	15.9	72.6	7.8	12.3	710.6	19.7	39.1	23.5	143.9	68.9	15.1	18.8	52.0	30.5	26.7	13.4	19.7
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	Transport	"Chaperone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 133.0;pituitary gland: 402.7"	"Cell type enriched"	"Detected in many"	4	"Enteroendocrine cells: 470.8"	"Group enriched"	"Detected in many"	5	"glioma: 38.2;pancreatic cancer: 82.9;thyroid cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 26.9;HSkMC: 33.5;NTERA-2: 15.3;SCLC-21H: 31.5;SH-SY5Y: 36.4;U-87 MG: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	NA	NA		100000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.7	61.1	54.0	3.3	62.0	0.3	3.7	52.2	100.4	1.0	77.3	7.9	17.9	5.3	42.5	0.5	3.4	5.5	1.3	58.9	75.1	0.9	3.6	3.8	1.3	56.5	48.3	3.2	133.0	73.7	402.7	0.3	58.7	5.0	9.8	26.7	0.2	0.9	0.2	1.3	5.6	6.7	57.7	0.5	37.8	5.3	56.3	0.3	5.8	0.1	0.3	2.6	2.7	58.9	0.5	0.2	0.1	0.2	0.6	4.5	0.1	4.2	0.4	0.4	0.4	0.1	0.0	0.5	1.9	0.4	1.7	1.2	0.5	0.2	1.2	0.7	0.3	0.6	0.0	0.1	26.9	0.2	0.7	33.5	0.1	0.8	0.4	0.9	0.7	1.0	0.3	0.6	0.8	0.0	0.3	0.3	15.3	0.1	0.8	0.1	0.4	0.6	0.4	0.0	31.5	36.4	0.2	0.0	0.2	0.4	0.1	0.4	0.0	5.2	3.8	0.3	0.5	0.6	2.3	0.4	47.2	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	62.0	52.2	100.4	58.9	75.1	56.5	48.3	58.7	57.7	56.3	58.9	0.2	0.0	0.5	20.2	0.3	0.6	0.2	6.2	0.0	51.0	0.5	16.5	0.4	0.0	3.9	0.0	2.1	0.2	0.1	1.1	0.0	0.6	52.1	3.7	19.3	1.1	470.8	0.0	82.8	78.3	0.3	17.9	23.0	0.6	2.5	51.4	0.4	11.9	6.0	50.5	97.8	14.5	97.6	0.6	0.8	80.0	2.1	1.6	3.6	20.6	0.6	15.6	0.0	52.3	79.7	22.9	1.1	7.9	0.3	1.4	0.5	0.0	0.5	32.6	0.0	0.3	34.2	39.2	2.9	0.1	0.3	0.3	0.3	51.8	2.4	1.0
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107702154-107824317	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 10.1;lymphoid tissue: 12.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 31.7;Early spermatids: 72.1;Late spermatids: 168.4;NK-cells: 35.0;T-cells: 73.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 48.2;MAIT T-cell: 47.7;memory CD4 T-cell: 74.8;memory CD8 T-cell: 65.7;naive CD4 T-cell: 69.1;naive CD8 T-cell: 59.5;NK-cell: 53.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 53.2;T-cells: 74.8"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063326, HPA065958"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA063326: AB_2684986, HPA065958: AB_2685587"	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	0.6	0.8	0.8	7.2	0.6	3.3	1.0	1.2	0.7	0.5	0.2	2.3	10.1	0.5	4.6	0.9	0.7	1.4	0.6	0.6	0.9	0.6	1.6	1.7	12.1	0.5	0.5	0.6	0.7	0.2	1.9	0.3	0.3	0.6	2.0	0.9	1.0	0.4	0.4	0.9	8.2	0.5	0.1	7.4	2.8	2.2	1.3	9.3	0.8	0.2	9.8	1.1	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.3	0.8	0.1	0.0	0.0	0.0	1.4	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.1	65.1	0.0	0.1	0.4	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.3	0.1	0.1	13.8	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.3	0.2	0.7	0.1	0.1	0.1	4.2	0.3	3.5	48.2	0.1	47.7	10.1	74.8	65.7	0.2	5.8	69.1	59.5	6.6	53.2	0.4	1.2	5.8	26.6	0.8	0.6	1.2	0.7	0.6	0.9	0.5	0.5	0.3	0.1	1.3	0.6	0.5	0.0	0.0	0.7	18.0	1.5	0.0	0.0	0.6	0.6	0.4	0.4	1.1	0.0	0.0	0.0	0.0	1.3	31.7	0.4	0.0	1.2	72.1	0.0	0.1	0.7	0.0	1.3	2.7	0.0	0.2	1.0	4.6	0.1	1.3	0.0	1.1	1.8	0.2	1.7	2.5	1.4	0.0	0.8	1.4	168.4	0.9	1.2	3.6	1.9	2.0	0.0	35.0	0.5	0.1	0.1	2.6	0.7	11.6	0.0	5.5	0.4	0.7	0.0	0.0	0.3	0.6	1.1	0.5	0.3	0.1	0.1	73.3	0.0	4.7	0.1
SCN2B		ENSG00000149575	"Sodium voltage-gated channel beta subunit 2"	O60939	11	118162806-118176639	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;heart muscle: 12.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.8;Cardiomyocytes: 16.8;Excitatory neurons: 21.9;Horizontal cells: 13.5;Inhibitory neurons: 32.0;Oligodendrocytes: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3;thyroid cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (9.01e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.71e-4)"	"unprognostic (5.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.88e-3)"	0.6	1.5	19.1	0.3	20.7	0.0	0.7	14.9	34.0	1.4	0.0	1.7	0.6	1.6	1.3	1.8	1.3	1.3	12.8	20.9	12.3	0.4	0.0	1.1	0.0	5.7	13.3	1.3	0.1	0.0	0.8	0.0	9.1	1.0	0.7	3.7	0.5	1.2	7.3	0.2	1.1	1.9	4.9	0.1	0.3	0.2	19.5	1.8	0.7	7.5	0.0	0.3	0.4	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	19.1	20.7	14.9	34.0	20.9	12.3	5.7	13.3	9.1	4.9	19.5	22.1	0.1	0.0	0.0	3.9	0.0	0.4	0.6	0.7	1.8	8.8	0.1	2.0	16.8	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.5	0.2	0.0	0.0	21.9	0.0	0.0	1.6	0.0	0.3	0.0	0.2	0.0	0.0	0.1	13.5	32.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.9	0.0	0.9	0.0	2.5	7.4	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.1	1.9	0.0	0.9	0.8	0.1	0.6	0.0	0.1	0.0	0.1	0.5	0.0	0.3
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;choroid plexus: 15.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Muller glia cells: 148.3;Oligodendrocyte precursor cells: 102.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA		240000	"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	1.3	0.8	19.0	0.6	20.5	0.7	0.5	20.6	30.7	1.6	15.2	4.4	0.5	1.8	0.9	0.4	2.5	1.5	2.9	19.4	20.3	0.2	0.1	0.4	0.2	22.8	19.9	0.8	0.3	0.0	1.0	0.2	22.5	2.3	0.5	2.3	1.1	3.2	0.5	0.5	0.9	4.7	21.6	0.5	2.8	10.8	19.4	0.0	0.3	0.0	0.1	2.0	0.8	24.7	0.1	0.0	0.6	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.5	0.2	0.1	3.5	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	17.1	1.8	0.5	0.3	0.2	0.4	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.3	1.2	0.5	0.5	0.3	0.1	0.1	19.0	20.5	20.6	30.7	19.4	20.3	22.8	19.9	22.5	21.6	19.4	24.7	1.3	0.0	3.0	46.4	1.0	3.6	1.1	0.0	0.0	14.5	2.4	3.9	1.3	0.0	0.7	0.0	37.5	0.2	3.3	0.3	0.0	0.3	18.3	0.7	1.7	2.1	1.2	0.0	19.0	0.0	0.4	17.3	1.1	0.4	8.9	0.9	4.2	0.3	0.6	16.8	20.9	0.5	0.0	3.3	2.6	32.3	26.1	3.8	23.2	2.8	1.9	148.3	2.1	102.1	26.4	0.2	0.1	20.7	1.0	1.9	0.4	0.3	0.8	28.3	13.1	2.4	20.3	3.1	2.4	0.1	2.6	0.7	3.1	0.5	0.3	1.0
SDHAF3	"ACN9, DC11, LYRM10, Sdh7"	ENSG00000196636	"Succinate dehydrogenase complex assembly factor 3"	Q9NRP4	7	97117698-97181763	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 148.7;Early spermatids: 136.0;Proximal tubular cells: 150.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA020515, HPA020523"	Approved		Approved	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020515: , HPA020523: AB_2670464"	"unprognostic (3.94e-2)"	"unprognostic (9.11e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.61e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.34e-1)"	"unprognostic (8.45e-2)"	12.4	17.5	9.3	12.4	9.8	16.7	18.7	10.5	13.3	15.0	13.5	20.7	19.9	12.4	22.2	15.0	14.6	13.0	27.0	9.4	11.2	33.5	32.1	8.4	18.5	10.6	10.4	10.7	18.4	12.2	3.6	9.6	11.0	14.8	20.3	16.4	22.0	12.0	29.0	14.1	17.4	12.2	11.6	11.2	18.3	14.5	10.2	24.5	19.0	25.6	14.5	12.8	3.7	12.1	36.6	27.6	24.5	82.3	15.8	12.8	14.8	15.8	7.6	15.6	22.8	5.0	30.7	57.4	40.1	14.1	20.7	13.4	49.6	38.8	33.7	44.2	59.6	34.6	24.8	54.8	23.8	89.4	16.0	24.3	30.3	25.7	32.0	11.6	14.5	57.2	99.5	1.6	34.8	0.0	94.5	126.7	37.3	74.1	34.6	21.0	14.0	83.7	26.0	24.9	63.8	40.7	38.5	47.9	55.5	33.9	0.4	31.6	16.0	4.2	53.2	88.6	10.7	41.4	87.0	139.5	14.6	144.7	51.9	30.0	21.4	8.0	26.5	26.3	36.3	36.3	33.3	39.1	27.9	32.1	45.9	44.4	20.2	23.9	26.7	82.6	33.2	37.9	9.3	9.8	10.5	13.3	9.4	11.2	10.6	10.4	11.0	11.6	10.2	12.1	24.4	19.2	12.5	8.5	34.4	0.0	23.1	0.0	29.0	13.8	38.6	44.4	37.9	18.6	6.8	25.8	4.2	35.2	31.3	7.2	148.7	30.6	136.0	31.3	20.6	17.3	13.3	32.6	16.6	39.1	30.0	20.1	29.0	21.4	5.1	22.2	16.4	55.9	31.1	10.1	14.3	24.2	0.0	20.1	0.0	20.7	22.7	20.2	0.0	9.4	13.9	44.8	36.0	14.6	18.5	24.0	29.1	24.8	30.9	17.0	35.1	150.9	16.0	19.5	32.9	19.5	20.4	32.7	49.3	53.5	0.0	9.6	26.3	45.6	39.8	25.0
SDHAF4	"C6orf57, Sdh8"	ENSG00000154079	"Succinate dehydrogenase complex assembly factor 4"	Q5VUM1	6	70566917-70589569	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031824	Supported		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA031824: AB_10602113"	"unprognostic (8.72e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (2.45e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.94e-2)"	11.2	12.3	7.1	4.2	7.5	4.3	10.5	6.8	10.5	6.6	7.3	6.8	5.0	5.8	9.3	7.5	10.3	4.2	14.5	7.6	9.4	12.5	8.5	5.4	6.0	6.9	6.3	6.4	6.6	14.4	12.7	6.8	7.3	7.6	6.7	10.0	8.7	5.4	23.6	8.6	5.4	4.2	5.8	5.6	7.0	5.3	7.8	6.4	7.3	10.6	5.2	6.8	6.7	7.6	13.3	4.2	18.8	11.6	9.0	13.6	3.5	7.1	5.1	3.4	5.0	3.8	11.3	9.1	12.7	3.8	8.0	2.3	6.2	5.9	5.2	18.3	4.3	6.6	1.8	3.9	15.3	6.3	5.1	9.6	19.3	2.6	14.8	11.6	8.0	14.8	4.2	13.9	11.0	9.0	5.9	15.7	8.8	6.5	4.5	6.4	12.6	10.8	14.9	4.4	16.8	12.1	4.3	2.1	9.6	8.0	9.6	16.5	6.3	3.5	2.7	2.8	7.7	6.2	4.5	3.1	3.9	15.1	8.5	4.0	4.6	4.4	3.4	4.3	3.3	3.7	3.7	4.1	5.1	4.7	3.9	3.8	3.3	4.7	4.6	6.2	4.2	3.0	7.1	7.5	6.8	10.5	7.6	9.4	6.9	6.3	7.3	5.8	7.8	7.6	5.4	12.8	13.9	4.9	3.3	0.0	7.9	0.0	3.4	7.4	6.5	7.5	21.3	10.0	5.6	7.3	8.4	10.5	5.0	2.9	23.5	9.1	5.5	20.2	8.2	5.0	3.6	2.5	7.7	11.6	8.5	6.6	2.6	6.0	5.1	6.1	4.2	11.8	10.0	18.5	7.5	5.8	0.0	5.3	0.0	2.5	12.5	6.2	0.0	2.8	10.1	10.1	3.1	12.1	7.7	13.2	5.3	6.8	2.2	9.5	6.2	16.8	13.8	6.4	13.1	5.1	4.9	10.0	6.1	5.7	0.0	5.1	3.9	6.1	5.3	8.0
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 2087.6;liver: 6268.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 448.7;Alveolar cells type 2: 529.3;Granulosa cells: 458.1;Hofbauer cells: 858.5;Macrophages: 373.3;Proximal tubular cells: 1044.7"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Hep G2: 567.4;HSkMC: 451.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	1800000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	719.1	424.3	164.8	179.9	345.6	40.1	617.5	386.0	290.0	460.0	145.5	644.0	620.0	335.8	459.7	240.7	376.5	670.5	237.2	156.3	231.3	853.7	6268.1	512.0	552.4	519.4	316.4	701.2	229.0	246.0	108.3	973.0	490.3	214.2	714.2	59.2	170.8	374.1	156.4	171.8	2087.6	233.2	310.3	948.8	257.0	87.8	284.7	170.4	147.0	265.6	177.4	414.3	213.1	524.3	0.7	1.7	7.7	1.0	43.6	12.2	7.3	4.1	10.9	0.0	0.0	12.5	65.3	2.0	36.3	1.5	1.4	1.7	0.2	0.1	0.0	2.4	52.7	3.1	0.2	567.4	25.9	3.2	0.4	451.1	0.7	0.0	0.1	1.9	0.1	1.5	6.4	12.9	23.5	1.3	1.1	6.4	30.6	17.0	0.9	1.3	2.0	100.8	12.5	8.0	2.2	2.7	2.7	16.7	1.6	54.6	125.4	0.7	0.7	3.2	1.7	5.2	1.0	8.4	1.5	2.0	1.7	5.9	1.5	0.1	0.1	0.5	0.5	0.1	0.6	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.5	0.6	0.2	0.9	0.3	0.3	164.8	345.6	386.0	290.0	156.3	231.3	519.4	316.4	490.3	310.3	284.7	524.3	312.7	448.7	529.3	0.0	15.2	0.0	0.0	0.0	0.0	0.0	312.0	271.1	0.0	0.0	102.1	125.0	0.0	223.4	9.4	0.0	197.6	73.4	0.0	83.8	231.0	75.8	0.0	0.0	0.0	52.8	17.5	358.7	0.0	116.1	26.5	458.1	0.0	0.0	858.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	373.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	4.9	0.0	0.0	1044.7	52.5	0.0	0.0	0.0	133.1	0.0	0.0	0.0	0.0	112.9	10.0	361.8	0.0	0.0
SELPLG	"CD162, PSGL-1"	ENSG00000110876	"Selectin P ligand"	Q14242	12	108621895-108633894	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 159.7;Kupffer cells: 84.9;Macrophages: 64.8;monocytes: 123.8;NK-cells: 154.5;Plasma cells: 65.1;T-cells: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 136.2;HMC-1: 130.0;JURKAT: 102.2;Karpas-707: 195.1;RPMI-8226: 286.7;U-266/70: 326.8;U-266/84: 214.5"	"Low region specificity"	"Detected in all"							"CAB002431, HPA011256, HPA069062"	Enhanced		Approved	Vesicles		NA	NA		2700000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB002431: AB_563509, HPA011256: , HPA069062: "	"unprognostic (2.32e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (3.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (5.88e-2)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (5.44e-2)"	17.5	9.1	12.1	47.4	10.5	21.1	6.9	11.7	12.1	9.2	8.2	9.6	8.6	3.7	2.1	8.6	7.8	17.0	5.0	12.0	14.1	4.0	6.5	40.8	62.2	17.8	13.5	2.8	3.4	4.4	3.0	13.0	16.4	3.3	8.4	0.7	7.0	3.9	2.2	4.7	15.5	11.5	17.0	86.6	11.3	2.2	17.2	52.1	3.4	7.3	30.6	21.5	3.3	24.5	0.5	0.4	1.4	0.8	0.7	1.5	0.8	4.9	4.8	1.8	1.4	0.3	1.9	0.5	1.7	7.4	2.0	0.3	0.1	0.1	1.3	136.2	0.0	45.7	0.2	0.2	0.4	35.1	130.0	1.8	0.5	2.5	0.6	5.0	0.4	102.2	0.8	195.1	6.0	0.0	28.3	18.9	0.2	0.1	1.6	0.3	0.5	286.7	2.9	0.0	0.3	0.0	0.6	0.2	2.2	3.3	0.1	42.6	1.7	2.6	0.8	3.5	1.4	326.8	214.5	6.4	1.5	74.2	1.9	1543.6	297.6	940.2	419.2	509.2	344.3	22.0	396.6	362.9	299.9	22.3	300.3	323.7	1257.2	309.2	762.7	518.3	662.2	1035.5	12.1	10.5	11.7	12.1	12.0	14.1	17.8	13.5	16.4	17.0	17.2	24.5	1.2	3.2	12.4	0.0	11.6	3.4	0.1	0.2	0.0	0.2	0.6	1.4	2.2	4.3	2.7	0.0	0.0	0.5	159.7	0.2	0.0	0.3	8.2	1.8	0.6	2.6	0.0	10.9	0.2	0.2	2.3	2.4	2.6	0.9	29.7	0.4	3.6	2.2	40.1	0.0	0.3	0.0	0.0	84.9	49.6	12.2	0.3	64.8	7.2	15.9	123.8	0.0	154.5	0.0	0.1	0.5	0.0	0.0	65.1	0.1	0.0	0.5	6.4	0.2	0.0	1.2	0.9	0.8	0.5	0.5	1.8	1.0	65.9	0.1	0.0	0.0
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 92.2;Breast myoepithelial cells: 93.5;Fibroblasts: 109.6;Ionocytes: 91.6;Oligodendrocytes: 223.7;Respiratory ciliated cells: 103.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 49.6"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 49.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 252.7;RT4: 238.3;T-47d: 267.0;U-2197: 349.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		13000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	53.8	9.5	4.9	12.7	8.1	0.8	57.3	9.1	5.5	53.0	2.6	38.4	10.6	42.7	23.1	20.5	15.4	30.0	22.1	11.0	12.7	10.0	1.3	18.4	1.0	15.0	8.0	48.5	2.6	0.8	3.7	6.0	17.5	66.6	31.3	1.0	27.3	42.3	19.3	17.9	14.1	44.4	10.0	22.2	20.6	12.9	8.4	1.4	1.8	34.3	1.1	69.8	14.4	12.8	6.6	77.0	156.4	0.6	35.2	82.5	0.3	51.8	59.7	25.9	32.5	12.4	144.7	0.0	2.1	17.7	252.7	31.2	0.7	47.0	42.4	0.1	15.8	9.9	63.6	0.7	41.3	0.7	0.2	36.1	32.3	63.6	62.0	220.2	0.5	0.0	0.5	0.1	46.4	113.7	0.2	0.3	1.4	22.2	12.2	0.1	75.5	1.2	142.9	238.3	0.8	82.4	145.7	38.9	9.5	66.3	267.0	0.2	125.2	140.1	64.2	349.2	93.9	1.2	0.0	0.1	52.8	0.0	142.3	49.6	5.7	0.9	0.0	2.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	2.6	0.0	1.9	3.3	0.0	1.7	4.9	8.1	9.1	5.5	11.0	12.7	15.0	8.0	17.5	10.0	8.4	12.8	7.4	9.6	8.9	3.3	0.3	26.4	41.8	92.2	10.8	0.3	15.8	93.5	38.2	1.5	39.8	7.3	6.2	0.5	1.7	56.1	1.9	3.8	0.5	20.3	11.9	7.7	6.0	4.6	41.7	6.6	1.3	109.6	17.9	34.4	5.1	13.2	1.1	0.0	8.8	0.0	16.7	15.7	91.6	3.1	14.9	2.3	7.8	9.0	55.2	20.6	8.3	1.5	1.0	3.0	223.7	68.2	12.4	52.3	0.0	53.7	12.5	0.4	103.0	0.6	0.0	38.8	17.3	0.7	2.7	3.0	18.9	0.3	1.5	9.9	30.4	70.0
SEMA5A	"SEMAF, semF"	ENSG00000112902	"Semaphorin 5A"	Q13591	5	9035033-9546075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 1189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.2;fHDF/TERT166: 37.1;RT4: 66.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004632	Approved					NA	NA		13000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA004632: AB_1079905"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.15e-2)"	"prognostic favorable (3.66e-8)"	"unprognostic (8.51e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.01e-2)"	4.6	1.2	7.8	2.7	9.1	0.0	6.8	5.6	23.6	13.0	3.6	9.5	2.9	8.9	2.2	3.1	2.9	5.4	9.5	35.4	17.0	11.6	4.9	11.1	4.7	10.9	11.1	1.7	4.4	1.9	2.3	7.0	17.1	2.9	7.5	7.0	2.1	4.9	1.3	4.4	5.3	2.4	8.3	6.3	1.9	1.6	16.4	1.7	1.9	3.1	3.7	5.8	3.8	13.4	0.0	0.0	15.0	0.0	10.1	14.1	0.0	24.2	64.2	4.7	2.5	0.0	0.1	0.0	0.0	37.1	0.3	21.6	0.0	1.4	2.4	0.0	0.2	0.0	0.1	0.0	1.4	0.0	0.1	3.6	0.7	5.3	21.6	10.5	0.0	0.0	0.0	0.0	5.7	0.7	0.0	0.0	1.5	13.2	1.1	0.0	0.0	0.9	1.8	66.7	3.1	0.3	0.2	0.0	19.9	5.1	0.0	0.0	0.0	23.0	0.5	0.0	0.5	0.0	0.0	0.0	21.4	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	7.8	9.1	5.6	23.6	35.4	17.0	10.9	11.1	17.1	8.3	16.4	13.4	8.0	150.6	5.6	63.6	0.3	9.2	6.4	30.8	8.0	2.8	1.6	49.0	37.0	22.8	14.3	1.8	0.0	1.8	9.6	23.9	0.0	3.4	32.6	6.3	151.5	6.4	5.4	0.0	60.6	2.3	1.2	27.8	0.5	9.3	1.3	1.8	5.3	4.3	1.3	247.3	53.1	10.9	0.0	0.0	5.2	50.5	10.2	0.8	33.8	134.9	0.1	44.8	0.0	1189.7	152.3	1.2	8.0	14.7	0.0	8.2	16.9	14.4	2.0	3.6	39.5	4.3	40.5	0.6	0.5	11.4	4.8	1.9	1.4	29.0	20.5	14.1
SEMA5B	"FLJ10372, KIAA1445, SEMAG, SemG"	ENSG00000082684	"Semaphorin 5B"	Q9P283	3	122909082-123028605	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Excitatory neurons: 30.8;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 45.2;Smooth muscle cells: 14.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 79.7;NTERA-2: 15.7;SH-SY5Y: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066548	Enhanced		Supported	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA066548: AB_2685689"	"unprognostic (7.34e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.92e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (1.31e-3)"	"unprognostic (5.96e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-1)"	1.7	1.5	12.1	0.4	11.8	0.0	1.3	7.3	15.9	1.8	6.7	1.3	0.9	1.4	2.8	0.7	3.5	2.5	9.5	16.2	8.0	9.1	0.9	1.2	0.6	8.4	8.5	1.4	1.7	0.6	2.7	2.6	9.7	1.4	0.8	7.1	0.4	1.4	0.9	1.5	1.5	1.9	7.7	0.2	0.6	0.7	7.8	0.2	2.6	0.5	0.6	1.6	1.6	10.9	0.0	0.0	79.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	21.3	0.0	0.2	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	11.8	7.3	15.9	16.2	8.0	8.4	8.5	9.7	7.7	7.8	10.9	1.2	0.0	1.1	9.4	0.0	0.0	0.0	0.1	0.0	7.2	0.1	0.0	3.5	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.8	0.0	0.0	30.8	0.0	0.3	0.7	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.9	0.6	7.3	0.0	45.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	14.3	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443555-116574823	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 60.1;brain: 75.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 20.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"		NA	NA		620000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	13.4	60.1	24.1	4.9	48.6	3.5	13.1	39.9	31.9	10.0	0.3	20.6	19.9	6.0	2.8	4.4	8.2	12.9	7.1	24.5	40.3	8.6	5.6	17.9	4.5	51.9	41.0	18.1	11.2	2.0	5.8	31.9	50.0	6.0	17.5	10.4	16.6	2.5	8.2	6.9	25.5	5.8	32.9	11.2	7.0	7.5	44.1	3.6	9.1	6.5	2.2	5.6	8.1	75.2	0.3	0.1	36.9	44.3	0.2	0.0	38.2	0.7	0.4	0.2	0.2	2.2	1.5	1.6	1.7	0.6	0.7	0.4	52.0	0.0	0.1	1.6	7.7	0.7	0.7	13.1	0.5	0.5	2.6	0.7	0.0	0.0	0.0	0.5	0.2	0.3	0.3	0.4	0.2	0.8	0.7	3.9	115.2	0.2	0.3	6.9	24.2	1.8	19.0	33.7	10.3	3.7	0.2	0.7	19.7	221.1	14.4	2.6	0.9	3.6	3.1	0.4	1.5	0.6	0.7	0.8	0.6	1.8	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.1	48.6	39.9	31.9	24.5	40.3	51.9	41.0	50.0	32.9	44.1	75.2	64.7	0.0	0.6	71.8	1.1	6.5	0.7	13.1	34.7	17.9	17.0	8.3	8.6	61.5	3.1	14.7	2.1	128.9	0.3	73.3	0.0	42.9	13.6	12.2	4.8	60.9	28.1	2.7	26.9	1.3	8.1	15.4	1.1	10.6	0.0	9.7	145.6	0.9	12.5	138.0	62.2	30.7	0.0	14.8	4.6	2.4	6.5	1.1	24.9	54.4	0.1	5.8	0.0	138.7	311.3	2.0	46.7	1.9	2.6	1.5	40.7	4.4	0.6	3.5	0.0	36.1	8.1	0.9	1.5	11.3	4.1	348.1	0.8	3.5	40.3	2.2
SEPTIN2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	246.0	155.0	192.8	159.7	216.1	125.3	177.2	208.8	220.6	233.8	183.2	179.7	140.8	209.0	176.7	161.1	168.7	193.8	211.8	180.5	209.6	212.6	117.1	184.5	157.2	227.2	203.3	221.7	214.2	220.1	112.7	217.3	232.2	186.1	188.6	114.0	163.3	218.2	160.6	119.0	154.8	253.1	224.1	164.9	152.6	145.0	198.3	141.8	224.6	163.5	180.5	221.0	116.7	245.3	245.1	207.7	561.7	370.8	511.5	555.0	289.1	517.3	508.9	329.1	417.2	118.7	258.4	96.1	119.4	599.0	176.7	209.6	377.7	347.9	535.5	241.9	262.2	388.9	200.5	444.5	311.6	374.4	228.0	495.1	224.8	275.0	259.1	369.8	576.2	240.9	357.4	138.0	491.9	171.5	226.7	227.3	412.5	215.2	152.8	216.2	707.4	204.7	483.5	359.9	401.4	270.0	363.0	245.7	353.0	397.9	146.9	333.4	555.5	399.2	166.2	392.9	320.6	267.7	251.9	340.9	344.7	225.1	571.6	172.0	165.0	98.3	101.0	184.1	125.1	87.4	97.9	104.2	183.8	77.2	84.4	89.6	58.9	191.4	144.8	138.7	108.0	241.2	192.8	216.1	208.8	220.6	180.5	209.6	227.2	203.3	232.2	224.1	198.3	245.3	89.9	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	135.9	39.9	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	190.1	50.4	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	139.0	6.5	0.0	0.0	0.0
SEPTIN7	"CDC10, CDC3, SEPT7, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 570.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 192.1;Cardiomyocytes: 227.0;Cytotrophoblasts: 171.4;dendritic cells: 196.6;Extravillous trophoblasts: 198.2;Fibroblasts: 153.5;Hofbauer cells: 191.0;Smooth muscle cells: 190.0;Syncytiotrophoblasts: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Approved	"Nucleoli,Plasma membrane,Actin filaments,Midbody,Cytosol"		Yes	No		4300000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoli, Plasma membrane, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	127.1	95.1	352.6	98.8	386.1	131.0	99.5	334.3	570.9	111.5	289.5	116.4	55.7	126.5	121.5	106.6	84.1	117.5	172.1	344.1	341.6	82.9	76.9	98.6	150.9	337.4	355.9	138.2	37.0	81.1	62.6	143.5	339.1	93.9	94.8	119.5	50.3	95.5	82.9	105.0	74.9	145.2	345.1	108.3	59.4	70.3	367.7	159.0	78.2	104.3	149.7	125.0	86.9	411.9	198.1	94.3	232.0	153.2	256.7	263.1	119.3	248.6	228.6	206.7	177.0	147.7	148.9	186.2	164.2	254.9	274.9	146.3	166.3	166.4	294.0	127.8	88.4	149.8	123.4	80.8	149.4	182.7	157.7	171.7	127.1	163.8	159.4	215.6	221.0	143.3	120.1	141.9	341.6	92.8	185.6	304.3	249.7	183.1	132.6	188.3	220.9	107.6	202.6	146.1	124.3	217.4	173.5	220.1	151.8	377.1	163.1	198.7	187.3	207.2	246.7	129.9	278.5	165.9	163.4	470.2	132.4	301.2	449.3	266.8	86.0	150.1	214.8	100.1	220.7	165.6	151.5	199.6	100.8	155.5	134.4	171.2	160.9	298.7	110.5	71.0	147.4	241.7	352.6	386.1	334.3	570.9	344.1	341.6	337.4	355.9	339.1	345.1	367.7	411.9	192.1	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.0	0.0	0.0	0.0	0.0	171.4	196.6	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	198.2	153.5	0.0	0.0	0.0	0.0	0.0	0.0	191.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.0	0.0	0.0	0.0	0.0	124.2	30.4	0.0	0.0	0.0
SERP2	"bA269C23.1, C13orf21"	ENSG00000151778	"Stress associated endoplasmic reticulum protein family member 2"	Q8N6R1	13	44373665-44397714	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.7;choroid plexus: 53.7"	"Group enriched"	"Detected in many"	11	"Early spermatids: 577.8;Late spermatids: 237.7"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.7;SH-SY5Y: 5.1;U-2197: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (6.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	1.2	2.0	67.6	1.0	70.7	0.0	2.6	60.7	87.7	2.7	53.7	3.9	2.9	4.0	9.0	0.8	2.3	0.9	18.8	71.5	67.0	3.3	1.2	1.1	1.4	63.4	66.0	4.7	1.7	1.3	8.5	0.3	65.0	3.5	1.1	14.2	1.1	3.8	2.1	0.6	2.0	2.0	61.1	0.4	2.7	27.3	66.7	1.9	1.2	0.4	1.2	2.0	2.0	68.4	0.0	0.0	2.1	0.0	0.3	1.8	0.0	0.4	0.6	2.3	1.5	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.4	0.0	0.1	1.9	0.0	0.0	0.3	0.0	1.6	0.0	0.4	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.4	5.1	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	0.1	4.7	0.0	0.0	0.1	0.0	1.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	67.6	70.7	60.7	87.7	71.5	67.0	63.4	66.0	65.0	61.1	66.7	68.4	4.0	0.0	1.5	19.6	0.1	1.8	3.7	1.9	4.6	21.0	12.0	7.2	20.0	4.3	1.0	9.2	14.6	2.5	1.1	2.9	17.6	11.3	577.8	0.7	4.6	3.9	14.4	0.8	34.6	12.9	2.5	10.3	0.5	1.2	17.8	7.8	1.4	6.2	0.2	15.2	29.8	4.0	0.0	0.0	1.1	237.7	13.1	0.7	12.4	9.4	0.6	25.0	1.0	13.0	27.1	6.3	1.7	19.2	0.1	3.4	3.9	8.9	1.3	23.3	26.3	15.1	10.0	8.5	12.5	0.4	1.0	2.1	1.8	4.6	4.4	3.2
SERPINA3	"AACT, ACT"	ENSG00000196136	"Serpin family A member 3"	P01011	14	94612384-94624055	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 9176.5;pancreas: 4910.2"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 20.9;Exocrine glandular cells: 33.0;Fibroblasts: 68.6;Late spermatids: 12.2;Pancreatic endocrine cells: 18.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"Hep G2: 449.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000893, HPA002560, CAB016647"	Enhanced				"Secreted to blood"	NA	NA	697000000000	94000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717"	"prognostic favorable (8.92e-4)"	"unprognostic (3.33e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.74e-12)"	"unprognostic (6.47e-2)"	"unprognostic (1.33e-2)"		"unprognostic (2.02e-2)"	91.8	58.0	100.4	43.4	116.5	2.1	371.0	117.7	293.8	368.8	110.3	79.5	11.7	44.9	11.5	42.5	116.6	146.0	311.7	103.6	320.0	215.5	9176.5	169.9	5.0	196.3	183.1	181.5	4910.2	1.0	271.2	14.6	138.3	580.5	13.3	131.5	1505.8	54.9	177.8	55.7	91.6	83.1	141.4	31.7	290.5	66.9	176.3	2.6	72.6	38.9	6.4	207.4	70.4	173.0	0.2	0.5	0.0	0.3	0.2	0.8	0.3	0.1	0.1	0.0	0.0	1.2	4.9	0.6	4.5	0.0	3.3	0.9	0.0	4.4	0.0	2.7	0.0	1.0	0.2	449.9	56.9	1.9	0.7	52.0	63.9	0.0	2.5	5.4	0.0	0.0	0.3	0.2	0.0	17.1	0.5	0.5	0.8	1.6	0.0	0.6	2.2	0.2	3.8	0.2	0.1	0.0	1.8	2.5	65.6	0.4	2.4	0.0	0.6	0.0	8.5	0.1	19.4	1.1	2.0	2.1	0.4	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.4	116.5	117.7	293.8	103.6	320.0	196.3	183.1	138.3	141.4	176.3	173.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.5	1.8	0.0	5.6	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	20.9	3.7	0.2	0.1	0.3	0.0	0.0	0.0	33.0	0.0	68.6	9.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.3	0.0	0.0	1.0	0.2	0.0	0.0	0.0	18.7	0.0	0.4	0.3	0.5	0.0	0.1	1.5	0.0	0.0	1.7	0.8	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20774113-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 1253.1"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 283.7"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 208.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		50000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.3	0.2	0.1	0.0	0.8	0.2	0.4	1.7	0.8	1.0	87.7	0.0	0.0	2.0	0.0	0.1	0.9	0.4	1.1	1.7	0.0	0.3	1253.1	2.5	0.0	0.0	0.0	1.8	0.5	10.1	0.8	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.2	0.4	0.1	0.2	0.0	0.7	0.0	0.0	0.8	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	208.2	0.1	0.8	0.5	0.1	0.0	1.6	0.0	0.0	20.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	2.4	16.5	0.0	0.7	0.0	0.0	3.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.1	0.1	0.0	0.2	7.2	0.2	13.9	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.3	0.0	0.5	0.1	0.0	0.1	0.8	1.7	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	11.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	1.6	0.0	0.1	2.3	0.0	0.0	1.3	0.0	3.9	283.7	0.1	0.0	0.9	0.0	0.0	6.3	0.0	0.0	1.2	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	3.4	0.0	0.0
SERPINF1	"EPC-1, PEDF, PIG35"	ENSG00000132386	"Serpin family F member 1"	P36955	17	1762029-1777565	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 1875.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 697.8;Cytotrophoblasts: 795.6;Fibroblasts: 951.9;Hepatocytes: 765.0;Leydig cells: 1818.0;Peritubular cells: 1045.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 245.2"	"Region enhanced"	"Detected in many"		"hippocampal formation: 85.4"	"Immune cell enriched"	"Detected in many"	18	"plasmacytoid DC: 1454.4"	"Lineage enriched"	"Detected in all"	121	"dendritic cells: 1454.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 1232.0;ASC TERT1: 956.3;Hep G2: 606.0;HHSteC: 410.6;HSkMC: 1313.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005825	Uncertain				"Secreted to blood"	NA	NA	9290000000	44000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA005825: AB_1079921"	"unprognostic (3.85e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (9.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.18e-2)"	"prognostic unfavorable (1.40e-8)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.25e-3)"	535.5	57.5	5.7	124.2	9.6	11.9	490.2	17.9	28.0	558.7	1875.2	131.3	41.9	358.2	90.2	109.3	557.4	559.7	376.5	85.4	1.1	35.1	974.8	158.9	133.5	0.1	5.1	408.3	207.6	11.2	62.4	311.6	1.3	202.8	52.0	61.4	124.6	105.8	434.8	162.9	131.7	221.7	2.8	133.2	124.7	277.7	25.4	106.2	193.1	465.5	117.7	323.4	273.5	7.0	0.5	3.7	2.8	2.0	1232.0	956.3	20.4	56.8	49.8	0.6	0.0	9.7	0.5	2.3	1.9	71.8	0.3	3.2	86.0	4.4	0.0	0.6	46.0	1.0	1.2	606.0	410.6	1.1	1.1	1313.4	6.9	0.9	1.1	11.4	0.6	4.2	117.5	0.4	63.2	0.2	7.0	7.2	30.7	0.3	1.0	2.9	219.9	1.6	0.1	6.0	1.9	42.2	0.7	0.7	57.0	3.4	6.7	184.2	2.0	0.5	17.6	14.1	1.2	0.7	2.4	28.1	1.7	0.6	0.8	0.1	12.0	1.1	0.6	4.4	0.4	9.0	0.7	0.9	79.8	5.2	2.0	5.5	1.7	1.3	0.2	1454.4	0.8	14.2	5.7	9.6	17.9	28.0	85.4	1.1	0.1	5.1	1.3	2.8	25.4	7.0	59.0	3.2	10.4	0.3	10.8	95.0	238.0	697.8	27.9	59.3	6.7	71.2	12.1	11.5	167.7	1.8	223.1	795.6	226.1	0.0	0.0	0.3	11.2	12.5	372.4	26.2	0.0	19.2	5.3	24.5	98.7	951.9	11.2	6.7	22.9	1.7	28.2	765.0	151.6	3.3	2.6	0.0	366.2	60.4	262.6	53.0	1818.0	79.0	108.5	9.4	79.0	11.6	1.0	0.5	2.0	6.8	0.1	1045.7	7.0	155.5	0.2	27.3	105.5	39.1	19.7	193.3	202.8	12.7	8.7	4.5	78.6	534.8	14.3	10.2	0.3	47.7
SERTAD4	DJ667H12.2	ENSG00000082497	"SERTA domain containing 4"	Q9NUC0	1	210232796-210246631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 28.5;Breast glandular cells: 23.1;Extravillous trophoblasts: 54.9;Ionocytes: 24.4;Squamous epithelial cells: 27.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.5;BEWO: 7.4;SCLC-21H: 7.4;SK-BR-3: 8.5;T-47d: 10.5;U-2 OS: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027344, HPA028514"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA027344: AB_10601770, HPA028514: AB_10611391"	"unprognostic (1.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.85e-2)"	"unprognostic (6.55e-2)"	"unprognostic (4.24e-1)"	1.1	0.3	0.6	0.3	1.6	0.0	3.6	1.0	1.1	2.0	0.2	4.8	0.4	3.8	0.6	4.2	1.7	0.7	3.0	0.6	1.0	1.9	0.0	1.5	0.1	0.9	1.4	1.0	0.1	0.6	0.9	1.0	1.0	1.8	1.4	0.1	5.9	1.4	0.2	3.3	0.8	2.7	1.2	0.1	1.4	0.2	0.8	0.6	1.4	0.7	0.7	0.6	1.8	1.1	7.5	0.1	1.6	0.0	0.8	0.7	7.4	1.8	1.8	1.4	2.4	0.3	0.8	0.0	0.2	0.4	1.1	3.6	0.2	0.6	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	1.7	0.2	0.0	0.0	0.0	0.3	1.8	0.0	0.0	5.2	6.0	0.3	0.0	2.4	0.0	1.2	1.3	7.4	6.3	1.2	8.5	0.1	2.9	10.5	0.0	2.3	2.0	8.7	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	1.0	1.1	0.6	1.0	0.9	1.4	1.0	1.2	0.8	1.1	5.0	6.4	3.9	1.6	0.0	16.7	9.6	16.0	28.5	2.5	23.1	9.3	0.7	1.5	10.9	9.2	0.0	14.2	0.0	1.5	7.9	2.1	0.5	4.8	1.2	5.2	1.2	0.0	10.1	3.9	54.9	7.5	2.6	5.8	0.0	9.3	2.5	0.0	1.4	0.0	3.7	5.6	24.4	0.0	5.0	0.6	0.6	0.3	10.6	3.7	0.0	0.5	0.0	1.0	9.4	8.1	1.3	1.5	0.0	2.5	0.0	0.4	13.9	0.3	0.0	1.8	3.7	0.1	1.7	27.4	4.7	4.4	0.3	0.1	6.5	3.4
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.6"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Karpas-707: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		66000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: AB_2680602, HPA057259: AB_2683384"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favorable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	7.3	1.9	2.0	3.7	3.7	1.8	6.3	11.6	5.7	11.6	0.0	10.9	1.7	8.3	7.2	4.5	7.2	5.0	4.3	2.6	0.2	7.4	4.7	6.6	5.3	0.0	0.1	7.7	5.8	3.7	2.7	7.2	0.1	7.8	3.5	3.0	4.3	9.2	10.7	4.4	4.6	7.4	0.0	3.7	5.6	1.8	0.0	4.4	5.1	9.7	4.7	8.1	8.5	3.8	0.0	2.4	16.1	0.0	4.1	1.2	1.0	1.3	3.0	1.5	1.3	0.2	0.0	1.0	0.5	1.8	1.0	4.8	1.8	4.9	1.0	1.4	0.8	0.0	1.8	1.2	0.0	0.0	0.0	3.8	2.0	0.0	3.0	2.7	0.5	0.0	0.1	44.7	0.4	0.8	0.0	0.1	2.0	0.0	1.1	5.6	0.0	5.5	4.9	3.9	8.2	4.2	0.0	0.0	0.9	7.1	2.2	0.0	0.0	9.5	3.3	0.0	7.7	8.6	0.5	0.0	5.8	0.2	5.5	0.1	0.0	0.0	0.4	0.6	0.0	2.0	0.0	0.2	0.0	3.0	0.0	0.1	0.0	0.0	1.0	2.8	0.0	0.1	2.0	3.7	11.6	5.7	2.6	0.2	0.0	0.1	0.1	0.0	0.0	3.8	7.6	0.0	1.8	85.5	42.4	15.4	8.6	8.3	7.4	12.5	11.0	12.6	3.9	14.3	4.2	16.5	18.8	1.5	25.5	1.6	3.9	4.5	1.3	12.9	15.6	8.3	12.0	0.8	349.0	3.5	1.4	29.3	4.1	14.8	0.0	0.7	17.9	16.5	2.0	3.3	548.3	4.4	10.2	2.4	8.7	3.7	62.7	4.6	3.6	88.1	1.5	10.7	6.2	170.4	62.9	3.7	9.1	39.9	29.6	8.1	0.4	10.5	5.8	18.2	6.6	18.4	28.6	0.3	0.8	4.0	15.2	0.8	5.9	0.1	4.7	1.5
SFRP4	"FRP-4, frpHE, FRZB-2"	ENSG00000106483	"Secreted frizzled related protein 4"	Q6FHJ7	7	37905932-38025695	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 619.9;endometrium 1: 467.1;fallopian tube: 214.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 472.1;Fibroblasts: 196.4;Granulosa cells: 102.8;Peritubular cells: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.0;HSkMC: 3.9;U-937: 3.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 53.5"	"HPA009712, HPA050585"	Enhanced				"Secreted in female reproductive system"	NA	NA		2500000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA009712: AB_1856778, HPA050585: AB_2681183"	"unprognostic (5.93e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.36e-5)"	"unprognostic (7.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.89e-3)"	29.1	15.6	2.3	1.4	3.0	0.8	60.0	2.7	4.5	619.9	2.1	4.4	1.2	467.1	18.7	2.3	214.0	17.3	22.4	2.5	4.6	4.3	0.6	14.7	7.3	4.0	4.8	79.2	5.0	2.8	20.5	0.2	3.2	16.1	2.6	2.3	6.5	43.9	4.1	1.5	1.4	87.9	4.0	13.9	2.3	16.8	2.7	1.6	14.9	7.0	2.0	37.4	61.0	3.9	0.0	1.8	2.1	0.0	10.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	2.2	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	1.5	0.1	0.3	0.0	3.9	0.5	0.4	0.0	0.7	0.1	0.1	0.0	0.2	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.7	0.0	0.8	1.2	0.1	0.4	0.1	0.1	0.2	3.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	2.7	4.5	2.5	4.6	4.0	4.8	3.2	4.0	2.7	3.9	5.5	0.0	1.8	0.3	0.7	1.0	1.5	0.1	0.6	0.0	0.5	2.3	1.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	1.0	22.5	472.1	4.6	0.0	0.0	0.0	0.5	0.3	196.4	0.0	14.1	0.0	102.8	3.3	0.1	0.2	0.0	0.5	0.0	0.0	0.0	4.4	2.8	41.7	7.1	0.0	2.8	0.0	2.7	0.0	17.6	0.2	0.1	0.0	188.4	0.0	2.4	0.0	1.8	0.0	0.3	0.0	30.5	25.3	0.2	0.4	0.1	1.6	0.3	9.2	1.2	0.1	0.5
SGCA	"A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1"	ENSG00000108823	"Sarcoglycan alpha"	Q16586	17	50164214-50175928	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 155.6;skeletal muscle: 522.4;tongue: 237.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 128.4;Early spermatids: 162.6;Late spermatids: 705.4;Skeletal myocytes: 195.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 1.4;memory B-cell: 3.3;myeloid DC: 2.2;naive B-cell: 3.3;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	15	"B-cells: 3.3;dendritic cells: 2.2;monocytes: 1.8"	"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 78.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007537	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA007537: AB_1079944"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.15e-2)"	12.2	1.5	1.8	7.3	2.9	0.0	4.3	3.5	2.2	10.1	1.0	53.7	5.3	36.9	1.6	22.8	18.1	11.9	155.6	1.4	1.5	2.7	4.8	29.7	0.5	1.6	1.5	5.1	1.3	0.8	0.9	6.7	1.8	26.0	3.2	0.1	8.7	27.1	522.4	12.4	14.8	23.0	1.1	3.4	24.1	1.7	1.7	2.3	3.4	237.0	0.4	46.5	11.6	4.7	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	78.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.1	0.0	1.4	0.0	3.3	0.0	0.0	2.2	3.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.4	1.8	2.9	3.5	2.2	1.4	1.5	1.6	1.5	1.8	1.1	1.7	4.7	1.1	0.0	0.0	0.0	1.3	8.7	0.5	0.4	0.0	0.6	0.1	0.5	128.4	0.0	0.3	0.0	0.0	0.5	1.4	0.0	0.0	0.6	162.6	0.0	0.2	4.6	0.0	0.0	0.0	5.8	0.1	30.4	0.5	0.0	0.0	0.0	2.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	16.5	705.4	3.1	0.8	8.8	1.9	1.9	0.0	0.0	0.0	0.1	4.1	0.0	3.8	0.1	0.6	0.0	2.1	0.0	0.0	13.1	195.2	48.2	2.3	1.9	0.1	9.9	0.3	0.9	0.0	0.0	0.2
SHISAL2A	"FAM159A, MGC52498"	ENSG00000182183	"Shisa like 2A"	Q6UWV7	1	52633168-52669683	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;intestine: 3.7;lymphoid tissue: 5.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.3;dendritic cells: 9.8;Endometrial stromal cells: 2.6;Hofbauer cells: 1.8;Macrophages: 2.2;T-cells: 6.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.7"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 10.1;NK-cells: 5.9;T-cells: 7.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.1;Karpas-707: 9.4;NB-4: 2.9;RPMI-8226: 13.0"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.0"	"Low region specificity"	"Detected in some"			HPA030744	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA030744: AB_10963060"	"unprognostic (7.94e-6)"	"unprognostic (8.50e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.64e-2)"	0.4	0.2	0.8	2.3	0.7	1.7	0.2	0.8	1.0	1.0	0.4	0.4	0.3	0.4	0.7	0.2	0.6	0.3	0.1	0.5	8.7	0.3	0.2	0.7	5.6	1.0	1.6	0.0	0.2	0.0	2.0	0.1	1.1	0.4	0.3	0.1	0.3	0.3	0.3	0.0	3.7	0.0	0.9	5.4	0.5	0.8	2.5	1.0	0.7	0.2	5.2	0.3	0.2	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	2.9	1.6	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.0	0.0	3.9	10.1	6.2	5.6	0.0	9.8	4.3	2.6	0.0	5.9	0.0	0.0	2.1	1.6	0.8	0.7	0.8	1.0	0.5	8.7	1.0	1.6	1.1	0.9	2.5	1.2	0.6	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.6	2.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	6.4	0.5	0.0	0.0
SHROOM4	KIAA1202	ENSG00000158352	"Shroom family member 4"	Q9ULL8	X	50591642-50814302	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 463.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.7;HUVEC TERT2: 26.7;RH-30: 5.0;RPTEC TERT1: 5.5;TIME: 10.0;WM-115: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010089, HPA010565"	Uncertain		Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites"	"Nucleoplasm, Vesicles"	"HPA010089: , HPA010565: AB_1079961"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (7.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	8.1	1.8	9.8	1.9	20.0	1.2	5.4	17.1	12.4	3.3	0.9	1.8	1.1	3.6	1.6	2.7	2.2	3.0	7.8	8.9	12.6	5.3	0.9	13.3	0.9	23.8	17.6	1.3	0.9	1.9	2.0	9.0	21.8	2.2	1.4	1.3	2.0	1.8	3.6	1.7	1.5	4.1	13.8	1.0	1.3	0.6	17.3	0.6	3.3	5.0	1.0	3.5	2.3	30.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	6.7	0.9	0.0	0.6	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	0.0	5.5	2.5	0.1	0.0	0.0	0.8	1.5	3.6	0.1	0.1	10.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	1.3	0.2	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	20.0	17.1	12.4	8.9	12.6	23.8	17.6	21.8	13.8	17.3	30.7	45.0	25.6	18.6	3.3	0.0	3.6	2.0	1.9	2.2	0.3	1.0	1.5	4.2	0.0	2.0	5.5	0.0	0.6	0.2	1.1	3.9	0.7	0.1	2.8	5.4	46.5	3.0	0.0	1.1	0.2	3.0	3.0	0.0	2.9	3.8	2.3	30.7	0.9	0.5	0.0	1.1	2.8	0.0	2.4	2.7	0.6	1.2	0.6	0.0	51.5	0.0	3.6	0.0	126.7	463.4	2.3	1.0	1.2	0.0	1.2	0.3	3.5	2.5	0.6	0.0	2.5	2.6	0.0	1.0	2.0	3.1	0.3	0.6	3.0	3.2	1.6
SIDT1	"FLJ20174, SID-1"	ENSG00000072858	"SID1 transmembrane family member 1"	Q9NXL6	3	113532555-113629575	"Predicted membrane proteins, Transporters"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 47.4;dendritic cells: 34.5;Excitatory neurons: 117.8;Inhibitory neurons: 86.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 33.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 15.4;OE19: 16.2;PC-3: 21.0;RT4: 14.9;T-47d: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035862	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA035862: AB_10671110"	"unprognostic (4.23e-1)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.43e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.64e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.50e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.32e-2)"	"prognostic favorable (4.09e-5)"	1.2	2.8	5.2	5.2	5.6	3.4	5.4	4.7	6.4	3.1	0.0	6.2	2.0	0.7	0.2	1.4	1.9	3.7	0.4	6.4	3.6	0.8	0.6	1.8	8.8	2.8	3.5	0.2	0.7	0.5	5.4	1.0	2.1	5.1	10.2	0.4	10.8	1.5	0.3	0.5	5.4	0.7	5.7	7.1	3.5	0.9	4.9	5.2	0.4	0.4	8.8	4.5	0.9	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	1.5	0.0	0.5	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	4.2	0.0	15.4	4.2	0.2	0.0	16.2	21.0	6.2	0.0	0.5	0.0	14.9	0.2	0.1	0.0	4.2	0.2	0.0	13.8	1.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	7.0	0.1	7.1	7.5	4.7	5.8	1.5	6.6	5.9	5.1	0.3	9.1	0.0	33.7	3.9	3.4	5.2	5.6	4.7	6.4	6.4	3.6	2.8	3.5	2.1	5.7	4.9	3.3	1.6	6.4	3.3	7.2	47.4	0.4	1.4	1.9	0.0	1.4	9.7	4.7	1.1	4.3	4.2	1.8	0.0	0.0	34.5	17.2	0.0	0.4	5.0	3.1	0.7	1.0	10.2	0.8	117.8	1.1	0.2	0.4	8.2	6.3	3.8	0.0	0.4	0.5	11.2	0.0	86.8	23.3	2.0	3.5	1.8	1.5	0.0	10.1	5.4	23.4	2.6	0.1	21.6	4.5	4.0	0.8	3.9	0.0	14.5	3.9	2.2	0.1	9.3	0.2	0.0	0.7	0.7	0.2	0.1	0.9	0.3	0.1	16.4	0.3	7.0	1.9
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	19.2	12.4	10.0	19.8	10.9	42.5	18.0	21.0	11.7	21.0	12.5	19.6	13.8	25.6	16.6	19.1	24.3	17.4	14.8	9.6	13.3	15.1	16.0	18.0	25.9	11.7	12.0	30.0	15.3	22.5	12.1	20.1	10.3	19.7	16.1	24.1	16.6	20.7	16.6	21.5	16.3	19.6	8.3	22.1	16.5	29.6	14.0	43.2	27.2	18.7	26.3	20.2	16.7	10.8	31.2	63.6	55.5	36.7	27.0	28.4	32.1	22.9	35.3	33.0	35.2	35.2	41.2	67.8	23.3	34.0	45.0	54.5	81.2	34.4	35.9	55.0	42.1	64.0	46.2	27.9	20.5	61.4	52.5	34.7	26.1	38.5	39.8	34.0	30.0	47.5	51.5	73.2	27.0	36.2	60.7	39.1	54.2	41.3	26.3	60.5	73.3	41.8	23.6	56.4	43.7	43.7	56.6	25.0	31.0	53.0	38.1	47.9	26.4	40.6	54.5	27.2	34.3	49.8	85.0	70.8	24.2	61.2	23.2	2.9	4.2	5.9	6.3	3.8	9.6	7.0	8.1	8.1	5.2	7.7	8.2	7.2	7.3	8.1	7.4	3.5	7.7	5.7	10.0	10.9	21.0	11.7	9.6	13.3	11.7	12.0	10.3	8.3	14.0	10.8	26.0	35.3	32.4	13.7	35.8	39.4	23.6	21.2	60.9	19.7	36.5	25.4	13.4	17.2	30.5	27.6	31.3	23.5	29.0	17.8	5.9	15.1	10.1	35.7	30.8	32.1	17.3	24.4	19.2	12.8	11.1	24.4	15.3	42.1	29.9	30.1	26.0	17.4	13.2	20.2	18.3	19.0	10.2	21.3	31.7	5.8	23.0	19.5	10.6	27.2	18.8	16.8	24.7	16.6	24.1	14.1	14.0	20.3	33.1	29.8	13.7	9.2	33.4	33.8	13.1	34.7	24.7	42.1	42.7	37.5	53.1	21.9	34.6	21.2	19.2	19.4
SKI		ENSG00000157933	"SKI proto-oncogene"	P12755	1	2228319-2310213	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Craniosynostosis, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010449, HPA066567"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB010449: AB_2187342, HPA066567: AB_2685692"	"unprognostic (3.99e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.69e-2)"	"unprognostic (5.24e-3)"	38.3	14.3	22.0	14.1	20.9	11.5	31.5	59.5	24.2	37.5	3.4	34.6	9.3	42.0	8.3	23.5	34.1	14.6	34.4	24.1	11.0	23.6	24.3	33.9	11.6	20.1	16.9	36.4	13.1	7.3	23.0	13.9	17.2	26.8	7.0	5.1	25.2	19.8	22.1	38.6	24.1	16.8	17.1	22.9	22.6	13.2	19.4	8.7	25.4	11.7	10.2	30.8	29.2	15.7	18.3	10.4	24.5	23.9	40.0	23.8	16.1	26.7	14.8	16.3	11.9	15.8	13.7	11.5	19.5	34.4	6.8	21.0	13.8	21.6	15.0	12.7	30.0	29.0	16.4	22.5	26.7	16.5	29.8	25.8	11.8	24.5	18.2	30.0	20.2	4.8	16.6	8.6	20.2	11.6	2.0	18.1	24.8	12.0	19.8	9.1	15.5	9.6	13.9	7.0	35.0	22.9	26.0	22.9	26.7	15.6	7.7	20.9	36.9	27.7	17.5	39.6	21.1	6.7	5.2	10.5	14.8	28.2	11.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	22.0	20.9	59.5	24.2	24.1	11.0	20.1	16.9	17.2	17.1	19.4	15.7	44.2	9.6	12.6	18.9	18.8	47.0	13.1	7.0	32.5	8.9	20.3	25.8	12.7	11.5	6.7	7.3	0.0	7.3	32.2	7.3	1.9	8.2	0.8	10.1	28.9	34.3	6.0	14.7	22.6	6.9	15.5	35.5	9.7	18.5	13.3	6.4	33.9	23.0	13.7	11.8	24.1	14.3	0.0	16.4	29.5	5.0	49.7	28.9	16.0	48.7	9.4	11.1	12.3	11.6	11.4	13.0	9.4	55.3	16.9	14.9	8.1	6.0	4.0	4.4	46.0	36.2	37.3	4.7	12.8	32.2	45.0	16.3	33.4	6.7	10.7	11.4
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73653992	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 310.5"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.9;ASC TERT1: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	10.4	10.5	5.9	6.4	6.0	6.8	13.8	6.2	7.0	10.7	5.9	20.4	16.4	9.4	44.6	8.4	5.3	10.4	8.5	6.5	8.5	31.9	17.6	13.2	5.3	6.5	7.0	4.0	11.6	310.5	9.9	21.7	7.8	16.8	22.1	18.3	30.3	14.7	5.4	7.1	21.1	10.6	5.7	7.0	14.4	6.1	7.1	4.5	43.5	6.2	5.6	12.6	6.3	7.6	7.4	9.9	9.7	15.6	99.9	74.2	12.8	23.8	59.4	6.3	22.0	6.6	17.6	6.8	11.2	32.9	14.8	12.6	13.7	5.9	11.2	4.8	15.5	2.8	5.1	15.4	19.4	5.6	10.8	34.2	8.8	14.2	9.7	26.4	16.2	9.0	7.1	7.2	22.3	4.9	2.3	3.3	7.1	30.9	5.7	5.0	12.1	28.5	16.0	20.2	3.8	6.7	4.8	14.0	14.4	14.0	6.3	34.1	23.5	3.0	2.8	12.1	5.7	20.4	30.6	1.9	10.5	11.6	9.0	13.3	7.9	3.3	6.0	7.4	5.8	3.9	6.6	5.8	7.6	2.4	5.4	6.0	5.7	8.9	4.8	5.5	6.6	4.9	5.9	6.0	6.2	7.0	6.5	8.5	6.5	7.0	7.8	5.7	7.1	7.6	8.8	22.4	20.7	16.3	8.2	9.6	13.2	13.7	5.7	8.2	22.6	5.5	6.8	18.6	17.4	51.5	29.2	19.4	11.0	46.4	3.9	14.2	36.6	16.6	7.8	13.8	12.1	3.8	47.7	13.7	13.5	25.8	14.8	19.6	14.5	3.2	23.9	32.9	64.6	0.0	46.8	47.7	20.3	24.8	22.7	48.3	7.5	25.4	10.6	14.0	11.2	8.3	13.4	17.6	16.3	19.2	17.5	11.3	20.6	29.1	23.9	36.3	21.5	28.9	0.0	10.5	9.1	8.4	3.6	10.2	11.2	22.8	11.0	2.9	19.2	30.7
SLC25A21	"ODC, ODC1"	ENSG00000183032	"Solute carrier family 25 member 21"	Q9BQT8	14	36677921-37172606	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.8;Excitatory neurons: 14.1;Exocrine glandular cells: 10.0;Inhibitory neurons: 10.4;Oligodendrocyte precursor cells: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"K-562: 26.4;Karpas-707: 54.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000662	Uncertain					NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000662: AB_1080000"	"unprognostic (6.81e-3)"	"unprognostic (6.98e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.07e-1)"	0.9	1.2	0.2	0.3	0.3	6.3	0.5	0.3	0.3	0.6	0.1	0.6	0.7	1.3	0.2	1.2	0.7	0.6	1.3	0.2	0.4	1.6	0.4	0.5	0.1	0.4	0.3	2.0	2.8	0.9	0.3	0.1	0.4	1.6	0.3	1.0	1.6	0.4	0.7	0.3	1.2	0.7	0.4	0.5	0.8	3.9	0.3	0.3	1.5	0.9	0.1	0.6	0.3	0.5	1.3	1.0	0.4	3.2	0.1	1.0	0.0	0.3	0.8	1.7	0.7	0.2	0.9	0.1	1.4	0.4	0.0	1.0	0.0	0.7	0.6	0.8	9.5	0.9	0.8	0.8	1.0	0.0	0.0	0.7	1.1	0.0	0.5	0.9	3.9	0.0	26.4	54.4	0.8	2.7	0.0	0.0	2.1	0.0	4.1	0.0	0.0	0.0	0.8	3.9	2.6	0.0	2.6	0.2	1.3	0.4	2.9	0.0	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.4	0.4	0.3	0.4	0.4	0.3	0.5	0.3	0.0	0.0	2.3	0.2	1.0	1.8	1.8	6.8	0.1	1.0	0.9	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.9	0.9	1.4	0.1	1.0	0.7	1.8	27.8	14.1	10.0	0.0	0.9	0.0	0.2	0.0	0.4	0.7	0.3	0.2	1.7	10.4	0.5	2.0	0.0	0.4	1.4	1.5	0.1	0.0	4.7	0.0	4.3	0.0	11.6	5.2	3.7	0.0	0.7	0.0	2.7	0.1	4.2	0.4	1.5	0.0	1.1	1.1	3.1	3.6	3.6	0.9	0.0	0.1	1.9	1.0	0.6
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143266-185150382	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Host-virus interaction, Transport"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 245.1;skeletal muscle: 190.8;tongue: 346.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 4722.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		380000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	4.7	5.7	14.0	1.6	15.3	0.4	4.6	22.6	30.6	3.4	6.8	21.0	3.0	5.9	3.5	10.1	5.8	3.9	245.1	16.7	11.8	10.4	7.3	4.5	1.5	11.6	10.7	4.9	5.2	7.8	9.5	1.7	11.8	8.9	3.9	19.9	9.0	12.6	190.8	3.3	6.8	8.1	9.4	3.1	15.7	4.7	12.5	1.4	5.2	346.6	1.2	9.8	3.6	18.2	0.7	3.1	2.5	5.1	2.7	0.3	4.6	2.6	0.8	3.1	3.0	6.8	1.7	2.3	1.8	3.1	2.4	2.5	9.8	2.7	2.0	3.9	8.4	1.6	4.7	8.1	5.5	1.4	1.5	2.0	6.6	4.7	1.3	7.2	2.3	4.0	3.8	1.7	1.9	5.0	1.6	3.1	4.1	2.2	6.6	2.5	1.3	3.2	6.9	4.8	8.1	6.2	3.1	1.3	12.5	4.5	2.4	1.1	1.7	0.2	1.4	1.5	3.4	7.3	3.5	2.9	2.2	0.3	2.8	0.0	0.0	0.0	1.7	0.0	1.3	1.5	0.5	1.4	0.0	1.0	0.4	1.2	0.1	0.3	0.0	1.3	0.5	0.6	14.0	15.3	22.6	30.6	16.7	11.8	11.6	10.7	11.8	9.4	12.5	18.2	37.5	86.6	76.4	22.9	37.9	44.1	159.0	119.9	30.1	180.6	42.9	53.5	4722.0	115.8	80.0	71.7	104.3	69.2	41.1	44.4	988.0	75.3	20.6	77.8	7.4	80.1	53.8	3.0	35.1	74.1	56.5	120.1	54.0	33.6	12.0	18.6	27.5	92.1	65.9	159.9	43.7	40.6	215.7	8.5	13.8	16.7	46.6	6.8	190.3	19.7	9.0	541.2	16.5	26.7	29.2	51.4	28.5	112.8	76.4	59.1	113.8	178.3	144.0	221.0	105.2	134.5	402.7	28.0	34.0	33.2	18.2	40.5	27.7	23.7	54.2	50.7
SLC25A53	MCART6	ENSG00000269743	"Solute carrier family 25 member 53"	Q5H9E4	X	104099214-104157009	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Daudi: 6.1;Karpas-707: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034959	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA034959: AB_10602025"	"unprognostic (4.70e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.16e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.94e-2)"	"unprognostic (9.76e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-2)"	0.1	0.3	1.0	1.0	1.0	0.4	0.2	1.3	1.1	0.2	0.3	0.2	0.4	0.2	0.2	0.1	0.2	0.3	0.3	1.1	0.9	0.1	0.1	0.2	1.9	0.9	1.1	0.4	0.5	0.1	0.2	0.1	0.9	0.2	0.4	0.4	0.1	0.1	0.1	0.2	1.0	0.2	1.0	1.3	0.4	0.6	1.0	0.5	0.1	0.0	1.6	0.2	0.1	1.3	0.0	0.1	1.7	1.1	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	6.1	0.1	0.0	0.3	0.1	2.0	0.0	0.1	0.5	0.8	0.7	0.2	0.1	0.1	1.1	0.7	0.3	0.0	0.2	0.0	0.3	0.4	0.6	0.1	13.9	0.1	0.1	0.2	0.1	2.2	0.1	0.4	2.5	0.9	0.2	0.3	0.2	1.5	2.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.8	0.1	0.4	0.1	0.0	2.2	0.1	1.6	0.4	0.2	0.1	0.2	0.3	0.1	0.6	0.5	0.3	0.5	0.1	0.4	0.0	0.3	0.7	0.2	0.0	0.0	0.5	0.1	1.0	1.0	1.3	1.1	1.1	0.9	0.9	1.1	0.9	1.0	1.0	1.3	6.6	6.4	4.6	26.4	11.4	5.2	8.8	6.2	4.0	3.5	7.2	5.7	15.1	5.7	4.6	9.2	0.0	3.7	9.6	17.3	25.4	4.3	6.8	6.9	4.7	5.3	7.2	19.4	15.5	6.0	4.2	7.6	7.7	7.2	7.0	2.7	6.4	25.1	10.6	3.3	14.1	7.8	4.1	8.8	5.7	1.3	3.1	7.5	1.8	16.9	11.4	4.0	17.5	17.1	23.5	7.8	21.8	3.0	10.2	8.8	19.7	25.9	10.8	8.1	0.0	5.2	5.0	4.8	2.3	4.7	5.7	6.2	11.0	3.0	4.5	11.3
SLC29A1	ENT1	ENSG00000112759	"Solute carrier family 29 member 1 (Augustine blood group)"	Q99808	6	44219553-44234142	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 216.6;Extravillous trophoblasts: 224.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	26	"eosinophil: 1046.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 1046.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012384	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA012384: AB_1857073"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.76e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.34e-1)"	76.4	95.8	10.2	22.3	10.2	53.4	50.4	13.0	14.8	25.4	4.5	59.7	13.1	37.3	15.9	25.3	34.5	44.2	119.7	10.1	12.2	17.8	57.9	33.1	25.9	13.2	10.2	12.9	91.2	22.8	22.6	58.8	15.3	16.5	17.8	21.1	35.6	19.3	144.5	53.0	17.2	46.2	9.5	14.5	53.7	14.9	10.7	81.3	30.7	100.7	17.0	32.8	17.7	10.8	85.3	84.2	58.5	95.1	87.8	8.1	347.1	61.2	24.0	83.6	57.4	91.8	34.8	171.2	60.8	18.5	51.7	103.8	105.2	72.8	51.9	97.6	97.2	150.5	57.8	122.5	14.1	170.3	139.7	10.9	18.4	123.0	42.7	171.6	216.0	137.2	205.4	100.1	46.9	94.0	142.0	114.4	89.0	218.4	55.4	94.0	117.8	208.9	49.1	49.5	75.0	97.0	18.4	58.9	43.9	61.5	80.7	107.1	333.1	46.4	74.8	62.6	117.7	67.0	93.8	221.9	28.8	136.8	57.1	21.9	12.1	1046.6	5.1	38.8	4.2	4.4	2.7	3.9	6.8	2.4	1.1	2.4	1.8	3.1	32.5	40.0	8.2	6.6	10.2	10.2	13.0	14.8	10.1	12.2	13.2	10.2	15.3	9.5	10.7	10.8	64.2	0.0	10.5	1.3	4.0	10.7	9.0	4.1	2.2	10.9	20.2	30.1	46.4	17.2	6.0	7.3	14.6	216.6	5.7	3.0	3.9	24.2	0.5	4.3	3.5	31.7	31.2	49.2	18.4	56.7	224.6	40.0	26.5	11.2	8.2	25.4	25.7	16.7	63.6	5.0	25.4	2.9	79.3	37.0	13.3	2.8	32.9	19.2	35.6	16.9	8.3	4.3	0.0	5.0	2.6	61.9	3.4	53.8	14.2	18.2	0.7	0.9	6.9	11.9	92.1	21.0	22.5	0.4	11.0	4.6	15.6	42.0	3.2	4.1	6.2	9.8
SLC2A4RG	"GEF, HDBP1, Si-1-2, Si-1-2-19"	ENSG00000125520	"SLC2A4 regulator"	Q9NR83	20	63739776-63744050	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 150.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 116.2;Proximal tubular cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063050			Approved	"Nuclear speckles"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA063050: AB_2684930"	"unprognostic (2.89e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.07e-3)"	"unprognostic (6.48e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.22e-1)"	59.4	37.9	8.8	3.1	8.6	10.2	45.0	7.3	12.8	42.0	7.7	55.5	1.6	39.2	4.2	47.7	35.0	3.3	60.5	8.3	8.4	67.8	150.6	30.9	5.0	8.4	8.2	45.8	28.4	5.6	23.0	2.8	7.6	50.1	1.5	2.3	27.3	10.5	88.2	60.8	25.6	3.3	8.6	35.5	33.4	24.2	8.2	6.3	32.1	18.7	3.0	50.2	40.6	8.6	20.5	26.4	12.2	11.0	7.6	14.9	11.9	16.6	16.4	43.8	15.2	49.0	34.0	4.3	23.1	12.1	18.9	24.1	6.1	20.0	7.6	13.5	11.0	4.3	19.4	25.8	16.2	10.5	8.9	17.4	29.0	11.8	9.5	8.7	12.8	3.9	15.8	4.7	21.3	37.0	5.9	29.8	5.3	21.9	59.6	29.4	21.8	10.5	17.3	7.8	10.8	19.0	35.4	16.0	4.5	4.6	37.9	33.7	11.0	43.4	22.7	25.2	13.1	12.8	27.0	7.3	18.1	12.4	11.8	0.0	0.0	0.2	0.9	0.0	0.4	0.1	0.9	0.5	0.1	0.0	0.7	0.7	0.0	0.3	0.1	0.2	1.1	0.1	8.8	8.6	7.3	12.8	8.3	8.4	8.4	8.2	7.6	8.6	8.2	8.6	35.9	9.6	21.2	21.5	16.0	24.5	25.0	19.3	19.4	10.1	44.7	61.5	21.3	37.1	11.2	42.3	10.4	30.7	60.1	18.3	78.2	8.2	9.2	16.3	57.1	22.2	2.4	55.4	5.5	10.3	16.6	49.7	12.8	32.4	3.8	52.6	19.6	116.2	14.7	10.1	4.5	17.5	14.2	13.5	12.7	4.3	28.9	14.6	3.6	5.6	11.7	33.5	13.4	8.0	7.1	20.3	7.8	34.6	16.9	14.9	10.5	160.8	6.1	6.5	32.9	26.1	32.9	1.1	6.4	29.3	37.8	8.6	46.3	77.0	15.0	18.3
SLC35A1	"CMPST, hCST"	ENSG00000164414	"Solute carrier family 35 member A1"	P78382	6	87470623-87512336	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 103.0;Inhibitory neurons: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"				"unprognostic (3.04e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (2.85e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.04e-1)"	16.4	24.0	24.6	15.6	25.4	11.2	30.9	28.3	31.6	27.8	28.5	39.6	18.8	24.9	22.1	13.9	20.2	19.5	16.0	26.0	25.5	21.2	32.9	37.6	17.9	24.3	24.1	23.1	15.8	23.7	18.9	19.7	24.4	36.8	47.6	14.4	31.6	16.5	13.8	24.9	21.5	22.0	24.5	19.0	29.2	13.2	24.9	16.3	16.9	15.7	16.3	21.5	16.7	25.4	4.8	11.5	20.4	24.1	54.4	49.3	16.4	13.9	12.2	11.4	15.6	9.9	86.0	17.6	16.8	17.3	31.7	18.5	24.8	11.3	14.6	25.3	18.4	20.0	14.7	17.8	35.7	26.3	13.3	25.3	26.6	13.5	26.1	26.8	27.5	25.5	26.1	28.4	17.0	44.6	7.3	39.6	11.0	60.4	18.6	22.4	19.9	19.0	35.6	20.4	13.3	14.6	25.7	47.4	23.2	23.3	42.2	53.0	26.0	16.4	11.1	18.2	11.3	21.1	32.7	6.5	13.7	46.2	23.7	52.1	54.1	22.8	17.5	42.8	27.1	17.8	18.7	21.5	46.9	16.7	23.7	22.3	13.2	17.5	44.2	17.3	26.8	36.9	24.6	25.4	28.3	31.6	26.0	25.5	24.3	24.1	24.4	24.5	24.9	25.4	14.7	44.8	33.6	19.2	11.7	14.8	18.1	37.1	18.8	6.2	23.6	16.6	6.2	20.0	25.5	16.5	12.5	25.0	16.1	27.1	7.9	10.1	10.6	6.3	9.9	15.8	15.0	8.2	103.0	8.9	19.7	19.2	13.3	6.8	21.6	14.2	42.8	20.7	15.6	11.8	87.2	73.5	48.8	28.2	11.1	7.1	16.4	15.8	21.4	24.4	27.4	17.3	16.5	42.3	26.9	11.5	19.0	19.2	9.4	17.5	14.5	11.3	25.4	7.0	19.7	8.9	16.9	9.6	14.2	9.0	14.8	27.5	14.9	12.5	32.7	8.9
SLC35D2	"SQV7L, UGTrel8"	ENSG00000130958	"Solute carrier family 35 member D2"	Q76EJ3	9	96313444-96383711	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 117.2;Proximal enterocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 103.8;Hep G2: 132.3"									HPA064047	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA064047: AB_2685182"	"unprognostic (3.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.44e-1)"	14.7	8.8	13.5	14.4	20.6	11.4	16.4	17.8	20.6	16.5	12.3	49.1	65.1	14.9	12.1	13.7	14.6	20.6	12.2	14.3	16.0	32.1	56.4	19.2	12.4	25.5	19.7	17.3	31.4	16.4	7.2	25.5	22.1	14.2	46.4	4.3	13.0	11.0	3.9	9.4	65.8	13.9	16.6	10.0	43.1	7.2	20.1	7.5	29.5	6.9	11.7	17.2	13.1	27.8	33.2	27.6	15.8	30.2	20.3	37.3	27.9	14.7	30.2	21.6	17.5	60.4	103.8	0.6	24.5	13.5	49.9	47.6	22.2	21.8	18.7	16.4	16.8	11.3	9.8	132.3	32.5	0.1	0.0	32.2	27.6	16.3	48.7	51.0	46.7	0.0	22.3	0.4	23.7	27.2	0.3	0.1	13.2	67.5	28.5	0.1	0.0	0.0	54.4	21.3	5.5	35.9	11.9	24.8	68.5	53.3	16.4	24.7	41.3	14.5	16.2	21.2	13.8	0.0	0.9	0.1	30.2	0.1	20.4	1.2	0.9	0.6	1.3	1.1	1.6	0.7	2.1	2.9	1.2	0.9	0.7	1.4	0.1	1.8	2.1	0.2	3.9	0.5	13.5	20.6	17.8	20.6	14.3	16.0	25.5	19.7	22.1	16.6	20.1	27.8	14.5	9.6	11.0	12.1	4.3	5.2	8.9	2.1	1.8	1.1	15.1	13.1	7.2	27.1	4.6	12.9	2.1	28.1	12.9	61.7	11.7	8.1	0.2	21.0	14.0	12.6	9.6	1.3	0.8	24.5	45.1	9.5	20.4	31.6	4.5	20.0	13.2	43.2	20.5	1.7	1.1	42.0	4.1	23.0	9.7	0.6	10.8	17.7	17.8	20.6	8.9	10.2	7.2	11.1	117.2	25.4	43.5	6.0	6.3	15.5	67.0	23.6	6.7	3.6	13.1	6.8	11.2	1.4	4.4	8.6	5.4	26.5	14.6	7.0	34.9	17.9
SLC35G2	"DKFZp564K2464, MGC3295, TMEM22"	ENSG00000168917	"Solute carrier family 35 member G2"	Q8TBE7	3	136818647-136855888	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.2;Early spermatids: 65.4;Inhibitory neurons: 42.4;Spermatocytes: 35.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052054, HPA064728"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA052054: AB_2681709, HPA064728: AB_2685336"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.91e-4)"	"unprognostic (2.56e-4)"	"unprognostic (5.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.30e-2)"	14.9	15.4	20.9	2.1	21.2	0.5	11.1	23.1	26.4	5.1	16.5	3.8	1.0	4.3	4.6	2.6	5.7	5.3	8.1	20.0	24.4	3.9	4.4	7.0	1.9	21.4	25.0	5.5	7.6	6.7	19.3	7.4	26.9	4.1	2.0	5.3	3.1	2.6	2.4	3.7	2.9	5.1	22.1	3.2	2.9	14.4	22.6	2.8	8.5	5.4	1.2	6.5	5.0	21.0	3.9	10.7	10.6	4.8	20.8	17.1	0.0	16.9	73.1	24.7	37.0	10.1	5.7	0.0	12.7	17.5	39.3	1.3	12.7	0.7	22.8	0.1	3.5	3.2	12.0	6.3	26.6	0.1	0.0	24.2	1.8	21.5	5.9	18.0	18.8	6.8	1.8	0.1	32.1	0.0	4.7	3.3	2.3	0.0	7.9	4.2	7.1	0.2	21.1	0.9	17.5	11.7	13.7	0.0	24.0	3.6	0.0	1.8	13.1	18.4	4.7	8.2	18.6	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	20.9	21.2	23.1	26.4	20.0	24.4	21.4	25.0	26.9	22.1	22.6	21.0	22.4	12.8	7.0	54.2	2.5	3.3	4.9	12.0	7.4	4.7	0.7	0.8	2.5	1.5	7.1	1.8	12.5	1.3	2.7	0.8	1.9	3.3	65.4	1.0	1.6	30.6	4.2	4.4	34.0	10.7	1.3	12.4	0.5	1.3	2.5	3.6	27.8	2.3	0.7	6.7	42.4	1.0	0.0	2.2	7.3	30.3	9.9	2.1	3.6	17.8	3.7	7.8	15.5	15.6	6.1	10.0	0.1	3.0	3.7	4.7	0.6	0.7	1.4	4.6	6.6	4.7	4.8	35.5	16.1	1.2	3.0	2.2	3.8	3.1	0.6	2.0
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063302-125090516	"Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 78.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 13.4;Hofbauer cells: 36.5;Kupffer cells: 22.0;Macrophages: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 12.3;intermediate monocyte: 14.1;myeloid DC: 5.5;non-classical monocyte: 19.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.5;monocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;CAPAN-2: 70.3;hTCEpi: 34.9;hTERT-HME1: 64.8;U-138 MG: 47.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	4.2	24.2	1.7	16.9	2.6	1.4	4.6	2.4	3.7	2.3	2.1	8.0	9.1	1.0	1.3	13.4	1.2	5.1	1.5	1.9	2.3	0.7	5.9	5.9	5.7	4.3	2.7	1.0	1.2	1.1	0.2	7.4	3.8	2.6	10.2	0.5	78.8	1.4	0.6	20.9	7.7	3.1	3.2	15.8	2.1	1.6	5.2	2.1	0.6	0.9	5.1	11.9	7.7	7.3	33.8	0.1	1.0	0.4	0.6	0.8	0.6	1.6	2.8	1.0	2.5	0.2	70.3	0.4	9.4	0.4	2.5	21.0	0.4	20.9	3.8	0.9	0.6	6.6	1.6	2.4	0.1	0.3	0.9	0.7	34.9	2.6	64.8	2.7	1.7	1.3	0.5	2.2	3.1	0.3	0.3	4.6	1.9	0.2	1.0	0.4	2.7	0.8	1.0	17.6	0.3	0.3	4.8	2.9	2.6	0.5	0.3	1.8	3.7	47.2	1.9	0.7	1.6	1.8	1.5	1.1	1.7	2.4	4.1	0.2	12.3	0.0	0.0	14.1	0.0	0.4	0.0	0.1	5.5	0.1	0.1	0.1	1.3	0.0	19.2	0.2	0.0	5.4	1.7	2.6	2.4	3.7	1.9	2.3	4.3	2.7	3.8	3.2	5.2	7.3	0.7	0.0	0.6	0.3	3.8	0.3	1.4	0.5	1.2	1.5	1.4	1.1	1.1	1.5	1.6	0.0	2.1	0.6	0.7	13.4	0.0	0.1	1.6	1.9	1.4	1.3	0.0	2.7	0.3	0.0	0.8	0.5	0.0	4.9	2.5	0.4	1.8	0.3	36.5	0.0	0.3	0.1	0.0	22.0	1.4	2.2	0.9	22.7	0.0	8.4	7.3	0.3	3.1	1.0	0.2	0.1	3.3	1.2	1.7	1.0	0.0	0.1	0.2	0.8	0.0	0.8	0.6	2.7	1.1	5.7	0.9	3.4	1.2	0.4	0.1	3.2
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.2;Excitatory neurons: 98.8;Hofbauer cells: 100.3;Inhibitory neurons: 77.4;Late spermatids: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	7.6	9.1	6.0	4.7	6.6	2.9	7.4	6.1	9.5	7.3	8.9	4.8	3.1	5.1	13.2	3.3	5.6	9.9	3.7	6.9	6.5	12.0	6.3	8.6	7.8	5.4	6.0	5.8	3.4	21.3	7.2	9.6	6.0	5.1	6.6	7.5	5.9	3.9	2.1	2.9	3.5	5.3	5.0	6.6	3.8	5.0	7.4	5.0	6.3	3.0	4.8	7.0	5.0	6.7	16.2	21.5	6.8	12.3	68.7	25.3	4.9	11.6	34.5	10.7	10.2	5.4	41.0	4.0	19.2	10.6	22.5	13.5	6.8	11.9	9.8	6.0	3.2	6.7	8.6	14.2	22.7	3.7	12.1	19.9	4.9	10.5	12.2	43.2	14.3	6.8	9.3	8.4	37.5	9.2	6.6	8.4	4.0	9.5	14.3	1.6	20.1	11.9	30.7	8.5	3.3	3.0	9.9	7.0	19.1	9.3	10.4	5.8	15.6	16.4	7.1	20.0	6.5	1.6	4.9	1.6	34.0	3.0	13.1	0.0	6.6	0.1	1.7	7.1	2.2	2.2	3.1	2.4	3.6	2.0	2.7	3.4	0.2	0.8	4.5	4.4	4.5	2.8	6.0	6.6	6.1	9.5	6.9	6.5	5.4	6.0	6.0	5.0	7.4	6.7	6.8	22.4	6.7	31.6	6.0	5.2	11.4	14.6	8.0	19.7	7.2	7.5	4.3	7.2	10.0	5.5	22.9	5.6	4.9	2.6	1.9	5.3	178.2	13.0	11.0	7.2	4.2	3.4	98.8	2.8	9.4	11.2	5.1	6.2	6.3	7.3	4.2	4.6	100.3	5.0	77.4	3.1	6.1	24.8	10.0	124.4	10.8	26.2	5.4	20.6	6.4	11.7	2.1	54.3	30.8	7.4	1.9	6.0	5.8	6.6	3.3	23.1	40.4	24.9	0.0	12.3	9.1	16.6	11.5	6.4	2.8	6.7	7.8	5.0	2.8	6.9
SLC4A5	NBC4	ENSG00000188687	"Solute carrier family 4 member 5"	Q9BY07	2	74216242-74343414	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Sodium transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 73.4;retina: 42.0;thyroid gland: 26.7"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 168.2"	"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-266/70: 8.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 1.6;hippocampal formation: 5.2;pons and medulla: 6.5;thalamus: 3.5"	"Low region specificity"	"Detected in many"			HPA036621	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA036621: AB_10696779"	"unprognostic (1.30e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.37e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.72e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.27e-4)"	1.6	0.7	3.3	1.1	5.2	2.3	1.4	12.5	4.6	1.3	73.4	1.2	0.7	1.4	2.3	0.9	2.1	1.0	1.4	6.1	4.1	1.0	1.0	2.6	1.8	5.3	4.8	1.6	1.5	12.4	2.4	0.6	4.8	1.2	0.7	42.0	1.7	1.3	1.8	5.0	1.0	1.5	2.8	1.3	0.9	16.1	5.3	1.0	26.7	1.5	0.8	1.1	1.1	8.5	0.3	0.5	0.9	0.9	0.9	1.6	0.9	0.2	0.9	0.5	0.7	0.3	0.7	1.5	0.2	0.0	0.3	0.1	1.0	0.1	0.2	1.2	0.6	2.2	0.7	0.5	0.1	0.5	1.3	0.4	1.3	0.0	0.2	0.5	0.3	1.0	0.5	1.5	0.2	3.5	0.3	1.5	0.4	0.5	0.3	0.8	0.7	0.0	0.2	0.6	0.6	1.2	0.3	1.1	1.6	0.7	0.8	1.5	0.0	0.9	1.6	0.9	0.3	8.8	1.4	1.0	0.6	0.8	0.2	4.3	0.3	0.3	0.6	0.3	0.4	0.7	1.0	0.9	0.3	0.9	0.8	1.0	1.9	0.7	0.1	2.5	1.2	0.2	3.3	5.2	12.5	4.6	6.1	4.1	5.3	4.8	4.8	2.8	5.3	8.5	1.1	3.2	10.8	16.0	0.5	0.6	0.6	0.3	0.0	13.9	0.6	0.5	0.4	1.5	2.6	0.0	35.5	0.1	3.3	0.3	0.0	0.4	0.6	1.0	0.7	0.9	0.0	0.4	7.3	0.6	0.0	0.8	0.0	0.8	0.0	1.1	0.7	0.0	0.1	168.2	10.6	0.5	0.0	0.0	0.4	0.6	1.2	0.4	1.8	4.7	0.1	3.3	2.1	4.0	31.1	0.5	0.3	0.4	0.1	0.6	0.3	0.1	4.1	40.4	0.0	2.5	1.1	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.2	0.7
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 131.6;kidney: 300.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 216.5;Kupffer cells: 410.6;Macrophages: 146.2;monocytes: 164.0;Proximal enterocytes: 423.1;Proximal tubular cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 299.9;intermediate monocyte: 410.0;non-classical monocyte: 457.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 457.1"	"Group enriched"	"Detected in many"	4	"BEWO: 217.2;CACO-2: 385.7;OE19: 329.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	15.1	9.0	3.1	37.4	3.2	19.7	6.8	3.8	7.5	7.3	4.3	13.8	107.0	5.3	2.0	3.7	7.8	17.0	5.1	2.8	3.8	300.6	16.4	54.1	29.1	6.9	4.7	2.1	5.2	78.4	1.4	18.2	6.4	3.5	15.0	1.0	5.4	2.8	2.0	3.2	131.6	15.6	5.1	56.8	8.6	32.8	7.1	9.6	4.6	2.8	25.2	14.7	4.1	8.1	0.2	11.2	1.2	0.5	1.9	3.7	217.2	2.2	16.3	0.4	1.4	385.7	34.4	17.0	72.2	1.4	1.2	13.3	0.1	0.0	0.6	0.6	0.2	0.9	0.4	3.7	9.1	1.9	1.6	7.1	1.0	1.0	0.5	1.8	25.3	1.5	0.1	12.8	2.9	0.6	0.4	1.7	3.6	329.0	0.1	2.9	35.5	9.8	0.8	1.3	0.4	0.8	0.6	0.5	2.5	9.4	0.4	8.3	1.3	0.8	1.7	0.6	0.5	2.7	0.9	8.9	0.9	0.8	0.2	0.2	299.9	1.1	0.5	410.0	0.4	19.1	0.2	0.2	99.5	13.8	0.7	0.4	36.5	0.3	457.1	3.4	0.9	155.1	3.1	3.2	3.8	7.5	2.8	3.8	6.9	4.7	6.4	5.1	7.1	8.1	5.3	12.8	7.1	2.0	14.3	1.0	0.2	6.7	1.8	0.2	0.5	1.7	0.9	67.2	5.6	3.7	0.0	1.2	5.7	3.0	11.7	8.2	61.1	1.7	1.2	5.0	1.2	0.0	0.6	6.4	5.2	4.4	2.6	0.4	1.3	0.7	16.1	3.0	216.5	0.0	1.4	7.2	2.0	410.6	16.8	11.8	3.7	146.2	5.4	20.6	164.0	0.4	4.1	0.0	0.8	8.9	12.5	0.0	20.1	0.1	423.1	327.6	9.2	1.3	6.6	0.8	1.4	17.8	2.2	0.4	0.4	1.8	2.7	38.8	6.4	0.1
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.3;Horizontal cells: 48.8;Inhibitory neurons: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA059445: AB_2684021, HPA059590: AB_2684075"	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	5.1	6.3	11.6	5.6	11.9	4.6	3.3	1.2	15.7	5.6	0.0	6.0	8.5	6.4	3.3	6.3	5.7	5.5	8.6	12.7	19.0	6.9	4.5	6.7	5.7	7.8	4.4	8.0	3.8	10.4	2.2	4.7	8.9	4.0	6.1	14.4	4.1	4.9	7.5	4.7	7.8	7.4	3.4	5.7	5.8	5.8	15.3	5.6	6.7	7.1	6.6	5.6	1.6	4.2	20.0	10.5	9.1	3.8	14.8	14.2	17.3	15.9	16.9	13.3	27.9	9.2	15.5	14.8	35.2	18.4	19.8	11.6	14.3	14.0	19.1	11.7	12.9	4.0	15.3	5.3	7.9	11.6	13.3	7.7	11.6	22.0	10.8	9.4	11.2	12.5	7.5	20.5	14.9	8.7	15.5	3.4	6.0	7.1	14.0	10.4	16.0	15.2	9.4	9.8	9.5	7.2	11.4	1.2	8.9	8.8	4.5	8.7	16.4	16.5	10.9	24.5	20.7	9.6	23.8	12.7	10.0	19.4	9.4	2.0	5.0	3.0	6.4	7.0	11.1	4.1	7.1	5.9	5.8	2.6	7.6	5.7	2.0	5.1	6.0	3.5	6.9	5.4	11.6	11.9	1.2	15.7	12.7	19.0	7.8	4.4	8.9	3.4	15.3	4.2	4.3	3.2	5.4	22.9	5.9	7.5	1.4	6.2	7.4	14.2	2.7	3.4	11.2	12.8	4.0	12.9	8.4	2.5	6.1	8.9	0.0	4.3	0.8	4.2	4.1	4.9	10.7	5.0	40.3	6.0	2.4	5.1	8.6	6.8	1.3	4.6	8.2	9.6	9.9	48.8	42.0	4.0	8.2	13.0	7.0	1.4	5.6	9.8	8.8	15.9	8.2	12.9	4.1	19.6	22.7	6.1	6.0	4.5	3.8	2.0	10.3	6.0	3.1	7.8	0.0	5.1	8.4	9.0	11.9	7.0	6.8	2.9	8.9	3.1	6.0	3.1
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599251-46759118	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.3;Inhibitory neurons: 66.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	0.5	5.0	9.1	2.4	41.6	3.6	5.8	6.3	14.6	1.2	0.5	0.6	1.2	0.8	2.6	1.9	1.7	1.6	1.1	8.6	17.0	2.6	3.1	1.3	6.3	13.9	7.5	4.3	3.4	8.9	9.2	1.1	14.2	4.6	0.9	4.9	6.0	2.0	5.7	2.1	2.2	0.7	6.7	3.7	6.3	0.8	14.5	3.2	4.3	2.5	6.3	1.8	1.3	5.1	10.4	7.7	1.1	3.3	1.2	7.4	4.3	9.6	12.0	5.7	4.5	7.9	10.9	22.7	2.9	15.6	11.0	4.6	7.4	10.9	10.3	11.9	3.9	2.3	3.1	3.3	4.6	1.0	17.9	4.6	1.4	16.1	10.6	26.8	8.2	7.7	0.2	0.3	7.9	15.7	2.6	1.2	5.3	5.0	9.2	10.0	0.4	0.2	4.4	11.4	8.2	1.0	4.9	7.3	2.1	9.2	9.7	0.4	0.4	12.0	4.0	1.8	5.7	2.3	0.5	11.2	17.1	0.1	4.0	0.5	0.2	0.1	0.1	0.2	0.1	1.7	0.2	0.1	1.1	1.7	0.1	0.1	0.8	0.5	0.2	2.8	0.3	0.2	9.1	41.6	6.3	14.6	8.6	17.0	13.9	7.5	14.2	6.7	14.5	5.1	0.5	3.2	8.2	11.4	21.0	0.6	10.1	0.9	1.2	13.0	16.9	8.6	5.7	1.5	2.6	16.5	4.2	7.9	24.4	0.3	0.0	17.6	0.0	1.8	2.0	1.5	2.4	5.5	43.3	14.2	0.7	2.7	13.3	1.7	0.0	4.5	0.7	6.5	6.4	13.5	66.8	2.0	0.0	6.3	8.4	0.6	0.9	9.2	1.8	3.7	8.0	6.1	1.0	69.9	1.6	16.4	0.1	0.4	2.8	21.0	0.1	2.1	0.1	3.5	6.6	12.1	1.9	0.0	1.6	4.2	1.0	7.3	2.9	1.3	0.9	11.5
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 229.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 204.5;Hofbauer cells: 122.2;Kupffer cells: 155.8;Macrophages: 92.4;Microglial cells: 232.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 90.3;GAMG: 21.2;Hep G2: 20.4;HMC-1: 25.8;OE19: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	39.9	31.5	40.1	34.0	35.9	2.9	12.1	34.0	37.4	18.1	21.3	30.9	42.1	9.5	3.6	19.7	13.2	28.4	15.6	31.9	47.2	21.0	229.6	60.7	60.1	75.7	53.4	9.4	22.1	7.9	5.1	43.9	63.0	6.1	23.6	1.5	8.4	9.6	5.6	4.3	51.3	26.3	49.7	46.4	15.0	6.0	80.4	16.7	10.1	8.0	28.5	26.3	6.2	55.1	0.0	0.7	2.8	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	90.3	0.0	0.1	0.1	0.0	21.2	0.2	0.0	0.0	0.0	1.1	0.0	15.0	1.0	20.4	0.0	1.1	25.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.3	8.7	0.0	0.1	0.0	0.1	0.1	111.1	0.0	0.0	2.4	9.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.3	0.0	1.5	1.8	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	35.9	34.0	37.4	31.9	47.2	75.7	53.4	63.0	49.7	80.4	55.1	4.7	0.0	8.9	1.3	0.7	1.9	0.0	0.0	1.8	3.4	0.9	1.4	2.8	11.5	1.8	0.0	0.0	0.9	0.1	14.7	1.9	0.0	2.8	0.0	0.1	28.8	0.0	2.7	0.5	0.2	2.3	3.6	0.5	0.0	22.9	6.1	3.6	204.5	122.2	0.0	0.5	6.6	0.0	155.8	8.9	1.7	10.8	92.4	0.0	232.3	2.0	0.2	0.0	1.5	0.6	0.1	14.6	10.5	1.4	0.0	46.7	8.2	0.7	0.7	0.0	3.0	1.1	0.4	0.2	4.5	0.4	2.5	0.7	0.4	13.3	0.1
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 246.5;Inhibitory neurons: 263.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 1486.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA		19000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	51.9	55.9	68.9	36.1	73.9	95.7	62.0	87.4	81.7	42.1	40.2	31.0	20.2	53.2	57.3	41.7	57.4	46.0	43.8	60.3	53.7	45.9	58.3	40.3	50.9	43.2	54.4	166.0	36.8	170.3	32.7	48.2	50.6	42.5	31.7	63.6	50.7	53.2	97.7	48.2	27.7	44.2	40.3	52.3	32.0	56.3	55.7	42.2	55.7	60.1	47.8	31.8	28.8	52.9	45.7	32.9	23.7	33.8	47.2	56.6	71.7	59.4	44.6	24.9	19.5	0.5	17.7	76.2	22.0	50.7	13.5	18.8	12.9	46.5	17.6	1486.7	20.2	208.3	88.2	16.2	18.7	88.3	118.1	37.6	17.5	24.9	46.4	44.9	40.3	35.4	7.3	255.1	43.0	19.1	22.2	72.3	23.4	26.4	12.6	97.6	30.5	69.4	57.6	40.9	15.3	14.0	36.2	8.3	14.9	34.1	16.3	55.8	49.1	40.6	19.8	25.8	27.3	22.9	31.8	33.6	43.5	32.5	11.4	26.1	5.2	15.8	10.8	7.2	10.4	12.3	10.5	11.2	6.4	9.4	13.1	10.3	14.6	9.9	10.3	12.5	12.6	5.0	68.9	73.9	87.4	81.7	60.3	53.7	43.2	54.4	50.6	40.3	55.7	52.9	83.9	73.7	70.6	246.5	57.2	58.6	18.3	55.0	82.6	57.6	103.7	74.3	95.2	31.5	54.1	106.7	37.5	99.3	102.8	32.0	31.3	30.6	38.0	44.1	61.6	69.0	37.2	41.2	216.2	22.4	24.5	65.7	19.4	45.2	48.0	27.9	36.8	62.0	31.5	35.3	263.2	31.2	48.8	54.9	34.7	22.6	76.7	57.5	49.8	142.4	45.2	53.4	43.3	120.6	100.8	18.7	15.1	86.9	71.4	13.9	26.9	18.5	88.3	37.4	13.1	58.7	40.3	42.9	14.6	66.2	52.7	88.7	74.8	56.1	28.2	12.7
SMARCE1	BAF57	ENSG00000073584	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1"	Q969G3	17	40624962-40648654	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	Neurogenesis	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003916, CAB037318"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB037318: AB_476780, HPA003916: AB_1857279"	"unprognostic (7.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-2)"	39.4	22.2	10.5	37.8	11.9	43.2	35.6	10.6	13.3	45.9	14.3	40.2	38.9	56.2	28.3	43.6	39.0	41.4	40.1	9.2	11.7	31.2	31.5	36.1	49.6	13.7	10.7	58.6	35.4	38.3	13.3	48.4	13.2	34.2	38.5	17.5	33.6	42.1	42.5	27.7	39.3	57.4	11.7	40.5	30.9	31.5	11.2	76.1	40.8	44.7	54.2	46.8	26.2	16.5	86.5	139.6	169.1	126.5	87.7	125.5	82.8	105.9	145.4	122.1	91.0	92.7	72.7	135.9	149.6	145.3	81.0	114.5	106.1	112.3	145.1	128.3	138.0	97.2	73.4	165.2	87.8	179.8	94.5	109.3	87.6	97.7	140.6	122.1	133.4	106.5	144.2	52.2	118.2	96.5	331.6	37.1	95.4	70.8	68.6	183.3	190.2	103.7	147.5	144.9	134.6	130.0	94.5	269.4	86.6	181.5	161.5	111.4	109.7	98.1	107.6	89.7	132.6	97.7	122.8	204.5	100.0	80.9	154.9	106.3	64.4	88.2	91.7	67.8	95.0	99.8	82.4	96.1	77.9	112.3	68.3	79.3	26.5	124.7	82.2	80.3	114.7	112.2	10.5	11.9	10.6	13.3	9.2	11.7	13.7	10.7	13.2	11.7	11.2	16.5	41.4	48.1	45.1	13.1	67.5	38.1	43.0	69.5	65.4	75.8	19.7	20.2	53.0	38.6	61.5	20.2	16.7	101.8	68.7	38.7	15.6	41.5	27.1	34.9	47.0	60.4	96.5	84.1	17.1	32.3	75.7	72.4	44.9	32.1	74.0	41.3	62.8	44.0	51.6	82.4	18.8	53.5	65.1	42.9	39.6	11.8	90.4	30.9	24.9	19.7	63.2	63.3	105.0	26.7	32.7	35.7	46.7	82.4	44.2	36.5	52.8	30.5	59.3	37.1	39.5	62.7	57.0	49.7	50.9	63.3	40.1	114.8	53.8	35.3	62.5	34.3
SMIM35	TMPRSS4-AS1	ENSG00000255274	"Small integral membrane protein 35"	A0A1B0GVV1	11	118003634-118088299	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;kidney: 1.1"	"Cell type enhanced"	"Detected in single"		"Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Karpas-707: 10.9;RPMI-8226: 7.2"	"Group enriched"	"Detected in some"	5	"basal ganglia: 1.2;olfactory bulb: 3.5"	"Region enriched"	"Detected in some"	6	"basal ganglia: 7.9"							NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"					"unprognostic (8.83e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.64e-1)"		"unprognostic (1.58e-1)"		"unprognostic (3.04e-4)"		"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"			"unprognostic (1.64e-1)"			"unprognostic (1.88e-1)"	0.1	0.1	0.2	0.5	0.3	1.2	0.2	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	1.1	0.1	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.3	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.2	1.6	0.1	0.2	0.3	0.1	0.5	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNAI3	"SMUC, Zfp293, ZNF293"	ENSG00000185669	"Snail family transcriptional repressor 3"	Q3KNW1	16	88677688-88686507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 31.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 19.7;granulocytes: 9.5;Kupffer cells: 14.6;Langerhans cells: 9.3;Macrophages: 9.4;NK-cells: 17.5;Plasma cells: 14.0;T-cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"NB-4: 18.2;RPMI-8226: 28.6"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Not detected"	"Not detected"			HPA071127			Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA071127: AB_2686346"	"unprognostic (1.03e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.19e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.09e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.47e-2)"	0.7	0.5	1.5	2.4	2.4	1.8	0.4	0.0	3.3	0.6	0.0	1.2	1.5	0.6	0.3	0.6	0.8	1.0	2.4	1.9	0.0	0.7	0.8	2.2	3.9	2.1	0.0	0.5	1.7	1.5	0.7	0.1	3.7	0.8	0.3	0.3	1.2	0.2	31.3	0.6	3.7	0.2	0.0	6.9	3.3	0.9	0.0	0.8	0.9	7.3	2.6	1.4	0.5	0.0	0.3	0.9	0.3	1.3	0.0	0.0	0.6	0.3	0.0	0.0	0.1	3.5	0.3	2.3	0.5	0.0	0.8	0.8	0.3	0.2	0.0	0.4	1.2	1.1	0.1	1.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	1.5	2.1	4.3	0.0	3.2	0.2	18.2	0.4	0.3	0.4	3.9	0.3	28.6	0.0	0.4	1.7	0.2	0.7	0.0	0.2	0.4	1.2	2.2	0.3	0.1	1.0	0.2	0.0	0.7	4.2	4.0	0.3	4.9	0.5	5.2	14.1	48.5	10.2	5.3	18.8	7.8	16.7	9.8	16.7	6.1	10.0	6.4	30.9	1.1	1.5	11.9	21.4	10.9	1.5	2.4	0.0	3.3	1.9	0.0	2.1	0.0	3.7	0.0	0.0	0.0	0.3	3.2	0.0	2.0	8.5	0.5	0.1	0.4	0.0	0.2	0.4	0.5	2.0	0.0	0.7	0.0	0.0	0.0	19.7	0.0	1.9	0.1	0.0	0.6	0.0	0.4	0.0	0.4	6.4	0.4	0.5	0.2	0.5	0.1	9.5	0.0	0.4	0.1	6.9	0.0	3.7	0.1	2.0	14.6	9.3	0.3	0.0	9.4	5.4	0.0	5.3	0.1	17.5	1.0	1.9	0.1	1.1	0.4	14.0	0.1	0.0	0.2	1.0	0.9	0.0	0.7	0.4	0.0	1.5	0.2	0.3	0.1	14.0	0.0	0.3	0.1
SNCAIP	SYPH1	ENSG00000064692	"Synuclein alpha interacting protein"	Q9Y6H5	5	122311354-122464219	"Disease related genes, Predicted intracellular proteins"			"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.5;ovary: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Early spermatids: 68.1;Endometrial stromal cells: 56.9;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 7.6"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in some"		"AF22: 5.2;BJ hTERT+: 5.1;HBF TERT88: 3.2;OE19: 3.0;RPMI-8226: 5.2"	"Low region specificity"	"Detected in all"							HPA064687	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytoplasmic bodies"	Nucleoplasm	"HPA064687: AB_2685324"	"unprognostic (7.28e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-1)"	3.1	1.0	2.5	2.5	7.8	0.3	1.4	7.2	3.0	17.2	10.1	1.1	1.2	19.5	1.3	0.6	5.1	2.5	1.3	2.9	2.9	1.7	0.1	1.2	2.1	4.6	5.2	37.5	0.5	0.2	1.2	2.0	4.2	1.9	1.1	0.5	0.4	2.7	0.3	1.8	0.7	12.0	3.0	5.2	1.0	4.5	5.7	1.7	0.8	1.6	1.5	4.1	2.5	4.3	0.0	0.0	5.2	0.1	0.0	0.0	0.1	2.2	5.1	0.8	0.4	0.0	0.1	0.1	0.1	2.2	0.4	0.0	2.1	0.3	3.2	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.2	0.0	0.6	0.1	0.0	0.8	0.0	0.0	0.0	0.1	2.5	3.0	0.0	0.1	0.0	5.2	0.2	0.6	0.9	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.5	0.3	0.4	0.0	0.0	0.2	0.2	0.0	0.1	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.5	7.8	7.2	3.0	2.9	2.9	4.6	5.2	4.2	3.0	5.7	4.3	6.1	0.0	0.5	84.5	0.0	1.8	3.8	0.5	1.8	0.4	0.4	1.0	0.8	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	6.1	68.1	4.6	56.9	7.1	0.0	0.0	21.8	0.0	0.1	5.6	0.0	1.4	1.3	0.1	18.9	0.2	0.3	0.0	62.8	0.0	0.0	0.8	0.4	16.6	5.3	0.6	1.8	13.1	0.0	0.5	0.0	30.7	1.9	0.4	0.7	5.7	0.0	3.0	0.0	0.3	14.9	0.0	0.0	0.5	2.3	4.1	2.1	1.8	2.7	0.1	0.4	0.1	0.2	1.5
SNX29	"FLJ12363, RUNDC2A"	ENSG00000048471	"Sorting nexin 29"	Q8TEQ0	16	11976734-12574287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 354.5;Late spermatids: 430.7;Microglial cells: 169.6;Oligodendrocytes: 241.6;Rod photoreceptor cells: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 22.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008889, HPA062810"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Nucleoli, Cytosol"	"HPA008889: AB_1079856, HPA062810: "	"unprognostic (2.50e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.82e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.08e-2)"	"prognostic favorable (1.38e-7)"	"unprognostic (3.85e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (1.03e-4)"	8.6	3.5	7.4	8.2	18.8	9.5	6.2	13.6	11.8	6.6	7.4	5.3	2.3	5.8	2.6	8.2	8.4	4.8	4.5	7.5	9.9	19.0	2.3	6.8	13.0	17.0	15.6	10.2	3.5	22.5	7.1	8.0	18.3	3.5	3.4	23.8	5.6	4.8	6.0	6.9	4.6	5.7	11.4	9.0	4.3	8.5	17.9	21.0	6.5	5.7	16.0	6.3	5.0	26.7	5.0	2.9	4.4	3.5	25.4	20.8	5.7	10.7	29.1	4.3	4.7	0.6	5.7	18.7	13.9	16.6	2.8	4.2	2.9	6.8	6.2	7.2	3.0	2.5	2.5	6.4	4.9	2.7	6.6	19.1	4.4	6.3	2.8	6.5	7.6	6.1	3.9	5.2	4.4	6.7	5.0	3.1	2.4	3.2	2.6	11.3	5.6	15.2	19.3	4.6	5.2	4.4	12.2	7.2	2.5	3.8	4.1	3.2	11.7	7.6	3.0	5.8	2.1	29.5	24.4	11.5	14.1	2.8	4.9	3.8	6.9	1.6	2.0	4.5	2.5	10.6	4.3	2.7	2.5	22.3	5.2	3.6	2.5	1.3	2.3	7.4	4.0	1.9	7.4	18.8	13.6	11.8	7.5	9.9	17.0	15.6	18.3	11.4	17.9	26.7	14.4	12.8	22.9	71.2	61.0	15.3	6.5	5.3	19.9	63.9	8.5	7.4	9.7	4.3	10.8	16.5	354.5	18.6	26.9	4.4	21.5	4.6	124.0	35.3	27.8	13.8	13.1	6.1	59.0	2.9	5.0	20.8	14.8	62.6	42.5	15.2	17.9	4.8	28.7	92.5	54.6	4.6	8.2	29.3	39.6	430.7	21.5	36.7	12.4	169.6	24.3	23.1	16.5	51.8	241.6	7.7	4.3	15.4	23.9	3.6	3.3	42.6	27.2	256.1	6.6	20.8	14.2	20.0	10.8	21.9	15.5	17.1	15.4	14.1	4.0	5.5
SOBP	FLJ10159	ENSG00000112320	"Sine oculis binding protein homolog"	A7XYQ1	6	107490106-107661306	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 175.3;Excitatory neurons: 260.1;Granulosa cells: 149.3;Inhibitory neurons: 287.7;Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AF22: 10.5;AN3-CA: 13.9;ASC diff: 12.9;HDLM-2: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029242	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Vesicles	"HPA029242: AB_10603340"	"unprognostic (7.11e-2)"	"unprognostic (1.35e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.84e-2)"	"unprognostic (5.35e-3)"	"prognostic favorable (1.55e-5)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-3)"	4.5	6.6	12.4	1.7	14.5	0.0	3.4	9.0	16.9	6.2	0.4	14.6	1.2	5.6	2.0	2.0	4.3	2.7	10.9	15.3	8.2	3.4	1.6	2.4	0.9	6.7	9.1	10.8	1.4	3.1	9.4	2.3	6.2	8.2	1.3	5.3	10.4	2.6	16.7	1.2	3.2	3.9	6.5	1.9	4.8	4.2	9.5	2.7	4.2	5.9	1.1	11.9	4.4	11.4	0.0	0.3	10.5	13.9	12.9	4.9	1.2	0.0	0.0	0.3	0.6	0.0	0.0	5.7	0.3	0.0	0.9	0.0	7.0	0.2	0.2	9.0	6.8	0.6	0.0	6.8	1.6	3.0	0.5	5.2	0.0	5.1	0.0	1.1	4.2	2.6	0.0	0.3	0.0	2.9	1.3	0.3	2.5	0.3	0.9	3.1	1.3	0.0	0.0	0.2	3.3	5.6	1.2	0.0	0.1	0.4	0.4	2.0	0.0	3.3	1.1	5.7	0.5	2.6	0.5	3.5	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	14.5	9.0	16.9	15.3	8.2	6.7	9.1	6.2	6.5	9.5	11.4	6.0	3.2	9.8	175.3	9.2	0.5	10.3	11.4	3.4	40.4	0.5	7.4	19.4	17.2	6.1	23.9	0.0	0.2	1.8	0.2	0.0	2.5	96.2	0.6	15.8	4.4	10.8	5.3	260.1	0.2	0.7	23.6	3.1	0.4	0.0	149.3	5.3	1.4	3.0	92.5	287.7	0.1	4.1	9.6	4.1	61.4	45.1	1.8	3.6	51.5	0.1	7.6	0.0	263.9	278.8	0.4	0.0	48.9	0.2	9.3	0.0	11.9	10.9	10.1	26.3	42.8	21.0	61.2	5.6	0.6	0.9	0.1	1.3	13.3	0.2	1.0
SORBS2	"ARGBP2, KIAA0777"	ENSG00000154556	"Sorbin and SH3 domain containing 2"	O94875	4	185585444-185956652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 575.3;thyroid gland: 277.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 557.8;Cone photoreceptor cells: 771.5;Excitatory neurons: 397.4;Rod photoreceptor cells: 815.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 241.1;TIME: 133.1;WM-115: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (3.30e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (1.26e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.51e-2)"	27.4	166.6	32.3	11.5	62.5	0.1	38.9	0.0	40.3	31.8	14.1	85.9	10.5	17.6	34.3	36.5	37.0	29.0	575.3	38.0	2.1	32.4	126.5	19.2	5.3	16.1	0.9	17.6	117.3	100.5	29.1	69.0	18.2	56.1	25.9	156.1	74.4	62.3	6.9	8.1	16.1	31.6	1.9	26.2	40.5	3.0	2.8	31.1	277.6	12.8	11.3	50.1	16.3	26.7	0.4	0.5	241.1	0.2	33.6	59.4	12.0	0.5	0.2	0.0	0.6	6.8	19.4	0.0	25.8	2.2	1.6	0.0	0.0	9.1	0.2	0.1	3.6	3.8	18.4	16.0	0.0	0.0	0.2	22.0	2.7	37.1	2.9	31.7	44.8	6.7	0.1	0.2	2.7	0.0	0.0	0.7	23.4	0.0	0.0	23.9	0.0	0.2	32.8	5.9	30.2	9.0	0.0	0.1	14.9	23.3	7.3	0.0	133.1	18.2	2.4	0.3	9.4	0.3	0.4	0.3	39.3	0.0	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.3	62.5	0.0	40.3	38.0	2.1	16.1	0.9	18.2	1.9	2.8	26.7	71.1	22.4	41.4	18.9	2.4	6.5	18.5	44.1	21.6	99.7	81.4	45.6	557.8	228.8	85.5	64.4	771.5	12.8	1.9	8.5	5.9	166.1	3.2	80.8	4.0	69.6	41.9	5.3	397.4	110.1	2.6	30.7	30.1	75.3	2.5	102.4	26.7	206.6	1.6	5.0	247.3	14.0	61.1	4.1	8.0	6.9	5.6	2.5	19.6	150.9	3.1	265.7	12.3	204.1	7.2	57.7	27.1	3.8	5.3	25.8	15.8	25.8	149.3	815.8	118.3	4.4	297.8	0.3	1.4	12.4	5.5	10.9	1.8	13.2	26.8	19.3
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 111.3;stomach 1: 60.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 68.5;Distal tubular cells: 29.4;Gastric mucus-secreting cells: 76.5;Horizontal cells: 30.3;Ionocytes: 128.1;Melanocytes: 32.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;EFO-21: 12.7;HEL: 4.8;NTERA-2: 4.9;RPTEC TERT1: 23.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.2;hippocampal formation: 18.4;pons and medulla: 15.1;thalamus: 11.9"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.2	0.5	1.3	0.9	2.7	0.1	17.9	1.7	3.4	2.6	111.3	10.9	11.6	4.7	0.3	3.7	5.0	0.3	3.1	3.7	0.3	22.3	0.0	39.2	0.1	0.7	0.9	1.1	0.6	0.6	2.4	0.0	0.1	1.8	15.0	3.0	15.6	3.5	0.1	16.8	8.6	1.1	0.2	0.1	60.4	1.9	2.2	0.1	8.6	0.9	3.9	1.4	3.5	1.8	0.0	0.0	7.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	12.7	0.0	0.0	0.3	0.4	0.0	0.0	0.1	2.6	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.3	0.1	0.0	0.1	0.7	0.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.7	1.7	3.4	3.7	0.3	0.7	0.9	0.1	0.2	2.2	1.8	0.4	0.0	0.0	0.0	0.2	5.6	4.3	2.1	9.1	0.6	68.5	17.8	3.8	0.0	2.0	14.7	0.0	0.0	0.4	1.2	29.4	0.0	19.7	1.0	0.1	2.9	2.4	0.0	0.0	0.0	0.0	3.9	76.5	1.5	0.0	0.0	0.4	0.1	0.0	30.3	0.0	0.2	128.1	0.0	1.2	13.0	7.2	0.4	32.0	0.0	0.0	14.2	0.0	0.0	0.0	0.4	2.2	2.6	0.4	1.1	0.0	21.8	0.0	0.7	0.0	0.1	0.3	3.4	1.2	14.1	7.2	0.0	0.9	0.0	2.3	1.5
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box transcription factor 15"	O60248	17	7588178-7590094	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 87.4;skin 1: 48.2"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 209.2;Basal squamous epithelial cells: 447.3;Squamous epithelial cells: 388.1;Suprabasal keratinocytes: 169.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 6.7;non-classical monocyte: 10.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 10.6"	"Group enriched"	"Detected in many"	8	"A-431: 130.6;HaCaT: 142.1;HBEC3-KT: 57.8;hTCEpi: 56.6"	"Not detected"	"Not detected"							"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	2.2	0.9	15.0	0.8	14.6	2.7	3.4	17.4	23.3	21.1	11.8	12.4	0.7	8.2	1.7	87.4	11.0	1.0	8.6	14.5	15.3	1.7	1.3	1.5	0.5	14.3	15.0	15.3	1.0	0.2	7.9	0.3	14.1	12.1	0.5	5.0	14.6	7.1	2.3	48.2	3.5	1.3	14.5	1.1	4.7	2.6	14.7	1.0	2.3	1.8	2.8	10.4	32.7	15.0	130.6	3.2	1.8	1.0	0.1	0.3	9.6	1.4	0.5	1.1	1.7	2.5	0.8	0.4	1.2	0.1	0.4	142.1	0.1	57.8	0.4	3.3	3.9	0.5	1.7	0.5	0.2	0.3	2.6	0.0	56.6	0.7	11.9	3.6	0.0	2.6	2.9	0.8	0.2	0.9	0.6	1.5	3.6	0.3	0.7	1.6	1.8	1.0	2.7	0.7	0.8	2.2	1.5	0.5	0.7	5.5	1.1	1.0	1.6	1.3	2.3	1.6	4.4	0.9	1.5	1.6	4.4	1.7	3.2	0.1	2.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	10.6	1.0	0.0	0.4	15.0	14.6	17.4	23.3	14.5	15.3	14.3	15.0	14.1	14.5	14.7	15.0	0.8	0.0	0.0	2.6	0.1	209.2	51.8	72.7	447.3	13.6	6.3	13.0	4.7	0.0	20.6	1.8	14.6	1.7	0.7	0.5	1.9	0.1	0.2	0.4	4.9	3.1	1.2	0.0	8.1	0.5	2.0	10.4	0.0	0.4	0.0	1.3	1.4	0.0	0.4	10.1	7.7	0.4	10.2	1.2	19.3	1.1	31.4	0.9	26.6	1.0	1.2	50.0	0.0	4.0	2.4	0.5	0.1	36.9	4.9	21.2	0.3	0.2	16.2	9.4	32.9	7.8	7.1	0.7	10.9	388.1	169.9	1.1	1.1	0.6	0.8	73.8
SOX7		ENSG00000171056	"SRY-box transcription factor 7"	Q9BT81	8	10723768-10730511	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 42.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.4;Basal keratinocytes: 61.2;Basal prostatic cells: 67.6;Basal squamous epithelial cells: 148.5;Endothelial cells: 115.1;Squamous epithelial cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 11.8;hTCEpi: 21.3;HUVEC TERT2: 25.2;TIME: 6.8"	"Low region specificity"	"Detected in many"							HPA009065	Approved		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.45e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.41e-3)"	"unprognostic (4.84e-3)"	22.6	3.8	2.5	1.0	2.3	0.1	11.9	1.9	2.6	27.0	1.4	4.2	0.1	4.3	1.1	26.8	4.5	3.6	18.5	2.1	1.8	5.1	4.3	23.2	1.7	2.6	2.2	1.5	2.6	1.0	5.6	17.3	2.5	5.4	1.1	0.4	10.5	2.7	9.8	20.2	3.6	2.3	2.5	2.4	3.7	0.7	2.7	1.5	7.6	6.4	1.9	4.6	42.4	2.0	5.8	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.6	11.8	3.4	4.2	0.1	0.1	0.4	0.1	0.3	0.1	0.0	0.2	0.2	0.1	21.3	0.0	4.3	0.0	25.2	0.0	0.6	0.3	0.0	0.2	0.2	0.2	1.6	0.9	3.2	1.2	0.0	0.0	0.0	2.1	0.6	3.4	2.2	0.0	0.0	1.4	0.0	0.1	6.8	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	1.9	2.6	2.1	1.8	2.6	2.2	2.5	2.5	2.7	2.0	115.4	0.0	11.5	0.3	1.1	61.2	67.6	24.5	148.5	1.2	5.2	4.7	4.8	1.5	6.3	0.0	4.2	4.3	0.1	0.2	0.0	0.2	0.2	14.9	1.9	115.1	0.0	0.0	4.6	0.2	0.8	4.7	0.0	22.9	3.8	0.5	48.5	4.9	0.7	0.0	2.9	0.2	10.2	1.9	8.7	0.1	0.9	0.9	3.6	10.3	0.3	0.5	0.0	1.5	0.8	0.5	0.0	0.4	1.2	17.8	0.1	0.6	3.2	2.2	0.0	8.5	4.4	2.4	1.6	98.9	40.6	12.4	1.8	1.2	0.4	26.6
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230165186-230225729	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 99.3"					"Low region specificity"	"Detected in all"			HPA058554			Supported	Nucleoplasm		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA058554: AB_2683754"	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	14.0	7.3	8.4	38.5	10.3	29.8	11.8	9.4	10.8	11.6	11.5	12.6	11.9	10.5	7.9	9.2	9.6	18.0	8.1	8.1	10.3	11.9	14.8	21.0	53.7	15.3	10.9	16.5	7.9	9.7	5.3	17.5	11.6	9.6	14.0	2.0	17.0	7.6	5.7	7.8	17.6	13.4	12.1	49.8	12.9	3.1	10.9	35.7	7.4	8.4	50.1	18.9	9.3	12.3	8.3	4.4	2.7	4.7	14.2	23.6	8.3	14.8	30.8	70.3	99.3	0.2	12.7	34.5	13.8	15.8	67.0	5.1	9.0	23.0	25.7	30.5	6.0	14.9	6.2	8.9	14.5	22.1	17.1	32.7	11.8	20.8	27.4	13.2	25.3	23.6	5.3	12.1	20.6	4.9	33.0	43.5	8.6	4.2	5.1	20.1	25.4	12.8	56.2	11.1	0.5	5.7	5.7	12.7	32.7	0.9	9.6	18.5	18.8	12.9	7.9	3.2	7.5	12.9	4.6	16.2	14.4	20.6	10.7	92.2	49.7	124.4	55.2	85.8	47.8	142.8	53.5	50.5	44.1	135.8	54.1	58.7	268.6	56.9	143.4	84.4	70.7	48.5	8.4	10.3	9.4	10.8	8.1	10.3	15.3	10.9	11.6	12.1	10.9	12.3	77.8	44.8	23.8	17.3	141.7	9.9	5.2	25.7	16.5	0.4	21.6	19.3	3.7	7.2	19.6	11.0	0.0	3.8	84.0	17.0	13.7	19.9	5.2	17.2	21.3	28.6	6.7	9.7	1.1	28.5	12.7	22.8	9.2	20.1	38.0	21.2	26.4	6.2	26.9	0.0	2.1	11.4	73.2	47.4	25.8	4.2	11.8	62.3	19.6	42.2	56.7	9.7	59.8	19.6	18.2	26.0	11.6	10.1	35.7	3.5	10.7	14.4	21.0	4.9	6.6	8.6	16.2	4.8	2.3	9.8	10.1	4.7	68.8	23.5	6.1	3.0
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	14.8	10.7	9.4	16.6	11.6	19.4	15.4	16.1	11.5	12.9	6.9	14.3	14.9	14.7	12.0	17.2	15.1	11.5	18.3	9.6	10.1	12.5	8.7	14.9	20.6	12.4	10.4	15.1	16.0	23.5	9.8	13.6	11.1	13.5	13.3	10.5	16.2	12.5	32.2	14.8	15.6	12.8	8.3	17.7	13.0	17.8	11.8	25.3	18.1	26.6	15.0	13.6	13.4	13.3	33.5	37.3	25.1	21.6	12.1	11.2	26.1	19.3	13.6	19.0	17.1	41.3	16.2	28.6	17.4	24.7	20.1	25.6	17.5	16.4	19.9	41.7	26.6	28.5	25.6	22.3	11.2	26.4	34.2	16.4	19.1	22.4	21.1	13.5	18.5	26.3	31.8	47.5	18.8	45.0	64.6	16.8	11.8	29.6	24.9	30.8	34.4	18.6	13.4	52.1	26.8	31.4	16.9	17.9	20.0	15.0	26.7	25.6	30.3	34.8	18.1	24.2	30.1	42.3	50.6	26.0	19.0	18.5	29.2	13.6	6.1	9.9	8.3	7.0	7.3	4.9	6.3	7.9	4.9	5.6	7.1	7.4	11.3	9.7	6.6	4.5	7.2	6.6	9.4	11.6	16.1	11.5	9.6	10.1	12.4	10.4	11.1	8.3	11.8	13.3	14.6	9.6	19.5	5.2	17.7	6.2	15.8	7.8	12.0	9.0	9.8	9.9	9.7	12.8	8.3	11.0	0.0	10.7	11.3	16.4	15.6	7.0	9.8	8.1	6.2	11.6	15.6	25.2	5.2	7.6	9.2	9.4	8.6	10.7	13.3	5.5	8.2	7.5	8.9	11.8	4.8	9.0	14.2	10.9	8.2	10.5	10.5	14.2	8.8	6.5	11.7	12.1	17.5	9.0	9.9	7.3	13.2	3.4	12.7	11.0	8.6	8.1	10.2	6.5	6.6	12.6	12.5	9.8	6.3	9.6	7.5	20.5	14.8	5.3	7.9	17.0
SP3	SPR-2	ENSG00000172845	"Sp3 transcription factor"	Q02447	2	173880850-173965702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004580, HPA032145, HPA032146"	Supported	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.54e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.76e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.46e-5)"	"unprognostic (2.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.69e-1)"	32.6	19.8	15.8	35.2	16.0	53.1	43.1	21.3	19.8	50.9	16.1	34.3	26.9	45.1	34.6	32.1	37.1	28.9	23.8	14.2	17.1	29.7	40.1	29.9	46.1	16.9	16.7	40.3	24.9	43.1	13.2	49.1	16.4	31.9	38.9	21.0	26.1	30.4	22.5	38.5	29.6	36.3	16.3	38.6	27.0	25.2	15.5	68.0	47.5	33.7	53.8	33.7	28.0	18.5	41.6	34.5	74.6	45.8	91.8	82.3	83.5	47.5	67.1	62.2	66.1	56.8	59.7	65.1	39.3	65.0	46.3	41.0	57.8	46.0	91.7	55.2	21.2	65.9	33.9	54.0	45.5	60.4	48.9	60.6	53.2	72.9	63.6	48.4	49.4	51.3	51.4	86.8	65.7	44.4	84.0	49.9	66.1	60.1	37.8	74.2	68.5	53.0	48.4	55.8	67.8	48.1	67.1	38.1	52.4	81.7	30.0	80.0	44.1	70.6	61.8	47.5	50.4	58.8	46.7	85.8	53.0	41.6	67.2	8.9	9.4	13.0	11.6	7.0	12.9	9.5	12.3	12.3	9.9	7.4	13.8	12.8	27.3	21.9	10.3	6.2	13.8	9.9	15.8	16.0	21.3	19.8	14.2	17.1	16.9	16.7	16.4	16.3	15.5	18.5	36.1	19.2	22.9	44.7	55.2	57.6	31.7	25.7	64.9	29.1	36.8	23.4	18.8	14.3	23.3	20.2	27.1	30.9	67.9	37.9	11.7	18.6	4.3	22.3	57.8	33.9	30.5	31.7	52.7	19.3	42.7	43.9	17.9	29.5	23.5	31.3	32.2	43.8	24.6	23.5	50.7	28.8	20.3	54.1	72.8	7.1	45.4	55.6	42.7	81.5	39.0	30.5	46.4	60.3	74.7	30.8	22.9	36.9	63.7	34.2	22.1	24.4	26.6	20.2	19.7	40.4	53.4	10.5	20.4	48.6	57.0	34.6	50.8	26.0	29.0	59.0
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24 component of NDC80 kinetochore complex"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.0;lymphoid tissue: 14.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	1.9	1.7	1.3	4.8	1.5	26.0	1.2	3.9	2.1	2.1	1.7	4.7	4.5	2.7	0.8	5.0	1.3	2.3	2.7	1.6	1.5	0.8	1.6	1.6	6.3	1.1	0.8	1.3	1.1	0.4	0.4	3.2	1.3	1.6	4.3	1.2	1.3	2.0	4.0	3.9	4.1	8.1	0.5	3.1	2.9	4.3	1.4	14.7	0.9	1.1	6.5	2.5	2.0	2.4	73.6	26.9	36.9	30.1	5.0	9.7	16.6	42.3	15.7	38.6	43.6	28.4	24.6	58.2	46.0	18.5	22.8	38.8	29.0	30.3	28.7	30.9	24.9	78.5	68.9	43.2	1.1	55.5	33.7	1.9	1.1	27.8	12.8	10.0	34.7	62.3	42.8	118.3	27.6	48.7	76.4	32.9	25.5	19.8	43.9	59.8	56.7	18.6	11.2	23.8	38.4	27.2	37.0	22.4	9.6	17.5	22.0	19.8	33.2	36.8	38.3	49.6	51.2	70.5	39.8	55.6	26.9	53.9	30.5	1.9	0.4	0.4	0.5	0.5	0.4	0.8	0.9	1.5	0.2	0.7	0.9	0.6	2.2	2.0	0.5	0.5	1.7	0.3	1.3	1.5	3.9	2.1	1.6	1.5	1.1	0.8	1.3	0.5	1.4	2.4	0.2	0.0	0.5	0.3	1.5	1.1	1.2	1.3	0.0	0.0	1.0	0.4	9.0	1.5	0.8	5.5	6.2	10.0	0.9	2.8	0.0	0.2	0.3	1.0	2.2	2.2	2.4	35.0	0.3	0.0	15.5	3.5	3.6	1.8	5.7	6.5	4.6	0.7	14.0	0.0	0.3	2.6	0.0	3.0	2.5	3.0	0.6	1.0	0.0	1.0	0.0	2.1	2.1	0.5	0.3	0.3	0.0	0.4	6.3	0.3	0.7	0.6	0.2	0.6	0.0	1.3	2.4	6.9	10.8	2.1	0.3	2.1	2.2	0.5	6.6	1.2
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 71.8;lung: 28.3;lymphoid tissue: 51.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 131.6;Erythroid cells: 125.9;Macrophages: 65.8;monocytes: 66.4;NK-cells: 352.2;Plasma cells: 60.3;T-cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 218.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 278.8;HL-60: 281.5;HMC-1: 158.3;MOLT-4: 122.2;REH: 98.4;THP-1: 164.1;U-937: 205.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"		NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB002666: , HPA055244: AB_2682756"	"prognostic favorable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	4.0	0.6	0.8	14.4	1.0	71.8	1.8	1.1	0.9	1.4	0.2	3.9	5.5	1.6	1.1	3.0	2.0	4.3	2.8	0.9	1.4	0.8	2.6	28.3	26.3	3.5	1.3	0.6	1.0	0.6	0.2	0.9	2.5	1.3	5.3	0.3	2.3	1.1	0.8	2.8	6.3	2.3	1.8	19.0	5.0	0.4	2.5	51.1	0.8	0.3	23.0	4.2	0.5	4.1	0.2	0.2	0.1	0.3	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.9	0.1	0.6	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	278.8	0.2	2.0	0.0	281.5	158.3	0.0	0.0	0.1	0.0	0.1	0.0	68.0	96.1	76.9	0.5	0.2	122.2	70.1	0.1	0.0	0.0	98.4	1.1	2.2	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.3	0.1	164.1	0.4	0.0	0.2	0.2	0.2	0.3	5.8	40.7	0.3	205.4	0.3	13.6	23.2	14.6	96.3	96.3	51.4	3.7	38.5	65.5	34.0	1.1	26.3	47.6	3.6	69.4	218.0	27.2	34.7	52.1	0.8	1.0	1.1	0.9	0.9	1.4	3.5	1.3	2.5	1.8	2.5	4.1	1.2	9.6	16.9	0.0	10.8	2.2	0.9	0.0	0.0	0.6	1.0	0.8	5.3	1.5	2.5	1.8	0.0	0.2	131.6	0.1	0.0	0.1	0.1	0.5	0.6	3.0	0.0	125.9	0.0	0.0	0.4	3.0	5.1	0.7	43.7	0.8	4.6	1.5	27.0	1.7	0.0	0.3	0.0	28.8	30.3	0.0	0.0	65.8	1.8	1.9	66.4	0.5	352.2	1.5	0.0	0.0	0.1	0.0	60.3	0.5	0.1	0.6	1.5	1.9	0.0	0.8	1.0	0.2	0.6	0.1	2.0	0.3	94.8	0.1	0.2	0.6
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 187.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 427.0;Endometrial stromal cells: 256.6;Extravillous trophoblasts: 355.8;Fibroblasts: 257.7;NK-cells: 1096.8"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 255.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 255.9"	"Group enriched"	"Detected in many"	5	"HHSteC: 303.8;HSkMC: 546.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		2600000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	66.2	40.4	4.0	18.8	7.7	19.5	50.6	15.6	3.9	161.4	3.5	51.5	18.5	187.1	4.4	40.6	49.7	32.2	35.5	3.5	0.8	37.1	79.1	63.0	3.9	2.9	1.7	34.4	18.7	0.9	15.1	19.2	3.5	111.8	7.2	0.7	28.8	8.4	19.1	38.3	63.5	42.7	0.2	26.9	43.8	4.7	1.8	1.8	16.3	6.6	1.0	68.4	94.0	1.5	0.4	0.6	0.0	0.0	10.2	79.0	3.0	6.2	5.0	0.8	1.0	0.0	0.1	1.8	9.7	26.9	0.9	45.0	0.0	0.2	0.0	0.3	0.1	0.2	3.0	12.7	303.8	0.2	1.5	546.6	0.0	0.6	0.0	0.0	0.0	4.1	0.3	9.2	0.0	0.3	5.3	12.2	3.5	9.7	0.7	1.0	3.3	7.9	0.0	0.0	1.7	1.1	1.1	0.0	2.9	1.7	0.4	1.5	0.1	0.2	0.9	20.5	0.0	1.3	2.7	0.6	0.1	6.5	0.0	3.7	0.9	1.0	255.9	1.1	5.5	0.7	33.1	105.8	0.4	1.0	14.4	96.8	9.8	50.4	2.2	42.9	0.1	123.2	4.0	7.7	15.6	3.9	3.5	0.8	2.9	1.7	3.5	0.2	1.8	1.5	9.8	0.0	5.6	1.3	6.6	36.8	2.0	82.5	2.2	3.7	5.1	3.8	4.0	24.3	43.0	1.8	0.0	3.4	427.0	9.7	1.9	3.8	0.2	12.7	256.6	5.7	13.8	4.0	8.4	1.3	355.8	257.7	10.7	6.6	6.3	0.2	15.4	40.4	12.8	0.0	0.6	9.7	73.2	5.8	15.4	0.5	29.8	9.5	26.6	6.5	9.2	0.9	1096.8	0.5	0.7	1.5	6.7	9.4	64.0	15.8	16.3	28.3	32.6	0.4	6.6	22.5	89.9	0.2	0.5	21.3	21.5	38.9	100.8	8.1	7.9	13.2
SPTAN1		ENSG00000197694	"Spectrin alpha, non-erythrocytic 1"	Q13813	9	128552558-128633662	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 296.6;Cone photoreceptor cells: 310.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004581, HPA007927"	Enhanced		Approved	Vesicles,Microtubules		NA	NA		1600000	"Cluster 13: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Microtubules"		"CAB004581: AB_671135, HPA007927: AB_1857435"	"unprognostic (1.46e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.84e-12)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.19e-3)"	48.8	31.4	81.7	38.6	85.0	28.1	36.6	54.4	99.7	39.4	0.4	47.3	24.7	57.1	32.9	36.8	54.0	32.5	65.7	90.9	43.5	34.6	22.8	55.1	38.5	142.7	49.6	51.6	24.0	47.1	32.5	57.1	155.0	32.7	36.3	103.1	31.9	46.5	23.9	69.4	34.9	58.8	65.6	44.3	31.1	44.9	61.5	45.4	38.4	22.3	38.0	40.0	36.4	55.3	108.1	116.9	75.2	83.4	107.6	121.0	61.5	90.2	75.2	99.4	74.1	167.3	74.6	94.3	78.3	137.0	69.8	193.3	80.7	90.4	61.1	53.2	47.9	15.9	324.4	94.4	61.3	70.9	51.0	58.3	71.6	166.3	55.8	83.9	134.4	87.2	9.1	107.6	98.6	74.6	136.3	29.5	96.1	125.9	72.1	91.0	90.2	59.7	80.2	91.1	58.1	91.1	296.1	40.3	42.9	91.8	70.0	19.8	232.5	68.5	102.2	100.0	71.2	65.3	82.6	51.8	83.5	31.5	65.9	3.3	1.6	3.9	9.7	1.3	13.5	6.3	12.4	9.2	2.4	5.8	7.6	7.9	1.5	7.1	1.2	3.0	15.3	5.8	81.7	85.0	54.4	99.7	90.9	43.5	142.7	49.6	155.0	65.6	61.5	55.3	144.9	70.5	27.5	123.7	56.3	37.3	27.8	34.3	25.6	296.6	69.8	83.2	68.5	68.6	33.9	101.2	310.6	27.5	112.6	145.4	7.9	67.6	18.0	108.2	71.4	103.8	56.9	13.7	159.5	59.2	16.0	77.8	76.5	87.5	12.0	47.9	96.8	36.2	29.2	124.5	183.8	54.1	30.5	22.2	29.4	40.5	85.1	32.8	35.6	74.9	24.4	97.7	48.4	87.4	17.4	102.2	93.0	94.8	70.5	45.9	62.4	22.8	71.3	156.5	26.3	53.0	60.0	33.0	44.5	43.7	45.5	18.2	95.4	22.0	73.6	65.7
SPTBN1		ENSG00000115306	"Spectrin beta, non-erythrocytic 1"	Q01082	2	54456317-54671446	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 615.4;Peritubular cells: 663.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012685, HPA013149"	Supported		Approved	"Golgi apparatus"		NA	Yes		1500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA012685: AB_1857433, HPA013149: AB_1857434"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (2.59e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.18e-3)"	187.3	70.9	210.6	34.7	205.1	37.6	78.7	97.4	166.1	54.1	94.2	62.8	32.7	52.0	36.3	41.7	56.2	69.2	135.9	156.2	99.7	65.3	83.8	131.6	28.9	141.2	154.4	73.2	45.5	129.2	27.8	97.4	120.4	43.8	52.4	56.0	55.1	74.4	54.0	39.4	46.8	59.9	134.8	58.7	55.6	32.6	214.6	29.3	72.8	87.2	30.0	45.6	38.6	163.6	96.5	150.5	60.4	57.2	234.7	158.8	74.8	40.2	82.3	63.7	61.4	101.7	66.6	0.4	112.1	142.0	55.1	110.9	85.1	128.0	66.0	0.8	35.6	43.7	118.4	166.2	97.7	59.7	24.4	62.3	64.8	193.8	119.7	77.6	151.6	95.1	50.0	64.0	86.1	21.6	105.0	14.5	66.3	129.6	70.2	116.2	95.0	37.2	92.2	120.6	36.3	113.3	121.5	39.5	88.1	58.9	19.6	9.9	235.2	89.9	79.0	110.2	58.2	62.8	42.8	32.7	98.1	17.7	163.7	2.3	0.4	2.8	3.7	0.0	3.9	3.7	3.4	3.6	1.3	3.5	5.0	3.6	0.6	5.2	0.0	1.1	3.2	3.1	210.6	205.1	97.4	166.1	156.2	99.7	141.2	154.4	120.4	134.8	214.6	163.6	615.4	407.1	124.6	233.4	45.7	83.1	50.0	64.7	42.7	94.4	60.8	58.0	262.9	144.4	100.6	145.3	73.0	28.3	31.7	343.6	7.9	223.7	12.1	140.4	80.3	426.4	83.1	21.5	231.3	121.9	42.0	271.6	139.7	115.7	35.4	68.2	228.5	184.6	14.2	141.3	195.4	135.5	77.3	17.7	47.0	31.5	503.2	16.6	147.7	294.2	9.7	131.9	36.0	154.8	283.1	243.3	109.9	663.5	76.3	75.6	142.8	44.1	187.3	93.6	164.3	340.3	171.9	54.7	53.3	79.7	68.2	11.1	49.2	56.6	151.9	88.1
SRI		ENSG00000075142	Sorcin	P30626	7	88205115-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 566.0"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1172.0;Extravillous trophoblasts: 1475.3;Paneth cells: 1606.5;Proximal enterocytes: 1342.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		1100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favorable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	98.7	89.5	139.1	95.9	147.8	85.2	95.9	148.0	177.1	87.0	115.0	566.0	178.0	70.4	122.4	68.3	147.8	52.3	81.3	135.9	159.7	104.6	42.3	84.2	69.3	146.6	150.6	83.2	75.8	56.7	75.3	64.5	158.3	69.9	447.2	50.3	74.4	64.6	37.6	49.2	252.2	94.2	155.5	60.3	66.3	38.9	147.3	54.6	70.5	53.0	78.2	136.8	81.3	165.7	181.7	59.5	188.5	193.8	295.0	247.0	89.3	106.5	177.5	121.5	143.3	56.2	414.0	198.9	108.3	168.0	296.6	182.8	237.6	244.5	160.2	155.9	92.2	103.4	177.6	0.1	173.8	139.0	108.5	250.5	221.2	127.0	185.1	218.2	365.4	123.7	87.8	175.8	170.4	106.3	211.7	94.5	159.4	261.2	119.3	86.1	256.8	110.9	229.2	179.0	131.5	151.5	323.0	188.0	154.7	179.7	88.0	61.4	218.1	223.4	185.6	201.5	192.9	159.6	79.2	222.4	220.7	130.5	387.8	620.5	151.3	580.6	169.8	217.3	202.4	173.0	185.9	194.9	201.0	151.9	137.7	158.5	93.3	224.3	262.2	161.1	210.4	216.7	139.1	147.8	148.0	177.1	135.9	159.7	146.6	150.6	158.3	155.5	147.3	165.7	258.8	86.6	123.7	63.6	84.4	95.1	389.6	494.2	75.1	34.9	117.2	129.5	107.1	35.8	402.0	156.3	12.5	166.0	104.7	1172.0	442.2	223.0	89.7	307.3	148.6	135.6	94.3	198.6	29.4	418.5	1475.3	175.7	80.0	172.7	135.6	131.3	106.7	40.5	147.6	47.1	22.9	471.7	276.7	79.5	117.9	34.0	172.1	103.2	104.9	15.9	172.5	195.6	113.3	40.2	34.9	380.9	1606.5	141.4	75.2	422.9	1342.4	182.2	660.4	25.9	111.7	111.9	183.9	80.8	106.3	86.9	108.3	197.4	117.9	126.8	536.9	488.1
ST18	"KIAA0535, NZF-3, NZF3, ZC2H2C3, ZC2HC10, ZNF387"	ENSG00000147488	"ST18 C2H2C-type zinc finger transcription factor"	O60284	8	52110839-52460959	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 82.1"	"Cell type enriched"	"Detected in some"	39	"Oligodendrocytes: 4055.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;SCLC-21H: 9.6;U-87 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Low region specificity"	"Detected in all"			HPA044919	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA044919: AB_10959756"	"unprognostic (3.66e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-5)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.84e-3)"	0.0	0.9	18.4	0.1	48.6	0.0	0.0	44.1	24.1	0.0	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	18.0	29.0	0.3	0.1	0.1	0.0	47.8	37.4	0.0	1.9	0.0	4.4	0.1	43.5	0.1	0.3	8.5	0.0	0.0	0.0	0.0	0.5	0.0	22.3	0.0	1.5	0.3	35.7	0.1	0.0	0.0	0.1	0.0	0.0	82.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	48.6	44.1	24.1	18.0	29.0	47.8	37.4	43.5	22.3	35.7	82.1	0.0	0.0	0.0	4.9	0.6	0.1	0.1	0.0	0.0	101.5	0.0	0.0	1.1	4.3	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	0.2	49.6	1.3	3.4	0.0	0.4	0.2	5.1	0.0	0.0	0.0	0.0	0.2	1.3	1.7	8.5	0.8	10.2	1.6	11.0	1.7	0.0	3.4	0.0	0.0	0.7	2.4	0.0	13.0	4055.3	0.3	0.0	0.0	0.1	0.3	0.1	0.8	0.0	4.5	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.1	0.1	0.0	0.3	0.0
STARD13	"ARHGAP37, DLC2, GT650, LINC00464"	ENSG00000133121	"StAR related lipid transfer domain containing 13"	Q9Y3M8	13	33103137-33350630	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Astrocytes: 212.5;Excitatory neurons: 120.7;Inhibitory neurons: 135.6;Microglial cells: 167.7;Oligodendrocyte precursor cells: 212.6;Oligodendrocytes: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 50.2;TIME: 36.0;WM-115: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039535, HPA058867"	Supported					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039535: AB_10965929, HPA058867: AB_2683839"	"unprognostic (7.42e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.29e-2)"	16.0	10.9	10.0	5.6	13.2	0.3	11.1	8.7	10.9	16.6	13.4	28.0	4.8	14.8	5.3	7.2	10.4	10.8	12.5	12.6	8.1	8.4	6.1	12.5	2.5	11.1	11.9	7.2	10.8	16.9	4.3	24.6	9.6	9.0	6.8	1.8	6.4	8.1	5.4	5.3	7.0	15.7	8.4	7.4	11.2	2.8	11.7	1.4	20.4	6.3	1.4	14.0	9.6	13.6	11.4	1.6	3.4	2.4	6.8	16.0	0.6	21.2	26.2	17.4	10.8	0.9	4.0	0.1	2.8	10.2	10.7	10.4	1.5	7.5	22.0	10.0	3.6	5.2	3.9	5.2	5.7	0.0	4.6	13.3	4.3	19.7	24.0	9.7	17.1	0.1	0.0	1.7	50.2	3.3	0.0	0.0	2.2	1.2	5.7	0.2	16.6	0.1	10.6	3.2	0.1	5.5	3.2	8.0	2.6	3.0	18.5	4.7	36.0	8.7	9.3	22.0	11.0	2.9	0.0	0.1	7.0	0.1	40.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.0	13.2	8.7	10.9	12.6	8.1	11.1	11.9	9.6	8.4	11.7	13.6	30.5	28.9	15.1	212.5	0.1	2.4	2.8	1.1	4.0	5.3	8.6	5.1	19.8	7.2	2.0	9.2	0.0	9.4	4.2	11.8	0.0	7.7	1.2	5.5	26.6	18.4	6.7	0.0	120.7	2.2	3.7	18.8	10.7	6.4	5.1	6.2	17.9	10.7	16.7	5.0	135.6	4.4	0.0	8.8	6.8	1.4	7.2	10.8	14.2	167.7	0.8	1.1	0.0	212.6	470.9	5.5	4.3	7.5	4.7	4.4	3.4	2.1	6.3	0.4	13.1	15.6	33.1	0.1	0.3	1.0	2.3	7.5	0.6	31.1	5.4	1.5
STARD7	GTT1	ENSG00000084090	"StAR related lipid transfer domain containing 7"	Q9NQZ5	2	96184859-96208827	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033965, HPA064958, HPA064978"	Supported		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.56e-5)"	"prognostic favorable (3.89e-6)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.72e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.38e-6)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.42e-2)"	44.7	54.3	57.8	46.7	62.4	34.3	43.9	61.9	53.2	33.9	60.6	57.6	55.7	29.8	30.5	36.8	44.0	29.1	98.5	49.8	61.4	80.3	62.8	61.1	70.6	56.4	55.5	29.4	42.2	69.7	23.6	29.3	54.9	39.0	56.2	54.4	65.2	45.7	202.5	35.2	45.4	37.6	60.5	53.1	44.6	21.1	66.9	56.2	56.6	174.0	86.9	42.1	27.0	74.4	128.8	79.1	102.3	106.2	134.9	66.9	150.1	122.6	107.0	121.2	129.6	188.8	117.7	228.7	129.0	98.6	95.8	102.3	183.3	106.4	157.3	147.2	131.9	204.1	74.3	218.3	62.2	158.1	106.9	65.4	77.9	101.0	99.1	77.2	123.2	92.6	211.1	89.2	108.8	113.0	175.9	161.0	173.3	110.3	115.2	171.6	156.4	227.1	73.2	162.2	191.6	90.5	62.5	201.8	115.8	126.0	60.5	171.6	103.8	100.1	100.4	112.0	125.8	113.9	114.0	201.7	92.8	174.9	112.6	35.6	25.4	22.7	25.6	30.2	26.1	42.6	21.5	26.6	36.2	37.8	23.6	23.4	3.0	30.8	19.9	42.2	41.5	26.0	57.8	62.4	61.9	53.2	49.8	61.4	56.4	55.5	54.9	60.5	66.9	74.4	32.0	134.6	44.2	21.5	71.2	63.7	43.2	34.3	101.9	39.5	58.1	50.2	176.9	55.8	47.1	46.0	108.4	35.8	83.8	63.3	74.3	32.4	2.5	34.5	43.2	49.9	44.4	48.6	25.6	38.0	40.3	31.3	37.8	48.6	15.8	45.4	41.7	114.7	71.0	40.4	23.8	58.4	24.4	122.4	102.3	6.9	23.3	54.4	42.7	20.6	95.8	38.4	30.9	19.1	42.6	35.8	26.6	25.2	120.6	68.4	50.1	65.7	31.8	58.1	26.3	43.5	43.0	22.7	35.1	75.4	57.4	35.4	62.9	36.8	81.9	38.8
STARD9	"KIAA1300, KIF16A"	ENSG00000159433	"StAR related lipid transfer domain containing 9"	Q9P2P6	15	42575606-42720998	"Metabolic proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;Early spermatids: 52.8;Excitatory neurons: 39.3;Oligodendrocytes: 80.9;Rod photoreceptor cells: 57.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA014562	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA014562: AB_10603033"	"unprognostic (2.69e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.54e-5)"	"unprognostic (7.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.83e-3)"	6.2	0.5	1.5	1.2	5.2	0.6	4.3	3.1	3.3	5.9	2.4	9.1	1.3	5.3	3.0	2.2	3.3	2.4	3.3	1.3	1.6	0.8	0.4	4.5	1.2	4.7	2.5	6.0	0.4	0.4	0.8	3.9	2.8	2.6	2.8	12.9	1.5	3.2	2.5	2.6	3.2	4.8	1.0	2.0	3.2	8.5	4.4	3.5	1.7	3.5	1.1	4.4	5.0	9.9	0.9	0.5	5.9	2.3	3.1	4.5	0.3	1.0	1.3	1.8	2.7	0.0	0.0	0.7	0.1	1.1	1.2	0.1	2.0	0.9	2.4	3.5	1.7	0.3	4.3	1.3	1.3	0.9	1.1	2.6	0.4	1.5	1.0	1.5	1.8	2.5	1.6	3.8	1.5	0.0	0.7	0.7	0.9	0.0	1.1	5.1	3.2	1.1	0.7	0.0	1.2	2.9	1.3	0.0	0.4	0.7	0.1	0.4	3.6	2.5	1.9	0.9	2.4	3.8	2.2	1.3	1.0	2.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.2	3.1	3.3	1.3	1.6	4.7	2.5	2.8	1.0	4.4	9.9	26.1	12.8	2.8	7.2	2.9	3.6	1.2	0.8	1.2	8.1	0.6	1.0	6.8	0.0	0.7	1.8	52.1	0.2	4.2	0.3	0.0	0.3	52.8	3.5	12.2	19.8	8.4	3.2	39.3	0.0	0.3	15.2	2.6	0.6	2.5	3.6	9.7	0.5	2.8	11.8	33.5	2.8	0.0	2.4	7.7	15.4	24.5	2.3	8.8	24.4	2.4	2.9	11.3	20.1	80.9	0.2	0.0	22.2	2.7	0.9	0.1	0.3	9.1	57.7	19.7	11.8	13.7	3.9	8.0	0.3	3.1	0.3	6.3	7.8	0.4	0.7
STAU1	"PPP1R150, STAU"	ENSG00000124214	"Staufen double-stranded RNA binding protein 1"	O95793	20	49113339-49188367	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020839, HPA049892, HPA072004"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB020839: , HPA049892: AB_2680938, HPA072004: "	"unprognostic (7.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-2)"	46.4	40.4	33.6	34.1	36.5	66.0	40.5	35.5	41.5	41.5	33.7	45.2	54.9	42.3	36.8	47.2	66.3	48.7	49.6	33.5	35.2	88.4	122.8	41.8	36.8	39.3	39.1	36.3	69.7	81.4	15.0	49.9	39.4	46.3	47.1	36.4	39.2	46.1	62.5	41.6	50.9	52.1	37.2	33.3	52.8	35.9	36.5	42.8	69.6	47.1	40.9	51.9	31.1	42.5	113.9	85.1	90.7	40.2	90.1	111.3	100.7	84.4	100.8	246.8	111.2	292.0	121.8	77.1	141.7	106.2	118.3	121.5	122.4	150.8	205.9	30.2	70.5	63.3	62.1	233.0	76.1	51.7	59.9	89.6	126.9	100.5	117.0	100.9	123.0	57.4	112.3	46.7	94.6	72.3	90.7	83.5	74.5	109.1	117.9	69.1	119.4	75.0	100.1	98.2	104.8	93.1	209.9	199.0	124.8	91.6	127.4	72.9	113.0	148.2	128.1	92.6	101.6	41.8	52.3	86.8	108.5	54.6	87.4	31.5	19.3	19.8	17.8	15.8	19.7	16.8	18.9	19.1	16.9	15.4	17.1	16.7	38.0	14.2	20.2	15.9	22.9	13.6	33.6	36.5	35.5	41.5	33.5	35.2	39.3	39.1	39.4	37.2	36.5	42.5	76.5	89.8	82.0	45.7	66.4	112.5	125.5	79.9	95.0	32.9	87.5	65.0	63.1	97.2	71.3	77.3	14.6	105.4	72.2	98.4	93.9	130.6	18.6	146.1	80.1	83.0	76.0	137.4	47.9	118.2	45.0	84.8	71.4	87.3	48.1	79.2	72.8	158.3	64.7	43.7	42.2	77.5	59.0	62.9	91.3	21.9	65.6	66.8	49.8	26.2	85.9	57.0	61.8	39.2	51.2	138.5	89.9	70.0	86.8	189.7	107.8	170.0	105.9	29.1	59.2	72.6	74.2	109.1	69.8	92.1	119.8	194.4	78.5	64.6	69.3	196.5
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 49.3;testis: 51.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 213.8;Early spermatids: 98.8;Endometrial ciliated cells: 220.9;Late spermatids: 157.0;Oligodendrocyte precursor cells: 117.6;Respiratory ciliated cells: 155.3;Spermatocytes: 148.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.1;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.0;hTERT-RPE1: 22.0;Karpas-707: 21.2;SCLC-21H: 22.9;U-251 MG: 24.3;U-266/84: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: AB_2683257"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	1.3	8.1	6.7	2.0	6.6	1.3	0.5	8.5	4.9	5.6	49.3	8.3	3.3	12.0	11.3	2.7	42.3	5.1	16.2	6.1	10.1	10.2	0.4	7.1	2.0	14.7	15.6	13.4	6.5	23.1	24.1	0.1	13.3	6.4	1.5	15.6	2.1	11.5	3.9	0.2	3.4	9.3	12.0	1.5	6.0	51.8	12.8	3.8	20.0	6.0	2.2	3.4	1.7	8.3	0.0	3.4	15.4	0.0	0.0	0.0	0.0	3.0	3.1	7.0	6.2	2.2	0.0	23.0	11.5	0.6	8.7	0.0	6.9	2.5	6.0	0.0	18.9	0.0	4.2	5.6	2.5	13.4	0.0	1.1	0.0	0.2	0.0	22.0	0.5	11.2	0.0	21.2	0.3	0.0	0.4	0.0	11.2	0.0	0.0	8.8	2.2	14.3	6.1	0.0	22.9	6.2	0.0	0.0	0.1	4.3	0.0	1.3	0.0	0.0	10.6	0.2	24.3	5.1	21.2	0.3	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.7	0.0	2.2	0.0	0.6	0.0	0.1	0.0	0.4	0.1	0.2	6.7	6.6	8.5	4.9	6.1	10.1	14.7	15.6	13.3	12.0	12.8	8.3	0.1	19.2	14.5	213.8	6.2	0.0	1.3	1.9	0.0	20.7	0.1	0.3	37.8	8.6	27.5	20.2	70.9	0.1	1.4	0.2	3.9	9.5	98.8	220.9	5.5	1.8	9.1	1.7	12.0	4.9	3.3	5.0	6.1	17.8	1.3	29.3	0.4	0.0	0.3	1.7	15.4	1.6	6.1	0.0	0.0	157.0	4.4	0.6	0.0	23.4	0.0	31.0	0.0	117.6	19.7	4.4	0.4	17.0	5.2	0.5	3.6	13.5	155.3	77.4	0.0	0.2	2.7	148.3	26.8	0.2	0.0	0.0	1.3	6.3	3.5	0.0
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966479-45080021	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Cell type enhanced"	"Detected in all"		"B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	10.0	8.5	6.9	33.8	8.0	57.7	9.1	6.2	10.8	7.9	9.9	11.1	10.2	8.5	7.6	9.1	6.2	11.7	4.6	7.2	8.7	6.0	9.2	15.9	43.1	8.7	7.6	7.0	6.0	5.9	4.1	10.4	9.2	6.7	13.0	7.3	7.4	8.0	3.3	11.2	13.5	9.3	8.3	30.4	12.7	9.7	7.5	33.1	7.6	4.9	41.7	15.0	6.9	10.3	27.8	18.7	23.3	16.1	13.5	16.9	16.0	23.6	35.7	39.4	35.6	52.7	14.6	66.6	20.4	16.9	33.4	28.5	24.3	31.8	49.7	30.8	13.8	48.6	27.8	36.8	23.8	63.5	66.4	13.8	25.6	36.7	39.6	19.4	14.6	44.6	23.5	37.0	19.9	21.7	47.6	42.3	13.9	17.7	12.5	30.2	25.2	31.2	14.4	18.7	10.9	13.2	35.6	20.0	27.0	17.2	18.3	39.1	18.7	29.2	28.6	34.4	27.8	48.4	41.7	73.2	28.6	29.5	22.0	80.6	19.7	54.8	34.4	19.9	34.3	26.2	32.2	32.0	18.4	26.9	33.1	28.0	101.8	28.5	38.0	10.0	34.3	22.3	6.9	8.0	6.2	10.8	7.2	8.7	8.7	7.6	9.2	8.3	7.5	10.3	26.2	16.0	24.6	18.9	372.8	55.7	49.3	33.8	28.5	27.3	22.9	17.4	7.6	14.3	25.2	42.3	52.1	24.1	341.8	23.7	9.8	16.3	5.9	19.1	25.1	32.1	25.7	46.3	76.7	17.6	30.3	29.7	34.1	25.1	133.6	114.0	26.0	22.0	61.1	43.7	38.2	20.7	28.5	109.3	606.9	5.0	22.7	154.4	133.4	85.3	367.5	20.2	278.1	34.2	48.1	21.6	27.9	17.0	336.2	32.6	23.2	13.4	26.1	69.9	13.1	25.5	29.2	44.2	42.4	20.9	53.0	19.4	414.5	48.1	19.5	45.5
SUFU	"PRO1280, SUFUH, SUFUXL"	ENSG00000107882	"SUFU negative regulator of hedgehog signaling"	Q9UMX1	10	102503972-102633535	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ciliopathy, Disease variant, Joubert syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.2;Late spermatids: 115.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008700	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA008700: AB_1080125"	"unprognostic (1.55e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.15e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.82e-3)"	6.6	7.2	8.8	7.1	8.5	2.0	6.1	8.9	8.0	8.6	5.5	6.8	3.9	7.4	4.9	9.2	7.1	6.6	6.3	7.8	7.3	6.1	6.2	5.8	7.2	8.3	8.2	8.9	4.1	11.1	4.3	7.4	7.8	8.5	4.4	4.6	7.1	5.2	8.6	14.4	5.7	7.3	6.7	7.4	4.6	11.5	8.0	7.8	3.4	7.3	8.1	8.8	9.2	7.3	8.7	9.1	14.4	20.8	14.5	12.1	7.0	8.8	17.0	12.5	11.3	8.5	6.3	8.9	24.5	9.9	5.0	6.0	17.8	9.8	8.2	5.5	13.8	21.2	5.2	8.0	6.9	7.7	14.6	13.9	7.5	9.3	7.5	22.9	16.3	8.5	4.8	7.9	7.8	7.2	14.8	11.6	4.1	5.6	6.7	15.8	15.5	4.7	8.3	12.8	4.8	7.8	7.0	6.4	8.1	13.1	14.2	5.0	18.1	5.5	7.8	6.0	9.8	6.4	4.5	6.4	6.9	14.9	3.8	2.0	2.0	2.9	1.0	2.4	0.8	0.9	1.2	1.1	1.9	0.8	0.8	1.0	0.4	1.1	2.5	1.1	0.8	1.4	8.8	8.5	8.9	8.0	7.8	7.3	8.3	8.2	7.8	6.7	8.0	7.3	3.3	0.0	3.7	28.7	4.9	3.1	2.1	2.9	6.8	4.2	3.5	3.0	4.0	1.5	4.6	3.7	8.4	7.8	3.1	3.5	1.9	4.4	129.2	4.5	6.2	5.1	1.2	2.5	25.9	3.0	3.5	6.0	4.6	8.5	3.8	3.8	10.8	5.4	12.4	1.7	22.2	2.2	0.0	9.4	6.3	115.9	5.0	8.7	0.0	32.8	7.8	2.7	4.1	17.6	16.8	4.1	1.3	6.8	4.0	2.0	5.7	5.8	5.7	4.8	0.0	3.0	4.5	8.7	5.3	8.9	6.5	7.0	7.1	7.6	3.0	1.3
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Yes	No		750000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.71e-4)"	64.1	64.6	26.1	43.0	29.7	51.5	57.5	29.3	27.1	91.3	45.0	67.4	89.2	57.5	64.8	46.8	102.6	70.6	30.8	25.1	27.8	93.4	94.8	71.6	50.2	35.2	29.6	59.7	91.8	115.8	31.8	45.5	33.4	79.3	69.1	11.0	69.5	77.1	22.4	47.5	74.4	57.7	29.9	57.0	92.7	23.7	30.8	57.6	91.2	21.4	51.3	57.2	43.6	35.9	352.3	102.9	46.0	211.8	214.4	147.5	68.9	114.5	156.1	92.6	114.5	57.2	278.0	57.1	96.5	162.4	90.4	172.3	27.4	131.3	61.1	90.6	42.9	36.4	63.5	54.2	138.4	89.7	108.7	116.8	124.5	83.7	143.3	186.9	137.7	101.4	116.4	236.6	151.3	76.8	77.2	115.7	63.5	272.0	52.2	61.5	45.4	359.0	127.7	39.1	54.0	65.6	142.4	294.2	140.9	98.9	294.5	144.5	115.2	85.6	121.1	211.1	98.6	160.8	130.8	84.0	139.7	165.7	283.2	58.1	60.3	22.0	71.1	80.5	90.9	59.8	70.9	71.8	72.3	49.1	75.3	75.2	4.4	49.0	90.3	132.6	82.7	90.2	26.1	29.7	29.3	27.1	25.1	27.8	35.2	29.6	33.4	29.9	30.8	35.9	44.0	57.7	30.5	20.5	47.3	33.8	44.1	46.1	39.9	25.7	57.9	25.4	10.4	87.2	31.0	90.1	14.6	44.5	85.3	45.1	19.6	95.3	3.8	93.1	70.2	43.7	59.3	41.7	21.2	55.7	96.7	54.7	55.5	78.9	54.5	47.0	51.0	91.3	68.1	43.7	24.4	61.8	22.4	79.8	38.7	8.0	69.6	50.4	53.4	14.0	73.0	23.8	70.0	10.6	24.2	48.4	64.6	47.4	65.0	50.7	91.8	45.6	34.5	13.5	52.6	41.6	44.1	31.6	28.6	52.8	41.9	46.7	52.7	58.7	85.8	42.7
SUMO2	"SMT3B, SMT3H2"	ENSG00000188612	"Small ubiquitin like modifier 2"	P61956	17	75165586-75182959	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037314, HPA042123, HPA048064"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"		"CAB037314: AB_796170, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (6.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (9.80e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (5.23e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.89e-3)"	198.2	205.1	176.2	203.6	186.9	229.8	174.5	214.2	239.9	219.3	168.5	190.1	161.4	205.5	158.5	240.9	186.8	134.0	156.7	185.4	193.4	205.6	185.8	171.5	214.6	175.5	177.3	231.1	161.0	130.6	146.5	130.1	177.5	158.1	143.9	205.9	160.3	122.2	229.4	182.6	169.2	154.8	187.4	174.7	205.3	182.2	187.2	271.9	149.2	152.0	228.6	188.2	205.1	191.5	742.5	299.1	1035.7	534.4	296.8	283.6	486.1	571.2	276.9	384.5	354.5	343.6	396.0	641.8	398.1	327.9	503.0	353.4	470.3	351.7	451.6	373.6	712.4	644.0	282.1	597.4	194.1	856.1	555.7	290.1	195.9	343.9	187.2	615.6	403.8	628.3	540.7	508.7	288.3	317.8	1310.8	734.0	632.8	552.5	445.5	903.2	987.1	539.5	391.9	612.0	633.4	739.0	691.1	566.8	481.4	796.9	614.6	663.0	458.1	557.2	581.7	429.4	931.3	355.4	348.1	986.8	351.2	500.6	457.3	831.1	436.4	781.2	390.9	498.9	408.8	515.7	486.8	456.8	451.6	443.6	444.0	437.1	380.1	452.3	548.3	616.0	701.6	851.5	176.2	186.9	214.2	239.9	185.4	193.4	175.5	177.3	177.5	187.4	187.2	191.5	522.1	163.5	160.6	25.5	453.3	705.4	647.4	717.6	602.2	216.4	492.1	524.1	62.3	337.5	368.2	355.0	50.1	522.8	485.0	278.1	968.5	602.7	281.8	348.6	429.0	458.5	441.9	519.9	35.7	531.7	948.9	451.1	274.2	343.5	349.0	465.0	491.2	273.4	616.3	233.9	33.0	397.9	472.0	676.9	637.0	488.6	604.9	481.5	462.4	21.5	743.4	535.4	517.0	25.1	42.6	666.5	397.3	605.2	443.0	822.3	348.7	847.5	322.6	161.3	571.9	409.5	716.6	872.2	683.2	795.2	742.7	565.2	480.3	476.1	437.0	977.2
SWAP70	"KIAA0640, SWAP-70"	ENSG00000133789	"Switching B cell complex subunit SWAP70"	Q9UH65	11	9664077-9752993	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 80.6;naive B-cell: 84.8"	"Group enriched"	"Detected in all"	7	"B-cells: 84.8;granulocytes: 48.6;monocytes: 29.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006810, HPA006929"	Supported		Supported	"Plasma membrane,Actin filaments"		NA	NA		21000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Actin filaments"	"HPA006810: AB_1857683, HPA006929: "	"unprognostic (4.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	39.3	10.4	12.8	37.5	13.7	20.9	31.9	13.6	15.9	22.6	17.2	15.0	15.4	17.8	10.4	17.8	16.3	22.0	16.2	12.2	14.1	17.2	10.0	24.9	66.1	16.7	13.6	10.2	15.0	19.4	5.7	39.0	16.7	14.1	12.8	3.9	18.0	15.3	9.8	26.4	20.3	19.7	16.5	59.5	15.9	4.8	14.3	17.3	22.3	14.7	75.3	31.2	17.6	16.5	40.6	22.2	30.8	0.1	62.9	54.6	54.0	43.4	52.6	40.3	44.1	24.7	31.3	161.0	41.6	83.5	57.9	47.7	37.9	24.2	51.6	14.8	15.2	42.6	25.7	12.1	35.2	33.3	76.2	38.4	29.6	29.5	52.3	32.6	124.4	20.2	3.9	0.6	42.4	6.4	10.0	16.1	28.4	10.7	11.3	23.6	28.9	4.7	33.6	106.1	1.5	15.5	41.3	52.6	35.2	42.9	20.9	25.1	143.6	70.3	25.1	59.4	41.2	4.2	12.4	111.5	27.9	36.6	29.3	19.7	5.7	48.6	1.2	13.5	0.5	80.6	1.4	1.1	8.2	84.8	1.2	1.3	1.1	7.9	29.6	2.3	4.2	5.4	12.8	13.7	13.6	15.9	12.2	14.1	16.7	13.6	16.7	16.5	14.3	16.5	154.0	67.3	60.8	33.0	183.7	35.6	68.1	40.1	36.5	3.4	35.1	28.3	17.6	22.8	57.7	20.2	0.0	82.6	9.9	11.3	13.7	47.4	1.6	66.5	18.6	136.0	13.1	9.7	9.0	21.6	128.0	39.1	15.8	71.6	137.8	10.3	53.2	7.2	65.0	26.9	14.5	8.7	18.3	61.9	50.8	2.9	29.8	58.5	28.4	77.8	88.8	9.2	6.2	22.1	22.4	37.0	15.1	34.6	20.7	63.0	22.4	11.7	50.9	2.3	19.7	46.2	35.5	5.5	10.8	17.4	31.3	140.1	15.5	33.4	9.0	78.8
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 991.6;tongue: 493.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	57.5	10.8	6.1	47.4	7.9	0.3	35.9	4.1	5.7	55.0	2.2	346.4	34.3	137.1	33.4	197.1	89.5	50.0	66.8	10.7	13.3	8.7	7.0	16.2	10.5	5.4	7.5	39.0	3.8	3.6	7.5	20.8	6.1	180.5	58.0	1.2	16.0	267.4	991.6	17.9	75.5	244.4	9.2	10.2	126.2	6.7	5.8	14.3	16.0	493.5	6.5	226.5	54.0	12.0	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.1	7.9	4.1	5.7	10.7	13.3	5.4	7.5	6.1	9.2	5.8	12.0	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;pancreas: 106.3;skin 1: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 158.8;NK-cells: 208.1;Squamous epithelial cells: 179.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 4.3;cerebellum: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.8;CAPAN-2: 55.8;NB-4: 81.8;U-266/70: 44.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"	2.0	0.6	4.3	19.1	0.7	46.7	7.7	8.8	1.4	22.6	6.1	6.7	7.8	1.3	1.2	103.9	15.5	8.6	0.9	1.0	1.0	2.8	2.1	13.1	32.9	0.7	0.8	0.6	106.3	4.2	15.6	2.9	0.8	63.6	3.3	0.0	47.6	12.7	0.5	87.2	17.6	0.4	0.5	42.0	41.8	0.9	1.2	21.4	9.8	0.5	20.0	21.6	50.9	0.6	11.3	0.2	0.0	0.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	1.2	55.8	8.5	10.9	0.0	0.3	34.7	0.0	21.0	0.0	0.0	2.1	1.0	0.9	15.3	0.8	21.9	0.0	0.0	37.8	0.0	7.8	0.2	0.0	28.2	0.7	9.5	0.0	15.5	12.9	81.8	0.5	19.1	5.7	14.9	0.1	40.2	8.6	9.6	15.9	0.9	0.0	15.9	0.6	0.5	40.4	23.3	0.2	0.1	5.1	0.0	0.0	44.3	11.7	8.0	1.6	27.7	0.0	47.0	18.9	176.5	65.0	49.1	58.4	42.8	51.5	53.2	51.0	32.3	30.6	37.3	34.1	49.0	100.8	3.0	63.4	40.0	4.3	0.7	8.8	1.4	1.0	1.0	0.7	0.8	0.8	0.5	1.2	0.6	1.9	22.4	13.6	0.0	68.6	41.2	78.2	84.4	158.8	0.6	33.6	49.8	3.9	8.6	69.2	0.0	0.0	37.4	92.3	4.8	7.9	3.7	0.8	67.8	2.4	2.3	11.4	15.8	0.3	25.5	10.1	3.1	100.9	18.3	1.3	0.2	2.2	1.1	3.2	0.0	0.3	47.6	32.6	6.7	12.7	0.7	0.3	15.7	10.6	0.0	18.8	2.0	208.1	0.0	0.1	12.1	3.7	0.7	52.3	46.8	3.1	6.4	62.8	0.8	0.0	1.3	5.6	30.3	23.1	179.1	55.3	14.1	74.9	0.2	9.4	95.3
SYTL3	"exophilin-6, SLP3"	ENSG00000164674	"Synaptotagmin like 3"	Q4VX76	6	158650014-158764876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 334.2;granulocytes: 135.4;NK-cells: 132.8;Plasma cells: 135.2;T-cells: 230.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 232.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 232.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 23.9;U-138 MG: 18.9;U-2 OS: 19.1;U-266/70: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030584, HPA030585, HPA030586"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center, Vesicles"		"HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226"	"unprognostic (3.56e-3)"	"prognostic favorable (8.84e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	5.5	1.8	1.5	7.5	1.7	13.9	4.3	2.2	1.6	6.0	23.9	4.2	3.8	3.5	6.4	4.0	14.4	4.8	7.1	2.3	2.7	5.3	2.5	16.8	8.4	3.8	2.9	2.8	1.5	1.8	2.1	1.6	3.4	5.4	2.4	0.4	15.3	5.8	14.9	3.3	9.9	2.8	2.9	19.8	7.1	3.8	2.9	17.4	25.2	8.2	6.0	5.0	3.6	4.6	7.1	1.0	0.1	0.5	0.9	0.9	0.4	3.1	2.0	0.8	2.1	0.6	5.8	0.1	0.5	5.3	2.6	0.8	0.1	0.9	2.9	15.1	0.4	5.8	0.2	0.0	1.7	1.7	23.9	3.1	2.1	6.1	1.0	2.6	1.4	1.1	0.3	5.6	6.8	0.3	0.1	2.0	0.1	1.3	1.0	0.0	5.6	0.7	2.8	0.4	15.6	1.2	1.0	9.7	0.8	0.3	2.0	0.3	8.8	18.9	19.1	0.5	0.6	28.5	7.1	0.6	12.0	8.3	0.6	232.0	16.0	0.8	37.3	3.3	22.0	1.0	14.7	25.3	4.6	0.3	15.7	19.3	35.5	43.1	1.4	1.3	16.4	18.9	1.5	1.7	2.2	1.6	2.3	2.7	3.8	2.9	3.4	2.9	2.9	4.6	2.8	16.0	13.1	2.3	23.5	4.6	2.9	4.4	1.8	0.2	4.4	3.7	4.1	1.5	15.9	14.7	2.1	1.3	334.2	1.0	5.9	0.8	10.8	51.0	3.0	4.2	0.0	4.4	3.4	0.6	0.5	4.8	17.3	37.4	135.4	0.4	3.9	1.9	4.2	0.0	4.8	1.8	4.1	11.5	20.3	18.1	0.0	26.6	10.6	28.1	17.6	0.1	132.8	2.0	2.5	0.6	0.1	0.7	135.2	1.8	2.0	1.9	51.5	0.5	0.0	2.3	2.4	2.1	8.4	2.6	4.4	1.9	230.2	0.9	1.3	3.1
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853816	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	28.4	24.9	16.1	50.1	16.2	13.7	20.7	15.8	20.3	21.6	16.2	30.3	36.0	20.5	2.5	31.6	17.8	12.7	25.4	14.7	16.2	21.8	19.3	52.7	50.0	24.0	16.1	12.1	14.5	7.0	11.6	12.1	21.2	21.9	12.5	1.7	25.9	7.0	16.3	51.2	42.6	11.5	18.6	73.0	33.4	11.5	19.4	25.5	17.0	7.4	21.3	23.9	24.4	17.4	22.9	13.7	0.1	16.1	8.8	11.4	126.2	8.1	34.3	59.3	86.5	2.0	27.3	41.8	25.0	12.6	48.9	45.8	4.5	20.6	5.3	81.0	6.1	26.5	4.1	10.8	42.3	0.1	17.5	15.0	17.9	17.1	10.4	8.6	15.4	8.4	1.9	55.0	10.6	10.5	17.7	27.4	0.8	3.1	11.1	47.6	5.2	32.8	25.0	10.5	0.2	1.2	6.7	38.0	33.4	1.7	30.9	37.4	9.7	21.5	8.1	53.1	11.4	59.9	82.6	12.6	16.6	16.6	16.4	176.8	99.5	270.1	155.8	101.6	133.8	137.3	125.2	153.7	95.0	107.5	120.9	124.6	295.6	132.9	94.6	94.8	213.8	221.2	16.1	16.2	15.8	20.3	14.7	16.2	24.0	16.1	21.2	18.6	19.4	17.4	72.1	25.6	24.0	9.1	62.1	74.7	47.1	54.5	27.3	4.8	21.5	15.9	7.3	24.3	33.1	5.5	0.0	5.6	108.0	78.8	5.9	81.6	0.5	31.3	39.3	63.6	16.8	12.6	1.1	75.3	95.0	26.9	42.8	77.9	26.6	13.8	27.1	11.1	45.9	15.2	1.9	55.9	57.0	31.9	90.6	0.3	13.1	43.9	23.2	16.9	115.9	25.1	149.3	12.1	3.6	91.3	38.8	10.5	84.8	70.2	84.6	6.9	29.4	2.8	6.6	18.1	27.8	1.0	1.3	20.4	76.4	4.8	92.3	18.2	54.5	52.1
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838770	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.4;U-251 MG: 52.0"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	17.1	11.7	1.0	4.3	1.0	8.8	14.7	0.8	1.2	16.3	0.5	14.6	10.2	13.7	1.1	26.0	11.9	1.1	14.4	1.2	2.0	12.4	11.5	25.7	7.9	1.6	1.1	9.2	9.0	3.7	8.2	3.1	1.5	9.9	5.5	2.5	11.2	2.1	8.6	14.5	25.2	4.1	0.8	29.8	11.4	2.5	1.8	9.7	12.3	5.8	8.1	10.6	17.2	1.7	4.4	2.0	0.5	5.0	6.1	6.5	0.0	2.3	3.3	13.1	17.7	3.9	41.0	36.5	7.5	9.1	37.1	38.8	15.8	61.4	6.9	43.8	1.9	20.3	11.6	1.3	8.5	0.0	29.5	0.6	2.6	10.3	24.8	0.0	12.1	0.0	20.0	12.2	0.4	1.6	5.8	2.4	0.5	0.0	11.7	25.8	0.0	12.8	10.9	1.1	0.0	0.0	16.0	37.3	4.1	1.0	7.4	1.9	5.7	25.7	6.9	3.9	52.0	17.9	31.4	33.3	19.5	25.7	10.9	1.8	1.3	1.6	3.0	3.2	1.7	0.4	0.8	1.7	0.8	0.3	0.6	0.7	3.8	1.9	2.8	1.3	1.2	0.8	1.0	1.0	0.8	1.2	1.2	2.0	1.6	1.1	1.5	0.8	1.8	1.7	48.2	0.0	7.5	7.5	20.7	0.0	15.6	0.0	3.4	5.0	9.2	8.0	3.5	4.3	3.7	14.7	2.1	1.9	37.9	21.0	1.9	34.1	0.1	18.0	19.4	32.0	3.6	4.0	6.6	33.4	45.8	8.0	10.7	41.9	5.1	8.7	16.4	8.3	23.9	18.5	14.6	14.9	0.0	18.9	0.0	0.0	5.6	20.3	0.0	14.0	69.3	17.7	47.4	10.6	6.5	35.1	12.6	6.0	18.0	29.7	55.9	4.8	1.5	5.8	0.0	8.6	10.3	0.7	2.5	11.1	0.0	1.6	24.0	20.3	14.3	16.7
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6"	"Group enriched"	"Detected in many"	4	"B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069743	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA069743: AB_2686186"	"prognostic favorable (3.83e-4)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favorable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	2.3	0.7	0.7	25.8	1.2	40.4	1.1	0.4	1.2	1.4	0.8	4.1	5.5	0.9	0.1	2.3	1.9	3.2	0.9	0.6	0.6	2.5	2.6	8.9	56.7	0.9	0.5	0.5	0.8	0.2	0.5	0.8	0.6	1.9	1.5	0.0	3.8	0.7	0.9	1.4	25.6	0.5	0.5	58.6	7.6	0.5	0.7	46.0	7.6	0.6	21.8	3.2	1.7	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.1	1.2	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.1	0.0	0.0	0.3	47.1	64.7	0.0	0.0	0.0	6.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	4.5	0.0	0.0	0.1	0.2	0.0	0.4	0.5	12.2	0.0	24.6	0.0	191.0	46.0	270.4	237.7	120.4	169.7	177.3	201.5	208.3	65.6	184.2	206.7	192.0	237.6	148.0	167.0	55.8	286.6	261.6	0.7	1.2	0.4	1.2	0.6	0.6	0.9	0.5	0.6	0.5	0.7	1.1	2.5	6.4	19.5	0.0	109.6	1.1	0.1	0.1	0.6	1.0	1.4	1.9	1.5	2.8	2.5	0.0	0.0	0.2	144.4	0.2	0.0	0.2	0.2	2.4	0.4	1.9	1.2	12.6	0.2	0.0	0.3	2.0	2.0	1.1	23.4	0.1	5.0	1.4	23.7	0.0	0.1	0.0	0.0	16.0	6.9	0.6	0.0	23.1	3.6	1.0	24.5	0.3	284.2	0.0	0.5	0.0	0.0	0.0	40.2	0.1	0.1	1.1	1.3	0.5	0.0	1.3	1.1	0.1	0.2	0.0	1.0	0.4	147.7	0.1	0.1	0.1
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	17.9	17.4	13.7	17.0	21.1	25.2	18.6	18.2	15.5	20.1	6.0	13.5	10.8	17.6	12.1	16.8	22.5	19.2	15.8	13.8	16.1	19.9	14.7	18.0	23.1	21.9	17.7	28.1	18.3	25.7	8.5	17.5	22.8	14.0	13.9	10.9	14.1	16.4	9.3	14.0	13.8	18.3	18.3	24.0	13.8	18.9	16.0	20.3	30.0	11.3	23.2	14.8	10.1	29.9	26.3	28.8	23.2	22.0	45.0	65.5	25.4	27.6	39.7	17.7	15.3	14.0	23.2	48.5	29.1	56.3	27.1	8.0	20.6	33.6	36.6	43.0	7.9	46.6	11.1	16.5	28.8	45.7	39.0	42.6	39.3	38.5	23.2	39.8	40.9	28.3	29.6	43.6	43.5	17.6	22.5	10.5	19.1	16.8	30.0	48.9	29.6	34.7	26.3	20.0	8.8	41.0	52.5	12.2	18.6	21.7	34.6	37.6	44.7	48.7	21.6	25.6	30.4	25.2	36.6	46.7	37.5	42.3	46.5	11.7	8.1	11.9	5.8	6.5	7.5	10.3	4.4	4.2	9.2	11.3	3.2	3.8	10.4	4.3	6.3	5.8	5.2	4.8	13.7	21.1	18.2	15.5	13.8	16.1	21.9	17.7	22.8	18.3	16.0	29.9	40.4	16.0	35.0	226.6	56.0	18.4	20.0	15.8	42.7	20.3	23.0	19.9	18.6	25.8	27.8	14.7	10.4	17.1	28.9	9.2	5.9	17.7	64.1	19.6	28.9	30.7	13.1	31.3	333.2	9.9	16.7	32.5	20.4	28.2	18.9	31.5	34.6	19.9	21.4	35.3	350.5	13.4	10.2	35.6	22.9	40.2	30.7	34.9	14.2	324.2	23.2	26.6	32.0	341.8	565.6	12.3	9.1	30.5	20.7	9.8	13.7	15.9	16.3	22.3	6.6	34.0	20.4	20.7	25.5	28.4	17.0	8.2	30.0	35.5	14.5	17.6
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 103.8;Oligodendrocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	9.3	9.1	20.0	8.7	21.3	7.2	9.7	17.4	16.7	18.1	14.2	9.4	2.8	38.4	35.3	10.2	16.6	7.1	7.3	16.7	21.1	16.6	13.6	5.8	9.0	23.8	20.2	18.0	9.2	23.9	18.7	20.7	19.7	25.4	5.3	16.5	7.3	43.2	4.6	7.5	5.0	26.6	18.6	8.4	8.1	9.7	26.7	18.4	12.0	5.2	10.2	13.5	12.7	20.0	0.1	29.6	18.5	49.2	16.8	17.4	18.4	11.3	25.0	21.3	22.2	22.4	20.2	31.6	0.8	22.7	9.1	6.7	40.7	8.9	30.9	13.0	19.6	20.0	35.6	26.5	23.7	7.2	68.6	15.6	10.1	22.3	11.8	11.7	19.9	17.2	35.8	53.5	12.5	25.6	17.8	27.2	36.7	14.2	31.5	39.3	14.5	39.3	28.9	16.9	23.4	10.6	27.2	6.8	16.9	48.2	13.3	15.6	29.1	7.5	18.3	0.8	4.6	32.6	27.8	25.1	27.2	17.4	7.1	6.3	4.7	5.7	2.2	2.9	1.8	2.2	1.7	2.0	3.5	3.6	3.1	2.9	18.7	0.3	2.0	0.3	2.9	2.1	20.0	21.3	17.4	16.7	16.7	21.1	23.8	20.2	19.7	18.6	26.7	20.0	12.6	0.0	4.5	103.8	17.3	6.5	13.2	3.8	9.1	11.8	19.1	18.0	10.1	20.0	6.8	31.3	22.9	78.1	20.4	7.9	13.7	10.7	1.0	34.4	80.7	10.3	22.8	3.8	12.5	7.8	6.0	13.1	9.7	51.1	11.4	32.5	11.4	64.3	11.3	6.7	17.1	5.4	2.0	33.0	22.8	3.2	14.3	19.7	5.4	61.8	37.5	46.6	19.6	46.3	109.7	7.5	7.9	28.6	9.5	24.1	0.2	21.8	10.0	24.5	0.0	9.4	27.9	1.4	18.0	16.5	12.4	45.0	18.8	22.3	4.9	23.7
TCEAL5	WEX4	ENSG00000204065	"Transcription elongation factor A like 5"	Q5H9L2	X	103273691-103276750	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 67.3;choroid plexus: 35.5;pituitary gland: 62.2;retina: 23.5;testis: 60.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.4;Granulosa cells: 16.5;Late spermatids: 22.1;Muller glia cells: 75.5;Peritubular cells: 35.7"	"Cancer enhanced"	"Detected in many"		"glioma: 13.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 9.0;SH-SY5Y: 28.0"	"Low region specificity"	"Detected in all"							"HPA045564, HPA058982"	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (1.30e-3)"	"unprognostic (2.41e-1)"		"prognostic unfavorable (9.09e-4)"	"unprognostic (9.68e-2)"	"unprognostic (8.75e-4)"		"unprognostic (1.21e-1)"		"unprognostic (8.11e-2)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.03e-4)"	0.9	10.5	56.5	0.9	54.9	0.0	2.1	55.4	67.3	6.2	35.5	2.2	0.6	5.6	6.8	0.3	2.4	0.8	2.7	52.9	55.2	0.3	0.1	0.3	0.0	50.8	52.6	5.2	0.9	0.0	62.2	0.0	49.5	3.3	0.7	23.5	1.1	4.1	0.1	0.4	1.2	3.3	44.9	0.0	1.0	60.0	50.3	0.6	2.3	0.7	0.0	1.5	3.8	55.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.5	54.9	55.4	67.3	52.9	55.2	50.8	52.6	49.5	44.9	50.3	55.4	0.1	0.0	0.0	2.9	0.0	0.1	0.5	0.0	1.8	43.4	0.3	9.5	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.3	7.5	0.6	0.0	0.0	7.0	0.0	0.4	7.6	0.0	0.2	0.0	16.5	0.0	0.0	0.3	1.7	7.7	0.0	0.0	0.0	1.7	22.1	8.4	0.7	0.0	2.8	0.0	75.5	0.0	7.1	2.8	0.0	0.0	35.7	0.0	0.2	0.0	0.3	0.0	6.8	0.0	6.9	1.4	7.6	1.9	0.1	0.3	0.4	0.1	0.2	0.0	0.2
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 169.1;granulocytes: 152.3;Inhibitory neurons: 128.9;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: AB_2732759"	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	8.8	8.2	14.2	6.8	18.7	5.8	12.0	18.2	16.4	10.6	12.7	9.9	9.5	10.8	9.9	10.4	9.8	9.2	10.7	11.8	16.0	11.4	9.4	12.5	9.1	17.1	15.5	14.0	14.1	10.9	7.7	6.0	16.6	8.0	11.1	10.9	9.3	7.4	16.7	11.3	8.7	9.2	16.0	8.7	11.2	12.3	17.9	11.9	12.0	18.5	9.2	8.1	7.7	21.2	6.7	7.3	15.3	36.7	5.9	13.3	9.5	7.6	8.4	8.7	5.6	4.9	10.9	16.0	3.0	11.1	7.4	8.9	12.6	11.0	9.4	12.5	10.1	30.4	13.7	9.4	12.0	21.3	15.4	8.9	15.4	5.1	15.1	17.9	12.0	13.3	6.7	9.7	9.5	7.4	19.5	11.4	11.7	24.4	5.5	10.1	7.5	11.0	12.0	8.8	13.8	16.4	10.9	13.2	27.9	10.9	6.8	9.3	10.2	5.4	5.6	6.1	8.5	18.8	17.7	13.7	5.0	11.0	16.7	0.3	1.4	1.6	3.2	2.2	2.3	2.2	3.7	3.7	2.1	1.4	3.0	3.8	0.1	2.1	1.7	4.6	4.5	1.3	14.2	18.7	18.2	16.4	11.8	16.0	17.1	15.5	16.6	16.0	17.9	21.2	24.5	22.4	30.0	169.1	13.8	7.9	9.6	9.3	14.8	30.9	10.8	10.2	44.4	11.5	18.2	11.0	54.2	8.8	18.7	11.5	21.5	13.4	20.9	18.8	24.4	15.9	17.4	7.2	101.1	17.8	10.6	18.5	18.3	15.7	152.3	26.1	11.7	8.8	6.9	20.2	128.9	12.8	12.2	9.5	7.8	24.4	19.0	22.2	19.6	69.3	12.2	12.7	20.6	142.7	168.7	10.6	19.2	18.4	14.6	7.1	12.4	12.3	22.8	30.6	6.6	32.9	12.9	38.9	21.6	14.1	6.7	6.7	20.9	30.6	14.0	8.0
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1013.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		10000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.60e-4)"	102.7	162.6	189.0	43.1	201.7	74.2	100.4	220.8	237.5	156.8	216.5	78.5	106.1	53.2	103.2	373.2	87.1	49.7	78.4	180.1	200.0	112.2	133.9	67.8	55.7	209.6	191.2	80.9	105.5	306.1	78.7	68.0	212.2	85.7	59.3	82.8	222.3	83.5	366.3	263.5	95.9	36.7	207.6	75.4	81.7	182.7	199.9	65.8	92.7	209.6	85.3	51.6	185.9	230.2	220.5	162.1	149.5	169.6	214.7	97.2	156.9	62.8	175.2	196.3	242.9	225.3	246.2	113.8	127.4	134.2	152.4	328.8	158.1	254.3	84.0	192.3	165.9	193.7	225.4	254.6	129.7	139.5	143.7	144.9	201.8	174.3	96.1	98.4	93.7	169.2	128.9	391.5	104.0	289.3	170.1	248.3	155.6	556.1	227.6	154.4	96.1	521.1	275.1	115.8	183.2	113.0	103.1	278.4	139.6	77.2	151.3	274.4	55.2	160.5	66.8	141.0	212.6	118.4	119.8	122.7	163.8	212.6	162.2	55.6	72.7	52.5	137.8	106.4	148.8	100.1	180.1	159.1	124.2	99.1	207.1	164.5	32.7	183.7	83.9	137.1	290.1	170.9	189.0	201.7	220.8	237.5	180.1	200.0	209.6	191.2	212.2	207.6	199.9	230.2	60.4	73.7	71.1	47.7	87.6	169.5	227.5	297.9	125.7	90.8	161.1	155.6	52.9	120.1	221.5	165.5	123.0	509.5	88.1	159.2	56.7	166.2	443.9	102.2	40.1	64.7	100.0	80.1	15.3	225.1	525.5	81.8	89.7	64.2	36.1	90.1	73.2	143.1	188.0	112.7	19.2	144.0	199.4	113.8	99.3	1013.1	72.7	77.8	163.7	18.7	61.6	577.9	103.0	12.5	46.5	104.8	128.2	60.2	206.1	110.2	343.2	202.9	213.1	177.5	65.7	68.4	286.7	215.0	134.2	255.3	239.7	486.2	117.7	116.0	216.2	196.5
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.3"	"Group enriched"	"Detected in many"	10	"Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	20.1	9.1	8.1	5.8	7.0	0.2	14.0	6.1	8.4	9.3	4.3	5.0	3.7	12.4	2.3	5.3	6.7	11.2	16.8	7.1	6.8	23.0	10.5	28.8	3.7	7.2	6.6	3.5	3.5	4.4	3.0	46.3	7.6	3.8	5.4	0.7	3.1	6.2	10.5	2.8	5.5	12.7	6.8	28.8	4.0	1.4	9.4	1.8	9.1	22.9	2.8	6.9	3.9	6.8	0.3	0.0	3.5	0.0	0.4	5.6	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	1.6	0.0	0.0	1.8	0.0	2.2	0.8	0.1	90.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	45.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	99.1	0.0	0.5	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.1	8.4	7.1	6.8	7.2	6.6	7.6	6.8	9.4	6.8	70.8	3.2	1.3	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.5	8.6	0.0	0.6	1.8	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.6	0.8	73.9	0.0	2.7	4.3	0.0	2.8	4.2	0.0	0.7	0.0	0.3	122.0	1.3	0.3	0.0	5.0	0.0	0.0	6.7	2.2	0.9	0.6	0.4	0.0	38.4	0.0	0.1	0.0	137.7	2.1	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	1.9	0.1	0.4	0.3	1.3	1.4	0.5	1.8	0.0	0.0
TERF2IP	RAP1	ENSG00000166848	"TERF2 interacting protein"	Q9NYB0	16	75647773-75761872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006719, CAB018660, CAB018749"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nuclear bodies"		"CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267"	"unprognostic (3.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (6.14e-5)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-5)"	"unprognostic (6.26e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.99e-1)"	56.3	93.4	151.5	41.2	152.0	89.7	51.9	146.3	186.2	52.7	112.3	48.3	27.2	51.6	57.6	37.6	50.7	36.7	67.0	146.2	189.9	46.7	42.9	51.8	68.2	142.8	154.1	72.8	38.2	71.8	144.4	27.5	155.3	48.0	26.9	168.6	38.3	44.8	58.3	48.0	41.8	39.1	146.0	57.7	37.7	55.0	174.0	71.9	55.2	47.3	61.9	44.5	46.4	156.5	25.1	23.2	51.2	39.7	56.9	59.2	16.0	74.6	63.9	62.0	45.8	25.7	26.9	127.2	97.0	50.6	30.6	35.6	51.1	21.3	52.5	48.1	74.1	64.9	36.6	59.1	74.4	88.6	88.7	50.7	59.3	49.8	76.8	68.2	42.2	82.6	77.2	52.2	71.9	73.7	107.2	112.5	25.9	32.4	53.3	119.9	33.0	106.0	46.4	22.7	123.9	74.7	96.8	22.4	61.8	18.5	51.7	86.0	46.6	59.1	31.3	51.4	57.9	216.2	202.5	179.2	62.2	59.6	57.1	56.4	21.9	101.3	28.7	19.8	35.8	46.8	44.2	47.9	21.0	65.7	53.9	33.8	33.2	39.7	31.2	20.3	48.6	19.8	151.5	152.0	146.3	186.2	146.2	189.9	142.8	154.1	155.3	146.0	174.0	156.5	109.1	48.1	69.3	30.7	160.8	195.5	114.3	82.5	163.4	388.8	73.6	77.0	95.2	68.6	74.2	93.8	93.8	76.8	172.7	33.4	135.0	81.7	7.8	68.5	81.8	102.3	97.8	421.4	46.7	51.1	38.9	115.7	39.3	74.6	124.9	81.4	84.3	58.1	60.7	282.7	54.5	50.1	120.1	70.8	138.5	23.6	115.5	89.3	120.9	18.7	96.6	320.2	125.7	38.2	68.2	46.3	46.9	130.5	162.8	101.7	45.1	74.7	66.9	176.2	138.1	79.0	106.2	255.1	116.2	94.3	194.4	122.3	215.0	140.7	32.2	116.4
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560337-68694487	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	0.4	0.2	0.6	0.2	1.2	0.3	0.4	4.9	0.7	0.7	0.8	0.4	0.1	0.9	0.6	0.2	0.5	0.3	0.3	0.3	0.9	0.3	0.2	0.2	0.3	0.9	1.3	0.8	0.2	0.7	0.3	1.2	1.1	0.6	0.3	1.5	1.0	0.3	0.9	0.3	0.2	0.5	1.0	0.3	0.4	0.2	1.1	2.0	0.5	0.3	0.3	0.2	0.4	2.2	0.7	0.8	8.0	9.0	0.8	0.7	17.7	0.4	1.0	0.7	1.2	5.5	0.3	0.0	0.3	0.8	0.1	0.0	20.4	0.0	0.8	0.3	3.3	2.1	0.0	4.9	1.2	1.9	1.0	1.0	0.1	0.5	0.1	1.6	0.1	3.5	12.0	1.4	0.7	0.6	3.3	1.4	11.9	0.0	1.1	3.2	2.5	0.2	0.4	0.8	2.2	3.5	0.4	0.5	1.6	7.9	1.0	1.5	0.3	0.7	1.6	0.0	0.6	0.5	0.6	3.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.6	1.2	4.9	0.7	0.3	0.9	0.9	1.3	1.1	1.0	1.1	2.2	6.3	3.2	6.2	54.5	2.5	1.1	1.8	0.4	5.2	2.5	7.0	9.5	7.2	1.5	2.6	0.0	10.4	21.0	3.0	0.2	0.0	2.7	0.8	3.6	34.2	4.8	13.8	2.5	15.6	0.4	79.9	15.4	1.5	2.9	0.0	13.6	5.7	2.5	3.9	35.3	20.6	0.3	4.1	0.0	0.3	1.7	25.7	0.8	1.8	12.2	0.4	16.1	5.2	44.7	45.3	0.6	0.0	20.7	7.3	1.4	0.0	0.9	0.8	12.5	6.6	21.9	10.7	0.5	1.5	0.8	1.1	27.9	2.6	43.7	0.6	0.4
TFAP2E	AP2E	ENSG00000116819	"Transcription factor AP-2 epsilon"	Q6VUC0	1	35573314-35595328	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.8;Excitatory neurons: 9.0;Inhibitory neurons: 9.8;Oligodendrocytes: 11.3;Rod photoreceptor cells: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.6;SK-MEL-30: 1.7;U-937: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (7.06e-4)"	"unprognostic (1.96e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.27e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.67e-15)"	"unprognostic (2.03e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.40e-2)"	1.0	0.6	3.0	0.9	2.8	1.5	1.0	9.2	4.0	3.5	0.2	1.1	0.1	1.3	0.3	1.2	2.5	0.2	0.9	2.6	2.2	1.1	0.3	1.3	0.9	2.8	2.3	2.5	0.6	0.0	3.2	0.2	3.0	1.7	0.1	4.4	1.0	0.1	0.4	5.2	1.2	0.0	2.4	1.9	1.0	2.2	2.4	0.3	0.5	0.0	0.3	0.8	3.1	5.1	0.2	0.2	0.2	0.1	0.1	0.1	0.8	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.2	0.5	0.4	0.3	0.0	0.0	0.6	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	4.6	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.1	1.7	0.1	0.4	1.4	0.1	0.1	0.7	0.4	0.1	0.8	0.4	0.0	0.1	3.6	0.5	0.5	0.8	0.5	0.9	0.3	0.3	0.4	0.5	0.8	0.4	0.4	0.2	0.8	0.0	0.9	0.4	0.3	0.8	0.5	3.0	2.8	9.2	4.0	2.6	2.2	2.8	2.3	3.0	2.4	2.4	5.1	0.2	0.0	1.3	4.9	0.2	3.7	0.1	0.3	0.0	9.8	0.5	0.5	0.4	0.0	0.8	0.0	2.1	0.4	0.9	0.1	0.0	0.2	0.5	0.3	0.4	0.3	0.0	0.0	9.0	0.0	0.0	0.4	2.6	0.5	0.0	0.1	0.4	0.2	1.0	0.0	9.8	0.0	0.0	1.0	0.0	1.0	2.1	0.6	1.8	1.9	0.5	0.3	3.1	3.5	11.3	0.2	0.3	0.7	0.3	0.1	0.1	0.0	0.2	5.6	0.0	0.2	0.4	2.4	0.4	0.0	4.4	0.1	0.9	0.1	0.4	0.2
TFCP2	"CP2, LBP-1C, LSF, TFCP2C"	ENSG00000135457	"Transcription factor CP2"	Q12800	12	51093656-51173135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.0;Inhibitory neurons: 75.9;Microglial cells: 69.3;Oligodendrocyte precursor cells: 79.4;Oligodendrocytes: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070247			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA070247: AB_2686239"	"unprognostic (6.27e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.31e-2)"	16.7	12.9	12.4	18.5	14.7	9.8	16.9	13.9	16.4	18.4	10.1	17.0	14.9	18.0	16.1	13.5	19.6	13.5	17.7	13.2	13.1	16.1	11.3	13.5	21.0	12.4	13.0	18.6	13.8	25.0	14.2	18.8	12.6	18.5	20.3	32.1	16.3	15.0	26.7	14.3	15.1	18.1	12.6	18.5	15.2	9.1	12.8	27.3	17.1	22.1	26.0	15.5	13.4	16.9	17.3	29.5	43.0	40.4	25.2	31.3	64.1	30.7	18.6	29.8	17.4	52.4	37.6	1.5	27.9	29.4	21.9	33.8	56.0	35.2	29.4	35.5	28.3	47.4	26.6	23.8	20.3	57.9	48.4	21.3	33.3	29.4	47.8	34.0	28.4	15.1	54.1	0.1	32.0	0.0	55.2	39.5	64.0	39.9	55.3	41.2	23.6	0.4	39.2	39.4	41.1	36.0	38.8	34.6	28.1	41.7	13.0	49.0	24.3	27.1	27.9	27.8	28.4	30.8	53.3	0.1	25.8	35.3	19.5	7.4	6.1	6.6	2.3	5.4	3.8	2.8	2.4	2.6	5.6	1.8	3.1	2.4	2.1	6.9	7.2	2.2	3.8	3.3	12.4	14.7	13.9	16.4	13.2	13.1	12.4	13.0	12.6	12.6	12.8	16.9	9.3	9.6	16.4	57.8	11.0	6.6	6.9	10.7	9.1	21.6	11.5	10.5	23.8	8.6	8.7	12.9	20.9	13.2	19.6	11.4	5.9	9.2	0.8	11.0	14.1	10.2	10.8	5.9	73.0	7.7	10.5	9.7	10.7	14.6	10.8	22.5	12.5	9.3	13.7	10.1	75.9	13.2	10.2	21.1	10.8	0.7	12.2	17.0	10.6	69.3	36.8	9.8	24.7	79.4	103.6	12.2	11.0	10.9	7.3	11.1	8.7	9.4	9.2	27.3	0.0	14.0	13.1	6.7	11.3	9.9	5.3	16.7	10.7	12.2	13.4	6.4
TFDP1	"DILC, Dp-1, DP1, DRTF1"	ENSG00000198176	"Transcription factor Dp-1"	Q14186	13	113584721-113641473	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 344.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 31.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033605, HPA044754, HPA068909, HPA077304"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056, HPA077304: "	"unprognostic (4.28e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (5.50e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.57e-4)"	"prognostic favorable (6.17e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	28.2	23.5	24.3	38.6	24.0	164.0	27.2	24.5	24.4	33.5	32.5	37.8	30.5	27.6	19.4	50.1	32.8	24.6	34.3	24.1	22.8	23.2	25.9	21.8	67.1	27.5	24.4	19.3	18.4	28.5	21.3	40.6	25.3	26.1	42.4	20.2	26.1	30.8	58.2	42.8	32.3	34.3	26.6	30.8	31.3	49.6	26.8	53.4	33.1	59.0	68.3	37.5	30.1	25.7	343.2	82.5	104.4	89.5	138.4	122.7	118.5	187.8	168.7	238.1	218.6	173.3	155.9	314.6	61.3	181.3	130.3	160.3	183.0	167.1	232.2	215.9	212.8	184.4	129.2	109.8	86.8	468.3	155.7	102.1	147.3	151.3	87.4	85.0	162.7	116.2	154.1	82.6	215.5	117.7	207.0	181.4	96.6	322.7	105.0	138.9	93.0	181.1	91.3	129.1	268.2	79.3	84.8	228.8	58.7	75.1	157.9	371.7	114.4	77.2	122.9	165.6	210.8	69.5	92.4	326.4	171.9	285.2	133.2	31.9	3.0	4.6	3.1	3.8	3.4	4.4	4.1	3.7	5.9	3.6	6.3	3.2	3.8	2.3	5.5	3.0	5.3	2.5	24.3	24.0	24.5	24.4	24.1	22.8	27.5	24.4	25.3	26.6	26.8	25.7	21.4	9.6	15.8	12.7	38.8	59.8	32.1	16.1	33.6	10.3	45.6	35.2	26.6	28.6	14.7	29.5	14.6	83.2	33.8	29.8	80.3	12.3	5.5	34.4	28.2	25.8	40.2	344.3	22.5	11.9	128.0	30.8	38.7	31.0	21.0	23.3	34.6	58.7	49.2	6.7	19.5	36.1	12.2	49.1	51.2	10.7	28.6	41.1	35.6	5.6	24.8	14.7	16.5	9.5	10.2	19.0	24.2	28.2	67.3	35.7	29.4	66.5	21.0	22.5	6.6	20.0	32.7	76.7	52.7	74.6	60.0	66.6	32.1	30.3	47.4	35.8
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.2;kidney: 20.5;lymphoid tissue: 22.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 45.5;Kupffer cells: 56.3;Macrophages: 61.6;Microglial cells: 60.0;monocytes: 44.1;Proximal tubular cells: 77.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 7.1;intermediate monocyte: 2.8;memory B-cell: 3.8;myeloid DC: 6.3;naive B-cell: 2.5;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	29	"B-cells: 3.8;dendritic cells: 6.3;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;HUVEC TERT2: 11.0;THP-1: 21.5;TIME: 12.5;U-937: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	3.5	2.4	1.3	19.2	1.2	17.2	2.6	1.5	1.6	1.9	2.1	2.7	4.2	1.4	0.6	1.0	1.0	4.9	1.0	0.8	1.7	20.5	3.1	9.9	22.1	3.3	1.9	1.3	1.0	0.4	0.6	4.7	2.7	1.0	4.2	0.1	1.3	0.9	0.3	0.4	9.7	3.1	2.7	14.6	3.0	1.6	3.7	2.8	0.9	0.4	12.6	4.0	0.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	1.7	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	21.5	12.5	2.1	0.2	1.3	0.0	5.5	0.0	0.0	0.1	24.4	1.1	0.0	7.1	0.0	0.0	2.8	0.0	3.8	0.0	0.0	6.3	2.5	0.0	0.0	0.1	0.0	0.4	3.3	0.0	1.5	1.3	1.2	1.5	1.6	0.8	1.7	3.3	1.9	2.7	2.7	3.7	4.8	0.5	0.0	2.2	0.3	18.1	0.5	0.0	0.0	0.0	0.0	0.3	0.8	0.8	1.5	0.0	3.7	0.0	0.2	8.3	0.0	0.0	0.0	2.4	0.0	0.0	1.7	0.0	7.2	0.6	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	45.5	0.0	0.5	0.4	0.0	56.3	17.8	3.8	0.0	61.6	0.0	60.0	44.1	0.0	1.0	1.0	0.1	0.1	0.0	0.0	1.3	0.1	15.6	77.8	0.0	0.0	0.0	0.3	0.1	0.3	2.5	0.1	0.4	0.8	0.8	0.1	0.7	0.1
TGFB3	"ARVD, ARVD1"	ENSG00000119699	"Transforming growth factor beta 3"	P10600	14	75958097-75983011	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 28.8;Late spermatids: 48.9;Leydig cells: 27.1;Sertoli cells: 32.9;Smooth muscle cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"SK-BR-3: 104.6;T-47d: 75.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA063582			Approved	Vesicles	"Secreted to blood"	NA	NA	44800			"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA063582: AB_2685049"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (4.01e-7)"	"unprognostic (6.38e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.27e-3)"	22.2	13.0	43.4	15.8	45.8	1.0	15.6	33.5	58.4	46.6	18.4	12.8	4.1	25.5	9.6	7.7	14.5	36.6	27.9	31.2	38.4	20.5	17.6	25.7	7.2	40.9	42.3	8.0	27.7	9.9	8.3	55.4	40.0	43.6	4.8	1.8	10.8	17.9	38.6	5.0	6.6	34.3	38.9	5.3	14.1	4.5	42.2	6.5	12.3	11.0	8.8	45.8	16.2	70.1	1.1	1.5	1.1	13.4	2.1	4.3	0.4	1.0	1.5	0.7	0.7	0.8	3.4	0.1	1.0	2.8	0.4	0.9	2.9	0.7	0.3	0.8	1.5	0.1	3.5	1.5	2.7	0.6	0.9	10.2	0.4	1.0	0.4	2.3	3.2	2.7	1.5	6.3	0.8	7.0	0.8	0.8	0.4	0.8	5.3	3.3	4.2	0.7	1.2	0.6	21.9	6.3	4.3	104.6	0.8	1.5	75.2	0.5	0.8	2.0	4.5	2.1	5.8	0.8	1.3	0.4	3.6	1.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.4	45.8	33.5	58.4	31.2	38.4	40.9	42.3	40.0	38.9	42.2	70.1	8.6	0.0	2.8	5.5	0.8	4.5	1.2	2.1	1.2	0.7	15.1	6.1	3.6	0.0	3.3	1.8	4.2	0.5	1.2	1.3	0.0	0.5	16.4	2.6	9.9	10.2	0.0	0.0	1.3	1.3	0.4	28.8	0.0	2.4	0.0	0.5	7.9	0.8	0.9	0.0	3.0	2.6	6.1	0.6	4.4	48.9	27.1	0.9	10.6	1.0	0.7	2.1	3.1	5.5	4.7	0.4	0.1	12.8	0.5	20.6	1.4	0.4	4.2	3.9	32.9	13.9	24.4	0.4	1.4	2.4	3.1	1.4	1.3	1.6	0.4	0.8
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 128.4;Late spermatids: 101.7;Microglial cells: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 253.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144"	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	15.9	9.9	9.8	18.2	9.3	33.7	15.4	13.2	8.9	19.4	11.8	18.8	11.7	20.6	8.8	15.0	8.5	21.7	8.2	6.8	11.3	22.6	14.8	16.3	13.8	18.4	14.5	13.0	8.3	8.5	7.6	48.8	20.0	17.1	13.4	4.7	8.3	16.8	8.7	6.2	9.3	33.0	18.0	16.5	18.4	18.3	17.5	11.2	11.2	13.2	13.6	22.5	8.4	27.9	13.7	19.5	115.5	36.1	26.2	19.3	17.4	44.1	47.8	40.7	44.9	19.9	9.3	29.7	13.4	34.6	32.1	30.4	39.6	34.1	54.0	77.1	12.3	43.9	20.7	17.8	43.2	27.2	102.8	40.2	35.4	62.8	29.5	25.2	7.4	10.9	62.4	12.1	55.4	20.3	4.0	31.0	24.7	12.2	11.5	11.0	253.1	12.5	9.9	3.8	31.1	36.2	34.3	150.2	46.4	47.3	28.1	36.6	13.6	29.8	25.5	129.3	27.3	12.1	13.4	20.0	62.5	45.9	26.2	16.2	2.4	9.5	7.8	1.6	6.7	1.6	3.3	5.8	2.0	1.2	3.2	6.2	4.9	4.3	2.0	1.4	2.4	2.2	9.8	9.3	13.2	8.9	6.8	11.3	18.4	14.5	20.0	18.0	17.5	27.9	13.5	6.4	8.8	18.9	18.9	23.6	7.4	19.9	44.3	8.0	18.9	11.7	7.6	4.3	12.8	60.7	0.0	23.0	37.3	5.0	0.0	18.8	128.4	6.4	22.7	17.6	9.6	7.4	14.2	31.2	6.7	36.0	9.2	9.3	29.9	19.5	6.4	12.7	49.4	0.0	8.6	7.3	8.2	32.4	52.5	101.7	9.6	39.7	35.6	116.2	24.3	3.1	35.0	45.8	21.1	33.8	4.2	13.5	11.9	18.4	3.6	13.8	5.0	2.0	32.9	21.8	20.9	11.0	12.7	25.6	16.2	19.4	25.4	7.6	8.3	11.5
THEM6	"C8orf55, DSCD75"	ENSG00000130193	"Thioesterase superfamily member 6"	Q8WUY1	8	142727223-142736927	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 82.4;RT4: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023255	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"		"HPA023255: AB_1845782"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.76e-2)"	"prognostic favorable (6.66e-7)"	"unprognostic (7.02e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (4.49e-4)"	14.3	17.2	15.8	4.4	13.9	5.3	15.6	14.4	18.3	9.6	12.0	13.3	11.5	6.9	3.5	21.0	9.4	7.3	16.6	16.1	15.4	21.6	47.0	10.6	6.5	20.7	17.2	4.4	23.1	15.7	12.5	8.3	16.7	12.5	5.1	1.4	16.3	10.3	12.4	16.6	11.6	3.5	15.0	11.0	15.6	3.7	15.9	6.8	14.2	7.2	4.1	17.2	11.5	14.2	28.5	23.1	3.5	23.9	10.9	3.8	16.6	14.3	11.8	21.5	14.9	14.2	41.5	11.9	31.8	5.4	8.0	64.4	10.2	31.0	3.5	9.9	28.2	9.1	12.3	28.9	11.9	5.3	9.2	5.5	10.9	4.2	6.0	4.3	18.4	16.6	4.3	5.9	3.7	82.4	21.7	1.3	5.4	53.0	74.5	24.9	2.4	27.4	25.9	114.0	53.1	20.8	21.9	64.7	18.6	3.2	31.9	4.3	10.7	9.2	6.7	26.8	2.5	3.8	5.6	5.2	9.5	25.7	11.6	7.2	4.9	2.6	10.9	9.2	16.6	5.1	11.6	14.1	4.7	6.7	13.6	12.9	0.7	11.1	9.0	3.6	11.6	9.1	15.8	13.9	14.4	18.3	16.1	15.4	20.7	17.2	16.7	15.0	15.9	14.2	35.4	9.6	5.8	6.2	6.7	3.6	7.5	5.7	2.8	10.4	24.7	25.3	7.4	11.5	7.8	18.4	6.2	18.3	11.5	16.6	5.9	13.7	3.3	5.5	3.0	14.6	31.8	11.6	11.3	11.6	10.1	4.8	7.7	9.0	0.0	6.6	19.2	20.8	11.4	16.8	7.8	13.5	6.1	3.1	1.4	15.7	2.8	3.9	5.4	2.8	2.3	13.5	16.5	11.6	7.3	9.4	9.0	4.1	3.7	10.7	29.0	16.2	2.4	11.3	0.0	6.1	4.3	2.7	5.7	18.4	7.7	3.4	10.3	8.2	22.4	25.1
THEMIS2	"C1orf38, ICB-1"	ENSG00000130775	"Thymocyte selection associated family member 2"	Q5TEJ8	1	27872543-27886685	"Predicted intracellular proteins"	"Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 215.5;lymphoid tissue: 126.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.5;Hofbauer cells: 62.6;Kupffer cells: 135.9;Langerhans cells: 59.9;Macrophages: 125.4;monocytes: 144.8;Plasma cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 403.3;eosinophil: 341.0;intermediate monocyte: 441.4;myeloid DC: 309.6;neutrophil: 498.1;non-classical monocyte: 454.6;plasmacytoid DC: 125.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 309.6;granulocytes: 498.1;monocytes: 454.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 135.9;U-266/70: 98.4;U-937: 62.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027513, HPA031096"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA027513: , HPA031096: AB_10599254"	"unprognostic (7.38e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.56e-3)"	"unprognostic (4.13e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.52e-3)"	30.7	10.6	10.8	72.8	13.1	215.5	12.7	13.6	14.4	7.2	12.3	14.7	10.1	5.7	3.9	8.0	10.2	23.6	6.6	11.2	16.6	9.2	19.1	45.8	47.9	22.2	14.3	3.3	5.4	2.7	4.9	18.8	19.1	5.4	10.1	0.9	11.1	3.9	3.4	4.5	28.2	15.5	15.4	126.0	12.2	22.4	17.8	16.0	11.0	4.5	29.9	26.9	6.4	24.6	9.1	0.3	3.4	0.5	11.4	15.6	1.5	1.9	20.0	28.7	40.2	1.3	2.4	12.8	1.2	6.6	15.9	1.3	5.2	1.2	4.6	1.7	1.2	18.0	0.4	2.3	22.3	23.0	27.8	7.9	0.3	14.8	0.1	1.5	11.1	1.0	24.7	135.9	2.1	6.1	0.9	20.1	11.8	0.3	1.8	4.1	12.8	23.2	8.6	0.3	0.2	5.0	0.1	0.8	26.2	2.1	0.3	20.2	6.9	1.7	0.2	5.6	0.3	98.4	6.1	0.8	32.3	62.1	0.5	41.7	403.3	341.0	71.9	441.4	66.1	41.5	53.1	60.2	309.6	21.8	45.6	48.2	498.1	61.9	454.6	125.2	56.4	380.7	10.8	13.1	13.6	14.4	11.2	16.6	22.2	14.3	19.1	15.4	17.8	24.6	2.2	3.2	20.0	0.3	42.6	3.2	1.1	2.7	0.6	0.4	1.0	0.6	0.7	2.8	8.7	0.0	0.0	0.8	87.5	0.3	0.0	0.9	2.3	4.5	1.8	6.8	10.7	6.1	6.2	8.3	1.3	1.8	1.1	6.4	13.3	7.1	3.6	1.3	62.6	0.0	0.7	0.2	36.7	135.9	59.9	5.2	0.6	125.4	17.8	6.5	144.8	0.1	54.6	0.5	14.7	8.7	0.0	0.4	57.3	3.0	0.0	0.4	3.2	0.2	0.0	21.9	2.1	1.8	2.9	0.1	1.1	2.5	21.2	3.0	0.8	5.0
THRB	"ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2"	ENSG00000151090	"Thyroid hormone receptor beta"	P10828	3	24117153-24495756	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 199.2;Cone photoreceptor cells: 164.7;Excitatory neurons: 688.0;Inhibitory neurons: 631.3;Oligodendrocyte precursor cells: 329.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 7.7;basal ganglia: 15.1;cerebral cortex: 17.6;hippocampal formation: 18.5;white matter: 6.7"	"Group enriched"	"Detected in some"	5	"basophil: 7.2;naive B-cell: 2.2"	"Group enriched"	"Detected in many"	15	"B-cells: 2.2;granulocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"K-562: 45.6;RT4: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002008, CAB002009, HPA061035"	Approved		Supported	"Nuclear bodies"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"		"CAB002008: , CAB002009: , HPA061035: AB_2684422"	"unprognostic (1.82e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-6)"	"unprognostic (3.37e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.46e-8)"	"unprognostic (1.32e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.34e-2)"	11.1	4.9	7.7	1.7	15.1	1.0	10.0	0.0	17.6	2.8	0.0	11.7	2.5	7.0	1.8	6.4	3.8	2.2	7.7	18.5	2.0	12.1	20.1	5.0	1.5	0.0	0.0	2.3	9.0	7.3	15.7	4.4	0.0	7.5	8.4	20.1	6.2	7.7	23.6	6.8	3.9	7.0	0.0	5.7	8.3	0.7	1.4	3.6	4.4	27.0	1.4	8.9	4.2	6.7	10.3	3.1	0.6	0.1	17.4	8.8	6.7	0.5	2.1	1.5	3.2	6.7	9.7	0.1	2.5	6.8	1.1	15.4	10.8	3.9	1.0	0.0	6.4	0.0	2.5	8.9	0.5	0.0	0.0	16.0	7.3	0.2	1.2	3.5	0.0	0.0	45.6	0.0	1.5	0.6	0.0	0.0	6.5	0.6	3.4	0.0	0.0	0.0	10.0	32.7	1.7	0.6	16.5	8.9	0.2	4.6	9.7	0.0	0.9	3.9	3.0	0.0	1.9	0.1	0.5	0.0	2.7	0.1	0.3	7.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	7.7	15.1	0.0	17.6	18.5	2.0	0.0	0.0	0.0	0.0	1.4	6.7	3.0	3.2	11.4	199.2	3.3	9.9	29.5	13.2	1.8	17.9	24.5	18.7	11.6	8.6	14.1	23.9	164.7	12.4	0.0	39.9	1.9	2.4	2.3	3.4	0.5	6.0	25.2	3.8	688.0	12.5	23.2	13.7	16.3	5.7	0.0	0.3	7.5	37.7	1.7	0.0	631.3	8.1	10.2	11.3	11.7	2.4	0.6	4.6	1.8	97.4	0.2	11.7	0.0	329.2	32.4	10.3	17.5	2.2	0.1	40.1	4.8	8.1	10.3	21.8	6.6	12.0	7.5	0.3	0.7	5.1	23.9	5.5	1.0	0.4	9.8	81.3
THSD4	"ADAMTSL6, FLJ13710, FVSY9334, PRO34005"	ENSG00000187720	"Thrombospondin type 1 domain containing 4"	Q6ZMP0	15	71096952-71783383	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 103.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 106.4;Basal squamous epithelial cells: 449.0;Microglial cells: 247.3;Squamous epithelial cells: 141.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 45.3;BJ hTERT+: 53.0;T-47d: 43.3;TIME: 66.6;U-2197: 44.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.0"						"Secreted - unknown location"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.01e-3)"	4.8	8.4	9.8	1.6	7.8	0.0	14.7	6.1	8.6	103.7	9.5	7.0	7.9	22.2	7.8	60.3	37.0	10.9	41.6	8.5	7.2	14.2	7.0	10.3	0.9	7.8	9.1	3.1	6.4	0.7	9.7	3.6	7.6	34.0	6.9	1.2	11.4	15.0	3.0	8.5	8.7	10.3	7.0	1.9	12.0	3.1	15.9	1.6	8.8	2.5	2.5	13.3	38.5	5.9	6.0	45.3	0.8	13.0	6.7	40.2	0.2	22.0	53.0	11.2	5.8	0.3	8.7	0.0	17.7	7.8	38.5	17.0	1.8	9.1	6.8	2.0	2.0	0.0	4.4	0.0	4.3	0.0	0.0	3.0	6.7	6.7	26.6	30.5	20.7	0.0	0.0	0.5	9.2	9.1	0.0	0.1	3.9	0.1	7.8	0.0	0.7	0.8	29.5	6.0	0.7	5.5	8.8	10.9	0.0	5.0	43.3	0.1	66.6	0.2	1.0	44.4	11.8	0.0	0.3	0.0	10.4	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	7.8	6.1	8.6	8.5	7.2	7.8	9.1	7.6	7.0	15.9	5.9	1.1	19.2	9.0	6.5	0.0	13.9	106.4	11.3	449.0	3.0	48.7	43.9	60.1	58.6	7.5	5.5	6.2	0.4	0.8	16.2	1.9	18.3	7.5	19.3	13.2	9.8	3.0	0.0	17.1	1.8	0.4	12.5	2.6	31.8	0.0	0.3	6.1	12.3	0.2	0.0	19.1	6.1	0.0	0.0	2.1	16.9	17.4	1.6	8.8	247.3	0.0	0.3	0.0	8.5	6.7	13.6	11.0	74.4	1.2	94.6	29.3	0.5	11.0	0.9	0.0	16.8	6.6	0.9	1.7	141.5	10.9	0.8	3.1	42.2	13.2	29.7
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677718	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.9;retina: 19.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 25.0;Horizontal cells: 90.9;Inhibitory neurons: 153.4;Rod photoreceptor cells: 32.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Daudi: 11.0;SCLC-21H: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051416: AB_2681477, HPA056745: AB_2683224"	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	1.9	0.0	0.8	0.0	1.2	0.0	0.7	0.6	1.2	0.2	0.1	0.1	0.0	0.2	4.1	0.3	0.9	0.2	0.5	1.2	2.3	0.9	0.1	0.1	0.0	8.2	3.3	0.0	0.0	0.3	0.6	0.2	8.9	0.7	0.0	19.7	0.4	0.2	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	1.6	0.8	0.7	0.1	0.0	0.2	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.2	1.2	2.3	8.2	3.3	8.9	0.6	1.6	1.6	1.1	0.0	0.0	2.6	0.0	0.1	0.7	0.0	13.6	1.6	0.1	0.9	0.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	1.9	0.0	3.7	0.5	0.2	0.8	0.0	0.0	9.5	0.0	0.0	0.2	0.0	1.4	0.0	1.7	1.8	0.0	0.0	90.9	153.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	8.4	0.0	1.8	0.0	1.5	7.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	32.2	6.6	0.3	3.3	0.5	0.5	1.4	0.0	0.0	0.0	0.4	0.0	0.1
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119415476-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 286.8;smooth muscle: 304.7;urinary bladder: 216.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.6;Excitatory neurons: 116.0;Fibroblasts: 201.9;Inhibitory neurons: 104.1;Muller glia cells: 108.1;Proximal tubular cells: 199.9;Smooth muscle cells: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 461.3;BJ: 738.4;BJ hTERT+: 832.5;fHDF/TERT166: 1330.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	90.6	16.4	97.9	78.6	114.8	0.2	25.6	12.9	286.8	78.9	0.0	35.4	10.2	58.6	27.8	29.4	23.1	101.0	12.9	135.4	73.3	142.2	7.4	21.6	40.4	83.6	37.0	9.2	14.8	39.4	18.1	62.0	60.8	15.5	41.8	25.3	8.5	47.0	3.4	13.9	14.5	304.7	35.4	21.9	17.4	11.4	43.6	73.2	37.9	8.3	35.6	216.7	21.7	108.7	0.7	3.9	108.5	0.1	461.3	331.5	0.3	738.4	832.5	263.6	289.3	0.2	0.2	0.4	0.1	1330.6	121.9	0.9	4.3	1.1	200.7	65.1	0.0	41.5	14.4	0.0	142.7	0.0	0.2	247.5	0.0	335.6	11.6	355.2	0.3	22.6	0.0	0.6	206.5	0.1	0.6	0.1	173.9	0.0	1.4	0.5	50.7	0.3	0.1	0.2	18.1	47.9	0.1	0.4	0.2	32.9	1.0	2.1	0.0	368.6	120.9	107.3	110.1	0.3	19.7	0.4	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.9	114.8	12.9	286.8	135.4	73.3	83.6	37.0	60.8	35.4	43.6	108.7	68.2	0.0	1.8	17.3	2.1	17.7	0.3	1.7	0.0	27.2	1.6	40.0	0.9	0.0	0.0	9.2	0.0	1.9	0.2	0.0	21.5	0.9	1.0	5.1	141.6	69.2	0.0	0.0	116.0	0.0	2.6	201.9	1.5	3.2	1.3	0.0	17.5	0.1	4.0	32.0	104.1	0.0	0.0	0.0	25.0	2.7	96.3	2.7	17.8	21.5	0.0	108.1	0.0	64.3	22.7	0.4	0.0	77.5	0.1	0.3	0.0	199.9	0.0	27.5	32.9	9.3	226.6	0.3	0.6	0.2	17.6	4.0	4.5	6.2	0.0	0.6
TIE1	"JTK14, TIE"	ENSG00000066056	"Tyrosine kinase with immunoglobulin like and EGF like domains 1"	P35590	1	43300982-43323108	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 130.8;Endothelial cells: 108.8;Hepatic stellate cells: 128.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 2.1;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"granulocytes: 2.1;NK-cells: 2.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 106.3;HUVEC TERT2: 238.4;TIME: 210.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		87000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-2)"	47.0	10.1	16.6	8.1	14.8	0.9	37.8	14.6	16.9	14.0	10.1	11.2	5.2	20.4	5.3	6.5	16.0	13.3	34.2	13.1	14.2	19.8	6.7	35.3	10.1	16.4	16.5	7.5	4.2	3.2	8.0	48.6	16.8	10.8	3.1	0.4	7.4	6.5	14.0	7.9	11.0	14.1	13.9	19.9	8.8	3.0	21.1	2.1	24.2	20.7	2.9	15.1	11.8	14.8	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	106.3	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	41.9	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.7	238.4	0.0	0.0	0.0	0.0	0.0	0.0	20.4	1.3	0.0	0.1	8.1	16.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.1	210.0	1.2	0.4	0.0	0.2	0.0	0.2	0.4	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	16.6	14.8	14.6	16.9	13.1	14.2	16.4	16.5	16.8	13.9	21.1	14.8	130.8	0.0	4.2	0.0	0.4	2.2	0.6	0.0	1.2	0.3	1.0	0.9	4.9	1.5	1.8	0.0	0.0	0.3	0.7	0.9	0.0	0.0	2.0	0.1	0.4	108.8	0.0	2.5	0.4	0.2	0.1	3.1	0.0	0.4	20.3	0.1	128.8	1.3	0.5	0.0	0.2	0.1	0.0	5.6	3.1	2.5	2.1	1.1	1.8	29.0	0.1	0.1	1.0	1.0	1.1	0.0	0.0	0.7	0.1	0.7	0.1	0.9	3.6	0.9	0.0	2.2	2.2	0.9	0.7	0.5	1.4	0.3	2.3	0.5	0.2	0.7
TIFAB		ENSG00000255833	"TIFA inhibitor"	Q6ZNK6	5	135444226-135452351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.0;Early spermatids: 4.2;Hofbauer cells: 4.0;Langerhans cells: 17.6;Late spermatids: 9.2;monocytes: 4.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"myeloid DC: 4.5;plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 13.9"	"Cell line enriched"	"Detected in some"	5	"THP-1: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049372	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA049372: AB_2680733"	"unprognostic (1.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-5)"	"unprognostic (3.87e-1)"	"unprognostic (3.25e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.01e-2)"	0.1	0.0	0.0	3.7	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.9	1.0	0.1	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.5	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.2	0.0	0.0	0.9	1.0	0.2	0.0	2.6	0.7	0.3	0.0	1.9	0.0	0.0	4.9	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	17.6	9.2	0.0	2.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153068-12158912	"Plasma proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 177.7;breast: 119.6"	"Cell type enriched"	"Detected in many"	10	"Adipocytes: 363.9"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 212.9;ASC TERT1: 53.0;HSkMC: 91.9;NTERA-2: 50.7;U-87 MG: 53.6"	"Region enhanced"	"Detected in all"		"cerebellum: 106.1"	"Region enriched"	"Detected in all"	9	"cerebellum: 47.7"						"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	177.7	8.3	7.7	3.9	8.4	0.6	119.6	49.6	7.2	9.3	3.9	12.1	1.4	8.1	1.0	2.9	6.8	4.4	31.0	6.8	8.8	2.8	1.1	6.6	0.6	13.7	8.6	3.8	4.0	1.4	12.3	9.9	11.7	5.5	4.3	1.0	8.9	2.3	16.7	7.7	11.0	4.4	11.3	3.4	9.2	0.7	7.1	2.0	23.1	30.1	0.1	9.8	8.7	11.6	0.7	24.2	0.7	0.0	212.9	53.0	26.4	0.8	8.9	1.0	1.3	0.5	0.1	0.0	2.2	0.9	0.8	0.9	0.0	0.8	0.4	1.0	0.0	0.0	12.7	0.9	33.2	0.0	0.1	91.9	2.2	5.8	0.2	1.6	0.0	0.0	0.5	17.3	0.2	0.6	0.0	0.0	50.7	0.0	6.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	5.0	0.0	0.0	6.1	0.0	0.0	1.0	0.1	0.0	0.6	0.9	0.0	0.1	0.0	53.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.4	49.6	7.2	6.8	8.8	13.7	8.6	11.7	11.3	7.1	11.6	363.9	0.0	0.0	0.0	0.4	0.1	1.3	0.3	0.6	0.4	12.4	2.8	7.0	0.0	0.2	0.0	0.0	0.4	1.4	1.3	0.0	0.6	1.6	0.2	2.1	33.6	6.6	5.3	0.1	2.6	2.7	15.7	0.0	0.0	0.0	0.2	22.5	0.0	3.4	0.0	0.2	2.8	0.0	1.2	0.3	7.5	12.2	0.8	3.6	0.0	0.0	0.7	0.0	9.0	0.1	4.6	4.8	2.6	0.0	4.2	2.7	0.5	5.5	0.0	32.9	3.1	29.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	2.0	2.2
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333220-61353295	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 192.8;liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.9;Proximal enterocytes: 415.8;Proximal tubular cells: 91.2;Theca cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 133.2;RPMI-8226: 140.7;T-47d: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Nucleoplasm	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	9.5	82.8	5.9	9.4	6.0	16.6	12.1	5.8	6.6	9.5	5.7	12.5	192.8	11.0	7.6	16.3	15.4	9.2	7.6	6.4	5.1	45.5	115.8	9.0	13.6	6.8	6.3	10.3	24.0	6.7	14.0	6.1	6.2	12.2	5.7	5.6	16.2	8.9	10.9	17.8	138.0	5.2	6.5	13.0	16.6	28.2	6.0	7.5	14.7	5.6	8.0	10.9	11.0	7.2	19.9	51.3	8.5	30.0	10.7	11.4	24.2	11.7	12.4	10.4	6.9	23.1	47.1	25.0	39.3	8.5	11.0	27.7	16.3	21.8	3.5	42.5	21.7	15.7	26.2	133.2	17.9	13.4	25.0	18.2	14.5	9.9	35.4	9.4	10.7	17.1	27.2	46.7	7.9	91.8	11.9	11.9	23.8	19.2	33.8	20.0	13.8	140.7	17.1	35.0	33.0	29.6	21.0	36.4	19.3	6.0	135.4	9.2	13.0	21.0	21.6	16.6	7.0	85.8	76.5	22.9	21.3	12.3	19.7	2.6	13.4	6.5	7.1	7.8	9.6	10.3	8.3	7.1	21.2	9.7	5.8	6.2	1.2	6.5	6.5	10.1	12.9	9.7	5.9	6.0	5.8	6.6	6.4	5.1	6.8	6.3	6.2	6.5	6.0	7.2	8.0	0.0	14.5	0.0	9.5	0.0	13.8	0.0	11.4	12.8	19.1	16.0	3.8	11.5	6.8	14.7	14.6	31.2	8.3	4.8	29.4	19.6	16.2	16.4	6.6	8.0	13.3	7.8	0.0	14.6	6.2	11.2	20.4	12.1	7.6	10.8	7.5	115.9	17.1	8.4	0.0	31.6	0.0	17.2	0.0	12.0	15.2	8.2	0.0	0.0	21.2	10.0	9.2	0.0	0.0	11.2	32.9	22.6	11.0	11.1	415.8	91.2	10.9	17.8	6.6	4.7	3.6	37.5	14.1	12.6	0.0	15.2	6.5	93.6	47.6	13.4
TLK1	"KIAA0137, PKU-BETA"	ENSG00000198586	"Tousled like kinase 1"	Q9UKI8	2	170990823-171231314	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016043	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA016043: AB_1858027"	"unprognostic (2.13e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.36e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.53e-1)"	7.7	10.2	5.9	10.7	8.3	11.1	12.3	4.1	10.5	12.7	5.1	13.0	9.4	10.6	5.4	9.4	9.5	9.6	7.0	10.1	4.6	13.0	14.8	8.4	15.0	3.5	7.3	14.0	10.4	18.0	6.2	15.2	3.4	11.8	12.3	15.8	9.2	14.6	16.3	8.5	11.8	11.7	4.4	13.2	13.5	17.7	10.6	13.8	17.6	5.5	15.7	11.7	8.3	7.6	16.6	15.6	22.0	17.3	15.4	15.3	24.7	22.5	31.9	21.8	18.2	21.8	25.9	34.2	18.7	33.4	23.6	13.7	28.5	24.6	23.8	42.1	14.9	39.1	18.5	28.0	16.5	50.3	19.0	16.7	24.6	43.4	28.4	23.0	24.3	21.2	42.3	27.4	13.2	20.3	43.8	15.5	20.6	15.5	8.9	31.9	26.9	34.7	17.7	30.9	25.0	19.7	24.7	16.7	16.1	14.9	13.8	17.0	33.2	19.3	24.0	12.7	17.8	24.5	43.0	59.7	23.9	20.1	19.9	11.1	3.1	5.7	5.2	2.6	7.3	8.3	8.3	5.7	3.0	8.3	9.3	6.2	4.2	8.1	5.3	4.4	8.5	5.2	5.9	8.3	4.1	10.5	10.1	4.6	3.5	7.3	3.4	4.4	10.6	7.6	34.2	51.3	27.8	135.8	76.7	41.3	33.2	27.1	30.7	34.8	45.9	28.4	32.1	37.1	29.2	51.5	60.5	82.7	42.6	55.8	88.0	29.2	58.1	29.5	33.9	34.5	23.9	33.7	196.2	32.7	52.7	30.3	37.8	38.4	27.3	39.5	27.5	40.0	27.4	45.4	161.0	36.7	36.7	29.0	30.4	32.0	43.2	54.7	37.4	74.0	29.1	26.6	49.4	84.9	92.0	35.6	36.5	44.8	66.3	51.0	33.4	58.0	30.7	77.5	0.0	41.6	29.6	31.1	54.9	24.5	39.1	174.9	66.4	59.2	33.9	43.0
TLR1	"CD281, KIAA0012, rsc786"	ENSG00000174125	"Toll like receptor 1"	Q15399	4	38790677-38856817	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;lymphoid tissue: 26.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 15.4;Hofbauer cells: 14.9;Kupffer cells: 34.9;Macrophages: 32.7;Microglial cells: 29.0;monocytes: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 128.5"	"Group enriched"	"Detected in all"	6	"granulocytes: 128.5;monocytes: 42.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.3;HUVEC TERT2: 12.6;RPMI-8226: 14.4;U-698: 20.6;U-937: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (7.82e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.25e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.97e-2)"	8.8	4.1	1.9	26.9	2.1	34.3	7.3	2.3	1.8	4.6	2.8	4.9	6.5	6.0	2.1	3.3	6.0	9.6	2.3	1.8	2.4	4.4	8.8	10.8	16.2	4.9	3.2	10.2	5.1	1.6	1.0	10.0	5.2	3.5	6.8	1.4	9.0	3.7	0.5	1.8	6.2	9.8	3.9	24.9	6.4	1.3	4.1	8.1	1.6	3.4	19.7	8.0	1.1	6.7	0.2	2.0	0.1	0.0	0.3	1.5	0.0	0.0	0.5	0.1	1.1	0.2	5.4	11.3	1.1	0.0	5.3	0.3	0.1	1.4	0.3	1.3	0.5	1.4	0.5	0.0	0.1	2.1	0.6	0.4	0.3	0.5	0.0	0.4	12.6	0.2	1.6	3.3	1.7	0.0	0.5	4.6	0.0	0.0	0.0	7.7	0.1	14.4	1.3	0.0	0.0	1.5	0.0	0.1	0.5	0.1	0.1	2.7	3.3	1.1	0.5	0.1	0.7	1.2	0.2	20.6	2.8	7.7	0.3	0.1	22.0	8.3	3.0	30.8	2.3	6.5	3.2	2.5	13.8	5.6	3.1	1.8	128.5	5.6	42.7	4.5	1.3	9.0	1.9	2.1	2.3	1.8	1.8	2.4	4.9	3.2	5.2	3.9	4.1	6.7	1.0	0.0	1.5	1.0	15.4	0.3	0.6	3.0	1.8	0.3	2.9	1.1	0.2	0.0	4.4	1.8	0.0	0.1	8.6	0.6	1.9	5.5	0.0	6.1	0.7	2.6	0.0	0.8	0.7	4.4	0.2	3.1	2.0	4.7	3.8	0.1	0.4	2.5	14.9	0.0	1.6	0.4	2.0	34.9	14.6	0.2	0.0	32.7	0.0	29.0	19.2	1.9	6.2	3.5	2.2	2.0	0.3	2.6	2.1	1.1	0.6	1.1	7.8	0.2	0.0	3.9	0.5	0.1	0.3	0.8	0.6	0.1	6.1	2.6	1.4	1.4
TLR7		ENSG00000196664	"Toll like receptor 7"	Q9NYK1	X	12867072-12890361	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 6.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 10.1;dendritic cells: 24.1;Hofbauer cells: 24.6;Macrophages: 20.2;Microglial cells: 14.0;monocytes: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 20.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 16.3;U-266/70: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059613	Supported					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA059613: AB_2684083"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.34e-1)"	1.1	1.6	1.3	4.3	1.2	0.6	4.1	1.6	1.3	1.3	1.0	1.9	1.8	0.9	0.5	0.6	0.8	2.9	0.7	1.1	1.5	0.6	0.6	4.6	4.3	3.5	2.5	0.7	0.3	0.9	0.2	6.4	3.5	0.8	2.3	0.1	1.4	1.0	0.1	0.1	1.8	2.0	3.4	3.8	1.7	0.5	2.7	3.8	0.4	0.3	5.6	2.5	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	16.3	0.0	3.1	0.0	0.3	0.0	0.4	10.0	4.5	0.0	11.6	0.0	8.7	0.0	0.0	4.9	7.2	0.0	0.0	0.5	0.1	9.7	20.7	0.0	3.3	1.3	1.2	1.6	1.3	1.1	1.5	3.5	2.5	3.5	3.4	2.7	6.1	0.2	0.0	3.9	0.0	10.1	1.3	1.3	0.0	0.0	0.0	0.2	0.6	0.5	0.0	0.6	0.0	2.1	0.3	24.1	0.0	0.0	0.0	0.0	0.3	0.2	1.3	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.5	1.3	0.0	0.7	0.2	24.6	0.0	0.1	0.0	0.0	6.2	8.1	0.7	0.6	20.2	1.8	14.0	11.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	5.7	0.9	0.0	0.0	2.2	0.7	0.0	4.5	0.5	0.0	0.1	0.1	1.0	0.3	2.5	0.1	0.0	1.6
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 246.0"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 482.7;Hepatocytes: 220.6;Muller glia cells: 204.7;Theca cells: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 38.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 69.2;RPTEC TERT1: 86.2;T-47d: 143.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: AB_2686551"	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	63.4	246.0	27.8	2.6	28.5	4.1	29.1	32.8	33.9	17.4	64.1	7.8	9.4	3.4	17.0	39.6	12.8	7.0	47.3	30.0	29.7	18.9	86.4	10.1	3.4	34.0	32.0	36.5	69.9	36.3	19.5	3.9	32.5	41.1	3.9	6.0	46.9	6.0	7.1	68.2	8.3	1.9	30.1	5.1	35.6	11.5	32.6	5.6	15.5	3.7	8.4	5.5	22.1	35.1	7.7	10.9	27.3	35.1	8.1	1.3	15.4	1.8	4.5	2.7	3.0	26.0	35.8	16.3	26.9	2.2	1.0	13.3	11.6	21.2	1.9	16.7	5.0	10.2	2.7	54.5	18.8	4.2	10.6	3.7	5.0	14.6	3.9	12.6	3.9	28.7	5.8	13.9	0.8	69.2	8.3	18.6	12.6	18.4	11.2	22.4	1.2	39.9	86.2	12.6	27.2	30.5	1.2	28.2	6.1	19.5	143.9	11.4	3.1	0.4	3.4	3.8	2.3	27.1	18.1	8.4	2.5	5.9	1.0	1.1	1.6	3.4	9.1	1.5	7.0	12.4	5.6	7.8	1.5	11.9	11.8	9.0	1.1	12.5	0.9	38.1	5.6	4.9	27.8	28.5	32.8	33.9	30.0	29.7	34.0	32.0	32.5	30.1	32.6	35.1	4.0	9.6	43.7	23.5	12.7	1.9	6.2	33.6	5.7	19.2	52.2	38.5	99.4	52.9	36.6	44.1	10.4	72.9	16.3	23.3	17.6	27.1	28.8	17.9	2.6	5.7	59.4	13.7	11.6	27.7	4.6	4.3	31.1	16.5	7.0	482.7	5.0	220.6	15.6	25.2	15.3	21.8	52.9	6.3	2.7	59.3	9.9	5.8	12.4	2.8	9.4	204.7	7.2	17.1	36.5	21.7	23.7	2.2	12.9	31.3	29.0	77.5	37.9	23.6	13.1	1.6	21.8	13.3	17.9	18.0	7.0	82.1	8.3	204.8	19.0	10.4
TMC6	"EVER1, EVIN1, LAK-4P, TNRC6C-AS1"	ENSG00000141524	"Transmembrane channel like 6"	Q7Z403	17	78107397-78132407	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 110.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 108.7;SK-BR-3: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051430	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA051430: AB_2681483"	"unprognostic (6.34e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.20e-4)"	29.5	6.8	19.2	45.4	50.5	72.7	25.2	43.4	33.5	11.3	5.2	23.5	21.7	7.6	1.0	25.4	14.1	9.7	35.9	19.3	26.4	20.6	9.1	40.3	69.7	59.3	49.7	3.8	14.6	3.1	5.6	8.8	55.9	20.2	6.6	0.6	29.3	7.9	3.5	17.9	50.6	3.5	35.8	110.5	14.6	2.6	48.4	26.3	12.9	1.8	32.4	14.6	18.4	81.9	17.9	14.0	7.5	6.0	0.0	0.0	15.2	0.0	0.0	0.2	0.2	25.2	19.2	19.7	23.7	0.0	6.3	31.0	1.0	5.9	0.0	2.0	11.3	41.3	4.2	31.0	1.9	38.3	67.0	1.1	16.2	0.0	1.3	0.2	14.7	9.2	108.7	73.3	0.0	36.1	18.9	65.4	5.9	32.9	4.9	8.4	0.6	58.9	11.4	65.1	1.9	4.9	5.7	121.0	33.2	9.7	68.7	57.6	5.2	0.0	8.7	0.1	0.3	57.6	27.3	13.2	0.0	60.4	1.0	17.7	11.6	23.2	56.2	38.3	49.0	28.5	41.7	46.2	18.6	21.7	36.5	39.6	15.3	35.8	63.5	5.7	38.0	33.5	19.2	50.5	43.4	33.5	19.3	26.4	59.3	49.7	55.9	35.8	48.4	81.9	43.8	41.7	29.6	8.1	69.5	11.1	21.0	22.3	7.4	3.2	17.4	6.5	14.7	10.0	41.5	16.5	0.0	1.2	79.8	25.0	0.0	41.2	0.3	5.1	1.6	19.7	9.1	28.4	0.2	23.1	26.4	4.6	10.2	8.0	40.5	0.7	23.6	2.2	67.0	1.7	0.2	14.0	40.7	66.2	29.9	1.2	9.6	44.7	14.2	20.6	62.0	7.5	85.5	1.5	50.8	40.5	53.7	1.2	62.6	31.5	20.3	2.0	20.3	1.8	13.1	4.6	13.5	0.5	2.2	8.4	10.2	3.7	83.7	2.5	30.3	37.4
TMCC1	KIAA0779	ENSG00000172765	"Transmembrane and coiled-coil domain family 1"	O94876	3	129647792-129893606	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Alveolar cells type 1: 54.5;Astrocytes: 119.1;Excitatory neurons: 206.7;Inhibitory neurons: 201.5;Microglial cells: 127.4;Oligodendrocyte precursor cells: 181.0;Oligodendrocytes: 209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 9.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053894	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA053894: AB_2682295"	"unprognostic (4.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (7.75e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (6.82e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.32e-1)"	7.5	6.8	12.9	4.8	13.1	3.2	7.3	23.5	14.8	9.8	1.1	6.7	4.1	7.8	6.7	7.6	6.9	8.6	8.2	10.8	12.1	6.7	34.5	6.7	5.0	10.1	13.1	8.0	4.8	7.8	6.5	9.8	9.9	7.5	5.1	15.2	5.5	6.2	30.1	7.7	4.4	6.8	10.0	6.8	4.0	13.5	16.9	8.3	6.8	21.1	5.5	7.8	6.9	14.5	10.6	11.3	8.8	7.2	12.9	9.1	8.9	4.1	5.4	3.6	3.7	7.3	5.7	6.5	11.4	7.9	4.2	9.6	5.0	8.2	2.6	8.6	1.6	4.3	3.4	26.7	4.4	3.2	2.6	5.3	15.1	2.8	6.7	7.7	11.0	3.9	2.2	4.7	8.2	11.6	5.7	1.9	6.7	7.7	3.6	5.2	7.4	5.5	8.4	12.9	8.2	5.7	14.0	4.8	4.1	8.5	9.2	3.5	9.6	5.7	9.2	5.3	8.5	6.9	5.1	4.8	4.2	3.8	3.0	0.6	0.9	2.1	1.1	0.9	1.2	0.7	0.9	0.9	0.5	1.1	1.1	1.4	9.6	0.8	2.0	1.4	1.9	0.8	12.9	13.1	23.5	14.8	10.8	12.1	10.1	13.1	9.9	10.0	16.9	14.5	14.1	54.5	7.4	119.1	9.4	6.6	12.6	9.9	12.5	37.1	17.4	12.1	23.0	7.2	16.0	22.0	31.3	10.6	8.3	9.0	7.9	15.8	9.6	30.5	14.6	13.2	12.6	4.6	206.7	8.1	20.7	10.9	10.2	38.3	3.8	12.0	9.7	36.8	9.9	35.3	201.5	12.2	10.2	18.6	6.6	10.5	13.1	13.5	1.8	127.4	6.8	27.0	12.3	181.0	209.2	24.9	22.8	8.6	14.5	20.4	4.7	13.1	19.6	29.5	6.6	18.1	12.2	33.5	19.4	15.8	7.0	23.9	8.9	9.6	8.3	25.2
TMCO4	DKFZp686C23231	ENSG00000162542	"Transmembrane and coiled-coil domains 4"	Q5TGY1	1	19682240-19799945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014601, HPA014620"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA014601: AB_2204302, HPA014620: AB_2669051"	"unprognostic (3.31e-3)"	"unprognostic (8.94e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (6.99e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-2)"	"prognostic favorable (4.12e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.81e-2)"	"prognostic favorable (3.64e-4)"	7.9	8.9	1.4	5.3	2.4	4.7	9.5	1.3	1.4	8.7	6.5	7.9	17.3	9.8	21.0	8.4	10.3	6.4	4.8	1.6	1.7	9.2	5.4	6.1	6.9	1.9	2.2	7.2	10.8	34.6	3.6	3.1	1.7	13.2	6.1	0.3	17.0	10.6	2.3	5.7	9.6	5.6	1.7	9.5	11.7	1.7	2.0	3.7	11.5	2.4	5.0	9.4	7.9	1.5	9.3	5.6	0.0	0.3	7.5	5.2	6.2	6.8	20.9	13.1	7.3	4.6	42.5	16.2	9.9	19.7	5.8	6.9	1.7	6.8	2.7	13.8	1.7	6.1	6.6	2.3	6.1	0.0	8.1	5.4	7.6	4.4	2.5	4.8	6.3	0.3	1.2	10.7	5.8	7.9	0.0	3.6	0.6	12.6	7.9	3.1	17.5	10.0	11.2	7.2	0.0	0.7	9.0	12.3	13.9	0.9	10.6	10.4	4.0	10.0	4.6	7.2	4.7	1.2	0.6	4.6	11.4	13.8	6.5	0.1	3.8	2.1	4.7	6.7	4.7	4.2	5.0	5.0	7.4	4.9	3.7	3.2	0.3	4.2	4.1	0.2	3.9	3.6	1.4	2.4	1.3	1.4	1.6	1.7	1.9	2.2	1.7	1.7	2.0	1.5	5.8	12.8	11.0	8.8	9.9	2.8	9.6	6.3	4.6	0.2	17.0	15.4	8.0	2.8	12.0	11.0	0.0	9.3	6.0	12.3	9.8	13.2	0.3	10.6	8.1	5.2	6.0	6.5	2.4	16.9	18.6	7.7	15.8	16.5	3.8	7.7	5.3	5.1	9.1	0.0	5.0	15.9	12.2	7.1	3.3	0.5	6.2	6.7	10.6	11.2	9.5	3.0	5.2	3.0	0.4	11.0	7.5	5.7	6.9	11.4	4.5	7.9	18.8	0.5	0.0	6.1	7.7	0.3	2.1	7.9	2.6	7.3	8.2	5.7	14.2	7.9
TMEM106C	MGC5576	ENSG00000134291	"Transmembrane protein 106C"	Q9BVX2	12	47963569-47968878	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 244.8;Muller glia cells: 268.4;Paneth cells: 208.3;Proximal enterocytes: 385.7;Undifferentiated cells: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 876.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047204	Enhanced					NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047204: AB_2679982"	"unprognostic (1.63e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.27e-8)"	"unprognostic (1.05e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.62e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.83e-1)"	28.1	41.9	37.4	36.3	37.5	48.2	66.6	38.2	46.1	52.0	56.7	138.2	113.2	35.8	135.8	42.0	48.5	45.5	58.9	39.7	42.4	80.9	44.7	39.4	38.4	36.4	36.3	55.5	66.5	146.2	62.9	73.4	37.1	41.0	145.3	121.7	59.7	51.7	26.5	37.4	120.1	55.3	35.5	78.1	53.5	40.0	43.4	55.9	49.3	34.3	46.8	28.9	32.8	33.7	243.9	166.4	151.7	167.7	68.5	50.0	143.2	133.6	191.0	238.5	203.8	250.2	243.3	212.2	182.9	147.6	221.8	162.1	239.2	146.1	226.6	203.8	229.1	163.7	217.2	101.7	52.4	172.6	117.9	34.4	98.4	217.8	114.2	163.4	154.2	224.0	113.4	235.6	169.6	174.4	248.2	75.5	27.0	258.7	226.5	217.9	195.9	180.9	127.2	183.2	100.9	120.5	206.8	138.5	142.4	78.4	503.5	136.9	38.3	99.8	168.9	145.0	240.9	130.8	228.9	240.1	127.3	876.5	97.9	39.3	8.8	23.9	44.4	8.6	54.9	36.9	42.8	46.5	12.5	30.8	39.7	44.0	7.6	19.6	10.4	1.9	66.4	41.0	37.4	37.5	38.2	46.1	39.7	42.4	36.4	36.3	37.1	35.5	43.4	33.7	14.5	32.1	20.7	6.8	26.5	47.9	39.2	45.8	36.5	30.2	54.9	78.7	39.1	61.5	21.9	35.0	18.8	75.3	17.7	244.8	86.1	63.8	2.8	35.7	5.7	17.3	36.0	49.2	14.1	45.1	32.8	45.4	37.2	18.6	10.8	86.3	55.0	19.6	54.3	30.3	13.0	150.8	101.7	16.4	20.7	6.8	32.6	21.5	21.4	8.4	10.1	268.4	27.8	4.5	1.2	35.5	208.3	41.3	72.5	22.6	385.7	82.2	11.5	47.2	13.1	46.4	36.9	52.8	36.0	55.4	40.9	14.9	31.5	35.0	220.5	39.4
TMEM119	OBIF	ENSG00000183160	"Transmembrane protein 119"	Q4V9L6	12	108589851-108598320	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Biomineralization, Differentiation, Osteogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.3;Fibroblasts: 30.5;Late spermatids: 9.3;Melanocytes: 8.8;Microglial cells: 15.0;Peritubular cells: 24.0;Smooth muscle cells: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 559.2;ASC TERT1: 152.6;BJ hTERT+: 168.0;fHDF/TERT166: 81.9;HSkMC: 238.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051870, HPA052650"	Enhanced					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA051870: AB_2681645, HPA052650: AB_2681901"	"unprognostic (4.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (1.29e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	29.6	8.0	7.6	16.2	8.9	3.0	27.1	8.5	9.2	61.0	5.3	12.6	15.1	18.9	14.1	6.9	11.9	35.8	9.4	7.7	9.3	6.0	0.9	37.6	47.8	17.2	12.1	1.4	7.5	5.6	6.1	6.6	14.9	12.7	15.1	0.9	6.8	26.0	1.6	13.9	23.1	11.2	13.4	11.4	10.5	5.9	16.4	5.1	21.7	1.7	27.2	32.2	18.4	21.9	0.1	0.3	1.3	0.7	559.2	152.6	0.8	11.8	168.0	0.4	3.0	0.2	0.6	0.3	0.4	81.9	0.3	0.2	0.1	0.2	0.1	0.5	0.0	0.3	0.6	1.0	7.2	0.3	1.2	238.4	0.3	7.0	0.1	0.7	0.1	0.2	0.5	0.5	0.5	0.7	0.3	1.6	0.1	0.0	0.9	0.6	0.9	0.8	0.1	0.7	0.2	39.5	0.0	0.3	0.3	4.5	0.2	1.8	1.2	13.1	0.4	11.2	0.5	2.6	3.1	0.6	6.8	0.5	0.1	1.4	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.4	0.3	0.3	1.4	0.2	0.4	0.2	0.1	0.1	7.6	8.9	8.5	9.2	7.7	9.3	17.2	12.1	14.9	13.4	16.4	21.9	1.3	0.0	0.0	0.0	0.2	3.8	0.1	0.0	0.6	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	8.3	0.2	5.8	1.3	0.0	0.0	0.0	0.0	0.2	30.5	0.0	0.2	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	1.9	4.4	9.3	4.1	1.1	8.8	15.0	1.6	0.0	0.0	0.0	0.0	0.1	1.1	24.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	9.7	0.1	0.1	0.0	3.7	0.3	0.7	0.5	0.0	0.1
TMEM135	FLJ22104	ENSG00000166575	"Transmembrane protein 135"	Q86UB9	11	87037844-87328824	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 121.8;Excitatory neurons: 99.6;Inhibitory neurons: 93.7;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 88.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056685, HPA069473"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA056685: AB_2683208, HPA069473: AB_2686139"	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.80e-1)"	26.1	14.9	4.2	5.6	6.0	3.7	14.2	2.8	5.2	5.6	5.8	10.5	15.6	6.4	4.7	4.4	6.0	8.3	6.7	4.9	5.2	12.0	24.7	6.5	5.9	5.0	5.8	7.3	6.2	9.4	5.4	10.2	5.6	10.7	8.5	7.0	10.0	6.4	8.4	3.9	14.5	6.9	2.5	5.8	7.4	10.2	4.3	6.6	10.1	7.5	4.8	5.5	4.4	6.7	8.8	15.7	9.8	13.7	31.3	28.6	9.2	6.5	16.7	7.6	17.0	27.1	39.9	24.2	17.1	8.9	19.9	8.3	13.3	14.9	8.5	22.7	7.5	18.5	14.0	88.5	17.6	10.8	9.2	34.8	9.2	11.0	7.6	10.2	19.5	26.4	19.3	35.9	9.0	5.9	28.3	10.8	11.5	47.2	11.7	12.5	7.5	19.2	17.5	28.1	4.8	11.0	9.6	30.0	13.6	18.8	42.0	9.6	10.3	7.9	10.3	30.6	4.6	13.4	28.2	28.2	6.0	11.5	15.7	0.9	4.8	1.4	7.5	5.1	6.7	4.7	4.7	8.1	5.6	3.4	5.3	5.1	1.5	7.2	2.2	5.7	5.4	4.1	4.2	6.0	2.8	5.2	4.9	5.2	5.0	5.8	5.6	2.5	4.3	6.7	14.4	9.6	7.5	121.8	7.1	4.2	4.0	4.6	8.6	5.6	12.7	7.1	6.3	5.7	6.8	1.8	4.2	2.6	7.7	10.5	5.9	2.8	2.8	5.8	11.0	8.1	3.6	3.8	99.6	3.2	8.6	11.0	8.6	4.2	9.5	11.5	7.9	16.2	4.9	1.7	93.7	6.8	10.2	7.8	6.0	7.7	7.2	5.4	5.4	48.7	4.1	5.0	9.2	123.1	202.4	3.1	10.9	7.2	10.3	6.1	21.8	10.6	8.7	4.2	32.9	5.7	8.4	2.2	3.8	4.8	4.8	1.5	8.3	24.6	8.7	3.8
TMEM147	"MGC1936, NIFIE14"	ENSG00000105677	"Transmembrane protein 147"	Q9BVK8	19	35545600-35547526	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (6.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (4.98e-6)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	78.5	153.3	75.1	36.6	80.3	41.8	71.1	84.8	85.8	72.7	117.4	67.6	43.2	77.5	101.8	105.0	64.1	36.3	112.2	74.1	83.1	96.5	63.8	68.2	29.9	80.8	79.0	69.1	149.6	129.5	76.1	46.1	79.6	54.8	54.0	42.0	80.6	58.1	137.7	118.9	52.3	57.5	80.9	58.6	84.0	76.3	80.3	26.7	99.7	85.8	45.1	77.2	73.5	85.2	161.2	353.2	68.9	162.0	298.4	135.8	110.5	94.3	167.2	124.6	115.2	168.6	96.9	93.3	156.8	156.4	135.1	62.8	119.9	147.4	101.7	140.8	156.3	99.3	98.9	200.3	237.2	145.4	105.6	148.8	226.3	117.5	291.5	107.2	115.6	126.8	127.9	325.2	134.1	201.6	82.4	80.8	96.9	492.8	141.3	79.1	62.3	225.4	198.5	164.6	60.5	101.0	93.7	215.3	204.9	69.2	78.2	121.4	73.8	140.5	109.9	81.0	205.0	165.9	182.2	52.8	122.3	195.7	115.6	41.0	219.7	103.3	100.6	212.6	142.6	177.0	135.9	116.3	199.9	149.0	101.0	102.6	12.2	106.1	154.0	237.5	147.1	237.4	75.1	80.3	84.8	85.8	74.1	83.1	80.8	79.0	79.6	80.9	80.3	85.2	74.4	44.8	44.1	7.2	71.5	101.2	135.7	195.5	63.2	55.3	167.2	165.1	101.5	118.7	110.2	156.3	18.8	176.3	63.2	59.6	111.6	223.0	102.5	56.4	72.5	96.8	88.9	42.5	6.0	255.2	228.7	94.7	51.0	68.1	50.2	90.9	82.8	95.5	260.6	45.4	8.0	105.9	140.4	133.6	113.3	333.8	139.4	96.5	240.1	7.5	83.7	138.9	71.1	10.1	12.2	179.9	74.1	121.1	136.0	349.1	100.3	277.1	77.9	62.8	118.3	58.1	138.9	327.9	155.7	94.9	167.8	138.3	60.6	86.1	144.3	200.6
TMEM17	FLJ34583	ENSG00000186889	"Transmembrane protein 17"	Q86X19	2	62500218-62511894	"Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 25.4;Spermatocytes: 39.2;Spermatogonia: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018100	Uncertain		Approved	"Actin filaments"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Actin filaments"		"HPA018100: AB_2240686"	"unprognostic (8.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.87e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.49e-6)"	2.4	5.0	4.1	0.5	4.3	0.8	2.4	2.6	4.2	1.8	4.8	1.4	1.0	2.3	1.6	2.6	4.3	2.9	2.2	4.4	9.5	4.3	2.3	1.8	1.0	4.5	5.5	3.1	3.2	6.1	4.3	1.7	5.5	2.5	0.9	4.0	2.2	2.0	1.8	2.4	0.8	1.6	3.5	0.8	1.3	4.8	8.5	1.4	4.6	1.8	0.9	1.5	1.3	3.4	3.3	4.6	4.7	1.8	2.4	3.1	3.0	2.5	2.3	2.0	2.1	0.3	6.1	0.0	3.2	3.3	6.7	3.2	2.1	1.4	1.5	3.2	1.4	1.5	1.8	0.3	3.5	2.3	1.8	2.8	3.9	1.7	3.9	3.4	2.5	0.3	1.4	0.2	5.3	0.9	0.4	0.5	2.3	3.0	2.3	0.2	0.6	0.2	4.3	1.0	1.2	4.0	2.6	0.9	9.1	1.6	1.5	3.0	1.7	4.0	2.2	4.8	2.6	0.4	0.0	0.0	5.8	0.4	8.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.3	0.1	1.9	0.0	0.4	4.1	4.3	2.6	4.2	4.4	9.5	4.5	5.5	5.5	3.5	8.5	3.4	2.9	3.2	4.1	2.6	0.4	5.0	2.3	10.7	9.1	7.1	3.0	2.8	2.6	4.3	7.5	5.5	8.4	2.3	1.5	0.1	0.0	5.3	4.8	11.4	2.1	2.7	1.2	1.7	2.8	8.5	2.2	4.2	1.1	1.7	1.3	2.8	3.9	2.5	2.6	10.1	3.9	0.9	6.1	0.6	1.5	2.8	4.7	1.4	3.6	1.0	0.9	9.9	0.0	0.0	2.9	7.9	0.3	3.8	1.4	1.0	0.4	2.5	25.4	4.8	6.6	2.4	1.8	39.2	21.7	5.5	2.8	0.4	0.3	5.4	1.1	1.5
TMEM185A	"CXorf13, FAM11A, FRAXF"	ENSG00000269556	"Transmembrane protein 185A"	Q8NFB2	X	149596556-149631912	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (9.76e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"	15.0	13.8	5.7	8.0	6.6	6.8	13.1	6.8	9.0	14.6	19.7	12.9	7.1	15.0	17.3	15.5	14.4	11.3	30.1	6.7	6.4	10.6	8.9	9.9	10.7	6.0	6.1	30.9	9.5	16.4	8.1	26.8	6.1	13.9	9.4	10.6	12.9	16.8	13.6	20.0	9.1	16.6	6.4	16.8	9.7	17.0	6.9	10.7	9.9	15.9	11.0	12.8	15.1	6.1	18.0	17.7	20.0	12.4	27.0	17.8	8.2	16.9	20.8	16.6	24.2	10.9	29.9	21.4	37.7	19.0	22.8	22.1	23.1	16.4	17.0	14.3	17.3	12.1	19.6	11.8	19.9	18.5	12.8	17.4	27.6	16.9	10.8	19.8	14.6	16.6	5.1	13.1	12.4	29.5	13.1	13.6	14.9	9.5	19.8	12.1	29.8	12.3	20.1	22.8	6.9	9.9	12.5	21.2	23.1	17.9	11.7	10.4	17.6	13.5	11.8	24.7	21.9	12.7	12.0	30.8	22.6	21.9	18.6	2.2	5.1	12.9	9.9	3.1	8.4	5.2	6.9	10.0	7.5	5.0	9.5	8.9	7.1	14.9	2.7	5.6	9.6	6.4	5.7	6.6	6.8	9.0	6.7	6.4	6.0	6.1	6.1	6.4	6.9	6.1	13.5	6.4	2.6	5.9	7.6	11.1	12.1	19.8	6.2	17.4	13.5	12.1	12.3	2.8	9.8	14.7	6.2	29.1	13.1	9.6	3.9	4.4	0.6	22.6	10.5	12.1	13.1	6.5	12.1	9.3	10.7	15.4	2.0	11.2	5.7	22.7	23.9	7.2	11.2	18.5	12.3	5.9	18.3	11.7	12.0	3.2	22.7	11.4	14.2	6.5	16.1	12.2	17.5	10.6	8.2	12.7	9.3	23.7	4.1	8.6	8.3	6.8	17.5	9.2	46.0	9.4	14.1	11.7	16.8	11.0	20.0	17.2	9.8	24.3	5.1	17.7
TMEM200B	TTMB	ENSG00000253304	"Transmembrane protein 200B"	Q69YZ2	1	29119429-29123903	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 60.6"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 8.8;Fibroblasts: 6.1;Leydig cells: 12.8;Melanocytes: 8.8;Peritubular cells: 15.1;Sertoli cells: 6.6;Smooth muscle cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 28.2;BJ hTERT+ SV40 Large T+: 26.7;BJ hTERT+ SV40 Large T+ RasG12V: 29.5;fHDF/TERT166: 29.0;HBF TERT88: 25.3"	"Low region specificity"	"Detected in all"							HPA055254	Uncertain					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA055254: AB_2682760"	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-3)"	16.8	4.4	2.0	4.0	6.3	0.0	11.8	6.9	3.3	47.2	6.6	29.5	2.3	60.6	7.8	5.6	21.5	7.3	7.0	1.9	2.4	9.4	8.4	10.5	1.2	2.2	2.1	33.3	2.5	26.1	3.6	6.5	2.2	24.6	4.1	0.3	4.1	39.7	2.2	5.8	9.2	35.1	2.0	6.4	6.4	13.3	2.6	1.0	5.0	2.6	1.3	20.9	24.3	2.1	21.0	0.0	3.4	0.0	28.2	23.4	1.1	14.4	22.6	26.7	29.5	1.1	2.3	0.0	3.5	29.0	9.8	0.4	2.3	0.0	25.3	0.1	0.9	0.1	5.7	1.8	19.6	0.0	0.1	12.5	2.7	20.1	3.9	1.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.3	1.9	0.0	5.8	0.0	0.0	0.0	0.3	0.1	0.0	1.7	20.7	0.0	0.1	9.5	0.0	0.0	0.0	9.4	0.4	19.9	0.4	0.0	0.0	0.0	11.6	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.3	6.9	3.3	1.9	2.4	2.2	2.1	2.2	2.0	2.6	2.1	2.0	3.2	0.6	0.7	0.2	1.9	0.4	0.2	2.8	0.8	0.6	1.8	1.0	1.5	0.7	0.0	2.1	0.1	0.2	0.1	0.0	0.0	0.1	1.0	8.8	1.3	0.0	0.0	0.3	0.0	0.5	6.1	0.0	0.6	0.0	0.0	1.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	1.2	2.4	12.8	0.1	8.8	1.9	0.1	0.1	0.0	0.0	0.1	0.0	0.1	15.1	0.0	0.3	0.0	5.9	0.4	1.9	6.6	1.1	9.5	0.3	0.6	0.2	0.6	0.5	0.4	0.0	0.0	0.3
TMEM220		ENSG00000187824	"Transmembrane protein 220"	Q6QAJ8	17	10699015-10730023	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 103.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 173.3;Proximal enterocytes: 576.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.71e-2)"	"unprognostic (4.60e-2)"	"unprognostic (6.31e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.84e-4)"	"prognostic favorable (2.23e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.97e-2)"	8.6	10.9	3.3	4.9	3.8	5.8	7.2	3.3	3.3	6.4	5.5	8.2	15.7	6.9	4.5	4.3	6.1	5.1	5.1	3.3	3.7	10.3	103.8	5.5	6.2	4.2	3.8	6.9	9.5	3.6	3.2	3.2	4.7	21.7	4.9	19.0	5.5	7.8	8.1	6.6	26.8	3.8	4.4	6.5	13.0	9.1	3.9	1.2	13.0	0.8	1.9	5.9	5.0	4.6	0.5	3.1	1.1	7.2	4.4	4.4	0.7	6.0	6.6	4.2	5.7	0.0	0.3	0.7	0.4	4.0	0.2	0.4	2.8	0.2	3.0	0.3	1.2	0.4	0.1	2.7	6.7	0.8	0.7	3.0	0.3	1.3	0.3	0.8	1.9	2.7	0.3	0.2	2.6	0.4	1.1	1.3	4.4	0.4	0.0	4.4	0.2	0.5	9.8	0.2	0.4	5.5	0.3	0.1	0.7	1.5	0.3	1.6	4.4	0.2	0.9	2.2	0.4	0.7	0.3	0.2	4.3	1.1	0.4	1.6	2.1	2.1	0.7	1.6	0.9	4.0	1.8	1.1	2.6	9.0	7.4	5.2	1.6	4.2	0.7	1.9	0.4	1.7	3.3	3.8	3.3	3.3	3.3	3.7	4.2	3.8	4.7	4.4	3.9	4.6	10.1	3.2	11.0	18.3	7.5	9.6	17.7	9.2	23.3	2.5	20.9	26.4	11.6	57.2	9.9	18.4	8.4	12.0	3.1	41.3	21.5	18.0	99.0	6.1	16.3	8.1	3.0	21.7	1.4	23.6	20.6	16.3	33.6	7.6	40.0	13.4	16.1	173.3	24.0	0.0	2.8	32.6	4.1	13.5	6.4	22.2	18.0	13.1	24.9	12.2	4.6	55.0	5.2	17.6	1.6	12.6	32.5	9.8	6.6	36.5	576.7	31.7	6.9	23.6	19.7	17.2	12.7	90.6	8.7	20.7	8.0	4.5	3.0	30.0	21.1	22.3
TMEM221		ENSG00000188051	"Transmembrane protein 221"	A6NGB7	19	17435509-17448668	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 7.9;retina: 9.4"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 14.6;Muller glia cells: 49.2;Rod photoreceptor cells: 24.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;PC-3: 6.8;REH: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041580, HPA062945"	Supported		Approved	"Nuclear membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane"		"HPA041580: AB_10795700, HPA062945: "	"unprognostic (3.60e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.51e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-2)"	"unprognostic (9.14e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.47e-4)"	"unprognostic (2.37e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-1)"	0.6	4.2	3.6	0.2	3.6	0.1	1.2	3.2	4.4	0.8	2.7	0.7	0.1	0.6	0.7	0.5	2.7	0.2	0.6	3.7	3.2	0.6	0.4	0.3	0.2	3.6	3.1	7.9	2.2	5.4	1.7	0.1	3.1	1.3	0.0	9.4	0.8	1.0	0.2	0.4	0.4	0.1	3.4	0.4	0.4	0.5	3.8	0.5	0.7	0.1	0.1	0.4	1.0	3.4	0.5	1.5	0.6	4.6	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.9	0.0	0.4	0.2	1.3	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.2	1.0	0.3	6.8	3.9	0.1	0.0	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	3.6	3.2	4.4	3.7	3.2	3.6	3.1	3.1	3.4	3.8	3.4	0.5	0.0	0.5	1.0	0.1	0.0	0.1	0.0	0.0	1.3	0.3	0.3	0.3	1.5	0.0	0.0	14.6	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	2.0	0.0	0.0	2.2	0.0	0.2	0.0	0.2	3.3	0.0	3.7	1.7	3.9	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	49.2	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.5	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.1
TMEM232	FLJ43080	ENSG00000186952	"Transmembrane protein 232"	C9JQI7	5	110289233-110738956	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.4;testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 154.8;Early spermatids: 130.7;Endometrial ciliated cells: 80.5;Excitatory neurons: 258.9;Inhibitory neurons: 175.0;Respiratory ciliated cells: 114.0;Spermatocytes: 83.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049386	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA049386: AB_2680739"	"unprognostic (1.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.49e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-4)"	"unprognostic (8.96e-2)"	0.6	1.2	2.7	0.2	2.4	0.1	1.1	1.1	1.8	1.1	8.3	0.4	0.5	0.8	1.7	0.6	14.4	1.8	0.7	1.8	2.3	3.7	0.7	1.7	0.4	6.6	7.9	0.7	0.4	2.1	1.3	0.4	6.0	0.9	0.4	3.6	0.6	0.7	0.0	0.4	0.3	0.4	5.1	0.2	0.9	16.9	2.8	0.4	3.8	0.3	0.3	0.3	0.1	5.3	0.4	0.1	1.0	0.3	0.8	1.5	0.2	0.0	0.0	0.2	0.2	0.2	0.1	0.5	0.3	0.0	1.6	0.3	0.2	0.8	0.2	1.0	0.1	0.1	0.0	0.0	0.7	0.3	0.1	0.4	0.1	0.2	0.4	1.4	0.0	1.2	0.3	0.3	0.5	0.1	0.5	0.3	0.1	0.1	0.0	0.2	0.1	0.2	1.0	0.0	0.8	1.0	0.1	0.0	0.9	1.6	0.4	0.1	0.0	1.1	0.1	0.0	0.0	2.5	0.9	0.4	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.4	1.1	1.8	1.8	2.3	6.6	7.9	6.0	5.1	2.8	5.3	0.6	0.0	5.4	154.8	0.4	0.4	0.9	4.8	1.2	5.0	1.2	0.8	2.4	1.5	11.7	7.3	27.1	0.3	0.0	0.4	9.8	1.3	130.7	80.5	1.4	0.7	1.2	0.8	258.9	0.5	0.1	0.8	0.0	2.3	0.0	0.7	1.1	0.6	0.1	3.3	175.0	0.6	8.2	1.3	0.0	68.0	1.2	0.7	0.0	32.8	0.0	4.5	0.0	54.8	66.1	0.2	0.1	0.7	0.5	0.7	0.4	5.5	114.0	16.9	0.0	1.6	1.8	83.9	4.3	0.1	0.4	0.3	0.2	1.6	0.3	0.6
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.7;ovary: 19.6"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 32.6;Skeletal myocytes: 14.6"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 25.3;NTERA-2: 9.5;RPMI-8226: 17.1;SK-MEL-30: 27.7;U-2 OS: 11.8;U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	4.7	3.3	7.4	1.8	5.8	0.7	3.2	4.8	9.2	11.9	1.7	2.6	0.7	1.9	1.6	2.8	3.8	1.1	1.3	3.8	27.4	1.4	0.6	3.0	3.6	22.7	48.7	19.6	0.4	1.4	3.8	0.2	33.0	1.4	2.3	1.5	1.2	1.8	1.4	2.6	2.3	0.9	19.9	1.7	1.8	0.2	36.8	8.1	0.4	2.7	3.8	1.9	8.5	11.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.2	0.0	0.1	0.3	0.0	2.9	0.0	1.9	0.7	0.7	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	25.3	0.4	0.0	0.0	0.1	9.5	0.0	0.0	0.1	0.0	17.1	0.0	0.0	5.1	0.1	0.5	0.0	27.7	0.3	0.0	0.3	0.0	0.0	11.8	0.0	5.1	0.0	5.2	3.7	29.7	0.0	0.0	0.0	0.3	0.0	2.8	0.1	1.4	0.2	0.2	1.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	7.4	5.8	4.8	9.2	3.8	27.4	22.7	48.7	33.0	19.9	36.8	11.5	0.1	3.2	0.0	1.6	0.0	0.4	0.1	0.1	0.6	1.9	0.2	1.3	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.2	0.0	0.0	4.4	0.0	0.4	0.0	0.3	0.4	0.0	1.3	0.0	4.3	0.0	0.0	1.0	0.7	1.6	0.6	1.6	5.4	1.9	3.7	0.3	0.0	32.6	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	14.6	0.6	0.1	0.1	0.0	1.3	0.1	0.4	0.0	0.0	0.0
TMEM47	"BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9"	ENSG00000147027	"Transmembrane protein 47"	Q9BQJ4	X	34627075-34657285	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 110.7;Astrocytes: 85.5;Leydig cells: 74.3;Muller glia cells: 148.0;Peritubular cells: 92.9;Sertoli cells: 92.1;Skeletal myocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 112.6;fHDF/TERT166: 348.1;RPTEC TERT1: 83.6;U-2197: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046658	Approved		Approved	"Nuclear membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane"		"HPA046658: AB_2679742"	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.67e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.05e-6)"	"unprognostic (2.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.94e-2)"	40.0	20.8	34.8	8.5	38.3	0.0	18.8	27.1	39.5	46.7	41.6	25.9	8.6	45.7	33.4	34.6	35.1	28.6	36.1	30.8	35.8	27.7	24.8	21.9	6.2	36.5	38.7	21.7	11.3	5.6	6.6	1.2	33.7	32.9	14.9	17.8	29.6	45.6	23.8	6.3	11.5	51.0	37.8	7.5	13.8	4.9	39.5	3.1	20.2	31.1	4.2	36.2	20.1	33.4	0.0	1.7	50.7	21.4	43.8	33.1	0.0	112.6	0.3	21.8	18.7	0.1	0.0	0.0	9.2	348.1	0.0	0.1	14.5	4.0	32.0	0.0	9.9	0.0	13.2	0.0	25.3	0.0	0.0	30.0	0.1	8.9	9.7	38.9	24.8	0.0	0.0	0.0	41.6	0.9	0.0	0.0	6.0	0.6	0.3	0.0	25.3	0.0	83.6	33.0	0.5	0.0	0.1	1.3	0.0	5.4	0.2	0.0	0.9	44.0	4.4	74.4	4.8	0.0	0.0	0.0	18.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	38.3	27.1	39.5	30.8	35.8	36.5	38.7	33.7	37.8	39.5	33.4	110.7	19.2	0.6	85.5	0.1	8.2	15.9	0.9	1.8	8.3	10.8	12.7	27.7	10.0	1.5	16.5	6.2	0.0	0.6	0.0	7.9	0.8	0.4	7.6	4.6	29.8	0.0	0.0	4.3	5.3	0.2	48.3	1.1	6.2	2.5	0.7	46.4	17.5	0.1	30.3	25.6	0.0	0.0	0.8	11.7	3.8	74.3	1.2	65.8	13.1	0.0	148.0	0.0	5.0	2.2	3.0	0.0	92.9	0.1	14.3	0.0	13.4	2.0	7.3	92.1	84.7	67.1	0.3	2.1	1.9	5.3	0.1	0.7	0.8	0.0	12.1
TMEM64	DKFZp762C1112	ENSG00000180694	"Transmembrane protein 64"	Q6YI46	8	90621995-90791632	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"choroid plexus: 42.5;epididymis: 144.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 62.0;Hepatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034221	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB034221: AB_1567653"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.55e-3)"	"unprognostic (4.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-1)"	17.1	12.0	5.2	9.3	9.3	3.4	8.4	7.1	7.1	15.4	42.5	10.5	9.6	10.9	144.9	10.5	8.8	10.4	7.2	4.9	6.8	13.6	20.8	9.5	12.9	9.4	7.4	16.3	15.3	6.8	4.7	10.3	7.8	11.4	5.5	1.0	17.8	17.3	8.9	6.4	9.8	16.3	7.5	8.9	7.1	12.2	7.4	5.1	22.9	7.1	12.1	10.6	7.8	14.5	26.5	20.3	10.0	5.4	45.7	33.0	5.5	19.2	18.2	14.8	16.3	5.7	17.8	17.2	7.5	11.8	6.4	9.0	26.9	13.0	19.5	34.8	9.8	32.1	7.3	12.8	16.1	1.9	5.1	43.4	14.0	6.1	13.8	17.1	15.1	4.1	14.8	36.9	25.1	35.3	0.1	4.6	1.5	13.6	10.6	3.8	22.1	8.7	29.2	50.6	7.1	20.0	12.6	10.9	23.5	13.3	10.9	1.5	15.1	14.9	13.1	10.8	15.8	24.3	0.4	18.8	13.4	3.9	20.0	2.7	0.1	0.1	1.5	0.3	1.9	3.1	1.6	1.7	0.3	2.0	0.7	1.1	0.0	3.2	0.4	0.2	0.8	0.9	5.2	9.3	7.1	7.1	4.9	6.8	9.4	7.4	7.8	7.5	7.4	14.5	16.7	9.6	12.5	5.2	15.7	24.1	12.7	5.4	62.0	0.7	7.3	11.4	20.4	7.2	3.7	22.0	0.0	25.3	18.6	2.5	1.9	3.9	3.7	3.3	9.6	9.0	7.8	18.7	9.9	10.2	6.2	18.1	6.1	4.6	14.0	13.5	6.1	51.7	4.0	1.7	14.1	4.5	8.2	9.7	11.6	3.2	46.9	11.1	24.9	9.4	1.9	4.0	4.1	8.0	46.8	8.8	2.4	21.4	12.6	19.7	16.7	30.6	3.7	0.0	0.0	10.5	11.9	3.4	2.2	17.4	23.4	15.7	13.3	23.7	7.2	8.6
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867214-137883312	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 519.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	57.0	15.6	4.4	114.6	3.8	519.5	23.3	2.9	23.9	27.5	12.0	22.6	21.4	31.3	5.2	26.6	23.4	47.8	23.0	3.2	2.8	13.8	27.4	56.2	76.8	6.1	3.9	73.2	25.8	25.8	7.5	28.9	6.7	17.3	24.7	19.1	16.1	10.3	8.6	50.5	30.7	33.5	6.6	46.1	22.8	8.3	9.5	71.1	11.7	3.8	55.7	171.1	14.6	6.2	32.6	4.8	1.8	2.8	10.1	16.9	7.8	18.8	67.6	4.8	5.7	34.9	8.8	7.3	43.1	20.0	106.5	22.6	1.1	50.4	8.9	46.8	2.2	7.5	19.8	21.1	11.2	10.3	12.8	15.6	7.3	56.4	53.6	5.6	2.9	21.2	17.4	161.3	8.4	1.8	56.2	41.4	1.5	2.1	1.4	151.5	39.4	6.1	14.8	15.1	0.7	0.3	3.6	5.3	16.9	7.0	3.4	11.7	14.8	46.9	6.8	46.0	9.6	48.7	131.4	14.0	16.9	13.1	6.1	7.3	12.6	9.6	19.6	9.3	27.9	7.4	19.4	18.0	14.3	7.8	13.1	10.1	13.6	11.1	5.1	26.2	19.2	14.8	4.4	3.8	2.9	23.9	3.2	2.8	6.1	3.9	6.7	6.6	9.5	6.2	71.8	38.5	76.3	2.0	94.5	774.9	150.2	102.1	384.7	1.1	29.0	42.3	4.6	25.8	53.7	0.0	29.2	8.1	395.5	53.9	1.9	60.0	2.6	605.2	365.9	114.8	11.9	5.2	0.1	26.9	104.8	110.1	111.1	1498.3	255.9	2.3	48.5	13.5	45.7	0.0	0.3	38.6	67.1	125.2	461.8	3.2	6.8	596.6	129.9	8.4	59.1	1.7	14.4	2.0	0.3	30.5	29.5	6.0	331.4	170.2	37.3	3.1	84.3	13.3	6.6	29.0	94.9	2.7	2.2	367.9	745.7	23.1	624.2	14.9	20.9	78.1
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391288	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.5;salivary gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.6;Intestinal goblet cells: 24.0;Paneth cells: 42.3;Proximal enterocytes: 25.5;Undifferentiated cells: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 5.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 5.3"	"Cell line enriched"	"Detected in many"	6	"HDLM-2: 125.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		110000	"Cluster 48: NK-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	1.8	1.1	0.8	5.7	1.6	0.4	4.1	0.1	1.9	1.4	0.3	17.1	30.5	0.9	0.3	2.8	0.9	7.6	0.6	2.0	1.1	0.4	0.6	1.0	1.2	0.7	1.1	0.4	1.7	0.9	6.8	3.2	0.2	1.3	17.6	0.2	25.4	2.7	0.3	2.7	18.6	1.7	0.7	0.8	5.5	0.9	1.2	1.0	1.2	0.1	1.9	1.6	1.6	2.1	3.2	2.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.6	0.4	0.6	0.0	3.5	0.4	1.4	2.2	8.3	0.9	0.2	125.9	5.4	0.0	1.3	1.7	0.0	0.5	1.3	0.2	0.4	0.8	3.1	4.2	3.1	0.3	0.0	0.0	0.0	1.1	0.0	0.1	5.9	7.0	19.3	0.4	0.0	0.6	1.5	1.5	20.4	0.7	0.6	3.0	0.1	0.8	1.3	0.4	2.0	0.0	0.1	0.1	0.0	1.2	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.3	0.6	0.0	0.8	1.6	0.1	1.9	2.0	1.1	0.7	1.1	0.2	0.7	1.2	2.1	0.4	0.0	2.2	0.0	0.4	1.3	3.8	1.1	0.6	0.6	4.5	3.3	1.3	8.6	2.3	0.0	0.0	0.1	3.3	35.6	0.0	8.3	0.3	3.2	0.5	5.3	10.8	0.0	4.0	7.5	0.6	0.7	11.7	6.2	0.0	2.0	7.1	0.3	15.5	3.3	0.2	24.0	0.0	17.0	2.4	0.4	0.6	7.7	1.8	8.4	19.7	0.0	3.1	0.5	0.4	14.7	42.3	0.0	0.5	2.8	25.5	0.0	3.8	0.2	0.0	0.5	0.4	0.8	1.9	1.7	2.3	0.1	0.7	0.0	42.2	4.4
TNFRSF13B	"CD267, IGAD2, TACI"	ENSG00000240505	"TNF receptor superfamily member 13B"	O14836	17	16929816-16972118	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 18.9;lymphoid tissue: 33.0;skeletal muscle: 62.9"	"Group enriched"	"Detected in some"	4	"B-cells: 117.3;Plasma cells: 143.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	41	"memory B-cell: 130.9;naive B-cell: 51.8"	"Lineage enriched"	"Detected in many"	59	"B-cells: 130.9"	"Group enriched"	"Detected in some"	9	"Karpas-707: 167.2;RPMI-8226: 106.7;U-266/70: 72.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030453	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA030453: AB_10601700"	"unprognostic (3.94e-5)"	"unprognostic (1.11e-3)"	"unprognostic (4.88e-2)"	"unprognostic (4.30e-3)"		"unprognostic (1.23e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.61e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.59e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	0.4	0.1	0.3	8.9	0.4	1.1	0.7	0.0	0.5	0.3	0.0	3.4	4.1	0.1	0.0	1.3	0.4	0.5	5.3	0.1	0.3	0.3	0.3	0.8	17.3	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.4	2.5	0.3	2.1	0.3	62.9	0.0	18.9	0.1	0.2	33.0	5.2	0.1	0.4	2.0	0.5	0.0	21.6	2.6	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.2	106.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.6	0.0	13.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	130.9	0.0	0.0	0.0	51.8	0.0	0.1	0.5	0.0	0.0	0.0	2.2	2.7	0.3	0.4	0.0	0.5	0.1	0.3	0.4	0.3	0.9	0.2	0.4	1.2	0.0	0.0	0.0	0.0	117.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.4	1.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.5	32.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	143.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.6	0.0	6.2	0.0	0.0	0.0
TNNT3	"AMCD2B, DA2B, DKFZp779M2348, FSSV"	ENSG00000130595	"Troponin T3, fast skeletal type"	P45378	11	1919703-1938706	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	43	"skeletal muscle: 13906.8;tongue: 4507.7"	"Cell type enriched"	"Detected in many"	4	"Skeletal myocytes: 542.6"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 28.8;urothelial cancer: 19.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	17	"basophil: 5.3"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 5.3"	"Cell line enriched"	"Detected in some"	21	"HSkMC: 24.0"	"Region enhanced"	"Detected in some"		"olfactory bulb: 5.1"	"Low region specificity"	"Detected in single"			"CAB002451, HPA037810, HPA056909"	Enhanced					NA	NA		470000	"Cluster 34: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273"	"unprognostic (1.01e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (2.17e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.53e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.42e-5)"	"unprognostic (2.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.90e-2)"	31.2	2.4	0.2	1.4	0.4	1.5	20.0	0.1	0.4	16.3	0.1	5.8	0.2	6.6	2.8	62.5	14.4	1.9	185.3	0.2	0.1	0.8	1.4	3.7	1.4	0.1	0.1	1.7	2.2	0.3	2.5	41.3	0.1	20.7	0.5	0.0	216.0	3.1	13906.8	8.8	3.0	1.3	0.1	2.8	3.3	5.2	0.1	5.4	7.6	4507.7	2.0	20.3	12.0	0.2	0.0	0.0	0.0	0.0	0.5	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	33.1	0.0	1.9	0.0	0.8	2.9	3.9	5.9	2.2	0.0	0.4	0.3	17.8	0.0	10.1	0.0	0.0	24.5	1.5	0.0	0.0	0.1	0.3	2.4	0.3	33.9	0.0	0.0	0.1	0.0	6.7	42.0	0.0	0.1	0.0	3.0	0.0	0.0	2.7	0.0	0.0	0.0	6.1	0.0	2.3	2.5	110.9	2.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	94.8	0.3	0.2	0.0	0.0	42.5	0.0	0.0	542.6	11.2	0.1	0.6	2.9	3.4	18.3	2.0	0.7	0.0	17.1
TNR		ENSG00000116147	"Tenascin R"	Q92752	1	175315194-175743616	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 31.3;retina: 16.2"	"Group enriched"	"Detected in some"	6	"Horizontal cells: 580.5;Oligodendrocyte precursor cells: 2288.6"	"Cancer enriched"	"Detected in single"	46	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.9;U-937: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022343, HPA027134, HPA027150, HPA029859"	Enhanced				"Secreted in brain"	NA	NA		58000		"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916"	"unprognostic (1.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.79e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.03e-3)"	"unprognostic (7.26e-4)"	"unprognostic (4.48e-4)"	"unprognostic (3.26e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	0.0	1.4	30.7	0.2	24.3	0.1	0.0	15.2	26.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.3	27.7	0.0	0.4	0.5	0.2	23.3	16.4	0.0	0.4	0.0	2.7	0.0	20.3	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.2	0.3	0.4	18.2	0.1	0.1	0.0	0.3	0.0	0.0	30.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.7	24.3	15.2	26.3	31.3	27.7	23.3	16.4	20.3	20.8	18.2	30.5	0.0	0.0	0.0	20.2	2.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	226.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	580.5	179.6	0.0	0.0	0.0	0.3	1.6	0.0	0.1	0.0	3.7	0.0	1.8	0.0	2288.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.8	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TNXB	"TNXB1, TNXB2, TNXBS, XB, XBS"	ENSG00000168477	"Tenascin XB"	P22105	6	32041153-32115334	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 274.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 54.7;Fibroblasts: 318.4;Granulosa cells: 94.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 12.4;ASC TERT1: 20.1;U-2197: 15.8;U-87 MG: 8.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		1500000000		"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.51e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.01e-1)"	68.0	274.8	2.0	0.9	3.1	3.4	40.0	4.4	1.8	45.1	3.5	35.9	3.0	66.7	3.2	18.1	37.4	4.7	73.8	0.7	0.8	13.0	17.6	51.1	0.8	1.5	1.1	67.0	3.7	0.4	6.8	3.8	1.5	15.6	1.7	0.3	19.5	1.0	14.2	27.4	29.0	3.1	2.2	30.7	18.8	11.4	3.0	0.7	27.7	7.2	0.4	34.5	35.2	0.4	0.1	0.3	0.3	0.2	12.4	20.1	0.2	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.4	1.2	0.0	0.1	0.0	0.0	0.1	1.3	1.1	0.2	0.6	0.0	2.8	0.0	0.3	0.2	0.2	0.5	0.0	0.5	0.0	0.5	0.7	0.4	0.0	0.2	0.0	0.1	0.3	0.0	3.5	0.3	0.1	0.2	0.0	0.1	0.1	0.2	1.3	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.4	15.8	0.0	0.4	0.4	0.2	8.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.1	4.4	1.8	0.7	0.8	1.5	1.1	1.5	2.2	3.0	0.4	54.7	3.2	2.4	2.6	0.5	32.9	0.2	0.3	0.6	1.3	1.3	1.8	2.5	4.3	0.2	0.0	0.0	0.5	1.0	0.0	0.0	0.2	3.0	1.3	39.7	38.8	0.0	25.0	7.1	0.0	2.6	318.4	6.1	1.1	0.0	94.8	12.8	0.9	0.7	0.0	4.2	0.1	0.0	0.6	39.1	2.8	27.1	4.7	32.0	17.8	0.0	1.2	0.0	1.0	1.2	0.0	0.1	4.5	2.5	0.5	0.0	0.3	0.9	0.6	0.0	21.7	20.8	4.1	2.1	1.6	26.6	1.0	4.8	5.6	0.2	0.4
TOGARAM1	"crescerin, Crescerin-1, FAM179B, KIAA0423"	ENSG00000198718	"TOG array regulator of axonemal microtubules 1"	Q9Y4F4	14	44962190-45074431	"Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 65.7;Endometrial stromal cells: 28.6;Granulosa cells: 30.1;Respiratory ciliated cells: 38.6;Theca cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 4.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050849, HPA053559"	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA050849: AB_2681257, HPA053559: AB_2682190"	"unprognostic (2.91e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.63e-2)"	"unprognostic (6.49e-2)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.60e-1)"	4.5	6.6	9.6	2.9	13.4	3.9	5.2	10.1	13.0	6.7	9.6	4.5	2.7	6.0	5.2	4.6	10.4	4.7	8.3	11.2	8.9	7.9	4.6	3.9	3.9	7.2	8.0	7.6	6.3	8.5	7.1	5.8	8.7	5.5	3.7	16.8	4.8	6.4	12.4	4.2	3.8	5.4	7.5	4.3	4.3	6.5	9.3	8.4	9.0	12.1	3.9	5.4	4.3	19.9	3.5	5.7	5.3	1.4	12.2	14.2	3.8	4.9	10.4	9.1	10.8	2.3	3.7	3.3	5.6	7.9	4.9	6.4	9.8	3.3	10.0	3.0	3.6	2.7	2.8	2.7	8.6	4.6	2.7	8.3	5.6	5.2	8.8	10.8	7.4	1.8	1.9	3.7	9.2	5.0	5.9	2.5	1.8	5.2	4.3	2.9	12.9	2.2	8.6	12.0	5.5	2.1	5.8	8.4	9.1	5.5	6.2	3.6	5.5	6.1	4.9	7.8	3.7	3.8	3.0	3.7	3.5	0.9	5.2	4.8	0.4	1.0	0.4	0.4	0.5	0.4	0.6	0.4	0.6	0.6	0.5	0.3	0.0	0.8	0.4	0.7	0.6	0.3	9.6	13.4	10.1	13.0	11.2	8.9	7.2	8.0	8.7	7.5	9.3	19.9	15.8	16.0	14.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	15.2	10.9	0.0	0.0	20.4	16.5	0.0	11.9	13.2	0.0	1.9	10.2	0.0	65.7	28.6	6.6	0.0	0.0	0.0	5.6	8.1	8.8	0.0	16.0	10.1	30.1	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	3.8	0.0	0.0	10.4	38.6	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	9.9	6.3	34.4	0.0	0.0
TOMM70	"KIAA0719, Tom70, TOMM70A"	ENSG00000154174	"Translocase of outer mitochondrial membrane 70"	O94826	3	100363431-100401089	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 34.9;Extravillous trophoblasts: 33.2;Proximal tubular cells: 48.6;Theca cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014589, CAB017156, HPA048020"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234"	"unprognostic (2.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.01e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.98e-3)"	29.7	23.1	21.8	19.5	38.7	16.6	31.5	20.6	24.4	19.8	19.1	27.7	29.3	24.5	21.3	28.9	20.4	16.1	38.8	23.6	23.0	36.8	61.7	15.9	22.2	21.3	18.6	30.8	26.8	27.2	14.8	23.4	21.9	26.4	29.8	45.4	21.9	26.9	66.4	19.8	24.4	26.7	17.9	19.2	21.5	19.6	22.9	29.6	30.1	76.1	25.9	27.3	17.8	19.5	70.2	48.3	39.8	57.9	55.4	60.0	52.0	57.9	49.6	52.2	53.8	68.7	39.0	83.2	49.9	49.7	46.6	67.4	73.1	53.4	76.7	31.6	33.7	95.2	30.3	67.3	34.6	117.2	41.8	53.7	48.6	46.5	75.6	46.5	38.8	40.1	69.2	65.6	63.3	51.9	79.6	47.5	55.2	107.4	101.2	72.0	80.9	89.0	42.6	52.2	72.2	60.1	42.3	67.0	77.9	38.2	87.1	65.8	35.2	45.5	60.3	25.8	44.0	71.1	108.8	139.1	44.1	70.0	35.2	1.1	1.0	1.2	1.9	1.1	2.3	2.0	2.3	2.0	1.4	1.4	2.3	2.5	0.2	2.7	1.3	1.4	1.0	0.8	21.8	38.7	20.6	24.4	23.6	23.0	21.3	18.6	21.9	17.9	22.9	19.5	24.2	6.4	25.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	30.0	20.2	0.0	0.0	11.2	14.7	0.0	26.8	11.5	0.0	11.7	19.0	0.0	13.8	34.9	10.0	0.0	0.0	0.0	20.1	33.2	12.9	0.0	25.4	7.6	27.1	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.3	0.0	0.0	48.6	10.2	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	16.3	6.3	32.9	0.0	0.0
TOR1AIP1	"FLJ13142, LAP1, LAP1B, LAP1C"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179920077	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 275.9;Late spermatids: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546, HPA070991"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: "	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	39.7	34.8	20.4	27.2	23.6	84.5	33.9	22.4	25.0	42.6	29.0	46.5	15.9	40.5	35.9	40.6	31.6	34.3	38.5	18.1	21.4	36.5	38.4	35.5	34.2	23.6	23.3	54.5	27.9	36.9	20.1	28.5	22.0	43.8	22.8	25.1	31.5	43.2	54.1	20.1	23.6	41.0	21.2	35.0	31.3	27.0	21.5	27.5	46.8	74.8	27.6	40.4	26.4	24.5	37.1	36.4	24.9	32.3	109.7	73.6	47.7	48.2	57.7	44.5	45.6	28.5	68.5	9.7	52.1	50.2	31.8	63.5	23.6	39.6	52.8	62.9	23.2	26.4	31.5	28.5	50.4	90.8	78.4	57.8	29.8	55.3	51.3	50.1	40.9	39.5	39.2	47.6	47.9	33.1	37.4	28.5	35.5	47.9	13.9	22.8	38.9	25.5	43.7	71.3	20.9	29.2	60.7	57.9	83.6	36.6	44.3	91.9	41.9	60.7	26.5	42.0	58.8	53.4	75.3	19.5	23.6	49.3	95.1	177.7	86.0	205.3	76.4	94.8	89.6	54.9	68.9	76.8	90.8	66.7	71.0	73.1	132.8	74.6	127.5	65.1	81.9	115.5	20.4	23.6	22.4	25.0	18.1	21.4	23.6	23.3	22.0	21.2	21.5	24.5	42.4	32.1	36.1	21.2	33.9	43.3	64.4	21.3	48.3	11.8	27.5	17.8	30.2	18.6	24.2	20.2	16.7	16.2	44.1	13.1	13.7	20.5	275.9	25.9	30.9	33.6	20.3	25.2	13.6	25.2	26.0	51.7	23.4	48.4	36.1	19.8	36.8	27.4	27.6	6.7	16.9	10.6	20.3	48.5	26.1	190.0	47.5	40.4	14.2	21.5	36.6	40.5	35.0	15.6	26.9	29.0	12.5	58.6	32.8	48.4	11.1	19.2	29.2	13.6	26.3	72.5	38.0	14.0	20.4	38.1	37.5	18.2	47.5	23.6	8.3	54.0
TOX	"KIAA0808, TOX1"	ENSG00000198846	"Thymocyte selection associated high mobility group box"	O94900	8	58805412-59119147	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 52.4"	"Group enriched"	"Detected in many"	5	"Astrocytes: 316.3;Excitatory neurons: 198.3;Inhibitory neurons: 155.0;Oligodendrocyte precursor cells: 455.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 36.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.5;NK-cells: 18.4;T-cells: 36.6"	"Cell line enhanced"	"Detected in many"		"JURKAT: 75.9;MOLT-4: 149.1;SH-SY5Y: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018322, HPA073241"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA018322: AB_1858199, HPA073241: AB_2686584"	"unprognostic (7.60e-4)"	"unprognostic (6.16e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.73e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	0.7	1.0	7.1	5.8	9.3	2.9	1.0	0.1	10.7	1.8	0.0	11.4	9.5	1.3	0.4	3.3	0.8	4.6	0.7	6.4	8.0	3.0	1.1	4.6	18.2	2.0	4.4	5.7	1.4	2.4	1.8	1.3	2.2	2.0	8.6	6.0	1.6	1.0	0.1	0.5	10.3	2.5	0.0	5.5	7.9	6.3	5.8	52.4	1.1	0.6	18.9	2.0	1.4	4.9	0.9	0.2	15.7	0.0	1.6	3.5	0.0	3.3	7.5	1.8	0.3	0.0	0.0	0.0	0.0	14.4	0.8	1.2	3.9	0.0	0.4	0.5	1.5	0.0	2.8	0.0	12.7	2.8	0.7	1.9	0.5	2.3	2.9	1.0	25.9	75.9	0.0	0.0	1.2	0.0	149.1	0.0	2.7	0.2	0.4	3.1	10.7	0.1	0.4	0.4	14.3	43.8	0.0	0.1	0.0	3.6	0.0	0.0	0.2	3.9	1.8	12.9	4.4	0.0	0.0	9.9	0.5	0.1	2.8	21.5	0.2	3.2	12.1	0.0	5.5	5.4	8.6	18.2	1.4	1.3	3.3	9.7	0.3	18.4	0.0	0.0	36.6	5.6	7.1	9.3	0.1	10.7	6.4	8.0	2.0	4.4	2.2	0.0	5.8	4.9	0.6	9.6	31.6	316.3	12.3	1.3	0.1	0.1	1.2	18.4	0.2	0.9	1.8	1.5	2.5	1.8	0.0	3.9	23.2	3.7	0.0	0.9	2.0	1.9	2.7	1.8	46.0	4.2	198.3	0.7	0.2	2.7	6.1	0.8	16.5	0.0	0.4	0.7	3.7	0.0	155.0	34.8	2.0	0.6	9.6	2.2	0.9	2.8	0.0	47.8	0.6	14.3	34.0	455.4	5.0	2.6	9.6	0.4	22.4	0.1	4.0	1.3	10.4	2.2	0.0	0.2	0.6	1.0	0.7	0.5	1.3	0.8	35.0	0.0	10.3	0.1
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693352	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 185.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Excitatory neurons: 45.2;Horizontal cells: 42.1;Inhibitory neurons: 32.6;Oligodendrocytes: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.4;AN3-CA: 5.4;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favorable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.8	6.6	100.8	0.7	136.7	0.2	2.5	55.3	120.4	1.8	0.0	12.8	5.2	3.3	0.5	11.0	10.4	1.7	9.8	112.3	69.9	4.4	2.7	10.2	0.3	110.3	102.3	1.8	6.0	2.1	19.5	2.2	107.7	2.3	1.8	6.3	5.7	3.6	10.5	8.2	9.5	3.6	47.5	2.6	4.9	2.2	124.6	0.4	6.9	5.3	1.4	6.8	2.7	185.2	0.2	7.4	0.3	5.4	0.8	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.5	0.0	1.9	2.9	2.9	0.0	0.0	1.5	2.5	0.2	3.6	0.2	0.8	0.2	0.3	0.0	0.7	0.0	0.1	0.2	0.0	0.1	0.1	2.7	0.0	0.2	0.2	0.5	0.2	0.8	0.7	0.3	0.1	1.0	0.2	1.0	13.2	1.6	0.8	0.3	3.6	0.3	0.7	0.2	0.1	0.2	2.7	0.0	0.2	1.0	0.2	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	100.8	136.7	55.3	120.4	112.3	69.9	110.3	102.3	107.7	47.5	124.6	185.2	1.6	38.5	10.0	6.8	0.7	4.1	1.4	0.6	9.6	21.3	3.1	2.4	18.4	2.8	5.3	1.8	0.0	0.0	1.1	5.7	1.9	2.4	9.1	26.6	0.9	2.0	10.2	0.0	45.2	0.7	0.3	3.3	3.1	5.8	4.5	0.1	2.2	4.3	3.3	42.1	32.6	6.5	0.0	0.0	2.2	7.2	0.3	1.2	1.8	4.7	0.1	0.9	0.0	6.6	104.7	0.7	5.2	0.4	3.3	0.8	10.3	1.1	13.5	2.4	0.0	1.5	4.2	2.2	0.8	6.7	3.1	0.0	4.8	0.1	4.8	4.1
TPPP3	"CGI-38, p20, p25gamma"	ENSG00000159713	"Tubulin polymerization promoting protein family member 3"	Q9BW30	16	67389809-67393518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 858.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 962.0;Melanocytes: 501.6;Respiratory ciliated cells: 1825.2;Suprabasal keratinocytes: 495.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 61.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 65.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 59.9;OE19: 40.8;RH-30: 31.1;SCLC-21H: 47.8;SH-SY5Y: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047629, HPA061691"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		43000	"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"		"HPA047629: AB_2680108, HPA061691: "	"unprognostic (1.63e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.86e-3)"	44.3	27.1	199.2	8.0	200.1	1.0	81.0	186.0	225.7	50.3	168.7	96.4	23.7	29.3	9.7	99.3	858.4	21.9	81.4	188.1	222.0	60.7	4.4	148.0	4.4	258.7	291.6	8.6	23.9	13.6	40.7	78.5	231.2	18.9	14.1	9.6	39.5	13.3	72.2	170.5	38.0	21.4	223.6	17.7	43.6	15.4	228.3	4.7	18.4	55.8	9.1	32.8	36.4	296.2	0.4	59.9	0.6	0.4	0.4	9.4	0.2	1.7	0.4	0.4	0.9	3.9	12.0	0.0	0.9	0.8	0.2	11.3	9.2	0.0	0.1	0.0	3.5	0.0	1.5	1.7	0.1	0.0	0.0	2.4	0.3	3.6	0.0	1.8	0.6	0.0	0.1	0.0	5.4	0.3	0.0	0.2	1.9	40.8	0.0	0.0	31.1	0.2	0.0	0.0	47.8	20.7	0.0	0.1	2.4	1.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.9	0.0	25.4	12.4	0.0	37.6	0.2	0.0	0.0	0.0	33.1	0.1	0.0	0.0	5.8	0.0	65.8	0.3	0.0	9.4	199.2	200.1	186.0	225.7	188.1	222.0	258.7	291.6	231.2	223.6	228.3	296.2	14.7	16.0	129.8	17.0	0.2	303.9	8.8	92.5	5.7	3.8	5.9	5.0	4.1	30.0	160.4	18.4	4.2	8.3	0.2	28.4	5.9	166.8	60.1	962.0	30.9	31.6	177.9	0.0	0.5	1.8	4.3	141.9	7.1	14.7	25.4	1.0	5.0	0.1	2.9	0.0	0.7	65.1	132.2	3.8	82.5	23.7	29.2	13.7	501.6	1.0	10.7	68.7	1.0	1.0	30.0	8.4	39.7	3.4	0.0	5.6	29.8	0.9	1825.2	8.9	236.7	259.3	163.7	8.1	5.8	1.6	495.3	80.0	5.5	0.8	27.3	10.1
TRABD2B	TIKI2	ENSG00000269113	"TraB domain containing 2B"	A6NFA1	1	47760528-47997385	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.5;Cholangiocytes: 15.7;Fibroblasts: 6.6;Hepatocytes: 11.3;Microglial cells: 7.5;Proximal tubular cells: 22.8"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 6.7;U-2197: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA045817	Approved				"Intracellular and membrane"	NA	NA		41000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045817: AB_2679460"	"unprognostic (2.38e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	2.3	0.9	0.1	0.6	0.2	0.0	2.7	1.0	0.3	2.8	0.5	2.9	0.4	1.5	0.8	1.3	1.9	1.6	7.0	0.1	0.0	16.6	4.2	1.7	0.0	0.1	0.2	0.8	2.6	0.0	1.5	0.4	0.2	3.6	0.7	0.0	1.6	3.3	0.6	1.6	1.6	0.9	0.1	1.2	1.6	0.9	0.1	0.4	1.0	0.6	0.1	3.8	2.6	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.0	6.7	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.3	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.2	1.6	0.0	0.5	0.3	0.3	0.8	1.4	0.6	2.8	0.0	0.6	2.9	7.5	15.7	0.1	1.8	0.0	0.0	0.0	0.0	5.9	3.8	0.1	0.1	0.5	1.9	0.0	0.0	0.3	2.2	0.0	6.6	0.0	0.1	0.0	0.0	1.4	11.3	0.1	0.0	0.3	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	7.5	0.0	0.0	0.0	0.5	0.7	1.3	0.0	2.2	0.1	0.4	0.0	22.8	0.0	0.0	0.0	0.3	4.1	0.0	4.0	0.1	0.3	0.0	0.2	0.1	0.0	0.2
TRAF5	RNF84	ENSG00000082512	"TNF receptor associated factor 5"	O00463	1	211326615-211374946	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 75.9;Early spermatids: 55.0;Late spermatids: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008052, CAB010277"	Enhanced		Supported	Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	Centrosome	"CAB010277: AB_2287961, HPA008052: AB_1858230"	"unprognostic (6.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.94e-10)"	"unprognostic (3.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (7.29e-5)"	8.6	3.3	3.6	17.0	4.6	4.1	6.0	1.5	3.2	10.8	26.3	14.0	5.0	17.3	7.4	5.6	17.8	8.1	3.5	3.6	2.2	5.0	1.8	5.7	29.7	2.7	2.7	6.2	21.3	1.6	2.9	5.4	2.8	9.0	9.5	0.7	7.5	10.8	1.5	2.8	17.4	20.0	2.2	16.7	9.3	6.9	3.1	13.5	3.0	2.6	27.2	13.5	6.5	2.4	6.2	4.5	7.9	7.1	6.8	4.9	2.8	8.6	10.3	12.2	10.8	2.2	11.9	18.8	4.8	13.6	6.2	1.2	15.1	1.4	6.1	36.3	5.4	0.9	7.1	0.0	9.9	3.0	13.3	5.8	2.7	6.6	2.0	18.4	8.6	16.3	7.6	8.7	3.4	4.8	8.3	3.4	9.5	9.7	3.8	12.6	11.0	17.6	9.3	4.3	14.0	14.6	6.4	0.3	18.3	29.2	4.4	0.3	5.4	7.9	6.1	2.7	9.8	2.4	3.8	20.0	2.1	0.0	3.0	13.8	0.3	0.4	9.2	0.3	17.3	22.2	11.6	12.5	1.5	19.6	10.2	10.2	0.7	21.3	0.5	1.1	17.7	7.4	3.6	4.6	1.5	3.2	3.6	2.2	2.7	2.7	2.8	2.2	3.1	2.4	15.2	12.8	7.2	3.3	75.9	3.7	4.0	2.7	9.6	2.5	13.9	13.7	2.5	0.0	6.8	11.0	0.0	9.5	31.0	3.6	0.0	0.9	55.0	5.3	23.6	9.0	14.8	4.6	13.4	9.8	2.2	16.9	16.8	8.1	15.2	5.3	6.1	0.3	10.0	0.0	14.1	11.4	4.1	4.8	12.6	47.9	14.3	17.3	8.8	20.6	16.3	1.0	32.0	7.5	2.8	7.1	11.4	27.4	11.3	3.4	1.8	0.8	8.6	0.7	13.1	7.3	29.1	3.8	2.7	4.4	4.0	1.4	41.6	5.0	14.3	2.6
TRAPPC6A	"HSPC289, MGC2650, TRS33"	ENSG00000007255	"Trafficking protein particle complex 6A"	O75865	19	45162928-45178237	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 246.5;Proximal tubular cells: 303.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 164.5;U-266/70: 135.3"	"Low region specificity"	"Detected in all"							HPA043043	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043043: AB_10794650"	"unprognostic (2.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.86e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.23e-6)"	"unprognostic (3.85e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-2)"	27.3	32.7	25.4	14.1	28.9	48.7	31.0	27.9	35.1	20.5	19.9	33.1	18.3	21.6	19.5	25.4	29.1	15.9	21.4	24.3	25.5	57.5	59.8	18.6	34.2	30.0	27.2	23.0	28.9	17.1	20.5	12.7	29.2	39.1	11.5	4.6	30.7	16.8	35.2	56.0	28.1	7.0	27.0	42.4	32.2	24.8	26.6	20.6	38.4	15.8	17.4	23.7	24.5	33.2	7.6	42.1	9.4	18.7	15.7	11.3	18.3	2.3	8.2	2.6	5.8	12.6	38.2	76.1	40.0	4.8	22.0	15.8	3.3	6.8	1.1	42.5	30.8	28.0	3.5	14.0	33.0	12.3	28.2	27.8	37.9	2.0	12.8	10.4	8.9	48.8	27.6	57.7	4.1	104.0	30.5	42.0	11.9	164.5	21.0	52.8	10.2	93.9	27.2	26.6	44.2	18.3	16.4	77.9	29.1	16.0	45.1	39.3	3.5	6.3	6.8	4.4	2.7	135.3	43.0	57.0	14.4	25.6	10.5	25.7	59.5	30.5	78.2	60.3	94.8	92.1	105.5	81.8	91.2	93.7	110.4	95.1	4.8	113.6	62.8	87.6	112.7	86.2	25.4	28.9	27.9	35.1	24.3	25.5	30.0	27.2	29.2	27.0	26.6	33.2	28.8	44.8	51.7	5.2	61.6	58.1	64.3	149.3	55.2	13.6	66.6	71.4	17.9	68.6	71.5	58.8	2.1	122.7	63.4	41.7	246.5	53.4	15.1	56.8	26.9	33.7	83.8	23.8	2.7	42.1	43.7	24.8	29.6	65.2	40.6	63.9	42.1	113.7	72.0	13.5	2.3	84.6	148.5	56.6	67.3	94.0	19.3	45.3	108.5	5.6	114.2	54.9	60.8	4.5	10.7	24.4	73.8	10.5	39.9	35.1	61.8	303.6	62.0	13.6	13.1	23.9	34.4	14.2	68.9	43.0	83.5	88.5	72.1	72.7	81.8	71.6
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822770-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 79.8"	"Cell type enriched"	"Detected in some"	10	"T-cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 395.1"	"Group enriched"	"Detected in many"	155	"granulocytes: 395.1;T-cells: 313.1"	"Group enriched"	"Detected in some"	25	"JURKAT: 29.9;MOLT-4: 76.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	1.1	0.6	0.0	11.0	0.0	2.7	0.8	0.0	0.0	0.4	0.0	1.3	1.4	0.4	0.4	1.0	0.3	2.5	0.4	0.1	0.0	0.3	1.3	2.1	23.9	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	1.5	0.0	0.6	0.1	0.1	0.6	3.0	0.5	0.0	8.5	2.4	0.4	0.0	79.8	0.4	0.4	12.4	2.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	2.1	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	395.1	0.6	0.2	57.0	0.2	116.4	1.0	229.5	119.6	0.3	0.4	313.1	77.7	3.5	2.2	0.7	0.8	111.1	139.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.0	3.3	8.4	0.1	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	1.8	0.0	0.0	8.9	0.1	0.0	0.0	2.3	0.1	0.1	1.1	0.0	2.7	0.1	0.0	0.0	1.7	7.7	0.1	2.5	0.0	1.8	0.6	0.2	0.0	0.2	0.0	0.0	1.0	12.2	2.2	0.0	1.8	3.6	0.0	3.2	0.0	3.1	0.0	0.2	0.0	0.0	0.0	5.1	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.0	8.0	0.1	129.3	0.6	0.0	0.2
TRAV12-1		ENSG00000211785	"T cell receptor alpha variable 12-1"	A0A0B4J245	14	21841240-21841774	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 21.1"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 4.1;Plasma cells: 1.4;T-cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	72	"MAIT T-cell: 128.5;memory CD4 T-cell: 205.2;memory CD8 T-cell: 199.7;naive CD4 T-cell: 138.6;naive CD8 T-cell: 251.7;T-reg: 193.9"	"Lineage enriched"	"Detected in many"	97	"T-cells: 251.7"	"Not detected"	"Not detected"																	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (4.83e-3)"	"unprognostic (9.56e-5)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-3)"		"unprognostic (8.05e-2)"	"unprognostic (2.99e-4)"	"unprognostic (3.16e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.97e-4)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.92e-2)"	0.5	0.0	0.0	6.5	0.0	1.2	1.3	0.0	0.2	0.6	0.0	1.3	2.8	0.4	0.8	0.7	0.4	2.5	0.1	0.0	0.0	0.1	0.5	1.3	13.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.2	0.0	0.4	0.0	2.3	1.2	0.0	4.9	1.9	0.1	0.0	21.1	0.2	0.2	14.3	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.9	1.9	0.4	128.5	0.2	205.2	199.7	0.3	0.6	138.6	251.7	2.6	0.3	1.0	0.2	193.9	100.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0
TRAV12-2		ENSG00000211789	"T cell receptor alpha variable 12-2"	A0A075B6T6	14	21887857-21888502	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 22.4"	"Cell type enriched"	"Detected in some"	6	"T-cells: 6.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"memory CD4 T-cell: 101.9;memory CD8 T-cell: 87.7;naive CD4 T-cell: 90.3;naive CD8 T-cell: 65.2;T-reg: 143.3"	"Lineage enriched"	"Detected in many"	77	"T-cells: 143.3"	"Not detected"	"Not detected"																	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.22e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.23e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.01e-2)"	0.8	0.8	0.0	7.5	0.0	0.9	1.0	0.0	0.1	1.0	0.0	1.6	4.1	0.8	0.5	0.8	1.2	2.5	0.3	0.0	0.0	0.3	0.6	2.5	15.7	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.8	2.1	0.0	1.7	0.1	0.2	0.5	2.9	0.5	0.0	5.9	2.3	0.0	0.0	22.4	0.6	0.0	13.5	3.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.5	1.2	0.0	5.7	0.1	101.9	87.7	0.2	0.1	90.3	65.2	1.8	0.1	0.2	0.1	143.3	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0
TRAV12-3	"TCRAV12S3, TCRAV2S2, TRAV123"	ENSG00000211794	"T cell receptor alpha variable 12-3"	A0A0B4J271	14	21965451-21966061	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 60.3"	"Group enriched"	"Detected in some"	4	"Erythroid cells: 1.7;T-cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 186.5;T-reg: 256.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 256.6"	"Cell line enriched"	"Detected in single"	43	"JURKAT: 4.5"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.62e-4)"	"unprognostic (7.68e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.55e-4)"	"unprognostic (9.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.52e-5)"	"unprognostic (3.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.68e-2)"	0.5	0.1	0.0	9.3	0.0	1.5	1.1	0.0	0.1	1.7	0.0	2.1	2.2	0.6	0.9	0.4	0.6	6.1	0.5	0.0	0.0	0.3	0.4	2.8	18.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	3.2	0.0	0.3	0.2	0.1	0.4	2.7	0.5	0.0	4.6	1.9	0.1	0.0	60.3	0.2	0.0	17.4	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.5	0.2	0.4	0.2	12.7	0.4	186.5	57.4	0.4	1.8	119.7	153.3	4.6	0.9	0.7	0.5	256.6	48.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0
TRAV13-1		ENSG00000211788	"T cell receptor alpha variable 13-1"	A0A0B4J241	14	21868839-21869365	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 62.5"	"Cell type enriched"	"Detected in single"	26	"T-cells: 15.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 329.3"	"Lineage enriched"	"Detected in many"	28	"T-cells: 329.3"	"Cell line enriched"	"Detected in single"	20	"JURKAT: 1.9"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.10e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.04e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.30e-5)"	"unprognostic (7.68e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.59e-2)"	1.1	0.3	0.0	13.7	0.1	2.2	1.1	0.0	0.2	0.2	0.0	3.7	3.6	0.7	0.3	0.8	0.9	3.7	0.5	0.0	0.0	0.4	1.0	4.4	29.2	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	1.1	3.0	0.0	1.2	0.4	0.2	0.2	7.5	0.4	0.0	8.4	3.8	0.2	0.0	62.5	0.6	0.7	29.9	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.7	0.4	1.4	0.4	62.6	0.4	203.8	179.6	0.5	0.6	232.3	292.5	6.2	0.5	0.5	0.9	329.3	80.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.6	0.0	0.0	0.0
TRAV13-2		ENSG00000211791	"T cell receptor alpha variable 13-2"	A0A0B4J235	14	21918188-21918756	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	24	"lymphoid tissue: 51.7"	"Group enriched"	"Detected in some"	4	"NK-cells: 4.1;T-cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	38	"MAIT T-cell: 32.9;memory CD4 T-cell: 94.0;memory CD8 T-cell: 57.3;naive CD4 T-cell: 101.8;naive CD8 T-cell: 114.1;T-reg: 114.8"	"Lineage enriched"	"Detected in many"	53	"T-cells: 114.8"	"Cell line enriched"	"Detected in some"	4	"JURKAT: 6.1"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (6.15e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.58e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.66e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-2)"	0.3	0.0	0.0	6.6	0.0	1.4	0.9	0.0	0.2	0.4	0.0	1.3	2.1	0.2	1.2	0.7	0.3	1.4	0.2	0.0	0.0	0.2	0.4	1.6	14.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.0	0.0	0.5	0.1	0.1	0.5	1.6	0.5	0.1	4.6	1.9	0.2	0.0	51.7	0.2	0.0	10.0	1.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.2	0.1	2.2	0.2	32.9	0.4	94.0	57.3	0.1	0.2	101.8	114.1	2.1	0.6	0.2	0.3	114.8	40.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.7	0.0	0.0	0.0
TRAV14DV4	"hADV14S1, TCRAV6S1-hDV104S1, TRAV14/DV4"	ENSG00000211792	"T cell receptor alpha variable 14/delta variable 4"	A0A0A6YYC5	14	21924063-21924651	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 25.7"	"Cell type enriched"	"Detected in single"	12	"T-cells: 6.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 38.2;memory CD8 T-cell: 78.1;naive CD4 T-cell: 30.7;naive CD8 T-cell: 122.3;T-reg: 42.6"	"Lineage enriched"	"Detected in single"	176	"T-cells: 122.3"	"Cell line enhanced"	"Detected in single"		"JURKAT: 1.6"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (6.82e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-3)"		"unprognostic (3.00e-5)"	"unprognostic (2.52e-1)"	"unprognostic (7.61e-4)"	"unprognostic (3.77e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.62e-5)"	"unprognostic (3.01e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.60e-2)"	0.6	0.1	0.0	4.2	0.0	1.5	0.6	0.0	0.1	0.5	0.0	0.8	2.0	0.3	0.0	0.6	0.6	1.6	0.2	0.0	0.0	0.2	1.1	2.5	12.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.1	0.0	0.2	1.7	0.1	0.0	3.4	1.3	0.0	0.0	25.7	0.2	0.0	8.0	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.2	9.9	0.1	38.2	78.1	0.0	0.2	30.7	122.3	0.3	0.4	0.3	0.0	42.6	21.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0
TRAV2		ENSG00000211776	"T cell receptor alpha variable 2"	A0A0B4J234	14	21712321-21712843	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	21	"lymphoid tissue: 56.3"	"Cell type enriched"	"Detected in single"	5	"T-cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 40.9"	"Lineage enriched"	"Detected in single"	124	"T-cells: 40.9"	"Cell line enriched"	"Detected in single"	21	"Daudi: 2.1"															NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.38e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.93e-2)"		"unprognostic (1.86e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (9.93e-5)"	"unprognostic (1.92e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"	0.4	0.2	0.0	8.2	0.0	2.5	0.3	0.0	0.5	0.3	0.0	2.0	0.8	0.0	0.0	0.9	0.3	0.9	0.3	0.0	0.0	0.2	0.3	1.6	19.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.8	0.0	0.2	0.0	0.0	0.1	1.7	0.0	0.0	3.3	2.7	0.2	0.0	56.3	0.2	0.0	13.2	2.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	31.3	0.0	31.5	9.9	0.0	0.0	24.5	9.6	0.1	0.0	0.0	0.3	40.9	5.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0
TRAV21		ENSG00000211801	"T cell receptor alpha variable 21"	A0A0B4J279	14	22052514-22053056	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 63.2"	"Group enriched"	"Detected in some"	12	"Gastric mucus-secreting cells: 6.1;T-cells: 23.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory CD4 T-cell: 220.5;memory CD8 T-cell: 233.5;naive CD4 T-cell: 198.6;naive CD8 T-cell: 204.8;T-reg: 391.9"	"Lineage enriched"	"Detected in many"	76	"T-cells: 391.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (2.53e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.69e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.20e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"	0.4	0.1	0.0	5.9	0.0	0.8	1.4	0.0	0.1	1.1	0.0	1.8	2.0	0.1	1.7	0.9	0.7	1.7	0.1	0.0	0.1	0.7	0.5	2.7	14.2	0.2	0.0	0.4	0.0	0.1	0.0	0.3	0.1	0.7	2.7	0.0	1.0	0.1	0.4	0.3	2.6	0.7	0.1	5.4	2.4	0.1	0.0	63.2	3.8	0.0	17.0	2.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.9	1.7	0.2	17.4	0.5	220.5	233.5	0.9	0.8	198.6	204.8	5.1	0.4	0.7	0.6	391.9	73.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.0	0.0	0.0	0.0
TRAV27		ENSG00000211809	"T cell receptor alpha variable 27"	A0A087WT01	14	22147995-22148633	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 19.8"	"Cell type enriched"	"Detected in some"	4	"T-cells: 4.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	19	"memory CD4 T-cell: 51.6;memory CD8 T-cell: 58.9;naive CD4 T-cell: 60.4;naive CD8 T-cell: 59.1;T-reg: 81.9"	"Lineage enriched"	"Detected in many"	63	"T-cells: 81.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (3.86e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.78e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.75e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.12e-3)"	0.1	0.0	0.0	2.3	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.6	0.3	0.2	0.0	0.4	0.3	0.2	0.1	0.0	0.0	0.1	0.1	0.7	5.0	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.2	0.0	0.2	0.2	0.7	0.0	0.0	1.7	0.9	0.0	0.1	19.8	0.1	0.0	5.6	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.5	0.0	3.2	0.2	51.6	58.9	0.0	0.0	60.4	59.1	1.0	1.3	0.1	0.3	81.9	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0
TRAV8-6		ENSG00000211795	"T cell receptor alpha variable 8-6"	A0A0B4J262	14	21978459-21979120	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 24.7"	"Group enriched"	"Detected in some"	19	"Spermatocytes: 1.2;Spermatogonia: 1.5;T-cells: 3.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 89.3;memory CD8 T-cell: 64.2;naive CD4 T-cell: 92.6;naive CD8 T-cell: 38.7;T-reg: 125.0"	"Lineage enriched"	"Detected in many"	45	"T-cells: 125.0"	"Cell line enriched"	"Detected in single"	97	"JURKAT: 9.6"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.42e-2)"	"unprognostic (9.23e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.27e-3)"	"unprognostic (7.80e-2)"	"unprognostic (7.74e-5)"	"unprognostic (2.88e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.24e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.92e-1)"	"unprognostic (9.78e-5)"	"unprognostic (4.65e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.61e-3)"	0.2	0.0	0.0	3.0	0.0	0.8	0.8	0.0	0.0	0.4	0.0	0.9	0.7	0.3	0.7	0.3	0.3	2.0	0.2	0.0	0.0	0.3	0.3	1.4	10.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.2	0.1	0.1	0.2	1.3	0.4	0.1	2.9	1.5	0.4	0.0	24.7	0.1	0.1	8.2	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	17.9	0.2	89.3	64.2	0.1	0.1	92.6	38.7	2.8	0.1	0.1	0.2	125.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0
TRAV9-2		ENSG00000211793	"T cell receptor alpha variable 9-2"	A0A087WT02	14	21941128-21941657	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 27.8"	"Cell type enriched"	"Detected in single"	6	"T-cells: 5.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 178.3;naive CD4 T-cell: 172.2;T-reg: 350.8"	"Lineage enriched"	"Detected in many"	78	"T-cells: 350.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (2.02e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-4)"		"unprognostic (1.14e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.98e-4)"	"unprognostic (9.53e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.00e-4)"	"unprognostic (2.49e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.56e-2)"	0.2	0.0	0.0	5.6	0.0	0.1	0.3	0.0	0.2	0.7	0.0	1.8	0.8	0.2	0.0	0.4	0.4	1.7	0.2	0.0	0.0	0.2	1.1	1.8	18.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.4	0.0	0.1	0.4	0.2	0.2	2.0	0.5	0.0	5.0	3.1	0.1	0.0	27.8	0.2	0.2	16.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.8	0.0	14.3	0.6	178.3	43.4	0.2	0.3	172.2	42.5	4.4	0.3	0.2	1.1	350.8	40.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0
TRBJ1-1	"TCRBJ1S1, TRBJ11"	ENSG00000282320	"T cell receptor beta joining 1-1"	A0A0J9YXA8	7	142786880-142786927	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 83.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 1111.5"	"Lineage enriched"	"Detected in all"	18	"T-cells: 1111.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.2;K-562: 1.2;U-266/84: 4.4;U-698: 1.0"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 58: T-cells - T-cell receptor"																					2.1	0.0	0.6	33.1	0.4	7.8	0.8	0.0	0.8	1.0	0.0	4.6	5.9	1.6	0.0	2.8	0.9	4.2	0.4	0.2	0.1	0.3	6.1	5.6	44.8	0.3	0.2	1.6	3.0	0.0	0.0	0.5	0.3	1.6	7.9	0.3	1.4	0.5	3.4	0.0	6.1	0.6	0.2	18.6	9.8	0.3	0.6	83.9	0.1	5.5	48.6	2.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.0	0.0	0.0	0.0	46.7	1.3	2.9	163.0	0.9	240.7	5.8	622.5	480.8	1.9	1.9	690.1	869.6	16.2	62.1	1.5	4.7	1111.5	312.7	0.6	0.4	0.0	0.8	0.2	0.1	0.3	0.2	0.3	0.2	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TRBJ1-2	"TCRBJ1S2, TRBJ12"	ENSG00000282420	"T cell receptor beta joining 1-2"	A0A0J9YX06	7	142787017-142787064	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 107.2"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 495.1;memory CD8 T-cell: 334.7;naive CD4 T-cell: 467.6;naive CD8 T-cell: 296.5;T-reg: 801.8"	"Lineage enriched"	"Detected in all"	90	"T-cells: 801.8"	"Cell line enriched"	"Detected in some"	151	"JURKAT: 255.2"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"																					0.6	1.0	0.2	32.4	1.2	7.6	0.4	0.0	0.9	0.0	0.1	3.5	2.9	0.7	1.6	0.3	0.3	4.3	0.4	0.5	0.2	0.2	2.1	8.3	39.4	0.5	0.1	0.0	0.0	0.0	0.0	0.6	0.4	1.7	5.6	0.4	4.7	1.0	0.0	1.1	6.2	1.5	0.1	20.3	10.0	0.2	0.4	107.2	0.3	0.0	46.3	0.8	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.2	0.6	0.6	59.0	0.8	56.9	2.5	495.1	334.7	1.2	2.0	467.6	296.5	7.3	8.9	1.8	1.7	801.8	183.4	0.2	1.2	0.0	0.9	0.5	0.2	0.5	0.1	0.4	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TRBJ1-5	"TCRBJ1S5, TRBJ15"	ENSG00000282173	"T cell receptor beta joining 1-5"	A0A0J9YXM7	7	142788498-142788547	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 322.1"	"Not detected"	"Not detected"							"Region enriched"	"Detected in some"	5	"cerebral cortex: 5.5"	"Group enriched"	"Detected in all"	31	"gdT-cell: 857.2;MAIT T-cell: 363.2;memory CD4 T-cell: 549.3;memory CD8 T-cell: 445.4;naive CD4 T-cell: 513.7;naive CD8 T-cell: 498.0;NK-cell: 363.5;T-reg: 845.4"	"Group enriched"	"Detected in all"	34	"NK-cells: 363.5;T-cells: 857.2"	"Group enriched"	"Detected in some"	164	"JURKAT: 425.6;U-266/84: 208.7"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"																					4.1	2.9	0.3	100.7	0.5	16.5	16.4	0.0	5.5	4.4	0.7	16.9	9.7	2.9	0.0	3.3	1.4	10.5	2.3	0.2	0.0	0.9	8.3	15.7	119.8	1.0	0.2	3.7	0.0	1.2	0.0	1.6	0.3	8.5	28.8	0.3	4.5	0.5	4.7	1.5	17.6	4.1	0.4	80.7	24.5	1.9	0.2	322.1	1.6	1.3	166.1	8.1	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	425.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.0	208.7	0.5	0.0	0.0	0.0	7.3	3.5	2.2	857.2	1.7	363.2	1.2	549.3	445.4	2.8	2.1	513.7	498.0	17.9	363.5	4.1	3.8	845.4	514.1	0.3	0.5	0.0	5.5	0.2	0.0	1.0	0.2	0.3	0.4	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRBJ2-1	"TCRBJ2S1, TRBJ21"	ENSG00000211764	"T cell receptor beta joining 2-1"	A0A0A0MTA7	7	142796365-142796414	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"bone marrow: 26.8;lymphoid tissue: 71.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 8.7"	"Immune cell enhanced"	"Detected in all"		"T-reg: 1684.5"	"Lineage enriched"	"Detected in all"	8	"T-cells: 1684.5"	"Cell line enriched"	"Detected in some"	16	"MOLT-4: 2783.5"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.57e-2)"	"prognostic favorable (8.15e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"		"unprognostic (2.30e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.12e-2)"		"unprognostic (3.74e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (2.31e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.65e-3)"	0.7	4.2	0.8	26.9	1.0	26.8	0.4	0.0	1.4	1.0	0.0	2.1	7.8	0.4	0.0	0.0	1.4	2.2	0.7	0.3	0.0	1.0	0.6	4.5	41.7	0.0	2.2	1.6	0.0	0.0	0.0	0.7	0.2	2.8	2.9	0.8	1.2	0.0	3.1	0.0	8.4	0.7	0.1	29.8	7.5	1.2	8.7	71.3	0.8	0.0	35.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	1.9	0.0	0.9	175.1	160.3	0.0	0.0	0.0	0.0	2783.5	2.6	1.7	0.0	0.0	0.0	0.0	1.4	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	8.7	0.0	0.0	3.2	0.0	57.2	0.0	0.0	0.0	10.9	3.2	2.6	255.6	2.4	535.8	97.1	906.2	1179.2	2.8	69.8	916.2	888.4	11.3	209.4	4.6	8.4	1684.5	527.9	0.8	1.0	0.0	1.4	0.3	0.0	0.0	2.2	0.2	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
TRBJ2-2	"TCRBJ2S2, TRBJ22"	ENSG00000211765	"T cell receptor beta joining 2-2"		7	142796560-142796610	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 19.5;lymphoid tissue: 33.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.6"	"Group enriched"	"Detected in many"	7	"MAIT T-cell: 518.4;memory CD4 T-cell: 335.7;memory CD8 T-cell: 331.8;naive CD4 T-cell: 388.7;naive CD8 T-cell: 324.2;T-reg: 721.0"	"Lineage enriched"	"Detected in all"	12	"T-cells: 721.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 21.0;JURKAT: 42.2;MOLT-4: 90.4;RT4: 13.6;U-698: 16.3"															NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"					"unprognostic (1.16e-3)"						"unprognostic (1.52e-1)"			"unprognostic (2.39e-1)"		"unprognostic (2.98e-4)"	"unprognostic (3.51e-1)"	"unprognostic (8.42e-2)"		"unprognostic (6.98e-4)"	0.3	1.3	0.4	17.1	0.2	19.5	0.4	0.0	1.6	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.1	0.4	2.8	26.4	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.1	1.3	0.0	0.0	0.0	6.8	0.0	0.1	12.4	3.9	0.5	0.8	33.1	0.0	0.0	15.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	42.2	0.0	0.0	0.0	0.0	90.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	2.1	0.8	1.1	57.6	0.6	518.4	31.6	335.7	331.8	0.7	31.2	388.7	324.2	9.8	58.7	1.6	1.2	721.0	191.0	0.4	0.2	0.0	1.6	0.0	0.0	0.4	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TRBJ2-3	"TCRBJ2S3, TRBJ23"	ENSG00000211767	"T cell receptor beta joining 2-3"	A0A0B4J200	7	142796847-142796895	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.4"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"thalamus: 19.7"	"Group enriched"	"Detected in all"	12	"gdT-cell: 1486.3;MAIT T-cell: 905.3;memory B-cell: 1210.1;memory CD4 T-cell: 1124.0;memory CD8 T-cell: 1154.0;naive B-cell: 1430.2;naive CD4 T-cell: 1106.3;naive CD8 T-cell: 1031.1;NK-cell: 933.5;T-reg: 2317.4"	"Group enriched"	"Detected in all"	15	"B-cells: 1430.2;NK-cells: 933.5;T-cells: 2317.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 31.8;JURKAT: 65.6;MOLT-4: 72.9;RT4: 39.1;U-698: 218.9"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (4.65e-3)"	"unprognostic (7.01e-3)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.47e-5)"		"unprognostic (1.76e-5)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.64e-3)"	2.9	2.1	4.4	86.4	2.0	17.6	4.7	1.2	5.7	1.9	1.0	5.4	19.2	3.4	0.0	0.8	0.5	2.9	0.4	2.4	1.8	1.1	5.3	12.2	82.8	2.1	9.3	5.0	0.0	0.0	0.0	0.9	1.2	2.6	7.2	1.6	5.0	0.0	4.4	1.0	22.2	1.6	2.2	78.6	20.5	2.3	19.7	60.8	0.4	2.7	51.8	2.6	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	21.5	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	31.8	65.6	0.0	0.0	0.0	0.0	72.9	0.0	5.0	0.0	7.5	0.0	0.0	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.3	218.9	0.0	0.0	0.0	106.3	7.7	5.8	1486.3	3.1	905.3	1210.1	1124.0	1154.0	9.3	1430.2	1106.3	1031.1	43.1	933.5	10.8	18.1	2317.4	1057.6	4.4	2.0	1.2	5.7	2.4	1.8	2.1	9.3	1.2	2.2	19.7	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRBJ2-7	"TCRBJ2S7, TRBJ27"	ENSG00000211771	"T cell receptor beta joining 2-7"	A0A0A0MT78	7	142797456-142797502	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 45.4;lymphoid tissue: 155.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 10.8"	"Group enriched"	"Detected in all"	7	"MAIT T-cell: 1275.2;memory CD4 T-cell: 2387.1;memory CD8 T-cell: 2649.6;naive CD4 T-cell: 2393.9;naive CD8 T-cell: 2831.0;T-reg: 4224.6"	"Lineage enriched"	"Detected in all"	18	"T-cells: 4224.6"	"Cell line enhanced"	"Detected in some"		"JURKAT: 43.8;MOLT-4: 212.6;U-698: 55.5"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (9.07e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.37e-2)"	"prognostic favorable (4.79e-4)"		"unprognostic (1.14e-3)"	"unprognostic (2.57e-3)"	"unprognostic (6.68e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.17e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (7.27e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.13e-3)"	3.5	4.6	1.9	96.9	3.1	45.4	2.5	1.5	4.2	0.0	0.0	7.5	18.1	5.2	0.0	0.7	0.5	9.5	0.8	0.7	2.8	0.4	0.0	4.4	108.7	1.0	2.3	2.8	5.1	0.0	0.0	1.1	0.9	2.3	6.2	0.3	3.6	0.9	0.0	0.0	36.0	0.0	0.9	54.0	25.2	2.0	10.8	155.0	0.0	0.0	47.7	4.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	8.3	43.8	0.0	0.0	0.0	3.7	212.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	42.7	6.9	10.3	360.2	6.3	1275.2	233.4	2387.1	2649.6	6.9	233.7	2393.9	2831.0	64.7	122.4	13.1	9.8	4224.6	1638.0	1.9	3.1	1.5	4.2	0.7	2.8	1.0	2.3	0.9	0.9	10.8	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
TRBV10-3	"TCRBV10S3, TCRBV12S1A1N2, TRBV103"	ENSG00000275791	"T cell receptor beta variable 10-3"	A0A0K0K1G6	7	142544212-142544685	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	31	"lymphoid tissue: 88.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 1.7;T-cells: 5.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 160.1;T-reg: 203.1"	"Lineage enriched"	"Detected in single"	375	"T-cells: 203.1"	"Cell line enriched"	"Detected in single"	53	"MOLT-4: 49.7"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (3.61e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.44e-2)"	"unprognostic (8.96e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.23e-6)"	"unprognostic (9.84e-4)"	"unprognostic (7.96e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.99e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.59e-6)"	"unprognostic (5.93e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-3)"	0.3	0.2	0.0	8.0	0.0	2.8	0.2	0.0	0.0	0.4	0.0	1.1	0.0	0.1	0.0	0.3	0.2	1.0	0.1	0.0	0.0	0.1	0.4	0.5	16.8	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.9	0.1	0.0	0.0	1.4	0.3	0.0	2.1	2.3	0.1	0.1	88.6	0.2	0.0	12.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.9	0.0	49.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	9.3	0.4	77.0	160.1	0.0	0.3	101.7	41.2	0.3	0.1	0.5	0.5	203.1	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0
TRBV12-3	"TCRBV12S3, TCRBV8S1, TRBV123"	ENSG00000274752	"T cell receptor beta variable 12-3"	P01733	7	142560423-142560931	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"lymphoid tissue: 61.0"	"Group enriched"	"Detected in some"	19	"Gastric mucus-secreting cells: 4.6;T-cells: 10.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"memory CD4 T-cell: 29.2;memory CD8 T-cell: 14.9;naive CD4 T-cell: 32.5;naive CD8 T-cell: 23.9;T-reg: 46.0"	"Lineage enriched"	"Detected in many"	11	"T-cells: 46.0"	"Cell line enriched"	"Detected in some"	339	"JURKAT: 1248.3"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (5.41e-3)"	"unprognostic (9.35e-4)"	"unprognostic (5.34e-3)"	"unprognostic (1.39e-4)"		"unprognostic (5.43e-6)"	"unprognostic (1.97e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.57e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-2)"	0.3	0.0	0.0	4.4	0.0	2.3	0.4	0.0	0.0	1.4	0.0	1.0	1.0	0.2	0.3	0.5	0.1	1.3	0.3	0.0	0.0	0.2	0.6	1.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.3	0.0	0.8	0.0	0.4	0.1	2.2	0.1	0.0	3.8	2.1	0.2	0.0	61.0	0.3	0.0	12.6	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.2	1.0	0.9	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.7	0.0	1248.3	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	4.0	0.0	0.0	0.5	0.1	1.2	0.0	29.2	14.9	0.0	0.0	32.5	23.9	1.0	0.0	0.0	0.0	46.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0
TRBV15	"TCRBV15S1, TCRBV24S1A3T"	ENSG00000276819	"T cell receptor beta variable 15"		7	142592928-142593473	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	67	"lymphoid tissue: 46.9"	"Cell type enriched"	"Detected in single"	27	"T-cells: 2.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	48	"MAIT T-cell: 21.9;memory CD4 T-cell: 14.6;memory CD8 T-cell: 21.1;naive CD4 T-cell: 18.8;naive CD8 T-cell: 12.3;T-reg: 27.8"	"Lineage enriched"	"Detected in single"	158	"T-cells: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.07e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.39e-3)"		"unprognostic (2.09e-4)"	"unprognostic (1.08e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (7.77e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.34e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.55e-2)"	0.1	0.1	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	3.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.4	0.1	0.0	46.9	0.1	0.0	3.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	21.9	0.0	14.6	21.1	0.0	0.0	18.8	12.3	0.1	0.0	0.0	0.0	27.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0
TRBV2	"TCRBV22S1A2N1T, TCRBV2S1"	ENSG00000226660	"T cell receptor beta variable 2"	A0A1B0GX68	7	142300924-142301432	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 89.2"	"Cell type enriched"	"Detected in single"	80	"T-cells: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory CD4 T-cell: 120.3;memory CD8 T-cell: 64.5;naive CD4 T-cell: 71.5;naive CD8 T-cell: 44.5;T-reg: 122.7"	"Lineage enriched"	"Detected in many"	21	"T-cells: 122.7"	"Cell line enriched"	"Detected in single"	10	"RPMI-8226: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (6.62e-4)"	"unprognostic (4.94e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.71e-5)"	"unprognostic (3.60e-2)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.70e-5)"	"unprognostic (3.83e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.41e-2)"	1.1	0.3	0.0	8.3	0.0	3.9	1.2	0.0	0.1	1.1	0.0	2.6	2.5	0.3	1.1	1.7	0.2	2.4	0.1	0.0	0.0	0.4	0.9	1.6	25.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	2.1	0.0	0.3	0.5	0.0	0.3	1.7	0.8	0.0	6.8	3.5	0.3	0.0	89.2	0.5	0.3	22.1	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.9	0.0	5.5	0.1	120.3	64.5	0.3	0.1	71.5	44.5	1.2	0.1	0.1	5.8	122.7	29.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0
TRBV24-1	"TCRBV15S1, TCRBV24S1, TRBV241"	ENSG00000211750	"T cell receptor beta variable 24-1"	A0A075B6N3	7	142656701-142657213	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;lymphoid tissue: 6.7"	"Cell type enriched"	"Detected in single"	23	"T-cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 2.7"	"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 26.6"	"Lineage enriched"	"Detected in single"	129	"T-cells: 26.6"	"Not detected"	"Not detected"																	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.42e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-7)"	"unprognostic (2.36e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.39e-2)"	0.2	0.0	0.1	0.0	2.7	0.2	0.0	0.0	0.5	0.3	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.4	2.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	1.0	0.0	0.9	0.2	0.0	1.3	1.6	0.4	0.5	6.7	0.1	0.0	0.5	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	9.0	0.0	5.7	0.0	15.4	15.5	0.0	0.0	11.4	26.6	0.2	0.0	0.0	0.0	23.2	4.6	0.1	2.7	0.0	0.5	0.2	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
TRBV27	"TCRBV14S1, TCRBV27S1"	ENSG00000211752	"T cell receptor beta variable 27"	A0A0K0K1C4	7	142715346-142715861	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 81.6"	"Cell type enriched"	"Detected in some"	4	"T-cells: 6.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 61.1;memory CD8 T-cell: 112.2;naive CD4 T-cell: 48.2;naive CD8 T-cell: 75.8;T-reg: 94.7"	"Lineage enriched"	"Detected in single"	137	"T-cells: 112.2"	"Group enriched"	"Detected in some"	4	"HAP1: 2.9;JURKAT: 3.3;U-937: 3.6"					"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (3.08e-2)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-2)"			"unprognostic (5.85e-4)"	"unprognostic (8.84e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.91e-7)"	"unprognostic (4.03e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.43e-2)"	0.6	0.5	0.0	3.5	0.6	1.9	0.8	0.0	0.3	0.7	0.0	1.2	1.0	0.9	0.1	0.8	0.2	1.8	0.2	0.0	0.0	0.4	0.5	1.7	19.7	0.0	0.3	0.5	0.2	0.0	0.1	0.1	0.0	0.5	1.7	0.0	1.7	0.0	0.3	0.2	2.8	0.2	0.0	4.8	1.9	5.7	0.2	81.6	0.6	0.8	10.6	1.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.4	0.1	0.6	3.3	0.0	10.4	0.1	61.1	112.2	0.1	0.1	48.2	75.8	0.8	0.1	0.2	0.1	94.7	27.3	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0
TRBV28	"TCRBV28S1, TCRBV3S1"	ENSG00000211753	"T cell receptor beta variable 28"	A0A5B6	7	142720660-142721160	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"lymphoid tissue: 199.4"	"Cell type enriched"	"Detected in some"	12	"T-cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 154.5"	"Lineage enriched"	"Detected in many"	79	"T-cells: 154.5"	"Cell line enriched"	"Detected in single"	30	"JURKAT: 23.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.34e-3)"	"prognostic favorable (1.52e-4)"	"unprognostic (1.94e-3)"	"prognostic favorable (2.48e-5)"	"unprognostic (5.54e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.76e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.47e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.48e-8)"	"unprognostic (1.27e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-3)"	0.5	0.9	0.0	9.3	0.2	3.0	2.1	0.2	0.2	1.2	0.0	2.6	3.4	0.6	0.3	1.3	0.3	2.9	0.5	0.0	0.0	0.5	1.9	3.5	24.8	0.0	0.0	0.5	0.2	0.0	0.1	0.1	0.0	0.7	1.7	0.0	1.3	0.3	0.2	0.1	4.0	0.3	0.0	9.5	2.0	0.4	0.0	199.4	0.5	0.6	33.8	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	3.8	0.0	26.1	0.5	94.5	80.1	0.1	0.2	98.1	53.3	1.9	1.6	0.1	0.4	154.5	34.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.6	0.0
TRBV29-1	"TCRBV29S1, TCRBV4S1A1T, TRBV291"	ENSG00000232869	"T cell receptor beta variable 29-1"	A0A5B7	7	142740206-142740894	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 98.5"	"Cell type enriched"	"Detected in single"	11	"T-cells: 4.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	44	"MAIT T-cell: 45.1;memory CD4 T-cell: 128.6;memory CD8 T-cell: 83.2;naive CD4 T-cell: 137.8;naive CD8 T-cell: 110.8;T-reg: 178.2"	"Lineage enriched"	"Detected in many"	69	"T-cells: 178.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"prognostic favorable (1.23e-4)"	"unprognostic (9.31e-4)"	"unprognostic (1.29e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.47e-4)"	"unprognostic (6.84e-3)"	"unprognostic (1.71e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	0.8	0.3	0.0	6.5	0.0	4.4	1.2	0.3	0.1	1.4	0.1	1.9	2.7	0.6	0.0	1.0	0.3	2.6	0.2	0.0	0.0	0.4	1.2	1.5	21.7	0.0	0.0	0.6	21.2	0.0	0.1	0.0	0.0	0.7	2.0	0.0	0.7	0.6	0.1	0.4	3.9	1.2	0.0	5.4	2.3	0.1	0.0	98.5	0.6	0.5	23.4	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	0.7	0.1	45.1	2.0	128.6	83.2	0.1	1.8	137.8	110.8	2.5	0.2	0.3	0.7	178.2	51.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0
TRBV3-1	"TCRBV3S1, TCRBV9S1A1T, TRBV31"	ENSG00000237702	"T cell receptor beta variable 3-1"	A0A576	7	142308542-142309048	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	22	"lymphoid tissue: 51.1"	"Group enriched"	"Detected in some"	22	"Plasma cells: 10.1;T-cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 52.4;memory CD8 T-cell: 45.9;naive CD4 T-cell: 71.6;naive CD8 T-cell: 117.4;T-reg: 99.6"	"Lineage enriched"	"Detected in many"	32	"T-cells: 117.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (7.98e-5)"	"unprognostic (2.38e-3)"	"unprognostic (5.19e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.26e-2)"	0.4	0.0	0.0	5.3	0.0	1.9	0.4	0.0	0.1	0.3	0.0	0.9	0.5	0.3	0.1	0.3	0.3	1.2	0.2	0.0	0.0	0.1	0.2	0.8	10.7	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	1.0	0.0	0.8	0.2	0.0	0.2	2.2	0.2	0.0	2.7	1.0	0.0	0.0	51.1	0.3	0.1	10.4	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.1	0.3	1.8	0.1	16.6	0.2	52.4	45.9	0.1	0.1	71.6	117.4	2.0	0.4	0.1	0.4	99.6	29.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0
TRBV4-1	"BV07S1J2.7, TCRBV4S1, TCRBV7S1A1N2T, TRBV41"	ENSG00000211710	"T cell receptor beta variable 4-1"	A0A577	7	142313184-142313666	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 115.0"	"Cell type enriched"	"Detected in some"	7	"T-cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 176.7"	"Lineage enriched"	"Detected in many"	89	"T-cells: 176.7"	"Cell line enriched"	"Detected in single"	8	"U-266/84: 1.5"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.58e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (6.71e-5)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.99e-2)"	0.5	0.0	0.0	7.1	0.1	2.6	0.7	0.0	0.2	0.8	0.0	0.8	0.1	0.2	0.7	1.1	0.9	0.8	0.1	0.0	0.0	0.4	0.4	0.7	15.3	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.8	0.0	0.2	0.0	0.1	0.2	4.3	0.4	0.1	4.1	2.3	0.1	0.0	115.0	0.3	0.0	10.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.0	0.2	0.1	2.5	0.1	40.2	0.1	69.8	167.3	0.0	0.2	152.1	152.7	1.9	0.8	0.4	0.8	176.7	43.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0
TRBV4-2	"TCRBV4S2, TCRBV7S3A2T, TRBV42"	ENSG00000211745	"T cell receptor beta variable 4-2"	A0A539	7	142345421-142345985	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 21.0"	"Cell type enriched"	"Detected in some"	8	"T-cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 100.2"	"Lineage enriched"	"Detected in single"	293	"T-cells: 100.2"	"Not detected"	"Not detected"																	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (2.89e-3)"	"unprognostic (4.65e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.05e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.82e-4)"	"unprognostic (5.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.48e-2)"	0.2	0.0	0.0	1.4	0.0	0.6	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.3	0.2	0.4	5.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.1	0.0	2.3	0.3	0.5	0.0	21.0	0.3	0.0	4.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	100.2	0.0	25.6	27.8	0.1	0.0	23.9	14.4	0.1	0.0	0.2	0.3	44.8	8.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	23.9	0.0	0.0	0.0
TRBV5-4	"TCRBV5S4, TCRBV5S6A3N2T, TRBV54"	ENSG00000230099	"T cell receptor beta variable 5-4"	A0A0C4DH59	7	142462916-142463581	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"lymphoid tissue: 22.1;pancreas: 11.6"	"Group enriched"	"Detected in some"	9	"Plasma cells: 6.1;T-cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 115.7"	"Lineage enriched"	"Detected in many"	115	"T-cells: 115.7"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 11.1"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (6.48e-3)"	"unprognostic (6.75e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.76e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.64e-2)"	0.2	0.1	0.0	2.4	0.2	1.2	0.1	0.0	0.0	0.2	0.0	0.7	0.8	0.0	0.1	0.3	0.1	0.5	0.3	0.0	0.0	0.1	0.2	0.4	8.2	0.2	0.0	0.0	11.6	0.0	0.0	0.0	0.2	0.2	1.0	0.7	0.5	0.0	0.2	0.3	1.1	0.0	0.0	2.2	1.0	0.2	0.0	22.1	0.2	0.0	8.1	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.3	0.0	0.0	0.5	0.0	0.2	0.2	0.0	1.3	0.1	2.1	0.0	49.7	26.7	0.0	0.1	62.8	36.4	1.0	0.1	0.1	0.1	115.7	18.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0
TRBV5-5	"TCRBV5S3A2T, TCRBV5S5, TRBV55"	ENSG00000211725	"T cell receptor beta variable 5-5"	A0A597	7	142482548-142483019	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	23	"lymphoid tissue: 18.6"	"Cell type enriched"	"Detected in single"	23	"T-cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.0;naive CD4 T-cell: 38.6;naive CD8 T-cell: 29.0;T-reg: 41.9"	"Lineage enriched"	"Detected in many"	30	"T-cells: 41.9"	"Not detected"	"Not detected"																	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (4.96e-5)"	"unprognostic (4.74e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-4)"		"unprognostic (2.84e-3)"	"unprognostic (9.58e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.27e-4)"	"unprognostic (7.42e-2)"	"unprognostic (8.32e-3)"	"unprognostic (9.06e-2)"		0.1	0.0	0.2	1.8	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.5	0.0	0.8	18.6	0.1	0.0	4.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.6	0.0	0.8	0.0	36.7	28.0	0.1	0.1	38.6	29.0	0.8	0.0	0.1	0.0	41.9	11.3	0.2	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
TRBV5-6	"TCRBV5S2, TCRBV5S6, TRBV56"	ENSG00000211728	"T cell receptor beta variable 5-6"	A0A599	7	142500028-142500534	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	19	"lymphoid tissue: 33.8"	"Group enriched"	"Detected in some"	21	"Early spermatids: 13.5;Late spermatids: 14.6;T-cells: 3.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory CD4 T-cell: 40.2;memory CD8 T-cell: 22.9;naive CD4 T-cell: 35.9;naive CD8 T-cell: 45.2;T-reg: 66.0"	"Lineage enriched"	"Detected in many"	56	"T-cells: 66.0"	"Not detected"	"Not detected"																	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (6.27e-3)"	"unprognostic (8.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.45e-4)"	"unprognostic (5.72e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.26e-7)"	"unprognostic (7.62e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.34e-1)"	0.2	0.0	0.0	2.1	0.0	0.7	0.3	0.0	0.1	0.5	0.0	0.6	0.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.8	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.3	0.0	0.2	1.1	0.1	0.0	1.9	0.4	1.7	0.0	33.8	0.1	0.1	5.8	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.0	3.0	0.1	40.2	22.9	0.1	0.1	35.9	45.2	1.1	0.0	0.1	0.2	66.0	17.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0
TRBV6-2	"TCRBV13S2A1T, TCRBV6S2, TRBV62"	ENSG00000283063	"T cell receptor beta variable 6-2"	"A0A0J9YXY3, P0DPF7"	7	142349152-142349664	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 8.2"	"Cell type enriched"	"Detected in single"	10	"T-cells: 6.2"					"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 92.1"	"Lineage enriched"	"Detected in single"	175	"T-cells: 92.1"	"Not detected"	"Not detected"																	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"																					0.2	0.0	0.0	2.4	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.5	8.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	2.3	0.2	0.0	0.0	4.6	0.3	0.0	5.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	92.1	0.2	24.0	26.4	0.0	0.0	21.7	17.5	0.5	0.0	0.1	0.1	40.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0
TRBV6-6	"TCRBV13S6A2T, TCRBV6S6, TRBV66"	ENSG00000211724	"T cell receptor beta variable 6-6"	A0A0A6YYG2	7	142469537-142470013	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 14.7"	"Cell type enriched"	"Detected in single"	37	"T-cells: 3.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 81.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 81.4"	"Cell line enriched"	"Detected in some"	10	"HL-60: 10.4"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.69e-4)"	"unprognostic (3.82e-4)"	"unprognostic (3.66e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.93e-5)"	"unprognostic (4.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.01e-2)"	0.2	0.0	0.0	2.7	0.1	0.8	0.5	0.0	0.1	0.1	0.0	0.8	0.8	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.9	5.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.1	1.6	0.0	0.0	0.1	1.2	0.1	0.0	2.9	0.8	0.0	0.0	14.7	0.2	0.0	10.6	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.5	0.3	14.7	0.0	34.6	47.9	0.0	0.1	48.9	21.3	0.8	0.1	0.2	0.2	81.4	12.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
TRBV7-3	"TCRBV6S1A1N1, TCRBV7S3, TRBV73"	ENSG00000211714	"T cell receptor beta variable 7-3"		7	142384329-142384841	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.9;testis: 2.7"	"Group enriched"	"Detected in some"	9	"Early spermatids: 32.5;Late spermatids: 39.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 31.9"	"Lineage enriched"	"Detected in single"	48	"T-cells: 31.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.4;HBF TERT88: 2.3;HL-60: 1.6;RPTEC TERT1: 7.4;U-937: 3.8"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (3.78e-3)"	"unprognostic (5.75e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.28e-4)"	"unprognostic (4.17e-3)"	"unprognostic (2.34e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.49e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.10e-1)"	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.6	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.0	0.0	1.9	0.2	2.7	0.0	6.9	0.2	0.0	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.6	0.0	1.9	0.1	3.6	0.0	31.9	7.8	0.5	0.6	7.3	9.9	0.0	0.0	0.0	0.4	16.4	5.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	3.7	0.1	0.0	0.0
TRBV7-4	"TCRBV6S8A2T, TCRBV7S4, TRBV74"	ENSG00000253409	"T cell receptor beta variable 7-4"	A0A1B0GX95	7	142455174-142455635	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	17	"lymphoid tissue: 25.5;pancreas: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enriched"	"Detected in some"	7	"HL-60: 90.9"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (8.71e-5)"	"unprognostic (4.23e-3)"				"unprognostic (7.05e-5)"		"unprognostic (8.94e-4)"		"unprognostic (2.75e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.97e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.93e-3)"		0.0	0.0	0.0	0.6	0.1	1.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	3.5	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	25.5	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	90.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	1.0	0.6	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	2.9	0.5	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
TRBV7-6	"TCRBV6S3A1N1T, TCRBV7S6, TRBV76"	ENSG00000211727	"T cell receptor beta variable 7-6"	A0A1B0GX31	7	142492132-142492673	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 35.3"	"Group enriched"	"Detected in some"	15	"Gastric mucus-secreting cells: 5.1;T-cells: 7.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	22	"memory CD4 T-cell: 54.7;memory CD8 T-cell: 42.7;naive CD4 T-cell: 62.0;naive CD8 T-cell: 37.2;T-reg: 86.1"	"Lineage enriched"	"Detected in many"	52	"T-cells: 86.1"	"Not detected"	"Not detected"																	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (4.74e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.25e-5)"	"unprognostic (4.86e-3)"	"unprognostic (4.06e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.83e-5)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.86e-5)"	"unprognostic (1.83e-1)"	"unprognostic (7.27e-2)"	"unprognostic (5.90e-2)"	"unprognostic (6.22e-3)"	0.1	0.0	0.5	3.7	0.3	1.3	0.2	0.2	0.4	0.1	0.1	0.6	0.0	0.1	5.3	1.7	0.1	1.4	0.0	0.5	0.2	0.1	0.4	0.8	6.9	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.6	0.0	0.4	0.3	0.0	0.3	1.1	0.0	0.4	3.7	1.1	0.5	1.0	35.3	0.2	0.0	7.6	2.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	2.5	0.1	54.7	42.7	0.1	0.3	62.0	37.2	1.6	0.1	0.1	0.1	86.1	17.1	0.5	0.3	0.2	0.4	0.5	0.2	0.5	0.3	0.3	0.4	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0
TRBV9	"TCRBV1S1A1N1, TCRBV9S1"	ENSG00000211716	"T cell receptor beta variable 9"	A0A0B4J1U6	7	142391891-142392412	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.1;testis: 2.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 5.8;Late spermatids: 4.8;T-cells: 7.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 20.0;memory CD8 T-cell: 21.7;naive CD4 T-cell: 14.8;naive CD8 T-cell: 13.2;T-reg: 27.2"	"Lineage enriched"	"Detected in single"	31	"T-cells: 27.2"	"Group enriched"	"Detected in some"	16	"HL-60: 3.4;LHCN-M2: 6.0;U-937: 13.3"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (7.28e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.58e-4)"	"unprognostic (8.88e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.60e-10)"	"unprognostic (1.04e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.46e-3)"	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.3	0.0	0.4	0.2	0.4	0.0	0.6	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.3	0.0	0.1	2.1	0.0	0.0	3.0	0.6	2.6	0.0	9.1	0.4	0.4	2.9	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	13.3	0.0	0.1	0.8	0.0	0.2	0.2	2.5	0.0	20.0	21.7	0.5	0.0	14.8	13.2	0.1	0.0	0.0	0.4	27.2	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0
TRDC		ENSG00000211829	"T cell receptor delta constant"		14	22462932-22465787	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 404.4"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 746.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 19.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	87	"gdT-cell: 5873.4;NK-cell: 2243.9"	"Group enriched"	"Detected in all"	150	"NK-cells: 2243.9;T-cells: 5873.4"	"Cell line enriched"	"Detected in some"	38	"NB-4: 356.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.21e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.67e-5)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.99e-2)"	13.4	0.4	1.3	7.8	1.0	26.2	3.8	1.4	1.4	2.9	0.6	8.9	3.9	7.6	2.1	2.0	4.1	7.9	2.7	2.0	0.9	1.1	11.1	11.6	22.7	0.9	1.2	1.9	0.2	0.4	0.7	2.8	0.8	1.0	7.5	0.0	4.6	1.2	1.6	1.3	5.6	2.2	0.7	54.2	2.0	2.7	0.9	404.4	1.8	1.3	18.3	4.6	0.9	1.3	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	356.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	3.1	0.9	1.4	0.0	0.0	0.1	3.2	4.8	2.3	5873.4	7.9	3.8	5.7	16.7	31.7	9.2	1.9	16.2	46.6	27.0	2243.9	5.5	7.1	27.5	1292.0	1.3	1.0	1.4	1.4	2.0	0.9	0.9	1.2	0.8	0.7	0.9	1.3	1.1	3.2	5.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.6	0.0	0.0	0.0	165.7	0.3	0.0	0.5	0.0	0.9	0.8	0.7	0.0	1.3	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	4.2	0.5	0.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	746.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	123.5	0.0	0.0	0.0
TRGV3	"TCRGV3, V1S3"	ENSG00000211699	"T cell receptor gamma variable 3"	P03979	7	38358512-38359162	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 12.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.8;Plasma cells: 2.6;T-cells: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 59.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 59.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.0;JURKAT: 12.1;Karpas-707: 28.9;U-266/84: 5.9"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (2.87e-2)"	"unprognostic (1.63e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.48e-3)"	"unprognostic (4.66e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.42e-2)"	0.6	0.3	0.1	1.3	0.1	2.8	0.5	0.1	0.2	0.7	0.1	1.8	1.0	0.6	0.0	0.5	0.6	3.9	0.3	0.1	0.3	0.4	0.7	1.4	12.4	0.7	1.3	0.1	0.2	0.3	0.2	1.0	0.4	1.3	1.9	0.0	1.1	0.4	0.1	0.3	3.1	0.7	0.5	7.6	1.3	0.5	0.5	9.3	0.4	0.0	8.9	2.0	0.3	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	3.8	12.1	0.7	28.9	0.0	0.2	0.0	1.4	0.2	0.0	0.0	1.5	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.1	0.8	0.0	0.0	0.0	0.1	3.0	5.9	0.4	0.1	1.6	0.0	0.1	1.6	0.0	59.0	0.7	50.1	3.4	11.0	34.0	5.7	1.8	9.4	27.6	0.1	11.4	2.2	11.1	6.3	8.0	0.1	0.1	0.1	0.2	0.1	0.3	0.7	1.3	0.4	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
TRGV4	"TCRGV4, V1S4"	ENSG00000211698	"T cell receptor gamma variable 4"	A0A0C4DH28	7	38353715-38354517	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.1"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 2.7;Plasma cells: 2.1;T-cells: 2.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 97.8"	"Lineage enriched"	"Detected in many"	15	"T-cells: 97.8"	"Cell line enriched"	"Detected in some"	4	"Karpas-707: 72.0"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (7.44e-3)"	"unprognostic (7.26e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.75e-3)"	"unprognostic (9.66e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.71e-3)"	0.4	0.4	0.2	0.4	0.2	3.0	0.4	0.3	0.2	0.3	0.8	1.6	0.4	0.4	0.2	0.4	0.5	2.2	0.2	0.2	0.2	0.4	1.4	1.7	11.1	0.8	1.2	0.1	0.1	0.1	0.2	0.4	0.5	1.9	1.4	0.0	0.9	0.3	0.1	0.5	3.5	0.3	0.4	9.0	1.6	0.7	0.9	7.1	0.4	0.0	4.9	0.8	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	13.9	0.1	8.3	0.0	0.0	0.0	4.9	0.5	0.0	0.0	0.0	0.0	0.0	0.1	8.3	4.6	72.0	0.1	0.2	0.0	16.8	0.4	0.0	0.1	0.6	0.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.2	0.0	0.0	0.0	2.7	1.9	0.0	1.1	14.5	0.0	0.2	1.5	0.1	97.8	0.3	30.1	1.0	4.4	26.8	1.7	0.6	2.0	23.8	0.6	6.5	0.1	5.8	1.4	7.2	0.2	0.2	0.3	0.2	0.2	0.2	0.8	1.2	0.5	0.4	0.9	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0
TRGV8	"TCRGV8, V1S8"	ENSG00000211696	"T cell receptor gamma variable 8"	A0A0C4DH27	7	38330343-38330935	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.8;prostate: 4.9"	"Cell type enriched"	"Detected in some"	4	"T-cells: 12.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.1"	"Group enriched"	"Detected in many"	6	"gdT-cell: 34.4;MAIT T-cell: 40.6;memory CD8 T-cell: 31.1;naive CD8 T-cell: 17.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 40.6"	"Cell line enriched"	"Detected in some"	4	"JURKAT: 44.9"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"																					0.3	0.3	0.3	1.5	0.0	0.7	0.3	0.0	0.2	0.4	0.0	0.8	0.8	0.7	0.6	0.6	0.9	1.2	0.3	0.5	0.1	0.2	1.4	2.3	3.5	1.0	3.1	0.3	0.3	0.1	0.0	1.4	1.0	4.9	1.2	0.0	0.3	0.4	0.1	0.0	1.9	0.9	0.2	6.8	0.7	0.4	0.4	4.5	0.2	0.0	2.0	1.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	2.4	0.1	0.5	0.0	0.0	0.9	0.0	0.3	0.2	0.0	0.0	0.0	2.1	3.1	0.0	1.4	0.0	0.0	0.0	3.6	0.5	0.0	0.0	1.2	0.0	0.0	0.0	44.9	1.0	2.5	0.0	0.7	0.0	1.7	0.0	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	2.7	10.6	0.0	0.0	0.7	0.0	34.4	0.1	40.6	0.0	3.7	31.1	0.9	0.0	0.2	17.2	0.2	5.5	0.1	0.2	0.1	4.5	0.3	0.0	0.0	0.2	0.5	0.1	1.0	3.1	1.0	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.0
TRIL	KIAA0644	ENSG00000255690	"TLR4 interactor with leucine rich repeats"	Q7L0X0	7	28953358-28958330	"Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.0"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 72.1"	"Cancer enhanced"	"Detected in many"		"glioma: 20.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 22.2;SH-SY5Y: 40.0;SK-BR-3: 35.7;T-47d: 15.8"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.26e-3)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (4.27e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.07e-2)"	4.7	2.3	40.8	0.6	61.3	0.0	4.1	57.4	35.0	2.9	7.3	2.0	2.0	3.6	1.7	2.4	2.3	1.0	4.3	32.5	40.8	5.9	0.6	2.6	0.4	58.2	65.2	1.6	0.5	0.8	1.6	1.1	46.1	1.9	1.8	1.0	8.2	1.4	3.1	1.9	2.4	3.4	49.7	2.6	2.3	0.5	68.0	0.4	2.9	0.7	0.3	2.3	3.5	35.9	0.0	0.0	22.2	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	6.1	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.8	40.0	0.1	35.7	0.0	3.2	15.8	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	61.3	57.4	35.0	32.5	40.8	58.2	65.2	46.1	49.7	68.0	35.9	7.0	12.8	5.3	72.1	0.0	0.0	0.2	0.0	4.0	0.4	7.4	11.0	2.7	0.0	0.6	1.8	0.0	0.2	0.0	0.1	3.9	0.1	0.0	0.4	0.2	4.3	0.0	0.0	0.7	0.0	1.9	15.9	0.0	1.1	0.0	0.2	2.5	0.4	0.1	6.7	0.6	0.4	0.0	0.0	0.0	0.2	1.2	0.5	0.0	5.6	0.0	17.1	0.0	13.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	1.8	0.0	0.8	13.1	15.2	4.9	0.5	0.7	2.2	0.0	0.1	0.1	2.0	0.8	0.1
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689697-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 135.9;dendritic cells: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"	54.0	21.3	13.1	101.3	18.8	90.3	50.7	16.3	23.7	42.7	25.5	36.0	25.2	50.6	70.2	37.1	49.3	78.6	22.6	14.7	16.5	21.2	72.5	83.4	139.0	17.9	16.7	60.3	17.2	8.0	12.6	21.5	16.7	43.3	53.4	11.0	65.4	52.6	13.4	18.1	53.4	52.1	17.7	143.1	39.5	15.4	12.8	101.2	21.7	40.6	120.7	61.6	22.6	29.3	2.8	1.2	13.9	2.4	88.6	174.6	5.0	53.3	93.9	89.8	209.9	1.7	8.6	111.9	13.0	80.2	20.6	10.5	34.0	56.4	10.7	2.0	0.0	6.4	5.6	1.4	107.8	18.2	11.4	190.6	54.3	18.7	9.6	124.5	128.7	1.0	2.3	4.7	111.6	1.5	54.1	16.9	40.3	0.5	4.9	62.6	3.4	2.3	51.1	14.9	1.4	2.7	4.5	4.5	2.1	56.8	4.5	17.9	153.6	56.4	29.8	2.5	2.4	4.9	4.4	11.2	67.7	28.9	7.2	108.7	118.5	79.6	109.0	143.3	145.9	149.4	118.4	117.2	138.7	158.2	106.5	102.7	103.1	61.3	181.1	177.0	197.9	181.9	13.1	18.8	16.3	23.7	14.7	16.5	17.9	16.7	16.7	17.7	12.8	29.3	54.4	67.3	57.7	2.0	135.9	12.6	17.0	42.5	56.3	0.5	17.7	14.0	6.0	7.2	60.5	29.5	0.0	1.5	113.9	4.7	5.9	11.2	0.3	16.1	27.0	40.5	4.2	16.8	4.9	8.0	4.7	36.2	20.9	23.8	17.7	5.4	33.5	4.3	18.7	1.7	0.3	9.0	30.5	87.1	46.6	2.0	36.1	67.8	5.4	52.5	59.0	6.4	83.4	1.0	0.5	5.4	6.3	30.1	18.8	9.9	4.4	3.3	52.5	1.0	13.1	35.1	24.4	0.6	0.3	14.1	8.7	2.3	89.3	13.0	5.0	18.8
TRIM46	"FLJ23229, TRIFIC"	ENSG00000163462	"Tripartite motif containing 46"	Q7Z4K8	1	155173787-155184971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.9;Early spermatids: 6.5;Excitatory neurons: 13.1;Inhibitory neurons: 9.7;Late spermatids: 7.5;Oligodendrocytes: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055583	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA055583: AB_2732599"	"unprognostic (1.06e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (2.61e-7)"	"unprognostic (1.75e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.65e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-12)"	"unprognostic (8.58e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-2)"	0.6	0.4	8.3	0.5	9.2	0.3	0.5	8.4	10.1	1.1	4.0	0.8	0.3	3.1	3.3	0.4	2.3	0.4	0.3	9.4	7.6	0.6	0.1	0.5	0.5	7.3	6.3	0.3	0.5	0.1	4.9	0.1	7.5	1.1	0.1	1.1	0.4	0.8	0.1	0.3	0.7	0.9	6.2	1.0	1.0	1.9	7.9	1.1	0.3	0.0	0.2	0.5	0.9	8.8	1.7	2.2	1.5	0.1	0.3	1.3	0.1	1.6	1.7	1.9	2.2	0.0	0.8	0.7	1.1	2.0	0.4	1.8	0.0	0.7	0.6	3.9	0.7	1.3	2.6	0.1	0.8	0.4	4.1	1.4	0.4	2.0	0.7	4.5	2.5	4.1	0.0	3.2	1.0	1.1	2.4	0.2	5.7	0.2	2.3	4.1	0.1	0.8	0.3	0.0	3.9	9.3	0.7	0.5	1.2	0.6	2.8	3.4	3.7	3.8	1.2	0.2	0.8	3.2	1.2	0.7	4.0	0.6	1.1	0.4	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.1	8.3	9.2	8.4	10.1	9.4	7.6	7.3	6.3	7.5	6.2	7.9	8.8	0.2	0.0	0.0	1.0	0.3	0.4	0.8	0.2	0.0	6.9	2.9	1.8	1.1	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.7	6.5	2.9	0.4	0.7	1.8	0.8	13.1	0.2	0.0	0.8	1.5	3.9	0.0	0.1	0.4	0.0	0.8	0.0	9.7	0.0	0.0	0.0	1.0	7.5	0.3	0.2	0.0	0.0	2.6	0.6	2.1	3.0	9.8	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.6	0.0	1.4	0.9	1.3	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.8
TRIQK	"C8orf83, DKFZp779L1068, LOC286144, PRO0845"	ENSG00000205133	"Triple QxxK/R motif containing"	Q629K1	8	92883532-93017673	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 32.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.47e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.13e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.23e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-2)"	12.8	21.9	12.3	7.7	15.7	14.5	14.5	18.6	14.9	19.4	10.5	20.7	12.4	12.5	9.7	9.8	15.7	22.9	20.1	13.7	13.5	19.4	31.3	17.0	5.3	13.4	12.6	19.6	18.0	20.6	10.7	19.6	14.0	18.1	21.0	12.4	11.1	10.2	2.4	5.7	12.1	11.4	14.2	13.2	17.5	6.5	13.5	7.3	23.4	5.6	5.2	15.5	7.9	17.0	7.4	9.2	19.8	7.0	27.1	42.8	6.6	26.4	28.4	14.7	20.9	1.3	22.9	0.0	31.6	24.9	9.8	11.9	16.1	15.9	23.7	0.0	7.6	28.9	10.1	15.6	22.9	8.1	24.0	32.0	35.4	8.0	27.1	33.3	15.7	16.3	5.6	16.7	21.3	19.7	13.1	6.3	6.8	31.3	33.8	0.0	20.5	9.6	27.8	9.1	11.4	16.0	10.0	3.9	25.6	16.3	27.2	7.1	20.5	21.8	6.7	38.3	8.3	5.8	0.0	0.0	33.8	0.1	22.5	0.9	17.0	15.9	0.1	18.8	8.1	2.8	0.9	0.7	9.4	1.9	0.0	0.0	14.6	2.0	32.9	2.5	0.2	4.7	12.3	15.7	18.6	14.9	13.7	13.5	13.4	12.6	14.0	14.2	13.5	17.0	19.0	19.2	17.9	21.9	4.0	15.0	21.4	17.1	22.8	18.9	17.7	12.4	13.8	25.8	14.1	16.5	6.2	7.3	2.1	16.2	50.9	14.8	7.0	21.3	27.7	17.8	19.2	6.7	36.8	16.4	23.8	23.5	20.9	24.5	2.5	11.7	17.2	18.3	11.9	6.7	43.6	35.6	12.2	20.0	13.6	8.0	16.4	18.5	23.2	31.9	24.3	22.8	3.1	34.7	56.3	12.5	14.0	21.8	1.0	22.2	17.0	39.1	29.5	6.3	32.9	18.4	18.2	12.1	5.3	12.3	8.4	3.7	3.3	21.6	20.0	22.6
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Calcium channel, Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.2;brain: 26.4;lymphoid tissue: 18.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.7;Hofbauer cells: 18.3;Inhibitory neurons: 45.1;Macrophages: 16.7;Microglial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.8;plasmacytoid DC: 15.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 41.7;NB-4: 58.6;OE19: 41.3;THP-1: 71.3;U-266/84: 31.8;U-937: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035260	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035260: AB_2674540"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favorable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favorable (7.59e-4)"	4.8	4.1	14.0	6.7	14.5	28.2	3.0	11.1	26.4	2.1	7.7	3.8	3.6	1.6	0.7	1.6	2.1	4.7	1.8	13.9	11.8	2.5	2.3	5.0	8.0	20.9	14.5	0.9	1.8	1.1	4.8	6.0	20.8	2.7	2.3	0.9	2.3	0.8	0.9	2.3	6.9	2.5	12.2	18.4	2.5	2.7	16.0	3.3	1.8	0.4	4.1	3.5	1.6	17.4	20.8	7.5	0.0	0.1	0.0	0.0	20.9	0.0	0.0	0.6	0.4	0.0	0.0	0.5	24.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.9	0.0	0.0	41.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	6.7	58.6	0.0	41.3	23.5	2.3	7.2	8.0	0.0	0.0	14.4	0.1	0.0	23.5	0.1	0.0	27.7	71.3	0.0	1.2	20.9	0.1	0.7	0.3	31.8	0.1	0.0	67.7	0.0	0.0	7.8	0.0	1.0	2.7	0.5	0.3	0.3	0.4	2.6	1.9	0.3	0.4	0.4	0.5	2.5	15.5	1.3	2.0	14.0	14.5	11.1	26.4	13.9	11.8	20.9	14.5	20.8	12.2	16.0	17.4	2.0	0.0	0.5	1.3	2.0	0.4	0.0	0.0	0.6	1.4	2.8	3.0	1.7	0.0	0.0	0.0	0.0	1.8	9.9	0.8	0.0	0.1	2.1	0.7	0.2	2.7	0.0	0.0	52.7	0.2	8.8	0.5	1.1	1.2	1.3	0.3	0.4	0.4	18.3	0.0	45.1	1.0	0.0	11.0	5.5	2.0	0.6	16.7	0.0	27.2	5.5	0.5	6.2	4.0	1.7	1.2	0.1	0.0	1.4	0.0	0.0	0.3	0.0	1.0	6.6	0.5	0.4	1.0	0.1	0.1	0.3	1.4	4.2	0.0	0.7	0.0
TSHZ2	"C20orf17, OVC10-2, TSH2, ZABC2, ZNF218"	ENSG00000182463	"Teashirt zinc finger homeobox 2"	Q9NRE2	20	52972358-53495330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 395.6;Leydig cells: 468.2;Peritubular cells: 803.8;Theca cells: 396.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 26.7;ASC diff: 11.3;HeLa: 23.6;SiHa: 15.3;U-2197: 13.7"	"Low region specificity"	"Detected in all"							HPA038123	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA038123: AB_10670657"	"unprognostic (9.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (3.30e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.88e-8)"	"unprognostic (6.26e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.37e-7)"	"unprognostic (2.97e-3)"	21.5	14.8	3.4	4.5	4.7	0.2	10.6	2.9	4.3	9.0	0.0	7.3	2.3	6.8	16.5	8.2	8.7	12.4	3.7	5.7	8.9	3.3	12.6	2.9	3.9	5.9	8.2	18.4	3.5	5.4	2.7	1.3	5.5	5.4	2.0	1.7	12.9	13.6	1.6	5.9	2.8	8.8	10.3	5.1	6.1	4.8	8.1	2.0	5.3	2.6	3.4	7.6	5.7	7.5	0.0	0.0	1.8	26.7	11.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.8	0.0	0.1	0.0	0.1	0.0	5.2	1.4	0.0	23.6	0.0	0.3	0.0	0.6	4.1	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.7	4.4	15.3	0.1	0.0	0.7	0.0	0.0	0.0	0.1	2.6	13.7	0.0	0.1	0.3	0.0	2.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.4	3.0	0.2	0.6	0.1	0.0	0.1	2.4	0.5	3.4	4.7	2.9	4.3	5.7	8.9	5.9	8.2	5.5	10.3	8.1	7.5	171.4	0.0	0.6	32.7	7.0	45.4	19.9	43.8	37.0	6.7	24.4	161.5	2.8	54.3	41.6	36.8	2.1	1.3	1.3	0.1	0.0	52.2	11.1	32.7	144.4	125.7	6.6	0.0	188.2	9.8	0.5	93.3	3.1	68.9	1.3	395.6	11.7	92.1	1.2	0.0	58.1	1.9	18.3	1.3	16.6	20.3	468.2	2.8	12.4	104.9	1.9	39.0	1.0	23.6	4.9	6.8	2.7	803.8	16.0	27.5	0.8	0.4	19.9	1.9	39.5	10.9	48.2	2.6	1.8	43.9	40.5	0.8	24.2	396.9	2.6	8.2
TSKS	"PPP1R161, TSSKS"	ENSG00000126467	"Testis specific serine kinase substrate"	Q9UJT2	19	49739753-49763306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"testis: 120.0"	"Group enriched"	"Detected in some"	46	"Early spermatids: 887.3;Late spermatids: 1022.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.1;testis cancer: 2.2"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"NB-4: 11.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA045729	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA045729: AB_10963430"	"unprognostic (3.56e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.51e-8)"	"unprognostic (7.89e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-2)"	1.1	0.1	0.2	0.1	0.2	0.5	0.9	0.8	0.3	0.8	0.1	0.2	0.0	0.9	0.0	0.3	1.0	0.3	1.5	0.2	0.2	0.1	0.2	0.4	0.4	0.1	0.2	0.3	0.2	0.0	0.0	0.9	0.2	0.4	0.0	0.1	0.3	0.1	0.3	1.8	0.2	0.1	0.1	0.5	0.2	120.0	0.2	0.3	0.7	0.0	0.1	0.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	11.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.8	0.0	0.4	0.0	0.0	0.0	1.0	0.7	0.7	0.2	0.2	0.2	0.8	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.1	2.0	0.0	0.0	3.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	887.3	1.0	0.5	0.7	0.0	0.8	0.4	0.0	8.6	1.9	0.0	0.1	0.0	0.2	0.4	0.0	2.5	0.0	0.3	0.0	0.0	1.3	0.4	1022.9	9.6	1.5	0.0	1.0	0.2	1.2	1.0	0.5	0.5	0.0	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.3	20.5	8.4	0.7	1.4	6.7	0.5	0.2	0.0	0.1
TSPAN11		ENSG00000110900	"Tetraspanin 11"	A1L157	12	30926428-30996602	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.9"	"Cell type enhanced"	"Detected in some"		"Hepatic stellate cells: 5.7;Inhibitory neurons: 5.7;Late spermatids: 10.6;Oligodendrocyte precursor cells: 27.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.2;HSkMC: 22.8;NTERA-2: 18.2;SCLC-21H: 9.7;SH-SY5Y: 18.6;SuSa: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066789			Approved	Vesicles		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA066789: AB_2685723"	"unprognostic (4.10e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.51e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.28e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.79e-1)"	2.5	2.1	5.5	7.5	5.1	0.0	1.9	9.3	5.0	6.5	0.8	25.9	3.9	1.7	5.8	3.5	1.9	7.1	6.5	5.0	3.9	1.0	0.7	3.4	2.2	4.5	5.7	0.8	1.1	0.1	1.0	0.7	3.7	4.1	8.8	1.4	2.4	4.8	0.4	5.6	9.6	6.4	2.3	2.4	3.8	1.0	6.3	0.8	3.1	1.2	4.1	4.5	3.6	4.8	0.0	0.3	25.2	0.0	0.1	0.3	0.2	0.3	0.8	0.0	0.0	0.0	0.8	0.0	1.4	2.2	0.1	0.6	0.3	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.1	22.8	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	18.2	0.0	0.2	0.1	0.1	0.5	0.0	0.1	9.7	18.6	0.2	0.0	0.1	11.2	0.0	0.0	0.0	0.1	1.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.1	9.3	5.0	5.0	3.9	4.5	5.7	3.7	2.3	6.3	4.8	0.6	0.0	0.0	3.6	0.0	0.8	0.0	0.0	0.0	1.7	0.1	0.0	2.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.5	2.4	3.3	0.0	0.0	1.5	0.0	0.0	4.3	0.0	0.4	0.0	0.2	5.7	0.2	0.1	0.0	5.7	0.0	0.0	0.0	1.7	10.6	4.7	0.2	1.8	1.0	0.0	3.6	0.0	27.2	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.9	0.5	0.0	0.3	1.1	0.2	0.5	0.1	1.1	0.0	0.2	0.1	0.0	0.1
TTC16	FLJ32780	ENSG00000167094	"Tetratricopeptide repeat domain 16"	Q8NEE8	9	127716079-127731590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"fallopian tube: 6.9;testis: 16.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 103.1;Late spermatids: 258.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (3.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-4)"	"unprognostic (4.08e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.87e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.35e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.54e-3)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.2	0.0	6.9	0.1	0.0	0.1	0.1	0.1	0.0	0.7	0.4	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	1.0	0.0	0.5	1.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.6	0.2	0.2	0.1	0.1	0.1	0.0	0.6	0.0	0.4	0.1	0.1	1.0	0.0	0.0	0.2	0.1	0.8	1.5	5.7	0.0	0.0	0.0	13.7	0.0	0.0	0.0	103.1	6.0	0.1	0.5	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.3	0.0	258.3	1.2	0.3	1.8	0.0	0.3	0.2	9.2	4.5	0.1	0.0	0.0	3.8	2.6	0.0	0.0	0.4	41.8	0.5	0.0	0.1	0.4	17.9	1.6	0.0	0.0	0.0	7.4	3.8	0.0	0.1
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	45.8	29.3	28.1	27.1	25.0	26.4	43.1	36.3	35.3	59.3	45.7	34.6	24.7	38.9	58.6	27.9	34.9	35.4	28.0	38.9	15.5	37.7	31.7	24.4	29.4	10.0	11.1	60.6	42.9	39.1	35.6	29.0	11.8	51.2	36.3	63.0	50.0	41.4	27.7	30.7	30.3	34.6	6.7	27.3	40.9	27.4	15.3	38.0	64.8	30.6	29.2	30.6	9.4	21.4	72.9	25.4	115.3	22.2	108.9	156.8	40.0	77.5	96.0	34.2	46.1	34.0	35.8	62.3	26.6	130.9	32.1	23.3	35.3	47.9	48.2	66.3	25.0	125.6	38.0	44.1	39.6	70.9	39.1	81.9	28.8	35.0	31.0	68.8	51.6	54.1	77.3	71.1	65.2	56.0	69.4	18.8	33.3	48.0	42.6	91.6	55.3	33.2	39.4	55.3	87.7	67.6	97.2	55.2	49.1	26.5	62.2	27.3	68.3	49.2	19.5	61.2	30.4	71.1	55.1	60.6	80.7	69.9	37.9	4.8	6.2	6.8	11.5	6.4	17.1	13.0	13.3	15.8	10.8	15.1	23.2	14.4	1.0	12.8	8.6	17.3	10.0	4.8	28.1	25.0	36.3	35.3	38.9	15.5	10.0	11.1	11.8	6.7	15.3	21.4	78.3	125.0	142.7	161.3	144.8	65.9	94.8	102.7	86.0	347.7	175.8	140.1	134.7	68.6	118.2	75.4	227.2	50.1	129.5	67.8	166.3	91.1	192.7	115.0	217.4	78.9	190.2	65.4	424.5	75.3	93.5	171.0	131.5	132.0	64.6	256.8	99.6	94.4	61.4	329.7	396.0	163.1	99.7	95.2	83.7	192.4	210.0	86.8	211.7	111.5	87.4	196.5	93.7	321.7	261.9	73.3	96.5	261.1	167.6	121.4	72.8	96.1	108.6	233.9	52.6	245.8	127.9	400.0	258.4	91.7	62.8	52.7	109.7	204.1	148.1	103.9
TTC5	Strap	ENSG00000136319	"Tetratricopeptide repeat domain 5"	Q8N0Z6	14	20256558-20305960	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045008, HPA054198"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA045008: AB_10960209, HPA054198: AB_2682414"	"unprognostic (2.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.07e-2)"	2.1	2.8	2.8	1.8	2.8	2.9	3.8	2.2	3.1	3.1	4.8	2.2	2.1	3.1	3.2	2.2	5.7	2.2	1.8	2.6	3.1	3.5	1.4	2.5	3.2	2.1	2.7	3.0	1.9	6.1	2.1	2.4	2.1	3.8	2.3	2.6	2.3	3.0	0.7	3.4	1.6	2.9	2.1	2.4	2.4	2.5	4.3	2.6	4.9	2.3	3.1	2.3	1.7	2.2	3.4	5.4	6.5	0.7	4.7	6.8	3.5	4.3	5.0	6.4	6.6	2.4	7.6	7.2	2.7	4.5	3.3	2.8	6.4	3.0	9.8	6.3	2.4	5.9	2.2	4.3	4.8	11.0	3.5	4.2	6.7	5.6	7.2	5.8	6.3	5.1	4.3	3.5	6.3	4.6	6.5	4.6	5.5	5.6	5.2	3.4	4.8	5.2	5.6	3.5	2.2	4.3	4.9	5.1	3.0	2.6	4.0	5.3	6.6	2.5	4.1	3.4	2.3	5.0	4.7	8.9	2.0	4.6	6.0	1.3	2.0	2.9	2.7	2.0	2.3	2.7	2.0	2.2	2.2	3.0	2.1	2.5	0.8	3.0	2.9	1.6	2.7	2.0	2.8	2.8	2.2	3.1	2.6	3.1	2.1	2.7	2.1	2.1	4.3	2.2	13.9	12.8	7.2	6.5	15.2	6.4	9.4	21.5	13.6	15.5	9.4	12.8	4.3	12.8	9.8	18.4	16.7	20.4	12.2	2.3	11.7	10.6	1.6	27.7	13.4	12.3	9.0	6.7	18.2	6.5	12.4	12.5	8.6	7.9	12.0	16.0	10.8	6.4	15.4	5.0	12.4	6.9	18.3	11.2	6.8	3.4	10.2	10.5	7.2	6.5	11.5	12.4	19.6	11.6	8.7	6.4	5.0	9.8	7.8	4.6	8.6	13.1	32.8	19.4	6.6	14.1	11.6	26.6	36.1	8.8	8.7	4.7	12.7	14.6	8.3	5.3
TULP4	"KIAA1397, TUSP"	ENSG00000130338	"TUB like protein 4"	Q9NRJ4	6	158232236-158511828	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 32.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Oligodendrocytes: 544.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005445	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA005445: AB_1080421"	"unprognostic (6.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.65e-2)"	2.4	2.5	27.1	2.1	32.7	1.1	3.1	15.0	16.1	2.8	0.0	2.5	4.0	3.0	2.8	3.5	2.1	2.2	2.6	15.2	13.1	3.1	2.3	2.7	3.1	16.1	23.9	2.5	2.7	5.0	4.6	2.6	10.8	2.4	2.0	7.0	3.1	2.4	6.3	6.0	4.3	2.4	14.8	2.9	3.0	4.0	19.3	3.2	4.6	3.6	3.0	2.4	3.0	27.1	2.7	5.7	4.1	9.1	7.2	4.5	8.6	2.6	3.7	2.4	2.9	8.4	1.7	7.4	2.5	5.3	7.0	4.7	4.9	6.4	4.4	4.8	2.7	3.7	4.2	8.7	5.2	3.4	3.9	3.5	7.3	4.0	8.3	8.7	6.2	7.0	5.8	11.3	6.8	4.1	3.5	3.9	2.8	3.2	2.6	7.4	9.8	4.7	4.0	4.3	7.9	9.8	7.5	11.1	8.0	3.9	6.5	4.5	10.0	6.2	7.4	9.2	10.1	7.7	10.1	6.2	5.9	2.6	7.8	0.3	1.4	0.0	1.8	1.5	2.4	1.8	2.1	2.4	0.9	1.9	1.5	1.7	0.1	1.3	2.1	3.2	2.9	1.6	27.1	32.7	15.0	16.1	15.2	13.1	16.1	23.9	10.8	14.8	19.3	27.1	27.0	3.2	25.4	62.7	25.8	21.4	16.4	12.3	16.5	51.2	31.3	22.5	52.8	12.8	20.6	25.8	171.0	29.4	25.9	16.5	15.6	18.0	5.3	46.5	51.2	25.7	20.4	7.8	157.3	15.7	8.9	20.0	13.7	51.6	5.1	17.7	16.8	15.2	12.9	158.2	153.4	13.3	8.2	17.9	10.7	8.4	28.3	15.4	16.0	76.8	13.0	16.1	14.4	137.2	544.9	22.5	15.3	41.8	24.7	20.8	53.2	26.0	18.8	79.8	13.1	33.9	26.8	21.8	33.5	19.6	39.2	18.9	21.1	52.4	17.3	23.6
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.2;Peritubular cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"	No	No		3500000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	23.7	19.5	7.7	16.7	9.6	8.2	17.5	9.2	12.2	40.6	12.7	22.1	11.1	51.3	45.8	26.1	30.5	36.3	18.6	7.4	9.2	36.3	10.0	19.7	11.8	10.5	9.4	32.3	9.7	33.2	9.8	24.8	10.4	43.0	22.4	5.7	11.1	64.6	5.7	12.9	12.5	80.1	9.7	13.6	14.9	11.8	8.9	7.0	34.9	16.5	14.9	34.7	16.2	11.0	57.3	19.9	57.6	28.6	111.2	99.7	26.6	107.2	132.4	57.6	81.9	21.2	73.5	8.2	52.7	142.5	37.4	19.5	57.1	42.4	105.3	22.0	15.4	14.7	15.9	10.8	98.7	10.8	29.4	102.0	34.1	48.3	23.3	78.7	90.8	7.8	22.7	14.6	149.2	17.0	11.9	13.2	18.9	33.6	16.1	20.7	58.7	5.0	65.7	75.2	7.4	20.0	83.3	23.1	22.9	23.9	26.1	25.0	75.6	104.9	52.4	99.5	67.5	21.2	20.1	15.1	64.5	14.9	37.9	8.3	2.7	4.0	4.3	1.5	2.8	2.1	2.0	4.5	5.5	1.6	2.3	4.8	1.2	2.9	0.5	5.3	1.0	2.1	7.7	9.6	9.2	12.2	7.4	9.2	10.5	9.4	10.4	9.7	8.9	11.0	9.0	25.6	18.4	13.1	8.1	39.6	21.3	18.5	51.2	4.8	18.5	11.6	7.8	10.0	21.0	75.4	0.0	6.3	12.1	12.1	1.9	9.1	141.2	13.3	38.6	18.1	6.0	9.9	28.0	7.6	18.3	61.9	10.2	23.4	6.3	31.6	17.2	7.5	16.0	3.3	31.0	8.2	57.0	9.4	30.1	30.7	37.6	12.2	23.2	17.8	15.3	16.1	7.2	29.1	31.6	9.2	10.7	95.2	17.8	46.3	1.3	12.6	12.4	5.0	72.3	28.9	56.6	24.6	9.6	26.6	26.9	4.7	10.1	20.4	12.2	27.1
TXNDC16	KIAA1344	ENSG00000087301	"Thioredoxin domain containing 16"	Q9P2K2	14	52430596-52552522	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 69.8;Glandular and luminal cells: 124.9;Inhibitory neurons: 88.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002543	Approved		Approved	Mitochondria	"Secreted to blood"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA002543: AB_1079199"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.36e-1)"	"unprognostic (5.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.04e-1)"	6.2	4.0	4.6	3.5	4.6	5.1	6.9	10.1	6.0	9.3	0.6	5.8	4.1	6.9	14.6	3.7	4.1	5.2	3.7	4.9	4.3	5.0	7.4	4.4	4.5	3.9	4.0	10.3	6.4	7.0	3.8	5.8	4.3	26.7	5.9	9.1	4.0	13.0	2.0	4.6	4.8	4.3	4.0	10.2	6.3	7.1	4.1	5.9	4.0	4.0	3.9	3.4	3.8	6.7	8.3	0.8	8.9	5.0	6.5	4.7	7.0	2.7	3.6	4.5	8.7	3.0	6.6	13.5	8.9	2.2	2.8	7.7	10.3	3.7	6.9	5.7	13.5	6.2	6.2	2.8	4.7	7.4	2.9	8.8	3.4	5.8	4.2	4.0	5.1	5.8	8.0	20.4	3.9	4.0	9.3	5.1	9.9	5.5	4.9	18.4	16.9	12.4	5.7	8.4	29.0	10.0	13.2	13.5	3.9	7.5	8.6	5.4	2.7	6.0	3.0	6.9	4.6	5.6	8.0	13.5	1.7	7.7	3.5	1.3	3.0	1.2	1.3	2.4	1.3	0.5	1.3	0.9	2.6	0.3	0.6	0.6	1.7	0.6	2.9	1.0	2.4	1.0	4.6	4.6	10.1	6.0	4.9	4.3	3.9	4.0	4.3	4.0	4.1	6.7	9.1	9.6	6.4	23.2	6.1	6.6	6.0	2.5	9.6	42.3	26.6	19.0	10.1	8.6	5.0	7.3	8.4	2.3	15.1	8.8	1.9	5.2	4.0	69.8	9.6	7.4	18.5	21.8	61.0	3.9	1.6	7.2	13.3	124.9	2.5	13.9	15.4	14.1	3.3	10.1	88.8	17.9	0.0	18.8	8.6	4.2	27.7	13.0	1.8	24.4	5.9	7.3	7.2	45.8	51.5	1.3	8.5	52.3	11.3	19.0	5.9	2.8	4.4	44.8	0.0	11.1	11.2	12.0	9.5	8.1	8.4	1.1	7.7	5.7	10.9	4.5
TXNRD3	"TGR, TR2, TR2IT1, TRXR3, TXNRD3IT1, TXNRD3NB, TXNRD3NT1"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126571779-126655124	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 20.4"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	4.9	4.0	2.4	2.2	2.4	1.1	6.1	3.4	1.9	4.7	3.1	2.4	1.3	5.1	5.9	4.8	3.6	3.6	3.1	1.8	3.3	5.7	8.7	4.2	1.1	2.8	3.0	6.7	6.3	8.2	1.7	2.9	2.8	3.8	3.0	1.9	3.7	4.1	5.6	3.2	1.4	4.9	3.0	2.6	3.6	20.4	3.0	4.6	6.1	5.8	1.4	3.2	1.9	2.8	16.0	3.8	4.9	8.3	8.7	13.1	2.7	6.7	5.8	5.4	7.4	7.6	8.7	0.0	8.5	9.7	3.4	6.4	6.3	7.1	6.4	0.0	5.1	1.5	3.7	5.9	7.8	6.4	0.6	13.1	5.9	1.8	12.1	7.0	3.8	5.2	3.7	0.0	9.0	12.2	1.4	3.4	7.3	4.3	3.4	0.5	4.2	2.6	6.0	8.0	8.9	5.1	19.9	5.7	10.3	3.7	8.0	2.6	6.9	6.8	1.8	9.3	3.3	4.0	1.9	0.0	3.5	2.2	5.6	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	2.4	2.4	3.4	1.9	1.8	3.3	2.8	3.0	2.8	3.0	3.0	2.8	1.3	3.2	7.2	14.4	0.4	1.0	5.7	1.6	6.2	2.0	2.9	2.4	4.1	4.3	3.0	3.7	2.1	9.4	0.1	0.5	3.9	5.1	18.2	1.5	4.0	1.7	4.2	3.0	7.5	3.8	5.4	5.3	4.1	1.0	5.7	6.1	2.9	8.0	2.9	0.0	5.8	2.4	0.0	0.8	0.7	4.0	4.7	1.0	0.0	3.7	0.0	3.2	0.0	11.1	4.7	3.8	0.3	8.6	0.1	5.5	0.1	4.5	3.3	0.9	0.0	5.7	2.8	71.5	18.2	6.1	0.6	7.3	0.6	6.6	1.5	3.2
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 293.0;Cardiomyocytes: 175.1;Endothelial cells: 177.4;Microglial cells: 184.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 244.5;BJ hTERT+: 148.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503, HPA056006"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: "	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (1.03e-4)"	37.7	17.9	10.5	7.8	13.1	1.0	33.0	11.0	12.9	25.1	24.2	14.6	22.2	22.1	21.5	28.9	21.6	32.2	28.0	9.4	11.8	30.8	17.3	30.7	8.0	13.3	12.8	31.2	12.7	12.5	11.5	28.6	13.0	21.6	15.4	11.9	25.3	18.4	142.0	19.4	22.3	16.0	12.1	30.0	15.9	16.1	14.2	4.6	35.6	106.0	6.7	13.2	25.4	14.7	42.7	34.8	15.2	20.2	29.9	127.9	0.1	244.5	148.4	62.7	53.8	58.5	61.5	29.2	65.6	61.4	18.4	48.1	34.4	19.4	78.3	0.1	15.3	16.4	27.9	12.3	38.8	0.4	6.0	60.8	10.7	37.1	28.1	103.3	67.7	6.9	4.1	0.1	78.7	14.0	0.1	2.6	12.7	19.3	18.0	0.0	109.6	0.2	30.3	14.4	4.0	7.6	46.5	7.1	48.9	30.3	13.4	4.9	130.5	3.6	24.8	20.6	39.1	2.3	8.8	0.2	31.4	4.4	27.4	0.1	0.9	0.0	0.0	1.7	0.0	0.5	0.0	0.0	0.8	1.2	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3	10.5	13.1	11.0	12.9	9.4	11.8	13.3	12.8	13.0	12.1	14.2	14.7	293.0	6.4	6.4	31.6	5.4	11.3	14.6	13.7	10.2	6.3	22.2	33.3	175.1	18.6	19.2	49.7	4.2	1.0	2.1	66.5	3.9	49.0	21.0	75.3	46.3	177.4	9.1	3.0	0.9	48.7	1.9	81.6	33.6	53.0	15.2	34.9	47.5	18.8	9.6	25.2	0.7	33.1	6.1	24.3	8.6	15.2	125.2	15.8	30.2	184.6	9.5	49.4	2.1	6.0	62.0	78.8	35.7	141.1	0.8	21.8	45.3	5.0	61.9	4.2	52.6	53.5	96.2	46.4	35.2	16.4	13.1	1.0	2.9	62.7	24.2	10.9
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	29.1	29.0	28.0	27.6	30.3	32.4	32.6	42.8	41.7	33.5	14.0	33.5	22.9	32.9	29.5	32.9	29.9	24.5	40.6	31.0	28.2	32.6	42.2	24.9	33.3	22.3	23.6	37.1	27.2	38.4	15.3	28.4	24.0	31.8	28.9	32.8	23.3	28.4	109.2	26.8	29.5	30.9	19.9	26.9	26.1	45.6	28.1	41.7	41.5	92.0	34.2	32.8	20.0	29.2	55.9	33.6	77.7	46.1	45.0	56.4	38.4	84.8	54.8	59.9	55.6	76.0	27.6	103.4	61.2	68.2	57.8	51.2	106.8	62.2	75.2	54.1	32.7	85.8	49.0	43.1	65.5	107.0	60.2	60.6	56.2	58.3	71.6	60.0	47.6	87.0	89.0	71.1	95.1	32.3	84.0	29.1	50.3	62.1	46.6	88.6	117.8	45.6	51.7	91.1	80.0	59.6	72.1	72.1	102.1	51.3	57.9	56.7	59.2	102.1	84.7	52.1	64.5	77.5	103.4	139.5	60.4	56.6	55.3	14.4	12.7	17.2	17.0	11.2	19.9	17.3	18.5	20.8	16.7	22.8	20.8	18.7	2.2	29.6	22.3	15.2	15.8	9.7	28.0	30.3	42.8	41.7	31.0	28.2	22.3	23.6	24.0	19.9	28.1	29.2	56.6	96.1	80.5	112.6	74.7	71.1	83.8	40.6	84.2	82.7	59.5	42.3	175.3	42.9	58.7	38.6	56.3	52.3	74.3	43.3	19.6	51.6	139.4	53.6	75.2	58.7	68.7	64.3	187.7	49.6	49.6	64.1	52.5	63.8	62.8	84.1	44.3	58.6	46.0	80.8	196.3	55.0	12.2	60.9	41.1	61.6	56.8	64.4	53.4	87.1	53.3	54.5	54.6	126.2	124.4	59.8	41.5	64.7	95.7	102.8	51.4	50.3	59.4	59.2	78.9	119.0	80.5	146.1	88.3	78.3	90.6	74.0	63.3	65.7	52.6	98.6
UBTD2	"DC-UbP, MGC30022"	ENSG00000168246	"Ubiquitin domain containing 2"	Q8WUN7	5	172209646-172283764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.1;Late spermatids: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035891, HPA035892"	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA035891: AB_2674846, HPA035892: AB_10670670"	"unprognostic (2.89e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.92e-5)"	"unprognostic (3.45e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.52e-1)"	13.5	11.4	7.6	8.7	9.0	1.6	17.5	24.7	9.5	24.6	8.7	15.0	18.4	21.0	9.3	10.6	12.0	16.1	10.3	7.9	8.4	15.6	15.7	13.2	9.2	8.4	8.2	21.1	12.5	11.1	7.0	17.1	8.3	13.4	15.8	9.2	11.9	12.7	9.8	9.9	22.1	17.9	7.9	7.2	12.2	35.4	7.8	12.0	11.5	15.7	10.2	14.5	11.3	8.3	21.9	16.7	78.1	61.0	48.1	42.9	38.0	27.8	33.2	29.9	43.8	36.5	15.9	18.7	23.5	43.6	51.4	15.1	41.7	30.3	40.1	18.0	30.3	5.7	17.6	28.4	32.6	13.3	10.3	33.1	37.1	31.9	25.7	25.8	36.5	28.8	2.3	7.5	28.6	23.8	23.7	27.8	33.4	19.0	21.1	43.5	38.0	7.2	36.3	23.0	22.9	57.9	30.1	27.0	28.4	39.9	23.3	21.7	26.6	39.6	29.2	21.0	23.9	6.8	19.9	17.8	13.9	18.2	31.0	0.0	0.3	0.0	0.2	0.4	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.2	0.0	0.1	0.2	0.7	0.5	0.1	7.6	9.0	24.7	9.5	7.9	8.4	8.4	8.2	8.3	7.9	7.8	8.3	15.2	6.4	4.8	14.0	3.7	22.0	25.7	12.8	15.9	8.4	22.2	12.1	5.5	11.5	11.9	9.2	0.0	9.8	5.6	22.8	17.6	14.5	76.1	9.7	28.3	12.3	8.9	0.0	14.9	12.0	21.7	31.4	8.6	23.6	0.0	14.2	13.9	15.1	6.8	25.2	22.5	12.2	14.2	6.5	44.5	130.9	24.8	9.8	14.2	9.4	5.8	16.2	1.0	25.6	19.8	21.6	9.8	21.1	2.9	29.8	20.5	17.2	6.8	3.4	6.6	16.7	19.6	5.8	9.7	17.0	18.8	8.1	4.0	11.9	13.7	39.6
UNC119B	"MGC5139, POC7B"	ENSG00000175970	"Unc-119 lipid binding chaperone B"	A6NIH7	12	120710458-120723640	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA077812	Enhanced					NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA077812: "	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (9.35e-2)"	"prognostic favorable (6.69e-10)"	"unprognostic (2.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.42e-2)"	14.6	34.8	21.6	10.6	20.9	12.2	17.8	18.6	18.2	16.1	28.1	14.1	9.3	20.0	15.7	11.9	47.1	9.9	11.3	19.8	26.7	29.7	10.8	15.4	11.1	26.6	26.2	35.7	18.4	40.2	26.0	11.4	22.0	18.8	13.1	20.1	13.0	24.8	7.9	15.1	13.1	18.9	25.3	14.6	17.0	18.4	30.1	22.3	31.3	11.2	15.7	11.3	10.0	19.2	27.0	25.8	52.3	45.0	51.2	37.8	44.3	32.7	38.0	36.5	16.3	31.1	10.9	27.1	12.7	36.8	17.5	28.1	55.9	36.6	37.4	21.2	28.3	12.5	19.5	19.4	34.6	34.9	19.1	29.9	37.1	27.2	41.6	58.7	41.7	40.3	31.1	2.9	31.1	23.7	32.2	28.5	64.8	30.6	31.5	38.0	34.8	14.0	43.3	55.7	31.4	39.5	78.5	15.3	27.5	36.7	60.2	23.6	26.2	33.7	22.9	14.6	22.3	21.1	19.7	16.6	40.1	17.4	37.4	0.0	0.4	0.5	1.3	0.2	0.7	0.6	1.1	1.4	0.5	0.7	1.5	1.2	0.8	1.1	2.7	1.0	1.2	0.6	21.6	20.9	18.6	18.2	19.8	26.7	26.6	26.2	22.0	25.3	30.1	19.2	10.1	3.2	7.5	7.8	3.4	2.9	7.6	5.8	6.8	8.1	11.9	11.7	4.6	7.2	5.9	18.4	10.4	11.4	6.3	7.0	15.6	7.1	17.2	30.7	9.6	9.9	14.3	8.2	6.8	7.7	5.3	7.3	1.1	7.2	2.5	8.3	6.1	6.0	3.0	8.4	8.6	5.3	4.1	3.8	1.4	4.0	13.1	3.3	5.4	7.5	3.3	12.8	1.0	4.5	4.7	8.6	4.5	16.1	3.5	11.4	4.8	14.0	33.0	10.4	13.1	7.6	7.3	15.6	13.6	6.3	3.3	5.2	5.9	9.0	8.0	8.1
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1 prefoldin like chaperone"	O94763	19	29923644-30016612	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 499.7;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA071709: AB_2686434"	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	25.0	30.6	29.7	24.8	39.6	36.4	36.7	57.8	40.7	27.9	21.0	26.1	23.5	34.2	32.3	28.5	30.2	25.1	28.1	25.0	36.8	25.6	30.5	22.9	39.9	35.9	32.3	44.1	21.9	31.4	11.0	24.1	34.5	37.7	32.1	32.4	27.2	30.4	52.8	44.9	23.4	22.8	28.4	30.0	25.0	51.6	30.9	31.7	55.4	36.2	37.3	24.8	10.7	45.6	64.8	85.9	39.5	61.7	27.5	39.8	66.5	41.3	34.4	29.5	33.7	45.4	41.5	99.7	79.4	48.2	23.4	44.6	84.8	52.7	66.5	69.7	48.5	90.8	44.3	59.7	39.7	88.5	37.3	35.1	70.6	25.7	95.7	31.7	22.1	58.2	109.7	27.2	37.4	55.3	58.0	37.1	37.1	83.4	26.2	56.7	73.2	40.5	19.4	75.3	63.4	49.7	47.1	56.3	62.2	41.7	23.5	54.8	29.1	72.1	63.9	35.6	63.3	74.4	86.2	67.7	35.5	76.5	44.4	3.4	1.3	1.8	2.9	1.4	2.5	1.9	2.6	3.0	1.1	4.5	3.1	3.1	0.1	2.2	1.4	1.6	2.2	0.8	29.7	39.6	57.8	40.7	25.0	36.8	35.9	32.3	34.5	28.4	30.9	45.6	51.6	44.8	38.8	59.1	48.6	57.0	95.3	19.4	40.5	60.6	67.6	68.1	52.8	48.6	28.2	40.5	25.0	19.2	84.4	21.7	105.7	16.9	499.7	48.5	82.8	32.5	28.9	38.5	79.9	27.8	28.7	45.6	41.3	41.8	30.9	54.5	31.8	50.9	15.4	52.2	122.3	36.5	18.3	33.6	24.0	514.0	43.8	32.9	32.0	74.9	25.0	58.5	70.0	137.7	178.4	19.4	23.7	41.3	53.3	123.9	19.4	85.2	38.8	59.8	13.1	82.3	48.5	72.2	52.2	44.8	73.6	13.1	74.2	91.6	37.0	94.3
UXS1	"FLJ23591, SDR6E1, UGD"	ENSG00000115652	"UDP-glucuronate decarboxylase 1"	Q8NBZ7	2	106093308-106194301	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 323.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008825	Uncertain				"Intracellular and membrane"	NA	NA		24000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA008825: AB_1858708"	"unprognostic (4.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.45e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.20e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.32e-2)"	16.3	17.6	20.4	25.0	18.7	40.4	15.3	30.4	29.3	19.6	20.6	21.7	15.5	24.3	33.1	24.1	29.2	19.6	29.3	25.9	20.3	60.0	15.7	46.0	27.9	15.0	23.0	24.4	15.8	37.3	16.3	54.6	19.3	23.2	24.0	10.5	14.6	25.9	31.9	14.0	14.3	21.4	18.5	25.0	26.2	31.9	31.0	22.2	30.0	28.6	30.4	29.5	18.3	23.7	66.5	48.8	50.9	39.0	88.4	65.2	110.2	71.4	66.9	49.9	61.5	96.9	110.4	12.0	87.0	74.1	111.2	32.8	22.6	58.2	54.5	64.2	40.5	37.0	21.4	110.6	34.9	30.5	39.0	42.8	63.8	50.3	33.5	57.5	52.5	22.8	22.1	28.5	103.6	46.8	34.3	66.8	60.1	64.2	65.4	70.3	38.6	34.3	323.0	60.9	16.7	19.0	51.5	45.7	44.3	67.7	17.0	93.7	48.0	55.1	58.5	45.4	45.4	34.4	51.4	17.9	55.0	70.1	103.8	11.3	24.7	28.5	23.1	20.8	25.7	15.3	64.3	41.4	19.1	30.5	68.8	49.1	6.1	37.5	16.0	13.5	130.4	44.3	20.4	18.7	30.4	29.3	25.9	20.3	15.0	23.0	19.3	18.5	31.0	23.7	15.4	89.8	88.8	18.9	22.1	16.8	26.8	117.3	14.8	9.9	11.6	10.5	18.7	17.2	61.6	86.5	4.2	71.2	17.7	20.5	50.9	46.9	80.2	41.5	19.3	25.5	6.6	12.0	49.8	25.0	74.1	34.2	16.8	40.6	29.8	13.1	10.8	15.0	33.2	8.4	37.5	15.6	34.6	20.1	12.5	18.5	15.2	33.9	14.2	33.7	56.2	10.8	18.6	24.1	11.7	30.4	16.2	12.8	10.2	35.7	9.6	17.5	38.8	7.9	19.7	19.0	35.1	17.0	81.6	22.6	13.2	24.6	33.7	51.6	18.0	19.8
VAV2		ENSG00000160293	"Vav guanine nucleotide exchange factor 2"	P52735	9	133761894-133992604	"Plasma proteins, Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 48.3;Inhibitory neurons: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.3"	"Group enriched"	"Detected in many"	22	"B-cells: 3.3;dendritic cells: 1.1;monocytes: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003224	Uncertain		Approved	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA003224: AB_1080554"	"unprognostic (1.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.16e-2)"	"prognostic favorable (7.39e-7)"	"unprognostic (8.64e-3)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (3.97e-2)"	8.4	26.8	9.3	10.7	8.8	3.0	7.7	7.4	9.8	12.0	10.9	11.8	20.9	9.9	7.2	6.7	12.2	10.8	7.4	11.6	9.9	21.3	46.1	16.8	13.3	11.6	16.0	5.5	38.6	10.8	8.0	13.1	13.2	10.2	9.6	3.0	13.2	8.9	2.0	6.1	22.4	6.9	8.9	13.9	9.5	4.4	9.9	6.2	13.8	2.3	13.3	11.4	7.9	8.4	12.5	21.6	33.3	13.5	9.0	15.1	85.8	24.6	13.5	20.3	12.2	33.0	19.0	3.6	19.6	24.6	26.2	72.8	31.6	53.0	10.4	21.3	7.3	4.2	28.3	37.2	33.4	10.3	1.6	15.0	33.5	17.9	25.3	13.6	22.9	7.3	7.3	6.0	14.2	63.5	0.8	5.1	16.3	54.3	20.5	33.9	28.2	12.1	46.1	22.4	36.9	24.9	64.7	42.7	8.8	21.3	26.0	14.5	18.7	28.6	16.0	28.7	34.5	0.4	0.3	6.8	19.1	8.8	18.0	0.0	0.8	0.0	0.0	2.0	0.0	3.3	0.0	0.0	1.1	2.1	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.5	9.3	8.8	7.4	9.8	11.6	9.9	11.6	16.0	13.2	8.9	9.9	8.4	4.8	0.0	5.4	20.5	11.2	5.1	3.0	10.1	4.0	1.9	6.7	5.6	4.7	21.5	7.5	36.8	0.0	1.3	0.6	27.0	3.9	9.2	2.5	6.9	6.4	6.6	28.2	0.4	8.5	12.5	18.3	5.0	9.7	13.9	0.0	24.6	6.8	48.3	6.2	0.0	40.9	9.8	6.1	5.4	7.2	7.9	7.2	7.7	1.8	8.4	9.3	4.2	2.1	31.2	2.6	24.7	15.6	6.0	3.3	6.3	35.7	13.6	3.3	1.8	13.1	6.4	8.8	0.1	3.8	2.1	2.7	1.0	1.7	12.0	13.5	2.1
VEGFB	"VEGFL, VRF"	ENSG00000173511	"Vascular endothelial growth factor B"	P49765	11	64234584-64239264	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 204.9;Muller glia cells: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 30.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 30.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	186000		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (4.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.31e-3)"	209.8	82.0	45.7	12.0	51.3	3.9	151.3	41.8	53.1	103.6	48.2	151.5	12.1	99.9	7.2	50.8	72.5	19.2	253.3	38.7	45.1	84.6	44.0	82.5	14.4	54.8	47.4	82.6	84.9	18.3	104.2	9.8	45.0	92.7	4.7	12.7	57.7	28.5	143.8	77.3	59.5	10.2	44.2	55.9	89.2	17.5	50.6	6.6	83.7	51.5	9.1	118.0	77.5	37.3	15.4	25.9	9.9	28.1	49.7	36.8	12.7	14.7	27.8	13.1	16.0	13.8	31.7	19.8	28.6	14.0	28.8	20.8	15.8	11.5	2.3	20.6	15.1	16.7	33.9	13.3	45.4	4.8	20.1	39.6	12.0	19.6	12.2	33.9	18.4	20.6	20.2	32.5	22.2	31.8	27.4	12.6	7.0	10.9	22.3	32.1	20.5	46.5	11.0	19.5	14.0	46.4	12.4	38.1	57.4	7.6	25.1	5.6	13.0	50.8	30.2	23.1	8.7	90.5	45.5	15.4	41.6	5.3	25.1	0.3	0.2	0.6	0.9	0.0	0.8	3.0	0.8	0.9	0.4	2.4	0.9	1.6	0.0	0.4	0.0	30.5	0.5	0.4	45.7	51.3	41.8	53.1	38.7	45.1	54.8	47.4	45.0	44.2	50.6	37.3	54.1	19.2	32.6	43.8	27.6	12.7	6.7	10.1	2.2	47.9	32.8	65.7	204.9	10.0	7.6	14.7	33.3	9.6	68.3	11.9	39.2	14.8	1.1	24.2	47.7	21.9	53.3	4.4	7.3	12.9	16.8	68.6	5.1	31.6	18.4	62.7	19.6	9.8	51.4	65.6	26.6	12.2	20.3	31.5	21.5	3.5	60.9	50.0	35.6	19.7	17.7	130.6	12.3	29.1	11.8	14.5	7.3	109.1	12.3	11.5	20.3	31.6	8.9	39.6	6.6	47.4	53.7	0.5	1.2	6.4	13.9	8.9	19.0	34.3	12.8	7.5
VENTX	"HPX42B, VENTX2"	ENSG00000151650	"VENT homeobox"	O95231	10	133237855-133241928	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 30.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2"	"Group enriched"	"Detected in some"	10	"NB-4: 18.2;NTERA-2: 10.9"									HPA050955	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Cytosol	"HPA050955: AB_2681288"	"unprognostic (9.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.70e-4)"	"unprognostic (4.22e-1)"	"unprognostic (2.51e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.14e-1)"	4.8	2.3	1.6	3.6	1.1	2.8	1.9	1.6	1.5	1.5	1.9	1.9	0.4	1.6	0.5	0.5	1.8	1.5	1.5	1.5	1.5	1.7	0.5	3.8	0.5	1.9	1.7	1.5	1.2	0.5	1.4	0.5	1.5	1.3	0.4	0.2	1.3	0.8	0.9	1.2	1.0	1.2	0.9	5.7	0.9	1.0	2.5	0.2	0.8	0.1	0.4	1.4	1.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.2	10.9	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	1.9	2.6	0.3	0.1	3.2	0.0	0.3	0.1	0.0	1.8	0.2	0.1	0.1	0.9	0.3	2.4	0.1	0.0	0.7	1.6	1.1	1.6	1.5	1.5	1.5	1.9	1.7	1.5	0.9	2.5	1.8	0.0	0.0	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	7.9	0.2	0.0	7.8	0.0	0.0	5.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
VIM		ENSG00000026025	Vimentin	P08670	10	17228241-17237593	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 4879.0;Langerhans cells: 4893.1;Leydig cells: 5013.2;Muller glia cells: 8977.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18287.8;fHDF/TERT166: 10084.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000080, HPA001762, CAB058687"	Enhanced		Supported	"Intermediate filaments"		NA	NA		35000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (9.75e-6)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.87e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.47e-3)"	3467.6	423.1	349.3	610.6	369.5	1455.5	2362.8	289.1	527.4	1816.3	568.1	923.2	218.4	1226.5	400.0	451.5	1458.7	960.2	1364.3	337.5	404.6	473.6	192.8	1133.2	806.2	667.4	328.2	3690.8	370.0	224.8	574.5	1030.0	443.7	570.0	400.8	731.0	628.5	551.8	363.7	1126.8	674.7	1109.3	414.6	819.9	522.8	251.7	472.7	412.2	1391.1	555.8	744.7	983.5	1366.6	425.5	21.2	1119.0	1981.0	3180.7	6407.4	18287.8	3.0	5238.5	3458.9	3859.2	3421.5	8.5	70.4	2.9	273.2	10084.4	1804.7	8.4	283.8	147.0	3734.1	3567.5	387.2	563.2	523.5	0.3	1967.3	301.1	222.8	6746.8	6.5	5712.0	3213.4	9020.8	6366.3	372.4	889.3	1575.4	6939.5	4.5	736.6	911.2	632.4	1.4	1394.0	564.8	2745.9	95.7	3925.3	0.8	8.1	946.6	1.4	6.9	5447.5	1133.1	8.6	341.8	5459.0	3819.8	1644.5	3244.7	6311.5	1754.4	953.7	130.4	5775.4	28.9	3726.3	667.8	751.8	215.2	219.5	469.3	278.7	176.3	357.0	285.0	866.0	117.5	217.1	217.2	409.3	99.2	471.2	342.3	481.5	615.4	349.3	369.5	289.1	527.4	337.5	404.6	667.4	328.2	443.7	414.6	472.7	425.5	3211.7	157.0	349.4	53.5	605.8	725.8	21.6	361.2	58.1	74.2	108.8	539.1	109.5	94.4	157.3	108.5	50.1	22.1	1110.1	9.1	5.9	198.8	58.1	922.9	2314.1	2923.2	309.1	236.5	0.4	569.0	45.8	3443.0	101.4	693.7	2776.4	4879.0	2195.6	19.2	3541.4	33.7	0.3	1.8	16.2	2841.2	4893.1	131.6	5013.2	3177.8	3082.5	85.3	3893.1	8977.0	259.5	1.0	0.4	525.9	1.5	2336.6	2097.2	79.5	3.1	181.6	90.7	284.1	1420.0	3171.9	3714.2	55.1	27.5	39.4	473.0	52.7	1566.3	1791.1	6.2	28.9
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.6;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 63.6;Ionocytes: 22.4;Macrophages: 41.1;monocytes: 57.5;Respiratory ciliated cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 477.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 477.4"	"Cell line enriched"	"Detected in some"	7	"Daudi: 59.7"					"Low region specificity"	"Detected in some"									NA	NA		240000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	21.7	2.7	0.6	23.9	0.9	31.6	1.3	0.7	2.8	4.3	1.4	3.8	2.4	1.3	0.4	4.1	5.3	22.5	2.3	0.5	0.7	2.4	10.1	22.5	39.0	1.5	1.0	1.5	4.3	0.7	0.9	20.7	1.7	1.8	3.0	0.1	1.5	0.9	0.6	0.3	4.6	6.3	0.8	56.6	7.3	0.6	1.0	11.7	1.2	7.9	42.0	17.8	1.2	1.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.7	1.1	0.0	1.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	1.4	0.0	0.0	11.6	65.2	0.3	24.6	14.5	10.3	40.3	8.4	29.0	14.1	32.2	27.0	39.4	477.4	36.1	9.9	2.6	6.1	40.4	0.6	0.9	0.7	2.8	0.5	0.7	1.5	1.0	1.7	0.8	1.0	1.0	0.2	0.0	6.7	0.0	11.0	0.0	0.5	4.3	0.0	0.0	0.2	0.0	1.5	7.2	11.8	0.0	0.0	0.8	10.9	0.1	0.0	63.6	0.0	0.3	0.0	1.4	0.0	1.3	0.2	0.4	0.2	1.9	13.3	0.2	5.1	0.1	3.3	1.0	13.9	0.0	0.0	0.0	22.4	18.6	1.0	0.0	0.0	41.1	0.0	1.9	57.5	0.3	20.6	0.0	0.1	3.6	0.0	0.0	2.7	8.0	0.0	0.6	25.4	0.1	6.6	2.5	1.2	0.1	0.0	0.1	0.0	1.4	10.9	6.5	0.2	14.5
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132736935	"Enzymes, Metabolic proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 34.9;liver: 34.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 20.7;Club cells: 42.5;Gastric mucus-secreting cells: 15.8;Respiratory ciliated cells: 86.1"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 76.2"	"Lineage enriched"	"Detected in many"	33	"granulocytes: 76.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	150000000		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.2	0.1	0.1	2.2	0.1	34.9	0.2	0.1	0.5	1.6	0.2	0.1	0.0	0.1	0.0	0.8	1.9	1.0	0.4	0.1	0.1	0.3	34.7	4.5	0.4	0.1	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.3	0.0	0.0	1.0	0.1	0.1	0.2	0.2	0.2	0.1	5.5	0.4	0.1	0.2	0.4	0.1	1.1	0.4	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	20.7	0.0	0.0	0.2	0.0	0.4	0.0	42.5	0.0	0.0	0.0	0.1	0.2	0.0	3.7	0.2	2.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	15.8	1.7	0.0	0.0	0.4	10.0	0.1	0.0	0.0	0.0	6.1	5.8	0.0	0.2	0.0	3.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.0	0.1	86.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.3	4.1
VPS45	"h-vps45, H1, VPS45A, VPS45B"	ENSG00000136631	"Vacuolar protein sorting 45 homolog"	Q9NRW7	1	150067279-150145329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.8;Late spermatids: 267.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027425, HPA027441"	Uncertain		Approved	Microtubules		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	Microtubules		"HPA027425: AB_10599415, HPA027441: AB_10602284"	"unprognostic (1.57e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.36e-3)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (4.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-2)"	19.1	26.8	32.3	12.0	34.6	6.6	17.8	40.2	43.0	20.1	27.7	22.0	12.6	18.7	22.5	16.7	16.1	13.7	38.6	34.0	33.2	21.1	12.5	15.4	13.5	30.6	31.4	14.0	11.1	26.4	19.1	17.3	31.5	18.8	17.2	29.2	14.3	20.1	19.3	16.5	15.3	25.2	31.5	16.2	17.4	11.0	32.9	17.0	19.8	16.6	15.3	18.5	15.9	32.8	31.5	24.3	40.9	27.0	37.1	29.4	19.0	44.7	23.7	45.3	37.4	17.7	26.1	19.3	26.5	37.0	19.9	26.0	42.4	27.0	49.0	38.7	31.1	24.6	33.5	16.8	24.7	17.6	30.2	25.8	24.8	43.5	22.8	29.7	37.1	38.6	34.4	28.3	40.0	53.5	34.7	17.5	28.4	28.7	38.4	23.7	41.9	27.4	31.2	30.0	28.5	59.7	34.9	29.8	46.9	46.2	48.9	45.6	32.6	20.8	25.1	18.7	31.3	21.3	49.4	18.9	30.9	24.4	30.2	23.6	26.6	4.7	16.0	28.0	15.0	15.6	13.6	15.1	25.9	12.8	13.2	13.9	2.5	14.1	19.9	14.6	16.8	18.4	32.3	34.6	40.2	43.0	34.0	33.2	30.6	31.4	31.5	31.5	32.9	32.8	9.4	12.8	14.0	85.8	11.9	7.4	8.2	12.7	13.1	20.9	11.0	10.2	44.0	8.6	11.0	16.5	18.8	20.9	12.5	8.3	7.9	12.3	202.8	9.7	14.2	10.4	7.8	4.6	79.4	7.2	9.5	14.7	12.8	10.1	6.3	24.6	12.1	7.2	19.0	30.3	90.2	8.1	14.2	18.0	8.6	267.9	21.5	13.6	10.6	45.9	19.7	17.9	6.2	92.5	59.5	11.4	11.6	14.7	8.4	6.4	13.6	9.2	11.5	23.8	32.9	7.3	17.1	18.1	15.1	11.6	7.7	14.8	11.2	21.2	9.7	7.9
VSTM5	"C11orf90, LOC387804"	ENSG00000214376	"V-set and transmembrane domain containing 5"	A8MXK1	11	93818232-93850618	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;placenta: 4.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Excitatory neurons: 5.2;Inhibitory neurons: 9.2;Syncytiotrophoblasts: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;OE19: 3.7;PC-3: 5.4;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029525, HPA063591"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA029525: AB_10600789, HPA063591: AB_2732704"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-4)"	"unprognostic (2.45e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	0.2	0.2	2.2	0.1	1.9	0.0	0.4	1.0	3.4	1.1	0.1	1.1	0.1	0.4	1.2	0.1	0.2	0.4	0.1	1.8	3.7	0.8	0.0	0.1	0.0	3.1	2.0	0.1	0.5	0.1	0.6	4.4	3.3	0.5	1.7	0.5	0.4	0.4	0.0	0.1	0.7	0.7	1.4	0.0	1.9	0.2	3.3	0.0	0.1	0.0	0.1	0.2	0.1	2.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.5	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.0	0.0	0.1	0.0	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	1.0	3.4	1.8	3.7	3.1	2.0	3.3	1.4	3.3	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.9	0.5	0.5	0.3	0.0	0.1	0.0	0.0	22.3	0.1	1.1	0.0	0.4	0.0	0.3	0.2	0.1	0.0	0.0	5.2	3.0	0.7	0.3	1.5	0.7	0.0	0.1	0.0	0.0	1.5	0.0	9.2	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	1.1	2.1	0.4	0.0	0.1	0.5	1.5	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	5.9	0.0	0.0	1.6	0.1
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;choroid plexus: 19.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 10.9;Inhibitory neurons: 1.8;Late spermatids: 9.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"SCLC-21H: 1.2"	"Low region specificity"	"Detected in many"							"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	0.4	0.8	0.1	0.9	0.0	0.0	0.1	0.1	0.0	19.1	0.0	0.0	0.0	1.3	0.0	0.3	0.2	0.0	1.1	2.9	1.3	0.0	0.1	0.1	3.7	6.3	0.0	0.0	1.1	2.9	0.1	5.1	0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.2	3.0	0.0	0.2	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.1	0.1	1.1	2.9	3.7	6.3	5.1	1.5	3.0	0.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1
WDPCP	"BBS15, C2orf86, CPLANE5, fritz, hFrtz"	ENSG00000143951	"WD repeat containing planar cell polarity effector"	O95876	2	63119559-63827843	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 18.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 169.9;Alveolar cells type 2: 128.0;Astrocytes: 124.7;Excitatory neurons: 261.4;Inhibitory neurons: 240.9;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 296.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044144	Uncertain		Approved	"Cell Junctions"		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 6: Brain - Smell perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"		"HPA044144: AB_10969458"	"unprognostic (3.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.22e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-1)"	4.7	3.5	11.3	2.5	11.7	8.2	3.2	17.7	15.7	2.5	6.5	1.6	1.8	3.9	4.0	2.0	4.2	2.8	4.9	10.4	6.9	3.6	2.4	2.5	3.3	6.4	5.4	4.6	1.5	2.9	1.9	2.6	8.4	2.6	1.8	12.2	2.2	2.1	5.3	3.4	1.7	3.0	3.2	3.3	3.3	5.1	6.3	3.6	3.5	2.9	2.7	1.8	1.1	18.6	5.2	4.6	3.3	4.0	3.7	4.6	3.0	4.3	2.2	2.8	2.3	3.3	2.6	5.8	3.5	2.9	3.3	3.4	2.3	2.8	3.3	5.7	3.8	6.1	3.5	2.8	2.5	5.0	4.1	2.3	1.9	2.9	1.9	3.7	2.9	6.7	2.3	5.7	2.9	5.3	5.8	5.1	3.9	2.7	1.7	6.2	4.3	5.0	1.9	2.5	5.2	5.2	3.7	4.4	5.3	4.7	3.8	3.9	4.7	4.6	7.2	4.0	3.6	5.3	3.6	10.3	5.2	5.3	5.3	6.6	2.8	1.5	1.9	1.5	3.7	1.8	1.7	2.6	2.3	3.1	2.3	3.6	1.9	3.8	1.3	2.7	1.5	1.1	11.3	11.7	17.7	15.7	10.4	6.9	6.4	5.4	8.4	3.2	6.3	18.6	6.0	169.9	128.0	124.7	8.0	4.1	3.2	4.3	2.8	16.1	4.4	3.2	10.1	7.2	59.6	1.8	22.9	2.5	5.5	0.8	1.9	2.6	46.7	17.9	6.2	14.4	0.0	7.8	261.4	2.2	2.6	13.5	6.6	3.7	65.0	7.4	5.0	1.8	4.0	11.8	240.9	1.3	4.1	3.0	4.4	17.5	4.4	8.4	5.4	103.0	3.8	7.5	6.2	136.2	296.3	1.8	1.6	3.8	5.1	1.5	0.5	4.5	98.8	27.4	0.0	8.6	5.7	16.1	9.5	2.3	3.4	1.9	9.4	4.0	1.1	1.7
WDR7	"KIAA0541, TRAG"	ENSG00000091157	"WD repeat domain 7"	Q9Y4E6	18	56651343-57029811	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 99.6;Excitatory neurons: 268.8;Inhibitory neurons: 223.0;Microglial cells: 111.5;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 244.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042074, HPA051057"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA042074: AB_2677833, HPA051057: AB_2732563"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (4.80e-2)"	"unprognostic (4.52e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	5.9	7.6	13.2	5.9	14.2	7.2	4.9	7.0	19.8	4.8	3.1	5.4	4.1	4.8	5.3	4.4	4.2	5.3	5.9	16.2	11.1	5.3	7.4	5.0	7.4	14.6	8.8	4.2	4.2	9.2	8.4	4.7	14.7	7.5	4.9	18.8	4.2	5.7	8.2	4.3	4.3	5.6	7.8	6.2	4.9	4.6	9.6	10.3	9.1	9.6	5.8	5.0	4.5	16.0	4.7	7.7	8.7	4.9	13.5	7.8	2.2	9.2	7.8	7.4	8.8	3.1	2.9	13.0	3.6	8.3	6.3	4.9	8.8	7.2	9.2	15.1	5.4	12.3	5.8	2.8	8.1	18.7	15.0	6.7	5.9	9.9	6.6	6.1	9.3	6.1	6.0	17.5	9.3	4.6	13.0	5.5	3.7	2.4	5.1	5.8	6.7	6.3	5.7	8.4	11.3	5.6	6.5	3.1	4.3	7.4	4.9	5.2	8.3	10.5	5.3	3.2	5.0	17.4	14.2	13.9	8.6	9.3	7.2	4.0	3.0	5.5	3.6	4.4	4.5	2.4	4.0	3.7	3.6	2.2	4.2	3.8	2.6	4.6	5.5	1.7	5.2	2.0	13.2	14.2	7.0	19.8	16.2	11.1	14.6	8.8	14.7	7.8	9.6	16.0	8.7	3.2	4.8	99.6	7.5	2.9	1.9	2.3	2.8	24.5	3.4	2.4	12.5	5.7	6.8	0.0	31.3	2.0	7.7	5.8	3.9	3.2	21.0	4.4	6.0	6.6	8.4	8.2	268.8	3.6	1.2	6.3	7.7	3.9	10.8	9.0	9.3	8.9	5.8	26.9	223.0	2.7	0.0	16.2	2.8	7.0	5.6	11.3	0.0	111.5	8.8	7.1	10.3	146.3	244.7	2.6	2.6	8.2	10.1	2.6	4.5	3.2	5.7	26.3	6.6	10.7	5.8	2.0	1.7	5.8	2.4	0.7	9.9	9.3	4.1	1.6
WIPF3	"CR16, FLJ36931"	ENSG00000122574	"WAS/WASL interacting protein family member 3"	A6NGB9	7	29806486-29917066	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;ovary: 41.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 45.1;Granulosa cells: 149.4;Leydig cells: 50.7;Peritubular cells: 100.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 22.1;cerebral cortex: 49.9;hippocampal formation: 40.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.1;HEK 293: 4.1;K-562: 6.6;NTERA-2: 5.1;RPMI-8226: 11.3;SK-MEL-30: 4.5"	"Region enhanced"	"Detected in all"		"hippocampal formation: 213.9"	"Region enhanced"	"Detected in all"		"hippocampal formation: 156.3"	"HPA041145, HPA041211"	Uncertain		Uncertain	Mitochondria		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA041145: AB_10795001, HPA041211: AB_10795003"	"prognostic favorable (7.93e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.12e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.41e-1)"	1.0	5.6	8.7	1.0	22.1	0.5	1.1	0.0	49.9	0.4	0.0	0.7	2.9	3.3	19.7	1.2	8.8	1.4	4.0	40.3	4.2	2.5	0.5	0.5	0.7	0.4	2.6	41.7	1.7	1.2	0.9	0.2	0.1	4.4	0.5	3.8	4.0	4.8	25.0	0.9	2.6	4.1	0.5	1.0	5.9	18.8	7.4	0.4	2.0	8.8	0.7	1.4	0.2	8.1	0.3	1.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	18.1	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.1	0.0	0.1	0.0	0.0	5.1	0.0	3.6	0.0	0.0	11.3	0.0	0.0	1.8	1.5	0.1	0.1	4.5	2.4	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.1	0.0	8.7	22.1	0.0	49.9	40.3	4.2	0.4	2.6	0.1	0.5	7.4	8.1	1.5	0.0	0.0	6.2	0.0	2.2	1.5	0.6	1.2	8.2	4.9	4.6	9.3	0.0	1.4	3.7	2.1	0.0	0.3	0.5	3.9	3.8	1.8	5.0	0.4	4.1	1.8	3.0	45.1	3.5	0.1	7.3	11.7	1.2	0.0	149.4	0.4	0.5	4.5	5.0	27.0	0.7	0.0	0.0	1.0	4.8	50.7	1.0	5.4	1.9	0.0	6.2	0.0	2.0	1.9	2.4	1.5	100.4	0.1	1.1	5.5	5.5	5.1	2.9	6.6	7.2	16.0	4.4	9.9	0.9	0.4	0.0	1.0	8.7	2.0	0.4
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP"	ENSG00000116729	"Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 22.1;neutrophil: 61.7"	"Group enriched"	"Detected in many"	46	"granulocytes: 61.7;monocytes: 22.1"	"Cell line enhanced"	"Detected in many"		"AF22: 392.1;ASC TERT1: 294.1;SuSa: 357.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	36.8	42.9	77.4	21.5	70.8	4.6	36.4	63.6	73.5	46.9	124.7	73.9	23.8	49.1	135.8	62.3	48.7	68.2	63.7	62.0	89.1	92.6	23.4	53.0	13.0	109.4	127.8	76.7	83.6	38.5	16.9	77.3	91.6	71.7	57.4	137.2	32.6	102.0	14.2	45.9	34.0	61.9	101.6	29.7	56.6	23.9	132.2	13.5	22.6	25.2	19.2	64.4	37.8	98.8	11.5	17.3	392.1	0.3	214.0	294.1	228.4	55.6	135.1	75.7	104.0	24.3	26.2	0.2	54.9	16.0	70.7	116.0	89.3	91.7	63.6	0.6	67.8	0.4	45.4	0.2	187.2	0.1	0.9	214.0	60.3	185.3	60.6	77.2	181.0	21.4	0.0	1.0	113.0	1.7	0.3	1.3	17.7	24.7	27.3	0.1	82.2	0.5	13.5	60.3	21.8	46.0	51.0	2.3	67.3	357.0	10.6	1.6	209.7	71.7	56.9	116.9	76.1	26.6	0.8	0.2	165.0	1.8	134.1	0.0	22.1	0.0	0.0	5.4	0.1	0.1	0.0	0.0	0.9	0.1	0.0	0.0	61.7	0.0	0.7	0.3	0.0	4.8	77.4	70.8	63.6	73.5	62.0	89.1	109.4	127.8	91.6	101.6	132.2	98.8	20.9	48.1	34.6	145.3	1.2	42.4	60.1	28.5	95.0	8.9	25.4	61.2	32.6	42.9	41.3	27.6	139.7	134.7	0.9	65.7	9.8	74.3	15.3	110.8	60.1	31.5	9.6	0.0	27.0	60.3	6.7	44.9	28.5	235.3	5.7	4.6	43.5	10.9	24.9	13.5	132.3	24.5	61.1	10.6	11.2	9.4	32.6	14.7	19.6	61.8	18.0	11.8	0.0	59.3	3.7	69.1	27.2	55.3	0.2	31.3	8.9	36.2	81.1	166.4	39.5	15.7	46.4	0.8	1.0	39.7	30.0	55.1	3.2	39.2	38.4	46.8
WNT1	INT1	ENSG00000125084	"Wnt family member 1"	P04628	12	48978322-48982620	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease variant, Osteogenesis imperfecta, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 4.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.1;Gastric mucus-secreting cells: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basal ganglia: 4.5;cerebral cortex: 2.1"	"Group enriched"	"Detected in some"	8	"gdT-cell: 3.1;MAIT T-cell: 5.1;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	29	"T-cells: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.1"						"Secreted to extracellular matrix"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (2.02e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-3)"	"unprognostic (5.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.76e-2)"	0.0	0.0	0.8	0.5	4.5	1.1	0.0	0.0	2.1	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.7	0.2	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.3	0.7	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.1	0.1	2.0	2.9	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.2	0.5	0.8	4.5	0.0	2.1	0.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0
WNT10A		ENSG00000135925	"Wnt family member 10A"	Q9GZT5	2	218880852-218899581	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 7.0;skin 1: 8.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 12.2;Basal keratinocytes: 17.1;Basal respiratory cells: 15.5;Basal squamous epithelial cells: 30.1;Bipolar cells: 16.2;dendritic cells: 16.4;Plasma cells: 30.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 6.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 50.8;HaCaT: 140.1;HDLM-2: 58.7;RPTEC TERT1: 29.2;U-266/70: 69.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.1"	HPA013898	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA013898: AB_1858847"	"unprognostic (2.99e-4)"	"unprognostic (4.31e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (9.52e-2)"	"unprognostic (6.64e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.82e-1)"	0.7	0.2	0.7	1.0	1.6	0.5	0.5	0.2	1.3	1.5	0.2	1.6	3.7	0.0	0.4	7.0	1.2	0.3	0.1	1.2	0.5	2.4	0.2	0.7	2.5	0.4	0.6	0.2	0.1	0.0	4.3	3.4	0.5	1.7	1.0	1.4	2.5	1.0	0.0	8.9	2.1	0.0	0.3	2.0	2.5	0.4	0.7	1.1	0.2	0.0	1.9	2.7	2.9	0.7	15.8	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	50.8	2.8	10.4	0.0	3.8	140.1	0.0	0.1	0.0	58.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	10.5	29.2	0.4	0.0	0.4	0.3	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	69.0	1.1	1.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	6.2	1.0	0.0	0.7	1.6	0.2	1.3	1.2	0.5	0.4	0.6	0.5	0.3	0.7	0.7	0.2	0.0	0.0	0.3	12.2	17.1	8.2	15.5	30.1	16.2	0.5	1.3	1.4	0.0	1.1	9.2	2.1	1.2	16.4	0.0	0.0	0.3	1.2	0.3	0.1	0.2	0.0	0.4	1.3	0.0	0.4	1.9	0.5	0.2	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.0	2.0	0.0	1.3	0.1	0.6	1.0	7.2	0.0	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.0	30.4	2.5	0.0	0.3	0.6	1.5	0.0	0.1	0.8	0.9	0.6	5.2	4.7	0.1	9.8	0.0	0.2	3.2
WNT5B		ENSG00000111186	"Wnt family member 5B"	Q9H1J7	12	1529891-1647212	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 32.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 25.6;Microglial cells: 19.7;Muller glia cells: 40.4;Urothelial cells: 16.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8;eosinophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 231.4;BJ hTERT+: 143.5;BJ hTERT+ SV40 Large T+: 165.4;BJ hTERT+ SV40 Large T+ RasG12V: 136.4;fHDF/TERT166: 162.6;HBF TERT88: 144.1;hTEC/SVTERT24-B: 144.8;U-138 MG: 142.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061991			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA061991: "	"unprognostic (7.44e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.71e-2)"	3.0	2.3	3.6	4.1	4.1	0.5	3.0	2.8	3.7	5.5	1.8	24.6	4.3	7.2	5.0	14.9	6.2	2.8	4.0	2.8	5.3	1.9	4.6	3.0	2.6	4.7	3.9	8.2	1.5	9.0	11.2	3.9	4.6	32.4	5.8	5.4	15.7	20.0	1.4	5.3	5.0	5.4	3.9	5.2	6.4	1.8	4.2	3.7	2.0	6.7	3.0	13.9	9.7	3.1	0.3	0.1	1.4	0.2	34.6	61.2	0.0	231.4	143.5	165.4	136.4	8.7	0.9	2.9	0.4	162.6	111.1	3.5	3.3	0.0	144.1	55.0	7.9	12.8	0.0	0.0	8.5	0.2	0.1	51.3	3.3	144.8	41.3	66.6	0.0	0.1	9.5	51.9	39.4	0.1	0.0	0.3	5.7	0.2	0.5	0.0	2.3	4.0	2.0	0.0	1.0	3.2	4.9	0.5	0.2	17.7	0.2	0.9	0.0	142.4	5.9	56.7	119.7	13.9	2.2	0.7	13.9	0.0	1.5	0.0	1.8	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	3.6	4.1	2.8	3.7	2.8	5.3	4.7	3.9	4.6	3.9	4.2	3.1	0.9	0.0	0.6	7.5	1.5	0.9	11.0	1.9	25.6	1.8	0.7	6.5	2.2	0.0	3.3	0.0	0.0	1.0	0.2	2.4	0.0	1.1	0.2	1.7	10.4	1.4	0.0	0.0	6.9	0.7	1.1	8.0	0.5	2.7	0.0	0.3	0.4	1.7	5.3	0.0	7.9	1.9	2.0	2.1	2.9	0.5	2.1	2.7	3.6	19.7	4.1	40.4	0.0	4.0	5.6	2.8	5.0	2.6	4.5	8.8	1.0	0.2	4.3	2.7	6.6	7.9	4.3	0.7	5.7	7.7	1.3	0.7	0.2	0.0	1.7	16.2
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129288-108250537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;thyroid gland: 16.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.7;Excitatory neurons: 30.1;Horizontal cells: 21.9;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 9.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"RT4: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	0.9	0.7	8.9	0.1	14.3	0.0	0.8	36.7	13.9	3.5	0.3	3.3	0.3	10.1	2.1	1.0	2.6	0.1	0.4	17.9	4.2	1.0	0.0	0.3	0.1	0.6	2.4	0.3	1.4	0.0	1.4	0.2	2.2	4.2	0.3	11.9	0.3	13.5	0.2	0.8	0.7	6.8	2.7	0.1	1.9	0.2	10.0	0.0	16.8	0.4	0.1	2.5	1.3	7.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.4	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.9	14.3	36.7	13.9	17.9	4.2	0.6	2.4	2.2	2.7	10.0	7.2	0.8	0.0	0.0	5.9	0.6	0.1	0.0	0.1	0.0	43.7	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	30.1	0.0	0.0	1.6	3.1	0.0	0.0	0.0	0.7	0.0	0.0	21.9	27.7	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	2.8	0.0	0.3	0.0	9.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
XCL1	"ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1"	ENSG00000143184	"X-C motif chemokine ligand 1"	P47992	1	168576605-168582069	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 185.3;T-cells: 213.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"NK-cell: 88.5"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 88.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.8;Hep G2: 4.1;SCLC-21H: 3.3;SuSa: 6.1;U-266/70: 5.0;U-266/84: 1.9"	"Not detected"	"Not detected"							HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA057725: AB_2683511"	"unprognostic (5.38e-3)"	"unprognostic (5.72e-2)"	"unprognostic (8.23e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.34e-10)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.15e-2)"	0.5	0.1	0.1	1.0	0.1	3.5	1.0	0.0	0.2	1.0	0.0	0.7	1.0	2.2	0.8	0.2	0.6	1.1	0.5	0.1	0.2	0.5	2.6	1.8	2.3	0.1	0.1	0.2	0.5	0.0	0.1	2.2	0.2	0.4	1.0	0.0	1.5	0.3	0.1	0.1	1.5	0.3	0.1	4.6	1.2	0.2	0.6	4.1	0.3	0.0	1.6	0.9	0.4	0.1	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.3	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.0	1.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	6.2	0.0	0.2	0.0	1.0	5.9	0.0	0.0	0.3	4.0	0.3	88.5	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.6	0.1	2.3	3.2	5.5	0.0	1.5	4.0	0.5	0.0	2.2	0.0	1.3	1.5	2.0	1.5	0.0	0.0	0.0	1.4	185.3	0.7	0.0	0.0	1.3	2.0	1.9	1.9	0.0	8.4	0.0	0.2	1.2	1.9	8.2	2.9	2.5	0.0	1.4	0.9	0.4	0.0	0.1	0.8	0.0	1.9	10.6	0.0	0.0	3.1	39.2	0.0	0.1	0.0	42.2	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.1	0.0	0.0	0.0	0.3	1.7	0.2	0.2	1.8	4.3	0.8	213.4	0.0	0.4	0.1
XCL2	"SCM-1b, SCYC2"	ENSG00000143185	"X-C motif chemokine ligand 2"	Q9UBD3	1	168540768-168543997	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 513.6;NK-cells: 277.1;T-cells: 240.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"NK-cell: 423.5"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 423.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;RT4: 1.1;SuSa: 1.1"									HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA057725: AB_2683511"	"unprognostic (9.88e-3)"	"unprognostic (7.89e-3)"	"unprognostic (4.77e-2)"	"unprognostic (9.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (6.79e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (8.36e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.06e-1)"	1.1	0.8	0.3	3.2	0.3	14.1	0.9	0.3	0.5	1.0	0.4	1.9	3.2	3.6	0.9	0.6	1.8	1.9	0.7	0.3	0.4	0.4	5.6	3.3	5.6	0.5	0.3	0.4	0.6	0.3	0.2	1.4	0.4	0.5	1.5	0.0	1.9	1.0	0.3	0.1	2.0	1.4	0.4	13.4	2.9	0.3	0.6	3.8	0.6	0.5	3.6	2.0	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.1	0.4	47.2	0.2	2.7	0.3	3.6	50.1	0.3	0.1	2.1	37.1	1.9	423.5	0.3	0.1	0.0	17.1	0.3	0.3	0.3	0.5	0.3	0.4	0.5	0.3	0.4	0.4	0.6	0.4	2.9	0.0	1.1	0.0	3.3	2.4	0.0	0.0	1.8	0.0	1.6	1.4	0.8	0.0	0.0	0.0	0.0	0.1	513.6	0.3	0.0	0.1	0.0	2.4	2.0	1.0	0.0	19.2	0.0	0.0	0.0	1.1	8.2	2.2	1.3	0.0	1.4	0.6	0.4	0.0	0.0	0.7	0.0	5.0	4.0	0.0	0.0	3.7	33.8	0.0	0.8	0.0	277.1	0.0	0.0	0.0	1.1	0.0	13.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.9	1.1	0.0	240.6	0.0	0.1	0.1
XKR4	KIAA1889	ENSG00000206579	"XK related 4"	Q5GH76	8	55102028-55542054	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 8.1"	"Group enriched"	"Detected in some"	19	"Excitatory neurons: 306.3;Inhibitory neurons: 1019.5;Oligodendrocyte precursor cells: 721.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"REH: 2.6;RPTEC TERT1: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025072, HPA028083"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA025072: AB_1858886, HPA028083: AB_10601025"	"unprognostic (7.15e-4)"	"unprognostic (1.28e-3)"	"unprognostic (6.98e-2)"	"unprognostic (5.63e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.96e-2)"	0.1	0.2	7.6	0.5	7.1	0.0	0.0	0.9	8.1	0.3	0.0	1.7	0.2	0.1	0.2	0.5	0.1	0.2	0.7	7.0	2.2	0.1	0.0	0.0	0.4	0.1	2.2	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.4	0.6	0.3	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.3	0.1	5.8	0.5	0.0	0.0	0.4	0.3	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.6	7.1	0.9	8.1	7.0	2.2	0.1	2.2	0.0	0.0	5.8	1.1	0.5	9.6	18.7	7.8	0.1	0.4	0.6	0.0	0.6	12.5	0.1	0.3	2.1	0.0	9.3	3.7	35.5	0.1	0.4	0.1	0.0	0.1	0.9	0.6	0.2	2.4	0.0	0.0	306.3	0.9	0.1	2.3	0.0	1.1	0.0	0.2	1.1	0.4	0.1	0.0	1019.5	0.0	0.0	0.0	1.0	0.0	0.0	1.4	8.8	30.0	1.8	0.6	0.0	721.3	9.4	0.4	0.0	0.0	0.4	0.6	0.0	0.1	5.2	1.6	0.0	2.6	0.4	1.1	0.1	0.2	0.9	0.1	0.5	0.1	0.0	0.7
XYLB	"FLJ10343, FLJ12539"	ENSG00000093217	Xylulokinase	O75191	3	38346760-38421348	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Xylose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.3;Hepatocytes: 49.3;Inhibitory neurons: 35.9;Proximal tubular cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037863, HPA038415"	Uncertain		Approved	"Nuclear speckles"		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA037863: AB_10672729, HPA038415: AB_10672592"	"unprognostic (2.48e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.37e-2)"	1.4	2.3	1.3	1.5	1.0	2.2	3.0	5.4	2.0	1.6	0.0	4.1	5.8	1.9	0.8	1.9	1.1	1.6	0.5	0.9	0.7	11.4	33.4	0.7	1.0	0.9	0.2	2.2	2.5	1.1	0.8	0.9	1.1	1.6	4.6	2.1	5.3	0.9	0.6	1.5	6.4	1.4	0.0	1.0	3.5	1.0	0.9	1.6	0.7	0.5	0.8	1.2	1.3	0.6	3.5	6.4	2.8	6.7	4.2	4.3	6.3	5.9	2.0	4.5	4.4	8.2	3.6	3.7	1.4	7.6	5.4	2.5	8.1	2.5	5.6	5.0	6.2	7.5	5.0	24.1	2.2	10.1	7.7	3.0	5.2	5.8	2.7	1.9	4.7	8.5	18.0	6.2	5.0	2.4	8.3	1.4	3.8	8.9	7.9	4.2	5.5	5.0	0.6	6.3	3.6	3.2	3.7	16.0	12.7	2.4	7.2	6.1	2.6	9.0	7.3	15.6	2.5	3.5	6.6	8.5	5.4	9.1	7.2	1.4	0.9	2.0	0.6	1.6	0.5	0.2	0.5	0.3	1.7	0.3	0.6	0.6	1.9	0.5	1.4	0.6	1.5	0.4	1.3	1.0	5.4	2.0	0.9	0.7	0.9	0.2	1.1	0.0	0.9	0.6	1.0	0.0	1.3	14.0	0.9	0.9	2.1	1.8	6.8	3.2	3.0	3.4	1.1	2.8	1.5	0.0	0.0	4.3	1.7	3.8	1.9	1.0	0.5	0.4	3.5	1.8	0.0	3.4	39.3	3.0	3.8	2.3	8.6	1.0	0.0	1.3	1.1	49.3	4.0	0.0	35.9	5.7	2.0	1.0	3.7	1.0	1.5	2.0	0.0	17.8	1.0	0.4	0.0	17.1	17.7	1.3	5.8	1.9	1.6	1.7	13.0	31.7	1.3	5.1	0.0	2.4	1.4	0.5	2.7	4.1	0.9	1.4	0.8	1.8	5.1	2.1
YEATS4	"GAS41, NuBI-1, YAF9"	ENSG00000127337	"YEATS domain containing 4"	O95619	12	69359710-69390870	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Spermatocytes: 364.9;Spermatogonia: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072532			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"HPA072532: AB_2686530"	"unprognostic (7.23e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.05e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.77e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	9.4	11.8	5.6	10.4	6.1	45.8	17.8	9.4	8.2	10.1	9.5	12.3	13.3	10.3	14.9	11.6	12.2	8.3	11.1	6.1	6.2	15.3	14.9	8.9	22.5	6.2	5.9	9.9	17.3	11.1	10.1	10.9	6.3	10.8	13.7	20.1	12.0	9.6	14.3	11.3	13.6	8.4	6.4	10.9	11.0	37.1	5.9	25.9	13.8	19.5	20.4	11.3	9.5	8.0	54.3	27.0	52.1	32.5	11.8	18.9	41.3	32.0	33.7	54.7	45.6	31.1	15.4	108.1	30.5	17.3	28.2	40.8	41.6	32.3	53.2	54.2	45.4	63.0	20.5	37.6	16.5	92.4	53.3	14.0	40.3	29.1	43.1	27.9	31.7	90.1	53.4	127.9	26.8	27.5	130.4	99.8	72.5	36.0	37.6	68.9	49.0	53.6	30.9	47.7	57.6	39.4	33.0	31.4	54.9	32.2	60.5	52.9	18.9	22.5	22.9	63.4	39.4	34.2	44.5	120.2	24.4	43.7	40.1	9.3	13.1	26.4	21.1	19.2	24.0	22.7	29.5	22.2	17.9	21.2	34.8	30.3	6.0	21.6	28.4	14.9	31.8	21.2	5.6	6.1	9.4	8.2	6.1	6.2	6.2	5.9	6.3	6.4	5.9	8.0	14.5	6.4	25.8	11.4	29.0	29.7	36.1	36.3	17.6	25.5	29.5	25.7	23.4	14.3	24.4	11.0	12.5	51.2	24.9	16.8	46.9	31.4	8.0	27.2	10.6	16.3	17.6	50.9	13.6	38.9	58.0	17.4	13.3	19.9	19.0	21.8	12.5	17.0	37.6	18.5	15.5	26.4	22.4	15.1	24.3	14.6	18.6	19.8	12.4	6.5	44.1	26.5	20.6	10.1	18.4	33.2	17.3	24.0	18.3	37.0	23.7	35.2	26.1	28.2	19.7	26.4	18.6	364.9	109.1	26.5	32.0	23.5	33.0	30.7	34.3	34.9
Z82206.1		ENSG00000225528	"Novel protein similar to translation machinery associated 7 homolog (S. cerevisiae) TMA7"		22	39960397-39964718	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 7.9;granulocytes: 3.8;Proximal tubular cells: 3.2;T-cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"K-562: 12.5"									HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.1	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.1	0.1	0.1	0.0	4.3	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	12.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.1	2.7	2.9	1.3	2.5	2.3	3.5	3.2	1.6	2.0	3.6	4.4	2.4	1.3	1.2	1.7	2.6	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.9	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
ZCCHC18	"PNMA7B, SIZN2"	ENSG00000166707	"Zinc finger CCHC-type containing 18"	P0CG32	X	104112131-104115842	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;ovary: 4.2"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 4.2;NK-cells: 9.2;Oligodendrocyte precursor cells: 6.6;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;Karpas-707: 4.6;SH-SY5Y: 3.1"					"Low region specificity"	"Detected in all"			"HPA034940, HPA078516"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA034940: AB_10671098, HPA078516: "	"unprognostic (7.20e-2)"	"unprognostic (7.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.44e-6)"	"unprognostic (4.05e-2)"	"unprognostic (1.02e-6)"	"unprognostic (3.82e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.14e-3)"	0.5	0.8	3.0	1.3	2.9	0.4	0.3	2.9	3.0	1.8	1.1	0.7	0.3	1.5	0.2	0.3	1.3	0.4	0.5	2.7	5.0	0.4	0.1	0.4	2.0	2.2	2.5	4.2	0.9	0.0	1.6	0.1	2.2	0.8	0.3	1.2	0.2	0.6	0.1	0.2	2.0	0.6	2.4	2.2	0.5	1.0	4.9	0.4	0.3	0.1	2.0	0.6	0.7	2.1	0.0	0.1	1.9	1.3	0.1	0.0	0.1	0.4	0.0	0.3	0.3	0.1	0.0	2.5	0.0	0.1	0.4	0.0	1.1	0.0	0.1	0.7	0.9	0.4	0.1	0.0	0.2	1.4	0.4	0.1	0.0	0.2	0.0	1.1	0.3	0.1	0.0	4.6	0.1	0.0	0.0	0.0	1.0	0.0	0.3	1.7	0.4	0.0	0.2	0.2	1.3	3.1	0.1	0.0	0.0	0.2	0.0	0.1	0.8	0.1	0.5	0.1	0.6	0.1	0.0	1.2	0.0	1.4	0.4	0.0	0.0	0.0	0.4	0.0	0.6	0.7	0.3	0.5	0.0	0.8	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.1	3.0	2.9	2.9	3.0	2.7	5.0	2.2	2.5	2.2	2.4	4.9	2.1	0.9	0.0	0.6	3.3	4.0	0.1	0.2	0.0	0.0	0.8	0.3	0.3	0.7	0.0	1.3	1.8	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.6	0.9	1.2	4.2	0.8	2.6	0.2	0.0	1.2	0.0	0.3	0.0	1.3	0.7	0.0	0.0	1.7	1.5	0.0	0.0	0.3	0.4	0.3	1.5	0.1	1.8	0.0	0.1	3.4	9.2	6.6	0.3	0.0	0.0	1.2	1.7	0.1	0.0	0.2	1.5	1.0	6.6	0.2	2.4	0.0	0.2	0.1	0.0	0.0	3.6	1.0	0.0	0.1
ZDHHC11B		ENSG00000206077	"Zinc finger DHHC-type containing 11B"	P0C7U3	5	710355-784729	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	6	"brain: 29.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 23.0;Excitatory neurons: 47.2;Inhibitory neurons: 38.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 70.1;Respiratory ciliated cells: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;SCLC-21H: 2.4;THP-1: 3.4"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.81e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.79e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.39e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.31e-1)"	0.7	1.2	15.1	0.2	19.6	0.0	0.8	5.9	19.9	0.5	0.0	2.0	2.7	0.4	0.1	1.5	2.0	0.3	4.5	14.6	9.0	0.7	1.2	2.4	0.0	14.2	8.6	0.6	1.8	0.4	4.5	0.2	14.9	0.5	2.3	4.3	1.7	0.5	3.6	2.2	2.4	0.4	3.3	1.2	2.3	0.7	15.5	0.0	1.1	1.6	0.3	1.0	0.6	29.5	0.0	0.8	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	2.1	0.1	0.0	0.3	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.4	0.4	0.0	0.0	0.7	0.3	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.8	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	19.6	5.9	19.9	14.6	9.0	14.2	8.6	14.9	3.3	15.5	29.5	0.2	19.2	23.0	17.0	0.0	2.7	1.0	0.1	2.2	7.0	1.1	0.9	8.9	1.5	5.7	3.7	0.0	0.0	0.4	2.0	0.0	0.8	2.5	11.9	0.7	2.8	3.0	0.0	47.2	0.8	0.1	4.7	4.1	3.6	1.3	0.0	0.7	2.3	1.7	10.1	38.3	6.7	0.0	0.6	1.1	0.4	0.9	0.8	0.0	1.9	0.0	0.6	0.0	26.7	70.1	0.1	1.4	0.0	1.7	0.3	7.7	0.5	21.8	0.3	6.6	1.4	2.4	5.0	2.5	2.3	3.1	0.0	1.5	0.5	2.4	2.6
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type palmitoyltransferase 14"	Q8IZN3	6	157381133-157678157	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 161.7;Horizontal cells: 122.8;Inhibitory neurons: 108.1;Oligodendrocyte precursor cells: 315.2;Oligodendrocytes: 221.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013437, HPA063754"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA013437: , HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	2.9	1.6	7.3	1.8	7.6	2.5	1.6	9.7	6.8	5.3	1.1	2.4	2.8	12.4	0.4	1.7	2.0	2.3	5.2	7.5	5.1	4.6	4.4	3.0	2.4	12.5	9.1	1.4	2.5	5.6	1.6	2.2	10.9	3.5	1.7	1.3	2.1	1.4	2.3	1.4	4.1	6.1	13.5	3.1	3.8	3.3	10.8	0.9	1.7	3.9	2.4	2.4	1.9	22.7	2.6	2.7	0.8	3.8	2.0	1.5	8.7	4.1	3.7	2.8	2.5	3.3	1.9	6.4	1.4	3.3	5.4	1.3	2.2	2.2	2.5	50.9	3.2	12.7	1.0	1.5	2.7	1.7	2.8	1.1	2.3	2.9	1.2	2.4	4.3	2.8	10.4	4.7	1.6	1.7	1.1	4.2	1.6	5.1	3.2	0.2	0.4	3.9	5.8	1.1	6.3	1.9	4.8	3.1	3.5	1.6	0.4	2.0	6.0	4.2	3.1	8.3	5.2	1.1	1.3	0.9	1.5	4.5	4.7	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	7.3	7.6	9.7	6.8	7.5	5.1	12.5	9.1	10.9	13.5	10.8	22.7	23.4	3.2	0.0	45.4	9.8	12.9	2.1	3.0	4.0	25.3	5.8	8.0	18.3	12.8	1.4	7.3	6.2	12.5	11.2	7.4	11.7	7.5	10.7	5.0	16.6	15.1	2.4	4.2	161.7	3.1	2.2	11.4	6.1	9.4	0.0	7.7	22.5	23.1	11.4	122.8	108.1	9.8	6.1	15.5	6.7	5.9	8.1	8.8	10.6	65.6	3.8	5.4	7.2	315.2	221.0	2.7	8.5	10.1	4.5	14.2	6.0	3.8	0.4	6.0	0.0	6.2	8.4	7.2	10.0	1.5	8.4	21.1	6.6	4.6	11.5	2.7
ZFYVE21	"MGC2550, ZF21"	ENSG00000100711	"Zinc finger FYVE-type containing 21"	Q9BQ24	14	103715730-103733668	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055721	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA055721: AB_2682896"	"unprognostic (1.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (8.89e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.32e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.11e-3)"	"unprognostic (5.02e-2)"	"unprognostic (9.13e-2)"	"prognostic favorable (2.58e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.06e-1)"	57.4	28.9	117.0	14.2	121.0	11.9	54.0	115.6	143.1	69.3	113.2	52.3	18.2	70.8	50.3	68.4	71.8	28.4	51.6	112.8	116.0	37.0	34.7	31.6	16.5	121.3	114.4	56.1	26.7	34.1	32.0	30.1	118.0	41.0	25.7	15.2	61.5	53.3	22.0	73.2	31.0	45.6	123.6	28.1	44.9	35.5	120.0	19.3	50.3	29.9	17.5	65.1	67.8	127.4	27.1	34.1	29.1	26.7	76.9	61.6	48.2	49.8	35.2	41.5	36.2	40.2	34.3	6.0	31.5	53.2	29.9	45.4	25.3	59.4	37.3	11.5	30.9	33.5	23.0	55.3	60.8	8.6	21.4	42.1	61.6	18.4	29.8	37.4	51.0	19.6	13.0	11.4	29.9	165.5	23.3	26.8	13.4	41.3	47.9	12.6	21.6	9.2	81.5	95.5	16.6	11.5	35.2	44.3	26.2	32.2	56.6	22.3	44.7	20.1	16.3	68.4	25.6	12.8	13.8	9.2	22.7	18.7	19.5	28.3	36.2	42.1	20.0	57.6	19.8	18.1	18.7	20.1	23.9	24.7	19.4	18.5	29.6	16.3	47.8	19.4	21.7	24.6	117.0	121.0	115.6	143.1	112.8	116.0	121.3	114.4	118.0	123.6	120.0	127.4	68.0	19.2	23.9	61.7	9.5	45.5	83.5	161.9	59.2	27.8	58.8	68.6	36.0	41.5	83.1	80.9	33.3	115.7	20.9	33.6	121.3	56.4	14.2	25.3	54.7	71.0	19.3	76.2	30.9	54.5	40.0	65.3	12.2	30.3	19.7	22.0	66.4	26.9	55.4	20.2	11.8	34.2	81.4	22.6	29.5	23.0	109.6	28.4	103.2	19.7	32.3	91.6	24.7	11.6	21.8	79.3	51.9	197.1	7.4	87.7	31.5	98.9	47.1	29.6	65.7	57.2	60.7	46.3	78.4	50.9	60.2	101.5	13.4	36.3	32.4	81.9
ZHX3	"KIAA0395, TIX1"	ENSG00000174306	"Zinc fingers and homeoboxes 3"	Q9H4I2	20	41178448-41317672	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 370.5;Early spermatids: 106.3;Excitatory neurons: 99.0;Inhibitory neurons: 96.5;Oligodendrocyte precursor cells: 139.7;Oligodendrocytes: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046498			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA046498: AB_2679676"	"unprognostic (6.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.53e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (7.52e-4)"	"prognostic unfavorable (1.84e-5)"	14.4	15.4	33.8	6.5	32.8	3.4	13.3	31.6	27.4	11.6	16.4	19.8	8.6	15.8	5.7	13.6	15.7	8.4	12.2	30.2	27.7	26.4	17.2	11.6	4.5	37.6	32.1	16.3	11.9	15.4	7.8	4.9	29.9	10.6	8.0	10.8	5.7	11.9	28.5	11.0	11.4	12.1	29.4	4.3	15.5	35.0	36.0	7.0	19.0	20.1	4.8	18.1	11.0	28.6	22.5	6.3	6.6	14.2	52.6	56.3	7.6	31.0	35.4	28.3	19.1	11.4	2.9	15.6	14.7	58.5	7.6	7.0	7.9	39.2	30.0	4.3	7.1	6.6	8.6	8.8	21.6	7.6	7.9	34.6	18.7	21.3	27.3	19.2	12.3	11.7	6.2	10.6	38.3	45.0	11.9	4.5	2.9	10.4	23.0	5.8	18.6	6.2	38.6	6.7	23.0	8.3	20.7	12.0	7.4	5.7	11.6	10.5	19.9	70.2	10.8	25.0	15.5	12.2	8.0	6.9	28.9	11.0	11.4	0.1	0.1	0.4	0.2	0.1	0.4	0.6	0.2	0.1	0.2	0.6	0.4	0.3	0.1	0.6	0.2	0.1	0.2	0.1	33.8	32.8	31.6	27.4	30.2	27.7	37.6	32.1	29.9	29.4	36.0	28.6	29.8	19.2	16.4	370.5	4.7	2.9	3.9	2.6	2.8	19.5	6.3	4.7	12.7	17.2	5.8	22.0	4.2	0.6	3.8	5.5	11.7	3.7	106.3	12.3	33.2	15.1	14.9	3.8	99.0	2.7	2.7	20.5	6.6	26.3	1.3	3.7	16.4	31.6	3.0	40.4	96.5	5.6	4.1	3.5	1.7	32.3	18.6	3.5	1.8	52.5	1.9	28.6	1.0	139.7	142.4	4.6	1.3	24.5	2.7	2.6	12.6	27.0	3.2	7.1	26.3	41.2	10.9	11.0	5.2	6.3	3.7	0.4	2.7	19.7	4.7	2.3
ZMYND15	DKFZp434N127	ENSG00000141497	"Zinc finger MYND-type containing 15"	Q9H091	17	4739833-4746119	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 28.3"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 191.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;CAPAN-2: 1.9;HaCaT: 1.6;T-47d: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023286			Uncertain	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear speckles"	Cytosol	"HPA023286: AB_1859076"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.62e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.49e-1)"	"unprognostic (6.72e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	1.8	1.3	1.6	2.4	1.6	1.0	1.7	1.6	2.5	0.9	1.7	0.8	4.0	0.6	0.5	0.9	1.1	2.8	0.6	1.6	1.8	1.9	3.1	4.6	1.7	2.4	2.0	0.7	1.2	5.5	1.4	1.2	2.0	1.7	0.7	0.3	3.1	0.8	0.4	1.4	3.0	0.7	2.0	5.5	1.9	28.3	2.4	0.8	1.1	0.1	0.4	1.8	0.7	2.6	2.1	0.3	0.0	0.9	0.0	0.1	0.1	0.0	0.5	0.5	1.1	0.9	1.9	0.0	0.0	0.0	0.2	1.6	0.4	0.1	0.0	0.2	0.7	0.0	0.2	0.5	0.3	0.0	0.6	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.6	0.6	0.9	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.6	1.6	1.6	2.5	1.6	1.8	2.4	2.0	2.0	2.0	2.4	2.6	0.8	0.0	2.0	1.3	0.6	0.9	8.0	1.8	0.6	0.3	4.4	3.7	0.7	2.8	3.1	1.8	0.0	0.1	0.2	3.3	0.0	1.6	191.4	2.8	0.3	1.4	1.2	0.0	0.0	3.9	0.0	0.7	4.6	2.7	0.0	0.3	3.9	0.6	5.2	0.0	0.1	2.9	0.0	11.9	7.3	30.9	0.6	12.9	1.8	1.9	21.9	2.0	0.0	1.0	0.5	3.5	1.4	2.2	0.1	6.7	3.8	0.8	3.7	0.3	0.0	0.2	1.0	24.3	2.0	0.5	0.9	0.0	0.2	0.3	1.3	8.5
ZNF25	"FLJ31890, KOX19, Zfp9"	ENSG00000175395	"Zinc finger protein 25"	P17030	10	37949573-37976647	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 44.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030190	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA030190: AB_10602687"	"unprognostic (9.42e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.61e-1)"	10.2	10.1	12.3	3.5	12.5	2.6	8.2	12.5	19.1	9.7	4.1	12.3	2.2	9.9	6.1	5.4	9.2	6.1	10.0	12.5	15.9	5.7	3.0	6.4	4.8	11.9	10.9	11.1	5.4	7.6	14.3	4.7	12.4	7.3	4.4	10.6	4.6	8.9	22.3	4.8	5.3	8.9	9.8	6.5	5.8	4.7	14.6	4.6	6.0	21.5	4.3	8.8	7.1	12.6	1.6	3.0	3.3	6.7	12.1	9.2	0.6	3.6	4.9	2.8	4.2	0.5	2.3	3.1	1.0	6.4	1.0	0.4	0.9	1.5	4.5	7.3	1.6	5.0	0.0	1.0	7.7	3.3	3.1	6.5	6.6	3.1	3.6	11.1	4.9	4.0	0.4	2.3	6.9	1.0	1.1	2.6	0.6	0.6	2.2	1.2	3.7	0.6	3.3	0.6	1.2	7.6	1.2	0.2	4.7	1.2	2.9	5.3	7.1	4.3	0.8	7.1	2.2	2.8	1.4	1.3	8.2	6.3	2.9	1.3	1.5	3.4	1.6	2.5	1.7	1.0	1.4	1.3	1.9	1.3	1.8	1.5	0.2	1.0	5.2	0.3	1.2	1.2	12.3	12.5	12.5	19.1	12.5	15.9	11.9	10.9	12.4	9.8	14.6	12.6	10.0	3.2	3.2	17.9	4.8	3.4	2.5	2.5	3.4	17.3	3.8	3.6	23.6	4.3	2.9	7.3	6.2	1.2	3.5	1.0	1.9	2.0	27.9	2.4	7.0	7.6	0.0	2.1	46.7	2.5	0.5	10.6	4.1	2.7	8.2	8.2	10.4	2.9	5.7	16.8	44.6	1.2	4.1	13.2	6.8	41.9	12.2	9.5	3.6	14.0	8.1	13.7	5.2	38.2	36.7	1.8	0.3	16.1	1.5	2.6	1.3	3.1	8.1	7.1	0.0	11.4	10.4	4.4	6.4	2.4	4.0	0.3	5.2	4.8	0.8	1.3
ZNF280D	"FLJ20086, SUHW4, ZNF634"	ENSG00000137871	"Zinc finger protein 280D"	Q6N043	15	56630176-56734086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 176.6;Oligodendrocyte precursor cells: 200.1;Oligodendrocytes: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA030233	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"	"Golgi apparatus, Centrosome"	"HPA030233: AB_10602590"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.72e-2)"	11.3	11.4	3.4	8.7	3.9	23.1	15.4	9.0	4.6	18.0	4.8	10.2	7.5	20.1	8.1	8.4	12.4	9.6	9.2	3.6	3.8	10.3	13.2	10.1	10.0	3.1	3.0	23.7	13.7	11.1	4.5	11.5	3.6	10.6	11.5	12.4	10.5	9.9	12.6	6.6	9.5	15.1	4.0	10.3	10.3	7.8	3.5	35.9	11.5	11.6	9.9	10.9	8.5	9.8	13.4	7.4	13.6	20.9	13.3	18.7	9.9	20.2	14.3	8.2	9.3	5.4	13.6	22.7	8.4	14.5	7.9	10.0	6.7	5.3	9.9	11.6	4.1	2.4	12.5	8.2	13.3	20.4	6.6	12.8	7.6	5.6	8.0	20.6	18.3	23.0	11.9	25.7	13.0	9.6	14.4	2.3	0.0	15.6	5.8	4.3	22.2	16.1	10.1	15.4	11.2	20.0	16.9	10.5	6.7	0.7	11.4	19.9	16.2	12.1	18.2	11.3	16.1	13.2	21.6	0.0	13.7	31.0	13.2	7.8	2.6	3.5	2.1	2.2	2.0	3.4	1.9	1.7	3.6	3.2	2.0	2.4	0.4	1.8	2.0	3.6	1.9	1.0	3.4	3.9	9.0	4.6	3.6	3.8	3.1	3.0	3.6	4.0	3.5	9.8	32.4	9.6	18.9	176.6	31.1	11.1	18.3	12.9	42.7	79.8	20.5	20.7	37.9	22.8	14.6	3.7	83.4	23.0	25.5	12.2	7.9	12.0	18.3	14.3	33.0	36.5	32.3	27.5	107.2	14.0	21.5	37.5	26.0	14.2	17.7	37.8	34.2	31.1	36.6	69.0	151.3	25.7	16.2	35.6	18.1	49.5	33.2	22.9	16.0	91.8	27.0	24.9	28.8	200.1	293.3	10.5	10.4	21.1	41.4	21.1	26.8	14.2	12.8	84.5	6.6	47.4	30.8	49.4	33.8	26.8	13.9	13.3	21.4	27.7	22.2	16.3
ZNF423	"Ebfaz, hOAZ, JBTS19, KIAA0760, NPHP14, OAZ, Zfp104"	ENSG00000102935	"Zinc finger protein 423"	Q2M1K9	16	49487524-49857919	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4;skeletal muscle: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.4;Late spermatids: 115.7;Microglial cells: 53.4;Oligodendrocyte precursor cells: 38.7;Peritubular cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 62.6;NTERA-2: 33.2;REH: 27.5;SCLC-21H: 35.1;SH-SY5Y: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015258, HPA065820"			Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA015258: , HPA065820: AB_2685563"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.84e-2)"	9.1	2.9	13.5	2.3	9.6	0.3	6.7	14.0	10.2	6.3	1.0	4.3	1.3	5.4	3.4	4.7	9.3	5.8	7.8	9.7	11.0	2.0	0.7	2.9	1.9	14.9	30.4	7.6	3.4	3.0	4.0	4.2	11.8	6.0	2.7	3.6	2.8	9.5	27.5	2.0	2.6	6.5	8.6	1.4	2.0	4.5	26.3	1.8	4.3	14.7	1.2	3.9	5.4	7.8	0.0	0.0	62.6	3.3	5.1	0.6	7.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	1.4	0.0	0.0	1.9	0.5	0.0	3.6	0.1	0.2	0.0	0.0	4.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	8.8	0.4	33.2	0.0	0.0	27.5	0.1	0.0	0.0	1.7	35.1	87.7	0.0	0.1	0.0	17.6	0.0	0.0	0.0	0.0	1.0	16.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.5	9.6	14.0	10.2	9.7	11.0	14.9	30.4	11.8	8.6	26.3	7.8	12.7	0.0	0.0	75.4	0.0	2.7	0.3	0.1	1.2	9.8	0.6	0.6	2.6	0.0	0.0	0.0	0.0	0.5	0.1	2.3	1.9	0.2	23.5	2.7	7.6	11.4	0.0	0.0	10.9	0.2	0.7	15.8	0.0	0.6	0.0	1.6	15.4	0.9	0.7	0.0	7.4	1.0	0.0	0.3	5.1	115.7	27.7	0.4	1.8	53.4	0.0	11.7	0.0	38.7	5.1	0.2	0.4	54.5	0.2	0.1	0.2	0.6	0.0	1.1	0.0	4.5	6.4	0.8	1.9	0.1	1.7	0.3	0.3	5.5	0.7	0.1
ZNF469	"KIAA1858, Zfp469"	ENSG00000225614	"Zinc finger protein 469"	Q96JG9	16	88382959-88440757	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 7.5;Excitatory neurons: 9.4;Granulosa cells: 9.3;Inhibitory neurons: 8.3;Oligodendrocyte precursor cells: 16.6;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;BJ hTERT+: 4.6;HeLa: 4.7;SiHa: 4.9;THP-1: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA077792			Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Cell Junctions"	"HPA077792: "	"unprognostic (1.80e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.71e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.17e-3)"	"unprognostic (7.08e-3)"	"unprognostic (5.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.71e-7)"	"unprognostic (2.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.34e-2)"	0.9	0.5	3.2	0.9	1.1	0.1	0.5	0.3	2.0	1.4	0.0	0.3	0.2	1.6	0.0	0.1	0.7	0.9	0.4	3.4	0.4	0.1	0.1	0.3	0.6	2.2	1.6	2.2	0.4	0.1	0.1	0.3	1.3	0.8	0.0	0.0	0.4	0.3	0.7	0.3	0.4	0.8	1.0	0.8	0.4	0.2	1.3	0.4	0.1	0.1	0.2	0.9	0.4	1.2	0.0	4.3	0.1	0.0	0.6	0.9	0.0	2.6	4.6	0.6	0.0	0.0	0.1	0.0	0.1	3.6	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.7	0.0	2.9	0.1	0.1	1.0	0.0	1.0	0.0	0.7	2.7	0.0	0.0	0.0	0.7	0.4	0.0	0.6	0.5	0.0	3.4	0.3	0.0	0.0	0.0	0.0	0.0	2.1	4.9	0.0	0.0	0.0	0.9	6.4	3.3	3.6	0.9	2.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	1.1	0.3	2.0	3.4	0.4	2.2	1.6	1.3	1.0	1.3	1.2	0.3	0.0	1.8	2.0	0.8	0.3	0.6	1.1	0.0	0.5	2.1	1.1	7.5	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.2	0.6	1.1	2.3	0.0	0.0	9.4	0.0	0.1	3.9	0.0	0.1	0.0	9.3	2.9	0.0	3.1	3.3	8.3	0.0	0.0	1.4	0.6	0.2	0.0	1.9	0.0	1.9	1.6	0.6	2.1	16.6	0.8	0.7	0.0	1.5	0.2	1.1	0.0	0.2	1.1	0.1	6.6	1.3	4.8	0.1	0.7	0.0	0.1	0.1	0.5	1.7	0.0	0.3
ZNF519	"FLJ36809, HsT2362"	ENSG00000175322	"Zinc finger protein 519"	Q8TB69	18	14057457-14132490	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.3;Inhibitory neurons: 64.3;Oligodendrocyte precursor cells: 30.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 5.5;SCLC-21H: 6.6"									HPA028982	Uncertain		Approved	Nucleoli		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA028982: AB_10610705"	"unprognostic (1.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.65e-4)"	0.9	0.5	0.3	0.3	0.3	0.3	0.9	1.3	1.0	2.4	0.0	2.4	0.1	1.9	0.3	1.7	1.5	0.4	0.8	0.3	0.2	0.3	0.4	0.5	0.6	0.2	0.2	2.0	0.6	0.2	0.8	0.2	0.3	1.2	0.5	0.4	0.8	0.4	0.4	0.9	1.0	0.7	0.2	0.9	0.7	0.8	0.2	0.6	0.9	0.3	0.4	1.6	1.7	0.4	0.6	0.0	2.3	2.2	0.0	0.5	0.9	0.4	0.3	1.7	1.6	0.7	0.6	1.2	0.8	0.2	0.5	0.6	2.3	0.3	2.5	1.0	1.4	2.7	1.3	0.4	0.0	5.5	0.8	0.1	0.6	1.2	0.3	0.3	0.2	1.9	0.9	1.8	0.7	0.3	3.7	0.8	0.9	1.2	0.7	3.3	2.9	1.6	0.3	0.4	6.6	1.2	1.2	0.1	0.8	1.8	0.4	0.8	0.2	2.7	2.5	1.1	0.9	0.3	0.6	1.3	0.7	1.8	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	1.3	1.0	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.4	4.6	6.4	9.5	17.6	7.6	2.0	2.4	2.5	11.4	15.0	2.8	3.8	4.9	1.5	1.3	0.0	2.1	3.2	3.3	0.6	1.9	2.5	1.1	0.6	11.2	3.2	1.2	8.0	83.3	2.0	4.2	7.6	3.1	1.1	3.8	18.2	2.9	0.7	1.7	3.3	64.3	1.9	4.1	3.1	1.9	1.8	6.5	2.3	1.8	23.4	1.6	5.9	6.2	30.2	15.9	1.0	0.4	9.1	6.0	1.2	0.3	0.7	2.0	7.4	0.0	8.4	4.2	10.7	12.2	18.3	1.3	0.8	6.4	3.6	2.4	1.4
ZNF569	"FLJ32053, ZAP1, Zfp74"	ENSG00000196437	"Zinc finger protein 569"	Q5MCW4	19	37411155-37469275	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 137.7;Late spermatids: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052994	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA052994: AB_2682007"	"unprognostic (1.40e-1)"	"unprognostic (3.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.00e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.41e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	3.3	4.1	4.0	2.8	4.1	4.6	3.5	7.2	4.5	3.3	4.0	2.2	1.7	3.8	4.7	2.2	3.3	2.3	4.3	3.3	5.9	3.5	3.3	2.5	4.0	3.6	4.8	5.6	1.8	4.5	3.3	3.0	4.2	2.9	1.8	13.7	2.3	2.8	4.4	3.2	1.8	3.4	3.6	3.4	2.3	10.9	5.8	5.1	5.6	4.7	3.2	2.2	1.8	6.5	3.3	6.2	7.6	12.2	6.0	5.5	3.7	5.9	3.4	6.1	6.5	2.3	1.5	4.0	8.4	4.5	6.0	1.2	8.4	2.0	6.6	9.0	5.1	10.3	1.8	3.8	3.6	1.9	4.0	3.8	1.4	6.3	0.2	6.3	5.2	11.7	3.3	0.8	8.7	2.0	12.0	4.1	8.0	0.2	4.4	8.1	9.6	4.1	4.4	3.3	6.4	9.8	0.2	1.3	3.4	7.1	5.3	8.1	5.3	4.9	10.1	3.9	9.6	10.2	18.6	15.0	0.2	4.2	7.8	3.7	1.8	5.9	6.4	2.6	5.5	4.6	5.7	6.1	2.2	5.4	8.0	6.5	1.8	4.8	3.3	2.4	6.1	2.4	4.0	4.1	7.2	4.5	3.3	5.9	3.6	4.8	4.2	3.6	5.8	6.5	5.1	0.0	1.7	14.0	7.8	1.7	1.7	2.0	2.8	16.1	3.5	4.2	16.3	0.0	5.2	1.8	31.3	3.2	8.1	0.5	1.9	1.5	137.7	5.1	3.9	6.5	0.0	2.1	14.5	2.0	4.0	4.0	1.5	2.3	2.5	5.3	5.3	2.5	2.9	3.3	17.4	0.4	0.0	3.8	3.9	41.8	4.7	4.0	0.0	8.4	3.0	9.3	8.2	20.6	23.4	1.6	0.4	7.5	2.4	0.9	1.0	4.7	5.3	30.2	0.0	6.9	6.3	32.3	13.1	3.4	2.0	0.8	9.1	4.2	0.7	0.9
ZNF683	"Hobit, MGC33414"	ENSG00000176083	"Zinc finger protein 683"	Q8IZ20	1	26361634-26374522	"Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 81.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 473.7;Late spermatids: 482.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 172.4;memory CD8 T-cell: 113.1"	"Lineage enriched"	"Detected in many"	15	"T-cells: 172.4"	"Group enriched"	"Detected in some"	8	"NB-4: 2.2;OE19: 4.8"					"Not detected"	"Not detected"			HPA023865	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"			"HPA023865: AB_2671333"	"unprognostic (3.95e-3)"	"unprognostic (5.58e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (2.90e-5)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-4)"	"unprognostic (7.90e-2)"	"unprognostic (5.05e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.54e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (3.45e-5)"	0.2	0.4	0.3	0.6	0.6	1.9	0.8	0.3	0.3	0.9	0.1	0.3	0.3	0.6	0.1	0.7	1.7	1.7	0.8	0.8	0.3	0.3	0.6	4.7	1.9	1.1	0.3	1.0	0.3	0.2	0.3	0.4	0.5	0.9	0.5	0.0	10.1	0.8	0.1	0.5	0.6	0.3	0.5	2.2	3.4	81.9	0.5	2.9	1.1	0.0	0.4	0.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.2	0.1	172.4	0.1	0.4	0.2	35.4	113.1	0.0	0.0	13.4	63.2	0.9	11.8	3.8	0.3	1.1	24.2	0.3	0.6	0.3	0.3	0.8	0.3	1.1	0.3	0.5	0.5	0.5	0.6	0.9	3.2	0.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.7	1.1	0.2	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	473.7	0.2	0.5	0.8	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.4	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	482.4	1.8	1.8	0.0	0.0	0.3	0.0	6.2	0.0	0.1	0.0	0.0	1.2	1.7	0.1	0.0	0.2	0.7	0.0	0.0	0.4	0.7	3.3	2.2	0.2	0.0	0.0	39.8	0.0	0.0	0.0
ZNF831	"C20orf174, dJ492J12.1"	ENSG00000124203	"Zinc finger protein 831"	Q5JPB2	20	59123381-59259113	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lymphoid tissue: 6.2"	"Group enriched"	"Detected in some"	4	"dendritic cells: 20.5;Excitatory neurons: 19.5;NK-cells: 17.5;Plasma cells: 9.5;T-cells: 31.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 1.2;T-cells: 2.1"	"Group enriched"	"Detected in some"	6	"Daudi: 4.0;HMC-1: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	25	"amygdala: 4.6;basal ganglia: 4.1;cerebral cortex: 3.4;hippocampal formation: 5.0;olfactory bulb: 5.4"	HPA016839	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA016839: AB_1859466"	"unprognostic (2.90e-3)"	"unprognostic (7.70e-6)"	"unprognostic (9.71e-4)"	"unprognostic (1.31e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.00e-5)"	"unprognostic (3.08e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.31e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.93e-2)"	0.3	0.1	2.2	2.3	1.6	0.9	0.3	0.0	2.7	0.1	0.0	0.3	0.2	0.1	0.2	0.2	0.2	0.5	0.0	3.4	0.3	0.1	0.2	0.6	6.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.1	1.9	0.0	0.0	2.6	0.6	0.2	0.9	1.5	0.3	0.0	3.8	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	1.4	0.2	1.0	1.5	0.0	0.1	0.8	1.0	0.1	1.2	0.0	0.0	2.1	0.4	2.2	1.6	0.0	2.7	3.4	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.6	0.7	4.8	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.7	0.0	0.0	1.8	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	19.5	0.0	0.0	0.1	0.5	0.1	2.5	0.0	0.7	0.0	0.0	0.0	2.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	17.5	0.5	0.9	0.0	0.0	0.0	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	0.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0
ZRANB3	"AH2, DKFZP434B1727"	ENSG00000121988	"Zinc finger RANBP2-type containing 3"	Q5FWF4	2	135136916-135531218	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.9;Excitatory neurons: 69.4;Inhibitory neurons: 46.2;Oligodendrocytes: 67.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035234			Supported	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA035234: AB_2674530"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.52e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.88e-2)"	0.8	1.4	0.5	0.9	0.7	1.1	0.8	0.2	0.8	1.0	0.2	0.7	0.5	0.9	0.5	0.7	0.9	0.7	0.9	0.6	0.3	0.7	1.1	0.6	0.6	0.1	0.1	1.5	1.3	0.6	1.4	0.5	0.2	0.9	0.4	1.5	0.7	0.5	2.0	0.8	0.6	0.4	0.1	0.8	0.7	3.2	0.3	0.8	1.0	0.6	0.4	0.8	0.8	0.7	0.9	0.9	1.7	1.1	0.8	1.5	1.5	1.3	0.9	0.9	1.1	1.5	0.7	2.8	1.3	1.0	0.6	0.9	2.4	1.1	1.6	2.5	1.8	3.2	0.4	3.5	0.6	2.5	0.6	1.3	1.0	1.3	3.2	1.5	1.3	1.6	3.1	1.3	0.7	1.3	1.5	1.4	1.1	0.8	1.1	1.8	1.3	1.0	1.3	0.6	1.8	2.3	1.1	0.5	0.9	1.6	0.9	1.1	1.0	0.7	0.6	0.4	0.8	1.1	1.4	2.6	1.0	1.7	1.0	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.5	0.7	0.2	0.8	0.6	0.3	0.1	0.1	0.2	0.1	0.3	0.7	1.7	3.2	1.5	34.9	7.3	1.3	4.5	4.5	8.0	5.8	2.8	2.3	3.3	2.8	4.3	0.0	8.4	5.7	2.0	0.5	0.0	2.0	16.9	3.2	5.0	1.9	1.8	10.1	69.4	0.9	8.3	4.7	1.5	3.5	0.0	9.1	1.8	8.9	2.5	5.0	46.2	1.2	4.1	0.8	1.5	4.5	3.1	2.3	0.0	26.2	2.9	2.7	2.1	24.6	67.0	1.4	1.7	2.2	4.7	2.1	0.4	4.5	1.6	7.5	0.0	8.3	3.4	14.1	10.3	4.8	2.3	3.8	3.9	10.8	2.6	3.0